PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gou, SP; Wang, YY; Wang, ZL; Peng, Y; Zhang, XP; Jiao, LC; Wu, JS				Gou, Shuiping; Wang, Yueyue; Wang, Zhilong; Peng, Yong; Zhang, Xiaopeng; Jiao, Licheng; Wu, Jianshe			CT Image Sequence Restoration Based on Sparse and Low-Rank Decomposition	PLOS ONE			English	Article								Blurry organ boundaries and soft tissue structures present a major challenge in biomedical image restoration. In this paper, we propose a low-rank decomposition-based method for computed tomography (CT) image sequence restoration, where the CT image sequence is decomposed into a sparse component and a low-rank component. A new point spread function of Weiner filter is employed to efficiently remove blur in the sparse component; a wiener filtering with the Gaussian PSF is used to recover the average image of the low-rank component. And then we get the recovered CT image sequence by combining the recovery low-rank image with all recovery sparse image sequence. Our method achieves restoration results with higher contrast, sharper organ boundaries and richer soft tissue structure information, compared with existing CT image restoration methods. The robustness of our method was assessed with numerical experiments using three different low-rank models: Robust Principle Component Analysis (RPCA), Linearized Alternating Direction Method with Adaptive Penalty (LADMAP) and Go Decomposition (GoDec). Experimental results demonstrated that the RPCA model was the most suitable for the small noise CT images whereas the GoDec model was the best for the large noisy CT images.	[Gou, Shuiping; Wang, Yueyue; Jiao, Licheng; Wu, Jianshe] Xidian Univ, Minist Educ, Key Lab Intelligent Percept & Image Understanding, Xian, Shaanxi, Peoples R China; [Wang, Zhilong; Zhang, Xiaopeng] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Shaanxi, Peoples R China; [Peng, Yong] Peking Univ, Sch Oncol, Beijing Canc Hosp, Beijing 100871, Peoples R China	Xidian University; Air Force Military Medical University; Peking University	Gou, SP (corresponding author), Xidian Univ, Minist Educ, Key Lab Intelligent Percept & Image Understanding, Xian, Shaanxi, Peoples R China.	shuipinggou@gmail.com			Fundamental Funds for the Center Universities [K5051302027]; National Basic Research Program (973 Program) of China [2013CB329402]; Foreign Scholars in University Research and Teaching Programs (the 111 Project) [B07048]; Provincial Natural Science Foundation of Shaanxi of China [2011JQ8020]	Fundamental Funds for the Center Universities; National Basic Research Program (973 Program) of China(National Basic Research Program of China); Foreign Scholars in University Research and Teaching Programs (the 111 Project); Provincial Natural Science Foundation of Shaanxi of China	This work was supported in part by the Fundamental Funds for the Center Universities (No. K5051302027), the National Basic Research Program (973 Program) of China (No. 2013CB329402), the fund for Foreign Scholars in University Research and Teaching Programs (the 111 Project) (No. B07048), and the Provincial Natural Science Foundation of Shaanxi of China (No. 2011JQ8020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab K, 2012, IMAGING SYSTEMS TECH; Bertsekas D., 1999, NONLINEAR PROGRAMMIN; Bertsekas D., 1982, CONSTRAINED OPTIMIZA; Bredies K, 2008, SIAM J SCI COMPUT, V30, P657, DOI 10.1137/060663556; CAI J, 2008, SINGULAR VALUE THRES; Cai JF, 2012, IEEE T IMAGE PROCESS, V21, P562, DOI 10.1109/TIP.2011.2164413; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Cai JF, 2009, MULTISCALE MODEL SIM, V8, P337, DOI 10.1137/090753504; Chen S, 2012, SIAM J SCI COMPUT, V29, P456; Cheng L, 2011, IEEE T IMAGE PROCESS, V20, P1401, DOI 10.1109/TIP.2010.2087764; Dong J, 2011, INT J COMPUT ASS RAD, V6, P635, DOI 10.1007/s11548-010-0544-2; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Fazel M, 2001, P AMER CONTR CONF, P4734, DOI 10.1109/ACC.2001.945730; Fazel M., 2002, THESIS STANFORD U; Fergus R, 2006, ACM T GRAPHIC, V25, P787, DOI 10.1145/1141911.1141956; Hu XP, 2007, CHINESE J SCI INSTRU, V28; Hussien MN, 2010, P 2010 IEEE STUD C R; Jiang M, 2003, IEEE T MED IMAGING, V22, P251; Jiang M, 2003, J X-RAY SCI TECHNOL, V11, P13; Lin Z., 2011, AUGMENTED LAGRANGE M, P57; Lin Z., 2009, UILUENG092215; Lin Z., 2011, LINEARIZED ALTERNATI; Liu G., 2010, P 27 INT C MACH LEAR; Liu WB, 2007, BLIND DEBLURRING ALG; Rosenfield A., 1982, DIGITAL PICTURE PROC, P154; Sulong G., 2012, INT J BIO SCI BIO TE, V4, P9; Tao M, 2011, SIAM J OPTIMIZ, V21, P57, DOI 10.1137/100781894; Tohnak S, 2011, DENTOMAXILLOFAC RAD, V40, P184, DOI 10.1259/dmfr/25260548; Wang J, 2005, J X-RAY SCI TECHNOL, V13, P49; Wang Z, 2002, INT CONF ACOUST SPEE, P3313; Wen C.-Y., 2002, FORENSIC SCI J, V1, P15; William KP, 1997, FAST COMPUTATIONAL T, P06; Wright AGanesh, ADV NEURAL INFORM PR; Xing Bo, 2012, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V29, P456; Xu YQ, 2012, SINGLE IMAGE BLIND D; Yang J., 2011, MATH COMPUT, V82, P301; Yuan X, 2009, SPARSE LOW RANK MATR; Zhou Ji-Liu, 2001, Chinese Journal of Computers, V24, P959; Zhou T, 2011, TECHNICAL REPORT; Zhou Tianyi, 2011, GODEC RANDOMIZED LOW	41	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72696	10.1371/journal.pone.0072696	http://dx.doi.org/10.1371/journal.pone.0072696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023764	gold, Green Published			2022-12-27	WOS:000324515600037
J	Matoba, T; Kutsukake, N; Hasegawa, T				Matoba, Tomoyuki; Kutsukake, Nobuyuki; Hasegawa, Toshikazu			Head Rubbing and Licking Reinforce Social Bonds in a Group of Captive African Lions, Panthera leo	PLOS ONE			English	Article							FELIS-SILVESTRIS-CATUS; COATIS NASUA-NASUA; INTERACTION PATTERNS; FEMALE PRIMATES; SPOTTED HYENA; GROUP LEVEL; BEHAVIOR; RECIPROCITY; METAANALYSIS; GREETINGS	Many social animals have a species-specific repertoire of affiliative behaviours that characterise individualised relationships within a group. To date, however, quantitative studies on intragroup affiliative behaviours in social carnivores have been limited. Here, we investigated the social functions of the two most commonly observed affiliative behaviours in captive African lions (Panthera leo): head rubbing and licking. We conducted behavioural observations on a captive group of lions composed of 7 males and 14 females, and tested hypotheses regarding three social functions: tension reduction, social bonding, and social status expression. Disproportionately frequent male-male and female-to-male head rubbing was observed, while more than 95% of all licking interactions occurred in female-female dyads. In accordance with the social bond hypothesis, and in disagreement with the social status expression hypothesis, both head rubbing and licking interactions were reciprocal. After controlling for spatial association, the dyadic frequency of head rubbing was negatively correlated with age difference while licking was positively correlated with relatedness. Group reunion after daily separation did not affect the frequencies of the affiliative behaviours, which was in disagreement with the predictions from the tension reduction hypothesis. These results support the social bond hypothesis for the functions of head rubbing and licking. Different patterns of affiliative behaviour between the sexes may reflect differences in the relationship quality in each sex or the differential predisposition to licking due to its original function in offspring care.	[Matoba, Tomoyuki; Hasegawa, Toshikazu] Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Tokyo, Japan; [Kutsukake, Nobuyuki] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Japan; [Kutsukake, Nobuyuki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Japan	University of Tokyo; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Matoba, T (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Tokyo, Japan.	tmatoba@darwin.c.u-tokyo.ac.jp			PRESTO (Japan Science and Technology Agency (JST); Hayama Center for Advanced Studies; Center for the Promotion of Integrated Sciences at The Graduate University for Advanced Studies; Grants-in-Aid for Scientific Research [25118003] Funding Source: KAKEN	PRESTO (Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Hayama Center for Advanced Studies; Center for the Promotion of Integrated Sciences at The Graduate University for Advanced Studies; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by PRESTO (Japan Science and Technology Agency (JST)), Hayama Center for Advanced Studies, and The Center for the Promotion of Integrated Sciences at The Graduate University for Advanced Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anestis SF, 2004, INT J PRIMATOL, V25, P477, DOI 10.1023/B:IJOP.0000019163.09540.17; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; BERTRAM BCR, 1975, J ZOOL, V177, P463; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Bradshaw John, 2000, P67; Buesching CD, 2003, BEHAVIOUR, V140, P965, DOI 10.1163/156853903322589597; Burgener N, 2009, ANIM BEHAV, V77, P707, DOI 10.1016/j.anbehav.2008.11.022; Cafazzo S, 2009, BEHAV PROCESS, V80, P60, DOI 10.1016/j.beproc.2008.09.008; Cameron-Beaumont C, 2002, BIOL J LINN SOC, V75, P361, DOI 10.1111/j.1095-8312.2002.tb02077.x; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Connor R, 2006, ETHOLOGY, V112, P631, DOI 10.1111/j.1439-0310.2006.01203.x; Cords M., 1997, MACHIAVELLIAN INTELL, P24; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Curtis TM, 2003, AM J VET RES, V64, P1151, DOI 10.2460/ajvr.2003.64.1151; Dias PAD, 2008, AM J PRIMATOL, V70, P621, DOI 10.1002/ajp.20535; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; EAST ML, 1993, BEHAV ECOL SOCIOBIOL, V33, P355; Fraser O, 2007, INT J PRIMATOL, V28, P1439, DOI 10.1007/s10764-007-9185-x; Funston PJ, 2003, J ZOOL, V259, P131, DOI 10.1017/S0952836902003126; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; HEMELRIJK CK, 1990, J THEOR BIOL, V143, P405, DOI 10.1016/S0022-5193(05)80036-0; Hohmann G, 2000, ANIM BEHAV, V60, P107, DOI 10.1006/anbe.2000.1451; Holekamp KE, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P587; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; Kutsukake N, 2010, ANIM BEHAV, V79, P271, DOI 10.1016/j.anbehav.2009.10.014; Laporte MNC, 2010, ANIM BEHAV, V80, P467, DOI 10.1016/j.anbehav.2010.06.005; Lu A, 2008, ANIM BEHAV, V76, P415, DOI 10.1016/j.anbehav.2008.04.006; Massen JJM, 2010, BEHAVIOUR, V147, P1379, DOI 10.1163/000579510X528224; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Mech L. David, 1996, Journal of Wildlife Research, V1, P195; Mosser A, 2009, ANIM BEHAV, V78, P359, DOI 10.1016/j.anbehav.2009.04.024; Packer C., 1988, P363; Packer C, 2001, SCIENCE, V293, P690, DOI 10.1126/science.1062320; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Patterson BD, 2007, EVOL BIOL, V34, P55, DOI 10.1007/s11692-007-9003-6; Pusey A. E., 1994, INFANTICIDE PARENTAL, P277; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; R Development Core Team, 2011, R LANG ENV STAT COMP; Radford AN, 2008, P ROY SOC B-BIOL SCI, V275, P2787, DOI 10.1098/rspb.2008.0787; Romero T, 2008, J COMP PSYCHOL, V122, P19, DOI 10.1037/0735-7036.122.1.19; Romero T, 2007, BEHAVIOUR, V144, P179, DOI 10.1163/156853907779947355; Romero T, 2010, J ETHOL, V28, P113, DOI 10.1007/s10164-009-0162-z; Rudnai JA, 1973, SOCIAL LIFE LIONS; Schaller G. B., 1972, SERENGETI LION; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Schino G, 2008, BIOL LETTERS, V4, P9, DOI 10.1098/rsbl.2007.0506; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; Seidler RG, 2012, J ETHOL, V30, P345, DOI 10.1007/s10164-012-0330-4; Smith JE, 2011, ANIM BEHAV, V81, P401, DOI 10.1016/j.anbehav.2010.11.007; Soini HA, 2012, J CHEM ECOL, V38, P145, DOI 10.1007/s10886-012-0075-0; Theis KR, 2012, SCI REPORTS; van den Bos R, 1998, J ETHOL, V16, P1, DOI 10.1007/BF02896348; VanderWaal KL, 2009, ANIM BEHAV, V77, P949, DOI 10.1016/j.anbehav.2008.12.028; Venkataraman V, 2009, J THREAT TAXA, V1, P158; Wahaj SA, 2001, ETHOLOGY, V107, P1057, DOI 10.1046/j.1439-0310.2001.00717.x; Whitham JC, 2003, ETHOLOGY, V109, P847, DOI 10.1046/j.0179-1613.2003.00922.x; WILKINSON GS, 1986, ANIM BEHAV, V34, P1880, DOI 10.1016/S0003-3472(86)80274-3	62	13	14	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73044	10.1371/journal.pone.0073044	http://dx.doi.org/10.1371/journal.pone.0073044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023806	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600060
J	Wu, XL; Xu, Y; Feng, K; Tompkins, JD; Her, CT				Wu, Xiling; Xu, Yang; Feng, Katey; Tompkins, Joshua D.; Her, Chengtao			MutS Homologue hMSH5: Recombinational DSB Repair and Non-Synonymous Polymorphic Variants	PLOS ONE			English	Article							STRAND BREAK REPAIR; CEREVISIAE MSH5 GENE; MISMATCH REPAIR; SACCHAROMYCES-CEREVISIAE; HUMAN-CELLS; C-ABL; IONIZING-RADIATION; HOLLIDAY JUNCTIONS; ESCHERICHIA-COLI; DNA-DAMAGE	Double-strand breaks (DSBs) constitute the most deleterious form of DNA lesions that can lead to genome alterations and cell death, and the vast majority of DSBs arise pathologically in response to DNA damaging agents such as ionizing radiation (IR) and chemotherapeutic agents. Recent studies have implicated a role for the human MutS homologue hMSH5 in homologous recombination (HR)-mediated DSB repair and the DNA damage response. In the present study, we show that hMSH5 promotes HR-based DSB repair, and this property resides in the carboxyl-terminal portion of the protein. Our results demonstrate that DSB-triggered hMSH5 chromatin association peaks at the proximal regions of the DSB and decreases gradually with increased distance from the break. Furthermore, the DSB-triggered hMSH5 chromatin association is preceded by and relies on the assembly of hMRE11 and hRad51 at the proximal regions of the DSB. Lastly, the potential effects of hMSH5 non-synonymous variants (L85F, Y202C, V206F, R351G, L377F, and P786S) on HR and cell survival in response to DSB-inducing anticancer agents have been analyzed. These experiments show that the expression of hMSH5 variants elicits different survival responses to anticancer drugs cisplatin, bleomycin, doxorubicin and camptothecin. However, the effects of hMSH5 variants on survival responses to DSB-inducing agents are not directly correlated to their effects exerted on HR-mediated DSB repair, suggesting that the roles of hMSH5 variants in the processes of DNA damage response and repair are multifaceted.	[Wu, Xiling; Xu, Yang; Feng, Katey; Tompkins, Joshua D.; Her, Chengtao] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Her, CT (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.	cher@wsu.edu	Xu, Yang/H-6154-2013		National Institutes of Health, USPHS from the National Institute of General Medical Sciences [GM084353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084353] Funding Source: NIH RePORTER	National Institutes of Health, USPHS from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, USPHS Grant GM084353 (to CH) from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bannwarth S, 2012, MITOCHONDRION; Bawa S, 1997, CANCER RES, V57, P2715; Bocher T, 1999, CANCER RES, V59, P816; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Chu YL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-51; Clark N, 2013, CURR GENOMICS, V14, P81, DOI 10.2174/1389202911314020002; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Her C, 1998, GENOMICS, V52, P50, DOI 10.1006/geno.1998.5374; Her C, 2003, CANCER RES, V63, P865; Her C, 2007, FRONT BIOSCI-LANDMRK, V12, P905, DOI 10.2741/2112; Her CT, 1999, MAMM GENOME, V10, P1054, DOI 10.1007/s003359901161; Hoffmann ER, 2004, CYTOGENET GENOME RES, V107, P232, DOI 10.1159/000080601; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; Kelly KO, 2000, GENETICS, V156, P617; Kneitz B, 2000, GENE DEV, V14, P1085; Lee TH, 2006, DNA REPAIR, V5, P32, DOI 10.1016/j.dnarep.2005.07.004; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Mohrenweiser HW, 2003, MUTAT RES-FUND MOL M, V526, P93, DOI 10.1016/S0027-5107(03)00049-6; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nguyen HTQ, 2012, J BIOL INORG CHEM, V17, P1209, DOI 10.1007/s00775-012-0934-8; Nguyen TV, 2012, J BIOL INORG CHEM, V17, P1, DOI 10.1007/s00775-011-0818-3; Nowosielska A, 2005, DNA REPAIR, V4, P773, DOI 10.1016/j.dnarep.2005.03.006; Nowosielska A, 2004, DNA REPAIR, V3, P719, DOI 10.1016/j.dnarep.2004.02.009; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Olive PL, 2009, CYTOM PART B-CLIN CY, V76B, P79, DOI 10.1002/cyto.b.20450; PaquisFlucklinger V, 1997, GENOMICS, V44, P188, DOI 10.1006/geno.1997.4857; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Rinaldo C, 2002, GENETICS, V160, P471; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Sekine H, 2007, P NATL ACAD SCI USA, V104, P7193, DOI 10.1073/pnas.0700815104; Shimizu H, 2009, BIOCHEM BIOPH RES CO, V382, P286, DOI 10.1016/j.bbrc.2009.03.020; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Taghian DG, 1997, MOL CELL BIOL, V17, P6386, DOI 10.1128/MCB.17.11.6386; Tompkins JD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-10; Tompkins JD, 2009, EXP CELL RES, V315, P2420, DOI 10.1016/j.yexcr.2009.05.004; Vo AT, 2005, EMBO REP, V6, P438, DOI 10.1038/sj.embor.7400392; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Winand NJ, 1998, GENOMICS, V53, P69, DOI 10.1006/geno.1998.5447; Xu KQ, 2012, J BIOL CHEM, V287, P29543, DOI 10.1074/jbc.M112.352302; Yi W, 2006, CANCER RES, V66, P151, DOI 10.1158/0008-5472.CAN-05-3019; Yi W, 2005, BIOCHEM BIOPH RES CO, V332, P524, DOI 10.1016/j.bbrc.2005.04.154	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73284	10.1371/journal.pone.0073284	http://dx.doi.org/10.1371/journal.pone.0073284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023853	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600090
J	Yang, MM; Cao, HX; Guo, X; Zhang, TH; Hu, PP; Du, JJ; Liu, Q				Yang, Miaomiao; Cao, Hongxin; Guo, Xi; Zhang, Tiehong; Hu, Pingping; Du, Jiajun; Liu, Qi			The Number of Resected Lymph Nodes (nLNs) Combined with Tumor Size as a Prognostic Factor in Patients with Pathologic N0 and Nx Non-Small Cell Lung Cancer	PLOS ONE			English	Article							STAGE-I; POSTOPERATIVE SURVIVAL; SURGICAL RESECTION; PREDICT SURVIVAL; IMPACT	Background: The prognostic role of the number of resected lymph nodes (nLNs) in pathologic N0 (lymph node negative) and Nx (no lymph node examined) non-small cell lung cancer (NSCLC) patients remains uncertain. Guidelines for optimal nLNs have not been established. In the current study, we evaluated whether a higher number of resected lymph nodes (LNs) results in better survival in different tumor size categories among NSCLC patients without metastatic LNs. Method: A retrospective study was conducted. Based on nLNs (LN = 0, 1-7, >7) and tumor size (T-a: <= 3.5cm, T-b: >3.5cm) during surgery, patients were categorized into 6 groups (LN0Ta, LN0Tb, LN1-7Ta, LN1-7Tb, LN7-T-a and LN7-T-b). Survival and multivariate analyses were carried out to determine whether nLNs combined with tumor size was significant for overall survival (OS) or disease free survival (DFS) after adjusting for potential confounders. Results: A total of 428 patients were enrolled in the study. Multivariate analysis demonstrated that nLNs, tumor size and pathological stage were the independent prognosticators for OS and DFS. Data from our study suggested that lung cancer lymphadenectomy with more than 7 LNs removed should be considered a benchmark for surgery or pathology at an early stage. Survival was significantly better in the LN7-Ta group, compared with other 5 groups (p<0.001). Conclusions: The combined predictor (nLNs combined with tumor size) is an independent prognostic factor and a reasonable stratification criterion in patients with pathologic N0 and Nx NSCLC. The validation of our finding is warranted in further investigation.	[Yang, Miaomiao; Cao, Hongxin; Zhang, Tiehong; Hu, Pingping; Du, Jiajun; Liu, Qi] Shandong Univ, Inst Oncol, Prov Hosp, Jinan 250100, Peoples R China; [Yang, Miaomiao] Qingdao Univ, Sch Med, Yantai Yuhuangding Hosp, Dept Med Oncol, Yantai, Peoples R China; [Guo, Xi] Shandong Univ, Dept Intens Care Med, Qilu Hosp, Jinan 250100, Peoples R China	Shandong University; Qingdao University; Shandong University	Du, JJ (corresponding author), Shandong Univ, Inst Oncol, Prov Hosp, Jinan 250100, Peoples R China.	dujiajun@sdu.edu.cn; liuqi66@sdu.edu.cn	Sunny, QI/M-5188-2019	Sunny, QI/0000-0002-5817-1609	Provincial Science and Technology Development Planning of Shandong [2011GGH21819, 2012G0021836]	Provincial Science and Technology Development Planning of Shandong	This study was supported by Provincial Science and Technology Development Planning of Shandong (2011GGH21819) and Provincial Science and Technology Development Planning of Shandong (2012G0021836). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2010, LUNG CANCER, V68, P398, DOI 10.1016/j.lungcan.2009.08.008; Bria E, 2009, LUNG CANCER, V66, P365, DOI 10.1016/j.lungcan.2009.02.024; Fukui T, 2006, J THORAC ONCOL, V1, P120, DOI 10.1097/01243894-200602000-00004; Greenstein AJ, 2008, CANCER-AM CANCER SOC, V112, P1239, DOI 10.1002/cncr.23309; Johnson PM, 2006, J CLIN ONCOL, V24, P3570, DOI 10.1200/JCO.2006.06.8866; Ludwig MS, 2005, CHEST, V128, P1545, DOI 10.1378/chest.128.3.1545; Mersin H, 2003, EUR J SURG ONCOL, V29, P132, DOI 10.1053/ejso.2002.1285; Ogbata Obiageli Uchenna, 2012, 2012 ASCO ANN M; Osarogiagbon RU, 2012, J THORAC DIS, V4, P214, DOI 10.3978/j.issn.2072-1439.2012.03.06; Osarogiagbon RU, 2010, J THORAC ONCOL, V5, P191, DOI 10.1097/JTO.0b013e3181c8cc32; Ou SHI, 2008, J THORAC ONCOL, V3, P880, DOI 10.1097/JTO.0b013e31817dfced; Qiu C, 2013, J THORAC ONCOL, V8, P429, DOI 10.1097/JTO.0b013e3182829c16; Ramirez RA, 2012, J CLIN ONCOL, V30, P2823, DOI 10.1200/JCO.2011.39.2589; Rusch VW, 2011, J CLIN ONCOL, V29, P4313, DOI 10.1200/JCO.2011.35.2500; Saji H, 2011, J THORAC ONCOL, V6, P1865, DOI 10.1097/JTO.0b013e31822a35c3; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Varlotto JM, 2009, CANCER-AM CANCER SOC, V115, P851, DOI 10.1002/cncr.23985; Veeramachaneni NK, 2008, EUR J CARDIO-THORAC, V33, P466, DOI 10.1016/j.ejcts.2007.12.015; Wei SH, 2011, J THORAC ONCOL, V6, P310, DOI 10.1097/JTO.0b013e3181ff9b45; Wu YC, 2003, EUR J CARDIO-THORAC, V24, P994, DOI 10.1016/S1010-7940(03)00567-0; Xu DZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038681; Xu F, 2012, CLIN LUNG CANC	22	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73220	10.1371/journal.pone.0073220	http://dx.doi.org/10.1371/journal.pone.0073220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023836	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600078
J	Basak, SK; Veena, MS; Oh, S; Lai, C; Vangala, S; Elashoff, D; Fishbein, MC; Sharma, S; Rao, NP; Rao, D; Phan, R; Srivatsan, ES; Batra, RK				Basak, Saroj K.; Veena, Mysore S.; Oh, Scott; Lai, Chi; Vangala, Sitaram; Elashoff, David; Fishbein, Michael C.; Sharma, Sanjai; Rao, Nagesh P.; Rao, Dinesh; Phan, Ryan; Srivatsan, Eri S.; Batra, Raj K.			The CD44(high) Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression	PLOS ONE			English	Article							STEM-CELLS; PROSTATE-CANCER; PLEURAL EFFUSION; PROGNOSTIC VALUE; POOR-PROGNOSIS; TUMOR; CD44; ADENOCARCINOMA; GENE; IDENTIFICATION	Cellular heterogeneity is an integral part of cancer development and progression. Progression can be associated with emergence of cells that exhibit high phenotypic plasticity (including "de-differentiation" to primitive developmental states), and aggressive behavioral properties (including high tumorigenic potentials). We observed that many biomarkers that are used to identify Cancer Stem Cells (CSC) can label cell subsets in an advanced clinical stage of lung cancer (malignant pleural effusions, or MPE). Thus, CSC-biomarkers may be useful for live sorting functionally distinct cell subsets from individual tumors, which may enable investigators to hone in on the molecular basis for functional heterogeneity. We demonstrate that the CD44(hi) (CD44-high) cancer cell subsets display higher clonal, colony forming potential than CD44(lo) cells (n = 3) and are also tumorigenic (n = 2/2) when transplanted in mouse xenograft model. The CD44(hi) subsets express different levels of embryonal (de-differentiation) markers or chromatin regulators. In archived lung cancer tissues, ALDH markers co-localize more with CD44 in squamous cell carcinoma (n = 5/7) than Adeno Carcinoma (n = 1/12). MPE cancer cells and a lung cancer cell line (NCI-H-2122) exhibit chromosomal abnormalities and 1p36 deletion (n = 3/3). Since miR-34a maps to the 1p36 deletion site, low miR-34a expression levels were detected in these cells. The colony forming efficiency of CD44(hi) cells, characteristic property of CSC, can be inhibited by mir-34a replacement in these samples. In addition the highly tumorigenic CD44(hi) cells are enriched for cells in the G2 phase of cell cycle.	[Basak, Saroj K.; Veena, Mysore S.; Oh, Scott; Sharma, Sanjai; Phan, Ryan; Srivatsan, Eri S.; Batra, Raj K.] VAGLAHS, Wadsworth Stem Cell Inst, Los Angeles, CA USA; [Fishbein, Michael C.; Rao, Nagesh P.; Rao, Dinesh; Phan, Ryan] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Srivatsan, Eri S.; Batra, Raj K.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Srivatsan, Eri S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Gen Surg, Los Angeles, CA 90095 USA; [Basak, Saroj K.; Oh, Scott; Vangala, Sitaram; Elashoff, David; Sharma, Sanjai; Batra, Raj K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Basak, SK (corresponding author), VAGLAHS, Wadsworth Stem Cell Inst, Los Angeles, CA USA.	Saroj.Basak@va.gov; RBatra@mednet.ucla.edu	Rao, Dinesh/AAE-9625-2019; Rao, Dinesh/ABG-1257-2021	Rao, Dinesh/0000-0002-0794-9337; Batra, Raj K./0000-0002-1126-543X	Department of Medicine, UCLA; UCLA; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Department of Medicine, UCLA; UCLA(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Department of Medicine, UCLA and The Robert W. Green, Head and Neck Surgical Oncology Program at UCLA. The grants funds were used for reagents and salary support of the researchers involved in the study. The funders had no role in study design, data collection and analysis.	Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; Basak SK, 2002, BLOOD, V99, P2869, DOI 10.1182/blood.V99.8.2869; Batra RK, 2010, AM J RESP CRIT CARE, V182, P4, DOI 10.1164/rccm.201003-0381ED; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; de Antonellis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024584; Eaton CL, 2010, PROSTATE, V70, P875, DOI 10.1002/pros.21121; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Harper LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-166; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Joshua B, 2012, HEAD NECK-J SCI SPEC, V34, P42, DOI 10.1002/hed.21699; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Miki J, 2008, PROSTATE CANCER P D, V11, P32, DOI 10.1038/sj.pcan.4501018; Mitsuuchi Y, 2002, AM J MED GENET, V115, P183, DOI 10.1002/ajmg.10692; Moreb JS, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-87; Mott FE, 2001, CHEST, V119, P317, DOI 10.1378/chest.119.1.317; Nalls D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024099; Naruke T, 1997, CHEST, V112, pS242, DOI 10.1378/chest.112.4_Supplement.242S; Neumeister V, 2010, AM J PATHOL, V176, P2131, DOI 10.2353/ajpath.2010.090712; Patrawala L, 2007, CANCER RES, V67, P8973; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Phelps RM, 1996, J CELL BIOCHEM, P32; Qin M, 2003, CLIN CANCER RES, V9, P4992; Shi C, CANC BIOL THER, V10, P1182; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simpson-Abelson MR, 2008, J IMMUNOL, V180, P7009, DOI 10.4049/jimmunol.180.10.7009; Srivatsan ES, 2002, ONCOGENE, V21, P5631, DOI 10.1038/sj.onc.1205698; Srivatsan ES, 2000, GENE CHROMOSOME CANC, V29, P157, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1024>3.0.CO;2-P; Su J, 2011, ARCH MED RES, V42, P15, DOI 10.1016/j.arcmed.2011.01.007; Sugiura S, 1997, CLIN CANCER RES, V3, P47; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Takanami I, 2000, ONCOL REP, V7, P1065; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Veena MS, 2009, LAB INVEST, V89, P875, DOI 10.1038/labinvest.2009.56; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015; Wei HJ, 2011, HEPATOB PANCREAT DIS, V10, P428, DOI 10.1016/S1499-3872(11)60073-8; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Winokur ST, 1996, HUM MOL GENET, V5, P1567, DOI 10.1093/hmg/5.10.1567; Zhang Y, 2012, ONCOL REP, V27, P1599, DOI 10.3892/or.2012.1681	43	21	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73195	10.1371/journal.pone.0073195	http://dx.doi.org/10.1371/journal.pone.0073195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019906	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200048
J	Chen, YY; Chao, CC; Liu, FC; Hsu, PC; Chen, HF; Peng, SC; Chuang, YJ; Lan, CY; Hsieh, WP; Wong, DSH				Chen, Yan Yu; Chao, Chun-Cheih; Liu, Fu-Chen; Hsu, Po-Chen; Chen, Hsueh-Fen; Peng, Shih-Chi; Chuang, Yung-Jen; Lan, Chung-Yu; Hsieh, Wen-Ping; Wong, David Shan Hill			Dynamic Transcript Profiling of Candida albicans Infection in Zebrafish: A Pathogen-Host Interaction Study	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RESPONSE REGULATOR GENE; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; IRON ACQUISITION; MORPHOGENESIS; ADAPTATION; EXPRESSION; VIRULENCE; IDENTIFICATION	Candida albicans is responsible for a number of life-threatening infections and causes considerable morbidity and mortality in immunocompromised patients. Previous studies of C. albicans pathogenesis have suggested several steps must occur before virulent infection, including early adhesion, invasion, and late tissue damage. However, the mechanism that triggers C. albicans transformation from yeast to hyphae form during infection has yet to be fully elucidated. This study used a systems biology approach to investigate C. albicans infection in zebrafish. The surviving fish were sampled at different postinfection time points to obtain time-lapsed, genome-wide transcriptomic data from both organisms, which were accompanied with in sync histological analyses. Principal component analysis (PCA) was used to analyze the dynamic gene expression profiles of significant variations in both C. albicans and zebrafish. The results categorized C. albicans infection into three progressing phases: adhesion, invasion, and damage. Such findings were highly supported by the corresponding histological analysis. Furthermore, the dynamic interspecies transcript profiling revealed that C. albicans activated its filamentous formation during invasion and the iron scavenging functions during the damage phases, whereas zebrafish ceased its iron homeostasis function following massive hemorrhage during the later stages of infection. Most of the immune related genes were expressed as the infection progressed from invasion to the damage phase. Such global, interspecies evidence of virulence-immune and iron competition dynamics during C. albicans infection could be crucial in understanding control fungal pathogenesis.	[Chen, Yan Yu; Wong, David Shan Hill] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan; [Chao, Chun-Cheih; Liu, Fu-Chen; Chuang, Yung-Jen] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Chao, Chun-Cheih; Liu, Fu-Chen; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Hsu, Po-Chen; Chen, Hsueh-Fen; Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Peng, Shih-Chi] Chang Gung Mem Hosp, Nucl Med & Mol Imaging Ctr, Tao Yuan, Taiwan; [Hsieh, Wen-Ping] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; Chang Gung Memorial Hospital; National Tsing Hua University	Wong, DSH (corresponding author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan.	dshwong@che.nthu.edu.tw	Hsu, Po-Chen/G-8257-2014; Chuang, Yung-Jen/D-2362-2013; Wong, David S. H./I-6233-2012	Wong, David S. H./0000-0001-8574-8234; Lan, Chung-Yu/0000-0002-1533-3049; Chuang, Yung-Jen/0000-0002-6022-0107	National Science Council (Taiwan, Republic of China) [NSC 100-2627-B-007-001, NSC100-2627-B-007-002, NSC100-2627-B-007-003]	National Science Council (Taiwan, Republic of China)(Ministry of Science and Technology, Taiwan)	This study was supported by grants NSC 100-2627-B-007-001, NSC100-2627-B-007-002 and NSC100-2627-B-007-003 from the National Science Council (Taiwan, Republic of China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Andes D, 2005, J INFECT DIS, V192, P893, DOI 10.1086/432104; Arnaud MB, 2009, TRENDS MICROBIOL, V17, P295, DOI 10.1016/j.tim.2009.04.007; Arnaud MB, 2005, NUCLEIC ACIDS RES, V33, pD358, DOI 10.1093/nar/gki003; Baek YU, 2008, EUKARYOT CELL, V7, P1168, DOI 10.1128/EC.00108-08; Barker KS, 2008, J INFECT DIS, V198, P193, DOI 10.1086/589516; Barker KS, 2005, J INFECT DIS, V192, P901, DOI 10.1086/432487; Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Bendel CM, 1999, MOL GENET METAB, V67, P343, DOI 10.1006/mgme.1999.2875; Bensen ES, 2005, MOL BIOL CELL, V16, P3387, DOI 10.1091/mbc.E04-12-1081; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bonhomme J, 2011, MOL MICROBIOL, V80, P995, DOI 10.1111/j.1365-2958.2011.07626.x; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Brand A, 2007, CURR BIOL, V17, P347, DOI 10.1016/j.cub.2006.12.043; Brothers KM, 2011, EUKARYOT CELL, V10, P932, DOI 10.1128/EC.05005-11; Calderone RA., 2002, CANDIDA CANDIDIASIS; Calera JA, 2000, INFECT IMMUN, V68, P518, DOI 10.1128/IAI.68.2.518-525.2000; Chao CC, 2010, INFECT IMMUN, V78, P2512, DOI 10.1128/IAI.01293-09; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Chen Y, 2005, BIOCHEM BIOPH RES CO, V337, P52, DOI 10.1016/j.bbrc.2005.09.018; Davis D, 2003, CURR GENET, V44, P58, DOI [10.1007/s00294-003-0415-2, 10.1007/s00294-003-0431-2]; Dunkel N, 2011, EUKARYOT CELL, V10, P54, DOI 10.1128/EC.00281-10; Dunkler A, 2005, FUNGAL GENET BIOL, V42, P935, DOI 10.1016/j.fgb.2005.08.001; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Fonzi WA, 1999, J BACTERIOL, V181, P7070, DOI 10.1128/JB.181.22.7070-7079.1999; Fradin C, 2003, MOL MICROBIOL, V47, P1523, DOI 10.1046/j.1365-2958.2003.03396.x; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Hnisz D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000889; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hoyer LL, 1998, CURR GENET, V33, P451, DOI 10.1007/s002940050359; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Jackson AN, 2007, IMMUNOGENETICS, V59, P861, DOI 10.1007/s00251-007-0251-5; Jima DD, 2009, MOL IMMUNOL, V46, P1505, DOI 10.1016/j.molimm.2008.12.021; Johnson DC, 2005, EUKARYOT CELL, V4, P1662, DOI 10.1128/EC.4.10.1662-1676.2005; Jolliffe IT, 2002, PRINCIPAL COMPONENT, pxxix; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; Kuo ZY, 2013, J INNATE IMMUN, V5, P137, DOI 10.1159/000347104; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; MacCallum DM, 2009, FEMS YEAST RES, V9, P1111, DOI 10.1111/j.1567-1364.2009.00576.x; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Navarro-Garcia F, 2001, FEMS MICROBIOL REV, V25, P245, DOI 10.1016/S0168-6445(00)00066-8; Odds FC, 1979, CANDIDA CANDIDOSIS; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P123; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Ray S., 1999, INT C ADV PATT REC D, P27; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; SanJose C, 1996, J BACTERIOL, V178, P5850, DOI 10.1128/jb.178.19.5850-5852.1996; Sarthy AV, 1997, MICROBIOL-SGM, V143, P367, DOI 10.1099/00221287-143-2-367; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Skrzypek MS, 2010, NUCLEIC ACIDS RES, V38, pD428, DOI 10.1093/nar/gkp836; Soloviev DA, 2011, INFECT IMMUN, V79, P1546, DOI 10.1128/IAI.00650-10; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Tebarth B, 2003, J MOL BIOL, V329, P949, DOI 10.1016/S0022-2836(03)00505-9; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Walker LA, 2009, FUNGAL GENET BIOL, V46, P210, DOI 10.1016/j.fgb.2008.10.012; Wang LJ, 2009, J INNATE IMMUN, V1, P455, DOI 10.1159/000210016; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Wilson D, 2009, FEMS YEAST RES, V9, P688, DOI 10.1111/j.1567-1364.2009.00524.x; Woo M, 2003, FEMS MICROBIOL LETT, V218, P195, DOI 10.1111/j.1574-6968.2003.tb11518.x; Yamaguchi Y, 2007, J BIOL CHEM, V282, P29, DOI 10.1074/jbc.M609308200; Zaragoza O, 2000, J BACTERIOL, V182, P320, DOI 10.1128/JB.182.2.320-326.2000	78	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72483	10.1371/journal.pone.0072483	http://dx.doi.org/10.1371/journal.pone.0072483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019870	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200012
J	Dickerson, F; Stallings, C; Origoni, A; Vaughan, C; Katsafanas, E; Khushalani, S; Yolken, R				Dickerson, Faith; Stallings, Cassie; Origoni, Andrea; Vaughan, Crystal; Katsafanas, Emily; Khushalani, Sunil; Yolken, Robert			A Combined Marker of Inflammation in Individuals with Mania	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TOXOPLASMA-GONDII; CYTOKINE PROFILES; BIPOLAR; SCHIZOPHRENIA; DISORDER; SENSITIVITY; ANTIBODIES; SCALE	Background: Markers of immune activation have been associated with mania but have not been examined in combination. We studied the association between mania and an inflammation score based on four immune markers. Methods: A total of 57 individuals with mania were assessed at up to three time points: the day of hospital admission, evaluation several days later, and six-month follow-up. Also assessed were 207 non-psychiatric controls and 330 individuals with recent onset psychosis, multi-episode schizophrenia, or bipolar disorder depression. A combined inflammation score was calculated by factor analysis of the levels of class-specific antibodies to the NR peptide of the NMDA receptor; gliadin; Mason-Pfizer monkey virus protein 24; and Toxoplasma gondii. Inflammation scores among groups were compared by multivariate analyses. The inflammation score of the mania group at evaluation was studied as a predictor of re-hospitalization in the follow-up period. Results: The combined inflammation score of the mania group at hospital admission and at evaluation differed significantly from that of the non-psychiatric controls (t = 3.95, 4.10, p<.001). The inflammation score was significantly decreased at six month follow-up (F = 5.85, p = 0.004). There were not any significant differences in the inflammation scores of any of the other psychiatric groups and that of the controls. Within the mania group, an elevated inflammation score at evaluation predicted re-hospitalization (Hazard ratio = 7.12, p = .005). Conclusions: Hospitalization for mania is associated with immune activation. The level of this activation is predictive of subsequent re-hospitalization. Interventions for the modulation of inflammation should be evaluated for the therapy of individuals with mania.	[Dickerson, Faith; Stallings, Cassie; Origoni, Andrea; Vaughan, Crystal; Katsafanas, Emily; Khushalani, Sunil] Sheppard Pratt Hlth Syst, Stanley Res Program, Baltimore, MD USA; [Yolken, Robert] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Dickerson, F (corresponding author), Sheppard Pratt Hlth Syst, Stanley Res Program, Baltimore, MD USA.	Fdickerson@sheppardpratt.org	Dickerson, Faith/C-8311-2019; yolken, robert/AAW-2556-2021	Dickerson, Faith/0000-0003-3800-2864; 	Stanley Medical Research Institute [07R-1690]; NARSAD [18383]	Stanley Medical Research Institute; NARSAD(NARSAD)	This work was supported by grant (# 07R-1690) from the Stanley Medical Research Institute and by an independent investigator award (# 18383) from NARSAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandeen-Roche K, 2009, REJUV RES, V12, P403, DOI 10.1089/rej.2009.0883; Dickerson F, 2007, SCHIZOPHRENIA BULL, V33, P737, DOI 10.1093/schbul/sbm005; Dickerson F, 2007, PROG NEURO-PSYCHOPH, V31, P952, DOI 10.1016/j.pnpbp.2007.02.018; Dickerson F, 2012, BIPOLAR DISORD, V14, P547, DOI 10.1111/j.1399-5618.2012.01028.x; Dickerson F, 2012, SCHIZOPHR RES, V138, P198, DOI 10.1016/j.schres.2012.03.037; Dickerson F, 2012, PSYCHIAT RES, V196, P68, DOI 10.1016/j.psychres.2011.11.007; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; First M. B., 1998, STRUCTURED CLIN INTE; First MB, 1996, USERS GUIDE SCID I S; Gershon ES, 2011, AM J PSYCHIAT, V168, P253, DOI 10.1176/appi.ajp.2010.10091340; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Huang TL, 2007, PROG NEURO-PSYCHOPH, V31, P370, DOI 10.1016/j.pnpbp.2006.09.010; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Liu HC, 2004, J NEUROIMMUNOL, V150, P116, DOI 10.1016/j.jneuroim.2004.01.006; O'Brien SM, 2006, J AFFECT DISORDERS, V90, P263, DOI 10.1016/j.jad.2005.11.015; Ortiz-Dominguez A, 2007, BIPOLAR DISORD, V9, P596, DOI 10.1111/j.1399-5618.2007.00493.x; Perron H, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.125; Potash JB, 2000, BIPOLAR DISORD, V2, P8, DOI 10.1034/j.1399-5618.2000.020103.x; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Remlinger-Molenda A, 2012, NEUROPSYCHOBIOLOGY, V66, P193, DOI 10.1159/000339949; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	22	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73520	10.1371/journal.pone.0073520	http://dx.doi.org/10.1371/journal.pone.0073520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019926	Green Submitted, gold, Green Published			2022-12-27	WOS:000324338200068
J	Grundmann, S; Lindmayer, C; Hans, FP; Hoefer, I; Helbing, T; Pasterkamp, G; Bode, C; de Kleijn, D; Moser, M				Grundmann, Sebastian; Lindmayer, Christian; Hans, Felix P.; Hoefer, Imo; Helbing, Thomas; Pasterkamp, Gerard; Bode, Christoph; de Kleijn, Dominique; Moser, Martin			FoxP1 Stimulates Angiogenesis by Repressing the Inhibitory Guidance Protein Semaphorin 5B in Endothelial Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; AXON GUIDANCE; IN-VITRO; ARTERIOGENESIS; GENE; MORPHOGENESIS; EXPRESSION; REGULATOR; NEURONS; DOMAIN	Forkhead box (Fox) transcription factors are important regulators of cardiovascular development and several Fox-proteins have recently been shown to modulate embryonic and post-natal angiogenesis. However, the role of the FoxP subfamily, which is highly expressed in cardiovascular tissue, has not been investigated so far. Here, we show that the transcription factor FoxP1 is the highest expressed FoxP-protein in endothelial cells and that it is upregulated at the site of neovascularization during hindlimb ischemia in mice. Silencing of FoxP1 results in a strong inhibition of proliferation, tube formation and migration of cultured endothelial cells. Accordingly, knockdown of FoxP1 in zebrafish was followed by a disruption of intersomitic vascular formation. Using gene expression profiling, we show that FoxP1 induces a specific change of the endothelial transcriptome and functions as a suppressor of semaphorin 5B, which has previously been described as a neuronal inhibitory factor. Our findings now demonstrate that semaphorin 5B also acts as a FoxP1-dependent suppressor of endothelial cell proliferation, migration and sprouting, mediating the effects of FoxP1. In summary, our data indicate that the transcription factor FoxP1 is essential for the angiogenic function of endothelial cells and functions as a suppressor of the inhibitory guidance cue semaphorin 5B, suggesting an important function of FoxP1 in the regulation of neovascularization.	[Grundmann, Sebastian; Lindmayer, Christian; Hans, Felix P.; Helbing, Thomas; Bode, Christoph; Moser, Martin] Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 1, Freiburg, Germany; [Hoefer, Imo; Pasterkamp, Gerard] Univ Med Ctr, Expt Cardiol Lab, Utrecht, Netherlands; [de Kleijn, Dominique] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	University of Freiburg; Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Grundmann, S (corresponding author), Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 1, Freiburg, Germany.	sebastian.grundmann@universitaets-herzzentrum.de	Hans, Felix Patricius/AFR-0890-2022	Hans, Felix Patricius/0000-0002-7164-7624	German Foundation of Heart Research [F/21/08]; German Research Foundation (DFG) [Gr 3459/2-1, Mo 973/5-1, Mo 973/6-1]	German Foundation of Heart Research; German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by a grant for the German Foundation of Heart Research to SG (F/21/08), and by grants from the German Research Foundation (DFG) to SG (Gr 3459/2-1) and MM (Mo 973/5-1 and 6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; Banham AH, 2001, CANCER RES, V61, P8820; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Browne K, 2012, J NEUROCHEM, V123, P135, DOI 10.1111/j.1471-4159.2012.07885.x; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Delli Carri A, 2013, STEM CELL REV; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Grundmann S, 2009, J CELL MOL MED; Grundmann S, 2009, J CELL MOL MED, V13, P3463, DOI 10.1111/j.1582-4934.2009.00735.x; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; Heinke J, 2008, CIRC RES, V103, P804, DOI 10.1161/CIRCRESAHA.108.178434; Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lett RLM, 2009, CEREB CORTEX, V19, P1408, DOI 10.1093/cercor/bhn179; LI C, 1993, P NATL ACAD SCI USA, V90, P11583, DOI 10.1073/pnas.90.24.11583; Li SR, 2004, SCIENCE, V305, P1619, DOI 10.1126/science.1098674; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; Nagase T, 2000, DNA RES, V7, P143, DOI 10.1093/dnares/7.2.143; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Seo S, 2012, P NATL ACAD SCI USA, V109, P2015, DOI 10.1073/pnas.1109540109; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Suchting S, 2006, EXP CELL RES, V312, P668, DOI 10.1016/j.yexcr.2005.11.009; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wang BA, 2005, CURR PROTEIN PEPT SC, V6, P473, DOI 10.2174/138920305774329340; Xue ZH, 2010, J IMMUNOL, V184, P3697, DOI 10.4049/jimmunol.0903316	34	20	22	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e70873	10.1371/journal.pone.0070873	http://dx.doi.org/10.1371/journal.pone.0070873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023716	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400004
J	Myung, DS; Park, YL; Chung, CY; Park, HC; Kim, JS; Cho, SB; Lee, WS; Lee, KH; Lee, JH; Joo, YE				Myung, Dae-Seong; Park, Young-Lan; Chung, Cho-Yun; Park, Hyung-Chul; Kim, Jong-Sun; Cho, Sung-Bum; Lee, Wan-Sik; Lee, Kyung-Hwa; Lee, Jae-Hyuk; Joo, Young-Eun			Expression of Livin in Colorectal Cancer and Its Relationship to Tumor Cell Behavior and Prognosis	PLOS ONE			English	Article							NF-KAPPA-B; COLON-CANCER; APOPTOSIS PROTEIN; MOLECULAR MARKERS; SIGNALING PATHWAY; LUNG-CANCER; ACTIVATION; INHIBITOR; IAP; TARGET	Backgrounds: Expression of Livin, a member of the inhibitors of apoptosis protein family, is associated with tumor development and progression. The aims of this study were to evaluate whether Livin affects oncogenic biological behavior of colorectal cancer cells, and to document the relationship between its expression and various clinicopathological parameters in colorectal cancer. Methods: We investigated the impact of Livin on tumor cell behavior by using the small interfering RNA and pcDNA3.1 vector in SW480 and DKO1 colorectal cancer cell lines. The expression of Livin was investigated by RT-PCR and immunohistochemistry in coloretcal cancer tissues. The apoptotic cells were visualized by TUNEL assay, and proliferative cells were visualized by Ki-67 antibody staining. Results: Knockdown of Livin suppressed tumor cell migration and invasion in colorectal cancer cells. Knockdown of Livin induced the apoptosis by up-regulating of caspase-3, -7 and PARP activities and the cell cycle arrest by decreasing cyclin D1, cyclin D3, cyclin-dependent kinase 4 and 6, and by inducing p27 expression. The MAPK signaling cascades were significantly blocked by knockdown of Livin. In contrast, overexpression of Livin enhanced tumor cell migration and invasion, and inhibited the apoptosis and cell cycle arrest. The mean apoptotic index (AI) value of Livin positive tumors was significantly lower than AI of Livin negative tumors. However, there was no significant difference between Livin expression and Ki-67 labeling index (KI). Livin expression was significantly increased in colorectal cancer and metastatic lymph node tissues compared to normal colorectal mucosa and non-metastatic lymph node tissues and was associated with tumor stage, lymphovascular invasion, lymph node metastasis and poor survival. Conclusions: These results indicate that Livin is associated with tumor progression by increasing tumor cell motility and inhibiting apoptosis in colorectal cancer.	[Myung, Dae-Seong; Park, Young-Lan; Chung, Cho-Yun; Park, Hyung-Chul; Kim, Jong-Sun; Cho, Sung-Bum; Lee, Wan-Sik; Joo, Young-Eun] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Lee, Kyung-Hwa; Lee, Jae-Hyuk] Chonnam Natl Univ, Sch Med, Dept Pathol, Kwangju, South Korea	Chonnam National University; Chonnam National University	Joo, YE (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.	yejoo@chonnam.ac.kr			National Research & Development Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [0720570]	National Research & Development Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant (0720570) from the National Research & Development Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2005, EXPERT REV MOL DIAGN, V5, P337, DOI 10.1586/14737159.5.3.337; Allan Alison L, 2006, Breast Dis, V26, P87; Allen WL, 2005, PHARMACOGENOMICS, V6, P603, DOI 10.2217/14622416.6.6.603; Bottini C, 2009, INT J ONCOL, V34, P69, DOI 10.3892/ijo_00000130; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chang H, 2007, MOL CANCER THER, V6, P24, DOI 10.1158/1535-7163.MCT-06-0443; Chen F, 2012, IUBMB LIFE, V64, P274, DOI 10.1002/iub.606; Chen YS, 2010, MOL BIOL REP, V37, P2241, DOI 10.1007/s11033-009-9711-3; Filipits M, 2009, CLIN CANCER RES, V15, P5888, DOI 10.1158/1078-0432.CCR-09-0728; Gazzaniga P, 2003, ANN ONCOL, V14, P85, DOI 10.1093/annonc/mdg002; GRANA X, 1995, ONCOGENE, V11, P211; Greene F.L, 2002, AJCC CANC STAGING MA, pxiv; Hariu H, 2005, CLIN CANCER RES, V11, P1000; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jankowski JA, 2009, AM J GASTROENTEROL, V104, P1093, DOI 10.1038/ajg.2008.172; Kempkensteffen C, 2007, TUMOR BIOL, V28, P132, DOI 10.1159/000103008; Kenneth NS, 2012, CURR OPIN CELL BIOL, V24, P871, DOI 10.1016/j.ceb.2012.11.004; Kiechle FL, 2002, CLIN CHIM ACTA, V326, P27, DOI 10.1016/S0009-8981(02)00297-8; Kim DK, 2005, PEDIATR DEVEL PATHOL, V8, P621, DOI 10.1007/s10024-005-4108-3; Labianca R, 2010, TUMORI, V96, P889, DOI 10.1177/548.6506; Lee KH, 2008, PATHOBIOLOGY, V75, P364, DOI 10.1159/000164221; Liu B, 2007, CANCER LETT, V250, P168, DOI 10.1016/j.canlet.2006.09.024; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Oh BY, 2011, WORLD J GASTROENTERO, V17, P2563, DOI 10.3748/wjg.v17.i20.2563; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864; Wang L, 2008, MOL CANCER THER, V7, P3661, DOI 10.1158/1535-7163.MCT-08-0480; Wang XD, 2010, CLIN BIOCHEM, V43, P655, DOI 10.1016/j.clinbiochem.2010.02.004; Xi RC, 2011, ONKOLOGIE, V34, P428, DOI 10.1159/000331132; Yan B, 2011, MOL CELL BIOCHEM, V357, P39, DOI 10.1007/s11010-011-0873-7; Zhu ZT, 2012, INT J MOL SCI, V13, P2025, DOI 10.3390/ijms13022025	35	27	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73262	10.1371/journal.pone.0073262	http://dx.doi.org/10.1371/journal.pone.0073262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023847	gold, Green Published, Green Submitted			2022-12-27	WOS:000324238400056
J	Woodard, CL; Goodwin, CR; Wan, J; Xia, SL; Newman, R; Hu, JF; Zhang, J; Hayward, SD; Qian, J; Laterra, J; Zhu, H				Woodard, Crystal L.; Goodwin, C. Rory; Wan, Jun; Xia, Shuli; Newman, Robert; Hu, Jianfei; Zhang, Jin; Hayward, S. Diane; Qian, Jiang; Laterra, John; Zhu, Heng			Profiling the Dynamics of a Human Phosphorylome Reveals New Components in HGF/c-Met Signaling	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; PROTEIN-KINASE-C; GLOBAL ANALYSIS; POSTTRANSLATIONAL MODIFICATIONS; MASS-SPECTROMETRY; DNA-DAMAGE; CANCER; IDENTIFICATION; CELLS; YEAST	Protein phosphorylation is a dynamic and reversible event that greatly influences cellular function. Identifying the key regulatory elements that determine cellular phenotypes during development and oncogenesis requires the ability to dynamically monitor proteome-wide events. Here, we report the development of a new strategy to monitor dynamic changes of protein phosphorylation in cells and tissues using functional protein microarrays as the readout. To demonstrate this technology's ability to identify condition-dependent phosphorylation events, human protein microarrays were incubated with lysates from cells or tissues under activation or inhibition of c-Met, a receptor tyrosine kinase involved in tissue morphogenesis and malignancy. By comparing the differences between the protein phosphorylation profiles obtained using the protein microarrays, we were able to recover many of the proteins that are known to be specifically activated (i.e., phosphorylated) upon c-Met activation by the hepatocyte growth factor (HGF). Most importantly, we discovered many proteins that were differentially phosphorylated by lysates from cells or tissues when the c-Met pathway was active. Using phosphorylation-specific antibodies, we were able to validate several candidate proteins as new downstream components of the c-Met signaling pathway in cells. We envision that this new approach, like its DNA microarray counterpart, can be further extended toward profiling dynamics of global protein phosphorylation under many different physiological conditions both in cellulo and in vivo in a high-throughput and cost-effective fashion.	[Woodard, Crystal L.; Newman, Robert; Zhang, Jin; Hayward, S. Diane; Zhu, Heng] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA; [Goodwin, C. Rory; Xia, Shuli; Zhang, Jin; Laterra, John] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Goodwin, C. Rory; Xia, Shuli; Laterra, John] Kennedy Krieger Inst, Dept Neurol, Baltimore, MD USA; [Wan, Jun; Hu, Jianfei; Qian, Jiang] Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD USA; [Hayward, S. Diane; Qian, Jiang] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; [Laterra, John] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Zhu, Heng] Johns Hopkins Sch Med, High Throughput Biol Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Zhu, H (corresponding author), Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA.	Heng.Zhu@jhmi.edu	Wan, Jun/AAN-1337-2020; Wan, Jun/H-7132-2013; Wan, Jun/A-2177-2014	Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562; Jianfei, Hu/0000-0001-8458-6683; Goodwin, C. Rory/0000-0002-6540-2751; Newman, Robert/0000-0002-3865-0266	National Institutes of Health [RR020839, DK082840, RO1 CA129192, RO1 NS43987, R01 EY017589, R21 CA138163]; United Negro College Fund/Merck Science Initiative; NATIONAL CANCER INSTITUTE [R01CA129192, R21CA138163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073368, R24DK082840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043987] Funding Source: NIH RePORTER; Division Of Human Resource Development [1038160] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Negro College Fund/Merck Science Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Human Resource Development(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	National Institutes of Health (http://grants.nih.gov/grants/oer.htm) grants were provided to the following researchers to fund this work: Heng Zhu - RR020839 and DK082840; John Laterra - RO1 CA129192 and RO1 NS43987; Jiang Qian - R01 EY017589; S. Diane Hayward - R21 CA138163. The United Negro College Fund/Merck Science Initiative (http://umsi.uncf.org/sif) provided funding to C. Rory Godwin to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Castaneda CA, 2010, CANC METASTASIS REV; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Evans-Nguyen KM, 2008, ANAL CHEM, V80, P1448, DOI 10.1021/ac701800h; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hammond DE, 2010, J PROTEOME RES, V9, P2734, DOI 10.1021/pr100145w; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim KJ, 2006, CLIN CANCER RES, V12, P1292, DOI 10.1158/1078-0432.CCR-05-1793; Lal BC, 2005, CLIN CANCER RES, V11, P4479, DOI 10.1158/1078-0432.CCR-05-0166; Larocca MC, 2004, MOL BIOL CELL, V15, P2771, DOI 10.1091/mbc.E03-10-0757; Li R, 2011, CELL HOST MICROBE; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lin J, 2010, BRIEF FUNCT GENOMICS, V9, P32, DOI 10.1093/bfgp/elp045; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; Lu Jin-Ying, 2013, Methods Mol Biol, V981, P151, DOI 10.1007/978-1-62703-305-3_12; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Martucci P, 2010, RESP MED, V104, P61, DOI 10.1016/j.rmed.2009.08.002; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Newman RH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.12; Organ SL, 2011, J PROTEOME RES, V10, P3200, DOI 10.1021/pr200238t; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Piazzi M, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.003152; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; Rush S, 2007, EXP CELL RES, V313, P121, DOI 10.1016/j.yexcr.2006.09.018; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Smith MG, 2005, MECH AGEING DEV, V126, P171, DOI 10.1016/j.mad.2004.09.019; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sutandy F X Reymond, 2013, Curr Protoc Protein Sci, VChapter 27, DOI 10.1002/0471140864.ps2701s72; Tao SC, 2006, NAT BIOTECHNOL, V24, P1253, DOI 10.1038/nbt1249; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Uzoma Ijeoma, 2013, Genomics Proteomics & Bioinformatics, V11, P18, DOI 10.1016/j.gpb.2012.12.005; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Voshol H, 2009, FEBS J, V276, P6871, DOI 10.1111/j.1742-4658.2009.07395.x; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Yuan RQ, 2001, CANCER RES, V61, P8022; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu H, 2012, PROTEOM CLIN APPL, V6, P548, DOI 10.1002/prca.201200041; Zhu J, 2009, J VIROL, V83, P5219, DOI 10.1128/JVI.02378-08	55	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72671	10.1371/journal.pone.0072671	http://dx.doi.org/10.1371/journal.pone.0072671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023761	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400021
J	Howerton, A; Patra, M; Abel-Santos, E				Howerton, Amber; Patra, Manomita; Abel-Santos, Ernesto			Fate of Ingested Clostridium difficile Spores in Mice	PLOS ONE			English	Article							GERMINATION; INFECTION; COMPONENT; BACTERIA; ANALOGS; MODEL; ACID	Clostridium difficile infection (CDI) is a leading cause of antibiotic-associated diarrhea, a major nosocomial complication. The infective form of C. difficile is the spore, a dormant and resistant structure that forms under stress. Although spore germination is the first committed step in CDI onset, the temporal and spatial distribution of ingested C. difficile spores is not clearly understood. We recently reported that CamSA, a synthetic bile salt analog, inhibits C. difficile spore germination in vitro and in vivo. In this study, we took advantage of the anti-germination activity of bile salts to determine the fate of ingested C. difficile spores. We tested four different bile salts for efficacy in preventing CDI. Since CamSA was the only anti-germinant tested able to prevent signs of CDI, we characterized CamSa's in vitro stability, distribution, and cytotoxicity. We report that CamSA is stable to simulated gastrointestinal (GI) environments, but will be degraded by members of the natural microbiota found in a healthy gut. Our data suggest that CamSA will not be systemically available, but instead will be localized to the GI tract. Since in vitro pharmacological parameters were acceptable, CamSA was used to probe the mouse model of CDI. By varying the timing of CamSA dosage, we estimated that C. difficile spores germinated and established infection less than 10 hours after ingestion. We also showed that ingested C. difficile spores rapidly transited through the GI tract and accumulated in the colon and cecum of CamSA-treated mice. From there, C. difficile spores were slowly shed over a 96-hour period. To our knowledge, this is the first report of using molecular probes to obtain disease progression information for C. difficile infection.	[Howerton, Amber; Patra, Manomita; Abel-Santos, Ernesto] Univ Nevada, Dept Chem, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Abel-Santos, E (corresponding author), Univ Nevada, Dept Chem, Las Vegas, NV 89154 USA.	ernesto.abelsantos@unlv.edu			National Science Foundation [0957400]; Division Of Chemistry [0957400] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This material is based upon work supported by the National Science Foundation under grant number 0957400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Best EL, 2012, GUT MICROBES, V3, P145, DOI 10.4161/gmic.19526; Buckley AM, 2011, J MED MICROBIOL, V60, P1174, DOI 10.1099/jmm.0.028514-0; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Freeman J, 2005, J ANTIMICROB CHEMOTH, V56, P717, DOI 10.1093/jac/dki321; Howerton A, 2013, J INFECT DIS, V207, P1498, DOI 10.1093/infdis/jit068; Howerton A, 2011, J BACTERIOL, V193, P274, DOI 10.1128/JB.00980-10; Kachrimanidou M, 2011, CRIT REV MICROBIOL, V37, P178, DOI 10.3109/1040841X.2011.556598; KLAASSEN CD, 1973, TOXICOL APPL PHARM, V24, P37, DOI 10.1016/0041-008X(73)90179-8; Liggins M, 2011, J BACTERIOL, V193, P2776, DOI 10.1128/JB.00058-11; Ramirez N, 2010, J BACTERIOL, V192, P4215, DOI 10.1128/JB.00488-10; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; ROLFE RD, 1981, J INFECT DIS, V143, P470, DOI 10.1093/infdis/143.3.470; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Setlow P, 2012, BACTERIAL SPORES: CURRENT RESEARCH AND APPLICATIONS, P199; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Speight S, 2011, J HOSP INFECT, V79, P18, DOI 10.1016/j.jhin.2011.05.016; Strober W., 2001, CURRENT PROTOCOLS IM; Sun XM, 2011, INFECT IMMUN, V79, P2856, DOI 10.1128/IAI.01336-10; Sutton PA, 2008, CLIN EXP IMMUNOL, V153, P439, DOI 10.1111/j.1365-2249.2008.03690.x; Takano M, 1998, EUR J PHARMACOL, V358, P289, DOI 10.1016/S0014-2999(98)00607-4; Tanaka H, 1999, J DAIRY SCI, V82, P2530, DOI 10.3168/jds.S0022-0302(99)75506-2; Teksin ZS, 2010, AAPS J, V12, P238, DOI 10.1208/s12248-010-9176-2; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; Walum E, 1998, ENVIRON HEALTH PERSP, V106, P497, DOI 10.2307/3433801; Yan R, 2008, DRUG METAB DISPOS, V36, P400, DOI 10.1124/dmd.107.017707	30	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72620	10.1371/journal.pone.0072620	http://dx.doi.org/10.1371/journal.pone.0072620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023628	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200023
J	Manninen, T; Huttunen, H; Ruusuvuori, P; Nykter, M				Manninen, Tapio; Huttunen, Heikki; Ruusuvuori, Pekka; Nykter, Matti			Leukemia Prediction Using Sparse Logistic Regression	PLOS ONE			English	Article							FLOW-CYTOMETRY; CLASSIFICATION	We describe a supervised prediction method for diagnosis of acute myeloid leukemia (AML) from patient samples based on flow cytometry measurements. We use a data driven approach with machine learning methods to train a computational model that takes in flow cytometry measurements from a single patient and gives a confidence score of the patient being AML-positive. Our solution is based on an l(1) regularized logistic regression model that aggregates AML test statistics calculated from individual test tubes with different cell populations and fluorescent markers. The model construction is entirely data driven and no prior biological knowledge is used. The described solution scored a 100% classification accuracy in the DREAM6/FlowCAP2 Molecular Classification of Acute Myeloid Leukaemia Challenge against a golden standard consisting of 20 AML-positive and 160 healthy patients. Here we perform a more extensive validation of the prediction model performance and further improve and simplify our original method showing that statistically equal results can be obtained by using simple average marker intensities as features in the logistic regression model. In addition to the logistic regression based model, we also present other classification models and compare their performance quantitatively. The key benefit in our prediction method compared to other solutions with similar performance is that our model only uses a small fraction of the flow cytometry measurements making our solution highly economical.	[Manninen, Tapio; Huttunen, Heikki; Ruusuvuori, Pekka] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Nykter, Matti] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland	Tampere University; Tampere University	Manninen, T (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	tapio.manninen@tut.fi	Ruusuvuori, Pekka/C-9229-2016; Ruusuvuori, Pekka/AAC-2617-2022	Ruusuvuori, Pekka/0000-0001-9086-9591; Huttunen, Heikki/0000-0002-6571-0797; Nykter, Matti/0000-0001-6956-2843	Tampere Doctoral Programme in Information Science and Engineering (TISE); Academy of Finland [140052, 132877]	Tampere Doctoral Programme in Information Science and Engineering (TISE); Academy of Finland(Academy of Finland)	The work has been supported by the Tampere Doctoral Programme in Information Science and Engineering (TISE) and Academy of Finland projects #140052 and #132877. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; ANDERSON TW, 1962, ANN MATH STAT, V33, P1148, DOI 10.1214/aoms/1177704477; Biehl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059401; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hand DJ, 2006, STAT SCI, V21, P1, DOI 10.1214/088342306000000060; Hastie T., 2009, UNSUPERVISED LEARNIN; Henel G, 2007, LABMEDICINE, V38, P428, DOI 10.1309/GHLEWLV0CD8025JL; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Huttunen H, 2012, MACH VISION APPL, P1; Knijnenburg TA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.64; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822	19	18	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72932	10.1371/journal.pone.0072932	http://dx.doi.org/10.1371/journal.pone.0072932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023658	Green Submitted, gold, Green Published			2022-12-27	WOS:000323880200054
J	Gergely, A; Petro, E; Topal, J; Miklosi, A				Anna Gergely; Eszter Petro; Jozsef Topal; Adam Miklosi			What Are You or Who Are You? The Emergence of Social Interaction between Dog and an Unidentified Moving Object (UMO)	PLOS ONE			English	Article							INTERSPECIFIC COMMUNICATION; CANIS-FAMILIARIS; BEHAVIOR; ROBOTS; INFANTS; OTHERS; REASON	Robots offer new possibilities for investigating animal social behaviour. This method enhances controllability and reproducibility of experimental techniques, and it allows also the experimental separation of the effects of bodily appearance (embodiment) and behaviour. In the present study we examined dogs' interactive behaviour in a problem solving task (in which the dog has no access to the food) with three different social partners, two of which were robots and the third a human behaving in a robot-like manner. The Mechanical UMO (Unidentified Moving Object) and the Mechanical Human differed only in their embodiment, but showed similar behaviour toward the dog. In contrast, the Social UMO was interactive, showed contingent responsiveness and goal-directed behaviour and moved along varied routes. The dogs showed shorter looking and touching duration, but increased gaze alternation toward the Mechanical Human than to the Mechanical UMO. This suggests that dogs' interactive behaviour may have been affected by previous experience with typical humans. We found that dogs also looked longer and showed more gaze alternations between the food and the Social UMO compared to the Mechanical UMO. These results suggest that dogs form expectations about an unfamiliar moving object within a short period of time and they recognise some social aspects of UMOs' behaviour. This is the first evidence that interactive behaviour of a robot is important for evoking dogs' social responsiveness.	[Anna Gergely; Eszter Petro; Adam Miklosi] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Jozsef Topal] Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Adam Miklosi] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; MTA-ELTE Comparative Ethology Research Group	Gergely, A (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	anna.gergely66@gmail.com	Miklosi, Adam/N-5147-2017	Miklosi, Adam/0000-0003-4831-8985	Swiss National Science Foundation (SNSF) Sinergia project SWARMIX [CRSI22 133059]; Hungarian Science Foundation (OTKA) [K-100695]	Swiss National Science Foundation (SNSF) Sinergia project SWARMIX(Swiss National Science Foundation (SNSF)); Hungarian Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research was supported by the Swiss National Science Foundation (SNSF) Sinergia project SWARMIX ( project number CRSI22 133059) and the Hungarian Science Foundation (OTKA grant K-100695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bshary R, 2006, PLOS BIOL, V4, P2393, DOI 10.1371/journal.pbio.0040431; Buchsbaum D., 2005, 14 IEEE INT WORKSH R; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Gaunet F, 2010, ANIM COGN, V13, P311, DOI 10.1007/s10071-009-0279-z; Heyes C, 2012, PHILOS T R SOC B, V367, P2695, DOI 10.1098/rstb.2012.0217; Horn L, 2012, ANIM COGN, V15, P57, DOI 10.1007/s10071-011-0432-3; ISACK HA, 1989, SCIENCE, V243, P1343, DOI 10.1126/science.243.4896.1343; Ishii H, 2006, LECT NOTES COMPUT SC, V4095, P643; Kamil Alan C., 1998, P1, DOI 10.1016/B978-012077030-4/50053-2; Kostan KM, 2002, J COMP PSYCHOL, V116, P206, DOI 10.1037//0735-7036.116.2.206; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; KRAMER GUSTAV, 1937, ZEITSCHR MORPH U OKOL TIERE, V32, P752, DOI 10.1007/BF00407457; Krause J, 2011, TRENDS ECOL EVOL, V26, P369, DOI 10.1016/j.tree.2011.03.015; Kubinyi E, 2004, BEHAV PROCESS, V65, P231, DOI 10.1016/j.beproc.2003.10.003; Lack D, 1943, BRIT BIRDS, V34, P216; Lakatos G, 2012, ANIM COGN, V15, P201, DOI 10.1007/s10071-011-0446-x; Leaver SDA, 2008, BEHAVIOUR, V145, P377, DOI 10.1163/156853908783402894; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Meltzoff AN, 2010, NEURAL NETWORKS, V23, P966, DOI 10.1016/j.neunet.2010.09.005; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00075; MikluEsi A., 2000, ANIM COGN, V3, P159, DOI [DOI 10.1007/S100710000072, 10.1007/s100710000072]; Mitri S, 2013, BIOL REV, V88, P31, DOI 10.1111/j.1469-185X.2012.00236.x; Munakata Y, 2000, INFANCY, V1, P471, DOI 10.1207/S15327078IN0104_7; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; Opfer JE, 2002, COGNITION, V86, P97, DOI 10.1016/S0010-0277(02)00171-3; Partan SR, 2009, ANIM BEHAV, V77, P1127, DOI 10.1016/j.anbehav.2008.12.029; Rakison DH, 2001, PSYCHOL BULL, V127, P209, DOI 10.1037//0033-2909.127.2.209; Scheier C, 1999, UNDERSTANDING INTELL; Szekely T., 2010, SOCIAL BEHAV GENES E; Tinbergen, 1951, STUDY INSTINCT; Topal J, 2009, ADV STUD BEHAV, V39, P71, DOI 10.1016/S0065-3454(09)39003-8; Ziemke T, 2009, COGN COMPUT, V1, P104, DOI 10.1007/s12559-009-9012-0	34	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72727	10.1371/journal.pone.0072727	http://dx.doi.org/10.1371/journal.pone.0072727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015272	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800076
J	Becker, EM; Stasch, JP; Bechem, M; Keldenich, J; Klipp, A; Schaefer, K; Ulbrich, HF; Truebel, H				Becker, Eva Maria; Stasch, Johannes-Peter; Bechem, Martin; Keldenich, Joerg; Klipp, Alexandra; Schaefer, Katja; Ulbrich, Hannes-Friedrich; Truebel, Hubert			Effects of Different Pulmonary Vasodilators on Arterial Saturation in a Model of Pulmonary Hypertension	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; GAS-EXCHANGE; SURVIVAL; VENTILATION; DISEASE	Background: Approved therapies for pulmonary arterial hypertension can induce oxygen desaturation when administered to patients with secondary forms of pulmonary hypertension (PH), probably due to an increase in ventilation/perfusion mismatch. Thus, so far these treatments have largely failed in secondary forms of PH. Methods: We established an animal model of heterogeneous lung ventilation to evaluate the desaturation potential of mechanistically distinct vasoactive drugs launched or currently in clinical development for the treatment of PH. Single-lung ventilation was induced in five groups (N = 6) of anesthetized minipigs (7 weeks, 4 to 5 kg BW), and their hemodynamic parameters were monitored before and after intravenous injection of control (vehicle only), endothelin antagonist (bosentan; 0.3, 1, 3, 10 mg/kg), phosphodiesterase type 5 inhibitor (sildenafil; 3, 10, 30, 100 mu g/kg), and soluble guanylate cyclase stimulators (BAY 41-8543 and riociguat; 1, 3, 10, 30 mu g/kg). Cumulative doses were administered before successive unilateral ventilation cycles. The doses were chosen to achieve equal effect on blood pressure by the different pharmacologic principles. Results: Single-lung ventilation resulted in transient increases in mean pulmonary artery pressure (mPAP) and desaturation. In contrast to control, all drugs dose-dependently decreased hypoxic mPAP (a positive treatment effect) and increased area under the arterial hemoglobin saturation curve (unwanted desaturation effect). Riociguat and bosentan reduced hypoxic mPAP to the greatest extent, while the soluble guanylate cyclase stimulators riociguat and BAY 41-8543 lowered arterial oxygen saturation of hemoglobin the least. Conclusions: Future investigations will be required to confirm these findings in clinical settings.	[Becker, Eva Maria; Stasch, Johannes-Peter; Bechem, Martin; Keldenich, Joerg; Klipp, Alexandra; Schaefer, Katja; Truebel, Hubert] Bayer Pharma AG, Cardiol Res, Wuppertal, Germany; [Becker, Eva Maria; Truebel, Hubert] Univ Witten Herdecke, Fak Gesundheit, Witten, Germany; [Ulbrich, Hannes-Friedrich] Bayer Pharma AG, Res & Ind Stat, Berlin, Germany; [Stasch, Johannes-Peter] Univ Halle Wittenberg, Inst Pharm, Witten, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Witten Herdecke University; Bayer AG; Bayer Healthcare Pharmaceuticals; Martin Luther University Halle Wittenberg	Becker, EM (corresponding author), Bayer Pharma AG, Cardiol Res, Wuppertal, Germany.	eva.becker1@bayer.com			Bayer HealthCare	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	At the time of manuscript submission all authors were full-time employees of Bayer HealthCare in Germany. Medical writing support was provided by Adelphi Communications and funded by Bayer HealthCare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barbera JA, 2009, DRUGS, V69, P1153, DOI 10.2165/00003495-200969090-00002; Amen EM, 2011, BIOMARKERS, V16, pS5, DOI 10.3109/1354750X.2011.585243; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Barbera JA, 1996, LANCET, V347, P436, DOI 10.1016/S0140-6736(96)90011-2; Blanco I, 2010, AM J RESP CRIT CARE, V181, P270, DOI 10.1164/rccm.200907-0988OC; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Grimminger F, 2009, EUR RESPIR J, V33, P785, DOI 10.1183/09031936.00039808; KAPITAN KS, 1989, AM REV RESPIR DIS, V139, P1149, DOI 10.1164/ajrccm/139.5.1149; Kunieda T, 1999, INTERNAL MED, V38, P543, DOI 10.2169/internalmedicine.38.543; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; MELOT C, 1983, CHEST, V83, P203, DOI 10.1378/chest.83.2.203; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Park T, 2002, STAT MED, V21, P143, DOI 10.1002/sim.949; Pfizer Limited. European Medicine Agency website, 2013, REV SUMM PROD CHAR; Pharmaceuticals Actelion, 2012, TRACL BOS SUMM PROD; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Stolz D, 2008, EUR RESPIR J, V32, P619, DOI 10.1183/09031936.00011308; Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709; Tunnicliffe B, 2008, CORE TOPICS MECH VEN, P115; WAGNER PD, 1977, J CLIN INVEST, V59, P203, DOI 10.1172/JCI108630; WAGNER PD, 1974, CHEST, V65, pS32, DOI 10.1378/chest.65.4_Supplement.32S; West JB, 1995, RESP PHYSL ESSENTIAL; West JB, 1996, RESP PHYSL PEOPLE ID	27	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73502	10.1371/journal.pone.0073502	http://dx.doi.org/10.1371/journal.pone.0073502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015306	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800101
J	Jones, SA; Groome, M; Koen, A; Van Niekerk, N; Sewraj, P; Kuwanda, L; Izu, A; Adrian, PV; Madhi, SA				Jones, Stephanie A.; Groome, Michelle; Koen, Anthonet; Van Niekerk, Nadia; Sewraj, Poonam; Kuwanda, Locadiah; Izu, Alane; Adrian, Peter V.; Madhi, Shabir A.			Immunogenicity of Seven-Valent Pneumococcal Conjugate Vaccine Administered at 6, 14 and 40 Weeks of Age in South African Infants	PLOS ONE			English	Article							CHILDREN; EFFICACY; RESPONSES; SEROTYPE; SAFETY; IPV	Background: The high cost of pneumococcal conjugate vaccine (PCV) and local epidemiological factors contributed to evaluating different PCV dosing-schedules. This study evaluated the immunogenicity of seven-valent PCV (PCV7) administered at 6-weeks; 14-weeks and 9-months of age. Methods: 250 healthy, HIV-unexposed infants were immunized with PCV7 concurrently with other childhood vaccines. Serotype-specific anti-capsular IgG concentrations were measured one-month following the 1st and 2nd PCV-doses, prior to and two-weeks following the 3rd dose. Opsonophagocytic killing assay (OPA) was measured for three serotypes following the 2nd and 3rd PCV7-doses. Immunogenicity of the current schedule was compared to a historical cohort of infants who received PCV7 at 6, 10 and 14 weeks of age. Results: The proportion of infants with serotype-specific antibody >= 0.35 mu g/ml following the 2nd PCV7-dose ranged from 84% for 6B to >= 89% for other serotypes. Robust antibody responses were observed following the 3rd dose. The proportion of children with OPA >= 8 for serotypes 9V, 19F and 23F increased significantly following the 3rd PCV7-dose to 93.6%; 86.0% and 89.7% respectively. The quantitative antibody concentrations following the 2nd PCV7-dose were comparable to that after the 3rd -dose in the 6-10-14 week schedule. Geometric mean concentrations (GMCs) following the 3rd PCV7-dose were higher for all serotypes in this study compared to the historical cohort. Conclusions: The studied PCV7 dosing schedule induced good immune responses, including higher GMCs following the 3rd-dose at 9-months compared to when given at 14-weeks of age. This may confer longer persistence of antibodies and duration of protection against pneumococcal disease.	[Jones, Stephanie A.; Groome, Michelle; Koen, Anthonet; Van Niekerk, Nadia; Sewraj, Poonam; Kuwanda, Locadiah; Izu, Alane; Adrian, Peter V.; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Dept Sci, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Jones, Stephanie A.; Groome, Michelle; Koen, Anthonet; Van Niekerk, Nadia; Sewraj, Poonam; Kuwanda, Locadiah; Izu, Alane; Adrian, Peter V.; Madhi, Shabir A.] MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.] Ctr Vaccines & Immunol, Natl Inst Communicable Dis, Johannesburg, South Africa	National Research Foundation - South Africa; University of Witwatersrand; National Institute for Communicable Diseases (NICD)	Madhi, SA (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Sci, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa.	shabirm@nicd.ac.za	Groome, Michelle Jennifer/AAI-9967-2021	Groome, Michelle Jennifer/0000-0001-5893-3725	National Research Foundation	National Research Foundation	This study was funded by an investigator's grant from the National Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2004, INFECT IMMUN, V72, P5383, DOI 10.1128/IAI.72.9.5383-5391.2004; Dagan R, 2008, EXPERT REV VACCINES, V7, P97, DOI 10.1586/14760584.7.1.97; Dagan R, 2012, VACCINE, V30, P5132, DOI 10.1016/j.vaccine.2012.05.059; Goldblatt D, 2010, PEDIATR INFECT DIS J, V29, P401, DOI 10.1097/INF.0b013e3181c67f04; Jodar L, 2003, VACCINE, V21, P3265, DOI 10.1016/S0264-410X(03)00230-5; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Knuf A, 2006, VACCINE, V24, P4727, DOI 10.1016/j.vaccine.2006.03.032; Knuf M, 2009, PEDIATR INFECT DIS J, V28, pS97, DOI 10.1097/INF.0b013e318199f61b; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; Madhi SA, 2013, VACCINE, V31, P777, DOI 10.1016/j.vaccine.2012.11.076; Madhi SA, 2012, VACCINE, V30, pC21, DOI 10.1016/j.vaccine.2012.05.055; Madhi SA, 2010, J INFECT DIS, V202, P355, DOI 10.1086/653704; Madhi SA, 2009, J INFECT DIS, V199, P1168, DOI 10.1086/597388; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Ruckinger S, 2011, VACCINE, V29, P9600, DOI 10.1016/j.vaccine.2011.09.011; Schmitt HJ, 2003, VACCINE, V21, P3653, DOI 10.1016/S0264-410X(03)00389-X; Scott P, 2011, VACCINE, V29, P9711, DOI 10.1016/j.vaccine.2011.07.042; Silberbauer EJ, 2011, DIAGN MICR INFEC DIS, V71, P309, DOI 10.1016/j.diagmicrobio.2011.07.006	22	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72794	10.1371/journal.pone.0072794	http://dx.doi.org/10.1371/journal.pone.0072794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015277	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800081
J	Orlin, A; Sondhi, D; Witmer, MT; Wessel, MM; Mezey, JG; Kaminsky, SM; Hackett, NR; Yohay, K; Kosofsky, B; Souweidane, MM; Kaplitt, MG; D'Amico, DJ; Crystal, RG; Kiss, S				Orlin, Anton; Sondhi, Dolan; Witmer, Matthew T.; Wessel, Matthew M.; Mezey, Jason G.; Kaminsky, Stephen M.; Hackett, Neil R.; Yohay, Kaleb; Kosofsky, Barry; Souweidane, Mark M.; Kaplitt, Michael G.; D'Amico, Donald J.; Crystal, Ronald G.; Kiss, Szilard			Spectrum of Ocular Manifestations in CLN2-Associated Batten (Jansky-Bielschowsky) Disease Correlate with Advancing Age and Deteriorating Neurological Function	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; LATE-INFANTILE; STORAGE; PROTEIN; RETINA; MUTATIONS; JUVENILE	Background: Late infantile neuronal ceroid lipofuscinosis (LINCL), one form of Batten's disease is a progressive neurodegenerative disorder resulting from a CLN2 gene mutation. The spectrum of ophthalmic manifestations of LINCL and the relationship with neurological function has not been previously described. Methods: Patients underwent ophthalmic evaluations, including anterior segment and dilated exams, optical coherence tomography, fluorescein and indocyanine green angiography. Patients were also assessed with the LINCL Neurological Severity Scale. Ophthalmic findings were categorized into one of five severity scores, and the association of the extent of ocular disease with neurological function was assessed. Results: Fifty eyes of 25 patients were included. The mean age at the time of exam was 4.9 years (range 2.5 to 8.1). The mean ophthalmic severity score was 2.6 (range 1 to 5). The mean neurological severity score was 6.1 (range 2 to 11). Significantly more severe ophthalmic manifestations were observed among older patients (p<0.005) and patients with more severe neurological findings (p<0.03). A direct correlation was found between the Ophthalmic Severity Scale and the Weill Cornell Neurological Scale (p<0.002). A direct association was also found between age and the ophthalmic manifestations (p<0.0002), with older children having more severe ophthalmic manifestations. Conclusions: Ophthalmic manifestations of LINCL correlate closely with the degree of neurological function and the age of the patient. The newly established LINCL Ophthalmic Scale may serve as an objective marker of LINCL severity and disease progression, and may be valuable in the evaluation of novel therapeutic strategies for LINCL, including gene therapy.	[Orlin, Anton; Witmer, Matthew T.; Wessel, Matthew M.; D'Amico, Donald J.; Kiss, Szilard] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Sondhi, Dolan; Mezey, Jason G.; Kaminsky, Stephen M.; Hackett, Neil R.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Yohay, Kaleb; Kosofsky, Barry; Souweidane, Mark M.; Kaplitt, Michael G.] Weill Cornell Med Coll, Dept Neurol, New York, NY USA	Cornell University; Cornell University; Cornell University; Cornell University	Kiss, S (corresponding author), Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA.	geneticmedicine@med.cornell.edu	Yohay, Kaleb/Y-8298-2019; Kaminsky, Stephen/J-5141-2016	Kaminsky, Stephen/0000-0003-1869-834X; Kiss, Szilard/0000-0003-3433-8432; Yohay, Kaleb/0000-0001-5560-3392	NIH [R01 NS061848, U54 N506578]; Foundation for Life, Chicago, IL; Research to Prevent Blindness, Inc. NY, NY; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061848] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Life, Chicago, IL; Research to Prevent Blindness, Inc. NY, NY(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported, in part, by NIH R01 NS061848 and U54 N506578; the Foundation for Life, Chicago, IL, and Research to Prevent Blindness, Inc. NY, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensaoula T, 2000, OPHTHALMOLOGY, V107, P1746, DOI 10.1016/S0161-6420(00)00264-5; Biswas J, 2008, CURR OPIN OPHTHALMOL, V19, P507, DOI 10.1097/ICU.0b013e32831215c3; Boustany R., 1996, HDB CLIN NEUROLOGY, V66, P671; Bozorg S, 2009, SURV OPHTHALMOL, V54, P463, DOI 10.1016/j.survophthal.2009.04.007; Collins J, 2006, BRIT J OPHTHALMOL, V90, P1119, DOI 10.1136/bjo.2006.091637; GOEBEL HH, 1988, RETINA-J RET VIT DIS, V8, P59, DOI 10.1097/00006982-198808010-00011; Hainsworth DP, 2009, RETINA-J RET VIT DIS, V29, P657, DOI 10.1097/IAE.0b013e31819b0542; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kelly JP, 2009, OPHTHALMIC GENET, V30, P190, DOI 10.3109/13816810903258829; Kohlschutter A, 2009, BRAIN DEV-JPN, V31, P499, DOI 10.1016/j.braindev.2008.12.008; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; LANZL I, 2008, US OPHTHALMIC REV, P44; Palmer DN, 1997, NEUROPEDIATRICS, V28, P45, DOI 10.1055/s-2007-973666; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Puga ACS, 2000, ARQ NEURO-PSIQUIAT, V58, P597, DOI 10.1590/S0004-282X2000000400001; Rawlings ND, 1999, BBA-PROTEIN STRUCT M, V1429, P496, DOI 10.1016/S0167-4838(98)00238-6; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; Sleat DE, 1999, AM J HUM GENET, V64, P1511, DOI 10.1086/302427; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Steinfeld R, 2002, AM J MED GENET, V112, P347, DOI 10.1002/ajmg.10660; TRABOULSI EI, 1987, GRAEF ARCH CLIN EXP, V225, P391, DOI 10.1007/BF02334164; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Weleber RG, 2004, MOL GENET METAB, V83, P128, DOI 10.1016/j.ymgme.2004.06.019; Weleber RG, 1998, EYE, V12, P580, DOI 10.1038/eye.1998.148; Williams RE, 1999, BIOM HLTH R, V33, P37; Worgall S, 2007, NEUROLOGY, V69, P521, DOI 10.1212/01.wnl.0000267885.47092.40	27	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73128	10.1371/journal.pone.0073128	http://dx.doi.org/10.1371/journal.pone.0073128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015292	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800092
J	Zhang, D; Asenjo, AB; Greenbaum, M; Xie, LP; Sharp, DJ; Sosa, H				Zhang, Dong; Asenjo, Ana B.; Greenbaum, Michaela; Xie, Luping; Sharp, David J.; Sosa, Hernando			A Second Tubulin Binding Site on the Kinesin-13 Motor Head Domain Is Important during Mitosis	PLOS ONE			English	Article							CENTROMERE-ASSOCIATED KINESIN; KINETOCHORE-MICROTUBULE INTERFACE; CHROMOSOME ALIGNMENT; METAPHASE SPINDLE; MITOTIC KINESINS; RING COMPLEX; CENP-E; PROTEIN; CELLS; MECHANISM	Kinesin-13s are microtubule (MT) depolymerases different from most other kinesins that move along MTs. Like other kinesins, they have a motor or head domain (HD) containing a tubulin and an ATP binding site. Interestingly, kinesin-13s have an additional binding site (Kin-Tub-2) on the opposite side of the HD that contains several family conserved positively charged residues. The role of this site in kinesin-13 function is not clear. To address this issue, we investigated the in-vitro and in-vivo effects of mutating Kin-Tub-2 family conserved residues on the Drosophila melanogaster kinesin-13, KLP10A. We show that the Kin-Tub-2 site enhances tubulin cross-linking and MT bundling properties of KLP10A in-vitro. Disruption of the Kin-Tub-2 site, despite not having a deleterious effect on MT depolymerization, results in abnormal mitotic spindles and lagging chromosomes during mitosis in Drosophila S2 cells. The results suggest that the additional Kin-Tub-2 tubulin biding site plays a direct MT attachment role in-vivo.	[Zhang, Dong; Asenjo, Ana B.; Greenbaum, Michaela; Xie, Luping; Sharp, David J.; Sosa, Hernando] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA; [Zhang, Dong] Nanjing Med Univ, Coll Basic Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Yeshiva University; Albert Einstein College of Medicine; Nanjing Medical University	Sosa, H (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA.	hernando.sosa@einstein.yu.edu			National Institutes of Health [R01-GM083338N/A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health R01-GM083338N/A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asenjo AB, 2013, CELL REP, V3, P759, DOI 10.1016/j.celrep.2013.01.030; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Buster DW, 2007, MOL BIOL CELL, V18, P3094, DOI 10.1091/mbc.E06-11-0994; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Diaz-Valencia JD, 2011, BIOPHYS J, V100, P2440, DOI 10.1016/j.bpj.2011.03.062; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Garcia-Saez I, 2007, J BIOL CHEM, V282, P9740, DOI 10.1074/jbc.M608883200; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Grant BJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001207; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Lakamper S, 2005, BIOPHYS J, V89, P3223, DOI 10.1529/biophysj.104.057505; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Moores CA, 2006, CELL CYCLE, V5, P1812, DOI 10.4161/cc.5.16.3134; Morales-Mulia S, 2005, MOL BIOL CELL, V16, P3176, DOI 10.1091/mbc.E04-12-1110; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Oguchi Y, 2011, NAT CELL BIOL, V13, P846, DOI 10.1038/ncb2256; Peters C, 2010, EMBO J, V29, P3437, DOI 10.1038/emboj.2010.220; Rankin KE, 2010, J CELL BIOL, V190, P35, DOI 10.1083/jcb.201004017; Rath U, 2011, CHROMOSOME RES, V19, P423, DOI 10.1007/s10577-011-9199-2; Rath U, 2009, MOL BIOL CELL, V20, P4696, DOI 10.1091/mbc.E09-07-0557; Rogers GC, 2005, J CELL SCI, V118, P1105, DOI 10.1242/jcs.02284; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Tan DY, 2008, STRUCTURE, V16, P1732, DOI 10.1016/j.str.2008.08.017; Tan DY, 2006, J CELL BIOL, V175, P25, DOI 10.1083/jcb.200605194; Tanenbaum Marvin E, 2011, Bioarchitecture, V1, P80; Varma D, 2012, J CELL SCI, V125, P5927, DOI 10.1242/jcs.093724; Welburn JPI, 2012, MOL BIOL CELL, V23, P4786, DOI 10.1091/mbc.E12-03-0214; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wickstead B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015020; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Wordeman L, 1999, CELL BIOL INT, V23, P275, DOI 10.1006/cbir.1999.0359; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	59	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73075	10.1371/journal.pone.0073075	http://dx.doi.org/10.1371/journal.pone.0073075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015286	gold, Green Submitted, Green Published			2022-12-27	WOS:000323733800089
J	Wang, H; Song, K; Chen, ZG; Yu, YM				Wang, Hong; Song, Kang; Chen, Zenggan; Yu, Yanmin			Poor Metabolizers at the Cytochrome P450 2C19 Loci Is at Increased Risk of Developing Cancer in Asian Populations	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; JAPANESE PATIENTS; GENOTYPE ANALYSIS; BLADDER-CANCER; GASTRIC-CANCER; LUNG-CANCER; PHASE-I; CYP2C19; ASSOCIATION; ENZYMES	Background: CYP2C19 encodes a member of the cytochrome P450 superfamily of enzymes, which play a central role in activating and detoxifying many carcinogens and endogenous compounds thought to be involved in the development of cancer. In the past decade, two common polymorphisms among CYP2C19 (CYP2C19*2 and CYP2C19*3) that are responsible for the poor metabolizers (PMs) phenotype in humans and cancer susceptibility have been investigated extensively; however, these studies have yielded contradictory results. Methods and Results: To investigate this inconsistency, we conducted a comprehensive meta-analysis of 11,554 cases and 16,592 controls from 30 case-control studies. Overall, the odds ratio (OR) of cancer was 1.52 [95% confidence interval (CI): 1.23-1.88, P<10(-4)] for CYP2C19 PMs genotypes. However, this significant association vanished when the analyses were restricted to 5 larger studies (no. of cases >= 500 cases). In the subgroup analysis for different cancer types, PMs genotypes had an effect of increasing the risks of esophagus cancer, gastric cancer, lung cancer and hepatocellular carcinoma as well as head neck cancer. Significant results were found in Asian populations when stratified by ethnicity; whereas no significant associations were found among Caucasians. Stratified analyses according to source of controls, significant associations were found only in hospital base controls. Conclusions: Our meta-analysis suggests that the CYP2C19 PMs genotypes most likely contributes to cancer susceptibility, particularly in the Asian populations.	[Wang, Hong] Fudan Univ, Dept Gen Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Song, Kang] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Chen, Zenggan] Fudan Univ, Dept Orthoped, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Yu, Yanmin] Huangpu Cent Hosp Shanghai, Dept Breast Surg, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Chen, ZG (corresponding author), Fudan Univ, Dept Orthoped, Zhongshan Hosp, Shanghai 200433, Peoples R China.	Zenggan_Chen01@163.com; Yanmin_Yu001@163.com	Yu, Yan/GYV-4514-2022					Brockmoller J, 1996, CANCER RES, V56, P3915; Chang FH, 2010, ZHONGGUO YAO LI TONG, V27, P22; Chang-Claude J, 2010, BREAST CANCER RES TR, V119, P463, DOI 10.1007/s10549-009-0407-0; Chau TKH, 2000, LIFE SCI, V67, P1719, DOI 10.1016/S0024-3205(00)00757-8; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Feng J, 2011, GENET MOL RES, V10, P3331, DOI 10.4238/2011.December.5.9; Fujita K, 2001, ENVIRON MOL MUTAGEN, V38, P339, DOI 10.1002/em.10036; Gan CQ, 2011, GENET MOL RES, V10, P3514, DOI 10.4238/2011.December.5.3; Gao CM, 2002, CANCER EPIDEM BIOMAR, V11, P29; Gemignani F, 2007, CARCINOGENESIS, V28, P1287, DOI 10.1093/carcin/bgm021; Goldstein JA, 2001, BRIT J CLIN PHARMACO, V52, P349, DOI 10.1046/j.0306-5251.2001.01499.x; Gra OA, 2008, AM J HEMATOL, V83, P279, DOI 10.1002/ajh.21113; GUENGERICH FP, 1992, PHARMACOL THERAPEUT, V54, P17; Isomura Y, 2010, J GASTROENTEROL, V45, P1045, DOI 10.1007/s00535-010-0246-0; Jiang W, 2008, WEI CHANG BING XUE, V13, P39; Justenhoven C, 2009, BREAST CANCER RES TR, V115, P391, DOI 10.1007/s10549-008-0076-4; Kappers WA, 2001, TOXICOL APPL PHARM, V177, P68, DOI 10.1006/taap.2001.9294; Khedhaier A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-109; Kubota T, 1996, CLIN PHARMACOL THER, V60, P661, DOI 10.1016/S0009-9236(96)90214-3; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Mochizuki J, 2005, J GASTROEN HEPATOL, V20, P1191, DOI 10.1111/j.1440-1746.2005.03808.x; Roddam PL, 2000, PHARMACOGENETICS, V10, P605, DOI 10.1097/00008571-200010000-00004; Saadat I, 2001, CANCER LETT, V169, P21, DOI 10.1016/S0304-3835(01)00550-X; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Sainz J, 2011, ENDOCR-RELAT CANCER, V18, P265, DOI 10.1530/ERC-10-0264; Sameer AEI, 2009, J POPUL THER CLIN PH, V16, pE156; Shi WX, 2004, WORLD J GASTROENTERO, V10, P1961, DOI 10.3748/wjg.v10.i13.463; Sugimoto M, 2005, ALIMENT PHARM THER, V22, P1033, DOI 10.1111/j.1365-2036.2005.02678.x; Sugimoto M, 2004, CLIN PHARMACOL THER, V76, P290, DOI 10.1016/j.clpt.2004.06.008; Sugiyama A, 1998, CANCER RES, V58, P2067; Suzuki S, 2004, J GASTROENTEROL, V39, P220, DOI 10.1007/s00535-003-1281-x; Tamer L, 2006, J GASTROINTEST CANC, V37, P1, DOI 10.1385/IJGC:37:1:1; Tsuneoka Y, 1996, LIFE SCI, V59, P1711, DOI 10.1016/S0024-3205(96)00507-3; Wadelius M, 1999, PHARMACOGENETICS, V9, P333, DOI 10.1097/00008571-199906000-00008; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Wen H, 2009, INT UROL NEPHROL, V41, P855, DOI 10.1007/s11255-009-9560-y; Wu ML, 2006, MED SCI MONITOR, V12, pBR174; [邢东亮 XING Dongliang], 2006, [郑州大学学报. 医学版, Journal of Zhengzhou University.Medical Sciences], V41, P285; Yadav SS, 2008, MUTAT RES-FUND MOL M, V644, P31, DOI 10.1016/j.mrfmmm.2008.06.010; Yamazaki Y, 2004, MUTAT RES-GEN TOX EN, V562, P151, DOI 10.1016/j.mrgentox.2004.06.003; Yang ZF, 2008, ZHONGLIU YAN JIU YU, V20, P65; Zhang LiWei, 2009, Journal of Practical Oncology, V24, P232; Zhou YH, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/92642	45	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73126	10.1371/journal.pone.0073126	http://dx.doi.org/10.1371/journal.pone.0073126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015291	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200067
J	del Alamo, JC; Meili, R; Alvarez-Gonzalez, B; Alonso-Latorre, B; Bastounis, E; Firtel, R; Lasheras, JC				del Alamo, Juan C.; Meili, Ruedi; Alvarez-Gonzalez, Begona; Alonso-Latorre, Baldomero; Bastounis, Effie; Firtel, Richard; Lasheras, Juan C.			Three-Dimensional Quantification of Cellular Traction Forces and Mechanosensing of Thin Substrata by Fourier Traction Force Microscopy	PLOS ONE			English	Article							CELLS; RATIO; MIGRATION; RIGIDITY; STRESSES	We introduce a novel three-dimensional (3D) traction force microscopy (TFM) method motivated by the recent discovery that cells adhering on plane surfaces exert both in-plane and out-of-plane traction stresses. We measure the 3D deformation of the substratum on a thin layer near its surface, and input this information into an exact analytical solution of the elastic equilibrium equation. These operations are performed in the Fourier domain with high computational efficiency, allowing to obtain the 3D traction stresses from raw microscopy images virtually in real time. We also characterize the error of previous two-dimensional (2D) TFM methods that neglect the out-of-plane component of the traction stresses. This analysis reveals that, under certain combinations of experimental parameters (cell size, substratums' thickness and Poisson's ratio), the accuracy of 2D TFM methods is minimally affected by neglecting the out-of-plane component of the traction stresses. Finally, we consider the cell's mechanosensing of substratum thickness by 3D traction stresses, finding that, when cells adhere on thin substrata, their out-of-plane traction stresses can reach four times deeper into the substratum than their in-plane traction stresses. It is also found that the substratum stiffness sensed by applying out-of-plane traction stresses may be up to 10 times larger than the stiffness sensed by applying in-plane traction stresses.	[del Alamo, Juan C.; Meili, Ruedi; Alvarez-Gonzalez, Begona; Alonso-Latorre, Baldomero; Bastounis, Effie; Lasheras, Juan C.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [del Alamo, Juan C.; Lasheras, Juan C.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Meili, Ruedi; Bastounis, Effie; Firtel, Richard] Univ Calif San Diego, Div Cell & Dev Biol, La Jolla, CA 92093 USA; [Bastounis, Effie; Lasheras, Juan C.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	del Alamo, JC (corresponding author), Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA.	jalamo@ucsd.edu	del Alamo, Juan C./ABB-7702-2021; Bastounis, Effie/K-1905-2019	del Alamo, Juan C./0000-0001-5683-0239; Bastounis, Effie/0000-0003-3656-7888	National Institutes of Health [USPHS 1R01GM084227]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037830, R01GM084227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants USPHS 1R01GM084227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Latorre B, 2010, THESIS; Aung A, 2012, BIOPHYS J, V102, p706A, DOI 10.1016/j.bpj.2011.11.3833; Bastounis E, 2011, MOL BIOL CELL TBD TB; Beningo KA, 2002, METHOD CELL BIOL, V69, P325, DOI 10.1016/S0091-679X(02)69021-1; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Chippada U, 2010, J MATER RES, V25, P545, DOI 10.1557/JMR.2010.0067; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; Dembo M, 1996, BIOPHYS J, V70, P2008, DOI 10.1016/S0006-3495(96)79767-9; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Hur SS, 2012, P NATL ACAD SCI; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; Kevorkian J, 2010, APPL MATH SCI; Landau L. D., 1999, THEORY ELASTICITY; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340; LI Y, 1993, J APPL POLYM SCI, V50, P1107, DOI 10.1002/app.1993.070500619; Lin YC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041918; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Maloney JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041923; Maskarinec SA, 2009, P NATL ACAD SCI; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Rabodzey A, 2008, BIOPHYS J, V95, P1428, DOI 10.1529/biophysj.107.119156; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z; Takigawa T, 1996, POLYM GELS NETW, V4, P1, DOI 10.1016/0966-7822(95)00013-5; Trepat X, 2009, NATURE PHYS; Vincent LG, 2012, BIOPHYS J, V102, p716A, DOI 10.1016/j.bpj.2011.11.3886; Yip AK, 2013, BIOPHYS J, V104, P19, DOI 10.1016/j.bpj.2012.11.3805	33	64	64	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e69850	10.1371/journal.pone.0069850	http://dx.doi.org/10.1371/journal.pone.0069850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023712	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600004
J	Del-Corso, A; Balestri, F; Di Bugno, E; Moschini, R; Cappiello, M; Sartini, S; La-Motta, C; Da-Settimo, F; Mura, U				Del-Corso, Antonella; Balestri, Francesco; Di Bugno, Elisa; Moschini, Roberta; Cappiello, Mario; Sartini, Stefania; La-Motta, Concettina; Da-Settimo, Federico; Mura, Umberto			A New Approach to Control the Enigmatic Activity of Aldose Reductase	PLOS ONE			English	Article							ACETIC-ACID DERIVATIVES; BOVINE LENS; LIPID-PEROXIDATION; DIABETIC COMPLICATIONS; OXIDATIVE STRESS; KETO REDUCTASES; INDUCED RELEASE; MOLECULAR-BASIS; POLYOL PATHWAY; INHIBITORS	Aldose reductase (AR) is an NADPH-dependent reductase, which acts on a variety of hydrophilic as well as hydrophobic aldehydes. It is currently defined as the first enzyme in the so-called polyol pathway, in which glucose is transformed into sorbitol by AR and then to fructose by an NAD(+)-dependent dehydrogenase. An exaggerated flux of glucose through the polyol pathway (as can occur in diabetes) with the subsequent accumulation of sorbitol, was originally proposed as the basic event in the aethiology of secondary diabetic complications. For decades this has meant targeting the enzyme for a specific and strong inhibition. However, the ability of AR to reduce toxic alkenals and alkanals, which are products of oxidative stress, poses the question of whether AR might be better classified as a detoxifying enzyme, thus raising doubts as to the unequivocal advantages of inhibiting the enzyme. This paper provides evidence of the possibility for an effective intervention on AR activity through an intra-site differential inhibition. Examples of a new generation of aldose reductase "differential" inhibitors (ARDIs) are presented, which can preferentially inhibit the reduction of either hydrophilic or hydrophobic substrates. Some selected inhibitors are shown to preferentially inhibit enzyme activity on glucose or glyceraldehyde and 3-glutathionyl-4-hydroxy-nonanal, but are less effective in reducing 4-hydroxy-2-nonenal. We question the efficacy of D, L-glyceraldehyde, the substrate commonly used in in vitro inhibition AR studies, as an in vitro reference AR substrate when the aim of the investigation is to impair glucose reduction.	[Del-Corso, Antonella; Balestri, Francesco; Di Bugno, Elisa; Moschini, Roberta; Cappiello, Mario; Mura, Umberto] Univ Pisa, Biochem Unit, Dept Biol, Pisa, Italy; [Sartini, Stefania; La-Motta, Concettina; Da-Settimo, Federico] Univ Pisa, Dept Pharmaceut Sci, Pisa, Italy	University of Pisa; University of Pisa	Mura, U (corresponding author), Univ Pisa, Biochem Unit, Dept Biol, Pisa, Italy.	umura@biologia.unipi.it	Cappiello, Mario/L-3877-2019; Moschini, Roberta/AAL-8338-2020; Da Settimo, Federico/M-1451-2015; LA MOTTA, Concettina/M-3821-2015	Moschini, Roberta/0000-0001-5227-2348; Da Settimo, Federico/0000-0002-7897-7917; LA MOTTA, Concettina/0000-0002-0194-5431; Mura, Umberto/0000-0001-8280-6275; CAPPIELLO, MARIO/0000-0002-8864-5043; balestri, francesco/0000-0003-3758-8517; DEL CORSO, ANTONELLA/0000-0003-3165-6128; Sartini, Stefania/0000-0002-7671-5243	Pisa University; Opocrin, S.p.A. (Modena, Italy)	Pisa University; Opocrin, S.p.A. (Modena, Italy)	This work was supported in part by Pisa University and in part by Opocrin, S.p.A. (Modena, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, CURR MED CHEM, V16, P734, DOI 10.2174/092986709787458362; BHATNAGAR A, 1994, BBA-PROTEIN STRUCT M, V1205, P207, DOI 10.1016/0167-4838(94)90235-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bresson E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00098; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; CAPPIELLO M, 1994, EXP EYE RES, V58, P491, DOI 10.1006/exer.1994.1042; CAPPIELLO M, 1995, BIOCHEM BIOPH RES CO, V207, P775, DOI 10.1006/bbrc.1995.1254; Cappiello M, 2000, EXP EYE RES, V70, P795, DOI 10.1006/exer.2000.0838; Chung SSM, 2005, CURR DRUG TARGETS, V6, P475, DOI 10.2174/1389450054021891; Costantino L, 1996, J MED CHEM, V39, P4396, DOI 10.1021/jm960124f; Da Settimo F, 2005, J MED CHEM, V48, P6897, DOI 10.1021/jm050382p; Da Settimo F, 2001, J MED CHEM, V44, P4359, DOI 10.1021/jm0109210; DaSettimo A, 1996, FARMACO, V51, P261; Del Corso A, 2000, EXP EYE RES, V71, P515, DOI 10.1006/exer.2000.0906; Del Corso A, 2008, CURR MED CHEM, V15, P1452; Del Corso A, 1998, ARCH BIOCHEM BIOPHYS, V350, P245; DELCORSO A, 1990, ARCH BIOCHEM BIOPHYS, V283, P512, DOI 10.1016/0003-9861(90)90675-O; El-Kabbani O, 2004, CELL MOL LIFE SCI, V61, P750, DOI 10.1007/s00018-003-3403-2; Endo S, 2013, CHEM-BIOL INTERACT, V202, P146, DOI 10.1016/j.cbi.2012.11.026; Endo S, 2009, ARCH BIOCHEM BIOPHYS, V487, P1, DOI 10.1016/j.abb.2009.05.009; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Foppiano M, 1997, LANCET, V349, P399, DOI 10.1016/S0140-6736(97)80018-9; GABBAY KH, 1972, P NATL ACAD SCI USA, V69, P1435, DOI 10.1073/pnas.69.6.1435; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; GREENE DA, 1993, DIABETES METAB REV, V9, P189, DOI 10.1002/dmr.5610090304; GRIMSHAW CE, 1992, BIOCHEMISTRY-US, V31, P10139, DOI 10.1021/bi00157a001; Hamada Y, 1996, BIOCHEM BIOPH RES CO, V228, P539, DOI 10.1006/bbrc.1996.1695; HAYMAN S, 1965, J BIOL CHEM, V240, P877; HERS HG, 1956, BIOCHIM BIOPHYS ACTA, V22, P202, DOI 10.1016/0006-3002(56)90247-5; Hirakawa H, 2009, J BIOCHEM, V146, P51, DOI 10.1093/jb/mvp042; Inoue J, 2000, BIOORGAN MED CHEM, V8, P2167, DOI 10.1016/S0968-0896(00)00158-9; JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117; KIM TH, 2013, BIOMED RES INT, V2013, P8, DOI DOI 10.1155/2013/727143.PUBMED:23586057; KINOSHIT.JH, 1974, INVEST OPHTH VISUAL, V13, P713; KRANS HMJ, 1993, DIABETIC MED, V10, pS44, DOI 10.1111/j.1464-5491.1993.tb00198.x; Kumar H, 2012, J MOL MODEL, V18, P1791, DOI 10.1007/s00894-011-1195-0; La Motta C, 2008, J MED CHEM, V51, P3182, DOI 10.1021/jm701613h; La Motta C, 2007, J MED CHEM, V50, P4917, DOI 10.1021/jm070398a; Laffin B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00104; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Ottana R, 2011, EUR J MED CHEM, V46, P2797, DOI 10.1016/j.ejmech.2011.03.068; Pandey S, 2012, EXPERT OPIN INV DRUG, V21, P329, DOI 10.1517/13543784.2012.656198; PARK YS, 1991, BIOCHEM BIOPH RES CO, V175, P738, DOI 10.1016/0006-291X(91)91628-P; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; Petrash JM, 1997, ADV EXP MED BIOL, V414, P465; Primofiore G, 1997, FARMACO, V52, P583; Ramana KV, 2006, J BIOL CHEM, V281, P33019, DOI 10.1074/jbc.M603819200; Ramana KV, 2010, INT J BIOCHEM CELL B, V42, P17, DOI 10.1016/j.biocel.2009.09.009; Ramana KV, 2000, BIOCHEMISTRY-US, V39, P12172, DOI 10.1021/bi000796e; SELWYN MJ, 1965, BIOCHIM BIOPHYS ACTA, V105, P193, DOI 10.1016/S0926-6593(65)80190-4; Shen Y, 2010, BIOCHIMIE, V92, P530, DOI 10.1016/j.biochi.2010.02.001; Srivastava S, 1999, BIOCHEMISTRY-US, V38, P42, DOI 10.1021/bi981794l; Srivastava S, 1995, BIOCHEM BIOPH RES CO, V217, P741, DOI 10.1006/bbrc.1995.2835; Srivastava S, 1998, BIOCHEM J, V329, P469, DOI 10.1042/bj3290469; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Steffgen J, 2003, NEPHROL DIAL TRANSPL, V18, P2255, DOI 10.1093/ndt/gfg397; STEVENS VJ, 1977, J BIOL CHEM, V252, P2998; Tang WH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00087; VANDERJAGT DL, 1990, J BIOL CHEM, V265, P10912; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; WERMUTH B, 1983, EUR J BIOCHEM, V131, P423, DOI 10.1111/j.1432-1033.1983.tb07280.x; Zheng XH, 2012, FEBS LETT, V586, P55, DOI 10.1016/j.febslet.2011.11.023	62	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74076	10.1371/journal.pone.0074076	http://dx.doi.org/10.1371/journal.pone.0074076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019949	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200092
J	Lindstrom, R; Lindholm, P; Kallijarvi, J; Yu, LY; Piepponen, TP; Arumae, U; Saarma, M; Heino, TI				Lindstrom, Riitta; Lindholm, Paivi; Kallijarvi, Jukka; Yu, Li-ying; Piepponen, T. Petteri; Arumae, Urmas; Saarma, Mart; Heino, Tapio I.			Characterization of the Structural and Functional Determinants of MANF/CDNF in Drosophila In Vivo Model	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NEUROTROPHIC FACTOR; CDNF PROTECTS; MANF; STRESS; EXPRESSION; MARKER; SYSTEM; FAMILY; DOMAIN	Mammalian MANF and CDNF proteins are evolutionarily conserved neurotrophic factors that can protect and repair mammalian dopaminergic neurons in vivo. In Drosophila, the sole MANF protein (DmManf) is needed for the maintenance of dopaminergic neurites and dopamine levels. Although both secreted and intracellular roles for MANF and CDNF have been demonstrated, very little is known about the molecular mechanism of their action. Here, by using a transgenic rescue approach in the DmManf mutant background we show that only full-length MANF containing both the amino-terminal saposin-like and carboxy-terminal SAP-domains can rescue the larval lethality of the DmManf mutant. Independent N- or C-terminal domains of MANF, even when co-expressed together, fail to rescue. Deleting the signal peptide or mutating the CXXC motif in the C-terminal domain destroys the activity of full-length DmManf. Positively charged surface amino acids and the C-terminal endoplasmic reticulum retention signal are necessary for rescue of DmManf mutant lethality when DmManf is expressed in a restricted pattern. Furthermore, rescue experiments with non-ubiquitous expression reveals functional differences between the C-terminal domain of human MANF and CDNF. Finally, DmManf and its C-terminal domain rescue mammalian sympathetic neurons from toxin-induced apoptosis in vitro demonstrating functional similarity of the mammalian and fly proteins. Our study offers further insights into the functional conservation between invertebrate and mammalian MANF/CDNF proteins and reveals the importance of the C-terminal domain for MANF activity in vivo.	[Lindstrom, Riitta; Heino, Tapio I.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Lindholm, Paivi; Kallijarvi, Jukka; Yu, Li-ying; Arumae, Urmas; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Piepponen, T. Petteri] Univ Helsinki, Fac Pharm, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Heino, TI (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	tapio.heino@helsinki.fi	Arumäe, Urmas/E-8290-2016; Kallijarvi, Jukka/AAV-5091-2021; Lindström, Riitta/K-4448-2015	Arumäe, Urmas/0000-0003-3658-6464; Kallijarvi, Jukka/0000-0003-3773-7025; Lindström, Riitta/0000-0001-5177-0564; Pulkkila, Paivi/0000-0003-3022-5035; Piepponen, Petteri/0000-0002-2318-1612	Viikki Doctoral Programme in Molecular Biosciences; Finnish Parkinson Foundation; Ella and Georg Ehrnrooth Foundation; University of Helsinki Funds; Alfred Kordelin Foundation; Academy of Finland [139910]	Viikki Doctoral Programme in Molecular Biosciences; Finnish Parkinson Foundation; Ella and Georg Ehrnrooth Foundation; University of Helsinki Funds; Alfred Kordelin Foundation; Academy of Finland(Academy of Finland)	RL was supported by Viikki Doctoral Programme in Molecular Biosciences (http://www.helsinki.fi/vgsb/), The Finnish Parkinson Foundation (http://www.parkinsonsaatio.fi/), The Ella and Georg Ehrnrooth Foundation (http://www.ellageorg.fi/), The University of Helsinki Funds, and Alfred Kordelin Foundation (http://www.kordelin.fi/). PL was supported by The Academy of Finland (grant No. 139910; http://www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Airavaara M, 2006, SYNAPSE, V59, P321, DOI 10.1002/syn.20245; Airavaara M, 2012, CELL TRANSPLANT, V21, P1213, DOI 10.3727/096368911X600948; Airavaara M, 2010, EXP NEUROL, V225, P104, DOI 10.1016/j.expneurol.2010.05.020; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; BIRMAN S, 1994, J BIOL CHEM, V269, P26559; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Hoseki J, 2010, FEBS LETT, V584, P1536, DOI 10.1016/j.febslet.2010.03.008; LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009	29	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73928	10.1371/journal.pone.0073928	http://dx.doi.org/10.1371/journal.pone.0073928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019940	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200083
J	Malmstrom, M; Jentoft, S; Gregers, TF; Jakobsen, KS				Malmstrom, Martin; Jentoft, Sissel; Gregers, Tone F.; Jakobsen, Kjetill S.			Unraveling the Evolution of the Atlantic Cod's (Gadus morhua L.) Alternative Immune Strategy	PLOS ONE			English	Article							MHC CLASS-I; MAJOR HISTOCOMPATIBILITY COMPLEX; CROSS-PRESENTATION; RAINBOW-TROUT; MOLECULES; ANTIGEN; POLYMORPHISM; GENES; LOCI; INFERENCE	Genes encoding the major histocompatibility complex (MHC) have been thought to play a vital role in the adaptive immune system in all vertebrates. The discovery that Atlantic cod (Gadus morhua) has lost important components of the MHC II pathway, accompanied by an unusually high number of MHC I genes, shed new light on the evolution and plasticity of the immune system of teleosts as well as in higher vertebrates. The overall aim of this study was to further investigate the highly expanded repertoire of MHC I genes using a cDNA approach to obtain sequence information of both the binding domains and the sorting signaling potential in the cytoplasmic tail. Here we report a novel combination of two endosomal sorting motifs, one tyrosine-based associated with exogenous peptide presentation by cross-presenting MHCI molecules, and one dileucine-based associated with normal MHC II functionality. The two signal motifs were identified in the cytoplasmic tail in a subset of the genes. This indicates that these genes have evolved MHC II-like functionality, allowing a more versatile use of MHC I through cross-presentation. Such an alternative immune strategy may have arisen through adaptive radiation and acquisition of new gene function as a response to changes in the habitat of its ancestral lineage.	[Malmstrom, Martin; Jentoft, Sissel; Jakobsen, Kjetill S.] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Gregers, Tone F.] Univ Oslo, Dept Biosci, CIR, Oslo, Norway	University of Oslo; University of Oslo	Jakobsen, KS (corresponding author), Univ Oslo, Dept Biosci, CEES, Oslo, Norway.	k.s.jakobsen@bio.uio.no		Jentoft, Sissel/0000-0001-8707-531X	Norwegian Research Council [187940/S10]; University of Oslo, EMBIO	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Oslo, EMBIO	Supported by Norwegian Research Council grant# 187940/S10 and University of Oslo, EMBIO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Bakke O, 1999, IMMUNOL REV, V172, P171, DOI 10.1111/j.1600-065X.1999.tb01365.x; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; BingulacPopovic J, 1997, IMMUNOGENETICS, V46, P129, DOI 10.1007/s002510050251; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Breitfeld PP, 1989, CURR OPIN CELL BIOL, V1, P617, DOI 10.1016/0955-0674(89)90024-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dijkstra JM, 2006, IMMUNOGENETICS, V58, P152, DOI 10.1007/s00251-006-0086-5; DUPASQUIER L, 1992, APMIS, V100, P383; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; ESPELID S, 1991, J FISH DIS, V14, P185, DOI 10.1111/j.1365-2761.1991.tb00588.x; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Hansen JD, 1999, J IMMUNOL, V163, P774; Hashimoto K, 1999, IMMUNOL REV, V167, P81, DOI 10.1111/j.1600-065X.1999.tb01384.x; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Klein J, 1998, CYTOGENET CELL GENET, V80, P123, DOI 10.1159/000014967; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; Landsverk OJB, 2009, SCAND J IMMUNOL, V70, P184, DOI 10.1111/j.1365-3083.2009.02301.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Lizee G, 2005, TRENDS IMMUNOL, V26, P141, DOI 10.1016/j.it.2005.01.005; Lukacs MF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-154; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Malaga-Trillo E, 1998, GENETICS, V149, P1527; Matsuo MY, 2002, IMMUNOGENETICS, V53, P930, DOI 10.1007/s00251-001-0427-3; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mikkelsen H, 2011, FISH SHELLFISH IMMUN, V30, P330, DOI 10.1016/j.fsi.2010.11.007; Miller KM, 1998, IMMUNOL REV, V166, P279, DOI 10.1111/j.1600-065X.1998.tb01269.x; Miller KM, 2002, IMMUNOGENETICS, V53, P941, DOI 10.1007/s00251-001-0398-4; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ohta Y, 2000, P NATL ACAD SCI USA, V97, P4712, DOI 10.1073/pnas.97.9.4712; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Pamer Eric G., 1993, Trends in Microbiology, V1, P35, DOI 10.1016/0966-842X(93)90023-K; Persson AC, 1999, IMMUNOGENETICS, V50, P49, DOI 10.1007/s002510050685; Pilstrom L, 2005, FISHERIES SCI, V71, P961, DOI 10.1111/j.1444-2906.2005.01052.x; Ramachandra L, 2009, CURR OPIN IMMUNOL, V21, P98, DOI 10.1016/j.coi.2009.01.001; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sato A, 1997, IMMUNOGENETICS, V46, P63, DOI 10.1007/s002510050243; Sato A, 2000, IMMUNOGENETICS, V51, P108, DOI 10.1007/s002510050019; Schluter SF, 1999, DEV COMP IMMUNOL, V23, P107; Schroder MB, 2009, FISH SHELLFISH IMMUN, V27, P112, DOI 10.1016/j.fsi.2008.11.016; Silva DSP, 2007, MOL IMMUNOL, V44, P3758, DOI 10.1016/j.molimm.2007.03.025; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Star B, 2012, BIOESSAYS, V34, P648, DOI 10.1002/bies.201200005; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zou LY, 2009, P NATL ACAD SCI USA, V106, P15801, DOI 10.1073/pnas.0905684106	61	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74004	10.1371/journal.pone.0074004	http://dx.doi.org/10.1371/journal.pone.0074004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019946	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200089
J	Singh, SK; Sethi, S; Aravamudhan, S; Kruger, M; Grabher, C				Singh, Sachin Kumar; Sethi, Sachin; Aravamudhan, Sriram; Krueger, Marcus; Grabher, Clemens			Proteome Mapping of Adult Zebrafish Marrow Neutrophils Reveals Partial Cross Species Conservation to Human Peripheral Neutrophils	PLOS ONE			English	Article							MS/MS ANALYSIS; PROTEINS; PROFILE; REGENERATION; DISEASE; BIOLOGY; DAMAGE; ROLES; CELLS; S100	Neutrophil granulocytes are pivotal cells within the first line of host defense of the innate immune system. In this study, we have used a gel-based LC-MS/MS approach to explore the proteome of primary marrow neutrophils from adult zebrafish. The identified proteins originated from all major cellular compartments. Gene ontology analysis revealed significant association of proteins with different immune-related network and pathway maps. 75% of proteins identified in neutrophils were identified in neutrophils only when compared to neutrophil-free brain tissue. Moreover, cross-species comparison with human peripheral blood neutrophils showed partial conservation of immune-related proteins between human and zebrafish. This study provides the first zebrafish neutrophil proteome and may serve as a valuable resource for an understanding of neutrophil biology and innate immunity.	[Singh, Sachin Kumar; Sethi, Sachin; Grabher, Clemens] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Aravamudhan, Sriram; Krueger, Marcus] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society	Grabher, C (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany.	clemens.grabher@gmail.com		Sethi, Sachin/0000-0002-7090-0659	International Reintegration Grant within the Seventh European Community Framework Program [PIRG07-GA-2010-267552]; KIT/MWK Baden-Wurttemberg Research Seed Capital Award	International Reintegration Grant within the Seventh European Community Framework Program; KIT/MWK Baden-Wurttemberg Research Seed Capital Award	This work was supported by an International Reintegration Grant within the Seventh European Community Framework Program (PIRG07-GA-2010-267552) and a KIT/MWK Baden-Wurttemberg Research Seed Capital Award to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crowhurst MO, 2002, INT J DEV BIOL, V46, P483; De Souza AG, 2009, ZEBRAFISH, V6, P229, DOI 10.1089/zeb.2009.0591; Ellett F, 2010, CURR OPIN PHARMACOL, V10, P563, DOI 10.1016/j.coph.2010.05.004; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hermann A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00067; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kato A, 2008, BIOCHEM J, V414, P261, DOI 10.1042/BJ20071655; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lu T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00365; Luerman GC, 2010, J PROTEOMICS, V73, P552, DOI 10.1016/j.jprot.2009.06.013; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Perskvist N, 2002, RAB5A GTPASE REGULAT; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Renshaw SA, 2012, DIS MODEL MECH, V5, P38, DOI 10.1242/dmm.007138; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Saxena S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014118; Saxena S, 2011, J PROTEOMICS, V74, P2937, DOI 10.1016/j.jprot.2011.07.021; Singh S. K., 2010, J PROTEOM BIOINFORM, V3, P135, DOI DOI 10.4172/JPB.1000132; Singh SK, 2011, J SEP SCI, V34, P225, DOI 10.1002/jssc.201000626; Singh SK, 2010, ZEBRAFISH, V7, P169, DOI 10.1089/zeb.2010.0657; Stow JL, 2013, CYTOKINE GROWTH F R, V24, P227, DOI 10.1016/j.cytogfr.2013.04.001; Svahn AJ, 2013, DEV NEUROBIOL, V73, P60, DOI 10.1002/dneu.22039; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Tomazella GG, 2010, J PROTEOME RES, V9, P2030, DOI 10.1021/pr1000253; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang N, 2007, J PROTEOME RES, V6, P263, DOI 10.1021/pr060367o; Xiong XP, 2011, DEV COMP IMMUNOL, V35, P431, DOI 10.1016/j.dci.2010.11.006; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154	40	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73998	10.1371/journal.pone.0073998	http://dx.doi.org/10.1371/journal.pone.0073998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019943	Green Published, gold			2022-12-27	WOS:000324338200086
J	Tyler, CR; Allan, AM				Tyler, Christina R.; Allan, Andrea M.			Adult Hippocampal Neurogenesis and mRNA Expression are Altered by Perinatal Arsenic Exposure in Mice and Restored by Brief Exposure to Enrichment	PLOS ONE			English	Article							SODIUM ARSENITE; RAT HIPPOCAMPUS; ALCOHOL EXPOSURE; DENTATE GYRUS; LEAD-EXPOSURE; INTELLECTUAL FUNCTION; CELL-PROLIFERATION; GENE-EXPRESSION; NMDA RECEPTOR; BRAIN	Arsenic is a common and pervasive environmental contaminant found in drinking water in varying concentrations depending on region. Exposure to arsenic induces behavioral and cognitive deficits in both human populations and in rodent models. The Environmental Protection Agency (EPA) standard for the allotment of arsenic in drinking water is in the parts-per-billion range, yet our lab has shown that 50 ppb arsenic exposure during development can have far-reaching consequences into adulthood, including deficits in learning and memory, which have been linked to altered adult neurogenesis. Given that the morphological impact of developmental arsenic exposure on the hippocampus is unknown, we sought to evaluate proliferation and differentiation of adult neural progenitor cells in the dentate gyrus after 50 ppb arsenic exposure throughout the perinatal period of development in mice (equivalent to all three trimesters in humans) using a BrdU pulse-chase assay. Proliferation of the neural progenitor population was decreased by 13% in arsenic-exposed mice, but was not significant. However, the number of differentiated cells was significantly decreased by 41% in arsenic-exposed mice compared to controls. Brief, daily exposure to environmental enrichment significantly increased proliferation and differentiation in both control and arsenic-exposed animals. Expression levels of 31% of neurogenesis-related genes including those involved in Alzheimer's disease, apoptosis, axonogenesis, growth, Notch signaling, and transcription factors were altered after arsenic exposure and restored after enrichment. Using a concentration previously considered safe by the EPA, perinatal arsenic exposure altered hippocampal morphology and gene expression, but did not inhibit the cellular neurogenic response to enrichment. It is possible that behavioral deficits observed during adulthood in animals exposed to arsenic during development derive from the lack of differentiated neural progenitor cells necessary for hippocampal-dependent learning. This study is the first to determine the impact of arsenic exposure during development on adult hippocampal neurogenesis and related gene expression.	[Tyler, Christina R.; Allan, Andrea M.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico	Allan, AM (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	aallan@salud.unm.edu	Allan, Andrea M/L-8919-2015; Calderon, Jaqueline/B-5841-2014	Calderon, Jaqueline/0000-0002-7865-3357; Steadman, Christina/0000-0002-9672-5529; Allan, Andrea/0000-0002-6745-4352	National Institute of Environmental Health Sciences [1RO1ES019583-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH101984] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by 1RO1ES019583-01 (Andrea Allan) from the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Abrous DN, 2002, J NEUROSCI, V22, P3656; Aung KH, 2013, NEUROTOXICOLOGY, V34, P226, DOI 10.1016/j.neuro.2012.09.008; Brady ML, 2013, J NEUROSCI, V33, P1062, DOI 10.1523/JNEUROSCI.1217-12.2013; Brinkel J, 2009, INT J ENV RES PUB HE, V6, P1609, DOI 10.3390/ijerph6051609; Calderon J, 2001, ENVIRON RES, V85, P69, DOI 10.1006/enrs.2000.4106; Chattopadhyay S, 2002, TOXICOL LETT, V128, P73, DOI 10.1016/S0378-4274(01)00535-5; Choi IY, 2005, ALCOHOL CLIN EXP RES, V29, P2053, DOI 10.1097/01.alc.0000187037.02670.59; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dhar P, 2007, TOXICOLOGY, V234, P10, DOI 10.1016/j.tox.2007.01.024; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Falluel-Morel A, 2007, J NEUROCHEM, V103, P1968, DOI 10.1111/j.1471-4159.2007.04882.x; Fan Mei-Qing, 2013, Sichuan Da Xue Xue Bao Yi Xue Ban, V44, P53; Faustman EM, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110s5859; Frick KM, 2003, NEUROBIOL AGING, V24, P615, DOI 10.1016/S0197-4580(02)00138-0; Ghosal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011866; Gil-Mohapel J, 2011, BRAIN RES, V1384, P29, DOI 10.1016/j.brainres.2011.01.116; Gilbert ME, 2005, TOXICOL SCI, V86, P365, DOI 10.1093/toxsci/kfi156; Goggin SL, 2012, NEUROTOXICOLOGY, V33, P1338, DOI 10.1016/j.neuro.2012.08.010; Guo WX, 2011, NEURON, V70, P924, DOI 10.1016/j.neuron.2011.03.027; Hagihara H., 2009, J VIS EXP; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Hong GM, 2012, TOXICOL SCI, V129, P146, DOI 10.1093/toxsci/kfs186; Jaako-Movits K, 2005, INT J DEV NEUROSCI, V23, P627, DOI 10.1016/j.ijdevneu.2005.07.005; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Klintsova AY, 2007, ALCOHOL CLIN EXP RES, V31, P2073, DOI 10.1111/j.1530-0277.2007.00528.x; Koh S, 2007, EPILEPSY BEHAV, V10, P26, DOI 10.1016/j.yebeh.2006.11.008; Liu S, 2012, NEUROTOXICOLOGY, V33, P1033, DOI 10.1016/j.neuro.2012.04.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JH, 2012, TOXICOL LETT, V211, P39, DOI 10.1016/j.toxlet.2012.02.021; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Martinez EJ, 2008, NEUROTOXICOLOGY, V29, P647, DOI 10.1016/j.neuro.2008.05.004; Martinez L, 2011, NEUROCHEM INT, V58, P574, DOI 10.1016/j.neuint.2011.01.020; Martinez-Finley EJ, 2011, NEUROTOXICOL TERATOL, V33, P530, DOI 10.1016/j.ntt.2011.07.003; Martinez-Finley EJ, 2009, PHARMACOL BIOCHEM BE, V94, P271, DOI 10.1016/j.pbb.2009.09.006; NAGARAJA TN, 1994, HUM EXP TOXICOL, V13, P353, DOI 10.1177/096032719401300511; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; O'Bryant SE, 2011, INT J ENV RES PUB HE, V8, P861, DOI 10.3390/ijerph8030861; Piao FY, 2005, J OCCUP HEALTH, V47, P445, DOI 10.1539/joh.47.445; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Reichard JF, 2010, EPIGENOMICS-UK, V2, P87, DOI [10.2217/epi.09.45, 10.2217/EPI.09.45]; Rodriguez VM, 2002, NEUROTOXICOL TERATOL, V24, P743, DOI 10.1016/S0892-0362(02)00313-6; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Shimojo H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00078; Shingo AS, 2005, J NEURAL TRANSM, V112, P1475, DOI 10.1007/s00702-005-0370-2; Shors TJ, 2012, BEHAV BRAIN RES, V227, P450, DOI 10.1016/j.bbr.2011.04.023; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Sidhu JS, 2006, TOXICOL SCI, V89, P475, DOI 10.1093/toxsci/kfj032; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Veena J, 2011, J Nat Sci Biol Med, V2, P26, DOI 10.4103/0976-9668.82312; Veena J, 2009, J NEUROSCI RES, V87, P831, DOI 10.1002/jnr.21907; Verina T, 2007, NEUROSCIENCE, V145, P1037, DOI 10.1016/j.neuroscience.2006.12.040; von Ehrenstein OS, 2007, EPIDEMIOLOGY, V18, P44, DOI 10.1097/01.ede.0000248900.65613.a9; Wasserman GA, 2007, ENVIRON HEALTH PERSP, V115, P285, DOI 10.1289/ehp.9501; Xie J, 2011, J MOL CELL BIOL, V3, P250, DOI 10.1093/jmcb/mjq047; Yadav RS, 2011, NEUROTOXICOLOGY, V32, P760, DOI 10.1016/j.neuro.2011.07.004; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	59	46	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73720	10.1371/journal.pone.0073720	http://dx.doi.org/10.1371/journal.pone.0073720			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019935	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200077
J	Vila, B; Oms, O; Fondevilla, V; Gaete, R; Galobart, A; Riera, V; Canudo, JI				Vila, Bernat; Oms, Oriol; Fondevilla, Victor; Gaete, Rodrigo; Galobart, Angel; Riera, Violeta; Ignacio Canudo, Jose			The Latest Succession of Dinosaur Tracksites in Europe: Hadrosaur Ichnology, Track Production and Palaeoenvironments	PLOS ONE			English	Article							SOUTH-CENTRAL PYRENEES; FOOTPRINTS; DEPOSITS; ENVIRONMENTS; EXTINCTION; DIVERSITY; CATALONIA; LLEIDA	A comprehensive review and study of the rich dinosaur track record of the Tremp Formation in the southern Pyrenees of Spain (Southwestern Europe) shows a unique succession of footprint localities prior to the end-Cretaceous mass extinction event. A description of some 30 new tracksites and data on sedimentary environments, track occurrence and preservation, ichnology and chronostratigraphy are provided. These new track localities represent various facies types within a diverse set of fluvial environments. The footprint discoveries mostly represent hadrosaurian and, less abundantly, to sauropod dinosaurs. The hadrosaur tracks are significantly smaller in size than, but morphologically similar to, those of North America and Asia and are attributable to the ichnogenus Hadrosauropodus. The track succession, with more than 40 distinct track levels, indicates that hadrosaur footprints in the Ibero-Armorican region occur predominantly in the late Maaastrichtian (at least above the early Maastrichtian-late Maastrichtian boundary). The highest abundance is found noticeably found in the late Maastrichtian, with tracks occurring in the C29r magnetochron, within about the latest 300,000 years of the Cretaceous.	[Vila, Bernat; Ignacio Canudo, Jose] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Vila, Bernat; Galobart, Angel] Inst Catala Paleontol Miquel Crusafont, Barcelona, Spain; [Oms, Oriol; Fondevilla, Victor; Riera, Violeta] Univ Autonoma Barcelona, Fac Ciencies, Dept Geol Estratig, E-08193 Barcelona, Spain; [Gaete, Rodrigo] Museu Conca Della, Isona I Conca Della, Lleida, Spain	University of Zaragoza; Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona	Vila, B (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain.	bernat.vila@unizar.es	VILA, BERNAT/AAA-7367-2021; Galobart, Àngel À/H-5024-2011; Oms, Oriol/AAZ-6312-2020; Fondevilla, Víctor/F-5726-2015	VILA, BERNAT/0000-0002-5935-1732; Galobart, Àngel À/0000-0003-1508-4561; Fondevilla, Víctor/0000-0001-9355-2389; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155; Oms, Oriol/0000-0001-8355-847X	Committee for Research and Exploration of the National Geographic Society; Ministerio de Ciencia e Innovacion of Spain [CGL2011-30069-C02-01,02/BTE, CGL2010-16447]; European Regional Development Fund; Government of Catalonia ("Direccio General de Patrimoni Cultural, Departament de Cultura"); Government of Aragon ("Grupos Consolidados", and the "Direccion General de Patrimonio Cultural"); Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC)); Ministerio de Economia y Competitividad, (FPI) [BES-2012-052366]	Committee for Research and Exploration of the National Geographic Society(National Geographic Society); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Government of Catalonia ("Direccio General de Patrimoni Cultural, Departament de Cultura"); Government of Aragon ("Grupos Consolidados", and the "Direccion General de Patrimonio Cultural"); Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC))(Ministry of Science and Innovation, Spain (MICINN)); Ministerio de Economia y Competitividad, (FPI)	The research was partially funded by a grant from the Committee for Research and Exploration of the National Geographic Society. This paper is a contribution to the projects CGL2011-30069-C02-01,02/BTE and CGL2010-16447, subsidized by the Ministerio de Ciencia e Innovacion of Spain, the European Regional Development Fund, and the Governments of Catalonia ("Direccio General de Patrimoni Cultural, Departament de Cultura") and Aragon ("Grupos Consolidados", and the "Direccion General de Patrimonio Cultural"). B. Vila acknowledges support from the Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC) 2011). V. Fondevilla acknowledges support from the Ministerio de Economia y Competitividad, (FPI grant, BES-2012-052366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barco J.L., 2001, Geogaceta, V30, P235; Bridge J.S., 2006, SEPM SPECIAL PUBLICA, V84, P85, DOI [DOI 10.2110/PEC.06.84.0085, DOI 10.2110/PEC.06.84.0019]; Brusatte SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1815; Buffetaut Eric, 2005, Acta Palaeontologica Romaniae, V5, P39; Carpenter K, 1992, U WYOMING CONTRIBUTI, V29, P81; Casanovas-Cladellas M.L., 1995, Paleontologia i Evolucio, V26-27, P121; Cruzado-Caballero P., 2012, P 10 ANN M EUR ASS V, P45; Cruzado-Caballero P, 2010, CAN J EARTH SCI, V47, P1507, DOI 10.1139/E10-081; Cuevas J.L., 1992, ACTA GEOLOGICA HISPA, V27, P95; Currie P.J., 1989, P293; Currie Philip J., 2003, Ichnos, V10, P1, DOI 10.1080/10420940390235071; CURRIE PJ, 1991, CAN J EARTH SCI, V28, P102, DOI 10.1139/e91-009; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Dalla Vecchia FM, HADROSAURS IN PRESS; Diaz Molina M., 1987, ESTUD GEOL-MADRID, V43, P69; Difley Rose L., 2002, Palaios, V17, P327, DOI 10.1669/0883-1351(2002)017<0327:FOUSLD>2.0.CO;2; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Fastovsky D.E., 2005, GEOLOGICAL SOC AM TO, V15, P4; Gierlinski Gerard D., 2008, Oryctos, V8, P107; Godefroit P, 2009, NATURWISSENSCHAFTEN, V96, P495, DOI 10.1007/s00114-008-0499-0; Herrero-Santos E, 2008, 19 JORN PATR CULT RE, P37; Ishigaki S, 2009, GEOL Q, V53, P449; LELOUEFF J, 1994, GEOL MAG, V131, P625, DOI 10.1017/S0016756800012413; Llompart C., 1984, Acta Geologica Hispanica, V19, P143; LLOMPART C, 1979, Acta Geologica Hispanica, V14, P333; Llompart Carme, 2006, Revista Espanola de Paleontologia, V21, P1; Lockley M., 1989, P121; Lockley M.G., 1987, Mountain Geologist, V24, P107; Lockley M.G., 2000, DINOSAUR TRACKS OTHE; Lockley Martin G., 2004, Ichnos, V11, P229, DOI 10.1080/10420940490428625; Lockley Martin G, 2012, [地层学杂志, Journal of Stratigraphy], V36, P503; Lockley MG, 2013, ACTA GEOL SIN-ENGL, V87, P1, DOI 10.1111/1755-6724.12026; Lockley Martin G., 2000, Bulletin of the New Mexico Museum of Natural History and Science, V17, P9; Lockley MG, 1991, LATEST CRETACEOUS DI, P359; Lopez-Martinez N, 2006, REV SOC GEOL ESPANA, V19, P233; Lopez-Martinez N, 1998, B SOC GEOL FR, V169, P11; Lopez-Martinez N, 2001, CRETACEOUS RES, V22, P41, DOI 10.1006/cres.2000.0236; Lopez-Martinez N, 1997, ILERDA CIENCIES, V52, P35; Lopez-Martinez N, 2012, PALAEONTOLOGY, V55, P325, DOI 10.1111/j.1475-4983.2011.01114.x; Marmi J, 2012, CRETACEOUS RES, V35, P133, DOI 10.1016/j.cretres.2011.12.004; Martinell J, 2001, PALAIOS, V16, P409, DOI 10.2307/3515580; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; Nadon G.C., 2001, P395; NADON GC, 1993, PALAIOS, V8, P31, DOI 10.2307/3515220; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P793, DOI 10.1016/B978-0-444-59425-9.00027-5; Oms O, 2007, PALAEOGEOGR PALAEOCL, V255, P35, DOI 10.1016/j.palaeo.2007.02.039; Oms O., 2004, GEOTEMAS, V6, P51; Pereda-Suberbiola X, 2004, GEOTEMAS, V6, P55; Pereda-Suberbiola X, 2009, CR PALEVOL, V8, P559, DOI 10.1016/j.crpv.2009.05.002; Perez Suberbiola X., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P375; Philip J, 2000, ATLAS PERI TETHYS PA, P85; Pujalte V., 2005, GEOGACETA, V38, P79; Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Riera V., 2010, THESIS U AUTONOMA BA; Riera V, 2010, PALAEOGEOGR PALAEOCL, V288, P82, DOI 10.1016/j.palaeo.2010.01.037; Riera V, 2009, PALAEOGEOGR PALAEOCL, V283, P160, DOI 10.1016/j.palaeo.2009.09.018; Rosell J., 2001, REV SOC GEOLOGICA ES, V14, P47; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Thulborn RA., 1990, DINOSAUR TRACKS; Upchurch P, 2011, GEOL SOC SPEC PUBL, V358, P209, DOI 10.1144/SP358.14; Vila B, 2005, LETHAIA, V38, P211, DOI 10.1080/00241160510013312; Vila B, 2012, PALAEOGEOGR PALAEOCL, V350, P19, DOI 10.1016/j.palaeo.2012.06.008; Vila B, 2006, ACT 3 JORN INT PAL D, P365; Vila B, 2008, ORYCTOS, V8, P150; Vila B, 2011, DIN TRACK S 2011, P34; Vila B, 2011, CRETACEOUS RES, V32, P378, DOI 10.1016/j.cretres.2011.01.009; Villalba-Breva S, 2013, FACIES, V59, P319, DOI 10.1007/s10347-012-0317-1; Viseras C, 2010, SEDIMENTOLOGIA PROCE, P261; Xing LD, 2010, ACTA GEOL SINICA, V86, P304; Xing Li-da, 2009, Dizhi Tongbao, V28, P829; Zhao ZK, 2009, CHINESE SCI BULL, V54, P806, DOI 10.1007/s11434-008-0565-1	71	46	48	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72579	10.1371/journal.pone.0072579	http://dx.doi.org/10.1371/journal.pone.0072579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019873	Green Published, gold			2022-12-27	WOS:000324338200015
J	Yee, A; Tan, FL; Ginsburg, D				Yee, Andrew; Tan, Fen-Lai; Ginsburg, David			Functional Display of Platelet-Binding VWF Fragments on Filamentous Bacteriophage	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR A1 DOMAIN; GLYCOPROTEIN-IB-IX; VONWILLEBRAND-FACTOR; CRYSTAL-STRUCTURE; PHAGE DISPLAY; SHEAR-STRESS; AGGREGATION; ADHESION; RECEPTOR	von Willebrand factor (VWF) tethers platelets to sites of vascular injury via interaction with the platelet surface receptor, GPIb. To further define the VWF sequences required for VWF-platelet interaction, a phage library displaying random VWF protein fragments was screened against formalin-fixed platelets. After 3 rounds of affinity selection, DNA sequencing of platelet-bound clones identified VWF peptides mapping exclusively to the A1 domain. Aligning these sequences defined a minimal, overlapping segment spanning P1254-A1461, which encompasses the C1272-C1458 cystine loop. Analysis of phage carrying a mutated A1 segment (C1272/1458A) confirmed the requirement of the cystine loop for optimal binding. Four rounds of affinity maturation of a randomly mutagenized A1 phage library identified 10 and 14 unique mutants associated with enhanced platelet binding in the presence and absence of botrocetin, respectively, with 2 mutants (S1370G and I1372V) common to both conditions. These results demonstrate the utility of filamentous phage for studying VWF protein structure-function and identify a minimal, contiguous peptide that bind to formalin-fixed platelets, confirming the importance of the VWF A1 domain with no evidence for another independently platelet-binding segment within VWF. These findings also point to key structural elements within the A1 domain that regulate VWF-platelet adhesion.	[Yee, Andrew; Tan, Fen-Lai; Ginsburg, David] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Ginsburg, D (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu		Ginsburg, David/0000-0002-6436-8942	National Institutes of Health [HL039693]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039693, R37HL039693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL039693) and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auton M, 2012, J BIOL CHEM; BRINKHOUS KM, 1983, P NATL ACAD SCI-BIOL, V80, P1463, DOI 10.1073/pnas.80.5.1463; Cauwenberghs N, 2000, ARTERIOSCL THROM VAS, V20, P1347, DOI 10.1161/01.ATV.20.5.1347; CRUZ MA, 1995, J BIOL CHEM, V270, P19668; CRUZ MA, 1993, J BIOL CHEM, V268, P21238; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; FUJIMURA Y, 1986, J BIOL CHEM, V261, P381; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Gurevitz O, 1998, ARTERIOSCL THROM VAS, V18, P200, DOI 10.1161/01.ATV.18.2.200; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Kageyama S, 2000, ARTERIOSCL THROM VAS, V20, P2303, DOI 10.1161/01.ATV.20.10.2303; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; LAWRENCE DA, 1994, BIOCHEMISTRY-US, V33, P3643, DOI 10.1021/bi00178a022; Miura S, 2000, J BIOL CHEM, V275, P7539, DOI 10.1074/jbc.275.11.7539; Nakayama T, 2002, J BIOL CHEM, V277, P22063, DOI 10.1074/jbc.M201327200; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Nowak AA, 2012, BLOOD, V120, P214, DOI 10.1182/blood-2012-02-410050; PRIOR CP, 1993, BIO-TECHNOL, V11, P709, DOI 10.1038/nbt0693-709; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sixma JJ, 1996, ARTERIOSCL THROM VAS, V16, P64, DOI 10.1161/01.ATV.16.1.64; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Tan FL, 2008, THROMB RES, V121, P519, DOI 10.1016/j.thromres.2007.05.015; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73518	10.1371/journal.pone.0073518	http://dx.doi.org/10.1371/journal.pone.0073518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019925	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200067
J	Brudzynski, K; Sjaarda, C; Maldonado-Alvarez, L				Brudzynski, Katrina; Sjaarda, Calvin; Maldonado-Alvarez, Liset			A New Look on Protein-Polyphenol Complexation during Honey Storage: Is This a Random or Organized Event with the Help of Dirigent-Like Proteins?	PLOS ONE			English	Article							PROOXIDANT ACTIVITIES; DISEASE RESISTANCE; CAFFEIC ACID; ANTIOXIDANT; PLANT; MELANOIDINS; DERIVATIVES; OXIDATION; PRODUCTS; QUINONES	Honey storage initiates melanoidin formation that involves a cascade of seemingly unguided redox reactions between amino acids/proteins, reducing sugars and polyphenols. In the process, high molecular weight protein-polyphenol complexes are formed, but the mechanism involved remains unknown. The objective of this study was twofold: to determine quantitative and qualitative changes in proteins in honeys stored for prolonged times and in different temperatures and to relate these changes to the formation of protein-polyphenol complexes. Six-month storage decreased the protein content by 46.7% in all tested honeys (t-test, p<0.002) with the rapid reduction occurring during the first three month. The changes in protein levels coincided with alterations in molecular size and net charge of proteins on SDS -PAGE. Electro-blotted proteins reacted with a quinone-specific nitro blue tetrazolium (NBT) on nitrocellulose membranes indicating that quinones derived from oxidized polyphenols formed covalent bonds with proteins. Protein-polyphenol complexes isolated by size-exclusion chromatography differed in size and stoichiometry and fall into two categories: (a) high molecular weight complexes (230-180 kDa) enriched in proteins but possessing a limited reducing activity toward the NBT and (b) lower molecular size complexes (110-85 kDa) enriched in polyphenols but strongly reducing the dye. The variable stoichiometry suggest that the large, "protein-type" complexes were formed by protein cross-linking, while in the smaller, "polyphenol-type" complexes polyphenols were first polymerized prior to protein binding. Quinones preferentially bound a 31 kDa protein which, by the electrospray quadrupole time of flight mass spectrometry (ESI-Qtof-MS) analysis, showed homology to dirigent-like proteins known for assisting in radical coupling and polymerization of phenolic compounds. These findings provide a new look on protein-polyphenol interaction in honey where the reaction of quinones with proteins and polyphenols could possibly be under assumed guidance of dirigent proteins.	[Brudzynski, Katrina; Sjaarda, Calvin] Bee Biomed Inc, Dept Drug Discovery & Dev, St Catharines, ON, Canada; [Brudzynski, Katrina; Sjaarda, Calvin; Maldonado-Alvarez, Liset] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada	Brock University	Brudzynski, K (corresponding author), Bee Biomed Inc, Dept Drug Discovery & Dev, St Catharines, ON, Canada.	beebio@sympatico.ca			Ontario Centres of Excellence [BM 50849]; OCE	Ontario Centres of Excellence; OCE	This work was supported in part by the grant from the Ontario Centres of Excellence (number BM 50849 to KB) and the OCE graduate student stipend award (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Bekedam EK, 2007, J AGR FOOD CHEM, V55, P761, DOI 10.1021/jf063010d; Borrelli RC, 2002, EUR FOOD RES TECHNOL, V215, P210, DOI 10.1007/s00217-002-0531-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brudzynski K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00036; Brudzynski K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00242; Brudzynski K, 2012, FOOD CHEM, V133, P329, DOI 10.1016/j.foodchem.2012.01.035; Brudzynski K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00213; Brudzynski K, 2011, FOOD CHEM, V127, P1023, DOI 10.1016/j.foodchem.2011.01.075; Brudzynski K, 2011, FOOD CHEM, V126, P1155, DOI 10.1016/j.foodchem.2010.11.151; Brudzynski K, 2011, FOOD CHEM, V125, P570, DOI 10.1016/j.foodchem.2010.09.049; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; CHEYNIER V, 1988, J FOOD SCI, V53, P1729, DOI 10.1111/j.1365-2621.1988.tb07828.x; Davin LB, 2005, CURR OPIN BIOTECH, V16, P398, DOI 10.1016/j.copbio.2005.06.010; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; Fayle S.E., 2002, MAILLARD REACTION; FRISTENSKY B, 1988, PLANT MOL BIOL, V11, P713, DOI 10.1007/BF00017470; Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w; Henle T, 2005, AMINO ACIDS, V29, P313, DOI 10.1007/s00726-005-0200-2; HODGE JE, 1953, J AGR FOOD CHEM, V1, P928, DOI 10.1021/jf60015a004; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; HURRELL RF, 1982, BRIT J NUTR, V47, P191, DOI 10.1079/BJN19820027; Ito S, 2003, PIGM CELL RES, V16, P230, DOI 10.1034/j.1600-0749.2003.00037.x; Karabournioti S., 2001, APIACTA, V4, P1; Kroh LW, 2008, ANN NY ACAD SCI, V1126, P210, DOI 10.1196/annals.1433.058; Labenski MT, 2009, DRUG METAB DISPOS, V37, P1211, DOI 10.1124/dmd.108.026211; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEATHAM GF, 1980, PHYTOPATHOLOGY, V70, P1134, DOI 10.1094/Phyto-70-1134; Namiki M, 2001, BIOSCI BIOTECH BIOCH, V65, P2131, DOI 10.1271/bbb.65.2131; Nunes FM, 2006, J AGR FOOD CHEM, V54, P3428, DOI 10.1021/jf052971+; Oddo LP, 1999, APIDOLOGIE, V30, P57, DOI 10.1051/apido:19990107; Paine HS, 1934, IND ENG CHEM, V26, P73, DOI 10.1021/ie50289a018; PAZ MA, 1991, J BIOL CHEM, V266, P689; PIERPOINT WS, 1969, BIOCHEM J, V112, P619, DOI 10.1042/bj1120619; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Prigent SVE, 2007, J SCI FOOD AGR, V87, P2502, DOI 10.1002/jsfa.3011; Pryor MGM, 1940, PROC R SOC SER B-BIO, V128, P393, DOI 10.1098/rspb.1940.0018; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Rawel HM, 2010, PHYTOCHEM REV, V9, P93, DOI 10.1007/s11101-009-9154-4; Sakihama Y, 2002, TOXICOLOGY, V177, P67, DOI 10.1016/S0300-483X(02)00196-8; Semkiw P, 2010, J APIC SCI, V54, P55; Siebert KJ, 1999, J AGR FOOD CHEM, V47, P353, DOI 10.1021/jf980703o; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; SPENCER CM, 1988, PHYTOCHEMISTRY, V27, P2397, DOI 10.1016/0031-9422(88)87004-3; Tressl R, 1998, J AGR FOOD CHEM, V46, P1765, DOI 10.1021/jf970973r; Turkmen N, 2006, FOOD CHEM, V95, P653, DOI 10.1016/j.foodchem.2005.02.004; WHITE JW, 1964, FOOD TECHNOL-CHICAGO, V18, P555; Wu LC, 2002, J AGR FOOD CHEM, V50, P3828, DOI 10.1021/jf011471n	48	35	35	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72897	10.1371/journal.pone.0072897	http://dx.doi.org/10.1371/journal.pone.0072897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023654	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200050
J	Kraus, B; Fischer, K; Buchner, SM; Wels, WS; Lower, R; Sliva, K; Schnierle, BS				Kraus, Benjamin; Fischer, Katrin; Buechner, Sarah M.; Wels, Winfried S.; Loewer, Roswitha; Sliva, Katja; Schnierle, Barbara S.			Vaccination Directed against the Human Endogenous Retrovirus-K Envelope Protein Inhibits Tumor Growth in a Murine Model System	PLOS ONE			English	Article							VACCINIA VIRUS ANKARA; GERM-CELL TUMORS; HERV-K; IMMUNOSUPPRESSIVE PROPERTIES; INFECTIOUS-DISEASES; IMMUNE-RESPONSES; BREAST-CANCER; HIV-INFECTION; HUMAN GENOME; RNA TITERS	Human endogenous retrovirus (HERV) genomes are chromosomally integrated in all cells of an individual. They are normally transcriptionally silenced and transmitted only vertically. Enhanced expression of HERV-K accompanied by the emergence of anti-HERV-K-directed immune responses has been observed in tumor patients and HIV-infected individuals. As HERV-K is usually not expressed and immunological tolerance development is unlikely, it is an appropriate target for the development of immunotherapies. We generated a recombinant vaccinia virus (MVA-HKenv) expressing the HERV-K envelope glycoprotein (ENV), based on the modified vaccinia virus Ankara (MVA), and established an animal model to test its vaccination efficacy. Murine renal carcinoma cells (Renca) were genetically altered to express E. coli beta-galactosidase (RLZ cells) or the HERV-K ENV gene (RLZ-HKenv cells). Intravenous injection of RLZ-HKenv cells into syngenic BALB/c mice led to the formation of pulmonary metastases, which were detectable by X-gal staining. A single vaccination of tumor-bearing mice with MVA-HKenv drastically reduced the number of pulmonary RLZ-HKenv tumor nodules compared to vaccination with wild-type MVA. Prophylactic vaccination of mice with MVA-HKenv precluded the formation of RLZ-HKenv tumor nodules, whereas wild-type MVA-vaccinated animals succumbed to metastasis. Protection from tumor formation correlated with enhanced HERV-K ENV-specific killing activity of splenocytes. These data demonstrate for the first time that HERV-K ENV is a useful target for vaccine development and might offer new treatment opportunities for diverse types of cancer.	[Kraus, Benjamin; Fischer, Katrin; Buechner, Sarah M.; Loewer, Roswitha; Sliva, Katja; Schnierle, Barbara S.] Paul Ehrlich Inst, Langen, Germany; [Wels, Winfried S.] Chemotherapeut Forschungsinst Georg Speyer Haus, Frankfurt, Germany	Paul Ehrlich Institute	Schnierle, BS (corresponding author), Paul Ehrlich Inst, Langen, Germany.	schba@pei.de	Schnierle, Barbara/AAG-8108-2019	Schnierle, Barbara/0000-0001-9563-4564; Fischer, Katrin/0000-0001-5278-3949; Wels, Winfried/0000-0001-9858-3643	Deutsche Forschungsgemeinschaft (DFG);  [GRK 1172]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); 	The work was partly sponsored by the graduate school (GRK 1172) sponsored by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Blaise S, 2001, J GEN VIROL, V82, P1597, DOI 10.1099/0022-1317-82-7-1597; Buscher K, 2005, CANCER RES, V65, P4172, DOI 10.1158/0008-5472.CAN-04-2983; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Contreras-Galindo R, 2013, GENOME RES      0508, V8; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P1083, DOI 10.1089/aid.2007.0054; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2006, J VIROL METHODS, V136, P51, DOI 10.1016/j.jviromet.2006.03.029; de Parseval N, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-117; Depil S, 2002, LEUKEMIA, V16, P254, DOI 10.1038/sj.leu.2402355; Ejthadi HD, 2005, ARCH VIROL, V150, P177, DOI 10.1007/s00705-004-0378-8; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Goering W, 2011, CARCINOGENESIS, V32, P1484, DOI 10.1093/carcin/bgr181; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2011, CURR GENE THER, V11, P189; Hahn S, 2008, AIDS RES HUM RETROV, V24, P717, DOI 10.1089/aid.2007.0286; Hanke K, 2009, J VIROL, V83, P12790, DOI 10.1128/JVI.01368-09; Herbst H, 1999, VIRCHOWS ARCH, V434, P11, DOI 10.1007/s004280050298; Humer J, 2006, CANCER RES, V66, P1658, DOI 10.1158/0008-5472.CAN-05-2452; Ishida Toshiaki, 2008, Cancer Immun, V8, P15; Jager E, 2006, P NATL ACAD SCI USA, V103, P14453, DOI 10.1073/pnas.0606512103; Jha AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020234; Jones RB, 2012, J CLIN INVEST, V122, P4473, DOI 10.1172/JCI64560; Jones RB, 2012, CLIN VACCINE IMMUNOL, V19, P288, DOI 10.1128/CVI.05583-11; Kammerer U, 2011, J REPROD IMMUNOL, V91, P1, DOI 10.1016/j.jri.2011.06.102; Kleiman A, 2004, INT J CANCER, V110, P459, DOI 10.1002/ijc.11649; Kraus B, 2012, ANTICANCER RES, V32, P4797; Laderoute MP, 2007, AIDS, V21, P2417, DOI 10.1097/QAD.0b013e3282f14d64; LOWER R, 1984, J GEN VIROL, V65, P887, DOI 10.1099/0022-1317-65-5-887; LOWER R, 1995, J VIROL, V69, P141; Mangeney M, 1998, P NATL ACAD SCI USA, V95, P14920, DOI 10.1073/pnas.95.25.14920; Mangeney M, 2001, J GEN VIROL, V82, P2515, DOI 10.1099/0022-1317-82-10-2515; Maurer-Gebhard M, 1998, CANCER RES, V58, P2661; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Reus K, 2001, J VIROL, V75, P8917, DOI 10.1128/JVI.75.19.8917-8926.2001; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Sacha JB, 2012, J IMMUNOL, V189, P1467, DOI 10.4049/jimmunol.1200079; SenGupta D, 2011, J VIROL, V85, P6977, DOI 10.1128/JVI.00179-11; Staib C, 2003, BIOTECHNIQUES, V34, P694, DOI 10.2144/03344bm02; Staib Caroline, 2004, Methods Mol Biol, V269, P77; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90; Sverdlov ED, 2000, BIOESSAYS, V22, P161, DOI 10.1002/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; Wang-Johanning F, 2003, ONCOGENE, V22, P1528, DOI 10.1038/sj.onc.1206241	47	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72756	10.1371/journal.pone.0072756	http://dx.doi.org/10.1371/journal.pone.0072756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023643	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200039
J	Lilburn, DML; Hughes-Riley, T; Six, JS; Stupic, KF; Shaw, DE; Pavlovskaya, GE; Meersmann, T				Lilburn, David M. L.; Hughes-Riley, Theodore; Six, Joseph S.; Stupic, Karl F.; Shaw, Dominick E.; Pavlovskaya, Galina E.; Meersmann, Thomas			Validating Excised Rodent Lungs for Functional Hyperpolarized Xenon-129 MRI	PLOS ONE			English	Article							MAGNETIC-RESONANCE; HE-3 MRI; REGIONAL VENTILATION; RAT LUNG; GAS; XENON; RESPONSIVENESS; TOMOGRAPHY; INHALATION; DYNAMICS	Ex vivo rodent lung models are explored for physiological measurements of respiratory function with hyperpolarized (hp) Xe-129 MRI. It is shown that excised lung models allow for simplification of the technical challenges involved and provide valuable physiological insights that are not feasible using in vivo MRI protocols. A custom designed breathing apparatus enables MR images of gas distribution on increasing ventilation volumes of actively inhaled hp Xe-129. Straightforward hp Xe-129 MRI protocols provide residual lung volume (RV) data and permit for spatially resolved tracking of small hp Xe-129 probe volumes during the inhalation cycle. Hp Xe-129 MRI of lung function in the excised organ demonstrates the persistence of post mortem airway responsiveness to intravenous methacholine challenges. The presented methodology enables physiology of lung function in health and disease without additional regulatory approval requirements and reduces the technical and logistical challenges with hp gas MRI experiments. The post mortem lung functional data can augment histological measurements and should be of interest for drug development studies.	[Lilburn, David M. L.; Hughes-Riley, Theodore; Six, Joseph S.; Stupic, Karl F.; Pavlovskaya, Galina E.; Meersmann, Thomas] Univ Nottingham, Sch Clin Sci, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, England; [Shaw, Dominick E.] City Hosp Nottingham, Nottingham Resp Res Unit, Nottingham, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Meersmann, T (corresponding author), Univ Nottingham, Sch Clin Sci, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, England.	Thomas.Meersmann@Nottingham.ac.uk	pavlovskaya, galina/AAA-3732-2021; shaw, dominick/N-1293-2014; Hughes-Riley, Theodore/I-8167-2019	pavlovskaya, galina/0000-0003-4352-3269; shaw, dominick/0000-0003-4106-8469; Hughes-Riley, Theodore/0000-0001-8020-430X; Meersmann, Thomas/0000-0003-0243-0672	Medical Research Council of the United Kingdom [G0900785]; Royal Society through the Paul Instrument Fund; Medical Research Council [G0900785] Funding Source: researchfish; MRC [G0900785] Funding Source: UKRI	Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society through the Paul Instrument Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Medical Research Council of the United Kingdom under Grant No. G0900785 and by the Royal Society through the Paul Instrument Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0; Altes TA, 2001, J MAGN RESON IMAGING, V13, P378, DOI 10.1002/jmri.1054; BALL WC, 1962, J CLIN INVEST, V41, P519, DOI 10.1172/JCI104505; Barrenschee Martina, 2010, PLoS One, V5, pe13889, DOI 10.1371/journal.pone.0013889; Bates JHT, 2003, J APPL PHYSIOL, V94, P1297, DOI 10.1152/japplphysiol.00706.2002; Cleveland ZI, 2008, J MAGN RESON, V195, P232, DOI 10.1016/j.jmr.2008.09.020; Couch MJ, 2012, MAGN RESON MED, V68, P1623, DOI 10.1002/mrm.24152; CULLEN SC, 1951, SCIENCE, V113, P580, DOI 10.1126/science.113.2942.580; Driehuys B, 2007, TOXICOL PATHOL, V35, P49, DOI 10.1080/01926230601132048; Driehuys B, 2006, P NATL ACAD SCI USA, V103, P18278, DOI 10.1073/pnas.0608458103; EIDELMAN DH, 1991, AM REV RESPIR DIS, V144, P792, DOI 10.1164/ajrccm/144.4.792; Ewing P, 2008, J AEROSOL MED PULM D, V21, P169, DOI 10.1089/jamp.2007.0654; Fain S, 2010, J MAGN RESON IMAGING, V32, P1398, DOI 10.1002/jmri.22375; Fain SB, 2007, J MAGN RESON IMAGING, V25, P910, DOI 10.1002/jmri.20876; FARIDY EE, 1973, J APPL PHYSIOL, V34, P597, DOI 10.1152/jappl.1973.34.5.597; FRAZER DG, 1979, RESP PHYSIOL, V38, P325, DOI 10.1016/0034-5687(79)90058-6; FRAZER DG, 1976, J APPL PHYSIOL, V40, P915, DOI 10.1152/jappl.1976.40.6.915; Goodson BM, 2002, J MAGN RESON, V155, P157, DOI 10.1006/jmre.2001.2341; GREENWALD SE, 1988, MED BIOL ENG COMPUT, V26, P497, DOI 10.1007/BF02441917; Harris RS, 2007, J APPL PHYSIOL, V102, P448, DOI 10.1152/japplphysiol.00763.2006; HERGET J, 1985, AM J PHYSIOL, V248, pH55, DOI 10.1152/ajpheart.1985.248.1.H55; HERGET J, 1987, AM J PHYSIOL, V253, pH574, DOI 10.1152/ajpheart.1987.253.3.H574; Herget J, 2010, DRUG DISCOV TODAY, V7, P131; HORIE T, 1974, J APPL PHYSIOL, V36, P317, DOI 10.1152/jappl.1974.36.3.317; Hoymann Heinz Gerd, 2007, Journal of Pharmacological and Toxicological Methods, V55, P16, DOI 10.1016/j.vascn.2006.04.006; HUGHES JMB, 1970, J APPL PHYSIOL, V29, P332, DOI 10.1152/jappl.1970.29.3.332; Hughes-Riley T, 2013, UNPUB; JAMESON CJ, 1988, J CHEM PHYS, V89, P4074, DOI 10.1063/1.454842; Kauczor HU, 2001, INVEST RADIOL, V36, P110, DOI 10.1097/00004424-200102000-00007; KIRSCH RA, 1971, COMPUT BIOMED RES, V4, P315, DOI 10.1016/0010-4809(71)90034-6; KLEINMAN LI, 1964, J APPL PHYSIOL, V19, P204, DOI 10.1152/jappl.1964.19.2.204; Kyriazis A, 2012, IEEE T BIO-MED ENG, V59, P777, DOI 10.1109/TBME.2011.2179299; LAI YL, 1978, J APPL PHYSIOL, V45, P255, DOI 10.1152/jappl.1978.45.2.255; Lam WW, 2007, J APPL PHYSIOL, V103, P1848, DOI 10.1152/japplphysiol.00009.2007; Lauzon AM, 2008, AIRWAY SMOOTH MUSCLE IN ASTHMA AND COPD: BIOLOGY AND PHARMACOLOGY, P159, DOI 10.1002/9780470754221.ch9; Lei Zhao, 1996, Journal of Magnetic Resonance, Series B, V113, P179, DOI 10.1006/jmrb.1996.0173; Lilburn DML, 2013, J MAGN RESON, V229, P173, DOI 10.1016/j.jmr.2012.11.014; Mansson S, 2005, J APPL PHYSIOL, V98, P2259, DOI 10.1152/japplphysiol.00245.2004; Marcucci C, 2001, J APPL PHYSIOL, V90, P421, DOI 10.1152/jappl.2001.90.2.421; Martin C, 1996, EUR RESPIR J, V9, P2479, DOI 10.1183/09031936.96.09122479; Martin C, 1999, AM J RESP CRIT CARE, V159, pA871; MICHELS DB, 1979, J APPL PHYSIOL, V47, P851, DOI 10.1152/jappl.1979.47.4.851; MIDDLETON H, 1995, MAGNET RESON MED, V33, P271, DOI 10.1002/mrm.1910330219; MILICEMI.J, 1966, J APPL PHYSIOL, V21, P749, DOI 10.1152/jappl.1966.21.3.749; Nagao M, 2000, J NUCL MED, V41, P590; ONEIL JJ, 1984, ENVIRON HEALTH PERSP, V56, P11, DOI 10.2307/3429831; Oros AM, 2004, PHYS MED BIOL, V49, pR105, DOI 10.1088/0031-9155/49/20/R01; ORPHANIDOU D, 1986, THORAX, V41, P542, DOI 10.1136/thx.41.7.542; PATRA AL, 1986, J TOXICOL ENV HEALTH, V17, P163, DOI 10.1080/15287398609530813; Patz S, 2008, ACAD RADIOL, V15, P713, DOI 10.1016/j.acra.2008.01.008; Puderbach M, 2007, EUR J RADIOL, V64, P345, DOI 10.1016/j.ejrad.2007.08.009; RAFTERY D, 1991, PHYS REV LETT, V66, P584, DOI 10.1103/PhysRevLett.66.584; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; Sakai K, 1996, J MAGN RESON SER B, V111, P300, DOI 10.1006/jmrb.1996.0098; Santyr GE, 2009, J APPL PHYS, V105, DOI 10.1063/1.3112143; Selg E., 2012, J AEROSOL MED PULM D; Siegl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041464; Six JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049927; STRUHAR D, 1990, LAB ANIM, V24, P328, DOI 10.1258/002367790780865930; Stupic KF, 2011, PHYS MED BIOL, V56, P3731, DOI 10.1088/0031-9155/56/13/001; Sturton RG, 2008, J PHARMACOL EXP THER, V324, P270, DOI 10.1124/jpet.107.129296; SU SY, 1995, MAGNET RESON MED, V33, P760, DOI 10.1002/mrm.1910330604; Swanson SD, 1999, MAGNET RESON MED, V42, P1137, DOI 10.1002/(SICI)1522-2594(199912)42:6<1137::AID-MRM19>3.0.CO;2-4; TAKEZAWA J, 1978, AM REV RESPIR DIS, V117, P405; UHLIG S, 1994, J PHARMACOL TOXICOL, V31, P85, DOI 10.1016/1056-8719(94)90047-7; von Bethmann AN, 1998, AM J RESP CRIT CARE, V157, P263, DOI 10.1164/ajrccm.157.1.9608052; Walker TG, 1997, REV MOD PHYS, V69, P629, DOI 10.1103/RevModPhys.69.629; Wang CG, 1997, J APPL PHYSIOL, V82, P1445, DOI 10.1152/jappl.1997.82.5.1445; WEST JB, 1962, J APPL PHYSIOL, V17, P14, DOI 10.1152/jappl.1962.17.1.14; WEST JB, 1962, J APPL PHYSIOL, V17, P893, DOI 10.1152/jappl.1962.17.6.893; Woodhouse N, 2009, J MAGN RESON IMAGING, V30, P981, DOI 10.1002/jmri.21949	71	10	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73468	10.1371/journal.pone.0073468	http://dx.doi.org/10.1371/journal.pone.0073468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023683	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200080
J	Martins, G; Lauga, B; Miot-Sertier, C; Mercier, A; Lonvaud, A; Soulas, ML; Soulas, G; Masneuf-Pomarede, I				Martins, Guilherme; Lauga, Beatrice; Miot-Sertier, Cecile; Mercier, Anne; Lonvaud, Aline; Soulas, Marie-Louise; Soulas, Guy; Masneuf-Pomarede, Isabelle			Characterization of Epiphytic Bacterial Communities from Grapes, Leaves, Bark and Soil of Grapevine Plants Grown, and Their Relations	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; RIBOSOMAL-RNA GENES; LENGTH-POLYMORPHISM PROFILES; WEB-BASED TOOL; MICROBIAL COMMUNITIES; PSEUDOMONAS-SYRINGAE; PLASMOPARA-VITICOLA; BIOLOGICAL-CONTROL; SEQUENCE-ANALYSIS; BOTRYTIS-CINEREA	Despite its importance in plant health and crop quality, the diversity of epiphytic bacteria on grape berries and other plant parts, like leaves and bark, remains poorly described, as does the role of telluric bacteria in plant colonization. In this study, we compare the bacterial community size and structure in vineyard soils, as well as on grapevine bark, leaves and berries. Analyses of culturable bacteria revealed differences in the size and structure of the populations in each ecosystem. The highest bacteria population counts and the greatest diversity of genera were found in soil samples, followed by bark, grapes and leaves. The identification of isolates revealed that some genera - Pseudomonas, Curtobacterium, and Bacillus - were present in all ecosystems, but in different amounts, while others were ecosystem-specific. About 50% of the genera were common to soil and bark, but absent from leaves and grapes. The opposite was also observed: grape and leaf samples presented 50% of genera in common that were absent from trunk and soil. The bacterial community structure analyzed by T-RFLP indicated similarities between the profiles of leaves and grapes, on the one hand, and bark and soil, on the other, reflecting the number of shared T-RFs. The results suggest an interaction between telluric bacterial communities and the epiphytic bacteria present on the different grapevine parts.	[Martins, Guilherme; Miot-Sertier, Cecile; Mercier, Anne; Lonvaud, Aline; Soulas, Marie-Louise; Soulas, Guy; Masneuf-Pomarede, Isabelle] Univ Bordeaux Segalen, ISW, USC Oenol INRA, Villenave Dornon, France; [Martins, Guilherme; Masneuf-Pomarede, Isabelle] Bordeaux Sci Agro, Bordeaux, France; [Lauga, Beatrice] Univ Pau & Pays Adour, Equipe Environm & Microbiol, UMR IPREM IBEAS 5254, Pau, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Universite de Pau et des Pays de l'Adour	Martins, G (corresponding author), Univ Bordeaux Segalen, ISW, USC Oenol INRA, Villenave Dornon, France.	oenopro.martins@gmail.com	Lauga, Beatrice/K-4849-2012	MIOT-SERTIER, Cecile/0000-0002-5158-3803; Martins, Guilherme/0000-0002-4049-3482; Lauga, Beatrice/0000-0001-5997-1176; Masneuf-Pomarede, Isabelle/0000-0002-8806-8944; Lonvaud, Aline/0000-0002-9352-3366	CIVB (Conseil Interprofessionnel du Vin de Bordeaux); Bordeaux Sciences Agro	CIVB (Conseil Interprofessionnel du Vin de Bordeaux); Bordeaux Sciences Agro	This work was supported by the CIVB (Conseil Interprofessionnel du Vin de Bordeaux) and by Bordeaux Sciences Agro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JH, 1992, ANNU REV PHYTOPATHOL, V30, P603, DOI 10.1146/annurev.py.30.090192.003131; Bae S, 2006, J APPL MICROBIOL, V100, P712, DOI 10.1111/j.1365-2672.2006.02890.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Barbe JC, 2001, J APPL MICROBIOL, V90, P34, DOI 10.1046/j.1365-2672.2001.01200.x; Bavaresco L, 1997, VITIS, V36, P77; Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Blakeman JP., 1985, BIOL CONTROL PHYLLOP, P6; Bulgari D, 2009, J MICROBIOL, V47, P393, DOI 10.1007/s12275-009-0082-1; BURR TJ, 1983, PHYTOPATHOLOGY, V73, P163, DOI 10.1094/Phyto-73-163; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Compant S, 2011, MICROB ECOL, V62, P188, DOI 10.1007/s00248-011-9883-y; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; Coombe B. G., 1995, Australian Journal of Grape and Wine Research, V1, P104, DOI 10.1111/j.1755-0238.1995.tb00086.x; Cortesi P, 1997, PLANT DIS, V81, P922, DOI 10.1094/PDIS.1997.81.8.922; Davenport R.R., 1973, SAMPLING MICROBIOLOG, P143; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; GLAD C, 1992, AM J ENOL VITICULT, V43, P275; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; GOTO M, 1972, CAN J BOT, V50, P2629, DOI 10.1139/b72-336; Gray EJ, 2005, SOIL BIOL BIOCHEM, V37, P395, DOI 10.1016/j.soilbio.2004.08.030; Grove GG, 2004, PLANT DIS, V88, P242, DOI 10.1094/PDIS.2004.88.3.242; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Harm A, 2011, AM J ENOL VITICULT, V62, P184, DOI 10.5344/ajev.2011.09054; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Horn BW, 2005, MYCOLOGIA, V97, P202, DOI 10.3852/mycologia.97.1.202; Hunter JJ, 2001, AUST J GRAPE WINE R, V7, P118, DOI 10.1111/j.1755-0238.2001.tb00198.x; JOYEUX A, 1984, APPL ENVIRON MICROB, V48, P153, DOI 10.1128/AEM.48.1.153-156.1984; Kent AD, 2003, APPL ENVIRON MICROB, V69, P6768, DOI 10.1128/AEM.69.11.6768-6776.2003; KINKEL LL, 1987, OECOLOGIA, V71, P405, DOI 10.1007/BF00378714; Lacey J, 1996, MYCOL RES, V100, P641, DOI 10.1016/S0953-7562(96)80194-8; LAFONLAFOURCADE S, 1983, APPL ENVIRON MICROB, V46, P874, DOI 10.1128/AEM.46.4.874-880.1983; Leveau JHJ, 2011, ACTA HORTIC, V905, P31; LINDEMANN J, 1985, APPL ENVIRON MICROB, V50, P1229, DOI 10.1128/AEM.50.5.1229-1232.1985; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Line MA, 1997, LETT APPL MICROBIOL, V25, P220, DOI 10.1046/j.1472-765X.1997.00213.x; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; Martins G, 2012, THESIS U BORDEAUX 2; Martins G, 2012, INT J FOOD MICROBIOL, V158, P93, DOI 10.1016/j.ijfoodmicro.2012.06.013; MUNKVOLD GP, 1993, PHYTOPATHOLOGY, V83, P624, DOI 10.1094/Phyto-83-624; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; Nisiotou AA, 2011, INT J FOOD MICROBIOL, V145, P432, DOI 10.1016/j.ijfoodmicro.2011.01.017; OBRIEN RD, 1989, PHYTOPATHOLOGY, V79, P619, DOI 10.1094/Phyto-79-619; PADGETT M, 1990, J AM SOC HORTIC SCI, V115, P269, DOI 10.21273/JASHS.115.2.269; PANAGOPOULOS C G, 1969, Annales de l'Institut Phytopathologique Benaki, V9, P59; Park JY, 2011, J BACTERIOL, V193, P6795, DOI 10.1128/JB.06217-11; Prakitchaiwattana CJ, 2004, FEMS YEAST RES, V4, P865, DOI 10.1016/j.femsyr.2004.05.004; Rekah Y, 2000, PHYTOPATHOLOGY, V90, P1322, DOI 10.1094/PHYTO.2000.90.12.1322; Rivas R, 2003, INT J SYST EVOL MICR, V53, P99, DOI 10.1099/ijs.0.02207-0; Sabate J, 2002, MICROBIOL RES, V157, P267, DOI 10.1078/0944-5013-00163; Schmitt-Wagner D, 2003, APPL ENVIRON MICROB, V69, P6007, DOI 10.1128/AEM.69.10.6007-6017.2003; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; van Overbeek LS, 2002, J MICROBIOL METH, V48, P69, DOI 10.1016/S0167-7012(01)00347-5; VENETTE JR, 1975, PHYTOPATHOLOGY, V65, P737, DOI 10.1094/Phyto-65-737; Verginer M, 2010, J AGR FOOD CHEM, V58, P8344, DOI 10.1021/jf100393w; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wawrik B, 2005, APPL ENVIRON MICROB, V71, P6776, DOI 10.1128/AEM.71.11.6776-6783.2005; West E, 2010, AM HIST, V45, P56; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; WINKLER AJ, 1945, PLANT PHYSIOL, V20, P412, DOI 10.1104/pp.20.3.412; Yanagida F, 2008, LETT APPL MICROBIOL, V47, P134, DOI 10.1111/j.1472-765X.2008.02398.x; Zott K, 2008, INT J FOOD MICROBIOL, V125, P197, DOI 10.1016/j.ijfoodmicro.2008.04.001	66	108	112	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73013	10.1371/journal.pone.0073013	http://dx.doi.org/10.1371/journal.pone.0073013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023666	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200062
J	Soderholm, C; Hayry, E; Laine, M; Karrasch, M				Soderholm, Carina; Hayry, Emilia; Laine, Matti; Karrasch, Mira			Valence and Arousal Ratings for 420 Finnish Nouns by Age and Gender	PLOS ONE			English	Article							AFFECTIVE NORMS; NEGATIVE AFFECT; SEX-DIFFERENCES; EMOTIONAL EXPERIENCE; ENGLISH WORDS; OLDER-ADULTS; PLEASANTNESS; ADAPTATION; INTENSITY; GERMAN	Language-and culture-specific norms are needed for research on emotion-laden stimuli. We present valence and arousal ratings for 420 Finnish nouns for a sample of 996 Finnish speakers. Ratings are provided both for the whole sample and for subgroups divided by age and gender in light of previous research suggesting age- and gender-specific reactivity to the emotional content in stimuli. Moreover, corpus-based frequency values and word length are provided as objective psycholinguistic measures of the nouns. The relationship between valence and arousal mainly showed the curvilinear relationship reported in previous studies. Age and gender effects on valence and arousal ratings were statistically significant but weak. The inherent affective properties of the words in terms of mean valence and arousal ratings explained more of the variance in the ratings. In all, the findings suggest that language- and culture-related factors influence the way affective properties of words are rated to a greater degree than demographic factors. This database will provide researchers with normative data for Finnish emotion-laden and emotionally neutral words. The normative database is available in Database S1.	[Soderholm, Carina; Hayry, Emilia; Laine, Matti; Karrasch, Mira] Abo Akad Univ, Dept Psychol & Logoped, Turku, Finland; [Soderholm, Carina] Univ Turku, Ctr Cognit Neurosci, Turku, Finland	Abo Akademi University; University of Turku	Soderholm, C (corresponding author), Abo Akad Univ, Dept Psychol & Logoped, Turku, Finland.	carina.soderholm@abo.fi		Karrasch, Mira/0000-0002-6996-9157	Waldemar von Frenckell Foundation; Paulo Foundation; Professor Jan-Magnus Jansson's Foundation for Geriatric Research; Victoria Foundation; Uulo Arhio Foundation	Waldemar von Frenckell Foundation; Paulo Foundation; Professor Jan-Magnus Jansson's Foundation for Geriatric Research; Victoria Foundation; Uulo Arhio Foundation	This work was supported by the Waldemar von Frenckell Foundation (www.foundationweb.net/frenckell/), the Paulo Foundation (www.paulo.fi), Professor Jan-Magnus Jansson's Foundation for Geriatric Research (www.folkhalsan.fi), the Victoria Foundation (victoriastiftelsen.fi), and the Uulo Arhio Foundation (www.laakariliitto.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarriba J, 2004, AM J PSYCHOL, V117, P389, DOI 10.2307/4149007; Anderson R., 2009, 2 EUROPEAN QUALITY L; BELLEZZA FS, 1986, BEHAV RES METH INSTR, V18, P299, DOI 10.3758/BF03204403; Bensafi M, 2003, BRAIN COGNITION, V51, P270, DOI 10.1016/S0278-2626(03)00019-8; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Briesemeister BB, 2011, BEHAV RES METHODS, V43, P441, DOI 10.3758/s13428-011-0059-y; Carstensen L.L., 2006, HDB PSYCHOL AGING, P343, DOI DOI 10.1016/B978-012101264-9/50018-5; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; Diana RA, 2006, J EXP PSYCHOL LEARN, V32, P805, DOI 10.1037/0278-7393.32.4.805; DIENER E, 1985, DEV PSYCHOL, V21, P542, DOI 10.1037/0012-1649.21.3.542; Dillman D., 1998, 9850 SESRC; Dillman D. A., 2001, DIMENSIONS INTERNET; DUFFY E, 1957, PSYCHOL REV, V64, P265, DOI 10.1037/h0048837; Eilola TM, 2010, BEHAV RES METHODS, V42, P134, DOI 10.3758/BRM.42.1.134; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Ferre P, 2012, BEHAV RES METHODS, V44, P395, DOI 10.3758/s13428-011-0165-x; Gilet AL, 2012, EUR REV APPL PSYCHOL, V62, P173, DOI 10.1016/j.erap.2012.03.003; GROSSMAN M, 1993, J PERS SOC PSYCHOL, V65, P1010, DOI 10.1037/0022-3514.65.5.1010; Gruhn D, 2008, BEHAV RES METHODS, V40, P1088, DOI 10.3758/BRM.40.4.1088; Grunwald I S, 1999, Appl Neuropsychol, V6, P226, DOI 10.1207/s15324826an0604_5; Janschewitz K, 2008, BEHAV RES METHODS, V40, P1065, DOI 10.3758/BRM.40.4.1065; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kanske P, 2010, BEHAV RES METHODS, V42, P987, DOI 10.3758/BRM.42.4.987; Keil A, 2009, PSYCHOL AGING, V24, P668, DOI 10.1037/a0016969; Kensinger EA, 2002, EMOTION, V2, P118, DOI 10.1037//1528-3542.2.2.118; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; LAWTON MP, 1992, PSYCHOL AGING, V7, P171, DOI 10.1037/0882-7974.7.2.171; Levine LJ, 1997, PSYCHOL AGING, V12, P514, DOI 10.1037/0882-7974.12.3.514; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; MYERS DG, 1995, PSYCHOL SCI, V6, P10, DOI 10.1111/j.1467-9280.1995.tb00298.x; Osgood C.E., 1957, MEASUREMENT MEANING; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Plichta MM, 2011, NEUROIMAGE, V55, P1200, DOI 10.1016/j.neuroimage.2011.01.011; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Schaefer A, 2011, NEUROIMAGE, V54, P714, DOI 10.1016/j.neuroimage.2010.07.030; Soares AP, 2012, BEHAV RES METHODS, V44, P256, DOI 10.3758/s13428-011-0131-7; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Stevenson RA, 2007, BEHAV RES METHODS, V39, P1020, DOI 10.3758/BF03192999; Tehan G, 2007, J MEM LANG, V56, P35, DOI 10.1016/j.jml.2006.08.015; Thomsen DK, 2005, PERS INDIV DIFFER, V38, P1935, DOI 10.1016/j.paid.2004.12.001; Virtanen, 1999, WORDMILL LEXICAL SEA; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; Wurm LH, 2004, PSYCHOL AGING, V19, P523, DOI 10.1037/0882-7974.19.3.523	50	40	40	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72859	10.1371/journal.pone.0072859	http://dx.doi.org/10.1371/journal.pone.0072859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211BX	24023650	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200046
J	Subramanian, VS; Nabokina, SM; Lin-Moshier, Y; Marchant, JS; Said, HM				Subramanian, Veedamali S.; Nabokina, Svetlana M.; Lin-Moshier, Yaping; Marchant, Jonathan S.; Said, Hamid M.			Mitochondrial Uptake of Thiamin Pyrophosphate: Physiological and Cell Biological Aspects	PLOS ONE			English	Article							CARRIER; TRANSLOCATION; TRANSPORT; MEMBRANE; RESIDUES; PROTEIN; COMPARTMENTATION; TRAFFICKING; DERIVATIVES; DEFICIENCY	Mammalian cells obtain vitamin B1 (thiamin) from their surrounding environment and convert it to thiamin pyrophosphate (TPP) in the cytoplasm. Most of TPP is then transported into the mitochondria via a carrier-mediated process that involves the mitochondrial thiamin pyrophosphate transporter (MTPPT). Knowledge about the physiological parameters of the MTPP-mediated uptake process, MTPPT targeting and the impact of clinical mutations in MTPPT in patients with Amish lethal microcephaly and neuropathy and bilateral striatal necrosis are not fully elucidated, and thus, were addressed in this study using custom-made H-3-TPP as a substrate and mitochondria isolated from mouse liver and human-derived liver HepG2 cells. Results showed H-3-TPP uptake by mouse liver mitochondria to be pH-independent, saturable (K-m = 6.79 +/- 0.53 mu M), and specific for TPP. MTPPT protein was expressed in mouse liver and HepG2 cells, and confocal images showed a human (h) MTPPT-GFP construct to be targeted to mitochondria of HepG2 cells. A serial truncation analysis revealed that all three modules of hMTPPT protein cooperated (although at different levels of efficiency) in mitochondrial targeting rather than acting autonomously as independent targeting module. Finally, the hMTPPT clinical mutants (G125S and G177A) showed proper mitochondrial targeting but displayed significant inhibition in H-3-TPP uptake and a decrease in level of expression of the MTPPT protein. These findings advance our knowledge of the physiology and cell biology of the mitochondrial TPP uptake process. The results also show that clinical mutations in the hMTPPT system impair its functionality via affecting its level of expression with no effect on its targeting to mitochondria.	[Subramanian, Veedamali S.; Nabokina, Svetlana M.; Said, Hamid M.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Subramanian, Veedamali S.; Nabokina, Svetlana M.; Said, Hamid M.] Univ Calif Irvine, Dept Physiol, Irvine, CA USA; [Subramanian, Veedamali S.; Nabokina, Svetlana M.; Said, Hamid M.] Univ Calif Irvine, Dept Biophys, Irvine, CA USA; [Subramanian, Veedamali S.; Nabokina, Svetlana M.; Said, Hamid M.] Dept Vet Affairs Med Ctr, Long Beach, CA USA; [Lin-Moshier, Yaping; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of Minnesota System; University of Minnesota Twin Cities	Said, HM (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA.	hmsaid@uci.edu	MARCHANT, Jonathan/B-8051-2009; Marchant, Jonathan/Q-5484-2019	MARCHANT, Jonathan/0000-0001-6592-0877; Marchant, Jonathan/0000-0001-6592-0877	Dept. of Veterans Affairs; NIH [DK-58057, DK-56061, GM-088790]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058057] Funding Source: NIH RePORTER	Dept. of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by grants from the Dept. of Veterans Affairs, and the NIH [DK-58057, DK-56061 to HMS, GM-088790 to JSM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARILE M, 1990, ARCH BIOCHEM BIOPHYS, V280, P352, DOI 10.1016/0003-9861(90)90341-U; Berdanier C.D., 2018, ADV NUTR MACRONUTRIE; BETTENDORFF L, 1994, BBA-MOL CELL RES, V1222, P1, DOI 10.1016/0167-4889(94)90018-3; BETTENDORFF L, 1995, J NEUROCHEM, V64, P2013; BETTENDORFF L, 1995, NEUROCHEM INT, V26, P295, DOI 10.1016/0197-0186(94)00123-C; BETTENDORFF L, 1994, BBA-MOL CELL RES, V1222, P7, DOI 10.1016/0167-4889(94)90019-1; Biswas A, 2012, AM J PHYSIOL-CELL PH, V302, pC203, DOI 10.1152/ajpcell.00283.2011; Calingasan NY, 1999, J NEUROPATH EXP NEUR, V58, P946, DOI 10.1097/00005072-199909000-00005; Cappello AR, 2006, J MOL BIOL, V363, P51, DOI 10.1016/j.jmb.2006.08.041; Cusaro G, 1997, INT J VITAM NUTR RES, V47, P99; Deus D., 1970, BIOCHIM BIOPHYS ACTA, V219, P489; Diaz GA, 1999, NAT GENET, V22, P309, DOI 10.1038/10385; Endres M, 1999, EMBO J, V18, P3214, DOI 10.1093/emboj/18.12.3214; Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379; Frederikse PH, 1999, BIOCHEM BIOPH RES CO, V258, P703, DOI 10.1006/bbrc.1999.0560; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; HOPFER U, 1973, J BIOL CHEM, V248, P25; Kaplan RS, 2000, J BIOL CHEM, V275, P12009, DOI 10.1074/jbc.275.16.12009; Lin-Moshier Y, 2013, COLD SPRING HARB PRO, V72793, P262; Lin-Moshier Y, 2013, COLD SPRING HARB PRO, V72785, P255; Lindhurst MJ, 2006, P NATL ACAD SCI USA, V103, P15927, DOI 10.1073/pnas.0607661103; LIU XQ, 1988, J CELL BIOL, V107, P503, DOI 10.1083/jcb.107.2.503; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchant JS, 2002, AM J PHYSIOL-CELL PH, V282, pC1374, DOI 10.1152/ajpcell.00446.2001; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2010, FEBS LETT, V584, P1931, DOI 10.1016/j.febslet.2009.10.063; PFANNER N, 1987, J BIOL CHEM, V262, P14851; Portari GV, 2008, BASIC CLIN PHARMACOL, V103, P482, DOI 10.1111/j.1742-7843.2008.00311.x; Rajgopal A, 2001, BBA-MOL BASIS DIS, V1537, P175, DOI 10.1016/S0925-4439(01)00073-4; Rosenberg MJ, 2002, NAT GENET, V32, P175, DOI 10.1038/ng948; SAID HM, 1992, AM J PHYSIOL, V263, pG81, DOI 10.1152/ajpgi.1992.263.1.G81; Schleiff E, 2000, J CELL SCI, V113, P2267; Singleton Charles K., 2001, Current Molecular Medicine (Hilversum), V1, P197, DOI 10.2174/1566524013363870; Siu VM, 2010, AM J MED GENET A, V152A, P1747, DOI 10.1002/ajmg.a.33373; SMAGULA C, 1988, J BIOL CHEM, V263, P6783; Spiegel R, 2009, ANN NEUROL, V66, P419, DOI 10.1002/ana.21752; Subramanian VS, 2012, AM J PHYSIOL-GASTR L, V302, pG572, DOI 10.1152/ajpgi.00484.2011; Subramanian VS, 2009, AM J PHYSIOL-CELL PH, V296, pC663, DOI 10.1152/ajpcell.00396.2008; Subramanian VS, 2006, J BIOL CHEM, V281, P5233, DOI 10.1074/jbc.M512765200; Subramanian VS, 2001, AM J PHYSIOL-GASTR L, V281, pG1477, DOI 10.1152/ajpgi.2001.281.6.G1477; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; Zara V, 2007, J CELL SCI, V120, P4099, DOI 10.1242/jcs.018929	43	18	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73503	10.1371/journal.pone.0073503	http://dx.doi.org/10.1371/journal.pone.0073503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023687	Green Published, gold			2022-12-27	WOS:000323880200084
J	Zhao, YZ; Lv, HF; Lu, CT; Chen, LJ; Lin, M; Zhang, M; Jiang, X; Shen, XT; Jin, RR; Cai, J; Tian, XQ; Wong, HL				Zhao, Ying-Zheng; Lv, Hai-Feng; Lu, Cui-Tao; Chen, Li-Juan; Lin, Min; Zhang, Ming; Jiang, Xi; Shen, Xiao-Tong; Jin, Rong-Rong; Cai, Jun; Tian, Xin-Qiao; Wong, Ho Lun			Evaluation of a Novel Thermosensitive Heparin-Poloxamer Hydrogel for Improving Vascular Anastomosis Quality and Safety in a Rabbit Model	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; VEIN GRAFT ANASTOMOSES; FIBRIN GLUE; DELIVERY; GELS; PROLIFERATION; TEMPERATURE; COPOLYMERS; GELATION; STRENGTH	Despite progress in the design of advanced surgical techniques, stenosis recurs in a large percentage of vascular anastomosis. In this study, a novel heparin-poloxamer (HP) hydrogel was designed and its effects for improving the quality and safety of vascular anastomosis were studied. HP copolymer was synthesized and its structure was confirmed by Fourier transform infrared spectroscopy (FTIR) and nuclear magnetic resonance spectroscopy (H-1-NMR). Hydrogels containing HP were prepared and their important characteristics related to the application in vascular anastomosis including gelation temperature, rheological behaviour and micromorphology were measured. Vascular anastomosis were performed on the right common carotid arteries of rabbits, and the in vivo efficiency and safety of HP hydrogel to achieve vascular anastomosis was verified and compared with Poloxamer 407 hydrogel and the conventional hand-sewn method using Doppler ultrasound, CT angiograms, scanning electron microscopy (SEM) and histological technique. Our results showed that HP copolymer displayed special gel-sol-gel phase transition behavior with increasing temperature from 5 to 60 degrees C. HP hydrogel prepared from 18 wt% HP solution had a porous sponge-like structure, with gelation temperature at approximately 38 degrees C and maximum elastic modulus at 10,000 Pa. In animal studies, imaging and histological examination of rabbit common jugular artery confirmed that HP hydrogel group had similar equivalent patency, flow and burst strength as Poloxamer 407 group. Moreover, HP hydrogel was superior to poloxamer 407 hydrogel and hand-sewn method for restoring the functions and epithelial structure of the broken vessel junctions after operation. By combining the advantages of heparin and poloxamer 407, HP hydrogel holds high promise for improving vascular anastomosis quality and safety.	[Zhao, Ying-Zheng; Lv, Hai-Feng; Lu, Cui-Tao; Chen, Li-Juan; Lin, Min; Zhang, Ming; Jiang, Xi; Shen, Xiao-Tong; Jin, Rong-Rong] Wenzhou Med Univ, Wenzhou City, Zhejiang, Peoples R China; [Zhao, Ying-Zheng] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Cai, Jun] Univ Louisville, Sch Med, Dept Pediat, Louisville, KY 40292 USA; [Cai, Jun] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Tian, Xin-Qiao] Wenzhou Med Univ, Affiliated Hosp 2, Dept Ultrasonog, Wenzhou, Peoples R China; [Wong, Ho Lun] Temple Univ, Sch Pharm, Philadelphia, PA 19122 USA	Wenzhou Medical University; Drexel University; University of Louisville; University of Louisville; Wenzhou Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Lu, CT (corresponding author), Wenzhou Med Univ, Wenzhou City, Zhejiang, Peoples R China.	lctuua@sina.com; pharmtds@163.com; ho-lun.wong@temple.edu	Cai, Jun/AFP-0700-2022	Cai, Jun/0000-0003-1721-7786	National Natural Science Funds [81272160]; Zhejiang Provincial Natural Science Foundation [LY12H30003, LY12H18001]; Zhejiang Provincial Foundation for Health Department [2011ZDA017, 2012KYB126, 2012KYA134]; Zhejiang Provincial Project of Key Scientific Group [2010R50042, 2012R10042-06]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Foundation for Health Department; Zhejiang Provincial Project of Key Scientific Group	This research was supported by the National Natural Science Funds (Grant No. 81272160), Zhejiang Provincial Natural Science Foundation (Grant No. LY12H30003 and LY12H18001), Zhejiang Provincial Foundation for Health Department (Grant No. 2011ZDA017, 2012KYB126 and 2012KYA134), Zhejiang Provincial Project of Key Scientific Group (Grant No. 2010R50042 and 2012R10042-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghoul MS, 2011, MICROSURG, V31, P72, DOI 10.1002/micr.20813; Beris AE, 2010, ARCH ORTHOP TRAUM SU, V130, P1141, DOI 10.1007/s00402-009-1021-7; CASTELLOT JJ, 1986, J CELL BIOL, V102, P1979, DOI 10.1083/jcb.102.5.1979; Chang EI, 2011, NAT MED, V17, P1147, DOI 10.1038/nm.2424; Chen JP, 2011, J PHARM SCI-US, V100, P655, DOI 10.1002/jps.22309; Chernichenko N, 2008, LARYNGOSCOPE, V118, P2146, DOI 10.1097/MLG.0b013e3181839b75; Cho AB, 2009, MICROSURG, V29, P24, DOI 10.1002/micr.20554; CLOWES AW, 1977, NATURE, V265, P625, DOI 10.1038/265625a0; Nguyen DH, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055004; Dumortier G, 2006, DRUG DEV IND PHARM, V32, P63, DOI 10.1080/03639040500390934; Egemen O, 2011, J CRANIOFAC SURG, V22, P1047, DOI 10.1097/SCS.0b013e3182135f39; Heitmann C, 2007, J PLAST RECONSTR AES, V60, P1296, DOI 10.1016/j.bjps.2006.10.017; Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3; Khorgami Z, 2011, MED HYPOTHESES, V77, P94, DOI 10.1016/j.mehy.2011.03.035; Kloppel M, 2007, J RECONSTR MICROSURG, V23, P45, DOI 10.1055/s-2006-958702; Koffi AA, 2006, EUR J PHARM SCI, V27, P328, DOI 10.1016/j.ejps.2005.11.001; Koppensteiner R, 2006, J VASC SURG, V44, P1247, DOI 10.1016/j.jvs.2006.07.044; Leclere FMP, 2011, ANN CHIR PLAST ESTH, V56, P232, DOI 10.1016/j.anplas.2009.12.009; Lee JS, 2007, J CONTROL RELEASE, V117, P204, DOI 10.1016/j.jconrel.2006.11.004; Liu LQ, 2006, ANN THORAC SURG, V82, P303, DOI 10.1016/j.athoracsur.2006.01.099; Menzoian JO, 2011, J VASC SURG, V54, P571, DOI 10.1016/j.jvs.2011.04.028; Mori H, 2013, MAT SCI ENG C-MATER, V33, P3230, DOI 10.1016/j.msec.2013.03.047; Nisbet DR, 2006, BIOPHYS CHEM, V121, P14, DOI 10.1016/j.bpc.2005.12.005; Niu GG, 2008, BIOMACROMOLECULES, V9, P2621, DOI 10.1021/bm800573e; Park KM, 2009, ACTA BIOMATER, V5, P1956, DOI 10.1016/j.actbio.2009.01.040; Rangelov S, 2005, J PHYS CHEM B, V109, P1162, DOI 10.1021/jp046118+; Rectenwald JE, 2006, J VASC SURG, V43, P800, DOI 10.1016/j.jvs.2005.12.010; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SCHMIDT A, 1992, J BIOL CHEM, V267, P19242; Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058; Tian JL, 2010, DRUG DEV IND PHARM, V36, P832, DOI 10.3109/03639040903520983; Waisberg DR, 2011, MICROSURG, V31, P584, DOI 10.1002/micr.20924; Wiklund L, 2005, J THORAC CARDIOV SUR, V129, P146, DOI 10.1016/j.jtcvs.2004.02.027; Xu HHK, 2004, BIOMATERIALS, V25, P1029, DOI 10.1016/S0142-9612(03)00608-2; Xuan JJ, 2010, INT J PHARMACEUT, V395, P317, DOI 10.1016/j.ijpharm.2010.05.042; Yong CS, 2004, INT J PHARMACEUT, V269, P169, DOI 10.1016/j.ijpharm.2003.09.013; Yong CS, 2001, INT J PHARM, V226, P195, DOI 10.1016/S0378-5173(01)00809-2; Yoo MK, 2005, DRUG DEV IND PHARM, V31, P455, DOI 10.1080/03639040500214688; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k	39	31	34	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73178	10.1371/journal.pone.0073178	http://dx.doi.org/10.1371/journal.pone.0073178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015296	Green Published, gold			2022-12-27	WOS:000323815200070
J	Becknell, B; Carpenter, AR; Allen, JL; Wilhide, ME; Ingraham, SE; Hains, DS; McHugh, KM				Becknell, Brian; Carpenter, Ashley R.; Allen, Jordan L.; Wilhide, Michael E.; Ingraham, Susan E.; Hains, David S.; McHugh, Kirk M.			Molecular Basis of Renal Adaptation in a Murine Model of Congenital Obstructive Nephropathy	PLOS ONE			English	Article							URETERAL OBSTRUCTION; RISK-FACTORS; INJURY; FIBROSIS; DISEASE; GENDER; KIDNEY; MOUSE; DIFFERENTIATION; PROLIFERATION	Congenital obstructive nephropathy is a common cause of chronic kidney disease and a leading indication for renal transplant in children. The cellular and molecular responses of the kidney to congenital obstruction are incompletely characterized. In this study, we evaluated global transcription in kidneys with graded hydronephrosis in the megabladder (mgb(-/-)) mouse to better understand the pathophysiology of congenital obstructive nephropathy. Three primary pathways associated with kidney remodeling/repair were induced in mgb(-/-) kidneys independent of the degree of hydronephrosis. These pathways included retinoid signaling, steroid hormone metabolism, and renal response to injury. Urothelial proliferation and the expression of genes with roles in the integrity and maintenance of the renal urothelium were selectively increased in mgb(-/-) kidneys. Ngal/Lcn2, a marker of acute kidney injury, was elevated in 36% of kidneys with higher grades of hydronephrosis. Evaluation of Ngal(high) versus Ngal(low) kidneys identified the expression of several novel candidate markers of renal injury. This study indicates that the development of progressive hydronephrosis in mgb(-/-) mice results in renal adaptation that includes significant changes in the morphology and potential functionality of the renal urothelium. These observations will permit the development of novel biomarkers and therapeutic approaches to progressive renal injury in the context of congenital obstruction.	[Becknell, Brian; Ingraham, Susan E.; Hains, David S.; McHugh, Kirk M.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA; [Becknell, Brian; Ingraham, Susan E.; Hains, David S.] Nationwide Childrens Hosp, Div Pediat Nephrol, Columbus, OH USA; [Carpenter, Ashley R.; McHugh, Kirk M.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA; [Carpenter, Ashley R.] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Allen, Jordan L.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Wilhide, Michael E.; Ingraham, Susan E.; Hains, David S.] Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Carpenter, AR (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA.	ashley.carpenter@nationwidechildrens.org	Hains, David/AAR-1112-2020; Becknell, Michael/E-6995-2014; Ingraham, Susan/B-4565-2012	Jackson, Ashley R./0000-0002-1571-3906; Hains, David/0000-0001-6511-9561	NIDDK of the NIH [R01-DK085242, K08-DK09234, F32-DK089733]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK092340, R01DK085242, F32DK089733] Funding Source: NIH RePORTER	NIDDK of the NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by R01-DK085242, K08-DK09234 and F32-DK089733 from the NIDDK of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MS, 2010, J PEDIATR UROL, V6, P261, DOI 10.1016/j.jpurol.2009.09.001; Balasubramanian S, 2012, J AM SOC NEPHROL, V23, P674, DOI 10.1681/ASN.2011070646; Batourina E, 2002, NAT GENET, V32, P109, DOI 10.1038/ng952; Carpenter Ashley R, 2012, Methods Mol Biol, V886, P403, DOI 10.1007/978-1-61779-851-1_35; Chevalier RL, 2010, PEDIATR NEPHROL, V25, P687, DOI 10.1007/s00467-009-1316-5; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; DeFoor W, 2008, J UROLOGY, V180, P1705, DOI 10.1016/j.juro.2008.03.090; Delle H, 2012, J AM SOC NEPHROL, V23, P37, DOI 10.1681/ASN.2011010046; Devarajan P, 2011, CURR OPIN PEDIATR, V23, P194, DOI 10.1097/MOP.0b013e328343f4dd; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Furness PD, 1999, J UROLOGY, V162, P1033, DOI 10.1016/S0022-5347(01)68056-X; Girshovich A, 2012, KIDNEY INT, V82, P428, DOI 10.1038/ki.2012.110; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Heikkila J, 2011, J UROLOGY, V186, P2392, DOI 10.1016/j.juro.2011.07.109; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Hutchens MP, 2008, ANESTH ANALG, V107, P239, DOI 10.1213/ane.0b013e318178ca42; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; Ingelfinger JR, 2002, AM J HYPERTENS, V15, p46S, DOI 10.1016/S0895-7061(01)02302-0; INGRAHAM SE, 2012, CONGENITAL OBSTRUCTI; Ingraham SE, 2011, PEDIATR NEPHROL, V26, P1453, DOI 10.1007/s00467-011-1799-8; Ingraham SE, 2010, PEDIATR RES, V68, P500, DOI 10.1203/PDR.0b013e3181f82f15; Kishimoto K, 2011, NEPHRON EXP NEPHROL, V118, pE69, DOI 10.1159/000322409; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; LIU KD, 2013, URINE NEUTROPHIL GEL; Mauney JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011513; Merlet-Benichou C, 1999, CURR OPIN NEPHROL HY, V8, P39, DOI 10.1097/00041552-199901000-00007; Metcalfe PD, 2008, AM J PHYSIOL-ENDOC M, V294, pE435, DOI 10.1152/ajpendo.00704.2006; Metcalfe PD, 2006, J UROLOGY, V176, P15, DOI 10.1016/S0022-5347(06)00490-3; Pohl M, 2012, PEDIATR NEPHROL, V27, P443, DOI 10.1007/s00467-011-1999-2; Reyes D, 2005, MED CLIN N AM, V89, P613, DOI 10.1016/j.mcna.2004.11.010; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schaier M, 2003, J UROLOGY, V170, P1398, DOI 10.1097/01.ju.0000084620.64255.b3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P910, DOI 10.1210/en.132.2.910; Seliger SL, 2001, CURR OPIN NEPHROL HY, V10, P219, DOI 10.1097/00041552-200103000-00010; Si H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004802; Silverstein DM, 2003, KIDNEY INT, V64, P25, DOI 10.1046/j.1523-1755.2003.00067.x; Singh S, 2007, J AM SOC NEPHROL, V18, P461, DOI 10.1681/ASN.2006040405; Vinsonneau C, 2010, AM J PHYSIOL-RENAL, V299, pF479, DOI 10.1152/ajprenal.00585.2009; Wasilewska A, 2011, PEDIATR NEPHROL, V26, P579, DOI 10.1007/s00467-011-1773-5; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142	44	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72762	10.1371/journal.pone.0072762	http://dx.doi.org/10.1371/journal.pone.0072762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023768	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600040
J	Cornillot, E; Dassouli, A; Garg, A; Pachikara, N; Randazzo, S; Depoix, D; Carcy, B; Delbecq, S; Frutos, R; Silva, JC; Sutton, R; Krause, PJ; Ben Mamoun, C				Cornillot, Emmanuel; Dassouli, Amina; Garg, Aprajita; Pachikara, Niseema; Randazzo, Sylvie; Depoix, Delphine; Carcy, Bernard; Delbecq, Stephane; Frutos, Roger; Silva, Joana C.; Sutton, Richard; Krause, Peter J.; Ben Mamoun, Choukri			Whole Genome Mapping and Re-Organization of the Nuclear and Mitochondrial Genomes of Babesia microti Isolates	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SUBTELOMERIC REGIONS; THEILERIA-PARVA; PARASITES; SEQUENCE; SIZE; RECOMBINATION; POLYMORPHISM; REPLICATION; TELOMERES	Babesia microti is the primary causative agent of human babesiosis, an emerging pathogen that causes a malaria-like illness with possible fatal outcome in immunocompromised patients. The genome sequence of the B. microti R1 strain was reported in 2012 and revealed a distinct evolutionary path for this pathogen relative to that of other apicomplexa. Lacking from the first genome assembly and initial molecular analyses was information about the terminal ends of each chromosome, and both the exact number of chromosomes in the nuclear genome and the organization of the mitochondrial genome remained ambiguous. We have now performed various molecular analyses to characterize the nuclear and mitochondrial genomes of the B. microti R1 and Gray strains and generated high-resolution Whole Genome maps. These analyses show that the genome of B. microti consists of four nuclear chromosomes and a linear mitochondrial genome present in four different structural types. Furthermore, Whole Genome mapping allowed resolution of the chromosomal ends, identification of areas of misassembly in the R1 genome, and genomic differences between the R1 and Gray strains, which occur primarily in the telomeric regions. These studies set the stage for a better understanding of the evolution and diversity of this important human pathogen.	[Cornillot, Emmanuel; Frutos, Roger] Ctr Etud Agents Pathogenes & Biotechnol Sante, UMR 5236, Montpellier, France; [Cornillot, Emmanuel] Inst Biol Computat, Montpellier, France; [Dassouli, Amina; Garg, Aprajita; Pachikara, Niseema; Sutton, Richard; Ben Mamoun, Choukri] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Dassouli, Amina; Randazzo, Sylvie; Depoix, Delphine; Carcy, Bernard; Delbecq, Stephane] Univ Montpellier I, UFR Pharm, EA4558, LBCM, Montpellier, France; [Frutos, Roger] Cirad Ird, UMR 17, Cirad, Montpellier, France; [Silva, Joana C.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Silva, Joana C.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Krause, Peter J.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Krause, Peter J.] Yale Univ, Sch Med, New Haven, CT USA	Universite de Montpellier; Yale University; Universite de Montpellier; CIRAD; Institut de Recherche pour le Developpement (IRD); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Yale University; Yale University	Ben Mamoun, C (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	choukri.benmamoun@yale.edu	Cornillot, Emmanuel/P-9656-2017; Silva, Joana/GVT-6441-2022; Silva, Joana/GYQ-9526-2022	Cornillot, Emmanuel/0000-0002-1202-1162; Delbecq, Stephane/0000-0002-2813-1219	National Institutes of Health [AI007603, R21AI088079]; Burroughs Wellcome Fund [1006267]; Bill and Melinda Gates Foundation [OPP1069779]; Gordon and Llura Gund Foundation; ANR program Investissement d'avenir [ANR-11-BINF-0002]; Intervet Schering Plough Animal Health; French Ministry of Research (LBCM); Burroughs Wellcome Award, Investigators of Pathogenesis of Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gordon and Llura Gund Foundation; ANR program Investissement d'avenir(French National Research Agency (ANR)); Intervet Schering Plough Animal Health(Merck & CompanyIntervet International B.V.); French Ministry of Research (LBCM); Burroughs Wellcome Award, Investigators of Pathogenesis of Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the National Institutes of Health [AI007603 to CBM; R21AI088079 to PK], by the Burroughs Wellcome Fund [award 1006267 to CBM] and the Bill and Melinda Gates Foundation (Award OPP1069779 to CBM), by the Gordon and Llura Gund Foundation [PK], the ANR program Investissement d'avenir (ANR-11-BINF-0002 to EC), the Intervet Schering Plough Animal Health and the French Ministry of Research (LBCM). CBM is a recipient of the Burroughs Wellcome Award, Investigators of Pathogenesis of Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Barry JD, 2003, INT J PARASITOL, V33, P29, DOI 10.1016/S0020-7519(02)00247-3; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; CORCORAN LM, 1988, CELL, V53, P807, DOI 10.1016/0092-8674(88)90097-9; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; DEBRUIN D, 1994, P NATL ACAD SCI USA, V91, P619, DOI 10.1073/pnas.91.2.619; Depoix D, 2002, PARASITOLOGY, V125, P313, DOI 10.1017/S0031182002002202; Figueiredo LM, 2002, EMBO J, V21, P815, DOI 10.1093/emboj/21.4.815; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GLEASON NN, 1970, J PARASITOL, V56, P1256, DOI 10.2307/3277582; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Hatcher JC, 2001, CLIN INFECT DIS, V32, P1117, DOI 10.1086/319742; Hayashida K, 2012, MBIO, V3, DOI 10.1128/mBio.00204-12; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; Hikosaka K, 2013, MOL BIOCHEM PARASIT, V188, P26, DOI 10.1016/j.molbiopara.2013.02.006; Hikosaka K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-622; Hikosaka K, 2011, PARASITOL INT, V60, P175, DOI 10.1016/j.parint.2011.02.001; Hikosaka K, 2011, MITOCHONDRION, V11, P273, DOI 10.1016/j.mito.2010.10.003; Homer MJ, 2000, J CLIN MICROBIOL, V38, P362; Jalan N, 2011, J BACTERIOL, V193, P6342, DOI 10.1128/JB.05777-11; Jing JP, 1999, GENOME RES, V9, P175; KAIRO A, 1994, EMBO J, V13, P898, DOI 10.1002/j.1460-2075.1994.tb06333.x; Kappmeyer LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-603; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; LANZER M, 1995, MOL BIOCHEM PARASIT, V70, P1, DOI 10.1016/0166-6851(95)00021-R; Lau AOT, 2009, MOL BIOCHEM PARASIT, V164, P1, DOI 10.1016/j.molbiopara.2008.11.013; Lodes MJ, 2000, INFECT IMMUN, V68, P2783, DOI 10.1128/IAI.68.5.2783-2790.2000; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Nakajima R, 2009, J VET MED SCI, V71, P55, DOI 10.1292/jvms.71.55; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; PATARAPOTIKUL J, 1988, NUCLEIC ACIDS RES, V16, P4331, DOI 10.1093/nar/16.10.4331; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Pryde FE, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1232; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Riley MC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-252; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; Schnittger L, 2012, INFECT GENET EVOL, V12, P1788, DOI 10.1016/j.meegid.2012.07.004; Shukla SK, 2012, J CLIN MICROBIOL, V50, P3526, DOI 10.1128/JCM.01168-12; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; van het Hoog M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r52; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Zahler M, 2000, PARASITOL RES, V86, P642, DOI 10.1007/PL00008545; Zhou SG, 2004, MOL BIOCHEM PARASIT, V138, P97, DOI 10.1016/j.molbiopara.2004.08.002	48	29	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72657	10.1371/journal.pone.0072657	http://dx.doi.org/10.1371/journal.pone.0072657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023759	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600033
J	Kozubek, J; Ma, ZH; Fleming, E; Duggan, T; Wu, R; Shin, DG; Dadras, SS				Kozubek, James; Ma, Zhihai; Fleming, Elizabeth; Duggan, Tatiana; Wu, Rong; Shin, Dong-Guk; Dadras, Soheil S.			In-Depth Characterization of microRNA Transcriptome in Melanoma	PLOS ONE			English	Article							DOWN-REGULATION; CELL PROLIFERATION; PROGRESSION; EXPRESSION; GENES; DISCOVERY; BIOMARKER; MIR-200C; CLUSTER; TARGET	The full repertoire of human microRNAs (miRNAs) that could distinguish common (benign) nevi from cutaneous (malignant) melanomas remains to be established. In an effort to gain further insight into the role of miRNAs in melanoma, we applied Illumina next-generation sequencing (NGS) platform to carry out an in-depth analysis of miRNA transcriptome in biopsies of nevi, thick primary (>4.0 mm) and metastatic melanomas with matched normal skin in parallel to melanocytes and melanoma cell lines (both primary and metastatic) (n = 28). From this data representing 698 known miRNAs, we defined a set of top-40 list, which properly classified normal from cancer; also confirming 23 (58%) previously discovered miRNAs while introducing an additional 17 (42%) known and top-15 putative novel candidate miRNAs deregulated during melanoma progression. Surprisingly, the miRNA signature distinguishing specimens of melanoma from nevus was significantly different than that of melanoma cell lines from melanocytes. Among the top list, miR-203, miR-204-5p, miR-205-5p, miR-211-5p, miR-23b-3p, miR-26a-5p and miR-26b-5p were decreased in melanomas vs. nevi. In a validation cohort (n = 101), we verified the NGS results by qRT-PCR and showed that receiver-operating characteristic curves for miR-211-5p expression accurately discriminated invasive melanoma (AUC = 0.933), melanoma in situ (AUC = 0.933) and dysplastic (atypical) nevi (AUC = 0.951) from common nevi. Target prediction analysis of co-transcribed miRNAs showed a cooperative regulation of key elements in the MAPK signaling pathway. Furthermore, we found extensive sequence variations (isomiRs) and other non-coding small RNAs revealing a complex melanoma transcriptome. Deep-sequencing small RNAs directly from clinically defined specimens provides a robust strategy to improve melanoma diagnostics.	[Kozubek, James; Fleming, Elizabeth; Duggan, Tatiana; Dadras, Soheil S.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT USA; [Kozubek, James; Shin, Dong-Guk] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA; [Ma, Zhihai] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Wu, Rong] Univ Connecticut, Ctr Hlth, Connecticut Inst Clin & Translat Sci, Ctr Biostat, Farmington, CT USA; [Dadras, Soheil S.] Univ Connecticut, Ctr Hlth, Dept Dermatol, Farmington, CT USA	University of Connecticut; University of Connecticut; Stanford University; University of Connecticut; University of Connecticut	Dadras, SS (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT USA.	dadras@uchc.edu	Ma, Zhihai/E-7130-2015		Melanoma Research Foundation Career Development Award; American Cancer Society [IRG-06-00201]	Melanoma Research Foundation Career Development Award; American Cancer Society(American Cancer Society)	This work was funded in part by the Melanoma Research Foundation Career Development Award to SSD and the American Cancer Society (IRG-06-00201) to SSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cerroni L, 2010, AM J SURG PATHOL, V34, P314, DOI 10.1097/PAS.0b013e3181cf7fa0; Chan E, 2011, CELL CYCLE, P10; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Doeden K, 2009, J CUTAN PATHOL, V36, P772, DOI 10.1111/j.1600-0560.2008.01166.x; Duncan LM, 1998, CANCER RES, V58, P1515; Elson-Schwab I, 2010, PLOS ONE, P5, DOI DOI 10.1371/J0URNAL.P0NE.0013176; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Glud M, 2010, MELANOMA RES, V20, P479, DOI 10.1097/CMR.0b013e32833e32a1; Greenberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018936; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Grignol V, 2011, BRIT J CANCER, V105, P1023, DOI 10.1038/bjc.2011.288; Hanna JA, 2012, LAB INVESTIGATION J; HAYASHITA Y, 2005, CANCER RES, V65, P9628, DOI [DOI 10.1158/0008-5472.CAN-05-2352, 10.1158/0008-5472.CAN-05-2352]; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Howlader N, 2012, SEER CANC STAT REV 1; Hwang SJ, 2012, MOL CELLS, V34, P329, DOI 10.1007/s10059-012-0171-6; Jiang L, 2011, ACTA HISTOCHEMICA; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kelly AD, 2013, GENOMICS, V102, P8, DOI 10.1016/j.ygeno.2013.03.008; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Li J, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/527610; Liu SJ, 2012, AM J PATHOL, V181, P1823, DOI 10.1016/j.ajpath.2012.07.009; Liu SJ, 2012, LAB INVEST, V92, P1084, DOI 10.1038/labinvest.2012.62; Ma ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020494; Ma ZH, 2009, J MOL DIAGN, V11, P420, DOI 10.2353/jmoldx.2009.090041; MacGregor S, 2011, NAT GENET, V43, P1114, DOI 10.1038/ng.958; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mattia G, 2011, PIGM CELL MELANOMA R, V24, P953, DOI 10.1111/j.1755-148X.2011.00881.x; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; McGinnis KS, 2002, ARCH DERMATOL, V138, P617, DOI 10.1001/archderm.138.5.617; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Mueller DW, 2010, INT J CANC; Noguchi S, 2012, J BIOL CHEM; Pacheco I, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S146239941100202X; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Penna E, 2011, EMBO J; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Poliseno L, 2012, J INVEST DERMATOL, V132, P1860, DOI 10.1038/jid.2011.451; Satzger I, 2010, INT J CANCER, V126, P2553, DOI 10.1002/ijc.24960; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568	60	94	98	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72699	10.1371/journal.pone.0072699	http://dx.doi.org/10.1371/journal.pone.0072699			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023765	Green Submitted, gold, Green Published			2022-12-27	WOS:000324515600038
J	Xu, ZH; Liu, Y; Liu, LM; Li, XD; Bai, SY; Rong, YH; Wang, HB; Mao, YL; Xin, SJ; Xu, DP				Xu, Zhihui; Liu, Yan; Liu, Liming; Li, Xiaodong; Bai, Siyu; Rong, Yihui; Wang, Haibin; Mao, Yuanli; Xin, Shaojie; Xu, Dongping			Association of Interferon-gamma Induced Protein 10 Promoter Polymorphisms with the Disease Progression of Hepatitis B Virus Infection in Chinese Han Population	PLOS ONE			English	Article							REGULATORY T-CELLS; HCV-GENOTYPE 1; IP-10; EXPRESSION; CXCL10; LIVER; GENE	Background and Aims: Interferon-gamma induced protein 10 (IP-10) was suggested to be involved in liver injury in viral hepatitis. This study aimed to investigate the impact of the single nucleotide polymorphisms (SNP) G-201A (rs1439490) in IP-10 gene on disease progression of hepatitis B virus (HBV) infection. Methods: The -201 SNP in IP-10 promoter was genotyped from 577 patients with different illness categories and 275 health controls; In vitro IP-10 promoter activity was compared between haplotype GG and AA homozygotes using luciferase reporter system in HepG2 cells. In vivo expression of IP-10 was compared between patients with -201 AA genotype and GG genotype. Results: The detected frequency of G-201A SNP was 17.8%, 25.3%, 26.6%, and 13.8% for patients with acute hepatitis B (AHB), patients with mild chronic hepatitis B (CHB-M), patients with severe chronic hepatitis B (CHB-S), and health controls, respectively. In vitro IP-10 promoter-driven luciferase activity in pGL3-Enhancer-201A transfected HepG2 cells was 1.43-fold higher than that in pGL3-Enhancer-201G transfected HepG2 cells (P<0.01). In vivo IP-10 transcriptional expression of peripheral blood mononuclear cells was 1.38-fold higher in patients with -201 AA genotype than in patients with -201 GG genotype (P<0.01). Conclusion: G-201A in promoter region of IP-10 gene was associated with liver disease progression in patients with HBV infection through up-regulating IP-10 expression.	[Xu, Zhihui; Liu, Yan; Li, Xiaodong; Bai, Siyu; Xu, Dongping] Beijing 302 Hosp, Viral Hepatitis Res Lab, Beijing, Peoples R China; [Liu, Liming; Wang, Haibin; Mao, Yuanli] Beijing 302 Hosp, Ctr Clin Lab, Beijing, Peoples R China; [Rong, Yihui; Xin, Shaojie] Beijing 302 Hosp, Med Ctr Liver Failure, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Xin, SJ (corresponding author), Beijing 302 Hosp, Med Ctr Liver Failure, Beijing, Peoples R China.	xsj302@yahoo.com.cn; xudongping@yahoo.com			National Natural Science Foundation of China [81271847]; National 12th Five-Year Special Grand Project for Infectious Diseases [2012ZX10002004-005, 2012ZX10004503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 12th Five-Year Special Grand Project for Infectious Diseases	This work was supported by the National Natural Science Foundation of China (81271847), and National 12th Five-Year Special Grand Project for Infectious Diseases (2012ZX10002004-005, 2012ZX10004503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045128; Bayard F, 2012, J VIRAL HEPATITIS, V19, P872, DOI 10.1111/j.1365-2893.2012.01611.x; Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Berenguer J, 2012, CYTOKINE, V57, P25, DOI 10.1016/j.cyto.2011.10.020; Chinese Society of Infectious Disease and Parasitology and Chinese Society of Hepatology of Chinese Medical Association, 2000, CHIN J HEPATOL, V8, P324; Deng GH, 2008, GASTROENTEROLOGY, V134, P716, DOI 10.1053/j.gastro.2007.12.044; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Grebely J, 2013, HEPATOLOGY, V57, P2124, DOI 10.1002/hep.26263; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Hou FQ, 2013, J VIRAL HEPATITIS, V20, P18, DOI 10.1111/jvh.12060; Ismail N, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-26; Kimkong I, 2013, INT J IMMUNOGENET, V40, P476, DOI 10.1111/iji.12055; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032230; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C; Martinet J, 2012, GASTROENTEROLOGY, V143, P1586, DOI 10.1053/j.gastro.2012.08.046; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Oo YH, 2010, J IMMUNOL, V184, P2886, DOI 10.4049/jimmunol.0901216; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Singh M, 2011, RHEUMATOL INT, V31, P421, DOI 10.1007/s00296-010-1449-7; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Zhong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028839	27	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72799	10.1371/journal.pone.0072799	http://dx.doi.org/10.1371/journal.pone.0072799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023775	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600046
J	Chang, CW; Chen, CR; Huang, CY; Shu, WY; Chiang, CS; Hong, JH; Hsu, IC				Chang, Cheng-Wei; Chen, Chaang-Ray; Huang, Chao-Ying; Shu, Wun-Yi; Chiang, Chi-Shiun; Hong, Ji-Hong; Hsu, Ian C.			Comparative Transcriptome Profiling of an SV40-Transformed Human Fibroblast (MRC5CVI) and Its Untransformed Counterpart (MRC-5) in Response to UVB Irradiation	PLOS ONE			English	Article							LARGE T-ANTIGEN; SIMIAN-VIRUS-40 LARGE T; HUMAN CANCER-CELLS; LARGE GENE LISTS; DNA-REPAIR; CELLULAR-TRANSFORMATION; IONIZING-RADIATION; EXCISION-REPAIR; MICROARRAY DATA; P53	Simian virus 40 (SV40) transforms cells through the suppression of tumor-suppressive responses by large T and small t antigens; studies on the effects of these two oncoproteins have greatly improved our knowledge of tumorigenesis. Large T antigen promotes cellular transformation by binding and inactivating p53 and pRb tumor suppressor proteins. Previous studies have shown that not all of the tumor-suppressive responses were inactivated in SV40-transformed cells; however, the underlying cause is not fully studied. In this study, we investigated the UVB-responsive transcriptome of an SV40-transformed fibroblast (MRC5CVI) and that of its untransformed counterpart (MRC-5). We found that, in response to UVB irradiation, MRC-5 and MRC5CVI commonly up-regulated the expression of oxidative phosphorylation genes. MRC-5 up-regulated the expressions of chromosome condensation, DNA repair, cell cycle arrest, and apoptotic genes, but MRC5CVI did not. Further cell death assays indicated that MRC5CVI was more sensitive than MRC-5 to UVB-induced cell death with increased caspase-3 activation; combining with the transcriptomic results suggested that MRC5CVI may undergo UVB-induced cell death through mechanisms other than transcriptional regulation. Our study provides a further understanding of the effects of SV40 transformation on cellular stress responses, and emphasizes the value of SV40-transformed cells in the researches of sensitizing neoplastic cells to radiations.	[Chang, Cheng-Wei; Chen, Chaang-Ray; Huang, Chao-Ying; Chiang, Chi-Shiun; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Shu, Wun-Yi] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Hong, Ji-Hong] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan; [Hong, Ji-Hong] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan	National Tsing Hua University; National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung University	Hsu, IC (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	ichsu@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008	Chiang, Chi-Shiun/0000-0002-2581-4129; Chen, Chaang-Ray/0000-0003-2106-8699	National Science Council, Taiwan [101B3004K6]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, Taiwan (Grant number: 101B3004K6, http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Azimzadeh O, 2011, PROTEOMICS, V11, P3299, DOI 10.1002/pmic.201100178; Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Brash DE, 1996, J INVEST DERMATOL S, V1, P136; Busser B, 2010, MOL THER, V18, P528, DOI 10.1038/mt.2009.226; Cantalupo PG, 2009, VIROLOGY, V386, P183, DOI 10.1016/j.virol.2008.12.038; Chang THT, 1997, ONCOGENE, V14, P2383, DOI 10.1038/sj.onc.1201196; Chen CR, 2012, COMPUT BIOL MED, V42, P228, DOI 10.1016/j.compbiomed.2011.11.012; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; DeCaprio JA, 2009, VIROLOGY, V384, P274, DOI 10.1016/j.virol.2008.12.010; Epping MT, 2011, NAT CELL BIOL, V13, P102, DOI 10.1038/ncb2142; Eschrich SA, 2009, INT J RADIAT ONCOL, V75, P489, DOI 10.1016/j.ijrobp.2009.06.014; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Francis J, 2011, TLS-TIMES LIT SUPPL, P6; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gerweck LE, 2006, CANCER RES, V66, P8352, DOI 10.1158/0008-5472.CAN-06-0533; Hein J, 2009, J VIROL, V83, P117, DOI 10.1128/JVI.01515-08; Hess RD, 1997, ONCOGENE, V15, P2501, DOI 10.1038/sj.onc.1201404; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; HONG JH, 1994, RADIAT RES, V140, P17, DOI 10.2307/3578563; Hsueh SP, 2012, CANCER LETT, V324, P48, DOI 10.1016/j.canlet.2012.04.019; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin SQ, 2002, ONCOGENE, V21, P8696, DOI 10.1038/sj.onc.1206034; Kim EJ, 2010, BIOCHEM BIOPH RES CO, V392, P448, DOI 10.1016/j.bbrc.2010.01.045; Kim HS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-348; Kohli M, 1999, BIOCHEM BIOPH RES CO, V257, P168, DOI 10.1006/bbrc.1999.0389; Kottemann MC, 2009, DNA REPAIR, V8, P944, DOI 10.1016/j.dnarep.2009.06.001; Lai SK, 2011, CELL DEATH DIFFER, V18, P996, DOI 10.1038/cdd.2010.165; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Li CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040824; Lin YC, 2000, ONCOGENE, V19, P2704, DOI 10.1038/sj.onc.1203582; Maeda T, 2003, J CUTAN MED SURG, V7, P119, DOI 10.1007/s10227-002-0108-3; Maeda T, 2002, J INVEST DERMATOL, V119, P22, DOI 10.1046/j.1523-1747.2002.01781.x; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McKay BC, 1997, PHOTOCHEM PHOTOBIOL, V66, P659, DOI 10.1111/j.1751-1097.1997.tb03203.x; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; McKay BC, 1998, ONCOGENE, V17, P545, DOI 10.1038/sj.onc.1201963; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Pipas JM, 2009, VIROLOGY, V384, P294, DOI 10.1016/j.virol.2008.11.024; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Smith ML, 2002, MUTAGENESIS, V17, P149, DOI 10.1093/mutage/17.2.149; SMITH PJ, 1985, EXP CELL RES, V159, P37, DOI 10.1016/S0014-4827(85)80035-5; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Sriharshan A, 2012, J PROTEOMICS, V75, P2319, DOI 10.1016/j.jprot.2012.02.009; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tsai ML, 2009, RADIAT RES, V171, P716, DOI 10.1667/RR1625.1; Uchida Y, 2010, J INVEST DERMATOL, V130, P2472, DOI 10.1038/jid.2010.153; Uittenbogaard M, 2009, BIOCHEM BIOPH RES CO, V389, P657, DOI 10.1016/j.bbrc.2009.09.049; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Q, 2011, ONCOGENE; Wen CC, 2006, CANCER RES, V66, P5847, DOI 10.1158/0008-5472.CAN-05-2109; Yan DW, 2012, BBA-MOL BASIS DIS, V1822, P918, DOI 10.1016/j.bbadis.2012.02.021; Yang XY, 2012, ONCOL REP, V27, P250, DOI 10.3892/or.2011.1472; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	66	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73311	10.1371/journal.pone.0073311	http://dx.doi.org/10.1371/journal.pone.0073311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019915	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200057
J	Gaete, M; Tucker, AS				Gaete, Marcia; Tucker, Abigail S.			Organized Emergence of Multiple-Generations of Teeth in Snakes Is Dysregulated by Activation of Wnt/Beta-Catenin Signalling	PLOS ONE			English	Article							EPITHELIAL-CELL FATE; STEM-CELLS; TOOTH MORPHOGENESIS; DENTAL LAMINA; WNT; REPLACEMENT; EXPRESSION; MOUSE; LEF1; DIFFERENTIATION	In contrast to mammals, most reptiles constantly regenerate their teeth. In the snake, the epithelial dental lamina ends in a successional lamina, which proliferates and elongates forming multiple tooth generations, all linked by a permanent dental lamina. To investigate the mechanisms used to control the initiation of new tooth germs in an ordered sequential pattern we utilized the polyphodont (multiple-generation) corn snake (Pantherophis guttatus). We observed that the dental lamina expressed the transcription factor Sox2, a multipotent stem cell marker, whereas the successional lamina cells expressed the transcription factor Lef1, a Wnt/beta-catenin pathway target gene. Activation of the Wnt/beta-catenin pathway in culture increased the number of developing tooth germs, in comparison to control untreated cultures. These additional tooth germs budded off from ectopic positions along the dental lamina, rather than in an ordered sequence from the successional lamina. Wnt/beta-catenin activation enhanced cell proliferation, particularly in normally non-odontogenic regions of the dental lamina, which widely expressed Lef1, restricting the Sox2 domain. This suggests an expansion of the successional lamina at the expense of the dental lamina. Activation of the Wnt/beta-catenin pathway in cultured snake dental organs, therefore, led to changes in proliferation and to the molecular pattern of the dental lamina, resulting in loss of the organised emergence of tooth germs. These results suggest that epithelial compartments are critical for the arrangement of organs that develop in sequence, and highlight the role of Wnt/beta-catenin signalling in such processes.	[Gaete, Marcia; Tucker, Abigail S.] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London, England; [Gaete, Marcia] Pontificia Univ Catolica Chile, Dept Anat, Fac Med, Santiago, Chile	University of London; King's College London; Pontificia Universidad Catolica de Chile	Tucker, AS (corresponding author), Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London, England.	abigail.tucker@kcl.ac.uk	Tucker, Abigail S/K-1788-2016; Gaete, Marcia/GSN-3608-2022	Tucker, Abigail S/0000-0001-8871-6094; Gaete, Marcia/0000-0003-1846-2417	Becas Chile	Becas Chile	Marcia Gaete is funded by a fellowship from Becas Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Boback SM, 2012, ZOOLOGY, V115, P38, DOI 10.1016/j.zool.2011.09.001; Buchtova M, 2008, DEV BIOL, V319, P132, DOI 10.1016/j.ydbio.2008.03.004; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Cobourne MT, 2010, SEMIN CELL DEV BIOL, V21, P314, DOI 10.1016/j.semcdb.2010.01.007; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gaete M, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-13; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Greco V, 2010, DEVELOPMENT, V137, P1585, DOI 10.1242/dev.041103; Handrigan GR, 2010, DEV BIOL, V348, P130, DOI 10.1016/j.ydbio.2010.09.003; Handrigan GR, 2010, DEVELOPMENT, V137, P3545, DOI 10.1242/dev.052415; Handrigan GR, 2010, DEV BIOL, V337, P171, DOI 10.1016/j.ydbio.2009.10.020; Hashimoto S, 2012, J CELL SCI, V125, P932, DOI 10.1242/jcs.092734; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jarvinen E, 2009, J EXP ZOOL PART B, V312B, P281, DOI 10.1002/jez.b.21275; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Juuri E., 2012, DEV CELL; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Lohi M, 2010, DEV DYNAM, V239, P160, DOI 10.1002/dvdy.22047; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Petersson M, 2011, EMBO J, V30, P3004, DOI 10.1038/emboj.2011.199; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richman JM, 2011, GENESIS, V49, P247, DOI 10.1002/dvg.20721; Sasaki T, 2005, DEV BIOL, V278, P130, DOI 10.1016/j.ydbio.2004.10.021; Smith MM, 2009, J EXP ZOOL PART B, V312B, P260, DOI 10.1002/jez.b.21272; Tanaka A, 2007, J ORAL PATHOL MED, V36, P400, DOI 10.1111/j.1600-0714.2007.00550.x; Valdivia LE, 2011, DEVELOPMENT, V138, P3931, DOI 10.1242/dev.062695; VOSKAS D, 2010, BIOL REP, V2, P82; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Waters JM, 2007, SEMIN CELL DEV BIOL, V18, P245, DOI 10.1016/j.semcdb.2007.02.003; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	41	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74484	10.1371/journal.pone.0074484	http://dx.doi.org/10.1371/journal.pone.0074484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019968	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200111
J	Lockhart, SR; Iqbal, N; Harris, JR; Grossman, NT; DeBess, E; Wohrle, R; Marsden-Haug, N; Vugia, DJ				Lockhart, Shawn R.; Iqbal, Naureen; Harris, Julie R.; Grossman, Nina T.; DeBess, Emilio; Wohrle, Ron; Marsden-Haug, Nicola; Vugia, Duc J.			Cryptococcus gattii in the United States: Genotypic Diversity of Human and Veterinary Isolates	PLOS ONE			English	Article							NEOFORMANS VAR GATTII; EPIDEMIOLOGIC CUTOFF VALUES; IN-VITRO SUSCEPTIBILITIES; VANCOUVER-ISLAND; PACIFIC-NORTHWEST; 2 VARIETIES; BRITISH-COLUMBIA; SEROTYPE-B; CLINICAL-MANIFESTATIONS; SPECIES COMPLEX	Background: Cryptococcus gattii infections are being reported in the United States (US) with increasing frequency. Initially, US reports were primarily associated with an ongoing C. gattii outbreak in the Pacific Northwest (PNW) states of Washington and Oregon, starting in 2004. However, reports of C. gattii infections in patients from other US states have been increasing since 2009. Whether this is due to increasing frequency of disease, greater recognition within the clinical community, or both is currently unknown. Methodology/Principal Findings: During 2005-2013, a total of 273 C. gattii isolates from human and veterinary sources in 16 US states were collected. Of these, 214 (78%) were from the Pacific Northwest (PNW) and comprised primarily the clonal C. gattii genotypes VGIIa (64%), VGIIc (21%) and VGIIb (9%). The 59 isolates from outside the PNW were predominantly molecular types VGIII (44%) and VGI (41%). Genotyping using multilocus sequence typing revealed small clusters, including a cluster of VGI isolates from the southeastern US, and an unrelated cluster of VGI isolates and a large cluster of VGIII isolates from California. Most of the isolates were mating type MAT alpha, including all of the VGII isolates, but one VGI and three VGIII isolates were mating type MATa. Conclusions/Significance: We provide the most comprehensive report to date of genotypic diversity of US C. gattii isolates both inside and outside of the PNW. C. gattii may have multiple endemic regions in the US, including a previously-unrecognized endemic region in the southeast. Regional clusters exist both in California and the Southeastern US. VGII strains associated with the PNW outbreak do not appear to have spread substantially beyond the PNW.	[Lockhart, Shawn R.; Iqbal, Naureen; Harris, Julie R.; Grossman, Nina T.] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA 30329 USA; [DeBess, Emilio] Oregon Dept Human Serv, Portland, OR USA; [Wohrle, Ron; Marsden-Haug, Nicola] Washington State Dept Hlth, Tumwater, WA USA; [Vugia, Duc J.] Calif Dept Publ Hlth, Richmond, CA USA	Centers for Disease Control & Prevention - USA; California Department of Public Health	Lockhart, SR (corresponding author), Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA 30329 USA.	gyi2@cdc.gov	Grossman, Nina/AAX-4195-2020	Grossman, Nina/0000-0003-1976-9357				BENNETT JE, 1977, AM J EPIDEMIOL, V105, P582, DOI 10.1093/oxfordjournals.aje.a112423; BOTTONE EJ, 1986, J CLIN MICROBIOL, V23, P186, DOI 10.1128/JCM.23.1.186-188.1986; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Brandt ME, 1996, J CLIN MICROBIOL, V34, P912, DOI 10.1128/JCM.34.4.912-917.1996; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002205; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Campbell LT, 2005, EUKARYOT CELL, V4, P1410, DOI 10.1128/EC.4.8.1410-1419.2005; Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936; Chaturvedi S, 2005, EMERG INFECT DIS, V11, P1686, DOI 10.3201/eid1111.040875; Chen SCA, 2012, CLIN INFECT DIS, V55, P789, DOI 10.1093/cid/cis529; Chen YC, 2000, DIAGN MICR INFEC DIS, V36, P175, DOI 10.1016/S0732-8893(99)00137-6; Chowdhary A, 2012, EMERG INFECT DIS, V18, P172, DOI 10.3201/eid1801.111190; Chowdhary A, 2011, J MED MICROBIOL, V60, P961, DOI 10.1099/jmm.0.029025-0; Datta K, 2009, EMERG INFECT DIS, V15, P1185, DOI 10.3201/eid1508.081384; DENTON J F, 1968, Sabouraudia, V6, P213; Diaz MR, 2000, SYST APPL MICROBIOL, V23, P535, DOI 10.1016/S0723-2020(00)80028-4; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P5898, DOI 10.1128/AAC.01115-12; EVANS EE, 1949, P SOC EXP BIOL MED, V71, P644, DOI 10.3181/00379727-71-17283; Feng XB, 2008, FEMS YEAST RES, V8, P930, DOI 10.1111/j.1567-1364.2008.00422.x; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Friedman GD, 2005, MYCOSES, V48, P122, DOI 10.1111/j.1439-0507.2004.01082.x; FROMTLING RA, 1982, J CLIN MICROBIOL, V16, P408, DOI 10.1128/JCM.16.2.408-410.1982; Galanis E, 2009, CAN J INFECT DIS MED, V20, P23, DOI 10.1155/2009/719659; Hagen F, 2012, EMERG INFECT DIS, V18, P1618, DOI 10.3201/eid1810.120068; Hagen F, 2010, ANTIMICROB AGENTS CH, V54, P5139, DOI 10.1128/AAC.00746-10; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harris JR, 2011, CLIN INFECT DIS, V53, P1188, DOI 10.1093/cid/cir723; Harris JR, 2013, EMERG INFEC IN PRESS; Hoang LMN, 2004, J MED MICROBIOL, V53, P935, DOI 10.1099/jmm.0.05427-0; Iqbal N, 2010, J CLIN MICROBIOL, V48, P539, DOI 10.1128/JCM.01505-09; Kidd SE, 2007, APPL ENVIRON MICROB, V73, P1433, DOI 10.1128/AEM.01330-06; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kunadharaju R, 2013, EMERG INFECT DIS, V19, P519, DOI 10.3201/eid1903.121399; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P942, DOI 10.2307/3758813; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; KWONCHUNG KJ, 1978, INT J SYST BACTERIOL, V28, P616, DOI 10.1099/00207713-28-4-616; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; KWONCHUNG KJ, 1984, ZBL BAKT-INT J MED M, V257, P213, DOI 10.1016/S0174-3031(84)80074-8; Litvintseva AP, 2005, J INFECT DIS, V192, P888, DOI 10.1086/432486; Lockhart SR, 2012, DIAGN MICR INFEC DIS, V73, P144, DOI 10.1016/j.diagmicrobio.2012.02.018; LopezMartinez R, 1996, MYCOPATHOLOGIA, V134, P61, DOI 10.1007/BF00436865; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; McCulloh RJ, 2011, PEDIATR INFECT DIS J, V30, P1111, DOI 10.1097/INF.0b013e31822d14fd; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2011, CRYPTOCOCCUS HUMAN P, P358; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; MITCHELL DH, 1995, CLIN INFECT DIS, V20, P611, DOI 10.1093/clinids/20.3.611; MUCHMORE HG, 1980, AM J EPIDEMIOL, V112, P32, DOI 10.1093/oxfordjournals.aje.a112974; Ngamskulrungroj P, 2008, MED MYCOL, V46, P665, DOI 10.1080/13693780802210734; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Okamoto K, 2010, EMERG INFECT DIS, V16, P1155, DOI 10.3201/eid1607.100106; PFEIFFER T, 1991, J INFECT DIS, V163, P929, DOI 10.1093/infdis/163.4.929; Sellers B, 2012, AM J MED SCI, V343, P510, DOI 10.1097/MAJ.0b013e3182464bc7; SPEED B, 1995, CLIN INFECT DIS, V21, P28, DOI 10.1093/clinids/21.1.28; Steele KT, 2010, MED MYCOL, V48, P1112, DOI 10.3109/13693781003774689; Stephen C, 2002, CAN VET J, V43, P792; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008; Upton A, 2007, J CLIN MICROBIOL, V45, P3086, DOI 10.1128/JCM.00593-07; Walraven CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028625; WILSON DE, 1968, P SOC EXP BIOL MED, V127, P820, DOI 10.3181/00379727-127-32812	64	64	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74737	10.1371/journal.pone.0074737	http://dx.doi.org/10.1371/journal.pone.0074737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019979	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200122
J	Pinheiro, A; Woof, JM; Abi-Rached, L; Parham, P; Esteves, PJ				Pinheiro, Ana; Woof, Jenny M.; Abi-Rached, Laurent; Parham, Peter; Esteves, Pedro J.			Computational Analyses of an Evolutionary Arms Race between Mammalian Immunity Mediated by Immunoglobulin A and Its Subversion by Bacterial Pathogens	PLOS ONE			English	Article							FC-ALPHA-RI; MULTIPLE SEQUENCE ALIGNMENT; AMINO-ACID SITES; POSITIVE SELECTION; STRUCTURAL REQUIREMENTS; PHYLOGENETIC ANALYSIS; LEUKOCYTE IGA; HINGE REGION; CLEAVAGE; GENE	IgA is the predominant immunoglobulin isotype in mucosal tissues and external secretions, playing important roles both in defense against pathogens and in maintenance of commensal microbiota. Considering the complexity of its interactions with the surrounding environment, IgA is a likely target for diversifying or positive selection. To investigate this possibility, the action of natural selection on IgA was examined in depth with six different methods: CODEML from the PAML package and the SLAC, FEL, REL, MEME and FUBAR methods implemented in the Datamonkey webserver. In considering just primate IgA, these analyses show that diversifying selection targeted five positions of the C alpha 1 and C alpha 2 domains of IgA. Extending the analysis to include other mammals identified 18 positively selected sites: ten in C alpha 1, five in C alpha 2 and three in C alpha 3. All but one of these positions display variation in polarity and charge. Their structural locations suggest they indirectly influence the conformation of sites on IgA that are critical for interaction with host IgA receptors and also with proteins produced by mucosal pathogens that prevent their elimination by IgA-mediated effector mechanisms. Demonstrating the plasticity of IgA in the evolution of different groups of mammals, only two of the eighteen selected positions in all mammals are included in the five selected positions in primates. That IgA residues subject to positive selection impact sites targeted both by host receptors and subversive pathogen ligands highlights the evolutionary arms race playing out between mammals and pathogens, and further emphasizes the importance of IgA in protection against mucosal pathogens.	[Pinheiro, Ana; Esteves, Pedro J.] Univ Porto, InBio Lab Associado, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Pinheiro, Ana] Univ Porto, Dept Biol, Fac Ciencias, P-4100 Oporto, Portugal; [Pinheiro, Ana] JCCM, UCLM, CSIC, SaBio Inst Invest Recursos Cineget, Ciudad Real, Spain; [Woof, Jenny M.] Univ Dundee, Div Canc Res, Med Res Inst, Med Sch,Ninewells Hosp, Dundee, Scotland; [Abi-Rached, Laurent] Aix Marseille Univ, Equipe ATIP, Lab Anal, CNRS,Probabilites UMR 7353, Marseille, France; [Parham, Peter] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Esteves, Pedro J.] Inst Invest & Formacao Avancada Ciencias & Tecnol, CESPU, Gandra Prd, Portugal	Universidade do Porto; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Dundee; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Stanford University	Esteves, PJ (corresponding author), Univ Porto, InBio Lab Associado, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal.	pjesteves@cibio.up.pt	Esteves, Pedro J/A-7537-2010; Abi-Rached, Laurent/H-7236-2012	Esteves, Pedro J/0000-0002-6055-8298; Pinheiro, Ana/0000-0002-9047-954X	Portuguese Foundation for Science and Technology [SFRH/BD/71252/2010, SPRH/BPD/27021/2006, PTDC/BIA-BEC/103158/2008]; Asthma UK [11/002, 09/014] Funding Source: researchfish	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Asthma UK	The Portuguese Foundation for Science and Technology (www.fct.pt) supported the doctoral fellowship of Ana Pinheiro (SFRH/BD/71252/2010) and the post-doctoral fellowship of Pedro J. Esteves (SPRH/BPD/27021/2006). This work was also supported by a project of the Portuguese Foundation for Science and Technology (PTDC/BIA-BEC/103158/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2007, J IMMUNOL, V178, P7943, DOI 10.4049/jimmunol.178.12.7943; Anisimova M, 2003, GENETICS, V164, P1229; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Batten MR, 2003, INFECT IMMUN, V71, P1462, DOI 10.1128/IAI.71.3.1462-1469.2003; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; Brezski RJ, 2010, MABS-AUSTIN, V2, P212, DOI 10.4161/mabs.2.3.11780; BURNETT RC, 1989, EMBO J, V8, P4041, DOI 10.1002/j.1460-2075.1989.tb08587.x; CHINTALACHARUVU KR, 1994, J IMMUNOL, V152, P5299; Chintalacharuvu KR, 2003, INFECT IMMUN, V71, P2563, DOI 10.1128/IAI.71.5.2563-2570.2003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esteves PJ, 2006, INT J IMMUNOGENET, V33, P171, DOI 10.1111/j.1744-313X.2006.00588.x; Esteves PJ, 2002, EUR J IMMUNOGENET, V29, P529, DOI 10.1046/j.1365-2370.2002.00355.x; Ghumra A, 2009, EUR J IMMUNOL, V39, P1147, DOI 10.1002/eji.200839184; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; Johnson TA, 2009, J MOL BIOL, V389, P559, DOI 10.1016/j.jmb.2009.04.041; KAWAMURA S, 1992, J BIOL CHEM, V267, P7359; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; Lewis MJ, 2005, J IMMUNOL, V175, P6694, DOI 10.4049/jimmunol.175.10.6694; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nielsen R, 1998, GENETICS, V148, P929; Pleass RJ, 1999, J BIOL CHEM, V274, P23508, DOI 10.1074/jbc.274.33.23508; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Ramsland PA, 2007, P NATL ACAD SCI USA, V104, P15051, DOI 10.1073/pnas.0706028104; Rotkiewicz P., 2007, IMOL MOL VISUALIZATI; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Senior BW, 2006, J IMMUNOL, V177, P3913, DOI 10.4049/jimmunol.177.6.3913; Senior BW, 2005, INFECT IMMUN, V73, P1515, DOI 10.1128/IAI.73.3.1515-1522.2005; Shriner D, 2003, GENET RES, V81, P115, DOI 10.1017/S0016672303006128; Slack E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00100; SPIEKERPOLET H, 1993, J IMMUNOL, V150, P5457; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Wines BD, 2006, J BIOL CHEM, V281, P1389, DOI 10.1074/jbc.M509334200; Wines BD, 2011, J BIOL CHEM, V286, P33118, DOI 10.1074/jbc.M111.272252; Wlasiuk G, 2010, MOL BIOL EVOL, V27, P2172, DOI 10.1093/molbev/msq104; Woof JM, 2011, MUCOSAL IMMUNOL, V4, P590, DOI 10.1038/mi.2011.39; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	49	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73934	10.1371/journal.pone.0073934	http://dx.doi.org/10.1371/journal.pone.0073934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019941	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200084
J	Rong, Y; Bao, W; Shan, ZL; Liu, J; Yu, XF; Xia, SF; Gao, H; Wang, X; Yao, P; Hu, FB; Liu, LG				Rong, Ying; Bao, Wei; Shan, Zhilei; Liu, Jun; Yu, Xuefeng; Xia, Songfan; Gao, Hui; Wang, Xia; Yao, Ping; Hu, Frank B.; Liu, Liegang			Increased MicroRNA-146a Levels in Plasma of Patients with Newly Diagnosed Type 2 Diabetes Mellitus	PLOS ONE			English	Article							NF-KAPPA-B; CIRCULATING MICRORNAS; INSULIN-RESISTANCE; HEME OXYGENASE; CANCER; EXPRESSION; BIOMARKERS; VESICLES; MIR-146A; GLUCOSE	Background: gene expression. Dysregulated expression of miRNAs has been described in various diseases and may contribute to related pathologic processes. Our aim was to examine circulating miRNA-146a levels in newly diagnosed type 2 diabetes mellitus (new-T2DM) patients from a Chinese Han population. Methodology/Principal Findings: Circulating miRNA-146a was extracted from plasma samples of 90 new-T2DM patients and 90 age-and sex-matched controls. Quantitative PCR assessment revealed that circulating miRNA-146a levels were significantly elevated in new-T2DM patients compared with controls. Participants in the highest tertile of circulating miRNA-146a levels showed a notably higher risk for new-T2DM (crude OR 4.333, 95% CI, 1.935 to 9.705, P = 0.001) than persons in the lowest tertile. Controlling for known risk factors and some biochemical indicators did not attenuate the aforementioned association. In addition, receiver operating characteristic (ROC) curves generated for miRNA-146a revealed an area under the curve (AUC) of 0.725 (95% CI, 0.651 to 0.799, P < 0.001). Moreover, higher circulating miRNA-146a levels were significantly associated with higher plasma heme oxygenase-1 (HO-1) concentrations (beta coefficient = 0.131, P < 0.001) and lower HOMA-beta (beta coefficient = -0.153, P = 0.015). Conclusions/Significance: We found that circulating miRNA-146a levels were significantly elevated in new-T2DM patients compared with healthy controls. Whether expression of circulating miRNA-146a holds predictive value for T2DM warrants further investigations.	[Rong, Ying; Bao, Wei; Shan, Zhilei; Liu, Jun; Gao, Hui; Wang, Xia; Yao, Ping; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Hubei Key Lab Food Nutr & Safety,Dept Nutr & Food, Wuhan, Peoples R China; [Rong, Ying; Bao, Wei; Shan, Zhilei; Liu, Jun; Gao, Hui; Wang, Xia; Yao, Ping; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan, Peoples R China; [Yu, Xuefeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med,Div Endocrinol, Wuhan, Peoples R China; [Xia, Songfan] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan Puai Hosp, Med Examinat Ctr, Wuhan, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health	Liu, LG (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Hubei Key Lab Food Nutr & Safety,Dept Nutr & Food, Wuhan, Peoples R China.	lgliu@mails.tjmu.edu.cn	Shan, Zhilei/S-5189-2019; Bao, Wei/AAG-2431-2019	Bao, Wei/0000-0002-7301-5786; Rong, Ying/0000-0002-8561-7872; Shan, Zhilei/0000-0002-6723-3381	National Science and Technology Support Program of China [2012BAI02B02]; National Natural Science Foundation of China [NSFC 81072291]	National Science and Technology Support Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Science and Technology Support Program (2012BAI02B02) of China and the National Natural Science Foundation of China (NSFC 81072291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Balasubramanyam M, 2011, MOL CELL BIOCHEM, V351, P197, DOI 10.1007/s11010-011-0727-3; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Devaux Y, 2012, CLIN CHEM, V58, P559, DOI 10.1373/clinchem.2011.173823; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fu JY, 2011, HUM MOL GENET, V20, pR206, DOI 10.1093/hmg/ddr386; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kozakowska M, 2012, ANTIOXID REDOX SIGN, V16, P113, DOI 10.1089/ars.2011.3964; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lukiw WJ, 2011, J TOXICOL ENV HEAL A, V74, P1460, DOI 10.1080/15287394.2011.618973; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McMillan DH, 2013, AM J PHYSIOL-LUNG C, V304, pL774, DOI 10.1152/ajplung.00352.2012; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pauley KM, 2011, EUR J IMMUNOL, V41, P2029, DOI 10.1002/eji.201040757; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Platt JL, 1998, NAT MED, V4, P1364, DOI 10.1038/3947; Saba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030832; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323; Swaminathan S, 2007, DIABETES CARE, V30, P1926, DOI 10.2337/dc06-2625; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xie YF, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-20; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	45	82	87	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73272	10.1371/journal.pone.0073272	http://dx.doi.org/10.1371/journal.pone.0073272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023848	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400057
J	Van der Eecken, V; Clippe, A; Dekoninck, S; Goemaere, J; Walbrecq, G; Van Veldhoven, PP; Knoops, B				Van der Eecken, Valerie; Clippe, Andre; Dekoninck, Sophie; Goemaere, Julie; Walbrecq, Geoffroy; Van Veldhoven, Paul P.; Knoops, Bernard			Abolition of Peroxiredoxin-5 Mitochondrial Targeting during Canid Evolution	PLOS ONE			English	Article							ANTIOXIDANT ENZYME PEROXIREDOXIN-5; IN-VITRO; INTRAMOLECULAR DISULFIDE; CRYSTAL-STRUCTURES; OXIDATIVE STRESS; PROTEINS; SEQUENCE; FORMS; IDENTIFICATION; EXPRESSION	In human, the subcellular targeting of peroxiredoxin-5 (PRDX5), a thioredoxin peroxidase, is dependent on the use of multiple alternative transcription start sites and two alternative in-frame translation initiation sites, which determine whether or not the region encoding a mitochondrial targeting sequence (MTS) is translated. In the present study, the abolition of PRDX5 mitochondrial targeting in dog is highlighted and the molecular mechanism underlying the loss of mitochondrial PRDX5 during evolution is examined. Here, we show that the absence of mitochondrial PRDX5 is generalized among the extant canids and that the first events leading to PRDX5 MTS abolition in canids involve a mutation in the more 59 translation initiation codon as well as the appearance of a STOP codon. Furthermore, we found that PRDX5 MTS functionality is maintained in giant panda and northern elephant seal, which are phylogenetically closely related to canids. Also, the functional consequences of the restoration of mitochondrial PRDX5 in dog Madin-Darby canine kidney (MDCK) cells were investigated. The restoration of PRDX5 mitochondrial targeting in MDCK cells, instead of protecting, provokes deleterious effects following peroxide exposure independently of its peroxidase activity, indicating that mitochondrial PRDX5 gains cytotoxic properties under acute oxidative stress in MDCK cells. Altogether our results show that, although mitochondrial PRDX5 cytoprotective function against oxidative stress has been clearly demonstrated in human and rodents, PRDX5 targeting to mitochondria has been evolutionary lost in canids. Moreover, restoration of mitochondrial PRDX5 in dog MDCK cells, instead of conferring protection against peroxide exposure, makes them more vulnerable.	[Van der Eecken, Valerie; Clippe, Andre; Dekoninck, Sophie; Goemaere, Julie; Walbrecq, Geoffroy; Knoops, Bernard] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Dept Cellular & Mol Med, LIPIT, Louvain, Belgium	Universite Catholique Louvain; KU Leuven	Knoops, B (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium.	bernard.knoops@uclouvain.be	, Van Veldhoven Paul/U-6359-2019	, Van Veldhoven Paul/0000-0002-4478-2564	National Fund for Scientific Research (FRFC) [2.4.603.09F]; Communaute francaise de Belgique-Actions de Recherche Concertees [10/15-026]	National Fund for Scientific Research (FRFC)(Fonds de la Recherche Scientifique - FNRS); Communaute francaise de Belgique-Actions de Recherche Concertees	This work was supported by grants from the National Fund for Scientific Research (FRFC No2.4.603.09F) and the Communaute francaise de Belgique-Actions de Recherche Concertees (10/15-026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banmeyer I, 2005, FEBS LETT, V579, P2327, DOI 10.1016/j.febslet.2005.03.027; Banmeyer I, 2004, FREE RADICAL BIO MED, V36, P65, DOI 10.1016/j.freeradbiomed.2003.10.019; Birdsey GM, 2004, MOL BIOL EVOL, V21, P632, DOI 10.1093/molbev/msh054; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; De Simoni S, 2008, NEUROSCI LETT, V433, P219, DOI 10.1016/j.neulet.2007.12.068; Debier C, 2012, COMP BIOCHEM PHYS A, V162, P323, DOI 10.1016/j.cbpa.2012.04.001; DECLERCQ PE, 1984, J BIOL CHEM, V259, P9064; Dubuisson M, 2004, FEBS LETT, V571, P161, DOI 10.1016/j.febslet.2004.06.080; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Halliwell B., 2007, FREE RADICALS BIOL M; Holbrook JD, 2000, MOL BIOL EVOL, V17, P387, DOI 10.1093/oxfordjournals.molbev.a026318; Knoops B, 1999, J BIOL CHEM, V274, P30451, DOI 10.1074/jbc.274.43.30451; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; Kropotov A, 1999, EUR J BIOCHEM, V260, P336, DOI 10.1046/j.1432-1327.1999.00162.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leyens G, 2004, MOL REPROD DEV, V69, P243, DOI 10.1002/mrd.20145; Li JA, 2011, FISH SHELLFISH IMMUN, V30, P309, DOI 10.1016/j.fsi.2010.11.011; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lu HR, 2012, J PHARMACOL TOX MET, V66, P135, DOI 10.1016/j.vascn.2012.03.002; Lu JL, 2006, J PERIPHER NERV SYST, V11, P318, DOI 10.1111/j.1529-8027.2006.00104.x; Nguyen-nhu NT, 2007, BBA-GENE STRUCT EXPR, V1769, P472, DOI 10.1016/j.bbaexp.2007.05.004; Nguyen-nhu NT, 2003, FEBS LETT, V544, P148, DOI 10.1016/S0014-5793(03)00493-9; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oberley TD, 2001, FREE RADICAL BIO MED, V30, P412, DOI 10.1016/S0891-5849(00)00486-X; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Peng Y, 2004, J MOL BIOL, V340, P819, DOI 10.1016/j.jmb.2004.05.047; Peng Y, 2004, INVEST OPHTH VIS SCI, V45, P23, DOI 10.1167/iovs.03-0550; Plaisant F, 2003, FREE RADICAL BIO MED, V34, P862, DOI 10.1016/S0891-5849(02)01440-5; Radyuk SN, 2009, BIOCHEM J, V419, P437, DOI 10.1042/BJ20082003; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Smeets A, 2005, PROTEIN SCI, V14, P2610, DOI 10.1110/ps.051632905; Smeets A, 2008, ARCH BIOCHEM BIOPHYS, V477, P98, DOI 10.1016/j.abb.2008.04.036; Trujillo M, 2007, ARCH BIOCHEM BIOPHYS, V467, P95, DOI 10.1016/j.abb.2007.08.008; Usmanova N, 2011, BIOCHIMIE, V93, P306, DOI 10.1016/j.biochi.2010.10.002; Van der Eecken V, 2011, MITOCHONDRION, V11, P973, DOI 10.1016/j.mito.2011.06.013; Van Der Heyden MAG, 2007, DNA SEQUENCE, V18, P380, DOI 10.1080/10425170701400589; Van Valkenburgh B, 2010, CURR BIOL, V20, pR915, DOI 10.1016/j.cub.2010.09.013; VanVeldhoven PP, 1996, FEBS LETT, V388, P80, DOI 10.1016/0014-5793(96)00508-X; Wang MX, 2001, BIOCHEM BIOPH RES CO, V284, P667, DOI 10.1006/bbrc.2001.4991; Yamashita H, 1999, J BIOL CHEM, V274, P29897, DOI 10.1074/jbc.274.42.29897; Zhang S, 2003, CURR SCI INDIA, V84, P213; Zhou Y, 2000, BIOCHEM BIOPH RES CO, V268, P921, DOI 10.1006/bbrc.2000.2231	44	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72844	10.1371/journal.pone.0072844	http://dx.doi.org/10.1371/journal.pone.0072844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023783	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400027
J	Gregersen, I; Skjelland, M; Holm, S; Holven, KB; Krogh-Sorensen, K; Russell, D; Askevold, ET; Dahl, CP; Orn, S; Gullestad, L; Mollnes, TE; Ueland, T; Aukrust, P; Halvorsen, B				Gregersen, Ida; Skjelland, Mona; Holm, Sverre; Holven, Kirsten B.; Krogh-Sorensen, Kirsten; Russell, David; Askevold, Erik T.; Dahl, Christen P.; Orn, Stein; Gullestad, Lars; Mollnes, Tom E.; Ueland, Thor; Aukrust, Pal; Halvorsen, Bente			Increased Systemic and Local Interleukin 9 Levels in Patients with Carotid and Coronary Atherosclerosis	PLOS ONE			English	Article							ACTIVATED MAST-CELLS; IL-9; EXPRESSION; INFECTION; CYTOKINES; RECEPTOR; PROTEIN; ALPHA	Objective: Atherosclerosis is a chronic inflammatory disorder that involves a range of inflammatory mediators. Although interleukin (IL)-9 has been related to inflammation, there are at present no data on its role in atherosclerosis. Here we have examined IL-9 and IL-9 receptor (IL-9R) systemically and locally in patients with coronary and carotid atherosclerosis. Methods: Plasma IL-9 was quantified by enzyme immunoassay and multiplex technology. IL-9 and IL-9R mRNA were quantified by real-time RT-PCR, and their localization within the lesion was assessed by immunohistochemistry. Results: The main findings were: (i) Patients with carotid atherosclerosis had significantly raised IL-9 plasma levels compared with healthy controls (n = 28), with no differences between asymptomatic (n = 56) and symptomatic (n = 88) patients. (ii) On admission, patients with acute ST-elevation myocardial infarction (STEMI) (n = 42) had markedly raised IL-9 plasma levels which gradually declined during the first week post-MI. (iii) T cells and monocytes from patients with unstable angina (n = 17) had increased mRNA levels of IL-9 as compared with controls (n = 11). (iv) Carotid plaques (n = 68) showed increased mRNA levels of IL-9 and IL-9R compared to non-atherosclerotic vessels (n = 10). Co-localization to T cells (IL-9 and IL-9R) and macrophages (IL-9) were shown by immunohistochemistry. (v) IL-9 increased IL-17 release in peripheral blood mononuclear cells from patients with unstable angina (n = 5) and healthy controls (n = 5) with a particularly enhancing effect in cells from the patient group. Conclusion: Our findings show increased IL-9 levels in different atherosclerotic disorders both systemically and within the lesion, suggesting a role for the IL-9/IL-9R axis in the atherosclerotic process, potentially involving IL-17 mediated mechanisms. However, the functional consequences of these findings should be further investigated.	[Gregersen, Ida; Holm, Sverre; Askevold, Erik T.; Dahl, Christen P.; Ueland, Thor; Aukrust, Pal; Halvorsen, Bente] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Gregersen, Ida; Holven, Kirsten B.; Russell, David; Mollnes, Tom E.; Ueland, Thor; Aukrust, Pal; Halvorsen, Bente] Univ Oslo, Fac Med, Oslo, Norway; [Skjelland, Mona; Russell, David] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurol, N-0027 Oslo, Norway; [Holven, Kirsten B.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Fac Med, Oslo, Norway; [Krogh-Sorensen, Kirsten] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Thorac & Cardiovasc Surg, N-0027 Oslo, Norway; [Askevold, Erik T.; Dahl, Christen P.; Gullestad, Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway; [Askevold, Erik T.; Dahl, Christen P.; Gullestad, Lars] Univ Oslo, Fac Med, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Askevold, Erik T.; Dahl, Christen P.; Gullestad, Lars] Univ Oslo, Fac Med, Ctr Heart Failure Res, Oslo, Norway; [Orn, Stein] Stavanger Univ Hosp, Div Cardiol, Stavanger, Norway; [Mollnes, Tom E.] Univ Tromso, Nordland Hosp, Res Lab, Somat Res Ctr, Tromso, Norway; [Mollnes, Tom E.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0027 Oslo, Norway; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Stavanger University Hospital; UiT The Arctic University of Tromso; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Gregersen, I (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway.	ida.gregersen@rr-research.no	Mollnes, Tom/ABI-5183-2020; Ørn, Stein/ABD-5883-2020; Skjelland, Mona/B-7362-2016; Skjelland, Mona/Q-4674-2017	Ørn, Stein/0000-0002-5098-4592; Holm, Sverre/0000-0003-1064-3926; Skjelland, Mona/0000-0001-7950-4882				Abdelilah SG, 2001, J IMMUNOL, V166, P2768, DOI 10.4049/jimmunol.166.4.2768; Anderson GB, 2000, STROKE, V31, P2168, DOI 10.1161/01.STR.31.9.2168; Arendse B, 2005, J IMMUNOL, V174, P2205, DOI 10.4049/jimmunol.174.4.2205; Aukrust P, 1999, J IMMUNOL, V162, P1178; Blom L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021695; Cappuzzello C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-28; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Fontaine RH, 2008, CELL DEATH DIFFER, V15, P1542, DOI 10.1038/cdd.2008.79; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gounni AS, 2000, J ALLERGY CLIN IMMUN, V106, P460, DOI 10.1067/mai.2000.109172; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; Li HM, 2010, J NEUROIMMUNE PHARM, V5, P198, DOI 10.1007/s11481-009-9186-y; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Ormstad H, 2011, J NEUROL, V258, P677, DOI 10.1007/s00415-011-6006-0; Orn S, 2009, AM J CARDIOL, V104, P1179, DOI 10.1016/j.amjcard.2009.06.028; Orn S, 2009, EUR HEART J, V30, P1180, DOI 10.1093/eurheartj/ehp070; Pilette C, 2002, J IMMUNOL, V168, P4103, DOI 10.4049/jimmunol.168.8.4103; Poulin LF, 2003, TRANSPLANTATION, V76, P572, DOI 10.1097/01.TP.0000071201.32424.D2; Qi XY, 2003, JPN HEART J, V44, P451, DOI 10.1536/jhj.44.451; Singh TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051752; Soussi-Gounni A, 2001, J ALLERGY CLIN IMMUN, V107, P575, DOI 10.1067/mai.2001.114238; Stylianou E, 2001, CYTOKINE, V14, P56, DOI 10.1006/cyto.2000.0850; Vistnes M, 2010, J APPL PHYSIOL, V108, P1357, DOI 10.1152/japplphysiol.01084.2009; von der Thusen JH, 2003, PHARMACOL REV, V55, P133, DOI 10.1124/pr.55.1.5; Wiener Z, 2004, CYTOKINE, V26, P122, DOI 10.1016/j.cyto.2004.01.006; Wu B, 2008, CLIN IMMUNOL, V126, P202, DOI 10.1016/j.clim.2007.09.009; Yanaba K, 2011, J RHEUMATOL, V38, P2193, DOI 10.3899/jrheum.110268; ZHOU LJ, 1995, BLOOD, V86, P3295, DOI 10.1182/blood.V86.9.3295.bloodjournal8693295	30	38	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72769	10.1371/journal.pone.0072769	http://dx.doi.org/10.1371/journal.pone.0072769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023645	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200041
J	Korrapati, S; Roux, I; Glowatzki, E; Doetzlhofer, A				Korrapati, Soumya; Roux, Isabelle; Glowatzki, Elisabeth; Doetzlhofer, Angelika			Notch Signaling Limits Supporting Cell Plasticity in the Hair Cell-Damaged Early Postnatal Murine Cochlea	PLOS ONE			English	Article							NERVOUS-SYSTEM; EPITHELIAL INTEGRITY; POTASSIUM CURRENT; DEAFNESS GENE; EXPRESSION; REGENERATION; ORGAN; FATE; PROLIFERATION; INHIBITION	In mammals, auditory hair cells are generated only during embryonic development and loss or damage to hair cells is permanent. However, in non-mammalian vertebrate species, such as birds, neighboring glia-like supporting cells regenerate auditory hair cells by both mitotic and non-mitotic mechanisms. Based on work in intact cochlear tissue, it is thought that Notch signaling might restrict supporting cell plasticity in the mammalian cochlea. However, it is unresolved how Notch signaling functions in the hair cell-damaged cochlea and the molecular and cellular changes induced in supporting cells in response to hair cell trauma are poorly understood. Here we show that gentamicin-induced hair cell loss in early postnatal mouse cochlear tissue induces rapid morphological changes in supporting cells, which facilitate the sealing of gaps left by dying hair cells. Moreover, we provide evidence that Notch signaling is active in the hair cell damaged cochlea and identify Hes1, Hey1, Hey2, HeyL, and Sox2 as targets and potential Notch effectors of this hair cell-independent mechanism of Notch signaling. Using Cre/loxP based labeling system we demonstrate that inhibition of Notch signaling with a gamma-secretase inhibitor (GSI) results in the trans-differentiation of supporting cells into hair cell-like cells. Moreover, we show that these hair cell-like cells, generated by supporting cells have molecular, cellular, and basic electrophysiological properties similar to immature hair cells rather than supporting cells. Lastly, we show that the vast majority of these newly generated hair cell-like cells express the outer hair cell specific motor protein prestin.	[Korrapati, Soumya; Glowatzki, Elisabeth; Doetzlhofer, Angelika] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Roux, Isabelle; Glowatzki, Elisabeth; Doetzlhofer, Angelika] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Korrapati, Soumya; Roux, Isabelle; Glowatzki, Elisabeth; Doetzlhofer, Angelika] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD USA; [Korrapati, Soumya; Roux, Isabelle; Glowatzki, Elisabeth; Doetzlhofer, Angelika] Johns Hopkins Univ, Sch Med, Ctr Hearing & Balance, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Doetzlhofer, A (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	adoetzlhofer@jhmi.edu	Roux, Isabelle/AAC-8120-2020	Roux, Isabelle/0000-0001-7527-7520; Glowatzki, Elisabeth/0000-0003-3135-658X	National Institutes of Health grant [DC011571, DC006476, DC 005211]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, R01DC011571, R01DC006476] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant DC011571 (A.D.), DC006476 (E.G.) and DC 005211 (Sensory Mechanisms Research Core Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HJ, 1997, INT J DEV NEUROSCI, V15, P375, DOI 10.1016/S0736-5748(96)00098-6; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Bird JE, 2010, J NEUROSCI, V30, P12545, DOI 10.1523/JNEUROSCI.3042-10.2010; Brooker R, 2006, DEVELOPMENT; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Chen FQ, 2009, J NEUROCHEM, V108, P1226, DOI 10.1111/j.1471-4159.2009.05871.x; Chen P, 2002, DEVELOPMENT, V129, P2495; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Glowatzki E, 2006, J NEUROSCI, V26, P7659, DOI 10.1523/JNEUROSCI.1545-06.2006; Golub JS, 2012, J NEUROSCI, V32, P15093, DOI 10.1523/JNEUROSCI.1709-12.2012; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guthrie OW, 2008, TOXICOLOGY, V249, P91, DOI 10.1016/j.tox.2008.04.015; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hartman BH, 2010, JARO-J ASSOC RES OTO, V11, P187, DOI 10.1007/s10162-009-0203-x; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Hayashi T, 2007, DEV DYNAM, V236, P525, DOI 10.1002/dvdy.21026; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Jahan I, 2012, HEAR RES; Kawamoto K, 2009, HEARING RES, V247, P17, DOI 10.1016/j.heares.2008.08.010; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Kim YH, 2007, CELL CYCLE, V6, P612, DOI 10.4161/cc.6.5.3929; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kruger M, 2006, EUR J NEUROSCI, V24, P1581, DOI 10.1111/j.1460-9568.2006.05051.x; Lanford RJ, 2000, JARO-J ASSOC RES OTO, V1, P161, DOI 10.1007/sl01620010023; Li SD, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-20; Lin V, 2011, J NEUROSCI, V31, P15329, DOI 10.1523/JNEUROSCI.2057-11.2011; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Marcotti W, 2012, EXP PHYSIOL, V97, P438, DOI 10.1113/expphysiol.2011.059303; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; Oesterle EC, 2009, JARO-J ASSOC RES OTO, V10, P525, DOI 10.1007/s10162-009-0183-x; Oliver D, 1997, PFLUG ARCH EUR J PHY, V434, P772, DOI 10.1007/s004240050464; Pan W, 2010, P NATL ACAD SCI USA, V107, P15798, DOI 10.1073/pnas.1003089107; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Raphael Y, 2007, INT J DEV BIOL, V51, P649, DOI 10.1387/ijdb.072370yr; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Simmons DD, 2010, J COMP NEUROL, V518, P3785, DOI 10.1002/cne.22424; Sinkkonen ST, 2011, SCI REP-UK, V1, DOI 10.1038/srep00026; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Taylor RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030577; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Yamamoto N, 2006, J MOL MED, V84, P37, DOI 10.1007/s00109-005-0706-9; Yang D, 2004, J NEUROBIOL, V58, P479, DOI 10.1002/neu.10289; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010; Zhang N, 2000, CURR BIOL, V10, P659, DOI 10.1016/S0960-9822(00)00522-4; Zhao LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023729; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng JL, 2000, DEVELOPMENT, V127, P4551; Zine A, 2000, DEVELOPMENT, V127, P3373; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	79	57	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73276	10.1371/journal.pone.0073276	http://dx.doi.org/10.1371/journal.pone.0073276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023676	gold, Green Submitted, Green Published			2022-12-27	WOS:000323880200072
J	Liu, LL; Yang, ZJ; Xu, YQ; Li, JY; Xu, DX; Zhang, L; Sun, JB; Xia, SH; Zou, FY; Liu, YZ				Liu, Lanlan; Yang, Zhaojuan; Xu, Yingqian; Li, Jingyi; Xu, Dongxu; Zhang, Li; Sun, Jiabin; Xia, Suhua; Zou, Feiyan; Liu, Yongzhong			Inhibition of Oxidative Stress-Elicited AKT Activation Facilitates PPAR gamma Agonist-Mediated Inhibition of Stem Cell Character and Tumor Growth of Liver Cancer Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; RECEPTOR-GAMMA; SELF-RENEWAL; IN-VITRO; EXPRESSION; DIFFERENTIATION; CD133; THIAZOLIDINEDIONES; PROGRESSION; SORAFENIB	Emerging evidence suggests that tumor-initiating cells (TICs) are the most malignant cell subpopulation in tumors because of their resistance to chemotherapy or radiation treatment. Targeting TICs may be a key innovation for cancer treatment. In this study, we found that PPAR gamma agonists inhibited the cancer stem cell-like phenotype and attenuated tumor growth of human hepatocellular carcinoma (HCC) cells. Reactive oxygen species (ROS) initiated by NOX2 upregulation were partially responsible for the inhibitory effects mediated by PPAR gamma agonists. However, PPAR gamma agonist-mediated ROS production significantly activated AKT, which in turn promoted TIC survival by limiting ROS generation. Inhibition of AKT, by either pharmacological inhibitors or AKT siRNA, significantly enhanced PPAR gamma agonist-mediated inhibition of cell proliferation and stem cell-like properties in HCC cells. Importantly, in nude mice inoculated with HCC Huh7 cells, we demonstrated a synergistic inhibitory effect of the PPAR gamma agonist rosiglitazone and the AKT inhibitor triciribine on tumor growth. In conclusion, we observed a negative feedback loop between oxidative stress and AKT hyperactivation in PPAR gamma agonist-mediated suppressive effects on HCCs. Combinatory application of an AKT inhibitor and a PPAR gamma agonist may provide a new strategy for inhibition of stem cell-like properties in HCCs and treatment of liver cancer.	[Liu, Lanlan; Yang, Zhaojuan; Xu, Yingqian; Li, Jingyi; Xu, Dongxu; Zhang, Li; Sun, Jiabin; Xia, Suhua; Liu, Yongzhong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200030, Peoples R China; [Liu, Lanlan; Zou, Feiyan] Jinan Univ, Coll Life Sci & Technol, Dept Dev & Regenerat Biol, Guangzhou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Jinan University	Liu, YZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200030, Peoples R China.	liuyzg@yahoo.com			Chinese National Key Project [2013ZX10002-011]	Chinese National Key Project	This work was supported by Chinese National Key Project (2013ZX10002-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Bruedigam C, 2010, STEM CELLS, V28, P916, DOI 10.1002/stem.405; Cerbone A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040149; Chai DJ, 2008, FREE RADICAL BIO MED, V44, P1334, DOI 10.1016/j.freeradbiomed.2007.12.022; Charytonowicz E, 2012, J CLIN INVEST, V122, P886, DOI 10.1172/JCI60015; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Choudhary R, 2010, NEOPLASIA, V12, P224, DOI 10.1593/neo.91638; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Dong RC, 1989, PRIMARY LIVER CANC, P145; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; Gilbertson RJ, 2012, NATURE, V488, P462, DOI 10.1038/nature11480; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Kohga K, 2010, J HEPATOL, V52, P872, DOI 10.1016/j.jhep.2009.12.030; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lyles BE, 2009, CELL CYCLE, V8, P268, DOI 10.4161/cc.8.2.7584; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Maniati E, 2011, J CLIN INVEST, V121, P4685, DOI 10.1172/JCI45797; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Min KW, 2012, TOXICOL APPL PHARM, V263, P225, DOI 10.1016/j.taap.2012.06.014; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Person EC, 2001, ENDOCRINOLOGY, V142, P551, DOI 10.1210/en.142.2.551; Pestereva E, 2012, BRIT J CANCER, V106, P1702, DOI 10.1038/bjc.2012.161; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Prakash J, 2009, NEOPLASIA, V11, P1348, DOI 10.1593/neo.91188; Robbins GT, 2012, FRONT BIOSCI-LANDMRK, V17, P1816, DOI 10.2741/4021; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shen B, 2012, BRIT J CANCER, V106, P1486, DOI 10.1038/bjc.2012.130; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yang W, 2012, J HEPATOL, V57, P613, DOI 10.1016/j.jhep.2012.04.024; Yang Z, 2011, PLOS ONE, V6; Yau T, 2009, CANCER-AM CANCER SOC, V115, P428, DOI 10.1002/cncr.24029; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544; Yu J, 2010, HEPATOLOGY, V51, P2008, DOI 10.1002/hep.23550; Zhang F, 2012, CELL SIGNAL, V24, P596, DOI 10.1016/j.cellsig.2011.11.008	47	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73038	10.1371/journal.pone.0073038	http://dx.doi.org/10.1371/journal.pone.0073038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023668	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200064
J	Marsh, CJ; Louzada, J; Beiroz, W; Ewers, RM				Marsh, Charles J.; Louzada, Julio; Beiroz, Wallace; Ewers, Robert M.			Optimising Bait for Pitfall Trapping of Amazonian Dung Beetles (Coleoptera: Scarabaeinae)	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; ECOSYSTEM FUNCTION; LOS-TUXTLAS; BIODIVERSITY; ASSEMBLAGE; COMMUNITIES; SPECIFICITY; COMPETITION; SECONDARY; PASTURES	The accurate sampling of communities is vital to any investigation of ecological processes and biodiversity. Dung beetles have emerged as a widely used focal taxon in environmental studies and can be sampled quickly and inexpensively using baited pitfalls. Although there is now a wealth of available data on dung beetle communities from around the world, there is a lack of standardisation between sampling protocols for accurately sampling dung beetle communities. In particular, bait choice is often led by the idiosyncrasies of the researcher, logistic problems and the dung sources available, which leads to difficulties for inter-study comparisons. In general, human dung is the preferred choice, however, it is often in short supply, which can severely limit sampling effort. By contrast, pigs may produce up to 20 times the volume. We tested the ability of human and pig dung to attract a primary forest dung beetle assemblage, as well as three mixes of the two baits in different proportions. Analyses focussed on the comparability of sampling with pig or human-pig dung mixes with studies that have sampled using human dung. There were no significant differences between richness and abundance sampled by each bait. The assemblages sampled were remarkably consistent across baits, and ordination analyses showed that the assemblages sampled by mixed dung baits were not significantly different from that captured by pure human dung, with the assemblages sampled by 10% and 90% pig mixes structurally most similar to assemblages sampled by human dung. We suggest that a 10:90 human:pig ratio, or similar, is an ideal compromise between sampling efficiency, inter-study comparability and the availability of large quantities of bait for sampling Amazonian dung beetles. Assessing the comparability of assemblage samples collected using different baits represents an important step to facilitating large-scale meta-analyses of dung beetle assemblages collected using non-standard methodology.	[Marsh, Charles J.; Ewers, Robert M.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Louzada, Julio; Beiroz, Wallace] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil	University of Leeds; Universidade Federal de Lavras	Marsh, CJ (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	C.Marsh@leeds.ac.uk	Marsh, Charles J/D-2891-2012; Louzada, Julio/F-1265-2010; Beiroz, Wallace/E-2808-2014	Marsh, Charles J/0000-0002-0281-3115; Louzada, Julio/0000-0002-1481-3112; Beiroz, Wallace/0000-0002-9677-6799	Natural Environment Research Council (NERC); CNPq; FAPEMI; CAPES	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMI; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CJM was funded through a Natural Environment Research Council (NERC) studentship. JL was funded by by CNPq, FAPEMI and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen E, 2002, ECOL ENTOMOL, V27, P257, DOI 10.1046/j.1365-2311.2002.00408.x; Ari Noriega Jorge, 2012, Psyche (Cambridge), V2012, DOI 10.1155/2012/437589; Barlow J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009609; Boonrotpong Singtoe, 2004, ScienceAsia, V30, P59, DOI 10.2306/scienceasia1513-1874.2004.30.059; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Braga RF, 2012, ECOSYSTEMS, V15, P1173, DOI 10.1007/s10021-012-9576-5; BRUMM MC, 1980, T ASAE, V23, P165, DOI 10.13031/2013.34545; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Davis ALV, 2010, ENVIRON ENTOMOL, V39, P811, DOI 10.1603/EN09256; Davis ALV, 2005, ENVIRON ENTOMOL, V34, P1081, DOI 10.1603/0046-225X(2005)034[1081:EODOAS]2.0.CO;2; Dormont L, 2007, CHEMOECOLOGY, V17, P23, DOI 10.1007/s00049-006-0355-7; DOUBE BM, 1990, ECOL ENTOMOL, V15, P371, DOI 10.1111/j.1365-2311.1990.tb00820.x; Edmonds W.D., 2010, Insecta Mundi, V0129, P1; Errouissi F, 2004, ENVIRON ENTOMOL, V33, P45, DOI 10.1603/0046-225X-33.1.45; Estrada A, 1998, J TROP ECOL, V14, P577, DOI 10.1017/S0266467498000418; ESTRADA A, 1993, J TROP ECOL, V9, P45, DOI 10.1017/S0266467400006933; Feer F, 2005, J TROP ECOL, V21, P21, DOI 10.1017/S0266467404002056; GARDNER TA, 2011, ECOLOGY EVOLUTION DU, P267; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gill B.D., 1991, P211; Gittings T, 1998, ECOGRAPHY, V21, P581, DOI 10.1111/j.1600-0587.1998.tb00550.x; HALFFTER G, 1966, NATURAL HIST DUNG BE; Hill CJ, 1996, J TROP ECOL, V12, P449, DOI 10.1017/S026646740000969X; Horgan FG, 2005, ECOGRAPHY, V28, P603, DOI 10.1111/j.2005.0906-7590.04177.x; Horgan FG, 2008, BIODIVERS CONSERV, V17, P2961, DOI 10.1007/s10531-008-9408-2; HOWDEN H F, 1975, Biotropica, V7, P77, DOI 10.2307/2989750; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Larsen TH, 2006, COLEOPTS BULL, V60, P315, DOI 10.1649/0010-065X(2006)60[315:ETAHSB]2.0.CO;2; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; Louzada JNC, 2009, INSECT CONSERV DIVER, V2, P45, DOI 10.1111/j.1752-4598.2008.00038.x; Martin-Piera F., 1996, Miscellania Zoologica (Barcelona), V19, P13; McGeoch MA, 2002, J APPL ECOL, V39, P661, DOI 10.1046/j.1365-2664.2002.00743.x; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Oksanen J., 2017, COMMUNITY ECOLOGY PA; PECK SB, 1984, BIOTROPICA, V16, P235, DOI 10.2307/2388057; R Core Team, 2021, R LANGUAGE ENV STAT; Shahabuddin, 2010, J TROP ECOL, V26, P53, DOI 10.1017/S0266467409990423; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Spector S, 2003, BIOTROPICA, V35, P394; SPECTOR S, 1998, CONSERVATION CHANGIN, P181; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Vernes K, 2005, J TROP ECOL, V21, P1, DOI 10.1017/S026646740400224X; Viljanen H, 2010, J TROP ECOL, V26, P481, DOI 10.1017/S0266467410000325; Vulinec K, 2002, BIOTROPICA, V34, P297, DOI 10.1111/j.1744-7429.2002.tb00541.x	48	61	61	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73147	10.1371/journal.pone.0073147	http://dx.doi.org/10.1371/journal.pone.0073147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023675	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200071
J	Sugimoto, K; Baba, M; Suzuki, S; Yagihashi, S				Sugimoto, Kazuhiro; Baba, Masayuki; Suzuki, Susumu; Yagihashi, Soroku			The Impact of Low-Dose Insulin on Peripheral Nerve Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; DORSAL-ROOT GANGLION; SENSORY NEURONS; FIBER DENSITY; MECHANICAL HYPERALGESIA; PAIN SENSATION; LOCAL INSULIN; NEUROPATHY; REGENERATION; HYPERGLYCEMIA	Background: The precise mechanisms of the neuroprotective effects of insulin in streptozotocin (STZ)-induced diabetic animals remain unknown, but altered peripheral nerve insulin receptor signaling due to insulin deficiency might be one cause. Methodology and Principal Findings: Diabetes was induced in 10-week-old, male Wistar rats by injecting them with STZ (45 mg/kg). They were assigned to one group that received half of an insulin implant (similar to 1 U/day; I-group, n = 11) or another that remained untreated (U-group, n = 10) for 6 weeks. The controls were age-and sex-matched, non-diabetic Wistar rats (C-group, n = 12). Low-dose insulin did not change haemoglobin A1c, which increased by 136% in the U-group compared with the C-group. Thermal hypoalgesia and mechanical hyperalgesia developed in the U-group, but not in the I-group. Sensory and motor nerve conduction velocities decreased in the U-group, whereas sensory nerve conduction velocity increased by 7% (p = 0.0351) in the I-group compared with the U-group. Western blots showed unaltered total insulin receptor (IR), but a 31% decrease and 3.1- and 4.0-fold increases in phosphorylated IR, p44, and p42 MAPK protein levels, respectively, in sciatic nerves from the U-group compared with the C-group. Phosphorylated p44/42 MAPK protein decreased to control levels in the I-group (p<0.0001). Conclusions and Significance: Low-dose insulin deactivated p44/42 MAPK and ameliorated peripheral sensory nerve dysfunction in rats with STZ-induced diabetes. These findings support the notion that insulin deficiency per se introduces impaired insulin receptor signaling in type 1 diabetic neuropathy.	[Sugimoto, Kazuhiro] Hirosaki Univ, Grad Sch Med, Dept Lab Med, Hirosaki, Aomori, Japan; [Sugimoto, Kazuhiro; Suzuki, Susumu] Ohta Nishinouchi Hosp, Ctr Diabet, Koriyama, Fukushima, Japan; [Baba, Masayuki] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Japan; [Yagihashi, Soroku] Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Sugimoto, K (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Lab Med, Hirosaki, Aomori, Japan.	sugimoto@cc.hirosaki-u.ac.jp			Japan Society for the Promotion of Science [21590609]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (21590609). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Brussee V, 2004, DIABETES, V53, P1824, DOI 10.2337/diabetes.53.7.1824; Daulhac L, 2006, MOL PHARMACOL, V70, P1246, DOI 10.1124/mol.106.025478; Delaney CA, 1998, NEUROREPORT, V9, P2775, DOI 10.1097/00001756-199808240-00017; DELANEY CA, 1994, NEUROSCI LETT, V180, P277, DOI 10.1016/0304-3940(94)90538-X; Divisova S, 2012, J PERIPHER NERV SYST, V17, P341, DOI 10.1111/j.1529-8027.2012.00420.x; Dobretsov M, 2007, WORLD J GASTROENTERO, V13, P175, DOI 10.3748/wjg.v13.i2.175; Duarte Ana I, 2012, J Aging Res, V2012, P384017, DOI 10.1155/2012/384017; Evans L, 2012, NEUROSCI LETT, V506, P59, DOI 10.1016/j.neulet.2011.10.049; Fazan VPS, 2009, J PERIPHER NERV SYST, V14, P137, DOI 10.1111/j.1529-8027.2009.00223.x; FERNYHOUGH P, 1993, BRAIN RES, V607, P117, DOI 10.1016/0006-8993(93)91496-F; Francis G, 2009, DIABETES, V58, P934, DOI 10.2337/db08-1287; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Guo GF, 2011, NEUROBIOL DIS, V43, P414, DOI 10.1016/j.nbd.2011.04.012; HEIDENREICH KA, 1988, J NEUROCHEM, V51, P878, DOI 10.1111/j.1471-4159.1988.tb01824.x; Holland NR, 1997, NEUROLOGY, V48, P708, DOI 10.1212/WNL.48.3.708; Huang TJ, 2003, DIABETES, V52, P2129, DOI 10.2337/diabetes.52.8.2129; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jolivalt CG, 2011, DIABETES OBES METAB, V13, P990, DOI 10.1111/j.1463-1326.2011.01431.x; Kim B, 2011, ENDOCRINOLOGY, V152, P3638, DOI 10.1210/en.2011-0029; Kluding PM, 2012, J DIABETES COMPLICAT, V26, P424, DOI 10.1016/j.jdiacomp.2012.05.007; Liu WJ, 2010, EUR J PHARMACOL, V637, P70, DOI 10.1016/j.ejphar.2010.04.004; Loseth S, 2008, J NEUROL, V255, P1197, DOI 10.1007/s00415-008-0872-0; Ozkul Y, 2001, EUR J NEUROL, V8, P329, DOI 10.1046/j.1468-1331.2001.00240.x; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Piercy V, 1999, J DIABETES COMPLICAT, V13, P163, DOI 10.1016/S1056-8727(99)00034-3; Pierson CR, 2003, J NEUROPATH EXP NEUR, V62, P260, DOI 10.1093/jnen/62.3.260; Pierson CR, 2002, J NEUROPATH EXP NEUR, V61, P857, DOI 10.1093/jnen/61.10.857; Purves T, 2001, FASEB J, V15, P2508, DOI 10.1096/fj.01-0253hyp; Romanovsky D, 2006, NEUROBIOL DIS, V24, P384, DOI 10.1016/j.nbd.2006.07.009; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; Sima AAF, 2000, DIABETOLOGIA, V43, P786, DOI 10.1007/s001250051376; Singh B, 2012, J NEUROCHEM, V121, P263, DOI 10.1111/j.1471-4159.2012.07681.x; Smith AG, 2006, DIABETES CARE, V29, P1294, DOI 10.2337/dc06-0224; Sugimoto K, 2000, DIABETES-METAB RES, V16, P354, DOI 10.1002/1520-7560(200009/10)16:5<354::AID-DMRR149>3.0.CO;2-H; Sugimoto K, 2004, ACTA NEUROPATHOL, V108, P503, DOI 10.1007/s00401-004-0915-2; Sugimoto K, 2002, J PERIPHER NERV SYST, V7, P44, DOI 10.1046/j.1529-8027.2002.02005.x; Sugimoto K, 2000, DIABETES-METAB RES, V16, P408; Sugimoto K, 2008, J PAIN, V9, P237, DOI 10.1016/j.jpain.2007.10.016; Sugimoto K, 2011, J HYPERTENS, V29, P1337, DOI 10.1097/HJH.0b013e328347da0f; Sugimoto K, 2008, DIABETES-METAB RES, V24, P642, DOI 10.1002/dmrr.903; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tomlinson DR, 1999, DIABETOLOGIA, V42, P1271, DOI 10.1007/s001250051439; Toth C, 2006, DIABETOLOGIA, V49, P1081, DOI 10.1007/s00125-006-0169-8; Umapathi T, 2007, MUSCLE NERVE, V35, P591, DOI 10.1002/mus.20732; Vella V, 2001, J CLIN PATHOL-MOL PA, V54, P121, DOI 10.1136/mp.54.3.121; WRIGHT A, 1994, ACTA NEUROPATHOL, V88, P571; ZEMP C, 1981, ACTA NEUROPATHOL, V53, P99, DOI 10.1007/BF00689989; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zochodne DW, 2012, J PERIPHER NERV SYST, V17, P4, DOI 10.1111/j.1529-8027.2012.00388.x; Zotova EG, 2008, EXP NEUROL, V213, P439, DOI 10.1016/j.expneurol.2008.07.009	50	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e74247	10.1371/journal.pone.0074247	http://dx.doi.org/10.1371/journal.pone.0074247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023699	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200097
J	Lucchi, C; Curia, G; Vinet, J; Gualtieri, F; Bresciani, E; Locatelli, V; Torsello, A; Biagini, G				Lucchi, Chiara; Curia, Giulia; Vinet, Jonathan; Gualtieri, Fabio; Bresciani, Elena; Locatelli, Vittorio; Torsello, Antonio; Biagini, Giuseppe			Protective but Not Anticonvulsant Effects of Ghrelin and JMV-1843 in the Pilocarpine Model of Status epilepticus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GROWTH-HORMONE SECRETAGOGUES; GH-RELEASING ACTIVITY; CELL-DEATH; HIPPOCAMPAL-NEURONS; DENTATE GYRUS; RATS; EXPRESSION; HEXARELIN; APOPTOSIS	In models of status epilepticus ghrelin displays neuroprotective effects mediated by the growth hormone secretagogue-receptor 1a (GHS-R-1a). This activity may be explained by anticonvulsant properties that, however, are controversial. We further investigated neuroprotection and the effects on seizures by comparing ghrelin with a more effective GHS-R-1a agonist, JMV-1843. Rats were treated either with ghrelin, JMV-1843 or saline 10 min before pilocarpine, which was used to induce status epilepticus. Status epilepticus, developed in all rats, was attenuated by diazepam. No differences were observed among the various groups in the characteristics of pilocarpine-induced seizures. In saline group the area of lesion, characterized by lack of glial fibrillary acidic protein immunoreactivity, was of 0.45 +/- 0.07 mm(2) in the hippocampal stratum lacunosum-moleculare, and was accompanied by upregulation of laminin immunostaining, and by increased endothelin-1 expression. Both ghrelin (P<0.05) and JMV-1843 (P<0.01) were able to reduce the area of loss in glial fibrillary acidic protein immunostaining. In addition, JMV-1843 counteracted (P<0.05) the changes in laminin and endothelin-1 expression, both increased in ghrelin-treated rats. JMV-1843 was able to ameliorate neuronal survival in the hilus of dentate gyrus and medial entorhinal cortex layer III (P<0.05 vs saline and ghrelin groups). These results demonstrate diverse protective effects of growth hormone secretagogues in rats exposed to status epilepticus.	[Lucchi, Chiara; Curia, Giulia; Vinet, Jonathan; Gualtieri, Fabio; Biagini, Giuseppe] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Bresciani, Elena; Locatelli, Vittorio; Torsello, Antonio] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Biagini, Giuseppe] NOCSAE Hosp, Dept Neurosci, Modena, Italy	Universita di Modena e Reggio Emilia; University of Milano-Bicocca	Biagini, G (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy.	gbiagini@unimore.it	Biagini, Giuseppe/I-3227-2013; Gualtieri, Fabio/E-7325-2013; Vinet, Jonathan/O-2934-2015; Bresciani, Elena/AAG-6172-2019; Curia, Giulia/A-8863-2008; Locatelli, Vittorio/A-5348-2011; Bresciani, Elena/AAG-3149-2020	Biagini, Giuseppe/0000-0002-7130-2511; Gualtieri, Fabio/0000-0002-4972-0039; Vinet, Jonathan/0000-0001-9011-6207; Curia, Giulia/0000-0002-8472-350X; Bresciani, Elena/0000-0002-8247-276X	Ministry of Health [RF-2010-2309921]; University of Milano-Bicocca; Italian Ministry of Education, University and Research [17DZE8RZEA]	Ministry of Health; University of Milano-Bicocca; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Ministry of Health (grant RF-2010-2309921 to GB; https://www.salute.gov.it/ricercaSanitaria/ricercaSanitaria.jsp), the University of Milano-Bicocca (Fondo di Ateneo per la Ricerca FAR, to AT and VL; http://www.unimib.it/go/101/Home/Italiano) and the Italian Ministry of Education, University and Research ("Rientro Cervelli" project 17DZE8RZEA to GC; http://sito.cineca.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Biagini G, 2005, NEUROMOL MED, V7, P325, DOI 10.1385/NMM:7:4:325; Biagini G, 2008, J NEUROPATH EXP NEUR, V67, P687, DOI 10.1097/NEN.0b013e318181b8ae; Biagini G, 2006, EXP NEUROL, V201, P519, DOI 10.1016/j.expneurol.2006.04.029; Biagini G, 2011, EUR J PHARMACOL, V670, P130, DOI 10.1016/j.ejphar.2011.08.020; Borges K, 2006, EXP NEUROL, V201, P416, DOI 10.1016/j.expneurol.2006.04.031; Broglio F, 2002, J ENDOCRINOL INVEST, V25, pRC26, DOI 10.1007/BF03345096; Castro OW, 2011, BRAIN RES, V1374, P43, DOI 10.1016/j.brainres.2010.12.012; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; DEGHENGHI R, 1994, LIFE SCI, V54, P1321, DOI 10.1016/0024-3205(94)00510-9; DEGIORGIO CM, 1992, EPILEPSIA, V33, P23, DOI 10.1111/j.1528-1157.1992.tb02278.x; DU F, 1995, J NEUROSCI, V15, P6301; Fabene PF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001105; Gualtieri F, 2012, NEUROSCIENCE, V218, P278, DOI 10.1016/j.neuroscience.2012.05.018; Guerlavais V, 2003, J MED CHEM, V46, P1191, DOI 10.1021/jm020985q; Hwang S, 2009, ENDOCR J, V56, P609, DOI 10.1507/endocrj.K09E-072; Jo SM, 2011, NEUROSCI LETT, V501, P25, DOI 10.1016/j.neulet.2011.06.032; Kleinz MJ, 2006, CARDIOVASC RES, V69, P227, DOI 10.1016/j.cardiores.2005.09.001; Klitgaard H, 2002, EPILEPSY RES, V51, P93, DOI 10.1016/S0920-1211(02)00099-2; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Lee J, 2010, J ENDOCRINOL, V205, P262, DOI 10.1677/JOE-10-0040; Locatelli V, 1999, ENDOCRINOLOGY, V140, P4024, DOI 10.1210/en.140.9.4024; LOCHE S, 1995, J CLIN ENDOCR METAB, V80, P674, DOI 10.1210/jc.80.2.674; Lopez-Meraz ML, 2010, EPILEPSIA, V51, P56, DOI 10.1111/j.1528-1167.2010.02611.x; Massoud AF, 1996, J CLIN ENDOCR METAB, V81, P4338, DOI 10.1210/jc.81.12.4338; Mathern G.W., 1997, EPILEPSY COMPREHENSI, P133; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; Miao YY, 2007, BIOCHEM BIOPH RES CO, V359, P795, DOI 10.1016/j.bbrc.2007.05.192; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Piccoli F, 2007, J CLIN ENDOCR METAB, V92, P1814, DOI 10.1210/jc.2006-2160; Pitkanen A, 2005, EPILEPSY RES, V63, P27, DOI 10.1016/j.eplepsyres.2004.10.003; Portelli J, 2012, NEUROTHERAPEUTICS, V9, P658, DOI 10.1007/s13311-012-0125-x; Portelli J, 2012, EPILEPSIA, V53, P585, DOI 10.1111/j.1528-1167.2012.03423.x; Rigau V, 2007, BRAIN, V130, P1942, DOI 10.1093/brain/awm118; Rindi G, 2002, HISTOCHEM CELL BIOL, V117, P511, DOI 10.1007/s00418-002-0415-1; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Ryu JK, 2009, NEUROSCIENCE, V163, P601, DOI 10.1016/j.neuroscience.2009.07.006; Schellekens H, 2012, PHARMACOL THERAPEUT, V135, P316, DOI 10.1016/j.pharmthera.2012.06.004; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schwenke DO, 2008, ENDOCRINOLOGY, V149, P237, DOI 10.1210/en.2007-0833; Smith RG, 2005, TRENDS ENDOCRIN MET, V16, P436, DOI 10.1016/j.tem.2005.09.004; Szabo A, 2004, NEUROPATH APPL NEURO, V30, P169, DOI 10.1046/j.0305-1846.2003.00524.x; Torsello A, 2012, PHARMACOL RES, V66, P317, DOI 10.1016/j.phrs.2012.06.006; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Weise J, 2005, NEUROBIOL DIS, V18, P582, DOI 10.1016/j.nbd.2004.10.025; Wiley KE, 2002, BRIT J PHARMACOL, V136, P1146, DOI 10.1038/sj.bjp.0704815; Wu RQ, 2005, CARDIOVASC RES, V68, P318, DOI 10.1016/j.cardiores.2005.06.011; Xu JJ, 2009, NEUROSCI LETT, V453, P58, DOI 10.1016/j.neulet.2009.01.067; Yepes M, 2000, BLOOD, V96, P569; Yuan MJ, 2009, EUR J PHARMACOL, V618, P52, DOI 10.1016/j.ejphar.2009.07.015; Zaniolo K, 2011, INVEST OPHTH VIS SCI, V52, P5376, DOI 10.1167/iovs.10-7152	58	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72716	10.1371/journal.pone.0072716	http://dx.doi.org/10.1371/journal.pone.0072716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015271	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800075
J	Peralta, DA; Araya, A; Nardi, CF; Busi, MV; Gomez-Casati, DF				Peralta, Diego A.; Araya, Alejandro; Nardi, Cristina F.; Busi, Maria V.; Gomez-Casati, Diego F.			Characterization of the Arabidopsis thaliana E3 Ubiquitin-Ligase AtSINAL7 and Identification of the Ubiquitination Sites	PLOS ONE			English	Article							MURINE HOMOLOGS; GENE-EXPRESSION; RING DOMAIN; PROTEIN; PLANTS; OLIGOMERIZATION; TRANSCRIPTION; PROTEOLYSIS; INDUCTION; SYNTHASE	Protein ubiquitination leading to degradation by the proteasome is an important mechanism in regulating key cellular functions. Protein ubiquitination is carried out by a three step process involving ubiquitin (Ub) activation by a E1 enzyme, the transfer of Ub to a protein E2, finally an ubiquitin ligase E3 catalyzes the transfer of the Ub peptide to an acceptor protein. The E3 component is responsible for the specific recognition of the target, making the unveiling of E3 components essential to understand the mechanisms regulating fundamental cell processes through the protein degradation pathways. The Arabidopsis thaliana seven in absentia-like 7 (AtSINAL7) gene encodes for a protein with characteristics from a C3HC4-type E3 ubiquitin ligase. We demonstrate here that AtSINAL7 protein is indeed an E3 protein ligase based on the self-ubiquitination in vitro assay. This activity is dependent of the presence of a Lys residue in position 124. We also found that higher AtSINAL7 transcript levels are present in tissues undergoing active cell division during floral development. An interesting observation is the circadian expression pattern of AtSINAL7 mRNA in floral buds. Furthermore, UV-B irradiation induces the expression of this transcript indicating that AtSINAL7 may be involved in a wide range of different cell processes.	[Peralta, Diego A.; Busi, Maria V.; Gomez-Casati, Diego F.] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim CEFOBI CONICET, RA-2000 Rosario, Santa Fe, Argentina; [Nardi, Cristina F.] Univ Nacl San Martin, Inst Invest Biotecnol, Inst Tecnol Chascomus IIB INTECH CONICET, Chascomus, Argentina; [Araya, Alejandro] Inst Natl Rech Agron INRA Bordeaux Aquitaine, CNRS, Villenave Dornon, France; [Araya, Alejandro] Inst Natl Rech Agron INRA Bordeaux Aquitaine, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Centre National de la Recherche Scientifique (CNRS); INRAE; INRAE	Busi, MV (corresponding author), Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim CEFOBI CONICET, RA-2000 Rosario, Santa Fe, Argentina.	busi@cefobi-conicet.gov.ar; gomezcasati@cefobi-conicet.gov.ar		Busi, Maria Victoria/0000-0003-3638-7043; Gomez-Casati, Diego/0000-0002-4569-2579; Nardi, Cristina/0000-0001-7536-6320	ANPCyT [PICT 0729, 0512]; PICS-CNRS Program [3641]; Institut National de Recherche Agronimique (INRA, France)	ANPCyT(ANPCyT); PICS-CNRS Program; Institut National de Recherche Agronimique (INRA, France)	This work was supported by grants from ANPCyT (PICT 0729 and 0512), the PICS-CNRS Program 3641 and the Institut National de Recherche Agronimique (INRA, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Beryink S, 2007, DNA REPAIR, V6, P1231, DOI 10.1016/j.dnarep.2007.01.012; BOLLAG DM, 1996, ROTEINS METHODS, P415; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busi MV, 2011, MOL PLANT, V4, P127, DOI 10.1093/mp/ssq065; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Cooper SE, 2007, MECH DEVELOP, V124, P584, DOI 10.1016/j.mod.2007.04.007; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Den Herder G, 2008, PLANT PHYSIOL, V148, P369, DOI 10.1104/pp.108.119453; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Geisler DA, 2012, PLANT CELL, V24, P2792, DOI 10.1105/tpc.112.099424; Holloway AJ, 1997, GENOMICS, V41, P160, DOI 10.1006/geno.1997.4642; Hu G, 1999, MOL CELL BIOL, V19, P724; Huang X, 2012, PLANT CELL, V24, P4590, DOI 10.1105/tpc.112.103994; Kim YS, 2006, MOL CELLS, V21, P389; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHUTZE V, 1995, EMBO J, V14, P660, DOI 10.1002/j.1460-2075.1995.tb07044.x; Lario LD, 2011, J EXP BOT, V62, P2925, DOI 10.1093/jxb/err001; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Linke B, 2003, PLANT J, V34, P27, DOI 10.1046/j.1365-313X.2003.01703.x; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Rius SP, 2008, PLANT PHYSIOL, V148, P1655, DOI 10.1104/pp.108.128769; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Thomas B, 2006, J EXP BOT, V57, P3387, DOI 10.1093/jxb/erl071; Tohge T, 2011, PLANT SIGNAL BEHAV, V6, P1987, DOI 10.4161/psb.6.12.18240; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605	41	7	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73104	10.1371/journal.pone.0073104	http://dx.doi.org/10.1371/journal.pone.0073104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015288	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800091
J	Osborn, MP; Park, Y; Parks, MB; Burgess, LG; Uppal, K; Lee, KC; Jones, DP; Brantley, MA				Osborn, Melissa P.; Park, Youngja; Parks, Megan B.; Burgess, L. Goodwin; Uppal, Karan; Lee, Kichun; Jones, Dean P.; Brantley, Milam A., Jr.			Metabolome-Wide Association Study of Neovascular Age-Related Macular Degeneration	PLOS ONE			English	Article							OXIDATIVE STRESS; VITAMIN-D; MARKERS; PATHOGENESIS; BIOMARKERS; DISEASE; PEPT2; ACID	Purpose: To determine if plasma metabolic profiles can detect differences between patients with neovascular age-related macular degeneration (NVAMD) and similarly-aged controls. Methods: Metabolomic analysis using liquid chromatography with Fourier-transform mass spectrometry (LC-FTMS) was performed on plasma samples from 26 NVAMD patients and 19 controls. Data were collected from mass/charge ratio (m/z) 85 to 850 on a Thermo LTQ-FT mass spectrometer, and metabolic features were extracted using an adaptive processing software package. Both non-transformed and log2 transformed data were corrected using Benjamini and Hochberg False Discovery Rate (FDR) to account for multiple testing. Orthogonal Partial Least Squares-Discriminant Analysis was performed to determine metabolic features that distinguished NVAMD patients from controls. Individual m/z features were matched to the Kyoto Encyclopedia of Genes and Genomes database and the Metlin metabolomics database, and metabolic pathways associated with NVAMD were identified using MetScape. Results: Of the 1680 total m/z features detected by LC-FTMS, 94 unique m/z features were significantly different between NVAMD patients and controls using FDR (q = 0.05). A comparison of these features to those found with log2 transformed data (n = 132, q = 0.2) revealed 40 features in common, reaffirming the involvement of certain metabolites. Such metabolites included di- and tripeptides, covalently modified amino acids, bile acids, and vitamin D-related metabolites. Correlation analysis revealed associations among certain significant features, and pathway analysis demonstrated broader changes in tyrosine metabolism, sulfur amino acid metabolism, and amino acids related to urea metabolism. Conclusions: These data suggest that metabolomic analysis can identify a panel of individual metabolites that differ between NVAMD cases and controls. Pathway analysis can assess the involvement of certain metabolic pathways, such as tyrosine and urea metabolism, and can provide further insight into the pathophysiology of AMD.	[Osborn, Melissa P.; Parks, Megan B.; Burgess, L. Goodwin; Brantley, Milam A., Jr.] Vanderbilt Univ, Ctr Med, Vanderbilt Eye Inst, Nashville, TN 37232 USA; [Park, Youngja; Uppal, Karan; Jones, Dean P.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Lee, Kichun] Hanyang Univ, Dept Ind Engn, Seoul 133791, South Korea	Vanderbilt University; Emory University; Hanyang University	Brantley, MA (corresponding author), Vanderbilt Univ, Ctr Med, Vanderbilt Eye Inst, Nashville, TN 37232 USA.	milam.brantley@vanderbilt.edu		Park, Youngja/0000-0002-1310-148X; Uppal, Karan/0000-0001-5985-1668	National Institutes of Health [ES016731]; NIH [AG038746]; American Geriatrics Society; Carl M. & Mildred A. Reeves Foundation [P30 EY08126]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Geriatrics Society; Carl M. & Mildred A. Reeves Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding Sources: National Institutes of Health Grant ES016731 (DPJ), NIH Grant AG038746 (DPJ), Jahnigen Career Development Award from the American Geriatrics Society (MAB), Carl M. & Mildred A. Reeves Foundation (MAB), Core Grant P30 EY08126 to Vanderbilt University, and an unrestricted departmental grant to Vanderbilt University from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiago VM, 2010, CANCER RES, V70, P8309, DOI 10.1158/0008-5472.CAN-10-1319; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Beauchet O, 2011, J AM GERIATR SOC, V59, P568, DOI 10.1111/j.1532-5415.2010.03299.x; Berger UV, 1999, ANAT EMBRYOL, V199, P439, DOI 10.1007/s004290050242; Brantley MA, 2012, OXID STRESS APPL BAS, P367, DOI 10.1007/978-1-61779-606-7_18; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Brito MA, 2008, NEUROTOXICOLOGY, V29, P259, DOI 10.1016/j.neuro.2007.11.002; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Caudle WM, 2010, EXPERT REV NEUROTHER, V10, P925, DOI [10.1586/ern.10.54, 10.1586/ERN.10.54]; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Dunn WB, 2007, METABOLOMICS, V3, P413, DOI 10.1007/s11306-007-0063-5; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Graffe A, 2012, J AM GERIATR SOC, V60, P1367, DOI 10.1111/j.1532-5415.2012.04015.x; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Johnson JM, 2010, ANALYST, V135, P2864, DOI 10.1039/c0an00333f; Jones DP, 2012, ANNU REV NUTR, V32, P183, DOI 10.1146/annurev-nutr-072610-145159; Kamal MA, 2008, DRUG METAB PHARMACOK, V23, P236, DOI 10.2133/dmpk.23.236; Klein R, 2003, ARCH OPHTHALMOL-CHIC, V121, P674, DOI 10.1001/archopht.121.5.674; Klein R, 2009, ARCH OPHTHALMOL-CHIC, V127, P193, DOI 10.1001/archophthalmol.2008.551; Lin L, 2011, J PROTEOME RES, V10, P1396, DOI 10.1021/pr101161u; Mantell DJ, 2000, CIRC RES, V87, P214, DOI 10.1161/01.RES.87.3.214; Mantopoulos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024245; Millen AE, 2011, ARCH OPHTHALMOL-CHIC, V129, P481, DOI 10.1001/archophthalmol.2011.48; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Oakman C, 2011, ANN ONCOL, V22, P1295, DOI 10.1093/annonc/mdq606; OKAJIMA K, 1985, J LAB CLIN MED, V105, P132; Parekh N, 2007, ARCH OPHTHALMOL-CHIC, V125, P661, DOI 10.1001/archopht.125.5.661; Park S, 2012, PHARM BIOL, V50, P582; Rochtchina E, 2007, AM J OPHTHALMOL, V143, P344, DOI 10.1016/j.ajo.2006.08.032; Roede JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033020; Soltow QA, 2013, METABOLOMICS, V9, pS132, DOI 10.1007/s11306-011-0332-1; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Uppal K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-15; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Woo SJ, 2010, J OCUL PHARMACOL TH, V26, P223, DOI 10.1089/jop.2010.0012; Xu L, 2013, INVEST OPHTH VIS SCI, V54, P1616, DOI 10.1167/iovs.12-10260; Yu TW, 2009, BIOINFORMATICS, V25, P1930, DOI 10.1093/bioinformatics/btp291	42	85	89	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72737	10.1371/journal.pone.0072737	http://dx.doi.org/10.1371/journal.pone.0072737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015273	gold, Green Submitted, Green Published			2022-12-27	WOS:000323815200055
J	Arinaitwe, E; Ades, V; Walakira, A; Ninsiima, B; Mugagga, O; Patil, TS; Schwartz, A; Kamya, MR; Nasr, S; Chang, M; Filler, S; Dorsey, G				Arinaitwe, Emmanuel; Ades, Veronica; Walakira, Andrew; Ninsiima, Boaz; Mugagga, Olive; Patil, Teja S.; Schwartz, Alanna; Kamya, Moses R.; Nasr, Sussann; Chang, Michelle; Filler, Scott; Dorsey, Grant			Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy: A Cross-Sectional Study from Tororo, Uganda	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; INSECTICIDE-TREATED NETS; LOW-BIRTH-WEIGHT; PLASMODIUM-FALCIPARUM; DRUG-RESISTANCE; HIGH PREVALENCE; WOMEN; EFFICACY; INFECTION; PARASITES	Background: Intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is widely recommended in sub-Saharan Africa to reduce the risk of malaria and improve birth outcomes. However, there are reports that the efficacy of IPTp with SP is waning, especially in parts of Africa where antimalarial resistance to this drug has become widespread. Methodology/Principal Findings: We conducted a cross-sectional study of 565 HIV-uninfected women giving birth at Tororo District Hospital in southeastern Uganda. The primary objective of the study was to measure associations between use of SP during pregnancy from antenatal records and the risk of adverse outcomes including placental malaria, low birth weight, maternal parasitemia and maternal anemia. The proportion of women who reported taking 0, 1, 2, and 3 doses of SP during pregnancy was 5.7%, 35.8%, 56.6% and 2.0% respectively. Overall, the prevalence of placental malaria was 17.5%, 28.1%, and 66.2% by placental smear, PCR, and histopathology, respectively. In multivariate analyses controlling for potential confounders, >= 2 doses of SP was associated with non-significant trends towards lower odds of placental malaria by placental smear (OR = 0.75, p = 0.25), placental malaria by PCR (OR = 0.93, p = 0.71), placental malaria by histopathology (OR = 0.75, p = 0.16), low birth weight (OR = 0.63, p = 0.11), maternal parasitemia (OR = 0.88, p = 0.60) and maternal anemia (OR = 0.88, p = 0.48). Using a composite outcome, >= 2doses of SP was associated with a significantly lower odds of placental malaria, low birth weight, maternal parasitemia, or maternal anemia (OR = 0.52, p = 0.01). Conclusions/Significance: In this area of Uganda with intense malaria transmission, the prevalence of placental malaria by histopathology was high even among women who reported taking at least 2 doses of SP during pregnancy. The reported use of >= 2 doses of SP was not associated with protection against individual birth and maternal outcome measures but did protect against a composite measure of any adverse outcome.	[Arinaitwe, Emmanuel; Walakira, Andrew; Ninsiima, Boaz; Mugagga, Olive] Infect Dis Res Collaborat, Kampala, Uganda; [Ades, Veronica] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Patil, Teja S.; Schwartz, Alanna; Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Nasr, Sussann; Chang, Michelle] Ctr Dis Control & Prevent, Atlanta, GA USA; [Filler, Scott] Global Fund Fight Acquired Immune Deficiency Synd, Geneva, Switzerland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University; Centers for Disease Control & Prevention - USA	Dorsey, G (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	gdorsey@medsfgh.ucsf.edu		Walakira, Andrew/0000-0002-3651-2679; Ades, Veronica/0000-0002-9163-7511	U.S. President's Malaria Initiative [1U51CK000117]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	U.S. President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. President's Malaria Initiative through a cooperative agreement with the Centers for Disease Control and Prevention (1U51CK000117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Diakite OS, 2011, CLIN INFECT DIS, V53, P215; Feng GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012012; Filler SJ, 2006, J INFECT DIS, V194, P286, DOI 10.1086/505080; Gesase S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004569; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Hamer DH, 2007, J INFECT DIS, V196, P1585, DOI 10.1086/522142; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Iriemenam NC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-134; Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231; Luntamo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041123; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Naidoo I, 2011, PARASITOLOGY, V138, P1469, DOI 10.1017/S0031182011000746; Nankabirwa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013438; Ndyomugyenyi R, 2011, T ROY SOC TROP MED H, V105, P607, DOI 10.1016/j.trstmh.2011.07.012; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Sandison TG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1617; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Taylor SM, 2012, CLIN INFECT DIS, V55, P42, DOI 10.1093/cid/cis301; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Verhoeff FH, 1998, ANN TROP MED PARASIT, V92, P141, DOI 10.1080/00034989859979; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2007, TECHN EXP GROUP M PR; World Health Organization, 2012, UPD WHO POL REC OCT	30	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73073	10.1371/journal.pone.0073073	http://dx.doi.org/10.1371/journal.pone.0073073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023811	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600065
J	Fritz, Z; Malyon, A; Frankau, JM; Parker, RA; Cohn, S; Laroche, CM; Palmer, CR; Fuld, JP				Fritz, Zoe; Malyon, Alexandra; Frankau, Jude M.; Parker, Richard A.; Cohn, Simon; Laroche, Clare M.; Palmer, Chris R.; Fuld, Jonathan P.			The Universal Form of Treatment Options (UFTO) as an Alternative to Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) Orders: A Mixed Methods Evaluation of the Effects on Clinical Practice and Patient Care	PLOS ONE			English	Article							EARLY WARNING SCORE; LIFE-SUSTAINING TREATMENT; HOSPITALIZED-PATIENTS; MEDICAL PATIENTS; VALIDATION; MORBIDITY; MORTALITY; DECISIONS; QUALITY; IMPACT	Aims: To determine whether the introduction of the Universal Form of Treatment Options (the UFTO), as an alternative approach to Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) orders, reduces harms in patients in whom a decision not to attempt cardiopulmonary resuscitation (CPR) was made, and to understand the mechanism for any observed change. Methods: A mixed-methods before-and-after study with contemporaneous case controls was conducted in an acute hospital. We examined DNACPR (103 patients with DNACPR orders in 530 admissions) and UFTO (118 decisions not to attempt resuscitation in 560 admissions) practice. The Global Trigger Tool was used to quantify harms. Qualitative interviews and observations were used to understand mechanisms and effects. Results: Rate of harms in patients for whom there was a documented decision not to attempt CPR was reduced: Rate difference per 1000 patient-days was 12.9 (95% CI: 2.6-23.2, p-value = 0.01). There was a difference in the proportion of harms contributing to patient death in the two period (23/71 in the period to 4/44 in the period (95% CI 7.8-36.1, p-value = 0.006). Significant differences were maintained after adjustment for known confounders. No significant change was seen on contemporaneous case control wards. Interviews with clinicians and observation of ward practice revealed the UFTO helped provide clarity of goals of care and reduced negative associations with resuscitation decisions. Conclusions: Introducing the UFTO was associated with a significant reduction in harmful events in patients in whom a decision not to attempt CPR had been made. Coupled with supportive qualitative evidence, this indicates the UFTO improved care for this vulnerable group.	[Fritz, Zoe; Malyon, Alexandra; Frankau, Jude M.; Fuld, Jonathan P.] Cambridge Univ Hosp NHS Fdn Trust, Dept Acute Med, Cambridge, England; [Parker, Richard A.; Palmer, Chris R.] Univ Cambridge, Ctr Appl Med Stat, Inst Publ Hlth, Cambridge, England; [Cohn, Simon] Univ Cambridge, Primary Care Unit, Inst Publ Hlth, Cambridge, England; [Laroche, Clare M.] W Suffolk Hosp, Dept Resp Med, Bury St Edmunds, Suffolk, England	University of Cambridge; University of Cambridge; University of Cambridge	Fritz, Z (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Dept Acute Med, Cambridge, England.	zoe.fritz@addenbrookes.nhs.uk		Fuld, Jonathan/0000-0003-1847-184X; Fritz, Zoe/0000-0001-9403-409X	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme [PB-PG-0808-17218]; National Institute for Health Research [PB-PG-0808-17218] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0808-17218). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune S, 2005, RESUSCITATION, V65, P291, DOI 10.1016/j.resuscitation.2004.11.028; Beach MC, 2002, J AM GERIATR SOC, V50, P2057, DOI 10.1046/j.1532-5415.2002.50620.x; Cei M, 2009, INT J CLIN PRACT, V63, P591, DOI 10.1111/j.1742-1241.2008.01986.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen JLT, 2008, AM HEART J, V156, P78, DOI 10.1016/j.ahj.2008.01.030; Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Cohen RI, 2009, J CRIT CARE, V24, P311, DOI 10.1016/j.jcrc.2008.01.007; Cohn S, 2013, QJM-INT J MED, V106, P165, DOI 10.1093/qjmed/hcs222; Field RBA, 2012, RES COUNC 2012 SCI S; Fritz Z, 2010, J MED ETHICS, V36, P593, DOI 10.1136/jme.2010.035725; Fritz Z, 2010, RESUSCITATION, V81, P1138, DOI 10.1016/j.resuscitation.2010.05.014; Fullerton JN, 2012, RESUSCITATION, V83, P557, DOI 10.1016/j.resuscitation.2012.01.004; Gray T, 2012, J CLIN PATHOL; Henneman E A, 1994, Am J Crit Care, V3, P467; Kazaure H, 2011, ARCH SURG-CHICAGO, V146, P922, DOI 10.1001/archsurg.2011.69; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; LAPUMA J, 1988, ARCH INTERN MED, V148, P2193, DOI 10.1001/archinte.148.10.2193; McAdam Catherine, 2005, Br J Nurs, V14, P1061; McNeill D, 2012, QJM-INT J MED, V105, P63, DOI 10.1093/qjmed/hcr137; MORGAN R, 1994, BRIT MED J, V308, P1677, DOI 10.1136/bmj.308.6945.1677a; National Confidential Enquiry into Patient Outcomes and Death, 2012, TIM INT REV PAT WHO, P1; National Office of Statistics, 2011, DEATHS REG ENGL WAL, V12; Nicolasora N, 2006, J HOSP MED, V1, P161, DOI 10.1002/jhm.78; Obolensky L, 2010, J MED ETHICS, V36, P518, DOI 10.1136/jme.2009.033977; R Development Core Team, 2012, R LANG ENV STAT COMP; Seaman J., 2008, QUALITATIVE METHODS; Shepardson LB, 1999, MED CARE, V37, P727, DOI 10.1097/00005650-199908000-00003; Sivakumar R, 2004, J MED ETHICS, V30, P311, DOI 10.1136/jme.2002.002915; SPSS/PASW for Windows, 2010, SPSS PASW WIND; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Taylor EM, 1998, BIOETHICS, V12, P64, DOI 10.1111/1467-8519.00093; Tolle SW, 1998, J AM GERIATR SOC, V46, P1097, DOI 10.1111/j.1532-5415.1998.tb06647.x; Venneman SS, 2008, J MED ETHICS, V34, P2, DOI 10.1136/jme.2006.018317; WENGER NS, 1995, ARCH INTERN MED, V155, P2063, DOI 10.1001/archinte.155.19.2063	34	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e70977	10.1371/journal.pone.0070977	http://dx.doi.org/10.1371/journal.pone.0070977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023718	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000324515600007
J	Gao, WT; Chen, ZX; Wang, W; Stang, MT				Gao, Wentao; Chen, Zhixia; Wang, Wei; Stang, Michael T.			E1-Like Activating Enzyme Atg7 Is Preferentially Sequestered into p62 Aggregates via Its Interaction with LC3-I	PLOS ONE			English	Article							BINDING PROTEIN P62; AUTOPHAGY; LIPIDATION; SEQUESTOSOME; DEGRADATION; INCLUSIONS; DISEASE; SYSTEM; CELLS	p62 is constitutively degraded by autophagy via its interaction with LC3. However, the interaction of p62 with LC3 species in the context of the LC3 lipidation process is not specified. Further, the p62-mediated protein aggregation's effect on autophagy is unclear. We systemically analyzed the interactions of p62 with all known Atg proteins involved in LC3 lipidation. We find that p62 does not interact with LC3 at the stages when it is being processed by Atg4B or when it is complexed or conjugated with Atg3. p62 does interact with LC3-I and LC3-I: Atg7 complex and is preferentially recruited by LC3-II species under autophagic stimulation. Given that Atg4B, Atg3 and LC3-Atg3 are indispensable for LC3-II conversion, our study reveals a protective mechanism for Atg4B, Atg3 and LC3-Atg3 conjugate from being inappropriately sequestered into p62 aggregates. Our findings imply that p62 could potentially impair autophagy by negatively affecting LC3 lipidation and contribute to the development of protein aggregate diseases.	[Gao, Wentao; Chen, Zhixia; Stang, Michael T.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Wang, Wei] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jilin University	Gao, WT (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA.	gaowent@pitt.edu; stangmt@upmc.edu			National Institutes of Health/National Cancer Institute ARRA Cancer Center Support Career Development Award [3P30CA047904-21S5]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute ARRA Cancer Center Support Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by National Institutes of Health/National Cancer Institute ARRA Cancer Center Support Career Development Award and Grant 3P30CA047904-21S5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakano T, 2004, ACTA NEUROPATHOL, V107, P359, DOI 10.1007/s00401-004-0821-7; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670	23	16	22	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73229	10.1371/journal.pone.0073229	http://dx.doi.org/10.1371/journal.pone.0073229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023838	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600080
J	Skinner, AL; Kent, C; Rossiter, JM; Benton, CP; Groen, MGM; Noyes, JM				Skinner, Andy L.; Kent, Christopher; Rossiter, Jonathan M.; Benton, Christopher P.; Groen, Martin G. M.; Noyes, Jan M.			On the Edge: Haptic Discrimination of Edge Sharpness	PLOS ONE			English	Article							TACTILE DISCRIMINATION; ANGLE DISCRIMINATION; SHAPE-DISCRIMINATION; LINE-DRAWINGS; OBJECT SHAPE; HUMANS; PERCEPTION; CURVATURE; MECHANISMS; DISPLAY	The increasing ubiquity of haptic displays (e. g., smart phones and tablets) necessitates a better understanding of the perceptual capabilities of the human haptic system. Haptic displays will soon be capable of locally deforming to create simple 3D shapes. This study investigated the sensitivity of our haptic system to a fundamental component of shapes: edges. A novel set of eight high quality shape stimuli with test edges that varied in sharpness were fabricated in a 3D printer. In a two alternative, forced choice task, blindfolded participants were presented with two of these shapes side by side (one the reference, the other selected randomly from the remaining set of seven) and after actively exploring the test edge of each shape with the tip of their index finger, reported which shape had the sharper edge. We used a model selection approach to fit optimal psychometric functions to performance data, and from these obtained just noticeable differences and Weber fractions. In Experiment 1, participants performed the task with four different references. With sharpness defined as the angle at which one surface meets the horizontal plane, the four JNDs closely followed Weber's Law, giving a Weber fraction of 0.11. Comparisons to previously reported Weber fractions from other haptic manipulations (e. g. amplitude of vibration) suggests we are sufficiently sensitive to changes in edge sharpness for this to be of potential utility in the design of future haptic displays. In Experiment 2, two groups of participants performed the task with a single reference but different exploration strategies; one was limited to a single touch, the other unconstrained and free to explore as they wished. As predicted, the JND in the free exploration condition was lower than that in the single touch condition, indicating exploration strategy affects sensitivity to edge sharpness.	[Skinner, Andy L.; Kent, Christopher; Benton, Christopher P.; Groen, Martin G. M.; Noyes, Jan M.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Rossiter, Jonathan M.] Univ Bristol, Dept Engn Math, Bristol, Avon, England	University of Bristol; University of Bristol	Kent, C (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.	c.kent@bristol.ac.uk	Groen, Martin/B-7687-2009	Groen, Martin/0000-0002-2871-7228; Kent, Christopher/0000-0001-5634-9031	Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [EP/J501426/1, EP/K503484/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Institutional Sponsorship from the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk) to the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary F, 2008, EXP BRAIN RES, V187, P587, DOI 10.1007/s00221-008-1327-7; Bau Olivier, 2010, P 23 ANN ACM S US IN, P283, DOI [10.1145/1866029.1866074, DOI 10.1145/1866029.1866074]; Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; Blake DT, 1997, J NEUROSCI, V17, P7480; Buxton W., 1985, Computer Graphics, V19, P215, DOI 10.1145/325165.325239; Chorley C, 2010, IEEE SENSOR, P2593, DOI 10.1109/ICSENS.2010.5690181; CRAIG JC, 1974, PERCEPT PSYCHOPHYS, V15, P123, DOI 10.3758/BF03205839; Drewing K, 2012, ACTA PSYCHOL, V141, P295, DOI 10.1016/j.actpsy.2012.09.011; Efron B, 1998, ANN STAT, V26, P1687; Fernandes AM, 2012, COGN PROCESS, V13, P285, DOI 10.1007/s10339-012-0443-2; Frisoli A, 2008, PRESENCE-TELEOP VIRT, V17, P550, DOI 10.1162/pres.17.6.550; Garcia-Hernandez N, 2012, IEEE SYS MAN CYBERN, P2998, DOI 10.1109/ICSMC.2012.6378251; Garcia-Hernandez N, 2011, IEEE T HAPTICS, V4, P100, DOI [10.1109/TOH.2010.59, 10.1109/ToH.2010.59]; GESCHEID.GA, 1974, PERCEPT MOTOR SKILL, V38, P15, DOI 10.2466/pms.1974.38.1.15; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; GOODWIN AW, 1991, EXP BRAIN RES, V86, P663; Harris J, 2005, PERCEPTION, V34, P81; JOHNSON KO, 1981, J PHYSIOL-LONDON, V310, P117, DOI 10.1113/jphysiol.1981.sp013540; Kappers AML, 2011, PHILOS T R SOC B, V366, P3106, DOI 10.1098/rstb.2011.0171; KLATZKY RL, 1985, PERCEPT PSYCHOPHYS, V37, P299, DOI 10.3758/BF03211351; Klatzky RL, 1999, ATTENTION PERFORM, V17, P165; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lederman SJ, 2009, ATTEN PERCEPT PSYCHO, V71, P1439, DOI 10.3758/APP.71.7.1439; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Levy M, 2007, EXP BRAIN RES, V178, P240, DOI 10.1007/s00221-006-0728-8; Manduchi R, 2012, COMMUN ACM, V55, P96, DOI 10.1145/2063176.2063200; Maschmeyer R, 2012, Patent No. [20120105333 US, 20120105333]; Michelitsch G, 2004, CHI 04 HUM FACT COMP, P1305, DOI DOI 10.1145/985921.986050; Panday V, 2012, IEEE T HAPTICS, V5, P58, DOI [10.1109/ToH.2011.53, 10.1109/TOH.2011.53]; Park J, 2012, IEEE T HAPTICS, V5, P323, DOI [10.1109/ToH.2012.14, 10.1109/TOH.2012.14]; Provancher WR, 2005, INT J ROBOT RES, V24, P691, DOI 10.1177/0278364905057121; Pushkarich PG, 2012, Patent No. [20120068957 US, 20120068957]; Roudaut A, 2013, P SIGCHI C HUM FACT, P593, DOI DOI 10.1145/2470654.2470738; SRINIVASAN MA, 1987, J NEUROSCI, V7, P1682; Symmons M, 2000, PERCEPTION, V29, P621, DOI 10.1068/p2964; Ullman Shimon, 1995, P339; van der Horst BJ, 2007, EXP BRAIN RES, V177, P304, DOI 10.1007/s00221-006-0670-9; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Voisin J, 2005, EXP BRAIN RES, V164, P347, DOI 10.1007/s00221-005-2256-3; Voisin J, 2002, EXP BRAIN RES, V145, P239, DOI 10.1007/s00221-002-1117-6; Voisin J, 2002, EXP BRAIN RES, V145, P251, DOI 10.1007/s00221-002-1118-5; Wijntjes MWA, 2008, ACTA PSYCHOL, V128, P255, DOI 10.1016/j.actpsy.2008.01.006; Wu JL, 2010, PERCEPTION, V39, P993, DOI 10.1068/p6264	43	4	4	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73283	10.1371/journal.pone.0073283	http://dx.doi.org/10.1371/journal.pone.0073283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023852	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600089
J	Steglich, C; Grund, C; Ramp, K; Breithaupt, A; Hoper, D; Keil, G; Veits, J; Ziller, M; Granzow, H; Mettenleiter, TC; Romer-Oberdorfer, A				Steglich, Constanze; Grund, Christian; Ramp, Kristina; Breithaupt, Angele; Hoeper, Dirk; Keil, Guenther; Veits, Jutta; Ziller, Mario; Granzow, Harald; Mettenleiter, Thomas C.; Roemer-Oberdoerfer, Angela			Chimeric Newcastle Disease Virus Protects Chickens against Avian Influenza in the Presence of Maternally Derived NDV Immunity	PLOS ONE			English	Article							EXPRESSING H5 HEMAGGLUTININ; VESICULAR STOMATITIS-VIRUS; LIVE VACCINATION; COMPLETE GENOME; REPLICATION; GENERATION; CHALLENGE; PATHOGENICITY; SEROTYPES; SEQUENCE	Newcastle disease virus (NDV), an avian paramyxovirus type 1, is a promising vector for expression of heterologous proteins from a variety of unrelated viruses including highly pathogenic avian influenza virus (HPAIV). However, preexisting NDV antibodies may impair vector virus replication, resulting in an inefficient immune response against the foreign antigen. A chimeric NDV-based vector with functional surface glycoproteins unrelated to NDV could overcome this problem. Therefore, an NDV vector was constructed which carries the fusion (F) and hemagglutinin-neuraminidase (HN) proteins of avian paramyxovirus type 8 (APMV-8) instead of the corresponding NDV proteins in an NDV backbone derived from the lentogenic NDV Clone 30 and a gene expressing HPAIV H5 inserted between the F and HN genes. After successful virus rescue by reverse genetics, the resulting chNDVFHN (PMV8)H5 was characterized in vitro and in vivo. Expression and virion incorporation of the heterologous proteins was verified by Western blot and electron microscopy. Replication of the newly generated recombinant virus was comparable to parental NDV in embryonated chicken eggs. Immunization with chNDVFHN (PMV8)H5 stimulated full protection against lethal HPAIV infection in chickens without as well as with maternally derived NDV antibodies. Thus, tailored NDV vector vaccines can be provided for use in the presence or absence of routine NDV vaccination.	[Steglich, Constanze; Ramp, Kristina; Keil, Guenther; Veits, Jutta; Mettenleiter, Thomas C.; Roemer-Oberdoerfer, Angela] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Biol, Greifswald, Germany; [Grund, Christian; Hoeper, Dirk] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Breithaupt, Angele] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany; [Ziller, Mario] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, AG Bioinformat, Greifswald, Germany; [Granzow, Harald] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Infectol, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Romer-Oberdorfer, A (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Biol, Greifswald, Germany.	angela.roemer-oberdoerfer@fli.bund.de	Breithaupt, Angele/GON-7227-2022; Breithaupt, Angele/B-6155-2013; Mettenleiter, h. c. Thomas C./U-1016-2019	Breithaupt, Angele/0000-0002-6373-5923; Hoper, Dirk/0000-0001-8408-2274	MSD Animal Health	MSD Animal Health(Merck & CompanyIntervet International B.V.)	The study was funded by MSD Animal Health. The study design was discussed with the funder however, funder had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander, 1998, AM ASS AVIAN PATHOLO, P156; [Anonymous], 1992, OFFICIAL J EUROPEA L; BRAY M, 1991, P NATL ACAD SCI USA, V88, P10342, DOI 10.1073/pnas.88.22.10342; Breithaupt A, 2011, VET PATHOL, V48, P924, DOI 10.1177/0300985810386467; Briand FX, 2012, J VIROL, V86, P7710, DOI 10.1128/JVI.00946-12; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Chen H, 2009, REV SCI TECH OIE, V28, P267, DOI 10.20506/rst.28.1.1860; Cornelissen LAHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044447; DiNapoli JM, 2010, J VIROL, V84, P1489, DOI 10.1128/JVI.01946-09; Foley HD, 2000, P NATL ACAD SCI USA, V97, P14680, DOI 10.1073/pnas.011510698; Gao HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022549; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Ge JY, 2010, AVIAN DIS, V54, P294, DOI 10.1637/8731-032509-ResNote.1; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; HANSON RP, 1955, SCIENCE, V122, P156; Kim SH, 2011, J VIROL, V85, P8582, DOI 10.1128/JVI.00652-11; King AMQ, 2012, VIRUS TAXONOMY PARAM, P672; Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10; Muik A, 2011, J VIROL, V85, P5679, DOI 10.1128/JVI.02511-10; Nayak B, 2012, VACCINE, V30, P2220, DOI 10.1016/j.vaccine.2011.12.090; Park MS, 2006, P NATL ACAD SCI USA, V103, P8203, DOI 10.1073/pnas.0602566103; Pavlova SP, 2009, VACCINE, V27, P5085, DOI 10.1016/j.vaccine.2009.06.048; Pavlova SP, 2009, VACCINE, V27, P773, DOI 10.1016/j.vaccine.2008.11.033; Peeters BPH, 2000, ARCH VIROL, V145, P1829, DOI 10.1007/s007050070059; Peeters BPH, 2001, VACCINE, V19, P1616, DOI 10.1016/S0264-410X(00)00419-9; Qiao CL, 2003, AVIAN PATHOL, V32, P25, DOI 10.1080/0307945021000070688; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramp K, 2012, AVIAN DIS, V56, P208, DOI 10.1637/9870-080311-Reg.1; Ramp K, 2011, AVIAN DIS, V55, P413, DOI 10.1637/9652-011111-Reg.1; Ramp K, 2011, J GEN VIROL, V92, P355, DOI 10.1099/vir.0.027268-0; Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999; Romer-Oberdorfer A, 2008, VACCINE, V26, P2307, DOI 10.1016/j.vaccine.2008.02.061; Romer-Oberdorfer A, 1999, J GEN VIROL, V80, P2987, DOI 10.1099/0022-1317-80-11-2987; Samuel AS, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-38; Samuel AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009269; Sarfati-Mizrahi D, 2010, AVIAN DIS, V54, P239, DOI 10.1637/8735-032509-Reg.1; Schroer D, 2009, AVIAN DIS, V53, P190, DOI 10.1637/8416-072308-Reg.1; SHIBATA R, 1991, J VIROL, V65, P3514, DOI 10.1128/JVI.65.7.3514-3520.1991; Swayne DE, 2011, REV SCI TECH OIE, V30, P839; Terregino C, 2013, ARCH VIROL, DOI [0.1007/s00703-013-1735-2, DOI 10.1007/S00703-013-1735-2.PUBMED:23708253]; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; Werner O, 1999, AVIAN PATHOL, V28, P79, DOI 10.1080/03079459995082	44	29	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72530	10.1371/journal.pone.0072530	http://dx.doi.org/10.1371/journal.pone.0072530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023747	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600026
J	Chen, XR; Xing, YP; Li, YP; Tong, YH; Xu, JY				Chen, Xiao-Ren; Xing, Yu-Ping; Li, Yan-Peng; Tong, Yun-Hui; Xu, Jing-You			RNA-Seq Reveals Infection-Related Gene Expression Changes in Phytophthora capsici	PLOS ONE			English	Article							CELL-DEATH; INFESTANS REVEALS; EFFECTOR PROTEINS; GENOME SEQUENCE; PLANT; PATHOGEN; SOJAE; AVIRULENCE; DISCOVERY; BLIGHT	Phytophthora capsici is a soilborne plant pathogen capable of infecting a wide range of plants, including many solanaceous crops. However, genetic resistance and fungicides often fail to manage P. capsici due to limited knowledge on the molecular biology and basis of P. capsici pathogenicity. To begin to rectify this situation, Illumina RNA-Seq was used to perform massively parallel sequencing of three cDNA samples derived from P. capsici mycelia (MY), zoospores (ZO) and germinating cysts with germ tubes (GC). Over 11 million reads were generated for each cDNA library analyzed. After read mapping to the gene models of P. capsici reference genome, 13,901, 14,633 and 14,695 putative genes were identified from the reads of the MY, ZO and GC libraries, respectively. Comparative analysis between two of samples showed major differences between the expressed gene content of MY, ZO and GC stages. A large number of genes associated with specific stages and pathogenicity were identified, including 98 predicted effector genes. The transcriptional levels of 19 effector genes during the developmental and host infection stages of P. capsici were validated by RT-PCR. Ectopic expression in Nicotiana benthamiana showed that P. capsici RXLR and Crinkler effectors can suppress host cell death triggered by diverse elicitors including P. capsici elicitin and NLP effectors. This study provides a first look at the transcriptome and effector arsenal of P. capsici during the important pre-infection stages.	[Chen, Xiao-Ren; Xing, Yu-Ping; Li, Yan-Peng; Tong, Yun-Hui; Xu, Jing-You] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Peoples R China	Yangzhou University	Chen, XR (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Peoples R China.	xrchen@yzu.edu.cn; jyxu@yzu.edu.cn	Chen, Xiao-Ren/AAI-3800-2020	Chen, Xiao-Ren/0000-0003-2395-0562	National Natural Science Foundation of China [31101395]; Jiangsu Province Basic Research Program (Natural Science Foundation) of China [BK2011443]; Special Fund for Agro-scientific Research in the Public Interest of China [201303018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Basic Research Program (Natural Science Foundation) of China; Special Fund for Agro-scientific Research in the Public Interest of China	This work is supported by National Natural Science Foundation of China (Grant no. 31101395), the Jiangsu Province Basic Research Program (Natural Science Foundation) of China (Grant no. BK2011443) and the Special Fund for Agro-scientific Research in the Public Interest of China (Grant no. 201303018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARAKI F, 1977, J PESTIC SCI, V2, P457; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Asmann YW, 2008, GASTROENTEROLOGY, V135, P1466, DOI 10.1053/j.gastro.2008.09.042; Babadoost M, 2008, CUCURBITACEAE 2008: PROCEEDINGS OF THE IXTH EUCARPIA MEETING ON GENETICS AND BREEDING OF CUCURBITACEAE, P399; Bailey K, 2011, MOL PLANT MICROBE IN, V24, P827, DOI 10.1094/MPMI-12-10-0278; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benjamini Y, 2001, ANN STAT, V29, P1165; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bouwmeester K, 2009, ANNU PLANT REV, V34, P102, DOI 10.1111/b.9781405175326.2009.00005.x; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Chen XR, 2011, CURR GENET, V57, P297, DOI 10.1007/s00294-011-0348-0; Clem RJ, 2007, CURR DRUG TARGETS, V8, P1069, DOI 10.2174/138945007782151405; Dong SM, 2012, MOL PLANT MICROBE IN, V25, P896, DOI 10.1094/MPMI-01-12-0023-R; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Erwin D. C., 1996, Phytophthora diseases worldwide.; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Feng BZ, 2011, GENET MOL RES, V10, P910, DOI 10.4238/vol10-2gmr1248; Forbes B. E., 2002, BAILEY SCOTTS DIAGNO; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Gevens AJ, 2008, PLANT DIS, V92, P201, DOI 10.1094/PDIS-92-2-0201; Gevens AJ, 2004, VEGETABLE DIS CAUSED; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hardham AR, 2007, CELL MICROBIOL, V9, P31, DOI 10.1111/j.1462-5822.2006.00833.x; HO HH, 1990, BOT BULL ACAD SINICA, V31, P89; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kelley BS, 2010, PLANT J, V62, P357, DOI 10.1111/j.1365-313X.2010.04160.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kunjeti SG, 2012, MOL PLANT PATHOL, V13, P454, DOI 10.1111/j.1364-3703.2011.00761.x; Lacomme C, 1999, P NATL ACAD SCI USA, V96, P7956, DOI 10.1073/pnas.96.14.7956; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Lamour KH, 2012, MOL PLANT PATHOL, V13, P329, DOI 10.1111/j.1364-3703.2011.00754.x; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Orsomando G, 2001, J BIOL CHEM, V276, P21578, DOI 10.1074/jbc.M101377200; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Savidor A, 2008, MOL CELL PROTEOMICS, V7, P1501, DOI 10.1074/mcp.M700431-MCP200; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Shan WX, 2004, MOL PLANT PATHOL, V5, P317, DOI 10.1111/j.1364-3703.2004.00231.x; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; van Damme M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002875; Van Poppel PMJA, 2009, MOL PLANT PATHOL, V10, P611, DOI [10.1111/j.1364-3703.2009.00556.x, 10.1111/J.1364-3703.2009.00556.X]; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wang Y, 2013, PLANT CELL ENVIRON, V36, P1192, DOI 10.1111/pce.12052; Winnepenninckx B, 1996, MOL BIOL EVOL, V13, P1306, DOI 10.1093/oxfordjournals.molbev.a025577; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Ye WW, 2011, MOL PLANT MICROBE IN, V24, P1530, DOI 10.1094/MPMI-05-11-0106; Yousef LF, 2009, J CHEM ECOL, V35, P824, DOI 10.1007/s10886-009-9653-1; Yu XL, 2012, NEW PHYTOL, V196, P247, DOI 10.1111/j.1469-8137.2012.04241.x	79	33	38	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74588	10.1371/journal.pone.0074588	http://dx.doi.org/10.1371/journal.pone.0074588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019970	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200113
J	Pante, E; Simon-Bouhet, B				Pante, Eric; Simon-Bouhet, Benoit			marmap: A Package for Importing, Plotting and Analyzing Bathymetric and Topographic Data in R	PLOS ONE			English	Article							ATLANTIC	In this communication we introduce marmap, a package designed for downloading, plotting and manipulating bathymetric and topographic data in R. marmap can query the ETOPO1 bathymetry and topography database hosted by the NOAA, use simple latitude-longitude-depth data in ascii format, and take advantage of the advanced plotting tools available in R to build publication-quality bathymetric maps. Functions to query data (bathymetry, sampling information.) are available interactively by clicking on marmap maps. Bathymetric and topographic data can also be used to calculate projected surface areas within specified depth/altitude intervals, and constrain the calculation of realistic shortest path distances. Such information can be used in molecular ecology, for example, to evaluate genetic isolation by distance in a spatially-explicit framework.	[Pante, Eric; Simon-Bouhet, Benoit] Univ La Rochelle, Littoral Environm & Soc Joint Res Unit 7266, CNRS, La Rochelle, France	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite	Pante, E (corresponding author), Univ La Rochelle, Littoral Environm & Soc Joint Res Unit 7266, CNRS, La Rochelle, France.	pante.eric@gmail.com	Pante, Eric/C-4230-2011	Pante, Eric/0000-0001-7680-2112				Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Becker RA, 2013, MAPS DRAW GEOGRAPHIC; Bivand RS, 2008, USE R, P1; Chessel D., 2004, R NEWS, V4, P5; Dray S., 2007, R NEWS, V7, P47; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Google, 2013, GOOGL EARTH; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; NOAA National Geophysical Data Center, 2013, GEODAS GRID TRANSL D; Pante E, 2013, MARMAP IMPORT PLOT A; Pante E, 2012, OCEANOGRAPHY, V25, P214; Pante E, 2012, J MAR BIOL ASSOC UK, V92, P911, DOI 10.1017/S0025315411001354; Pebesma E.J., 2005, R NEWS, V5; R Development Core Team, 2012, R LANG ENV STAT COMP; Ryan WBF, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002332; Sarkar D, 2008, USE R, P1; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; Van Etten J., 2012, GDISTANCE DISTANCES; van Etten RJHJ, 2012, NGDC24 NOAA NESDIS	20	312	315	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73051	10.1371/journal.pone.0073051	http://dx.doi.org/10.1371/journal.pone.0073051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019892	Green Published, gold			2022-12-27	WOS:000324338200034
J	Sharma, G; Wang, Y; Graham, JE; Kuo, YF; Goodwin, JS				Sharma, Gulshan; Wang, Yue; Graham, James E.; Kuo, Yong-Fang; Goodwin, James S.			Provider Continuity Prior to the Diagnosis of Advanced Lung Cancer and End-of-Life Care	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT USE; INTERPERSONAL CONTINUITY; PREVENTIVE SERVICES; PHYSICIAN; PATIENT; HOSPITALIZATION; BREAST	Background: Little is known about the effect of provider continuity prior to the diagnosis of advanced lung cancer and end-of-life care. Methods: Retrospective analysis of 69,247 Medicare beneficiaries aged 67 years or older diagnosed with Stage IIIB or IV lung cancer between January 1, 1993 and December 31, 2005 who died within two years of diagnosis. We examined visit patterns to a primary care physician (PCP) and/or any provider one year prior to the diagnosis of advanced lung cancer as measures of continuity of care. Outcome measures were hospitalization, ICU use and chemotherapy use during the last month of life, and hospice use during the last week of life. Results: Seeing a PCP or any provider in the year prior to the diagnosis of advanced lung cancer increased the likelihood of hospitalization, ICU care, chemotherapy and hospice use during the end of life. Patients with 1-3, 4-7 or >7 visits to their PCP in the year prior to the diagnosis of lung cancer had 1.0 (reference), 1.08 (95% CI; 1.04-1.13), and 1.14 (95% CI; 1.08-1.19) odds of hospitalization during the last month of life, respectively. Odds of hospice use during the last week of life were higher in patients with visits to multiple PCPs (OR 1.10: 95% CI; 1.06-1.15) compared to those whose visits were all to the same PCP. Conclusion: Provider continuity in the year prior to the diagnosis of advanced lung cancer was not associated with lower use of aggressive care during end of life. Our study did not have information on patient preferences and result should be interpreted accordingly.	[Sharma, Gulshan] Univ Texas Med Branch, Dept Internal Med, Div Pulm & Crit Care Med, Galveston, TX 77555 USA; [Wang, Yue] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Graham, James E.] Univ Texas Med Branch, Dept Rehabil Sci, Galveston, TX 77555 USA; [Kuo, Yong-Fang] Univ Texas Med Branch, Dept PMCH Epidemiol & Biostat, Galveston, TX 77555 USA; [Goodwin, James S.] Univ Texas Med Branch, Dept Internal Med, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Sharma, G (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Pulm & Crit Care Med, Galveston, TX 77555 USA.	gulshan.sharma@utmb.edu	Sharma, Gulshan/AAC-5804-2019		National Institutes of Health [K-08 AG 031583, K05-CA134923, R01-AG033134]; Cancer Prevention and Research Institute of Texas [RP101207]; NATIONAL CANCER INSTITUTE [K05CA134923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG031583, P30AG024832, R01AG033134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant K-08 AG 031583, K05-CA134923, and R01-AG033134 from the National Institutes of Health and RP101207 from the Cancer Prevention and Research Institute of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burge F, 2003, MED CARE, V41, P992, DOI 10.1097/00005650-200308000-00012; Burge Frederick, 2003, J Palliat Med, V6, P911, DOI 10.1089/109662103322654794; Cheng SH, 2010, ARCH INTERN MED, V170, P1671, DOI 10.1001/archinternmed.2010.340; Dumont I, 2005, J PALLIATIVE CARE, V21, P49, DOI 10.1177/082585970502100108; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Ettner SL, 1999, MED CARE, V37, P547, DOI 10.1097/00005650-199906000-00004; Ettner SL, 1996, AM J PUBLIC HEALTH, V86, P1748, DOI 10.2105/AJPH.86.12.1748; Gill JM, 1998, ARCH FAM MED, V7, P352, DOI 10.1001/archfami.7.4.352; Gill JM, 2000, ARCH FAM MED, V9, P333, DOI 10.1001/archfami.9.4.333; Goodwin JS, 2011, MED CARE, V49, P225, DOI 10.1097/MLR.0b013e31820194f2; HOLLI K, 1993, SUPPORT CARE CANCER, V1, P263, DOI 10.1007/BF00366047; Jang TL, 2010, ARCH INTERN MED, V170, P440, DOI 10.1001/archinternmed.2010.1; King M, 2008, BRIT J CANCER, V98, P529, DOI 10.1038/sj.bjc.6604164; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kronman AC, 2008, J GEN INTERN MED, V23, P1330, DOI 10.1007/s11606-008-0638-5; Mainous AG, 2004, FAM MED, V36, P35; Mainous AG, 1998, AM J PUBLIC HEALTH, V88, P1539, DOI 10.2105/AJPH.88.10.1539; OMalley AS, 1997, ARCH INTERN MED, V157, P1462, DOI 10.1001/archinte.157.13.1462; Parchman ML, 2004, FAM MED, V36, P22; Reid BC, 2006, ORAL ONCOL, V42, P510, DOI 10.1016/j.oraloncology.2005.10.009; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Sharma G, 2009, ARCH INTERN MED, V169, P81, DOI 10.1001/archinternmed.2008.514; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; WASSON J H, 1984, Journal of the American Medical Association, V252, P2413, DOI 10.1001/jama.252.17.2413; Wolinsky FD, 2007, J GERONTOL B-PSYCHOL, V62, pS160, DOI 10.1093/geronb/62.3.S160; Wolinsky FD, 2010, J GERONTOL A-BIOL, V65, P421, DOI 10.1093/gerona/glp188	26	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74690	10.1371/journal.pone.0074690	http://dx.doi.org/10.1371/journal.pone.0074690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019974	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200117
J	Rygg, AD; van Duin, ACT; Craven, BA				Rygg, Alex D.; van Duin, Adri C. T.; Craven, Brent A.			Molecular Dynamics Simulations of Water/Mucus Partition Coefficients for Feeding Stimulants in Fish and the Implications for Olfaction	PLOS ONE			English	Article							ODORANT RECEPTOR EXPRESSION; MUCOSAL ACTIVITY PATTERNS; ATOM FORCE-FIELD; RAT NASAL CAVITY; COMPOSITE REPRESENTATION; FUNCTIONAL-MORPHOLOGY; ORGANIC-COMPOUNDS; EPITHELIUM; MUCUS; WATER	The odorant partition coefficient is a physicochemical property that has been shown to dramatically influence odorant deposition patterns in the mammalian nose, leading to a chromatographic separation of odorants along the sensory epithelium. It is unknown whether a similar phenomenon occurs in fish. Here we utilize molecular dynamics simulations, based on a simplified molecular model of olfactory mucus, to calculate water/mucus partition coefficients for amino acid odorants (alanine, glycine, cysteine, and valine) that are known to elicit feeding behavior in fish. Both fresh water and salt water environments are considered. In fresh water, all four amino acids prefer the olfactory mucus phase to water, and the partition coefficient is shown to correlate with amino acid hydrophobicity. In salt water, a reversal in odorant partitioning is found, where each of the feeding stimulants (except glycine) prefer the water phase to olfactory mucus. This is due to the interactions between the salt ions and the odorant molecules (in the water phase), and between the salt and simplified mucin (in the olfactory mucus phase). Thus, slightly different odorant deposition patterns may occur in the fish olfactory organ in fresh and salt water environments. However, in both underwater environments we found that the variation of the water/mucus odorant partition coefficient is approximately one order of magnitude, in stark contrast to air/mucus odorant partition coefficients that can span up to six orders of magnitude. We therefore anticipate relatively similar deposition patterns for most amino acid odorants in the fish olfactory chamber. Thus, in contrast to terrestrial species, living in an underwater environment may preclude appreciable chromatographic odorant separation that may be used for spatial coding of odor identity across the olfactory epithelium. This is consistent with the reported lack of spatial organization of olfactory receptor neurons in the fish olfactory epithelium.	[Rygg, Alex D.; van Duin, Adri C. T.; Craven, Brent A.] Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA; [Rygg, Alex D.; Craven, Brent A.] Penn State Univ, Appl Res Lab, University Pk, PA 16802 USA; [Craven, Brent A.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Rygg, AD (corresponding author), Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA.	adr5023@psu.edu; craven@psu.edu			Pennsylvania State University Applied Research Laboratory	Pennsylvania State University Applied Research Laboratory	This work was supported by the Pennsylvania State University Applied Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel RL, 2010, COMP BIOCHEM PHYS A, V155, P464, DOI 10.1016/j.cbpa.2009.10.029; AMOORE JE, 1978, CHEM SENS FLAV, V3, P57, DOI 10.1093/chemse/3.1.57; BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bertmar G, 1972, CELL TISSUE RES, V128, P336; BRIGHAM MP, 1960, J CLIN INVEST, V39, P1633, DOI 10.1172/JCI104186; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; CARR WES, 1986, J CHEM ECOL, V12, P989, DOI 10.1007/BF01638992; Carr WES, 1996, BIOL BULL, V190, P149, DOI 10.2307/1542535; Chang QH, 1996, CHEM SENSES, V21, P519, DOI 10.1093/chemse/21.5.519; Cox JPL, 2013, FISH FISH, V14, P364, DOI 10.1111/j.1467-2979.2012.00476.x; Craven BA, 2010, J R SOC INTERFACE, V7, P933, DOI 10.1098/rsif.2009.0490; Damm W, 1997, J COMPUT CHEM, V18, P1955, DOI 10.1002/(SICI)1096-987X(199712)18:16<1955::AID-JCC1>3.0.CO;2-L; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dixit SB, 1997, J CHEM SOC FARADAY T, V93, P1105, DOI 10.1039/a603913h; Garrido NM, 2009, J CHEM THEORY COMPUT, V5, P2436, DOI 10.1021/ct900214y; Getchell M, 1991, SMELL TASTE HLTH DIS, P83; GETCHELL ML, 1984, ANAT REC, V208, P553, DOI 10.1002/ar.1092080411; GETCHELL ML, 1992, MICROSC RES TECHNIQ, V23, P111, DOI 10.1002/jemt.1070230203; GETCHELL TV, 1984, PROG NEUROBIOL, V23, P317, DOI 10.1016/0301-0082(84)90008-X; Ghosh Saroj Kumar, 2010, Proceedings of the Zoological Society (Calcutta), V63, P115; Gomes MFC, 2007, DEVELOPMENTS AND APPLICATIONS IN SOLUBILITY, P153; GSCHWEND PM, 1985, ENVIRON SCI TECHNOL, V19, P90, DOI 10.1021/es00131a011; Hansen A, 1998, CHEM SENSES, V23, P39, DOI 10.1093/chemse/23.1.39; HANSEN A, 1993, J COMP NEUROL, V333, P289, DOI 10.1002/cne.903330213; Hara T, 1982, CHEMORECEPTION FISHE, V8; HARA T J, 1975, Progress in Neurobiology (Oxford), V5, P271, DOI 10.1016/0301-0082(75)90014-3; HARA TJ, 1994, ACTA PHYSIOL SCAND, V152, P207, DOI 10.1111/j.1748-1716.1994.tb09800.x; HARA TJ, 1994, REV FISH BIOL FISHER, V4, P1, DOI 10.1007/BF00043259; Hara Toshiaki J., 1992, Fish and Fisheries Series, V6, P150; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HORNUNG DE, 1987, BRAIN RES, V413, P147, DOI 10.1016/0006-8993(87)90163-6; Jones Keith A., 1992, Fish and Fisheries Series, V6, P288; JORGENSEN WL, 1990, J PHYS CHEM-US, V94, P1683, DOI 10.1021/j100367a084; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kent PF, 1996, J NEUROSCI, V16, P345; Khanvilkar K, 2001, ADV DRUG DELIVER REV, V48, P173, DOI 10.1016/S0169-409X(01)00115-6; Kurtz DB, 2004, CHEM SENSES, V29, P763, DOI 10.1093/chemse/bjh079; Laberge F, 2001, BRAIN RES REV, V36, P46, DOI 10.1016/S0165-0173(01)00064-9; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; Lyubartsev AP, 2001, J PHYS CHEM B, V105, P7775, DOI 10.1021/jp0036902; MENCO BPM, 1992, CELL TISSUE RES, V270, P47, DOI 10.1007/BF00381878; Meredith TL, 2012, J EXP BIOL, V215, P2660, DOI 10.1242/jeb.066241; Meredith TL, 2010, J EXP BIOL, V213, P3449, DOI 10.1242/jeb.045849; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOZELL MM, 1966, J GEN PHYSIOL, V50, P25, DOI 10.1085/jgp.50.1.25; MOZELL MM, 1987, J GEN PHYSIOL, V90, P625, DOI 10.1085/jgp.90.5.625; MOZELL MM, 1970, J GEN PHYSIOL, V56, P46, DOI 10.1085/jgp.56.1.46; MOZELL MM, 1964, NATURE, V203, P1181, DOI 10.1038/2031181a0; MOZELL MM, 1991, CHEM SENSES, V16, P631, DOI 10.1093/chemse/16.6.631; Negi A. S, 1985, TXB PHYS CHEM; Nernst W., 1891, PHYS THEM, V8, P110; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NOCEDAL J, 1980, MATH COMPUT, V35, P773, DOI 10.1090/S0025-5718-1980-0572855-7; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Quraishi MS, 1998, CLIN OTOLARYNGOL, V23, P403, DOI 10.1046/j.1365-2273.1998.00172.x; REESE TS, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.2.209; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RIDDLE DR, 1991, J NEUROSCI, V11, P3752; RIDDLE DR, 1993, J NEUROSCI, V13, P3018; Rygg AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059783; SATO A, 1979, BRIT J IND MED, V36, P231; Schluessel V, 2008, J MORPHOL, V269, P1365, DOI 10.1002/jmor.10661; SELLERS LA, 1988, CARBOHYD RES, V178, P93, DOI 10.1016/0008-6215(88)80104-6; SHEPHARD KL, 1994, REV FISH BIOL FISHER, V4, P401, DOI 10.1007/BF00042888; SLEIGH MA, 1989, COMP BIOCHEM PHYS A, V94, P359, DOI 10.1016/0300-9629(89)90559-8; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; TAKAMI S, 1994, ANAT EMBRYOL, V190, P211; THEISEN B, 1986, ACTA ZOOL-STOCKHOLM, V67, P73, DOI 10.1111/j.1463-6395.1986.tb00851.x; Tomenzoli D, 2005, MED RAD DIA IMG, P29; Tricas TC, 2009, J COMP PHYSIOL A, V195, P947, DOI 10.1007/s00359-009-0470-3; TUCKER D, 1983, FISH NEUROBIOLOGY, V1, P311; van Duin ACT, 2001, ORG GEOCHEM, V32, P143, DOI 10.1016/S0146-6380(00)00143-1; Van Duin ACT, 1998, ORG GEOCHEM, V29, P1043, DOI 10.1016/S0146-6380(98)00076-X; Varki A., 1999, ESSENTIALS GLYCOBIOL; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wiesenburg D, 1987, OCEAN PHYS ENG, V12, P127; Yang GC, 2007, CHEM SENSES, V32, P273, DOI 10.1093/chemse/bjl056; Yang L, 2013, J COMPUT CHEM, V34, P284, DOI 10.1002/jcc.23127; ZEISKE E, 1987, CAN J ZOOL, V65, P2406, DOI 10.1139/z87-362	84	4	4	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72271	10.1371/journal.pone.0072271	http://dx.doi.org/10.1371/journal.pone.0072271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023732	gold, Green Submitted, Green Published			2022-12-27	WOS:000324238400011
J	Iordanova, B; Hitchens, TK; Robison, CS; Ahrens, ET				Iordanova, Bistra; Hitchens, T. Kevin; Robison, Clinton S.; Ahrens, Eric T.			Engineered Mitochondrial Ferritin as a Magnetic Resonance Imaging Reporter in Mouse Olfactory Epithelium	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; ODORANT RECEPTOR; IN-VIVO; IRON-METABOLISM; CELL BIOLOGY; EXPRESSION; ADENOVIRUS; BRAIN; NEURONS; CHOICE	We report the design of a MRI reporter gene with applications to non-invasive molecular imaging. We modified mitochondrial ferritin to localize to the cell cytoplasm. We confirmed the efficient cellular processing of this engineered protein and demonstrated high iron loading in mammalian cells. The reporter's intracellular localization appears as distinct clusters that deliver robust MRI contrast. We used this new reporter to image in vivo and ex vivo the gene expression in native olfactory sensory neurons in the mouse epithelium. This robust MRI reporter can facilitate the study of the molecular mechanisms of olfaction and to monitor intranasal gene therapy delivery, as well as a wide range of cell tracking and gene expression studies in living subjects.	[Iordanova, Bistra; Robison, Clinton S.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Iordanova, Bistra; Hitchens, T. Kevin] Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [Ahrens, Eric T.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego	Ahrens, ET (corresponding author), Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.	eta@ucsd.edu	Iordanova, Bistra/GZM-8210-2022	Iordanova, Bistra/0000-0001-7015-5006	National Institutes of Health [R01-EB005740, P41-EB001977]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001977, R01EB005740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health (R01-EB005740 and P41-EB001977). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb AA, 2010, BBA-GEN SUBJECTS, V1800, P793, DOI 10.1016/j.bbagen.2010.03.017; Bennett KM, 2008, BIOPHYS J, V95, P342, DOI 10.1529/biophysj.107.116145; Bou-Abdallah F, 2005, J MOL BIOL, V347, P543, DOI 10.1016/j.jmb.2005.01.007; Chuang KH, 2010, NEUROIMAGE, V49, P1350, DOI 10.1016/j.neuroimage.2009.09.060; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Cohen B, 2007, NAT MED, V13, P498, DOI 10.1038/nm1497; Cohen B, 2009, WIRES NANOMED NANOBI, V1, P181, DOI 10.1002/wnan.11; Corsi B, 2002, J BIOL CHEM, V277, P22430, DOI 10.1074/jbc.M105372200; Deans AE, 2006, MAGN RESON MED, V56, P51, DOI 10.1002/mrm.20914; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Doi K, 2005, ANN OTO RHINOL LARYN, V114, P629, DOI 10.1177/000348940511400808; Drysdale J, 2002, BLOOD CELL MOL DIS, V29, P376, DOI 10.1006/bcmd.2002.0577; Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208; Gilad AA, 2007, NMR BIOMED, V20, P275, DOI 10.1002/nbm.1134; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Hasan MR, 2005, FEBS J, V272, P822, DOI 10.1111/j.1742-4658.2004.04520.x; Iordanova B, 2012, NEUROIMAGE, V59, P1004, DOI 10.1016/j.neuroimage.2011.08.068; Iordanova B, 2010, J BIOL INORG CHEM, V15, P957, DOI 10.1007/s00775-010-0657-7; Kaikkonen MU, 2009, GENE THER, V16, P894, DOI 10.1038/gt.2009.47; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Levi S, 2001, J BIOL CHEM, V276, P24437, DOI 10.1074/jbc.C100141200; Lowenstein PR, 2003, INT REV NEUROBIOL, V55, P3, DOI 10.1016/S0074-7742(03)01001-8; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nie GJ, 2005, BLOOD, V105, P2161, DOI 10.1182/blood-2004-07-2722; Pain F, 2011, CELL MOL LIFE SCI, V68, P2689, DOI 10.1007/s00018-011-0708-4; Plessy C, 2012, GENOME RES, V22, P486, DOI 10.1101/gr.126201.111; Touhara K, 2007, NEUROCHEM INT, V51, P132, DOI 10.1016/j.neuint.2007.05.020; Yau ST, 2000, J MOL BIOL, V303, P667, DOI 10.1006/jmbi.2000.4171; Zhang YH, 2010, ANTIOXID REDOX SIGN, V13, P999, DOI 10.1089/ars.2010.3129; Zhao HQ, 1996, J NEUROBIOL, V30, P521, DOI 10.1002/(SICI)1097-4695(199608)30:4<521::AID-NEU7>3.0.CO;2-5; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	33	14	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72720	10.1371/journal.pone.0072720	http://dx.doi.org/10.1371/journal.pone.0072720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023635	Green Submitted, gold, Green Published			2022-12-27	WOS:000323880200030
J	Tahiri, A; Roe, K; Ree, AH; de Wijn, R; Risberg, K; Busch, C; Lonning, PE; Kristensen, V; Geisler, J				Tahiri, Andliena; Roe, Kathrine; Ree, Anne H.; de Wijn, Rik; Risberg, Karianne; Busch, Christian; Lonning, Per E.; Kristensen, Vessela; Geisler, Jurgen			Differential Inhibition of Ex-Vivo Tumor Kinase Activity by Vemurafenib in BRAF(V600E) and BRAF Wild-Type Metastatic Malignant Melanoma	PLOS ONE			English	Article							OPEN-LABEL; CANCER; RESISTANCE; MULTICENTER; MECHANISMS; MUTATIONS; PLX4032; MEK; PROLIFERATION; CHEMOTHERAPY	Background: Treatment of metastatic malignant melanoma patients harboring BRAF(V600E) has improved drastically after the discovery of the BRAF inhibitor, vemurafenib. However, drug resistance is a recurring problem, and prognoses are still very bad for patients harboring BRAF wild-type. Better markers for targeted therapy are therefore urgently needed. Methodology: In this study, we assessed the individual kinase activity profiles in 26 tumor samples obtained from patients with metastatic malignant melanoma using peptide arrays with 144 kinase substrates. In addition, we studied the overall ex-vivo inhibitory effects of vemurafenib and sunitinib on kinase activity status. Results: Overall kinase activity was significantly higher in lysates from melanoma tumors compared to normal skin tissue. Furthermore, ex-vivo incubation with both vemurafenib and sunitinib caused significant decrease in phosphorylation of kinase substrates, i.e kinase activity. While basal phosphorylation profiles were similar in BRAF wild-type and BRAF(V600E) tumors, analysis with ex-vivo vemurafenib treatment identified a subset of 40 kinase substrates showing stronger inhibition in BRAF(V600E) tumor lysates, distinguishing the BRAF wild-type and BRAF(V600E) tumors. Interestingly, a few BRAF wildtype tumors showed inhibition profiles similar to BRAF(V600E) tumors. The kinase inhibitory effect of vemurafenib was subsequently analyzed in cell lines harboring different BRAF mutational status with various vemurafenib sensitivity in-vitro. Conclusions: Our findings suggest that multiplex kinase substrate array analysis give valuable information about overall tumor kinase activity. Furthermore, intra-assay exposure to kinase inhibiting drugs may provide a useful tool to study mechanisms of resistance, as well as to identify predictive markers.	[Tahiri, Andliena; Roe, Kathrine; Kristensen, Vessela; Geisler, Jurgen] Akershus Univ Hosp, Dept Clin Mol Biol & Lab Sci, Lorenskog, Norway; [Tahiri, Andliena; Ree, Anne H.; Kristensen, Vessela; Geisler, Jurgen] Univ Oslo, Inst Clin Med, Oslo, Norway; [Roe, Kathrine; Ree, Anne H.; Risberg, Karianne; Geisler, Jurgen] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway; [de Wijn, Rik] PamGene Int BV, sHertogenbosch, Netherlands; [Busch, Christian; Lonning, Per E.] Univ Bergen, Inst Med, Sect Oncol, Bergen, Norway; [Lonning, Per E.] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; PamGene International BV; University of Bergen; University of Bergen; Haukeland University Hospital	Geisler, J (corresponding author), Akershus Univ Hosp, Dept Clin Mol Biol & Lab Sci, Lorenskog, Norway.	juergen.geisler@medisin.uio.no	Geisler, Jurgen/AAI-4613-2020; Redalen, Kathrine Roe/AAA-6623-2019; Redalen, Kathrine/F-3383-2017	Geisler, Jurgen/0000-0001-6239-3856; Ree, Anne H./0000-0002-8264-3223; Lonning, Per Eystein/0000-0002-8890-6303; Redalen, Kathrine/0000-0002-1172-4632	South-Eastern Norway Regional Health Authority [2011030]; Division of Medicine, Akershus University Hospital	South-Eastern Norway Regional Health Authority; Division of Medicine, Akershus University Hospital	This work was supported by Grant No. 2011030 from the South-Eastern Norway Regional Health Authority to VNK, and grants received from Division of Medicine, Akershus University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala AM, 2012, CLIN CANCER RES, V18, P33, DOI 10.1158/1078-0432.CCR-11-0997; Barouch-Bentov R, 2011, EXPERT OPIN INV DRUG, V20, P153, DOI 10.1517/13543784.2011.546344; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Busch C, 2010, J INVEST DERMATOL, V130, P2514, DOI 10.1038/jid.2010.138; Busch C, 2010, EUR J CANCER, V46, P2127, DOI 10.1016/j.ejca.2010.04.023; Dahlman KB, 2012, CANCER DISCOV, V2, P791, DOI 10.1158/2159-8290.CD-12-0097; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Folkvord S, 2010, INT J RADIAT ONCOL, V78, P555, DOI 10.1016/j.ijrobp.2010.04.036; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Jeter JM, 2012, CLIN MED INSIGHTS-ON, V6, DOI 10.4137/CMO.S7245; Joensuu G, 2012, ACTA ONCOL, V51, P130, DOI 10.3109/0284186X.2011.617387; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Lai F, 2012, ADV PHARMACOL, V65, P27, DOI 10.1016/B978-0-12-397927-8.00002-6; Lai F, 2012, MELANOMA RES, V22, P244, DOI 10.1097/CMR.0b013e328353eff2; Lindholm EM, 2012, MOL ONCOL, V6, P418, DOI 10.1016/j.molonc.2012.03.006; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Serrone L, 2000, J EXP CLIN CANC RES, V19, P21; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Tap WD, 2010, NEOPLASIA, V12, P637, DOI 10.1593/neo.10414; Tsai KY, 2012, 2012 ASCO ANN M CHIC; Versele M, 2009, MOL CANCER THER, V8, P1846, DOI 10.1158/1535-7163.MCT-08-1029; Villanueva J, 2011, CANCER RES, V71, P7137, DOI 10.1158/0008-5472.CAN-11-1243; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Weber CK, 2001, CANCER RES, V61, P3595; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6	40	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72692	10.1371/journal.pone.0072692	http://dx.doi.org/10.1371/journal.pone.0072692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023633	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200028
J	Zhou, X; Chai, YL; Chen, K; Yang, YY; Liu, Z				Zhou, Xi; Chai, YanLan; Chen, Ke; Yang, YunYi; Liu, Zi			A Meta-Analysis of Reference Values of Leptin Concentration in Healthy Postmenopausal Women	PLOS ONE			English	Article							HORMONE-THERAPY RISKS; BONE-MINERAL DENSITY; ENDOCRINE SYSTEM; BODY-COMPOSITION; BIOCHEMICAL MARKERS; FAT DISTRIBUTION; HUMAN PHYSIOLOGY; BREAST-CANCER; OBESE; MENOPAUSE	Objective: There are numerous reports about the leptin concentration (LC) in postmenopausal women (PW). Changes in LC can elicit different clinical outcomes. We systematically analyzed the LC in PW. Methods: A search was conducted in original English-language studies published from 1994 to October 2012 in the following databases: Medline (78), Cochrane Center (123) Embase (505), Biological abstracts (108), Cochrane (53) and Science Finder Scholar (0). A meta-analysis was undertaken on the correction coefficient (r) between the serum LC and body mass index (BMI) for healthy PW across studies containing a dataset and sample size. Pre-analytical and analytical variations were examined. Pre-analytical variables included fasting status (FS) and sampling timing. Analytical variation comprised assay methodology, LC in those undertaking hormone replacement therapy (HRT) and those not having HRT as well as LC change according to age. Results: Twenty-seven studies met the inclusion criteria. Eighteen studies detected LC in the morning in a FS, 15 studies denoted the r between leptin and the BMI. A combined r was counted for the 15 studies (r = 0.51 [95% confidence interval (CI), 0.46-0.54], P = 0.025), and if sampling collection was in the FSat morning, a combined r was form 10 studies (r = 0.54 [95% CI, 0.45-0.54], P = 0.299) and heterogeneity was diminished. LC did not change between HRT users and non-users in 7 studies. Five studies analyzed changes in LC according to age. Conclusion: Based on all studies that investigated both LC and BMI, LC was positively correlated with the BMI. No studies established reference ranges according to the Clinical and Laboratory Standards Institute (CLSI) in healthy PW, and there was a wide variation in LC values. These differences suggest that caution should be used in the interpretation and comparison between studies.	[Zhou, Xi; Chai, YanLan; Yang, YunYi; Liu, Zi] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Radiat Oncol, Xian, Peoples R China; [Zhou, Xi] Hubei Univ Med, Renmin Hosp, Shiyan, Hubei, Peoples R China; [Chen, Ke] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Xian, Peoples R China	Xi'an Jiaotong University; Hubei University of Medicine; Xi'an Jiaotong University	Liu, Z (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Radiat Oncol, Xian, Peoples R China.	liuzmail@163.com			National Natural Science Foundation of China [81071838]; Department of Health Key Program of Shaanxi Province [2010A02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Health Key Program of Shaanxi Province	Funding provided by the National Natural Science Foundation of China (General Program, NO.81071838) and the Department of Health Key Program of Shaanxi Province (NO.2010A02). The role of funders in this study was to support the data collection and analysis and the charge for publication.	Ayub Nishat, 2006, JPMA Journal of the Pakistan Medical Association, V56, P3; Banks E, 2009, AM J EPIDEMIOL, V170, P24, DOI 10.1093/aje/kwp113; Bednarek-Tupikowska G, 2006, GYNECOL ENDOCRINOL, V22, P207, DOI 10.1080/09513590600702774; Bergendahl M, 2000, J CLIN ENDOCR METAB, V85, P207, DOI 10.1210/jc.85.1.207; Blain H, 2002, J CLIN ENDOCR METAB, V87, P1030, DOI 10.1210/jc.87.3.1030; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; Britt K, 2012, LANCET ONCOL, V13, P1071, DOI 10.1016/S1470-2045(12)70456-4; Cagnacci A, 2002, MENOPAUSE, V9, P65, DOI 10.1097/00042192-200201000-00010; Carlton ED, 2012, HORM BEHAV, V62, P272, DOI 10.1016/j.yhbeh.2012.04.010; Casadesus G, 2008, ADV CLIN CHEM, V45, P139, DOI 10.1016/S0065-2423(07)00006-6; Chahal HS, 2007, J PATHOL, V211, P173, DOI 10.1002/path.2110; Cheung WW, 2012, ISRN ENDOCRINOL, DOI DOI 10.5402/2012/536905; Cordero-MacIntyre Z. R., 2004, Journal of Applied Research, V4, P60; Coylewright M, 2008, HYPERTENSION, V51, P952, DOI 10.1161/HYPERTENSIONAHA.107.105742; Davey DA, 2012, WOMENS HEALTH, V8, P169, DOI [10.2217/WHE.12.1, 10.2217/whe.12.1]; Di Carlo C, 2000, MENOPAUSE, V7, P36; Di Carlo C, 2004, MENOPAUSE, V11, P466, DOI 10.1097/01.GME.0000109313.11228.2B; Di Carlo C, 2007, MENOPAUSE, V14, P450, DOI 10.1097/01.gme.0000236936.28454.6a; Douchi T, 2002, MATURITAS, V42, P219, DOI 10.1016/S0378-5122(02)00078-6; Flegal KM, 2001, J NUTR, V131, p440S, DOI 10.1093/jn/131.2.440S; Fliedner S, 2006, ENDOCRINOLOGY, V147, P2088, DOI 10.1210/en.2005-1016; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Goulding A, 1998, CALCIFIED TISSUE INT, V63, P456, DOI 10.1007/s002239900557; Hadji P, 2003, MATURITAS, V44, P141, DOI 10.1016/S0378-5122(02)00324-9; Hadji P, 2000, MATURITAS, V37, P105, DOI 10.1016/S0378-5122(00)00166-3; Hadji P, 2000, EUR J ENDOCRINOL, V143, P55, DOI 10.1530/eje.0.1430055; Haffner SM, 1997, AM J EPIDEMIOL, V146, P581; Hancox RJ, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-23; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hedges LV, 2014, STAT METHODS META AN; Himms-Hagen J, 1999, CRIT REV CL LAB SCI, V36, P575, DOI 10.1080/10408369991239259; Hinds Lynsey, 2010, Menopause Int, V16, P89, DOI 10.1258/mi.2010.010018; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Jaleel Farhan, 2006, J Pak Med Assoc, V56, P391; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Khokhar KK, 2010, EUR J ENDOCRINOL, V163, P873, DOI 10.1530/EJE-10-0714; Koutkia P, 2003, AM J PHYSIOL-ENDOC M, V285, pE372, DOI 10.1152/ajpendo.00097.2003; Kristensen K, 1999, J ENDOCRINOL, V163, P55, DOI 10.1677/joe.0.1630055; Lambrinoudaki I, 2003, J ENDOCRINOL INVEST, V26, P1225, DOI 10.1007/BF03349162; Langendonk JG, 1998, J CLIN ENDOCR METAB, V83, P1706, DOI 10.1210/jc.83.5.1706; Larsson H, 1996, DIABETES, V45, P1580, DOI 10.2337/diabetes.45.11.1580; Leibel RL, 2002, NUTR REV, V60, pS15, DOI 10.1301/002966402320634788; Licinio J, 1998, J CLIN ENDOCR METAB, V83, P4140, DOI 10.1210/jc.83.11.4140; Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575; MacKay NJ, 2010, J BIOMECH, V43, P764, DOI 10.1016/j.jbiomech.2009.10.038; Manson JE, 2013, METABOLISM, V62, pS15, DOI 10.1016/j.metabol.2012.08.015; Marjoribanks J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8141; Marjoribanks J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004143.pub4; Meyers JA, 2008, J ENDOCRINOL, V199, P51, DOI 10.1677/JOE-07-0569; Munoz J, 2003, J CLIN ENDOCR METAB, V88, P1157, DOI 10.1210/jc.2002-020959; Nagy TR, 1997, J CLIN ENDOCR METAB, V82, P2148, DOI 10.1210/jc.82.7.2148; Oswal A, 2010, OBESITY, V18, P221, DOI 10.1038/oby.2009.228; Pralong FP, 2002, FASEB J, V16, P712, DOI 10.1096/fj.01-0754fje; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; Price TO, 2010, J PHARMACOL EXP THER, V333, P253, DOI 10.1124/jpet.109.158147; Procaccini C, 2009, CURR SIGNAL TRANSD T, V4, P22, DOI 10.2174/157436209787048711; Ptak A, 2013, ENDOCRINE, V43, P394, DOI 10.1007/s12020-012-9788-7; Rappelli A, 2002, J HYPERTENS, V20, pS26; Ray A, 2012, J BIOSCIENCES, V37, P289, DOI 10.1007/s12038-012-9191-9; Ren RX, 2010, WORLD J PEDIATR, V6, P311, DOI 10.1007/s12519-010-0216-x; Rolland YM, 2006, METABOLISM, V55, P1630, DOI 10.1016/j.metabol.2006.07.026; Rozenberg S, 2013, NAT REV ENDOCRINOL, V9, P216, DOI 10.1038/nrendo.2013.17; Sahin G, 2003, RHEUMATOL INT, V23, P87, DOI 10.1007/s00296-002-0257-0; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Sayakhot P, 2012, CLIMACTERIC, V15, P59, DOI 10.3109/13697137.2011.603772; Scherer T, 2013, ENDOCRIN METAB CLIN, V42, P109, DOI 10.1016/j.ecl.2012.11.002; Shaarawy M, 2003, FERTIL STERIL, V79, P919, DOI 10.1016/S0015-0282(02)04915-4; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simon JA, 2010, NAT REV ENDOCRINOL, V6, P661, DOI 10.1038/nrendo.2010.191; Soni AC, 2011, MENOPAUSE, V18, P296, DOI 10.1097/gme.0b013e3181f2e611; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; TAYLOR GT, 1993, J ENDOCRINOL, V137, P115, DOI 10.1677/joe.0.1370115; Thompson KJ, 2011, HPB, V13, P225, DOI 10.1111/j.1477-2574.2010.00259.x; Uddin S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-74; Ushiroyama T, 2003, GYNECOL ENDOCRINOL, V17, P31, DOI 10.1080/713603183; Van Staa TP, 2008, MENOPAUSE, V15, P374, DOI 10.1097/gme.0b013e31812e558f; Venner AA, 2009, ANN CLIN BIOCHEM, V46, P65, DOI 10.1258/acb.2008.008168; Vila R, 1998, ENDOCRINOLOGY, V139, P4466, DOI 10.1210/en.139.11.4466; Wang SN, 2010, WORLD J GASTROENTERO, V16, P5801, DOI 10.3748/wjg.v16.i46.5801; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P561, DOI 10.1210/jc.82.2.561; Wu XY, 2010, CLIN CHIM ACTA, V411, P1296, DOI 10.1016/j.cca.2010.05.006; Yildiz BO, 2006, INT J BIOCHEM CELL B, V38, P820, DOI 10.1016/j.biocel.2005.09.013; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	84	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72734	10.1371/journal.pone.0072734	http://dx.doi.org/10.1371/journal.pone.0072734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023638	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200033
J	Zou, S; Chisholm, R; Tauskela, JS; Mealing, GA; Johnston, LJ; Morris, CE				Zou, Shan; Chisholm, Roderick; Tauskela, Joseph S.; Mealing, Geoff A.; Johnston, Linda J.; Morris, Catherine E.			Force Spectroscopy Measurements Show That Cortical Neurons Exposed to Excitotoxic Agonists Stiffen before Showing Evidence of Bleb Damage	PLOS ONE			English	Article							GATED CHANNEL ACTIVITY; ANOXIC DEPOLARIZATION; MECHANICAL-PROPERTIES; MEMBRANE TENSION; SODIUM-CHANNELS; CA1 NEURONS; CALCIUM; NA+; CYTOSKELETON; INJURY	In ischemic and traumatic brain injury, hyperactivated glutamate (N-methyl-D-aspartic acid, NMDA) and sodium (Nav) channels trigger excitotoxic neuron death. Na+, Ca++ and H2O influx into affected neurons elicits swelling (increased cell volume) and pathological blebbing (disassociation of the plasma membrane's bilayer from its spectrin-actomyosin matrix). Though usually conflated in injured tissue, cell swelling and blebbing are distinct processes. Around an injury core, salvageable neurons could be mildly swollen without yet having suffered the bleb-type membrane damage that, by rendering channels leaky and pumps dysfunctional, exacerbates the excitotoxic positive feedback spiral. Recognizing when neuronal inflation signifies non-lethal osmotic swelling versus blebbing should further efforts to salvage injury-penumbra neurons. To assess whether the mechanical properties of osmotically-swollen versus excitotoxically-blebbing neurons might be cytomechanically distinguishable, we measured cortical neuron elasticity (gauged via atomic force microscopy (AFM)-based force spectroscopy) upon brief exposure to hypotonicity or to excitotoxic agonists (glutamate and Nav channel activators, NMDA and veratridine). Though unperturbed by solution exchange per se, elasticity increased abruptly with hypotonicity, with NMDA and with veratridine. Neurons then invariably softened towards or below the pre-treatment level, sometimes starting before the washout. The initial channel-mediated stiffening bespeaks an abrupt elevation of hydrostatic pressure linked to NMDA or Nav channel-mediated ion/H2O fluxes, together with increased [Ca++](int)-mediated submembrane actomyosin contractility. The subsequent softening to below-control levels is consistent with the onset of a lethal level of bleb damage. These findings indicate that dissection/identification of molecular events during the excitotoxic transition from stiff/swollen to soft/blebbing is warranted and should be feasible.	[Zou, Shan; Chisholm, Roderick; Tauskela, Joseph S.; Mealing, Geoff A.; Johnston, Linda J.] Natl Res Council Canada, Ottawa, ON, Canada; [Morris, Catherine E.] Ottawa Hosp Res Inst, Ottawa, ON, Canada	National Research Council Canada; University of Ottawa; Ottawa Hospital Research Institute	Johnston, LJ (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	Linda.Johnston@nrc-cnrc.gc.ca	Zou, Shan/AAD-5515-2020	Zou, Shan/0000-0002-2480-6821; Johnston, Linda/0000-0002-9136-4920; Morris, Catherine/0000-0002-7401-6545	National Research Council Canada	National Research Council Canada	This work was funded by the National Research Council Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banasiak KJ, 2004, NEUROSCIENCE, V126, P31, DOI 10.1016/S0306-4522(03)00425-1; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Boal D. H., 2002, MECH CELL; Bobryshev YV, 2013, PATHOBIOLOGY, V80, P24, DOI 10.1159/000339430; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; Calabrese B, 2002, BIOPHYS J, V83, P2560, DOI 10.1016/S0006-3495(02)75267-3; Callies C, 2011, J CELL SCI, V124, P1936, DOI 10.1242/jcs.084657; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Chao DM, 2010, PROG NEUROBIOL, V90, P439, DOI 10.1016/j.pneurobio.2009.12.007; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Chorzalska A, 2010, CELL MOL BIOL LETT, V15, P406, DOI 10.2478/s11658-010-0012-6; Dai JW, 1998, J NEUROSCI, V18, P6681; Devaux JJ, 2010, J PHYSIOL-LONDON, V588, P4719, DOI 10.1113/jphysiol.2010.196022; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Hains BC, 2004, EXP NEUROL, V188, P365, DOI 10.1016/j.expneurol.2004.04.001; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Ikeda J, 1996, J NEUROSCI RES, V43, P613; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Irmscher M, 2012, BIOPHYS J, V102, P698, DOI 10.1016/j.bpj.2011.12.054; Ishmael JE, 2007, BRAIN RES, V1143, P46, DOI 10.1016/j.brainres.2007.01.061; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086; Kelly CV, 2009, J BIOL PHYS, V35, P279, DOI 10.1007/s10867-009-9167-7; Koenig X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020300; LANGTON PD, 1993, J PHYSIOL-LONDON, V471, P1; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Liu XX, 2008, J MEMBRANE BIOL, V226, P17, DOI 10.1007/s00232-008-9135-3; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lulevich V, 2010, ULTRAMICROSCOPY, V110, P1435, DOI 10.1016/j.ultramic.2010.07.009; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; Markin VS, 1999, BIOPHYS J, V76, P2852, DOI 10.1016/S0006-3495(99)77439-4; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Mere J, 2005, BIOCHEM J, V386, P47, DOI 10.1042/BJ20041054; MILTON RL, 1990, J NEUROSCI, V10, P885; Morris CE, 2012, PROG BIOPHYS MOL BIO, V110, P245, DOI 10.1016/j.pbiomolbio.2012.07.003; Morris CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00019; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; MORRIS CE, 2011, CELL PHYSL SOURCE BO, P493; Muller M, 2000, J NEUROPHYSIOL, V84, P1869, DOI 10.1152/jn.2000.84.4.1869; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; Ohta S, 1996, J CEREBR BLOOD F MET, V16, P915, DOI 10.1097/00004647-199609000-00015; Okuyama K, 2000, EUR J PHARMACOL, V398, P209, DOI 10.1016/S0014-2999(00)00305-8; Rasband MN, 2013, CURR BIOL, V23, pR197, DOI 10.1016/j.cub.2013.01.050; Sakaguchi T, 1999, NEUROSCI LETT, V274, P135, DOI 10.1016/S0304-3940(99)00702-8; Sanchez D, 2008, BIOPHYS J, V95, P3017, DOI 10.1529/biophysj.108.129551; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Shi XR, 2005, AM J PHYSIOL-CELL PH, V288, pC1332, DOI 10.1152/ajpcell.00522.2004; SMALL DL, 1994, AM J PHYSIOL, V267, pC598, DOI 10.1152/ajpcell.1994.267.2.C598; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Spagnoli C, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031916; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steltenkamp S, 2006, SMALL, V2, P1016, DOI 10.1002/smll.200600018; Sun GC, 2006, ACTA PHARMACOL SIN, V27, P1537, DOI 10.1111/j.1745-7254.2006.00452.x; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Takahashi M, 1996, BRAIN RES, V735, P1, DOI 10.1016/S0006-8993(96)00536-7; Tauskela JS, 2012, J NEUROCHEM, V122, P470, DOI 10.1111/j.1471-4159.2012.07791.x; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Tauskela JS, 2005, FASEB J, V19, P1734, DOI 10.1096/fj.05-3795fje; Tauskela JS, 2003, AM J PHYSIOL-CELL PH, V285, pC899, DOI 10.1152/ajpcell.00110.2003; Underhill SM, 2007, NEUROBIOL DIS, V25, P284, DOI 10.1016/j.nbd.2006.09.011; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; WAN X, 1995, J MEMBRANE BIOL, V145, P21; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318, DOI 10.1152/ajpcell.1999.276.2.C318; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; Wilson JR, 2014, WORLD NEUROSURG, V81, P825, DOI 10.1016/j.wneu.2013.01.001; Wu BJ, 2001, J EXP BIOL, V204, P4271; Xiang K, 2012, EPILEPSY RES, V99, P293, DOI 10.1016/j.eplepsyres.2011.12.011; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yilmaz C, 2009, TURK NEUROSURG, V19, P367; Zhang J, 2012, BRAIN RES, V1471, P129, DOI 10.1016/j.brainres.2012.06.031; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P117, DOI 10.1111/j.1469-7793.2000.t01-1-00117.x	82	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73499	10.1371/journal.pone.0073499	http://dx.doi.org/10.1371/journal.pone.0073499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023686	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200083
J	Jung, WS; Singh, RK; Lee, JK; Pan, CH				Jung, Woo-Suk; Singh, Raushan Kumar; Lee, Jung-Kul; Pan, Cheol-Ho			Crystal Structure and Substrate Specificity of D-Galactose-6-Phosphate Isomerase Complexed with Substrates	PLOS ONE			English	Article							TAGATOSE 6-PHOSPHATE PATHWAY; D-GALACTOSE METABOLISM; RIBOSE-5-PHOSPHATE ISOMERASE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; TAGATOSE-1,6-BISPHOSPHATE ALDOLASE; PHOSPHOGLUCOSE ISOMERASE; PYROBACULUM-AEROPHILUM; LACTOSE METABOLISM; GENE-CLUSTER	D-Galactose-6-phosphate isomerase from Lactobacillus rhamnosus (LacAB; EC 5.3.1.26), which is encoded by the tagatose-6-phosphate pathway gene cluster (lacABCD), catalyzes the isomerization of D-galactose-6-phosphate to D-tagatose-6-phosphate during lactose catabolism and is used to produce rare sugars as low-calorie natural sweeteners. The crystal structures of LacAB and its complex with D-tagatose-6-phosphate revealed that LacAB is a homotetramer of LacA and LacB subunits, with a structure similar to that of ribose-5-phosphate isomerase (Rpi). Structurally, LacAB belongs to the RpiB/LacAB superfamily, having a Rossmann-like alpha beta alpha sandwich fold as has been identified in pentose phosphate isomerase and hexose phosphate isomerase. In contrast to other family members, the LacB subunit also has a unique alpha 7 helix in its C-terminus. One active site is distinctly located at the interface between LacA and LacB, whereas two active sites are present in RpiB. In the structure of the product complex, the phosphate group of D-tagatose-6-phosphate is bound to three arginine residues, including Arg-39, producing a different substrate orientation than that in RpiB, where the substrate binds at Asp-43. Due to the proximity of the Arg-134 residue and backbone Ca of the alpha 6 helix in LacA to the last Asp-172 residue of LacB with a hydrogen bond, a six-carbon sugar-phosphate can bind in the larger pocket of LacAB, compared with RpiB. His-96 in the active site is important for ring opening and substrate orientation, and Cys-65 is essential for the isomerization activity of the enzyme. Two rare sugar substrates, D-psicose and D-ribulose, show optimal binding in the LacAB-substrate complex. These findings were supported by the results of LacA activity assays.	[Jung, Woo-Suk; Pan, Cheol-Ho] Korea Inst Sci & Technol, Gangneung Inst, Funct Food Ctr, Kangnung, South Korea; [Singh, Raushan Kumar; Lee, Jung-Kul] Konkuk Univ, Dept Chem Engn, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Konkuk University	Lee, JK (corresponding author), Konkuk Univ, Dept Chem Engn, Seoul, South Korea.	jkrhee@konkuk.ac.kr; panc@kist.re.kr	Lee, Jungkukl/D-9104-2011	Singh, Raushan Kumar/0000-0001-8031-1041	KIST Gangneung Institute [2Z03850]; Converging Research Center Program through National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2011-50210]	KIST Gangneung Institute; Converging Research Center Program through National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a KIST Gangneung Institute intramural grant (2Z03850) and the Converging Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2011-50210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDERSON RL, 1982, METHOD ENZYMOL, V89, P562; BISSETT DL, 1980, J BIOL CHEM, V255, P8740; BISSETT DL, 1974, J BACTERIOL, V117, P318, DOI 10.1128/JB.117.1.318-320.1974; BISSETT DL, 1974, J BACTERIOL, V119, P698, DOI 10.1128/JB.119.3.698-704.1974; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DEVOS WM, 1994, FEMS MICROBIOL REV, V15, P217, DOI 10.1016/0168-6445(94)90114-7; DISCHE Z, 1951, J BIOL CHEM, V192, P583; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Fridovich-Keil JL, 2006, J CELL PHYSIOL, V209, P701, DOI 10.1002/jcp.20820; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hall DR, 2002, J BIOL CHEM, V277, P22018, DOI 10.1074/jbc.M202464200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JAGUSZTYNKRYNICKA EK, 1992, J BACTERIOL, V174, P6152, DOI 10.1128/JB.174.19.6152-6158.1992; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LowKam C, 2010, J BIOL CHEM, V285, P21143, DOI 10.1074/jbc.M109.080358; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miallau L, 2007, J BIOL CHEM, V282, P19948, DOI 10.1074/jbc.M701480200; MORSE ML, 1968, J BACTERIOL, V95, P2270, DOI 10.1128/JB.95.6.2270-2274.1968; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park CS, 2007, BIOTECHNOL LETT, V29, P1387, DOI 10.1007/s10529-007-9393-7; Park HY, 2007, J BIOTECHNOL, V132, P88, DOI 10.1016/j.jbiotec.2007.08.022; Rangarajan ES, 2002, PROTEINS, V48, P737, DOI 10.1002/prot.10203; Roos AK, 2004, J MOL BIOL, V335, P799, DOI 10.1016/j.jmb.2003.11.021; Roos AK, 2008, J MOL BIOL, V382, P667, DOI 10.1016/j.jmb.2008.06.090; ROSEY EL, 1991, J BACTERIOL, V173, P5992, DOI 10.1128/jb.173.19.5992-5998.1991; ROSEY EL, 1992, J BACTERIOL, V174, P6159, DOI 10.1128/JB.174.19.6159-6170.1992; Stern AL, 2007, BIOCHEM J, V401, P279, DOI 10.1042/BJ20061049; Swan MK, 2004, BIOCHEMISTRY-US, V43, P14088, DOI 10.1021/bi048608y; Swan MK, 2004, J BIOL CHEM, V279, P39838, DOI 10.1074/jbc.M406855200; VANROOIJEN RJ, 1991, J BIOL CHEM, V266, P7176; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeom SJ, 2009, APPL ENVIRON MICROB, V75, P4705, DOI 10.1128/AEM.00310-09; Yoon RY, 2009, J BIOTECHNOL, V139, P26, DOI 10.1016/j.jbiotec.2008.09.012; Zeng L, 2012, APPL ENVIRON MICROB, V78, P5597, DOI 10.1128/AEM.01393-12; Zhang RG, 2003, J MOL BIOL, V332, P1083, DOI 10.1016/j.jmb.2003.08.009; Zhang RG, 2003, STRUCTURE, V11, P31, DOI 10.1016/S0969-2126(02)00933-4	41	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72902	10.1371/journal.pone.0072902	http://dx.doi.org/10.1371/journal.pone.0072902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015281	Green Submitted, gold, Green Published			2022-12-27	WOS:000323733800084
J	Kim, SH; Wanasen, N; Paldurai, A; Xiao, S; Collins, PL; Samal, SK				Kim, Shin-Hee; Wanasen, Nanchaya; Paldurai, Anandan; Xiao, Sa; Collins, Peter L.; Samal, Siba K.			Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine	PLOS ONE			English	Article							FOREIGN GENE; CHICKEN; EXPRESSION; OUTBREAKS; EFFICACY; STRAINS; HN; REPLICATION; SEQUENCE; DOMAIN	Virulent strains of Newcastle disease virus (NDV) can cause devastating disease in chickens worldwide. Although the current vaccines are substantially effective, they do not completely prevent infection, virus shedding and disease. To produce genotype-matched vaccines, a full-genome reverse genetics system has been used to generate a recombinant virus in which the F protein cleavage site has been changed to that of avirulent vaccine virus. In the other strategy, the vaccines have been generated by replacing the F and HN genes of a commercial vaccine strain with those from a genotype-matched virus. However, the protective efficacy of a chimeric virus vaccine has not been directly compared with that of a full-genome virus vaccine developed by reverse genetics. Therefore, in this study, we evaluated the protective efficacy of genotype VII matched chimeric vaccines by generating three recombinant viruses based on avirulent LaSota (genotype II) strain in which the open reading frames (ORFs) encoding the F and HN proteins were replaced, individually or together, with those of the circulating and highly virulent Indonesian NDV strain Ban/010. The cleavage site of the Ban/010 F protein was mutated to the avirulent motif found in strain LaSota. In vitro growth characteristics and a pathogenicity test indicated that all three chimeric viruses retained the highly attenuated phenotype of the parental viruses. Immunization of chickens with chimeric and full-length genome VII vaccines followed by challenge with virulent Ban/010 or Texas GB (genotype II) virus demonstrated protection against clinical disease and death. However, only those chickens immunized with chimeric rLaSota expressing the F or F plus HN proteins of the Indonesian strain were efficiently protected against shedding of Ban/010 virus. Our findings showed that genotype-matched vaccines can provide protection to chickens by efficiently preventing spread of virus, primarily due to the F protein.	[Kim, Shin-Hee; Wanasen, Nanchaya; Paldurai, Anandan; Xiao, Sa; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Collins, Peter L.] NIAID, Infect Dis Lab, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Samal, SK (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu			NIAID [N01A060009]; NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID contract N01A060009 (85% support) and the NIAID, NIH, Intramural Research Program (15% support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous EW, 2004, AVIAN PATHOL, V33, P258, DOI 10.1080/0307945042000195768; Alexander D.J., 1989, LAB MANUAL ISOLATION; BOURSNELL MEG, 1990, VIROLOGY, V178, P297, DOI 10.1016/0042-6822(90)90408-J; Cattoli G, 2010, VET MICROBIOL, V142, P168, DOI 10.1016/j.vetmic.2009.09.063; Cho SH, 2008, CLIN VACCINE IMMUNOL, V15, P1572, DOI 10.1128/CVI.00156-08; COSSET FL, 1991, VIROLOGY, V185, P862, DOI 10.1016/0042-6822(91)90560-X; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dortmans JCFM, 2012, VET MICROBIOL, V160, P17, DOI 10.1016/j.vetmic.2012.05.003; Hu SL, 2009, VACCINE, V27, P904, DOI 10.1016/j.vaccine.2008.11.091; Huang ZH, 2001, J GEN VIROL, V82, P1729, DOI 10.1099/0022-1317-82-7-1729; Jeon WJ, 2008, J VET SCI, V9, P295, DOI 10.4142/jvs.2008.9.3.295; Karaca K, 1998, VACCINE, V16, P1496, DOI 10.1016/S0264-410X(97)00295-8; Khan TA, 2010, J CLIN MICROBIOL, V48, P1892, DOI 10.1128/JCM.00148-10; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; Kim SH, 2012, J VIROL, V86, P11394, DOI 10.1128/JVI.01922-12; Kim SH, 2011, J VIROL, V85, P8582, DOI 10.1128/JVI.00652-11; Krishnamurthy S, 2000, VIROLOGY, V278, P168, DOI 10.1006/viro.2000.0618; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Melanson VR, 2004, J VIROL, V78, P13053, DOI 10.1128/JVI.78.23.13053-13061.2004; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Pedersen JC, 2004, J CLIN MICROBIOL, V42, P2329, DOI 10.1128/JCM.42.5.2329-2334.2004; Perozo F, 2012, J CLIN MICROBIOL, V50, P1204, DOI 10.1128/JCM.06506-11; Peter HD, 1965, P NATL ACAD SCI USA, V54, P794, DOI DOI 10.1073/PNAS.54.3.794.PUBMED:5217460; Qin ZM, 2008, J CLIN MICROBIOL, V46, P601, DOI 10.1128/JCM.01356-07; REED L. J., 1938, AMER JOUR HYG, V27, P493; Samal SK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P69; Samal S, 2011, J GEN VIROL, V92, P2333, DOI 10.1099/vir.0.033399-0; Xiao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052751; Xiao S, 2012, J VIROL, V86, P5969, DOI 10.1128/JVI.00546-12	35	64	65	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e74022	10.1371/journal.pone.0074022	http://dx.doi.org/10.1371/journal.pone.0074022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015313	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800108
J	Ponce, E; Aquino, NB; Louie, MC				Ponce, Esmeralda; Aquino, Natalie B.; Louie, Maggie C.			Chronic Cadmium Exposure Stimulates SDF-1 Expression in an ER alpha Dependent Manner	PLOS ONE			English	Article							BREAST-CANCER CELLS; ESTROGEN-RECEPTOR-ALPHA; CYCLIN D1 GENE; TARGET GENES; HEAVY-METALS; TUMOR-CELLS; IN-VIVO; C-JUN; ACTIVATION; TRANSCRIPTION	Cadmium is an omnipotent environmental contaminant associated with the development of breast cancer. Studies suggest that cadmium functions as an endocrine disruptor, mimicking the actions of estrogen in breast cancer cells and activating the receptor to promote cell growth. Although acute cadmium exposure is known to promote estrogen receptor-mediated gene expression associated with growth, the consequence of chronic cadmium exposure is unclear. Since heavy metals are known to bioaccumulate, it is necessary to understand the effects of prolonged cadmium exposure. This study aims to investigate the effects of chronic cadmium exposure on breast cancer progression. A MCF7 breast cancer cell line chronically exposed to 10(-7) M CdCl2 serves as our model system. Data suggest that prolonged cadmium exposures result in the development of more aggressive cancer phenotypes - increased cell growth, migration and invasion. The results from this study show for the first time that chronic cadmium exposure stimulates the expression of SDF-1 by altering the molecular interactions between ER alpha, c-jun and c-fos. This study provides a mechanistic link between chronic cadmium exposure and ER alpha and demonstrates that prolonged, low-level cadmium exposure contributes to breast cancer progression.	[Ponce, Esmeralda; Aquino, Natalie B.; Louie, Maggie C.] Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA USA		Louie, MC (corresponding author), Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA USA.	maggie.louie@dominican.edu		Ponce, Esmeralda/0000-0002-4174-356X	National Science Foundation [1039728]; National Cancer Institute [CA121983-02, CA121983-02S1]; NATIONAL CANCER INSTITUTE [R15CA121983] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Science Foundation (1039728 to MCL) and the National Cancer Institute (CA121983-02 to MCL and CA121983-02S1 to EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 2001, CANCER RES, V61, P455; Ali I, 2010, ENVIRON HEALTH PERSP, V118, P1389, DOI 10.1289/ehp.1001967; Alonso-Gonzalez C, 2007, J PINEAL RES, V42, P403, DOI 10.1111/j.1600-079X.2007.00434.x; Antila E, 1996, SCI TOTAL ENVIRON, V186, P251, DOI 10.1016/0048-9697(96)05119-4; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Choe SY, 2003, SCI TOTAL ENVIRON, V312, P15, DOI 10.1016/S0048-9697(03)00190-6; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Florin L, 2005, J CELL SCI, V118, P1981, DOI 10.1242/jcs.02303; Florin L, 2004, ONCOGENE, V23, P7005, DOI 10.1038/sj.onc.1207938; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; GUNN SA, 1964, P SOC EXP BIOL MED, V115, P653; Haga A, 1996, EUR J CANCER, V32A, P2342, DOI 10.1016/S0959-8049(96)00349-8; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hofer N, 2009, TOXICOL LETT, V191, P123, DOI 10.1016/j.toxlet.2009.08.014; Ionescu JG, 2006, NEUROENDOCRINOL LETT, V27, P36; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Liu ZW, 2008, TOXICOL APPL PHARM, V228, P286, DOI 10.1016/j.taap.2007.12.017; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; Mukherjee D, 2013, AM J CANCER RES, V3, P46; POIRIER LA, 1983, CANCER RES, V43, P4575; Qi XM, 2004, J BIOL CHEM, V279, P6769, DOI 10.1074/jbc.M311492200; Romanowicz-Makowska H, 2011, POL J PATHOL, V62, P257; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Siewit CL, 2010, MOL ENDOCRINOL, V24, P981, DOI 10.1210/me.2009-0410; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Strumylaite L, 2008, MEDICINA-LITHUANIA, V44, P415, DOI 10.3390/medicina44060054; Strumylaite L, 2011, BREAST CANCER RES TR, V125, P511, DOI 10.1007/s10549-010-1007-8; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; Waalkes MP, 1999, CARCINOGENESIS, V20, P65, DOI 10.1093/carcin/20.1.65; Waalkes MP, 2000, TOXICOL SCI, V54, P110, DOI 10.1093/toxsci/54.1.110; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Yu XY, 2010, TOXICOL APPL PHARM, V245, P83, DOI 10.1016/j.taap.2010.02.005; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	39	17	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72639	10.1371/journal.pone.0072639	http://dx.doi.org/10.1371/journal.pone.0072639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015267	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800072
J	Ljungberg, JK; Hansson, P; Andres, P; Josefsson, M; Nilsson, LG				Ljungberg, Jessica K.; Hansson, Patrik; Andres, Pilar; Josefsson, Maria; Nilsson, Lars-Goran			A Longitudinal Study of Memory Advantages in Bilinguals	PLOS ONE			English	Article							COGNITIVE CONTROL; PROSPECTIVE COHORT; RETRIEVAL; FLUENCY; RESERVE; ABILITY; HEALTH; BETULA; ONSET	Typically, studies of cognitive advantages in bilinguals have been conducted previously by using executive and inhibitory tasks (e.g. Simon task) and applying cross-sectional designs. This study longitudinally investigated bilingual advantages on episodic memory recall, verbal letter and categorical fluency during the trajectory of life. Monolingual and bilingual participants (n= 178) between 35-70 years at baseline were drawn from the Betula Prospective Cohort Study of aging, memory, and health. Results showed that bilinguals outperformed monolinguals at the first testing session and across time both in episodic memory recall and in letter fluency. No interaction with age was found indicating that the rate of change across ages was similar for bilinguals and monolinguals. As predicted and in line with studies applying cross-sectional designs, no advantages associated with bilingualism were found in the categorical fluency task. The results are discussed in the light of successful aging.	[Ljungberg, Jessica K.; Hansson, Patrik] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Ljungberg, Jessica K.] Cardiff Univ, Sch Psychol, Cardiff, Wales; [Andres, Pilar] Univ Balearic Isl, Dept Psychol, Palma De Mallorca, Spain; [Nilsson, Lars-Goran] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Josefsson, Maria] Umea Univ, Umea Sch Business & Econ, Dept Stat, Umea, Sweden	Umea University; Cardiff University; Universitat de les Illes Balears; Stockholm University; Umea University	Ljungberg, JK (corresponding author), Umea Univ, Dept Psychol, S-90187 Umea, Sweden.	jessica.korningljungberg@psy.umu.se	Benito, Pilar Andres/G-3411-2011	Andres, Pilar/0000-0003-2220-8198; Hansson, Patrik/0000-0002-4040-5657; Josefsson, Maria/0000-0002-1812-3581	Bank of Sweden Tercentenary Foundation [1988-0082:17, J2001-0682]; Swedish Council for Planning and Coordination of Research [D1988-0092, D1989-0115, D1990-0074, D1991-0258, D1992-0143, D1997-0756, D1997-1841, D1999-0739, B1999-474]; Swedish Council for Research in the Humanities and Social Sciences [F377/1988-2000]; Swedish Council for Social Research [1988-1990: 88-0082, 311/1991-2000]; Swedish Research Council [345-2003-3883, 315-2004-6977, 421-2011-1782]; Swedish Council for Working Life and Social Research [2211-0505]; Spanish Ministry of Science and Innovation [PSI2010-21609-C02-02]	Bank of Sweden Tercentenary Foundation; Swedish Council for Planning and Coordination of Research; Swedish Council for Research in the Humanities and Social Sciences; Swedish Council for Social Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The Betula Study is supported by the Bank of Sweden Tercentenary Foundation (grant number 1988-0082:17, J2001-0682); Swedish Council for Planning and Coordination of Research (grant number D1988-0092, D1989-0115, D1990-0074, D1991-0258, D1992-0143, D1997-0756, D1997-1841, D1999-0739, B1999-474); Swedish Council for Research in the Humanities and Social Sciences (grant number F377/1988-2000); Swedish Council for Social Research (grant number 1988-1990: 88-0082, 311/1991-2000); and the Swedish Research Council (grant number 345-2003-3883, 315-2004-6977). Jessica K. Ljungberg is supported by grants from the Swedish Research Council (421-2011-1782) and the Swedish Council for Working Life and Social Research (2211-0505) and Pilar Andres is supported by a grant from the Spanish Ministry of Science and Innovation (PSI2010-21609-C02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J., 2001, BILING-LANG COGN, V4, P179, DOI [DOI 10.1017/S136672890100027X, 10.1017/S136672890100027, DOI 10.1017/S136672890100027]; Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; Aiken L. S., 1991, MULTIPLE REGRESSION; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Baltes PB, 2005, CAMBRIDGE HDB AGE AG, P47; Bates D, 2011, IME4 LINEAR MIXED EF; Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bialystok E, 2008, J EXP PSYCHOL LEARN, V34, P859, DOI 10.1037/0278-7393.34.4.859; Bialystok E, 2012, TRENDS COGN SCI, V16, P240, DOI 10.1016/j.tics.2012.03.001; Bialystok Ellen, 2009, Psychol Sci Public Interest, V10, P89, DOI 10.1177/1529100610387084; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001; Craik FIM, 2010, NEUROLOGY, V75, P1726, DOI 10.1212/WNL.0b013e3181fc2a1c; De Bleser R, 2003, J NEUROLINGUIST, V16, P439, DOI 10.1016/S0911-6044(03)00022-8; Depue BE, 2012, NEUROSCI BIOBEHAV R, V36, P1382, DOI 10.1016/j.neubiorev.2012.02.012; Emmorey K, 2008, PSYCHOL SCI, V19, P1201, DOI 10.1111/j.1467-9280.2008.02224.x; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Fernandes MA, 2007, CAN J EXP PSYCHOL, V61, P128, DOI 10.1037/cjep2007014; Finkel D, 2009, PSYCHOL AGING, V24, P563, DOI 10.1037/a0015511; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Grogan A, 2009, CEREB CORTEX, V19, P2690, DOI 10.1093/cercor/bhp023; Hernandez M, 2010, BILING-LANG COGN, V13, P315, DOI 10.1017/S1366728909990010; Hertzog C, 2009, SCI AM MIND, V20, P24, DOI DOI 10.1038/SCIENTIFICAMERICANMIND0709-24; Josefsson M, 2012, J AM GERIATR SOC, V60, P2308, DOI 10.1111/jgs.12000; Kroll JF, 2008, ACTA PSYCHOL, V128, P416, DOI 10.1016/j.actpsy.2008.02.001; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Luo L, 2010, COGNITION, V114, P29, DOI 10.1016/j.cognition.2009.08.014; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; Morton JB, 2007, DEVELOPMENTAL SCI, V10, P719, DOI 10.1111/j.1467-7687.2007.00623.x; Morton JB, BILINGUAL A IN PRESS; Nilsson LG, 2009, NEUROBIOL AGING, V30, P521, DOI 10.1016/j.neurobiolaging.2008.11.013; Nilsson LG, 2003, ACTA NEUROL SCAND, V107, P7, DOI 10.1034/j.1600-0404.107.s179.5.x; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Park DC, 2007, J GERONTOL B-PSYCHOL, V62, P45, DOI 10.1093/geronb/62.special_issue_1.45; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodriguez-Fornells A, 2005, J COGNITIVE NEUROSCI, V17, P422, DOI 10.1162/0898929053279559; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Ronnlund M, 2006, BALTIC J PSYCHOL, V7, P6, DOI DOI 10.1037/E629902012-003; Salthouse TA, 2006, PERSPECT PSYCHOL SCI, V1, P68, DOI 10.1111/j.1745-6916.2006.00005.x; SCHAIE KW, 1994, AM PSYCHOL, V49, P304, DOI 10.1037/0003-066X.49.4.304; Schroeder SR, 2012, J COGN PSYCHOL, V24, P591, DOI 10.1080/20445911.2012.669367; Schweizer TA, 2012, CORTEX, V48, P991, DOI 10.1016/j.cortex.2011.04.009; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Snow R., 1984, ADV PSYCHOL HUMAN IN, V2, P47; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Tao L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00123; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wodniecka Z, 2010, INT J BILING EDUC BI, V13, P575, DOI 10.1080/13670050.2010.488287; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	55	50	51	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73029	10.1371/journal.pone.0073029	http://dx.doi.org/10.1371/journal.pone.0073029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023803	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600058
J	Aubertot, JN; Robin, MH				Aubertot, Jean-Noel; Robin, Marie-Helene			Injury Profile SIMulator, a Qualitative Aggregative Modelling Framework to Predict Crop Injury Profile as a Function of Cropping Practices, and the Abiotic and Biotic Environment. I. Conceptual Bases	PLOS ONE			English	Article							MULTICRITERIA ASSESSMENT; WINTER-WHEAT; SYSTEMS; PEST; MANAGEMENT; DESIGN; TOOL; METHODOLOGY; DISEASES; INPUT	The limitation of damage caused by pests (plant pathogens, weeds, and animal pests) in any agricultural crop requires integrated management strategies. Although significant efforts have been made to i) develop, and to a lesser extent ii) combine genetic, biological, cultural, physical and chemical control methods in Integrated Pest Management (IPM) strategies (vertical integration), there is a need for tools to help manage Injury Profiles (horizontal integration). Farmers design cropping systems according to their goals, knowledge, cognition and perception of socio-economic and technological drivers as well as their physical, biological, and chemical environment. In return, a given cropping system, in a given production situation will exhibit a unique injury profile, defined as a dynamic vector of the main injuries affecting the crop. This simple description of agroecosystems has been used to develop IPSIM (Injury Profile SIMulator), a modelling framework to predict injury profiles as a function of cropping practices, abiotic and biotic environment. Due to the tremendous complexity of agroecosystems, a simple holistic aggregative approach was chosen instead of attempting to couple detailed models. This paper describes the conceptual bases of IPSIM, an aggregative hierarchical framework and a method to help specify IPSIM for a given crop. A companion paper presents a proof of concept of the proposed approach for a single disease of a major crop (eyespot on wheat). In the future, IPSIM could be used as a tool to help design ex-ante IPM strategies at the field scale if coupled with a damage sub-model, and a multicriteria sub-model that assesses the social, environmental, and economic performances of simulated agroecosystems. In addition, IPSIM could also be used to help make diagnoses on commercial fields. It is important to point out that the presented concepts are not crop- or pest-specific and that IPSIM can be used on any crop.	[Aubertot, Jean-Noel; Robin, Marie-Helene] INRA, Unite Mixte Rech Agrosyst & Agr Gest Ressources I, F-31326 Castanet Tolosan, France; [Aubertot, Jean-Noel] Univ Toulouse, Inst Natl Polytech Toulouse, Unite Mixte Rech Agrosyst & Agr Gest Ressources I, Castanet Tolosan, France; [Robin, Marie-Helene] Univ Toulouse, Inst Natl Polytech Toulouse, Ecole Ingenieurs Purpan, Toulouse, France	INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Aubertot, JN (corresponding author), INRA, Unite Mixte Rech Agrosyst & Agr Gest Ressources I, F-31326 Castanet Tolosan, France.	Jean-Noel.Aubertot@toulouse.inra.fr			INRA; INPT EI Purpan; project MICMAC design [ANR-09-STRA-06]; French National Agency for Research (ANR); Programme "Assessing and reducing environmental risks from plant protection products (pesticides)"; French Ministry in charge of Ecology and Sustainable Development (project "ASPIB")	INRA; INPT EI Purpan; project MICMAC design; French National Agency for Research (ANR)(French National Research Agency (ANR)); Programme "Assessing and reducing environmental risks from plant protection products (pesticides)"; French Ministry in charge of Ecology and Sustainable Development (project "ASPIB")	This study was carried out within a PhD project co-funded by INRA and INPT EI Purpan, by the project MICMAC design (ANR-09-STRA-06) supported by the French National Agency for Research (ANR), and by the Programme "Assessing and reducing environmental risks from plant protection products (pesticides)", funded by the French Ministry in charge of Ecology and Sustainable Development (project "ASPIB"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2010, MATCHED PAIRS DATA O, P225; Mojca SA, 2010, J ENVIRON MANAGE, V91, P2554, DOI 10.1016/j.jenvman.2010.07.006; Aubertot J. N., 2006, Bulletin OILB/SROP, V29, P277; Bergez JE, 2010, EUR J AGRON, V32, P3, DOI 10.1016/j.eja.2009.06.001; Birch ANE, 2011, J EXP BOT, V62, P3251, DOI 10.1093/jxb/err064; Bohanec M, 2003, SPRING INT SER ENG C, V745, P23; Bohanec M, 2008, ECOL MODEL, V215, P247, DOI 10.1016/j.ecolmodel.2008.02.016; Bolton MD, 2008, MOL PLANT PATHOL, V9, P563, DOI [10.1111/j.1364-3703.2008.00487.x, 10.1111/J.1364-3703.2008.00487.X]; BREMAN H, 1983, SCIENCE, V221, P1341, DOI 10.1126/science.221.4618.1341; Brisson N, 1998, AGRONOMIE, V18, P311, DOI 10.1051/agro:19980501; Carpani M, 2012, ENVIRON MODELL SOFTW, V27-28, P15, DOI 10.1016/j.envsoft.2011.10.002; CAVELIER N, 1985, AGRONOMIE, V5, P693, DOI 10.1051/agro:19850804; Colbach N, 1997, CROP PROT, V16, P415, DOI 10.1016/S0261-2194(97)00018-5; DAAMEN RA, 1989, J PHYTOPATHOL, V125, P305, DOI 10.1111/j.1439-0434.1989.tb01075.x; Debaeke P, 2009, AGRON SUSTAIN DEV, V29, P73, DOI [10.1051/agro:2008050, 10.1007/978-90-481-2666-8_43]; Delmotte S, 2009, CONTEXTUALIZATION FA, P180; Ferron P, 2005, AGRON SUSTAIN DEV, V25, P17, DOI 10.1051/agro:2004050; Fess TL, 2011, SUSTAINABILITY-BASEL, V3, P1742, DOI 10.3390/su3101742; Griffiths BS, 2010, APPL SOIL ECOL, V46, P43, DOI 10.1016/j.apsoil.2010.06.012; Jeger MJ, 2000, CROP PROT, V19, P787, DOI 10.1016/S0261-2194(00)00105-8; Kolmer JA, 2005, CURR OPIN PLANT BIOL, V8, P441, DOI 10.1016/j.pbi.2005.05.001; Kropff MJ, 1995, AGR SYST, V49, P413, DOI 10.1016/0308-521X(95)00034-3; Kropff MJ, 2001, AGR SYST, V70, P369, DOI 10.1016/S0308-521X(01)00052-X; Lancon J, 2007, AGRON SUSTAIN DEV, V27, P101, DOI 10.1051/agro:2006037; Li BL, 2010, ECOL COMPLEX, V7, P421, DOI 10.1016/j.ecocom.2010.10.001; Madden LV, 2006, EUR J PLANT PATHOL, V115, P3, DOI 10.1007/s10658-005-1229-5; Meynard JM, 2003, CR BIOL, V326, P37, DOI 10.1016/S1631-0691(03)00006-4; Oblak L., 2007, Zbornik Gozdarstva in Lesarstva, P33; Ould-Sidi MM, 2011, AGRON SUSTAIN DEV, V31, P571, DOI 10.1007/s13593-011-0002-8; Pazek K., 2005, Agricultura (Slovenia), V3, P13; Pazek K., 2007, Agricultura (Slovenia), V5, P15; Pazek K., 2012, 47th Croatian and 7th International Symposium on Agriculture, Opatija, Croatia, 13-17 February 2012. Proceedings, P222; Pazek K., 2009, Zbornik Radova 44. Hrvatski i 4 Medunarodni Simpozij Agronoma, Opatija, Hrvatska, 16-20 Veljace 2009, P360; Pazek K, 2010, J SUSTAIN AGR, V34, P778, DOI 10.1080/10440046.2010.507531; Pelzer E, 2012, ECOL INDIC, V18, P171, DOI 10.1016/j.ecolind.2011.11.019; RABBINGE R, 1983, Bulletin OEPP, V13, P297, DOI 10.1111/j.1365-2338.1983.tb01616.x; REINECKE P, 1979, Z PFLANZENK PFLANZEN, V86, P190; Robin MH, 2013, PLOS ONE IN PRESS; Rozman C, 2006, J SUSTAIN AGR, V28, P159, DOI 10.1300/J064v28n02_12; Rozman C, 2009, TOURISM MANAGE, V30, P629, DOI 10.1016/j.tourman.2008.11.008; Sadok W, 2009, AGRON SUSTAIN DEV, V29, P447, DOI 10.1051/agro/2009006; Savary S, 2000, PLANT DIS, V84, P341, DOI 10.1094/PDIS.2000.84.3.341; Savary S, 2006, EUR J PLANT PATHOL, V115, P123, DOI 10.1007/s10658-005-0651-z; Sebillotte M, 1990, SYSTEMES CULTURE, P165; STOCKLE CO, 1994, AGR SYST, V46, P335, DOI 10.1016/0308-521X(94)90006-2; Sundman K.F., 1912, ACTA MATHEMATICA, V36, P105, DOI DOI 10.1007/BF02422379; Tchamitchian M, 2011, ACTA HORTIC, P1239, DOI 10.17660/ActaHortic.2011.893.145; Vindis P, 2012, POL J ENVIRON STUD, V21, P763; Wallach D, 2011, AGRON J, V103, P1144, DOI 10.2134/agronj2010.0432; Willocquet L, 2008, FIELD CROP RES, V107, P12, DOI 10.1016/j.fcr.2007.12.013; Willocquet L, 2002, ECOL MODEL, V153, P247, DOI 10.1016/S0304-3800(02)00014-5; Zadoks J. C., 1988, Bulletin SROP, V11, P82; ZADOKS JC, 1984, PLANT DIS, V68, P352, DOI 10.1094/PD-69-352; Zadoks JC, 1993, MODERN CROP PROTECTI; Znidarsic M, 2006, ENVIRON MODELL SOFTW, V21, P1514, DOI 10.1016/j.envsoft.2006.04.003	55	36	36	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73202	10.1371/journal.pone.0073202	http://dx.doi.org/10.1371/journal.pone.0073202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019908	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200050
J	Blumberg, BJ; Trop, S; Das, S; Dimopoulos, G				Blumberg, Benjamin J.; Trop, Stefanie; Das, Suchismita; Dimopoulos, George			Bacteria- and IMD Pathway-Independent Immune Defenses against Plasmodium falciparum in Anopheles gambiae	PLOS ONE			English	Article							DORSAL-VENTRAL PATTERN; SERINE PROTEASES; LEPIDOPTERAN INSECT; CYTOKINE SPATZLE; MALARIA; TOLL; PARASITE; SERPIN; MELANIZATION; ACTIVATION	The mosquito Anopheles gambiae uses its innate immune system to control bacterial and Plasmodium infection of its midgut tissue. The activation of potent IMD pathway-mediated anti-Plasmodium falciparum defenses is dependent on the presence of the midgut microbiota, which activate this defense system upon parasite infection through a peptidoglycan recognition protein, PGRPLC. We employed transcriptomic and reverse genetic analyses to compare the P. falciparum infection-responsive transcriptomes of septic and aseptic mosquitoes and to determine whether bacteria-independent anti-Plasmodium defenses exist. Antibiotic treated aseptic mosquitoes mounted molecular immune responses representing a variety of immune functions upon P. falciparum infection. Among other immune factors, our analysis uncovered a serine protease inhibitor (SRPN7) and Clip-domain serine protease (CLIPC2) that were transcriptionally induced in the midgut upon P. falciparum infection, independent of bacteria. We also showed that SRPN7 negatively and CLIPC2 positively regulate the anti-Plasmodium defense, independently of the midgut-associated bacteria. Co-silencing assays suggested that these two genes may function together in a signaling cascade. Neither gene was regulated, nor modulated, by infection with the rodent malaria parasite Plasmodium berghei, suggesting that SRPN7 and CLIPC2 are components of a defense system with preferential activity towards P. falciparum. Further analysis using RNA interference determined that these genes do not regulate the anti-Plasmodium defense mediated by the IMD pathway, and both factors act as agonists of the endogenous midgut microbiota, further demonstrating the lack of functional relatedness between these genes and the bacteria-dependent activation of the IMD pathway. This is the first study confirming the existence of a bacteria-independent, anti-P. falciparum defense. Further exploration of this anti-Plasmodium defense will help clarify determinants of immune specificity in the mosquito, and expose potential gene and/or protein targets for malaria intervention strategies based on targeting the parasite in the mosquito vector.	[Blumberg, Benjamin J.; Trop, Stefanie; Das, Suchismita; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dimopoulos, G (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	gdimopou@jhsph.edu		Dimopoulos, George/0000-0001-6755-8111; Trop, Stefanie/0000-0003-0094-248X	National Institutes of Health/National Institute of Allergy and Infectious Disease [R01AI061576]; Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061576] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by National Institutes of Health/National Institute of Allergy and Infectious Disease grant R01AI061576 and the Bloomberg Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; Arrighi RBG, 2009, DEV COMP IMMUNOL, V33, P216, DOI 10.1016/j.dci.2008.08.009; Ashok Y, 2009, INT J MED MICROBIOL; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045580; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Crampton JM, 1997, PLOS PATHOG, pxxv; Danielli A, 2000, P NATL ACAD SCI USA, V97, P7136, DOI 10.1073/pnas.97.13.7136; DELOTTO R, 1986, NATURE, V323, P688, DOI 10.1038/323688a0; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Dudoit S, 2003, BIOTECHNIQUES, P45; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Fullaondo A, 2011, MOL CELL BIOL, V31, P2960, DOI 10.1128/MCB.01397-10; Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gonzalez-Lazaro M, 2009, INSECT BIOCHEM MOLEC, V39, P395, DOI 10.1016/j.ibmb.2009.03.008; Gulland A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e895; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kellenberger C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182741; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McTaggart SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-175; Meister S, 2004, INT J PARASITOL, V34, P1473, DOI 10.1016/j.ijpara.2004.10.004; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Molina-Cruz A, 2010, AM J TROP MED HYG, V83, P257; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nehme NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014743; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Paskewitz SM, 2006, INSECT BIOCHEM MOLEC, V36, P701, DOI 10.1016/j.ibmb.2006.06.001; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Reichhart JM, 2011, METHOD ENZYMOL, V499, P205, DOI 10.1016/B978-0-12-386471-0.00011-0; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Yang IV, 2002, GENOME BIOL, V3	61	29	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72130	10.1371/journal.pone.0072130	http://dx.doi.org/10.1371/journal.pone.0072130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019865	Green Submitted, gold, Green Published			2022-12-27	WOS:000324338200007
J	Buglione-Corbett, R; Pouliot, K; Marty-Roix, R; West, K; Wang, SX; Lien, E; Lu, S				Buglione-Corbett, Rachel; Pouliot, Kimberly; Marty-Roix, Robyn; West, Kim; Wang, Shixia; Lien, Egil; Lu, Shan			Serum Cytokine Profiles Associated with Specific Adjuvants Used in a DNA Prime-Protein Boost Vaccination Strategy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; HIV-1 VACCINE; ISCOMATRIX ADJUVANT; IMMUNE-RESPONSES; ANTIBODY-RESPONSE; NY-ESO-1 PROTEIN; RHESUS MACAQUES; PHASE-I; LIPID-A	In recent years, heterologous prime-boost vaccines have been demonstrated to be an effective strategy for generating protective immunity, consisting of both humoral and cell-mediated immune responses against a variety of pathogens including HIV-1. Previous reports of preclinical and clinical studies have shown the enhanced immunogenicity of viral vector or DNA vaccination followed by heterologous protein boost, compared to using either prime or boost components alone. With such approaches, the selection of an adjuvant for inclusion in the protein boost component is expected to impact the immunogenicity and safety of a vaccine. In this study, we examined in a mouse model the serum cytokine and chemokine profiles for several candidate adjuvants: QS-21, Al(OH)(3), monophosphoryl lipid A (MPLA) and ISCOMATRIX (TM) adjuvant, in the context of a previously tested pentavalent HIV-1 Env DNA prime-protein boost formulation, DP6-001. Our data revealed that the candidate adjuvants in the context of the DP6-001 formulation are characterized by unique serum cytokine and chemokine profiles. Such information will provide valuable guidance in the selection of an adjuvant for future AIDS vaccine development, with the ultimate goal of enhancing immunogenicity while minimizing reactogenicity associated with the use of an adjuvant. More significantly, results reported here will add to the knowledge on how to include an adjuvant in the context of a heterologous prime-protein boost vaccination strategy in general.	[Buglione-Corbett, Rachel; Pouliot, Kimberly; Marty-Roix, Robyn; West, Kim; Wang, Shixia; Lien, Egil; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Buglione-Corbett, R (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	shan.lu@umassmed.edu	Psoinos, Rachel/AAV-7465-2021	Psoinos, Rachel/0000-0001-7892-2070	NIH [AI082274, AI082676, AI065250]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082274, U19AI082676, T32AI007349, R01AI065250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study reported here was funded in part by NIH grants AI082274, AI082676 and AI065250. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2008, VACCINE, V26, P3036, DOI 10.1016/j.vaccine.2007.12.002; Anderson JS, 2009, JAIDS-J ACQ IMM DEF, V52, P371, DOI 10.1097/QAI.0b013e3181b7354c; Bansal A, 2008, J VIROL, V82, P6458, DOI 10.1128/JVI.00068-08; Boyle J, 2007, VACCINE, V25, P2541, DOI 10.1016/j.vaccine.2006.12.018; Brown SA, 2005, AIDS RES HUM RETROV, V21, P165, DOI 10.1089/aid.2005.21.165; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Cristillo AD, 2006, VIROLOGY, V346, P151, DOI 10.1016/j.virol.2005.10.038; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Drane D, 2009, HUM VACCINES, V5, P151, DOI 10.4161/hv.5.3.6614; Duewell P, 2011, J IMMUNOL, V187, P55, DOI 10.4049/jimmunol.1004114; Evans TG, 2001, VACCINE, V19, P2080, DOI 10.1016/S0264-410X(00)00415-1; Frazer IH, 2004, VACCINE, V23, P172, DOI 10.1016/j.vaccine.2004.05.013; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Keefer MC, 1997, AIDS RES HUM RETROV, V13, P1163, DOI 10.1089/aid.1997.13.1163; Kennedy JS, 2008, VACCINE, V26, P4420, DOI 10.1016/j.vaccine.2008.05.090; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Luheshi G, 1996, INT ARCH ALLERGY IMM, V109, P301, DOI 10.1159/000237256; Maraskovsky E, 2004, CLIN CANCER RES, V10, P2879, DOI 10.1158/1078-0432.CCR-03-0245; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McKenzie A, 2010, HUM VACCINES, V6, P237, DOI 10.4161/hv.6.3.10754; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Morelli AB, 2012, J MED MICROBIOL, V61, P935, DOI 10.1099/jmm.0.040857-0; Nicholaou T, 2011, CANCER IMMUNOL IMMUN, V60, P1625, DOI 10.1007/s00262-011-1041-3; Ogilvie AC, 1996, J IMMUNOL, V156, P389; Pal R, 2006, VACCINE, V24, P1225, DOI 10.1016/j.vaccine.2005.07.112; Pal R, 2005, J MED PRIMATOL, V34, P226, DOI 10.1111/j.1600-0684.2005.00120.x; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Pearse MJ, 2004, VACCINE, V22, P2391, DOI 10.1016/j.vaccine.2003.12.031; Pitisuttithum P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027837; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sanders MT, 2005, IMMUNOL CELL BIOL, V83, P119, DOI 10.1111/j.1440-1711.2005.01319.x; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Sjolander A, 1997, CELL IMMUNOL, V177, P69, DOI 10.1006/cimm.1997.1088; Sjolander A, 2001, VACCINE, V19, P2661, DOI 10.1016/S0264-410X(00)00497-7; Sunderkotter C, 2009, EXP DERMATOL, V18, P91, DOI 10.1111/j.1600-0625.2008.00791.x; Thompson BS, 2005, J LEUKOCYTE BIOL, V78, P1273, DOI 10.1189/jlb.0305172; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Wilson NS, 2011, ISCOMATRIX VACCINES, P1; Yamashiro S, 1999, J LEUKOCYTE BIOL, V65, P671, DOI 10.1002/jlb.65.5.671	46	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74820	10.1371/journal.pone.0074820	http://dx.doi.org/10.1371/journal.pone.0074820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019983	Green Published, gold			2022-12-27	WOS:000324338200126
J	Heller, S; Schubert, S; Krehan, M; Schafer, I; Seibel, M; Latorre, D; Villani, G; Seibel, P				Heller, Sandra; Schubert, Susanna; Krehan, Mario; Schaefer, Ingo; Seibel, Martina; Latorre, Dominga; Villani, Gaetano; Seibel, Peter			Efficient Repopulation of Genetically Derived Rho Zero Cells with Exogenous Mitochondria	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; RESPIRATORY-CHAIN; IN-VIVO; MUTATION; DNA; DISEASE; GENOME	Mitochondria are involved in a variety of cellular biochemical pathways among which the ATP production by oxidative phosphorylation (OXPHOS) represents the most important function of the organelle. Since mitochondria contain their own genome encoding subunits of the OXPHOS apparatus, mtDNA mutations can cause different mitochondrial diseases. The impact of these mutations can be characterized by the trans-mitochondrial cybrid technique based on mtDNA-depleted cells (rho(0)) as acceptors of exogenous mitochondria. The aim of the present work was to compare rho(0) cells obtained by long term ethidium bromide treatment and by a mitochondrial targeted restriction endonuclease, respectively, as mitochondrial acceptors for trans-mitochondrial cybrid generation. Fusion cells have mitochondrial respiratory functions comparable to their parental wild type cells, regardless the strategy utilized to obtain the rho(0) acceptor cells. Therefore, the newly developed enzymatic strategy for mtDNA depletion is a more convenient and suitable tool for a broader range of applications.	[Heller, Sandra; Schubert, Susanna; Krehan, Mario; Schaefer, Ingo; Villani, Gaetano; Seibel, Peter] Univ Leipzig, Ctr Biotechnol & Biomed BBZ, D-04109 Leipzig, Germany; [Seibel, Martina] RhoZero Technol, Uettingen, Germany; [Latorre, Dominga; Villani, Gaetano] Univ Bari, Sch Med, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy	Leipzig University; Universita degli Studi di Bari Aldo Moro	Villani, G (corresponding author), Univ Leipzig, Ctr Biotechnol & Biomed BBZ, D-04109 Leipzig, Germany.	gaetano.villani@uniba.it; peter.seibel@bbz.uni-leipzig.de		Heller, Sandra/0000-0002-8704-2646; Seibel, Markus J/0000-0002-2701-378X	Saxony (SMWK) [13397]; Federal Ministry of Economics and Technology [KF2802401AJ0]	Saxony (SMWK); Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi))	Saxony (SMWK, Project 13397) and supported by: Federal Ministry of Economics and Technology on the basis of a decision by the German Bundestag (Cooperation Project KF2802401AJ0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; MATTERN IE, 1976, MUTAT RES, V38, P120, DOI 10.1016/0165-1161(76)90038-8; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McLean JE, 2001, BIOCHEMISTRY-US, V40, P2194, DOI 10.1021/bi001810q; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; Seibel P, 2008, NUCLEIC ACIDS RES, V36, P5872, DOI 10.1093/nar/gkn592; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Villani G, 2007, METHOD CELL BIOL, V80, P121, DOI 10.1016/S0091-679X(06)80005-1; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; WIGLER MH, 1975, BIOCHEM BIOPH RES CO, V63, P669, DOI 10.1016/S0006-291X(75)80436-0	19	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73207	10.1371/journal.pone.0073207	http://dx.doi.org/10.1371/journal.pone.0073207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019909	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200051
J	Itakura, A; Aslan, JE; Kusanto, BT; Phillips, KG; Porter, JE; Newton, PK; Nan, XL; Insall, RH; Chernoff, J; McCarty, OJT				Itakura, Asako; Aslan, Joseph E.; Kusanto, Branden T.; Phillips, Kevin G.; Porter, Juliana E.; Newton, Paul K.; Nan, Xiaolin; Insall, Robert H.; Chernoff, Jonathan; McCarty, Owen J. T.			p21-Activated Kinase (PAK) Regulates Cytoskeletal Reorganization and Directional Migration in Human Neutrophils	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; CELL-MIGRATION; RHO-GTPASES; IN-VIVO; ACTIVATION; RAC; CHEMOTAXIS; INHIBITION; POLARITY; DYNAMICS	Neutrophils serve as a first line of defense in innate immunity owing in part to their ability to rapidly migrate towards chemotactic factors derived from invading pathogens. As a migratory function, neutrophil chemotaxis is regulated by the Rho family of small GTPases. However, the mechanisms by which Rho GTPases orchestrate cytoskeletal dynamics in migrating neutrophils remain ill-defined. In this study, we characterized the role of p21-activated kinase (PAK) downstream of Rho GTPases in cytoskeletal remodeling and chemotactic processes of human neutrophils. We found that PAK activation occurred upon stimulation of neutrophils with f-Met-Leu-Phe (fMLP), and PAK accumulated at the actin-rich leading edge of stimulated neutrophils, suggesting a role for PAK in Rac-dependent actin remodeling. Treatment with the pharmacological PAK inhibitor, PF3758309, abrogated the integrity of RhoA-mediated actomyosin contractility and surface adhesion. Moreover, inhibition of PAK activity impaired neutrophil morphological polarization and directional migration under a gradient of fMLP, and was associated with dysregulated Ca2+ signaling. These results suggest that PAK serves as an important effector of Rho-family GTPases in neutrophil cytoskeletal reorganization, and plays a key role in driving efficient directional migration of human neutrophils.	[Itakura, Asako; Aslan, Joseph E.; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; [Aslan, Joseph E.; Kusanto, Branden T.; Phillips, Kevin G.; Porter, Juliana E.; Nan, Xiaolin; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Sch Med, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Porter, Juliana E.; Newton, Paul K.] Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA USA; [Insall, Robert H.] CRUK Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Chernoff, Jonathan] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Southern California; Beatson Institute; Fox Chase Cancer Center	Itakura, A (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA.	itakura@ohsu.edu	Insall, Robert/G-5611-2011; Chernoff, Jonathan/I-7631-2014	Insall, Robert/0000-0003-4898-040X; Chernoff, Jonathan/0000-0002-4803-7836; Aslan, Joseph/0000-0002-8873-0387; Nan, Xiaolin/0000-0002-0597-0255	National Institutes of Health [R01HL101972, U54CA143906, R01CA142928]; American Heart Association [13POST1373003, 13UFEL16820020]; Johnson scholarship; USC-VSOE Undergraduate Merit Research Program; USC-Zumberge Foundation Award; Cancer Research UK [15672] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U54CA143906, R01CA142928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Johnson scholarship; USC-VSOE Undergraduate Merit Research Program; USC-Zumberge Foundation Award; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (R01HL101972, OJTM; U54CA143906, PKN and OJTM; R01CA142928, JC) and American Heart Association (13POST1373003, JEA; 13UFEL16820020, BTK). OJTM is an American Heart Association Established Investigator. AI is a Vertex Scholar. BTK is the recipient of a Johnson scholarship. JEP is supported by the USC-VSOE Undergraduate Merit Research Program and a USC-Zumberge Foundation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Aslan JE, 2013, ARTERIOSCL THROM VAS, V33, P1544, DOI 10.1161/ATVBAHA.112.301165; Aslan JE, 2011, BLOOD, V118, P3129, DOI 10.1182/blood-2011-02-331579; Barac A, 2004, J BIOL CHEM, V279, P6182, DOI 10.1074/jbc.M309579200; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Dorrance AM, 2013, BLOOD, V121, P2474, DOI 10.1182/blood-2012-10-460709; Eddy RJ, 2000, J CELL SCI, V113, P1287; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang RY, 1998, MOL CELL BIOL, V18, P7130, DOI 10.1128/MCB.18.12.7130; Itakura A, 2011, J LEUKOCYTE BIOL, V90, P923, DOI 10.1189/jlb.0411182; Itakura A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-75; Kelly Mollie L, 2012, Cell Logist, V2, P84; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Kosoff R, 2013, J BIOL CHEM, V288, P974, DOI 10.1074/jbc.M112.422295; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Taglieri DM, 2011, J MOL CELL CARDIOL, V51, P988, DOI 10.1016/j.yjmcc.2011.09.016; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zhao TM, 2007, J LEUKOCYTE BIOL, V81, P1127, DOI 10.1189/jlb.0406251; Zhao Zhuo-Shen, 2012, Cell Logist, V2, P59; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000	47	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73063	10.1371/journal.pone.0073063	http://dx.doi.org/10.1371/journal.pone.0073063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019894	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000324338200036
J	Komarova, NL				Komarova, Natalia L.			Principles of Regulation of Self-Renewing Cell Lineages	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TGF-BETA; TRANSCRIPTIONAL CONTROL; MATHEMATICAL-MODELS; GROWTH-FACTORS; COLONIC CRYPT; CYCLE CONTROL; DYNAMICS; DIFFERENTIATION; INHIBITION	Identifying the exact regulatory circuits that can stably maintain tissue homeostasis is critical for our basic understanding of multicellular organisms, and equally critical for identifying how tumors circumvent this regulation, thus providing targets for treatment. Despite great strides in the understanding of the molecular components of stem-cell regulation, the overall mechanisms orchestrating tissue homeostasis are still far from being understood. Typically, tissue contains the stem cells, transit amplifying cells, and terminally differentiated cells. Each of these cell types can potentially secrete regulatory factors and/or respond to factors secreted by other types. The feedback can be positive or negative in nature. This gives rise to a bewildering array of possible mechanisms that drive tissue regulation. In this paper, we propose a novel method of studying stem cell lineage regulation, and identify possible numbers, types, and directions of control loops that are compatible with stability, keep the variance low, and possess a certain degree of robustness. For example, there are exactly two minimal (two-loop) control networks that can regulate two-compartment (stem and differentiated cell) tissues, and 20 such networks in three-compartment tissues. If division and differentiation decisions are coupled, then there must be a negative control loop regulating divisions of stem cells (e. g. by means of contact inhibition). While this mechanism is associated with the highest robustness, there could be systems that maintain stability by means of positive divisions control, coupled with specific types of differentiation control. Some of the control mechanisms that we find have been proposed before, but most of them are new, and we describe evidence for their existence in data that have been previously published. By specifying the types of feedback interactions that can maintain homeostasis, our mathematical analysis can be used as a guide to experimentally zero in on the exact molecular mechanisms in specific tissues.	Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine	Komarova, NL (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu			National Institutes of Health [1R01CA129286-01A1]; NATIONAL CANCER INSTITUTE [R01CA129286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health 1R01CA129286-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2008, GENE THER, V15, P96, DOI 10.1038/sj.gt.3303063; Adimy M, 2006, B MATH BIOL, V68, P2321, DOI 10.1007/s11538-006-9121-9; Agur Z, 2002, J MATH BIOL, V44, P79, DOI 10.1007/s002850100115; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; ARINO O, 1986, MATH MODELLING, V7, P1269, DOI 10.1016/0270-0255(86)90081-3; Assaf M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.200602; Boman BM, 2008, CANCER RES, V68, P3304, DOI 10.1158/0008-5472.CAN-07-2061; Chou CS, 2010, BIOPHYS J, V99, P3145, DOI 10.1016/j.bpj.2010.09.034; Colijn C, 2005, J THEOR BIOL, V237, P117, DOI 10.1016/j.jtbi.2005.03.033; d'Onofrio A, 2007, J THEOR BIOL, V244, P367, DOI 10.1016/j.jtbi.2006.08.022; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; de Graaf CA, 2010, P NATL ACAD SCI USA, V107, P21689, DOI 10.1073/pnas.1016166108; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Doering CR, 2005, MULTISCALE MODEL SIM, V3, P283, DOI 10.1137/030602800; Elgjo K, 2004, CELL CYCLE, V3, P1208; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Glauche I, 2007, STEM CELLS, V25, P1791, DOI 10.1634/stemcells.2007-0025; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hardy K, 2002, APOPTOSIS, V7, P373, DOI 10.1023/A:1016183731694; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Khammash M, 2008, BIOTECHNIQUES, V44, P323, DOI 10.2144/000112772; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Lo WC, 2009, MATH BIOSCI ENG, V6, P59, DOI 10.3934/mbe.2009.6.59; Loeffler M, 2002, CELLS TISSUES ORGANS, V171, P8, DOI 10.1159/000057688; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nakata Y, 2012, J BIOL DYNAM, V6, P2, DOI 10.1080/17513758.2011.558214; Novak B, 2003, BIOCHEM SOC T, V31, P1526; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Ordonez-Moran P, 2012, EMBO J; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Rodriguez-Brenes IA, 2011, P NATL ACAD SCI USA, V108, P18983, DOI 10.1073/pnas.1107621108; Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Stiehl T, 2011, MATH COMPUT MODEL, V53, P1505, DOI 10.1016/j.mcm.2010.03.057; Sun Z, 2012, MATH BIOSCIENCES; Takashima S, 2012, STEM CELL REV REP, P1; TOMLINSON IPM, 1995, P NATL ACAD SCI USA, V92, P11130, DOI 10.1073/pnas.92.24.11130; Tsankov AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100106; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vogelstein B., 1998, GENETIC BASIS HUMAN; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Wallace EWJ, 2012, IET SYST BIOL, V6, P102, DOI 10.1049/iet-syb.2011.0038; Wu A, 2008, STEM CELLS DEV, V17, P173, DOI 10.1089/scd.2007.0133; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Yamasaki K, 2003, J INVEST DERMATOL, V120, P1030, DOI 10.1046/j.1523-1747.2003.12239.x; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998	64	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72847	10.1371/journal.pone.0072847	http://dx.doi.org/10.1371/journal.pone.0072847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019882	Green Published, gold			2022-12-27	WOS:000324338200024
J	Meilinger, T; Bulthoff, HH				Meilinger, Tobias; Buelthoff, Heinrich H.			Verbal Shadowing and Visual Interference in Spatial Memory	PLOS ONE			English	Article							REAL-WORLD; INTRINSIC FRAMES; WORKING-MEMORY; REPRESENTATIONS; ENVIRONMENTS; PERSPECTIVE; RECOGNITION; INFORMATION; SELECTION; ROTATION	Spatial memory is thought to be organized along experienced views and allocentric reference axes. Memory access from different perspectives typically yields V-patterns for egocentric encoding (monotonic decline in performance along with the angular deviation from the experienced perspectives) and W-patterns for axes encoding (better performance along parallel and orthogonal perspectives than along oblique perspectives). We showed that learning an object array with a verbal secondary task reduced W-patterns compared with learning without verbal shadowing. This suggests that axes encoding happened in a verbal format; for example, by rows and columns. Alternatively, general cognitive load from the secondary task prevented memorizing relative to a spatial axis. Independent of encoding, pointing with a surrounding room visible yielded stronger W-patterns compared with pointing with no room visible. This suggests that the visible room geometry interfered with the memorized room geometry. With verbal shadowing and without visual interference only V-patterns remained; otherwise, V-and W-patterns were combined. Verbal encoding and visual interference explain when W-patterns can be expected alongside V-patterns and thus can help in resolving different performance patterns in a wide range of experiments.	[Meilinger, Tobias; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Meilinger, Tobias] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; University of Tokyo; Korea University	Meilinger, T (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	tobias.meilinger@tuebingen.mpg.de; heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012; Meilinger, Tobias/C-3969-2014	Bülthoff, Heinrich H/0000-0003-2568-0607; Meilinger, Tobias/0000-0002-1326-1213	German Research Foundation [ME 3476/2]; National Research Foundation of Korea's World Class University program [R31-10008]	German Research Foundation(German Research Foundation (DFG)); National Research Foundation of Korea's World Class University program	This research was supported by the German Research Foundation (Grant ME 3476/2) and by the National Research Foundation of Korea's World Class University program (Grant R31-10008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Diwadkar VA, 1997, PSYCHOL SCI, V8, P302, DOI 10.1111/j.1467-9280.1997.tb00442.x; EVANS GW, 1980, J EXP PSYCHOL-HUM L, V6, P13, DOI 10.1037/0278-7393.6.1.13; Frankenstein J, 2012, PSYCHOL SCI, V23, P120, DOI 10.1177/0956797611429467; Greenauer N, 2010, J EXP PSYCHOL LEARN, V36, P938, DOI 10.1037/a0019647; HINTZMAN DL, 1981, COGNITIVE PSYCHOL, V13, P149, DOI 10.1016/0010-0285(81)90007-4; Hodgson E, 2006, J EXP PSYCHOL LEARN, V32, P854, DOI 10.1037/0278-7393.32.4.854; Iachini T, 2003, APPL COGNITIVE PSYCH, V17, P715, DOI 10.1002/acp.904; Kelly JW, 2008, PSYCHON B REV, V15, P322, DOI 10.3758/PBR.15.2.322; Kelly JW, 2007, J EXP PSYCHOL LEARN, V33, P1092, DOI 10.1037/0278-7393.33.6.1092; Kelly JW, 2010, COGNITION, V116, P409, DOI 10.1016/j.cognition.2010.06.002; Levin JR, 1999, PSYCHOL METHODS, V4, P44, DOI 10.1037/1082-989X.4.1.44; Li XO, 2011, J MEM LANG, V65, P222, DOI 10.1016/j.jml.2011.04.001; Marchette SA, 2011, MEM COGNITION, V39, P1401, DOI 10.3758/s13421-011-0108-x; May M, 2004, COGNITIVE PSYCHOL, V48, P163, DOI 10.1016/S0010-0285(03)00127-0; MAY M, 1996, PSYCHOL BEITR, V38, P418; McNamara T. P., 2008, LEARNING MEMORY COMP, V2, P157; McNamara TP, 2003, PSYCHON B REV, V10, P589, DOI 10.3758/BF03196519; Meilinger T, 2008, COGNITIVE SCI, V32, P755, DOI 10.1080/03640210802067004; Mou WM, 2007, J EXP PSYCHOL LEARN, V33, P145, DOI 10.1037/0278-7393.33.1.145; Mou WM, 2002, J EXP PSYCHOL LEARN, V28, P162, DOI 10.1037//0278-7393.28.1.162; Mou WM, 2004, J EXP PSYCHOL LEARN, V30, P142, DOI 10.1037/0278-7393.30.1.142; Riecke BE, 2007, P 48 ANN M PSYCH SOC, P63; SCHOOLER JW, 1990, COGNITIVE PSYCHOL, V22, P36, DOI 10.1016/0010-0285(90)90003-M; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; Shelton AL, 2004, MEM COGNITION, V32, P416, DOI 10.3758/BF03195835; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Snijders T, 1999, MULTILEVEL ANAL; Valiquette C, 2007, PSYCHON B REV, V14, P676, DOI 10.3758/BF03196820; Waller D, 2006, J EXP PSYCHOL LEARN, V32, P867, DOI 10.1037/0278-7393.32.4.867; Waller D, 2009, MEM COGNITION, V37, P90, DOI 10.3758/MC.37.1.90; Wang RF, 2002, TRENDS COGN SCI, V6, P376, DOI 10.1016/S1364-6613(02)01961-7; Wang RXF, 2000, COGNITION, V77, P215, DOI 10.1016/S0010-0277(00)00105-0; Yamamoto N, 2005, MEM COGNITION, V33, P140, DOI 10.3758/BF03195304; Yamamoto N, 2007, ACTA PSYCHOL, V125, P346, DOI 10.1016/j.actpsy.2006.09.001	36	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74177	10.1371/journal.pone.0074177	http://dx.doi.org/10.1371/journal.pone.0074177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019953	Green Published, gold			2022-12-27	WOS:000324338200096
J	Xing, LP; Qian, C; Cao, AZ; Li, YB; Jiang, ZN; Li, MH; Jin, XH; Hu, JM; Zhang, YP; Wang, X; Chen, PD				Xing, Liping; Qian, Chen; Cao, Aizhong; Li, Yingbo; Jiang, Zhengning; Li, Minghao; Jin, Xiahong; Hu, Jiameng; Zhang, Yiping; Wang, Xiue; Chen, Peidu			The Hv-SGT1 Gene from Haynaldia villosa Contributes to Resistances Towards Both Biotrophic and Hemi-Biotrophic Pathogens in Common Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; SCF UBIQUITIN-LIGASE; DISEASE RESISTANCE; JASMONIC ACID; ESSENTIAL COMPONENT; SGT1; PLANT; ARABIDOPSIS; PROTEIN; RAR1	The SGT1 protein is essential for R protein-mediated and PAMPs-triggered resistance in many plant species. Here we reported the isolation and characterization of the Hv-SGT1 gene from Haynaldia villosa (2n = 14, VV). Analysis of the subcellular location of Hv-SGT1 by transient expression of a fusion to GFP indicated its presence in the cytoplasm and nucleus. Levels of Hv-SGT1 transcripts were increased by inoculation with either the biotrophic pathogen Blumeria graminis DC. f. Sp. tritici (Bgt) or the hemi-biotrophic pathogen Fusarium graminearum (Fg). Levels of Hv-SGT1 showed substantial increase following treatment with H2O2 and methyl jasmonate (MeJA), only slightly induced following exposure to ethephon or abscisic acid, but not changed following exposure to salicylic acid. The demonstration that silencing of Hv-SGT1 substantially reduced resistance to Bgt indicated that Hv-SGT1 was an essential component of disease resistance in H. villosa. The over-expression of Hv-SGT1 in Yangmai 158 enhanced resistance to powdery mildew, and this correlated with increased levels of whole-cell reactive oxygen intermediates at the sites of penetration by the pathogens. Compared with wild-type plants, the expression levels of genes related to the H2O2 and JA signaling pathways were lower in the Hv-SGT1 silenced plants and higher in the Hv-SGT1 over-expressing plants. Therefore, the involvement of Hv-SGT1 in H2O2 production correlates with the hypersensitive response and jasmonic acid signaling. Our novel demonstration that wheat with over-expressed Hv-SGT1 showed enhanced resistance to both powdery mildew and FHB suggests that it could served as a transgenic genetic resource in wheat breeding for multiple disease resistance.	[Xing, Liping; Qian, Chen; Cao, Aizhong; Li, Yingbo; Jiang, Zhengning; Li, Minghao; Jin, Xiahong; Hu, Jiameng; Zhang, Yiping; Wang, Xiue; Chen, Peidu] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, X (corresponding author), Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	xiuew@njau.edu.cn; pdchen@njau.edu.cn			Important National Science & Technology Specific Projects of Transgenic Research [2011ZX08002-001, 2009ZX08002-001B]; Nature Science Foundation of China [31101206, 31171540]; National University Doctoral Fund of China [20100097120036]; Jiangsu Natural Science Foundation [BK2011636]	Important National Science & Technology Specific Projects of Transgenic Research; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National University Doctoral Fund of China; Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This research was supported by grants from the Important National Science & Technology Specific Projects of Transgenic Research (Grant No. 2011ZX08002-001, 2009ZX08002-001B); Nature Science Foundation of China (Grant No. 31101206, 31171540); the National University Doctoral Fund of China (Grant No. 20100097120036); and Jiangsu Natural Science Foundation (Grant No. BK2011636). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Bhaskar PB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-8; Cao AZ, 2006, PLANT BREEDING, V125, P201, DOI 10.1111/j.1439-0523.2006.01222.x; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; CHEN PD, 1995, THEOR APPL GENET, V91, P1125, DOI 10.1007/BF00223930; Chen YP, 2007, PLANT CELL PHYSIOL, V48, P1702, DOI 10.1093/pcp/pcm142; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cuzick A, 2009, NEW PHYTOL, V181, P901, DOI 10.1111/j.1469-8137.2008.02712.x; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; El Oirdi M, 2007, NEW PHYTOL, V175, P131, DOI 10.1111/j.1469-8137.2007.02086.x; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Hill-Ambroz K, 2006, CROP SCI, V46, pS15, DOI 10.2135/cropsci2005.07.0206tpg; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Jakobson I, 2006, THEOR APPL GENET, V112, P760, DOI 10.1007/s00122-005-0181-2; JING H, 2012, AUS J CROPS SCI, V8, P1221; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kallenbach M, 2010, PLANT PHYSIOL, V152, P96, DOI 10.1104/pp.109.149013; Kawamura Y, 2009, PLANT CELL PHYSIOL, V50, P924, DOI 10.1093/pcp/pcp044; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Li A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016929; Liu Y, 2002, PLANT CELL, V14, P1483, DOI 10.1105/tpc.002493; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lu ZX, 2005, PHYSIOL MOL PLANT P, V67, P138, DOI 10.1016/j.pmpp.2005.12.001; Meldau S, 2011, NEW PHYTOL, V189, P1143, DOI 10.1111/j.1469-8137.2010.03558.x; Muskett P, 2003, MICROBES INFECT, V5, P969, DOI 10.1016/S1286-4579(03)00183-7; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Thomma BPHJ, 1999, PLANT PHYSIOL, V121, P1093, DOI 10.1104/pp.121.4.1093; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; UNVER T, 2008, BIOTECHNOLOGY; Unver T, 2013, PLANT MOL BIOL REP, V31, P323, DOI 10.1007/s11105-012-0502-y; Wang K, 2010, MOL PLANT PATHOL, V11, P597, DOI [10.1111/J.1364-3703.2010.00631.X, 10.1111/j.1364-3703.2010.00631.x]; Wang XY, 2010, MOL BIOL REP, V37, P967, DOI 10.1007/s11033-009-9766-1; Wang YL, 2008, MOL PLANT MICROBE IN, V21, P294, DOI 10.1094/MPMI-21-3-0294; Xiao J, 2011, CHROMOSOME RES, V19, P225, DOI 10.1007/s10577-011-9192-9; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xing LiPing, 2008, Acta Agronomica Sinica, V34, P349, DOI 10.1016/S1875-2780(08)60014-0; Xu Y, 2002, ACTA BOT SIN, V44, P1194	50	19	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72571	10.1371/journal.pone.0072571	http://dx.doi.org/10.1371/journal.pone.0072571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019872	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200014
J	de Jonge, N; Muylaert, DEP; Fioretta, ES; Baaijens, FPT; Fledderus, JO; Verhaar, MC; Bouten, CVC				de Jonge, Nicky; Muylaert, Dimitri E. P.; Fioretta, Emanuela S.; Baaijens, Frank P. T.; Fledderus, Joost O.; Verhaar, Marianne C.; Bouten, Carlijn V. C.			Matrix Production and Organization by Endothelial Colony Forming Cells in Mechanically Strained Engineered Tissue Constructs	PLOS ONE			English	Article							PROGENITOR CELLS; GROWTH-FACTOR; DIFFERENTIATION; PROLIFERATION; COLLAGEN; BIOMATERIALS; RECRUITMENT; STEM; IDENTIFICATION; SCAFFOLD	Aims: Tissue engineering is an innovative method to restore cardiovascular tissue function by implanting either an in vitro cultured tissue or a degradable, mechanically functional scaffold that gradually transforms into a living neo-tissue by recruiting tissue forming cells at the site of implantation. Circulating endothelial colony forming cells (ECFCs) are capable of differentiating into endothelial cells as well as a mesenchymal ECM-producing phenotype, undergoing Endothelial-to-Mesenchymal-transition (EndoMT). We investigated the potential of ECFCs to produce and organize ECM under the influence of static and cyclic mechanical strain, as well as stimulation with transforming growth factor beta 1 (TGF beta 1). Methods and Results: A fibrin-based 3D tissue model was used to simulate neo-tissue formation. Extracellular matrix organization was monitored using confocal laser-scanning microscopy. ECFCs produced collagen and also elastin, but did not form an organized matrix, except when cultured with TGFb1 under static strain. Here, collagen was aligned more parallel to the strain direction, similar to Human Vena Saphena Cell-seeded controls. Priming ECFC with TGF beta 1 before exposing them to strain led to more homogenous matrix production. Conclusions: Biochemical and mechanical cues can induce extracellular matrix formation by ECFCs in tissue models that mimic early tissue formation. Our findings suggest that priming with bioactives may be required to optimize neo-tissue development with ECFCs and has important consequences for the timing of stimuli applied to scaffold designs for both in vitro and in situ cardiovascular tissue engineering. The results obtained with ECFCs differ from those obtained with other cell sources, such as vena saphena-derived myofibroblasts, underlining the need for experimental models like ours to test novel cell sources for cardiovascular tissue engineering.	[de Jonge, Nicky; Fioretta, Emanuela S.; Baaijens, Frank P. T.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Muylaert, Dimitri E. P.; Fledderus, Joost O.; Verhaar, Marianne C.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Bouten, Carlijn V. C.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Utrecht University; Utrecht University Medical Center; Eindhoven University of Technology	Bouten, CVC (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	c.v.c.bouten@tue.nl	Fioretta, Emanuela/J-5477-2019; Bouten, Carlijn/AAT-5187-2020; Verhaar, Marianne/AAM-6788-2020	Fioretta, Emanuela/0000-0002-9343-3328; Bouten, Carlijn/0000-0003-1035-5094; Verhaar, Marianne/0000-0002-3276-6428; Baaijens, Frank/0000-0002-0975-5376; Muylaert, Dimitri/0000-0001-9301-5970	research program iValve of the BioMedical Materials (BMM) institute; Translational excellence in Regenerative Medicine Smart Mix Program; Dutch Ministry of Economic affairs, Agriculture and Innovation; Nederlandse Hartstichting	research program iValve of the BioMedical Materials (BMM) institute; Translational excellence in Regenerative Medicine Smart Mix Program; Dutch Ministry of Economic affairs, Agriculture and Innovation; Nederlandse Hartstichting	The authors gratefully acknowledge the support of the research program iValve of the BioMedical Materials (BMM) institute and the Translational excellence in Regenerative Medicine Smart Mix Program. BMM is co-funded by the Dutch Ministry of Economic affairs, Agriculture and Innovation. The financial contribution of the Nederlandse Hartstichting is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andukuri A, 2012, TISSUE ENG C; [Anonymous], 1997, Cardiovasc Res, V35, P2; Balachandran K, 2011, P NATL ACAD SCI USA, V108, P19943, DOI 10.1073/pnas.1106954108; Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008; Broxmeyer HE, 2006, METHOD ENZYMOL, V419, P439, DOI 10.1016/S0076-6879(06)19018-7; de Jonge N, 2012, ANN BIOMED ENG; de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k; De Visscher G, 2007, EUR HEART J, V28, P1389, DOI 10.1093/eurheartj/ehl422; Dvorin EL, 2003, TISSUE ENG, V9, P487, DOI 10.1089/107632703322066660; Fioretta ES, 2012, MACROMOL BIOSCI, V12, P577, DOI 10.1002/mabi.201100315; Foolen J, 2012, BIOMATERIALS, V33, P7508, DOI 10.1016/j.biomaterials.2012.06.103; Ghazanfari S, 2009, BIOCHEM BIOPH RES CO, V388, P601, DOI 10.1016/j.bbrc.2009.08.072; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Holmes DR, 2012, J THORAC CARDIOV SUR, V144, pE29, DOI 10.1016/j.jtcvs.2012.03.001; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Ingber DE, 2010, ANN BIOMED ENG, V38, P1148, DOI 10.1007/s10439-010-9946-0; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jordan JE, 2012, J THORAC CARDIOV SUR, V143, P201, DOI 10.1016/j.jtcvs.2011.10.005; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; Krenning G, 2008, BIOMATERIALS, V29, P3703, DOI 10.1016/j.biomaterials.2008.05.034; Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Mazzolai L, 2011, J VASC RES, V48, P443, DOI 10.1159/000324844; Medici D., 2012, SEMIN CANC BIOL; Michalopoulos E, 2012, TISSUE ENG PART C-ME, V18, P252, DOI [10.1089/ten.tec.2011.0347, 10.1089/ten.TEC.2011.0347]; Mol A, 2005, ANN BIOMED ENG, V33, P1778, DOI 10.1007/s10439-005-8025-4; Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007; Mol A, 2009, EXPERT REV MED DEVIC, V6, P259, DOI [10.1586/erd.09.12, 10.1586/ERD.09.12]; Mund JA, 2012, ARTERIOSCL THROM VAS, V32, P1045, DOI 10.1161/ATVBAHA.111.244210; Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Reardon Michael J, 2012, Methodist Debakey Cardiovasc J, V8, P26; Rippel RA, 2012, WORLD J SURG, V36, P1581, DOI 10.1007/s00268-012-1535-y; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Rosengart TK, 2008, CIRCULATION, V117, P1750, DOI 10.1161/CIRCULATIONAHA.107.188525; Rubbens MP, 2009, TISSUE ENG PT A, V15, P999, DOI 10.1089/ten.tea.2007.0396; Sales VL, 2010, TISSUE ENG PT A, V16, P257, DOI 10.1089/ten.TEA.2009.0424; Sales VL, 2006, CIRCULATION, V114, pI193, DOI 10.1161/CIRCULATIONAHA.105.001628; Schnell AM, 2001, THORAC CARDIOV SURG, V49, P221, DOI 10.1055/s-2001-16113; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359; Sengupta D, 2010, TISSUE ENG PART B-RE, V16, P285, DOI 10.1089/ten.teb.2009.0591; Sewell-Loftin MK, 2011, J CARDIOVASC TRANSL, V4, P658, DOI 10.1007/s12265-011-9300-4; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Syedain ZH, 2011, J BIOMECH, V44, P848, DOI 10.1016/j.jbiomech.2010.12.007; Thomas LV, 2012, INT J CARDIOL; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; van Geemen D, 2011, TISSUE ENG PART C-ME, V17, P607, DOI [10.1089/ten.tec.2010.0556, 10.1089/ten.TEC.2010.0556]; Vranken I, 2008, BIOMATERIALS, V29, P797, DOI 10.1016/j.biomaterials.2007.10.041; Wang JHC, 2000, CONNECT TISSUE RES, V41, P29, DOI 10.3109/03008200009005639; Weidenhamer NK, 2013, TISSUE ENG C; Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003; Yang Z, 2006, BIOCHEM BIOPH RES CO, V342, P577, DOI 10.1016/j.bbrc.2006.01.172; Yang Z, 2007, J THROMB THROMBOLYS, V23, P121, DOI 10.1007/s11239-006-9045-0	56	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73161	10.1371/journal.pone.0073161	http://dx.doi.org/10.1371/journal.pone.0073161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023827	gold, Green Published, Green Submitted			2022-12-27	WOS:000324238400048
J	Nkyimbeng, T; Ruppert, C; Shiomi, T; Dahal, B; Lang, G; Seeger, W; Okada, Y; D'Armiento, J; Gunther, A				Nkyimbeng, Takwi; Ruppert, Clemens; Shiomi, Takayuki; Dahal, Bhola; Lang, Gyoergy; Seeger, Werner; Okada, Yasunori; D'Armiento, Jeanine; Guenther, Andreas			Pivotal Role of Matrix Metalloproteinase 13 in Extracellular Matrix Turnover in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							INTERSTITIAL PNEUMONIA; LUNG FIBROSIS; EXPRESSION; TISSUE; MMP-13; MICE; INHIBITORS; EMPHYSEMA; COLLAGEN; DISEASE	Rationale: Idiopathic pulmonary fibrosis (IPF) is a fatal disease characterized by excessive deposition of extracellular matrix (ECM). Objectives: We investigated the regulation of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lung fibrosis. Methods: MMP and TIMP expression, collagenolytic activity and collagen content was assessed in IPF (n=16) versus donor (n=6) lung homogenates and accomplished by in-situ-zymography for gelatinolytic and collagenolytic activities, combined with MMP antigen detection. Role of MMP13 was assessed employing the bleomycin model of lung fibrosis in MMP-13(-/-) versus wild-type mice. Measurements and Main Results: In IPF, MMPs-1, 2, 7, 9 and 13, but not MMP-8, were significantly upregulated, whereas none of the TIMPs (1-4) were significantly altered. Collagen content was slightly increased and collagenolytic activity was most prominent in the airways and co-localized with MMP-13. We observed an exaggerated early inflammatory response and an augmented lung fibrosis in bleomycin-challenged MMP-13(-/-) versus wild-type mice, with elevated lung collagen content 28d after bleomycin challenge in the MMP-13(-/-) mice. Conclusions: Our data suggest that i) collagen deposition in IPF lungs is not primarily due to excessive TIMP production, but rather due to overwhelming ECM production in face of an overall increased, but spatially imbalanced collagenolytic activity, ii) preferential distribution of collagenolytic activity, largely MMP-13, in the airways offers an explanation for the development of honeycomb cysts and iii) despite an overall increase in inflammatory cell content the presence of MMP-13 seems to limit the overall extent of ECM deposition in lung fibrosis.	[Nkyimbeng, Takwi; Ruppert, Clemens; Dahal, Bhola; Seeger, Werner; Guenther, Andreas] UGMLC, Giessen, Germany; [Nkyimbeng, Takwi; Shiomi, Takayuki; D'Armiento, Jeanine] Columbia Univ, Coll Phys & Surg, Div Mol Med, Dept Med, New York, NY USA; [Lang, Gyoergy] Vienna Gen Hosp, Dept Thorac Surg, Vienna, Austria; [Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Guenther, Andreas] Lung Clin Waldhof Elgershausen, Greifenstein, Germany	Columbia University; Keio University	Gunther, A (corresponding author), UGMLC, Giessen, Germany.	andreas.guenther@innere.med.uni-giessen.de	Lang, György/O-5256-2017; Shiomi, Takayuki/A-2228-2014; Okada, Yasunori/B-5550-2014	Lang, György/0000-0002-8839-6649; Shiomi, Takayuki/0000-0002-4250-1204; Okada, Yasunori/0000-0001-9208-4755; Seeger, Werner/0000-0003-1946-0894	German Research Council (Deutsche Forschungsgemeinschaft, DFG); European Commission (FP7, European IPF Network); National Institutes of Health [HL086936]; German Research Foundation (DFG - International Graduate Program "Signalling Mechanisms in Lung Physiology and Disease"); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086936] Funding Source: NIH RePORTER	German Research Council (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); European Commission (FP7, European IPF Network); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG - International Graduate Program "Signalling Mechanisms in Lung Physiology and Disease"); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study has been funded through the German Research Council (Deutsche Forschungsgemeinschaft, DFG) in the frame of the Clinical Research Group 118 ("Pathomechanisms and Therapy of Interstitial Lung Diseases"), the European Commission (FP7, European IPF Network), and National Institutes of Health grant HL086936 (JD). TN is recipient of a predoctoral fellowship of the German Research Foundation (DFG - International Graduate Program "Signalling Mechanisms in Lung Physiology and Disease"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Betsuyaku T, 2000, AM J PATHOL, V157, P525, DOI 10.1016/S0002-9440(10)64563-4; CAMPBELL EJ, 1988, J CELL BIOL, V106, P667, DOI 10.1083/jcb.106.3.667; DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; DOZIER S, 2006, J MED CHEM, V2, P523, DOI DOI 10.2174/157340606778250261; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Foronjy RF, 2003, AM J PHYSIOL-LUNG C, V284, pL727, DOI 10.1152/ajplung.00349.2002; Gurlek A, 2007, EUR J ENDOCRINOL, V156, P143, DOI 10.1530/eje.1.02339; Hunninghake GW, 2003, CHEST, V124, P1215, DOI 10.1378/chest.124.4.1215; Iimuro Y, 2008, PHARM RES-DORDR, V25, P249, DOI 10.1007/s11095-007-9311-7; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Janssens S, 2006, CARDIOVASC RES, V69, P585, DOI 10.1016/j.cardiores.2005.12.010; Katzenstein ALA, 2000, AM J SURG PATHOL, V24, P1, DOI 10.1097/00000478-200001000-00001; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Manoury Boris, 2006, J Inflamm (Lond), V3, P2, DOI 10.1186/1476-9255-3-2; Matute-Bello G, 2007, AM J RESP CELL MOL, V37, P210, DOI 10.1165/rcmb.2006-0471OC; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Ortiz LA, 2001, AM J RESP CRIT CARE, V163, P244, DOI 10.1164/ajrccm.163.1.2002123; Pardo A, 2002, INT J BIOCHEM CELL B, V34, P1534, DOI 10.1016/S1357-2725(02)00091-2; Pardo A, 2008, INT J BIOCHEM CELL B, V40, P1141, DOI 10.1016/j.biocel.2007.11.020; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Raulo SM, 2001, AM J VET RES, V62, P1142, DOI 10.2460/ajvr.2001.62.1142; Ruiz V, 2003, AM J PHYSIOL-LUNG C, V285, pL1026, DOI 10.1152/ajplung.00183.2003; Schubert C, 2006, NAT MED, V12, P391, DOI 10.1038/nm0406-391; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Takaishi H, 2008, CURR PHARM BIOTECHNO, V9, P47, DOI 10.2174/138920108783497659; Toriseva MJ, 2007, J INVEST DERMATOL, V127, P49, DOI 10.1038/sj.jid.5700500; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	34	59	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73279	10.1371/journal.pone.0073279	http://dx.doi.org/10.1371/journal.pone.0073279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023851	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400058
J	Wang, W; Zhou, MW; Huang, WB; Chen, SD; Zhang, XL				Wang, Wei; Zhou, Minwen; Huang, Wenbin; Chen, Shida; Zhang, Xiulan			Lack of Association of Apolipoprotein E (Apo E) epsilon 2/epsilon 3/epsilon 4 Polymorphisms with Primary Open-Angle Glaucoma: A Meta-Analysis from 1916 Cases and 1756 Controls	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NORMAL-TENSION GLAUCOMA; RETINAL GANGLION-CELLS; E GENE POLYMORPHISMS; EPSILON 4 ALLELE; SUSCEPTIBILITY LOCI; JAPANESE POPULATION; RISK; CHINESE	Background: A number of case-control studies were conducted to investigate the association of apolipoprotein E (Apo E) polymorphisms with primary open angle glaucoma (POAG). But the results remain controversial. This meta-analysis aims to comprehensively evaluate the relationship between a common epsilon 2/epsilon 3/epsilon 4 polymorphism in Apo E gene on the risk of POAG. Method: A comprehensive literature search for studies published up to April 2013 was performed. Summary odds ratios (ORs) and 95% confidence intervals (CI) were calculated employing random-effects models irrespective of between-study heterogeneity. Publication bias of literatures was evaluated using funnel plots and Egger's test. Results: A total of 12 studies including 1916 cases and 1756 controls meeting the predefined criteria were involved in this meta-analysis. Overall, the Apo E epsilon 2 allele and epsilon 4 allele were not associated with POAG, compared with those carrying epsilon 3 allele, with ORs of 0.98 (95% CI, 0.79 to 1.23; P = 0.872) and 1.05 (95% CI, 0.78 to 1.41; P = 0.743), respectively. Genotypic analysis also found no significant association between the e4 carriers (epsilon 3/epsilon 4+epsilon 4/epsilon 4), epsilon 2 carriers (epsilon 2/epsilon 3+epsilon 2/epsilon 2) and POAG, compared with participants with Apo E epsilon 3/3, with ORs of 0.91 (95% CI, 0.66 to 1.25; P = 0.543) and 1.08 (95% CI, 0.74 to 1.57; P = 0.694), respectively. In the subgroup analysis by ethnicity, source of controls, genotyping methods, Hardy-Weinberg equilibrium or not, or type of the POAG, still no obvious associations were found. Conclusions: This meta-analysis suggests that Apo E epsilon 2/epsilon 3/epsilon 4 polymorphisms may not be associated with the risk of POAG. However, well-designed studies with larger sample size and more ethnic groups are required to further validate the results.	[Wang, Wei; Zhou, Minwen; Huang, Wenbin; Chen, Shida; Zhang, Xiulan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, XL (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn			National Natural Science Foundation of China [81170849]; Guangdong Provincial Natural Science Foundation [S2011020002401]; Fundamental Research Funds of State Key Laboratory of Ophthalmology [2011C02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds of State Key Laboratory of Ophthalmology	This work was supported in whole or in part by the National Natural Science Foundation of China (81170849), Guangdong Provincial Natural Science Foundation (S2011020002401), and the Fundamental Research Funds of State Key Laboratory of Ophthalmology (2011C02). No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dabbagh NM, 2009, MOL VIS, V15, P912; Amaratunga A, 1996, J BIOL CHEM, V271, P5628, DOI 10.1074/jbc.271.10.5628; Burdon KP, 2012, CLIN EXP OPHTHALMOL, V40, P358, DOI 10.1111/j.1442-9071.2011.02744.x; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Daly AK, 2001, BRIT J CLIN PHARMACO, V52, P489, DOI 10.1046/j.0306-5251.2001.01510.x; Fan BJ, 2005, MOL VIS, V11, P625; Gemenetzi M, 2012, EYE, V26, P355, DOI 10.1038/eye.2011.309; Gibson J, 2012, MOL VIS, V18, P1083; Hu Y, 2007, APOE GENE ITS INTERA; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Jia LY, 2009, MOL VIS, V15, P89; Junemann A, 2004, BRIT J OPHTHALMOL, V88, P581, DOI 10.1136/bjo.2003.020305; Kountouras J, 2007, AM J OPHTHALMOL, V144, P638, DOI 10.1016/j.ajo.2007.06.017; Lake S, 2004, BRIT J OPHTHALMOL, V88, P491, DOI 10.1136/bjo.2003.023366; Lam CY, 2006, J GLAUCOMA, V15, P218, DOI 10.1097/01.ijg.0000212217.19804.a7; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lorber B, 2009, J NEUROSCI RES, V87, P2645, DOI 10.1002/jnr.22095; Mabuchi F, 2005, MOL VIS, V11, P609; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ressiniotis T, 2004, ARCH OPHTHALMOL-CHIC, V122, P258, DOI 10.1001/archopht.122.2.258; Sadigh-Eteghad S, 2012, NEUROSCIENCES, V17, P321; Saglar E, 2009, MOL VIS, V15, P1270; Scheetz TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058657; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tsolaki F, 2011, CLIN OPHTHALMOL, V5, P887, DOI 10.2147/OPTH.S22485; Vickers JC, 2002, MOL VIS, V8, P389; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607; Wiggs JL, 2012, J GLAUCOMA; Xuan C, 2011, J NEUROL SCI, V308, P110, DOI 10.1016/j.jns.2011.05.040; Yuan Hui-ping, 2007, Zhonghua Yan Ke Za Zhi, V43, P416; Zetterberg M, 2007, AM J OPHTHALMOL, V143, P1059, DOI 10.1016/j.ajo.2007.01.031	35	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72644	10.1371/journal.pone.0072644	http://dx.doi.org/10.1371/journal.pone.0072644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023758	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400020
J	Yokoyama, K; Hiyama, A; Arai, F; Nukaga, T; Sakai, D; Mochida, J				Yokoyama, Katsuya; Hiyama, Akihiko; Arai, Fumiyuki; Nukaga, Tadashi; Sakai, Daisuke; Mochida, Joji			C-Fos Regulation by the MAPK and PKC Pathways in Intervertebral Disc Cells	PLOS ONE			English	Article							NUCLEUS PULPOSUS CELLS; PROTEIN-KINASE-C; MESENCHYMAL STEM-CELLS; SIGNAL-TRANSDUCTION; IN-VITRO; ADENYLATE-CYCLASE; EXPRESSION; DIFFERENTIATION; TARGET; AP-1	Background: The gene encoding c-fos is an important factor in the pathogenesis of joint disease in patients with osteoarthritis. However, it is unknown whether the signal mechanism of c-fos acts in intervertebral disc (IVD) cells. We investigated whether c-fos is activated in relation to mitogen-activated protein kinases (MAPKs) and the protein kinase C (PKC) pathway in nucleus pulposus (NP) cells. Methodology/Results: Reverse transcription-polymerase chain reaction and western blotting analyses were used to measure the expression of c-fos in rat IVD cells. Transfections were performed to determine the effects of c-fos on target gene activity. The effect of c-fos protein expression was examined in transfection experiments and in a 3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide cell viability assay. Phorbol 12-myristate 13-acetate (PMA), the most commonly used phorbol ester, binds to and activates protein kinase C (PKC), causing a wide range of effects in cells and tissues. PMA induced the expression of c-fos gene transcription and protein expression, and led to activation of the MAPK pathways in NP cells. The c-fos promoter was suppressed completely in the presence of the MAPK inhibitor PD98059, an inhibitor of the MEK/ERK kinase cascade, but not in the presence of SKF86002, SB202190, or SP600125. The effects of the PKC pathway on the transcriptional activity of the c-fos were evaluated. PKC gamma and PKC delta suppressed the promoter activity of c-fos. Treatment with c-fos inhibited aggrecan and Col2 promoter activities and the expression of these genes in NP cells. Conclusions: This study demonstrated, for the first time, that the MAPK and PKC pathways had opposing effects on the regulation of c-fos in NP cells. Thus, the expression of c-fos can be suppressed in the extracellular matrix of NP cells.	[Yokoyama, Katsuya; Hiyama, Akihiko; Arai, Fumiyuki; Nukaga, Tadashi; Sakai, Daisuke; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthopaed Surg, Hiratsuka, Kanagawa 25912, Japan; [Yokoyama, Katsuya; Hiyama, Akihiko; Arai, Fumiyuki; Nukaga, Tadashi; Sakai, Daisuke; Mochida, Joji] Tokai Univ, Sch Med, Res Ctr Regenerat Med, Hiratsuka, Kanagawa 25912, Japan	Tokai University; Tokai University	Hiyama, A (corresponding author), Tokai Univ, Sch Med, Dept Orthopaed Surg, Hiratsuka, Kanagawa 25912, Japan.	a.hiyama@tokai-u.jp	Hiyama, Akihiko/AAW-7362-2021; Sakai, Daisuke/X-9164-2019	Hiyama, Akihiko/0000-0002-2474-9118; Sakai, Daisuke/0000-0003-4189-9270	Tokai University Educational System General Research Organization; Tokai University School of Medicine;  [24791570]	Tokai University Educational System General Research Organization; Tokai University School of Medicine; 	This study was supported in part by the Research and Study Program of Tokai University Educational System General Research Organization, a grant from Tokai University School of Medicine Research Aid, a grant for matching fund subsidy for a private university, and a grant-in-aid for young scientists (B) (24791570) to A. H.	ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Arai F, 2012, J ORTHOP RES, V30, P1478, DOI 10.1002/jor.22095; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; CLEMENS MJ, 1992, J CELL SCI, V103, P881; Crespo PM, 2008, J BIOL CHEM, V283, P31163, DOI 10.1074/jbc.M709257200; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584; Hiyama A, 2007, J ORTHOP RES, V25, P1574, DOI 10.1002/jor.20460; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Hutton WC, 2001, CLIN BIOMECH, V16, P728, DOI 10.1016/S0268-0033(01)00080-8; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jiang Y, 2012, J CELL BIOCHEM, V113, P1599, DOI 10.1002/jcb.24028; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Li J, 2009, J CELL PHYSIOL, V221, P609, DOI 10.1002/jcp.21890; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Niu CC, 2011, J ORTHOP RES, V29, P14, DOI 10.1002/jor.21195; Pardo VG, 2006, INT J BIOCHEM CELL B, V38, P1181, DOI 10.1016/j.biocel.2005.12.018; REBOIS RV, 1985, J BIOL CHEM, V260, P8026; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Smith ER, 2001, J BIOL CHEM, V276, P32094, DOI 10.1074/jbc.M105009200; Sobajima Satoshi, 2005, Spine J, V5, P14, DOI 10.1016/j.spinee.2004.05.251; STACHOWIAK MK, 1990, ONCOGENE, V5, P69; Studer RK, 2008, J ORTHOP RES, V26, P991, DOI 10.1002/jor.20604; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; Thomas DP, 2000, J CELL SCI, V113, P439; Tsai TT, 2007, J BONE MINER RES, V22, P965, DOI 10.1359/JBMR.070322; Tsuji M, 1996, FEBS LETT, V381, P222, DOI 10.1016/0014-5793(96)00118-4; Vogt PK, 2002, NAT REV CANCER, V2, P465, DOI 10.1038/nrc818; Wang DL, 2007, SPINE, V32, P2521, DOI 10.1097/BRS.0b013e318158cb61; WANG ZQ, 1991, EMBO J, V10, P2437, DOI 10.1002/j.1460-2075.1991.tb07783.x; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P3994, DOI 10.1073/pnas.94.8.3994; Watanabe T, 2010, J ORTHOP RES, V28, P623, DOI 10.1002/jor.21036; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; WURTHNER JU, 1995, ENDOCRINE, V3, P579, DOI 10.1007/BF02953022	45	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73210	10.1371/journal.pone.0073210	http://dx.doi.org/10.1371/journal.pone.0073210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023832	gold, Green Submitted, Green Published			2022-12-27	WOS:000324238400051
J	Andrews, K; Abdelsamed, H; Yi, AK; Miller, MA; Fitzpatrick, EA				Andrews, Kelly; Abdelsamed, Hossam; Yi, Ae-Kyung; Miller, Mark A.; Fitzpatrick, Elizabeth A.			TLR2 Regulates Neutrophil Recruitment and Cytokine Production with Minor Contributions from TLR9 during Hypersensitivity Pneumonitis	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; MURINE MODEL; T-CELLS; LUNG; EXPRESSION; FIBROSIS; TH1	Hypersensitivity pneumonitis (HP) is an interstitial lung disease that develops following repeated exposure to environmental antigens. The disease results in alveolitis, granuloma formation and may progress to a fibrotic chronic form, which is associated with significant morbidity and mortality. The severity of the disease correlates with a neutrophil rich influx and an IL-17 response. We used the Saccharopolyspora rectivirgula (SR) model of HP to determine whether Toll-like receptors (TLR) 2 and 9 cooperate in neutrophil recruitment and IL-17-associated cytokine production during the development of HP. Stimulation of bone marrow derived macrophages (BMDMs) from C57BL/6, MyD88(-/-) and TLR2/9(-/-) mice with SR demonstrate that SR is a strong inducer of neutrophil chemokines and growth factors. The cytokines induced by SR were MyD88-dependent and, of those, most were partially or completely dependent on TLRs 2 and 9. Following in vivo exposure to SR, CXCL2 production and neutrophil recruitment were reduced in TLR2(-/-) and TLR2/9(-/-) mice suggesting that the response was largely dependent on TLR2; however the reduction was greatest in the TLR2/9(-/-) double knockout mice indicating TLR9 may also contribute to the response. There was a reduction in the levels of pro-inflammatory cytokines TNF alpha and IL-6 as well as CCL3 and CCL4 in the BALF from TLR2/9(-/-) mice compared to WT and single knockout (SKO) mice exposed one time to SR. The decrease in neutrophil recruitment and TNFa production in the TLR2/9(-/-) mice was maintained throughout 3 weeks of SR exposures in comparison to WT and SKO mice. Both TLRs 2 and 9 contributed to the Th17 response; there was a decrease in Th17 cells and IL-17 mRNA in the TLR2/9(-/-) mice in comparison to the WT and SKO mice. Despite the effects on neutrophil recruitment and the IL-17 response, TLR2/9(-/-) mice developed granuloma formation similarly to WT and SKO mice suggesting that there are additional mediators and pattern recognition receptors involved in the disease.	[Andrews, Kelly; Abdelsamed, Hossam; Miller, Mark A.; Fitzpatrick, Elizabeth A.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Yi, Ae-Kyung] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Fitzpatrick, EA (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	efitzpatrick@uthsc.edu		Abdelsamed, Hossam/0000-0002-5448-6056	National Institutes of Health Grant [HL084172]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084172] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This publication was made possible by National Institutes of Health Grant HL084172. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsamed HA, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-15; Agostini C, 2004, CURR OPIN PULM MED, V10, P378, DOI 10.1097/01.mcp.0000133067.71469.b2; Ando M, 1997, Curr Opin Pulm Med, V3, P391, DOI 10.1097/00063198-199709000-00013; Butler NS, 2002, J IMMUNOL, V169, P3700, DOI 10.4049/jimmunol.169.7.3700; DENIS M, 1991, AM J RESP CELL MOL, V5, P198, DOI 10.1165/ajrcmb/5.2.198; DENIS M, 1991, AM J RESP CELL MOL, V5, P477, DOI 10.1165/ajrcmb/5.5.477; Erkinjuntti-Pekkanen R, 1998, AM J RESP CRIT CARE, V158, P662, DOI 10.1164/ajrccm.158.2.9710012; Fong DJ, 2010, IMMUNOLOGY, V130, P125, DOI 10.1111/j.1365-2567.2009.03219.x; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Girard M, 2009, ALLERGY, V64, P322, DOI 10.1111/j.1398-9995.2009.01949.x; GIRARD M, 2009, EUR RESP J; Gudmundsson G, 1998, J IMMUNOL, V161, P991; GURNEY JW, 1992, RADIOL CLIN N AM, V30, P1219; HASLAM PL, 1987, AM REV RESPIR DIS, V135, P35; Ismail T, 2006, RESPIROLOGY, V11, P262, DOI 10.1111/j.1440-1843.2006.00839.x; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Joshi AD, 2009, AM J RESP CRIT CARE, V179, P705, DOI 10.1164/rccm.200811-1700OC; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Matsuno Y, 2007, AM J RESP CRIT CARE, V176, P1015, DOI 10.1164/rccm.200612-1887OC; Mroz RM, 2008, J PHYSIOL PHARMACOL, V59, P499; Nance S, 2005, EUR J IMMUNOL, V35, P1928, DOI 10.1002/eji.200425762; Nance SC, 2008, J LEUKOCYTE BIOL, V83, P1207, DOI 10.1189/jlb.0607391; Pardo A, 2000, AM J RESP CRIT CARE, V161, P1698, DOI 10.1164/ajrccm.161.5.9907065; Patel AM, 2001, J ALLERGY CLIN IMMUN, V108, P661; REMYJARDIN M, 1993, RADIOLOGY, V189, P111, DOI 10.1148/radiology.189.1.8372179; SALVAGGIO JE, 1986, CHEST, V89, pS190, DOI 10.1378/chest.89.3_Supplement.190S; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Sharma O P, 1995, Semin Respir Infect, V10, P96; Sharma S K, 1989, Indian J Chest Dis Allied Sci, V31, P187; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Simonian PL, 2009, TRANSL RES, V154, P222, DOI 10.1016/j.trsl.2009.08.006; Simonian PL, 2009, J IMMUNOL, V182, P6540, DOI 10.4049/jimmunol.0900013; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; Vasakova M, 2009, SCAND J IMMUNOL, V69, P268, DOI 10.1111/j.1365-3083.2008.02222.x; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Zacharisen MC, 2011, IMMUNOL ALLERGY CLIN, V31, P769, DOI 10.1016/j.iac.2011.07.004	36	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73143	10.1371/journal.pone.0073143	http://dx.doi.org/10.1371/journal.pone.0073143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023674	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200070
J	Campo-Bescos, MA; Munoz-Carpena, R; Kaplan, DA; Southworth, J; Zhu, LK; Waylen, PR				Campo-Bescos, Miguel A.; Munoz-Carpena, Rafael; Kaplan, David A.; Southworth, Jane; Zhu, Likai; Waylen, Peter R.			Beyond Precipitation: Physiographic Gradients Dictate the Relative Importance of Environmental Drivers on Savanna Vegetation	PLOS ONE			English	Article							COMMON TRENDS; WOODY COVER; TREE COVER; AFRICAN SAVANNA; OKAVANGO DELTA; CLIMATE-CHANGE; SOIL-MOISTURE; AVHRR GIMMS; NDVI; RAINFALL	Background: Understanding the drivers of large-scale vegetation change is critical to managing landscapes and key to predicting how projected climate and land use changes will affect regional vegetation patterns. This study aimed to improve our understanding of the role, magnitude and spatial distribution of the key environmental factors driving vegetation change in southern African savanna, and how they vary across physiographic gradients. Methodology/Principal Findings: We applied Dynamic Factor Analysis (DFA), a multivariate times series dimension reduction technique to ten years of monthly remote sensing data (MODIS-derived normalized difference vegetation index, NDVI) and a suite of environmental covariates: precipitation, mean and maximum temperature, soil moisture, relative humidity, fire and potential evapotranspiration. Monthly NDVI was described by cyclic seasonal variation with distinct spatiotemporal patterns in different physiographic regions. Results support existing work emphasizing the importance of precipitation, soil moisture and fire on NDVI, but also reveal overlooked effects of temperature and evapotranspiration, particularly in regions with higher mean annual precipitation. Critically, spatial distributions of the weights of environmental covariates point to a transition in the importance of precipitation and soil moisture (strongest in grass-dominated regions with precipitation<750 mm) to fire, potential evapotranspiration, and temperature (strongest in tree-dominated regions with precipitation>950 mm). Conclusions/Significance: We quantified the combined spatiotemporal effects of an available suite of environmental drivers on NDVI across a large and diverse savanna region. The analysis supports known drivers of savanna vegetation but also uncovers important roles of temperature and evapotranspiration. Results highlight the utility of applying the DFA approach to remote sensing products for regional analyses of landscape change in the context of global environmental change. With the dramatic increase in global change research, this methodology augurs well for further development and application of spatially explicit time series modeling to studies at the intersection of ecology and remote sensing.	[Campo-Bescos, Miguel A.; Munoz-Carpena, Rafael] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32610 USA; [Kaplan, David A.] Univ Florida, Dept Environm Engn Sci, Gainesville, FL 32611 USA; [Southworth, Jane; Zhu, Likai; Waylen, Peter R.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Campo-Bescos, Miguel A.] Univ Publ Navarra, Projects & Rural Engn Dept, Pamplona, Spain	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidad Publica de Navarra	Munoz-Carpena, R (corresponding author), Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32610 USA.	carpena@ufl.edu	Kaplan, David A./G-5951-2010; Campo-Bescós, Miguel Ángel/P-1849-2016; Munoz-Carpena, Rafael/A-7588-2010	Kaplan, David A./0000-0002-0103-0928; Campo-Bescós, Miguel Ángel/0000-0002-0435-3765; Munoz-Carpena, Rafael/0000-0003-2838-1514; Southworth, Jane/0000-0002-7246-7879	National Aeronautics and Space Administration Land-Cover/Land-Use Change Program (NASA LCLUC) Project [NNX09AI25G]; National Science Foundation Integrative Graduate Education and Research Traineeship (NSF-IGERT) [0504422]	National Aeronautics and Space Administration Land-Cover/Land-Use Change Program (NASA LCLUC) Project; National Science Foundation Integrative Graduate Education and Research Traineeship (NSF-IGERT)(National Science Foundation (NSF))	This study was funded by National Aeronautics and Space Administration Land-Cover/Land-Use Change Program (NASA LCLUC) Project #NNX09AI25G, titled "The Role of Socioeconomic Institutions in Mitigating Impacts of Climate Variability and Climate Change in Southern Africa'', and National Science Foundation Integrative Graduate Education and Research Traineeship (NSF-IGERT) 0504422 Adaptive Management of Water, Wetlands and Watershed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis P, 2008, FISH RES, V92, P242, DOI 10.1016/j.fishres.2008.01.021; ANDRES L, 1994, INT J REMOTE SENS, V15, P1115, DOI 10.1080/01431169408954145; Anyamba A, 1996, INT J REMOTE SENS, V17, P2533, DOI 10.1080/01431169608949091; Archibald S, 2007, J VEG SCI, V18, P583, DOI 10.1111/j.1654-1103.2007.tb02572.x; BARET F, 1991, REMOTE SENS ENVIRON, V35, P161, DOI 10.1016/0034-4257(91)90009-U; BARNES RFW, 1983, J APPL ECOL, V20, P521, DOI 10.2307/2403524; Baxter PWJ, 2005, ECOL APPL, V15, P1331, DOI 10.1890/02-5382; Santos MB, 2012, ICES J MAR SCI, V69, P739, DOI 10.1093/icesjms/fsr186; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bucini G, 2007, GLOBAL ECOL BIOGEOGR, V16, P593, DOI 10.1111/j.1466-8238.2007.00325.x; Butt B, 2011, REMOTE SENS ENVIRON, V115, P3367, DOI 10.1016/j.rse.2011.08.001; Linares JC, 2012, EUR J FOREST RES, V131, P1001, DOI 10.1007/s10342-011-0572-7; Linares JC, 2011, OECOLOGIA, V167, P847, DOI 10.1007/s00442-011-2012-2; Carvalho LMT, 2001, INT J REMOTE SENS, V22, P3871, DOI 10.1080/01431160110069836; Ciais P, 2009, BIOGEOSCIENCES, V6, P1935, DOI 10.5194/bg-6-1935-2009; Eklundh L, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016772; ENGLE R, 1981, J AM STAT ASSOC, V76, P774, DOI 10.2307/2287567; Erzini K, 2005, FISH OCEANOGR, V14, P195, DOI 10.1111/j.1365-2419.2005.00332.x; Eswaran H, 1997, GEODERMA, V77, P1, DOI 10.1016/S0016-7061(97)00007-4; Fan Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004345; FARRAR TJ, 1994, REMOTE SENS ENVIRON, V50, P121, DOI 10.1016/0034-4257(94)90039-6; Favier C, 2012, GLOBAL ECOL BIOGEOGR, V21, P787, DOI 10.1111/j.1466-8238.2011.00725.x; Fensholt R, 2009, REMOTE SENS ENVIRON, V113, P1886, DOI 10.1016/j.rse.2009.04.004; Geweke J., 1977, LATENT VARIABLES SOC, P365; Giglio L, 2003, REMOTE SENS ENVIRON, V87, P273, DOI 10.1016/S0034-4257(03)00184-6; Gillson L, 2007, SCIENCE, V315, P53, DOI 10.1126/science.1136577; Good SP, 2011, P NATL ACAD SCI USA, V108, P4902, DOI 10.1073/pnas.1013100108; Hamandawana H, 2008, J ARID ENVIRON, V72, P1709, DOI 10.1016/j.jaridenv.2008.03.007; Harvey A. C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; Hellden U, 2008, GLOBAL PLANET CHANGE, V64, P169, DOI 10.1016/j.gloplacha.2008.10.006; Herrmann SM, 2005, GLOBAL ENVIRON CHANG, V15, P394, DOI 10.1016/j.gloenvcha.2005.08.004; Heumann BW, 2007, REMOTE SENS ENVIRON, V108, P385, DOI 10.1016/j.rse.2006.11.025; Jakubauskas ME, 2001, PHOTOGRAMM ENG REM S, V67, P461; Jeyaseelan AT, 2007, INT J REMOTE SENS, V28, P4927, DOI 10.1080/01431160701253279; Kaplan D, 2011, J HYDROL, V398, P221, DOI 10.1016/j.jhydrol.2010.12.019; Kaplan D, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR009038; Kovacs J., 2004, ACTA GEOL HUNG, V47, P1, DOI [10.1556/AGeol.47.2004.1.1, DOI 10.1556/AGEOL.47.2004.1.1]; Kuo Y, 2011, ATMOS ENVIRON, V45, DOI [10.1016/j.atmosenv.2011.08.043, DOI 10.1016/J.ATM0SENV.2011.08.043]; Kuo Y, 2011, J HYDROL, V409, DOI [10.1016/j.jhydrol.2011.09.015, DOI 10.1016/J.JHYDR0L.2011.09.015]; Kuo YM, 2010, J ENVIRON QUAL, V39, P176, DOI 10.2134/jeq2009.0098; Lanfredi M, 2004, REMOTE SENS ENVIRON, V93, P565, DOI 10.1016/j.rse.2004.08.012; LEGATES DR, 1990, INT J CLIMATOL, V10, P111, DOI 10.1002/joc.3370100202; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Linhoss A, 2013, J HYDROL ENG, V18, P1767, DOI 10.1061/(ASCE)HE.1943-5584.0000755; Lutkepohl H., 1991, INTRO MULTIPLE TIME; Mayer AL, 2011, SCIENCE, V334, P188, DOI 10.1126/science.1213908; McCarthy TS, 2000, S AFR J SCI, V96, P25; MCCLOY KR, 2005, EARSEL EPROCEEDINGS, V4, P52; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Munoz-Carpena R, 2005, J CONTAM HYDROL, V80, P49, DOI 10.1016/j.jconhyd.2005.07.003; Murphy BP, 2012, ECOL LETT, V15, P748, DOI 10.1111/j.1461-0248.2012.01771.x; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Neeti N, 2011, T GIS, V15, P599, DOI 10.1111/j.1467-9671.2011.01280.x; Ntumi CP, 2005, S AFR J WILDL RES, V35, P139; Olsson L, 2005, J ARID ENVIRON, V63, P556, DOI 10.1016/j.jaridenv.2005.03.008; Penuelas J, 2004, NEW PHYTOL, V161, P837, DOI 10.1111/j.1469-8137.2004.01003.x; Perez-Rodriguez A, 2012, ICES J MAR SCI, V69, P902, DOI 10.1093/icesjms/fss019; Pfeifer M, 2012, GLOBAL ECOL BIOGEOGR, V21, P603, DOI 10.1111/j.1466-8238.2011.00712.x; Poveda G, 2001, ENVIRON HEALTH PERSP, V109, P489, DOI 10.2307/3454707; Richard Y, 1998, INT J REMOTE SENS, V19, P2907, DOI 10.1080/014311698214343; RINGROSE S, 1990, PHOTOGRAMM ENG REM S, V56, P1253; Ritter A, 2007, HYDROL PROCESS, V21, P2464, DOI 10.1002/hyp.6483; Ritter A, 2009, VADOSE ZONE J, V8, P437, DOI 10.2136/vzj2008.0054; Ritter A, 2006, J HYDROL, DOI [317. 10.1016/j.jhydrol.2005.05.025, DOI 10.1016/J.JHYDR0L.2005.05.025]; Ritter A, 2013, J HYDROL, V480, P33, DOI 10.1016/j.jhydrol.2012.12.004; Sang HY, 2012, J R STAT SOC B, V74, P111, DOI 10.1111/j.1467-9868.2011.01007.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seaquist JW, 2009, BIOGEOSCIENCES, V6, P469, DOI 10.5194/bg-6-469-2009; Seghieri J, 2009, J HYDROL, V375, DOI [10.1016/j.jhydrol.2009.01.023, DOI 10.1016/J.JHYDR0L.2009.01.023]; Spessa A, 2005, GLOBAL ECOL BIOGEOGR, V14, P439, DOI 10.1111/j.1466-822x.2005.00174.x; Sposito G., 1998, SCALE DEPENDENCE SCA; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; Tulp I, 2008, J SEA RES, V60, P54, DOI 10.1016/j.seares.2008.04.004; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y; Vanacker V, 2005, GLOBAL ECOL BIOGEOGR, V14, P123, DOI 10.1111/j.1466-822X.2005.00136.x; Wagner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034074; Wint G. R. W., 2007, GRIDDED LIVESTOCK WO; Yu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049230; Zhang XY, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005263; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur AF, 2003, CAN J FISH AQUAT SCI, V60, P542, DOI 10.1139/F03-030; Zuur AF, 2004, J SEA RES, V52, P57, DOI 10.1016/j.seares.2003.08.008; Zuur AF, 2003, ENVIRONMETRICS, V14, P665, DOI 10.1002/env.611	89	37	37	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72348	10.1371/journal.pone.0072348	http://dx.doi.org/10.1371/journal.pone.0072348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023616	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200011
J	Elamin, F; Liversidge, HM				Elamin, Fadil; Liversidge, Helen M.			Malnutrition Has No Effect on the Timing of Human Tooth Formation	PLOS ONE			English	Article							DENTAL DEVELOPMENT; AGE; MATURITY; CHILDREN; TEETH; UNDERNUTRITION; NUTRITION; ERUPTION; OBESITY; CARIES	The effect of nutrition on the timing of human tooth formation is poorly understood. Delays and advancements in dental maturation have all been reported as well as no effect. We investigated the effect of severe malnutrition on the timing of human tooth formation in a large representative sample of North Sudanese children. The sample (1102 males, 1013 females) consisted of stratified randomly selected healthy individuals in Khartoum, Sudan, aged 2-22 years using a cross-sectional design following the STROBE statement. Nutritional status was defined using WHO criteria of height and weight. Body mass index Z-scores and height for age Z-scores of <= - 2 (cut-off) were used to identify the malnourished group (N = 474) while the normal was defined by Z-scores of >= 0 (N = 799). Clinical and radiographic examination of individuals, with known ages of birth was performed including height and weight measurements. Mandibular left permanent teeth were assessed using eight crown and seven root established tooth formation stages. Mean age at entry and mean age within tooth stages were calculated for each available tooth stage in each group and compared using a t-test. Results show the mean age at entry and mean age within tooth stages were not significantly different between groups affected by severe malnutrition and normal children (p>0.05). This remarkable finding was evident across the span of dental development. We demonstrate that there is little measurable effect of sustained malnutrition on the average timing of tooth formation. This noteworthy finding supports the notion that teeth have substantial biological stability and are insulated from extreme nutritional conditions compared to other maturing body systems.	[Elamin, Fadil; Liversidge, Helen M.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England; [Elamin, Fadil] Khartoum Ctr Res & Med Training, Khartoum, Sudan; [Elamin, Fadil] El Razi Dent Sch, Khartoum, Sudan	University of London; Queen Mary University London	Elamin, F (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England.	f.elamin@qmul.ac.uk		Liversidge, Helen/0000-0002-7056-9337				ALVAREZ JO, 1995, AM J CLIN NUTR, V61, p410S, DOI 10.1093/ajcn/61.2.410S; ALVAREZ JO, 1990, J DENT RES, V69, P1564, DOI 10.1177/00220345900690090501; Bagherian Ali, 2011, J Oral Sci, V53, P37; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Cameriere R, 2007, ANN HUM BIOL, V34, P547, DOI 10.1080/03014460701556296; CLEGG EJ, 1972, PHILOS T R SOC B, V264, P403, DOI 10.1098/rstb.1972.0015; Conceicao ELN, 2011, AM J PHYS ANTHROPOL, V144, P463, DOI 10.1002/ajpa.21433; DEMIRJIAN A, 1973, HUM BIOL, V45, P211; Eid R M R, 2002, Int J Paediatr Dent, V12, P423, DOI 10.1046/j.1365-263X.2002.00403.x; Elamin F, 2011, THESIS U LONDON; Fleshman K, 2000, TROP DOCT, V30, P16, DOI 10.1177/004947550003000109; Flores-Mir C, 2005, ANGLE ORTHOD, V75, P935; GARN SM, 1965, J DENT RES, V44, P228, DOI 10.1177/00220345650440011901; Gaur R, 2012, AM J PHYS ANTHROPOL, V148, P54, DOI 10.1002/ajpa.22041; Gaur R, 2011, ANN HUM BIOL, V38, P84, DOI 10.3109/03014460.2010.497499; HAGG U, 1985, ANGLE ORTHOD, V55, P93; Hilgers KK, 2006, PEDIATR DENT, V28, P18; MCCANCE RA, 1961, BRIT J NUTR, V15, P213, DOI 10.1079/BJN19610026; MELSEN B, 1986, ANN HUM BIOL, V13, P153, DOI 10.1080/03014468600008291; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; Must A, 2012, OBESITY; Nystrom M, 2000, ACTA ODONTOL SCAND, V58, P49, DOI 10.1080/000163500429280; Psoter W, 2008, COMMUNITY DENT ORAL, V36, P179, DOI 10.1111/j.1600-0528.2007.00386.x; Sanchez-Perez L, 2010, ACTA ODONTOL SCAND, V68, P57, DOI 10.3109/00016350903449367; Shetty P., 2006, MEDICINE, V34, P524, DOI [DOI 10.1053/J.MPMED.2006.09.014, 10.1053/j.mpmed.2006.09.014]; SMITH BH, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P143; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; TONGE CH, 1973, J ANAT, V115, P1; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weddell LS, 2011, PEDIATR DENT, V33, P221; World Health Organization (WHO), 2006, WHO CHILD GROWTH STA, DOI DOI 10.4067/S0370-41062009000400012; Zangouei-Booshehri M., 2011, Health, V3, P253, DOI 10.4236/health.2011.35045	32	64	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72274	10.1371/journal.pone.0072274	http://dx.doi.org/10.1371/journal.pone.0072274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023614	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200009
J	Fang, Z; Yang, Q; Xiong, W; Li, GH; Liao, H; Xiao, J; Li, F				Fang, Zhong; Yang, Qin; Xiong, Wei; Li, Guang-hui; Liao, Hui; Xiao, Jun; Li, Feng			Effect of CGRP-Adenoviral Vector Transduction on the Osteoblastic Differentiation of Rat Adipose-Derived Stem Cells	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; SEGMENTAL BONE DEFECTS; LENTIVIRAL VECTOR; STROMAL CELLS; TISSUE; EXPRESSION; MICE; PROLIFERATION; INVOLVEMENT; RABBITS	Calcitonin gene-related peptide (CGRP) promotes osteoblast recruitment and osteogenic activity. However, no evidence suggests that CGRP could affect the differentiation of stem cells toward osteoblasts. In this study, we genetically modified adipose-derived stem cells (ADSCs) by introducing the CGRP gene through adenoviral vector transduction and investigated on cellular proliferation and osteoblast differentiation in vitro and osteogenesis in vivo as well. For the in vitro analyses, rat ADSCs were transducted with adenoviral vectors containing the CGRP gene (Ad-CGRP) and were cultured in complete osteoblastic medium. The morphology, proliferative capacity, and formation of localized regions of mineralization in the cells were evaluated. The expression of alkaline phosphatase (ALP) and special markers of osteoblasts, such as Collagen I, Osteocalcin (BPG) and Osteopontin (OPN), were measured by cytochemistry, MMT, RT-PCR, and Western blot. For the in vivo analyses, the Ad-CGRP-ADSCs/Beta-tricalcium phosphate (beta-TCP) constructs were implanted in rat radial bone defects for 12 weeks. Radiography and histomorphology evaluations were carried out on 4 weeks and 12 weeks. Our analyses indicated that heterogeneous spindle-shaped cells and localized regions of mineralization were formed in the CGRP-transduced ADSCs (the transduced group). A higher level of cellular proliferation, a high expression level of ALP on days 7 and 14 (p<0.05), and increased expression levels of Collagen I, BPG and OPN presented in transduced group (p<0.05). The efficiency of new bone formation was dramatically enhanced in vivo in Ad-CGRP-ADSCs/beta-TCP group but not in beta-TCP group and ADSCs/beta-TCP group. Our results reveal that ADSCs transduced with an Ad-CGRP vector have stronger potential to differentiate into osteoblasts in vitro and are able to regenerate a promising new tissue engineering bone in vivo. Our findings suggest that CGRP-transduced ADSCs may serve as seed cells for bone tissue engineering and provide a potential way for treating bone defects.	[Fang, Zhong; Xiong, Wei; Li, Guang-hui; Liao, Hui; Xiao, Jun; Li, Feng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Orthoped, Wuhan 430074, Hubei, Peoples R China; [Yang, Qin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pathol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pathol, Wuhan 430074, Hubei, Peoples R China.	qinyangtjh@gmail.com	liao, hui/GSE-5758-2022		National Natural Science Foundation of China [30571873]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (number 30571873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballica R, 1999, J BONE MINER RES, V14, P1067, DOI 10.1359/jbmr.1999.14.7.1067; Colnot C, 2011, TISSUE ENG PART B-RE, V17, P449, DOI [10.1089/ten.teb.2011.0243, 10.1089/ten.TEB.2011.0243]; Cornish J, 1999, J BONE MINER RES, V14, P1302, DOI 10.1359/jbmr.1999.14.8.1302; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Fang Z, 2010, J HUAZHONG U SCI-MED, V30, P75, DOI 10.1007/s11596-010-0113-5; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; HUKKANEN M, 1993, NEUROSCIENCE, V54, P969, DOI 10.1016/0306-4522(93)90588-7; Imai S, 1997, J BONE MINER RES, V12, P1018, DOI 10.1359/jbmr.1997.12.7.1018; Irie K, 2002, MICROSC RES TECHNIQ, V58, P85, DOI 10.1002/jemt.10122; Jiang XQ, 2005, CHINESE MED J-PEKING, V118, P281; Lavery K, 2009, BONE, V45, P27, DOI 10.1016/j.bone.2009.03.656; Lee JH, 2006, BIOCHEM BIOPH RES CO, V341, P882, DOI 10.1016/j.bbrc.2006.01.038; Li JJ, 2012, J SURG RES, V176, pE13, DOI 10.1016/j.jss.2011.12.011; Li XY, 2010, ARTIF ORGANS, V34, P46, DOI 10.1111/j.1525-1594.2009.00795.x; Liu TM, 2007, STEM CELLS, V25, P750, DOI 10.1634/stemcells.2006-0394; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Mrak E, 2010, J CELL PHYSIOL, V225, P701, DOI 10.1002/jcp.22266; Qing W, 2012, J BIOMED BIOTECHNOL, V2012, DOI 10.1155/2012/ 410879.84; Roldan JC, 2010, J CRANIO MAXILL SURG, V38, P423, DOI 10.1016/j.jcms.2010.01.003; Schek RM, 2006, BIOMATERIALS, V27, P1160, DOI 10.1016/j.biomaterials.2005.07.029; Schinke T, 2004, J BONE MINER RES, V19, P2049, DOI 10.1359/JBMR.040915; Sun XZ, 2011, CHINESE MED J-PEKING, V124, P3093, DOI 10.3760/cma.j.issn.0366-6999.2011.19.026; Udehiya RK, 2013, RES VET SCI, V94, P743, DOI 10.1016/j.rvsc.2013.01.011; Valentijn K, 1997, BONE, V21, P269, DOI 10.1016/S8756-3282(97)00142-7; Villa I, 2003, AM J PHYSIOL-ENDOC M, V284, pE627, DOI 10.1152/ajpendo.00307.2002; Wedemeyer C, 2007, J BONE MINER RES, V22, P1011, DOI 10.1359/JBMR.070408; Xu J, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-83	28	18	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72738	10.1371/journal.pone.0072738	http://dx.doi.org/10.1371/journal.pone.0072738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023640	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200035
J	Prommana, P; Uthaipibull, C; Wongsombat, C; Kamchonwongpaisan, S; Yuthavong, Y; Knuepfer, E; Holder, AA; Shaw, PJ				Prommana, Parichat; Uthaipibull, Chairat; Wongsombat, Chayaphat; Kamchonwongpaisan, Sumalee; Yuthavong, Yongyuth; Knuepfer, Ellen; Holder, Anthony A.; Shaw, Philip J.			Inducible Knockdown of Plasmodium Gene Expression Using the glmS Ribozyme	PLOS ONE			English	Article							MALARIA PARASITES; DIHYDROFOLATE-REDUCTASE; TRANSGENE EXPRESSION; RNA-CLEAVAGE; FALCIPARUM; RECOMBINATION; DELETION; REVEALS; CULTURE; SYSTEM	Conventional reverse genetic approaches for study of Plasmodium malaria parasite gene function are limited, or not applicable. Hence, new inducible systems are needed. Here we describe a method to control P. falciparum gene expression in which target genes bearing a glmS ribozyme in the 3' untranslated region are efficiently knocked down in transgenic P. falciparum parasites in response to glucosamine inducer. Using reporter genes, we show that the glmS ribozyme cleaves reporter mRNA in vivo leading to reduction in mRNA expression following glucosamine treatment. Glucosamine-induced ribozyme activation led to efficient reduction of reporter protein, which could be rapidly reversed by removing the inducer. The glmS ribozyme was validated as a reverse-genetic tool by integration into the essential gene and antifolate drug target dihydrofolate reductase-thymidylate synthase (PfDHFR-TS). Glucosamine treatment of transgenic parasites led to rapid and efficient knockdown of PfDHFR-TS mRNA and protein. PfDHFR-TS knockdown led to a growth/arrest mutant phenotype and hypersensitivity to pyrimethamine. The glmS ribozyme may thus be a tool for study of essential genes in P. falciparum and other parasite species amenable to transfection.	[Prommana, Parichat; Uthaipibull, Chairat; Wongsombat, Chayaphat; Kamchonwongpaisan, Sumalee; Yuthavong, Yongyuth; Shaw, Philip J.] Natl Ctr Genet Engn & Biotechnol BIOTEC, Khlong Luang, Pathum Thani, Thailand; [Knuepfer, Ellen; Holder, Anthony A.] MRC Natl Inst Med Res, Div Parasitol, London, England	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); MRC National Institute for Medical Research	Shaw, PJ (corresponding author), Natl Ctr Genet Engn & Biotechnol BIOTEC, Khlong Luang, Pathum Thani, Thailand.	philip@biotec.or.th	Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Knuepfer, Ellen/0000-0002-6090-1877; Yuthavong, Yongyuth/0000-0002-3582-8401	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative round 4 [1007041]; CPM/NSTDA [P-11-00673, P-00-20388, P-10-10506, P-09-00707, P-12-01270]; HHMI International Scholar program; UK MRC [U117532067]; EU FP7 Network of Excellence, EviMalar [242095]; Medical Research Council [MC_U117532067] Funding Source: researchfish; MRC [MC_U117532067] Funding Source: UKRI	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative round 4; CPM/NSTDA; HHMI International Scholar program; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU FP7 Network of Excellence, EviMalar; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PJS acknowledges the Bill and Melinda Gates Foundation for funding through the Grand Challenges Explorations Initiative round 4 (grant number 1007041). PJS, CU, SK and YY acknowledge support from CPM/NSTDA grant numbers P-11-00673, P-00-20388, P-10-10506, P-09-00707, P-12-01270. SK also acknowledges support from the HHMI International Scholar program. EK and AAH were funded by the UK MRC (File No. U117532067) and the EU FP7 Network of Excellence, EviMalar (Grant agreement 242095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agop-Nersesian C, 2008, INT J PARASITOL, V38, P673, DOI 10.1016/j.ijpara.2007.10.015; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Augagneur Y, 2012, P NATL ACAD SCI USA, V109, P6235, DOI 10.1073/pnas.1203516109; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Chitnumsub P, 2004, ACTA CRYSTALLOGR D, V60, P780, DOI 10.1107/S0907444904001544; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Combe A, 2009, CELL HOST MICROBE, V5, P386, DOI 10.1016/j.chom.2009.03.008; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; de Azevedo MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040981; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Dvorin JD, 2011, SCIENCE, V328, P10; Ecker A, 2012, INT J PARASITOL, V42, P969, DOI 10.1016/j.ijpara.2012.09.003; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Epp C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-86; Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Naik RS, 2003, J BIOL CHEM, V278, P2036, DOI 10.1074/jbc.M208976200; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Pornthanakasem W, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-387; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Technologies E, 2011, PLOS MED, V8; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Watson PY, 2011, NAT STRUCT MOL BIOL, V18, P359, DOI 10.1038/nsmb.1989; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Yuthavong Y, 2012, P NATL ACAD SCI USA, V109, P16823, DOI 10.1073/pnas.1204556109	37	119	119	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73783	10.1371/journal.pone.0073783	http://dx.doi.org/10.1371/journal.pone.0073783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023691	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200088
J	Santos, A; Gurling, J; Dvorak, MF; Noonan, VK; Fehlings, MG; Burns, AS; Lewis, R; Soril, L; Fallah, N; Street, JT; Belanger, L; Townson, A; Liang, LP; Atkins, D				Santos, Argelio; Gurling, James; Dvorak, Marcel F.; Noonan, Vanessa K.; Fehlings, Michael G.; Burns, Anthony S.; Lewis, Rachel; Soril, Lesley; Fallah, Nader; Street, John T.; Belanger, Lise; Townson, Andrea; Liang, Liping; Atkins, Derek			Modeling the Patient Journey from Injury to Community Reintegration for Persons with Acute Traumatic Spinal Cord Injury in a Canadian Centre	PLOS ONE			English	Article							MORTALITY; CAPACITY; TRENDS; FLOW; CARE	Background: A patient's journey through the health care system is influenced by clinical and system processes across the continuum of care. Methods: To inform optimized access to care and patient flow for individuals with traumatic spinal cord injury (tSCI), we developed a simulation model that can examine the full impact of therapeutic or systems interventions across the care continuum for patients with traumatic spinal cord injuries. The objective of this paper is to describe the detailed development of this simulation model for a major trauma and a rehabilitation centre in British Columbia (BC), Canada, as part of the Access to Care and Timing (ACT) project and is referred to as the BC ACT Model V1.0. Findings: To demonstrate the utility of the simulation model in clinical and administrative decision-making we present three typical scenarios that illustrate how an investigator can track the indirect impact(s) of medical and administrative interventions, both upstream and downstream along the continuum of care. For example, the model was used to estimate the theoretical impact of a practice that reduced the incidence of pressure ulcers by 70%. This led to a decrease in acute and rehabilitation length of stay of 4 and 2 days, respectively and a decrease in bed utilization of 9% and 3% in acute and rehabilitation. Conclusion: The scenario analysis using the BC ACT Model V1.0 demonstrates the flexibility and value of the simulation model as a decision-making tool by providing estimates of the effects of different interventions and allowing them to be objectively compared. Future work will involve developing a generalizable national Canadian ACT Model to examine differences in care delivery and identify the ideal attributes of SCI care delivery.	[Santos, Argelio; Noonan, Vanessa K.; Soril, Lesley; Fallah, Nader] Rick Hansen Inst, Vancouver, BC, Canada; [Santos, Argelio; Dvorak, Marcel F.; Noonan, Vanessa K.; Fallah, Nader; Street, John T.] Univ British Columbia, Dept Orthopaed, Div Spine, Vancouver, BC V5Z 1M9, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Spinal Program, Toronto, ON, Canada; [Burns, Anthony S.] Univ Toronto, Div Physiatry, Toronto, ON, Canada; [Lewis, Rachel; Atkins, Derek] Univ British Columbia, Sauder Sch Business, Ctr Operat Excellence, Vancouver, BC V5Z 1M9, Canada; [Belanger, Lise] Vancouver Gen Hosp, Vancouver, BC, Canada; [Townson, Andrea] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC V5Z 1M9, Canada; [Liang, Liping] Lingnan Univ, Fac Business, Tuen Mun, Hong Kong, Peoples R China	University of British Columbia; University of Toronto; University of Toronto; University of Toronto; University of British Columbia; University of British Columbia; University of British Columbia; Lingnan University	Santos, A (corresponding author), Rick Hansen Inst, Vancouver, BC, Canada.	argelio.santos@rickhanseninstitute.org	Fallah, Nader/D-4145-2012	Fallah, Nader/0000-0002-7746-4773; Fehlings, Michael/0000-0002-5722-6364; Dvorak, Marcel/0000-0002-9404-8448; LIANG, Liping/0000-0002-6491-1503	Rick Hansen Institute; Health Canada; province of British Columbia; province of Ontario	Rick Hansen Institute; Health Canada; province of British Columbia; province of Ontario	The authors would like to acknowledge the Rick Hansen Institute (http://www.rickhanseninstitute.org/), Health Canada (http://www.hc-sc.gc.ca/indexeng.php), and the provinces of British Columbia (http://www2.gov.bc.ca/) and Ontario (http://www.ontario.ca/welcome-ontario) for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Barton M, 2012, QJM-INT J MED, V105, P665, DOI 10.1093/qjmed/hcs036; Cardoen B, 2008, J MED SYST, V32, P443, DOI 10.1007/s10916-008-9150-z; Chand S, 2009, HEALTH CARE MANAG SC, V12, P325, DOI 10.1007/s10729-008-9094-3; Chen D, 1999, ARCH PHYS MED REHAB, V80, P1397, DOI 10.1016/S0003-9993(99)90250-2; DeVivo MJ, 2011, ARCH PHYS MED REHAB, V92, P332, DOI 10.1016/j.apmr.2010.08.031; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Hagen EM, 2010, J NEUROL NEUROSUR PS, V81, P368, DOI 10.1136/jnnp.2009.178798; Harper P, 2005, CLIN INVEST MED, V28, P338; Higashi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025403; Hoot NR, 2008, ANN EMERG MED, V52, P116, DOI 10.1016/j.annemergmed.2007.12.011; Hoot NR, 2009, J AM MED INFORM ASSN, V16, P338, DOI 10.1197/jamia.M2772; Hung GR, 2007, PEDIATR EMERG CARE, V23, P5, DOI 10.1097/PEC.0b013e31802c611e; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kharroubi S, 2007, SOC SCI MED, V64, P1242, DOI 10.1016/j.socscimed.2006.10.040; Kolker A, 2009, J MED SYST, V33, P27, DOI 10.1007/s10916-008-9161-9; Krueger H, CHRONIC DIS IN PRESS; Lenehan B, 2012, SPINE, V37, P321, DOI 10.1097/BRS.0b013e31822e5ff8; National Spinal Cord Injury Statistical Center, 2009, 2009 ANN STAT REP SP; Noonan VK, 2012, SPINAL CORD, V50, P22, DOI 10.1038/sc.2011.109; Noonan VK, 2012, J NEUROTRAUM, V29, P2272, DOI 10.1089/neu.2012.2317; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Rauner MS, 2012, HEALTH CARE MANAG SC, V15, P254, DOI 10.1007/s10729-012-9198-7; Simpson KN, 2009, PHARMACOECONOMICS, V27, P159, DOI 10.2165/00019053-200927020-00006; Strauss DJ, 2006, ARCH PHYS MED REHAB, V87, P1079, DOI 10.1016/j.apmr.2006.04.022; Street JT, 2013, SPINAL CORD; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Ware J.E., 2000, SF 36 HLTH SURVEY MA; WHITENECK GG, 1992, PARAPLEGIA, V30, P617, DOI 10.1038/sc.1992.124; Zhu ZC, 2012, INT J HEALTH CARE Q, V25, P134, DOI 10.1108/09526861211198290	30	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72552	10.1371/journal.pone.0072552	http://dx.doi.org/10.1371/journal.pone.0072552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023623	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200018
J	Abuyaman, O; Andreasen, BH; Kronborg, C; Vittinghus, E; Nexo, E				Abuyaman, Omar; Andreasen, Birgitte H.; Kronborg, Camilla; Vittinghus, Erik; Nexo, Ebba			The Soluble Receptor for Vitamin B-12 Uptake (sCD320) Increases during Pregnancy and Occurs in Higher Concentration in Urine than in Serum	PLOS ONE			English	Article							TRANSCOBALAMIN-II; HUMAN-PLACENTA; TRANSPORT; COBALAMIN; PROTEINS	Background: Cellular uptake of vitamin B-12 (B12) demands binding of the vitamin to transcobalamin (TC) and recognition of TC-B12 (holoTC) by the receptor CD320, a receptor expressed in high quantities on human placenta. We have identified a soluble form of CD320 (sCD320) in serum and here we present data on the occurrence of this soluble receptor in both serum and urine during pregnancy. Methods: We examined serum from twenty-seven pregnant women (cohort 1) at gestational weeks 13, 24 and 36 and serum and urine samples from forty pregnant women (cohort 2) tested up to 8 times during gestational weeks 17-41. sCD320, holoTC, total TC and complex formation between holoTC and sCD320 were measured by in-house ELISA methods, while creatinine was measured on the automatic platform Cobas 6000. Size exclusion chromatography was performed on a Superdex 200 column. Results: Median (range) of serum sCD320 increased from 125 (87-839) pmol/L (week 15) to reach a peak value of 199 (72-672) pmol/L (week 35) then dropped back to its baseline level just before birth (week 40). Around one third of sCD320 was precipitated with holoTC at all-time points studied. The urinary concentration of sCD320 was around two fold higher than in serum. Urinary sCD320/creatinine ratio correlated with serum sCD320 and reached a peak median level of 53 (30-101) pmol/mmol creatinine (week 35). sCD320 present in serum and urine showed the same elution pattern upon size exclusion chromatography. Conclusion: We report for the first time that sCD320 is present in urine and in a higher concentration than in serum and that serum and urine sCD320 increase during pregnancy. The high urinary concentration and the strong correlation between urinary and serum sCD320 suggests that sCD320 is filtered in the kidney.	[Abuyaman, Omar; Andreasen, Birgitte H.; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Kronborg, Camilla; Vittinghus, Erik] Randers Cty Hosp, Dept Clin Biochem, Randers, Denmark; [Kronborg, Camilla] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Abuyaman, O (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	o.abuyaman@gmail.com		Kronborg, Camilla/0000-0001-9783-4340; Nexo, Ebba/0000-0001-9406-9081; Abuyaman, Omar/0000-0002-7694-7941	Aarhus University Research Foundation [AUFF-F2012-FLS 3-37]; Lundbeck foundation	Aarhus University Research Foundation; Lundbeck foundation(Lundbeckfonden)	This work was supported by Aarhus University Research Foundation (AUFF-F2012-FLS 3-37) (http://www.au.dk/en/research/) and the Lundbeck foundation (www.lundbeckfoundation.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1964, BIOCHEMISTRY-US, V3, P723, DOI 10.1021/bi00893a021; Arendt JFB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045979; Arendt JFB, 2012, CLIN CHEM LAB MED, V50, P515, DOI 10.1515/CCLM.2011.810; ARNHOLDT H, 1991, VIRCHOWS ARCH B, V60, P365, DOI 10.1007/BF02899568; Birn H, 2002, AM J PHYSIOL-RENAL, V282, pF408, DOI 10.1152/ajprenal.00206.2000; Birn H, 2006, AM J PHYSIOL-RENAL, V291, pF22, DOI 10.1152/ajprenal.00385.2005; FRIEDMAN PA, 1977, J CLIN INVEST, V59, P51, DOI 10.1172/JCI108621; Greibe E, 2011, CLIN CHEM LAB MED, V49, P1877, DOI 10.1515/CCLM.2011.682; Hoffmann-Lucke E, 2013, CLIN CHEM LAB MED, V51, P677, DOI 10.1515/cclm-2012-0554; HOM BL, 1969, BIOCHIM BIOPHYS ACTA, V175, P20, DOI 10.1016/0005-2795(69)90140-8; Koebnick C, 2002, CLIN CHEM, V48, P928; Morkbak AL, 2005, CLIN CHEM LAB MED, V43, P1058, DOI 10.1515/CCLM.2005.185; Nexo E, 2000, CLIN CHEM, V46, P1643; Nexo E, 2002, CLIN CHEM, V48, P561; NEXO E, 1980, BIOCHIM BIOPHYS ACTA, V628, P190, DOI 10.1016/0304-4165(80)90366-9; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Pepper MR, 2011, SEMIN CELL DEV BIOL, V22, P619, DOI 10.1016/j.semcdb.2011.05.005; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; QUADROS EV, 1986, J BIOL CHEM, V261, P5455; RIPPE B, 1994, PHYSIOL REV, V74, P163, DOI 10.1152/physrev.1994.74.1.163; SELIGMAN PA, 1978, J BIOL CHEM, V253, P1766; SHOJANIA AM, 1984, CLIN PERINATOL, V11, P433, DOI 10.1016/S0095-5108(18)30928-X; Tencer J, 1998, KIDNEY INT, V53, P709, DOI 10.1046/j.1523-1755.1998.00797.x; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; WINICK M, 1967, PEDIATRICS, V39, P248	25	13	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73110	10.1371/journal.pone.0073110	http://dx.doi.org/10.1371/journal.pone.0073110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015289	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200065
J	Perrone, R; Nadai, M; Poe, JA; Frasson, I; Palumbo, M; Palu, G; Smithgall, TE; Richter, SN				Perrone, Rosalba; Nadai, Matteo; Poe, Jerrod A.; Frasson, Ilaria; Palumbo, Manlio; Palu, Giorgio; Smithgall, Thomas E.; Richter, Sara N.			Formation of a Unique Cluster of G-Quadruplex Structures in the HIV-1 nef Coding Region: Implications for Antiviral Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TELOMERIC G-QUADRUPLEX; I-MOTIF STRUCTURES; CATIONIC PORPHYRINS; DNA QUADRUPLEX; CONSERVED CORE; MESSENGER-RNA; GENOME-WIDE; GENE; LOOP	G-quadruplexes are tetraplex structures of nucleic acids that can form in G-rich sequences. Their presence and functional role have been established in telomeres, oncogene promoters and coding regions of the human chromosome. In particular, they have been proposed to be directly involved in gene regulation at the level of transcription. Because the HIV-1 Nef protein is a fundamental factor for efficient viral replication, infectivity and pathogenesis in vitro and in vivo, we investigated G-quadruplex formation in the HIV-1 nef gene to assess the potential for viral inhibition through G-quadruplex stabilization. A comprehensive computational analysis of the nef coding region of available strains showed the presence of three conserved sequences that were uniquely clustered. Biophysical testing proved that G-quadruplex conformations were efficiently stabilized or induced by G-quadruplex ligands in all three sequences. Upon incubation with a G-quadruplex ligand, Nef expression was reduced in a reporter gene assay and Nef-dependent enhancement of HIV-1 infectivity was significantly repressed in an antiviral assay. These data constitute the first evidence of the possibility to regulate HIV-1 gene expression and infectivity through G-quadruplex targeting and therefore open a new avenue for viral treatment.	[Perrone, Rosalba; Nadai, Matteo; Frasson, Ilaria; Palu, Giorgio; Richter, Sara N.] Univ Padua, Dept Mol Med, Padua, Italy; [Poe, Jerrod A.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Palumbo, Manlio] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy	University of Padua; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Padua	Richter, SN (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	sara.richter@unipd.it	Richter, Sara/A-5578-2012; Frasson, Ilaria/M-1671-2019	Richter, Sara/0000-0002-5446-9029; Frasson, Ilaria/0000-0001-5135-5707; Palumbo, Manlio/0000-0002-3163-1564; Perrone, Rosalba/0000-0001-8894-4548	Bill & Melinda Gates Foundation through the Grand Challenges Explorations Initiative (GCE) [OPP1035881]; Italian Ministry of University and Research [FIRB-Ideas RBID082ATK_001]; University of Padua	Bill & Melinda Gates Foundation through the Grand Challenges Explorations Initiative (GCE); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); University of Padua	This work was supported by the Bill & Melinda Gates Foundation through the Grand Challenges Explorations Initiative (GCE grant #OPP1035881 to SNR), by the Italian Ministry of University and Research (FIRB-Ideas RBID082ATK_001 to SNR), and by the University of Padua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSinfo, 2011, HIV ITS TREATM FDA A; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Baral A, 2012, NUCLEIC ACIDS RES, V40, P3800, DOI 10.1093/nar/gkr1258; Basundra R, 2010, FEBS J, V277, P4254, DOI 10.1111/j.1742-4658.2010.07814.x; Beaume N, 2013, NUCLEIC ACIDS RES, V41, P76, DOI 10.1093/nar/gks1071; Belotserkovskii BP, 2010, P NATL ACAD SCI USA, V107, P12816, DOI 10.1073/pnas.1007580107; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bouaziz S, 1998, J MOL BIOL, V282, P637, DOI 10.1006/jmbi.1998.2031; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Campbell NH, 2008, J AM CHEM SOC, V130, P6722, DOI 10.1021/ja8016973; Cheng H, 1999, VIROLOGY, V264, P5, DOI 10.1006/viro.1999.9937; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; De Cian A, 2008, BIOCHIMIE, V90, P131, DOI 10.1016/j.biochi.2007.07.011; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Fedoroff OY, 1998, BIOCHEMISTRY-US, V37, P12367, DOI 10.1021/bi981330n; Folini M, 2011, EXPERT OPIN THER TAR, V15, P579, DOI 10.1517/14728222.2011.556621; Gallo RC, 2003, NEW ENGL J MED, V349, P2283, DOI 10.1056/NEJMp038194; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Harris M, 1999, CURR BIOL, V9, pR459, DOI 10.1016/S0960-9822(99)80282-6; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hu LY, 2009, J AM CHEM SOC, V131, P16824, DOI 10.1021/ja905611c; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Izbicka E, 1999, CANCER RES, V59, P639; Jang MY, 2005, J VIROL, V79, P3544, DOI 10.1128/JVI.79.6.3544-3556.2005; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kettani A, 1997, NAT STRUCT BIOL, V4, P382, DOI 10.1038/nsb0597-382; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Kuiken C, 2008, HIV SEQUENCE COMPEND; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lim KW, 2009, NUCLEIC ACIDS RES, V37, P6239, DOI 10.1093/nar/gkp630; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Lyonnais S, 2003, NUCLEIC ACIDS RES, V31, P5754, DOI 10.1093/nar/gkg716; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Morris MJ, 2012, NUCLEIC ACIDS RES, V40, P4137, DOI 10.1093/nar/gkr1308; Mullen MA, 2012, J AM CHEM SOC, V134, P812, DOI 10.1021/ja2096255; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Narute PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032561; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Ou TM, 2008, CHEMMEDCHEM, V3, P690, DOI 10.1002/cmdc.200700300; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Raiber EA, 2012, NUCLEIC ACIDS RES, V40, P1499, DOI 10.1093/nar/gkr882; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Richter SN, 2009, CURR MED CHEM, V16, P267, DOI 10.2174/092986709787002646; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; Vermeire J, 2011, CURR HIV RES, V9, P474, DOI 10.2174/157016211798842099; Vorlickova M, 2012, METHODS; Weitzmann MN, 1997, J BIOL CHEM, V272, P9517; Wieland M, 2009, NAT PROTOC, V4, P1632, DOI 10.1038/nprot.2009.111; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485; Zhang AYQ, 2011, BIOCHEMISTRY-US, V50, P7251, DOI 10.1021/bi200805j	73	83	85	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73121	10.1371/journal.pone.0073121	http://dx.doi.org/10.1371/journal.pone.0073121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015290	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000323815200066
J	Miyake, A; Kou, I; Takahashi, Y; Johnson, TA; Ogura, Y; Dai, J; Qiu, XS; Takahashi, A; Jiang, H; Yan, H; Kono, K; Kawakami, N; Uno, K; Ito, M; Minami, S; Yanagida, H; Taneichi, H; Hosono, N; Tsuji, T; Suzuki, T; Sudo, H; Kotani, T; Yonezawa, I; Kubo, M; Tsunoda, T; Watanabe, K; Chiba, K; Toyama, Y; Qiu, Y; Matsumoto, M; Ikegawa, S				Miyake, Atsushi; Kou, Ikuyo; Takahashi, Yohei; Johnson, Todd A.; Ogura, Yoji; Dai, Jin; Qiu, Xusheng; Takahashi, Atsushi; Jiang, Hua; Yan, Huang; Kono, Katsuki; Kawakami, Noriaki; Uno, Koki; Ito, Manabu; Minami, Shohei; Yanagida, Haruhisa; Taneichi, Hiroshi; Hosono, Naoya; Tsuji, Taichi; Suzuki, Teppei; Sudo, Hideki; Kotani, Toshiaki; Yonezawa, Ikuho; Kubo, Michiaki; Tsunoda, Tatsuhiko; Watanabe, Kota; Chiba, Kazuhiro; Toyama, Yoshiaki; Qiu, Yong; Matsumoto, Morio; Ikegawa, Shiro			Identification of a Susceptibility Locus for Severe Adolescent Idiopathic Scoliosis on Chromosome 17q24.3	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROSTATE-CANCER RISK; GENE POLYMORPHISMS; CANDIDATE REGIONS; VARIANTS; GROWTH; POPULATION; ASSIGNMENT; DYSPLASIA; DELETION	Adolescent idiopathic scoliosis (AIS) is the most common spinal deformity, affecting around 2% of adolescents worldwide. Genetic factors play an important role in its etiology. Using a genome-wide association study (GWAS), we recently identified novel AIS susceptibility loci on chromosomes 10q24.31 and 6q24.1. To identify more AIS susceptibility loci relating to its severity and progression, we performed GWAS by limiting the case subjects to those with severe AIS. Through a two-stage association study using a total of similar to 12,000 Japanese subjects, we identified a common variant, rs12946942 that showed a significant association with severe AIS in the recessive model (P = 4.00x10(-8), odds ratio [OR] = 2.05). Its association was replicated in a Chinese population (combined P = 6.43x10(-12), OR = 2.21). rs12946942 is on chromosome 17q24.3 near the genes SOX9 and KCNJ2, which when mutated cause scoliosis phenotypes. Our findings will offer new insight into the etiology and progression of AIS.	[Miyake, Atsushi; Kou, Ikuyo; Takahashi, Yohei; Ogura, Yoji; Ikegawa, Shiro] RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo, Japan; [Miyake, Atsushi; Takahashi, Yohei; Ogura, Yoji; Watanabe, Kota; Toyama, Yoshiaki; Matsumoto, Morio] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Johnson, Todd A.; Tsunoda, Tatsuhiko] RIKEN Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Dai, Jin] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Orthopaed,Ctr Diag & Treatment Joint Dis, Nanjing 210008, Jiangsu, Peoples R China; [Qiu, Xusheng; Jiang, Hua; Yan, Huang; Qiu, Yong] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Spine Surg, Nanjing 210008, Jiangsu, Peoples R China; [Takahashi, Atsushi] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Tokyo, Japan; [Kono, Katsuki] Saiseikai Cent Hosp, Scoliosis Ctr, Tokyo, Japan; [Kawakami, Noriaki; Tsuji, Taichi] Meijo Hosp, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Uno, Koki; Suzuki, Teppei] Kobe Med Ctr, Natl Hosp Org, Dept Orthopaed Surg, Kobe, Hyogo, Japan; [Ito, Manabu; Sudo, Hideki] Hokkaido Univ, Dept Adv Med Spine & Spinal Cord Disorders, Grad Sch Med, Sapporo, Hokkaido, Japan; [Minami, Shohei; Kotani, Toshiaki] Seirei Sakura Citizen Hosp, Dept Orthopaed Surg, Sakura, Japan; [Yanagida, Haruhisa] Fukuoka Childrens Hosp, Dept Orthopaed Surg, Fukuoka, Japan; [Taneichi, Hiroshi] Dokkyo Med Univ, Sch Med, Dept Orthopaed Surg, Mibu, Tochigi, Japan; [Hosono, Naoya; Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Yonezawa, Ikuho] Juntendo Univ, Sch Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Chiba, Kazuhiro] Kitasato Univ, Kitasato Inst Hosp, Dept Orthopaed Surg, Tokyo, Japan	RIKEN; Keio University; RIKEN; Nanjing University; Nanjing University; RIKEN; Tokyo Saiseikai Central Hospital; Kobe City Medical Center General Hospital; Hokkaido University; Dokkyo Medical University; RIKEN; Juntendo University; Kitasato University	Matsumoto, M (corresponding author), Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.	morio@a5.keio.jp; sikegawa@ims.u-tokyo.ac.jp	Sudo, Hideki/G-2748-2012; Ikegawa, Shiro/N-6895-2015; Dai, Jin/GVT-2414-2022; Johnson, Todd Andrew/ABG-4704-2021; Toyama, Yoshiaki/K-5743-2013; Ogura, Yoji/V-2740-2019; Kubo, Michiaki/N-7947-2015; Matsumoto, Morio M/L-6227-2013; Tsunoda, Tatsuhiko/K-2061-2014	Ikegawa, Shiro/0000-0003-0316-2147; Dai, Jin/0000-0003-3063-746X; Johnson, Todd Andrew/0000-0003-3377-6692; Tsunoda, Tatsuhiko/0000-0002-5439-7918	BioBank Japan	BioBank Japan	We thank the individuals who participated in this study. A part of the study is supported by BioBank Japan.	Alden KJ, 2006, SPINE, V31, P1815, DOI 10.1097/01.brs.0000227264.23603.dc; Andersen MO, 2007, SPINE, V32, P927, DOI 10.1097/01.brs.0000259865.08984.00; Blyth M, 2008, EUR J MED GENET, V51, P672, DOI 10.1016/j.ejmg.2008.09.002; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cha PC, 2011, NAT GENET, V43, P447, DOI 10.1038/ng.805; Chan V, 2002, AM J HUM GENET, V71, P401, DOI 10.1086/341607; Chen ZJ, 2009, EUR J HUM GENET, V17, P525, DOI 10.1038/ejhg.2008.203; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Gao XC, 2007, AM J HUM GENET, V80, P957, DOI 10.1086/513571; Gordon CT, 2009, J MED GENET, V46, P649, DOI 10.1136/jmg.2009.068361; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gurnett CA, 2009, SPINE, V34, pE94, DOI 10.1097/BRS.0b013e31818b88a5; Justice CM, 2003, SPINE, V28, P589, DOI 10.1097/00007632-200303150-00014; Kesling KL, 1997, SPINE, V22, P2009, DOI 10.1097/00007632-199709010-00014; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Lekovic GP, 2006, CHILD NERV SYST, V22, P1212, DOI 10.1007/s00381-006-0071-1; Lestner JM, 2012, EUR J MED GENET, V55, P700, DOI 10.1016/j.ejmg.2012.08.003; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Miller NH, 2005, SPINE, V30, P1181, DOI 10.1097/01.brs.0000162282.46160.0a; Ocaka L, 2008, J MED GENET, V45, P87, DOI 10.1136/jmg.2007.051896; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OHTSUKA Y, 1988, SPINE, V13, P1251, DOI 10.1097/00007632-198811000-00008; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Qiu XS, 2007, SPINE, V32, P1748, DOI 10.1097/BRS.0b013e3180b9f0ff; Salehi LB, 2002, HUM GENET, V111, P401, DOI 10.1007/s00439-002-0785-4; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Tristani-Firouzi M, 2010, PFLUG ARCH EUR J PHY, V460, P289, DOI 10.1007/s00424-010-0820-6; Wang H, 2008, SPINE, V33, P2199, DOI 10.1097/BRS.0b013e31817c03f9; Weinstein SL, 1999, SPINE, V24, P2592, DOI 10.1097/00007632-199912150-00006; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Wise CA, 2000, SPINE, V25, P2372, DOI 10.1097/00007632-200009150-00017; Wise CA, 2008, CURR GENOMICS, V9, P51, DOI 10.2174/138920208783884874; Wu J, 2006, SPINE, V31, P1131, DOI 10.1097/01.brs.0000216603.91330.6f; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; Yeung HY, 2006, STUD HEALTH TECHNOL, V123, P18; Zhang HQ, 2009, SPINE, V34, P760, DOI 10.1097/BRS.0b013e31818ad5ac; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111	41	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72802	10.1371/journal.pone.0072802	http://dx.doi.org/10.1371/journal.pone.0072802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023777	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600047
J	Ross, EM; Moate, PJ; Marett, LC; Cocks, BG; Hayes, BJ				Ross, Elizabeth M.; Moate, Peter J.; Marett, Leah C.; Cocks, Ben G.; Hayes, Ben J.			Metagenomic Predictions: From Microbiome to Complex Health and Environmental Phenotypes in Humans and Cattle	PLOS ONE			English	Article							GENE-CENTRIC METAGENOMICS; GUT MICROBIOME; GENOMIC SELECTION; METHANE EMISSIONS; WIDE ASSOCIATION; SF6 TRACER; RUMEN	Mammals have a large cohort of endo-and ecto-symbiotic microorganisms (the microbiome) that potentially influence host phenotypes. There have been numerous exploratory studies of these symbiotic organisms in humans and other animals, often with the aim of relating the microbiome to a complex phenotype such as body mass index (BMI) or disease state. Here, we describe an efficient methodology for predicting complex traits from quantitative microbiome profiles. The method was demonstrated by predicting inflammatory bowel disease (IBD) status and BMI from human microbiome data, and enteric greenhouse gas production from dairy cattle rumen microbiome profiles. The method uses unassembled massively parallel sequencing (MPS) data to form metagenomic relationship matrices (analogous to genomic relationship matrices used in genomic predictions) to predict IBD, BMI and methane production phenotypes with useful accuracies (r = 0.423, 0.422 and 0.466 respectively). Our results show that microbiome profiles derived from MPS can be used to predict complex phenotypes of the host. Although the number of biological replicates used here limits the accuracy that can be achieved, preliminary results suggest this approach may surpass current prediction accuracies that are based on the host genome. This is especially likely for traits that are largely influenced by the gut microbiota, for example digestive tract disorders or metabolic functions such as enteric methane production in cattle.	[Ross, Elizabeth M.; Cocks, Ben G.; Hayes, Ben J.] Dept Environm & Primary Ind, Biosci Res Div, Bundoora, Vic, Australia; [Ross, Elizabeth M.; Cocks, Ben G.; Hayes, Ben J.] Dairy Futures Cooperat Res Ctr, Bundoora, Vic, Australia; [Ross, Elizabeth M.; Cocks, Ben G.; Hayes, Ben J.] La Trobe Univ, Bundoora, Vic, Australia; [Moate, Peter J.; Marett, Leah C.] Dept Environm & Primary Ind, Future Farming Syst Div, Ellinbank, Vic, Australia	La Trobe University	Ross, EM (corresponding author), Dept Environm & Primary Ind, Biosci Res Div, Bundoora, Vic, Australia.	elizabeth.ross@depi.vic.gov.au	Hayes, Ben J/L-3308-2016; Moate, Peter/AAE-1555-2019; Ross, Elizabeth/AAQ-9079-2021; Marett, Leah/AAB-1663-2019	Hayes, Ben J/0000-0002-5606-3970; Ross, Elizabeth/0000-0002-7521-3671; Marett, Leah/0000-0001-9698-8401; Moate, Peter/0000-0003-4598-2047	Department of Environment and Primary Industries Victoria; Dairy Australia; Australian Government Department of Agriculture, Fisheries and Forestry; Meat and Livestock Australia	Department of Environment and Primary Industries Victoria; Dairy Australia(Dairy Australia); Australian Government Department of Agriculture, Fisheries and Forestry; Meat and Livestock Australia(Meat and Livestock Australia)	The authors thank the Dairy Futures Co-operative Research Centre and the Geoffrey Gardiner Dairy Foundation for funding this work. The authors are also very grateful to the Department of Environment and Primary Industries Victoria, Dairy Australia, Australian Government Department of Agriculture, Fisheries and Forestry and Meat and Livestock Australia for funding the phenotyping of the B. taurus samples for methane production under its Australia's Farming Future Climate Change Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051521; Barry KA, 2012, J PROTEOME RES, V11, P5924, DOI 10.1021/pr3006809; BELONSKY GM, 1988, J ANIM SCI, V66, P1124; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brito FV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-80; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Daetwyler H. D., 2012, GENET SEL EVOL, V44, P1; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Durso LM, 2011, J MICROBIOL METH, V84, P278, DOI 10.1016/j.mimet.2010.12.008; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Gilmour A., 2006, ASREML USER GUIDE RE; Grainger C, 2007, J DAIRY SCI, V90, P2755, DOI 10.3168/jds.2006-697; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Henderson C. R, 1984, APPL LINEAR MODELS A; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hildebrand F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-514; Hirschhorn JN, 2011, ANNU REV MED, V62, P11, DOI 10.1146/annurev.med.091708.162036; JOHNSON K, 1994, ENVIRON SCI TECHNOL, V28, P359, DOI 10.1021/es00051a025; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Lavery T, 2012, HIGH NUTR TRANSPORT; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Meuwissen THE, 2001, GENETICS, V157, P1819; Moate P. J., 2012, Australasian Dairy Science Symposium 2012. Proceedings of the 5th Australasian Dairy Science Symposium, Melbourne, Australia, 13-15 November 2012, P454; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Pryce J. E., 2012, Australasian Dairy Science Symposium 2012. Proceedings of the 5th Australasian Dairy Science Symposium, Melbourne, Australia, 13-15 November 2012, P45; Pryce JE, 2012, J DAIRY SCI, V95, P2108, DOI 10.3168/jds.2011-4628; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roccarina D, 2010, AM J GASTROENTEROL, V105, P1250, DOI 10.1038/ajg.2009.744; Ross EM, 2013, J DAIRY SCI, V96, P6030, DOI 10.3168/jds.2013-6766; Ross EM, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-53; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh KM, 2012, MOL BIOL REP, V39, P4841, DOI 10.1007/s11033-011-1278-0; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056565; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	49	74	77	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73056	10.1371/journal.pone.0073056	http://dx.doi.org/10.1371/journal.pone.0073056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023808	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600063
J	Singh, PK				Singh, Prashant Kumar			Trends in Child Immunization across Geographical Regions in India: Focus on Urban-Rural and Gender Differentials	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; SEX-SELECTIVE ABORTIONS; SUB-SAHARAN AFRICA; VACCINATION COVERAGE; DEMOGRAPHIC SURVEILLANCE; NUTRITIONAL-STATUS; HEALTH-CARE; MORTALITY; EQUITY; INEQUALITIES	Background: Although child immunization is regarded as a highly cost-effective lifesaver, about fifty percent of the eligible children aged 12-23 months in India are without essential immunization coverage. Despite several programmatic initiatives, urban-rural and gender difference in child immunization pose an intimidating challenge to India's public health agenda. This study assesses the urban-rural and gender difference in child immunization coverage during 1992-2006 across six major geographical regions in India. Data and Methods: Three rounds of the National Family Health Survey (NFHS) conducted during 1992-93, 1998-99 and 2005-06 were analyzed. Bivariate analyses, urban-rural and gender inequality ratios, and the multivariate-pooled logistic regression model were applied to examine the trends and patterns of inequalities over time. Key Findings: The analysis of change over one and half decades (1992-2006) shows considerable variations in child immunization coverage across six geographical regions in India. Despite a decline in urban-rural and gender differences over time, children residing in rural areas and girls remained disadvantaged. Moreover, northeast, west and south regions, which had the lowest gender inequality in 1992 observed an increase in gender difference over time. Similarly, urban-rural inequality increased in the west region during 1992-2006. Conclusion: This study suggests periodic evaluation of the health care system is vital to assess the between and within group difference beyond average improvement. It is essential to integrate strong immunization systems with broad health systems and coordinate with other primary health care delivery programs to augment immunization coverage.	Int Inst Populat Sci, Mumbai, Maharashtra, India	International Institute for Population Sciences	Singh, PK (corresponding author), Int Inst Populat Sci, Mumbai, Maharashtra, India.	prashant_iips@yahoo.co.in		Singh, Prashant Kumar/0000-0003-1742-5534	Government of India/National Eligibility Test (UGC/NET); Ministry of Health and Family Welfare, Government of India	Government of India/National Eligibility Test (UGC/NET); Ministry of Health and Family Welfare, Government of India	No current external funding sources for this study. PKS is supported by the Government of India/National Eligibility Test (UGC/NET) Doctoral Fellowship Award from the Ministry of Health and Family Welfare, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; Arnold F, 2002, POPUL DEV REV, V28, P759, DOI 10.1111/j.1728-4457.2002.00759.x; Arokiasamy P, 2011, HEALTH POLICY PLANN, V26, P429, DOI 10.1093/heapol/czq075; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Banerjee AV, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2220; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Basu R. N., 1985, WORLD HEALTH FORUM, V6, P35; Bhat PM., 2002, ECON POLIT WEEKLY, V37, P5244; Bhutta ZA, 2012, JAMA-J AM MED ASSOC, V307, P2035, DOI 10.1001/jama.2012.4659; Borooah VK, 2004, SOC SCI MED, V58, P1719, DOI 10.1016/S0277-9536(03)00342-3; Commission on Social Determinants of Health, 2008, FIN REP COMM SOC DET; Corsi DJ, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S3; Desai S, 2008, DEMOGRAPHY, V45, P245; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Farahani M, 2010, HEALTH ECON, V19, P1361, DOI 10.1002/hec.1557; Fay M, 2005, WORLD DEV, V33, P1267, DOI 10.1016/j.worlddev.2005.03.001; Firestone R, 2011, SOC SCI MED, V72, P1420, DOI 10.1016/j.socscimed.2011.03.003; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Gage AL, 2006, POP STUD-J DEMOG, V60, P271, DOI 10.1080/00324720600895934; Ghosh R, 2012, WORLD J PEDIATR, V8, P11, DOI 10.1007/s12519-012-0331-y; Global Alliance for Vaccines and Immunization (GAVI), 2012, GLOB IMM NEWS; Goldstein Susan, 2011, Morbidity and Mortality Weekly Report, V60, P1520; Griffiths P, 2002, SOC SCI MED, V55, P775, DOI 10.1016/S0277-9536(01)00202-7; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hazarika I, 2012, ASIA-PAC J PUBLIC HE, V24, P450, DOI 10.1177/1010539511401373; International Institute for Population Sciences, 1995, NAT FAM HLTH SURV NF, P1992; International Institute for Population Sciences, ORC MACR 2000 NAT FA, P1998; International Institute for Population Sciences, 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences and Macro International, 2007, NAT FAM HLTH SURV NF, V1; James KS, 2011, SCIENCE, V333, P576, DOI 10.1126/science.1207969; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Kandel DB, 2004, AM J PUBLIC HEALTH, V94, P128, DOI 10.2105/AJPH.94.1.128; Kanitkar T., 1979, DEMOGRAPHIC SOCIOECO; Kravdal O, 2004, POP STUD-J DEMOG, V58, P177, DOI 10.1080/0032472042000213721; Kumar C, 2013, J PUBLIC HEALTH-UK, V35, P598, DOI 10.1093/pubmed/fds108; Kumar C, 2013, J COMMUN HEALTH, V38, P120, DOI 10.1007/s10900-012-9590-8; Kumar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037515; Luman ET, 2009, VACCINE, V27, P2534, DOI 10.1016/j.vaccine.2008.10.002; Madhavi Y, 2005, PLOS MED, V2, P387, DOI 10.1371/journal.pmed.0020127; Makepeace G, 2006, 2390 I STUD LAB; Malhotra C, 2013, HEALTH POLICY PLANN, V28, P197, DOI 10.1093/heapol/czs051; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; Mulholland EK, 2012, NEW ENGL J MED, V366, P1755, DOI 10.1056/NEJMp1202396; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; Ndirangu J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-372; Ngom P, 2001, HEALTH POLICY PLANN, V16, P337, DOI 10.1093/heapol/16.4.337; Oster E, 2009, J DEV ECON, V89, P62, DOI 10.1016/j.jdeveco.2008.07.003; Pande RP, 2003, SOC SCI MED, V57, P2075, DOI 10.1016/S0277-9536(03)00085-6; Patel AR, 2010, VACCINE, V28, P604, DOI 10.1016/j.vaccine.2009.10.108; Phukan RK, 2009, J TROP PEDIATRICS, V55, P249, DOI 10.1093/tropej/fmn025; Planning Commission, 2011, HIGH LEV EXP GROUP R; Raj A, 2011, LANCET, V377, P618, DOI 10.1016/S0140-6736(10)62112-5; Reddy KS, 2012, NATL MED J INDIA, V25, P65; Registrar General of India and Census Commissioner, 2011, CENS IND 2011 PROV P; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; SHARMA V, 1991, HEALTH POLICY PLANN, V6, P287, DOI 10.1093/heapol/6.3.287; Siddiqi A, 2007, REGION SPHERE INFLUE; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035045; Singh L, 2012, J BIOSOC SCI, V44, P1, DOI 10.1017/S0021932011000472; Speybroeck N, 2012, INT J PUBLIC HEALTH, V57, P855, DOI 10.1007/s00038-012-0386-5; Starfield B, 2007, SOC SCI MED, V64, P1355, DOI 10.1016/j.socscimed.2006.11.027; Statacorp, 2007, STAT STAT SOFTW REL; Subramanian SV, 2011, LANCET, V377, P1893, DOI 10.1016/S0140-6736(11)60709-5; Subramanian SV, 2009, J EPIDEMIOL COMMUN H, V63, P245, DOI 10.1136/jech.2008.078477; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; UNICEF, 2012, COUNTD 2015 MAT NEWB; United Nations Children's Fund, 2010, LEV TRENDS CHILD MOR; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; WAGSTAFF A, 2002, 2795 WORLD BANK; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; World Economic Forum, 2011, GLOB GEND GAP REP 20; World Health Organization, 2012, MILL DEV GOALS IMM C; World Health Organization, 2012, RIO POL DECL SOC DET; World Health Organization, 2012, 65 WORLD HLTH ASS DR; World Health Organization United Nations Children's Fund, 2010, COUNT DOWN 2015 DEC; World Health Organization & United Nations Children's Fund, 2005, GLOB IMM VIS STRAT 2	79	64	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73102	10.1371/journal.pone.0073102	http://dx.doi.org/10.1371/journal.pone.0073102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023816	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600069
J	Tran, TDC; Bernard, C; Ammar, M; Chaouch, S; Comte, K				Thi Du Chi Tran; Bernard, Cecile; Ammar, Myriam; Chaouch, Soraya; Comte, Katia			Heat Shock Transcriptional Responses in an MC-Producing Cyanobacterium (Planktothrix agardhii) and Its MC-Deficient Mutant under High Light Conditions	PLOS ONE			English	Article							REAL-TIME PCR; GENE-EXPRESSION; STRESS-RESPONSE; MICROCYSTIN BIOSYNTHESIS; MOLECULAR CHAPERONES; RELATIVE EXPRESSION; SALT STRESS; PROTEINS; HTPG; ANABAENA	Microcystins (MCs) are the most commonly-reported hepatotoxins produced by various cyanobacterial taxa in fresh waters to constitute a potential threat to human and animal health. The biological role of MCs in the producer organisms is not known, and it would be very useful to understand the driving force behind the toxin production. Recent studies have suggested that MCs may have a protective function in cells facing environmental stress. Following this starting premise, we speculate that under adverse conditions the expression of stress-related genes coding for Heat Shock Proteins (Hsp) might be different in an MC-producing strain and its MC-deficient mutant. We therefore used RT-qPCR to compare the expression of 13 hsp genes of an MC-producing strain of Planktothrix agardhii (CYA126/8) and its MC-deficient DmcyD mutant over different periods of exposure to high light stress (HL). Three reference genes (RGs) were selected from six candidates to normalize the RT-qPCR data. Of these three RGs (rsh, rpoD, and gltA), gltA is used here for the first time as an RG in prokaryotes. Under HL stress, five genes were found to be strongly up-regulated in both strains (htpG, dnaK, hspA, groES, and groEL). Unexpectedly, we found that the MC-producing wild type strain accumulated higher levels of htpG and dnaK transcripts in response to HL stress than the MC-deficient mutant. In addition, a significant increase in the mcyE transcript was detected in the mutant, suggesting that MCs are required under HL conditions. We discuss several possible roles of MCs in the response to HL stress through their possible involvement in the protective mechanisms of the cells.	[Thi Du Chi Tran; Bernard, Cecile; Ammar, Myriam; Chaouch, Soraya; Comte, Katia] Museum Natl Hist Nat, UMR Mol Commun & Adaptat Microorganismes, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN)	Comte, K (corresponding author), Museum Natl Hist Nat, UMR Mol Commun & Adaptat Microorganismes, F-75231 Paris, France.	kcomte@mnhn.fr	Comte, Katia/H-4319-2019; Bernard, Cecile/AAE-4242-2022; COMTE, Katia/ABA-6294-2021	Bernard, Cecile/0000-0001-7032-3989; 	ATM ("Biodiversite et role des micro-organismes dans les ecosystemes actuels et passes") fellowship from the National Natural History Museum (MNHN); Yves Rocher foundation [660/09]	ATM ("Biodiversite et role des micro-organismes dans les ecosystemes actuels et passes") fellowship from the National Natural History Museum (MNHN); Yves Rocher foundation	TDCT was a PhD scholarship recipient of Vietnam. Financial support was provided through ATM ("Biodiversite et role des micro-organismes dans les ecosystemes actuels et passes") fellowship from the National Natural History Museum (MNHN) from 2010 to 2011 and an annual grant from Yves Rocher foundation (grant number 660/09). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexova R, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003749; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ayers D, 2007, BMC VET RES, V3, DOI 10-1186/1746-6148-3-7; Babica P, 2006, J PHYCOL, V42, P9, DOI 10.1111/j.1529-8817.2006.00176.x; Botteldoorn N, 2006, J MICROBIOL METH, V66, P125, DOI 10.1016/j.mimet.2005.11.003; Briand E, 2008, ENVIRON MICROBIOL, V10, P3337, DOI 10.1111/j.1462-2920.2008.01730.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaurasia AK, 2009, APPL ENVIRON MICROB, V75, P6008, DOI 10.1128/AEM.00838-09; CHITNIS PR, 1991, J BIOL CHEM, V266, P58; Christoffersen Kirsten, 1996, Phycologia, V35, P42, DOI 10.2216/i0031-8884-35-6S-42.1; Clark MS, 2009, MAR GENOM, V2, P11, DOI 10.1016/j.margen.2009.03.003; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; DEMOTT WR, 1991, LIMNOL OCEANOGR, V36, P1346, DOI 10.4319/lo.1991.36.7.1346; Dittmann E, 2005, TOXICOL APPL PHARM, V203, P192, DOI 10.1016/j.taap.2004.06.008; Dittmann E, 2001, MICROBIOL-SGM, V147, P3113, DOI 10.1099/00221287-147-11-3113; Dziallas C, 2011, PLOS ONE, P6; Fang F, 2003, CURR MICROBIOL, V47, P341, DOI 10.1007/s00284-002-4015-z; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fulda S, 2006, PROTEOMICS, V6, P2733, DOI 10.1002/pmic.200500538; Hesse K, 2001, CYANOTOXINS: OCCURRENCE CAUSES CONSEQUENCES, P104; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hossain MM, 2002, CURR MICROBIOL, V44, P291, DOI 10.1007/s00284-001-0005-9; Huang LX, 2002, J BACTERIOL, V184, P6845, DOI 10.1128/JB.184.24.6845-6858.2002; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Iwama GK, 2004, J EXP BIOL, V207, P15, DOI 10.1242/jeb.00707; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; Katano Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1592, DOI 10.1271/bbb.50631; Kruger T, 2009, TOXICON, V54, P302, DOI 10.1016/j.toxicon.2009.04.020; Kurmayer R, 2002, MICROB ECOL, V43, P107, DOI 10.1007/s00248-001-0039-3; Lee BH, 1997, PLANT MOL BIOL, V35, P763, DOI 10.1023/A:1005867420619; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Mary I, 2004, MICROBIOL-SGM, V150, P1271, DOI 10.1099/mic.0.27014-0; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Pearson LA, 2004, APPL ENVIRON MICROB, V70, P6370, DOI 10.1128/AEM.70.11.6370-6378.2004; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rantala A, 2006, APPL ENVIRON MICROB, V72, P6101, DOI 10.1128/AEM.01058-06; Rapala J, 1997, APPL ENVIRON MICROB, V63, P2206, DOI 10.1128/AEM.63.6.2206-2212.1997; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Ritz M, 2009, J MICROBIOL METH, V76, P196, DOI 10.1016/j.mimet.2008.10.014; Sato T, 2010, MOL MICROBIOL, V76, P576, DOI 10.1111/j.1365-2958.2010.07139.x; Schatz D, 2007, ENVIRON MICROBIOL, V9, P965, DOI 10.1111/j.1462-2920.2006.01218.x; Sedmak B, 1998, J PLANKTON RES, V20, P691, DOI 10.1093/plankt/20.4.691; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; Vaitomaa J, 2003, APPL ENVIRON MICROB, V69, P7289, DOI 10.1128/AEM.69.12.7289-7297.2003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wase N.V., 2013, STRESS BIOL CYANOBAC; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V352, P36, DOI 10.1016/j.bbrc.2006.10.144; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhao WJ, 2011, J IND MICROBIOL BIOT, V38, P1279, DOI 10.1007/s10295-010-0906-3; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	62	6	6	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73198	10.1371/journal.pone.0073198	http://dx.doi.org/10.1371/journal.pone.0073198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023831	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600076
J	Helliwell, JF; Huang, HF				Helliwell, John F.; Huang, Haifang			Comparing the Happiness Effects of Real and On-Line Friends	PLOS ONE			English	Article								A recent large Canadian survey permits us to compare face-to-face ('real-life') and on-line social networks as sources of subjective well-being. The sample of 5,000 is drawn randomly from an on-line pool of respondents, a group well placed to have and value on-line friendships. We find three key results. First, the number of real-life friends is positively correlated with subjective well-being (SWB) even after controlling for income, demographic variables and personality differences. Doubling the number of friends in real life has an equivalent effect on well-being as a 50% increase in income. Second, the size of online networks is largely uncorrelated with subjective well-being. Third, we find that real-life friends are much more important for people who are single, divorced, separated or widowed than they are for people who are married or living with a partner. Findings from large international surveys (the European Social Surveys 2002-2008) are used to confirm the importance of real-life social networks to SWB; they also indicate a significantly smaller value of social networks to married or partnered couples.	[Helliwell, John F.] Univ British Columbia, Canadian Inst Adv Res, Vancouver, BC, Canada; [Helliwell, John F.] Univ British Columbia, Vancouver Sch Econ, Vancouver, BC V5Z 1M9, Canada; [Huang, Haifang] Univ Alberta, Dept Econ, Edmonton, AB T6G 2E1, Canada	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of British Columbia; University of Alberta	Helliwell, JF (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Vancouver, BC, Canada.	john.helliwell@ubc.ca			Social Interactions, Identity and Well-Being program of the Canadian Institute for Advanced Research	Social Interactions, Identity and Well-Being program of the Canadian Institute for Advanced Research	This research is supported by the Social Interactions, Identity and Well-Being program of the Canadian Institute for Advanced Research. The corresponding author is co-director of that program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert A, 2012, SCI REPORTS, V1, P493, DOI [10.4172/scientificreports.493, DOI 10.4172/SCIENTIFICREPORTS.493]; Balliet D, 2010, J CONFLICT RESOLUT, V54, P39, DOI 10.1177/0022002709352443; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Ellison N, 2006, J COMPUT-MEDIAT COMM, V11; Ferrer-i-Carbonell A, 2004, ECON J, V114, P641, DOI 10.1111/j.1468-0297.2004.00235.x; Gross EF, 2002, J SOC ISSUES, V58, P75, DOI 10.1111/1540-4560.00249; Helliwell J., 2013, WORLD HAPPINESS REPO; Helliwell J., 2011, INT J WELL BEING, V1, P42, DOI DOI 10.5502/IJW.V1I1.9; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Helliwell JF, 2009, IND LABOR RELATIONS, V63; Helliwell JohnF., 2010, INT DIFFERENCES WELL, P291, DOI [DOI 10.1093/ACPR0F:0S0/9780199732739.003.0010, DOI 10.1093/ACPROF:OSO/9780199732739.003.0010]; Kim J, 2011, CYBERPSYCH BEH SOC N, V14, P359, DOI 10.1089/cyber.2010.0374; Putnam RD., 2000, BOWLING ALONE COLLAP; TANAKA JS, 1984, J PERS SOC PSYCHOL, V46, P621, DOI 10.1037/0022-3514.46.3.621; van der Horst M, 2012, SOC INDIC RES, V107, P509, DOI 10.1007/s11205-011-9861-2	15	41	41	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72754	10.1371/journal.pone.0072754	http://dx.doi.org/10.1371/journal.pone.0072754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019875	Green Published, gold			2022-12-27	WOS:000324338200017
J	Mohan, A; Schillinger, WF; Gill, KS				Mohan, Amita; Schillinger, William F.; Gill, Kulvinder S.			Wheat Seedling Emergence from Deep Planting Depths and Its Relationship with Coleoptile Length	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; WINTER-WHEAT; GIBBERELLIC-ACID; STAND ESTABLISHMENT; LONGER COLEOPTILES; DWARFING GENE; CROP RESIDUES; SPRING WHEAT; EARLY GROWTH; GRAIN-YIELD	Successful stand establishment is prerequisite for optimum crop yields. In some low-precipitation zones, wheat (Triticum aestivum L.) is planted as deep as 200 mm below the soil surface to reach adequate soil moisture for germination. To better understand the relationship of coleoptile length and other seed characteristics with emergence from deep planting (EDP), we evaluated 662 wheat cultivars grown around the world since the beginning of the 20th century. Coleoptile length of collection entries ranged from 34 to 114 mm. A specialized field EDP test showed dramatic emergence differences among cultivars ranging from 0-66% by 21 days after planting (DAP). Less than 1% of entries had any seedlings emerged by 7 DAP and 43% on day 8. A wide range of EDP within each coleoptile length class suggests the involvement of genes other than those controlling coleoptile length. Emergence was correlated with coleoptile length, but some lines with short coleoptiles ranked among the top emergers. Coleoptiles longer than 90 mm showed no advantage for EDP and may even have a negative effect. Overall, coleoptile length accounted for only 28% of the variability in emergence among entries; much lower than the 60% or greater reported in previous studies. Seed weight had little correlation with EDP. Results show that EDP is largely controlled by yet poorly understood mechanisms other than coleoptile length.	[Mohan, Amita; Schillinger, William F.; Gill, Kulvinder S.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Washington State University	Gill, KS (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	ksgill@wsu.edu	Schillinger, William/P-4112-2019	Schillinger, William/0000-0001-9285-8159	Washington State University; Washington Grain Commission; National Science Foundation (NSF-BREAD) grant [0965533]	Washington State University; Washington Grain Commission; National Science Foundation (NSF-BREAD) grant(National Science Foundation (NSF))	This research was funded by Washington State University, the Washington Grain Commission, and the National Science Foundation (NSF-BREAD) grant # 0965533 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 503285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDAE PC, 1992, AUST J EXP AGR, V32, P377, DOI 10.1071/EA9920377; ALLAN R. E., 1962, CROP SCI, V2, P522, DOI 10.2135/cropsci1962.0011183X000200060025x; Botwright TL, 2001, EUPHYTICA, V119, P349, DOI 10.1023/A:1017527911084; BROOKING IR, 1981, J AGR SCI-CAMBRIDGE, V97, P373, DOI 10.1017/S0021859600040806; CECCARELLI S, 1980, CAN J PLANT SCI, V60, P221, DOI 10.4141/cjps80-030; CHASTAIN TG, 1995, CROP SCI, V35, P213, DOI 10.2135/cropsci1995.0011183X003500010040x; CORNISH PS, 1988, AUST J EXP AGR, V28, P521, DOI 10.1071/EA9880521; Ellis MH, 2004, FUNCT PLANT BIOL, V31, P583, DOI 10.1071/FP03207; Evans LT., 1993, CROP EVOLUTION ADAPT; Feather JT, 1968, CALIF AGR, P12; FICK GN, 1976, EUPHYTICA, V25, P679, DOI 10.1007/BF00041606; HOOGENDOORN J, 1990, J PLANT PHYSIOL, V136, P72, DOI 10.1016/S0176-1617(11)81618-4; JESSOP RS, 1983, PLANT SOIL, V74, P101, DOI 10.1007/BF02178745; Kaufmann M, 1968, CAN J PLANT SCI, V361, P357; KEYES G, 1990, PLANT PHYSIOL, V92, P242, DOI 10.1104/pp.92.1.242; LAFOND GP, 1986, CROP SCI, V26, P341, DOI 10.2135/cropsci1986.0011183X002600020027x; Landjeva S, 2011, CROP PASTURE SCI, V62, P1017, DOI 10.1071/CP11257; Liatukas Z, 2011, ACTA SOC BOT POL, V80, P197, DOI 10.5586/asbp.2011.018; MIAN AR, 1992, J PROD AGRIC, V5, P265, DOI 10.2134/jpa1992.0265; Miralles DJ, 1995, PLANT BREEDING, V114, P392, DOI 10.1111/j.1439-0523.1995.tb00818.x; Nebreda I. M., 1977, Cereal Research Communications, V5, P387; Nik M. M., 2011, Scientific Research and Essays, V6, P2019; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pereira MJ, 2002, CROP SCI, V42, P1483, DOI 10.2135/cropsci2002.1483; RADFORD BJ, 1993, AUST J AGR RES, V44, P677, DOI 10.1071/AR9930677; Rebetzke GJ, 2007, THEOR APPL GENET, V114, P1173, DOI 10.1007/s00122-007-0509-1; Rebetzke GJ, 2007, FIELD CROP RES, V100, P10, DOI 10.1016/j.fcr.2006.05.001; Rebetzke GJ, 2005, PLANT SOIL, V272, P87, DOI 10.1007/s11104-004-4040-8; Rebetzke GJ, 1999, AUST J AGR RES, V50, P291, DOI 10.1071/A98125; Rebetzke GJ, 2001, AUST J AGR RES, V52, P1221, DOI 10.1071/AR01042; Richards RA, 2002, AUST J AGR RES, V53, P41, DOI 10.1071/AR00147; Schillinger WF, 1998, AGRON J, V90, P582, DOI 10.2134/agronj1998.00021962009000050002x; Schillinger WF, 2008, AGRON J, V100, pS166, DOI 10.2134/agronj2007.0027c; Spielmeyer W, 2007, THEOR APPL GENET, V115, P59, DOI 10.1007/s00122-007-0540-2; SUNDERMAN DONALD W., 1964, AGRON J, V56, P23; TONKINSON CL, 1995, J EXP BOT, V46, P1085, DOI 10.1093/jxb/46.9.1085; Wang JK, 2009, THEOR APPL GENET, V119, P65, DOI 10.1007/s00122-009-1017-2; Yu JB, 2010, CROP SCI, V50, P43, DOI 10.2135/cropsci2009.02.0065	38	42	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73314	10.1371/journal.pone.0073314	http://dx.doi.org/10.1371/journal.pone.0073314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019916	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200058
J	Pla, P; Orvoen, S; Benstaali, C; Dodier, S; Gardier, AM; David, DJ; Humbert, S; Saudou, F				Pla, Patrick; Orvoen, Sophie; Benstaali, Caroline; Dodier, Sophie; Gardier, Alain M.; David, Denis J.; Humbert, Sandrine; Saudou, Frederic			Huntingtin Acts Non Cell-Autonomously on Hippocampal Neurogenesis and Controls Anxiety-Related Behaviors in Adult Mouse	PLOS ONE			English	Article							TRANSPORT; NEURONS; DISEASE; MODEL; INACTIVATION; INHIBITION; SURVIVAL; BRAIN	Huntington's disease (HD) is a fatal neurodegenerative disease, characterized by motor defects and psychiatric symptoms, including mood disorders such as anxiety and depression. HD is caused by an abnormal polyglutamine (polyQ) expansion in the huntingtin (HTT) protein. The development and analysis of various mouse models that express pathogenic polyQ-HTT revealed a link between mutant HTT and the development of anxio-depressive behaviors and various hippocampal neurogenesis defects. However, it is unclear whether such phenotype is linked to alteration of HTT wild-type function in adults. Here, we report the analysis of a new mouse model in which HTT is inducibly deleted from adult mature cortical and hippocampal neurons using the CreER(T2)/Lox system. These mice present defects in both the survival and the dendritic arborization of hippocampal newborn neurons. Our data suggest that these non-cell autonomous effects are linked to defects in both BDNF transport and release upon HTT silencing in hippocampal neurons, and in BDNF/TrkB signaling. The controlled deletion of HTT also had anxiogenic-like effects. Our results implicate endogenous wild-type HTT in adult hippocampal neurogenesis and in the control of mood disorders.	[Pla, Patrick; Benstaali, Caroline; Dodier, Sophie; Humbert, Sandrine; Saudou, Frederic] Inst Curie, F-91405 Orsay, France; [Pla, Patrick; Benstaali, Caroline; Dodier, Sophie; Humbert, Sandrine; Saudou, Frederic] CNRS UMR3306, Orsay, France; [Pla, Patrick; Benstaali, Caroline; Dodier, Sophie; Humbert, Sandrine; Saudou, Frederic] INSERM U1005, Orsay, France; [Pla, Patrick] Univ Paris Sud, Orsay, France; [Orvoen, Sophie; Gardier, Alain M.; David, Denis J.] Univ Paris Sud, EA3544, Fac Pharm, Chatenay Malabry, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Saudou, F (corresponding author), Inst Curie, F-91405 Orsay, France.	frederic.saudou@curie.fr	DAVID, Denis/K-1173-2014; SAUDOU, Frédéric/L-3454-2014; Humbert, Sandrine/S-2981-2016	DAVID, Denis/0000-0002-0506-6688; SAUDOU, Frédéric/0000-0001-6107-1046; Humbert, Sandrine/0000-0002-9501-2658; Pla, Patrick/0000-0002-5957-2340	Agence Nationale pour la Recherche [ANR-08-MNP-039]; Fondation pour la Recherche Medicale (FRM); CNRS; INSERM; Institut Curie	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie	This work was supported by grants from Agence Nationale pour la Recherche (ANR-08-MNP-039, FS), Fondation pour la Recherche Medicale (FRM, equipe labellisee) (FS), CNRS, INSERM and the Institut Curie (FS). SO was supported by the French Minister of Research. FS and SH are INSERM investigators; AMG, DJD. and PP are respectively professors and assistant professors at Universite Paris-Sud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben M'Barek K, 2013, J NEUROSCI, V33, P8608, DOI 10.1523/JNEUROSCI.5110-12.2013; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; del Toro D, 2006, J NEUROSCI, V26, P12748, DOI 10.1523/JNEUROSCI.3873-06.2006; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gil-Mohapel J, 2011, BRAIN RES, V1406, P84, DOI 10.1016/j.brainres.2011.06.040; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Julien CL, 2007, J NEUROL NEUROSUR PS, V78, P939, DOI 10.1136/jnnp.2006.103309; Kandasamy M, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/124256; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lehmann K, 2005, EUR J NEUROSCI, V21, P3205, DOI 10.1111/j.1460-9568.2005.04156.x; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Orvoen S, 2012, NEUROSCI LETT, V507, P127, DOI 10.1016/j.neulet.2011.11.063; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Pineda JR, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-33; Simpson JM, 2011, NEUROBIOL DIS, V41, P249, DOI 10.1016/j.nbd.2010.09.012; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029	27	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73902	10.1371/journal.pone.0073902	http://dx.doi.org/10.1371/journal.pone.0073902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019939	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200082
J	Yang, Q; Liu, YH; Huang, Y; Huang, DK; Li, YF; Wu, J; Duan, ML				Yang, Qing; Liu, Yehai; Huang, Yang; Huang, Dake; Li, Yifan; Wu, Jing; Duan, Maoli			Expression of COX-2, CD44v6 and CD147 and Relationship with Invasion and Lymph Node Metastasis in Hypopharyngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE INDUCER; CYCLOOXYGENASE-2 EXPRESSION; BREAST-CANCER; LUNG-CANCER; NECK-CANCER; HEAD; ASSOCIATION; ANGIOGENESIS; PROGNOSIS; SURVIVAL	To assess the expression of COX-2, CD44v6 and CD147 in hypopharyngeal squamous cell carcinomas and the three biomarkers correlation with tumor invasion and lymph node metastasis of Chinese people. 101 cases of surgically excised primary tumor were included in this study, and 40 tissues of epithelium adjacent to carcinoma were used as controls. We characterized the immunohistochemical expression of COX-2, CD44v6, and CD147 in 141 formalin-fixed, paraffin-embedded tissues, and measured the mean optical density (OD) of the positive area to identify the expression of the three bio-markers and relationship with tumor invasion and lymph node metastasis. Our study demonstrates that the expression of the COX-2 and CD147 were significantly increased in carcinoma tissues compared to the epithelium adjacent to carcinoma. We also observed that the expression of COX-2, CD44v6, and CD147 were significantly associated with T classification, lymph node metastasis and clinical stage. There was strong significant correlation among the three biomarkers as well. Additionally, we indicated that recurrence and >= P-50 level of COX-2 expression had an independent prognostic effect on prognosis. In conclusion, the three biomarkers play important roles in tumor invasion and lymph node metastases and might be valuable indicators of tumor metastasis in hypopharyngeal squamous cell carcinoma.	[Yang, Qing; Liu, Yehai; Huang, Yang; Li, Yifan; Wu, Jing; Duan, Maoli] Anhui Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Hefei, Anhui, Peoples R China; [Huang, Dake] Anhui Med Univ, Dept Microbiol & Parasitol, Hefei, Anhui, Peoples R China; [Duan, Maoli] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	Anhui Medical University; Anhui Medical University; Karolinska Institutet	Liu, YH (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Hefei, Anhui, Peoples R China.	yehailiu2003@yahoo.com.cn; Maoli.Duan@ki.se			key program of Educational department, Anhui province, China [KJ2012A162]; Karolinska Institutet, Stockholm, Sweden	key program of Educational department, Anhui province, China; Karolinska Institutet, Stockholm, Sweden	This research was supported by key program of Educational department, Anhui province (KJ2012A162), China and Karolinska Institutet, Stockholm, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrino F, 1998, EUR J CANCER, V34, P2154, DOI 10.1016/S0959-8049(98)00328-1; Dohadwala M, 2001, J BIOL CHEM, V276, P20809, DOI 10.1074/jbc.C100140200; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Erdem NF, 2007, J ORAL MAXIL SURG, V65, P1725, DOI 10.1016/j.joms.2006.11.034; Gallo O, 2002, HUM PATHOL, V33, P708, DOI 10.1053/hupa.2002.125376; Grandis Jennifer R, 2004, Cancer Res, V64, P8126, DOI 10.1158/0008-5472.CAN-04-2445; Guler G, 2002, ARCH OTOLARYNGOL, V128, P393; Hall SF, 2008, LARYNGOSCOPE, V118, P1362, DOI 10.1097/MLG.0b013e318173dc4a; Heider KH, 1996, CANCER IMMUNOL IMMUN, V43, P245, DOI 10.1007/s002620050329; Huang CF, 2012, HISTOPATHOLOGY, V60, P793, DOI 10.1111/j.1365-2559.2011.04130.x; Huang ZQ, 2009, J ORAL PATHOL MED, V38, P518, DOI 10.1111/j.1600-0714.2009.00775.x; KAUFMANN M, 1995, LANCET, V345, P615, DOI 10.1016/S0140-6736(95)90521-9; Kawano T, 2004, AURIS NASUS LARYNX, V31, P35, DOI 10.1016/j.anl.2003.09.005; Kunishi M, 1997, INT J ORAL MAX SURG, V26, P280, DOI 10.1016/S0901-5027(97)80869-7; Kyzas PA, 2005, MODERN PATHOL, V18, P153, DOI 10.1038/modpathol.3800244; Lee DW, 2002, ANTICANCER RES, V22, P2089; Li F, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-27; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Nozoe T, 2004, J CANCER RES CLIN, V130, P334, DOI 10.1007/s00432-004-0542-2; Okayama H, 2009, ONCOL REP, V22, P745, DOI 10.3892/or_00000496; PRESCOTT SM, 2000, BIOCHIM BIOPHYS ACTA, V1470, P69, DOI [10.1016/s0304-419x(00)00006-8), DOI 10.1016/S0304-419X(00)00006-8]; Quemener C, 2007, CANCER RES, V67, P9, DOI 10.1158/0008-5472.CAN-06-2448; Rodrigo JP, 2002, AM J CLIN PATHOL, V118, P67; Rosenthal EL, 2003, LARYNGOSCOPE, V113, P1406, DOI 10.1097/00005537-200308000-00027; Scheer M, 2010, ORAL MAXILLOFAC SURG, V14, P53, DOI 10.1007/s10006-009-0181-5; Sikorska Beata, 2002, Polish Journal of Pathology, V53, P17; Visscher DW, 2008, J NATL CANCER I, V100, P421, DOI 10.1093/jnci/djn036; Wu B, 2011, ACTA HISTOCHEM, V113, P131, DOI 10.1016/j.acthis.2009.09.004; Yu P, 2010, J CANCER RES CLIN, V136, P1283, DOI 10.1007/s00432-010-0779-x; Zucker S, 2001, AM J PATHOL, V158, P1921, DOI 10.1016/S0002-9440(10)64660-3	30	23	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e71048	10.1371/journal.pone.0071048	http://dx.doi.org/10.1371/journal.pone.0071048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019861	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200003
J	Ciregia, F; Giusti, L; Molinaro, A; Niccolai, F; Agretti, P; Rago, T; Di Coscio, G; Vitti, P; Basolo, F; Iacconi, P; Tonacchera, M; Lucacchini, A				Ciregia, Federica; Giusti, Laura; Molinaro, Angelo; Niccolai, Filippo; Agretti, Patrizia; Rago, Teresa; Di Coscio, Giancarlo; Vitti, Paolo; Basolo, Fulvio; Iacconi, Pietro; Tonacchera, Massimo; Lucacchini, Antonio			Presence in the Pre-Surgical Fine-Needle Aspiration of Potential Thyroid Biomarkers Previously Identified in the Post-Surgical One	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE-B; PROTEIN EXPRESSION; PROTEOMIC ANALYSIS; BREAST-CANCER; MOESIN; EZRIN; ANNEXIN-1; CARCINOMA; DIAGNOSIS; INVASION	Fine-needle aspiration biopsy (FNA) is usually applied to distinguish benign from malignant thyroid nodules. However, cytological analysis cannot always allow a proper diagnosis. We believe that the improvement of the diagnostic capability of pre-surgical FNA could avoid unnecessary thyroidectomy. In a previous study, we performed a proteome analysis to examine FNA collected after thyroidectomy. With the present study, we examined the applicability of these results on pre-surgical FNA. We collected pre-surgical FNA from 411 consecutive patients, and to obtain a correct comparison with our previous results, we processed only benign (n = 114), papillary classical variant (cPTC) (n = 34) and papillary tall cell variant (TcPTC) (n = 14) FNA. We evaluated levels of five proteins previously found up-regulated in thyroid cancer with respect to benign nodules. ELISA and western blot (WB) analysis were used to assay levels of L-lactate dehydrogenase B chain (LDHB), Ferritin heavy chain, Ferritin light chain, Annexin A1 (ANXA1), and Moesin in FNA. ELISA assays and WB analysis confirmed the increase of LDHB, Moesin, and ANXA1 in pre-surgical FNA of thyroid papillary cancer. Sensitivity and specificity of ANXA1 were respectively 87 and 94% for cPTC, 85 and 100% for TcPTC. In conclusion, a proteomic analysis of FNA from patients with thyroid nodules may help to distinguish benign versus malignant thyroid nodules. Moreover, ANXA1 appears to be an ideal candidate given the high sensitivity and specificity obtained from ROC curve analysis.	[Ciregia, Federica; Giusti, Laura; Lucacchini, Antonio] Univ Pisa, Dept Pharm, Pisa, Italy; [Molinaro, Angelo; Niccolai, Filippo; Agretti, Patrizia; Rago, Teresa; Vitti, Paolo; Tonacchera, Massimo] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Di Coscio, Giancarlo] Univ Pisa, Sect Cytopathol, Pisa, Italy; [Di Coscio, Giancarlo] Pisa Univ Hosp, Pisa, Italy; [Basolo, Fulvio; Iacconi, Pietro] Univ Pisa, Dept Surg Med Mol Pathol & Crit Area, Pisa, Italy	University of Pisa; University of Pisa; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa	Lucacchini, A (corresponding author), Univ Pisa, Dept Pharm, Pisa, Italy.	lucas@farm.unipi.it	Tonacchera, Massimo/K-8523-2016; Basolo, Fulvio/AAC-2727-2019; agretti, patrizia/AAC-5774-2022; Rago, Teresa/AAC-3130-2019; Ciregia, Federica/K-6612-2016	Basolo, Fulvio/0000-0003-1657-5020; Ciregia, Federica/0000-0002-5851-9249; Giusti, Laura/0000-0001-7366-1932; agretti, patrizia/0000-0002-3504-5204; Tonacchera, Massimo/0000-0001-5431-5823; Molinaro, Angelo/0000-0002-8539-4429; LUCACCHINI, ANTONIO/0000-0002-0917-4491	Regione Toscana- Progetto Salute [156]	Regione Toscana- Progetto Salute(Regione Toscana)	This research was supported by grant from the "Regione Toscana- Progetto Salute 2009" (grant number 156) to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Baloch ZW, 2008, DIAGN CYTOPATHOL, V36, P425, DOI 10.1002/dc.20830; Ban Y, 2012, J THROID RES, V2012, DOI 10.1155/2012/815079; Bartholow TL, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-12; Bhat PJ, 2011, CLIN EPIGENETICS, V2, P113, DOI 10.1007/s13148-011-0030-x; Brown LM, 2006, MOL CARCINOGEN, V45, P613, DOI 10.1002/mc.20193; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; DESHPANDE UR, 1993, THYROID, V3, P301, DOI 10.1089/thy.1993.3.301; Ferraz C, 2011, J CLIN ENDOCR METAB, V96, P2016, DOI 10.1210/jc.2010-2567; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Giusti L, 2012, MOL BIOSYST, V8, P1088, DOI 10.1039/c2mb05394b; Govekar RB, 2009, PROTEOM CLIN APPL, V3, P1451, DOI 10.1002/prca.200900023; Heiska L, 2011, ONCOGENE, V30, P4953, DOI 10.1038/onc.2011.207; Kang H, 2012, BIOCHEM BIOPH RES CO, V423, P188, DOI 10.1016/j.bbrc.2012.05.114; Kim Ki-Su, 2012, J Prev Med Public Health, V45, P196, DOI 10.3961/jpmph.2012.45.3.196; Kim KS, 2012, CLIN CANCER RES, V18, P3071, DOI 10.1158/1078-0432.CCR-11-2757; Kinoshita T, 2012, BIOCHEM BIOPH RES CO, V418, P378, DOI 10.1016/j.bbrc.2012.01.030; Kinoshita T, 2012, INT J ONCOL, V40, P185, DOI 10.3892/ijo.2011.1196; Krause K, 2012, INT J BIOCHEM CELL B, V44, P290, DOI 10.1016/j.biocel.2011.10.024; Meding S, 2012, J PROTEOME RES, V11, P1996, DOI 10.1021/pr200784p; Petrella A, 2006, CANCER BIOL THER, V5, P643, DOI 10.4161/cbt.5.6.2700; Petrella A, 2005, CELL DEATH DIFFER, V12, P1358, DOI 10.1038/sj.cdd.4401645; Schlecht NF, 2012, HEAD NECK PATHOL, V6, P232, DOI 10.1007/s12105-011-0328-1; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sipina LV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1148, DOI 10.1134/S0006297910090087; Sofiadis A, 2012, EUR J ENDOCRINOL, V166, P657, DOI 10.1530/EJE-11-0856; Tao Xiao-feng, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P761; Thongwatchara P, 2011, ONCOL REP, V26, P185, DOI 10.3892/or.2011.1266; Trojanowicz B, 2010, MOL CELL ENDOCRINOL, V325, P110, DOI 10.1016/j.mce.2010.05.022; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Wang CC, 2012, HISTOPATHOLOGY, V61, P78, DOI 10.1111/j.1365-2559.2012.04204.x; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wang Shu-Jun, 2010, Chin J Cancer, V29, P451; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Welker MJ, 2003, AM FAM PHYSICIAN, V67, P559; Xu YH, 2011, HELL J NUCL MED, V14, P228; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zong JW, 2012, CLIN TRANSL ONCOL, V14, P21, DOI 10.1007/s12094-012-0757-7	40	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72911	10.1371/journal.pone.0072911	http://dx.doi.org/10.1371/journal.pone.0072911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023790	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400033
J	Dai, JX; Buhusi, M; Demyanenko, GP; Brennaman, LH; Hruska, M; Dalva, MB; Maness, PF				Dai, Jinxia; Buhusi, Mona; Demyanenko, Galina P.; Brennaman, Leann H.; Hruska, Martin; Dalva, Matthew B.; Maness, Patricia F.			Neuron Glia-Related Cell Adhesion Molecule (NrCAM) Promotes Topographic Retinocollicular Mapping	PLOS ONE			English	Article							RETINAL AXONS; ASSOCIATION ANALYSIS; SUPERIOR COLLICULUS; CYTOPLASMIC DOMAIN; BRANCH EXTENSION; MAP DEVELOPMENT; EPHB RECEPTORS; OPTIC CHIASM; NR-CAM; L1	NrCAM (Neuron-glial related cell adhesion molecule), a member of the L1 family of cell adhesion molecules, reversibly binds ankyrin and regulates axon growth, but it has not been studied for a role in retinotopic mapping. During development of retino-collicular topography, NrCAM was expressed uniformly in retinal ganglion cells (RGCs) along both mediolateral and anteroposterior retinal axes, and was localized on RGC axons within the optic tract and superior colliculus (SC). Anterograde tracing of RGC axons in NrCAM null mutant mice at P10, when the map resembles its mature form, revealed laterally displaced ectopic termination zones (eTZs) of axons from the temporal retina, indicating defective mediolateral topography, which is governed by ephrinB/EphBs. Axon tracing at P2 revealed that interstitial branch orientation of ventral-temporal RGC axons in NrCAM null mice was compromised in the medial direction, likely accounting for displacement of eTZs. A similar retinocollicular targeting defect in EphB mutant mice suggested that NrCAM and EphB interact to regulate mediolateral retino-collicular targeting. We found that EphB2 tyrosine kinase but not an EphB2 kinase dead mutant, phosphorylated NrCAM at a conserved tyrosine residue in the FIGQY ankyrin binding motif, perturbing ankyrin recruitment in NrCAM transfected HEK293 cells. Furthermore, the phosphorylation of NrCAM at FIGQY in SC was decreased in EphB1/3 and EphB1/2/3 null mice compared to WT, while phospho-FIGQY of NrCAM in SC was increased in EphB2 constitutively active (F620D/F620D) mice. These results demonstrate that NrCAM contributes to mediolateral retinocollicular axon targeting by regulating RGC branch orientation through a likely mechanism in which ephrinB/EphB phosphorylates NrCAM to modulate linkage to the actin cytoskeleton.	[Dai, Jinxia; Buhusi, Mona; Demyanenko, Galina P.; Brennaman, Leann H.; Maness, Patricia F.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Hruska, Martin; Dalva, Matthew B.] Thomas Jefferson Univ, Jefferson Hosp Neurosci, Dept Neurosci, Philadelphia, PA 19107 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Jefferson University	Maness, PF (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	srclab@med.unc.edu	Ariel, Pablo/AGJ-4118-2022	Dalva, Matthew/0000-0002-7737-8787	National Institutes of Health NIH [R21MH098138]; National Science Foundation NSF [0923667]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH098138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022727] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health NIH R21MH098138 and National Science Foundation NSF 0923667 research grants to PFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Bonora E, 2005, EUR J HUM GENET, V13, P198, DOI 10.1038/sj.ejhg.5201315; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Buhusi M, 2008, J NEUROSCI, V28, P177, DOI 10.1523/JNEUROSCI.3573-07.2008; Buhusi M, 2009, J NEUROSCI, V29, P15630, DOI 10.1523/JNEUROSCI.2215-09.2009; Claudepierre T, 2008, DEV DYNAM, V237, P3394, DOI 10.1002/dvdy.21759; Dai JX, 2012, MOL CELL NEUROSCI, V50, P201, DOI 10.1016/j.mcn.2012.05.001; Davey F, 2005, J NEUROCHEM, V94, P1243, DOI 10.1111/j.1471-4159.2005.03271.x; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Demyanenko GP, 2011, J NEUROSCI, V31, P1545, DOI 10.1523/JNEUROSCI.4467-10.2011; Demyanenko GP, 2003, J NEUROSCI, V23, P530, DOI 10.1523/JNEUROSCI.23-02-00530.2003; Dirks P, 2006, EUR J NEUROSCI, V24, P25, DOI 10.1111/j.1460-9568.2006.04899.x; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Hutcheson Holli B, 2004, BMC Med Genet, V5, P12, DOI 10.1186/1471-2350-5-12; Ishiguro H, 2006, NEUROPSYCHOPHARMACOL, V31, P572, DOI 10.1038/sj.npp.1300855; Ishiguro H., 2012, ADDICT BIOL; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kim HJ, 2009, PSYCHIAT CLIN NEUROS, V63, P123, DOI 10.1111/j.1440-1819.2008.01893.x; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Marui T, 2009, INT J NEUROPSYCHOPH, V12, P1, DOI 10.1017/S1461145708009127; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; More MI, 2001, J CELL BIOL, V154, P187, DOI 10.1083/jcb.200104038; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; Petros TJ, 2009, J NEUROSCI, V29, P3463, DOI 10.1523/JNEUROSCI.5655-08.2009; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Plas DT, 2005, J COMP NEUROL, V491, P305, DOI 10.1002/cne.20694; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; Sakurai T, 2006, PSYCHIAT GENET, V16, P251, DOI 10.1097/01.ypg.0000242196.81891.c9; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; SIMON DK, 1992, DEV BRAIN RES, V69, P167, DOI 10.1016/0165-3806(92)90155-P; Thakar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1445; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; Triplett JW, 2011, P NATL ACAD SCI USA, V108, P19060, DOI 10.1073/pnas.1102834108; Williams SE, 2006, NEURON, V50, P535, DOI 10.1016/j.neuron.2006.03.037; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Zelina P, 2005, DEVELOPMENT, V132, P3609, DOI 10.1242/dev.01934; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73000	10.1371/journal.pone.0073000	http://dx.doi.org/10.1371/journal.pone.0073000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023801	Green Submitted, Green Published, gold			2022-12-27	WOS:000324238400038
J	Huang, YP; Chen, LS; Yen, MF; Fann, CY; Chiu, YH; Chen, HH; Pan, SL				Huang, Ya-Ping; Chen, Li-Sheng; Yen, Ming-Fang; Fann, Ching-Yuan; Chiu, Yueh-Hsia; Chen, Hsiu-Hsi; Pan, Shin-Liang			Parkinson's Disease Is Related to an Increased Risk of Ischemic Stroke-A Population-Based Propensity Score-Matched Follow-Up Study	PLOS ONE			English	Article							ORTHOSTATIC HYPOTENSION; OXIDATIVE STRESS; PREVALENCE; MORTALITY; SURVIVAL; ATHEROSCLEROSIS; HYPERTENSION; DISORDERS; SMOKING; COHORT	Objective: The risk of stroke in patients with Parkinson's disease (PD) remains controversial. The purpose of this population-based propensity score-matched longitudinal follow-up study was to determine whether there is an increased risk of ischemic stroke after PD. Methods: We used a logistic regression model that includes age, sex, pre-existing comorbidities and socioeconomic status as covariates to compute the propensity score. A total of 2204 patients with at least two ambulatory visits with the principal diagnosis of PD in 2001 was enrolled in the PD group. The non-PD group consisted of 2204, propensity score-matched subjects without PD. The ischemic stroke-free survival rates of the two groups were estimated using the Kaplan-Meier method. Stratified Cox proportional hazard regression with patients matched on propensity score was used to estimate the effect of PD on the occurrence of ischemic stroke. Results: During the three-year follow-up period, 328 subjects in the PD group and 156 subjects in the non-PD group developed ischemic stroke. The ischemic stroke-free survival rate of the PD group was significantly lower than that of the non-PD group (P < 0.0001). The hazard ratio (HR) of stroke for the PD group was 2.37 (95% confidence interval [CI], 1.92 to 2.93, P < 0.0001) compared to the non-PD group. Conclusions: This study shows a significantly increased risk of ischemic stroke in PD patients. Further studies are required to investigate the underlying mechanism.	[Huang, Ya-Ping] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Phys Med & Rehabil, Yunlin, Taiwan; [Chen, Li-Sheng; Yen, Ming-Fang] Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei, Taiwan; [Fann, Ching-Yuan] Kainan Univ, Dept Nutr & Hlth Sci, Tao Yuan, Taiwan; [Chiu, Yueh-Hsia] Chang Gung Univ, Dept & Grad Inst Hlth Care Management, Tao Yuan, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Ctr Biostat Consultat, Taipei 10764, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Grad Inst Epidemiol, Div Biostat, Coll Publ Hlth, Taipei 10764, Taiwan; [Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Pan, Shin-Liang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Nan Kai University Technology; Chang Gung University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	panslcb@gmail.com		Chen, Hsiu-Hsi/0000-0002-5799-6705	Department of Health (DOH), Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]	Department of Health (DOH), Executive Yuan, Republic of China	This work was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health (DOH), Executive Yuan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker C, 2010, PARKINSONISM RELAT D, V16, P31, DOI 10.1016/j.parkreldis.2009.06.005; BENSHLOMO Y, 1995, J NEUROL NEUROSUR PS, V58, P293, DOI 10.1136/jnnp.58.3.293; Cereda E, 2012, NEUROLOGY, V78, P1507, DOI 10.1212/WNL.0b013e3182553cc9; Cereda E, 2011, DIABETES CARE, V34, P2614, DOI 10.2337/dc11-1584; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; De Silva DA, 2009, J NEUROL SCI, V285, P118, DOI 10.1016/j.jns.2009.06.013; DOBKIN BH, 1989, NEUROLOGY, V39, P30, DOI 10.1212/WNL.39.1.30; Driver JA, 2008, NEUROLOGY, V70, P1423, DOI 10.1212/01.wnl.0000310414.85144.ee; Eigenbrodt ML, 2000, STROKE, V31, P2307, DOI 10.1161/01.STR.31.10.2307; Elbaz A, 2003, ARCH NEUROL-CHICAGO, V60, P91, DOI 10.1001/archneur.60.1.91; Elkind MSV, 2010, ARCH NEUROL-CHICAGO, V67, P33, DOI 10.1001/archneurol.2009.271; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Facecchia K, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/683728; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GORELL JM, 1994, NEUROLOGY, V44, P1865, DOI 10.1212/WNL.44.10.1865; Guttman M, 2001, NEUROLOGY, V57, P2278, DOI 10.1212/WNL.57.12.2278; Ha AD, 2011, PARKINSONISM RELAT D, V17, P625, DOI 10.1016/j.parkreldis.2011.05.020; Harrison D, 2003, AM J CARDIOL, V91, p7A; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Hoshi T, 2005, STROKE, V36, P768, DOI 10.1161/01.STR.0000158915.28329.51; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Korten A, 2001, MOVEMENT DISORD, V16, P119, DOI 10.1002/1531-8257(200101)16:1<119::AID-MDS1024>3.0.CO;2-W; LEVINE RL, 1992, STROKE, V23, P839, DOI 10.1161/01.STR.23.6.839; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Liu CY HY, 2006, J HLTH MANAGE, P1; Mastaglia FL, 2002, MOVEMENT DISORD, V17, P772, DOI 10.1002/mds.10199; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; Morgante L, 2000, ARCH NEUROL-CHICAGO, V57, P507, DOI 10.1001/archneur.57.4.507; Pan SL, 2011, NEUROLOGY, V77, P1605, DOI 10.1212/WNL.0b013e3182343354; Parsons LS., 2004, SAS SUGI, V29, P165; Qiu CX, 2011, HYPERTENSION, V57, P1094, DOI 10.1161/HYPERTENSIONAHA.111.171249; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schernhammer E, 2011, DIABETES CARE, V34, P1102, DOI 10.2337/dc10-1333; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Scigliano G, 2006, STROKE, V37, P1184, DOI 10.1161/01.STR.0000217384.03237.9c; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; STRUCK LK, 1990, STROKE, V21, P1395, DOI 10.1161/01.STR.21.10.1395; Sun Y, 2012, DIABETES CARE, V35, P1047, DOI 10.2337/dc11-1511; Velseboer DC, 2011, PARKINSONISM RELAT D, V17, P724, DOI 10.1016/j.parkreldis.2011.04.016; Wolf PA, 1988, JAMA-J AM MED ASSOC, V259, P1025; Wu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049343	44	49	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e68314	10.1371/journal.pone.0068314	http://dx.doi.org/10.1371/journal.pone.0068314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023710	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400001
J	Maranhao, AQ; Costa, MBW; Guedes, L; Moraes-Vieira, PM; Raiol, T; Brigido, MM				Maranhao, Andrea Queiroz; Walter Costa, Maria Beatriz; Guedes, Leonardo; Moraes-Vieira, Pedro Manoel; Raiol, Taina; Brigido, Marcelo Macedo			A Mouse Variable Gene Fragment Binds to DNA Independently of the BCR Context: A Possible Role for Immature B-Cell Repertoire Establishment	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; ANTIBODIES; SELECTION; AUTOANTIBODY; EXPRESSION; ALIGNMENT	B-cell maturation occurs in several steps and requires constant stimulus for its continuing development. From the emergence of the pre-B-cell receptor, signal transduction stimulates and supports B-cell development. Current viewpoints indicate that both positive selection pressure for autoantigens and tonic signaling constitutively stimulate B-cell maturation. In this work, we tested for the presence of a putative DNA binding site in a variable gene segment in a germline configuration, independently of VDJ recombination. After a survey of the public antibody databases, we chose a single mouse heavy variable gene segment that is highly represented in anti-nucleic acid antibodies and tested it for ssDNA binding. A phage display approach was used to search for intrinsic binding to oligo deoxythymidine. The results revealed that binding to an antigen can be influenced by the use of a specific DNA binding VH gene segment. Our data support the idea that some variable genes have intrinsic reactivity towards specific types of endogenous autoantigens, and this property may contribute to the establishment of the immature B-cell repertoire.	[Maranhao, Andrea Queiroz; Brigido, Marcelo Macedo] Univ Brasilia, Inst Biol, Lab Biol Mol, Brasilia, DF, Brazil; [Walter Costa, Maria Beatriz; Raiol, Taina; Brigido, Marcelo Macedo] Univ Brasilia, Inst Biol, Lab Bioinformat, Brasilia, DF, Brazil; [Guedes, Leonardo; Moraes-Vieira, Pedro Manoel] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Guedes, Leonardo; Moraes-Vieira, Pedro Manoel] Harvard Univ, Sch Med, Boston, MA USA	Universidade de Brasilia; Universidade de Brasilia; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Brigido, MM (corresponding author), Univ Brasilia, Inst Biol, Lab Biol Mol, Brasilia, DF, Brazil.	brigido@unb.br	Brigido, Marcelo/H-2718-2019; Brigido, Marcelo Macedo/A-1972-2015; Maranhão, Andrea/AAC-3560-2019; de Rezende Guedes, Leonardo Guerra/D-5331-2013; Maranhão, Andrea Queiroz/S-8696-2019; Moraes-Vieira, Pedro/C-8701-2014; Maranhão, Andrea Q/L-4474-2013	Brigido, Marcelo/0000-0002-7136-7059; Brigido, Marcelo Macedo/0000-0002-7136-7059; Maranhão, Andrea/0000-0002-1946-7191; de Rezende Guedes, Leonardo Guerra/0000-0002-7854-1558; Moraes-Vieira, Pedro/0000-0002-8263-786X; Maranhão, Andrea Q/0000-0002-1946-7191; Raiol, Taina/0000-0001-9948-5164	CNPq; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank CNPq and CAPES for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen PS, 2007, MOL IMMUNOL, V44, P412, DOI 10.1016/j.molimm.2006.02.021; BRIGIDO MM, 1991, J IMMUNOL, V146, P2005; Chang S, 2009, MOL IMMUNOL, V46, P3420, DOI 10.1016/j.molimm.2009.07.014; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edry E, 2004, J IMMUNOL, V173, P4265, DOI 10.4049/jimmunol.173.7.4265; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; Herzog S, 2012, CURR OPIN IMMUNOL, V24, P166, DOI 10.1016/j.coi.2012.02.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jang YJ, 2003, CELL MOL LIFE SCI, V60, P309, DOI 10.1007/s000180300026; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Keren Z, 2004, J BIOL CHEM, V279, P13418, DOI 10.1074/jbc.M311970200; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kuzmicheva GA, 2009, PROTEIN ENG DES SEL, V22, P9, DOI 10.1093/protein/gzn060; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Li J, 2001, J IMMUNOL, V167, P3746, DOI 10.4049/jimmunol.167.7.3746; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Maranhao AQ, 2000, BRAZ J MED BIOL RES, V33, P569, DOI 10.1590/S0100-879X2000000500012; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Neeli I, 2007, MOL IMMUNOL, V44, P1914, DOI 10.1016/j.molimm.2006.09.027; Pini A, 2000, CURR PROTEIN PEPT SC, V1, P155, DOI 10.2174/1389203003381397; Rader C, 2001, SELECTION ANTIBODY L; Reth M, 2000, IMMUNOL REV, V176, P10; Rowland SL, 2010, J EXP MED, V207, P607, DOI 10.1084/jem.20091673; Ryvkin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041469; Sambrook J., 2001, MOL CLONING LAB MANU, V2, P81, DOI DOI 10.1093/nar/gku1003; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P2262, DOI 10.1073/pnas.96.5.2262; Shlens J., 2007, NOTES KULLBACK LEIBL; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Togawa RC, 2003, 1 INT C BIOINF COMP; Tu J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-43; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72625	10.1371/journal.pone.0072625	http://dx.doi.org/10.1371/journal.pone.0072625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023756	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400018
J	Ren, XF; Graham, JC; Jing, LC; Mikheev, AM; Gao, Y; Lew, JP; Xie, H; Kim, AS; Shang, X; Friedman, C; Vail, G; Fang, MZ; Bromberg, Y; Zarbl, H				Ren, Xuefeng; Graham, Jessica C.; Jing, Lichen; Mikheev, Andrei M.; Gao, Yuan; Lew, Jenny Pan; Xie, Hong; Kim, Andrea S.; Shang, Xiuling; Friedman, Cynthia; Vail, Graham; Fang, Ming Zhu; Bromberg, Yana; Zarbl, Helmut			Mapping of Mcs30, a New Mammary Carcinoma Susceptibility Quantitative Trait Locus (QTL30) on Rat Chromosome 12: Identification of Fry as a Candidate Mcs Gene	PLOS ONE			English	Article							BREAST-CANCER SUSCEPTIBILITY; RADIATION HYBRID MAP; PHOSPHORYLATION SITES; NORWAY RAT; PCR ASSAY; PROTEIN; SEQUENCE; LINKAGE; GENOME; EXPRESSION	Rat strains differ dramatically in their susceptibility to mammary carcinogenesis. On the assumption that susceptibility genes are conserved across mammalian species and hence inform human carcinogenesis, numerous investigators have used genetic linkage studies in rats to identify genes responsible for differential susceptibility to carcinogenesis. Using a genetic backcross between the resistant Copenhagen (Cop) and susceptible Fischer 344 (F344) strains, we mapped a novel mammary carcinoma susceptibility (Mcs30) locus to the centromeric region on chromosome 12 (LOD score of similar to 8.6 at the D12Rat59 marker). The Mcs30 locus comprises approximately 12 Mbp on the long arm of rat RNO12 whose synteny is conserved on human chromosome 13q12 to 13q13. After analyzing numerous genes comprising this locus, we identified Fry, the rat ortholog of the furry gene of Drosophila melanogaster, as a candidate Mcs gene. We cloned and determined the complete nucleotide sequence of the 13 kbp Fry mRNA. Sequence analysis indicated that the Fry gene was highly conserved across evolution, with 90% similarity of the predicted amino acid sequence among eutherian mammals. Comparison of the Fry sequence in the Cop and F344 strains identified two non-synonymous single nucleotide polymorphisms (SNPs), one of which creates a putative, de novo phosphorylation site. Further analysis showed that the expression of the Fry gene is reduced in a majority of rat mammary tumors. Our results also suggested that FRY activity was reduced in human breast carcinoma cell lines as a result of reduced levels or mutation. This study is the first to identify the Fry gene as a candidate Mcs gene. Our data suggest that the SNPs within the Fry gene contribute to the genetic susceptibility of the F344 rat strain to mammary carcinogenesis. These results provide the foundation for analyzing the role of the human FRY gene in cancer susceptibility and progression.	[Ren, Xuefeng; Shang, Xiuling] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Ren, Xuefeng] Anim Ctr, Guangdong Med Lab, Foshan, Guangdong, Peoples R China; [Graham, Jessica C.; Vail, Graham; Zarbl, Helmut] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 07103 USA; [Graham, Jessica C.; Zarbl, Helmut] Rutgers State Univ, Joint Grad Program Toxicol, Piscataway, NJ 07102 USA; [Graham, Jessica C.; Zarbl, Helmut] Univ Med & Dent New Jersey, Piscataway, NJ 07103 USA; [Fang, Ming Zhu; Zarbl, Helmut] Univ Med & Dent New Jersey, NIEHS Ctr Environm Exposures & Dis, Piscataway, NJ 07103 USA; [Fang, Ming Zhu; Zarbl, Helmut] Rutgers State Univ, Piscataway, NJ 07102 USA; [Bromberg, Yana] Rutgers State Univ, Dept Biochem & Microbiol, Piscataway, NJ 07102 USA; [Zarbl, Helmut] Canc Inst New Jersey, New Brunswick, NJ USA; [Ren, Xuefeng; Jing, Lichen; Mikheev, Andrei M.; Gao, Yuan; Lew, Jenny Pan; Xie, Hong; Kim, Andrea S.; Friedman, Cynthia; Zarbl, Helmut] FHCRC, Seattle, WA USA; [Ren, Xuefeng; Zarbl, Helmut] Univ Washington, NIEHS Ctr Ecogenet & Environm Hlth, Seattle, WA 98195 USA; [Ren, Xuefeng; Zarbl, Helmut] Univ Washington, Dept Environm & Occupat Hlth, Seattle, WA 98195 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zarbl, H (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 07103 USA.	zarbl@eohsi.rutgers.edu	Bromberg, Yana/AAA-7801-2020	Bromberg, Yana/0000-0002-8351-0844; Graham, Jessica/0000-0002-3601-1743	Public Health Services; National Cancer Institute [NCI RO1CA77222]; NIEHS [NIEHS P30ES007033, P30ES005022]; NIEHS sponsored Toxicogenomics Research Consortium [NIEHS U19ES011387]; New Jersey Commission on Cancer Research [09-1962-CCR-EO]; University at Buffalo; Natural Science Foundation of China [81272904]; NATIONAL CANCER INSTITUTE [R01CA077222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, U19ES011387, P30ES005022] Funding Source: NIH RePORTER	Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS sponsored Toxicogenomics Research Consortium; New Jersey Commission on Cancer Research; University at Buffalo; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by a Public Health Services Grants from the National Cancer Institute, Grant #: NCI RO1CA77222, NIEHS sponsored Center Grant #'s: NIEHS P30ES007033 and P30ES005022, the NIEHS sponsored Toxicogenomics Research Consortium, Grant #: NIEHS U19ES011387 and a fellowship to Jessica Graham from the New Jersey Commission on Cancer Research, Award #: 09-1962-CCR-EO. XR is currently supported by startup fund provided by University at Buffalo, and Natural Science Foundation of China (81272904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bieche I, 1999, CANCER RES, V59, P2759; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Cong JL, 2001, DEVELOPMENT, V128, P2793; Dellas A, 2002, CLIN CANCER RES, V8, P1210; denDekker AD, 2012, CANCER RES, V72, P6002, DOI 10.1158/0008-5472.CAN-12-0748; ESSERS J, 1995, CYTOGENET CELL GENET, V69, P246, DOI 10.1159/000133974; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Fleming MA, 2003, P NATL ACAD SCI USA, V100, P1151, DOI 10.1073/pnas.0237285100; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GOULD MN, 1991, ENVIRON HEALTH PERSP, V93, P161, DOI 10.2307/3431184; GOULD MN, 1986, CANCER RES, V46, P1199; Haag JD, 1996, MOL CARCINOGEN, V17, P134, DOI 10.1002/(SICI)1098-2744(199611)17:3<134::AID-MC5>3.3.CO;2-N; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hermsen MAJA, 1998, J PATHOL, V186, P356; Kainu T, 2000, P NATL ACAD SCI USA, V97, P9603, DOI 10.1073/pnas.97.17.9603; Karlsson E, 2007, CANCER GENET CYTOGEN, V172, P139, DOI 10.1016/j.cancergencyto.2006.09.019; Lan H, 2001, GENETICS, V157, P331; Li JJ, 2002, MOL CARCINOGEN, V33, P56, DOI 10.1002/mc.10022; Luthra R, 1998, AM J PATHOL, V153, P63, DOI 10.1016/S0002-9440(10)65546-0; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Nagaraja GM, 2004, BIOCHEM BIOPH RES CO, V313, P654, DOI 10.1016/j.bbrc.2003.12.001; Pravenec M, 1997, MAMM GENOME, V8, P387, DOI 10.1007/s003359900452; Quan XJ, 2006, MAMM GENOME, V17, P310, DOI 10.1007/s00335-005-0125-9; Radivojac P, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn267; Sanders J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019891; SASAKI M, 1979, CYTOGENET CELL GENET, V23, P231, DOI 10.1159/000131333; Shepel L A, 1999, Prog Exp Tumor Res, V35, P158; Shepel LA, 1998, GENETICS, V149, P289; Siegel AF, 1999, GENOME RES, V9, P297; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smits BMG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2933; Smits Bart M G, 2007, Breast Dis, V28, P53; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Steen RG, 1999, GENOME RES, V9, pAP1; Szpirer C, 1998, MAMM GENOME, V9, P721, DOI 10.1007/s003359900853; Thompson D, 2002, P NATL ACAD SCI USA, V99, P827, DOI 10.1073/pnas.012584499; Twigger S, 2002, NUCLEIC ACIDS RES, V30, P125, DOI 10.1093/nar/30.1.125; Veillet AL, 2011, CANCER PREV RES, V4, P97, DOI 10.1158/1940-6207.CAPR-10-0187; Watanabe TK, 1999, NAT GENET, V22, P27, DOI 10.1038/8737; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; WOOSTER R, 1995, TRENDS GENET, V11, P3, DOI 10.1016/S0168-9525(00)88974-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Xu X, 2012, MOL CARCINOG; Yamada S, 1997, MAMM GENOME, V8, P850, DOI 10.1007/s003359900591; Zeng ZB, 2005, GENETICA, V123, P25, DOI 10.1007/s10709-004-2705-0	50	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e70930	10.1371/journal.pone.0070930	http://dx.doi.org/10.1371/journal.pone.0070930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023717	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400005
J	Denis, V; Guillaume, MMM; Goutx, M; de Palmas, S; Debreuil, J; Baker, AC; Boonstra, RK; Bruggemann, JH				Denis, Vianney; Guillaume, Mireille M. M.; Goutx, Madeleine; de Palmas, Stephane; Debreuil, Julien; Baker, Andrew C.; Boonstra, Roxane K.; Bruggemann, J. Henrich			Fast Growth May Impair Regeneration Capacity in the Branching Coral Acropora muricata	PLOS ONE			English	Article							REEF-BUILDING CORALS; ENVIRONMENTAL CONTROLS; LESION REGENERATION; PARTIAL MORTALITY; REUNION-ISLAND; DAMAGE; RATES; SPP.; SIZE; POPULATIONS	Regeneration of artificially induced lesions was monitored in nubbins of the branching coral Acropora muricata at two reef-flat sites representing contrasting environments at Reunion Island (21 degrees 07'S, 55 degrees 32'E). Growth of these injured nubbins was examined in parallel, and compared to controls. Biochemical compositions of the holobiont and the zooxanthellae density were determined at the onset of the experiment, and the photosynthetic efficiency (F-v/F-m) of zooxanthellae was monitored during the experiment. Acropora muricata rapidly regenerated small lesions, but regeneration rates significantly differed between sites. At the sheltered site characterized by high temperatures, temperature variations, and irradiance levels, regeneration took 192 days on average. At the exposed site, characterized by steadier temperatures and lower irradiation, nubbins demonstrated fast lesion repair (81 days), slower growth, lower zooxanthellae density, chlorophyll a concentration and lipid content than at the former site. A trade-off between growth and regeneration rates was evident here. High growth rates seem to impair regeneration capacity. We show that environmental conditions conducive to high zooxanthellae densities in corals are related to fast skeletal growth but also to reduced lesion regeneration rates. We hypothesize that a lowered regenerative capacity may be related to limited availability of energetic and cellular resources, consequences of coral holobionts operating at high levels of photosynthesis and associated growth.	[Denis, Vianney; Guillaume, Mireille M. M.; de Palmas, Stephane; Debreuil, Julien; Bruggemann, J. Henrich] Univ La Reunion, CNRS, Lab Ecol Marine, FRE 3560, St Denis, Reunion, France; [Denis, Vianney; Guillaume, Mireille M. M.] Univ Paris 06, CNRS, Dept Milieux & Peuplements Aquat, Museum Natl Hist Nat,UMR,IRD,BOrEA, Paris, France; [Guillaume, Mireille M. M.; Bruggemann, J. Henrich] Lab Excellence CORAIL, Perpignan, France; [Goutx, Madeleine] Aix Marseille Univ, CNRS, INSU, IRD,MIO,UM 110, Marseille, France; [Goutx, Madeleine] Univ Toulon & Var, CNRS, INSU, IRD,MIO,UM 110, La Garde, France; [Baker, Andrew C.; Boonstra, Roxane K.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA	Centre National de la Recherche Scientifique (CNRS); University of La Reunion; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon; University of Miami	Denis, V (corresponding author), Acad Sinica, Biodivers Res Ctr, Coral Lab, Taipei 115, Taiwan.	vianney.denis@gmail.com	, de PALMAS Stéphane/AAS-8982-2021; Denis, Vianney/E-6868-2013	, de PALMAS Stéphane/0000-0002-2567-1789; Denis, Vianney/0000-0002-0914-5586; GUILLAUME, Mireille M. M./0000-0001-7249-0131; Baker, Andrew/0000-0002-7866-2587	Regional Council of Reunion Island; CNRS-INSU; MIO; National Science Council of Taiwan	Regional Council of Reunion Island; CNRS-INSU(Centre National de la Recherche Scientifique (CNRS)); MIO; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	A PhD fellowship to VD and a research grant to JHB and MMMG (ITUE program) were provided by the Regional Council of Reunion Island. CNRS-INSU and MIO financially support this collaborative work. VD is currently the recipient of a postdoctoral fellowship from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAK RP, 1981, P 4 INT CORAL REEF S, V2, P221; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; BAK RPM, 1980, B MAR SCI, V30, P883; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brickner I, 2006, J EXP BIOL, V209, P1690, DOI 10.1242/jeb.02168; Bruggemann H, 2008, MISE OEUVRE EFFET RE; Bucher DJ, 1998, J EXP MAR BIOL ECOL, V228, P117, DOI 10.1016/S0022-0981(98)00020-3; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Chauvin A, 2011, CORAL REEFS, V30, P911, DOI 10.1007/s00338-011-0786-7; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Crabbe MJC, 2009, MAR ENVIRON RES, V67, P189, DOI 10.1016/j.marenvres.2009.01.003; Denis V, 2011, MAR ECOL PROG SER, V428, P105, DOI 10.3354/meps09060; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Fine M, 2002, MAR ECOL PROG SER, V234, P119, DOI 10.3354/meps234119; Fisher EM, 2007, MAR ECOL PROG SER, V339, P61, DOI 10.3354/meps339061; Fisher P, 2006, THESIS; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; GUZMAN HM, 1994, MAR ECOL PROG SER, V105, P231, DOI 10.3354/meps105231; Hall VR, 1997, J EXP MAR BIOL ECOL, V212, P9, DOI 10.1016/S0022-0981(96)02760-8; Harriott, 1999, CORAL REEFS, V18, P281; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JOHANNES RE, 1970, LIMNOL OCEANOGR, V15, P822, DOI 10.4319/lo.1970.15.5.0822; Jones RJ, 2008, MAR BIOL, V154, P65, DOI 10.1007/s00227-007-0900-0; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kramarsky-Winter E, 2000, MAR BIOL, V137, P867, DOI 10.1007/s002270000416; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LESTER RT, 1985, MAR ECOL PROG SER, V24, P183, DOI 10.3354/meps024183; Lirman D, 2000, MAR ECOL PROG SER, V197, P209, DOI 10.3354/meps197209; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Meesters E.H., 1992, P 7 INT COR REEF S, V2, P681; MEESTERS EH, 1994, MAR ECOL PROG SER, V112, P119, DOI 10.3354/meps112119; Meesters EH, 1997, J SEA RES, V37, P131, DOI 10.1016/S1385-1101(96)00004-4; Meesters EH, 1996, B MAR SCI, V58, P838; Middlebrook R, 2010, J EXP BIOL, V213, P1026, DOI 10.1242/jeb.031633; Mioche D, 1999, CR ACAD SCI II A, V329, P53, DOI 10.1016/S1251-8050(99)80227-4; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; NAIM O, 1993, MAR ECOL PROG SER, V99, P137; Naim O., 2006, J NAT, V18, P13; Okubo Nami, 2008, Galaxea - Tokyo, V10, P83; Oren U, 1997, MAR ECOL PROG SER, V161, P117, DOI 10.3354/meps161117; Oren U, 1997, MAR ECOL PROG SER, V146, P101, DOI 10.3354/meps146101; Pratchett MS, 2013, MAR ENVIRON RES, V86, P29, DOI 10.1016/j.marenvres.2013.02.007; Rinkevich B, 1996, MAR ECOL PROG SER, V143, P297, DOI 10.3354/meps143297; SCOFFIN TP, 1992, CORAL REEFS, V11, P1, DOI 10.1007/BF00291929; Titlyanov EA, 2008, RUSS J MAR BIOL+, V34, P199, DOI 10.1134/S1063074008040019; van Woesik R, 1998, MAR ECOL PROG SER, V164, P213, DOI 10.3354/meps164213; van Woesik R, 2011, J EXP MAR BIOL ECOL, V408, P11, DOI 10.1016/j.jembe.2011.07.022; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P229, DOI 10.3354/meps109229; Wallace Carden C., 1999, pi; Wooldridge SA, 2010, BIOESSAYS, V32, P615, DOI 10.1002/bies.200900182; Wooldridge SA, 2009, MAR ECOL PROG SER, V396, P145, DOI 10.3354/meps08310; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029652, 10.1371/journal.pone.0035836]	60	19	19	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72618	10.1371/journal.pone.0072618	http://dx.doi.org/10.1371/journal.pone.0072618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023627	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200022
J	Kruizinga, I; Jansen, W; Mieloo, CL; Carter, AS; Raat, H				Kruizinga, Ingrid; Jansen, Wilma; Mieloo, Cathelijne L.; Carter, Alice S.; Raat, Hein			Screening Accuracy and Clinical Application of the Brief Infant-Toddler Social and Emotional Assessment (BITSEA)	PLOS ONE			English	Article							PSYCHOSOCIAL PROBLEMS; ASSESSMENT ITSEA; IDENTIFICATION; MANAGEMENT; RELIABILITY; BEHAVIOR	Background: The Brief Infant-Toddler Social and Emotional Assessment (BITSEA) is a promising questionnaire for the early detection of psychosocial problems in toddlers. The screening accuracy and clinical application were evaluated. Methods: In a community sample of 2-year-olds (N = 2060), screening accuracy of the BITSEA Problem scale was examined regarding a clinical CBCL1.5-5 Total Problem score. For the total population and subgroups by child's gender and ethnicity Receiver Operating Characteristic (ROC) curves were calculated, and across a range of BITSEA Problem scores, sensitivity, specificity, likelihood ratio's, diagnostic odds ratio and Youden's index. Clinical application of the BITSEA was examined by evaluating the relation between the scale scores and the clinical decision of the child health professional. Results: The area under the ROC curve (95% confidence interval) of the Problem scale was 0.97(0.95-0.98), there were no significant differences between subgroups. The association between clinical decision and BITSEA Problem score (B = 2.5) and Competence score (B = -0.7) was significant (p<0.05). Conclusions: The results indicate that the BITSEA Problem scale has good discriminative power to differentiate children with and without psychosocial problems. Referred children had less favourable scores compared to children that were not referred. The BITSEA may be helpful in the early detection of psychosocial problems.	[Kruizinga, Ingrid; Jansen, Wilma; Mieloo, Cathelijne L.; Raat, Hein] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Jansen, Wilma; Mieloo, Cathelijne L.] Rotterdam Municipal Hlth Serv GGD Rotterdam Rijnm, Dept Youth Policy, Rotterdam, Netherlands; [Carter, Alice S.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA	Erasmus University Rotterdam; Erasmus MC; University of Massachusetts System; University of Massachusetts Boston	Raat, H (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl	Jansen, Wilma/ABD-5066-2020; Carter, Alice/AAF-4694-2020	Jansen, Wilma/0000-0002-4453-9054; Carter, Alice/0000-0001-9861-1560	ZonMw, The Netherlands Organization for Health Research and Development [80-82435-98-8058]	ZonMw, The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study is funded by a grant from the funding body ZonMw, The Netherlands Organization for Health Research and Development (www.zonmw.nl), project number: 80-82435-98-8058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; [Anonymous], 2012, DEFINITIONS NATIVE I; Bevaart F., 2013, ETHNIC DIFFERENCES P; Briggs-Gowan M.J., 2002, BRIEF INFANT TODDLER; Briggs-Gowan MJ, 2008, PEDIATRICS, V121, P957, DOI 10.1542/peds.2007-1948; Briggs-Gowan MJ, 1998, INF MENTAL HLTH J, V19, P422, DOI 10.1002/(SICI)1097-0355(199824)19:4<422::AID-IMHJ5>3.0.CO;2-U; Briggs-Gowan MJ, 2004, J PEDIATR PSYCHOL, V29, P143, DOI 10.1093/jpepsy/jsh017; Brugman E, 2001, ARCH PEDIAT ADOL MED, V155, P462, DOI 10.1001/archpedi.155.4.462; Carter AS, 2003, J ABNORM CHILD PSYCH, V31, P495, DOI 10.1023/A:1025449031360; Cohen J.E., 1988, STAT POWER ANAL BEHA; Ellingson KD, 2004, ARCH PEDIAT ADOL MED, V158, P766, DOI 10.1001/archpedi.158.8.766; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; GLASCOE FP, 1991, CLIN PEDIATR, V30, P8, DOI 10.1177/000992289103000101; JELLINEK MS, 1988, AM J DIS CHILD, V142, P1153, DOI 10.1001/archpedi.1988.02150110031013; Karabekiroglu K, 2010, INFANT BEHAV DEV, V33, P503, DOI 10.1016/j.infbeh.2010.07.001; Karabekiroglu K, 2009, INFANT BEHAV DEV, V32, P291, DOI 10.1016/j.infbeh.2009.03.003; KOOT HM, 1991, ACTA PSYCHIAT SCAND, V83, P1, DOI 10.1111/j.1600-0447.1991.tb10574.x; Kruizinga I, 2012, PLOS ONE, P7; Kruizinga I, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-494; Laurent de Angulo MS, 2005, ONTWIKKELINGSONDERZO; Reijneveld SA, 2004, ARCH PEDIAT ADOL MED, V158, P811, DOI 10.1001/archpedi.158.8.811; STURNER RA, 1991, J DEV BEHAV PEDIATR, V12, P51; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Velderman MK, 2010, EUR J PUBLIC HEALTH, V20, P332, DOI 10.1093/eurpub/ckp169	26	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72602	10.1371/journal.pone.0072602	http://dx.doi.org/10.1371/journal.pone.0072602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211BX	24023626	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200021
J	Davies, GJG; Knight, DP; Vollrath, F				Davies, Gwilym J. G.; Knight, David P.; Vollrath, Fritz			Chitin in the Silk Gland Ducts of the Spider Nephila edulis and the Silkworm Bombyx mori	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; SPINNING APPARATUS; PROTEIN; FTIR; ULTRASTRUCTURE; TRANSITION; FLOW	Here we report the detection and localisation of chitin in the cuticle of the spinning ducts of both the spider Nephila edulis and the silkworm Bombyx mori. Our observations demonstrate that the duct walls of both animals contain chitin notwithstanding totally independent evolutionary pathways of the systems. We conclude that chitin may well be an essential component for the construction of spinning ducts; we further conclude that in both species chitin may indicate the evolutionary origin of the spinning ducts.	[Davies, Gwilym J. G.; Knight, David P.; Vollrath, Fritz] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Vollrath, F (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	fritz.vollrath@zoo.ox.ac.uk		Vollrath, Fritz/0000-0003-3484-9005	Engineering and Physical Sciences Research Council [EP/P504287/1]; European Research Council [SP2-GA-2008-233409]; US Air Force Office of Scientific Research [F49620-03-1-0111]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Financial support was provided by the Engineering and Physical Sciences Research Council (EP/P504287/1), the European Research Council (SP2-GA-2008-233409), and the US Air Force Office of Scientific Research (F49620-03-1-0111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI H, 1983, EXPERIENTIA, V39, P443, DOI 10.1007/BF01965158; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Asakura T, 2007, BIOMACROMOLECULES, V8, P175, DOI 10.1021/bm060874z; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; BELL AL, 1969, J CELL BIOL, V42, P284, DOI 10.1083/jcb.42.1.284; Boulet-Audet M, 2010, J PHYS CHEM B, V114, P8255, DOI 10.1021/jp101763y; CAMPBELL F. L., 1929, ANN ENT SOC AMER, V22, P401; Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647; Chen X, 2002, BIOCHEMISTRY-US, V41, P14944, DOI 10.1021/bi026550m; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; Davies GJG, 2013, STRUCTURE FUNCTION M; Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c; FOCHER B, 1992, CARBOHYD POLYM, V18, P43, DOI 10.1016/0144-8617(92)90186-T; Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f; GROOME JR, 1991, J INSECT PHYSIOL, V37, P9, DOI 10.1016/0022-1910(91)90013-P; HABEL RE, 1963, AM J VET RES, V24, P199; HAGSTRUM DW, 1971, ANN ENTOMOL SOC AM, V64, P757, DOI 10.1093/aesa/64.4.757; Holland C, 2012, ADV MATER, V24, P105, DOI 10.1002/adma.201103664; Ibrahim M, 2005, INDIAN J PURE AP PHY, V43, P911; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20176; Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667; Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0; Kovoor J., 1987, P160; Libowitzky E, 1997, AM MINERAL, V82, P1111; MAGOSHI J, 1994, ACS SYM SER, V544, P292; Nzai JM, 1999, J AM OIL CHEM SOC, V76, P61, DOI 10.1007/s11746-999-0048-9; PARKER KD, 1957, NATURE, V179, P905, DOI 10.1038/179905a0; Peters W, 1992, PERITROPHIC MEMBRANE; PHILLIPS CE, 1976, INT J INSECT MORPHOL, V5, P423, DOI 10.1016/0020-7322(76)90015-5; Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001; Porter D, 2013, ADV MATER, V25, P1275, DOI 10.1002/adma.201204158; PRUDHOMME JC, 1979, BIOCHIMIE, V61, P215, DOI 10.1016/S0300-9084(79)80068-1; Qin GK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2004; RAVINDRANATH M H R, 1975, Acta Histochemica, V53, P203; Ruiz-Herrera J, 1999, CHITIN CHITINASES; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Tamburro AM, 2010, CHEMBIOCHEM, V11, P83, DOI 10.1002/cbic.200900460; TANNER SF, 1990, MACROMOLECULES, V23, P3576, DOI 10.1021/ma00217a008; Vincent JFV, 2012, STRUCTURAL BIOMATERI, P129; Vollrath F, 1998, P ROY SOC B-BIOL SCI, V265, P817, DOI 10.1098/rspb.1998.0365; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Vollrath F, 2011, SOFT MATTER, V7, P9595, DOI 10.1039/c1sm05812f; Wainwright S.A., 1976, MECH DESIGN ORGANISM; WEISFOGH T, 1960, J EXP BIOL, V37, P889; Yonemura N, 2006, J MOL EVOL, V63, P42, DOI 10.1007/s00239-005-0119-y; Young JH, 2003, ARTHROPOD STRUCT DEV, V32, P157, DOI 10.1016/s1467-8039(03)00006-9	51	30	30	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73225	10.1371/journal.pone.0073225	http://dx.doi.org/10.1371/journal.pone.0073225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015298	gold, Green Submitted, Green Published			2022-12-27	WOS:000323733800095
J	Liang, WB; Chikritzhs, T				Liang, Wenbin; Chikritzhs, Tanya			Errors in Recall of Age at First Sex	PLOS ONE			English	Article							PROSTATE-CANCER; CERVICAL-CANCER; RISK-FACTORS; INTERCOURSE; ADOLESCENTS; INFECTION; DIAGNOSIS; SMOKING; COHORTS	Aims: To measure the degree and direction of errors in recall of age at first sex. Method: Participants were initially recruited in 1994-1995 (Wave I) with 3 subsequent follow-ups in: 1996 (Wave II); 2001-2002 (Wave III); and 2007-2008 (Wave IV). Participants' individual errors in recall of their age at first sex at Wave IV were estimated by the paired difference between responses given for age at first sex in Wave I and Wave IV (recalled age at first sex obtained at Wave IV minus the age at first sex obtained at Wave I). Results: The mean of the recall-estimation of age at first sex at Wave IV was found to be slightly increased comparing to the age at first sex at Wave I (less than 1 year). The errors in the recalled age at first sex tended to increase in participants who had their first sex younger or older than the average, and the recalled age at first sex tended to bias towards the mean (i.e. participants who had first sex younger than the average were more likely to recall an age at first sex that was older than the age, and vice versa). Conclusions: In this U.S. population-based sample, the average recall error for age at first sex was small. However, the accuracy of recalled information varied significantly among subgroup populations.	[Liang, Wenbin; Chikritzhs, Tanya] Curtin Univ, Natl Drug Res Inst, Perth, WA 6845, Australia	Curtin University	Liang, WB (corresponding author), Curtin Univ, Natl Drug Res Inst, Perth, WA 6845, Australia.	w.liang@curtin.edu.au	liang, wenbin/M-2454-2013	Chikritzhs, Tanya/0000-0001-8871-3205	Australian Government Department of Health and Ageing under National Drug Strategy's funding of the National Drug Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	Australian Government Department of Health and Ageing under National Drug Strategy's funding of the National Drug Research Institute(Australian GovernmentDepartment of Health & Ageing); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Australian Government Department of Health and Ageing under the National Drug Strategy's funding of the National Drug Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigham J, 2010, AM J EPIDEMIOL, V172, P828, DOI 10.1093/aje/kwq179; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Edelstein ZR, 2009, CANCER EPIDEM BIOMAR, V18, P1070, DOI 10.1158/1055-9965.EPI-08-0707; Goldberg SK, 2012, J SEX RES, P1; Harris K. M., 2011, DESIGN FEATURES ADD; Hayes RB, 2000, BRIT J CANCER, V82, P718, DOI 10.1054/bjoc.1999.0986; HONDA GD, 1988, BRIT J CANCER, V57, P326, DOI 10.1038/bjc.1988.74; Johnson R. A., 1997, RECALL DECAY TELESCO; Johnson RA, 1998, AM J PUBLIC HEALTH, V88, P27, DOI 10.2105/AJPH.88.1.27; Kaestle CE, 2005, AM J EPIDEMIOL, V161, P774, DOI 10.1093/aje/kwi095; KAMENGA MC, 1995, AM J OBSTET GYNECOL, V172, P919, DOI 10.1016/0002-9378(95)90022-5; Liang W, 2012, CONTEMP DRUG PROBL, V39, P8; LOFTUS EF, 1985, AM PSYCHOL, V40, P175, DOI 10.1037/0003-066X.40.2.175; Louie KS, 2009, BRIT J CANCER, V100, P1191, DOI 10.1038/sj.bjc.6604974; Plummer M, 2003, CANCER CAUSE CONTROL, V14, P805, DOI 10.1023/B:CACO.0000003811.98261.3e; Tu WZ, 2009, ARCH PEDIAT ADOL MED, V163, P1106, DOI 10.1001/archpediatrics.2009.203; Upchurch DM, 2002, J SEX RES, V39, P197, DOI 10.1080/00224490209552142; Zaba B, 2004, SEX TRANSM INFECT, V80, P28, DOI 10.1136/sti.2004.012674	18	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72947	10.1371/journal.pone.0072947	http://dx.doi.org/10.1371/journal.pone.0072947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015283	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800087
J	Pennington, M; Grieve, R; Black, N; van der Meulen, JH				Pennington, Mark; Grieve, Richard; Black, Nick; van der Meulen, Jan H.			Functional Outcome, Revision Rates and Mortality after Primary Total Hip Replacement - A National Comparison of Nine Prosthesis Brands in England	PLOS ONE			English	Article							ARTHROPLASTY; CEMENTLESS; REGISTRY	Background: The number of prosthesis brands used for hip replacement has increased rapidly, but there is little evidence on their effectiveness. We compared patient-reported outcomes, revision rates, and mortality for the three most frequently used brands within each prosthesis type: cemented (Exeter V40 Contemporary, Exeter V40 Duration and Exeter V40 Elite Plus Ogee), cementless (Corail Pinnacle, Accolade Trident, and Taperloc Exceed), and hybrid (Exeter V40 Trilogy, Exeter V40 Trilogy, and CPT Trilogy). Methods and Findings: We used three national databases of patients who had hip replacements between 2008 and 2011 in the English NHS to compare functional outcome (Oxford Hip Score (OHS) ranging from 0 (worst) to 48 (best)) in 43,524 patients at six months. We analysed revisions and mortality in 187,201 patients. We used multiple regression to adjust for pre-operative differences. Prosthesis type had an impact on post-operative OHS and revision rates (both p < 0.001). Patients with hybrid prostheses had the best functional outcome (mean OHS 39.4, 95% CI 39.1 to 39.7) and those with cemented prostheses the worst (37.7, 37.3 to 38.1). Patients with cemented prostheses had the lowest reported 5-year revision rates (1.3%, 1.2% to 1.4%) and those with cementless prostheses the highest (2.2%, 2.1% to 2.4%). Differences in mortality according to prosthesis type were small and not significant (p = 0.06). Functional outcome varied according to brand among cemented (p = 0.05, with Exeter V40 Duration having the best) and cementless prostheses (p = 0.01, with Corail Pinnacle having the best). Revision rates varied according to brand among hybrids (p = 0.05, with Exeter V40 Trident having the lowest). Conclusions: Functional outcomes were better with cementless cups and revision rates were lower with cemented stems, which underlies the good overall performance of hybrids. The hybrid Exeter V40 Trident seemed to produce the best overall results. This brand should be considered as a benchmark in randomised trials.	[Pennington, Mark; Grieve, Richard; Black, Nick; van der Meulen, Jan H.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	van der Meulen, JH (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England.	jan.vandermeulen@lshtm.ac.uk	Pennington, Mark/AAS-9946-2020	Pennington, Mark/0000-0002-1392-8700; van der Meulen, Jan/0000-0002-9451-2335; Grieve, Richard/0000-0001-8899-1301	English Department of Health (Commissioning Development); National Institute for Health Research [PDA/03/07/026] Funding Source: researchfish	English Department of Health (Commissioning Development); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the English Department of Health (Commissioning Development). The Department of Health did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Anesthesiologists Physical Status Classification System, ASA PHYS STAT CLASS; [Anonymous], 2010, PROV MONTHL PAT REP; Armitage JN, 2010, BRIT J SURG, V97, P772, DOI 10.1002/bjs.6930; Breusch SJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7137; Canadian Joint Replacement Registry, 2009, HIP KNEE REPL CAN 20; Chard J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6404; Dalgleish S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7144; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; Dolan P., 1994, MEASUREMENT VALUATIO; Graves S, 2011, ANN REPORT; Health and Social Care Information Centre, 2013, HOSP EP STAT; Health Care Quality Improvement Partnership, 2010, NJR ADDS ON MILL REC; Jameson SS, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7005; Judge A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002453; Laupacis A, 2002, J BONE JOINT SURG AM, V84A, P1823, DOI 10.2106/00004623-200210000-00013; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; Mendenhall S, 2004, ORTHOPEDIC NEWS NETW, V14, P1; National Joint Registry for England and Wales, 2010, 7 NAT JOINT REG ENGL; National Joint Registry for England and Wales, 2013, NJR; National joint registry for England and Wales, 2011, 8 NAT JOINT REG ENGL; National Joint Registry for England Wales Northern Ireland and the Isle of Man, 2012, 9 NAT JOINT REG ENGL; Noble M, 2007, ENGLISH INDICES DEPR; Ousey Karen, 2011, Br J Community Nurs, V16, P80; Pennington M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1026; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rothwell AG, 2010, J BONE JOINT SURG BR, V92B, P413, DOI 10.1302/0301-620X.92B3.22913; Rubin D. B., 2004, MULTIPLE IMPUTATION; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Stata, 2011, STATA VERSION 12; Stea S, 2009, INT ORTHOP, V33, P339, DOI 10.1007/s00264-007-0465-z; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yamada H, 2009, J ORTHOP SCI, V14, P228, DOI 10.1007/s00776-008-1317-4	34	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73228	10.1371/journal.pone.0073228	http://dx.doi.org/10.1371/journal.pone.0073228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023837	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600079
J	Wei, H; Wang, W; Yarbrough, JM; Baker, JO; Laurens, L; Van Wychen, S; Chen, XW; Taylor, LE; Xu, Q; Himmel, ME; Zhang, M				Wei, Hui; Wang, Wei; Yarbrough, John M.; Baker, John O.; Laurens, Lieve; Van Wychen, Stefanie; Chen, Xiaowen; Taylor, Larry E., II; Xu, Qi; Himmel, Michael E.; Zhang, Min			Genomic, Proteomic, and Biochemical Analyses of Oleaginous Mucor circinelloides : Evaluating Its Capability in Utilizing Cellulolytic Substrates for Lipid Production	PLOS ONE			English	Article							BIODIESEL PRODUCTION; BIOSYNTHESIS GENES; EXPRESSION; ENZYMES	Lipid production by oleaginous microorganisms is a promising route to produce raw material for the production of biodiesel. However, most of these organisms must be grown on sugars and agro-industrial wastes because they cannot directly utilize lignocellulosic substrates. We report the first comprehensive investigation of Mucor circinelloides, one of a few oleaginous fungi for which genome sequences are available, for its potential to assimilate cellulose and produce lipids. Our genomic analysis revealed the existence of genes encoding 13 endoglucanases (7 of them secretory), 3 beta-D-glucosidases (2 of them secretory) and 243 other glycoside hydrolase (GH) proteins, but not genes for exoglucanases such as cellobiohydrolases (CBH) that are required for breakdown of cellulose to cellobiose. Analysis of the major PAGE gel bands of secretome proteins confirmed expression of two secretory endoglucanases and one beta-D-glucosidase, along with a set of accessory cell wall-degrading enzymes and 11 proteins of unknown function. We found that M. circinelloides can grow on CMC (carboxymethyl cellulose) and cellobiose, confirming the enzymatic activities of endoglucanases and beta-D-glucosidases, respectively. The data suggested that M. circinelloides could be made usable as a consolidated bioprocessing (CBP) strain by introducing a CBH (e.g. CBHI) into the microorganism. This proposal was validated by our demonstration that M. circinelloides growing on Avicel supplemented with CBHI produced about 33% of the lipid that was generated in glucose medium. Furthermore, fatty acid methyl ester (FAME) analysis showed that when growing on pre-saccharified Avicel substrates, it produced a higher proportion of C14 fatty acids, which has an interesting implication in that shorter fatty acid chains have characteristics that are ideal for use in jet fuel. This substrate-specific shift in FAME profile warrants further investigation.	[Wei, Hui; Wang, Wei; Yarbrough, John M.; Baker, John O.; Taylor, Larry E., II; Xu, Qi; Himmel, Michael E.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA; [Laurens, Lieve; Van Wychen, Stefanie; Chen, Xiaowen; Zhang, Min] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Wei, H (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA.	hui.wei@nrel.gov; mike.himmel@nrel.gov; min.zhang@nrel.gov	chen, xiaowen/H-4823-2014	Yarbrough, John/0000-0001-5424-552X	U.S. Department of Energy's Office of the Biomass Program (DOE-OBP); U.S. Department of Energy under National Renewable Energy Laboratory [DE-AC36-08-GO28308]	U.S. Department of Energy's Office of the Biomass Program (DOE-OBP)(United States Department of Energy (DOE)); U.S. Department of Energy under National Renewable Energy Laboratory(United States Department of Energy (DOE))	Authors gratefully acknowledge support from the U.S. Department of Energy's Office of the Biomass Program (DOE-OBP). This work was supported by the U.S. Department of Energy Contract No. DE-AC36-08-GO28308 with the National Renewable Energy Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggelis G, 1996, FOLIA MICROBIOL, V41, P254, DOI 10.1007/BF02814626; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Baba Y, 2005, J BACTERIOL, V187, P3045, DOI 10.1128/JB.187.9.3045-3051.2005; Brown L., 1996, ENZYMATIC SACCHARIFI; Csernetics A, 2011, FUNGAL GENET BIOL, V48, P696, DOI 10.1016/j.fgb.2011.03.006; Cuellar MC, 2013, BIOTECHNOLOGY J; Fakas S, 2009, BIOMASS BIOENERG, V33, P573, DOI 10.1016/j.biombioe.2008.09.006; Garcia-Galan C, 2013, J MOL CATAL B-ENZYM, V93, P34, DOI 10.1016/j.molcatb.2013.04.005; Gutierrez A, 2011, J MICROBIOLOGICAL ME; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Immelman M, 1997, SYST APPL MICROBIOL, V20, P158, DOI 10.1016/S0723-2020(97)80061-6; Laurens LML, 2012, ANAL BIOANAL CHEM, V403, P167, DOI 10.1007/s00216-012-5814-0; Li Q, 2008, APPL MICROBIOL BIOT, V80, P749, DOI 10.1007/s00253-008-1625-9; Liu B, 2007, J CHEM TECHNOL BIOT, V82, P775, DOI 10.1002/jctb.1744; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Meng X, 2009, RENEW ENERG, V34, P1, DOI 10.1016/j.renene.2008.04.014; Nyilasi I, 2005, FOLIA MICROBIOL, V50, P415, DOI 10.1007/BF02931423; O'Donnell K, 2001, MYCOLOGIA, V93, P286, DOI 10.2307/3761650; Papanikolaou S, 2004, BIORESOURCE TECHNOL, V95, P287, DOI 10.1016/j.biortech.2004.02.016; Papanikolaou S, 2004, J APPL MICROBIOL, V97, P867, DOI 10.1111/j.1365-2672.2004.02376.x; Papp T, 2006, APPL MICROBIOL BIOT, V69, P526, DOI 10.1007/s00253-005-0026-6; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Petruccioli M, 1999, J APPL MICROBIOL, V86, P302, DOI 10.1046/j.1365-2672.1999.00655.x; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; ROUX MP, 1994, WORLD J MICROB BIOT, V10, P417, DOI 10.1007/BF00144464; Saha BC, 2004, PROCESS BIOCHEM, V39, P1871, DOI 10.1016/j.procbio.2003.09.013; Shi SB, 2011, BIOTECHNOL J, V6, P277, DOI 10.1002/biot.201000117; Shimonaka A, 2006, BIOSCI BIOTECH BIOCH, V70, P1013, DOI 10.1271/bbb.70.1013; Szczesna-Antczak M, 2006, ENZYME MICROB TECH, V39, P1214, DOI 10.1016/j.enzmictec.2006.03.008; Voigt K, 2001, GENE, V270, P113, DOI 10.1016/S0378-1119(01)00464-4; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Wu JG, 2011, BIORESOURCE TECHNOL, V102, P5255, DOI 10.1016/j.biortech.2011.02.004; Wynn JP, 2001, MICROBIOL-SGM, V147, P2857, DOI 10.1099/00221287-147-10-2857; Xia CJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-15; Zheng Y, 2012, BIOTECHNOLOGY BIOFUE, V5	36	76	79	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e71068	10.1371/journal.pone.0071068	http://dx.doi.org/10.1371/journal.pone.0071068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023719	Green Submitted, gold, Green Published			2022-12-27	WOS:000324515600008
J	Geibel, S; Lorinczi, E; Bamberg, E; Friedrich, T				Geibel, Sven; Loerinczi, Eva; Bamberg, Ernst; Friedrich, Thomas			Voltage Dependence of Proton Pumping by Bacteriorhodopsin Mutants with Altered Lifetime of the M Intermediate	PLOS ONE			English	Article							OPTICAL-DATA STORAGE; N INTERMEDIATE; STRUCTURAL-CHANGES; WILD-TYPE; PROTEIN; TRANSLOCATION; EXPRESSION; RHODOPSIN; MECHANISM; MODEL	The light-driven proton pump bacteriorhodopsin (BR) from Halobacterium salinarum is tightly regulated by the [H+] gradient and transmembrane potential. BR exhibits optoelectric properties, since spectral changes during the photocycle are kinetically controlled by voltage, which predestines BR for optical storage or processing devices. BR mutants with prolonged lifetime of the blue-shifted M intermediate would be advantageous, but the optoelectric properties of such mutants are still elusive. Using expression in Xenopus oocytes and two-electrode voltage-clamping, we analyzed photocurrents of BR mutants with kinetically destabilized (F171C, F219L) or stabilized (D96N, D96G) M intermediate in response to green light (to probe H+ pumping) and blue laser flashes (to probe accumulation/decay of M). These mutants have divergent M lifetimes. As for BR-WT, this strictly correlates with the voltage dependence of H+ pumping. BR-F171C and BR-F219L showed photocurrents similar to BR-WT. Yet, BR-F171C showed a weaker voltage dependence of proton pumping. For both mutants, blue laser flashes applied during and after green-light illumination showed reduced M accumulation and shorter M lifetime. In contrast, BR-D96G and BR-D96N exhibited small photocurrents, with nonlinear current-voltage curves, which increased strongly in the presence of azide. Blue laser flashes showed heavy M accumulation and prolonged M lifetime, which accounts for the strongly reduced H+ pumping rate. Hyperpolarizing potentials augmented these effects. The combination of M-stabilizing and -destabilizing mutations in BR-D96G/F171C/F219L (BR-tri) shows that disruption of the primary proton donor Asp-96 is fatal for BR as a proton pump. Mechanistically, M destabilizing mutations cannot compensate for the disruption of Asp-96. Accordingly, BR-tri and BR-D96G photocurrents were similar. However, BR-tri showed negative blue laser flash-induced currents even without actinic green light, indicating that Schiff base deprotonation in BR-tri exists in the dark, in line with previous spectroscopic investigations. Thus, M-stabilizing mutations, including the triple mutation, drastically interfere with electrochemical H+ gradient generation.	[Geibel, Sven; Loerinczi, Eva; Bamberg, Ernst; Friedrich, Thomas] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Friedrich, Thomas] Tech Univ Berlin, Berlin, Germany	Max Planck Society; Technical University of Berlin	Friedrich, T (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	friedrich@chem.tu-berlin.de	Friedrich, Thomas/AAA-3418-2022		German Research Foundation, DFG [SFB 472]; Max-Planck-Society for the Advancement of Sciences; German Research Foundation, DFG (Cluster of Excellence "Unifying Concepts in Catalysis")	German Research Foundation, DFG(German Research Foundation (DFG)); Max-Planck-Society for the Advancement of Sciences; German Research Foundation, DFG (Cluster of Excellence "Unifying Concepts in Catalysis")(German Research Foundation (DFG))	Work was supported by the German Research Foundation, DFG (SFB 472 to S. G. and E. B., and Cluster of Excellence "Unifying Concepts in Catalysis" to T.F.) and the Max-Planck-Society for the Advancement of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUTT HJ, 1989, EMBO J, V8, P1657, DOI 10.1002/j.1460-2075.1989.tb03556.x; Der A, 2007, PHOTOCHEM PHOTOBIOL, V83, P393, DOI 10.1562/2006-06-21-RA-944; Fabian L, 2011, OPT EXPRESS, V19, P18861, DOI 10.1364/OE.19.018861; Fischer T, 2003, IEEE T NANOBIOSCI, V2, P1, DOI 10.1109/TNB.2003.810163; Geibel S, 2001, BIOPHYS J, V81, P2059, DOI 10.1016/S0006-3495(01)75855-9; GRYGORCZYK R, 1989, METHOD ENZYMOL, V173, P453; Hagedorn R, 2008, BIOPHYS J, V95, P5005, DOI 10.1529/biophysj.107.125260; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Jiang X, 2008, P NATL ACAD SCI USA, V105, P12113, DOI 10.1073/pnas.0802289105; Jiang X, 2010, J AM CHEM SOC, V132, P10808, DOI 10.1021/ja102295g; Kamikubo H, 1996, P NATL ACAD SCI USA, V93, P1386, DOI 10.1073/pnas.93.4.1386; Kataoka M, 2000, BBA-BIOENERGETICS, V1460, P166, DOI 10.1016/S0005-2728(00)00137-7; Kotting C, 2005, CHEMPHYSCHEM, V6, P881, DOI 10.1002/cphc.200400504; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lorinczi E, 2009, J MOL BIOL, V393, P320, DOI 10.1016/j.jmb.2009.07.055; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mathesz A, 2013, BIOSENS BIOELECTRON, V46, P48, DOI 10.1016/j.bios.2013.02.022; MULLER KH, 1991, EUR BIOPHYS J, V19, P241, DOI 10.1007/BF00183531; Nagel G, 1995, FEBS LETT, V377, P263, DOI 10.1016/0014-5793(95)01356-3; Nagel G, 1998, BIOPHYS J, V74, P403, DOI 10.1016/S0006-3495(98)77797-5; Radu I, 2009, PHOTOCH PHOTOBIO SCI, V8, P1517, DOI 10.1039/b9pp00050j; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; Subramaniam S, 1999, J STRUCT BIOL, V128, P19, DOI 10.1006/jsbi.1999.4178; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Subramaniam S, 1999, J MOL BIOL, V287, P145, DOI 10.1006/jmbi.1999.2589; TITTOR J, 1989, EMBO J, V8, P3477, DOI 10.1002/j.1460-2075.1989.tb08512.x; Tittor J, 2002, J MOL BIOL, V319, P555, DOI 10.1016/S0022-2836(02)00307-8; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0; Vonck J, 2000, EMBO J, V19, P2152, DOI 10.1093/emboj/19.10.2152; Vonck J, 1996, BIOCHEMISTRY-US, V35, P5870, DOI 10.1021/bi952663c; Yao BL, 2005, APPL OPTICS, V44, P7344, DOI 10.1364/AO.44.007344; Yao BL, 2005, OPT LETT, V30, P3060, DOI 10.1364/OL.30.003060; Zhang J, 2012, PROTEINS, V80, P2384, DOI 10.1002/prot.24124	40	10	10	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73338	10.1371/journal.pone.0073338	http://dx.doi.org/10.1371/journal.pone.0073338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019918	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200060
J	Khayhan, K; Hagen, F; Pan, WH; Simwami, S; Fisher, MC; Wahyuningsih, R; Chakrabarti, A; Chowdhary, A; Ikeda, R; Taj-Aldeen, SJ; Khan, Z; Ip, M; Imran, D; Sjam, R; Sriburee, P; Liao, WQ; Chaicumpar, K; Vuddhakul, V; Meyer, W; Trilles, L; van Iersel, LJJ; Meis, JF; Klaassen, CHW; Boekhout, T				Khayhan, Kantarawee; Hagen, Ferry; Pan, Weihua; Simwami, Sitali; Fisher, Matthew C.; Wahyuningsih, Retno; Chakrabarti, Arunaloke; Chowdhary, Anuradha; Ikeda, Reiko; Taj-Aldeen, Saad J.; Khan, Ziauddin; Ip, Margaret; Imran, Darma; Sjam, Ridhawati; Sriburee, Pojana; Liao, Wanqing; Chaicumpar, Kunyaluk; Vuddhakul, Varaporn; Meyer, Wieland; Trilles, Luciana; van Iersel, Leo J. J.; Meis, Jacques F.; Klaassen, Corne H. W.; Boekhout, Teun			Geographically Structured Populations of Cryptococcus neoformans Variety grubii in Asia Correlate with HIV Status and Show a Clonal Population Structure	PLOS ONE			English	Article							EPIDEMIOLOGIC CUTOFF VALUES; END-POINT DISTRIBUTIONS; GATTII SPECIES COMPLEX; VAR. GRUBII; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC NETWORKS; PACIFIC-NORTHWEST; GENETIC DIVERSITY; BRITISH-COLUMBIA; INFECTION	Cryptococcosis is an important fungal disease in Asia with an estimated 140,000 new infections annually the majority of which occurs in patients suffering from HIV/AIDS. Cryptococcus neoformans variety grubii (serotype A) is the major causative agent of this disease. In the present study, multilocus sequence typing (MLST) using the ISHAM MLST consensus scheme for the C. neoformans/C. gattii species complex was used to analyse nucleotide polymorphisms among 476 isolates of this pathogen obtained from 8 Asian countries. Population genetic analysis showed that the Asian C. neoformans var. grubii population shows limited genetic diversity and demonstrates a largely clonal mode of reproduction when compared with the global MLST dataset. HIV-status, sequence types and geography were found to be confounded. However, a correlation between sequence types and isolates from HIV-negative patients was observed among the Asian isolates. Observations of high gene flow between the Middle Eastern and the Southeastern Asian populations suggest that immigrant workers in the Middle East were originally infected in Southeastern Asia.	[Khayhan, Kantarawee] Univ Phayao, Dept Microbiol & Parasitol, Fac Med Sci, Phayao, Thailand; [Khayhan, Kantarawee; Hagen, Ferry; Boekhout, Teun] CBS KNAW Fungal Biodivers Ctr, Dept Yeast & Basidiomycete Res, Utrecht, Netherlands; [Khayhan, Kantarawee; Boekhout, Teun] Univ Utrecht, Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Hagen, Ferry; Meis, Jacques F.; Klaassen, Corne H. W.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Pan, Weihua; Liao, Wanqing; Boekhout, Teun] Secondary Mil Med Univ, Shanghai Key Lab Mol Med Mycol, Inst Dermatol & Med Mycol, Dept Dermatol,Changzheng Hosp, Shanghai, Peoples R China; [Simwami, Sitali; Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Fac Med, London, England; [Wahyuningsih, Retno; Sjam, Ridhawati] Univ Indonesia, Div Mycol, Dept Parasitol, Fac Med, Jakarta, Indonesia; [Wahyuningsih, Retno] Christian Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia; [Chakrabarti, Arunaloke] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India; [Chowdhary, Anuradha] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India; [Ikeda, Reiko] Meiji Pharmaceut Univ, Dept Microbiol, Tokyo, Japan; [Taj-Aldeen, Saad J.] Hamad Med Corp, Div Microbiol, Dept Lab Med & Pathol, Mycol Unit, Doha, Qatar; [Khan, Ziauddin] Kuwait Univ, Dept Microbiol, Fac Med, Hlth Sci Ctr, Jabriya, Kuwait; [Ip, Margaret] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Imran, Darma] Univ Indonesia, Dept Neurol, Fac Med, Jakarta, Indonesia; [Imran, Darma] Cipto Mangunkusumo Hosp, Dept Neurol, Jakarta, Indonesia; [Sriburee, Pojana] Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai 50000, Thailand; [Chaicumpar, Kunyaluk] Khon Kaen Univ, Fac Med, Res & Diagnost Ctr Emerging Infect Dis, Khon Kaen, Thailand; [Chaicumpar, Kunyaluk] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Vuddhakul, Varaporn] Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Thailand; [Meyer, Wieland; Trilles, Luciana] Univ Sydney, Mol Mycol Res Lab, Ctr Infect Dis & Microbiol,Westmead Hosp, Westmead Millennium Inst,Sydney Med Sch Westmead, Sydney, NSW 2006, Australia; [Trilles, Luciana] Fundacao Oswaldo Cruz, Lab Micol, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [van Iersel, Leo J. J.] Ctr Math & Informat, Amsterdam, Netherlands; [Meis, Jacques F.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Phayao; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Utrecht University; Utrecht University Medical Center; Canisius-Wilhelmina Hospital; Naval Medical University; Imperial College London; University of Indonesia; The Christian University of Indonesia; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Delhi; Meiji Pharmaceutical University; Hamad Medical Corporation; Kuwait University; Chinese University of Hong Kong; University of Indonesia; University of Indonesia; Chiang Mai University; Khon Kaen University; Khon Kaen University; Prince of Songkla University; University of Sydney; Westmead Institute for Medical Research; Fundacao Oswaldo Cruz; Radboud University Nijmegen	Boekhout, T (corresponding author), CBS KNAW Fungal Biodivers Ctr, Dept Yeast & Basidiomycete Res, Utrecht, Netherlands.	t.boekhout@cbs.knaw.nl	Meis, Jacques F/A-9241-2010; Meyer, Wieland/G-1204-2015; Hagen, Ferry/B-9044-2009; Boekhout, Teunis/ABF-2538-2020; Fisher, Matthew/B-9094-2011; Chowdhary, Anuradha/ABF-1252-2020; Ip, Margaret/K-1096-2013	Meis, Jacques F/0000-0003-3253-6080; Meyer, Wieland/0000-0001-9933-8340; Hagen, Ferry/0000-0002-5622-1916; Boekhout, Teunis/0000-0002-0476-3609; Fisher, Matthew/0000-0002-1862-6402; Chowdhary, Anuradha/0000-0002-2028-7462; Ip, Margaret/0000-0003-1291-6537; Imran, Darma/0000-0002-4109-4192	University of Phayao, Thailand; Odo van Vloten Foundation, the Netherlands; National Natural Science Foundation of China [31270180]; National Basic Research Program of China [2013CB531606]; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/D52637X/1]; Qatar National Research Fund [NPRP 5-298-3-086]; MRC [MR/K000373/1] Funding Source: UKRI; Medical Research Council [MR/K000373/1] Funding Source: researchfish	University of Phayao, Thailand; Odo van Vloten Foundation, the Netherlands(Netherlands Government); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Qatar National Research Fund(Qatar National Research Fund (QNRF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a research grant from University of Phayao, Thailand (http://www.up.ac.th/). FH was funded by the Odo van Vloten Foundation, the Netherlands. WH was granted by the National Natural Science Foundation of China (no. 31270180) and the National Basic Research Program of China (no. 2013CB531606). MCF was granted by the Wellcome Trust (http://www.wellcome.ac.uk/) and the Biotechnology and Biological Sciences Research Council, grant number BB/D52637X/1 (www.bbsrc.ac.uk). TB and SJT were supported by a grant from the Qatar National Research Fund, grant number NPRP 5-298-3-086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Banerjee U, 2004, MED MYCOL, V42, P181, DOI 10.1080/13693780310001615376; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Byrnes EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002205; Chen JH, 2008, EMERG INFECT DIS, V14, P755, DOI 10.3201/eid1405.071312; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; Chowdhary A, 2012, CRIT REV MICROBIOL, V38, P1, DOI 10.3109/1040841X.2011.606426; Cogliati M, 2013, MED MYCOL; Datta K, 2009, EMERG INFECT DIS, V15, P1185, DOI 10.3201/eid1508.081384; Day JN, 2011, J CLIN MICROBIOL, V49, P658, DOI 10.1128/JCM.01985-10; de Oliveira MTB, 2004, J CLIN MICROBIOL, V42, P1356, DOI 10.1128/JCM.42.3.1356-1359.2004; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ELLIS DH, 1990, LANCET, V336, P923, DOI 10.1016/0140-6736(90)92283-N; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P5898, DOI 10.1128/AAC.01115-12; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P3107, DOI 10.1128/AAC.06252-11; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Colom MF, 2012, MED MYCOL, V50, P67, DOI 10.3109/13693786.2011.574239; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Franzot SP, 1997, J CLIN MICROBIOL, V35, P2243, DOI 10.1128/JCM.35.9.2243-2251.1997; Garcia-Hermoso D, 1999, J CLIN MICROBIOL, V37, P3204, DOI 10.1128/JCM.37.10.3204-3209.1999; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Hagen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071148; Hagen F, 2012, EMERG INFECT DIS, V18, P1618, DOI 10.3201/eid1810.120068; Hagen F, 2012, J CLIN MICROBIOL, V50, P1918, DOI 10.1128/JCM.06750-11; Hagen F, 2010, ANTIMICROB AGENTS CH, V54, P5139, DOI 10.1128/AAC.00746-10; Hagen F, 2010, MYCOPATHOLOGIA, V170, P209, DOI 10.1007/s11046-010-9313-6; Hanafy A, 2008, MED MYCOL, V46, P685, DOI 10.1080/13693780802027062; Heitman Joseph, 2011, Fungal Biology Reviews, V25, P48, DOI 10.1016/j.fbr.2011.01.003; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Hu XP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042439; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Illnait-Zaragozi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009124; Jain N, 2005, J CLIN MICROBIOL, V43, P5733, DOI 10.1128/JCM.43.11.5733-5742.2005; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Kidd SE, 2007, APPL ENVIRON MICROB, V73, P1433, DOI 10.1128/AEM.01330-06; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Liaw SJ, 2010, CLIN MICROBIOL INFEC, V16, P696, DOI 10.1111/j.1469-0691.2009.02930.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Litvintseva AP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002495; Litvintseva AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019688; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Litvintseva AP, 2005, J CLIN MICROBIOL, V43, P556, DOI 10.1128/JCM.43.2.556-564.2005; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Mihara T, 2012, MED MYCOL; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ou XT, 2011, J INFECT DIS, V203, P1686, DOI 10.1093/infdis/jir152; Pan WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032868; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Randhawa HS, 2008, MED MYCOL, V46, P823, DOI 10.1080/13693780802124026; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sar B, 2004, J ANTIMICROB CHEMOTH, V54, P563, DOI 10.1093/jac/dkh361; Simwami SP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001343; Springer DJ, 2010, EMERG INFECT DIS, V16, P14, DOI 10.3201/eid1601.090369; SR Wahyuningsih R, 2009, YEAST ISOLATED HIV I; Sriburee P, 2004, MYCOPATHOLOGIA, V158, P25, DOI 10.1023/B:MYCO.0000038435.14281.f4; Tay ST, 2006, MED MYCOL, V44, P617, DOI 10.1080/13693780600857330; Tibayrenc M, 2012, P NATL ACAD SCI USA, V109, pE3305, DOI 10.1073/pnas.1212452109; Trilles L, 2003, MED MYCOL, V41, P383, DOI 10.1080/1369378031000137206; van Iersel L, 2010, BIOINFORMATICS, V26, pi124, DOI 10.1093/bioinformatics/btq202; Viviani MA, 2006, FEMS YEAST RES, V6, P614, DOI 10.1111/j.1567-1364.2006.00081.x	68	66	72	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72222	10.1371/journal.pone.0072222	http://dx.doi.org/10.1371/journal.pone.0072222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019866	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200008
J	Kim, JR; Moon, YJ; Kwon, KS; Bae, JS; Wagle, S; Yu, TK; Kim, KM; Park, HS; Lee, JH; Moon, WS; Lee, H; Chung, MJ; Jang, KY				Kim, Jung Ryul; Moon, Young Jae; Kwon, Keun Sang; Bae, Jun Sang; Wagle, Sajeev; Yu, Taek Kyun; Kim, Kyoung Min; Park, Ho Sung; Lee, Ju-Hyung; Moon, Woo Sung; Lee, Ho; Chung, Myoung Ja; Jang, Kyu Yun			Expression of SIRT1 and DBC1 Is Associated with Poor Prognosis of Soft Tissue Sarcomas	PLOS ONE			English	Article							HISTONE DEACETYLASE; BREAST-CANCER; BETA-CATENIN; DNA-DAMAGE; TUMOR-SUPPRESSOR; REGULATES SIRT1; LIVER-CANCER; CELL-GROWTH; C-MYC; RESISTANCE	Recently, the roles of SIRT1 and deleted in breast cancer 1 (DBC1) in human cancer have been extensively studied and it has been demonstrated that they are involved in many human carcinomas. However, their clinical significance for soft-tissue sarcomas has not been examined. In this study, we evaluated the expression and prognostic significance of the expression of SIRT1, DBC1, P53, beta-catenin, cyclin D1, and KI67 in 104 cases of soft-tissue sarcomas. RESULTS: Immunohistochemical expression of SIRT1, DBC1, P53, beta-catenin, and cyclin D1 were seen in 71%, 74%, 53%, 48%, and 73% of sarcomas, respectively. The expression of SIRT1, DBC1, P53, b-catenin, and cyclin D1 were significantly correlated with advanced clinicopathological parameters such as higher clinical stage, higher histological grade, increased mitotic counts, and distant metastasis. The expression of SIRT1, DBC1, P53, b-catenin, cyclin D1, and KI67 were significantly correlated with each other and positive expression of all of these predicted shorter overall survival and event-free survival by univariate analysis. Multivariate analysis revealed the expression of SIRT1 as an independent prognostic indicator for overall survival and event-free survival of sarcoma patients. In conclusion, this study demonstrates that SIRT1- and DBC1-related pathways may be involved in the progression of soft-tissue sarcomas and can be used as clinically significant prognostic indicators for sarcoma patients. Moreover, the SIRT1- and DBC1-related pathways could be new therapeutic targets for the treatment of sarcomas.	[Kim, Jung Ryul; Moon, Young Jae] Chonbuk Natl Univ, Dept Orthopaed Surg, Sch Med, Res Inst Clin Med, Jeonju, South Korea; [Kim, Jung Ryul; Moon, Young Jae; Kwon, Keun Sang; Bae, Jun Sang; Wagle, Sajeev; Yu, Taek Kyun; Kim, Kyoung Min; Park, Ho Sung; Lee, Ju-Hyung; Moon, Woo Sung; Lee, Ho; Chung, Myoung Ja; Jang, Kyu Yun] Res Inst Endocrine Sci, Jeonju, South Korea; [Kwon, Keun Sang; Lee, Ju-Hyung] Chonbuk Natl Univ, Dept Prevent Med, Sch Med, Res Inst Clin Med, Jeonju, South Korea; [Bae, Jun Sang; Wagle, Sajeev; Yu, Taek Kyun; Kim, Kyoung Min; Park, Ho Sung; Moon, Woo Sung; Chung, Myoung Ja; Jang, Kyu Yun] Chonbuk Natl Univ, Dept Pathol, Sch Med, Res Inst Clin Med, Jeonju, South Korea; [Lee, Ho] Chonbuk Natl Univ, Dept Forens Med, Sch Med, Res Inst Clin Med, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Jang, KY (corresponding author), Chonbuk Natl Univ, Dept Pathol, Sch Med, Res Inst Clin Med, Jeonju, South Korea.	kyjang@chonbuk.ac.kr	Wagle, Sajeev/N-1524-2013	Wagle, Sajeev/0000-0001-9762-0262	National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0028928]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0028928). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Allred DC, 1998, MODERN PATHOL, V11, P155; Bae HJ, 2012, ONCOL LETT, V4, P873, DOI 10.3892/ol.2012.875; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calvisi DF, 2004, GASTROENTEROLOGY, V126, P1374, DOI 10.1053/j.gastro.2004.02.014; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Dickson BC, 2013, HUM PATHOL, V44, P1125, DOI 10.1016/j.humpath.2012.10.001; DROBNJAK M, 1994, J NATL CANCER I, V86, P549, DOI 10.1093/jnci/86.7.549; Edge S, 2010, AJCC CANC STAGING HD; Engellau J, 2005, HUM PATHOL, V36, P994, DOI 10.1016/j.humpath.2005.07.008; Engellau J, 2004, VIRCHOWS ARCH, V445, P224, DOI 10.1007/s00428-004-1065-6; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fu JJ, 2009, J BIOL CHEM, V284, P6832, DOI 10.1074/jbc.M808988200; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Hasegawa T, 2001, HUM PATHOL, V32, P257, DOI 10.1053/hupa.2001.22764; Hiraike H, 2010, BRIT J CANCER, V102, P1061, DOI 10.1038/sj.bjc.6605577; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Hoos A, 2001, CANCER, V92, P869, DOI 10.1002/1097-0142(20010815)92:4<869::AID-CNCR1395>3.0.CO;2-U; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Jang KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045119; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098; Kim SH, 2012, HISTOL HISTOPATHOL, V27, P49, DOI 10.14670/HH-27.49; Kim W, 2013, CANCER LETT, V333, P180, DOI 10.1016/j.canlet.2013.01.026; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Lehwald N, 2012, GASTROENTEROLOGY, V143, P754, DOI 10.1053/j.gastro.2012.05.048; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Li ZY, 2009, J BIOL CHEM, V284, P10361, DOI 10.1074/jbc.M900956200; Liang XJ, 2008, MOL CANCER RES, V6, P1499, DOI 10.1158/1541-7786.MCR-07-2130; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Mao BB, 2011, INT J BIOCHEM CELL B, V43, P1573, DOI 10.1016/j.biocel.2011.07.006; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Oh WK, 2010, MOL PHARMACOL, V78, P855, DOI 10.1124/mol.110.065961; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Park HS, 2013, TRANSL ONCOL, V6, P370, DOI 10.1593/tlo.13250; Park SH, 2013, APOPTOSIS, V18, P949, DOI 10.1007/s10495-013-0847-1; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; Trauernicht AM, 2010, CELL CYCLE, V9, P1218, DOI 10.4161/cc.9.6.11010; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Wurl P, 1999, CANCER LETT, V139, P159, DOI 10.1016/S0304-3835(99)00034-8; Zhang LH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-290	56	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74738	10.1371/journal.pone.0074738	http://dx.doi.org/10.1371/journal.pone.0074738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019980	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200123
J	Spalazzi, JP; Boskey, AL; Pleshko, N; Lu, HH				Spalazzi, Jeffrey P.; Boskey, Adele L.; Pleshko, Nancy; Lu, Helen H.			Quantitative Mapping of Matrix Content and Distribution across the Ligament-to-Bone Insertion	PLOS ONE			English	Article							INFRARED IMAGING SPECTROSCOPY; ANTERIOR CRUCIATE LIGAMENT; FT-IR MICROSCOPY; SOFT-TISSUES; CARTILAGE; TENDON; INTERFACE; COLLAGEN; PROTEOGLYCAN; FIXATION	The interface between bone and connective tissues such as the Anterior Cruciate Ligament (ACL) constitutes a complex transition traversing multiple tissue regions, including non-calcified and calcified fibrocartilage, which integrates and enables load transfer between otherwise structurally and functionally distinct tissue types. The objective of this study was to investigate region-dependent changes in collagen, proteoglycan and mineral distribution, as well as collagen orientation, across the ligament-to-bone insertion site using Fourier transform infrared spectroscopic imaging (FTIR-I). Insertion site-related differences in matrix content were also evaluated by comparing tibial and femoral entheses. Both region-and site-related changes were observed. Collagen content was higher in the ligament and bone regions, while decreasing across the fibrocartilage interface. Moreover, interfacial collagen fibrils were aligned parallel to the ligament-bone interface near the ligament region, assuming a more random orientation through the bulk of the interface. Proteoglycan content was uniform on average across the insertion, while its distribution was relatively less variable at the tibial compared to the femoral insertion. Mineral was only detected in the calcified interface region, and its content increased exponentially across the mineralized fibrocartilage region toward bone. In addition to new insights into matrix composition and organization across the complex multi-tissue junction, findings from this study provide critical benchmarks for the regeneration of soft tissue-to-bone interfaces and integrative soft tissue repair.	[Spalazzi, Jeffrey P.; Lu, Helen H.] Columbia Univ, Dept Biomed Engn, Biomat & Interface Tissue Engn Lab, New York, NY 10027 USA; [Boskey, Adele L.; Pleshko, Nancy] Hosp Special Surg, Musculoskeletal Integr Program, New York, NY 10021 USA; [Lu, Helen H.] Columbia Univ, Coll Dent Med, New York, NY USA	Columbia University; Columbia University	Lu, HH (corresponding author), Columbia Univ, Dept Biomed Engn, Biomat & Interface Tissue Engn Lab, New York, NY 10027 USA.	hhlu@columbia.edu		Boskey, Adele/0000-0002-6181-2219	Wallace H. Coulter Foundation; Presidential Early Career Award (PECASE); NIH-NIAMS [AR052402]; NIH-NIAMS (HSS Core Center Grant) [AR046121]; NSF [GK-12 0338329]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055280, P30AR046121, R21AR052402] Funding Source: NIH RePORTER	Wallace H. Coulter Foundation; Presidential Early Career Award (PECASE); NIH-NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH-NIAMS (HSS Core Center Grant); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the Wallace H. Coulter Foundation (HHL, www.whcf.org), Presidential Early Career Award (PECASE, HHL, www.whitehouse.gov/administration/eop/ostp), NIH-NIAMS (AR052402, HHL and HSS Core Center Grant AR046121, ALB, www.nih.gov), and an NSF graduate teaching fellowship (GK-12 0338329, JPS, www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2002, CALCIFIED TISSUE INT, V70, P422, DOI 10.1007/s00223-001-1016-z; BENJAMIN M, 1986, J ANAT, V149, P89; Bi X, 2005, OSTEOARTHR CARTILAGE, V13, P1050, DOI 10.1016/j.joca.2005.07.008; Bi XH, 2006, BBA-BIOMEMBRANES, V1758, P934, DOI 10.1016/j.bbamem.2006.05.014; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; Boskey AL, 2003, J BONE MINER RES, V18, P1005, DOI 10.1359/jbmr.2003.18.6.1005; Boskey AL, 2005, CELLS TISSUES ORGANS, V181, P144, DOI 10.1159/000091376; BOSKEY AL, 1992, CELL MATER, V2, P209; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; FRIEDMAN MJ, 1985, CLIN ORTHOP RELAT R, P9; Gadaleta SJ, 1996, CONNECT TISSUE RES, V34, P203, DOI 10.3109/03008209609000699; Girgis FG, 1975, CLIN ORTHOP RELAT RE, P216; Gourion-Arsiquaud S, 2009, J BONE MINER RES, V24, P1565, DOI [10.1359/JBMR.090414, 10.1359/jbmr.090414]; Iatridis JC, 2007, SPINE, V32, P1493, DOI 10.1097/BRS.0b013e318067dd3f; Kim M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922329; Kim M, 2010, TISSUE ENG PART C-ME, V16, P355, DOI [10.1089/ten.tec.2009.0020, 10.1089/ten.TEC.2009.0020]; KUROSAKA M, 1987, AM J SPORT MED, V15, P225, DOI 10.1177/036354658701500306; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; LANDEMORE G, 1991, HISTOCHEM J, V23, P534, DOI 10.1007/BF01041180; LEWIS EN, 1995, ANAL CHEM, V67, P3377, DOI 10.1021/ac00115a003; Lu HH, 2006, ADV BIOCHEM ENG BIOT, V102, P91, DOI 10.1007/b138509; Lu HH, 2013, ANNU REV BIOMED ENG, V15, P201, DOI 10.1146/annurev-bioeng-071910-124656; MATYAS JR, 1995, J BIOMECH, V28, P147, DOI 10.1016/0021-9290(94)00058-C; Messner K, 1997, ACTA ANAT, V160, P261; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Petersen W, 1999, ANAT EMBRYOL, V200, P325, DOI 10.1007/s004290050283; Pienkowski D, 1997, J BONE MINER RES, V12, P1936, DOI 10.1359/jbmr.1997.12.11.1936; Rieppo L, 2010, MICROSC RES TECHNIQ, V73, P503, DOI 10.1002/jemt.20789; ROBERTSON DB, 1986, AM J SPORT MED, V14, P398, DOI 10.1177/036354658601400512; RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009; Schwartz AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048630; Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497; Spalazzi JP, 2006, J ORTHOP RES, V24, P2001, DOI 10.1002/jor.20260; Thomopoulos S, 2003, J ORTHOP RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3; Villegas DF, 2008, ANN BIOMED ENG, V36, P123, DOI 10.1007/s10439-007-9403-x; Visconti CS, 1996, ARCH BIOCHEM BIOPHYS, V328, P135, DOI 10.1006/abbi.1996.0153; VOGEL KG, 1993, J ORTHOP RES, V11, P68, DOI 10.1002/jor.1100110109; Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475; Wang INE, 2006, J ORTHOP RES, V24, P1745, DOI 10.1002/jor.20149; Woo Savio L-Y, 2006, J Orthop Surg Res, V1, P2, DOI 10.1186/1749-799X-1-2; WOO SLY, 1988, J ORTHOP RES, V6, P907, DOI 10.1002/jor.1100060615; Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179	46	50	51	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74349	10.1371/journal.pone.0074349	http://dx.doi.org/10.1371/journal.pone.0074349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019964	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200107
J	Grady, SK; Hoang, TT; Gautam, SH; Shew, WL				Grady, Stephen K.; Hoang, Thanh T.; Gautam, Shree Hari; Shew, Woodrow L.			Millisecond, Micron Precision Multi-Whisker Detector	PLOS ONE			English	Article							RAT BARREL CORTEX; SENSORY RESPONSES; LAYER 2/3; MOVEMENTS; NEURONS; STIMULATION; INTEGRATION; INHIBITION; ADAPTATION; EXCITATION	The neural mechanisms of somatosensory information processing in the rodent vibrissae system are a topic of intense debate and research. Certain hypotheses emphasize the importance of stick-slip whisker motion, high-frequency resonant vibrations, and/or the ability to decode complex textures. Other hypotheses focus on the importance of integrating information from multiple whiskers. Tests of the former require measurements of whisker motion that achieve high spatiotemporal accuracy without altering the mechanical properties of whiskers. Tests of the latter require the ability to monitor the motion of multiple whiskers simultaneously. Here we present a device that achieves both these requirements for two-dimensional whisker motion in the plane perpendicular to the whiskers. Moreover, the system we present is significantly less expensive (,$ 2.5 k) and simpler to build than alternative devices which achieve similar detection capabilities. Our system is based on two laser diodes and two linear cameras. It attains millisecond temporal precision and micron spatial resolution. We developed automated algorithms for processing the data collected by our device and benchmarked their performance against manual detection by human visual inspection. By this measure, our detection was successful with less than 10 mm deviation between the automated and manual detection, on average. Here, we demonstrate its utility in anesthetized rats by measuring the motion of multiple whiskers in response to an air puff.	[Grady, Stephen K.; Hoang, Thanh T.; Gautam, Shree Hari; Shew, Woodrow L.] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Shew, WL (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.	shew@uark.edu		Shew, Woodrow/0000-0003-0679-1766				Bermejo R, 1998, J NEUROSCI METH, V83, P89, DOI 10.1016/S0165-0270(98)00050-8; Bermejo R, 2002, SOMATOSENS MOT RES, V19, P341, DOI 10.1080/0899022021000037809; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Ego-Stengel V, 2005, J NEUROPHYSIOL, V93, P1450, DOI 10.1152/jn.00912.2004; Estebanez L, 2012, NAT NEUROSCI, V15, P1691, DOI 10.1038/nn.3258; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Heiss JE, 2008, J NEUROSCI, V28, P13320, DOI 10.1523/JNEUROSCI.2646-08.2008; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Hirata A, 2008, J NEUROPHYSIOL, V100, P358, DOI 10.1152/jn.90538.2008; Jacob V, 2008, NEURON, V60, P1112, DOI 10.1016/j.neuron.2008.10.017; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Krupa DJ, 2001, J NEUROSCI METH, V104, P199, DOI 10.1016/S0165-0270(00)00345-9; Kyriazi HT, 1996, J NEUROPHYSIOL, V75, P547, DOI 10.1152/jn.1996.75.2.547; Lottem E, 2008, J NEUROPHYSIOL, V100, P2852, DOI 10.1152/jn.90302.2008; Lottem E, 2009, J NEUROSCI, V29, P11686, DOI 10.1523/JNEUROSCI.0705-09.2009; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Roy S, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00027; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Shimegi S, 1999, J NEUROSCI, V19, P10164; SIMONS DJ, 1983, BRAIN RES, V276, P178, DOI 10.1016/0006-8993(83)90561-9; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215; Zuo YF, 2011, PHILOS T R SOC B, V366, P3058, DOI 10.1098/rstb.2011.0161	28	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73357	10.1371/journal.pone.0073357	http://dx.doi.org/10.1371/journal.pone.0073357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023861	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400062
J	Shrestha, RK; Rosenberg, T; Makarovsky, D; Eckshtain-Levi, N; Zelinger, E; Kopelowitz, J; Sikorski, J; Burdman, S				Shrestha, Ram Kumar; Rosenberg, Tally; Makarovsky, Daria; Eckshtain-Levi, Noam; Zelinger, Einat; Kopelowitz, June; Sikorski, Johannes; Burdman, Saul			Phenotypic Variation in the Plant Pathogenic Bacterium Acidovorax citrulli	PLOS ONE			English	Article							AVENAE SUBSP CITRULLI; PHASE VARIATION; PSEUDOMONAS-FLUORESCENS; BIOFILM FORMATION; IV PILI; HAEMOPHILUS-INFLUENZAE; ANTIGENIC VARIATION; TWITCHING MOTILITY; ASSESSING ADHESION; ROOT-COLONIZATION	Acidovorax citrulli causes bacterial fruit blotch (BFB) of cucurbits, a disease that threatens the cucurbit industry worldwide. Despite the economic importance of BFB, little is known about pathogenicity and fitness strategies of the bacterium. We have observed the phenomenon of phenotypic variation in A. citrulli. Here we report the characterization of phenotypic variants (PVs) of two strains, M6 and 7a1, isolated from melon and watermelon, respectively. Phenotypic variation was observed following growth in rich medium, as well as upon isolation of bacteria from inoculated plants or exposure to several stresses, including heat, salt and acidic conditions. When grown on nutrient agar, all PV colonies possessed a translucent appearance, in contrast to parental strain colonies that were opaque. After 72 h, PV colonies were bigger than parental colonies, and had a fuzzy appearance relative to parental strain colonies that are relatively smooth. A. citrulli colonies are generally surrounded by haloes detectable by the naked eye. These haloes are formed by type IV pilus (T4P)-mediated twitching motility that occurs at the edge of the colony. No twitching haloes could be detected around colonies of both M6 and 7a1 PVs, and microscopy observations confirmed that indeed the PVs did not perform twitching motility. In agreement with these results, transmission electron microscopy revealed that M6 and 7a1 PVs do not produce T4P under tested conditions. PVs also differed from their parental strain in swimming motility and biofilm formation, and interestingly, all assessed variants were less virulent than their corresponding parental strains in seed transmission assays. Slight alterations could be detected in some DNA fingerprinting profiles of 7a1 variants relative to the parental strain, while no differences at all could be seen among M6 variants and parental strain, suggesting that, at least in the latter, phenotypic variation is mediated by slight genetic and/or epigenetic alterations.	[Shrestha, Ram Kumar; Rosenberg, Tally; Makarovsky, Daria; Eckshtain-Levi, Noam; Burdman, Saul] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel; [Shrestha, Ram Kumar; Rosenberg, Tally; Makarovsky, Daria; Eckshtain-Levi, Noam; Burdman, Saul] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Minerva Otto Warburg Ctr Agr Biotechnol, IL-76100 Rehovot, Israel; [Zelinger, Einat] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Interdept Equipment Facil, IL-76100 Rehovot, Israel; [Kopelowitz, June] Savyon Diagnost Ltd, Ashdod, Israel; [Sikorski, Johannes] Leibniz Inst DSMZ Deutsch Sammlung Mikroorganisme, Braunschweig, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Burdman, S (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel.	saul.burdman@mail.huji.ac.il	Sikorski, Johannes/AAD-9775-2019; Sikorski, Johannes/AAX-1960-2020; Eckshtain-Levi, Noam/W-9241-2019	Sikorski, Johannes/0000-0002-1890-5540; Eckshtain-Levi, Noam/0000-0002-6292-7309; Saul, Burdman/0000-0001-9544-7371	United States-Israel Binational Agricultural Research and Development Fund (BARD) [US-4216-09]	United States-Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation)	This research was partially supported by grant no. US-4216-09 from the United States-Israel Binational Agricultural Research and Development Fund (BARD; http://www.bard-isus.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Achouak W, 2004, MOL PLANT MICROBE IN, V17, P872, DOI 10.1094/MPMI.2004.17.8.872; Bahar O, 2008, PLANT PATHOL, V57, P754, DOI 10.1111/j.1365-3059.2008.01828.x; Bahar O, 2011, MOL PLANT MICROBE IN, V24, P1040, DOI 10.1094/MPMI-02-11-0041; Bahar O, 2010, ISR J PLANT SCI, V58, P19, DOI 10.1560/IJPS.58.1.19; Bahar O, 2010, FEMS MICROBIOL LETT, V312, P33, DOI 10.1111/j.1574-6968.2010.02094.x; Bahar O, 2009, MOL PLANT MICROBE IN, V22, P909, DOI 10.1094/MPMI-22-8-0909; Bayliss CD, 2009, FEMS MICROBIOL REV, V33, P504, DOI 10.1111/j.1574-6976.2009.00162.x; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; BRUMBLEY SM, 1990, J BACTERIOL, V172, P5677, DOI 10.1128/jb.172.10.5677-5685.1990; Bull HJ, 2001, P NATL ACAD SCI USA, V98, P8334, DOI 10.1073/pnas.151009798; Burdman S, 2005, PLANT DIS, V89, P1339, DOI 10.1094/PD-89-1339; Burdman S, 2012, MOL PLANT PATHOL, V13, P805, DOI 10.1111/j.1364-3703.2012.00810.x; Burdman S, 2011, GENES-BASEL, V2, P706, DOI 10.3390/genes2040706; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Clegg S, 1996, J BACTERIOL, V178, P542, DOI 10.1128/jb.178.2.542-545.1996; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; Foster PL, 1999, GENETICS, V152, P15; Hall BG, 1998, GENETICA, V102-3, P109, DOI 10.1023/A:1017015815643; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jana TK, 2000, CAN J MICROBIOL, V46, P28, DOI 10.1139/cjm-46-1-28; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; KELMAN A, 1973, J GEN MICROBIOL, V76, P177, DOI 10.1099/00221287-76-1-177; KIMURA A, 1986, INFECT IMMUN, V51, P69, DOI 10.1128/IAI.51.1.69-79.1986; Kivisaar M, 2003, ENVIRON MICROBIOL, V5, P814, DOI 10.1046/j.1462-2920.2003.00488.x; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kyme P, 2003, MICROBIOL-SGM, V149, P621, DOI 10.1099/mic.0.26014-0; Lerner A, 2010, ENV MICROBIOL REP, V2, P577, DOI 10.1111/j.1758-2229.2010.00149.x; Li D, 2012, FEMS MICROBIOL ECOL, V79, P751, DOI 10.1111/j.1574-6941.2011.01259.x; Li D, 2011, INT J SYST EVOL MICR, V61, P2589, DOI 10.1099/ijs.0.025296-0; Li YX, 2007, MICROBIOL-SGM, V153, P719, DOI 10.1099/mic.0.2006/002311-0; LOUWS FJ, 1994, APPL ENVIRON MICROB, V60, P2286, DOI 10.1128/AEM.60.7.2286-2295.1994; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Makin SA, 1996, MICROBIOL-UK, V142, P299, DOI 10.1099/13500872-142-2-299; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Martinez-Granero F, 2005, MICROBIOL-SGM, V151, P975, DOI 10.1099/mic.0.27583-0; Martinez-Granero F, 2006, APPL ENVIRON MICROB, V72, P3429, DOI 10.1128/AEM.72.5.3429-3434.2006; McKenzie GJ, 2001, CURR OPIN MICROBIOL, V4, P586, DOI 10.1016/S1369-5274(00)00255-1; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Rajeshwari R, 2000, J BACTERIOL, V182, P4797, DOI 10.1128/JB.182.17.4797-4802.2000; ROCHE RJ, 1995, MICROB PATHOGENESIS, V18, P129, DOI 10.1016/S0882-4010(95)90117-5; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Rosenberg SM, 2001, NAT REV GENET, V2, P645; Salaun L, 2003, ADV APPL MICROBIOL, V52, P263, DOI 10.1016/S0065-2164(03)01011-6; Sanchez-Contreras M, 2002, J BACTERIOL, V184, P1587, DOI 10.1128/JB.184.6.1587-1596.2002; Schaad NW, 2008, SYST APPL MICROBIOL, V31, P434, DOI 10.1016/j.syapm.2008.09.003; Schaad NW, 2003, PSEUDOMONAS SYRINGAE AND RELATED PATHOGENS: BIOLOGY AND GENETICS, P573; SCHAAD NW, 1978, INT J SYST BACTERIOL, V28, P117, DOI 10.1099/00207713-28-1-117; Tukel C, 2005, MOL MICROBIOL, V58, P289, DOI 10.1111/j.1365-2958.2005.04825.x; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vial L, 2006, J BACTERIOL, V188, P5364, DOI 10.1128/JB.00521-06; Vial L, 2010, ISME J, V4, P49, DOI 10.1038/ismej.2009.95; Villar MT, 1999, J BACTERIOL, V181, P4154, DOI 10.1128/JB.181.14.4154-4160.1999; Walcott RR, 2004, J PHYTOPATHOL, V152, P277, DOI 10.1111/j.1439-0434.2004.00841.x; Walcott RR, 2000, PHYTOPATHOLOGY, V90, P191, DOI 10.1094/PHYTO.2000.90.2.191; Wengelnik K, 1996, J BACTERIOL, V178, P1061, DOI 10.1128/jb.178.4.1061-1069.1996; WILLEMS A, 1992, INT J SYST BACTERIOL, V42, P107, DOI 10.1099/00207713-42-1-107; Wisniewski-Dye F, 2008, ANTON LEEUW INT J G, V94, P493, DOI 10.1007/s10482-008-9267-6	64	12	13	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73189	10.1371/journal.pone.0073189	http://dx.doi.org/10.1371/journal.pone.0073189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023830	Green Submitted, Green Published, gold			2022-12-27	WOS:000324238400050
J	Li, Y; Xia, W; Liu, Y; Remmer, HA; Voorhees, J; Fisher, GJ				Li, Yong; Xia, Wei; Liu, Ying; Remmer, Henriette A.; Voorhees, John; Fisher, Gary J.			Solar Ultraviolet Irradiation Induces Decorin Degradation in Human Skin Likely via Neutrophil Elastase	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; COLLAGEN FIBRILS; CATHEPSIN-G; PROTEOGLYCANS; EXPRESSION; FIBROBLASTS; FRAGMENTATION; MECHANISMS; INTERACTS; BIGLYCAN	Exposure of human skin to solar ultraviolet (UV) irradiation induces matrix metalloproteinase-1 (MMP-1) activity, which degrades type I collagen fibrils. Type I collagen is the most abundant protein in skin and constitutes the majority of skin connective tissue (dermis). Degradation of collagen fibrils impairs the structure and function of skin that characterize skin aging. Decorin is the predominant proteoglycan in human dermis. In model systems, decorin binds to and protects type I collagen fibrils from proteolytic degradation by enzymes such as MMP-1. Little is known regarding alterations of decorin in response to UV irradiation. We found that solar-simulated UV irradiation of human skin in vivo stimulated substantial decorin degradation, with kinetics similar to infiltration of polymorphonuclear (PMN) cells. Proteases that were released from isolated PMN cells degraded decorin in vitro. A highly selective inhibitor of neutrophil elastase blocked decorin breakdown by proteases released from PMN cells. Furthermore, purified neutrophil elastase cleaved decorin in vitro and generated fragments with similar molecular weights as those resulting from protease activity released from PMN cells, and as observed in UV-irradiated human skin. Cleavage of decorin by neutrophil elastase significantly augmented fragmentation of type I collagen fibrils by MMP-1. Taken together, these data indicate that PMN cell proteases, especially neutrophil elastase, degrade decorin, and this degradation renders collagen fibrils more susceptible to MMP-1 cleavage. These data identify decorin degradation and neutrophil elastase as potential therapeutic targets for mitigating sun exposure-induced collagen fibril degradation in human skin.	[Li, Yong; Xia, Wei; Liu, Ying; Voorhees, John; Fisher, Gary J.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Remmer, Henriette A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fisher, GJ (corresponding author), Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA.	dianemch@med.umich.edu	Voorhees, John/AAM-9966-2020	Voorhees, John/0000-0003-1856-785X	Department of Dermatology	Department of Dermatology	Funding was obtained from the Department of Dermatology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAVAN LA, 1993, J BIOL CHEM, V268, P9856; Boivin WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033163; Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488; Carrino DA, 2000, ARCH BIOCHEM BIOPHYS, V373, P91, DOI 10.1006/abbi.1999.1545; Carrino DA, 2011, GLYCOBIOLOGY, V21, P257, DOI 10.1093/glycob/cwq162; Clark RA, 2001, CURR PROTOC IMMUNOL, V7; Codriansky KA, 2009, PHOTOCHEM PHOTOBIOL, V85, P1356, DOI 10.1111/j.1751-1097.2009.00592.x; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fisher GJ, 2005, CUTIS, V75, P5; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 2001, J INVEST DERMATOL, V117, P219, DOI 10.1046/j.0022-202x.2001.01432.x; Flannery CR, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1925; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; GILCHREST BA, 1982, J AM GERIATR SOC, V30, P139, DOI 10.1111/j.1532-5415.1982.tb01289.x; Hiebert PR, 2011, EXP GERONTOL, V46, P489, DOI 10.1016/j.exger.2011.02.004; Honardoust D, 2012, J BURN CARE RES, V33, P668, DOI 10.1097/BCR.0b013e31824088e3; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JANOFF A, 1985, ANNU REV MED, V36, P207; Kapui Z, 2003, J PHARMACOL EXP THER, V305, P451, DOI 10.1124/jpet.102.044263; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; KUBES P, 1993, INFLAMMATION, V17, P321, DOI 10.1007/BF00918993; Kuwaba K, 2001, BIOCHEM J, V358, P157, DOI 10.1042/0264-6021:3580157; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Li Y, 2010, J DERMATOL SCI, V60, P105, DOI 10.1016/j.jdermsci.2010.08.003; Lochner K, 2007, BIOGERONTOLOGY, V8, P269, DOI 10.1007/s10522-006-9070-6; Marchica CL, 2011, AM J PHYSIOL-LUNG C, V300, pL863, DOI 10.1152/ajplung.00300.2009; Melrose J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2453; Mohan RR, 2011, CURR MOL MED, V11, P110; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Schornagel IJ, 2004, J INVEST DERMATOL, V123, P202, DOI 10.1111/j.0022-202X.2004.22734.x; SCOTT JE, 1991, INT J BIOL MACROMOL, V13, P157, DOI 10.1016/0141-8130(91)90041-R; SCOTT JE, 1992, FASEB J, V6, P2639, DOI 10.1096/fasebj.6.9.1612287; Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t; Stuart K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022139; Waddington RJ, 1998, ARCH ORAL BIOL, V43, P287, DOI 10.1016/S0003-9969(97)00119-2; Werth BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014830; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Zhang C, 2012, AM J PHYSIOL-CELL PH, V302, pC1213, DOI 10.1152/ajpcell.00179.2011	46	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72563	10.1371/journal.pone.0072563	http://dx.doi.org/10.1371/journal.pone.0072563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023624	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200019
J	Ortiz, SC; Trienens, M; Rohlfs, M				Ortiz, Silvia Caballero; Trienens, Monika; Rohlfs, Marko			Induced Fungal Resistance to Insect Grazing: Reciprocal Fitness Consequences and Fungal Gene Expression in the Drosophila-Aspergillus Model System	PLOS ONE			English	Article							SECONDARY METABOLISM; EXPERIMENTAL EVOLUTION; FILAMENTOUS FUNGI; DEFENSE; MELANOGASTER; PENICILLIUM; YEASTS; MOLD; MEROTERPENOIDS; COMPETITION	Background: Fungi are key dietary resources for many animals. Fungi, in consequence, have evolved sophisticated physical and chemical defences for repelling and impairing fungivores. Expression of such defences may entail costs, requiring diversion of energy and nutrients away from fungal growth and reproduction. Inducible resistance that is mounted after attack by fungivores may allow fungi to circumvent the potential costs of defence when not needed. However, no information exists on whether fungi display inducible resistance. We combined organism and fungal gene expression approaches to investigate whether fungivory induces resistance in fungi. Methodology/Principal Findings: Here we show that grazing by larval fruit flies, Drosophila melanogaster, induces resistance in the filamentous mould, Aspergillus nidulans, to subsequent feeding by larvae of the same insect. Larval grazing triggered the expression of various putative fungal resistance genes, including the secondary metabolite master regulator gene laeA. Compared to the severe pathological effects of wild type A. nidulans, which led to 100% insect mortality, larval feeding on a laeA loss-of-function mutant resulted in normal insect development. Whereas the wild type fungus recovered from larval grazing, larvae eradicated the chemically deficient mutant. In contrast, mutualistic dietary yeast, Saccharomyces cerevisiae, reached higher population densities when exposed to Drosophila larval feeding. Conclusions/Significance: Our study presents novel evidence that insect grazing is capable of inducing resistance to further grazing in a filamentous fungus. This phenotypic shift in resistance to fungivory is accompanied by changes in the expression of genes involved in signal transduction, epigenetic regulation and secondary metabolite biosynthesis pathways. Depending on reciprocal insect-fungus fitness consequences, fungi may be selected for inducible resistance to maintain high fitness in fungivore-rich habitats. Induced fungal defence responses thus need to be included if we wish to have a complete conception of animal-fungus co-evolution, fungal gene regulation, and multitrophic interactions.	[Ortiz, Silvia Caballero; Trienens, Monika; Rohlfs, Marko] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Trienens, Monika] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Trienens, Monika] Univ Munster, Dept Anim Evolutionary Ecol, Inst Evolut & Biodivers, D-48149 Munster, Germany	University of Gottingen; University of Groningen; University of Munster	Rohlfs, M (corresponding author), Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	mrohlfs@uni-goettingen.de	Rohlfs, Marko/AAF-6749-2019	Trienens, Monika/0000-0002-1874-1160; Rohlfs, Marko/0000-0002-8767-1629	DFG (German Research Foundation) [RO3523/3-1]	DFG (German Research Foundation)(German Research Foundation (DFG))	The work has been supported by a DFG (German Research Foundation) research grant to Marko Rohlfs (Grant number: RO3523/3-1). http://www.dfg.de/en/; http://gepris.dfg.de/gepris/OCTOPUS;jsessionid=GFThHN1bZ8512PbSCTK4WktLp716MWR2NVt6pymwlTzhnTgmtGDz! 1709242108! 1200488219358?module=gepris&task=showDetail&context=projekt&id=170990413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affeldt KJ, 2012, TOXINS, V4, P695, DOI 10.3390/toxins4090695; Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Batta YA, 2006, POSTHARVEST BIOL TEC, V40, P190, DOI 10.1016/j.postharvbio.2006.01.006; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002816; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Begon M., 1982, Genetics and Biology of Drosophila, V3b, P345; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; Bleuler-Martinez S, 2012, APPL ENVIRON MICROB, V78, P8485, DOI 10.1128/AEM.02286-12; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Brodhun F, 2010, BIOCHEM J, V425, P553, DOI 10.1042/BJ20091096; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Cray JA, 2013, MICROB BIOTECHNOL, V6, P453, DOI 10.1111/1751-7915.12027; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; GILBERT DG, 1980, OECOLOGIA, V46, P135, DOI 10.1007/BF00346979; Hamby KA, 2012, APPL ENVIRON MICROB, V78, P4869, DOI 10.1128/AEM.00841-12; Hernandez-Onate MA, 2012, P NATL ACAD SCI USA, V109, P14918, DOI 10.1073/pnas.1209396109; Hodge S., 1997, Drosophila Information Service, V80, P6; Hodge S, 1999, OIKOS, V87, P166, DOI 10.2307/3547007; Hodge Simon, 1997, Entomologist, V116, P87; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Inamdar AA, 2010, TOXICOL SCI, V117, P418, DOI 10.1093/toxsci/kfq222; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kataoka S, 2011, NEUROTOXICOLOGY, V32, P123, DOI 10.1016/j.neuro.2010.10.003; Kosalkova K, 2009, BIOCHIMIE, V91, P214, DOI 10.1016/j.biochi.2008.09.004; Lo HC, 2012, J AM CHEM SOC, V134, P4709, DOI 10.1021/ja209809t; Louis C, 1996, PHYTOPATHOLOGY, V86, P934, DOI 10.1094/Phyto-86-934; Nakamori T, 2007, MYCOL RES, V111, P1345, DOI 10.1016/j.mycres.2007.08.013; Nielsen ML, 2011, FEMS MICROBIOL LETT, V321, P157, DOI 10.1111/j.1574-6968.2011.02327.x; Oh DC, 2007, J NAT PROD, V70, P515, DOI 10.1021/np060381f; Rehrig EM, 2011, MOL ECOL RESOUR, V11, P294, DOI 10.1111/j.1755-0998.2010.02929.x; Rohlfs M, 2005, ECOL ENTOMOL, V30, P556, DOI 10.1111/j.0307-6946.2005.00722.x; Rohlfs Marko, 2005, Front Zool, V2, P2, DOI 10.1186/1742-9994-2-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sokal RR, 1995, BIOMETRY; Spiteller P, 2008, CHEM-EUR J, V14, P9100, DOI 10.1002/chem.200800292; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; Stotefeld L, 2012, ECOL ENTOMOL, V37, P323, DOI 10.1111/j.1365-2311.2012.01373.x; Tanney JB, 2012, MYCOSCIENCE, V53, P31, DOI 10.1007/s10267-011-0128-1; Trienens M, 2012, FUNGAL ECOL, V5, P191, DOI 10.1016/j.funeco.2011.07.009; Trienens M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-206; Trienens M, 2010, OIKOS, V119, P1765, DOI 10.1111/j.1600-0706.2010.18088.x; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wolfle S, 2009, OECOLOGIA, V161, P781, DOI 10.1007/s00442-009-1414-x; Yin WB, 2012, MOL MICROBIOL, V83, P1024, DOI 10.1111/j.1365-2958.2012.07986.x	50	33	34	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e74951	10.1371/journal.pone.0074951	http://dx.doi.org/10.1371/journal.pone.0074951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023705	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200103
J	Pitts, KL; Fenech, M				Pitts, Katie L.; Fenech, Marianne			An Analytic Study on the Effect of Alginate on the Velocity Profiles of Blood in Rectangular Microchannels Using Microparticle Image Velocimetry	PLOS ONE			English	Article							MICRO-PIV; IN-VIVO; VISCOSITY; FLOW; AGGREGATION; MICROCIRCULATION; RESUSCITATION; PRESSURE; DENSITY	It is desired to understand the effect of alginic acid sodium salt from brown algae (alginate) as a viscosity modifier on the behavior of blood in vitro using a micro-particle image velocimetry (mu PIV) system. The effect of alginate on the shape of the velocity profile, the flow rate and the maximum velocity achieved in rectangular microchannels channels are measured. The channels were constructed of polydimethylsiloxane (PDMS), a biocompatible silicone. Porcine blood cells suspended in saline was used as the working fluid at twenty percent hematocrit (H = 20). While alginate was only found to have minimal effect on the maximum velocity and the flow rate achieved, it was found to significantly affect the shear rate at the wall by between eight to a hundred percent.	[Pitts, Katie L.; Fenech, Marianne] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa	Fenech, M (corresponding author), Univ Ottawa, Ottawa, ON, Canada.	mfenech@uottawa.ca			Natural Science and Engineering Research Council of Canada (NSERC) [RGPIN-357112-2008, EQPEQ-390368-2010]	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by The Natural Science and Engineering Research Council of Canada (NSERC) grants RGPIN-357112-2008 and EQPEQ-390368-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4001292; Armstrong JK, 2001, BIORHEOLOGY, V38, P239; Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043; Brunker J, 2010, P SOC PHOTO-OPT INS, V7564; Cabrales P, 2005, SHOCK, V23, P549, DOI 10.1097/01.shk.0000164187.38741.19; Cabrales P, 2004, SHOCK, V22, P431, DOI 10.1097/01.shk.0000140662.72907.95; Cabrales P, 2004, AM J PHYSIOL-HEART C, V287, pH363, DOI 10.1152/ajpheart.01039.2003; Cabrales P, 2006, AM J PHYSIOL-HEART C, V291, pH2445, DOI 10.1152/ajpheart.00394.2006; Chandran KB, 2006, BIOUID MECH; Cheung YK, 2009, LAB CHIP TECHNOLOGY, P115; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Domachuk P, 2010, ADV MATER, V22, P249, DOI 10.1002/adma.200900821; Fenech M, 2008, I S BIOMED IMAGING, P153, DOI 10.1109/ISBI.2008.4540955; GOLDSMITH HL, 1989, AM J PHYSIOL, V257, pH1005, DOI 10.1152/ajpheart.1989.257.3.H1005; Hardy BS, 2009, LAB CHIP, V9, P935, DOI 10.1039/b813061b; Koutsiaris AG, 2009, CLIN HEMORHEOL MICRO, V43, P321, DOI 10.3233/CH-2009-1243; Launiere CA, 2011, BIOMED MICRODEVICES, V13, P549, DOI 10.1007/s10544-011-9524-8; Lauri J, 2008, PROC SPIE, V6863, DOI 10.1117/12.768500; Lima R, 2008, BIOMED MICRODEVICES, V10, P153, DOI 10.1007/s10544-007-9121-z; Markhefka JN, 2009, BIORHEOLOGY, V46, P281; Martini J, 2006, J INTERN MED, V259, P364, DOI 10.1111/j.1365-2796.2006.01622.x; Meinhart CD, 2000, J FLUID ENG-T ASME, V122, P285, DOI 10.1115/1.483256; Nguyen CV, 2010, EXP FLUIDS, V49, P701, DOI 10.1007/s00348-010-0837-9; Pitts KL, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/10/105302; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Solandt OM, 1942, Q J EXP PHYSIOL CMS, V31, P25; Tabeling P, 2006, INTRO MICROUIDICS; Tsai AG, 2001, BIORHEOLOGY, V38, P229; Weng X, 1996, BIORHEOLOGY, V33, P365, DOI 10.1016/0006-355X(96)00028-5; Wereley ST, 2002, AIAA J, V40, P1047, DOI 10.2514/2.1786; Wereley ST, 2010, ANNU REV FLUID MECH, V42, P557, DOI 10.1146/annurev-fluid-121108-145427; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; Wong KKL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005688; Zeng HS, 2009, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION 2008, VOL 2, P223; Zhao LA, 2010, ARTIF CELL BLOOD SUB, V38, P267, DOI 10.3109/10731191003776736	36	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72909	10.1371/journal.pone.0072909	http://dx.doi.org/10.1371/journal.pone.0072909			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023655	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200051
J	Zhou, H; Zeng, C; Wei, Y; Zhou, J; Yao, WX				Zhou, Hang; Zeng, Chao; Wei, Yang; Zhou, Jin; Yao, Wenxiu			Duration of Chemotherapy for Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							MAINTENANCE CHEMOTHERAPY; RANDOMIZED-TRIAL; INDUCTION CHEMOTHERAPY; PHASE-III; THERAPY; CISPLATIN; RADIOTHERAPY; CARCINOMA; ETOPOSIDE; NO	Background: Maintenance chemotherapy is widely provided to patients with small cell lung cancer (SCLC). However, the benefits of maintenance chemotherapy compared with observation are a subject of debate. Methodology and Principal Findings: To identify relevant literature, we systematically searched the Medline, Embase, and Cochrane Central Register of Controlled Trials databases. Eligible trials included patients with SCLC who either received maintenance chemotherapy (administered according to a continuous or switch strategy) or underwent observation. The primary outcome was 1-year mortality, and secondary outcomes were 2-year mortality, overall survival (OS), and progression-free survival (PFS). Of the 665 studies found in our search, we identified 14 relevant trials, which together reported data on 1806 patients with SCLC. When compared with observation, maintenance chemotherapy had no effect on 1-year mortality (odds ratio [OR]: 0.88; 95% confidence interval [CI]: 0.66-1.19; P = 0.414), 2-year mortality (OR: 0.82; 95% CI: 0.57-1.19; P = 0.302), OS (hazard ratio [HR]: 0.87; 95% CI: 0.71-1.06; P = 0.172), or PFS (HR: 0.87; 95% CI: 0.62-1.22; P = 0.432). However, subgroup analyses indicated that maintenance chemotherapy was associated with significantly longer PFS than observation in patients with extensive SCLC (HR, 0.72; 95% CI: 0.58-0.89; P = 0.003). Additionally, patients who were managed using the continuous strategy of maintenance chemotherapy appeared to be at a disadvantage in terms of PFS compared with patients who only underwent observation (HR, 1.27; 95% CI: 1.04-1.54; P = 0.018). Conclusions/Significance: Maintenance chemotherapy failed to improve survival outcomes in patients with SCLC. However, a significant advantage in terms of PFS was observed for maintenance chemotherapy in patients with extensive disease. Additionally, our results suggest that the continuous strategy is inferior to observation; its clinical value needs to be investigated in additional trials.	[Zhou, Hang; Wei, Yang; Zhou, Jin; Yao, Wenxiu] Sichuan Canc Hosp, Dept Chemotherapy, Chengdu, Peoples R China; [Zeng, Chao] Third Peoples Hosp Chengdu, Dept Gastroenterol, Chengdu, Peoples R China		Yao, WX (corresponding author), Sichuan Canc Hosp, Dept Chemotherapy, Chengdu, Peoples R China.	yaowenxiu_2011@126.com						Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Beith JM, 1996, EUR J CANCER, V32A, P438, DOI 10.1016/0959-8049(95)00608-7; BLEEHEN NM, 1989, BRIT J CANCER, V59, P584; BYRNE MJ, 1989, BRIT J CANCER, V60, P413, DOI 10.1038/bjc.1989.296; CULLEN M, 1986, CANCER CHEMOTH PHARM, V17, P157, DOI 10.1007/BF00306746; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ETTINGER DS, 1990, J CLIN ONCOL, V8, P230, DOI 10.1200/JCO.1990.8.2.230; GIACCONE G, 1993, J CLIN ONCOL, V11, P1230, DOI 10.1200/JCO.1993.11.7.1230; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Han JY, 2008, J THORAC ONCOL, V3, P1039, DOI 10.1097/JTO.0b013e3181834f8e; Hanna NH, 2002, ANN ONCOL, V13, P95, DOI 10.1093/annonc/mdf014; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; JOHNSON DH, 1993, J CLIN ONCOL, V11, P1223, DOI 10.1200/JCO.1993.11.7.1223; LEBEAU B, 1992, EUR RESPIR J, V5, P286; Minna JD, 1989, CANCER PRINCIPLES PR, P591; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; PATEL AM, 1993, MAYO CLIN PROC, V68, P475, DOI 10.1016/S0025-6196(12)60197-9; Payne DG, 1989, LUNG CANCER, V5, P135; PEREZ CA, 1984, J CLIN ONCOL, V2, P1200, DOI 10.1200/JCO.1984.2.11.1200; Rossi A, 2010, LUNG CANCER, V70, P119, DOI 10.1016/j.lungcan.2010.02.001; Schiller JH, 2001, J CLIN ONCOL, V19, P2114, DOI 10.1200/JCO.2001.19.8.2114; Sculier JP, 1996, J CLIN ONCOL, V14, P2337, DOI 10.1200/JCO.1996.14.8.2337; SEIFTER EJ, 1988, SEMIN ONCOL, V15, P278	28	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73805	10.1371/journal.pone.0073805	http://dx.doi.org/10.1371/journal.pone.0073805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023692	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200089
J	Houri, N; Huang, KC; Nalbantoglu, J				Houri, Nadia; Huang, Kuo-Cheng; Nalbantoglu, Josephine			The Coxsackievirus and Adenovirus Receptor (CAR) Undergoes Ectodomain Shedding and Regulated Intramembrane Proteolysis (RIP)	PLOS ONE			English	Article							NEURAL-CELL-ADHESION; INTRACELLULAR-DOMAIN FRAGMENT; MOLECULE-LIKE PROTEIN; GAMMA-SECRETASE; NEURITE OUTGROWTH; TIGHT JUNCTIONS; CLEAVAGE; MIGRATION; COMPLEX; KINASE	The Coxsackievirus and Adenovirus Receptor (CAR) is a cell adhesion molecule originally characterized as a virus receptor but subsequently shown to be involved in physiological processes such as neuronal and heart development, epithelial tight junction integrity, and tumour suppression. Proteolysis of cell adhesion molecules and a wide variety of other cell surface proteins serves as a mechanism for protein turnover and, in some cases, cell signaling. Metalloproteases such as A Disintegrin and Metalloprotease (ADAM) family members cleave cell surface receptors to release their substrates' ectodomains, while the presenilin/gamma-secretase complex mediates regulated intramembrane proteolysis (RIP), releasing intracellular domain fragments from the plasma membrane. In the case of some substrates such as Notch and amyloid precursor protein (APP), the released intracellular domains enter the nucleus to modulate gene expression. We report that CAR ectodomain is constitutively shed from glioma cells and developing neurons, and is also shed when cells are treated with the phorbol ester phorbol 12-myristate 13-acetate (PMA) and the calcium ionophore ionomycin. We identified ADAM10 as a sheddase of CAR using assays involving shRNA knockdown and rescue, overexpression of wild-type ADAM10 and inhibition of ADAM10 activity by addition of its prodomain. In vitro peptide cleavage, mass spectrometry and mutagenesis revealed the amino acids M224 to L227 of CAR as the site of ADAM10-mediated ectodomain cleavage. CAR also undergoes RIP by the presenilin/gamma-secretase complex, and the intracellular domain of CAR enters the nucleus. Ectodomain shedding is a prerequisite for RIP of CAR. Thus, CAR belongs to the increasing list of cell surface molecules that undergo ectodomain shedding and that are substrates for.-secretase-mediated RIP.	[Nalbantoglu, Josephine] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	McGill University; McGill University	Nalbantoglu, J (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	josephine.nalbantoglu@mcgill.ca			Canadian Institutes for Health Research (CIHR); Natural Sciences and Engineering Research Council; Principal's Graduate Fellowship (McGill University); CIHR Strategic Training Program in Neuroinflammation; Fonds de la recherche en sante du Quebec	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Principal's Graduate Fellowship (McGill University); CIHR Strategic Training Program in Neuroinflammation(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	The authors thank the Canadian Institutes for Health Research (CIHR) and the Natural Sciences and Engineering Research Council for financial support. NH was supported by a Principal's Graduate Fellowship (McGill University) and a studentship from the CIHR Strategic Training Program in Neuroinflammation. K-CH was supported by a studentship from the Fonds de la recherche en sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Asher DR, 2005, GENESIS, V42, P77, DOI 10.1002/gene.20127; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bolsover SR, 2005, CELL CALCIUM, V37, P395, DOI 10.1016/j.ceca.2005.01.007; Brennaman LH, 2008, MOL CELL NEUROSCI, V37, P781, DOI 10.1016/j.mcn.2008.01.006; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Carson SD, 1997, BIOCHEM BIOPH RES CO, V233, P325, DOI 10.1006/bbrc.1997.6449; Carson SD, 2001, REV MED VIROL, V11, P219, DOI 10.1002/rmv.318; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen JW, 2006, CIRC RES, V98, P923, DOI 10.1161/01.RES.0000218041.41932.e3; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Dorner AA, 2005, J CELL SCI, V118, P3509, DOI 10.1242/jcs.02476; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Guo YL, 2009, ARTERIOSCL THROM VAS, V29, P75, DOI 10.1161/ATVBAHA.108.177717; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Huang KC, 2005, INT J CANCER, V113, P738, DOI 10.1002/ijc.20623; Huang KC, 2007, FEBS LETT, V581, P2702, DOI 10.1016/j.febslet.2007.05.019; Hubschmann MV, 2005, J NEUROSCI RES, V80, P826, DOI 10.1002/jnr.20530; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Jiang SK, 2007, PROTEIN SCI, V16, P539, DOI 10.1110/ps.062643507; Jorissen E, 2010, CURR TOP DEV BIOL, V92, P201, DOI 10.1016/S0070-2153(10)92006-1; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kim M, 2003, BRIT J CANCER, V88, P1411, DOI 10.1038/sj.bjc.6600932; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matusica D, 2013, J BIOL CHEM, V288, P11144, DOI 10.1074/jbc.M112.436469; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Murphy G, 2010, INT J EXP PATHOL, V91, P303, DOI 10.1111/j.1365-2613.2010.00736.x; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nalbantoglu J, 1999, HUM GENE THER, V10, P1009, DOI 10.1089/10430349950018409; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Okegawa T, 2001, CANCER RES, V61, P6592; Patzke C, 2010, J NEUROSCI, V30, P2897, DOI 10.1523/JNEUROSCI.5725-09.2010; Pazirandeh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020203; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shaw CA, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-42; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Stoeck A, 2010, J CELL SCI, V123, P2319, DOI 10.1242/jcs.060830; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Tousseyn Thomas, 2006, Birth Defects Research, V78, P24, DOI 10.1002/bdrc.20066; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; van't Hof W, 2002, J VIROL, V76, P6382, DOI 10.1128/JVI.76.12.6382-6386.2002; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Wild-Bode C, 2006, J BIOL CHEM, V281, P23824, DOI 10.1074/jbc.M601542200; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698; YEE NS, 1993, J BIOL CHEM, V268, P14189; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	77	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73296	10.1371/journal.pone.0073296	http://dx.doi.org/10.1371/journal.pone.0073296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015300	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800096
J	Gomez, JMM; Chen, LP; Schwarz, H; Karrasch, T				Gomez, Julia M. Martinez; Chen, Lieping; Schwarz, Herbert; Karrasch, Thomas			CD137 Facilitates the Resolution of Acute DSS-Induced Colonic Inflammation in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL COLITIS; INTESTINAL INFLAMMATION; MONOCLONAL-ANTIBODIES; ULCERATIVE-COLITIS; IMMUNE-RESPONSES; DENDRITIC CELLS; TRANSGENIC MICE; CROHNS-DISEASE	Background: CD137 and its ligand (CD137L) are potent immunoregulatory molecules that influence activation, proliferation, differentiation and cell death of leukocytes. Expression of CD137 is upregulated in the lamina propria cells of Crohn's disease patients. Here, the role of CD137 in acute Dextran-Sodium-Sulfate (DSS)-induced colitis in mice was examined. Methods: We induced acute large bowel inflammation (colitis) via DSS administration in CD137(-/-) and wild-type (WT) mice. Colitis severity was evaluated by clinical parameters (weight loss), cytokine secretion in colon segment cultures, and scoring of histological inflammatory parameters. Additionally, populations of lamina propria mononuclear cells (LPMNC) and intraepithelial lymphocytes (IEL) were characterized by flow cytometry. In a subset of mice, resolution of intestinal inflammation was evaluated 3 and 7 days after withdrawal of DSS. Results: We found that both CD137(-/-) and WT mice demonstrated a similar degree of inflammation after 5 days of DSS exposure. However, the resolution of colonic inflammation was impaired in the absence of CD137. This was accompanied by a higher histological score of inflammation, and increased release of the pro-inflammatory mediators granulocyte macrophage colony-stimulating factor (GM-CSF), CXCL1, IL-17 and IFN-gamma. Further, there were significantly more neutrophils among the LPMNC of CD137(-/-) mice, and reduced numbers of macrophages among the IEL. Conclusion: We conclude that CD137 plays an essential role in the resolution of acute DSS-induced intestinal inflammation in mice.	[Gomez, Julia M. Martinez] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Schwarz, Herbert] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Karrasch, Thomas] Univ Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany	National University of Singapore; National University of Singapore; Yale University; University of Regensburg	Schwarz, H (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore.	phssh@nus.edu.sg; Thomas.Karrasch@klinik.uni-regensburg.de			National Medical Research Council, Singapore [NMRC/CNIG/1086/2012]; German Research Foundation [DFG KA 1846/2-1]; Robert-Bosch-Stiftung, Germany	National Medical Research Council, Singapore(National Medical Research Council, Singapore); German Research Foundation(German Research Foundation (DFG)); Robert-Bosch-Stiftung, Germany	This study was supported by grant NMRC/CNIG/1086/2012 from the National Medical Research Council, Singapore to HS. TK was supported by the German Research Foundation (DFG KA 1846/2-1) as well as the Robert-Bosch-Stiftung, Germany. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; COOPER HS, 1993, LAB INVEST, V69, P238; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Gomez JMM, 2012, J NEUROSCI, V32, P18246, DOI 10.1523/JNEUROSCI.2473-12.2012; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Heinisch IVWM, 2000, EUR J IMMUNOL, V30, P3441, DOI 10.1002/1521-4141(2000012)30:12<3441::AID-IMMU3441>3.0.CO;2-L; Irie J, 2007, DIABETES, V56, P186, DOI 10.2337/db06-0793; Jiang D, 2008, STEM CELLS, V26, P2372, DOI 10.1634/stemcells.2008-0158; Jiang DS, 2008, J IMMUNOL, V181, P3923, DOI 10.4049/jimmunol.181.6.3923; Jiang DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015565; Kang YJ, 2007, NAT IMMUNOL, V8, P601, DOI 10.1038/ni1471; Karrasch T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000596; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kim YH, 2011, J IMMUNOL, V187, P1120, DOI 10.4049/jimmunol.1002681; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Langstein J, 1998, J IMMUNOL, V160, P2488; Lee SC, 2009, INFECT IMMUN, V77, P2168, DOI 10.1128/IAI.01350-08; Lee SW, 2009, ADV EXP MED BIOL, V647, P120, DOI 10.1007/978-0-387-89520-8_8; Maerten P, 2006, CLIN EXP IMMUNOL, V143, P228, DOI 10.1111/j.1365-2249.2005.02991.x; Maerten P, 2004, CLIN IMMUNOL, V112, P239, DOI 10.1016/j.clim.2004.04.009; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Mittler RS, 1999, J EXP MED, V190, P1535, DOI 10.1084/jem.190.10.1535; Moh MC, 2013, FASEB J OFFICIAL PUB; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Qian BF, 2001, NEUROENDOCRINOLOGY, V73, P358, DOI 10.1159/000054653; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; Qualls JE, 2009, INFLAMM BOWEL DIS, V15, P236, DOI 10.1002/ibd.20733; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shao Z, 2011, J LEUKOCYTE BIOL, V89, P21, DOI 10.1189/jlb.0510315; Shih David Q, 2009, Curr Gastroenterol Rep, V11, P473; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Sun YL, 2002, J IMMUNOL, V168, P1457, DOI 10.4049/jimmunol.168.3.1457; Tamada K, 2006, CANCER IMMUNOL IMMUN, V55, P355, DOI 10.1007/s00262-005-0081-y; Tang Q, 2013, EUR J IMMUNOL, DOI [10.1002/eji.201243071, DOI 10.1002/EJI.201243071.[]; Thum E, 2009, FRONT BIOSCI-LANDMRK, V14, P4173, DOI 10.2741/3521; Veltkamp C, 2001, GASTROENTEROLOGY, V120, P900, DOI 10.1053/gast.2001.22547; Vinay DS, 2006, J IMMUNOL, V177, P5708, DOI 10.4049/jimmunol.177.8.5708; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Wilcox RA, 2002, J IMMUNOL, V169, P4230, DOI 10.4049/jimmunol.169.8.4230; Wilcox RA, 2002, J IMMUNOL, V168, P4262, DOI 10.4049/jimmunol.168.9.4262; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; Zhu YW, 2007, BLOOD, V109, P4882, DOI 10.1182/blood-2006-10-043463	50	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73277	10.1371/journal.pone.0073277	http://dx.doi.org/10.1371/journal.pone.0073277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023849	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600087
J	Motl, RW; Pilutti, LA; Learmonth, YC; Goldman, MD; Brown, T				Motl, Robert W.; Pilutti, Lara A.; Learmonth, Yvonne C.; Goldman, Myla D.; Brown, Ted			Clinical Importance of Steps Taken per Day among Persons with Multiple Sclerosis	PLOS ONE			English	Article							INCREASING PHYSICAL-ACTIVITY; INDIVIDUALS; ADULTS; SCORES; IMPACT	Background: The number of steps taken per day (steps/day) provides a reliable and valid outcome of free-living walking behavior in persons with multiple sclerosis (MS). Objective: This study examined the clinical meaningfulness of steps/day using the minimal clinically important difference (MCID) value across stages representing the developing impact of MS. Methods: This study was a secondary analysis of de-identified data from 15 investigations totaling 786 persons with MS and 157 healthy controls. All participants provided demographic information and wore an accelerometer or pedometer during the waking hours of a 7-day period. Those with MS further provided real-life, health, and clinical information and completed the Multiple Sclerosis Walking Scale-12 (MSWS-12) and Patient Determined Disease Steps (PDDS) scale. MCID estimates were based on regression analyses and analysis of variance for between group differences. Results: The mean MCID from self-report scales that capture subtle changes in ambulation (1-point change in PDSS scores and 10-point change in MSWS-12 scores) was 779 steps/day (14% of mean score for MS sample); the mean MCID for clinical/health outcomes (MS type, duration, weight status) was 1,455 steps/day (26% of mean score for MS sample); real-life anchors (unemployment, divorce, assistive device use) resulted in a mean MCID of 2,580 steps/day (45% of mean score for MS sample); and the MCID for the cumulative impact of MS (MS vs. control) was 2,747 steps/day (48% of mean score for MS sample). Conclusion: The change in motion sensor output of,800 steps/day appears to represent a lower-bound estimate of clinically meaningful change in free-living walking behavior in interventions of MS.	[Motl, Robert W.; Pilutti, Lara A.; Learmonth, Yvonne C.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Goldman, Myla D.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Brown, Ted] Evergreen Hlth, MS Ctr Evergreen, Evergreen, WA USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Virginia	Motl, RW (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA.	robmotl@illinois.edu	Goldman, Myla/AAG-8737-2020; Goldman, Myla D/D-1955-2017	Goldman, Myla/0000-0002-5675-945X; Learmonth, Yvonne/0000-0002-4857-8480	Acorda Therapeutics	Acorda Therapeutics	This research was supported by an investigator-initiated grant from Acorda Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders did receive and read a copy of the paper and provided approval before submission.	Busse ME, 2004, J NEUROL NEUROSUR PS, V75, P884, DOI 10.1136/jnnp.2003.020180; Cavanaugh JT, 2011, J NEUROL PHYS THER, V35, P26, DOI 10.1097/NPT.0b013e3182097190; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costelloe L, 2007, J NEUROL NEUROSUR PS, V78, P841, DOI 10.1136/jnnp.2006.105759; Dlugonski D, 2011, J REHABIL RES DEV, V48, P1129, DOI 10.1682/JRRD.2010.09.0192; Gijbels D, 2010, MULT SCLER J, V16, P618, DOI 10.1177/1352458510361357; Goldman Myla D, 2010, Ther Adv Neurol Disord, V3, P229, DOI 10.1177/1756285610374117; Grcic PF, 2011, MED SCI MONITOR, V17, pCR704, DOI 10.12659/MSM.882130; Hadjimichael O, 2007, PAIN, V127, P35, DOI 10.1016/j.pain.2006.07.015; Hobart J, 2010, MULT SCLER, V16, pS172; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Learmonth YC, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-37; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Motl RW, 2007, ADAPT PHYS ACT Q, V24, P245, DOI 10.1123/apaq.24.3.245; Motl RW, 2013, PHYS MED REH CLIN N, V24, P325, DOI 10.1016/j.pmr.2012.11.004; Motl RW, 2011, BEHAV MED, V37, P125, DOI 10.1080/08964289.2011.636769; Motl RW, 2011, DISABIL HEALTH J, V4, P52, DOI 10.1016/j.dhjo.2010.02.003; Motl RW, 2005, MULT SCLER, V11, P343, DOI 10.1191/1352458505ms1161oa; Pearson OR, 2004, QJM-INT J MED, V97, P463, DOI 10.1093/qjmed/hch084; WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry (1993: Geneva S Organization WH, 1995, PHYS STAT US INT ANT	20	48	48	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73247	10.1371/journal.pone.0073247	http://dx.doi.org/10.1371/journal.pone.0073247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023843	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600084
J	Yamamoto, Y; Yokoyama, K; Okumura, M; Kijima, A; Kadota, K; Gohara, K				Yamamoto, Yuji; Yokoyama, Keiko; Okumura, Motoki; Kijima, Akifumi; Kadota, Koji; Gohara, Kazutoshi			Joint Action Syntax in Japanese Martial Arts	PLOS ONE			English	Article							PHASE-TRANSITIONS; PREFRONTAL CORTEX; FRACTAL TRANSITION; DYNAMICAL-SYSTEMS; SERIAL ORDER; TRANSIENT; MOVEMENTS	Participation in interpersonal competitions, such as fencing or Japanese martial arts, requires players to make instantaneous decisions and execute appropriate motor behaviors in response to various situations. Such actions can be understood as complex phenomena emerging from simple principles. We examined the intentional switching dynamics associated with continuous movement during interpersonal competition in terms of their emergence from a simple syntax. Linear functions on return maps identified two attractors as well as the transitions between them. The effects of skill differences were evident in the second- and third-order state-transition diagrams for these two attractors. Our results suggest that abrupt switching between attractors is related to the diverse continuous movements resulting from quick responses to sudden changes in the environment. This abrupt-switching-quick-response behavior is characterized by a joint action syntax. The resulting hybrid dynamical system is composed of a higher module with discrete dynamics and a lower module with continuous dynamics. Our results suggest that intelligent human behavior and robust autonomy in real-life scenarios are based on this hybrid dynamical system, which connects interpersonal coordination and competition.	[Yamamoto, Yuji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan; [Yokoyama, Keiko; Gohara, Kazutoshi] Hokkaido Univ, Div Appl Phys, Dept Engn, Sapporo, Hokkaido, Japan; [Yokoyama, Keiko] Japan Soc Promot Sci, Res Fellowship Div, Tokyo, Japan; [Okumura, Motoki] Shizuoka Univ, Fac Educ, Shizuoka 4228529, Japan; [Kijima, Akifumi] Univ Yamanashi, Grad Sch Educ, Kofu, Yamanashi, Japan; [Kadota, Koji] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan	Nagoya University; Hokkaido University; Japan Society for the Promotion of Science; Shizuoka University; University of Yamanashi; Osaka University	Yamamoto, Y (corresponding author), Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan.	yamamoto@htc.nagoya-u.ac.jp		Gohara, Kazutoshi/0000-0002-0730-4969	MEXT, Japan [20240060, 24240085]; JSPS, Japan [22650146]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by Grants-in-Aid for Scientific Research (A) 20240060 and 24240085 from MEXT, Japan and a Grant-in-Aid for Challenging Exploratory Research 22650146 from the JSPS, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JW, 1998, J NEUROSCI, V18, P2777; BERRIDGE KC, 1987, BEHAV BRAIN RES, V23, P59, DOI 10.1016/0166-4328(87)90242-7; BERRIDGE KC, 1992, EXP BRAIN RES, V90, P275; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; ERDOS P, 1960, B INT STATIST INST, V38, P343; Frank TD, 2010, PHYSICA D, V239, P2084, DOI 10.1016/j.physd.2010.07.015; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Gohara K, 1999, FRACTALS, V7, P205, DOI 10.1142/S0218348X99000220; Gohara K, 1999, FRACTALS, V7, P313, DOI 10.1142/S0218348X99000311; Golubitsky M, 2002, SYMMETRY PERSPECTIVE, DOI 10.1007/978-3-0348-8167-8; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H, 1983, ADV SYNEGETICS INSTA; Haken H, 1978, SYNERGETICS INTRO NO, DOI [10.1007/978-3-642-96469-5, DOI 10.1007/978-3-642-96469-5]; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Huang X., 1990, HIDDEN MARKOV MODELS; KELSO JAS, 1987, PHYS SCRIPTA, V35, P79, DOI 10.1088/0031-8949/35/1/020; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kijima A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047911; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; Kozma R, 2008, PHYS LIFE REV, V5, P1, DOI 10.1016/j.plrev.2007.10.002; Kozma R, 2009, NEURAL NETWORKS, V22, P277, DOI 10.1016/j.neunet.2009.03.019; Kugler PN, 1987, INFORM NATURAL LAW S; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Nicolis G, 1977, SELF ORG NONEQUILIBR; Nishikawa J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036210; Nishikawa J, 2008, INT J BIFURCAT CHAOS, V18, P3665, DOI 10.1142/S0218127408022639; Okumura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051877; Press W. H., 1992, ART SCI COMPUTING; Ramenzoni VC, 2011, EXP BRAIN RES, V211, P447, DOI 10.1007/s00221-011-2653-8; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; SCHMIDT RC, 1994, BIOL CYBERN, V70, P369, DOI 10.1007/BF00200334; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Strogatz S.H., 2003, SYNC EMERGING SCI SP; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Yamamoto Y, 2000, HUM MOVEMENT SCI, V19, P341, DOI 10.1016/S0167-9457(00)00018-X; Yokoyama K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002181; [No title captured]	43	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72436	10.1371/journal.pone.0072436	http://dx.doi.org/10.1371/journal.pone.0072436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023740	gold, Green Published			2022-12-27	WOS:000324515600020
J	Zeng, ZY; Wang, JG; Zhao, LY; Hu, P; Zhang, HL; Tang, X; He, DL; Tang, SF; Zeng, ZF				Zeng, Zongyue; Wang, Jiangen; Zhao, Liuyang; Hu, Ping; Zhang, Hailong; Tang, Xi; He, Dali; Tang, Shifu; Zeng, Zhaofang			Potential Role of microRNA-21 in the Diagnosis of Gastric Cancer: A Meta-Analysis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CLINICAL-ASSOCIATION; SYSTEMATIC REVIEWS; TEST ACCURACY; SERUM; EXPRESSION; BIOMARKERS; PROGRESSION; MECHANISMS; GENES	Introduction: Accumulating evidences indicate that microRNA-21(miR-21) show significant high concentration in plasma of gastric cancer (GC) patients compared to normal individuals, suggesting that it may be a useful novel diagnostic biomarker for gastric cancer. Therefore, we aimed to assess the potential diagnostic value of miR-21 for gastric cancer in this study. Methods: Literature database including PubMed, Embase, the Cochrane Library, Web of Science, Ovid, SciVerse, Science Direct, Scopus, BioMed Central, Biosis previews, Chinese Biomedical Literature Database (CBM), Chinese National Knowledge Infrastructure (CNKI), Technology of Chongqing (VIP), and Wan Fang DATA were searched for publications concerning the diagnostic value of miR-21 for GC without language restriction. The quality of each study was scored with the Quality Assessment of Diagnostic Accuracy Studies (QUADAS). Then, data were retrieved from any qualified article hits and subject to meta-analysis. Receiver operating characteristic curves (ROC) were used to check the overall test performance. Evidence of heterogeneity was evaluated using the Chi-square and I 2 test. Results: Five studies with a total 251 GC patients and 184 control individuals were included in this meta-analysis. All of the included studies are of high quality (QUADAS score$13). The summary estimates revealed that the pooled sensitivity is 66.5% (95% confidence interval (CI): 55.0%-76.3%) and the specificity is 83.1% (95% CI: 69.4%-91.5%). In addition, the area under the summary ROC curve (AUC) is 0.80. Conclusion: The current evidence suggests that miR-21 has potential diagnostic value with a moderate sensitivity and specificity for GC. More prospective studies on the diagnostic value of miR-21 for GC are needed in the future.	[Zeng, Zongyue; Wang, Jiangen; Zhao, Liuyang; Hu, Ping; Zhang, Hailong; Tang, Xi; He, Dali; Tang, Shifu; Zeng, Zhaofang] Chong Qing Med Univ, Chinese Minist Educ, Coll Lab Med, Key Lab,Lab Med Diagnost, Chongqing, Peoples R China	Chongqing Medical University	Zeng, ZF (corresponding author), Chong Qing Med Univ, Chinese Minist Educ, Coll Lab Med, Key Lab,Lab Med Diagnost, Chongqing, Peoples R China.	zeng000@126.com		Zeng, Zongyue/0000-0002-4333-5412				Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan SH, 2008, ANTICANCER RES, V28, P907; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cui L, 2013, CANCER-AM CANCER SOC, V119, P1618, DOI 10.1002/cncr.27903; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Garcia M., 2011, GLOBAL CANC FACTS FI; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jiang Z, 2010, J GASTROENTEROL, V45, P17, DOI 10.1007/s00535-009-0135-6; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Li Y, 2011, HEPATO-GASTROENTEROL, V58, P2166, DOI 10.5754/hge11753; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nobili S, 2011, WORLD J GASTROENTERO, V17, P290, DOI 10.3748/wjg.v17.i3.290; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Sapari NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036275; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen J, 2012, J ZHENGZHOU U MED SC, V47, P722; Shiota S, 2010, FUTURE MICROBIOL, V5, P1885, DOI 10.2217/FMB.10.135; Sobin, 2009, UICC TNM CLASSIFICAT; Society AAC, 2011, GLOB CANC FACTS FIG; Tan YK, 2006, EUR J GASTROEN HEPAT, V18, P821, DOI 10.1097/00042737-200608000-00004; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Wang B, 2012, J CANCER RES CLIN, V138, P1659, DOI 10.1007/s00432-012-1244-9; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Yamashita K, 2011, SURG TODAY, V41, P24, DOI 10.1007/s00595-010-4370-5; Ye T, 2010, MINI-REV MED CHEM, V10, P1034, DOI 10.2174/1389557511009011034; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang YY, 2010, MED ONCOL, V27, P685, DOI 10.1007/s12032-009-9269-x; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zheng YY, 2011, CANCER BIOMARK, V10, P71, DOI 10.3233/CBM-2011-0231; Zhu Yu-bing, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P161	48	50	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73278	10.1371/journal.pone.0073278	http://dx.doi.org/10.1371/journal.pone.0073278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023850	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600088
J	Boeckx, C; Leivada, E				Boeckx, Cedric; Leivada, Evelina			Entangled Parametric Hierarchies: Problems for an Overspecified Universal Grammar	PLOS ONE			English	Article							LANGUAGE DESIGN; MODEL	This study addresses the feasibility of the classical notion of parameter in linguistic theory from the perspective of parametric hierarchies. A novel program-based analysis is implemented in order to show certain empirical problems related to these hierarchies. The program was developed on the basis of an enriched data base spanning 23 contemporary and 5 ancient languages. The empirical issues uncovered cast doubt on classical parametric models of language acquisition as well as on the conceptualization of an overspecified Universal Grammar that has parameters among its primitives. Pinpointing these issues leads to the proposal that (i) the (bio)logical problem of language acquisition does not amount to a process of triggering innately pre-wired values of parameters and (ii) it paves the way for viewing language, epigenetic ('parametric') variation as an externalization-related epiphenomenon, whose learning component may be more important than what sometimes is assumed.	[Boeckx, Cedric] ICREA, Barcelona, Spain; [Boeckx, Cedric; Leivada, Evelina] Univ Barcelona, Barcelona, Spain	ICREA; University of Barcelona	Leivada, E (corresponding author), Univ Barcelona, Barcelona, Spain.	evelina@biolinguistics.eu	Boeckx, Cedric a/F-4781-2016	Leivada, Evelina/0000-0003-3181-1917; Boeckx, Cedric/0000-0001-8882-9718	European Union [PIRG-GA-2009-256413]; Fundacio Bosch i Gimpera; Spanish Ministry of Economy and Competitiveness [FFI-2010-20634]; ICREA Funding Source: Custom	European Union(European Commission); Fundacio Bosch i Gimpera; Spanish Ministry of Economy and Competitiveness(Spanish Government); ICREA(ICREA)	The present work was made possible through a Marie Curie International Reintegration Grant from the European Union (PIRG-GA-2009-256413), research funds from the Fundacio Bosch i Gimpera, and a grant from the Spanish Ministry of Economy and Competitiveness (FFI-2010-20634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MC, 2005, LANG LEARN DEV, V1, P93, DOI 10.1207/s15473341lld0101_6; Baker Mark C., 1996, POLYSYNTHESIS PARAME; Baker MC, 2003, TRENDS COGN SCI, V7, P349, DOI 10.1016/S1364-6613(03)00157-8; Baltin M, 2004, STUD LANG, V28, P549, DOI 10.1075/sl.28.3.05bal; Boeckx Cedric, 2011, BIOLINGUISTIC ENTERP, P205; Chomsky N, 2005, LINGUIST INQ, V36, P1, DOI 10.1162/0024389052993655; Chomsky Noam, 1981, LECT GOVT BINDING; CLARK R, 1993, LINGUIST INQ, V24, P299; Colonna V, 2010, HUM HERED, V70, P245, DOI 10.1159/000317374; Evers Arnold, 2008, LIMITS SYNTACTIC VAR, P483; Gelman A., 2003, BAYESIAN DATA ANAL; Goldberg AE, 2004, COGNITION, V94, P77, DOI 10.1016/j.cognition.2004.03.003; Haspelmath Martin, 2008, LIMITS SYNTACTIC VAR, V132, P75, DOI DOI 10.1075/LA; Kemp C, 2007, DEVELOPMENTAL SCI, V10, P307, DOI 10.1111/j.1467-7687.2007.00585.x; Kohl KT, 1999, THESIS MIT; Longobardi G, 2012, PARAMETER THEORY LIN, P304; Longobardi G, 2009, LINGUA, V119, P1679, DOI 10.1016/j.lingua.2008.09.012; Lorenzo G, 2009, LINGUA, V119, P1300, DOI 10.1016/j.lingua.2009.02.003; NEWMEYER F., 2005, LINGUIST VAR, V4, P181, DOI [DOI 10.1075/LIVY.4.06NEW, 10.1075/livy.4.06new]; Newmeyer Frederick J., 2005, POSSIBLE PROBABLE LA; Niyogi P, 1996, COGNITION, V61, P161, DOI 10.1016/S0010-0277(96)00718-4; Piattelli-Palmarini M., 1980, LANGUAGE LEARNING DE; Pica P, 2001, LINGUISTIC VARIATION, V1, pv; Rigon G., 2009, THESIS U PISA; Roberts I, 2010, RETHINKING COMP SYNT; Sakas WG, 2012, LANG ACQUIS, V19, P83, DOI 10.1080/10489223.2012.660553; Tallerman M., 1998, UNDERSTANDING SYNTAX; Vainikka A, 1999, NAT LANG LINGUIST TH, V17, P613, DOI 10.1023/A:1006225032592	28	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72357	10.1371/journal.pone.0072357	http://dx.doi.org/10.1371/journal.pone.0072357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	217DY	24019867	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200009
J	Dugger, RA; El-Sayed, AM; Dogra, A; Messina, C; Bronson, R; Galea, S				Dugger, Robert A.; El-Sayed, Abdulrahman M.; Dogra, Anjali; Messina, Catherine; Bronson, Richard; Galea, Sandro			The Color of Debt: Racial Disparities in Anticipated Medical Student Debt in the United States	PLOS ONE			English	Article							SCHOOL APPLICANTS; KEY INDICATOR; EDUCATION; IMPACT; TUITION; FUTURE	Context: The cost of American medical education has increased substantially over the past decade. Given racial/ethnic inequalities in access to financial resources, it is plausible that increases in student debt burden resulting from these increases in cost may not be borne equally. Objective: To evaluate racial/ethnic disparities in medical student debt. Design, Setting, and Participants: Authors collected self-reported data from a non-representative sample of 2414 medical students enrolled at 111/159 accredited US medical schools between December 1st 2010 and March 27th 2011. After weighting for representativeness by race and class year and calculating crude anticipated debt by racial/ethnic category, authors fit multivariable regression models of debt by race/ethnicity adjusted for potential confounders. Main Outcome Measures: Anticipated educational debt upon graduation greater than $150,000. Results: 62.1% of medical students anticipated debt in excess of $ 150,000 upon graduation. The proportion of Blacks, Whites, Hispanics, and Asians reporting anticipated educational debt in excess of $150,000 was 77.3%, 65.1%, 57.2% and 50.2%, respectively. Both Black and White medical students demonstrated a significantly higher likelihood of anticipated debt in excess of $150,000 when compared to Asians [Blacks (OR = 2.7, 1.3-5.6), Whites (OR = 1.7, 1.3-2.2)] in adjusted models. Conclusion: Black medical students had significantly higher anticipated debt than Asian students. This finding has implications for understanding differential enrollment among minority groups in US medical schools.	[Dugger, Robert A.; El-Sayed, Abdulrahman M.; Galea, Sandro] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Dugger, Robert A.; Dogra, Anjali; Messina, Catherine; Bronson, Richard] SUNY Stony Brook, Stony Brook, NY 11794 USA; [El-Sayed, Abdulrahman M.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Columbia University	El-Sayed, AM (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA.	ame2145@columbia.edu	Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945				Adashi EY, 2010, ACAD MED, V85, P763, DOI 10.1097/ACM.0b013e3181d5cff7; American Association of Colleges of Osteopathic Medicine, 2012, TOT ENR RAC ETHN 197; American Association of Colleges of Osteopathic Medicine, 2012, 1 YEAR ENR US OST ME; American Association of Colleges of Osteopathic Medicine, 2011, AACOM 2010 11 AC YEA; [Anonymous], 2011, 2010 11 OST MED COLL; Antiel RM, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0907876; Association of American Medical Colleges, 2011, APPL 1 TIM APPL ACC; Association of American Medical Colleges, 2011, RES 2010 MED SCH ENR; Association of American Medical Colleges, 2010, 2010 MED SCH GRAD QU; Association of American Medical Colleges, 2012, TOT US MED SCH ENR R; Association of American Medical Colleges, 2010, TOT ENR US MED SCH R; AYERS WR, 1981, J MED EDUC, V56, P795; Burdman P., 2005, STUDENT DEBT DILEMMA; Cooper RA, 2003, ACAD MED, V78, P864, DOI 10.1097/00001888-200309000-00004; Grbic D, 2012, ACAD MED, V87, P246, DOI 10.1097/ACM.0b013e3182426a37; Greysen SR, 2011, ACAD MED, V86, P840, DOI 10.1097/ACM.0b013e31821daf03; Hauser R. M., 1993, PREJUDICE POLITICS A, P271; Hopkins K, 2012, US NEWS WORLD REPORT; Iglehart JK, 2011, NEW ENGL J MED, V365, P1340, DOI 10.1056/NEJMhpr1107519; Jolly P, 2005, HEALTH AFFAIR, V24, P527, DOI 10.1377/hlthaff.24.2.527; O'Connell HA, 2012, SOC FORCES, V90, P713, DOI 10.1093/sf/sor021; Phillips JP, 2010, FAM MED, V42, P616; Shapiro Thomas M., 2004, HIDDEN COST BEING AF; Shapiro TM., 2006, J LAW POLICY, V20, P53; Smedley BD, 2004, NATIONS COMPELLING I; Steinbrook R, 2008, NEW ENGL J MED, V359, P2629, DOI 10.1056/NEJMp0808520; U.S. Census Bureau, 2009, ED ATT US 2009; US Census Bureau, 2011, OVERVIEW RACE HISPAN; US Census Bureau, 2012, MON INC FAM MED INC; Youngclaus J, 2012, TRENDS COST DEBT US; Youngclaus J, 2012, ACAD MED, V87, P242, DOI 10.1097/ACM.0b013e31824269af; Zonia Susan C, 2002, J Am Osteopath Assoc, V102, P669	32	39	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74693	10.1371/journal.pone.0074693	http://dx.doi.org/10.1371/journal.pone.0074693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019975	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200118
J	Kalpouzos, G; Eriksson, J				Kalpouzos, Gregoria; Eriksson, Johan			Memory Self-Efficacy Beliefs Modulate Brain Activity when Encoding Real-World Future Intentions	PLOS ONE			English	Article							CONSTRUCTIVE EPISODIC SIMULATION; PREFRONTAL CORTEX; WORKING-MEMORY; BASAL GANGLIA; RETRIEVAL; ACTIVATION; DISTINCT; NETWORK; EVENTS; FMRI	Background: While the use of different cognitive strategies when encoding episodic memory information has been extensively investigated, modulation of brain activity by memory self-efficacy beliefs has not been studied yet. Methodology/Principal Findings: Sixteen young adults completed the prospective and retrospective metamemory questionnaire, providing individual subjective judgments of everyday memory function. The day after, using functional magnetic resonance imaging, the participants had to memorize real-world intentions (e. g., return a book to the library), which were performed later on in a virtual environment. Participants also performed offline cognitive tasks evaluating executive functions, working memory, and attention. During encoding, activity was found in medial temporal lobe, left prefrontal cortex, medial parietal regions, occipital areas, and regions involved in (pre) motor processes. Based on results from the questionnaire, the group was split into low and high memory self-efficacy believers. Comparison of encoding-related brain activity between the 2 groups revealed that the low memory self-efficacy believers activated more the hippocampus bilaterally, right posterior parahippocampal cortex, precuneus, and left lateral temporal cortex. By contrast, more activity was found in dorsal anterior cingulate gyrus for the high-memory believers. In addition, the low-memory believers performed more poorly at feature binding and (at trend) manipulating visuospatial information in working memory. Conclusion/Significance: Overall, these findings indicate that memory self-efficacy beliefs modulate brain activity during intentional encoding. Low memory self-efficacy believers activated more brain areas involved in visuospatial operations such as the hippocampus. Possibly, this increase reflects attempts to compensate for poor performance of certain neurocognitive processes, such as feature binding. By contrast, high-memory believers seemed to rely more on executive-like processes involved in cognitive control.	[Kalpouzos, Gregoria; Eriksson, Johan] Umea Ctr Funct Brain Imaging UFBI, Umea, Sweden; [Kalpouzos, Gregoria; Eriksson, Johan] Umea Univ, Physiol Sect, Dept Integrat Med Biol, Umea, Sweden; [Kalpouzos, Gregoria] Karolinska Inst, ARC, Stockholm, Sweden; [Kalpouzos, Gregoria] Stockholm Univ, S-10691 Stockholm, Sweden	Umea University; Karolinska Institutet; Stockholm University	Kalpouzos, G (corresponding author), Umea Ctr Funct Brain Imaging UFBI, Umea, Sweden.	gregoria.kalpouzos@ki.se			Goran Gustafsson Award in Medicine; Swedish Research Council	Goran Gustafsson Award in Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the 2007 Goran Gustafsson Award in Medicine and a grant from the Swedish Research Council to Lars Nyberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2008, HIPPOCAMPUS, V18, P227, DOI 10.1002/hipo.20405; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A, 1994, ENCY HUMAN BEHAV, DOI DOI 10.1002/9780470479216.CORPSY0836; Beaudoin M, 2011, PSYCHOL BULL, V137, P211, DOI 10.1037/a0022106; Bem DJ, 1972, ADV EXPT SOCIAL PSYC, V6, P1, DOI DOI 10.1016/S0065-2601(08)60024-6; BERRY JM, 1993, INT J BEHAV DEV, V16, P351, DOI 10.1177/016502549301600213; Bird CM, 2010, J NEUROSCI, V30, P11688, DOI 10.1523/JNEUROSCI.0723-10.2010; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Botzung A, 2008, BRAIN COGNITION, V66, P202, DOI 10.1016/j.bandc.2007.07.011; Brandimonte M, 1996, PROSPECTIVE MEMORY T; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Corsi P.M., 1972, THESIS MCGILL U MONT; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; D'Argembeau A, 2008, NEUROIMAGE, V40, P398, DOI 10.1016/j.neuroimage.2007.11.025; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; DIXON RA, 1989, EVERYDAY COGNITION IN ADULTHOOD AND LATE LIFE, P394; Dixon RA, 1988, MEMORY DEV UNIVERSAL, P293; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Eriksson J, 2011, NEUROSCI LETT, V505, P36, DOI 10.1016/j.neulet.2011.08.061; Eschen A, 2007, INT J PSYCHOPHYSIOL, V64, P259, DOI 10.1016/j.ijpsycho.2006.09.005; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Gilbert SJ, 2012, J COGNITIVE NEUROSCI, V24, P93, DOI 10.1162/jocn_a_00094; Gonneaud J, 2011, MEMORY, V19, P360, DOI 10.1080/09658211.2011.570765; HERTZOG C, 1990, PSYCHOL AGING, V5, P215, DOI 10.1037/0882-7974.5.2.215; Kalpouzos G, 2010, 2 HALVES BRAIN INFOR, P499; Kalpouzos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013304; Kliegel M, 2006, DEV NEUROPSYCHOL, V30, P819, DOI 10.1207/s15326942dn3003_4; Kondo Y, 2005, NEUROIMAGE, V24, P1154, DOI 10.1016/j.neuroimage.2004.10.033; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Mantyla T, 2003, MEM COGNITION, V31, P15, DOI 10.3758/BF03196078; Mantyla T, 2010, APPL NEUROPSYCHOL, V17, P289, DOI 10.1080/09084282.2010.525090; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Melrose RJ, 2007, BRAIN RES, V1142, P146, DOI 10.1016/j.brainres.2007.01.060; Mendes T, 2008, AGING MENT HEALTH, V12, P177, DOI 10.1080/13607860701797281; Menon V, 2000, NEUROREPORT, V11, P3641, DOI 10.1097/00001756-200011090-00048; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nyberg L, 1996, Psychon Bull Rev, V3, P135, DOI 10.3758/BF03212412; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Postma A, 2004, BRAIN COGNITION, V54, P24, DOI 10.1016/S0278-2626(03)00238-0; Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005; Quinette P, 2006, NEUROPSYCHOLOGIA, V44, P2508, DOI 10.1016/j.neuropsychologia.2006.03.031; Reynolds JR, 2006, CEREB CORTEX, V16, P519, DOI 10.1093/cercor/bhi131; Shigemune Y, 2013, CEREB CORTE IN PRESS; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stroop J. R., 1935, J EXP PSYCHOL, V12, P242; Szameitat AJ, 2007, NEUROIMAGE, V34, P702, DOI 10.1016/j.neuroimage.2006.09.033; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Uttl B, 2011, CAN J EXP PSYCHOL, V65, P57, DOI 10.1037/a0022843; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Vestergren P, 2011, THESIS UMEA U SWEDEN; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331	66	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73850	10.1371/journal.pone.0073850	http://dx.doi.org/10.1371/journal.pone.0073850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019938	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200081
J	Adland, E; Carlson, JM; Paioni, P; Kloverpris, H; Shapiro, R; Ogwu, A; Riddell, L; Luzzi, G; Chen, FB; Balachandran, T; Heckerman, D; Stryhn, A; Edwards, A; Ndung'u, T; Walker, BD; Buus, S; Goulder, P; Matthews, PC				Adland, Emily; Carlson, Jonathan M.; Paioni, Paolo; Kloverpris, Henrik; Shapiro, Roger; Ogwu, Anthony; Riddell, Lynn; Luzzi, Graz; Chen, Fabian; Balachandran, Thambiah; Heckerman, David; Stryhn, Anette; Edwards, Anne; Ndung'u, Thumbi; Walker, Bruce D.; Buus, Soren; Goulder, Philip; Matthews, Philippa C.			Nef-Specific CD8+T Cell Responses Contribute to HIV-1 Immune Control	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLASS-I ALLELES; T-LYMPHOCYTE EPITOPES; HLA-B; ESCAPE; GAG; ASSOCIATIONS; POLYMORPHISMS; IDENTIFICATION; INFECTION	Recent studies in the SIV-macaque model of HIV infection suggest that Nef-specific CD8+ T-cell responses may mediate highly effective immune control of viraemia. In HIV infection Nef recognition dominates in acute infection, but in large cohort studies of chronically infected subjects, breadth of T cell responses to Nef has not been correlated with significant viraemic control. Improved disease outcomes have instead been associated with targeting Gag and, in some cases, Pol. However analyses of the breadth of Nef-specific T cell responses have been confounded by the extreme immunogenicity and multiple epitope overlap within the central regions of Nef, making discrimination of distinct responses impossible via IFN-gamma ELISPOT assays. Thus an alternative approach to assess Nef as an immune target is needed. Here, we show in a cohort of >700 individuals with chronic C-clade infection that >50% of HLA-B-selected polymorphisms within Nef are associated with a predicted fitness cost to the virus, and that HLA-B alleles that successfully drive selection within Nef are those linked with lower viral loads. Furthermore, the specific CD8+ T cell epitopes that are restricted by protective HLA Class I alleles correspond substantially to effective SIV-specific epitopes in Nef. Distinguishing such individual HIV-specific responses within Nef requires specific peptide-MHC I tetramers. Overall, these data suggest that CD8+ T cell targeting of certain specific Nef epitopes contributes to HIV suppression. These data suggest that a re-evaluation of the potential use of Nef in HIV T-cell vaccine candidates would be justified.	[Adland, Emily; Paioni, Paolo; Kloverpris, Henrik; Goulder, Philip] Univ Oxford, Dept Paediat, Oxford, England; [Carlson, Jonathan M.; Heckerman, David] Microsoft Res, eSci Grp, Los Angeles, CA USA; [Shapiro, Roger] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Shapiro, Roger; Ogwu, Anthony] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Riddell, Lynn] Northampton Gen Hosp, Northamptonshire Healthcare NHS Trust, Dept Genitourinary Med, Northampton, England; [Luzzi, Graz] Wycombe Gen Hosp, Dept Genitourinary Med, High Wycombe, Bucks, England; [Chen, Fabian] Royal Berkshire Hosp, Dept Sexual Hlth, Reading RG1 5AN, Berks, England; [Balachandran, Thambiah] Luton & Dunstable Hosp, Dept Genitourinary Med, Luton, Beds, England; [Kloverpris, Henrik; Stryhn, Anette; Buus, Soren] Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark; [Edwards, Anne] Churchill Hosp, Oxford Dept Genitourinary Med, Oxford OX3 7LJ, England; [Ndung'u, Thumbi; Walker, Bruce D.; Goulder, Philip] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Ndung'u, Thumbi; Walker, Bruce D.; Goulder, Philip] Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02114 USA; [Kloverpris, Henrik] Univ KwaZulu Natal, Nelson R Mandela Sch Med, K RITH, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Ndung'u, Thumbi; Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Matthews, Philippa C.] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Oxford; Microsoft; Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Royal Berkshire Hospital; University of Copenhagen; University of Oxford; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; Howard Hughes Medical Institute; University of Oxford	Adland, E (corresponding author), Univ Oxford, Dept Paediat, Peter Medawar Bldg Pathogen Res, Oxford, England.	emily.adland@paediatrics.ox.ac.uk	Buus, Soren/F-5446-2010; Matthews, Philippa/P-7810-2019	Matthews, Philippa/0000-0002-4036-4269; Buus, Soren/0000-0001-8363-1999; Ndung'u, Thumbi/0000-0003-2962-3992; Kloverpris, Henrik/0000-0002-2165-3313; Paioni, Paolo/0000-0002-3904-1606	Oxford University; Wellcome Trust; National Institutes of Health [R01 AI46995]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046995] Funding Source: NIH RePORTER; Medical Research Council [G0501777] Funding Source: researchfish; National Institute for Health Research [CL-2011-13-005] Funding Source: researchfish; MRC [G0501777] Funding Source: UKRI	Oxford University; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PCM is funded by Oxford University as an National Institute for Health Research Clinical Lecturer. PG is supported by grants from the Wellcome Trust (Senior Clinical Fellowship) and by the National Institutes of Health, grant R01 AI46995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CAM, 2011, J IMMUNOL, V187, P2502, DOI 10.4049/jimmunol.1100691; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Bailey JR, 2009, J VIROL, V83, P88, DOI 10.1128/JVI.01958-08; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Boutwell CL, 2013, J VIROL, V87, P3952, DOI 10.1128/JVI.03233-12; Bredell H, 2007, AIDS RES HUM RETROV, V23, P477, DOI 10.1089/aid.2006.0232; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; BRONKE C, 2012, AIDS; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; BRUMME ZL, 2008, J VIROL; Budde ML, 2012, J VIROL, V86, P7596, DOI 10.1128/JVI.00716-12; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; DIBRINO M, 1995, BIOCHEMISTRY-US, V34, P10130, DOI 10.1021/bi00032a005; Draenert R, 2004, AIDS, V18, P871, DOI 10.1097/00002030-200404090-00004; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; FLEISCHHAUER K, 1994, TISSUE ANTIGENS, V44, P311, DOI 10.1111/j.1399-0039.1994.tb02401.x; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Goulder PJR, 1997, AIDS, V11, P536; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Gray CM, 2009, J VIROL, V83, P470, DOI 10.1128/JVI.01678-08; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kirchhoff F, 1999, J VIROL, V73, P5497, DOI 10.1128/JVI.73.7.5497-5508.1999; Kloverpris HN, 2012, J VIROL, V86, P11493, DOI 10.1128/JVI.01020-12; Landi A, 2011, CURR HIV RES, V9, P496, DOI 10.2174/157016211798842116; Leisner C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001678; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Loffredo JT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001152; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Mashishi T, 2001, AIDS RES HUM RETROV, V17, P1681, DOI 10.1089/088922201753342103; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Matthews PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047799; Matthews PC, 2012, J VIROL, V86, P12643, DOI 10.1128/JVI.01381-12; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; Matthews PC, 2009, J VIROL, V83, P4605, DOI 10.1128/JVI.02017-08; Minang JT, 2008, VIROLOGY, V375, P307, DOI 10.1016/j.virol.2008.02.005; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Mlotshwa M, 2010, J VIROL, V84, P12018, DOI 10.1128/JVI.01472-10; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Mothe BR, 2002, J IMMUNOL, V169, P210, DOI 10.4049/jimmunol.169.1.210; Mudd PA, 2012, J IMMUNOL, V188, P3364, DOI 10.4049/jimmunol.1102470; Mwimanzi P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-1; Navis M, 2008, J INFECT DIS, V197, P871, DOI 10.1086/528695; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; O'Neill E, 2006, J VIROL, V80, P1311, DOI 10.1128/JVI.80.3.1311-1320.2006; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Radebe M, 2011, J INFECT DIS, V204, P768, DOI 10.1093/infdis/jir394; ROLLAND M, 2013, J VIROL; Rolland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017969; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takahashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054300; Tolstrup Martin, 2006, Sex Health, V3, P281, DOI 10.1071/SH06002; van Harmelen J, 2001, AIDS RES HUM RETROV, V17, P1527, DOI 10.1089/08892220152644232; Walker PR, 2007, AIDS RES HUM RETROV, V23, P204, DOI 10.1089/aid.2006.0080; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08	67	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73117	10.1371/journal.pone.0073117	http://dx.doi.org/10.1371/journal.pone.0073117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023819	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400045
J	Lai, TY; Wu, SD; Tsai, MH; Chuang, EY; Chuang, LL; Hsu, LC; Lai, LC				Lai, Ting-Yu; Wu, Shang-Duen; Tsai, Mong-Hsun; Chuang, Eric Y.; Chuang, Li-Ling; Hsu, Li-Chung; Lai, Liang-Chuan			Transcription of Tnfaip3 Is Regulated by NF-kappa B and p38 via C/EBP beta in Activated Macrophages	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; GENE-EXPRESSION; SIGNALING PATHWAYS; LIPOPOLYSACCHARIDE; INFLAMMATION; PROTEIN; INDUCTION; SPECIFICITY; DISCOVERY; APOPTOSIS	Macrophages play a pivotal role in the immune system through recognition and elimination of microbial pathogens. Toll-like receptors (TLRs) on macrophages interact with microbial substances and initiate signal transduction through intracellular adapters. TLR4, which recognizes the lipopolysaccharides (LPS) on Gram-positive and Gram-negative bacteria, triggers downstream signaling mediators and eventually activates I kappa B kinase (IKK) complex and mitogen-activated protein kinases (MAPKs) such as p38. Previous reports revealed that, in addition to NF-kappa B, a core transcription factor of the innate immune response, the induction of some LPS-induced genes in macrophages required another transcription factor whose activity depends on p38. However, these additional transcription factors remain to be identified. In order to identify p38-activated transcription factors that cooperate with NF-kappa B in response to LPS stimulation, microarrays were used to identify genes regulated by both NF-kappa B and p38 using wild-type, IKK-depleted, and p38 inhibitor-treated mouse bone marrow-derived macrophages (BMDMs). In silico analysis of transcription factor binding sites was used to predict the potential synergistic transcription factors from the co-expressed genes. Among these genes, NF-kappa B and C/EBP beta, a p38 downstream transcription factor, were predicted to co-regulate genes in LPS-stimulated BMDMs. Based on the subsequent results of a chromatin immunoprecipitation assay and TNFAIP3 expression in C/EBP beta-ablated macrophages, we demonstrated that Tnfaip3 is regulated by both NF-kappa B and p38-dependent C/EBP beta. These results identify a novel regulatory mechanism in TLR4-mediated innate immunity.	[Lai, Ting-Yu; Hsu, Li-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 10764, Taiwan; [Wu, Shang-Duen; Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Tsai, Mong-Hsun; Chuang, Eric Y.; Lai, Liang-Chuan] Natl Taiwan Univ, Ctr Genom Med, Bioinformat & Biostat Core, Taipei 10764, Taiwan; [Chuang, Eric Y.] Natl Taiwan Univ, YongLin Biomed Engn Ctr, Taipei 10764, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan; [Chuang, Li-Ling] Chang Gung Univ, Dept Phys Therapy, Tao Yuan, Taiwan; [Chuang, Li-Ling] Chang Gung Univ, Grad Inst Rehabil Sci, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung University; Chang Gung University	Hsu, LC (corresponding author), Natl Taiwan Univ, Inst Mol Med, Taipei 10764, Taiwan.	lichunghsu@ntu.edu.tw; llai@ntu.edu.tw	lai, ting/HGD-7592-2022; Lai, Liang-Chuan/B-4768-2009	Lai, Liang-Chuan/0000-0002-3913-5338	Department of Health of Taiwan [DOH98-TD-G-111-014]; National Health Research Institutes of Taiwan [NHRI-EX102-10257SI]	Department of Health of Taiwan; National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This research was supported in part by grants from the Department of Health of Taiwan (Grant No. DOH98-TD-G-111-014) and the National Health Research Institutes of Taiwan (Grant No. NHRI-EX102-10257SI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HZ, 2002, IMMUNOL LETT, V81, P165, DOI 10.1016/S0165-2478(02)00010-X; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Couzin-Frankel J, 2010, SCIENCE, V330, P1621, DOI 10.1126/science.330.6011.1621; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Hsu LC, 2011, NAT IMMUNOL, V12, P144, DOI 10.1038/ni.1976; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee IT, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-33; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee YH, 1997, MOL CELL BIOL, V17, P2038, DOI 10.1128/MCB.17.4.2038; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lu YC, 2008, CYTOKINE; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Pavesi G, 2004, BRIEF BIOINFORM, V5, P217, DOI 10.1093/bib/5.3.217; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sandve GK, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-11; Serio KJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1125, DOI 10.1152/ajpcell.00296.2004; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yokota SI, 2007, FEMS IMMUNOL MED MIC, V51, P140, DOI 10.1111/j.1574-695X.2007.00288.x	41	24	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73153	10.1371/journal.pone.0073153	http://dx.doi.org/10.1371/journal.pone.0073153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023826	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400047
J	Dong, JJ; Chen, WL				Dong, Junjian; Chen, Wenli			The Role of Autophagy in Chloroplast Degradation and Chlorophagy in Immune Defenses during Pst DC3000 (AvrRps4) Infection	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; PLANT INNATE IMMUNITY; PIECEMEAL MICROAUTOPHAGY; ENDOPLASMIC-RETICULUM; VIRULENCE EFFECTOR; PROTEIN; LEAVES; MITOCHONDRIA; RECOGNITION; SENESCENCE	Background: Chlorosis of leaf tissue normally observed during pathogen infection may result from the degradation of chloroplasts. There is a growing evidence to suggest that the chloroplast plays a significant role during pathogen infection. Although most degradation of the organelles and cellular structures in plants is mediated by autophagy, its role in chloroplast catabolism during pathogen infection is largely unknown. Results: In this study, we investigated the function of autophagy in chloroplast degradation during avirulent Pst DC3000 (AvrRps4) infection. We examined the expression of defensive marker genes and suppression of bacterial growth using the electrolyte leakage assay in normal light (N) and low light (L) growing environments of wild-type and atg5-1 plants during pathogen treatment. Stroma-targeted GFP proteins (CT-GFP) were observed with LysoTracker Red (LTR) staining of autophagosome-like structures in the vacuole. The results showed that Arabidopsis expressed a significant number of small GFP-labeled bodies when infected with avirulent Pst DC3000 (AvrRps4). While barely detectable, there were small GFP-labeled bodies in plants with the CT-GFP expressing atg5-1 mutation. The results showed that chloroplast degradation depends on autophagy and this may play an important role in inhibiting pathogen growth. Conclusion: Autophagy plays a role in chloroplast degradation in Arabidopsis during avirulent Pst DC3000 (AvrRps4) infection. Autophagy dependent chloroplast degradation may be the primary source of reactive oxygen species (ROS) as well as the pathogen-response signaling molecules that induce the defense response.	[Dong, Junjian; Chen, Wenli] S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Dong, Junjian; Chen, Wenli] S China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Dong, Junjian; Chen, Wenli] S China Normal Univ, Coll Life Sci, Guangdong Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University; South China Normal University	Chen, WL (corresponding author), S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.	chenwl@scnu.edu.cn			National Natural Science Foundation of China [31170250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China [grant number 31170250]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Hernandez GJ, 2005, PLANT J, V43, P506, DOI 10.1111/j.1365-313X.2005.02468.x; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Beau I, 2008, TRENDS CELL BIOL, V18, P311, DOI 10.1016/j.tcb.2008.05.001; Bolwell GP, 2009, SIGNAL COMMUN PLANTS, P113, DOI 10.1007/978-3-642-00390-5_7; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; CERUTTI H, 1992, P NATL ACAD SCI USA, V89, P8068, DOI 10.1073/pnas.89.17.8068; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chung T, 2010, PLANT J, V62, P483, DOI 10.1111/j.1365-313X.2010.04166.x; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Desclos-Theveniau M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002513; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Dunn WA, 2005, AUTOPHAGY, V1, P75; [高玲 GAO Ling], 2011, [生物物理学报, Acta Biophysica Sinica], V27, P676; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; He HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034995; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Hofius D, 2009, CELL, V137, P773, DOI 10.1016/j.cell.2009.02.036; Inoue Y, 2006, PLANT CELL PHYSIOL, V47, P1641, DOI 10.1093/pcp/pcl031; Ishida H, 2009, PLANT PHYSIOL, V149, P885; Ishida H, 2008, PLANT PHYSIOL, V148, P142, DOI 10.1104/pp.108.122770; Ishida H, 2009, AUTOPHAGY, V5, P736, DOI 10.4161/auto.5.5.8568; Izumi M, 2010, PLANT PHYSIOL, V154, P1196, DOI 10.1104/pp.110.158519; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; KING EO, 1954, J LAB CLIN MED, V44, P301; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Kohler RH, 2000, J CELL SCI, V113, P3921; Kohler RH, 1997, SCIENCE, V276, P2039, DOI 10.1126/science.276.5321.2039; Krick R, 2009, AUTOPHAGY, V5, P270, DOI 10.4161/auto.5.2.7639; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lehto K, 2003, MOL PLANT MICROBE IN, V16, P1135, DOI 10.1094/MPMI.2003.16.12.1135; Li FQ, 2012, TRENDS PLANT SCI, V17, P526, DOI 10.1016/j.tplants.2012.05.006; Li Z, 2012, NEW PHYTOL, V195, P85, DOI 10.1111/j.1469-8137.2012.04131.x; Li Z, 2011, J EXP BOT, V62, P331, DOI 10.1093/jxb/erq279; Liu Jian, 2012, PLoS One, V7, pe33817, DOI 10.1371/journal.pone.0033817; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011883; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; MAKINO A, 1991, PLANT PHYSIOL, V96, P355, DOI 10.1104/pp.96.2.355; McDowell JM, 2000, PLANT J, V22, P523, DOI 10.1046/j.1365-313x.2000.00771.x; Muhlenbock P, 2008, PLANT CELL, V20, P2339, DOI 10.1105/tpc.108.059618; Munafo DB, 2001, J CELL SCI, V114, P3619; Natesan SKA, 2005, J EXP BOT, V56, P787, DOI 10.1093/jxb/eri088; Padmanabhan MS, 2010, MOL PLANT MICROBE IN, V23, P1368, DOI 10.1094/MPMI-05-10-0113; Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199; PYKE KA, 1991, PLANT PHYSIOL, V96, P1193, DOI 10.1104/pp.96.4.1193; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Rodriguez-Herva JJ, 2012, CELL MICROBIOL, V14, P669, DOI 10.1111/j.1462-5822.2012.01749.x; Seay M, 2009, CURR TOP MICROBIOL, V335, P287, DOI 10.1007/978-3-642-00302-8_14; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seo S, 2000, PLANT CELL, V12, P917, DOI 10.1105/tpc.12.6.917; Sheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045673; Sun AZ, 2012, PLANT PHYSIOL, V160, P1081, DOI 10.1104/pp.112.201798; Takatsuka C, 2004, PLANT CELL PHYSIOL, V45, P265, DOI 10.1093/pcp/pch031; Tamura K, 2003, PLANT J, V35, P545, DOI 10.1046/j.1365-313X.2003.01822.x; Tewari RK, 2012, PLANTA, V235, P99, DOI 10.1007/s00425-011-1495-8; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Wada S, 2009, PLANT PHYSIOL, V149, P885, DOI 10.1104/pp.108.130013; [王燕 Wang Yan], 2010, [中国细胞生物学学报, Chinese Journal of Cell Biology], V32, P677; WILD A, 1980, Z PFLANZENPHYSIOL, V97, P325, DOI 10.1016/S0044-328X(80)80006-7; Xie YD, 2010, PLANT CELL ENVIRON, V33, P828, DOI 10.1111/j.1365-3040.2009.02109.x; Xiong Y, 2007, PLANT PHYSIOL, V143, P291, DOI 10.1104/pp.106.092106; Yang L, 2011, ACTA BIOPHYS SINICA, V27, P1; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yoshimoto K, 2012, PLANT CELL PHYSIOL, V53, P1355, DOI 10.1093/pcp/pcs099; Yoshimoto K, 2010, FEBS LETT, V584, P1350, DOI 10.1016/j.febslet.2010.01.007; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Zhang WN, 2011, PHOTOCH PHOTOBIO SCI, V10, P947, DOI 10.1039/c0pp00305k; Zhang ZB, 2012, CELL HOST MICROBE, V11, P253, DOI 10.1016/j.chom.2012.01.015; Zhu SF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002318	77	41	42	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73091	10.1371/journal.pone.0073091	http://dx.doi.org/10.1371/journal.pone.0073091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023671	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200067
J	Goldenberg, SM; Engstrom, D; Rolon, ML; Silverman, JG; Strathdee, SA				Goldenberg, Shira M.; Engstrom, David; Luisa Rolon, Maria; Silverman, Jay G.; Strathdee, Steffanie A.			Sex Workers Perspectives on Strategies to Reduce Sexual Exploitation and HIV Risk: A Qualitative Study in Tijuana, Mexico	PLOS ONE			English	Article							INJECTION-DRUG USERS; HUMAN TRAFFICKING; SOCIAL NETWORK; HIV/STI RISK; VIOLENCE; WOMEN; INTERVENTION; PREVALENCE; INFECTION; SERVICES	Globally, female sex workers are a population at greatly elevated risk of HIV infection, and the reasons for and context of sex industry involvement have key implications for HIV risk and prevention. Evidence suggests that experiences of sexual exploitation (i.e., forced/coerced sex exchange) contribute to health-related harms. However, public health interventions that address HIV vulnerability and sexual exploitation are lacking. Therefore, the objective of this study was to elicit recommendations for interventions to prevent sexual exploitation and reduce HIV risk from current female sex workers with a history of sexual exploitation or youth sex work. From 2010-2011, we conducted in-depth interviews with sex workers (n = 31) in Tijuana, Mexico who reported having previously experienced sexual exploitation or youth sex work. Participants recommended that interventions aim to (1) reduce susceptibility to sexual exploitation by providing social support and peer-based education; (2) mitigate harms by improving access to HIV prevention resources and psychological support, and reducing gender-based violence; and (3) provide opportunities to exit the sex industry via vocational supports and improved access to effective drug treatment. Structural interventions incorporating these strategies are recommended to reduce susceptibility to sexual exploitation and enhance capacities to prevent HIV infection among marginalized women and girls in Mexico and across international settings.	[Goldenberg, Shira M.] Univ British Columbia, BC Ctr Excellence HIV AIDS, Div AIDS, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Goldenberg, Shira M.; Luisa Rolon, Maria; Silverman, Jay G.; Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Engstrom, David] San Diego State Univ, Sch Social Work, San Diego, CA 92182 USA; [Luisa Rolon, Maria] Univ Xochicalco, Sch Med, Tijuana, Baja California, Mexico	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of California System; University of California San Diego; California State University System; San Diego State University	Goldenberg, SM (corresponding author), Univ British Columbia, BC Ctr Excellence HIV AIDS, Div AIDS, Dept Med, Vancouver, BC V5Z 1M9, Canada.	sgoldenberg@cfenet.ubc.ca	Goldenberg, Shira/C-9627-2009; Strathdee, Steffanie A/B-9042-2009	Goldenberg, Shira/0000-0003-1633-9749; Mittal, Maria Luisa/0000-0002-4000-5370; Strathdee, Steffanie/0000-0002-7724-691X	Berkeley Health Initiative of the Americas' PIMSA Research Program on Migration and Health; National Institutes of Health [NIDA R01 DA027772]; Canada-US Fulbright Program; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027772] Funding Source: NIH RePORTER	Berkeley Health Initiative of the Americas' PIMSA Research Program on Migration and Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada-US Fulbright Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by a Berkeley Health Initiative of the Americas' PIMSA Research Program on Migration and Health (http://hia.berkeley.edu) grant and a National Institutes of Health grant (NIDA R01 DA027772). SG received support from the Canada-US Fulbright Program and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Niki, 2003, FEMINIST REV, V73, P135, DOI DOI 10.1057/PALGRAVE.FR.9400084; Agencia Fronteriza de Noticias, 2012, EXPL JOV MOT; Agencia Fronteriza de Noticias, 2012, DET SEIS TRAT PERS T; Arnott J, 2009, RIGHTS NOT RESCUE RE; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beletsky L, 2012, REV PANAM SALUD PUBL, V31, P403, DOI 10.1590/S1020-49892012000500008; Bhabha J, 2005, MIGRATION INFORM MAR, P1; Brennan D, 2005, INT MIGR, V43, P35, DOI 10.1111/j.0020-7985.2005.00311.x; Bucardo J, 2004, ARCH SEX BEHAV, V33, P343, DOI 10.1023/B:ASEB.0000028887.96873.f3; Busza J, 2004, BMJ-BRIT MED J, V328, P1369, DOI 10.1136/bmj.328.7452.1369; Carreno SS, 2009, ROSTROS DIVERSOS TRA; Chapkis W, 2003, GENDER SOC, V17, P923, DOI 10.1177/0891243203257477; Cicero-Dominguez S. A, 2005, NW J INT HUMAN RIGHT, V4, P303; Coffey P, 2004, LIT REV TRAFFICKING; Collins SP, 2013, AIDS CARE, V25, P459, DOI 10.1080/09540121.2012.720361; Comision de Derechos Humanos del Distrito Federal, 2006, COM DER HUM DISTR FE; Comision Nacional Contra las Adicciones, 2012, ACT AD PREV TRAT AD, V2; Comision Nacional de los Derechos Humanos, 2002, TRATA PERSONAS, P1; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; Decker MR, 2011, J EPIDEMIOL COMMUN H, V65, P334, DOI 10.1136/jech.2009.096834; Devine A, 2010, AIDS CARE, V22, P228, DOI 10.1080/09540120903039869; El-Bassel N, 2001, AIDS PATIENT CARE ST, V15, P41, DOI 10.1089/108729101460092; Fetterman David M., 2009, ETHNOGRAPHY STEP STE; Fuller CM, 2005, AM J PUBLIC HEALTH, V95, P689, DOI 10.2105/AJPH.2003.02178; Goldenberg S, 2011, THESIS U CALIFORNIA; Goldenberg S, INT MIGRATI IN PRESS; Goldenberg SM, 2012, AIDS BEHAV, V16, P969, DOI 10.1007/s10461-011-0063-3; Goldenberg SM, 2011, SOC SCI MED, V72, P1185, DOI 10.1016/j.socscimed.2011.02.014; Goldenberg SM, 2010, SEX TRANSM DIS, V37, P319, DOI 10.1097/OLQ.0b013e3181c5334f; Goldenberg SM, EXPLORING CONTEXT IN; Gozdziak EM, 2005, INT MIGR, V43, P99, DOI 10.1111/j.0020-7985.2005.00314.x; Greenfield SF, 2002, HARVARD REV PSYCHIAT, V10, P76, DOI 10.1093/hrp/10.2.76; Gushulak B D, 2000, J Immigr Health, V2, P67, DOI 10.1023/A:1009581817682; Hodge DR, 2007, AFFILIA J WOM SOC WO, V22, P163, DOI 10.1177/0886109907299055; Hossain M, 2010, AM J PUBLIC HEALTH, V100, P2442, DOI 10.2105/AJPH.2009.173229; Huda S, 2006, INT J GYNECOL OBSTET, V94, P374, DOI 10.1016/j.ijgo.2006.04.027; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Jana S., 2002, GENDER DEV, V10, P69; Jeffreys S, 2009, WOMEN STUD INT FORUM, V32, P316, DOI 10.1016/j.wsif.2009.07.002; Katsulis Y, 2010, MED ANTHROPOL Q, V24, P344, DOI 10.1111/j.1548-1387.2010.01108.x; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kuyper LM, 2005, ADDICT RES THEORY, V13, P193, DOI 10.1080/16066350500053349; Langberg L, 2005, INT MIGR, V43, P129, DOI 10.1111/j.0020-7985.2005.00315.x; Lautz TB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040816; Lippman SA, 2010, AM J PUBLIC HEALTH, V100, pS216, DOI 10.2105/AJPH.2008.147462; Loff B, 2004, LANCET, V363, P566, DOI 10.1016/S0140-6736(04)15548-7; Magis-Rodriguez C, 2005, J PSYCHOACTIVE DRUGS, V37, P333, DOI 10.1080/02791072.2005.10400528; Manopaiboon C, 2003, AIDS CARE, V15, P39, DOI 10.1080/012021000039743; Morisky DE, 2006, HEALTH PSYCHOL, V25, P595, DOI 10.1037/0278-6133.25.5.595; Morisky DE, 2010, ASIA-PAC J PUBLIC HE, V22, p151S, DOI 10.1177/1010539510373018; Odek WO, 2009, AIDS BEHAV, V13, P449, DOI 10.1007/s10461-008-9485-y; Okal J, 2011, AIDS CARE, V23, P612, DOI 10.1080/09540121.2010.525605; Oragnization of American States -Comision Interamericana para el Control del Abuso de Drogas ( CICAD), PERF EST DROG PAIS; Pando MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054147; Pena CPJ, 2013, TRATA PERSONAS MEXIC, P69; Pilowsky DJ, 2007, SUBST USE MISUSE, V42, P1629, DOI 10.1080/10826080701205372; Poudel P, 2000, Gend Dev, V8, P74, DOI 10.1080/741923626; Replogle J, 2008, TIME; Rieger A., 2007, HARVARD J LAW GENDER, V30, P231; Rolon ML, 2013, J TROPICAL PEDIAT; Roy E, 2000, INT J STD AIDS, V11, P241, DOI 10.1258/0956462001915778; Rudolph AE, 2010, AIDS EDUC PREV, V22, P238, DOI 10.1521/aeap.2010.22.3.238; Sanders T, 2007, BRIT J SOCIOL, V58, P1, DOI 10.1111/j.1468-4446.2007.00136.x; Sarkar K, 2008, J HEALTH POPUL NUTR, V26, P223; Secretaria de Salubridad y Asistencia (SSA), 2008, SIST VIG EP AD SISV; Sex Workers Project, 2009, USE RAIDS FIGHT TRAF; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Silverman JG, 2007, JAMA-J AM MED ASSOC, V298, P536, DOI 10.1001/jama.298.5.536; Silverman JG, 2006, JAIDS-J ACQ IMM DEF, V43, P588; Silverman JG, 2011, ARCH DIS CHILD, V96, P478, DOI 10.1136/adc.2009.178715; SIMONS RL, 1991, J FAM ISSUES, V12, P361, DOI 10.1177/019251391012003007; Strathdee SA, 2008, JAMA-J AM MED ASSOC, V300, P571, DOI 10.1001/jama.300.5.571; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; Strauss A., 1998, BASICS QUALITATIVE R; Surratt HL, 2004, CRIME DELINQUENCY, V50, P43, DOI 10.1177/0011128703258875; Syvertsen J, 2010, INT J DRUG POLICY, V21, P459, DOI 10.1016/j.drugpo.2010.06.006; Syvertsen JL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-136; UNAIDS, 2009, GUAT; UNAIDS, 2004, LAT AM FACTSH; United Nations, 2000, PROT PREV SUPPR PUN, P1; US Department of Transportation, 2009, BORD CROSS US MEX BO; US State Department, 2012, TRAFF PERS REP; USAID/ Guatemala, 2010, USAID HIV AIDS HLTH; Vaddiparti K, 2006, ARCH SEX BEHAV, V35, P451, DOI 10.1007/s10508-006-9044-4; Vijeyarasa R, 2009, CULTURE HLTH SEXUALI, V12, pS89; Zimmerman, 2003, WHO ETHICAL SAFETY R; Zimmerman C, 2008, AM J PUBLIC HEALTH, V98, P55, DOI 10.2105/AJPH.2006.108357	89	16	16	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72982	10.1371/journal.pone.0072982	http://dx.doi.org/10.1371/journal.pone.0072982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211BX	24023661	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200057
J	Karch, I; Schipper, E; Christgen, H; Kreipe, H; Lehmann, U; Christgen, M				Karch, Inga; Schipper, Elisa; Christgen, Henriette; Kreipe, Hans; Lehmann, Ulrich; Christgen, Matthias			Is Upregulation of BCL2 a Determinant of Tumor Development Driven by Inactivation of CDH1/E-Cadherin?	PLOS ONE			English	Article							LOBULAR BREAST-CANCER; E-CADHERIN; CELL-LINES; DOWN-REGULATION; EXPRESSION; CARCINOMA; IPH-926; PROGRESSION; MDA-MB-435; MUTATIONS	Inactivation of CDH1, encoding E-cadherin, promotes cancer initiation and progression. According to a newly proposed molecular mechanism, loss of E-cadherin triggers an upregulation of the anti-apoptotic oncoprotein BCL2. Conversely, reconstitution of E-cadherin counteracts overexpression of BCL2. This reciprocal regulation is thought to be critical for early tumor development. We determined the relevance of this new concept in human infiltrating lobular breast cancer (ILBC), the prime tumor entity associated with CDH1 inactivation. BCL2 expression was examined in human ILBC cell lines (IPH-926, MDA-MB-134, SUM-44) harboring deleterious CDH1 mutations. To test for an intact regulatory axis between E-cadherin and BCL2, wild-type E-cadherin was reconstituted in ILBC cells by ectopic expression. Moreover, BCL2 and E-cadherin were evaluated in primary invasive breast cancers and in synchronous lobular carcinomas in situ (LCIS). MDA-MB-134 and IPH-926 showed little or no BCL2 expression, while SUM-44 ILBC cells were BCL2-positive. Reconstitution of E-cadherin failed to impact on BCL2 expression in all cell lines tested. Primary ILBCs were almost uniformly E-cadherin-negative (97%) and were frequently BCL2-negative (46%). When compared with an appropriate control group, ILBCs showed a trend towards an increased frequency of BCL2-negative cases (P = 0.064). In terminal duct-lobular units affected by LCIS, the E-cadherin-negative neoplastic component showed a similar or a reduced BCL2-immunoreactivity, when compared with the adjacent epithelium. In conclusion, upregulation of BCL2 is not involved in lobular breast carcinogenesis and is unlikely to represent an important determinant of tumor development driven by CDH1 inactivation.	[Karch, Inga; Schipper, Elisa; Christgen, Henriette; Kreipe, Hans; Lehmann, Ulrich; Christgen, Matthias] Hannover Med Sch, Inst Pathol, D-30623 Hannover, Germany	Hannover Medical School	Christgen, M (corresponding author), Hannover Med Sch, Inst Pathol, D-30623 Hannover, Germany.	Christgen.Matthias@MH-Hannover.de			German Cancer Aid Grant [109435]; Hannelore-Munke Fellowship	German Cancer Aid Grant; Hannelore-Munke Fellowship	This work was supported by the German Cancer Aid Grant 109435 to MC and UL. MC was additionally supported by a Hannelore-Munke Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali HR, 2012, J PATHOL, V226, P97, DOI 10.1002/path.2976; Bertucci F, 2008, ONCOGENE, V27, P5359, DOI 10.1038/onc.2008.158; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Christgen M, 2008, INT J CANCER, V123, P2239, DOI 10.1002/ijc.23806; Christgen M, 2007, CANCER BIOL THER, V6, P1355; Christgen M, 2007, MOL CELL BIOCHEM, V306, P201, DOI 10.1007/s11010-007-9570-y; Christgen M, 2013, GENE CHROMOSOME CANC, V52, P69, DOI 10.1002/gcc.22007; Christgen M, 2012, LAB INVEST, V92, P1635, DOI 10.1038/labinvest.2012.126; Christgen M, 2010, J BIOL CHEM, V285, P6412, DOI 10.1074/jbc.M109.082941; Christgen M, 2009, J PATHOL, V217, P620, DOI 10.1002/path.2495; Coradini D, 2002, BRIT J CANCER, V87, P1105, DOI 10.1038/sj.bjc.6600556; DESBARATS L, 1994, J CELL SCI, V107, P1705; Dubois-Marshall S, 2011, CLIN EXP METASTAS, V28, P811, DOI 10.1007/s10585-011-9412-x; Ellis MJ, 2013, CANCER DISCOV, V3, P27, DOI 10.1158/2159-8290.CD-12-0462; ETHIER SP, 1993, CANCER RES, V53, P627; Ferreira AC, 2012, HUM MOL GENET, V21, P334, DOI 10.1093/hmg/ddr469; Fuchs M, 2004, CELL MOTIL CYTOSKEL, V59, P50, DOI 10.1002/cm.20019; Hanby AM, 2008, HISTOPATHOLOGY, V52, P58, DOI 10.1111/j.1365-2559.2007.02891.x; Hiraguri S, 1998, CANCER RES, V58, P1972; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; Hwang KT, 2012, INT J CANCER, V131, pE1109, DOI 10.1002/ijc.27539; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kaurah P, 2007, JAMA-J AM MED ASSOC, V297, P2360, DOI 10.1001/jama.297.21.2360; Krech T, 2012, CANCER LETT, V315, P153, DOI 10.1016/j.canlet.2011.09.038; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lakhani SR, 2012, WHO CLASSIFICATION T; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Morrogh M, 2012, BREAST CANCER RES TR, V132, P641, DOI 10.1007/s10549-011-1860-0; Park Sung-Hye, 2002, Pathology and Oncology Research, V8, P26; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rakha EA, 2005, HISTOPATHOLOGY, V46, P685, DOI 10.1111/j.1365-2559.2005.02156.x; Rakha EA, 2008, EUR J CANCER, V44, P73, DOI 10.1016/j.ejca.2007.10.009; Reis JS, 2006, CLIN CANCER RES, V12, P6652, DOI 10.1158/1078-0432.CCR-06-1164; REMMELE W, 1987, PATHOLOGE, V8, P138; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Schackmann RCJ, 2011, J CLIN INVEST, V121, P3176, DOI 10.1172/JCI41695; Sikora MJ, 2013, STEROIDS, V78, P568, DOI 10.1016/j.steroids.2012.11.002; van de Wetering M, 2001, CANCER RES, V61, P278; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Xie ZM, 2011, CANCER-AM CANCER SOC, V117, P3112, DOI 10.1002/cncr.25876; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	44	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73062	10.1371/journal.pone.0073062	http://dx.doi.org/10.1371/journal.pone.0073062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023670	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200066
J	Rumbo-Feal, S; Gomez, MJ; Gayoso, C; Alvarez-Fraga, L; Cabral, MP; Aransay, AM; Rodriguez-Ezpeleta, N; Fullaondo, A; Valle, J; Tomas, M; Bou, G; Poza, M				Rumbo-Feal, Soraya; Gomez, Manuel J.; Gayoso, Carmen; Alvarez-Fraga, Laura; Cabral, Maria P.; Aransay, Ana M.; Rodriguez-Ezpeleta, Naiara; Fullaondo, Ane; Valle, Jaione; Tomas, Maria; Bou, German; Poza, Margarita			Whole Transcriptome Analysis of Acinetobacter baumannii Assessed by RNA-Sequencing Reveals Different mRNA Expression Profiles in Biofilm Compared to Planktonic Cells	PLOS ONE			English	Article							CARBAPENEM RESISTANCE; ENTEROCOCCUS-FAECALIS; BACTERIAL BIOFILMS; ABIOTIC SURFACES; GENE-EXPRESSION; KEY ROLE; PROTEIN; PATHOGEN; SYSTEM; GENOME	Acinetobacter baumannii has emerged as a dangerous opportunistic pathogen, with many strains able to form biofilms and thus cause persistent infections. The aim of the present study was to use high-throughput sequencing techniques to establish complete transcriptome profiles of planktonic (free-living) and sessile (biofilm) forms of A. baumannii ATCC 17978 and thereby identify differences in their gene expression patterns. Collections of mRNA from planktonic (both exponential and stationary phase cultures) and sessile (biofilm) cells were sequenced. Six mRNA libraries were prepared following the mRNA-Seq protocols from Illumina. Reads were obtained in a HiScanSQ platform and mapped against the complete genome to describe the complete mRNA transcriptomes of planktonic and sessile cells. The results showed that the gene expression pattern of A. baumannii biofilm cells was distinct from that of planktonic cells, including 1621 genes over-expressed in biofilms relative to stationary phase cells and 55 genes expressed only in biofilms. These differences suggested important changes in amino acid and fatty acid metabolism, motility, active transport, DNA-methylation, iron acquisition, transcriptional regulation, and quorum sensing, among other processes. Disruption or deletion of five of these genes caused a significant decrease in biofilm formation ability in the corresponding mutant strains. Among the genes over-expressed in biofilm cells were those in an operon involved in quorum sensing. One of them, encoding an acyl carrier protein, was shown to be involved in biofilm formation as demonstrated by the significant decrease in biofilm formation by the corresponding knockout strain. The present work serves as a basis for future studies examining the complex network systems that regulate bacterial biofilm formation and maintenance.	[Rumbo-Feal, Soraya; Gayoso, Carmen; Alvarez-Fraga, Laura; Cabral, Maria P.; Tomas, Maria; Bou, German; Poza, Margarita] Univ Hosp, Biomed Res Inst, Dept Microbiol, La Coruna, Spain; [Gomez, Manuel J.] INTA CSIC, Dept Mol Evolut, Ctr Astrobiol, Madrid, Spain; [Aransay, Ana M.; Rodriguez-Ezpeleta, Naiara; Fullaondo, Ane] CIC BioGUNE, Derio, Spain; [Aransay, Ana M.; Rodriguez-Ezpeleta, Naiara; Fullaondo, Ane] CIBERehd, Derio, Spain; [Rodriguez-Ezpeleta, Naiara] Tecnalia, AZTI, Div Marine Res, Sukarrieta, Spain; [Valle, Jaione] Agrobiotechnol Inst, Dept Microbial Biofilms, Navarra, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); CIC bioGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; AZTI	Bou, G (corresponding author), Univ Hosp, Biomed Res Inst, Dept Microbiol, La Coruna, Spain.	german.bou.arevalo@sergas.es; margarita.poza.dominguez@sergas.es	Aransay, Ana M./F-8086-2011; jaione, valle/N-8005-2019; M, Poza/AAA-2962-2021; jaione, valle/G-6213-2011; Cabral, Maria P/AAA-9408-2020; Gómez, Manuel J/F-8854-2016; Tomas, Maria/AAQ-5899-2020; Alvarez-Fraga, Laura/HGB-5957-2022; Rodriguez-Ezpeleta, Naiara/B-7138-2014; Bou, German/H-6683-2015	Aransay, Ana M./0000-0002-8271-612X; jaione, valle/0000-0003-3115-0207; jaione, valle/0000-0003-3115-0207; Cabral, Maria P/0000-0002-7119-440X; Gómez, Manuel J/0000-0002-4111-4835; Tomas, Maria/0000-0003-4501-0387; Rodriguez-Ezpeleta, Naiara/0000-0001-6735-6755; Poza, Margarita/0000-0001-9423-7268; Bou, German/0000-0001-8837-0062; Alvarez-Fraga, Laura/0000-0003-3920-5866; Rumbo-Feal, Soraya/0000-0002-1796-1815	Instituto de Salud Carlos III -Ministerio Economia y Competitividad Union Europea - Fondo Europeo de Desarrollo Regional (FEDER) [PI11/01034, PI10/00056]; Ministerio de Economia y Competitividad, Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe" ERDF; Spanish Network for the Research in Infectious Diseases [REIPI RD12/0015]; Fondo de Investigaciones Sanitarias [PI081638, PI12/00552]; project Consolider INGENIO [CSD2007-0005]; INTA-CSIC (Madrid, Spain); Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs); Innovation Technology Department of the Bizkaia County	Instituto de Salud Carlos III -Ministerio Economia y Competitividad Union Europea - Fondo Europeo de Desarrollo Regional (FEDER); Ministerio de Economia y Competitividad, Instituto de Salud Carlos III(Spanish Government); European Development Regional Fund "A way to achieve Europe" ERDF(European Commission); Spanish Network for the Research in Infectious Diseases; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); project Consolider INGENIO(Spanish Government); INTA-CSIC (Madrid, Spain); Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs); Innovation Technology Department of the Bizkaia County	This work was supported by grants from Instituto de Salud Carlos III -Ministerio Economia y Competitividad Union Europea - Fondo Europeo de Desarrollo Regional (FEDER) PI11/01034 to MP and PI10/00056 to MT, by Ministerio de Economia y Competitividad, Instituto de Salud Carlos III - co-financed by European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015) and Fondo de Investigaciones Sanitarias (PI081638, PI12/00552) to GB and by the project Consolider INGENIO CSD2007-0005 and INTA-CSIC (Madrid, Spain) to MJG. CIC bioGUNE support was provided from The Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2010/2012) and from the Innovation Technology Department of the Bizkaia County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036696; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; De la Cruz MA, 2010, J MOL MICROB BIOTECH, V18, P24, DOI 10.1159/000274309; Aranda J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-279; Bou G, 2000, CLIN MICROBIOL INFEC, V6, P635, DOI 10.1046/j.1469-0691.2000.00181.x; Cabral MP, 2011, J PROTEOME RES, V10, P3399, DOI 10.1021/pr101299j; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Corbella X, 2000, J CLIN MICROBIOL, V38, P4086, DOI 10.1128/JCM.38.11.4086-4095.2000; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P333, DOI 10.1128/AAC.01037-09; de Breij A, 2009, RES MICROBIOL, V160, P213, DOI 10.1016/j.resmic.2009.01.002; de Celles MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045758; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Fernandez-Cuenca F, 2003, J ANTIMICROB CHEMOTH, V51, P565, DOI 10.1093/jac/dkg097; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hamad MA, 2009, GENE, V430, P123, DOI 10.1016/j.gene.2008.10.011; Hamilton S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-599; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P3198, DOI 10.1128/AAC.49.8.3198-3202.2005; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09; Jager D, 2009, P NATL ACAD SCI USA, V106, P21878, DOI 10.1073/pnas.0909051106; Jones Mark E, 2004, Ann Clin Microbiol Antimicrob, V3, P14, DOI 10.1186/1476-0711-3-14; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Liou ML, 2013, J MICROBIOL IN PRESS; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Mao CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-72; Marti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026030; Marti Sara, 2011, BMC Res Notes, V4, P5, DOI 10.1186/1756-0500-4-5; McAllister KA, 2006, J BACTERIOL, V188, P4737, DOI 10.1128/JB.01917-05; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; McQueary CN, 2011, J MICROBIOL, V49, P243, DOI 10.1007/s12275-011-0343-7; Montero A, 2002, ANTIMICROB AGENTS CH, V46, P1946, DOI 10.1128/AAC.46.6.1946-1952.2002; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; Moreno-Paz M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-404; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; Ong CWM, 2009, RESPIROLOGY, V14, P1200, DOI 10.1111/j.1440-1843.2009.01630.x; Petrova OE, 2011, MOL MICROBIOL, V81, P767, DOI 10.1111/j.1365-2958.2011.07733.x; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; Raad II, 2011, BIOMATERIALS, V32, P2689, DOI 10.1016/j.biomaterials.2010.12.015; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P228, DOI 10.1093/jac/dkp427; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P276, DOI 10.1111/j.1469-0691.2007.01916.x; Santillana E, 2007, P NATL ACAD SCI USA, V104, P5354, DOI 10.1073/pnas.0607557104; Saroj SD, 2013, ANTIMICROB AGENTS CH, V57, P1926, DOI 10.1128/AAC.02161-12; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Soares NC, 2010, J PROTEOME RES, V9, P1951, DOI 10.1021/pr901116r; Srinivasan VB, 2009, ANTIMICROB AGENTS CH, V53, P5312, DOI 10.1128/AAC.00748-09; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Tomas MD, 2005, CLIN MICROBIOL INFEC, V11, P540, DOI 10.1111/j.1469-0691.2005.01184.x; Valle J, 2008, J BACTERIOL, V190, P264, DOI 10.1128/JB.01405-07; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Vidal R, 1996, MICROBIOS, V86, P49; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627	72	96	99	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72968	10.1371/journal.pone.0072968	http://dx.doi.org/10.1371/journal.pone.0072968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023660	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200056
J	Seelig, E; Bilz, S; Keller, U; Meienberg, F; Christ-Crain, M				Seelig, Eleonora; Bilz, Stefan; Keller, Ulrich; Meienberg, Fabian; Christ-Crain, Mirjam			Concentrations of the Stress Hormone Copeptin Increase upon Hypoglycaemia in Patients with Type 1 Diabetes Dependent of Hypoglycaemia Awareness	PLOS ONE			English	Article							INSULIN-INDUCED HYPOGLYCEMIA; ARGININE-VASOPRESSIN; STABLE PEPTIDE; PRECURSOR; PLASMA; SECRETION; RESPONSES; FAILURE; ASSAY	Objective: Copeptin, a marker for stress mirroring vasopressin concentrations, has been shown to increase upon insulin-induced hypoglycaemia in patients after transsphenoidal surgery of pituitary adenomas. Patients with type 1 diabetes mellitus are prone to hypoglycaemia, but no data about copeptin levels upon hypoglycaemia are available. Furthermore, the perception of hypoglycaemia can vary from total unawareness to disabling episodes. The aim of this study was to investigate whether copeptin increases upon hypoglycaemia in patients with type 1 diabetes mellitus and is associated with the degree of hypoglycaemia awareness. Materials and Methods: In this prospective observational study, 17 patients with type 1 diabetes underwent a standardized insulin infusion test. Blood sampling for glucose and copeptin was performed at baseline and after 60 minutes (min). To assess hypoglycaemia associated symptoms the Mood and Symptom Questionnaire (MSQ) was conducted at baseline and after 60 min. Results: During insulin infusion, blood glucose decreased from 5.1 (SD +/- 0.2) to 3.0 (+/- 0.5) mmol/L at 60 min (p<0.001). Copeptin concentrations increased from 3.2 (+/- 1.7) to 3.8 (+/- 1.9) pmol/L (p = 0.03). Mood and Symptoms Questionnaire scores increased from 14 (+/- 3.0) to 18 (+/- 5.8), (p = 0.006). Patients with good hypoglycaemia awareness had an increase in copeptin from 3.0 (+/- 1.8) to 4.2 (+/- 2.4) pmol/L (p = 0.03) in contrast to patients more unaware of hypoglycaemia who only showed an increase in copeptin from 3.3 (+/- 1.6) to 3.6 (+/- 1.4) pmol/L (p = 0.4). There was a trend to a larger copeptin increase in patients aware of hypoglycemia compared to patients unaware of hypoglycemia (p = 0.074). Conclusion: Copeptin increases in patients with type 1 diabetes upon insulin induced hypoglycaemia. Interestingly, the copeptin increase seems associated with the degree of hypoglycaemia awareness. This hypothesis warrants further verification.	[Seelig, Eleonora; Keller, Ulrich; Meienberg, Fabian; Christ-Crain, Mirjam] Univ Basel Hosp, Dept Diabetol Endocrinol & Metab, CH-4031 Basel, Switzerland; [Bilz, Stefan] Kantonsspital, Dept Endocrinol, St Gallen, Switzerland	University of Basel; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen	Seelig, E (corresponding author), Univ Basel Hosp, Dept Diabetol Endocrinol & Metab, CH-4031 Basel, Switzerland.	seelige@uhbs.ch		Bilz, Stefan/0000-0002-7716-2791; Christ-Crain, Mirjam/0000-0002-6336-0965	University Hospital Basel	University Hospital Basel	The study was funded by the University Hospital Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONI FA, 1993, FRONT NEUROENDOCRIN, V14, P76, DOI 10.1006/frne.1993.1004; BAYLIS PH, 1977, LANCET, V2, P428; Cryer PE, 2004, NEW ENGL J MED, V350, P2272, DOI 10.1056/NEJMra031354; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; FISHER BM, 1989, J CLIN ENDOCR METAB, V68, P688, DOI 10.1210/jcem-68-3-688; Katan M, 2007, J CLIN ENDOCR METAB, V92, P2640, DOI 10.1210/jc.2006-2046; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Muller B, 2007, EUR J CLIN INVEST, V37, P145, DOI 10.1111/j.1365-2362.2007.01762.x; PREIBISZ JJ, 1983, HYPERTENSION, V5, pI129, DOI 10.1161/01.HYP.5.2_Pt_2.I129; Reichlin T, 2009, J AM COLL CARDIOL, V54, P60, DOI 10.1016/j.jacc.2009.01.076; ROBERTSON GL, 1973, J CLIN INVEST, V52, P2340, DOI 10.1172/JCI107423; Scott LV, 1998, LIFE SCI, V62, P1985, DOI 10.1016/S0024-3205(98)00027-7; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; Tesfaye N, 2010, ANN NY ACAD SCI, V1212, P12, DOI 10.1111/j.1749-6632.2010.05820.x; THOMPSON CJ, 1989, DIABETIC MED, V6, P158, DOI 10.1111/j.1464-5491.1989.tb02106.x; WEINGER K, 1995, AM J MED, V98, P22, DOI 10.1016/S0002-9343(99)80077-1	18	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72876	10.1371/journal.pone.0072876	http://dx.doi.org/10.1371/journal.pone.0072876			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023652	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200048
J	Talsma, EF; Melse-Boonstra, A; de Kok, BPH; Mbera, GNK; Mwangi, AM; Brouwer, ID				Talsma, Elise F.; Melse-Boonstra, Alida; de Kok, Brenda P. H.; Mbera, Gloria N. K.; Mwangi, Alice M.; Brouwer, Inge D.			Biofortified Cassava with Pro-Vitamin A Is Sensory and Culturally Acceptable for Consumption by Primary School Children in Kenya	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; PLANNED BEHAVIOR; CONSUMER ACCEPTABILITY; REPLICATED DIFFERENCE; MAIZE PRODUCTS; INTENTION; YELLOW; DRINKING; QUALITY; ROOTS	Background: Biofortification of cassava with pro-vitamin A can potentially reduce vitamin A deficiency in low-income countries. However, little is known about consumer acceptance of this deep yellow variety of cassava compared to the commonly available white varieties. We aimed to determine the sensory and cultural acceptability of the consumption of pro-vitamin A rich cassava in order to identify key factors predicting the intention to consume pro-vitamin A rich cassava by families with school-aged children in Eastern Kenya. Methods: Sensory acceptability was measured by replicated discrimination tests and paired preference tests among 30 children (7-12 yr) and 30 caretakers (18-45 yr) in three primary schools. Cultural acceptability was assessed with a questionnaire based on the combined model of The Theory of Planned Behavior and The Health Belief Model in one primary school among 140 caretakers of children aged 6 to 12 years. Correlations and multivariate analyses were used to determine associations between summed scores for model constructs. Results: Caretakers and children perceived a significant difference in taste between white and pro-vitamin A rich cassava. Both preferred pro-vitamin A rich cassava over white cassava because of its soft texture, sweet taste and attractive color. Knowledge about pro-vitamin A rich cassava and it's relation to health ('Knowledge' ((beta = 0.29, P = <.01)) was a strong predictor of 'Health behavior identity'. Worries related to bitter taste and color ('Perceived barriers 1' (beta = -0.21, P = .02)), the belief of the caretaker about having control to prepare cassava ('Control beliefs' (beta = 0.18, P = .02)) and activities like information sessions about pro-vitamin A rich cassava and recommendations from health workers ('Cues to action'(beta = 0.51, P = <.01)) were the best predictors of intention to consume pro-vitamin A rich cassava. Conclusions: Pro-vitamin A rich cassava is well accepted by school children in our study population.	[Talsma, Elise F.; Melse-Boonstra, Alida; de Kok, Brenda P. H.; Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Mbera, Gloria N. K.; Mwangi, Alice M.] Univ Nairobi, Dept Food Technol & Nutr, Appl Nutr Program, Nairobi, Kenya	Wageningen University & Research; University of Nairobi	Talsma, EF (corresponding author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.	Elise.talsma@wur.nl	Brouwer, Inge D/K-8455-2013; Melse, Alida/AAH-2446-2019	Brouwer, Inge/0000-0002-2554-7227; de Kok, Brenda/0000-0002-5267-327X; Talsma, Elise/0000-0002-6034-4708	European Union's Seventh Framework Programme [Fp7] [211484]	European Union's Seventh Framework Programme [Fp7]	This research was realized in the framework of INSTAPA Project, funded by the European Union's Seventh Framework Programme [Fp7/2007-2013] under grant agreement nr 211484. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerni P., 2006, AgBioForum, V9, P1; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bi J, 2000, FOOD QUAL PREFER, V11, P269, DOI 10.1016/S0950-3293(99)00032-4; Bi J, 1999, J SENS STUD, V14, P347, DOI 10.1111/j.1745-459X.1999.tb00121.x; BLUM L, 1997, COMMUNITY ASSESSMENT; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Chavez AL, 2005, EUPHYTICA, V143, P125, DOI 10.1007/s10681-005-3057-2; De Groote H, 2012, FOOD NUTR BULL, V33, P99, DOI 10.1177/156482651203300203; De Groote H, 2011, AGR ECON-BLACKWELL, V42, P1, DOI 10.1111/j.1574-0862.2010.00466.x; DenHartog AP, 2006, FOOD HABITS AND CONSUMPTION IN DEVELOPING COUNTRIES: MANUAL FOR FIELD STUDIES, P1, DOI 10.3920/978-90-8686-667-0; Fanou-Fogny N, 2011, J NUTR EDUC BEHAV, V43, P219, DOI 10.1016/j.jneb.2010.03.008; Field A, 2013, DISCOVERING STAT USI; Guinard JX, 2000, TRENDS FOOD SCI TECH, V11, P273, DOI 10.1016/S0924-2244(01)00015-2; Hotz C, 2012, BRIT J NUTR, V108, P163, DOI 10.1017/S0007114511005174; Jang S, 2009, INT J HOSP MANAG, V28, P63, DOI 10.1016/j.ijhm.2008.03.007; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Johnston KL, 2003, PSYCHOL HEALTH, V18, P63, DOI 10.1080/0887044021000037835; Lawless HT, 2010, FOOD SCI TEXT SERIES; Low JW, 2007, J NUTR, V137, P1320; Macharia-Mutie CW, 2009, ANN NUTR METAB, V55, P433; Meenakshi JV, 2012, J HEALTH ECON, V31, P62, DOI 10.1016/j.jhealeco.2012.01.002; Muzhingi T, 2008, FOOD POLICY, V33, P352, DOI 10.1016/j.foodpol.2007.09.003; Nestel P, 2006, J NUTR, V136, P1064, DOI 10.1093/jn/136.4.1064; PARKER D, 1992, J APPL PSYCHOL, V77, P94, DOI 10.1037/0021-9010.77.1.94; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39; Saltzman A, 2013, GLOB FOOD SECUR-AGR, V2, P9, DOI 10.1016/j.gfs.2012.12.003; Sanchez T, 2006, J SCI FOOD AGR, V86, P634, DOI 10.1002/jsfa.2371; Sheeran P, 2003, BRIT J SOC PSYCHOL, V42, P393, DOI 10.1348/014466603322438224; Sommer A, 2002, J NUTR, V132, p2845S, DOI 10.1093/jn/132.9.2845S; Spijkerman R, 2004, ADDICT BEHAV, V29, P1615, DOI 10.1016/j.addbeh.2004.02.030; Stevens R, 2008, FOOD POLICY, V33, P341, DOI 10.1016/j.foodpol.2007.12.003; Sun XY, 2006, J NUTR EDUC BEHAV, V38, P276, DOI [10.1016/j.jneb.2006.04.144, 10.1016/J.JNEB.2006.04.144]; Sutton S, 1998, J APPL SOC PSYCHOL, V28, P1317, DOI 10.1111/j.1559-1816.1998.tb01679.x; Talsma EF, 2009, ANN NUTR METAB, V55, P378; Tomlins K, 2007, J SCI FOOD AGR, V87, P2436, DOI 10.1002/jsfa.2931; World Health Organization (WHO), 2009, GLOB PREV VIT DEF PO	39	36	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73433	10.1371/journal.pone.0073433	http://dx.doi.org/10.1371/journal.pone.0073433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211BX	24023681	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200078
J	Ji, LD; Cai, XB; Zhang, LN; Fei, LJ; Wang, L; Su, J; Lazar, L; Xu, J; Zhang, YP				Ji, Lindan; Cai, Xiaobo; Zhang, Lina; Fei, Lijuan; Wang, Lin; Su, Jia; Lazar, Lissy; Xu, Jin; Zhang, Yaping			Association between Polymorphisms in the Renin-Angiotensin-Aldosterone System Genes and Essential Hypertension in the Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; ENVIRONMENT INTERACTION; WILL UNLOCK; EPIDEMIOLOGY; GENETICS; INFORMATION; VARIANTS; DESIGN; BMI	Background: Renin-angiotensin-aldosterone system (RAAS) is the most important endocrine blood pressure control mechanism in our body, genes encoding components of this system have been strong candidates for the investigation of the genetic basis of hypertension. However, previous studies mainly focused on limited polymorphisms, thus we carried out a case-control study in the Han Chinese population to systemically investigate the association between polymorphisms in the RAAS genes and essential hypertension. Methods: 905 essential hypertensive cases and 905 normotensive controls were recruited based on stringent inclusion and exclusion criteria. All 41 tagSNPs within RAAS genes were retrieved from HapMap, and the genotyping was performed using the GenomeLab SNPstream Genotyping System. Logistic regression analysis, Multifactor dimensionality reduction (MDR), stratified analysis and crossover analysis were used to identify and characterize interactions among the SNPs and the non-genetic factors. Results: Serum levels of total cholesterol (TC) and triglyceride (TG), and body mass index (BMI) were significantly higher in the hypertensive group than in the control group. Of 41 SNPs genotyped, rs3789678 and rs2493132 within AGT, rs4305 within ACE, rs275645 within AGTR1, rs3802230 and rs10086846 within CYP11B2 were shown to associate with hypertension. The MDR analysis demonstrated that the interaction between BMI and rs4305 increased the susceptibility to hypertension. Crossover analysis and stratified analysis further indicated that BMI has a major effect, and rs4305 has a minor effect. Conclusion: These novel findings indicated that together with non-genetic factors, these genetic variants in the RAAS may play an important role in determining an individual's susceptibility to hypertension in the Han Chinese.	[Ji, Lindan; Cai, Xiaobo] Ningbo Univ, Sch Med, Dept Biochem, Ningbo, Peoples R China; [Ji, Lindan; Zhang, Yaping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhang, Lina; Fei, Lijuan; Lazar, Lissy; Xu, Jin] Ningbo Univ, Sch Med, Dept Prevent Med, Ningbo, Peoples R China; [Wang, Lin] Ningbo Univ, Sch Med, Dept Pathol, Ningbo, Peoples R China; [Su, Jia] Ningbo Univ, Sch Med, Affiliated Ningbo Hosp 1, Ningbo, Peoples R China	Ningbo University; Chinese Academy of Sciences; Kunming Institute of Zoology; Ningbo University; Ningbo University; Ningbo University	Xu, J (corresponding author), Ningbo Univ, Sch Med, Dept Prevent Med, Ningbo, Peoples R China.	xujin1@nbu.edu.cn; zhangyp@mail.kiz.ac.cn		Ji, Lin-dan/0000-0003-2043-1150	Zhejiang Natural Science Foundation [LQ13C060001]; Ningbo Natural Science Foundation [2012A610237]; Research Project of Zhejiang Education Department [Y201224146]; KC Wong Magna Fund in Ningbo University	Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Ningbo Natural Science Foundation; Research Project of Zhejiang Education Department; KC Wong Magna Fund in Ningbo University	This study was financially supported by Zhejiang Natural Science Foundation (LQ13C060001), Ningbo Natural Science Foundation (2012A610237), Research Project of Zhejiang Education Department (Y201224146), as well as the KC Wong Magna Fund in Ningbo University. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Basson J, 2012, CURR HYPERTENS REP, V14, P46, DOI 10.1007/s11906-011-0241-8; Beeks E, 2004, J HYPERTENS, V22, P1243, DOI 10.1097/01.hjh.0000125443.28861.0d; Bell PA, 2002, BIOTECHNIQUES, P70; Brand SM, 2012, J HYPERTENS, V30, P877, DOI 10.1097/HJH.0b013e3283530957; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Chen BF, 2011, CLIN EXP HYPERTENS, V33, P106, DOI 10.3109/10641963.2010.531835; Chen BF, 2011, BIOCHEM GENET, V49, P122, DOI 10.1007/s10528-010-9393-5; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Dominiczak AF, 2010, HYPERTENSION, V56, P1017, DOI 10.1161/HYPERTENSIONAHA.110.156208; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ehret GB, 2010, CURR HYPERTENS REP, V12, P17, DOI 10.1007/s11906-009-0086-6; Farahani P, 2007, J CLIN EPIDEMIOL, V60, P1, DOI 10.1016/j.jclinepi.2006.04.002; Feng RN, 2012, J EPIDEMIOL, V22, P317, DOI 10.2188/jea.JE20110120; Franceschini N, 2011, AM J HYPERTENS, V24, P392, DOI 10.1038/ajh.2010.218; He J, 2007, J HUM HYPERTENS, V21, P639, DOI 10.1038/sj.jhh.1002207; He J, 2011, J HYPERTENS, V29, P1719, DOI 10.1097/HJH.0b013e32834a4d1f; HORAN MJ, 1990, HYPERTENSION, V15, pI20, DOI 10.1161/01.HYP.15.2_Suppl.I20; Ji LD, 2010, J HYPERTENS, V28, P419, DOI 10.1097/HJH.0b013e32833456b9; Johnson AD, 2011, HYPERTENSION, V57, P903, DOI 10.1161/HYPERTENSIONAHA.110.158667; Joseph PG, 2013, CAN J CARDIOL, V29, P37, DOI 10.1016/j.cjca.2012.10.009; Kazma R, 2011, AM J EPIDEMIOL, V173, P225, DOI 10.1093/aje/kwq352; Konoshita T, 2011, CURR HYPERTENS REP, V13, P356, DOI 10.1007/s11906-011-0212-0; Kotchen TA, 2010, AM J HYPERTENS, V23, P1170, DOI 10.1038/ajh.2010.172; Kunes J, 2006, CLIN SCI, V111, P295, DOI 10.1042/CS20050271; Kurtz TW, 2010, HYPERTENSION, V56, P1021, DOI 10.1161/HYPERTENSIONAHA.110.156190; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Marteau JB, 2005, J HYPERTENS, V23, P2127, DOI 10.1097/01.hjh.0000186024.12364.2e; Motsinger AA, 2006, GENET EPIDEMIOL, V30, P546, DOI 10.1002/gepi.20166; Mottl AK, 2008, GENET MED, V10, P560, DOI [10.1097/GIM.0b013e3181809613, 10.1097GIM.0b013e3181809613]; Mukherjee B, 2012, AM J EPIDEMIOL, V175, P177, DOI 10.1093/aje/kwr367; Navar LG, 2011, HYPERTENSION, V57, P355, DOI 10.1161/HYPERTENSIONAHA.110.163519; Nebert DW, 1997, AM J HUM GENET, V60, P265; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Parati G, 2007, J HYPERTENS, V25, P2377, DOI 10.1097/HJH.0b013e32801143b3; Pereira TV, 2008, HYPERTENSION, V51, P778, DOI 10.1161/HYPERTENSIONAHA.107.100370; PICKERING GW, 1959, LANCET, V2, P1027; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6; Simino J, 2012, CURR OPIN NEPHROL HY, V21, P500, DOI 10.1097/MNH.0b013e328354e78f; Sookoian S, 2007, J HYPERTENS, V25, P5, DOI 10.1097/01.hjh.0000254372.88488.a9; Taylor J, 2008, J HYPERTENS, V26, P2312, DOI 10.1097/HJH.0b013e3283110402; Wang J, 2005, BIOTECHNIQUES, V39, P885, DOI 10.2144/000112028; Wang LY, 2010, J HYPERTENS, V28, P2422, DOI 10.1097/HJH.0b013e32833ea74e; Wang TJ, 2005, CIRCULATION, V112, P1651, DOI 10.1161/CIRCULATIONAHA.104.490599; Xu J, 2012, J HUM HYPERTENS	45	29	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72701	10.1371/journal.pone.0072701	http://dx.doi.org/10.1371/journal.pone.0072701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015270	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800074
J	Olini, N; Kurth, S; Huber, R				Olini, Nadja; Kurth, Salome; Huber, Reto			The Effects of Caffeine on Sleep and Maturational Markers in the Rat	PLOS ONE			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; ADOLESCENT BRAIN MATURATION; ADENOSINE A(1) RECEPTOR; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; SLOW-WAVE ACTIVITY; CEREBRAL-CORTEX; POSTSYNAPTIC DENSITY; EXCITATORY SYNAPSES; DIVERSE REGIONS	Adolescence is a critical period for brain maturation during which a massive reorganization of cortical connectivity takes place. In humans, slow wave activity (<4.5 Hz) during NREM sleep was proposed to reflect cortical maturation which relies on use-dependent processes. A stimulant like caffeine, whose consumption has recently increased especially in adolescents, is known to affect sleep wake regulation. The goal of this study was to establish a rat model allowing to assess the relationship between cortical maturation and sleep and to further investigate how these parameters are affected by caffeine consumption. To do so, we assessed sleep and markers of maturation by electrophysiological recordings, behavioral and structural readouts in the juvenile rat. Our results show that sleep slow wave activity follows a similar inverted U-shape trajectory as already known in humans. Caffeine treatment exerted short-term stimulating effects and altered the trajectory of slow wave activity. Moreover, caffeine affected behavioral and structural markers of maturation. Thus, caffeine consumption during a critical developmental period shows long lasting effects on sleep and brain maturation.	[Olini, Nadja; Kurth, Salome; Huber, Reto] Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland; [Olini, Nadja; Kurth, Salome; Huber, Reto] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Olini, Nadja; Kurth, Salome; Huber, Reto] Swiss Fed Inst Technol, Zurich, Switzerland; [Kurth, Salome] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Huber, Reto] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; ETH Zurich; University of Colorado System; University of Colorado Boulder; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Huber, R (corresponding author), Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland.	reto.huber@kispi.uzh.ch	Kurth, Salome/M-4227-2017; Kurth, Salome/AAS-8067-2021	Kurth, Salome/0000-0003-1432-4367; Kurth, Salome/0000-0003-1432-4367	Neuroscience Center Zurich; Swiss National Science Foundation [PP00A-114923, PP00P3-13538]	Neuroscience Center Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Neuroscience Center Zurich and the Swiss National Science Foundation (PP00A-114923 and PP00P3-13538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; BENINGTON JH, 1995, BRAIN RES, V692, P79, DOI 10.1016/0006-8993(95)00590-M; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Bruel-Jungerman E, 2011, BEHAV BRAIN RES, V221, P379, DOI 10.1016/j.bbr.2011.01.021; Buchmann A, 2011, CEREB CORTEX, V21, P607, DOI 10.1093/cercor/bhq129; Campbell IG, 2009, P NATL ACAD SCI USA, V106, P5177, DOI 10.1073/pnas.0812947106; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; COHEN J, 1982, DEV BRAIN RES, V3, P160, DOI 10.1016/0165-3806(82)90086-4; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Hussein AE, 2000, SCIENCE, V290, P1364; FASTBOM J, 1987, NEUROSCIENCE, V22, P813, DOI 10.1016/0306-4522(87)92961-7; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; Feinberg I, 2013, AM J PHYSIOL-REG I, V304, pR296, DOI 10.1152/ajpregu.00422.2012; Feinberg I, 2010, BRAIN COGNITION, V72, P56, DOI 10.1016/j.bandc.2009.09.008; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Frank MG, 2012, SLEEP BRIAN ACTIVITY; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Gaudreau H, 2001, J SLEEP RES, V10, P165, DOI 10.1046/j.1365-2869.2001.00252.x; Gilmor ML, 1996, J NEUROSCI, V16, P2179; Gimenez-Llort L, 2002, EUR J NEUROSCI, V16, P547, DOI 10.1046/j.1460-9568.2002.02122.x; GOODMAN RR, 1982, J NEUROSCI, V2, P1230; GOULD E, 1989, DEV BRAIN RES, V46, P297, DOI 10.1016/0165-3806(89)90293-9; Guizzetti M, 2008, J BIOL CHEM, V283, P31884, DOI 10.1074/jbc.M801316200; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Huber R, 2013, CEREB CORTEX, V23, P1, DOI 10.1093/cercor/bhs014; Hunt CA, 1996, J NEUROSCI, V16, P1380; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; ICHIKAWA M, 1993, NEUROSCI RES, V16, P95, DOI 10.1016/0168-0102(93)90076-3; Jenni OG, 2004, AM J PHYSIOL-REG I, V286, pR528, DOI 10.1152/ajpregu.00503.2003; Jenni OG, 2004, SLEEP, V27, P774; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Juarez-Mendez S, 2006, SYNAPSE, V60, P450, DOI 10.1002/syn.20318; Krstic D, 2012, J NEUROINFL IN PRESS; Kurth S, 2012, NEUROIMAGE, V63, P959, DOI 10.1016/j.neuroimage.2012.03.053; Kurth S, 2010, J NEUROSCI, V30, P13211, DOI 10.1523/JNEUROSCI.2532-10.2010; LANDOLT HP, 1995, NEUROPSYCHOPHARMACOL, V12, P229, DOI 10.1016/0893-133X(94)00079-F; LEE VWK, 1975, J REPROD FERTIL, V42, P121, DOI 10.1530/jrf.0.0420121; LIDOW MS, 1991, P NATL ACAD SCI USA, V88, P10218, DOI 10.1073/pnas.88.22.10218; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; McGivern RF, 1996, PHYSIOL BEHAV, V59, P653, DOI 10.1016/0031-9384(95)02017-9; Meerlo P, 1997, NEUROSCI LETT, V225, P41, DOI 10.1016/S0304-3940(97)00180-8; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; PEDATA F, 1982, BRAIN RES, V233, P359, DOI 10.1016/0006-8993(82)91208-2; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Schwierin B, 1996, EUR J PHARMACOL, V300, P163, DOI 10.1016/0014-2999(96)00021-0; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Steger R, 2012, IMPACT CAFFEINE MORP; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Swulius MT, 2010, J COMP NEUROL, V518, P4243, DOI 10.1002/cne.22451; Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001; TICHO SR, 1991, PHARMACOL BIOCHEM BE, V40, P33, DOI 10.1016/0091-3057(91)90317-U; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vila-Luna S, 2012, NEUROSCIENCE, V202, P384, DOI 10.1016/j.neuroscience.2011.11.053; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Zhu XO, 1998, CEREB CORTEX, V8, P63, DOI 10.1093/cercor/8.1.63; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	67	29	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72539	10.1371/journal.pone.0072539	http://dx.doi.org/10.1371/journal.pone.0072539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023748	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000324515600027
J	Savage, LJ; Imre, KM; Hall, DA; Last, RL				Savage, Linda J.; Imre, Kathleen M.; Hall, David A.; Last, Robert L.			Analysis of Essential Arabidopsis Nuclear Genes Encoding Plastid-Targeted Proteins	PLOS ONE			English	Article							THYLAKOID MEMBRANE PROTEOME; CHLOROPLAST PROTEOME; PHOTOSYSTEM-II; INSERTIONAL MUTAGENESIS; EMBRYO DEVELOPMENT; ENVELOPE MEMBRANE; PLANT DEVELOPMENT; DEFICIENT MUTANT; SUBUNIT MUTANTS; THALIANA	The Chloroplast 2010 Project (http://www.plastid.msu.edu/) identified and phenotypically characterized homozygous mutants in over three thousand genes, the majority of which encode plastid-targeted proteins. Despite extensive screening by the community, no homozygous mutant alleles were available for several hundred genes, suggesting that these might be enriched for genes of essential function. Attempts were made to generate homozygotes in,1200 of these lines and 521 of the homozygous viable lines obtained were deposited in the Arabidopsis Biological Resource Center (http://abrc.osu.edu/). Lines that did not yield a homozygote in soil were tested as potentially homozygous lethal due to defects either in seed or seedling development. Mutants were characterized at four stages of development: developing seed, mature seed, at germination, and developing seedlings. To distinguish seed development or seed pigment-defective mutants from seedling development mutants, development of seeds was assayed in siliques from heterozygous plants. Segregating seeds from heterozygous parents were sown on supplemented media in an attempt to rescue homozygous seedlings that could not germinate or survive in soil. Growth of segregating seeds in air and air enriched to 0.3% carbon dioxide was compared to discover mutants potentially impaired in photorespiration or otherwise responsive to CO2 supplementation. Chlorophyll fluorescence measurements identified CO2-responsive mutants with altered photosynthetic parameters. Examples of genes with a viable mutant allele and one or more putative homozygous-lethal alleles were documented. RT-PCR of homozygotes for potentially weak alleles revealed that essential genes may remain undiscovered because of the lack of a true null mutant allele. This work revealed 33 genes with two or more lethal alleles and 73 genes whose essentiality was not confirmed with an independent lethal mutation, although in some cases second leaky alleles were identified.	[Savage, Linda J.; Imre, Kathleen M.; Hall, David A.; Last, Robert L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Last, Robert L.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Last, RL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	lastr@msu.edu		Last, Robert/0000-0001-6974-9587	National Science Foundation [MCB-0519740, MCB-1119778]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants MCB-0519740 and MCB-1119778. R. L. L. thanks the Lady Davis Foundation of the Hebrew University in Jerusalem, Israel and the Weizmann Institute of Science in Rehovot, Israel for sabbatical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjawi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025368; Ajjawi I, 2010, PLANT PHYSIOL, V152, P529, DOI 10.1104/pp.109.148494; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Asakura Y, 2006, PLANT PHYSIOL, V142, P1656, DOI 10.1104/pp.106.088096; Babiychuk E, 2011, P NATL ACAD SCI USA, V108, P6674, DOI 10.1073/pnas.1103442108; Badger MR, 2009, FUNCT PLANT BIOL, V36, P867, DOI 10.1071/FP09199; BARCZAK AJ, 1995, GENETICS, V140, P303; Boldt R, 2005, PLANT CELL, V17, P2413, DOI 10.1105/tpc.105.033993; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; Budziszewski GJ, 2001, GENETICS, V159, P1765; Coruzzi G., 2000, BIOCH MOL BIOL PLANT, P358; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Eisenhut M, 2013, PLANT BIOLOGY, V15, P676, DOI 10.1111/j.1438-8677.2012.00690.x; Ferro M, 2003, MOL CELL PROTEOMICS, V2, P325, DOI 10.1074/mcp.M300030-MCP200; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Gerdes L, 2006, J BIOL CHEM, V281, P16632, DOI 10.1074/jbc.M513623200; Giacomelli L, 2006, PLANT PHYSIOL, V141, P685, DOI 10.1104/pp.106.080150; Goyer A, 2005, J BIOL CHEM, V280, P26137, DOI 10.1074/jbc.M503106200; Hall M, 2010, PROTEOMICS, V10, P987, DOI 10.1002/pmic.200900654; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hsieh MH, 2006, PLANTA, V223, P779, DOI 10.1007/s00425-005-0140-9; Hsu SC, 2010, CURR GENOMICS, V11, P338, DOI 10.2174/138920210791616716; Huang M, 2012, J PROTEOME RES; Hudson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026765; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kim J, 2009, PLANT CELL, V21, P1669, DOI 10.1105/tpc.108.063784; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; Kuromori T, 2006, PLANT J, V47, P640, DOI 10.1111/j.1365-313X.2006.02808.x; LAST RL, 1988, SCIENCE, V240, P305, DOI 10.1126/science.240.4850.305; Lee MS, 2008, PLANT J, V54, P310, DOI 10.1111/j.1365-313X.2008.03419.x; Link S, 2012, PLANT PHYSIOL, V160, P2202, DOI 10.1104/pp.112.205104; Liu XL, 2012, MOL PLANT, V5, P1082, DOI 10.1093/mp/sss012; Lloyd J, 2012, PLANT PHYSIOL, V158, P1115, DOI 10.1104/pp.111.192393; Lu Y, 2008, PLANT PHYSIOL, V146, P1482, DOI 10.1104/pp.107.115220; Lu Y, 2011, METHODS MOL BIOL, V775, P161, DOI 10.1007/978-1-61779-237-3_9; Lu Y, 2011, PLANT CELL, V23, P1861, DOI 10.1105/tpc.111.085456; Lu Y, 2011, PLANT PHYSIOL, V155, P1589, DOI 10.1104/pp.110.170118; Lukowitz W, 2001, P NATL ACAD SCI USA, V98, P2262, DOI 10.1073/pnas.051625798; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; McElver J, 2001, GENETICS, V159, P1751; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Muralla R, 2008, PLANT PHYSIOL, V146, P60, DOI 10.1104/pp.107.107409; Muralla R, 2007, PLANT PHYSIOL, V144, P890, DOI 10.1104/pp.107.096511; Muralla R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028398; Myouga F, 2012, PLANT CELL PHYSL; Myouga F, 2010, PLANT J, V61, P529, DOI 10.1111/j.1365-313X.2009.04074.x; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; Olinares PDB, 2011, BBA-BIOENERGETICS, V1807, P999, DOI 10.1016/j.bbabio.2010.12.003; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Ouyang M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1278; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; Peterhansel Christoph, 2010, Arabidopsis Book, V8, pe0130, DOI 10.1199/tab.0130; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Radwanski ER, 1996, MOL GEN GENET, V253, P353; Robles P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042924; Rohdich F, 2000, P NATL ACAD SCI USA, V97, P6451, DOI 10.1073/pnas.97.12.6451; Romani I, 2012, PLANT J; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; SCHNEIDER T, 1989, DEV BIOL, V131, P161, DOI 10.1016/S0012-1606(89)80047-8; SOMERVILLE CR, 1979, NATURE, V280, P833, DOI 10.1038/280833a0; Stern DB, 2004, TRENDS PLANT SCI, V9, P293, DOI 10.1016/j.tplants.2004.04.001; Su N, 2012, PLANT PHYSIOL, V159, P227, DOI 10.1104/pp.112.195081; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Takahashi S, 2007, PLANT PHYSIOL, V144, P487, DOI 10.1104/pp.107.097253; Teng YS, 2006, PLANT CELL, V18, P2247, DOI 10.1105/tpc.106.044305; Timm S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042809; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Voll LM, 2006, PLANT PHYSIOL, V140, P59, DOI 10.1104/pp.105.071399; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Ward JK, 2004, ECOL LETT, V7, P427, DOI 10.1111/j.1461-0248.2004.00589.x; Wei LL, 2010, J BIOL CHEM, V285, P21391, DOI 10.1074/jbc.M110.105064; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Xiao JW, 2012, PLANT PHYSIOL, V160, P1911, DOI 10.1104/pp.112.204891; Xu HW, 2009, J EXP BOT, V60, P1799, DOI 10.1093/jxb/erp056; Yamaguchi K, 2000, PLANT CELL PHYSIOL, V41, P1397, DOI 10.1093/pcp/pcd074; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	86	34	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73291	10.1371/journal.pone.0073291	http://dx.doi.org/10.1371/journal.pone.0073291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023856	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600093
J	Shakely, D; Elfving, K; Aydin-Schmidt, B; Msellem, MI; Morris, U; Omar, R; Xu, WP; Petzold, M; Greenhouse, B; Baltzell, KA; Ali, AS; Bjorkman, A; Martensson, A				Shakely, Deler; Elfving, Kristina; Aydin-Schmidt, Berit; Msellem, Mwinyi I.; Morris, Ulrika; Omar, Rahila; Xu Weiping; Petzold, Max; Greenhouse, Bryan; Baltzell, Kimberly A.; Ali, Abdullah S.; Bjorkman, Anders; Martensson, Andreas			The Usefulness of Rapid Diagnostic Tests in the New Context of Low Malaria Transmission in Zanzibar	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; COMBINATION THERAPY; RANDOMIZED-TRIAL; FEBRILE PATIENTS; TANZANIA; PERFORMANCE; PARASITE; AMODIAQUINE; INFECTIONS; MICROSCOPY	Background: We assessed if histidine-rich-protein-2 (HRP2) based rapid diagnostic test (RDT) remains an efficient tool for Plasmodium falciparum case detection among fever patients in Zanzibar and if primary health care workers continue to adhere to RDT results in the new epidemiological context of low malaria transmission. Further, we evaluated the performance of RDT within the newly adopted integrated management of childhood illness (IMCI) algorithm in Zanzibar. Methods and Findings: We enrolled 3890 patients aged >= 2 months with uncomplicated febrile illness in this health facility based observational study conducted in 12 primary health care facilities in Zanzibar, between May-July 2010. One patient had an inconclusive RDT result. Overall 121/3889 (3.1%) patients were RDT positive. The highest RDT positivity rate, 32/528 (6.1%), was found in children aged 5-14 years. RDT sensitivity and specificity against PCR was 76.5% (95% CI 69.0-83.9%) and 99.9% (95% CI 99.7-100%), and against blood smear microscopy 78.6% (95% CI 70.8-85.1%) and 99.7% (95% CI 99.699.9%), respectively. All RDT positive, but only 3/3768 RDT negative patients received anti-malarial treatment. Adherence to RDT results was thus 3887/3889 (99.9%). RDT performed well in the IMCI algorithm with equally high adherence among children,5 years as compared with other age groups. Conclusions: The sensitivity of HRP-2 based RDT in the hands of health care workers compared with both PCR and microscopy for P. falciparum case detection was relatively low, whereas adherence to test results with anti-malarial treatment was excellent. Moreover, the results provide evidence that RDT can be reliably integrated in IMCI as a tool for improved childhood fever management. However, the relatively low RDT sensitivity highlights the need for improved quality control of RDT use in primary health care facilities, but also for more sensitive point-of-care malaria diagnostic tools in the new epidemiological context of low malaria transmission in Zanzibar.	[Shakely, Deler; Elfving, Kristina; Aydin-Schmidt, Berit; Morris, Ulrika; Xu Weiping; Bjorkman, Anders; Martensson, Andreas] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Martensson, Andreas] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Msellem, Mwinyi I.; Omar, Rahila; Ali, Abdullah S.] Minist Hlth, Zanzibar Malaria Control Programme, Zanzibar, Tanzania; [Elfving, Kristina] Univ Gothenburg, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden; [Greenhouse, Bryan] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Baltzell, Kimberly A.] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA; [Shakely, Deler] Kungalv Hosp, Dept Med, Kungalv, Sweden	Karolinska Institutet; Karolinska Institutet; University of Gothenburg; University of Gothenburg; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shakely, D (corresponding author), Karolinska Inst, Dept Med Solna, Stockholm, Sweden.	deler.shakely@ki.se	Morris, Ulrika/AAY-8512-2020	Morris, Ulrika/0000-0003-4734-5754; Elfving, Kristina/0000-0003-4477-8765; Greenhouse, Bryan/0000-0003-0287-9111	ACT Consortium through an award from the Bill and Melinda Gates Foundation; Swedish International Development Cooperation Agency (Sida); Swedish Civil Contingencies Agency (MSB); Goljes Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	ACT Consortium through an award from the Bill and Melinda Gates Foundation; Swedish International Development Cooperation Agency (Sida); Swedish Civil Contingencies Agency (MSB); Goljes Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the ACT Consortium through an award from the Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine, and by the Swedish International Development Cooperation Agency (Sida), Swedish Civil Contingencies Agency (MSB) and Goljes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-202; [Anonymous], 2003, ASS MON ANT DRUG EFF; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Baltzell K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-37; Beshir KB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-312; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Chinkhumba J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-209; Dahlstrom S, 2008, INFECT GENET EVOL, V8, P340, DOI 10.1016/j.meegid.2008.02.002; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-166; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; *HELS WMADO, 2008, ETH PRINC MED RES IN; Holmgren G, 2007, INFECT GENET EVOL, V7, P562, DOI 10.1016/j.meegid.2007.03.005; Hsiang MS, 2010, J CLIN MICROBIOL, V48, P3539, DOI 10.1128/JCM.00522-10; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Manjurano A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-370; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Nicastri E, 2009, AM J TROP MED HYG, V80, P712, DOI 10.4269/ajtmh.2009.80.712; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Veiga MI, 2006, MOL CELL PROBE, V20, P100, DOI 10.1016/j.mcp.2005.10.003; WHO, 1991, BAS MAL MICR 1; WHO, 2008, INT MAN CHILDH ILLN; WHO-FIND, 2012, SUMM RES WHO PROD TE, V4; World Health Organization, 1991, BAS MAL MICR 2; Zanzibar Ministry of Health Z, 2010, ANN HLTH INF B; ZMCP, 2010, EARL EP DET SYST, V1; ZMCP, 2009, NAT GUID MAL DIAGN T	34	46	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72912	10.1371/journal.pone.0072912	http://dx.doi.org/10.1371/journal.pone.0072912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023791	Green Published, gold			2022-12-27	WOS:000324515600052
J	Smith, E; Duede, S; Hanrahan, S; Davis, T; House, P; Greger, B				Smith, Elliot; Duede, Scott; Hanrahan, Sara; Davis, Tyler; House, Paul; Greger, Bradley			Seeing Is Believing: Neural Representations of Visual Stimuli in Human Auditory Cortex Correlate with Illusory Auditory Perceptions	PLOS ONE			English	Article							SPEECH-PERCEPTION; INTEGRATION; INFORMATION; VOICES; MCGURK; ECOG	In interpersonal communication, the listener can often see as well as hear the speaker. Visual stimuli can subtly change a listener's auditory perception, as in the McGurk illusion, in which perception of a phoneme's auditory identity is changed by a concurrent video of a mouth articulating a different phoneme. Studies have yet to link visual influences on the neural representation of language with subjective language perception. Here we show that vision influences the electrophysiological representation of phonemes in human auditory cortex prior to the presentation of the auditory stimulus. We used the McGurk effect to dissociate the subjective perception of phonemes from the auditory stimuli. With this paradigm we demonstrate that neural representations in auditory cortex are more closely correlated with the visual stimuli of mouth articulation, which drive the illusory subjective auditory perception, than the actual auditory stimuli. Additionally, information about visual and auditory stimuli transfer in the caudal-rostral direction along the superior temporal gyrus during phoneme perception as would be expected of visual information flowing from the occipital cortex into the ventral auditory processing stream. These results show that visual stimuli influence the neural representation in auditory cortex early in sensory processing and may override the subjective auditory perceptions normally generated by auditory stimuli. These findings depict a marked influence of vision on the neural processing of audition in tertiary auditory cortex and suggest a mechanistic underpinning for the McGurk effect.	[Smith, Elliot; Greger, Bradley] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT 84112 USA; [Smith, Elliot; Hanrahan, Sara; Davis, Tyler; Greger, Bradley] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Duede, Scott] Univ Utah, Dept Linguist, Salt Lake City, UT USA; [Davis, Tyler; House, Paul] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Greger, B (corresponding author), Univ Utah, Interdept Program Neurosci, Salt Lake City, UT 84112 USA.	bradley.greger@asu.edu	Hanrahan, Sara/H-9953-2019	Hanrahan, Sara/0000-0002-2512-3627; Davis, Tyler/0000-0001-8823-6189; Greger, Bradley/0000-0002-6702-7596	University of Utah; NIH NIDCD [5 T32 DC008553-02]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC008553] Funding Source: NIH RePORTER	University of Utah; NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by University of Utah Startup funds (www.utah.edu) and an NIH NIDCD training grant: 5 T32 DC008553-02 (www.nidcd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besle J, 2009, HEARING RES, V258, P143, DOI 10.1016/j.heares.2009.06.016; Besle J, 2008, J NEUROSCI, V28, P14301, DOI 10.1523/JNEUROSCI.2875-08.2008; Blakely T, 2008, IEEE ENG MED BIO, P4964, DOI 10.1109/IEMBS.2008.4650328; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Hackett TA, 2011, HEARING RES, V271, P133, DOI 10.1016/j.heares.2010.01.011; Hermes D, 2010, J NEUROSCI METH, V185, P293, DOI 10.1016/j.jneumeth.2009.10.005; Jiang JT, 2011, J EXP PSYCHOL HUMAN, V37, P1193, DOI 10.1037/a0023100; Kellis S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056007; Krzanowski WJ., 1990, PRINCIPLES MULTIVARI; Li XL, 2010, NEUROIMAGE, V52, P497, DOI 10.1016/j.neuroimage.2010.05.003; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Romanski LM, 2007, CEREB CORTEX, V17, pI61, DOI 10.1093/cercor/bhm099; Rosenblum LD, 1997, PERCEPT PSYCHOPHYS, V59, P347, DOI 10.3758/BF03211902; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Senkowski D, 2007, EXP BRAIN RES, V177, P184, DOI 10.1007/s00221-006-0664-7; Smith EH, 2012, C P ANN INT C IEEE E, P5178; Smith E, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016010; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102	29	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73148	10.1371/journal.pone.0073148	http://dx.doi.org/10.1371/journal.pone.0073148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023823	Green Published, gold			2022-12-27	WOS:000324515600072
J	Weiss, CS; Ochs, MM; Hagenmueller, M; Streit, MR; Malekar, P; Riffel, JH; Buss, SJ; Weiss, KH; Sadoshima, J; Katus, HA; Hardt, SE				Weiss, Celine S.; Ochs, Marco M.; Hagenmueller, Marco; Streit, Marcus R.; Malekar, Pratima; Riffel, Johannes H.; Buss, Sebastian J.; Weiss, Karl H.; Sadoshima, Junichi; Katus, Hugo A.; Hardt, Stefan E.			DYRK2 Negatively Regulates Cardiomyocyte Growth by Mediating Repressor Function of GSK-3 beta on eIF2B epsilon	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; GLYCOGEN-SYNTHASE KINASE-3-BETA; PROTEIN-SYNTHESIS; CARDIAC-HYPERTROPHY; TRANSLATION INITIATION; EIF2B; PHOSPHORYLATION; HEART; ACTIVATION; MECHANISMS	Background: A prerequisite of hypertrophic response of the myocardium is an increase in protein synthesis. A central regulator of translation initiation is Eukaryotic initiation factor 2B (eIF2B). Here we assessed the hypothesis that regulation of protein synthesis via eIF2B epsilon is essential to cardiac hypertrophic response in vivo. Methods: Two transgenic mouse lines were generated with cardiac restricted overexpression of eIF2Be or its mutant eIF2B epsilon-eIFS(535)A, which cannot be inactivated by phosphorylation through GSK-3 beta. Results: (1) Under baseline conditions eIF2B epsilon transgenic mice showed no difference in cardiac phenotype compared to wild type, whereas in the mutant eIF2B epsilon-S(535)A an increase in LV/tibia length (7.5 +/- 0.4 mg/mm vs. 6.2 +/- 0.2 mg/mm, p < 0.001) and cardiomyocyte cross sectional area (13004 +/- 570 vs. 10843 +/- 347 RU, p < 0.01) was observed. (2) Cardiac overexpression of eIF2B epsilon did not change the response of the heart to pathologic stress induced by chronic isoproterenol treatment. (3) Cardiac overexpression of the eIF2B epsilon transgene was followed by overexpression of DYRK2 which is known to prime the inhibitory action of GSK-3b on eIF2B epsilon, while DYRK1A and GSK-3 beta itself were not increased. (4) In C57BL/6 mice after 48 h of isoproterenol-stimulation or aortic banding, eIF2B epsilon was increased and DYRK2 was concomitantly decreased. (5) In line with these in vivo findings, siRNA knockdown of DYRK2 in cultured cardiomyocytes resulted in decreased levels of p(S535)eIF2B epsilon, (6) whereas adenoviral induced overexpression of DYRK2 was accompanied by clearly increased phosphorylation of eIF2B epsilon, indicating a coordinated response pattern (7) Adenoviral induced overexpression of DYRK2 leads to significantly reduced cardiomyocyte size and diminishes hypertrophic response to adrenergic stimulation. Conclusions: The interaction of GSK-3 beta and its priming kinase DYRK2 regulate the activity of eIF2B epsilon in cardiac myocytes. DYRK2 is a novel negative regulator of cardiomyocyte growth. DYRK2 could serve as a therapeutic option to regulate myocardial growth.	[Weiss, Celine S.; Ochs, Marco M.; Hagenmueller, Marco; Streit, Marcus R.; Malekar, Pratima; Riffel, Johannes H.; Buss, Sebastian J.; Weiss, Karl H.; Katus, Hugo A.; Hardt, Stefan E.] Univ Heidelberg Hosp, Heidelberg, Germany; [Weiss, Celine S.; Ochs, Marco M.; Hagenmueller, Marco; Streit, Marcus R.; Malekar, Pratima; Riffel, Johannes H.; Buss, Sebastian J.; Katus, Hugo A.; Hardt, Stefan E.] DZHK German Ctr Cardiovasc Res, Heidelberg, Germany; [Sadoshima, Junichi] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hardt, SE (corresponding author), Univ Heidelberg Hosp, Heidelberg, Germany.	stefan.hardt@med.uni-heidelberg.de	Weiss, Karl Heinz/AAA-9117-2022	Sadoshima, Junichi/0000-0003-3724-4132	Deutsche Forschungsgemeinschaft [HA 2959/3-1]; Ernst-und-Berta-Grimmke foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst-und-Berta-Grimmke foundation	This study was supported in part by the Deutsche Forschungsgemeinschaft (HA 2959/3-1 within the group 1036 to SEH), and by a research grant from the Ernst-und-Berta-Grimmke foundation (SEH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bauer A, 2004, CARDIOVASC RES, V61, P764, DOI 10.1016/j.cardiores.2003.12.013; Hannan RD, 2003, CLIN EXP PHARMACOL P, V30, P517, DOI 10.1046/j.1440-1681.2003.03873.x; Hardt SE, 2004, CIRC RES, V94, P926, DOI 10.1161/01.RES.0000124977.59827.80; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Kuhn C, 2009, J BIOL CHEM, V284, P17320, DOI 10.1074/jbc.M109.006759; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mohammad-Qureshi SS, 2008, BIOCHEM SOC T, V36, P658, DOI 10.1042/BST0360658; MORGAN HE, 1987, ANNU REV PHYSIOL, V49, P533; Nagatomo Y, 1999, AM J PHYSIOL-HEART C, V277, pH2176; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Schluter KD, 2004, CARDIOVASC RES, V63, P367, DOI 10.1016/j.cardiores.2004.06.012; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Wang XM, 2001, EMBO J, V20, P4349, DOI 10.1093/emboj/20.16.4349; WELSH GI, 1992, BIOCHEM J, V284, P19, DOI 10.1042/bj2840019; Welsh GI, 1996, J BIOL CHEM, V271, P11410, DOI 10.1074/jbc.271.19.11410; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609	19	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e70848	10.1371/journal.pone.0070848	http://dx.doi.org/10.1371/journal.pone.0070848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023715	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600006
J	Fend, L; Accart, N; Kintz, J; Cochin, S; Reymann, C; Le Pogam, F; Marchand, JB; Menguy, T; Slos, P; Rooke, R; Fournel, S; Bonnefoy, JY; Preville, X; Haegel, H				Fend, Laetitia; Accart, Nathalie; Kintz, Jacqueline; Cochin, Sandrine; Reymann, Carine; Le Pogam, Fabrice; Marchand, Jean-Baptiste; Menguy, Thierry; Slos, Philippe; Rooke, Ronald; Fournel, Sylvie; Bonnefoy, Jean-Yves; Preville, Xavier; Haegel, Helene			Therapeutic Effects of Anti-CD115 Monoclonal Antibody in Mouse Cancer Models through Dual Inhibition of Tumor-Associated Macrophages and Osteoclasts	PLOS ONE			English	Article							STIMULATING FACTOR-I; TYROSINE KINASE INHIBITOR; BREAST-CANCER; C-FMS; CELL MIGRATION; GROWTH-FACTOR; CERVICAL-CANCER; MAMMARY-TUMORS; PARACRINE LOOP; RECEPTOR	Tumor progression is promoted by Tumor-Associated Macrophages (TAMs) and metastasis-induced bone destruction by osteoclasts. Both myeloid cell types depend on the CD115-CSF-1 pathway for their differentiation and function. We used 3 different mouse cancer models to study the effects of targeting cancer host myeloid cells with a monoclonal antibody (mAb) capable of blocking CSF-1 binding to murine CD115. In mice bearing sub-cutaneous EL4 tumors, which are CD115-negative, the anti-CD115 mAb depleted F4/80(+) CD163(+) M2-type TAMs and reduced tumor growth, resulting in prolonged survival. In the MMTV-PyMT mouse model, the spontaneous appearance of palpable mammary tumors was delayed when the anti-CD115 mAb was administered before malignant transition and tumors became palpable only after termination of the immunotherapy. When administered to mice already bearing established PyMT tumors, anti-CD115 treatment prolonged their survival and potentiated the effect of chemotherapy with Paclitaxel. As shown by immunohistochemistry, this therapeutic effect correlated with the depletion of F4/80(+) CD163(+) M2-polarized TAMs. In a breast cancer model of bone metastasis, the anti-CD115 mAb potently blocked the differentiation of osteoclasts and their bone destruction activity. This resulted in the inhibition of cancer-induced weight loss. CD115 thus represents a promising target for cancer immunotherapy, since a specific blocking antibody may not only inhibit the growth of a primary tumor through TAM depletion, but also metastasis-induced bone destruction through osteoclast inhibition.	[Fend, Laetitia; Accart, Nathalie; Kintz, Jacqueline; Cochin, Sandrine; Reymann, Carine; Le Pogam, Fabrice; Marchand, Jean-Baptiste; Menguy, Thierry; Slos, Philippe; Rooke, Ronald; Bonnefoy, Jean-Yves; Preville, Xavier; Haegel, Helene] Transgene SA, Illkirch Graffenstaden, France; [Fournel, Sylvie] Univ Strasbourg, Fac Pharm, UMR 7199, CNRS, Illkirch Graffenstaden, France	Transgene SA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Haegel, H (corresponding author), Transgene SA, Illkirch Graffenstaden, France.	haegel@transgene.fr	Fournel, Sylvie/C-1195-2014	Fournel, Sylvie/0000-0003-3583-6548; Preville, Xavier/0000-0002-1416-7405	Industrial Training Conventions by REcherche (CIFRE) doctoral fellowship	Industrial Training Conventions by REcherche (CIFRE) doctoral fellowship	Laetitia Fend is recipient of a Industrial Training Conventions by REcherche (CIFRE) doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2004, ANN THORAC SURG, V77, P1751, DOI 10.1016/j.athoracsur.2003.10.050; Abraham D, 2010, INT J CANCER, V126, P1339, DOI 10.1002/ijc.24859; Aharinejad S, 2002, CANCER RES, V62, P5317; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; BARTOCCI A, 1987, P NATL ACAD SCI USA, V84, P6179, DOI 10.1073/pnas.84.17.6179; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Chambers SK, 1997, CLIN CANCER RES, V3, P999; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Droin N, 2010, J LEUKOCYTE BIOL, V87, P745, DOI 10.1189/jlb.1209780; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hammes LS, 2008, GYNECOL ONCOL, V110, P445, DOI 10.1016/j.ygyno.2008.04.038; Hernandez L, 2009, CANCER RES, V69, P3221, DOI 10.1158/0008-5472.CAN-08-2871; Hodge JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021462; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kirma N, 2007, CANCER RES, V67, P1918, DOI 10.1158/0008-5472.CAN-06-1991; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Kluger HM, 2004, CLIN CANCER RES, V10, P173, DOI 10.1158/1078-0432.CCR-0699-3; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lucas T, 2009, STEM CELLS, V27, P2342, DOI 10.1002/stem.145; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Manthey CL, 2009, MOL CANCER THER, V8, P3151, DOI 10.1158/1535-7163.MCT-09-0255; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-05-0313; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Paulus P, 2006, CANCER RES, V66, P4349, DOI 10.1158/0008-5472.CAN-05-3523; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; SCHOLL SM, 1994, JNCI-J NATL CANCER I, V86, P120, DOI 10.1093/jnci/86.2.120; SCHOLL SM, 1993, MOL CARCINOGEN, V7, P207; SHERR CJ, 1990, BLOOD, V75, P1; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; SMITH HO, 1995, CLIN CANCER RES, V1, P313; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Stanley ER, 2000, CYTOKINE REFERENCE C, P911; Sudo T, 1995, ONCOGENE, V11, P2469; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Vandyke K, 2010, BLOOD, V115, P766, DOI 10.1182/blood-2009-08-237404; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yagiz K, 2009, EXP CELL RES, V315, P2442, DOI 10.1016/j.yexcr.2009.05.002	51	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73310	10.1371/journal.pone.0073310	http://dx.doi.org/10.1371/journal.pone.0073310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019914	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200056
J	Hsu, JW; Chang, LC; Jang, LT; Huang, CF; Lee, FJS				Hsu, Jia-Wei; Chang, Lin-Chun; Jang, Li-Ting; Huang, Chun-Fang; Lee, Fang-Jen S.			The N-Terminus of Vps74p Is Essential for the Retention of Glycosyltransferases in the Golgi but Not for the Modulation of Apical Polarized Growth in Saccharomyces cerevisiae	PLOS ONE			English	Article							CELL-CYCLE CONTROL; MASS-SPECTROMETRY; GENE; UBIQUITINATION; IDENTIFICATION; PROTEOLYSIS; MUTATIONS; MUTANTS; COMPLEX; LINKS	Vps74p is a member of the PtdIns(4) P-binding protein family. Vps74p interacts with Golgi-resident glycosyltransferases and the coat protein COPI complex to modulate Golgi retention of glycosyltransferases and with the PtdIns(4) P phosphatase Sac1p to modulate PtdIns(4) P homeostasis at the Golgi. Genetic analysis has shown that Vps74p is required for the formation of abnormal elongated buds in cdc34-2 cells. The C-terminal region of Vps74p is required for Vps74p multimerization, Golgi localization, and glycosyltransferase interactions; however, the functional significance of the N-terminal region and three putative phosphorylation sites of Vps74p have not been well characterized. In this study, we demonstrate that Vps74p executes multiple cellular functions using different domains. We found that the N-terminal 66 amino acids of Vps74p are dispensable for its Golgi localization and modulation of cell wall integrity but are required for glycosyltransferase retention and glycoprotein processing. Deletion of the N-terminal 90 amino acids, but not the 66 amino acids, of Vps74p impaired its ability to restore the elongated bud phenotype in cdc34-2/vps74 Delta cells. Deletion of Sac1p and Arf1p also specifically reduced the abnormal elongated bud phenotype in cdc34-2 cells. Furthermore, we found that three N-terminal phosphorylation sites contribute to rapamycin hypersensitivity, although these phosphorylation residues are not involved in Vps74p localization, ability to modulate glycosyltransferase retention, or elongated bud formation in cdc34-2 cells. Thus, we propose that Vps74p may use different domains to interact with specific effectors thereby differentially modulating a variety of cellular functions.	[Hsu, Jia-Wei; Chang, Lin-Chun; Jang, Li-Ting; Huang, Chun-Fang; Lee, Fang-Jen S.] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10764, Taiwan; [Lee, Fang-Jen S.] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lee, FJS (corresponding author), Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10764, Taiwan.	fangjen@ntu.edu.tw		LEE, FANG-JEN/0000-0002-2167-2426	National Science Council, Taiwan [NSC 102-2321-B-002-070, NSC-100 2325-B-022-028]; Yung-Shin Biomedical Research Fund [YSP-86-019]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Yung-Shin Biomedical Research Fund	This work was supported by grants from the National Science Council, Taiwan (NSC 102-2321-B-002-070, NSC-100 2325-B-022-028), and the Yung-Shin Biomedical Research Fund (YSP-86-019) to F.-J.S. Lee. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2009, PIGM CELL MELANOMA R, V22, P378, DOI 10.1111/j.1755-148X.2009.00596.x; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BALLOU CE, 1990, METHOD ENZYMOL, V185, P440; Bidlingmaier Scott, 2002, Functional and Integrative Genomics, V1, P345, DOI 10.1007/s10142-001-0043-1; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Chun K T, 1996, Prog Cell Cycle Res, V2, P115; Chun KT, 1996, GENETICS, V142, P39; CLEVES AE, 1989, J CELL BIOL, V109, P2939, DOI 10.1083/jcb.109.6.2939; COHEN RE, 1980, J BIOL CHEM, V255, P7700; Corbacho I, 2010, GLYCOBIOLOGY, V20, P1336, DOI 10.1093/glycob/cwq114; DESHAIES RJ, 1995, EMBO J, V14, P303, DOI 10.1002/j.1460-2075.1995.tb07004.x; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Huang CF, 1999, J BIOL CHEM, V274, P3819, DOI 10.1074/jbc.274.6.3819; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; KOPECKA M, 1992, ARCH MICROBIOL, V158, P115, DOI 10.1007/BF00245214; LEW DJ, 1995, CURR OPIN GENET DEV, V5, P17, DOI 10.1016/S0959-437X(95)90048-9; Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luo ZL, 2003, J BIOL CHEM, V278, P791, DOI 10.1074/jbc.M209120200; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mogelsvang S, 2006, CURR OPIN CELL BIOL, V18, P438, DOI 10.1016/j.ceb.2006.06.001; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2012, TRAFFIC, V13, P1496, DOI 10.1111/j.1600-0854.2012.01403.x; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wood CM, 2012, FISH PHYSIOL, V31B, P1, DOI 10.1016/S1546-5098(11)31023-0; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; YAGLOM J, 1995, MOL CELL BIOL, V15, P731	42	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74715	10.1371/journal.pone.0074715	http://dx.doi.org/10.1371/journal.pone.0074715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019977	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200120
J	Richards, JE; Desselberger, U; Lever, AM				Richards, James E.; Desselberger, Ulrich; Lever, Andrew M.			Experimental Pathways towards Developing a Rotavirus Reverse Genetics System: Synthetic Full Length Rotavirus ssRNAs Are Neither Infectious nor Translated in Permissive Cells	PLOS ONE			English	Article							STRANDED-RNA GENOME; BLUETONGUE VIRUS; NUCLEOTIDE-SEQUENCE; BOVINE ROTAVIRUS; CODING ASSIGNMENTS; BINDING-PROTEIN; MESSENGER-RNAS; SECONDARY STRUCTURE; REPLICATION; EXPRESSION	At present the ability to create rationally engineered mutant rotaviruses is limited because of the lack of a tractable helper virus-free reverse genetics system. Using the cell culture adapted bovine RV RF strain (G6P6 [1]), we have attempted to recover infectious RV by co-transfecting in vitro transcribed ssRNAs which are identical in sequence to the positive sense strand of each of the 11 dsRNA genomic segments of the RF strain. The RNAs were produced either from cDNAs cloned by a target sequence-independent procedure, or from purified double layered RV particles (DLPs). We have validated their translational function by in vitro synthesis of 35 S-labelled proteins in rabbit reticulocyte lysates; all 11 proteins encoded by the RV genome were expressed. Transfection experiments with DLP- or cDNA-derived ssRNAs suggested that the RNAs do not act independently as mRNAs for protein synthesis, once delivered into various mammalian cell lines, and exhibit cytotoxicity. Transfected RNAs were not infectious since a viral cytopathic effect was not observed after infection of MA104 cells with lysates from transfected cells. By contrast, an engineered mRNA encoding eGFP was expressed when transfected under identical conditions into the same cell lines. Co-expression of plasmids encoding NSP2 and NSP5 using a fowlpox T7 polymerase recombinant virus revealed viroplasm-like structure formation, but this did not enable the translation of transfected RV ssRNAs. Attempts to recover RV from ssRNAs transcribed intracellularly from transfected cDNAs were also unsuccessful and suggested that these RNAs were also not translated, in contrast to successful translation from a transfected cDNA encoding an eGFP mRNA.	[Richards, James E.; Desselberger, Ulrich; Lever, Andrew M.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Desselberger, U (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.	ud207@medschl.cam.ac.uk; amll1@medschl.cam.ac.uk			Medical Research Council (MRC Doctoral Training Award); Wellcome Trust [092727/Z/10/2]; Biomedical Research Centre [RG56162]	Medical Research Council (MRC Doctoral Training Award)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biomedical Research Centre	This work was funded by grants from the Medical Research Council (MRC Doctoral Training Award 2006) (http://www.mrc.ac.uk) and The Wellcome Trust Project Grant (092727/Z/10/2) (http://www.wellcome.ac.uk) and the Biomedical Research Centre (Grant No RG56162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova I, 1998, J GEN VIROL, V79, P2679, DOI 10.1099/0022-1317-79-11-2679; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; APONTE C, 1993, ARCH VIROL, V133, P85, DOI 10.1007/BF01309746; Armah GE, 2012, VACCINE, V30, pA86, DOI 10.1016/j.vaccine.2011.10.006; Arnoldi F, 2007, J VIROL, V81, P2128, DOI 10.1128/JVI.01494-06; BASS DM, 1992, J CLIN INVEST, V90, P2313, DOI 10.1172/JCI116119; Blackhall J, 1996, VIROLOGY, V225, P181, DOI 10.1006/viro.1996.0586; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Boyce M, 2007, J VIROL, V81, P2179, DOI 10.1128/JVI.01819-06; BREMONT M, 1987, VIROLOGY, V161, P138, DOI 10.1016/0042-6822(87)90179-6; Britton P, 1996, J GEN VIROL, V77, P963, DOI 10.1099/0022-1317-77-5-963; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; Charpilienne A, 2002, J VIROL, V76, P7822, DOI 10.1128/JVI.76.15.7822-7831.2002; Chen D, 1998, J VIROL, V72, P7387, DOI 10.1128/JVI.72.9.7387-7396.1998; Chen DY, 2000, RNA, V6, P1455, DOI 10.1017/S1355838200001187; CHEN DY, 1994, J VIROL, V68, P7030, DOI 10.1128/JVI.68.11.7030-7039.1994; Chizhikov V, 2000, RNA, V6, P814, DOI 10.1017/S1355838200992264; COHEN J, 1977, J GEN VIROL, V36, P395, DOI 10.1099/0022-1317-36-3-395; COHEN J, 1989, VIROLOGY, V171, P131, DOI 10.1016/0042-6822(89)90519-9; COHEN J, 1979, ARCH VIROL, V60, P177, DOI 10.1007/BF01317489; COHEN J, 1979, BIOCHEM BIOPH RES CO, V88, P791, DOI 10.1016/0006-291X(79)91477-3; COHEN J, 1984, VIROLOGY, V138, P178, DOI 10.1016/0042-6822(84)90159-4; Cortes JE, 2011, NEW ENGL J MED, V365, P1108, DOI 10.1056/NEJMoa1000446; Das SC, 2000, J VIROL METHODS, V89, P119, DOI 10.1016/S0166-0934(00)00210-X; Desselberger U, 2001, NOVART FDN SYMP, V238, P125; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Estes MK, 2007, FIELDS VIROLOGY, P1917; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; FLORES J, 1982, J VIROL, V43, P1032, DOI 10.1128/JVI.43.3.1032-1037.1982; Graf S, 2006, NUCL ACID M, V17, P57; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HUNDLEY F, 1985, VIROLOGY, V143, P88, DOI 10.1016/0042-6822(85)90099-6; KANTHARIDIS P, 1983, J VIROL, V48, P330, DOI 10.1128/JVI.48.1.330-334.1983; Kerby MB, 2011, APPL BIOCHEM BIOTECH, V164, P497, DOI 10.1007/s12010-010-9152-4; Keryer-Bibens C, 2009, BIOCHEM BIOPH RES CO, V390, P302, DOI 10.1016/j.bbrc.2009.09.115; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Komoto S, 2008, J VIROL, V82, P6753, DOI 10.1128/JVI.00601-08; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; KUMAR A, 1989, NUCLEIC ACIDS RES, V17, P2126, DOI 10.1093/nar/17.5.2126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis KDC, 2012, VACCINE, V30, pA159, DOI 10.1016/j.vaccine.2011.07.126; Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663; Lourenco S, 2011, P NATL ACAD SCI USA, V108, P13746, DOI 10.1073/pnas.1108667108; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Macartney KK, 2011, J PAEDIATR CHILD H, V47, P266, DOI 10.1111/j.1440-1754.2010.01953.x; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Matsuo E, 2011, J VIROL, V85, P10213, DOI 10.1128/JVI.05412-11; Matsuo E, 2010, FEBS LETT, V584, P3386, DOI 10.1016/j.febslet.2010.06.030; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; MATTION NM, 1994, VIRAL INFECTIONS GAS, P169; MCCRAE MA, 1982, VIROLOGY, V117, P435, DOI 10.1016/0042-6822(82)90482-2; MCINTYRE M, 1987, J GEN VIROL, V68, P2961, DOI 10.1099/0022-1317-68-11-2961; Montero H, 2006, J VIROL, V80, P9031, DOI 10.1128/JVI.00437-06; MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279; Navarro A, 2013, J VIROLOGY IN PRESS; Padilla-Noriega L, 2002, VIROLOGY, V298, P1, DOI 10.1006/viro.2002.1477; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Poncet D, 2003, PERSP MED V, V9, P185; Poncet D, 1997, J VIROL, V71, P34, DOI 10.1128/JVI.71.1.34-41.1997; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Rau M, 1996, J BIOL CHEM, V271, P8983, DOI 10.1074/jbc.271.15.8983; Rojas M, 2010, J VIROL, V84, P10457, DOI 10.1128/JVI.00625-10; Roner MR, 2001, P NATL ACAD SCI USA, V98, P8036, DOI 10.1073/pnas.131203198; Rubio RM, 2013, J VIROLOGY IN PRESS; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; SMITH ML, 1980, J VIROL, V33, P976, DOI 10.1128/JVI.33.3.976-982.1980; SOMOGYI P, 1993, VIROLOGY, V197, P439, DOI 10.1006/viro.1993.1608; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tortorici MA, 2006, RNA, V12, P133, DOI 10.1261/rna.2122606; Tortorici MA, 2003, J BIOL CHEM, V278, P32673, DOI 10.1074/jbc.M305358200; Trask SD, 2010, P NATL ACAD SCI USA, V107, P18652, DOI 10.1073/pnas.1011948107; Troupin C, 2010, J VIROL, V84, P6711, DOI 10.1128/JVI.00547-10; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang AD, 2004, ARCH VIROL, V149, P303, DOI 10.1007/s00705-003-0211-9; Young DF, 2003, J VIROL, V77, P2174, DOI 10.1128/JVI.77.3.2174-2181.2003; Yunus MA, 2010, J VIROL METHODS, V169, P112, DOI 10.1016/j.jviromet.2010.07.006; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zeller M, 2011, J CLIN MICROBIOLOGY; Zhang XK, 2010, CELL CYCLE, V9, P4437, DOI 10.4161/cc.9.22.13887	93	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74328	10.1371/journal.pone.0074328	http://dx.doi.org/10.1371/journal.pone.0074328			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019962	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200105
J	Wang, HQ; Chen, NHG; Minev, BR; Zimmermann, M; Aguilar, RJ; Zhang, Q; Sturm, JB; Fend, F; Yu, YA; Cappello, J; Lauer, UM; Szalay, AA				Wang, Huiqiang; Chen, Nanhai G.; Minev, Boris R.; Zimmermann, Martina; Aguilar, Richard J.; Zhang, Qian; Sturm, Julia B.; Fend, Falko; Yu, Yong A.; Cappello, Joseph; Lauer, Ulrich M.; Szalay, Aladar A.			Optical Detection and Virotherapy of Live Metastatic Tumor Cells in Body Fluids with Vaccinia Strains	PLOS ONE			English	Article							CARCINOMATOSIS CYTOREDUCTIVE SURGERY; CANCER-CELLS; BREAST-CANCER; FLUORESCENT PROTEIN; ADHESION MOLECULE; EXPRESSION; VIRUS; ADENOVIRUS; BLOOD; HIPEC	Metastatic tumor cells in body fluids are important targets for treatment, and critical surrogate markers for evaluating cancer prognosis and therapeutic response. Here we report, for the first time, that live metastatic tumor cells in blood samples from mice bearing human tumor xenografts and in blood and cerebrospinal fluid samples from patients with cancer were successfully detected using a tumor cell-specific recombinant vaccinia virus (VACV). In contrast to the FDA-approved CellSearch system, VACV detects circulating tumor cells (CTCs) in a cancer biomarker-independent manner, thus, free of any bias related to the use of antibodies, and can be potentially a universal system for detection of live CTCs of any tumor type, not limited to CTCs of epithelial origin. Furthermore, we demonstrate for the first time that VACV was effective in preventing and reducing circulating tumor cells in mice bearing human tumor xenografts. Importantly, a single intraperitoneal delivery of VACV resulted in a dramatic decline in the number of tumor cells in the ascitic fluid from a patient with gastric cancer. Taken together, these results suggest VACV to be a useful tool for quantitative detection of live tumor cells in liquid biopsies as well as a potentially effective treatment for reducing or eliminating live tumor cells in body fluids of patients with metastatic disease.	[Wang, Huiqiang; Chen, Nanhai G.; Minev, Boris R.; Aguilar, Richard J.; Zhang, Qian; Yu, Yong A.; Cappello, Joseph; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Chen, Nanhai G.; Minev, Boris R.; Zhang, Qian; Yu, Yong A.; Szalay, Aladar A.] Univ Calif San Diego, Rebecca & John Moores Comprehens Canc Ctr, Dept Radiat Med & Appl Sci, San Diego, CA 92103 USA; [Minev, Boris R.] Univ Calif San Diego, UCSD Div Neurosurg, San Diego, CA 92103 USA; [Zimmermann, Martina; Sturm, Julia B.; Lauer, Ulrich M.] Univ Hosp, Dept Gastroenterol & Hepatol, Tubingen, Germany; [Fend, Falko] Univ Hosp, Inst Pathol, Tubingen, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Dept Biochem, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg; University of Wurzburg	Szalay, AA (corresponding author), Genelux Corp, San Diego Sci Ctr, San Diego, CA USA.	aaszalay@genelux.com	Wang, Huiqiang/N-3825-2013	Wang, Huiqiang/0000-0001-5144-3731	Genelux Corporation (RAMP;D facility in San Diego, CA)	Genelux Corporation (RAMP;D facility in San Diego, CA)	This work was supported by grants from Genelux Corporation (R&D facility in San Diego, CA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2011, MOL MED, V17, P628, DOI 10.2119/molmed.2011.00078; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Balic M, 2012, EXPERT REV MOL DIAGN, V12, P303, DOI [10.1586/ERM.12.12, 10.1586/erm.12.12]; Biondo A, 2011, EUR J CANCER, V47, pS162, DOI 10.1016/S0959-8049(11)70870-X; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Brucher BLDM, 2012, CANCER INVEST, V30, P209, DOI 10.3109/07357907.2012.654871; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chamberlain MC, 2010, CURR OPIN ONCOL, V22, P627, DOI 10.1097/CCO.0b013e32833de986; Chen NHG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-164; Chen NG, 2011, CANCER GROW PROG-DOR, V13, P295, DOI 10.1007/978-90-481-9704-0_16; Chen NG, 2010, FUTURE VIROL, V5, P763, DOI 10.2217/FVL.10.58; Donat U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045942; Fong SMB, 2009, SURGERY, V146, P498, DOI 10.1016/j.surg.2008.12.007; Gentschev I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037239; Grewal J, 2012, J NEURO-ONCOL, V106, P225, DOI 10.1007/s11060-011-0686-2; Kim SJ, 2011, BREAST CANCER RES TR, V128, P765, DOI 10.1007/s10549-011-1603-2; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Moss B, 2012, VIRUSES-BASEL, V4, P688, DOI 10.3390/v4050688; Paccione RJ, 2008, MOL CANCER THER, V7, P2894, DOI 10.1158/1535-7163.MCT-08-0450; Pierga JY, 2008, CLIN CANCER RES, V14, P7004, DOI 10.1158/1078-0432.CCR-08-0030; Rao CG, 2005, INT J ONCOL, V27, P49; Sanchez-Puig JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-10; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Spiliotis JD, 2010, HEPATO-GASTROENTEROL, V57, P1173; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tan SJ, 2009, BIOMED MICRODEVICES, V11, P883, DOI 10.1007/s10544-009-9305-9; Thurm H, 2003, CLIN CANCER RES, V9, P2598; van de Stolpe A, 2011, CANCER RES, V71, P5955, DOI 10.1158/0008-5472.CAN-11-1254; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wunder T, 2013, CANCER GENE THER, V20, P25, DOI 10.1038/cgt.2012.80; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146	33	7	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e71105	10.1371/journal.pone.0071105	http://dx.doi.org/10.1371/journal.pone.0071105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019862	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200004
J	Wang, Z; Zhou, XP; Lin, QX; Fang, WZ; Chen, XL				Wang, Zeng; Zhou, Xiaoping; Lin, Qingxian; Fang, Wenzhen; Chen, Xiaolin			Characterization, Polymorphism and Selection of Major Histocompatibility Complex (MHC) DAB Genes in Vulnerable Chinese Egret (Egretta eulophotes)	PLOS ONE			English	Article							CLASS-IIB GENES; CLASS-I; B GENE; EVOLUTION; PASSERINE; PATTERNS; BIRDS; LOCI; PCR; DNA	The major histocompatibility complex (MHC) is an excellent molecular marker for the studies of evolutionary ecology and conservation genetics because it is a family of highly polymorphic genes that play a key role in vertebrate immune response. In this study, the functional genes of MHC Class II B (DAB) were isolated for the first time in a vulnerable species, the Chinese egret (Egretta eulophotes). Using a full length DNA and cDNA produced by PCR and RACE methods, four potential MHC DAB loci were characterized in the genome of this egret and all four were expressed in liver and blood. At least four copies of the MHC gene complex were similar to two copies of the minimal essential MHC complex of chicken, but are less complex than the multiple copies expressed in passerine species. In MHC polymorphism, 19 alleles of exon 2 were isolated from 48 individuals using PCR. No stop codons or frameshift mutations were found in any of the coding regions. The signatures of positive selection detected in potential peptide-binding regions by Bayesian analysis, suggesting that all of these genes were functional. These data will provide the fundamental basis for further studies to elucidate the mechanisms and significance of MHC molecular adaptation in vulnerable Chinese egret and other ardeids.	[Wang, Zeng; Zhou, Xiaoping; Lin, Qingxian; Fang, Wenzhen; Chen, Xiaolin] Xiamen Univ, Sch Life Sci, Minist Educ Coast & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China; [Zhou, Xiaoping; Lin, Qingxian; Fang, Wenzhen; Chen, Xiaolin] Xiamen Univ, Coll Environm & Ecol, Minist Educ Coast & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Fang, WZ (corresponding author), Xiamen Univ, Sch Life Sci, Minist Educ Coast & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China.	wzfang@xmu.edu.cn; xlchen@xmu.edu.cn	Chen, Xiaolin/H-7224-2013	Chen, Xiaolin/0000-0001-8486-9747	National Natural Science Foundation of China [30970380, 40876077, 31000963]; Fujian Natural Science Foundation of China [2010Y2007, 2012J01149, 2009J01195, 2010J05084]; Fundamental Research Funds for the Xiamen Universities [2011121038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Natural Science Foundation of China; Fundamental Research Funds for the Xiamen Universities	This research was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (Grant # 30970380 to XC, 40876077 to WF, and 31000963 to XZ), the Fujian Natural Science Foundation of China (http://xmgl.fjkjt.gov.cn/) (Grant # 2010Y2007 and 2012J01149 to XC, 2009J01195 to WF, and 2010J05084 to XZ), and the Fundamental Research Funds for the Xiamen Universities (http://www.xmu.edu.cn/) (Grant # 2011121038 to XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2006, J HERED, V97, P133, DOI 10.1093/jhered/esj013; Alcaide M, 2007, J MOL EVOL, V65, P541, DOI 10.1007/s00239-007-9033-9; Alcaide M, 2009, CONSERV GENET, V10, P1349, DOI 10.1007/s10592-008-9653-7; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; BirdLife International, 2011, SPEC FACTSH EGR EUL; Bollmer JL, 2010, J HERED, V101, P448, DOI 10.1093/jhered/esq018; Bonneaud C, 2004, IMMUNOGENETICS, V55, P855, DOI 10.1007/s00251-004-0648-3; Bradley RD, 1997, MOL BIOL EVOL, V14, P592, DOI 10.1093/oxfordjournals.molbev.a025797; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burri R, 2008, MOL BIOL EVOL, V25, P1180, DOI 10.1093/molbev/msn065; Castillo S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012066; Cloutier A, 2011, IMMUNOGENETICS, V63, P377, DOI 10.1007/s00251-011-0516-x; Edwards SV, 1995, MOL ECOL, V4, P719, DOI 10.1111/j.1365-294X.1995.tb00272.x; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Ekblom R, 2003, IMMUNOGENETICS, V54, P734, DOI 10.1007/s00251-002-0503-3; Ekblom R, 2010, GENETICA, V138, P453, DOI 10.1007/s10709-008-9335-x; Fain MA, 2001, TISSUE ANTIGENS, V57, P332, DOI 10.1034/j.1399-0039.2001.057004332.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gasper JS, 2001, GENOMICS, V75, P26, DOI 10.1006/geno.2001.6596; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hess CM, 2002, BIOSCIENCE, V52, P423, DOI 10.1641/0006-3568(2002)052[0423:TEOTMH]2.0.CO;2; Huang XH, 2010, CONSERV GENET, V11, P1211, DOI 10.1007/s10592-009-9921-1; IUCN, 2012, IUCN RED LIST THREAT; Jacob JP, 2000, IMMUNOGENETICS, V51, P138, DOI 10.1007/s002510050022; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; Li L, 2011, J MOL EVOL, V72, P474, DOI 10.1007/s00239-011-9446-3; Mardon J, 2009, BEHAV ECOL SOCIOBIOL, V63, P537, DOI 10.1007/s00265-008-0688-z; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Miller HC, 2007, J HERED, V98, P666, DOI 10.1093/jhered/esm095; NEI M, 1986, MOL BIOL EVOL, V3, P418; Reichard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040780; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shiina T, 2004, J IMMUNOL, V172, P6751, DOI 10.4049/jimmunol.172.11.6751; Silva MC, 2009, J MOL EVOL, V68, P279, DOI 10.1007/s00239-009-9200-2; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Strandh M, 2011, IMMUNOGENETICS, V63, P653, DOI 10.1007/s00251-011-0534-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ujvari B, 2011, INT J MOL SCI, V12, P5168, DOI 10.3390/ijms12085168; Wang Z, 2011, MOL ECOL RESOUR, V11, P176, DOI 10.1111/j.1755-0998.2010.02879.x; Westerdahl H, 2004, HEREDITY, V92, P534, DOI 10.1038/sj.hdy.6800450; Westerdahl H, 2000, IMMUNOGENETICS, V52, P92, DOI 10.1007/s002510000256; Westerdahl H, 2007, J ORNITHOL, V148, pS469, DOI 10.1007/s10336-007-0230-5; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zhou XP, 2008, MOL ECOL RESOUR, V8, P412, DOI 10.1111/j.1471-8286.2007.01975.x; ZOOROB R, 1990, IMMUNOGENETICS, V31, P179, DOI 10.1007/BF00211553	50	76	78	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74185	10.1371/journal.pone.0074185	http://dx.doi.org/10.1371/journal.pone.0074185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019955	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200098
J	Jacob, M; Soltwedel, T; Boetius, A; Ramette, A				Jacob, Marianne; Soltwedel, Thomas; Boetius, Antje; Ramette, Alban			Biogeography of Deep-Sea Benthic Bacteria at Regional Scale (LTER HAUSGARTEN, Fram Strait, Arctic)	PLOS ONE			English	Article							PROKARYOTIC COMMUNITY DYNAMICS; CONTINENTAL-MARGIN; RIBOSOMAL-RNA; DIVERSITY; WATER; BIOMASS; RARE; SPITSBERGEN; DISTANCE; PHYTOPLANKTON	Knowledge on spatial scales of the distribution of deep-sea life is still sparse, but highly relevant to the understanding of dispersal, habitat ranges and ecological processes. We examined regional spatial distribution patterns of the benthic bacterial community and covarying environmental parameters such as water depth, biomass and energy availability at the Arctic Long-Term Ecological Research (LTER) site HAUSGARTEN (Eastern Fram Strait). Samples from 13 stations were retrieved from a bathymetric (1,284-3,535 m water depth, 54 km in length) and a latitudinal transect (, 2,500 m water depth; 123 km in length). 454 massively parallel tag sequencing (MPTS) and automated ribosomal intergenic spacer analysis (ARISA) were combined to describe both abundant and rare types shaping the bacterial community. This spatial sampling scheme allowed detection of up to 99% of the estimated richness on phylum and class levels. At the resolution of operational taxonomic units (97% sequence identity; OTU3%) only 36% of the Chao1 estimated richness was recovered, indicating a high diversity, mostly due to rare types (62% of all OTU3%). Accordingly, a high turnover of the bacterial community was also observed between any two sampling stations (average replacement of 79% of OTU3%), yet no direct correlation with spatial distance was observed within the region. Bacterial community composition and structure differed significantly with increasing water depth along the bathymetric transect. The relative sequence abundance of Verrucomicrobia and Planctomycetes decreased significantly with water depth, and that of Deferribacteres increased. Energy availability, estimated from phytodetrital pigment concentrations in the sediments, partly explained the variation in community structure. Overall, this study indicates a high proportion of unique bacterial types on relatively small spatial scales (tens of kilometers), and supports the sampling design of the LTER site HAUSGARTEN to study bacterial community shifts in this rapidly changing area of the world's oceans.	[Jacob, Marianne; Soltwedel, Thomas; Boetius, Antje; Ramette, Alban] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, HGF MPG Res Grp Deep Sea Ecol & Technol, Bremerhaven, Germany; [Jacob, Marianne; Soltwedel, Thomas; Boetius, Antje; Ramette, Alban] Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society	Jacob, M (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, HGF MPG Res Grp Deep Sea Ecol & Technol, Bremerhaven, Germany.	Marianne.Jacob@awi.de	Ramette, Alban/E-9197-2016; Soltwedel, Thomas/P-1852-2016; Boetius, Antje/D-5459-2013	Ramette, Alban/0000-0002-3437-4639; Soltwedel, Thomas/0000-0002-8214-5937; Boetius, Antje/0000-0003-2117-4176; Rehage, Marianne/0000-0002-9351-8014	European Research Council [ABYSS 294757]; Helmholtz Association; Max Planck Society; Deutsche Forschungsgemeinschaft	European Research Council(European Research Council (ERC)European Commission); Helmholtz Association(Helmholtz Association); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the European Research Council Advanced Investigator grant ABYSS 294757 and the Leibniz program of the Deutsche Forschungsgemeinschaft to AB. Additional funding came from the Helmholtz Association and Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE WG, 1995, J GEOPHYS RES-OCEANS, V100, P4411, DOI 10.1029/94JC01982; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; BARTLETT DH, 1995, RES MICROBIOL, V146, P697, DOI 10.1016/0923-2508(96)81066-7; Bauerfeind E, 2009, DEEP-SEA RES PT I, V56, P1471, DOI 10.1016/j.dsr.2009.04.011; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; Boetius A, 1998, DEEP-SEA RES PT I, V45, P239, DOI 10.1016/S0967-0637(97)00052-6; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; De Mesel I, 2004, ENVIRON MICROBIOL, V6, P733, DOI 10.1111/j.1462-2920.2004.00610.x; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Freitas S, 2012, ISME J, V6, P1499, DOI 10.1038/ismej.2012.3; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Gobet A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq545; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Hop H, 2006, PROG OCEANOGR, V71, P182, DOI 10.1016/j.pocean.2006.09.007; Hoste E, 2007, DEEP-SEA RES PT I, V54, P109, DOI 10.1016/j.dsr.2006.09.007; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; Kanzog C, 2009, MAR ECOL-EVOL PERSP, V30, P391, DOI 10.1111/j.1439-0485.2009.00290.x; Kanzog C, 2009, POLAR BIOL, V32, P105, DOI 10.1007/s00300-008-0510-4; Klages M, 2003, ARCTIC ORGANIC CARBO; Kraft A, 2010, MARINE BIODIVERSITY, P1; Lalande C, 2013, PROG OCEANOGR, V109, P70, DOI 10.1016/j.pocean.2012.09.006; Lee KC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-5; Legendre P., 2012, NUMERICAL ECOLOGY; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Li HR, 2009, EXTREMOPHILES, V13, P233, DOI 10.1007/s00792-009-0225-7; MacDonald IR, 2010, DEEP-SEA RES PT II, V57, P136, DOI 10.1016/j.dsr2.2009.08.012; MANLEY TO, 1995, J GEOPHYS RES-OCEANS, V100, P20627, DOI 10.1029/95JC01251; MEYERREIL LA, 1983, MAR BIOL, V77, P247, DOI 10.1007/BF00395813; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Pester M, 2010, ISME J, V4, P1591, DOI 10.1038/ismej.2010.75; Peter H, 2011, ISME J, V5, P351, DOI 10.1038/ismej.2010.119; Piechura J, 2009, OCEANOLOGIA, V51, P147, DOI 10.5697/oc.51-2.147; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Queric NV, 2008, MAR ECOL PROG SER, V370, P87, DOI 10.3354/meps07582; Queric NV, 2012, SEDIMENT GEOL, V263, P36, DOI 10.1016/j.sedgeo.2011.10.004; Queric NV, 2004, J MICROBIOL METH, V57, P351, DOI 10.1016/j.mimet.2004.02.005; R Core Team, 2018, R LANG ENV STAT COMP; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Ravenschlag K, 1999, APPL ENVIRON MICROB, V65, P3982; Redmond MC, 2012, P NATL ACAD SCI USA, V109, P20292, DOI 10.1073/pnas.1108756108; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; Schewe I, 2003, POLAR BIOL, V26, P610, DOI 10.1007/s00300-003-0526-8; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simpson G, 2012, PERMUTE FUNCTIONS GE; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Soltwedel T, 2005, DEEP-SEA RES PT I, V52, P815, DOI 10.1016/j.dsr.2004.11.011; Soltwedel T, 2001, MAR ECOL PROG SER, V219, P291, DOI 10.3354/meps219291; Soltwedel T, 2000, DEEP-SEA RES PT I, V47, P1761, DOI 10.1016/S0967-0637(00)00006-6; Soltwedel T., 2005, OCEANOGRAPHY, V18, P46, DOI [10.5670/oceanog.2005.24, DOI 10.5670/0CEAN0G.2005.24]; Soltwedel T, 2009, POLAR BIOL, V32, P1159, DOI 10.1007/s00300-009-0612-7; Teske A, 2011, APPL ENVIRON MICROB, V77, P2008, DOI 10.1128/AEM.01507-10; Thiel H., 1978, UPWELLING ECOSYSTEMS, p124?138; Tian F, 2009, POLAR BIOL, V32, P93, DOI 10.1007/s00300-008-0509-x; van Oevelen D, 2011, DEEP-SEA RES PT I, V58, P1069, DOI 10.1016/j.dsr.2011.08.002; Venables WN., 2002, MODERN APPL STAT S 4; Wlodarska-Kowalczuk M, 2004, DEEP-SEA RES PT I, V51, P1903, DOI 10.1016/j.dsr.2004.07.013; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	69	45	48	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72779	10.1371/journal.pone.0072779	http://dx.doi.org/10.1371/journal.pone.0072779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023770	Green Accepted, Green Published, gold			2022-12-27	WOS:000324238400023
J	Raymond, L; Plantegenest, M; Gauffre, B; Sarthou, JP; Vialatte, A				Raymond, Lucie; Plantegenest, Manuel; Gauffre, Bertrand; Sarthou, Jean-Pierre; Vialatte, Aude			Lack of Genetic Differentiation between Contrasted Overwintering Strategies of a Major Pest Predator Episyrphus balteatus (Diptera: Syrphidae): Implications for Biocontrol	PLOS ONE			English	Article							ECOLOGICAL SPECIATION; POPULATION-STRUCTURE; MIGRATORY DIVIDE; CEREAL APHIDS; WINTER-WHEAT; DETERMINANTS; EVOLUTION; SOFTWARE; WARBLERS; BIOLOGY	Winter ecology of natural enemies has a great influence on the level and efficiency of biological control at spring. The hoverfly Episyrphus balteatus (DeGeer) (Diptera: Syrphidae) is one of the most important natural predators of crop aphids in Europe. Three different overwintering strategies coexist in this species which makes it a good model in order to study ecologically-based speciation processes. The purpose of this study was to determine whether E. balteatus populations with alternative overwintering strategies are genetically differentiated. To that aim, we developed 12 specific microsatellite markers and evaluated the level of neutral genetic differentiation between E. balteatus field populations that overwinter in the three different ways described in this species (i.e. migration, local overwintering at a pre-imaginal stage, and local overwintering at adult stage). Results showed a lack of neutral genetic differentiation between individuals with different overwintering strategies although there are strong ecological differences between them. All pair-wise F-ST values are below 0.025 and non-significant, and Bayesian clustering showed K = 1 was the most likely number of genetic clusters throughout our sample. The three overwintering strategies form one unique panmictic population. This suggests that all the individuals may have genetic material for the expression of different overwintering phenotypes, and that their commitment in one particular overwintering strategy may depend on environmental and individual factors. Consequently, the prevalence of the different overwintering strategies would be potentially modified by landscape engineering and habitat management which could have major implications for biological control.	[Raymond, Lucie] INRA, UMR 1201 DYNAFOR, F-31326 Castanet Tolosan, France; [Raymond, Lucie; Plantegenest, Manuel] Agrocampus Ouest, UMR 1349 IGEPP, Rennes, France; [Gauffre, Bertrand] INRA, USC CEBC CNRS 1339, Beauvoir Sur Niort, France; [Gauffre, Bertrand] CEBC CNRS UPR 1934, Beauvoir Sur Niort, France; [Sarthou, Jean-Pierre] Univ Toulouse, INPT ENSAT, UMR AGIR 1248, Castanet Tolosan, France; [Vialatte, Aude] Univ Toulouse, INPT ENSAT, UMR 1201 DYNAFOR, Castanet Tolosan, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Raymond, L (corresponding author), INRA, UMR 1201 DYNAFOR, F-31326 Castanet Tolosan, France.	lucie.raymond@toulouse.inra.fr	martel, celine/O-6651-2016; Gauffre, Bertrand/J-8969-2012	martel, celine/0000-0002-1800-4558; Gauffre, Bertrand/0000-0001-5431-8098	ANR Systerra program [ANR-09-STRA-05]	ANR Systerra program(French National Research Agency (ANR))	This work is part of the Landscaphid project and was supported by the ANR Systerra program (ANR-09-STRA-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; ANKERSMIT GW, 1986, ENTOMOL EXP APPL, V42, P271, DOI 10.1007/BF00629314; [Anonymous], THEOR APPL GENET; Arrignon F, 2007, ECOL MODEL, V205, P423, DOI 10.1016/j.ecolmodel.2007.03.006; Aubert J., 1981, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V54, P377; Aubert J, 1963, MITTEILUNGEN SCHWEIZ, V36, P304; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Bensch S, 1999, EVOLUTION, V53, P1925, DOI 10.1111/j.1558-5646.1999.tb04573.x; Buerkle CA, 1999, EVOLUTION, V53, P1915, DOI 10.1111/j.1558-5646.1999.tb04572.x; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; CHAMBERS RJ, 1986, J APPL ECOL, V23, P895, DOI 10.2307/2403942; Dingle H, 2006, J ORNITHOL, V147, P212, DOI 10.1007/s10336-005-0052-2; Dusek J, 1974, FOLIA FAC SCI NAT U, V43, P71; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feder JL, 2003, GENETICS, V163, P939; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; GEUSENPFISTER H, 1987, J APPL ENTOMOL, V104, P261, DOI 10.1111/j.1439-0418.1987.tb00524.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hondelmann P, 2007, PUBLICATION IPP, VIPP DI 162; Hondelmann P, 2007, ENTOMOL EXP APPL, V124, P189, DOI 10.1111/j.1570-7458.2007.00568.x; LACK D, 1951, J ANIM ECOL, V20, P63; Lampert W, 2010, LIMNOL OCEANOGR, V55, P1893, DOI 10.4319/lo.2010.55.5.1893; Liedvogel M, 2011, TRENDS ECOL EVOL, V26, P561, DOI 10.1016/j.tree.2011.07.009; LYON JP, 1967, ANN EPIPHYT, V18, P117; Lyons JI, 2012, MOL ECOL, V21, P3433, DOI 10.1111/j.1365-294X.2012.05613.x; Medina RF, 2012, ENTOMOL EXP APPL, V142, P223, DOI 10.1111/j.1570-7458.2012.01220.x; Nosil P, 2004, P ROY SOC B-BIOL SCI, V271, P1521, DOI 10.1098/rspb.2004.2751; Peck LV, 1988, FAMILY SYRPHIDAE, P11; Pritchard JK, 2000, GENETICS, V155, P945; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Russell AL, 2005, MOL ECOL, V14, P2207, DOI 10.1111/j.1365-294X.2005.02552.x; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Sarthou JP, 2005, EUR J ENTOMOL, V102, P539, DOI 10.14411/eje.2005.077; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; TENHUMBERG B, 1995, AGR ECOSYST ENVIRON, V52, P39, DOI 10.1016/0167-8809(94)09007-T; Torp E, 1994, DANMARKS SVIRREFLUER, V6; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	44	13	13	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72997	10.1371/journal.pone.0072997	http://dx.doi.org/10.1371/journal.pone.0072997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023799	Green Published, gold			2022-12-27	WOS:000324238400037
J	Huang, YQ; Feng, HL; Kan, T; Huang, B; Zhang, MF; Li, YS; Shi, CY; Wu, MC; Luo, YQ; Yang, JM; Xu, F				Huang, Yangqing; Feng, Helin; Kan, Tong; Huang, Bin; Zhang, Minfeng; Li, Yesheng; Shi, Changying; Wu, Mengchao; Luo, Yunquan; Yang, Jiamei; Xu, Feng			Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CHRONIC LIVER-DISEASE; HYPOXIA-INDUCED VEGF; FACTOR EXPRESSION; PROANGIOGENIC CYTOKINES; PARTIAL-HEPATECTOMY; CIRRHOTIC RATS; ANGIOGENESIS; REGENERATION; MECHANISMS	Angiogenesis is a fundamental part of the response to tissue injury, which is involved in the development of hepatic fibrosis. Vascular endothelial growth factor plays an important role in angiogenesis. The expression of VEGF is increased during hepatic fibrogenesis and correlates with the micro-vessel density. In this study, we investigated the effects of bevacizumab, an anti-angiogenetic drug, on the formation of hepatic fibrosis. We found that bevacizumab could attenuate the development of hepatic fibrosis and contribute to the protection of liver function. Bevacizumab was also found to downregulate the expression alpha-SMA and TGF-beta 1, which have been reported to be profibrogenic genes in vivo. We also observed that the expression of VEGF increased significantly during the development of hepatic fibrosis and CCl4 was found to induce hepatocytes to secrete VEGF, which led to the activation and proliferation of HSCs. Bevacizumab was also found to block the effects of the hepatocytes on the activation and proliferation of HSCs. Our results suggest that bevacizumab might alleviate liver fibrosis by blocking the effect of VEGF on HSCs. Bevacizumab might be suitable as a potential agent for hepatic fibrosis therapy.	[Huang, Yangqing; Zhang, Minfeng; Li, Yesheng; Shi, Changying; Wu, Mengchao; Yang, Jiamei] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Special Treatment, Shanghai, Peoples R China; [Huang, Yangqing; Luo, Yunquan] Shuguang Hosp, Dept Hepatobiliary Surg, Shanghai, Peoples R China; [Kan, Tong] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Biliary Surg 2, Shanghai, Peoples R China; [Huang, Bin] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Radiol, Shanghai, Peoples R China; [Xu, Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China; [Feng, Helin] Hebei Med Univ, Affiliated Hosp 4, Dept Orthoped, Shijiazhuang, Hebei, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University; Hebei Medical University	Yang, JM (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Special Treatment, Shanghai, Peoples R China.	jmyang@smmu.edu.cn; victorf2255@hotmail.com			Shanghai Municipal Health Bureau [20114220]; Foundation of Second Military Medical University for youth [2010qn24]; Project of the Department of Science and Technology of Hebei Province [11276156]	Shanghai Municipal Health Bureau; Foundation of Second Military Medical University for youth; Project of the Department of Science and Technology of Hebei Province	Funded by Shanghai Municipal Health Bureau (Grant NO: 20114220); Foundation of Second Military Medical University for youth (Grant NO: 2010qn24); and Project of the Department of Science and Technology of Hebei Province (No. 11276156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965; Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3; Chen SW, 2008, GENE THER, V15, P1424, DOI 10.1038/gt.2008.93; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; Coulon S, 2011, LIVER INT, V31, P146, DOI 10.1111/j.1478-3231.2010.02369.x; De Souza MM, 2006, PATHOL RES PRACT, V202, P883, DOI 10.1016/j.prp.2006.07.004; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ishikawa K, 1999, BIOCHEM BIOPH RES CO, V254, P587, DOI 10.1006/bbrc.1998.9984; Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009; Kinoshita K, 2007, GUT, V56, P396, DOI 10.1136/gut.2005.085704; Lai WK, 2005, J HEPATOL, V42, P7, DOI 10.1016/j.jhep.2004.11.008; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Medina J, 2004, HEPATOLOGY, V39, P1185, DOI 10.1002/hep.20193; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887; Rosmorduc O, 1999, AM J PATHOL, V155, P1065, DOI 10.1016/S0002-9440(10)65209-1; Shimizu H, 2001, J HEPATOL, V34, P683, DOI 10.1016/S0168-8278(00)00055-6; Taniguchi E, 2001, J HISTOCHEM CYTOCHEM, V49, P121, DOI 10.1177/002215540104900112; Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065; Thabut D, 2010, J HEPATOL, V53, P976, DOI 10.1016/j.jhep.2010.07.004; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Valachis A, 2010, BREAST CANCER RES TR, V122, P1, DOI 10.1007/s10549-009-0727-0; Van Bergen T, 2010, INVEST OPHTH VIS SCI, V51, P6903, DOI 10.1167/iovs.10-6116; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V317, P358, DOI 10.1016/j.bbrc.2004.03.050; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zhong W, 2009, HEPATOLOGY, V50, P1524, DOI 10.1002/hep.23189	36	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73492	10.1371/journal.pone.0073492	http://dx.doi.org/10.1371/journal.pone.0073492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023685	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200082
J	Jin, XL; Diao, WY; Xiao, CH; Wang, FY; Chen, B; Wang, KR; Li, SK				Jin, Xiu-liang; Diao, Wan-ying; Xiao, Chun-hua; Wang, Fang-yong; Chen, Bing; Wang, Ke-ru; Li, Shao-kun			Estimation of Wheat Agronomic Parameters using New Spectral Indices	PLOS ONE			English	Article							REFLECTANCE SPECTRA; VEGETATION INDEX; LEAF CHLOROPHYLL; NITROGEN; SOIL; CANOPY; LEAVES; GREEN; CORN; RED	Crop agronomic parameters (leaf area index (LAI), nitrogen (N) uptake, total chlorophyll (Chl) content) are very important for the prediction of crop growth. The objective of this experiment was to investigate whether the wheat LAI, N uptake, and total Chl content could be accurately predicted using spectral indices collected at different stages of wheat growth. Firstly, the product of the optimized soil-adjusted vegetation index and wheat biomass dry weight (OSAVIxBDW) were used to estimate LAI, N uptake, and total Chl content; secondly, BDW was replaced by spectral indices to establish new spectral indices (OSAVIxOSAVI, OSAVIxSIPI, OSAVIxCI(red edge), OSAVIxCI(green mode) and OSAVIxEVI2); finally, we used the new spectral indices for estimating LAI, N uptake, and total Chl content. The results showed that the new spectral indices could be used to accurately estimate LAI, N uptake, and total Chl content. The highest R-2 and the lowest RMSEs were 0.711 and 0.78 (OSAVIxEVI2), 0.785 and 3.98 g/m(2) (OSAVIxCI(red edge)) and 0.846 and 0.65 g/m(2) (OSAVIxCI(red edge)) for LAI, nitrogen uptake and total Chl content, respectively. The new spectral indices performed better than the OSAVI alone, and the problems of a lack of sensitivity at earlier growth stages and saturation at later growth stages, which are typically associated with the OSAVI, were improved. The overall results indicated that this new spectral indices provided the best approximation for the estimation of agronomic indices for all growth stages of wheat.	[Jin, Xiu-liang; Wang, Ke-ru; Li, Shao-kun] Chinese Acad Agr Sci, Minist Agr, Inst Crop Sci, Key Lab Crop Physiol & Prod, Beijing 100193, Peoples R China; [Jin, Xiu-liang] Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China; [Diao, Wan-ying; Xiao, Chun-hua; Wang, Ke-ru; Li, Shao-kun] Key Lab Oasis Ecol Agr Xinjiang Construct Crops, Shihezi, Peoples R China; [Wang, Fang-yong; Chen, Bing] Xinjiang Acad Agr Reclamat Sci, Inst Cotton, Shihezi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Academy of Agriculture & Forestry; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Wang, KR (corresponding author), Chinese Acad Agr Sci, Minist Agr, Inst Crop Sci, Key Lab Crop Physiol & Prod, Beijing 100193, Peoples R China.	wkeru01@163.com; lishk@mail.caas.net.cn	Jin, Xiuliang/L-2802-2019	Jin, Xiuliang/0000-0003-2720-6247	National Natural Science Foundation of China [31071371, 30760109, 41161068]; Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period [2012BAH27B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period	The study is supported by the National Natural Science Foundation of China (grant numbers 31071371, 30760109, 41161068) and the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (grant number 2012BAH27B04). The National Natural Science Foundation of China had role in study design, data collection and analysis, the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period had role in decision to publish, or preparation of the manuscript.	BAUSCH WC, 1993, REMOTE SENS ENVIRON, V46, P213, DOI 10.1016/0034-4257(93)90096-G; BUSCHMANN C, 1993, INT J REMOTE SENS, V14, P711, DOI 10.1080/01431169308904370; Cheng JianPing, 2008, Plant Nutrition and Fertilizer Science, V14, P199; DAUGHTRY CST, 1992, REMOTE SENS ENVIRON, V39, P141, DOI 10.1016/0034-4257(92)90132-4; Eitel JUH, 2007, INT J REMOTE SENS, V28, P4183, DOI 10.1080/01431160701422213; ELVIDGE CD, 1985, REMOTE SENS ENVIRON, V17, P265, DOI 10.1016/0034-4257(85)90099-9; Fitzgerald G, 2010, FIELD CROP RES, V116, P318, DOI 10.1016/j.fcr.2010.01.010; Gamon JA, 1999, NEW PHYTOL, V143, P105, DOI 10.1046/j.1469-8137.1999.00424.x; GITELSON A, 1994, J PHOTOCH PHOTOBIO B, V22, P247, DOI 10.1016/1011-1344(93)06963-4; GITELSON A, 1994, J PLANT PHYSIOL, V143, P286, DOI 10.1016/S0176-1617(11)81633-0; Gitelson AA, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006017; Gitelson AA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022688; Gitelson AA, 2002, PHOTOCHEM PHOTOBIOL, V75, P272, DOI 10.1562/0031-8655(2002)075<0272:ACCIPL>2.0.CO;2; Gitelson AA, 2001, PHOTOCHEM PHOTOBIOL, V74, P38, DOI 10.1562/0031-8655(2001)074&lt;0038:OPANEO&gt;2.0.CO;2; Gitelson AA, 1996, J PLANT PHYSIOL, V148, P494, DOI 10.1016/S0176-1617(96)80284-7; Gitelson AA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045003; Goetz SJ, 1996, AGR FOREST METEOROL, V78, P149, DOI 10.1016/0168-1923(95)02268-6; Gurlin D, 2011, REMOTE SENS ENVIRON, V115, P3479, DOI 10.1016/j.rse.2011.08.011; Houborg R, 2011, REMOTE SENS ENVIRON, V115, P1694, DOI 10.1016/j.rse.2011.02.027; HUETE AR, 1985, REMOTE SENS ENVIRON, V17, P37, DOI 10.1016/0034-4257(85)90111-7; Jiang ZY, 2008, REMOTE SENS ENVIRON, V112, P3833, DOI 10.1016/j.rse.2008.06.006; Liu J, 1997, REMOTE SENS ENVIRON, V62, P158, DOI 10.1016/S0034-4257(97)00089-8; MacKinney G, 1941, J BIOL CHEM, V140, P315; Markwell J, 1995, PHOTOSYNTH RES, V46, P467, DOI 10.1007/BF00032301; Moges SM, 2004, J PLANT NUTR, V27, P1431, DOI 10.1081/pln-200025858; Moran M.S., 1995, REMOTE SENS REV, V12, P335, DOI DOI 10.1080/02757259509532290; Moran MS, 1997, REMOTE SENS ENVIRON, V61, P319, DOI 10.1016/S0034-4257(97)00045-X; Osborne SL, 2002, AGRON J, V94, P1215, DOI 10.2134/agronj2002.1215; Peng Y, 2011, REMOTE SENS ENVIRON, V115, P978, DOI 10.1016/j.rse.2010.12.001; PENUELAS J, 1995, PHOTOSYNTHETICA, V31, P221; Reyniers M, 2006, INT J REMOTE SENS, V27, P4159, DOI 10.1080/01431160600791650; Rhykerd CL, 1974, FORAGE FERTILIZATION, P416; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rouse J.W., 1974, NASA GSFC TYPE 3 FIN, P1; Sakamoto T, 2012, PRECIS AGRIC, V13, P285, DOI 10.1007/s11119-011-9246-1; SCHEPERS JS, 1989, COMMUN SOIL SCI PLAN, V20, P949, DOI 10.1080/00103628909368128; Steven MD, 1998, REMOTE SENS ENVIRON, V63, P49, DOI 10.1016/S0034-4257(97)00114-4; Stone M. L., 1996, TECH PAPER SERIES SA, V961757; Stone ML, 1996, T ASAE, V39, P1623, DOI 10.13031/2013.27678; TUCKER CJ, 1980, PHOTOGRAMM ENG REM S, V46, P657; Vigneau N, 2011, FIELD CROP RES, V122, P25, DOI 10.1016/j.fcr.2011.02.003; Yang JC, 1996, CHINESE AGR SCI, V29, P58; Zhu Y, 2008, INT J APPL EARTH OBS, V10, P1, DOI 10.1016/j.jag.2007.02.006	43	50	53	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72736	10.1371/journal.pone.0072736	http://dx.doi.org/10.1371/journal.pone.0072736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023639	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200034
J	Murta, D; Batista, M; Silva, E; Trindade, A; Henrique, D; Duarte, A; Lopes-da-Costa, L				Murta, Daniel; Batista, Marta; Silva, Elisabete; Trindade, Alexandre; Henrique, Domingos; Duarte, Antonio; Lopes-da-Costa, Luis			Dynamics of Notch Pathway Expression during Mouse Testis Post-Natal Development and along the Spermatogenic Cycle	PLOS ONE			English	Article							CELL NICHE FORMATION; STEM-CELLS; O-FUCOSE; SEMINIFEROUS EPITHELIUM; SERTOLI-CELLS; TRANSCRIPTION; ACTIVATION; FETAL; MICE; HYPERPLASIA	The transcription and expression patterns of Notch pathway components (Notch 1-3, Delta1 and 4, Jagged1) and effectors (Hes1, Hes2, Hes5 and Nrarp) were evaluated (through RT-PCR and IHC) in the mouse testis at key moments of post-natal development, and along the adult spermatogenic cycle. Notch pathway components and effectors are transcribed in the testis and expressed in germ, Sertoli and Leydig cells, and each Notch component shows a specific cell-type and time-window expression pattern. This expression at key testis developmental events prompt for a role of Notch signaling in prepubertal spermatogonia quiescence, onset of spermatogenesis, and regulation of the spermatogenic cycle.	[Murta, Daniel; Batista, Marta; Silva, Elisabete; Trindade, Alexandre; Duarte, Antonio; Lopes-da-Costa, Luis] Univ Tecn Lisboa, Fac Vet Med, CIISA, Lisbon, Portugal; [Trindade, Alexandre; Duarte, Antonio] Gulbenkian Inst Sci, Oeiras, Portugal; [Henrique, Domingos] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Lopes-da-Costa, L (corresponding author), Univ Tecn Lisboa, Fac Vet Med, CIISA, Lisbon, Portugal.	lcosta@fmv.utl.pt	Trindade, Alexandre/AAC-9726-2019; Henrique, Domingos M/E-5460-2010; Duarte, Antonio/V-1178-2018; Silva, Maria elisabete/H-1185-2014; Trindade, Alexandre/J-3606-2013	Henrique, Domingos M/0000-0001-8869-1894; Duarte, Antonio/0000-0002-9255-3635; Silva, Maria elisabete/0000-0002-2332-7642; Trindade, Alexandre/0000-0002-3104-9259; de Moura Murta, Daniel/0000-0002-5583-485X; Lopes-da-Costa, Luis/0000-0001-5165-3034	Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/105022/2008]; FCT [SFRH/BD/64416/2009, SFRH/BPD/47079/2008]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT; http://www.fct.pt/index.phtml.en), Project PTDC/CVT/105022/2008. DM is a PhD student supported by grant SFRH/BD/64416/2009 from FCT. MB has a research contract under the grant PTDC/CVT/105022/2008. ES is a Postdoctoral Researcher under the Portuguese Government initiative for research jobs, Ciencia 2008-FCT. AT is a Postdoctoral Researcher supported by grant SFRH/BPD/47079/2008 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; Ariyaratne HBS, 2000, BIOL REPROD, V62, P680, DOI 10.1095/biolreprod62.3.680; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Batista F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098103; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Boucher J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00081; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; CLERMONT Y, 1969, FERTIL STERIL, V20, P805; Das RM, 2012, EMBO REP, V13, P448, DOI 10.1038/embor.2012.42; DeFalco T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106138; Dirami G, 2001, J ANDROL, V22, P944; Feng XS, 2010, DEVELOPMENT, V137, P4191, DOI 10.1242/dev.052043; FIRLIT CF, 1965, Q J MICROSC SCI, V106, P93; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Garcia TX, 2013, DEV BIOL, V377, P188, DOI 10.1016/j.ydbio.2013.01.031; Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0; Hahn KL, 2009, REPRODUCTION, V137, P79, DOI 10.1530/REP-08-0207; Hasegawa K, 2012, MOL CELL BIOL, V32, P206, DOI 10.1128/MCB.06063-11; Hayashi T, 2004, FERTIL STERIL, V81, P697, DOI 10.1016/j.fertnstert.2003.08.026; Hayashi T, 2001, J ANDROL, V22, P999; HESS RA, 1993, BIOL REPROD, V48, P1299, DOI 10.1095/biolreprod48.6.1299; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Kimmins S, 2004, REPRODUCTION, V128, P5, DOI 10.1530/rep.1.00170; Kitadate Y, 2010, P NATL ACAD SCI USA, V107, P14241, DOI 10.1073/pnas.1003462107; Kitamoto T, 2005, BIOCHEM BIOPH RES CO, V331, P1154, DOI 10.1016/j.bbrc.2005.03.241; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; LAMBIE EJ, 1991, DEVELOPMENT, V112, P231; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Lupien M, 2006, DEV BIOL, V300, P497, DOI 10.1016/j.ydbio.2006.09.010; Mori S, 2003, DEV GROWTH DIFFER, V45, P7, DOI 10.1046/j.1440-169X.2003.00670.x; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; NEBEL BR, 1961, SCIENCE, V134, P832, DOI 10.1126/science.134.3482.832; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; OAKBERG EF, 1957, NATURE, V180, P1137, DOI 10.1038/1801137a0; Rahman M, 2012, BRAIN RES, V1448, P117, DOI 10.1016/j.brainres.2012.01.066; Sahin Z, 2005, FERTIL STERIL, V83, P86, DOI 10.1016/j.fertnstert.2004.09.006; Saravanamuthu SS, 2009, DEV BIOL, V332, P166, DOI 10.1016/j.ydbio.2009.05.566; Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528; Silva E, 2012, J REPROD IMMUNOL, V96, P45, DOI 10.1016/j.jri.2012.07.003; Silva E, 2010, J REPROD IMMUNOL, V84, P66, DOI 10.1016/j.jri.2009.10.004; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; von Schonfeldt V, 2004, CYTOGENET GENOME RES, V105, P235, DOI 10.1159/000078194; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Yuan ZY, 2012, J BIOL CHEM, V287, P34904, DOI 10.1074/jbc.M112.403287; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	57	35	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72767	10.1371/journal.pone.0072767	http://dx.doi.org/10.1371/journal.pone.0072767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015274	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800078
J	Abrieux, A; Debernard, S; Maria, A; Gaertner, C; Anton, S; Gadenne, C; Duportets, L				Abrieux, Antoine; Debernard, Stephane; Maria, Annick; Gaertner, Cyril; Anton, Sylvia; Gadenne, Christophe; Duportets, Line			Involvement of the G-Protein-Coupled Dopamine/Ecdysteroid Receptor DopEcR in the Behavioral Response to Sex Pheromone in an Insect	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MOTH AGROTIS-IPSILON; D2 DOPAMINE-RECEPTOR; BLACK CUTWORM MOTH; DROSOPHILA-MELANOGASTER; ECDYSONE RECEPTOR; JUVENILE-HORMONE; QUEEN PHEROMONE; MUSHROOM BODIES; OLFACTORY-BULB	Most animals including insects rely on olfaction to find their mating partners. In moths, males are attracted by female-produced sex pheromones inducing stereotyped sexual behavior. The behaviorally relevant olfactory information is processed in the primary olfactory centre, the antennal lobe (AL). Evidence is now accumulating that modulation of sex-linked behavioral output occurs through neuronal plasticity via the action of hormones and/or catecholamines. A G-protein-coupled receptor (GPCR) binding to 20-hydroxyecdysone, the main insect steroid hormone, and dopamine, has been identified in Drosophila (DmDopEcR), and was suggested to modulate neuronal signaling. In the male moth Agrotis ipsilon, the behavioral and central nervous responses to pheromone are age-dependent. To further unveil the mechanisms of this olfactory plasticity, we searched for DopEcR and tested its potential role in the behavioral response to sex pheromone in A. ipsilon males. Our results show that A. ipsilon DopEcR (named AipsDopEcR) is predominantly expressed in the nervous system. The corresponding protein was detected immunohistochemically in the ALs and higher brain centers including the mushroom bodies. Moreover, AipsDopEcR expression increased with age. Using a strategy of RNA interference, we also show that silencing of AipsDopEcR inhibited the behavioral response to sex pheromone in wind tunnel experiments. Altogether our results indicate that this GPCR is involved in the expression of sexual behavior in the male moth, probably by modulating the central nervous processing of sex pheromone through the action of one or both of its ligands.	[Abrieux, Antoine; Anton, Sylvia; Gadenne, Christophe] Univ Angers, Lab Recepteurs & Canaux Ion Membranaires RCIM, UPRES EA USC INRA 1330 2647, SFR QUASAV 4207, Angers, France; [Abrieux, Antoine; Debernard, Stephane; Maria, Annick; Duportets, Line] Univ Paris 06, UMR Physiol Insecte Signalisat & Commun 1272, INRA, Paris, France; [Gaertner, Cyril] Univ Paris 06, INRA, UMR Physiol Insecte Signalisat & Commun 1272, Versailles, France; [Duportets, Line] Univ Paris 11, Serv Enseignement Biol Anim, Orsay, France	INRAE; Universite d'Angers; INRAE; UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Gadenne, C (corresponding author), Univ Angers, Lab Recepteurs & Canaux Ion Membranaires RCIM, UPRES EA USC INRA 1330 2647, SFR QUASAV 4207, Angers, France.	christophe.gadenne@angers.inra.fr		abrieux, antoine/0000-0002-2977-2034	Region Pays de la Loire	Region Pays de la Loire(Region Pays de la Loire)	This work was supported by a grant to SA and C. Gadenne and a PhD grant to AA from "Region Pays de la Loire". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka S, 2010, J INSECT PHYSIOL, V56, P1160, DOI 10.1016/j.jinsphys.2010.03.013; Anton S, 1999, P NATL ACAD SCI USA, V96, P5764, DOI 10.1073/pnas.96.10.5764; Anton S, 2007, ENTOMOL EXP APPL, V123, P1, DOI 10.1111/j.1570-7458.2007.00516.x; Anton S, 2011, P NATL ACAD SCI USA, V108, P3401, DOI 10.1073/pnas.1008840108; Barrozo RB, 2010, J EXP BIOL, V213, P2933, DOI 10.1242/jeb.043430; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Beggs KT, 2009, CURR BIOL, V19, P1206, DOI 10.1016/j.cub.2009.05.051; Bigot L, 2012, INSECT BIOCHEM MOLEC, V42, P22, DOI 10.1016/j.ibmb.2011.10.003; Bodo C, 2007, EUR J NEUROSCI, V25, P2182, DOI 10.1111/j.1460-9568.2007.05484.x; Bues R., 1974, ANN ZOOL ECOL ANIM, V2, P79; Cayre M, 2000, EUR J NEUROSCI, V12, P633, DOI 10.1046/j.1460-9568.2000.00947.x; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Duportets L, 1998, J EXP BIOL, V201, P2425; Duportets L, 2013, GEN COMP ENDOCR, V186, P58, DOI 10.1016/j.ygcen.2013.02.024; Elekonich MM, 2000, J INSECT PHYSIOL, V46, P1509, DOI 10.1016/S0022-1910(00)00101-3; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; EVANS PD, 2009, ECDYSONE STRUCTURES, P425; Ezak MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009487; Fukumitsu Y, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-92; Gadenne C, 2001, P ROY SOC B-BIOL SCI, V268, P1631, DOI 10.1098/rspb.2001.1710; GADENNE C, 1993, EXPERIENTIA, V49, P721, DOI 10.1007/BF01923960; Gemeno C, 1998, J CHEM ECOL, V24, P999, DOI 10.1023/A:1022398318465; Griebler M, 2008, J INSECT PHYSIOL, V54, P997, DOI 10.1016/j.jinsphys.2008.04.019; Groh C, 2012, J COMP NEUROL, V520, P3509, DOI 10.1002/cne.23102; Gutierrez-Mecinas M, 2005, EUR J NEUROSCI, V22, P1357, DOI 10.1111/j.1460-9568.2005.04328.x; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Humphries MA, 2003, J NEUROBIOL, V55, P315, DOI 10.1002/neu.10209; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Jarriault D, 2009, HORM BEHAV, V56, P185, DOI 10.1016/j.yhbeh.2009.04.005; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Lemmen J, 2009, J EXP BIOL, V212, P1999, DOI 10.1242/jeb.030858; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Mani SK, 2009, J NEUROENDOCRINOL, V21, P243, DOI 10.1111/j.1365-2826.2009.01844.x; McQuillan HJ, 2012, J COMP PHYSIOL A, V198, P753, DOI 10.1007/s00359-012-0745-y; Meinertzhagen IA, 2001, ADV INSECT PHYSIOL, V28, P84, DOI 10.1016/S0065-2806(01)28009-6; Misiti S, 1999, ENDOCRINOLOGY, V140, P1957, DOI 10.1210/en.140.4.1957; Moffatt CA, 2003, BRAIN RES REV, V43, P192, DOI 10.1016/S0165-0173(03)00208-X; Mustard JA, 2010, J INSECT PHYSIOL, V56, P422, DOI 10.1016/j.jinsphys.2009.11.018; Picimbon JF, 1997, J CHEM ECOL, V23, P211, DOI 10.1023/B:JOEC.0000006355.13207.91; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Schwedes C, 2011, J INSECT PHYSIOL, V57, P899, DOI 10.1016/j.jinsphys.2011.03.027; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sokal R.R., 2012, BIOMETRY; Srivastava DP, 2011, J NEUROSCI, V31, P16056, DOI 10.1523/JNEUROSCI.4097-11.2011; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Tillerson JL, 2006, BEHAV BRAIN RES, V172, P97, DOI 10.1016/j.bbr.2006.04.025; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velarde RA, 2006, INSECT MOL BIOL, V15, P583, DOI 10.1111/j.1365-2583.2006.00679.x; Wei CJ, 2006, BEHAV NEUROSCI, V120, P393, DOI 10.1037/0735-7044.120.2.393; Wersinger SR, 2000, J NEUROENDOCRINOL, V12, P103, DOI 10.1046/j.1365-2826.2000.00418.x; Woodley SK, 2003, HORM BEHAV, V44, P110, DOI 10.1016/S0018-506X(03)00126-0; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Yoshikage M, 2007, NEUROSCI LETT, V413, P11, DOI 10.1016/j.neulet.2006.11.025	58	29	38	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72785	10.1371/journal.pone.0072785	http://dx.doi.org/10.1371/journal.pone.0072785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023771	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600042
J	Ancona, S; Drummond, H				Ancona, Sergio; Drummond, Hugh			Life History Plasticity of a Tropical Seabird in Response to El Nino Anomalies during Early Life	PLOS ONE			English	Article							BLUE-FOOTED BOOBY; LONG-LIVED BIRDS; CLIMATE-CHANGE; REPRODUCTIVE SUCCESS; SEX-RATIO; DEVELOPMENTAL PLASTICITY; WILD POPULATION; POOR START; RED DEER; SURVIVAL	Food shortage and other challenges associated with El Nino Southern Oscillation (ENSO) experienced early in life may have long-term impacts on life history traits, but these potential impacts remain virtually unexplored. By monitoring 2556 blue-footed boobies from 11 cohorts, we showed that birds facing warm water ENSO conditions (and probably low food availability) in the natal year were underweight at fledging, recruited earlier and bred less frequently, but showed no deficit in longevity or breeding success over the first 10 years. Life history impacts of ENSO were substantial when experienced in the prenatal year, the natal year, or the second year of life, and absent when experienced in the third year of life, implying that harsh conditions have greater effects when experienced earlier in life. Sexual differences in impacts depended on the age when warm water conditions were experienced: pre-natal and natal experience, respectively, induced early recruitment and influenced the relationship between age and laying date only in females, whereas second year experience reduced total breeding success only of males. Most surprising were positive transgenerational impacts in females: daughters of females that experienced ENSO conditions in their natal year showed improved breeding success. Developmental plasticity of boobies thus enables them to largely neutralize potential long-term impacts of harsh climatic conditions experienced early in life.	[Ancona, Sergio; Drummond, Hugh] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Ancona, S (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.	sancona@ecologia.unam.mx		Ancona, Sergio/0000-0003-4595-1953	Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia (CONACYT) [81823, 47599, 34500-V, 4722-N9407, D112-903581, PCCNCNA-031528, 31973H and 104313]; National Geographic Society; CONACYT (Programa de Doctorado en Ciencias Biomedicas)	Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Geographic Society(National Geographic Society); CONACYT (Programa de Doctorado en Ciencias Biomedicas)	Funds were provided by Universidad Nacional Autonoma de Mexico (UNAM), the Consejo Nacional de Ciencia y Tecnologia (CONACYT, 81823, 47599, 34500-V, 4722-N9407, D112-903581, PCCNCNA-031528, 31973H and 104313) and the National Geographic Society. S. Ancona was supported by a PhD student scholarship provided by CONACYT (Programa de Doctorado en Ciencias Biomedicas, UNAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBON SD, 1987, J ANIM ECOL, V56, P69, DOI 10.2307/4800; Ancona S, 2012, MAR ECOL PROG SER, V462, P261, DOI 10.3354/meps09851; Ancona S, 2011, J ANIM ECOL, V80, P799, DOI 10.1111/j.1365-2656.2011.01821.x; ANDERSON D J, 1987, National Geographic Research, V3, P152; Auer SK, 2010, AM NAT, V176, P818, DOI 10.1086/657061; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Beamonte-Barrientos R, 2010, AM NAT, V175, P469, DOI 10.1086/650726; Blount JD, 2003, P ROY SOC B-BIOL SCI, V270, P1691, DOI 10.1098/rspb.2003.2411; Bohning D, 1999, J ROY STAT SOC A STA, V162, P195, DOI 10.1111/1467-985X.00130; Braasch A, 2009, J ORNITHOL, V150, P401, DOI 10.1007/s10336-008-0362-2; Bruinzeel LW, 2004, BEHAV ECOL, V15, P290, DOI 10.1093/beheco/arh019; Cam E, 2003, J ANIM ECOL, V72, P411, DOI 10.1046/j.1365-2656.2003.00708.x; Cam E, 2011, J ORNITHOL, V152, P187, DOI 10.1007/s10336-011-0707-0; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Crawley M.J., 2007, R BOOK; Deeming DC., 1991, EGG INCUBATION ITS E; DeKogel CH, 1997, J ANIM ECOL, V66, P167; Dentressangle F, 2008, BEHAV ECOL SOCIOBIOL, V62, P1899, DOI 10.1007/s00265-008-0620-6; Descamps S, 2008, OIKOS, V117, P1406, DOI 10.1111/j.0030-1299.2008.16545.x; Devney CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011891; Drummond H, 2003, AM NAT, V161, P794, DOI 10.1086/375170; Erikstad KE, 1998, ECOLOGY, V79, P1781; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; FRANKIGNOUL C, 1985, REV GEOPHYS, V23, P357, DOI 10.1029/RG023i004p00357; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Gorman HE, 2004, P ROY SOC B-BIOL SCI, V271, P1923, DOI 10.1098/rspb.2004.2799; GREIG SA, 1983, ANIM BEHAV, V31, P1237, DOI 10.1016/S0003-3472(83)80030-X; GUERRA M, 1995, BEHAVIOUR, V132, P479, DOI 10.1163/156853995X00162; Hall AJ, 2001, J ANIM ECOL, V70, P138; Hector KL, 2012, J ANIM ECOL, V81, P583, DOI 10.1111/j.1365-2656.2011.01942.x; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; Jones KS, 2009, AM NAT, V174, P122, DOI 10.1086/599299; Kim SY, 2011, OECOLOGIA, V166, P615, DOI 10.1007/s00442-011-1914-3; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; Lewis S, 2012, OIKOS, V121, P2061, DOI 10.1111/j.1600-0706.2012.20293.x; Lewis S, 2009, OIKOS, V118, P521, DOI 10.1111/j.1600-0706.2009.17308.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lindstrom J, 2002, ECOL LETT, V5, P338, DOI 10.1046/j.1461-0248.2002.00317.x; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moe B, 2004, J EXP BIOL, V207, P4067, DOI 10.1242/jeb.01226; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; MORA JO, 1981, EARLY HUM DEV, V5, P243, DOI 10.1016/0378-3782(81)90032-3; Morrison KW, 2009, CONDOR, V111, P433, DOI 10.1525/cond.2009.080099; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Moyes K, 2009, J ANIM ECOL, V78, P406, DOI 10.1111/j.1365-2656.2008.01497.x; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Naguib M, 2006, P ROY SOC B-BIOL SCI, V273, P1901, DOI 10.1098/rspb.2006.3526; NELSON J.B., 2006, PELICANS CORMORANTS; Nevoux M, 2010, OECOLOGIA, V162, P383, DOI 10.1007/s00442-009-1482-y; Nussey DH, 2007, CURR BIOL, V17, pR1000, DOI 10.1016/j.cub.2007.10.005; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; OSORIOBERISTAIN M, 1993, AUK, V110, P234; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pena B., 2009, THESIS U NACL AUTONO; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 1997, P ROY SOC B-BIOL SCI, V264, P1317, DOI 10.1098/rspb.1997.0182; R Development Core Team, 2012, R LANG ENV STAT COMP; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; Royle NJ, 2005, P ROY SOC B-BIOL SCI, V272, P1917, DOI 10.1098/rspb.2005.3190; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; SEDINGER JS, 1995, ECOLOGY, V76, P2404, DOI 10.2307/2265816; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Solberg EJ, 2004, ECOGRAPHY, V27, P677, DOI 10.1111/j.0906-7590.2004.03864.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stienen EWM, 2002, IBIS, V144, P567, DOI 10.1046/j.1474-919X.2002.00086.x; Taborsky B, 2006, P ROY SOC B-BIOL SCI, V273, P741, DOI 10.1098/rspb.2005.3347; Thompson PM, 2001, NATURE, V413, P417, DOI 10.1038/35096558; Torres R, 1999, J ANIM ECOL, V68, P1133, DOI 10.1046/j.1365-2656.1999.00357.x; Torres R, 1999, OECOLOGIA, V118, P16, DOI 10.1007/s004420050698; Torres R, 1997, J ANIM ECOL, V66, P859, DOI 10.2307/6001; Torres R, 2009, OECOLOGIA, V161, P447, DOI 10.1007/s00442-009-1378-x; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tschirren B, 2009, J EVOLUTION BIOL, V22, P387, DOI 10.1111/j.1420-9101.2008.01656.x; Van de Pol M, 2006, J ANIM ECOL, V75, P616, DOI 10.1111/j.1365-2656.2006.01079.x; Velando A, 2006, P ROY SOC B-BIOL SCI, V273, P1443, DOI 10.1098/rspb.2006.3480; Velando A, 2010, BIOL LETTERS, V6, P194, DOI 10.1098/rsbl.2009.0759; WEIMERSKIRCH H, 1992, OIKOS, V64, P464, DOI 10.2307/3545162; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Wilkin TA, 2009, CURR BIOL, V19, P1998, DOI 10.1016/j.cub.2009.09.065; Young RL, 2004, J EVOLUTION BIOL, V17, P1355, DOI 10.1111/j.1420-9101.2004.00762.x; [No title captured]	86	17	18	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72665	10.1371/journal.pone.0072665	http://dx.doi.org/10.1371/journal.pone.0072665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023760	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600034
J	Fritz, TH; Schmude, P; Jentschke, S; Friederici, AD; Koelsch, S				Fritz, Thomas Hans; Schmude, Paul; Jentschke, Sebastian; Friederici, Angela D.; Koelsch, Stefan			From Understanding to Appreciating Music Cross-Culturally	PLOS ONE			English	Article							EMOTION; EXPRESSION	It has long been debated which aspects of music perception are universal and which are developed only after exposure to a specific musical culture. Here we investigated whether "iconic'' meaning in Western music, emerging from musical information resembling qualities of objects, or qualities of abstract concepts, can be recognized cross-culturally. To this end we acquired a profile of semantic associations (such as, for example, fight, river, etc.) to Western musical pieces from each participant, and then compared these profiles across cultural groups. Results show that the association profiles between Mafa, an ethnic group from northern Cameroon, and Western listeners are different, but that the Mafa have a consistent association profile, indicating that their associations are strongly informed by their enculturation. Results also show that listeners for whom Western music is novel, but whose association profile was more similar to the mean Western music association profile also had a greater appreciation of the Western music. The data thus show that, to some degree, iconic meaning transcends cultural boundaries, with a high inter-individual variance, probably because meaning in music is prone to be overwritten by individual and cultural experience.	[Fritz, Thomas Hans; Schmude, Paul] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Jentschke, Sebastian; Koelsch, Stefan] Free Univ Berlin, Dept Educ Sci & Psychol, Berlin, Germany; [Fritz, Thomas Hans] Univ Ghent, Inst Psychoacoust & Elect Mus, B-9000 Ghent, Belgium; [Fritz, Thomas Hans] Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany; [Friederici, Angela D.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany	Max Planck Society; Free University of Berlin; Ghent University; Leipzig University; Max Planck Society	Fritz, TH (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.	fritz@cbs.mpg.de	Jentschke, Sebastian/C-1618-2008; Koelsch, Stefan/AAV-1556-2020	Jentschke, Sebastian/0000-0003-2576-5432; Fritz, Thomas/0000-0003-1855-6026	German Academic Exchange Service (DAAD) [D/05/43777]; DFG499 research program of the German Research Foundation [KO 2266/2-1]; Max Planck Society	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); DFG499 research program of the German Research Foundation; Max Planck Society(Max Planck Society)	This work was supported by the German Academic Exchange Service (DAAD) with a grant awarded to TF (D/05/43777); the DFG499 research program of the German Research Foundation (grant KO 2266/2-1) with a grant awarded to SK, and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames DW, 1971, TAAKEN SAMAARII DRUM, P12; Carrington J.F., 1949, TALKING DRUMS AFRICA; Cross I, 2009, MUSIC SCI, P179; Daltrozzo J, 2009, J COGNITIVE NEUROSCI, V21, P1882, DOI 10.1162/jocn.2009.21113; Daltrozzo J, 2009, BRAIN RES, V1270, P88, DOI 10.1016/j.brainres.2009.03.019; Dowling WJ, 1986, EMOTION MEANING MUSI; Downey LE, 2013, CORTEX, V49, P1844, DOI 10.1016/j.cortex.2012.09.011; ECKERDAL P., 2009, INFANT DEV INTERPRET, P241; Eitan Z, 2006, MUSIC PERCEPT, V23, P221, DOI 10.1525/mp.2006.23.3.221; Eitan Z, 2010, COGNITION, V114, P405, DOI 10.1016/j.cognition.2009.10.013; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; Fritz T, 2013, MUSIC PERCEPT, V30, P511, DOI 10.1525/MP.2013.30.5.511; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Fritz TH, 2013, EUR J NEUROSCI, V38, P3099, DOI 10.1111/ejn.12305; Gaines Joseph, 1996, J BLACK PSYCHOL, V22, P202; Goerlich KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019501; Hanslick E, 1980, MUSIKALISCH SCHONEN; HARWOOD DL, 1976, ETHNOMUSICOLOGY, V20, P521, DOI 10.2307/851047; JUSLIN Patrik N., 2001, MUSIC EMOTION THEORY, P309; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Karbusicky Vladimir, 1986, GRUNDRISS MUSIKALISC; Keil Charles, 1979, TIV SONG; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Koelsch S, 2011, PHYS LIFE REV, V8, P89, DOI 10.1016/j.plrev.2011.04.004; Langer Susanne K., 1948, PHILOS NEW KEY STUDY; Logeswaran N, 2009, NEUROSCI LETT, V455, P129, DOI 10.1016/j.neulet.2009.03.044; Malloch S., 2008, COMMUNICATIVE MUSICA, P1; Merker BH., 1999, MUSIC SCI, V3, P59, DOI [DOI 10.1177/10298649000030S105, 10.1177/10298649000030S105]; Meyer L., 1956, EMOTION MEANING MUSI; Nettl B, 2000, ORIGINS OF MUSIC, P463; Omar R, 2010, BRAIN, V133, P1200, DOI 10.1093/brain/awp345; Parncutt R., 2006, CHILD MUSICIAN HDB M, P1, DOI [10.1093/acprof:oso/9780198530329.003.0001, DOI 10.1093/ACPROF:OSO/9780198530329.003.0001]; Parncutt R, 2009, MUSIC SCI, P119, DOI 10.1177/1029864909013002071; Romney A. Kimball, 1964, TRANSCULTURAL STUDIE; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; Scherer KR, 1997, J PERS SOC PSYCHOL, V73, P902, DOI 10.1037/0022-3514.73.5.902; SCHERER KR, 1995, J VOICE, V9, P235, DOI 10.1016/S0892-1997(05)80231-0; Steinbeis N, 2008, PLOS ONE, V3, pe2631; Steinbeis N, 2011, J COGNITIVE NEUROSCI, V23, P604, DOI 10.1162/jocn.2009.21383; Stern D. N, 2010, FORMS VITALITY EXPLO; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885	42	14	16	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72500	10.1371/journal.pone.0072500	http://dx.doi.org/10.1371/journal.pone.0072500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	219OE	24023745	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000324515600024
J	Cantini, L; Attaway, CC; Butler, B; Andino, LM; Sokolosky, ML; Jakymiw, A				Cantini, Liliana; Attaway, Christopher C.; Butler, Betsy; Andino, Lourdes M.; Sokolosky, Melissa L.; Jakymiw, Andrew			Fusogenic-Oligoarginine Peptide-Mediated Delivery of siRNAs Targeting the CIP2A Oncogene into Oral Cancer Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PENETRATING PEPTIDES; INTERFERING RNA; CELLULAR UPTAKE; GENE-TRANSFER; EXPRESSION; OLIGONUCLEOTIDES; CARCINOMAS; MECHANISM; DUPLEXES	Despite a better understanding of the pathogenesis of oral cancer, its treatment outcome remains poor. Thus, there is a need for new therapeutic strategies to improve the prognosis of this disease. RNA interference (RNAi) appears to be a promising therapeutic tool for the treatment of many diseases, including oral cancer. However, an obstacle for RNAi-mediated therapies has been delivery, in particular, the retention of small interfering RNAs (siRNAs) in endosomes and their subsequent degradation in lysosomes, resulting in inefficient gene silencing. Thus, the current study examined the feasibility of designing and utilizing a peptide, termed 599, consisting of a synthetic influenza virus-derived endosome-disruptive fusogenic peptide sequence and a stretch of cationic cell-penetrating nona(D-arginine) residues, to deliver siRNAs into oral cancer cells and induce silencing of the therapeutic target, CIP2A, an oncoprotein overexpressed in various human malignancies including oral cancer. Increasing the 599 peptide-to-siRNA molar ratio demonstrated a higher binding capacity for siRNA molecules and enhanced siRNA delivery into the cytoplasm of oral cancer cells. In fact, quantitative measurements of siRNA delivery into cells demonstrated that a 50: 1 peptide-to-siRNA molar ratio could deliver 18-fold higher amounts of siRNAs compared to cells treated with siRNA alone with no significant long-term cytotoxic effects. Most importantly, the 599 peptide-mediated siRNA delivery promoted significant CIP2A mRNA and protein silencing which resulted in decreased oral cancer cell invasiveness and anchorage-independent growth. Together, these data demonstrate that a chimeric peptide consisting of a fusogenic sequence, in combination with cell-penetrating residues, can be used to effectively deliver siRNAs into oral cancer cells and induce the silencing of its target gene, potentially offering a new therapeutic strategy in combating oral cancer.	[Jakymiw, Andrew] Med Univ S Carolina, Hollings Canc Ctr, Dept Craniofacial Biol, Charleston, SC 29425 USA; Med Univ S Carolina, Hollings Canc Ctr, Ctr Oral Hlth Res, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Jakymiw, A (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, Dept Craniofacial Biol, Charleston, SC 29425 USA.	jakymiw@musc.edu	Attaway, Christopher Charles/GYJ-7363-2022	Attaway, Christopher Charles/0000-0002-9135-7747; Jakymiw, Andrew/0000-0001-6431-8753	NIDCR [R00DE018191]; NCRR [P20RR017696]; Bankhead-Coley Florida Cancer Research Program grant [08BN-02]; National Science Foundation [1126407]; Clemson University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE018191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Bankhead-Coley Florida Cancer Research Program grant; National Science Foundation(National Science Foundation (NSF)); Clemson University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIDCR and NCRR grants R00DE018191 (AJ) and P20RR017696, respectively. This work was also funded by the Bankhead-Coley Florida Cancer Research Program grant 08BN-02 (AJ). Technical support provided by the Clemson Light Imaging Facility was made possible by the National Science Foundation Award #1126407 and a Clemson University Core Facility grant to Terri F. Bruce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andaloussi SEL, 2011, NUCLEIC ACIDS RES, V39, P3972, DOI 10.1093/nar/gkq1299; Blessing T, 1998, P NATL ACAD SCI USA, V95, P1427, DOI 10.1073/pnas.95.4.1427; Bockelman C, 2011, BRIT J CANCER, V104, P1890, DOI 10.1038/bjc.2011.167; Bramsen Jesper B., 2012, Frontiers in Genetics, V3, P154, DOI 10.3389/fgene.2012.00154; Campana JP, 2006, OTOLARYNG CLIN N AM, V39, P331, DOI 10.1016/j.otc.2005.11.005; Claffey DJ, 2000, BIOCHEM CELL BIOL, V78, P59, DOI 10.1139/bcb-78-1-59; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furgeson DY, 2003, BIOCONJUGATE CHEM, V14, P840, DOI 10.1021/bc0340565; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hatakeyama H, 2009, J CONTROL RELEASE, V139, P127, DOI 10.1016/j.jconrel.2009.06.008; Jarver P, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.18; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katz J, 2010, CANCER BIOL THER, V10, P694, DOI 10.4161/cbt.10.7.12895; Khalil IA, 2004, GENE THER, V11, P636, DOI 10.1038/sj.gt.3302128; Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Lundberg P, 2007, FASEB J, V21, P2664, DOI 10.1096/fj.06-6502com; Mae M, 2009, J CONTROL RELEASE, V134, P221, DOI 10.1016/j.jconrel.2008.11.025; Mastrobattista E, 2002, J BIOL CHEM, V277, P27135, DOI 10.1074/jbc.M200429200; Meade BR, 2008, ADV DRUG DELIVER REV, V60, P530, DOI 10.1016/j.addr.2007.10.004; Moschos SA, 2007, BIOCONJUGATE CHEM, V18, P1450, DOI 10.1021/bc070077d; Oliveira S, 2007, INT J PHARM, V331, P211, DOI 10.1016/j.ijpharm.2006.11.050; Plank C, 1998, ADV DRUG DELIVER REV, V34, P21, DOI 10.1016/S0169-409X(98)00005-2; PLANK C, 1994, J BIOL CHEM, V269, P12918; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492; Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stewart Sherri L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Turner JJ, 2007, BLOOD CELL MOL DIS, V38, P1, DOI 10.1016/j.bcmd.2006.10.003; Verdurmen WPR, 2011, CHEM BIOL, V18, P1000, DOI 10.1016/j.chembiol.2011.06.006; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Yockman JW, 2003, J CONTROL RELEASE, V87, P177, DOI 10.1016/S0168-3659(02)00362-0; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	45	43	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73348	10.1371/journal.pone.0073348	http://dx.doi.org/10.1371/journal.pone.0073348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019920	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200062
J	Lim, GGY; Chew, KCM; Ng, XH; Henry-Basil, A; Sim, RWX; Tan, JMM; Chai, C; Lim, KL				Lim, Grace G. Y.; Chew, Katherine C. M.; Ng, Xiao-Hui; Henry-Basil, Adeline; Sim, Roy W. X.; Tan, Jeanne M. M.; Chai, Chou; Lim, Kah-Leong			Proteasome Inhibition Promotes Parkin-Ubc13 Interaction and Lysine 63-Linked Ubiquitination	PLOS ONE			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; PROTEIN INCLUSIONS; LEWY BODIES; LIGASE; POLYUBIQUITIN; DEGRADATION; AGGRESOMES; CLEARANCE; PHOSPHORYLATION	Disruption of the ubiquitin-proteasome system, which normally identifies and degrades unwanted intracellular proteins, is thought to underlie neurodegeneration. Supporting this, mutations of Parkin, a ubiquitin ligase, are associated with autosomal recessive parkinsonism. Remarkably, Parkin can protect neurons against a wide spectrum of stress, including those that promote proteasome dysfunction. Although the mechanism underlying the preservation of proteasome function by Parkin is hitherto unclear, we have previously proposed that Parkin-mediated K63-linked ubiquitination (which is usually uncoupled from the proteasome) may serve to mitigate proteasomal stress by diverting the substrate load away from the machinery. By means of linkage-specific antibodies, we demonstrated here that proteasome inhibition indeed promotes K63-linked ubiquitination of proteins especially in Parkin-expressing cells. Importantly, we further demonstrated that the recruitment of Ubc13 (an E2 that mediates K63-linked polyubiquitin chain formation exclusively) by Parkin is selectively enhanced under conditions of proteasomal stress, thus identifying a mechanism by which Parkin could promote K63-linked ubiquitin modification in cells undergoing proteolytic stress. This mode of ubiquitination appears to facilitate the subsequent clearance of Parkin substrates via autophagy. Consistent with the proposed protective role of K63-linked ubiquitination in times of proteolytic stress, we found that Ubc13-deficient cells are significantly more susceptible to cell death induced by proteasome inhibitors compared to their wild type counterparts. Taken together, our study suggests a role for Parkin-mediated K63 ubiquitination in maintaining cellular protein homeostasis, especially during periods when the proteasome is burdened or impaired.	[Lim, Grace G. Y.; Chew, Katherine C. M.; Ng, Xiao-Hui; Henry-Basil, Adeline; Lim, Kah-Leong] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Tan, Jeanne M. M.; Chai, Chou; Lim, Kah-Leong] Duke NUS Grad Med Sch, Singapore, Singapore; [Lim, Grace G. Y.; Ng, Xiao-Hui; Henry-Basil, Adeline; Sim, Roy W. X.; Tan, Jeanne M. M.; Lim, Kah-Leong] Natl Inst Neurosci, Neurodegenerat Res Lab, Singapore, Singapore	National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI)	Lim, KL (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore.	phslkl@nus.edu.sg	Lim, Kah/L-5426-2019; Lim, Kah-Leong/AAY-3308-2020; Tan, Jeanne/GQI-3612-2022	Lim, Kah-Leong/0000-0002-5440-2588; Chew, Katherine C. M./0000-0003-2051-4386	Singapore Biomedical Research Council; National Research Foundation; Singapore Millennium Foundation (SMF); SMF	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Research Foundation; Singapore Millennium Foundation (SMF)(Singapore Millennium Foundation); SMF	This work was supported by grants from the Singapore Biomedical Research Council, National Research Foundation Competitive Research Program and Singapore Millennium Foundation (SMF). G. L. and J.T. are respectively supported by a graduate scholarship award and a postdoctoral fellowship from the SMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chew KCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019720; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Doss-Pepe EW, 2005, J BIOL CHEM, V280, P16619, DOI 10.1074/jbc.M413591200; Feany MB, 2003, NEURON, V38, P13, DOI 10.1016/S0896-6273(03)00201-0; Fortun J, 2003, J NEUROSCI, V23, P10672; Garfield AS, 2010, METHODS MOL BIOL, V633, P19, DOI 10.1007/978-1-59745-019-5_2; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ito T, 2003, J BIOL CHEM, V278, P29106, DOI 10.1074/jbc.M302763200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lim KL, 2007, EXPERT REV PROTEOMIC, V4, P769, DOI 10.1586/14789450.4.6.769; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Muller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Paine S, 2009, NEUROSCI LETT, V460, P205, DOI 10.1016/j.neulet.2009.05.074; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tan JMM, 2008, AUTOPHAGY, V4, P251, DOI 10.4161/auto.5444; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tan JMM, 2009, ANTIOXID REDOX SIGN, V11, P2119, DOI 10.1089/ARS.2009.2490; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; Wang HF, 2012, J BIOL CHEM, V287, P28576, DOI 10.1074/jbc.M111.299990; Wauer T, 2013, EMBO J; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	45	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73235	10.1371/journal.pone.0073235	http://dx.doi.org/10.1371/journal.pone.0073235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023840	gold, Green Submitted, Green Published			2022-12-27	WOS:000324238400054
J	Priore, SF; Kierzek, E; Kierzek, R; Baman, JR; Moss, WN; Dela-Moss, LI; Turner, DH				Priore, Salvatore F.; Kierzek, Elzbieta; Kierzek, Ryszard; Baman, Jayson R.; Moss, Walter N.; Dela-Moss, Lumbini I.; Turner, Douglas H.			Secondary Structure of a Conserved Domain in the Intron of Influenza A NS1 mRNA	PLOS ONE			English	Article							BASE-PAIRS; THERMODYNAMIC PROPERTIES; RNA/RNA HETERODUPLEXES; STRUCTURE PREDICTION; ANGSTROM RESOLUTION; RIBOSOMAL-SUBUNIT; VIRUS; CONSTRAINTS; PROTEIN; GENE	Influenza A virus is a segmented single-stranded (2) RNA virus that causes substantial annual morbidity and mortality. The transcriptome of influenza A is predicted to have extensive RNA secondary structure. The smallest genome segment, segment 8, encodes two proteins, NS1 and NEP, via alternative splicing. A conserved RNA domain in the intron of segment 8 may be important for regulating production of NS1. Two different multi-branch loop structures have been proposed for this region. A combination of in vitro chemical mapping and isoenergetic microarray techniques demonstrate that the consensus sequence for this region folds into a hairpin conformation. These results provide an alternative folding for this region and a foundation for designing experiments to probe its functional role in the influenza life cycle.	[Priore, Salvatore F.; Baman, Jayson R.; Moss, Walter N.; Dela-Moss, Lumbini I.; Turner, Douglas H.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Priore, Salvatore F.; Baman, Jayson R.; Moss, Walter N.; Dela-Moss, Lumbini I.; Turner, Douglas H.] Univ Rochester, Ctr RNA Biol, Rochester, NY USA; [Kierzek, Elzbieta; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	University of Rochester; University of Rochester; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Turner, DH (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	turner@chem.rochester.edu	Moss, Walter/H-8096-2019	Moss, Walter/0000-0001-6419-5570; Kierzek, Elzbieta/0000-0002-5563-003X; Kierzek, Ryszard/0000-0002-7644-0016	NIH [R01 GM22939, T32 GM07356, 1R03TW008739-01]; Polish National Science Center [N N301 788 440, UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098]; FOGARTY INTERNATIONAL CENTER [R03TW008739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, R01GM022939, T32GM007356] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish National Science Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily funded by NIH grant R01 GM22939. SFP is a trainee in the Medical Scientist Training Program funded by NIH T32 GM07356. EK was funded by NIH grant 1R03TW008739-01 and Polish National Science Center grant N N301 788 440. RK was funded by Polish National Science Center grants UMO-2011/03/B/NZ1/00576 and UMO-2011/03/B/ST5/01098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; CLEVER J, 1995, J VIROL, V69, P2101, DOI 10.1128/JVI.69.4.2101-2109.1995; Fratczak A, 2011, BIOCHEMISTRY-US, V50, P7647, DOI 10.1021/bi200463p; Ilyinskii PO, 2009, OMICS, V13, P421, DOI 10.1089/omi.2009.0036; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Jang SB, 1998, BIOCHEMISTRY-US, V37, P11726, DOI 10.1021/bi980758j; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawaoka Y, 1998, VIRUS RES, V55, P143, DOI 10.1016/S0168-1702(98)00038-0; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kierzek E, 2008, NUCLEIC ACIDS RES, V36, P1770, DOI 10.1093/nar/gkm1085; Kierzek E, 2006, NUCLEIC ACIDS RES, V34, P3609, DOI 10.1093/nar/gkl232; Kierzek E, 2009, BIOCHEMISTRY-US, V48, P11344, DOI 10.1021/bi901264v; Kierzek E, 2009, J MOL BIOL, V390, P428, DOI 10.1016/j.jmb.2009.04.048; KUO MYP, 1988, J VIROL, V62, P4439, DOI 10.1128/JVI.62.12.4439-4444.1988; Lee JC, 2003, J MOL BIOL, V325, P65, DOI 10.1016/S0022-2836(02)01106-3; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Lima S, 2002, RNA, V8, P924, DOI 10.1017/S1355838202028893; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Moss WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038323; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Pasternak A, 2007, NUCLEIC ACIDS RES, V35, P4055, DOI 10.1093/nar/gkm421; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Priore SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035989; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schroeder SJ, 2011, BIOPHYS J, V101, P167, DOI 10.1016/j.bpj.2011.05.053; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thulasi P, 2010, BIOCHEMISTRY-US, V49, P9058, DOI 10.1021/bi101164s; Velagapudi SP, 2010, ANGEW CHEM INT EDIT, V49, P3816, DOI 10.1002/anie.200907257; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Wilcox JL, 2013, J AM CHEM SOC, V135, P7390, DOI 10.1021/ja3125299; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xu ZJ, 2011, BIOINFORMATICS, V27, P626, DOI 10.1093/bioinformatics/btq726; Yamano H, 1996, EMBO J, V15, P5268, DOI 10.1002/j.1460-2075.1996.tb00912.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	22	22	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e70615	10.1371/journal.pone.0070615	http://dx.doi.org/10.1371/journal.pone.0070615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023714	gold, Green Published, Green Submitted			2022-12-27	WOS:000324238400003
J	Giannotti, S; Trombi, L; Bottai, V; Ghilardi, M; D'Alessandro, D; Danti, S; Dell'Osso, G; Guido, G; Petrini, M				Giannotti, Stefano; Trombi, Luisa; Bottai, Vanna; Ghilardi, Marco; D'Alessandro, Delfo; Danti, Serena; Dell'Osso, Giacomo; Guido, Giulio; Petrini, Mario			Use of Autologous Human mesenchymal Stromal Cell/Fibrin Clot Constructs in Upper Limb Non-Unions: Long-Term Assessment	PLOS ONE			English	Article							MESODERMAL PROGENITOR CELLS; STEM-CELLS; BONE-MARROW; REGENERATIVE MEDICINE; GRAFT HARVEST; RISK-FACTORS; FIBRIN GEL; IN-VITRO; REPAIR; SCAFFOLD	Background: Tissue engineering appears to be an attractive alternative to the traditional approach in the treatment of fracture non-unions. Mesenchymal stromal cells (MSCs) are considered an appealing cell source for clinical intervention. However, ex vivo cell expansion and differentiation towards the osteogenic lineage, together with the design of a suitable scaffold have yet to be optimized. Major concerns exist about the safety of MSC-based therapies, including possible abnormal overgrowth and potential cancer evolution. Aims: We examined the long-term efficacy and safety of ex vivo expanded bone marrow MSCs, embedded in autologous fibrin clots, for the healing of atrophic pseudarthrosis of the upper limb. Our research work relied on three main issues: use of an entirely autologous context (cells, serum for ex vivo cell culture, scaffold components), reduced ex vivo cell expansion, and short-term MSC osteoinduction before implantation. Methods and Findings: Bone marrow MSCs isolated from 8 patients were expanded ex vivo until passage 1 and short-term osteo-differentiated in autologous-based culture conditions. Tissue-engineered constructs designed to embed MSCs in autologous fibrin clots were locally implanted with bone grafts, calibrating their number on the extension of bone damage. Radiographic healing was evaluated with short-and long-term follow-ups (range averages: 6.7 and 76.0 months, respectively). All patients recovered limb function, with no evidence of tissue overgrowth or tumor formation. Conclusions: Our study indicates that highly autologous treatment can be effective and safe in the long-term healing of bone non-unions. This tissue engineering approach resulted in successful clinical and functional outcomes for all patients.	[Giannotti, Stefano; Bottai, Vanna; Ghilardi, Marco; Dell'Osso, Giacomo; Guido, Giulio] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Trombi, Luisa; Petrini, Mario] Univ Pisa, Dept Clin & Expt Med, Div Hematol, Pisa, Italy; [D'Alessandro, Delfo; Danti, Serena] Univ Pisa, Dept Surg Med Mol Pathol & Emergency, Pisa, Italy	University of Pisa; University of Pisa; University of Pisa	Trombi, L (corresponding author), Univ Pisa, Dept Clin & Expt Med, Div Hematol, Pisa, Italy.	l.trombi@yahoo.it	Danti, Serena/N-2375-2015	Danti, Serena/0000-0002-8155-8537	Hemathology Division, University of Pisa	Hemathology Division, University of Pisa	This work was exclusively supported only by the institutional funds of the Hemathology Division, University of Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed TAE, 2008, TISSUE ENG PART B-RE, V14, P199, DOI 10.1089/ten.teb.2007.0435; Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010; Bajada S, 2007, J BONE JOINT SURG BR, V89B, P1382, DOI 10.1302/0301-620X.89B10.19103; Barachini S, 2009, STEM CELLS DEV, V18, P293, DOI 10.1089/scd.2008.0017; Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bonfield TL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-51; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Butler DL, 2010, NAT PROTOC, V5, P849, DOI 10.1038/nprot.2010.14; Calori GM, 2007, INJURY, V38, pS11, DOI 10.1016/S0020-1383(07)80004-0; Cancedda R, 2003, STEM CELLS, V21, P610, DOI 10.1634/stemcells.21-5-610; Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082; Charles M, 2007, J CAN DENT ASSOC, V73, P67; Danti S, 2013, TISSUE ENG C; Frank C, 1999, J Sci Med Sport, V2, P190, DOI 10.1016/S1440-2440(99)80173-X; Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2; Gomez-Barrena E, 2011, J CELL MOL MED, V15, P1266, DOI 10.1111/j.1582-4934.2011.01265.x; Greco SJ, 2012, THER DELIV, V3, P997, DOI 10.4155/TDE.12.69; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Harris MT, 2004, J ORTHOP RES, V22, P998, DOI 10.1016/j.orthres.2004.02.012; Heary RF, 2002, NEUROSURGERY, V50, P510, DOI 10.1097/00006123-200203000-00015; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Jager M, 2009, CURR STEM CELL RES T, V4, P34, DOI 10.2174/157488809787169039; Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8; Kanakaris NK, 2007, INJURY, V38, pS77, DOI 10.1016/S0020-1383(07)80012-X; Kassem M, 2008, CELL TISSUE RES, V331, P157, DOI 10.1007/s00441-007-0509-0; Kim SJ, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-20; Kitoh Hiroshi, 2009, J Pediatr Orthop, V29, P643, DOI 10.1097/BPO.0b013e3181b2afb2; Kon E, 2000, J BIOMED MATER RES, V49, P328; Lynch JR, 2008, J AM ACAD ORTHOP SUR, V16, P88, DOI 10.5435/00124635-200802000-00006; Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Motaln H, 2010, CANCER-AM CANCER SOC, V116, P2519, DOI 10.1002/cncr.25056; Muller ME, 1990, COMPREHENSIVE CLASSI, P53; Muschler GF, 2003, CLIN ORTHOP RELAT R, P102, DOI 10.1097/01.blo.0000030504.43495.46; Niedzielski K, 2000, Ortop Traumatol Rehabil, V2, P46; Pacini S, 2007, TISSUE ENG, V13, P2949, DOI 10.1089/ten.2007.0108; Pacini S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009861; Petrini M, 2009, STEM CELLS DEV, V18, P857, DOI 10.1089/scd.2008.0291; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pneumaticos SG, 2011, TRENDS MOL MED, V17, P215, DOI 10.1016/j.molmed.2010.12.002; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769; Schmitt A, 2007, STEM CELLS INT, P1; Schwartz CE, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-49; Seebach C, 2010, INJURY, V41, P731, DOI 10.1016/j.injury.2010.02.017; Shearn JT, 2007, J BIOMECH ENG-T ASME, V129, P848, DOI 10.1115/1.2800769; Siggers K, 2010, J BIOMED MATER RES A, V94A, P877, DOI 10.1002/jbm.a.32766; SILBERSTEIN LE, 1988, TRANSFUSION, V28, P319, DOI 10.1046/j.1537-2995.1988.28488265257.x; Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106; Soucacos PN, 2006, INJURY, V37, pS41, DOI 10.1016/j.injury.2006.02.040; Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004; Trombi L, 2008, TRANSFUSION, V48, P2246, DOI 10.1111/j.1537-2995.2008.01829.x; Trombi L, 2008, J ORTHOP RES, V26, P176, DOI 10.1002/jor.20490; Trombi L, 2009, STEM CELLS DEV, V18, P1227, DOI 10.1089/scd.2009.0054; Umeda H, 2007, LARYNGOSCOPE, V117, P997, DOI 10.1097/MLG.0b013e3180471459; Veronesi F, 2013, STEM CELLS DEV, V22, P181, DOI 10.1089/scd.2012.0373; Vulcano E, 2012, SURG TECHNOL IN 0930, V30, pXXII; Wu XW, 2012, CYTOTHERAPY, V14, P555, DOI 10.3109/14653249.2011.638914; Xiang Ying, 2007, Journal of Zhejiang University-Science B, V8, P136, DOI 10.1631/jzus.2007.B0136; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	61	56	59	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73893	10.1371/journal.pone.0073893	http://dx.doi.org/10.1371/journal.pone.0073893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023694	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200091
J	Hoff-Risseti, C; Dorr, FA; Schaker, PDC; Pinto, E; Werner, VR; Fiore, MF				Hoff-Risseti, Caroline; Doerr, Felipe Augusto; Carvalho Schaker, Patricia Dayane; Pinto, Ernani; Werner, Vera Regina; Fiore, Marli Fatima			Cylindrospermopsin and Saxitoxin Synthetase Genes in Cylindrospermopsis raciborskii Strains from Brazilian Freshwater	PLOS ONE			English	Article							SUBBA RAJU; APHANIZOMENON-OVALISPORUM; INVASIVE CYANOBACTERIUM; TOXIC CYANOBACTERIA; BILLINGS RESERVOIR; LAKE KINNERET; 1ST REPORT; SAO-PAULO; IDENTIFICATION; BIOSYNTHESIS	The Cylindrospermopsis raciborskii population from Brazilian freshwater is known to produce saxitoxin derivatives (STX), while cylindrospermopsin (CYN), which is commonly detected in isolates from Australia and Asia continents, has thus far not been detected in South American strains. However, during the investigation for the presence of cyrA, cyrB, cyrC and cyrJ CYN synthetase genes in the genomes of four laboratory-cultured C. raciborskii Brazilian strains, the almost complete cyrA gene sequences were obtained for all strains, while cyrB and cyrC gene fragments were observed in two strains. These nucleotide sequences were translated into amino acids, and the predicted protein functions and domains confirmed their identity as CYN synthetase genes. Attempts to PCR amplify cyrJ gene fragments from the four strains were unsuccessful. Phylogenetic analysis grouped the nucleotide sequences together with their homologues found in known CYN synthetase clusters of C. raciborskii strains with high bootstrap support. In addition, fragments of sxtA, sxtB and sxtI genes involved in STX production were also obtained. Extensive LC-MS analyses were unable to detect CYN in the cultured strains, whereas the production of STX and its analogues was confirmed in CENA302, CENA305 and T3. To our knowledge, this is the first study reporting the presence of cyr genes in South American strains of C. raciborskii and the presence of sxt and cyr genes in a single C. raciborskii strain. This discovery suggests a shift in the type of cyanotoxin production over time of South American strains of C. raciborskii and contributes to the reconstruction of the evolutionary history and diversification of cyanobacterial toxins.	[Hoff-Risseti, Caroline; Carvalho Schaker, Patricia Dayane; Fiore, Marli Fatima] Univ Sao Paulo, Ctr Nucl Energy Agr, BR-05508 Sao Paulo, Brazil; [Hoff-Risseti, Caroline; Doerr, Felipe Augusto; Pinto, Ernani] Univ Sao Paulo, Fac Pharmaceut Sci, BR-05508 Sao Paulo, Brazil; [Werner, Vera Regina] Zoobot Fdn Rio Grande Sul, Museum Nat Sci, Porto Alegre, RS, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Fiore, MF (corresponding author), Univ Sao Paulo, Ctr Nucl Energy Agr, BR-05508 Sao Paulo, Brazil.	fiore@cena.usp.br	Pinto, Ernani/A-4617-2010; Dayane Carvalho Schaker, Patricia/G-4268-2012; Fiore, Marli F/C-1436-2012; Dorr, Felipe A/D-9689-2011	Pinto, Ernani/0000-0001-7614-3014; Dayane Carvalho Schaker, Patricia/0000-0002-1215-9735; Fiore, Marli F/0000-0003-2555-7967; Dorr, Felipe A/0000-0003-4207-4908	National Council for Scientific and Technological Development [CNPq - 559720/2009-2, 478097/2010-7]; State of Sao Paulo Research Foundation [FAPESP - 2010/16328-7]	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grants from The National Council for Scientific and Technological Development (CNPq - 559720/2009-2 and 478097/2010-7) and the State of Sao Paulo Research Foundation (FAPESP - 2010/16328-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1167; Ballot A, 2011, J PLANKTON RES, V33, P1736, DOI 10.1093/plankt/fbr071; Banker R, 2000, J NAT PROD, V63, P387, DOI 10.1021/np990498m; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bittencourt-Oliveira M. do C., 2011, Journal of Water Resource and Protection, V3, P349, DOI 10.4236/jwarp.2011.36044; Bouvy M, 2000, AQUAT MICROB ECOL, V23, P13, DOI 10.3354/ame023013; BRANCO C W C, 1991, Bulletin du Jardin Botanique National de Belgique, V61, P85, DOI 10.2307/3668446; Briand JF, 2002, WATER RES, V36, P3183, DOI 10.1016/S0043-1354(02)00016-7; Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781; Castenholz R.W., 2001, BERGEYS MANUAL SYSTE, V2nd ed., P474; Chonudomkul D, 2004, FEMS MICROBIOL ECOL, V48, P345, DOI 10.1016/j.femsec.2004.02.014; Costa I. A. S., 2006, Braz. J. Biol., V66, P211, DOI 10.1590/S1519-69842006000200005; Coute A., 2004, ALGOLOGICAL STUDIES, V113, P57; Cronberg G., 2006, MANUAL AQUATIC CYANO; de Carvalho LR, 2008, BRAZ J MICROBIOL, V39, P761, DOI [10.1590/S1517-83822008000400031, 10.1590/S1517-838220080004000031]; de Souza RCR, 1998, ENVIRON TOXIC WATER, V13, P73, DOI 10.1002/(SICI)1098-2256(1998)13:1<73::AID-TOX5>3.0.CO;2-4; Diener M, 2007, J SEP SCI, V30, P1821, DOI 10.1002/jssc.200700025; Diener M, 2006, EUR FOOD RES TECHNOL, V224, P147, DOI 10.1007/s00217-006-0302-4; Dittmann E, 2013, FEMS MICROBIOL REV, V37, P23, DOI 10.1111/j.1574-6976.2012.12000.x; Dorr FA, 2011, J AM SOC MASS SPECTR, V22, P2011, DOI 10.1007/s13361-011-0223-8; Dorr FA, 2008, RAPID COMMUN MASS SP, V22, P2015, DOI 10.1002/rcm.3567; Dyble J, 2002, APPL ENVIRON MICROB, V68, P2567, DOI 10.1128/AEM.68.5.2567-2571.2002; Everson S, 2011, HARMFUL ALGAE, V10, P265, DOI 10.1016/j.hal.2010.10.006; Fastner J, 2003, TOXICON, V42, P313, DOI 10.1016/S0041-0101(03)00150-8; Ferrao-Filho A. S., 2007, J BRAZ SOC ECOTOXICO, V2, P93; Figueredo CC, 2009, LIMNOLOGICA, V39, P264, DOI 10.1016/j.limno.2009.06.009; Fiore MF, 2007, J PHYCOL, V43, P789, DOI 10.1111/j.1529-8817.2007.00376.x; Fiore MF, 2000, J MICROBIOL METH, V39, P159, DOI 10.1016/S0167-7012(99)00110-4; Froscio SM, 2003, ENVIRON TOXICOL, V18, P243, DOI 10.1002/tox.10121; Gemelgo Marcina C. P., 2008, Hoehnea, V35, P297; Gorham PR, 1964, THEOR ANGEW LIMNOL, V15, P796; Gugger M, 2005, APPL ENVIRON MICROB, V71, P1097, DOI 10.1128/AEM.71.2.1097-1100.2005; Hackett JD, 2013, MOL BIOL EVOL, V30, P70, DOI 10.1093/molbev/mss142; Hawkins PR, 1997, TOXICON, V35, P341, DOI 10.1016/S0041-0101(96)00185-7; HAWKINS PR, 1985, APPL ENVIRON MICROB, V50, P1292, DOI 10.1128/AEM.50.5.1292-1295.1985; Hoffmann L., 2005, ALGOL STUD, V117, P95, DOI DOI 10.1127/1864-1318/2005/0117-0095; Humpage AR, 2000, MUTAT RES-GEN TOX EN, V472, P155, DOI 10.1016/S1383-5718(00)00144-3; Huszar VLM, 2000, HYDROBIOLOGIA, V424, P67, DOI 10.1023/A:1003996710416; Jiang YG, 2012, APPL ENVIRON MICROB, V78, P2256, DOI 10.1128/AEM.07321-11; Kellmann R, 2006, J MOL EVOL, V62, P267, DOI 10.1007/s00239-005-0030-6; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; KOMAREK J., 2013, CYANODBCZ ON LINE DA; KOMARKOVA J, 1999, ALGOL STUD, V94, P207; Lagos N, 1999, TOXICON, V37, P1359, DOI 10.1016/S0041-0101(99)00080-X; Li R, 2001, TOXICON, V39, P973, DOI 10.1016/S0041-0101(00)00236-1; Li RH, 2001, J PHYCOL, V37, P1121, DOI 10.1046/j.1529-8817.2001.01075.x; Loewe L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-125; Mazmouz R, 2010, APPL ENVIRON MICROB, V76, P4943, DOI 10.1128/AEM.00717-10; Mihali TK, 2008, APPL ENVIRON MICROB, V74, P716, DOI 10.1128/AEM.01988-07; Molica R, 2002, PHYCOLOGIA, V41, P606, DOI 10.2216/i0031-8884-41-6-606.1; Moschini-Carlos V, 2009, LIMNETICA, V28, P273; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Muenchhoff J, 2012, FEBS J, V279, P805, DOI 10.1111/j.1742-4658.2012.08472.x; Muenchhoff J, 2010, FEBS J, V277, P3844, DOI 10.1111/j.1742-4658.2010.07788.x; Neilan BA, 2003, MOL ECOL, V12, P133, DOI 10.1046/j.1365-294X.2003.01709.x; OHTANI I, 1992, J AM CHEM SOC, V114, P7941, DOI 10.1021/ja00046a067; Orr RJS, 2013, APPL ENVIRON MICROB, V79, P2128, DOI 10.1128/AEM.03279-12; Padisak J., 1997, ARCH HYDROBIOL, V107, P563; Piccini C, 2011, HARMFUL ALGAE, V10, P644, DOI 10.1016/j.hal.2011.04.016; Preussel K, 2006, TOXICON, V47, P156, DOI 10.1016/j.toxicon.2005.10.013; Saker ML, 1999, ENVIRON TOXICOL, V14, P179, DOI 10.1002/(SICI)1522-7278(199902)14:1<179::AID-TOX23>3.0.CO;2-G; Sant'Anna CL, 2000, NOVA HEDWIGIA, V71, P359; Schembri MA, 2001, ENVIRON TOXICOL, V16, P413, DOI 10.1002/tox.1051; Seenayya G, 1972, TAXONOMY BIOL BLUE G, P52; Sinha R, 2012, WATER RES, V46, P1408, DOI 10.1016/j.watres.2011.12.019; Soares MCS, 2009, AQUAT MICROB ECOL, V57, P137, DOI 10.3354/ame01336; Soto-Liebe K, 2012, TOXICON, V60, P1324, DOI 10.1016/j.toxicon.2012.09.001; Soto-Liebe K, 2010, TOXICON, V56, P1350, DOI 10.1016/j.toxicon.2010.07.022; Spoof L, 2006, ENVIRON TOXICOL, V21, P552, DOI 10.1002/tox.20216; Stucken K, 2009, SYST APPL MICROBIOL, V32, P37, DOI 10.1016/j.syapm.2008.10.002; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Stuken A, 2010, MICROBIOL-SGM, V156, P2438, DOI 10.1099/mic.0.036988-0; Su Z, 2004, J PHARMACOL EXP THER, V308, P324, DOI 10.1124/jpet.103.056564; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TERAO K, 1994, TOXICON, V32, P833, DOI 10.1016/0041-0101(94)90008-6; Tucci Andréa, 2003, Braz. J. Bot., V26, P97, DOI 10.1590/S0100-84042003000100011; van Gremberghe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019561; Wang JX, 2003, J GEN PHYSIOL, V121, P583, DOI 10.1085/jgp.200308812; Wiedner C, 2007, OECOLOGIA, V152, P473, DOI 10.1007/s00442-007-0683-5; Wood SA, 2003, NEW ZEAL J MAR FRESH, V37, P821, DOI 10.1080/00288330.2003.9517211; Wormer L, 2008, HARMFUL ALGAE, V7, P206, DOI 10.1016/j.hal.2007.07.004; Yilmaz M, 2008, TOXICON, V51, P130, DOI 10.1016/j.toxicon.2007.08.013; Yilmaz M, 2011, APPL ENVIRON MICROB, V77, P2502, DOI 10.1128/AEM.02252-10; Yunes J., 2003, COMMENTS TOXICOLOGY, V9, P103, DOI DOI 10.1080/08865140302426; Zagatto PA, 1998, TOXICITY ALGAE CYLIN, P23	85	50	54	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e74238	10.1371/journal.pone.0074238	http://dx.doi.org/10.1371/journal.pone.0074238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015317	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800112
J	Jayalekshmi, PA; Nandakumar, A; Akiba, S; Gangadharan, P; Koriyama, C				Jayalekshmi, Padmavathy Amma; Nandakumar, Athira; Akiba, Suminori; Gangadharan, Paleth; Koriyama, Chihaya			Associations of Tobacco Use and Alcohol Drinking with Laryngeal and Hypopharyngeal Cancer Risks among Men in Karunagappally, Kerala, India -Karunagappally Cohort Study	PLOS ONE			English	Article							BACKGROUND-RADIATION; SMOKING; EPIDEMIOLOGY; MUMBAI	Background: From among a cohort of 65,553 men aged 30-84 in Karunagappally Taluk, Kerala, India, 52 hypopharyngeal cancer cases and 85 laryngeal cancer cases were identified by the Karunagappally Cancer Registry during the period between 1990 and 2009. Methods: We conduct Poisson regression analysis of grouped data, taking into account age and education. Results: This study showed that the incidence rates of cancers of the hypopharynx and the larynx were strongly related to the number of bidis smoked a day (P<0.001 for both hypopharyngeal and laryngeal cancers) and duration of bidi smoking (P=0.009; P<0.001). Laryngeal cancer risk was significantly increased by bidi smoking (P<0.001), cigarette smoking (P=0.013) and regular alcohol use (P=0.005). Conclusion: The present study, the first cohort study to examine the association of hypopharyngeal and laryngeal cancer incidence rates with bidi smoking in South Asia, clearly showed dose-response relationships between those cancer risks and bidi smoking; larger amounts of bidi smoked a day and longer durations of bidi smoking increased the incidence rates of those cancers. Tobacco chewing was found not related to the risk of hypopharynx or larynx cancer.	[Jayalekshmi, Padmavathy Amma] Reg Canc Ctr, Trivandrum 695011, Kerala, India; [Jayalekshmi, Padmavathy Amma] Nat Background Radiat Canc Registry, Karunagappally, Kerala, India; [Nandakumar, Athira; Akiba, Suminori; Koriyama, Chihaya] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Gangadharan, Paleth] Amrita Inst Med Sci, Cochin, Kerala, India	Kagoshima University; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi	Akiba, S (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	akiba@m.kufm.kagoshima-u.ac.jp		Nandakumar, Athira/0000-0001-5156-7304	Ministry of Education, Culture, Sports, Science and Technology of Japan [12218231, 1701503]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Karunagappally tumor registry was supported by the Health Research Foundation, Japan (Chairman: Dr Kanji Torizuka, Professor Emeritus, Kyoto University). S. Akiba was supported by Grants-in-Aid for Scientific Research on Priority Areas of the Ministry of Education, Culture, Sports, Science and Technology of Japan (12218231 and 1701503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYLE P, 1990, J ROY SOC MED, V83, P724, DOI 10.1177/014107689008301116; Breslow N E, 1987, IARC Sci Publ, P1; Faggiano F, 1997, IARC Sci Publ, P65; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V83, P1; Jayalekshmy PA, 2008, INT J CANCER, V123, P1390, DOI 10.1002/ijc.23618; Jayaprakash P., 2008, INT J EMERG ELECT PO, V9; Menvielle G, 2004, INT J EPIDEMIOL, V33, P799, DOI 10.1093/ije/dyh090; Menvielle G, 2004, EUR J CANCER PREV, V13, P165, DOI 10.1097/01.cej.0000130017.93310.76; Nair M.K, 2002, CANC INCIDENCE 5 CON, P240; Nair MK, 1999, RADIAT RES, V152, pS145, DOI 10.2307/3580134; Nair MK, 1997, IARC SCI PUBL, VVII, p[i, 1]; Nair RRK, 2009, HEALTH PHYS, V96, P55, DOI 10.1097/01.HP.0000327646.54923.11; Rao DN, 1999, CANCER DETECT PREV, V23, P37, DOI 10.1046/j.1525-1500.1999.09906.x; Reddy KS, 2004, REPORT TOBACCO CONTR, P589; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Sapkota A, 2007, INT J CANCER, V121, P1793, DOI 10.1002/ijc.22832; TUYNS AJ, 1988, INT J CANCER, V41, P483, DOI 10.1002/ijc.2910410403	18	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73716	10.1371/journal.pone.0073716	http://dx.doi.org/10.1371/journal.pone.0073716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015309	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800104
J	Sun, YD; Liu, S; Li, W; Shan, YQ; Li, XP; Lu, XX; Li, Y; Guo, Q; Zhou, YB; Jia, JH				Sun, Yundong; Liu, Shuang; Li, Wen; Shan, Yuqun; Li, Xinpeng; Lu, Xingxiao; Li, Yan; Guo, Qing; Zhou, Yabin; Jia, Jihui			Proteomic Analysis of the Function of Sigma Factor sigma(54) in Helicobacter pylori Survival with Nutrition Deficiency Stress In Vitro	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; RPON SIGMA(54); GENE; RESISTANCE; MOTILITY; MUTANTS; SUBUNIT; PROTEIN; GROWTH	H. pylori can survive under a nutrition-deficient environment. During infection and transmission, H. pylori is confronted with nutrient limitation and the bacterium requires rapid alteration in gene expression for survival under stress conditions. However, the mechanism underlining this regulation remains unknown. A previous study showed that sigma(54) is an important regulation factor for H. pylori survival in the nutrition-deficient environment. Our results show that the expression of sigma(54) (rpoN) is significantly induced in the stationary phase (nutrition deficiency) and the rpoN mutant showed a significantly lower viability than wild-type H. pylori in the late stationary phase. Thus, sigma(54) is involved in H. pylori survival during nutrient limitation. We used comparative proteomics to analyze the protein differentiation between wild-type and rpoN mutant during the stationary phase. With depleted nutrients, sigma(54) can slow the process of proliferation by negatively regulating genes involved in energy metabolism and biosynthesis and enhance stress-resistant ability by positively regulating genes involved in protein fate and redox reaction. Especially, NapA positively regulated by sigma(54) plays an important function in H. pylori survival both in the stationary phase and in water, and the latter situation would be beneficial for bacterial in vitro transmission. Our investigations give new light on the adaptive regulation of H. pylori under stress conditions.	[Sun, Yundong; Liu, Shuang; Li, Wen; Shan, Yuqun; Li, Xinpeng; Lu, Xingxiao; Guo, Qing; Zhou, Yabin; Jia, Jihui] Shandong Univ, Dept Microbiol, Sch Med, Key Lab Expt Teratol,Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China; [Liu, Shuang] Dalian Med Univ, Affiliated Hosp 1, Clin Lab, Dalian, Liaoning, Peoples R China; [Li, Xinpeng] Dis Control & Prevent Shandong Prov, Jinan, Peoples R China; [Li, Yan] Shandong Univ, Sch Control Sci & Engn, Jinan 250100, Shandong, Peoples R China	Shandong University; Dalian Medical University; Shandong University	Sun, YD (corresponding author), Shandong Univ, Dept Microbiol, Sch Med, Key Lab Expt Teratol,Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China.	syd@sdu.edu.cn; jiajihui@sdu.edu.cn			National Natural Science Foundation of China [81071313, 30800037, 81171536, 30972775, 30971151]; Science Foundation of Shandong Province, China [ZR2009CZ001, ZR2009CM002, BS2010YY038, BS2010YY040, BS2011SW023]; National Basic Research Program of China (973 Program) [2012CB911202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Nos. 81071313, 30800037, 81171536, and 30972775, 30971151), the Science Foundation of Shandong Province, China (Nos. ZR2009CZ001, ZR2009CM002, BS2010YY038, BS2010YY040 and BS2011SW023) and the National Basic Research Program of China (973 Program 2012CB911202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada JK, 2000, MOL MICROBIOL, V36, P1071, DOI 10.1046/j.1365-2958.2000.01918.x; ALIFANO P, 1994, GENETICA, V94, P157, DOI 10.1007/BF01443430; Barnard FM, 2004, MOL MICROBIOL, V51, P15, DOI 10.1046/j.1365-2958.2003.03788.x; Beier D, 1998, MOL MICROBIOL, V30, P121, DOI 10.1046/j.1365-2958.1998.01043.x; Comtois SL, 2003, MICROBIOL-SGM, V149, P121, DOI 10.1099/mic.0.25896-0; Cooksley C, 2003, J MED MICROBIOL, V52, P461, DOI 10.1099/jmm.0.05070-0; Du XJ, 2007, MOL IMMUNOL, V44, P1085, DOI 10.1016/j.molimm.2006.07.288; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Fan XG, 1998, J GASTROEN HEPATOL, V13, P1096, DOI 10.1111/j.1440-1746.1998.tb00582.x; Fujinaga R, 2001, J Infect Chemother, V7, P148, DOI 10.1007/s101560100027; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; HELMANN JD, 1991, MOL MICROBIOL, V5, P2875, DOI 10.1111/j.1365-2958.1991.tb01847.x; Heurlier K, 2003, J BACTERIOL, V185, P2227, DOI 10.1128/JB.185.7.2227-2235.2003; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; ISHIMOTO KS, 1989, P NATL ACAD SCI USA, V86, P1954, DOI 10.1073/pnas.86.6.1954; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; KLEIN PD, 1991, LANCET, V337, P1503, DOI 10.1016/0140-6736(91)93196-G; Loughlin MF, 2003, INFECT IMMUN, V71, P2022, DOI 10.1128/IAI.71.4.2022-2031.2003; Magnusson LU, 2003, J BIOL CHEM, V278, P968, DOI 10.1074/jbc.M209881200; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Okada Y, 2006, FEMS MICROBIOL LETT, V263, P54, DOI 10.1111/j.1574-6968.2006.00405.x; Olczak AA, 2002, J BACTERIOL, V184, P3186, DOI 10.1128/JB.184.12.3186-3193.2002; REEVE CA, 1984, J BACTERIOL, V157, P758, DOI 10.1128/JB.157.3.758-763.1984; Robichon D, 1997, J BACTERIOL, V179, P7591, DOI 10.1128/jb.179.23.7591-7594.1997; SHAHAMAT M, 1993, APPL ENVIRON MICROB, V59, P1231, DOI 10.1128/AEM.59.4.1231-1235.1993; Shirai M, 1999, GENE, V239, P351, DOI 10.1016/S0378-1119(99)00389-3; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Spohn G, 2002, J BACTERIOL, V184, P2925, DOI 10.1128/JB.184.11.2925-2930.2002; Spohn G, 1999, J BACTERIOL, V181, P593, DOI 10.1128/JB.181.2.593-599.1999; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TOTTEN PA, 1990, J BACTERIOL, V172, P389, DOI 10.1128/JB.172.1.389-396.1990; Viducic D, 2007, ANTIMICROB AGENTS CH, V51, P1455, DOI 10.1128/AAC.00348-06; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003; Wolfe AJ, 2004, APPL ENVIRON MICROB, V70, P2520, DOI 10.1128/AEM.70.4.2520-2524.2004	35	8	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72920	10.1371/journal.pone.0072920	http://dx.doi.org/10.1371/journal.pone.0072920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015282	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800085
J	Ma, J; Han, HM; Liu, DR; Li, W; Feng, HX; Xue, X; Wu, XR; Niu, G; Zhang, G; Zhao, YF; Liu, CZ; Tao, H; Gao, B				Ma, Juan; Han, Huamin; Liu, Deruo; Li, Wei; Feng, Hongxiang; Xue, Xin; Wu, Xiaoran; Niu, Ge; Zhang, Ge; Zhao, Yunfeng; Liu, Changzhen; Tao, Hua; Gao, Bin			HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; TUMOR; ANTIBODY; OVEREXPRESSION; IMMUNOTHERAPY; RECEPTOR; GROWTH	Anti-HER2/neu antibody therapy has been reported to mediate tumor regression of HER2/ neu(+) tumors. Here we demonstrated the expression of HER2 in a wide range of human melanoma cells including a primary culture and seven cell lines, and we further investigated whether HER2 could be served as a target for T cell mediated immunotherapy of human melanoma. Specific cytolytic activity of activated T cells (ATC) armed with anti-CD3 x anti-HER2 bispecific antibody (HER2Bi-Ab) against Malme-3M-luc cells was evaluated by bioluminescent signal generated by luciferase reporter which did not alter HER2 expression or proliferation ability of Malme-3M cells. Contrast with unarmed ATC, increased cytotoxic activity of HER2Bi-armed ATC against Malme-3M-luc cells was observed at effector/target (E/T) ratios of 1: 1, 5: 1, and 20: 1. Moreover, HER2Bi-armed ATC expressed higher level of activation marker CD69 and secreted significantly higher level of IFN-gamma than unarmed ATC counterpart at the E/T ratio of 20: 1. In addition, compared with anti-HER2 mAb (Herceptin (R)) or unarmed ATC, HER2Bi-armed ATC showed remarkable suppression effect on Malme-3M-luc tumor cells. Furthermore, in melanoma tumor cell xenograft mice, infusion of HER2Bi-armed ATC successfully inhibited the growth of melanoma tumors. The anti-tumor effect of HER2Bi-armed ATC may provide a promising immunotherapy for melanoma in the future.	[Ma, Juan; Han, Huamin; Li, Wei; Niu, Ge; Zhang, Ge; Zhao, Yunfeng; Liu, Changzhen; Tao, Hua; Gao, Bin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Han, Huamin; Wu, Xiaoran] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Liu, Deruo; Feng, Hongxiang] China Japan Friendship Hosp, Dept Thorac Surg, Beijing, Peoples R China; [Xue, Xin] China Acad Chinese Med Sci, Dept Immunol, Beijing, Peoples R China; [Gao, Bin] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; China-Japan Friendship Hospital; China Academy of Chinese Medical Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, B (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	bgao2004@gmail.com			Ministry of Science and Technology of China [2012ZX1004701-001-002]; National Nature Science Foundation of China [31170829, 30771953, 31070783, 81021003]; Beijing Natural Science Foundation [5112022]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work is funded by the grants from the Ministry of Science and Technology of China (S & T major Program: No. 2012ZX1004701-001-002), the National Nature Science Foundation of China (No. 31170829, 30771953, 31070783, 81021003), and Beijing Natural Science Foundation (5112022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould L, 2006, BRIT J CANCER, V94, P259, DOI 10.1038/sj.bjc.6602930; Bodey B, 1997, ANTICANCER RES, V17, P1319; Brown CE, 2005, J IMMUNOL METHODS, V297, P39, DOI 10.1016/j.jim.2004.11.021; CHENEVIXTRENCH G, 1990, ONCOGENE, V5, P1187; Clay TM, 1999, J IMMUNOL, V163, P507; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Dillman RO, 2012, J IMMUNOTHER, V35, P641, DOI 10.1097/CJI.0b013e31826f79c8; EASTY DJ, 1995, INT J CANCER, V60, P129, DOI 10.1002/ijc.2910600119; Fu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011867; Gilcrease MZ, 2009, AM J SURG PATHOL, V33, P759, DOI 10.1097/PAS.0b013e31819437f9; Glisson B, 2004, CLIN CANCER RES, V10, P944, DOI 10.1158/1078-0432.CCR-03-0253; Grabert RC, 2006, CLIN CANCER RES, V12, P569, DOI 10.1158/1078-0432.CCR-05-2005; Han HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026380; Hansel DE, 2005, AM J CLIN PATHOL, V123, P28, DOI 10.1309/P3CH-DX9L-Y6H2-LY0G; Helmke BM, 2010, MELANOMA RES, V20, P431, DOI 10.1097/CMR.0b013e32833ab159; Hudis CA, 2007, NEW ENGL J MED, V357, P1665; Inman JL, 2003, J SURG ONCOL, V84, P82, DOI 10.1002/jso.10297; Jorgensen JT, 2012, J CANCER, V3, P137, DOI 10.7150/jca.4090; Kluger HM, 2004, MELANOMA RES, V14, P207, DOI 10.1097/01.cmr.0000130874.33504.2f; Ma J, 2012, EXP EYE RES, V96, P98, DOI 10.1016/j.exer.2011.12.014; Molina MA, 2001, CANCER RES, V61, P4744; Murer K, 2004, MELANOMA RES, V14, P257, DOI 10.1097/01.cmr.0000136713.21029.56; Pagni F, 2013, PATHOL ONCOL RES, V19, P103, DOI 10.1007/s12253-012-9564-2; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Patel D, 2008, ANTICANCER RES, V28, P2679; Persons DL, 2000, ANTICANCER RES, V20, P1965; Marin AP, 2010, J CANCER RES CLIN, V136, P1915, DOI 10.1007/s00432-010-0850-7; Potti Anil, 2003, J Carcinog, V2, P8, DOI 10.1186/1477-3163-2-8; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Seimetz D, 2010, CANCER TREAT REV, V36, P458, DOI 10.1016/j.ctrv.2010.03.001; Talebian F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031442; Tiffen JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-299; Ullenhag GJ, 2012, CANCER IMMUNOL IMMUN, V61, P725, DOI 10.1007/s00262-011-1182-4; Weber J, 2011, CURR OPIN ONCOL, V23, P163, DOI 10.1097/CCO.0b013e3283436e79; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478	35	16	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73261	10.1371/journal.pone.0073261	http://dx.doi.org/10.1371/journal.pone.0073261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015299	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200075
J	del Prado, A; Lazaro, JM; Villar, L; Salas, M; de Vega, M				del Prado, Alicia; Lazaro, Jose M.; Villar, Laurentino; Salas, Margarita; de Vega, Miguel			Dual Role of phi 29 DNA Polymerase Lys529 in Stabilisation of the DNA Priming-Terminus and the Terminal Protein-Priming Residue at the Polymerisation Site	PLOS ONE			English	Article							SLIDING-BACK MECHANISM; STRAND-DISPLACEMENT CAPACITY; EXONUCLEASE ACTIVE-SITE; CRYSTAL-STRUCTURE; PHAGE PHI-29; MUTATIONAL ANALYSIS; IN-VITRO; FUNCTIONAL-CHARACTERIZATION; 3'-5' EXONUCLEOLYSIS; PRIMED INITIATION	Resolution of the crystallographic structure of phi 29 DNA polymerase binary and ternary complexes showed that residue Lys529, located at the C-terminus of the palm subdomain, establishes contacts with the 3' terminal phosphodiester bond. In this paper, site-directed mutants at this Lys residue were used to analyse its functional importance for the synthetic activities of phi 29 DNA polymerase, an enzyme that starts linear phi 29 DNA replication using a terminal protein (TP) as primer. Our results show that single replacement of phi 29 DNA polymerase residue Lys529 by Ala or Glu decreases the stabilisation of the primer-terminus at the polymerisation active site, impairing both the insertion of the incoming nucleotide when DNA and TP are used as primers and the translocation step required for the next incoming nucleotide incorporation. In addition, combination of the DNA polymerase mutants with a TP derivative at residue Glu233, neighbour to the priming residue Ser232, leads us to infer a direct contact between Lys529 and Glu233 for initiation of TP-DNA replication. Altogether, the results are compatible with a sequential binding of phi 29 DNA polymerase residue Lys529 with TP and DNA during replication of TP-DNA.	[del Prado, Alicia; Lazaro, Jose M.; Villar, Laurentino; Salas, Margarita; de Vega, Miguel] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Inst Biol Mol Eladio Vinuela CSIC, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Inst Biol Mol Eladio Vinuela CSIC, Madrid, Spain.	msalas@cbm.uam.es	de Vega, Miguel/K-2878-2014; Salas, Margarita/J-9873-2014; del Prado, Alicia/K-4473-2017	de Vega, Miguel/0000-0003-1285-7549; Salas, Margarita/0000-0001-5939-3441; 	Spanish Ministry of Economy and Competitiveness [BFU2011-23645]; Spanish Ministry of Science and Innovation [Consolider-Ingenio CSD2007-00015]; Autonomous Community of Madrid [S2009MAT-1507]; Fundacion Ramon Areces	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomous Community of Madrid; Fundacion Ramon Areces	This work was supported by the Spanish Ministry of Economy and Competitiveness [grant BFU2011-23645 to M. S.], the Spanish Ministry of Science and Innovation [grant Consolider-Ingenio CSD2007-00015 to M. S.], the Autonomous Community of Madrid [grant S2009MAT-1507 to M. S.], and by an institutional grant from Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa". A.P. is a predoctoral fellow from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1985, P NATL ACAD SCI USA, V82, P6404, DOI 10.1073/pnas.82.19.6404; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Blanco L, 1995, METHOD ENZYMOL, V262, P283; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; CALDENTEY J, 1993, NUCLEIC ACIDS RES, V21, P3725, DOI 10.1093/nar/21.16.3725; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; de Vega M, 1998, J BIOL CHEM, V273, P28966, DOI 10.1074/jbc.273.44.28966; de Vega M, 1998, J MOL BIOL, V279, P807, DOI 10.1006/jmbi.1998.1805; del Prado A, 2012, NUCLEIC ACIDS RES, V40, P3886, DOI 10.1093/nar/gkr1283; deVega M, 1996, EMBO J, V15, P1182, DOI 10.1002/j.1460-2075.1996.tb00457.x; Dufour E, 2003, J MOL BIOL, V331, P781, DOI 10.1016/S0022-2836(03)00788-5; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Illana B, 1996, J MOL BIOL, V264, P453, DOI 10.1006/jmbi.1996.0653; Kamtekar S, 2006, EMBO J, V25, P1335, DOI 10.1038/sj.emboj.7601027; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; KING AJ, 1994, EMBO J, V13, P5786, DOI 10.1002/j.1460-2075.1994.tb06917.x; Kumar JK, 2004, J BIOL CHEM, V279, P42018, DOI 10.1074/jbc.M406103200; Lazaro JM, 1995, METHOD ENZYMOL, V262, P42; Longas E, 2006, NUCLEIC ACIDS RES, V34, P6051, DOI 10.1093/nar/gkl769; Longas E, 2008, P NATL ACAD SCI USA, V105, P18290, DOI 10.1073/pnas.0809882105; Martin AC, 1996, J MOL BIOL, V260, P369, DOI 10.1006/jmbi.1996.0407; MCDONELL MW, 1977, J MOL BIOL, V110, P119, DOI 10.1016/S0022-2836(77)80102-2; Mencia M, 2011, P NATL ACAD SCI USA, V108, P18655, DOI 10.1073/pnas.1114397108; Mendez J, 1997, EMBO J, V16, P2519, DOI 10.1093/emboj/16.9.2519; MENDEZ J, 1994, J BIOL CHEM, V269, P30030; MENDEZ J, 1992, P NATL ACAD SCI USA, V89, P9579, DOI 10.1073/pnas.89.20.9579; Munoz-Espin D, 2010, P NATL ACAD SCI USA, V107, P16548, DOI 10.1073/pnas.1010530107; Perez-Arnaiz P, 2007, NUCLEIC ACIDS RES, V35, P7061, DOI 10.1093/nar/gkm749; Perez-Arnaiz P, 2006, NUCLEIC ACIDS RES, V34, P3107, DOI 10.1093/nar/gkl402; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Rodriguez I, 2005, P NATL ACAD SCI USA, V102, P6407, DOI 10.1073/pnas.0500597102; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; Salas M, 1999, GENET ENG P, V21, P159; Salas M, 1996, MECH PRIMING DNA SYN, P131; Truniger V, 1996, EMBO J, V15, P3430, DOI 10.1002/j.1460-2075.1996.tb00709.x; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Zhao YX, 1999, STRUCTURE, V7, P1189, DOI 10.1016/S0969-2126(00)80053-2	39	5	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72765	10.1371/journal.pone.0072765	http://dx.doi.org/10.1371/journal.pone.0072765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023769	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600041
J	Somers, JM; Rezansoff, SN; Moniruzzaman, A; Palepu, A; Patterson, M				Somers, Julian M.; Rezansoff, Stefanie N.; Moniruzzaman, Akm; Palepu, Anita; Patterson, Michelle			Housing First Reduces Re-offending among Formerly Homeless Adults with Mental Disorders: Results of a Randomized Controlled Trial	PLOS ONE			English	Article							ASSERTIVE COMMUNITY TREATMENT; CRIMINAL-JUSTICE SETTINGS; NEW-YORK-CITY; PSYCHIATRIC DISABILITIES; HEALTH-CARE; ILLNESS; INDIVIDUALS; RECIDIVISM; HISTORIES; PATTERNS	Background: Homelessness and mental illness have a strong association with public disorder and criminality. Experimental evidence indicates that Housing First (HF) increases housing stability and perceived choice among those experiencing chronic homelessness and mental disorders. HF is also associated with lower residential costs than common alternative approaches. Few studies have examined the effect of HF on criminal behavior. Methods: Individuals meeting criteria for homelessness and a current mental disorder were randomized to one of three conditions treatment as usual (reference); scattered site HF; and congregate HF. Administrative data concerning justice system events were linked in order to study prior histories of offending and to test the relationship between housing status and offending following randomization for up to two years. Results: The majority of the sample (67%) was involved with the justice system, with a mean of 8.07 convictions per person in the ten years prior to recruitment. The most common category of crime was "property offences" (mean = 4.09). Following randomization, the scattered site HF condition was associated with significantly lower numbers of sentences than treatment as usual (Adjusted IRR = 0.29; 95% CI 0.12-0.72). Congregate HF was associated with a marginally significant reduction in sentences compared to treatment as usual (Adjusted IRR = 0.55; 95% CI: 0.26-1.14). Conclusions: This study is the first randomized controlled trial to demonstrate benefits of HF among a homeless sample with mental illness in the domain of public safety and crime. Our sample was frequently involved with the justice system, with great personal and societal costs. Further implementation of HF is strongly indicated, particularly in the scattered site format. Research examining interdependencies between housing, health, and the justice system is indicated. registration:	[Somers, Julian M.; Rezansoff, Stefanie N.; Moniruzzaman, Akm; Patterson, Michelle] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Palepu, Anita] Univ British Columbia, Fac Med, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia	Somers, JM (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	jsomers@sfu.ca			Health Canada	Health Canada	This research is supported by a grant to Simon Fraser University, made possible through a financial contribution from Health Canada to the Mental Health Commission of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair CE, 2012, J URBAN HEALTH, V89, P36, DOI 10.1007/s11524-011-9632-z; Bahr H. M., 1973, SKID ROW INTRO DISAF; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; BARKER S, 1994, COMMUNITY MENT HLT J, V30, P363, DOI 10.1007/BF02207489; Bonta J, 1996, CAN J CRIMINOL, V38, P61, DOI 10.3138/cjcrim.38.1.61; Calsyn Robert J, 2005, Crim Behav Ment Health, V15, P236, DOI 10.1002/cbm.24; Clifasefi SL, 2012, INT J DRUG POLICY; Culhane DP, 1998, J POLICY ANAL MANAG, V17, P23, DOI 10.1002/(SICI)1520-6688(199824)17:1<23::AID-PAM2>3.0.CO;2-J; Culhane DP, 1992, PSYCHOSOC REHABIL, V16, P63; Culhane DP, 2008, EUROPEAN J HOMELESSN, V2, P97; Epperson M.W., 2011, NEXT GENERATION BEHA; Fazel S., 2012, British Journal of Psychiatry, V200, P364, DOI 10.1192/bjp.bp.111.096370; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fischer SN, 2008, AM J COMMUN PSYCHOL, V42, P251, DOI 10.1007/s10464-008-9210-z; Fisher WH, 2007, COMMUNITY MENT HLT J, V43, P545, DOI 10.1007/s10597-007-9094-7; Greenberg GA, 2008, PSYCHIAT SERV, V59, P170, DOI 10.1176/ps.2008.59.2.170; Greenwood RM, 2005, AM J COMMUN PSYCHOL, V36, P223, DOI 10.1007/s10464-005-8617-z; Gulcur L, 2003, J COMMUNITY APPL SOC, V13, P171, DOI 10.1002/casp.723; Haimowitz S, 2004, PSYCHIAT SERV, V55, P373, DOI 10.1176/appi.ps.55.4.373; Hanratty M, 2011, HOUS POLICY DEBATE, V21, P405, DOI 10.1080/10511482.2011.594076; Kertesz SG, 2009, MILBANK Q, V87, P495, DOI 10.1111/j.1468-0009.2009.00565.x; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Ludwig J, 2012, SCIENCE, V337, P1505, DOI 10.1126/science.1224648; MCCARTHY B, 1991, BRIT J CRIMINOL, V31, P393, DOI 10.1093/oxfordjournals.bjc.a048137; Metraux S, 2010, J COMMUNITY PSYCHOL, V38, P28, DOI 10.1002/jcop.20349; MICHAELS D, 1992, HOSP COMMUNITY PSYCH, V43, P150; Morrissey J, 2007, COMMUNITY MENT HLT J, V43, P527, DOI 10.1007/s10597-007-9092-9; Padgett DK, 2011, COMMUNITY MENT HLT J, V47, P227, DOI 10.1007/s10597-009-9283-7; Padgett DK, 2006, RES SOCIAL WORK PRAC, V16, P74, DOI 10.1177/1049731505282593; Patterson M, 2012, J INTERPROF CARE, V26, P426, DOI 10.3109/13561820.2012.686537; Pleace Nicholas, 2011, EUROPEAN J HOMELESSN, V5, P113; Ross S, 2012, PSYCHIAT PSYCHOL LAW, V19, P75, DOI 10.1080/13218719.2010.543407; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Skeem JL, 2011, LAW HUMAN BEHAV, V35, P110, DOI 10.1007/s10979-010-9223-7; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stefancic A, 2004, EVAL PROGRAM PLANN, V27, P433, DOI 10.1016/j.evalprogplan.2004.07.006; Tabol C, 2010, EVAL PROGRAM PLANN, V33, P446, DOI 10.1016/j.evalprogplan.2009.12.002; Tsemberis S, 2004, AM J PUBLIC HEALTH, V94, P651, DOI 10.2105/AJPH.94.4.651; Tsemberis S, 2000, PSYCHIATR SERV, V51, P487, DOI 10.1176/appi.ps.51.4.487; Tsemberis S, 2010, HOW TO HOUSE THE HOMELESS, P37; Tsemberis SJ, 2003, AM J COMMUN PSYCHOL, V32, P305, DOI 10.1023/B:AJCP.0000004750.66957.bf; Ward T, 2003, PSYCHOL CRIME LAW, V9, P125, DOI 10.1080/1068316031000116247; Zabkiewicz D, 2012, J CLIN TRIALS, V2, P123; Zapf PA, 1996, CAN J PSYCHIAT, V41, P435, DOI 10.1177/070674379604100708	44	49	49	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72946	10.1371/journal.pone.0072946	http://dx.doi.org/10.1371/journal.pone.0072946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023796	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600054
J	Carre, C; Jacquier, C; Bouge, AL; de Chaumont, F; Besnard-Guerin, C; Thomassin, H; Pidoux, J; Da Silva, B; Chalatsi, E; Zahra, S; Olivo-Marin, JC; Munier-Lehmann, H; Antoniewski, C				Carre, Clement; Jacquier, Caroline; Bouge, Anne-Laure; de Chaumont, Fabrice; Besnard-Guerin, Corinne; Thomassin, Helene; Pidoux, Josette; Da Silva, Bruno; Chalatsi, Eleftheria; Zahra, Sarah; Olivo-Marin, Jean-Christophe; Munier-Lehmann, Helene; Antoniewski, Christophe			AutomiG, a Biosensor to Detect Alterations in miRNA Biogenesis and in Small RNA Silencing Guided by Perfect Target Complementarity	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; ENDOGENOUS SIRNA PATHWAY; DROSOPHILA-MELANOGASTER; DISTINCT ROLES; SOMATIC-CELLS; STEM-CELLS; MICRORNAS; INTERFERENCE; ARGONAUTE-2; MECHANISMS	Defects in miRNA biogenesis or activity are associated to development abnormalities and diseases. In Drosophila, miRNAs are predominantly loaded in Argonaute-1, which they guide for silencing of target RNAs. The miRNA pathway overlaps the RNAi pathway in this organism, as miRNAs may also associate with Argonaute-2, the mediator of RNAi. We set up a gene construct in which a single inducible promoter directs the expression of the GFP protein as well as two miRNAs perfectly matching the GFP sequences. We show that self-silencing of the resulting automiG gene requires Drosha, Pasha, Dicer-1, Dicer-2 and Argonaute-2 loaded with the anti-GFP miRNAs. In contrast, self-silencing of the automiG gene does not involve Argonaute-1. Thus, automiG reports in vivo for both miRNA biogenesis and Ago-2 mediated silencing, providing a powerful biosensor to identify situations where miRNA or siRNA pathways are impaired. As a proof of concept, we used automiG as a biosensor to screen a chemical library and identified 29 molecules that strongly inhibit miRNA silencing, out of which 5 also inhibit RNAi triggered by long double-stranded RNA. Finally, the automiG sensor is also self-silenced by the anti-GFP miRNAs in HeLa cells and might be easily used to identify factors involved in miRNA biogenesis and silencing guided by perfect target complementarity in mammals.	[Carre, Clement; Thomassin, Helene; Da Silva, Bruno; Chalatsi, Eleftheria; Zahra, Sarah; Antoniewski, Christophe] Univ Paris 06, Dev Biol Lab, CNRS UMR7622, Paris, France; [Jacquier, Caroline; Bouge, Anne-Laure; de Chaumont, Fabrice; Besnard-Guerin, Corinne; Thomassin, Helene; Pidoux, Josette; Olivo-Marin, Jean-Christophe; Antoniewski, Christophe] Inst Pasteur, Paris, France; [Jacquier, Caroline] Inst Human Genet, Montpellier, France; [Bouge, Anne-Laure] Inst Human Genet, mRNA Regulat & Dev, Montpellier, France; [Besnard-Guerin, Corinne] Fac Med Cochin, Inserm CNRS UMR 8104 U1016, Paris, France; [Munier-Lehmann, Helene] Inst Pasteur, Unite Chim & Biocatalyse, Dept Biol Struct & Chim, Paris, France; [Munier-Lehmann, Helene] CNRS, UMR3523, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Antoniewski, C (corresponding author), Univ Paris 06, Dev Biol Lab, CNRS UMR7622, Paris, France.	christophe.antoniewski@upmc.fr	Munier-Lehmann, Hélène/Q-1867-2019; Olivo-Marin, Jean-Christophe/K-4428-2015; Besnard-Guerin, Corinne/J-3985-2017; Antoniewski, Christophe/G-4519-2011; Munier-Lehmann, Helene/N-9889-2017	Munier-Lehmann, Hélène/0000-0001-7579-8561; Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Antoniewski, Christophe/0000-0001-7709-2116; Munier-Lehmann, Helene/0000-0001-7579-8561; THOMASSIN, Helene/0000-0003-4613-5587; de Chaumont, Fabrice/0000-0001-7613-7204	Institut Pasteur; Centre National de la Recherche Scientifique; University Pierre et Marie Curie; Institut National de la Sante et de la Recherche Medicale; Region Ile-de-France [Chemical Library Project] [I 06-222/R, I 09-1739/R]; Agence Nationale de la Recherche [ANR BLAN 1210 01]	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Pierre et Marie Curie; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Ile-de-France [Chemical Library Project](Region Ile-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Institut Pasteur, the Centre National de la Recherche Scientifique, the University Pierre et Marie Curie, the Institut National de la Sante et de la Recherche Medicale, the Region Ile-de-France [Chemical Library Project grants numbers I 06-222/R, I 09-1739/R] and the Agence Nationale de la Recherche [grant number ANR BLAN 1210 01 "nuclear endosiRNA"] to CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Chaturvedi A, 2001, J CLASSIF, V18, P35, DOI 10.1007/s00357-001-0004-3; Chou YT, 2007, FLY, V1, P311, DOI 10.4161/fly.5606; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Connelly CM, 2012, J BIOMOL SCREEN, V17, P822, DOI 10.1177/1087057112439606; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Davies BP, 2008, BIOORGAN MED CHEM, V16, P49, DOI 10.1016/j.bmc.2007.04.055; Davies BP, 2006, ANGEW CHEM INT EDIT, V45, P5550, DOI 10.1002/anie.200601332; Deiters A, 2010, AAPS J, V12, P51, DOI 10.1208/s12248-009-9159-3; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Fagegaltier D, 2009, P NATL ACAD SCI USA, V106, P21258, DOI 10.1073/pnas.0809208105; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gumireddy K, 2008, ANGEW CHEM INT EDIT, V47, P7482, DOI 10.1002/anie.200801555; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Huang ZX, 1998, DATA MIN KNOWL DISC, V2, P283, DOI 10.1023/A:1009769707641; Jouneau A, 2012, RNA, V18, P253, DOI 10.1261/rna.028878.111; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Nishida KM, 2013, MOL CELL, V49, P680, DOI 10.1016/j.molcel.2012.12.024; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Willett P., 1987, SIMILARITY CLUSTERIN; Young DD, 2010, J AM CHEM SOC, V132, P7976, DOI 10.1021/ja910275u; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018	48	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74296	10.1371/journal.pone.0074296	http://dx.doi.org/10.1371/journal.pone.0074296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019960	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200103
J	Dai, DW; Yuan, Q; Sun, YF; Yuan, F; Su, ZP; Ding, J; Tian, HL				Dai, Dawei; Yuan, Qiang; Sun, Yinfeng; Yuan, Fang; Su, Zuopeng; Ding, Jun; Tian, Hengli			Impact of Thoracic Injury on Traumatic Brain Injury Outcome	PLOS ONE			English	Article							PULMONARY CONTUSION; HEAD-INJURY; COMPUTED-TOMOGRAPHY; SECONDARY INSULTS; RISK	Background: To assessed the significance of thoracic injury on the 30-day mortality and outcome of traumatic brain injury (TBI). Methods: TBI patients admitted to our department were retrospectively evaluated. We developed two prognostic models based on admission predictors with logistic regression analysis to assess the significance of thoracic injuries in determining the 30-day mortality and outcome. The internal validity of the models was evaluated with the bootstrap re-sampling technique. We also validated the models in an external series of 165 patients that collected from our center. Discriminative ability was evaluated with C statistic. Calibrative ability was assessed with the Hosmer-Lemeshow test (H-L test). Results: Among 505 TBI patients admitted, 102 (20.2%) had thoracic injuries. Patients with a PCS >= 6 had a 3.142 and 8.065 times higher odds of mortality and poor outcome compared with patients with a PCS <6, respectively. Any one-score increase of the TTS had a 1.193 times higher odds of a poor outcome (p = 0.017). The predictive model for mortality and 30-day functional outcome both had good accuracy (AUC: 0.875; 95% confidence interval [CI], 0.841-0.910 and AUC: 0.888; 95% CI, 0.860-0.916, respectively). Internal validation showed no over optimism in any of the two models' predictive C statistics (C statistic 0.872 for 30-day mortality and C statistic 0.884 for the 30-day neurological outcome). The external validation confirmed the discriminatory ability of these models (C statistic 0.949 (95% CI: 0.919-0.980) for 30-day mortality and C statistic 0.915 (95% CI: 0.868-0.963) for the 30-day neurological outcome). The calibration was also good for patients from the validation population (H-L test p>0.05). Conclusion: Thoracic injury diagnosed by CT has a negative impact on the 30-day mortality and functional outcome of TBI patients. The extent of PC and the TTS are the predictors for TBI outcome.	[Dai, Dawei; Yuan, Qiang; Yuan, Fang; Su, Zuopeng; Ding, Jun; Tian, Hengli] Shanghai Jiao Tong Univ, Dept Neurosurg, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Sun, Yinfeng] Shanghai Jiao Tong Univ, Dept Hyperbar Oxygen, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ding, J (corresponding author), Shanghai Jiao Tong Univ, Dept Neurosurg, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China.	djdjdoc@126.com; tianhlsh@126.com			National Nature and Science Foundation of China [81271383]; Shanghai Science and Technique Committee [13411951400, 13411951401, 10JC1412500]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technique Committee	Grant support was provided by National Nature and Science Foundation of China (grant No. 81271383) and the Shanghai Science and Technique Committee (grant No. 13411951400, 13411951401 and 10JC1412500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese J, 2001, YB INTENSIVE CARE EM, P353; Allen GS, 1996, AM SURGEON, V62, P895; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Gayzik FS, 2007, STAPP CAR CRASH JO, V51, P189; Hamrick MC, 2009, AM SURGEON, V75, P1054; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; JOHNSON JA, 1986, J TRAUMA, V26, P695, DOI 10.1097/00005373-198608000-00002; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Leone M, 2003, CHEST, V124, P2261, DOI 10.1378/chest.124.6.2261; Leone M, 2002, ANN FR ANESTH, V21, P50, DOI 10.1016/S0750-7658(01)00550-0; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Miller PR, 2001, J TRAUMA, V51, P223, DOI 10.1097/00005373-200108000-00003; Orliaguet C, 2000, ANN FR ANESTH, V19, P164; Pape HC, 2000, J TRAUMA, V49, P496, DOI 10.1097/00005373-200009000-00018; PFENNINGER EG, 1991, ACTA ANAESTH SCAND, V35, P148, DOI 10.1111/j.1399-6576.1991.tb03263.x; Plurad D, 2007, J TRAUMA, V62, P631, DOI 10.1097/TA.0b013e31802bf009; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Steyerberg E., 2009, CLIN PREDICTION MODE; Tyburski JG, 1999, J TRAUMA, V46, P833, DOI 10.1097/00005373-199905000-00011; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac	24	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74204	10.1371/journal.pone.0074204	http://dx.doi.org/10.1371/journal.pone.0074204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019957	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200100
J	Fonseca-Pedrero, E; Menendez, LF; Paino, M; Lemos-Giraldez, S; Muniz, J				Fonseca-Pedrero, Eduardo; Fernando Menendez, Luis; Paino, Mercedes; Lemos-Giraldez, Serafin; Muniz, Jose			Development of a Computerized Adaptive Test for Schizotypy Assessment	PLOS ONE			English	Article							PERSONALITY QUESTIONNAIRE-BRIEF; ITEM RESPONSE THEORY; PSYCHOTIC SYMPTOMS; VALIDATION; RELIABILITY; INVARIANCE; SPANISH; SCALES	Background: Schizotypal traits in adolescents from the general population represent the behavioral expression of liability for psychotic disorders. Schizotypy assessment in this sector of population has advanced considerably in the last few years; however, it is necessary to incorporate recent advances in psychological and educational measurement. Objective: The main goal of this study was to develop a Computerized Adaptive Test (CAT) to evaluate schizotypy through "The Oviedo Questionnaire for Schizotypy Assessment" (ESQUIZO-Q), in non-clinical adolescents. Methods: The final sample consisted of 3,056 participants, 1,469 males, with a mean age of 15.9 years (SD = 1.2). Results: The results indicated that the ESQUIZO-Q scores presented adequate psychometric properties under both Classical Test Theory and Item Response Theory. The Information Function estimated using the Gradual Response Model indicated that the item pool effectively assesses schizotypy at the high end of the latent trait. The correlation between the CAT total scores and the paper-and-pencil test was 0.92. The mean number of presented items in the CAT with the standard error fixed at <= 0.30 was of 34 items. Conclusion: The CAT showed adequate psychometric properties for schizotypy assessment in the general adolescent population. The ESQUIZO-Q adaptive version could be used as a screening method for the detection of adolescents at risk for psychosis in both educational and mental health settings.	[Fonseca-Pedrero, Eduardo] Univ La Rioja, Dept Educ Sci, La Rioja, Spain; [Fernando Menendez, Luis; Paino, Mercedes; Lemos-Giraldez, Serafin; Muniz, Jose] Univ Oviedo, Dept Psychol, Oviedo, Spain; [Fonseca-Pedrero, Eduardo; Paino, Mercedes; Lemos-Giraldez, Serafin; Muniz, Jose] Ctr Biomed Res Mental Hlth Network CIBERSAM, Madrid, Spain	Universidad de La Rioja; University of Oviedo; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Fonseca-Pedrero, E (corresponding author), Univ La Rioja, Dept Educ Sci, La Rioja, Spain.	eduardo.fonseca@unirioja.es	Fonseca, Eduardo/L-4848-2019; Paino, Mercedes/I-3659-2015; Muñiz, José/AAI-4863-2021; Fonseca-Pedrero, Eduardo/C-4171-2011	Paino, Mercedes/0000-0002-2913-0322; Fonseca-Pedrero, Eduardo/0000-0001-7453-5225	Spanish Ministry of Science and Innovation (MICINN); Instituto Carlos III, Center for Biomedical Research in the Mental Health Network (CIBERSAM) [PSI 2011-28638, PSI 2011-23818]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto Carlos III, Center for Biomedical Research in the Mental Health Network (CIBERSAM)	This research was funded by the Spanish Ministry of Science and Innovation (MICINN) and by the Instituto Carlos III, Center for Biomedical Research in the Mental Health Network (CIBERSAM). Project references: PSI 2011-28638 and PSI 2011-23818. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anatchkova MD, 2009, J PAIN, V10, P932, DOI 10.1016/j.jpain.2009.03.007; Bartram D, 2006, COMPUTERIZED ADAPTIV; Birnbaum A, 1968, SOME LATENT TRAIT MO; Brennan RL, 2006, ED MEASUREMENT; Chapman J. P., 1995, SCHIZOTYPAL PERSONAL, P79, DOI DOI 10.1017/CBO9780511759031.006; De Ayala R.J., 2009, THEORY PRACTICE ITEM; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Edelen MO, 2007, QUAL LIFE RES, V16, P5, DOI 10.1007/s11136-007-9198-0; Fonseca-Pedrero E., 2010, ANSIEDAD ESTRES, V16, P215; Fonseca-Pedrero E, 2008, INT J CLIN HLTH PSYC, V8, P577; Fonseca-Pedrero E, 2013, PSICOTHEMA, V25, P171, DOI 10.7334/psicothema2012.74; Fonseca-Pedrero E, 2011, PSYCHIAT RES, V190, P309, DOI 10.1016/j.psychres.2011.05.021; Fonseca-Pedrero E, 2011, INT J CLIN HLTH PSYC, V11, P385; Fonseca-Pedrero E, 2011, PSICOTHEMA, V23, P87; Fonseca-Pedrero E, 2009, SCHIZOPHR RES, V111, P53, DOI 10.1016/j.schres.2009.03.006; Forbey JD, 2007, PSYCHOL ASSESSMENT, V19, P14, DOI 10.1037/1040-3590.19.1.14; Gooding DC, 2005, J ABNORM PSYCHOL, V114, P170, DOI 10.1037/0021-843X.114.1.170; Hambleton R. K., 1991, FUNDAMENTALS ITEM RE; Hambleton RK, 2004, PSICOTHEMA, V16, P696; Jiao H, 2012, EDUC PSYCHOL MEAS, V72, P493, DOI 10.1177/0013164411422903; Abad FJ, 2010, PSICOTHEMA, V22, P340; Kaymaz N, 2012, PSYCHOL MED, V20, P1; Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005; Kelleher I, 2011, SCHIZOPHRENIA BULL, V37, P362, DOI 10.1093/schbul/sbp057; Kim Y, 2013, PSYCHIAT RES, V207, P189, DOI 10.1016/j.psychres.2012.09.002; Kwapil TR, 2008, SCHIZOPHRENIA BULL, V34, P444, DOI 10.1093/schbul/sbm098; Kwapil TR, 2012, J PSYCHOPATHOL BEHAV, V34, P145, DOI 10.1007/s10862-011-9258-1; Kwapil TR, OXFORD HDB PERSONALI; Lenzenweger M.F., 2010, SCHIZOTYPY SCHIZOPHR; LENZENWEGER MF, 1994, SCHIZOPHRENIA BULL, V20, P121, DOI 10.1093/schbul/20.1.121; Linscott R.J., PSYCHOL MED IN PRESS; Markon KE, 2011, PSYCHOL BULL, V137, P856, DOI 10.1037/a0023678; McGorry PD, 2008, WORLD PSYCHIATRY, V7, P148; MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029; Muraki E, 1996, PARSCALE IRT BASED T; Olea J, 2010, PAPEL PSICOL, V31, P97; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Raine A, 2006, ANNU REV CLIN PSYCHO, V2, P291, DOI 10.1146/annurev.clinpsy.2.022305.095318; RAWLINGS D, 1994, PERS INDIV DIFFER, V17, P489, DOI 10.1016/0191-8869(94)90086-8; Rebollo P, 2010, MED CLIN, V133, P241; Rebollo P, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-147; Samejima F, 1969, PSYCHOMETRIK MONOGRA, V17; Smits N, 2011, PSYCHIAT RES, V188, P147, DOI 10.1016/j.psychres.2010.12.001; Statistical Package for the Social Sciences, 2006, SPSS BAS 15 0 US GUI; Thissen D, 1991, MULTILOG MULTIPLE CA; Van der Linden W.J., 1997, HDB MODERN ITEM RESP; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; VanderLinden WJ, 2010, STAT SOC BEHAV SC, P1; Wainer H, 2000, COMPUTERIZED ADAPTIV, DOI DOI 10.4324/9781410605931; Walker E, 2002, SCHIZOPHR RES, V54, P17, DOI 10.1016/S0920-9964(01)00347-4; Walter OB, 2010, ELEMENTS ADAPTATIVE, P123; Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760; Werbeloff N, 2012, ARCH GEN PSYCHIAT, V69, P467, DOI 10.1001/archgenpsychiatry.2011.1580; Winterstein BP, 2011, J PSYCHOPATHOL BEHAV, V33, P480, DOI 10.1007/s10862-011-9242-9; Yung AR, 2007, INT REV PSYCHIATR, V19, P633, DOI 10.1080/09540260701797803; Zumbo BD, 2007, J MOD APPL STAT METH, V6, P21, DOI 10.22237/jmasm/1177992180	58	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73201	10.1371/journal.pone.0073201	http://dx.doi.org/10.1371/journal.pone.0073201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019907	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200049
J	Gong, X; Westcott, S; Zhang, XQ; Yan, GJ; Lance, R; Zhang, GP; Sun, DF; Li, CD				Gong, Xue; Westcott, Sharon; Zhang, Xiao-Qi; Yan, Guijun; Lance, Reg; Zhang, Guoping; Sun, Dongfa; Li, Chengdao			Discovery of Novel Bmy1 Alleles Increasing beta-Amylase Activity in Chinese Landraces and Tibetan Wild Barley for Improvement of Malting Quality via MAS	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENETIC DIVERSITY; DIASTATIC POWER; THERMOSTABILITY; SELECTION	China has a large barley germplasm collection which has not been well characterized and is therefore underutilized. The Bmy1 locus encoding the beta-amylase enzyme on chromosome 4H has been well characterized in the worldwide barley germplasm collections due to its importance in the malting and brewing industry. The Bmy1 locus was chosen as an indicator to understand genetic potential for improvement of malting quality in Chinese landraces and Tibetan wild barley. The genetic diversity of 91 barley accessions was assessed using allele specific Multiplex-ready molecular markers. Eight accessions were further sequenced, based on the Multiplex-ready marker diversity for Bmy1 in the germplasm. Six of the eight accessions clustered together in a unique group, and showed similarities to 'Haruna Nijo', wild barley accession PI296896 and 'Ashqelon'. Sequence comparisons with the known Bmy1 alleles identified not only the existing 13 amino acid substitutions, but also a new substitution positioned at A387T from a Chinese landrace W127, which has the highest beta-amylase activity. Two new alleles/haplotypes namely Bmy1-Sd1c and Bmy1-Sd5 were designated based on different amino acid combinations. We identified new amino acid combination of C115, D165, V233, S347 and V430 in the germplasm. The broad variation in both beta-amylase activity and amino acid composition provides novel alleles for the improvement of malting quality for different brewing styles, which indicates the high potential value of the Chinese landraces and Tibetan wild barley.	[Gong, Xue; Sun, Dongfa] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Gong, Xue; Westcott, Sharon; Lance, Reg; Li, Chengdao] Dept Agr & Food Western Australia, Perth, WA, Australia; [Westcott, Sharon; Zhang, Xiao-Qi; Li, Chengdao] Murdoch Univ, Western Australia State Agr Biotechnol Ctr, Perth, WA, Australia; [Gong, Xue; Yan, Guijun] Univ Western Australia, Sch Plant Biol, Fac Nat & Agr Sci, Perth, WA 6009, Australia; [Zhang, Guoping] Zhejiang Univ, Fac Agr Life & Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China	Huazhong Agricultural University; Murdoch University; University of Western Australia; Zhejiang University	Sun, DF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	sundongfa@mail.hzau.edu.cn; chengdao.li@agric.wa.gov.au	Yan, Guijun/A-9809-2011	Yan, Guijun/0000-0001-9628-1211	Australian Grain Research and Development Corporation fund; Natural Science Foundation of China	Australian Grain Research and Development Corporation fund(Grains R&D Corp); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Australian Grain Research and Development Corporation fund to CL and Natural Science Foundation of China to DS and PZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahokas H, 2000, HEREDITAS, V132, P111, DOI 10.1111/j.1601-5223.2000.00111.x; Chiapparino E, 2006, MOL BREEDING, V18, P341, DOI 10.1007/s11032-006-9035-0; Clark SE, 2003, PLANT PHYSIOL BIOCH, V41, P798, DOI 10.1016/S0981-9428(03)00118-9; Coventry SJ, 2003, AUST J AGR RES, V54, P1241, DOI 10.1071/AR02193; Eglinton JK, 1998, J CEREAL SCI, V28, P301, DOI 10.1016/S0733-5210(98)90010-8; Erkkila MJ, 1998, PLANT PHYSIOL, V117, P679, DOI 10.1104/pp.117.2.679; Erkkila MJ, 1999, PLANT MOL BIOL REP, V17, P139, DOI 10.1023/A:1007595821379; Erkkila MJ, 2001, HEREDITAS, V134, P91, DOI 10.1111/j.1601-5223.2001.00091.x; Evans DE, 2009, ADV TOP SCI TECH CHI, P143, DOI 10.1007/978-3-642-01279-2_6; Filichkin TP, 2010, CROP SCI, V50, P826, DOI 10.2135/cropsci2009.04.0231; Fox GP, 2009, ADV TOP SCI TECH CHI, P63, DOI 10.1007/978-3-642-01279-2_3; Gong X, 2009, GENOME, V52, P849, DOI [10.1139/G09-058, 10.1139/g09-058]; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hayden MJ, 2008, MOL BREEDING, V21, P271, DOI 10.1007/s11032-007-9127-5; Hayes PM, 2003, DEV PL GEN, V7, P201, DOI 10.1016/S0168-7972(03)80012-9; Li CD, 2002, J CEREAL SCI, V35, P39, DOI 10.1006/jcrs.2001.0398; Ma YF, 2001, MOL GENET GENOMICS, V266, P345, DOI 10.1007/s004380100566; Malysheva-Otto LV, 2006, MOL BREEDING, V18, P143, DOI 10.1007/s11032-006-9023-4; MCCLEARY BV, 1989, J CEREAL SCI, V9, P17, DOI [10.1016/S0733-5210(89)80018-9, 10.1006/jcrs.1998.0224]; Paris M, 2002, PLANT MOL BIOL REP, V20, P149, DOI 10.1007/BF02799430; Sjakste TG, 2006, THEOR APPL GENET, V113, P1063, DOI 10.1007/s00122-006-0366-3; Vinje MA, 2011, PLANT PHYSIOL BIOCH, V49, P39, DOI 10.1016/j.plaphy.2010.09.019; Vinje MA, 2010, PLANT MOL BIOL REP, V28, P491, DOI 10.1007/s11105-009-0168-2; Wei K, 2009, J I BREWING, V115, P208, DOI 10.1002/j.2050-0416.2009.tb00370.x; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Zhang WS, 2007, THEOR APPL GENET, V114, P1039, DOI 10.1007/s00122-006-0497-6	26	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72875	10.1371/journal.pone.0072875	http://dx.doi.org/10.1371/journal.pone.0072875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019884	Green Published, gold			2022-12-27	WOS:000324338200026
J	Gonzalez, JC; Medina, SC; Rodriguez, A; Osma, JF; Almeciga-Diaz, CJ; Sanchez, OF				Gonzalez, Juan C.; Medina, Sandra C.; Rodriguez, Alexander; Osma, Johann F.; Almeciga-Diaz, Carlos J.; Sanchez, Oscar F.			Production of Trametes pubescens Laccase under Submerged and Semi-Solid Culture Conditions on Agro-Industrial Wastes	PLOS ONE			English	Article							WHITE-ROT FUNGI; SOLID-STATE FERMENTATION; PLEUROTUS-OSTREATUS; COFFEE PULP; LIGNINOLYTIC ENZYMES; PRESSURE COOKING; WOOD SAWDUST; PEROXIDASE; VERSICOLOR; COPPER	Laccases are copper-containing enzymes involved in the degradation of lignocellulosic materials and used in the treatment of phenol-containing wastewater. In this study we investigated the effect of culture conditions, i.e. submerged or semi-solid, and copper supplementation on laccase production by Trametes pubescens grown on coffee husk, soybean pod husk, or cedar sawdust. The highest specific laccase activity was achieved when the culture was conducted under submerged conditions supplemented with copper (5 mM), and using coffee husk as substrate. The crude extracts presented two laccase isoforms with molecular mass of 120 (Lac1) and 60 kDa (Lac2). Regardless of the substrate, enzymatic crude extract and purified fractions behaved similarly at different temperatures and pHs, most of them presented the maximum activity at 55 degrees C and a pH range between 2 and 3. In addition, they showed similar stability and electro-chemical properties. At optimal culture conditions laccase activity was 7.69 +/- 0.28 U mg(-1) of protein for the crude extract, and 0.08 +/- 0.001 and 2.86 +/- 0.05 U mg(-1) of protein for Lac1 and Lac2, respectively. In summary, these results show the potential of coffee husk as an important and economical growth medium to produce laccase, offering a new alternative use for this common agro-industrial byproduct.	[Gonzalez, Juan C.; Medina, Sandra C.; Sanchez, Oscar F.] Univ Los Andes, Dept Chem Engn, Bogota, Colombia; [Rodriguez, Alexander; Almeciga-Diaz, Carlos J.] Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Prot Express & Purificat Lab, Bogota, Colombia; [Osma, Johann F.] Univ Los Andes, Dept Elect & Elect Engn, CMUA, Bogota, Colombia	Universidad de los Andes (Colombia); Pontificia Universidad Javeriana; Universidad de los Andes (Colombia)	Almeciga-Diaz, CJ (corresponding author), Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Prot Express & Purificat Lab, Bogota, Colombia.	cjalmeciga@javeriana.edu.co; ofsanchezm@unal.edu.co	Rodriguez-Lopez, Edwin Alexander/E-6650-2015; Sanchez, Oscar/A-5612-2013; Alméciga-Díaz, Carlos J/A-2494-2017	Rodriguez-Lopez, Edwin Alexander/0000-0001-5409-3466; Sanchez, Oscar/0000-0003-2237-0945; Alméciga-Díaz, Carlos J/0000-0001-6484-1173; OSMA, JOHANN F/0000-0003-2928-3406; Gonzalez Rivera, Juan Camilo/0000-0002-9392-1946	Pontificia Universidad Javeriana [3400]; Chemical Engineering Department at Universidad de Los Andes	Pontificia Universidad Javeriana; Chemical Engineering Department at Universidad de Los Andes	This work was supported in part by Pontificia Universidad Javeriana (Grant ID 3400) and the Chemical Engineering Department at Universidad de Los Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bourbonnais R, 1998, BBA-GEN SUBJECTS, V1379, P381, DOI 10.1016/S0304-4165(97)00117-7; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Couto SR, 2002, PROCESS BIOCHEM, V38, P249, DOI 10.1016/S0032-9592(02)00087-0; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Couto Susana Rodriguez, 2008, Biotechnology Journal, V3, P859, DOI 10.1002/biot.200800031; Crowe JD, 2001, APPL ENVIRON MICROB, V67, P2088, DOI 10.1128/AEM.67.5.2088-2094.2001; Dekker R, 2007, ELEKTOR ELECTRON, V33, P10; DePeters E. J., 2000, PROF ANIM SCI, V16, P69, DOI DOI 10.15232/S1080-7446(15)31670-3; Dwivedi UN, 2011, J MOL CATAL B-ENZYM, V68, P117, DOI 10.1016/j.molcatb.2010.11.002; Economou CN, 2010, BIORESOURCE TECHNOL, V101, P1385, DOI 10.1016/j.biortech.2009.09.028; Elisashvili V, 2008, J IND MICROBIOL BIOT, V35, P1531, DOI 10.1007/s10295-008-0454-2; Fackler K, 2007, FOOD TECHNOL BIOTECH, V45, P269; Farani De Souza D, 2006, J BASIC MICROB, V46, P126, DOI 10.1002/jobm.200510014; Fernandez-Sanchez C, 2002, BIOELECTROCHEMISTRY, V58, P149, DOI 10.1016/S1567-5394(02)00119-6; Ferraz FDO, 2009, NEW BIOTECHNOL, V25, pS256, DOI 10.1016/j.nbt.2009.06.573; Gaitan IJ, 2011, BIORESOURCE TECHNOL, V102, P3632, DOI 10.1016/j.biortech.2010.11.040; Galhaup C, 2002, MICROBIOL-SGM, V148, P2159, DOI 10.1099/00221287-148-7-2159; Gonzalez LF, 2010, BIORESOURCE TECHNOL, V101, P3493, DOI 10.1016/j.biortech.2009.12.130; Gowda NKS, 2004, TROP ANIM HEALTH PRO, V36, P77, DOI 10.1023/B:TROP.0000009522.30949.1d; HARKIN JM, 1973, EXPERIENTIA, V29, P382, DOI 10.1007/BF01926734; HARKIN JM, 1973, CELL MOL LIFE SCI, V29, P381, DOI DOI 10.1007/BF01926734; Hilden K, 2009, BIOTECHNOL LETT, V31, P1117, DOI 10.1007/s10529-009-9998-0; Hossain SM, 2006, AFR J BIOTECHNOL, V5, P189; Iandolo D, 2011, APPL BIOCHEM BIOTECH, V163, P40, DOI 10.1007/s12010-010-9014-0; Jain A, 2013, APPL MICROBIOL BIOT, V97, P905, DOI 10.1007/s00253-012-4511-4; Kahraman SS, 2002, BIORESOURCE TECHNOL, V82, P215, DOI 10.1016/S0960-8524(01)00193-6; Karp SG, 2012, BIORESOURCE TECHNOL, V114, P735, DOI 10.1016/j.biortech.2012.03.058; Kurek B, 2000, J AGR FOOD CHEM, V48, P3058, DOI 10.1021/jf000015g; Larous S, 2005, DESALINATION, V185, P483, DOI 10.1016/j.desal.2005.03.090; Levin L, 2008, BIOCHEM ENG J, V39, P207, DOI 10.1016/j.bej.2007.09.004; Makela MR, 2006, CURR GENET, V50, P323, DOI 10.1007/s00294-006-0090-1; Makela MR, 2013, FUNGAL BIOL-UK, V117, P62, DOI 10.1016/j.funbio.2012.11.006; Martinez AT, 2005, INT MICROBIOL, V8, P195; Mata G, 2005, WORLD J MICROB BIOT, V21, P143, DOI 10.1007/s11274-004-3041-3; Meza JC, 2005, PROCESS BIOCHEM, V40, P3365, DOI 10.1016/j.procbio.2005.03.004; Moldes D, 2004, BIOTECHNOL LETT, V26, P327, DOI 10.1023/B:BILE.0000015452.40213.bf; Moldes D, 2003, BIOTECHNOL LETT, V25, P491, DOI 10.1023/A:1022660230653; Morozova OV, 2007, APPL BIOCHEM MICRO+, V43, P523, DOI 10.1134/S0003683807050055; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Munoz C, 1997, APPL ENVIRON MICROB, V63, P2166; NAKAMANEE G, 2003, P 8 M REG WORK GROUP, P66; Nikitina OV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1274, DOI 10.1007/s10541-005-0259-0; NIKUPAAVOLA ML, 1990, MYCOL RES, V94, P27, DOI 10.1016/S0953-7562(09)81260-4; Obernberger I, 2004, BIOMASS BIOENERG, V27, P653, DOI 10.1016/j.biombioe.2003.07.006; Osma JF, 2007, CHEMOSPHERE, V67, P1677, DOI 10.1016/j.chemosphere.2006.11.051; Osma JF, 2011, J ENVIRON MANAGE, V92, P2907, DOI 10.1016/j.jenvman.2011.06.052; Osma JF, 2011, FEMS MICROBIOL LETT, V318, P27, DOI 10.1111/j.1574-6968.2011.02234.x; Osma Johann F, 2010, Enzyme Res, V2010, P918761, DOI 10.4061/2010/918761; Pandey A, 2000, BIOCHEM ENG J, V6, P153, DOI 10.1016/S1369-703X(00)00084-X; Philippoussis A, 2011, WORLD J MICROB BIOT, V27, P285, DOI 10.1007/s11274-010-0458-8; Prasad KK, 2005, J MICROBIOL, V43, P301; Revankar MS, 2007, APPL BIOCHEM BIOTECH, V143, P16, DOI 10.1007/s12010-007-0029-0; Rodriguez CS, 1997, BIOTECHNOL LETT, V19, P995, DOI 10.1023/A:1018495216946; Romkaew J, 2008, PLANT PROD SCI, V11, P278, DOI 10.1626/pps.11.278; Sanchez O, 2011, ALTERNATIVE FUEL, P111; Sathishkumar P, 2010, J BASIC MICROB, V50, P360, DOI 10.1002/jobm.200900407; Sciban M, 2008, DESALINATION, V229, P170, DOI 10.1016/j.desal.2007.08.017; Shleev S, 2007, BIOORG CHEM, V35, P35, DOI 10.1016/j.bioorg.2006.08.001; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singhania RR, 2009, BIOCHEM ENG J, V44, P13, DOI 10.1016/j.bej.2008.10.019; Songulashvili G, 2007, ENZYME MICROB TECH, V41, P57, DOI 10.1016/j.enzmictec.2006.11.024; Sruamsiri S, 2008, MAEJO INT J SCI TECH, V2, P568; Vandamme E. J., 2009, BIOTECHNOLOGY AGROIN, P3, DOI DOI 10.1007/978-1-4020-9942-7_1; Velazquez-Cedeno MA, 2002, WORLD J MICROB BIOT, V18, P201, DOI 10.1023/A:1014999616381; Verma P, 2002, APPL BIOCHEM BIOTECH, V102, P109, DOI 10.1385/ABAB:102-103:1-6:109; Waterborg JH, 2009, SPRINGER PROTOC HAND, P7, DOI 10.1007/978-1-59745-198-7_2; Weil J, 1998, APPL BIOCHEM BIOTECH, V70-2, P99, DOI 10.1007/BF02920127; Weil J, 1997, APPL BIOCHEM BIOTECH, V68, P21, DOI 10.1007/BF02785978; Wesenberg D, 2003, BIOTECHNOL ADV, V22, P161, DOI 10.1016/j.biotechadv.2003.08.011; Xiao YZ, 2006, APPL MICROBIOL BIOT, V71, P493, DOI 10.1007/s00253-005-0188-2; Xiao YZ, 2004, MYCOLOGIA, V96, P26, DOI 10.2307/3761984; Yague S, 2000, RAPID COMMUN MASS SP, V14, P905, DOI 10.1002/(SICI)1097-0231(20000530)14:10<905::AID-RCM963>3.0.CO;2-7	74	38	40	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73721	10.1371/journal.pone.0073721	http://dx.doi.org/10.1371/journal.pone.0073721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019936	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200078
J	Sillen, MJH; Franssen, FME; Gosker, HR; Wouters, EFM; Spruit, MA				Sillen, Maurice J. H.; Franssen, Frits M. E.; Gosker, Harry R.; Wouters, Emiel F. M.; Spruit, Martijn A.			Metabolic and Structural Changes in Lower-Limb Skeletal Muscle Following Neuromuscular Electrical Stimulation: A Systematic Review	PLOS ONE			English	Review							FORCE PRODUCTION CHARACTERISTICS; CONCURRENT STRENGTH; ENDURANCE EXERCISE; HEART-FAILURE; THIGH MUSCLES; HEAVY; VOLUNTARY; COPD; CONTRACTIONS; ADAPTATIONS	Background: Transcutaneous neuromuscular electrical stimulation (NMES) can be applied as a complementary intervention to regular exercise training programs. A distinction can be made between high-frequency (HF) NMES and low-frequency (LF) NMES. In order to increase understanding of the mechanisms of functional improvements following NMES, the purpose of this study was to systematically review changes in enzyme activity, muscle fiber type composition and muscle fiber size in human lower-limb skeletal muscles following only NMES. Methods: Trials were collected up to march 2012 and were identified by searching the Medline/PubMed, EMBASE, Cochrane Central Register of Controlled Trials, CINAHL and The Physical Therapy Evidence Database (PEDro) databases and reference lists. 18 trials were reviewed in detail: 8 trials studied changes in enzyme activities, 7 trials studied changes in muscle fiber type composition and 14 trials studied changes in muscle fiber size following NMES. Results: The methodological quality generally was poor, and the heterogeneity in study design, study population, NMES features and outcome parameters prohibited the use of meta-analysis. Most of the LF-NMES studies reported significant increases in oxidative enzyme activity, while the results concerning changes in muscle fiber composition and muscle size were conflicting. HF-NMES significantly increased muscle size in 50% of the studies. Conclusion: NMES seems to be a training modality resulting in changes in oxidative enzyme activity, skeletal muscle fiber type and skeletal muscle fiber size. However, considering the small sample sizes, the variance in study populations, the non-randomized controlled study designs, the variance in primary outcomes, and the large heterogeneity in NMES protocols, it is difficult to draw definitive conclusions about the effects of stimulation frequencies on muscular changes.	[Sillen, Maurice J. H.; Franssen, Frits M. E.; Wouters, Emiel F. M.; Spruit, Martijn A.] CIRO, Ctr Expertise Chron Organ Failure, Program Dev Ctr, Horn, Netherlands; [Gosker, Harry R.; Wouters, Emiel F. M.] Maastricht Univ Med Ctr, Dept Resp Med, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Wouters, Emiel F. M.] CIRO, Ctr Expertise Chron Organ Failure, Horn, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Sillen, MJH (corresponding author), CIRO, Ctr Expertise Chron Organ Failure, Program Dev Ctr, Horn, Netherlands.	mauricesillen@ciro-horn.nl	Franssen, Frits M.E./L-3334-2019; Franssen, Frits M.E./B-6988-2018; Wouters, Emiel/ABD-6200-2021	Franssen, Frits M.E./0000-0002-1633-6356; Franssen, Frits M.E./0000-0002-1633-6356; Gosker, Harry/0000-0002-7659-0225	Netherlands Asthma Foundation, Leusden, The Netherlands [3.4.09.024]; Weijerhorst Foundation, Maastricht, The Netherlands	Netherlands Asthma Foundation, Leusden, The Netherlands(Netherlands Government); Weijerhorst Foundation, Maastricht, The Netherlands(Netherlands Government)	This research was supported by grants from The Netherlands Asthma Foundation, Leusden, The Netherlands, Grant 3.4.09.024 and the Weijerhorst Foundation, Maastricht, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JL, 2000, MUSCLE NERVE, V23, P1095; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Bell GJ, 2000, EUR J APPL PHYSIOL, V81, P418, DOI 10.1007/s004210050063; Bergquist AJ, 2011, EUR J APPL PHYSIOL, V111, P2409, DOI 10.1007/s00421-011-2087-9; Bickel CS, 2011, EUR J APPL PHYSIOL, V111, P2399, DOI 10.1007/s00421-011-2128-4; Bickel CS, 2005, J APPL PHYSIOL, V98, P482, DOI 10.1152/japplphysiol.00895.2004; BOWMAN BR, 1985, ANN BIOMED ENG, V13, P59, DOI 10.1007/BF02371250; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; CABRIC M, 1988, EUR J APPL PHYSIOL, V57, P1, DOI 10.1007/BF00691229; Canepari M, 2005, J APPL PHYSIOL, V98, P2390, DOI 10.1152/japplphysiol.01103.2004; Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386; Chan Kwan Kit-Lan P, 1991, HONG KONG PHYSIOTHER, V13, P23; Collins DF, 2002, J PHYSIOL-LONDON, V538, P289, DOI 10.1113/jphysiol.2001.012825; Dal Corso S, 2007, RESP MED, V101, P1236, DOI 10.1016/j.rmed.2006.10.023; EDWARDS RHT, 1977, CLIN SCI MOL MED, V52, P283, DOI 10.1042/cs0520283; Farup J, 2012, J STRENGTH COND RES, V26, P398, DOI 10.1519/JSC.0b013e318225a26f; Fernstrom M, 2004, J PHYSIOL-LONDON, V554, P755, DOI 10.1113/jphysiol.2003.055202; Foley NC, 2006, PHYS THER, V86, P817, DOI 10.1093/ptj/86.6.817; GAUTHIER JM, 1992, MED SCI SPORT EXER, V24, P1252; Gerovasili V, 2009, CRIT CARE, V13, DOI 10.1186/cc8123; Gondin J, 2005, MED SCI SPORT EXER, V37, P1291, DOI 10.1249/01.mss.0000175090.49048.41; Gondin J, 2011, EUR J APPL PHYSIOL, V111, P2473, DOI 10.1007/s00421-011-2101-2; Gondin J, 2011, J APPL PHYSIOL, V110, P433, DOI 10.1152/japplphysiol.00914.2010; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; GRIMBY L, 1977, J PHYSIOL-LONDON, V264, P865, DOI 10.1113/jphysiol.1977.sp011699; HAINAUT K, 1992, SPORTS MED, V14, P100, DOI 10.2165/00007256-199214020-00003; Hakkinen K, 1998, J GERONTOL A-BIOL, V53, pB415, DOI 10.1093/gerona/53A.6.B415; Hakkinen K, 2003, EUR J APPL PHYSIOL, V89, P42, DOI 10.1007/s00421-002-0751-9; HAKKINEN K, 1989, EUR J APPL PHYSIOL O, V59, P215, DOI 10.1007/BF02386190; Herrero JA, 2006, INT J SPORTS MED, V27, P533, DOI 10.1055/s-2005-865845; Holm L, 2008, J APPL PHYSIOL, V105, P1454, DOI 10.1152/japplphysiol.90538.2008; Howarth KR, 2004, J APPL PHYSIOL, V97, P579, DOI 10.1152/japplphysiol.01344.2003; Jancik J, 2002, SCRIPTA MED FM U BRU, V75, P203; KRAMER JF, 1987, PHYS THER, V67, P31, DOI 10.1093/ptj/67.1.31; LAKE DA, 1992, SPORTS MED, V13, P320, DOI 10.2165/00007256-199213050-00003; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Maffiuletti NA, 2010, EUR J APPL PHYSL; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Maillefert J F, 1998, J Cardiopulm Rehabil, V18, P277, DOI 10.1097/00008483-199807000-00004; Maltais F, 1996, AM J RESP CRIT CARE, V154, P442, DOI 10.1164/ajrccm.154.2.8756820; Martin L, 1994, J SPORT SCI, V12, P377, DOI 10.1080/02640419408732184; Nuhr M, 2003, EUR J APPL PHYSIOL, V89, P202, DOI 10.1007/s00421-003-0792-8; Nuhr MJ, 2004, EUR HEART J, V25, P136, DOI 10.1016/j.ehj.2003.09.027; Perez M, 2002, PFLUG ARCH EUR J PHY, V443, P866, DOI 10.1007/s00424-001-0769-6; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Putman CT, 2004, EUR J APPL PHYSIOL, V92, P376, DOI 10.1007/s00421-004-1104-7; Quittan M, 2001, AM J PHYS MED REHAB, V80, P206, DOI 10.1097/00002060-200103000-00011; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rebai H, 2002, INT J SPORTS MED, V23, P604, DOI 10.1055/s-2002-35525; Sherrington C, 2000, MANUAL THER, V5, P223, DOI 10.1054/math.2000.0372; Short KR, 2005, J APPL PHYSIOL, V99, P95, DOI 10.1152/japplphysiol.00129.2005; Sillen MJH, 2008, RESP MED, V102, P786, DOI 10.1016/j.rmed.2008.01.013; Sillen MJH, 2009, CHEST, V136, P44, DOI 10.1378/chest.08-2481; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Singer K P, 1986, Aust J Physiother, V32, P31, DOI 10.1016/S0004-9514(14)60641-3; Smart NA, 2013, INT J CARDIOL, V167, P1502, DOI 10.1016/j.ijcard.2012.04.029; TAKEKURA H, 1987, J MUSCLE RES CELL M, V8, P342, DOI 10.1007/BF01568890; TAYLOR A, 1976, BRAIN RES, V117, P331, DOI 10.1016/0006-8993(76)90742-3; TESCH PA, 1989, J APPL PHYSIOL, V67, P83, DOI 10.1152/jappl.1989.67.1.83; THERIAULT R, 1994, J APPL PHYSIOL, V77, P1885, DOI 10.1152/jappl.1994.77.4.1885; TRAPPE SW, 1995, J APPL PHYSIOL, V78, P823, DOI 10.1152/jappl.1995.78.3.823; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; TRIMBLE MH, 1991, PHYS THER, V71, P273, DOI 10.1093/ptj/71.4.273; Vanderthommen M, 2001, Rev Med Liege, V56, P391; Vanderthommen M, 2003, J APPL PHYSIOL, V94, P1012, DOI 10.1152/japplphysiol.00887.2001; Vanderthommen M, 2007, EXERC SPORT SCI REV, V35, P180, DOI 10.1097/jes.0b013e318156e785; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Vivodtzev I, 2008, J CARDIOPULM REHABIL, V28, P79, DOI 10.1097/01.HCR.0000314201.02053.a3; Vivodtzev I, 2012, CHEST, V141, P716, DOI 10.1378/chest.11-0839; Walls RJ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-119	70	46	51	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e69391	10.1371/journal.pone.0069391	http://dx.doi.org/10.1371/journal.pone.0069391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019860	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200002
J	Brown, M; Stafford, LJ; Onisk, D; Joaquim, T; Tobb, A; Goldman, L; Fancy, D; Stave, J; Chambers, R				Brown, Michael; Stafford, Lewis J.; Onisk, Dale; Joaquim, Tony; Tobb, Alhagie; Goldman, Larissa; Fancy, David; Stave, James; Chambers, Ross			Snorkel: An Epitope Tagging System for Measuring the Surface Expression of Membrane Proteins	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; CHANNEL; IMMUNIZATION; TRAFFICKING; ACTIVATION; GENERATION; CELLS	Tags are widely used to monitor a protein's expression level, interactions, protein trafficking, and localization. Membrane proteins are often tagged in their extracellular domains to allow discrimination between protein in the plasma membrane from that in internal pools. Multipass membrane proteins offer special challenges for inserting a tag since the extracellular regions are often composed of small loops and thus inserting an epitope tag risks perturbing the structure, function, or location of the membrane protein. We have developed a novel tagging system called snorkel where a transmembrane domain followed by a tag is appended to the cytoplasmic C-terminus of the membrane protein. In this way the tag is displayed extracellularly, but structurally separate from the membrane protein. We have tested the snorkel tag system on a diverse panel of membrane proteins including GPCRs and ion channels and demonstrated that it reliably allows for monitoring of the surface expression.	[Brown, Michael; Stafford, Lewis J.; Onisk, Dale; Joaquim, Tony; Tobb, Alhagie; Goldman, Larissa; Fancy, David; Stave, James; Chambers, Ross] SDIX, Newark, DE USA		Chambers, R (corresponding author), SDIX, Newark, DE USA.	rchambers@sdix.com		Fancy, David A./0000-0001-7786-936X	SDIX	SDIX	Financial support for this work was from SDIX. The SDIX management had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Balut CM, 2010, AM J PHYSIOL-CELL PH, V299, pC1015, DOI 10.1152/ajpcell.00120.2010; BOHME I, 2009, CELL COMMUNICATION S, V7, P1, DOI DOI 10.1186/1478-811X-7-1.PUBMED:19602276; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dreyer AM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-87; Dunham JH, 2009, TRENDS BIOTECHNOL, V27, P541, DOI 10.1016/j.tibtech.2009.06.005; Fritze CE, 2000, METHOD ENZYMOL, V327, P3, DOI 10.1016/S0076-6879(00)27263-7; Holleran JP, 2012, MOL MED, V18, P685, DOI 10.2119/molmed.2012.00001; Hultin LE, 1998, CYTOMETRY, V33, P123, DOI 10.1002/(SICI)1097-0320(19981001)33:2<123::AID-CYTO6>3.0.CO;2-K; Maue RA, 2007, J CELL PHYSIOL, V213, P618, DOI 10.1002/jcp.21259; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nagata S, 2003, J IMMUNOL METHODS, V280, P59, DOI 10.1016/S0022-1759(03)00192-3; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Pang J, 2009, PROTEIN SCI, V18, P1261, DOI 10.1002/pro.136; Park EJ, 2009, BIOL PHARM BULL, V32, P1790, DOI 10.1248/bpb.32.1790; Shapiro HM, 2005, PRACTICAL FLOW CYTOM; Smith C, 1993, PCR Methods Appl, V2, P328, DOI 10.1101/gr.2.4.328; Spiller OB, 1999, J IMMUNOL METHODS, V224, P51, DOI 10.1016/S0022-1759(99)00008-3; Steele DF, 2007, J PHYSIOL-LONDON, V582, P17, DOI 10.1113/jphysiol.2007.130245; van de Graaf SFJ, 2008, J BIOL CHEM, V283, P4077, DOI 10.1074/jbc.M706959200; von Heijne G, 2007, J INTERN MED, V261, P543, DOI 10.1111/j.1365-2796.2007.01792.x; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Watschinger K, 2008, CHANNELS, V2, P461, DOI 10.4161/chan.2.6.6793; Yoo D, 2004, J BIOL CHEM, V279, P6863, DOI 10.1074/jbc.M311599200; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	28	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73255	10.1371/journal.pone.0073255	http://dx.doi.org/10.1371/journal.pone.0073255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023844	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400055
J	Murphy, N; Norat, T; Ferrari, P; Jenab, M; Bueno-de-Mesquita, B; Skeie, G; Olsen, A; Tjonneland, A; Dahm, CC; Overvad, K; Boutron-Ruault, MC; Clavel-Chapelon, F; Nailler, L; Kaaks, R; Teucher, B; Boeing, H; Bergmann, MM; Trichopoulou, A; Lagiou, P; Trichopoulos, D; Palli, D; Pala, V; Tumino, R; Vineis, P; Panico, S; Peeters, PHM; Dik, VK; Weiderpass, E; Lund, E; Garcia, JRQ; Zamora-Ros, R; Perez, MJS; Dorronsoro, M; Navarro, C; Ardanaz, E; Manjer, J; Almquist, M; Johansson, I; Palmqvist, R; Khaw, KT; Wareham, N; Key, TJ; Crowe, FL; Fedirko, V; Gunter, MJ; Riboli, E				Murphy, Neil; Norat, Teresa; Ferrari, Pietro; Jenab, Mazda; Bueno-de-Mesquita, Bas; Skeie, Guri; Olsen, Anja; Tjonneland, Anne; Dahm, Christina C.; Overvad, Kim; Boutron-Ruault, Marie Christine; Clavel-Chapelon, Francoise; Nailler, Laura; Kaaks, Rudolf; Teucher, Birgit; Boeing, Heiner; Bergmann, Manuela M.; Trichopoulou, Antonia; Lagiou, Pagona; Trichopoulos, Dimitrios; Palli, Domenico; Pala, Valeria; Tumino, Rosario; Vineis, Paolo; Panico, Salvatore; Peeters, Petra H. M.; Dik, Vincent K.; Weiderpass, Elisabete; Lund, Eiliv; Quiros Garcia, Jose Ramon; Zamora-Ros, Raul; Sanchez Perez, Maria Jose; Dorronsoro, Miren; Navarro, Carmen; Ardanaz, Eva; Manjer, Jonas; Almquist, Martin; Johansson, Ingegerd; Palmqvist, Richard; Khaw, Kay-Tee; Wareham, Nick; Key, Timothy J.; Crowe, Francesca L.; Fedirko, Veronika; Gunter, Marc J.; Riboli, Elio			Consumption of Dairy Products and Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)	PLOS ONE			English	Article							DIETARY CALCIUM; VITAMIN-D; MILK-PRODUCTS; COLON-CANCER; RISK; COHORT; FOODS; FAT; METAANALYSIS; CALIBRATION	Background: Prospective studies have consistently reported lower colorectal cancer risks associated with higher intakes of total dairy products, total milk and dietary calcium. However, less is known about whether the inverse associations vary for individual dairy products with differing fat contents. Materials and Methods: In the European Prospective Investigation into Cancer and Nutrition (EPIC), we investigated the associations between intakes of total milk and milk subtypes (whole-fat, semi-skimmed and skimmed), yoghurt, cheese, and dietary calcium with colorectal cancer risk amongst 477,122 men and women. Dietary questionnaires were administered at baseline. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models, adjusted for relevant confounding variables. Results: During the mean 11 years of follow-up, 4,513 incident cases of colorectal cancer occurred. After multivariable adjustments, total milk consumption was inversely associated with colorectal cancer risk (HR per 200 g/day 0.93, 95% CI: 0.89-0.98). Similar inverse associations were observed for whole-fat (HR per 200 g/day 0.90, 95% CI: 0.82-0.99) and skimmed milk (HR per 200 g/day 0.90, 95% CI: 0.79-1.02) in the multivariable models. Inverse associations were observed for cheese and yoghurt in the categorical models; although in the linear models, these associations were non-significant. Dietary calcium was inversely associated with colorectal cancer risk (HR per 200 mg/day 0.95, 95% CI: 0.91-0.99); this association was limited to dairy sources of calcium only (HR per 200 mg/day 0.95, 95% CI: 0.91-0.99), with no association observed for non-dairy calcium sources (HR per 200 mg/day 1.00, 95% CI: 0.81-1.24). Conclusions: Our results strengthen the evidence for a possible protective role of dairy products on colorectal cancer risk. The inverse associations we observed did not differ by the fat content of the dairy products considered.	[Murphy, Neil; Norat, Teresa; Vineis, Paolo; Gunter, Marc J.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Ferrari, Pietro; Jenab, Mazda; Fedirko, Veronika] Int Agcy Res Canc, F-69372 Lyon, France; [Bueno-de-Mesquita, Bas] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Bueno-de-Mesquita, Bas; Dik, Vincent K.] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Skeie, Guri; Weiderpass, Elisabete; Lund, Eiliv] Univ Tromso, Inst Community Med, Tromso, Norway; [Olsen, Anja; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Dahm, Christina C.] Aarhus Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Dahm, Christina C.; Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Boutron-Ruault, Marie Christine; Clavel-Chapelon, Francoise; Nailler, Laura] Inst Gustave Roussy, INSERM, Ctr Res Epidemiol & Populat Hlth, F-94805 Villejuif, France; [Boutron-Ruault, Marie Christine; Clavel-Chapelon, Francoise; Nailler, Laura] Paris South Univ, UMRS 1018, F-94805 Villejuif, France; [Kaaks, Rudolf; Teucher, Birgit] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Boeing, Heiner; Bergmann, Manuela M.] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Trichopoulou, Antonia; Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Collaborating Ctr Food & Nutr Policies,WHO, GR-11527 Athens, Greece; [Trichopoulou, Antonia; Trichopoulos, Dimitrios] Hellen Hlth Fdn, Athens, Greece; [Lagiou, Pagona; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lagiou, Pagona; Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, Milan, Italy; [Tumino, Rosario] Civile MP Arezzo, Canc Registry, Asp Ragusa, Italy; [Tumino, Rosario] Civile MP Arezzo, Histopathol Unit, Asp Ragusa, Italy; [Vineis, Paolo] HuGeF Fdn, Turin, Italy; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr, Utrecht, Netherlands; [Quiros Garcia, Jose Ramon] Publ Hlth Directorate, Asturias, Spain; [Zamora-Ros, Raul] Environm & Canc Catalan Inst Oncol, Unit Nutr, Barcelona, Spain; [Sanchez Perez, Maria Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Sanchez Perez, Maria Jose; Navarro, Carmen; Ardanaz, Eva] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Dorronsoro, Miren] Basque Reg Hlth Dept & Ciberesp Biodonostia, Publ Hlth Div Gipuzkoa, San Sebastian, Spain; [Navarro, Carmen] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Navarro, Carmen] Univ Murcia, Sociosanitary Sci Dept, Murcia, Spain; [Ardanaz, Eva] Navarre Publ Hlth Inst, Pamplona, Spain; [Manjer, Jonas] Lund Univ, Dept Plast Surg, Malmo, Sweden; [Almquist, Martin] Lund Univ, Dept Surg, Malmo, Sweden; [Johansson, Ingegerd] Umea Univ, Dept Odontol, Umea, Sweden; [Palmqvist, Richard] Umea Univ, Dept Med Biosci, Umea, Sweden; [Khaw, Kay-Tee] Univ Cambridge, Cambridge, England; [Wareham, Nick] MRC Epidemiol Unit, Cambridge, England; [Key, Timothy J.; Crowe, Francesca L.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England	Imperial College London; World Health Organization; International Agency for Research on Cancer (IARC); Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; UiT The Arctic University of Tromso; Danish Cancer Society; Aarhus University; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Academy of Athens; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; University of Naples Federico II; Utrecht University; Utrecht University Medical Center; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Murcia Regional Health Council; University of Murcia; Public Health Institute of Navarra; Lund University; Lund University; Umea University; Umea University; University of Cambridge; University of Oxford	Norat, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	t.norat@imperial.ac.uk	Khaw, Kay-Tee/AAZ-3209-2021; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Boutron-Ruault, Marie-Christine/H-3936-2014; Weiderpass, Elisabete/M-4029-2016; Gunter, Marc/AAP-8621-2020; Teucher, Birgit/J-6380-2015; Sánchez, Maria-José/D-1087-2011; Weiderpass, Elisabete/AAP-2747-2021; Clavel-Chapelon, Francoise/G-6733-2014; Murphy, Neil/E-1189-2017; Almquist, Martin/H-7209-2019; Dahm, Christina C/G-9787-2014; Zamora-Ros, Raul/AAA-7111-2020; Pala, Valeria/K-4738-2016	TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Weiderpass, Elisabete/0000-0003-2237-0128; Sánchez, Maria-José/0000-0003-4817-0757; Weiderpass, Elisabete/0000-0003-2237-0128; Murphy, Neil/0000-0003-3347-8249; Almquist, Martin/0000-0002-0953-1188; Dahm, Christina C/0000-0003-0481-2893; Zamora-Ros, Raul/0000-0002-6236-6804; Pala, Valeria/0000-0001-5438-970X; Overvad, Kim/0000-0001-6429-7921; Crowe, Francesca/0000-0003-4026-1726; Panico, Salvatore/0000-0002-5498-8312; Jenab, Mazda/0000-0002-0573-1852; Rasul, holem/0000-0003-0579-9029; Riboli, Elio/0000-0001-6795-6080; Skeie, Guri/0000-0003-2476-4251; Olsen, Anja/0000-0003-4788-503X; Navarro, Carmen/0000-0001-8896-7483; Lund, Eiliv/0000-0002-8071-8711; Gunter, Marc/0000-0001-5472-6761; PALLI, Domenico/0000-0002-5558-2437; tumino, rosario/0000-0003-2666-414X; Tjonneland, Anne/0000-0003-4385-2097	European Commission (DG-SANCO); International Agency for Research on Cancer; Danish Cancer Society (Denmark); Ligue Contre le Cancer (France); Institut Gustave Roussy (France); Mutuelle Generale de l'Education Nationale (France); Institut National de la Santeet de la Recherche Medicale (France); Deutsche Krebshilfe (Germany); Deutsches Krebsforschungszentrum (Germany); Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Stavros Niarchos Foundation (Greece); Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer (Italy); National Research Council (Italy); Associazione Iblea per la Ricerca Epidemiologica (AIRE-ONLUS) Ragusa, Associazione Volontari Italiani Sangu Ragusa, Sicilian Government (Italy); Dutch Ministry of Public Health, Welfare and Sports (the Netherlands); Netherlands Cancer Registry (the Netherlands); LK Research Funds (the Netherlands); Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland) (the Netherlands); World Cancer Research Fund (the Netherlands); Statistics Netherlands (the Netherlands); European Research Council (Norway) [ERC-2009-AdG 232997]; Nordforsk (Norway); Nordic Center of Excellence Programme on Food, Nutrition and Health (Norway); Health Research Fund (Spain); Regional Government of Andalucia (Spain); Regional Government of Asturias (Spain); Regional Government of Basque Country (Spain); Regional Government of Murcia (Spain) [6236]; Regional Government of Navarra (Spain); Centro de Investigacion Biomedica en Red en Epidemiologia y Salud Publica (Spain); Instituto de Salud Carlos II (Spain); Swedish Cancer Society (Sweden); Swedish Scientific Council (Sweden); Regional Government of Skane and Vasterbotten (Sweden); Cancer Research UK (UK); Medical Research Council (UK); Stroke Association (UK); British Heart Foundation (UK); Department of Health, Food Standards Agency; Wellcome Trust (UK); Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143, G0801056B] Funding Source: researchfish	European Commission (DG-SANCO)(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer; Danish Cancer Society (Denmark)(Danish Cancer Society); Ligue Contre le Cancer (France); Institut Gustave Roussy (France); Mutuelle Generale de l'Education Nationale (France); Institut National de la Santeet de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Deutsche Krebshilfe (Germany)(Deutsche Krebshilfe); Deutsches Krebsforschungszentrum (Germany); Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Hellenic Health Foundation (Greece); Stavros Niarchos Foundation (Greece); Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer (Italy)(Fondazione AIRC per la ricerca sul cancro); National Research Council (Italy)(Consiglio Nazionale delle Ricerche (CNR)); Associazione Iblea per la Ricerca Epidemiologica (AIRE-ONLUS) Ragusa, Associazione Volontari Italiani Sangu Ragusa, Sicilian Government (Italy); Dutch Ministry of Public Health, Welfare and Sports (the Netherlands); Netherlands Cancer Registry (the Netherlands); LK Research Funds (the Netherlands)(Netherlands Government); Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland) (the Netherlands); World Cancer Research Fund (the Netherlands)(Netherlands Government); Statistics Netherlands (the Netherlands)(Netherlands Government); European Research Council (Norway); Nordforsk (Norway); Nordic Center of Excellence Programme on Food, Nutrition and Health (Norway); Health Research Fund (Spain); Regional Government of Andalucia (Spain)(Junta de Andalucia); Regional Government of Asturias (Spain); Regional Government of Basque Country (Spain); Regional Government of Murcia (Spain); Regional Government of Navarra (Spain); Centro de Investigacion Biomedica en Red en Epidemiologia y Salud Publica (Spain); Instituto de Salud Carlos II (Spain); Swedish Cancer Society (Sweden)(Swedish Cancer Society); Swedish Scientific Council (Sweden); Regional Government of Skane and Vasterbotten (Sweden); Cancer Research UK (UK)(Cancer Research UK); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association (UK); British Heart Foundation (UK)(British Heart Foundation); Department of Health, Food Standards Agency; Wellcome Trust (UK)(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, and Institut National de la Santeet de la Recherche Medicale (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, and Federal Ministry of Education and Research (Germany); Hellenic Health Foundation, Stavros Niarchos Foundation, and the Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer, National Research Council, and Associazione Iblea per la Ricerca Epidemiologica (AIRE-ONLUS) Ragusa, Associazione Volontari Italiani Sangu Ragusa, Sicilian Government (Italy); Dutch Ministry of Public Health, Welfare and Sports, Netherlands Cancer Registry, LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund, and Statistics Netherlands (the Netherlands); European Research Council (grant number ERC-2009-AdG 232997) and Nordforsk, and Nordic Center of Excellence Programme on Food, Nutrition and Health (Norway); Health Research Fund, Regional Governments of Andalucia, Asturias, Basque Country, Murcia (No. 6236) and Navarra, and the Centro de Investigacion Biomedica en Red en Epidemiologia y Salud Publica and Instituto de Salud Carlos II (RD06/0020) (Spain); Swedish Cancer Society, Swedish Scientific Council, and Regional Government of Skane and Vasterbotten (Sweden); Cancer Research UK, Medical Research Council, Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, and Wellcome Trust (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2008, BRIT J CANCER, V98, P1574, DOI 10.1038/sj.bjc.6604331; Aune D, 2011, ANN ONCOLOGY; Carroll C, 2010, CLIN THER, V32, P789, DOI 10.1016/j.clinthera.2010.04.024; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrari P, 2008, INT J EPIDEMIOL, V37, P368, DOI 10.1093/ije/dym242; Govers MJAP, 1996, CANCER RES, V56, P3270; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Gueguen L, 2000, J AM COLL NUTR, V19, p119S, DOI 10.1080/07315724.2000.10718083; HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43; Hjartaker A, 2002, PUBLIC HEALTH NUTR, V5, P1259, DOI 10.1079/PHN2002403; Holt PR, 1998, JAMA-J AM MED ASSOC, V280, P1074, DOI 10.1001/jama.280.12.1074; Jarvinen R, 2001, EUR J CLIN NUTR, V55, P1000, DOI 10.1038/sj.ejcn.1601260; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KAMPMAN E, 1994, CANCER RES, V54, P3186; Kesse E, 2005, INT J CANCER, V117, P137, DOI 10.1002/ijc.21148; Lamprecht SA, 2001, ANN NY ACAD SCI, V952, P73, DOI 10.1111/j.1749-6632.2001.tb02729.x; LAPRE JA, 1993, CANCER RES, V53, P784; Larsson SC, 2006, AM J CLIN NUTR, V83, P667, DOI 10.1093/ajcn.83.3.667; Larsson SC, 2005, AM J CLIN NUTR, V82, P894, DOI 10.1093/ajcn/82.4.894; LLOR X, 1991, CANCER RES, V51, P4305; Mazda J, 2010, BMJ, V340; MCMICHAEL AJ, 1980, INT J CANCER, V25, P431, DOI 10.1002/ijc.2910250402; Narisawa T, 1978, J GASTROENTEROL, V13, P206; Norat T, 2003, EUR J CLIN NUTR, V57, P1, DOI 10.1038/sj.ejcn.1601522; Pala V, 2011, INT J CANCER, V129, P2712, DOI 10.1002/ijc.26193; Park Y, 2009, ARCH INTERN MED, V169, P391, DOI 10.1001/archinternmed.2008.578; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Sanjoaquin MA, 2004, BRIT J CANCER, V90, P118, DOI 10.1038/sj.bjc.6601441; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Weaver CM, 1999, AM J CLIN NUTR, V70, p543S, DOI 10.1093/ajcn/70.3.543s; World Cancer Research Fund/American Institute for Cancer Research, 2011, CONT UPD PROJ REP SU; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu K, 2002, JNCI-J NATL CANCER I, V94, P437, DOI 10.1093/jnci/94.6.437	41	64	66	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72715	10.1371/journal.pone.0072715	http://dx.doi.org/10.1371/journal.pone.0072715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023767	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400022
J	Stewart, CJ; Marrs, ECL; Nelson, A; Lanyon, C; Perry, JD; Embleton, ND; Cummings, SP; Berrington, JE				Stewart, Christopher J.; Marrs, Emma C. L.; Nelson, Andrew; Lanyon, Clare; Perry, John D.; Embleton, Nicholas D.; Cummings, Stephen P.; Berrington, Janet E.			Development of the Preterm Gut Microbiome in Twins at Risk of Necrotising Enterocolitis and Sepsis	PLOS ONE			English	Article							INVASIVE ESCHERICHIA-COLI; DIVERSITY; BACTERIAL; SEQUENCES; DISEASE; MUCOSA; MILK	The preterm gut microbiome is a complex dynamic community influenced by genetic and environmental factors and is implicated in the pathogenesis of necrotising enterocolitis (NEC) and sepsis. We aimed to explore the longitudinal development of the gut microbiome in preterm twins to determine how shared environmental and genetic factors may influence temporal changes and compared this to the expressed breast milk (EBM) microbiome. Stool samples (n = 173) from 27 infants (12 twin pairs and 1 triplet set) and EBM (n = 18) from 4 mothers were collected longitudinally. All samples underwent PCR-DGGE (denaturing gradient gel electrophoresis) analysis and a selected subset underwent 454 pyrosequencing. Stool and EBM shared a core microbiome dominated by Enterobacteriaceae, Enterococcaceae, and Staphylococcaceae. The gut microbiome showed greater similarity between siblings compared to unrelated individuals. Pyrosequencing revealed a reduction in diversity and increasing dominance of Escherichia sp. preceding NEC that was not observed in the healthy twin. Antibiotic treatment had a substantial effect on the gut microbiome, reducing Escherichia sp. and increasing other Enterobacteriaceae. This study demonstrates related preterm twins share similar gut microbiome development, even within the complex environment of neonatal intensive care. This is likely a result of shared genetic and immunomodulatory factors as well as exposure to the same maternal microbiome during birth, skin contact and exposure to EBM. Environmental factors including antibiotic exposure and feeding are additional significant determinants of community structure, regardless of host genetics.	[Stewart, Christopher J.; Nelson, Andrew; Lanyon, Clare] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Marrs, Emma C. L.; Perry, John D.; Cummings, Stephen P.] Freeman Rd Hosp, Dept Microbiol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Embleton, Nicholas D.; Berrington, Janet E.] Royal Victoria Infirm, Newcastle Neonatal Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Northumbria University; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK	Cummings, SP (corresponding author), Freeman Rd Hosp, Dept Microbiol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	stephen.cummings@unn.ac.uk	Embleton, Nicholas/D-4905-2011; Stewart, Christopher/M-4615-2017; Cummings, Stephen P/S-8336-2018; Lanyon, Clare V/A-2682-2012	Embleton, Nicholas/0000-0003-3750-5566; Stewart, Christopher/0000-0002-6033-338X; Cummings, Stephen P/0000-0001-5298-2075; Berrington, Janet/0000-0002-6185-2843; Nelson, Andrew/0000-0001-6665-4929; Lanyon, Clare/0000-0002-5200-9336	charity Tiny Lives	charity Tiny Lives	This research was funded by the charity Tiny Lives. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter J, 2006, ANTON LEEUW INT J G, V90, P1, DOI 10.1007/s10482-006-9057-y; Berrington JE, 2012, ARCH DIS CHILD-FETAL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Embleton ND, 2008, SEMIN FETAL NEONAT M, V13, P35, DOI 10.1016/j.siny.2007.09.003; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Simoes CD, 2013, J NUTR, V143, P417, DOI 10.3945/jn.112.166322; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Stewart CJ, 2013, ARCH DIS CHILD-FETAL, V98, pF298, DOI 10.1136/archdischild-2012-302119; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	40	97	102	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73465	10.1371/journal.pone.0073465	http://dx.doi.org/10.1371/journal.pone.0073465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023682	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000323880200079
J	Vodstrcil, LA; Hocking, JS; Law, M; Walker, S; Tabrizi, SN; Fairley, CK; Bradshaw, CS				Vodstrcil, Lenka A.; Hocking, Jane S.; Law, Matthew; Walker, Sandra; Tabrizi, Sepehr N.; Fairley, Christopher K.; Bradshaw, Catriona S.			Hormonal Contraception Is Associated with a Reduced Risk of Bacterial Vaginosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SEXUALLY-TRANSMITTED INFECTIONS; FEMALE SEX WORKERS; NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; REPRODUCTIVE-TRACT; LACTIC-ACID; WOMEN; PREVALENCE; ACQUISITION; LACTOBACILLI	Objective: To examine the association between hormonal contraception (HC) and bacterial vaginosis (BV) by systematic review and meta-analysis. Methods: Medline, Web of Science and Embase databases were searched to 24/1/13 and duplicate references removed. Inclusion criteria 1) >20 BV cases; 2) accepted BV diagnostic method; 3) measure of HC-use either as combined oestrogen-progesterone HC (combined), progesterone-only contraception (POC) or unspecified HC (u-HC); 4) >= 10% of women using HC; 5) analysis of the association between BV and HC-use presented; 6) appropriate control group. Data extracted included: type of HC, BV diagnostic method and outcome (prevalent, incident, recurrent), and geographical and clinic-setting. Meta-analyses were conducted to calculate pooled effect sizes (ES), stratified by HC-type and BV outcome. This systematic review is registered with PROSPERO (CRD42013003699). Results: Of 1713 unique references identified, 502 full-text articles were assessed for eligibility and 55 studies met inclusion criteria. Hormonal contraceptive use was associated with a significant reduction in the odds of prevalent BV (pooled effect size by random-effects [reES] = 0.68, 95% CI0.63-0.73), and in the relative risk (RR) of incident (reES = 0.82, 95% CI: 0.72-0.92), and recurrent (reES = 0.69, 95% CI: 0.59-0.91) BV. When stratified by HC-type, combined-HC and POC were both associated with decreased prevalence of BV and risk of incident BV. In the pooled analysis of the effect of HC-use on the composite outcome of prevalent/incident/recurrent BV, HC-use was associated with a reduced risk of any BV (reES = 0.78, 95% CI: 0.74-0.82). Conclusion: HC-use was associated with a significantly reduced risk of BV. This negative association was robust and present regardless of HC-type and evident across all three BV outcome measures. When stratified by HC-type, combined-HC and POC were both individually associated with a reduction in the prevalence and incidence of BV. This meta-analysis provides compelling evidence that HC-use influences a woman's risk of BV, with important implications for clinicians and researchers in the field.	[Vodstrcil, Lenka A.; Walker, Sandra; Fairley, Christopher K.; Bradshaw, Catriona S.] Univ Melbourne, Sexual Hlth Unit, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3052, Australia; [Vodstrcil, Lenka A.; Walker, Sandra; Fairley, Christopher K.; Bradshaw, Catriona S.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Vodstrcil, Lenka A.; Tabrizi, Sepehr N.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Hocking, Jane S.] Univ Melbourne, Ctr Womens Hlth Gender & Soc, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3052, Australia; [Law, Matthew] Univ New S Wales, Kirby Inst, Coogee, Australia; [Tabrizi, Sepehr N.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Parkville, Vic, Australia; [Tabrizi, Sepehr N.] Univ Melbourne, Royal Womens Hosp Parkville, Dept Obstet & Gynaecol, Melbourne, Vic 3010, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic 3004, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; Murdoch Children's Research Institute; University of Melbourne; University of New South Wales Sydney; Kirby Institute; University of Melbourne; Monash University	Bradshaw, CS (corresponding author), Univ Melbourne, Sexual Hlth Unit, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3052, Australia.	cbradshaw@mshc.org.au	Vodstrcil, Lenka/AAF-8722-2020; Hocking, Jane/AAD-5203-2021; Vodstrcil, Lenka/AAC-1896-2019	Vodstrcil, Lenka/0000-0003-3679-9195; Hocking, Jane/0000-0001-9329-8501; Law, Matthew/0000-0002-3540-8837; Christopher, Fairley/0000-0001-9081-1664; bradshaw, catriona/0000-0002-6643-5678	NHMRC [1020457, 568971]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Two grants contributed funding to this study; an NHMRC Project Grant (1020457) & an NHMRC Program grant (568971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Amaral R, 2007, INT J STD AIDS, V18, P770, DOI 10.1258/095646207782212333; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Artz L, 2000, AM J PUBLIC HEALTH, V90, P237, DOI 10.2105/AJPH.90.2.237; Ashraf-Ganjoei T., 2005, Eastern Mediterranean Health Journal, V11, P410; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Bai GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036934; Baisley K, 2009, SEX TRANSM INFECT, V85, P370, DOI 10.1136/sti.2008.035543; BARBONE F, 1990, AM J OBSTET GYNECOL, V163, P510, DOI 10.1016/0002-9378(90)91186-G; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Bradshaw CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057688; Bradshaw CS, 2013, CLIN INFECT DIS, V56, P777, DOI 10.1093/cid/cis1030; Bradshaw CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034540; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bradshaw CS, 2005, OBSTET GYNECOL, V106, P105, DOI 10.1097/01.AOG.0000163247.78533.7b; Brotman RM, 2011, INT J STD AIDS, V22, P231, DOI 10.1258/ijsa.2011.010307; Bukusi E, 2011, SEX TRANSM DIS, V38, P483, DOI 10.1097/OLQ.0b013e318214b82d; Caldeira D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4260; Calzolari E, 2000, INT J GYNECOL OBSTET, V70, P341, DOI 10.1016/S0020-7292(00)00217-4; Cauci S, 2007, MOL HUM REPROD, V13, P243, DOI 10.1093/molehr/gam002; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; COHEN CR, 1995, AIDS, V9, P1093, DOI 10.1097/00002030-199509000-00017; Dan M, 2003, ISRAEL MED ASSOC J, V5, P629; Evans AL, 2007, SEX TRANSM INFECT, V83, P470, DOI 10.1136/sti.2006.022277; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fethers KA, 2009, J INFECT DIS, V200, P1662, DOI 10.1086/648092; Fonck K, 2001, SEX TRANSM INFECT, V77, P271, DOI 10.1136/sti.77.4.271; Gallo MF, 2012, ANN EPIDEMIOL, V22, P213, DOI 10.1016/j.annepidem.2011.11.005; Grio R, 2004, Minerva Ginecol, V56, P141; Guerreiro D, 1998, INT J GYNECOL OBSTET, V63, pS167, DOI 10.1016/S0020-7292(98)00201-X; HART G, 1993, INT J STD AIDS, V4, P21, DOI 10.1177/095646249300400105; Harville EW, 2005, J WOMENS HEALTH, V14, P627, DOI 10.1089/jwh.2005.14.627; Hassan WM, 2007, SEX TRANSM DIS, V34, P384, DOI 10.1097/01.olq.0000243624.74573.63; HAY PE, 1994, BRIT J OBSTET GYNAEC, V101, P1048, DOI 10.1111/j.1471-0528.1994.tb13580.x; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hel Z, 2010, ENDOCR REV, V31, P79, DOI 10.1210/er.2009-0018; Hensel KJ, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.013; HILLIER SL, 1991, GENITOURIN MED, V67, P26; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Holzman C, 2001, AM J PUBLIC HEALTH, V91, P1664, DOI 10.2105/AJPH.91.10.1664; Jarosik GP, 1998, INFECT IMMUN, V66, P5041, DOI 10.1128/IAI.66.10.5041-5047.1998; Joesoef MR, 2001, CONTRACEPTION, V64, P169, DOI 10.1016/S0010-7824(01)00246-3; Kampan NC, 2011, SEX REPROD HEALTHC, V2, P1, DOI 10.1016/j.srhc.2010.11.002; King Anne E, 2003, Reprod Biol Endocrinol, V1, P116, DOI 10.1186/1477-7827-1-116; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P184, DOI 10.1097/OLQ.0b013e3181c04865; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c; Kleinschmidt I, 2007, CONTRACEPTION, V75, P461, DOI 10.1016/j.contraception.2007.02.002; Koumans EH, 2002, CLIN INFECT DIS, V35, pS152, DOI 10.1086/342103; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; LEFEVRE JC, 1988, SEX TRANSM DIS, V15, P110, DOI 10.1097/00007435-198804000-00009; Mares D, 2008, J REPROD IMMUNOL, V77, P91, DOI 10.1016/j.jri.2007.04.004; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Mascarenhas Rita Elizabeth Moreira, 2012, Infect Dis Obstet Gynecol, V2012, P378640, DOI 10.1155/2012/378640; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moi H, 1990, Int J STD AIDS, V1, P86; Morison L, 2005, SEX TRANSM INFECT, V81, P242, DOI 10.1136/sti.2004.011684; Mossop H, 2011, OBSTET GYNECOL, V118, P840, DOI 10.1097/AOG.0b013e31822da9e9; Nansel TR, 2006, AM J OBSTET GYNECOL, V194, P381, DOI 10.1016/j.ajog.2005.07.047; Ness RB, 2003, J NATL MED ASSOC, V95, P201; Ness RB, 2002, OBSTET GYNECOL, V100, P765, DOI 10.1016/S0029-7844(02)02184-1; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; O'Hanlon DE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-120; Oduyebo OO, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006055.pub2; Peipert JF, 2008, SEX TRANSM DIS, V35, P363, DOI 10.1097/OLQ.0b013e31815e4179; Perla M E, 2012, Infect Dis Obstet Gynecol, V2012, P739624, DOI 10.1155/2012/739624; Pettifor A, 2009, CONTRACEPTION, V80, P555, DOI 10.1016/j.contraception.2009.06.007; Plitt SS, 2005, SEX TRANSM DIS, V32, P446, DOI 10.1097/01.olq.0000154567.21291.59; Rifkin SB, 2009, CONTRACEPTION, V80, P63, DOI 10.1016/j.contraception.2009.01.008; Riggs M, 2007, SEX TRANSM DIS, V34, P954, DOI 10.1097/OLQ.0b013e31811ed0e4; Rugpao S, 2008, SEX TRANSM DIS, V35, P643, DOI 10.1097/OLQ.0b013e31816f70f2; Schwebke JR, 1997, SEX TRANSM DIS, V24, P236, DOI 10.1097/00007435-199704000-00009; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Schwebke JR, 2004, SEX TRANSM DIS, V31, P433, DOI [10.1097/01.OLQ.0000129948.91055.9F, 10.1097/01.olq.0000129948.91055.9F]; Shoubnikova M, 1997, CONTRACEPTION, V55, P355, DOI 10.1016/S0010-7824(97)00044-9; Smart S, 2004, SEX TRANSM INFECT, V80, P58, DOI 10.1136/sti.2003.004978; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tibaldi C, 2009, CLIN MICROBIOL INFEC, V15, P670, DOI 10.1111/j.1469-0691.2009.02842.x; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Watcharotone Wiset, 2004, Journal of the Medical Association of Thailand, V87, P1419; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; Yen S, 2003, OBSTET GYNECOL, V102, P927, DOI 10.1016/S0029-7844(03)00858-5; Yotebieng M, 2009, TROP MED INT HEALTH, V14, P480, DOI 10.1111/j.1365-3156.2009.02235.x; Zenilman JM, 1999, SEX TRANSM INFECT, V75, P347, DOI 10.1136/sti.75.5.347	89	74	85	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73055	10.1371/journal.pone.0073055	http://dx.doi.org/10.1371/journal.pone.0073055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023807	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600062
J	Wang, JY; Zhu, KX; Zhao, G; Ren, J; Yue, C; Gao, DY				Wang, Jianye; Zhu, Kaixuan; Zhao, Gang; Ren, Jian; Yue, Cui; Gao, Dayong			Dual Dependence of Cryobiogical Properties of Sf21 Cell Membrane on the Temperature and the Concentration of the Cryoprotectant	PLOS ONE			English	Article							TRANSPORT-PROPERTIES; WATER PERMEABILITY; EXPRESSION SYSTEM; ACTIVATION-ENERGY; OSMOTIC RESPONSE; INSECT CELLS; COEFFICIENTS; RECOMBINANT; MICROSCOPE; MECHANISMS	The Sf21 cell line is extensively used for virus research and producing heterologous recombinant proteins. To develop optimal strategies for minimizing cell injury due to intracellular ice formation and excessive volume shrinkage during cryopreservation, the fundamental transport properties including the osmotic inactive volume (V-b), the hydraulic conductivity (L-p), and the glycerol permeability (P-s) of Sf21 cell membrane at 25, 15, 5 and -2 degrees C were characterized using a micro-perfusion chamber. The effects of temperature on the hydraulic conductivity and the glycerol permeability of Sf21 cell membrane, reflected by the activation energies, were quantitatively investigated. It was found that the hydraulic conductivity decreases along with the increase of the final CPA concentration at a given temperature, and quantitative analysis indicates that the hydraulic conductivity has a significant linear attenuation along with the increase of the concentration of glycerol. Therefore, we incorporate the concentration dependence of the hydraulic conductivity into the classic Arrhenius relationship by replacing the constant reference value of the hydraulic conductivity at the reference temperature with a function that is linearly dependent on the CPA concentration. Consequently, the prediction of the Arrhenius relationship is improved, and the novel Arrhenius relationship could be very important to the development of optimal strategies for cell cryopreservation.	[Wang, Jianye; Zhu, Kaixuan; Zhao, Gang; Ren, Jian; Yue, Cui; Gao, Dayong] Univ Sci & Technol China, Dept Elect Sci & Technol, Inst Biomed Engn, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhao, G (corresponding author), Univ Sci & Technol China, Dept Elect Sci & Technol, Inst Biomed Engn, Hefei 230026, Anhui, Peoples R China.	zhaog@ustc.edu.cn	Zhao, Gang/C-8125-2011; Ren, Jian/AAP-2636-2021	Zhao, Gang/0000-0002-0201-1825; 	National Natural Science Foundation of China [51076149, 51276179]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Nos. 51076149, 51276179) (http://www.nsfc.gov.cn), and the Fundamental Research Funds for the Central Universities (http://www.moe.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Chen HH, 2007, CRYOBIOLOGY, V55, P200, DOI 10.1016/j.cryobiol.2007.08.001; Devireddy RV, 2006, MOL REPROD DEV, V73, P330, DOI 10.1002/mrd.20418; DILLER KR, 1984, J BIOMECH ENG-T ASME, V106, P384, DOI 10.1115/1.3138510; Drugmand JC, 2012, BIOTECHNOL ADV, V30, P1140, DOI 10.1016/j.biotechadv.2011.09.014; GAO DY, 1994, J REPROD FERTIL, V102, P385, DOI 10.1530/jrf.0.1020385; Gao DY, 1996, BIOPHYS J, V71, P443, DOI 10.1016/S0006-3495(96)79246-9; Gomez-Sebastian S, 2008, J VIROL METHODS, V153, P29, DOI 10.1016/j.jviromet.2008.06.017; Hancock K, 2008, J IMMUNOL METHODS, V330, P130, DOI 10.1016/j.jim.2007.08.002; He X, 2006, J APPL PHYS, V100, P074702; HEMPLING HG, 1984, CRYOBIOLOGY, V21, P133, DOI 10.1016/0011-2240(84)90204-9; HUNTER JE, 1992, CRYOBIOLOGY, V29, P240, DOI 10.1016/0011-2240(92)90022-T; Ikonomou L, 2003, APPL MICROBIOL BIOT, V62, P1, DOI 10.1007/s00253-003-1223-9; KARLSSON JOM, 1994, J APPL PHYS, V75, P4442, DOI 10.1063/1.355959; KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5; LEIBO SP, 1980, J MEMBRANE BIOL, V53, P179, DOI 10.1007/BF01868823; LEVIN RL, 1976, BIOPHYS J, V16, P1411, DOI 10.1016/S0006-3495(76)85784-0; LOVELOCK JE, 1957, PROC R SOC SER B-BIO, V147, P427, DOI 10.1098/rspb.1957.0062; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MCGRATH JJ, 1985, J MICROSC-OXFORD, V139, P249, DOI 10.1111/j.1365-2818.1985.tb02641.x; McGrath JJ, 1988, AM SOC MECH ENG, P273; Metz SW, 2011, J INVERTEBR PATHOL, V107, pS16, DOI 10.1016/j.jip.2011.05.002; Pfaff RT, 2000, BIOL REPROD, V63, P1294, DOI 10.1095/biolreprod63.5.1294; RUBIN SC, 1993, OVARIAN CANC; Sandino E-M, 2005, PRINCIPLES APPL INSE, P627; STEVENS A, 1996, HUMAN HISTOLOGY; Takamatsu H, 2004, J BIOMECH ENG-T ASME, V126, P402, DOI 10.1115/1.1784474; TONER M, 1993, BIOPHYS J, V64, P1908, DOI 10.1016/S0006-3495(93)81562-5; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Vijayachandran LS, 2011, J STRUCT BIOL, V175, P198, DOI 10.1016/j.jsb.2011.03.007; WILLIAMS ML, 1955, J AM CHEM SOC, V77, P3701, DOI 10.1021/ja01619a008; Yoshimori T, 2009, CRYOBIOLOGY, V58, P52, DOI 10.1016/j.cryobiol.2008.10.128; Zhao G, 2010, CRYOLETTERS, V31, P279	33	8	10	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72836	10.1371/journal.pone.0072836	http://dx.doi.org/10.1371/journal.pone.0072836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023781	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600049
J	Goncalves, LCP; Da Silva, SM; DeRose, PC; Ando, RA; Bastos, EL				Pires Goncalves, Leticia Christina; Da Silva, Sandra Maria; DeRose, Paul C.; Ando, Romulo Augusto; Bastos, Erick Leite			Beetroot-Pigment-Derived Colorimetric Sensor for Detection of Calcium Dipicolinate in Bacterial Spores	PLOS ONE			English	Article							SENSITIZED SOLAR-CELLS; ENHANCED RAMAN-SPECTROSCOPY; BACILLUS-ANTHRACIS; BIOLOGICAL WEAPON; RAPID DETECTION; BETANIN; LUMINESCENCE; BIOMARKER; CEREUS; ASSAY	In this proof-of-concept study, we describe the use of the main red beet pigment betanin for the quantification of calcium dipicolinate in bacterial spores, including Bacillus anthracis. In the presence of europium(III) ions, betanin is converted to a water-soluble, non-luminescent orange 1: 1 complex with a stability constant of 1.4x10(5) L mol(-1). The addition of calcium dipicolinate, largely found in bacterial spores, changes the color of the aqueous solution of [Eu(Bn)(+)] from orange to magenta. The limit of detection (LOD) of calcium dipicolinate is around 2.0x10(-6) mol L-1 and the LOD determined for both spores, B. cereus and B. anthracis, is (1.1 +/- 0.3)x10(6) spores mL(-1). This simple, green, fast and low cost colorimetric assay was selective for calcium dipicolinate when compared to several analogous compounds. The importance of this work relies on the potential use of betalains, raw natural pigments, as colorimetric sensors for biological applications.	[Pires Goncalves, Leticia Christina] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Da Silva, Sandra Maria; DeRose, Paul C.] NIST, Biosyst & Biomat Div, Chem Sci Technol Lab, Gaithersburg, MD 20899 USA; [Ando, Romulo Augusto; Bastos, Erick Leite] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); National Institute of Standards & Technology (NIST) - USA; Universidade de Sao Paulo	Bastos, EL (corresponding author), Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil.	elbastos@iq.usp.br	Bastos, Erick L/F-8746-2012; Gonçalves, Letícia/AAB-9283-2021; Ando, Romulo Augusto/C-9665-2012; Goncalves, Letícia C. P./N-1439-2015	Bastos, Erick L/0000-0002-0592-9455; Gonçalves, Letícia/0000-0002-1195-9810; Ando, Romulo Augusto/0000-0002-3872-8094; Goncalves, Letícia C. P./0000-0002-1195-9810	Sao Paulo Research Foundation (FAPESP) [07/00684-6, 11/23036-5]; FAPESP [07/59407-1]; Coordination for the Improvement of Higher Education Personnel (CAPES) [PNPD 427-10/2009]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by the Sao Paulo Research Foundation (FAPESP, 07/00684-6 and 11/23036-5). LCPG was supported by a FAPESP fellowship (07/59407-1) and the Coordination for the Improvement of Higher Education Personnel (CAPES, PNPD 427-10/2009) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann AB, 2011, INT J MICROBIOL, V2011; ATTOE EL, 1984, Z LEBENSM UNTERS FOR, V179, P232, DOI 10.1007/BF01041900; Bartoloni FH, 2013, MONATSH CHEM, V144, P567, DOI 10.1007/s00706-012-0883-5; Cable ML, 2007, J AM CHEM SOC, V129, P1474, DOI 10.1021/ja061831t; Cable ML, 2009, J AM CHEM SOC, V131, P9562, DOI 10.1021/ja902291v; Cheng HW, 2011, ANAL CHIM ACTA, V707, P155, DOI 10.1016/j.aca.2011.09.007; Downey AS, 2012, APPL ENVIRON MICROB, V78, P5872, DOI 10.1128/AEM.00873-12; DRAGON DC, 1995, CAN VET J, V36, P295; Faille C, 1997, J FOOD PROTECT, V60, P544, DOI 10.4315/0362-028X-60.5.544; Fernandez-Ramos MD, 2011, ANAL BIOANAL CHEM, V401, P2881, DOI 10.1007/s00216-011-5366-8; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; GOULD GW, 1977, J APPL BACTERIOL, V42, P297, DOI 10.1111/j.1365-2672.1977.tb00697.x; GRENTHE I, 1961, J AM CHEM SOC, V83, P360, DOI 10.1021/ja01463a024; Hindle AA, 1999, ANALYST, V124, P1599, DOI 10.1039/a906846e; Hirose K, 2001, J INCL PHENOM MACRO, V39, P193, DOI 10.1023/A:1011117412693; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Irenge LM, 2012, APPL MICROBIOL BIOT, V93, P1411, DOI 10.1007/s00253-011-3845-7; KROPP JL, 1967, J PHYS CHEM-US, V71, P477, DOI 10.1021/j100862a003; Lee I, 2013, J HAZARD MATER, V252, P186, DOI 10.1016/j.jhazmat.2013.03.003; MURTY GGK, 1957, J BACTERIOL, V73, P235, DOI 10.1128/JB.73.2.235-240.1957; NILSSON T, 1970, Lantbrukshogskolans Annaler, V36, P179; Oh WK, 2011, BIOSENS BIOELECTRON, V29, P172, DOI 10.1016/j.bios.2011.08.013; Pellegrino PM, 1998, ANAL CHEM, V70, P1755, DOI 10.1021/ac971232s; PERRY J. J., 1955, JOUR BACT, V69, P337; Goncalves LCP, 2013, J FOOD ENG, V118, P49, DOI 10.1016/j.jfoodeng.2013.03.022; Goncalves LCP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053874; Goncalves LCP, 2012, FOOD CHEM, V131, P231, DOI 10.1016/j.foodchem.2011.08.067; Qin CY, 2007, CHEM PHYS LETT, V438, P26, DOI 10.1016/j.cplett.2007.02.063; Rao SS, 2010, J MICROBIOL METH, V82, P1, DOI 10.1016/j.mimet.2010.04.005; Ravichandran K, 2012, FOOD RES INT, V48, P16, DOI 10.1016/j.foodres.2012.01.011; Rosen DL, 1997, ANAL CHEM, V69, P1082, DOI 10.1021/ac960939w; Saleh L, 2010, NAT PROTOC, V5, P1635, DOI 10.1038/nprot.2010.121; Salter SJ, 2011, NAT REV MICROBIOL, V9, P83, DOI 10.1038/nrmicro2506; Sanderson WT, 2004, J APPL MICROBIOL, V96, P1048, DOI 10.1111/j.1365-2672.2004.02223.x; Sandquist C, 2011, J PHOTOCH PHOTOBIO A, V221, P90, DOI 10.1016/j.jphotochem.2011.04.030; Setlow B, 2008, J BACTERIOL, V190, P4759, DOI 10.1128/JB.00399-08; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Shafaat HS, 2006, APPL ENVIRON MICROB, V72, P6808, DOI 10.1128/AEM.00255-06; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; Wootton-Beard PC, 2011, J FUNCT FOODS, V3, P329, DOI 10.1016/j.jff.2011.05.007; Yang WW, 2009, INT J FOOD MICROBIOL, V133, P213, DOI 10.1016/j.ijfoodmicro.2009.04.024; Yilmaz MD, 2010, ANGEW CHEM INT EDIT, V49, P5938, DOI 10.1002/anie.201000540; Yoe J., 1944, IND ENG CHEM ANAL ED, V16, P111, DOI [DOI 10.1021/I560126A015, 10.1021/i560126a015]; Zhang BH, 2008, ADV FUNCT MATER, V18, P2348, DOI 10.1002/adfm.200800153; Zhang D, 2008, J PHOTOCH PHOTOBIO A, V195, P72, DOI 10.1016/j.jphotochem.2007.07.038; Zhang XY, 2005, J AM CHEM SOC, V127, P4484, DOI 10.1021/ja043623b	47	23	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73701	10.1371/journal.pone.0073701	http://dx.doi.org/10.1371/journal.pone.0073701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019934	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200076
J	Sigala, B; McKee, C; Soeda, J; Pazienza, V; Morgan, M; Lin, CI; Selden, C; Vander Borght, S; Mazzoccoli, G; Roskams, T; Vinciguerra, M; Oben, JA				Sigala, Barbara; McKee, Chad; Soeda, Junpei; Pazienza, Valerio; Morgan, Maelle; Lin, Ching-I; Selden, Clare; Vander Borght, Sara; Mazzoccoli, Gianluigi; Roskams, Tania; Vinciguerra, Manlio; Oben, Jude A.			Sympathetic Nervous System Catecholamines and Neuropeptide Y Neurotransmitters Are Upregulated in Human NAFLD and Modulate the Fibrogenic Function of Hepatic Stellate Cells	PLOS ONE			English	Article							PORTAL-HYPERTENSION; LIVER-CIRRHOSIS; FIBROSIS; NOREPINEPHRINE; DISEASE; LEPTIN; INHIBITION; EXPRESSION; RESISTANCE; RECEPTORS	Background: Sympathetic nervous system (SNS) signalling regulates murine hepatic fibrogenesis through effects on hepatic stellate cells (HSC), and obesity-related hypertension with SNS activation accelerates progression of non-alcoholic fatty liver disease (NAFLD), the commonest cause of chronic liver disease. NAFLD may lead to cirrhosis. The effects of the SNS neurotransmitters norepinephrine (NE), epinephrine (EPI) and neuropeptide Y (NPY) on human primary HSC (hHSC) function and in NAFLD pathogenesis are poorly understood. Aims: to determine the mechanistic effects of NE/EPI/NPY on phenotypic changes in cultured hHSC, and to study SNS signalling in human NAFLD livers. Methods: Freshly isolated hHSC were assessed for expression of cathecholamine/neuropeptide Y receptors and for the synthesis of NE/EPI. The effects of NE/EPI/NPY and adrenoceptor antagonists prazosin (PRZ)/propranolol (PRL) on hHSC fibrogenic functions and the involved kinases and interleukin pathways were examined. Human livers with proven NAFLD were then assessed for upregulation of SNS signalling components. Results: Activated hHSC express functional alpha/beta-adrenoceptors and NPY receptors, which are upregulated in the livers of patients with cirrhotic NAFLD. hHSC in culture synthesize and release NE/EPI, required for their optimal basal growth and survival. Exogenous NE/EPI and NPY dose-dependently induced hHSC proliferation, mediated via p38 MAP, PI3K and MEK signalling. NE and EPI but not NPY increased expression of collagen-1 alpha 2 via TGF-beta without involvement of the pro-fibrogenic cytokines leptin, IL-4 and IL-13 or the anti-fibrotic cytokine IL-10. Conclusions: hHSC synthesize and require cathecholamines for optimal survival and fibrogenic functionality. Activated hHSC express directly fibrogenic alpha/beta-adrenoceptors and NPY receptors, upregulated in human cirrhotic NAFLD. Adrenoceptor and NPY antagonists may be novel anti-fibrotic agents in human NAFLD.	[Sigala, Barbara; McKee, Chad; Soeda, Junpei; Morgan, Maelle; Lin, Ching-I; Selden, Clare; Vinciguerra, Manlio; Oben, Jude A.] UCL, Royal Free Hosp, Inst Liver & Digest Hlth, London, England; [Pazienza, Valerio; Vinciguerra, Manlio] Hosp San Giovanni Rotondo FG, IRCCS Casa Sollievo Sofferenza, Gastroenterol Unit, San Giovanni, Italy; [Vander Borght, Sara; Roskams, Tania] Univ Hosp Leuven, Lab Morphol & Mol Pathol, Dept Pathol, Louvain, Belgium; [Mazzoccoli, Gianluigi] IRCCS Sci Inst, Div Internal Med, Dept Med Sci, San Giovanni Rotondo, FG, Italy; [Mazzoccoli, Gianluigi] Reg Gen Hosp Casa Sollievo Sofferenza, San Giovanni Rotondo, FG, Italy; [Oben, Jude A.] Guys & St Thomas Hosp, Dept Gastroenterol & Hepatol, London SE1 9RT, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; IRCCS Casa Sollievo Della Sofferenza; KU Leuven; University Hospital Leuven; IRCCS Casa Sollievo Della Sofferenza; Guy's & St Thomas' NHS Foundation Trust	Vinciguerra, M (corresponding author), UCL, Royal Free Hosp, Inst Liver & Digest Hlth, London, England.	m.vinciguerra@ucl.ac.uk; j.oben@ucl.ac.uk	Mazzoccoli, Gianluigi/H-2447-2016; Pazienza, Valerio/K-5073-2012; Soeda, Junpei/AAC-4816-2020; OBEN, JUDE A/K-4331-2013; Vinciguerra, Manlio/N-1309-2015	Mazzoccoli, Gianluigi/0000-0003-3535-7635; Pazienza, Valerio/0000-0002-3492-1153; Vinciguerra, Manlio/0000-0002-1768-3894; Soeda, Junpei/0000-0003-3753-0999; Selden, Angela/0000-0003-2648-443X; Roskams, Tania/0000-0002-2816-1530; Oben, Jude/0000-0003-3350-8356	Wellcome Trust; Italian Ministry of Health, Bando [GR-2010-2311017]; My First AIRC Grant (MFAG) [13419]	Wellcome Trust(Wellcome TrustEuropean Commission); Italian Ministry of Health, Bando; My First AIRC Grant (MFAG)(Fondazione AIRC per la ricerca sul cancro)	JAO received funding from the Wellcome Trust. VP and MV were supported by the Italian Ministry of Health, Bando GR-2010-2311017. MV was supported also by a My First AIRC Grant (MFAG, n.13419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2013, NAT REV GASTROENTERO; Aoudjehane L, 2008, LAB INVEST, V88, P973, DOI 10.1038/labinvest.2008.61; Benegiamo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060527; Bonnefont-Rousselot D, 2002, REDOX REP, V7, P145, DOI 10.1179/135100002125000389; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Cassiman D, 1999, AM J PATHOL, V155, P1831, DOI 10.1016/S0002-9440(10)65501-0; Cavadas C, 2006, P NATL ACAD SCI USA, V103, P10497, DOI 10.1073/pnas.0600913103; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Deblon N, 2012, BRIT J PHARMACOL, V165, P2325, DOI 10.1111/j.1476-5381.2011.01716.x; Galuppo M, 2011, N-S ARCH PHARMACOL, V384, P21, DOI 10.1007/s00210-011-0637-7; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; James O, 1999, LANCET, V353, P1634, DOI 10.1016/S0140-6736(99)00163-4; Lee Y, 2010, PROG MOL BIOL TRANSL, V97, P151, DOI 10.1016/B978-0-12-385233-5.00006-4; LUNDBERG JM, 1985, REGUL PEPTIDES, V13, P41, DOI 10.1016/0167-0115(85)90085-0; Marra F, 1999, J HEPATOL, V31, P1120; Moller S, 2010, J HEPATOL, V53, P179, DOI 10.1016/j.jhep.2010.02.023; Oben J, 2008, BIOCHEMISTRY-US, V9, P47; Oben JA, 2004, GUT, V53, P438, DOI 10.1136/gut.2003.026658; Oben JA, 2003, BIOCHEM BIOPH RES CO, V308, P284, DOI 10.1016/S0006-291X(03)01360-3; Oben JA, 2003, BIOCHEM BIOPH RES CO, V302, P685, DOI 10.1016/S0006-291X(03)00232-8; Pazienza V, 2010, J GEN VIROL, V91, P1678, DOI 10.1099/vir.0.020644-0; Rappa F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054458; Rodriguez B, 2012, NAT REV GASTRO HEPAT, V9, P726, DOI 10.1038/nrgastro.2012.200; Rumantir MS, 1999, J HYPERTENS, V17, P1125, DOI 10.1097/00004872-199917080-00012; Sancho-Bru P, 2006, AM J PHYSIOL-GASTR L, V291, pG877, DOI 10.1152/ajpgi.00537.2005; Saxena NK, 2002, HEPATOLOGY, V36, p316A; Schwabe RF, 2001, J IMMUNOL, V166, P6812, DOI 10.4049/jimmunol.166.11.6812; Sivamani RK, 2007, DERMATOL CLIN, V25, P643, DOI 10.1016/j.det.2007.06.012; Soeda J, 2012, BIOCHEM BIOPH RES CO, V417, P17, DOI 10.1016/j.bbrc.2011.10.151; Strack I, 2011, LAB INVEST, V91, P252, DOI 10.1038/labinvest.2010.162; Theocharidou E, 2012, LIVER INT, V32, P1327, DOI 10.1111/j.1478-3231.2011.02751.x; Trebicka J, 2009, HEPATOLOGY, V50, P1924, DOI 10.1002/hep.23222; Vasina V, 2012, BRIT J PHARMACOL, V167, P1137, DOI 10.1111/j.1476-5381.2012.02074.x; YOUNG JB, 1977, SCIENCE, V196, P1473, DOI 10.1126/science.867049; Zhang LJ, 2007, HEPATO-GASTROENTEROL, V54, P2092	36	54	55	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72928	10.1371/journal.pone.0072928	http://dx.doi.org/10.1371/journal.pone.0072928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019886	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200028
J	Guo, PT; Zhu, Z; Sun, Z; Wang, ZN; Zheng, XY; Xu, HMA				Guo, Pengtao; Zhu, Zhi; Sun, Zhe; Wang, Zhenning; Zheng, Xinyu; Xu, Huimian			Expression of Legumain Correlates with Prognosis and Metastasis in Gastric Carcinoma	PLOS ONE			English	Article							CYSTEINE PEPTIDASES; CANCER; GROWTH; ANGIOGENESIS; ACTIVATION; INVASION; TUMORS	Objective: Legumain, a novel asparaginyl endopeptidase, has been observed to be highly expressed in several types of tumors, which may play a vital role in carcinogenesis. However, there is no study investigating the relationship among Legumain expression, clinicopathologic, biological variables and patient prognosis in gastric carcinoma. Methods: In this study, a tissue microarray (TMA) containing 282 samples of primary gastric cancer was assessed for Legumain expression by immunohistochemistry. The TMA included 98 lymph node metastasis samples. The protein expression levels of Legumain were evaluated by Western blot analysis. Results: Cytoplasmic immunoreactivity of Legumain was over-expressed in gastric cancer compared with paired normal gastric mucosa. Increased Legumain levels were significantly correlated with clinical stage, presence of distant metastasis. Legumain was significantly over-expressed in primary gastric cancer with metastasis than without metastasis. Patients with Legumain-positive localized tumors had lower 5-year overall survival (OS) than those with Legumain-negative tumors. Multivariate survival analysis showed that Legumain was an independent prognostic marker for OS (HR 1.459, 95% CI 1.251-1.703, P = 0.007). Conclusions: Legumain expression could serve as a prognostic biomarker in patients at risk of developing metastasis or recurrence with gastric carcinoma.	[Guo, Pengtao; Zhu, Zhi; Sun, Zhe; Wang, Zhenning; Zheng, Xinyu; Xu, Huimian] China Med Univ, Affiliated Hosp 1, Dept Gen Surg, Dept Surg Oncol, Shenyang, Peoples R China; [Zheng, Xinyu] China Med Univ, Inst Canc, Lab 1, Shenyang, Peoples R China	China Medical University; China Medical University	Xu, HMA (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gen Surg, Dept Surg Oncol, Shenyang, Peoples R China.	xuhuimian@126.com	Zheng, Xinyu/O-9847-2018; Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011	Zheng, Xinyu/0000-0001-8425-3379; wang, zhen ning/0000-0003-0557-3097	Young scholars' Research Fund for the Doctoral Program of Higher Education of China [20122104120008]	Young scholars' Research Fund for the Doctoral Program of Higher Education of China	Supported by grants from the Young scholars' Research Fund for the Doctoral Program of Higher Education of China (No. 20122104120008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajjuri KM, 2011, CHEMMEDCHEM, V6, P54, DOI 10.1002/cmdc.201000478; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; Choi SJ, 1999, J BIOL CHEM, V274, P27747, DOI 10.1074/jbc.274.39.27747; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gawenda J, 2007, BREAST CANCER RES TR, V102, P1, DOI 10.1007/s10549-006-9311-z; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lewen S, 2008, CANCER IMMUNOL IMMUN, V57, P507, DOI 10.1007/s00262-007-0389-x; Liu C, 2003, CANCER RES, V63, P2957; Ma JX, 2000, J BIOL CHEM, V275, P12806, DOI 10.1074/jbc.275.17.12806; Murthy RV, 2005, CLIN CANCER RES, V11, P2293, DOI 10.1158/1078-0432.CCR-04-1642; Ohno Y, 2012, WORLD J UROL; Rutkowski P, 2011, CANCER-AM CANCER SOC, V117, P4916, DOI 10.1002/cncr.26079; Santamaria ME, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-307; Siewinski Maciej, 2002, Med Sci Monit, V8, pBR540; Stern L, 2009, BIOCONJUGATE CHEM, V20, P500, DOI 10.1021/bc800448u; Vigneswaran N, 2006, LIFE SCI, V78, P898, DOI 10.1016/j.lfs.2005.05.096; Wang LN, 2012, J CELL BIOCHEM, V113, P2679, DOI 10.1002/jcb.24143; Wu WY, 2006, CANCER RES, V66, P970, DOI 10.1158/0008-5472.CAN-05-2591; Zhu Z, 2011, CANCER BIOL THER, V11, P874, DOI 10.4161/cbt.11.10.15182	21	47	49	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73090	10.1371/journal.pone.0073090	http://dx.doi.org/10.1371/journal.pone.0073090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023813	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400042
J	Ong, BA; Li, J; McDonough, JM; Wei, Z; Kim, C; Chiavacci, R; Mentch, F; Caboot, JB; Spergel, J; Allen, JL; Sleiman, PMA; Hakonarson, H				Ong, Bruce A.; Li, Jin; McDonough, Joseph M.; Wei, Zhi; Kim, Cecilia; Chiavacci, Rosetta; Mentch, Frank; Caboot, Jason B.; Spergel, Jonathan; Allen, Julian L.; Sleiman, Patrick M. A.; Hakonarson, Hakon			Gene Network Analysis in a Pediatric Cohort Identifies Novel Lung Function Genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PULMONARY-FUNCTION; N-CADHERIN; DISEASES; CATENIN; MORPHOGENESIS; EXPRESSION; HEALTH; TWIN	Lung function is a heritable trait and serves as an important clinical predictor of morbidity and mortality for pulmonary conditions in adults, however, despite its importance, no studies have focused on uncovering pediatric-specific loci influencing lung function. To identify novel genetic determinants of pediatric lung function, we conducted a genome-wide association study (GWAS) of four pulmonary function traits, including FVC, FEV1, FEV1/FVC and FEF25-75% in 1556 children. Further, we carried out gene network analyses for each trait including all SNPs with a P-value of <1.0x10(-3) from the individual GWAS. The GWAS identified SNPs with notable trends towards association with the pulmonary function measures, including the previously described INTS12 locus association with FEV1 (p(meta) = 1.41x10(-7)). The gene network analyses identified 34 networks of genes associated with pulmonary function variables in Caucasians. Of those, the glycoprotein gene network reached genome-wide significance for all four variables. P-value range p(meta) = 6.29x10(-4)-2.80x10(-8) on meta-analysis. In this study, we report on specific pathways that are significantly associated with pediatric lung function at genome-wide significance. In addition, we report the first loci associated with lung function in both pediatric Caucasian and African American populations.	[Ong, Bruce A.; McDonough, Joseph M.; Allen, Julian L.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Ong, Bruce A.; McDonough, Joseph M.; Allen, Julian L.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Cyst Fibrosis Ctr, Philadelphia, PA 19104 USA; [Li, Jin; Kim, Cecilia; Chiavacci, Rosetta; Mentch, Frank; Sleiman, Patrick M. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Caboot, Jason B.] Madigan Army Med Ctr, Div Pediat Pulmonol, Tacoma, WA 98431 USA; [Spergel, Jonathan] Childrens Hosp Philadelphia, Ctr Pediat Eosinophil Disorders, Philadelphia, PA 19104 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Spergel, Jonathan; Allen, Julian L.; Sleiman, Patrick M. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Spergel, Jonathan] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; New Jersey Institute of Technology; Madigan Army Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sleiman, PMA (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	sleimanp@email.chop.edu; hakonarson@email.chop.edu	, AndyWei/H-4415-2012	Spergel, Jonathan/0000-0002-4658-5353; Wei, Zhi/0000-0001-6059-4267	Pennsylvania State Grant (SAP) [4100042728]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006830] Funding Source: NIH RePORTER	Pennsylvania State Grant (SAP); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was funded by an Institutional Development Fund to The Center for Applied Genomics, and by a Pennsylvania State Grant (SAP Number: 4100042728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTIGAS MS, 2011, NAT GENET, V43, P1082, DOI DOI 10.1038/NG.941; Baughman P, 2011, COPD, V8, P103, DOI 10.3109/15412555.2011.558544; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlsen KCL, 2009, CURR OPIN ALLERGY CL, V9, P146, DOI 10.1097/ACI.0b013e3283292243; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Givelber RJ, 1998, AM J RESP CRIT CARE, V157, P1445, DOI 10.1164/ajrccm.157.5.9704021; Gottlieb DJ, 2001, AM J RESP CRIT CARE, V164, P1655, DOI 10.1164/ajrccm.164.9.2010122; Guerra S, 2010, THORAX, V65, P499, DOI 10.1136/thx.2009.126052; Gurnett CA, 2010, HUM MOL GENET, V19, P1165, DOI 10.1093/hmg/ddp587; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hsia CCW, 2004, AM J RESP CRIT CARE, V170, P319, DOI 10.1164/rccm.200209-1062ST; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ingebrigtsen TS, 2011, LUNG, V189, P323, DOI 10.1007/s00408-011-9306-3; Kaarteenaho R, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-113; Kim N, 2009, ANAT REC, V292, P123, DOI 10.1002/ar.20799; Kim SH, 2009, CLIN EXP ALLERGY, V39, P203, DOI 10.1111/j.1365-2222.2008.03117.x; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Liu P, 2012, CARCINOGENESIS; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; REDLINE S, 1987, AM REV RESPIR DIS, V135, P217; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Speizer F E, 1979, Epidemiol Rev, V1, P124; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wilk JB, 2000, GENET EPIDEMIOL, V19, P81, DOI 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zynger DL, 2008, HISTOPATHOLOGY, V52, P348, DOI 10.1111/j.1365-2559.2007.02952.x	37	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72899	10.1371/journal.pone.0072899	http://dx.doi.org/10.1371/journal.pone.0072899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023788	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400032
J	Singh, D; Roy, JK				Singh, Divya; Roy, Jagat Kumar			Rab11 Plays an Indispensable Role in the Differentiation and Development of the Indirect Flight Muscles in Drosophila	PLOS ONE			English	Article							MESSENGER-RNA LOCALIZATION; POST-GOLGI TRAFFICKING; MEMBRANE; EXPRESSION; PROLIFERATION; COMPONENTS; RHODOPSIN; MYOBLASTS; PROTEIN; GTPASES	Rab11, an evolutionary conserved, ubiquitously expressed subfamily of small monomeric GTPase has been known to regulate diverse cellular and developmental events, by regulating the exocytotic and transcytotic events inside the cell. Our studies show that Rab11 regulates Drosophila adult myogenesis by controlling proliferation and differentiation of the Adult muscle precursors (AMPs). Blocking Rab11 in the AMPs, which fuse to form the Indirect Flight Muscles (IFMs) of fly, renders flies completely flightless and non-viable. The indirect flight musculature, comprising of the differentially patterned dorsal longitudinal muscles (DLMs) and dorsal ventral muscles (DVMs), is affected to different extents. Abrogating or knocking down normal Rab11 function results in severely disrupted IFMs. DLMs forming from larval templates are reduced in number along with a significant reduction in their fibre size. The de novo developing DVMs are frequently absent. The DLMs in Rab11 hypomorphs are highly reduced, showing as a small constricted mass in one half of the thorax. Further, Rab11 function is essential for growth of these muscles during later half of adult myogenesis, as down regulation of Rab11 in IFMs results in degenerated muscles and broken fibres. Finally, we show that loss of Rab11 activity in the AMPs result in acquisition of migratory characteristic of myoblast as they show cellular protrusion at their polar ends accompanied with loss of cell-cell contacts. Our data provide the first evidence of a trafficking protein playing an indispensable role in regulating early stages of adult muscle development.	[Singh, Divya; Roy, Jagat Kumar] Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Roy, JK (corresponding author), Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India.	jkroy@bhu.ac.in	Tsai, Yu-Chen/B-5852-2008		UGC-Center of Advanced Study in Zoology, Banaras Hindu University, Varanasi, India; Department of Biotechnology, New Delhi, India [BT-BRB-TF-2-2012]	UGC-Center of Advanced Study in Zoology, Banaras Hindu University, Varanasi, India; Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	DS received Junior and Senior Research Fellowship from UGC-Center of Advanced Study in Zoology, Banaras Hindu University, Varanasi, India. This work was supported by research grant from Department of Biotechnology, New Delhi, India (Grant No : BT-BRB-TF-2-2012, URL : dbtindia.nic.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Ali BR, 2005, BIOCHEM SOC T, V33, P652, DOI 10.1042/BST0330652; Alone DP, 2005, INT J DEV BIOL, V49, P873, DOI 10.1387/ijdb.051986da; Anant S, 1998, DEVELOPMENT, V125, P1361; BATE M, 1991, DEVELOPMENT, V113, P79; Bate Michael, 1993, P1013; Bhuin T, 2009, CELL TISSUE RES, V336, P489, DOI 10.1007/s00441-009-0782-1; Bhuin T, 2009, CELL TISSUE RES, V335, P349, DOI 10.1007/s00441-008-0711-8; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; CURRIE DA, 1991, DEVELOPMENT, V113, P91; Deretic D, 1997, ELECTROPHORESIS, V18, P2537, DOI 10.1002/elps.1150181408; Dollar G, 2002, DEVELOPMENT, V129, P517; FERNANDES J, 1991, DEVELOPMENT, V113, P67; Fernandes JJ, 2005, DEV BIOL, V277, P493, DOI 10.1016/j.ydbio.2004.09.038; Gaewski MK, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010713, DOI 10.1371/J0URNAL.P0NE.0010713.PUBMED:20520827]; Jankovics F, 2001, GENETICS, V158, P1177; LAWRENCE PA, 1982, NATURE, V295, P55, DOI 10.1038/295055a0; Lighthouse DV, 2008, DEV BIOL, V317, P59, DOI 10.1016/j.ydbio.2008.02.009; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Muto A, 2006, DEV BIOL, V292, P90, DOI 10.1016/j.ydbio.2005.12.050; Pelissier A, 2003, CURR BIOL, V13, P1848, DOI 10.1016/j.cub.2003.10.023; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Roy S, 1997, DEVELOPMENT, V124, P3333; Sasikumar S, 2009, GENESIS, V47, P32, DOI 10.1002/dvg.20441; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; SPREIJ T E, 1971, Netherlands Journal of Zoology, V21, P221; Taylor MV, 2006, COMP MUSCLE DEV DROS; Tiwari AK, 2008, CELL BIOL INT, V32, P1158, DOI 10.1016/j.cellbi.2008.04.002; Tiwari AK, 2009, EUR J CELL BIOL, V88, P445, DOI 10.1016/j.ejcb.2009.02.188; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Xu J, 2012, PLOS ONE, V6; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	34	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73305	10.1371/journal.pone.0073305	http://dx.doi.org/10.1371/journal.pone.0073305			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023858	Green Submitted, Green Published, gold			2022-12-27	WOS:000324238400059
J	Morata, J; Bejar, S; Talavera, D; Riera, C; Lois, S; de Xaxars, GM; de la Cruz, X				Morata, Jordi; Bejar, Santi; Talavera, David; Riera, Casandra; Lois, Sergio; Mas de Xaxars, Gemma; de la Cruz, Xavier			The Relationship between Gene Isoform Multiplicity, Number of Exons and Protein Divergence	PLOS ONE			English	Article							COMPARATIVE GENOMICS; MESSENGER-RNA; SEQUENCE CONSERVATION; STOCHASTIC NOISE; EVOLUTION; MOUSE; LENGTH; DUPLICATION; PATTERNS; HUMANS	At present we know that phenotypic differences between organisms arise from a variety of sources, like protein sequence divergence, regulatory sequence divergence, alternative splicing, etc. However, we do not have yet a complete view of how these sources are related. Here we address this problem, studying the relationship between protein divergence and the ability of genes to express multiple isoforms. We used three genome-wide datasets of human-mouse orthologs to study the relationship between isoform multiplicity co-occurrence between orthologs (the fact that two orthologs have more than one isoform) and protein divergence. In all cases our results showed that there was a monotonic dependence between these two properties. We could explain this relationship in terms of a more fundamental one, between exon number of the largest isoform and protein divergence. We found that this last relationship was present, although with variations, in other species (chimpanzee, cow, rat, chicken, zebrafish and fruit fly). In summary, we have identified a relationship between protein divergence and isoform multiplicity co-occurrence and explained its origin in terms of a simple gene-level property. Finally, we discuss the biological implications of these findings for our understanding of inter-species phenotypic differences.	[Morata, Jordi; Bejar, Santi; de la Cruz, Xavier] CSIC, IBMB, Dept Struct Biol, Barcelona, Spain; [Talavera, David] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Riera, Casandra; Lois, Sergio; de la Cruz, Xavier] VHIR, Lab Translat Bioinformat Neurosci, Barcelona, Spain; [Mas de Xaxars, Gemma] Univ Barcelona, Fac Farm, Lab Bot, E-08028 Barcelona, Spain; [de la Cruz, Xavier] ICREA, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Manchester; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona; ICREA	de la Cruz, X (corresponding author), CSIC, IBMB, Dept Struct Biol, Barcelona, Spain.	xavier.delacruz@vhir.org	Talavera, David/AAD-2088-2021	Morata, Jordi/0000-0002-6146-4322; De la Cruz Montserrat, Fco. Xavier/0000-0002-9738-8472; Talavera, David/0000-0002-8820-3931	Spanish Ministerio de Economia [BIO2012-40133]; Spanish Ministerio de Educacion y Ciencia [BFU2009-11527]; Spanish Ministerio de Ciencia e Innovacion [BIO2006-15557]; Consejo Superior de Investigaciones Cientificas (CSIC) [200420E578]; ICREA Funding Source: Custom	Spanish Ministerio de Economia(Spanish Government); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejo Superior de Investigaciones Cientificas (CSIC); ICREA(ICREA)	Work supported by the Spanish Ministerio de Economia (gran number: BIO2012-40133) Spanish Ministerio de Educacion y Ciencia (grant number: BFU2009-11527); the Spanish Ministerio de Ciencia e Innovacion (grant number BIO2006-15557); and the Consejo Superior de Investigaciones Cientificas (CSIC) (grant number 200420E578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso CR, 2005, NAT REV GENET, V6, P709, DOI 10.1038/nrg1676; Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Altmann A, 2011, BIOINFORMATICS, V27, pI77, DOI 10.1093/bioinformatics/btr205; [Anonymous], 2013, R LANG ENV STAT COMP; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ara T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-189; Artamonova II, 2007, CHEM REV, V107, P3407, DOI 10.1021/cr068304c; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Barbany M, 2012, PROTEINS, V80, P2235, DOI 10.1002/prot.24112; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bishop C. M, 2006, PATTERN RECOGNITION; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Castillo-Davis CI, 2004, GENOME RES, V14, P1530, DOI 10.1101/gr.2662504; Chern TM, 2006, PLOS GENET, V2, P606, DOI 10.1371/journal.pgen.0020045; Chiba H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-152; Copley RR, 2008, PHILOS T R SOC B, V363, P1453, DOI 10.1098/rstb.2007.2235; de Souza JES, 2011, NUCLEIC ACIDS RES, V39, P4942, DOI 10.1093/nar/gkr081; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Ezkurdia I, 2012, MOL BIOL EVOL, V29, P2265, DOI 10.1093/molbev/mss100; Feller W., 1970, INTRO PROBABILITY TH, V3; Fichant Gwennaele A., 1992, Human Molecular Genetics, V1, P259, DOI 10.1093/hmg/1.4.259; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Gharib WH, 2011, BRIEF BIOINFORM, V12, P436, DOI 10.1093/bib/bbr031; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Graveley BR, 2008, TRENDS GENET, V24, P5, DOI 10.1016/j.tig.2007.10.004; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hon CC, 2013, NUCLEIC ACIDS RES, V41, P1936, DOI 10.1093/nar/gks1271; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; Kondrashov FA, 2004, NUCLEIC ACIDS RES, V32, P1731, DOI 10.1093/nar/gkh330; Kopelman NM, 2005, NAT GENET, V37, P588, DOI 10.1038/ng1575; Koralewski TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018055; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Latchman D, 2008, GENE REGULATION EUKA; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Lois S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-252; Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846; Marden JH, 2008, HEREDITY, V100, P111, DOI 10.1038/sj.hdy.6800904; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Melamud E, 2009, NUCLEIC ACIDS RES, V37, P4862, DOI 10.1093/nar/gkp444; Melamud E, 2009, NUCLEIC ACIDS RES, V37, P4873, DOI 10.1093/nar/gkp471; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Morata J, 2012, ALTERNATIVE SPLICING; Mudge JM, 2011, MOL BIOL EVOL, V28, P2949, DOI 10.1093/molbev/msr127; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Neme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-117; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nurtdinov RN, 2003, HUM MOL GENET, V12, P1313, DOI 10.1093/hmg/ddg137; Ohler U, 2005, PLOS COMPUT BIOL, V1, P113, DOI 10.1371/journal.pcbi.0010015; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pan Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/j.tig.2004.12.004; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Plass M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-50; Plass M, 2008, TRENDS GENET, V24, P590, DOI 10.1016/j.tig.2008.10.004; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rasche A, 2010, BIOINFORMATICS, V26, P84, DOI 10.1093/bioinformatics/btp626; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; Shabalina SA, 2010, GENOME BIOL EVOL, V2, P791, DOI 10.1093/gbe/evq058; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; Sugnet C W, 2004, Pac Symp Biocomput, P66; Takeda JI, 2008, NUCLEIC ACIDS RES, V36, P6386, DOI 10.1093/nar/gkn677; Talavera D, 2007, PLOS COMPUT BIOL, V3, P375, DOI 10.1371/journal.pcbi.0030033; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Thanaraj TA, 2003, NUCLEIC ACIDS RES, V31, P2544, DOI 10.1093/nar/gkg355; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Tirosh I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100198; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valenzuela A, 2004, J MOL BIOL, V335, P495, DOI 10.1016/j.jmb.2003.10.061; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang YP, 2009, EVOL BIOINFORM, V5, P81; Wetterbom A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-56; Whamond GS, 2006, J MOL BIOL, V359, P238, DOI 10.1016/j.jmb.2006.03.029; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zhang Zhi-ping, 2009, Shengwu Jiagong Guocheng, V7, P23	112	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72742	10.1371/journal.pone.0072742	http://dx.doi.org/10.1371/journal.pone.0072742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023641	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200036
J	Zhang, QZ; Esplin, BL; Iida, R; Garrett, KP; Huang, ZXL; Medina, KL; Kincade, PW				Zhang, Qingzhao; Esplin, Brandt L.; Iida, Ryuji; Garrett, Karla P.; Huang, Zhixin L.; Medina, Kay L.; Kincade, Paul W.			RAG-1 and Ly6D Independently Reflect Progression in the B Lymphoid Lineage	PLOS ONE			English	Article							BONE-MARROW-CELLS; HEMATOPOIETIC PROGENITOR CELLS; NEGATIVE REGULATORS; CHEMOKINE RECEPTORS; ADULT THYMUS; STEM-CELLS; IN-VITRO; IDENTIFICATION; PRECURSORS; MOUSE	Common lymphoid progenitors (CLPs) are thought to represent major intermediates in the transition of hematopoietic stem cells (HSCs) to B lineage lymphocytes. However, it has been obvious for some time that CLPs are heterogeneous, and there has been controversy concerning their differentiation potential. We have now resolved four Flt3(+) CLP subsets that are relatively homogenous and capable of forming B cells. Differentiation potential and gene expression patterns suggest Flt3(+) CLPs lacking both Ly6D and RAG-1 are the least differentiated. In addition to B cells, they generate natural killer (NK) and dendritic cells (DCs). At the other extreme is a subset of the recently described Flt3(+) Ly6D(+) CLPs that have a history of RAG-1 expression and are B lineage restricted. These relatively abundant and potent CLPs were depleted within 48 hours of acute in vivo estrogen elevation, suggesting they descend from hormone regulated progenitors. This contrasts with the hormone insensitivity of other CLP subsets that include NK lineage progenitors. This progenitor heterogeneity and differentiation complexity may add flexibility in response to environmental changes. Expression of RAG-1 and display of Ly6D are both milestone events, but they are neither synchronized nor dependent on each other.	[Zhang, Qingzhao; Esplin, Brandt L.; Iida, Ryuji; Garrett, Karla P.; Kincade, Paul W.] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Esplin, Brandt L.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Huang, Zhixin L.; Medina, Kay L.] Mayo Clin, Dept Immunol, Rochester, MN USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Kincade@omrf.org			National Institutes of Health [AI020069, F30AG031646, RO1HL096108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020069, R37AI020069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG031646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants AI020069 (P.W.K.), F30AG031646 (B.L.E.) and RO1HL096108 (K.L.M.) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Chen XR, 2008, J IMMUNOL, V180, P138, DOI 10.4049/jimmunol.180.1.138; Chi AWS, 2011, BLOOD, V118, P2723, DOI 10.1182/blood-2010-09-309989; de Sousa AP, 2012, J IMMUNOL, V189, P3822, DOI 10.4049/jimmunol.1103723; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Harman BC, 2008, J IMMUNOL, V181, P7514, DOI 10.4049/jimmunol.181.11.7514; Hoebeke I, 2007, LEUKEMIA, V21, P311, DOI 10.1038/sj.leu.2404488; Huang JX, 2005, J IMMUNOL, V175, P4858, DOI 10.4049/jimmunol.175.8.4858; Ichii M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012954; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kouro T, 2002, BLOOD, V100, P3672, DOI 10.1182/blood-2002-02-0653; Kouro T, 2001, BLOOD, V97, P2708, DOI 10.1182/blood.V97.9.2708; Kouro T, 2005, CURR PROTOC IMMUNOL, V22; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Kumar R, 2008, J IMMUNOL, V181, P7507, DOI 10.4049/jimmunol.181.11.7507; Lai AY, 2007, P NATL ACAD SCI USA, V104, P6311, DOI 10.1073/pnas.0609608104; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Payne KJ, 1999, BLOOD, V94, P713, DOI 10.1182/blood.V94.2.713.414k15_713_723; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Sanz E, 2010, P NATL ACAD SCI USA, V107, P5925, DOI 10.1073/pnas.0907942107; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; Serwold T, 2009, BLOOD, V113, P807, DOI 10.1182/blood-2008-08-173682; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Simmons S, 2012, BLOOD, V120, P3688, DOI 10.1182/blood-2012-03-414821; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Welner RS, 2009, J IMMUNOL, V183, P7768, DOI 10.4049/jimmunol.0902333; Yang Q, 2010, IMMUNOL REV, V238, P12, DOI 10.1111/j.1600-065X.2010.00956.x; Yokota T, 2003, IMMUNITY, V19, P365, DOI 10.1016/S1074-7613(03)00231-0; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061; Zhang QZ, 2012, CURR OPIN IMMUNOL, V24, P196, DOI 10.1016/j.coi.2011.12.007; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72397	10.1371/journal.pone.0072397	http://dx.doi.org/10.1371/journal.pone.0072397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023617	Green Published, gold			2022-12-27	WOS:000323880200012
J	Guo, SQ; Israel, AL; Basu, G; Donate, A; Heller, R				Guo, Siqi; Israel, Annelise L.; Basu, Gaurav; Donate, Amy; Heller, Richard			Topical Gene Electrotransfer to the Epidermis of Hairless Guinea Pig by Non-Invasive Multielectrode Array	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; NORMAL SKIN; HEMOPHILIA-B; PLASMID DNA; NUDE-MOUSE; NAKED DNA; DELIVERY; THERAPY; KERATINOCYTES; EXPRESSION	Topical gene delivery to the epidermis has the potential to be an effective therapy for skin disorders, cutaneous cancers, vaccinations and systemic metabolic diseases. Previously, we reported on a non-invasive multielectrode array (MEA) that efficiently delivered plasmid DNA and enhanced expression to the skin of several animal models by in vivo gene electrotransfer. Here, we characterized plasmid DNA delivery with the MEA in a hairless guinea pig model, which has a similar histology and structure to human skin. Significant elevation of gene expression up to 4 logs was achieved with intradermal DNA administration followed by topical non-invasive skin gene electrotransfer. This delivery produced gene expression in the skin of hairless guinea pig up to 12 to 15 days. Gene expression was observed exclusively in the epidermis. Skin gene electrotransfer with the MEA resulted in only minimal and mild skin changes. A low level of human Factor IX was detected in the plasma of hairless guinea pig after gene electrotransfer with the MEA, although a significant increase of Factor IX was obtained in the skin of animals. These results suggest gene electrotransfer with the MEA can be a safe, efficient, non-invasive skin delivery method for skin disorders, vaccinations and potential systemic diseases where low levels of gene products are sufficient.	[Guo, Siqi; Israel, Annelise L.; Basu, Gaurav; Donate, Amy; Heller, Richard] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA	Old Dominion University	Heller, R (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA.	rheller@odu.edu	Heller, Richard/ABF-1445-2020	Heller, Richard/0000-0003-1899-3859; Donate, Amy/0000-0002-0481-5675	National Institutes of Health [R01 EB005441]; Frank Reidy Research Center for Bioelectrics at Old Dominion University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frank Reidy Research Center for Bioelectrics at Old Dominion University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported in part by a research grant from the National Institutes of Health R01 EB005441 and by the Frank Reidy Research Center for Bioelectrics at Old Dominion University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MY, 1995, HUM MOL GENET, V4, P993, DOI 10.1093/hmg/4.6.993; Broderick KE, 2011, GENE THER, V18, P258, DOI 10.1038/gt.2010.137; DAYNES RA, 1983, J IMMUNOL, V130, P1536; DEMARCHEZ M, 1993, J INVEST DERMATOL, V100, P648, DOI 10.1111/1523-1747.ep12472304; Drabick JJ, 2001, MOL THER, V3, P249, DOI 10.1006/mthe.2000.0257; Fan HR, 1999, NAT BIOTECHNOL, V17, P870, DOI 10.1038/12856; Gao Z, 2007, J DERMATOL SCI, V47, P161, DOI 10.1016/j.jdermsci.2007.03.008; GERRARD AJ, 1993, NAT GENET, V3, P180, DOI 10.1038/ng0293-180; GILHAR A, 1994, DERMATOLOGY, V189, P5, DOI 10.1159/000246750; Gonzalez-Gonzalez E, 2011, SCI REP-UK, V1, DOI 10.1038/srep00158; Gothelf A, 2010, CURR GENE THER, V10, P287, DOI 10.2174/156652310791823443; Guo SQ, 2011, J CONTROL RELEASE, V151, P256, DOI 10.1016/j.jconrel.2011.01.014; Gutowska-Owsiak D, 2012, J INVEST DERMATOL, V132, P940, DOI 10.1038/jid.2011.398; Heller LC, 2007, GENE THER, V14, P275, DOI 10.1038/sj.gt.3302867; Heller R, 2010, HUM GENE THER, V21, P357, DOI 10.1089/hum.2009.065; Jensen TG, 2004, EXPERT OPIN BIOL TH, V4, P677, DOI 10.1517/eobt.4.5.677.31063; Khavari PA, 2002, J INTERN MED, V252, P1, DOI 10.1046/j.1365-2796.2002.00995.x; Khavari PA, 1997, MOL MED TODAY, V3, P533, DOI 10.1016/S1357-4310(97)01143-X; Maruyama H, 2001, GENE THER, V8, P1808, DOI 10.1038/sj.gt.3301604; Medi BM, 2005, INT J PHARMACEUT, V294, P53, DOI 10.1016/j.ijpharm.2004.12.014; Pavselj N, 2005, J CONTROL RELEASE, V106, P407, DOI 10.1016/j.jconrel.2005.05.003; Raychaudhuri SP, 2001, BRIT J DERMATOL, V144, P931, DOI 10.1046/j.1365-2133.2001.04178.x; Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226; Spirito F, 2001, J GENE MED, V3, P21, DOI 10.1002/1521-2254(2000)9999:9999<::AID-JGM156>3.0.CO;2-I; Sueki H, 2000, EUR J DERMATOL, V10, P357; Sundberg JP, 1999, EXP MOL PATHOL, V67, P118, DOI 10.1006/exmp.1999.2276; Trainer AH, 1997, HUM MOL GENET, V6, P1761, DOI 10.1093/hmg/6.10.1761; Vandermeulen G, 2009, PHARM RES-DORDR, V26, P1745, DOI 10.1007/s11095-009-9885-3; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Zhang L, 2002, BBA-GEN SUBJECTS, V1572, P1, DOI 10.1016/S0304-4165(02)00270-2; Zhang L, 1999, BIOELECTROCH BIOENER, V48, P453, DOI 10.1016/S0302-4598(99)00026-4	31	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73423	10.1371/journal.pone.0073423	http://dx.doi.org/10.1371/journal.pone.0073423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015305	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800100
J	Devine, AA; Gonzalez, A; Speck, KE; Knight, R; Helmrath, M; Lund, PK; Azcarate-Peril, MA				Devine, Anthony A.; Gonzalez, Antonio; Speck, K. Elizabeth; Knight, Rob; Helmrath, Michael; Lund, P. Kay; Azcarate-Peril, M. Andrea			Impact of Ileocecal Resection and Concomitant Antibiotics on the Microbiome of the Murine Jejunum and Colon	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; INFLAMMATORY-BOWEL-DISEASE; POSTOPERATIVE CROHNS-DISEASE; GUT MICROBIOTA; PCR; BACTERIA; PERTURBATION; POPULATIONS; RECURRENCE; MANAGEMENT	Ileocecal resection (ICR) is a commonly required surgical intervention in unmanageable Crohn's disease and necrotizing enterocolitis. However, the impact of ICR, and the concomitant doses of antibiotic routinely given with ICR, on the intestinal commensal microbiota has not been determined. In this study, wild-type C57BL6 mice were subjected to ICR and concomitant single intraperitoneal antibiotic injection. Intestinal lumen contents were collected from jejunum and colon at 7, 14, and 28 days after resection and compared to non-ICR controls. Samples were analyzed by16S rRNA gene pyrosequencing and quantitative PCR. The intestinal microbiota was altered by 7 days after ICR and accompanying antibiotic treatment, with decreased diversity in the colon. Phylogenetic diversity (PD) decreased from 11.8 +/- 1.8 in non-ICR controls to 5.9 +/- 0.5 in 7-day post-ICR samples. There were also minor effects in the jejunum where PD values decreased from 8.3 (+/-) 0.4 to 7.5 +/- 1.4. PCoA analysis indicated that bacterial populations 28 days post-ICR differed significantly from non-ICR controls. Moreover, colon and jejunum bacterial populations were remarkably similar 28 days after resection, whereas the initial communities differed markedly. Firmicutes and Bacteroidetes were the predominant phyla in jejunum and colon before ICR; however, Firmicutes became the vastly predominant phylum in jejunum and colon 28 days after ICR. Although the microbiota returned towards a homeostatic state, with re-establishment of Firmicutes as the predominant phylum, we did not detect Bacteroidetes in the colon 28 days after ICR. In the jejunum Bacteroidetes was detected at a 0.01% abundance after this time period. The changes in jejunal and colonic microbiota induced by ICR and concomitant antibiotic injection may therefore be considered as potential regulators of post-surgical adaptive growth or function, and in a setting of active IBD, potential contributors to post-surgical pathophysiology of disease recurrence.	[Devine, Anthony A.; Lund, P. Kay; Azcarate-Peril, M. Andrea] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Gonzalez, Antonio] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Speck, K. Elizabeth; Helmrath, Michael] Univ N Carolina, Sch Med, Dept Surg, Chapel Hill, NC USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Azcarate-Peril, M. Andrea] Univ N Carolina, Sch Med, Microbiome Core Facil, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Azcarate-Peril, MA (corresponding author), RTI Int, Ctr Agr & Environm Biosolut, Res Triangle Pk, NC USA.	azcarate@med.unc.edu	Core, UNC Microbiome/AAB-3304-2022; Knight, Rob/D-1299-2010; Azcarate-Peril, M. Andrea/ABH-5508-2020; Gonzalez, Antonio/A-6421-2018; Azcarate-Peril, M. Andrea/AAA-9056-2022; Azcarate-Peril, M. Andrea/AFO-7157-2022	Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Knight, Rob/0000-0002-0975-9019	NIDDK NIH HHS [P30 DK034987] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000; Bures J, 2010, WORLD J GASTROENTERO, V16, P2978, DOI 10.3748/wjg.v16.i24.2978; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole Conrad R, 2007, Curr Gastroenterol Rep, V9, P456, DOI 10.1007/s11894-007-0059-3; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; D'Haens GR, 2008, GASTROENTEROLOGY, V135, P1123, DOI 10.1053/j.gastro.2008.07.010; Dekaney CM, 2008, SURGERY, V144, P174, DOI 10.1016/j.surg.2008.03.035; Dekaney CM, 2007, AM J PHYSIOL-GASTR L, V293, pG1013, DOI 10.1152/ajpgi.00218.2007; Dethlefsen L, 2011, P NATL ACAD SCI US; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dore J, 1998, SYST APPL MICROBIOL, V21, P65, DOI 10.1016/S0723-2020(98)80009-X; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrison AP, 2009, AM J PHYSIOL-GASTR L, V296, pG643, DOI 10.1152/ajpgi.90588.2008; Gillingham MB, 2003, AM J PHYSIOL-REG I, V284, pR363, DOI 10.1152/ajpregu.00247.2002; Griga T, 2005, EUR J MED RES, V10, P183; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HULTEN L, 1992, INT SURG, V77, P2; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Klaus J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-61; Korzenik JR, 2007, GUT, V56, P2, DOI 10.1136/gut.2006.095588; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu TY, 2012, ANAEROBE, V18, P331, DOI 10.1016/j.anaerobe.2012.02.004; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Manichanh C, 2012, J GASTROENTEROL HEPA; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nava GM, 2011, ISME J; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ng SC, 2008, AM J GASTROENTEROL, V103, P1029, DOI 10.1111/j.1572-0241.2008.01795.x; Ng SC, 2009, INFLAMM BOWEL DIS, V15, P935, DOI 10.1002/ibd.20797; Nos P, 2008, WORLD J GASTROENTERO, V14, P5540, DOI 10.3748/wjg.14.5540; NYHLIN H, 1994, GUT, V35, P90, DOI 10.1136/gut.35.1.90; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Redinger RN, 2003, AM J SURG, V185, P168, DOI 10.1016/S0002-9610(02)01212-6; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rigby RJ, 2009, GUT; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Thiesen A, 2003, BEST PRACT RES CL GA, V17, P981, DOI 10.1016/S1521-6918(03)00097-0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Ziegler Thomas R, 2007, Curr Gastroenterol Rep, V9, P463, DOI 10.1007/s11894-007-0060-x	62	44	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73140	10.1371/journal.pone.0073140	http://dx.doi.org/10.1371/journal.pone.0073140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015295	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200069
J	Feiler, C; Fisher, AC; Boock, JT; Marrichi, MJ; Wright, L; Schmidpeter, PAM; Blankenfeldt, W; Pavelka, M; DeLisa, MP				Feiler, Christian; Fisher, Adam C.; Boock, Jason T.; Marrichi, Matthew J.; Wright, Lori; Schmidpeter, Philipp A. M.; Blankenfeldt, Wulf; Pavelka, Martin; DeLisa, Matthew P.			Directed Evolution of Mycobacterium tuberculosis beta-Lactamase Reveals Gatekeeper Residue That Regulates Antibiotic Resistance and Catalytic Efficiency	PLOS ONE			English	Article							FOLDING QUALITY-CONTROL; BACTERIAL PROTEIN EXPORT; IN-VITRO; SMEGMATIS; PATHWAY; SYSTEM; SUSCEPTIBILITY; INACTIVATION; SUBSTRATE	Directed evolution can be a powerful tool for revealing the mutational pathways that lead to more resistant bacterial strains. In this study, we focused on the bacterium Mycobacterium tuberculosis, which is resistant to members of the beta-lactam class of antibiotics and thus continues to pose a major public health threat. Resistance of this organism is the result of a chromosomally encoded, extended spectrum class A beta-lactamase, BlaC, that is constitutively produced. Here, combinatorial enzyme libraries were selected on ampicillin to identify mutations that increased resistance of bacteria to beta-lactams. After just a single round of mutagenesis and selection, BlaC mutants were evolved that conferred 5-fold greater antibiotic resistance to cells and enhanced the catalytic efficiency of BlaC by 3-fold compared to the wild-type enzyme. All isolated mutants carried a mutation at position 105 (e.g., broken vertical bar 105F) that appears to widen access to the active site by 3.6 angstrom while also stabilizing the reorganized topology. In light of these findings, we propose that broken vertical bar 105 is a 'gatekeeper' residue of the active site that regulates substrate hydrolysis by BlaC. Moreover, our results suggest that directed evolution can provide insight into the development of highly drug resistant microorganisms.	[Feiler, Christian; Fisher, Adam C.; Boock, Jason T.; Marrichi, Matthew J.; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Wright, Lori; Pavelka, Martin] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Schmidpeter, Philipp A. M.; Blankenfeldt, Wulf] Univ Bayreuth, Biochem Lab, Bayreuth, Germany; [Schmidpeter, Philipp A. M.; Blankenfeldt, Wulf] Univ Bayreuth, Bayreuther Zentrum Mol Biowissensch, Bayreuth, Germany	Cornell University; University of Rochester; University of Bayreuth; University of Bayreuth	DeLisa, MP (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	Blankenfeldt, Wulf/F-8877-2010; Boock, Jason/AAI-5558-2021; Schmidpeter, Philipp/Q-5540-2019; DeLisa, Matthew/AAE-7361-2019	Blankenfeldt, Wulf/0000-0001-9886-9668; Schmidpeter, Philipp/0000-0003-2871-9706; DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation [0449080]; New York State Office of Science, Technology and Academic Research (NYSTAR); NYSTAR Distinguished Faculty Award	National Science Foundation(National Science Foundation (NSF)); New York State Office of Science, Technology and Academic Research (NYSTAR); NYSTAR Distinguished Faculty Award	Funding was provided by a National Science Foundation CAREER Award (BES #0449080), a New York State Office of Science, Technology and Academic Research (NYSTAR) James D. Watson Award, and a NYSTAR Distinguished Faculty Award (all to MPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Barlow M, 2002, GENETICS, V160, P823; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; CHAMBERS HF, 1995, ANTIMICROB AGENTS CH, V39, P2620, DOI 10.1128/AAC.39.12.2620; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Edwards JR, 2000, J ANTIMICROB CHEMOTH, V45, P1, DOI 10.1093/jac/45.1.1; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Flores AR, 2005, J BACTERIOL, V187, P1892, DOI 10.1128/JB.187.6.1892-1900.2005; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Hayhurst EJ, 2008, P NATL ACAD SCI USA, V105, P14603, DOI 10.1073/pnas.0804138105; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; ILAND CN, 1946, J PATHOL BACTERIOL, V58, P495, DOI 10.1002/path.1700580320; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KADONAGA JT, 1984, J BIOL CHEM, V259, P2149; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Mansell TJ, 2010, PROTEIN SCI, V19, P1079, DOI 10.1002/pro.388; Marrichi M, 2008, J BIOL CHEM, V283, P35223, DOI 10.1074/jbc.M802660200; McCann JR, 2007, MICROBIOL-SGM, V153, P3350, DOI 10.1099/mic.0.2007/008516-0; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; McDonough JA, 2008, J BACTERIOL, V190, P6428, DOI 10.1128/JB.00749-08; Orencia MC, 2001, NAT STRUCT BIOL, V8, P238, DOI 10.1038/84981; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Pradel N, 2009, ANTIMICROB AGENTS CH, V53, P242, DOI 10.1128/AAC.00642-08; Rocco MA, 2012, P NATL ACAD SCI USA, V109, P13392, DOI 10.1073/pnas.1210140109; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang F, 2006, ANTIMICROB AGENTS CH, V50, P2762, DOI 10.1128/AAC.00320-06	40	10	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73123	10.1371/journal.pone.0073123	http://dx.doi.org/10.1371/journal.pone.0073123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023821	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600070
J	Giampieri, R; Scartozzi, M; Loretelli, C; Piva, F; Mandolesi, A; Lezoche, G; Del Prete, M; Bittoni, A; Faloppi, L; Bianconi, M; Cecchini, L; Guerrieri, M; Bearzi, I; Cascinu, S				Giampieri, Riccardo; Scartozzi, Mario; Loretelli, Cristian; Piva, Francesco; Mandolesi, Alessandra; Lezoche, Giovanni; Del Prete, Michela; Bittoni, Alessandro; Faloppi, Luca; Bianconi, Maristella; Cecchini, Luca; Guerrieri, Mario; Bearzi, Italo; Cascinu, Stefano			Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients	PLOS ONE			English	Article							CD133; CD44; EXPRESSION; FLUOROURACIL; LEUCOVORIN; LINE	Clinical data indicate that prognostic stratification of radically resected colorectal cancer based on disease stage only may not be always be adequate. Preclinical findings suggest that cancer stem cells may influence the biological behaviour of colorectal cancer independently from stage: objective of the study was to assess whether a panel of stemness markers were correlated with clinical outcome in resected stage II and III colon cancer patients. A panel of 66 markers of stemness were analysed and thus patients were divided into two groups (A and B) with most patients clustering in a manner consistent with different time to relapse by using a statistical algorithm. A total of 62 patients were analysed. Thirty-six (58%) relapsed during the follow-up period (range 1.63-86.5 months). Twelve (19%) and 50 (81%) patients were allocated into group A and B, respectively. A significantly different median relapse-free survival was observed between the 2 groups (22.18 vs 42.85 months, p = 0.0296). Among of all genes tested, those with the higher "weight" in determining different prognosis were CD44, ALCAM, DTX2, HSPA9, CCNA2, PDX1, MYST1, COL1A1 and ABCG2. This analysis supports the idea that, other than stage, biological variables, such as expression levels of colon cancer stem cell genes, may be relevant in determining an increased risk of relapse in resected colorectal cancer patients.	[Giampieri, Riccardo; Scartozzi, Mario; Loretelli, Cristian; Del Prete, Michela; Bittoni, Alessandro; Faloppi, Luca; Bianconi, Maristella; Cecchini, Luca; Cascinu, Stefano] AO Osped Riuniti UNIVPM, Dept Med Oncol, Ancona, Italy; [Piva, Francesco] UNIVPM, Ancona, Italy; [Mandolesi, Alessandra; Bearzi, Italo] AO Osped Riuniti UNIVPM, Inst Pathol, Ancona, Italy; [Lezoche, Giovanni; Guerrieri, Mario] AO Osped Riuniti UNIVPM, Inst Surg, Ancona, Italy	Marche Polytechnic University	Scartozzi, M (corresponding author), AO Osped Riuniti UNIVPM, Dept Med Oncol, Ancona, Italy.	marioscartozzi@libero.it	Cascinu, Stefano/G-2399-2017; Cascinu, Stefano/AAN-1923-2020; Faloppi, Luca/K-1030-2016; Loretelli, Cristian/AAO-7678-2020	Cascinu, Stefano/0000-0003-2215-0731; Faloppi, Luca/0000-0003-3689-3085; SCARTOZZI, MARIO/0000-0001-5977-5546; Loretelli, Cristian/0000-0002-7583-8540; Bianconi, Maristella/0000-0003-3475-2529; PIVA, Francesco/0000-0003-1850-2482; Lezoche, Giovanni/0000-0002-4210-6386	AIRC (Italian association of cancer research)	AIRC (Italian association of cancer research)(Fondazione AIRC per la ricerca sul cancro)	This study was funded by AIRC (Italian association of cancer research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CS, 2009, J BIOL CHEM, V284, P1177, DOI 10.1074/jbc.M805144200; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2007, J CLIN ONCOL, V25, P3732, DOI 10.1200/JCO.2007.12.2234; Artells R, 2010, EUR J CANCER, V46, P642, DOI 10.1016/j.ejca.2009.11.003; Coco C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-71; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; Dallas MR, 2012, FASEB J, V26, P2648, DOI 10.1096/fj.12-203786; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; Haller DG, 2011, J CLIN ONCOL, V29, P1465, DOI 10.1200/JCO.2010.33.6297; Haller DG, 2005, J CLIN ONCOL, V23, P8671, DOI 10.1200/JCO.2004.00.5686; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Huang XD, 2012, SURG ONCOL, V21, P103, DOI 10.1016/j.suronc.2011.06.001; Jay JJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S7; Langan RC, 2012, J CANCER, V3, P231, DOI 10.7150/jca.4542; Li GQ, 2010, CLIN EXP METASTAS, V27, P517, DOI 10.1007/s10585-010-9341-0; Lin SP, 2013, CANCER LETT, V328, P226, DOI 10.1016/j.canlet.2012.08.036; Mao Q, 2013, J CANCER RES CLIN, V139, P211, DOI 10.1007/s00432-012-1310-3; Navarro-Alvarez N, 2010, CELL TRANSPLANT, V19, P865, DOI 10.3727/096368910X508997; Oh PS, 2011, AM J PHYSIOL-GASTR L, V301, pG347, DOI 10.1152/ajpgi.00403.2010; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rao GH, 2013, ACTA PHARMACOL SIN, V34, P793, DOI 10.1038/aps.2013.56; Roy Sanchita, 2012, J Mol Signal, V7, P11, DOI 10.1186/1750-2187-7-11; Sanders MA, 2011, FRONT BIOSCI-LANDMRK, V16, P1651, DOI 10.2741/3811; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Wang CX, 2012, ONCOL REP, V28, P1301, DOI 10.3892/or.2012.1951; Wu XJ, 2012, J GASTROINTEST SURG, V16, P646, DOI 10.1007/s11605-011-1682-8; Yang ZL, 2012, ONCOL LETT, V4, P75, DOI 10.3892/ol.2012.694	27	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72843	10.1371/journal.pone.0072843	http://dx.doi.org/10.1371/journal.pone.0072843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023782	Green Published, gold			2022-12-27	WOS:000324515600050
J	Pan, HT; Huang, P; Wang, ZR; Wang, L; Li, CJ; Xia, JL				Pan, Haitao; Huang, Ping; Wang, Zuoren; Wang, Ling; Li, Chanjuan; Xia, Jielai			A Novel Bayesian Seamless Phase I/II Design	PLOS ONE			English	Article							I CLINICAL-TRIALS; TOXICITY	This paper proposes a novel bayesian phase I/II design featuring using a hybrid mTPI method in phase I for targeting the MTD level and a randomization allocation schema for adaptively assigning patients to desirable doses in phase II. The mechanism of simultaneously escalating dose in phase I and expanding promising doses to phase II is inherited from a design proposed in literature. Extensive simulation studies indicate that our proposed design can vastly save sample size and efficiently assign more patients to optimal dose when compared to two competing designs.	[Pan, Haitao; Wang, Ling; Li, Chanjuan; Xia, Jielai] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China; [Pan, Haitao; Wang, Zuoren] Xian Univ Finance & Econ, Sch Stat, Xian, Peoples R China; [Huang, Ping] Fourth Mil Med Univ, Sch Stomatol, Dept Clin Lab, Xian 710032, Peoples R China	Air Force Military Medical University; Xi'an University of Finance & Economics; Air Force Military Medical University	Li, CJ (corresponding author), Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China.	chanjuan-li@sohu.com; jielaixia@yahoo.com	Pan, Haitao/N-2529-2018	Pan, Haitao/0000-0003-4457-7349	National Science Foundation of China [81273176, 81001290]; Scientific Research Project of Education Department of Shaanxi Province [2013JK0762]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Education Department of Shaanxi Province	This work was partially supported by Research Grant 81273176 and 81001290 from National Science Foundation of China. The first author's work was partially supported by the Scientific Research Project of Education Department of Shaanxi Province (Grant 2013JK0762). No other additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekele BN, 2005, BIOMETRICS, V61, P344, DOI 10.1111/j.-1541-0420.2005.00314.x; Berry SM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/EBK1439825488; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Ji Y, 2007, CLIN TRIALS, V4, P235, DOI 10.1177/1740774507079442; Ji YA, 2010, CLIN TRIALS, V7, P653, DOI 10.1177/1740774510382799; Pan H, 2013, INT J DRUG DEV, V1, P185; Pan HT, 2014, COMMUN STAT-SIMUL C, V43, P254, DOI 10.1080/03610918.2012.700365; Seegers V, 2011, STAT MED, V30, P1574, DOI 10.1002/sim.4152; Thall PF, 2003, INT J GYNECOL CANCER, V13, P251, DOI 10.1046/j.1525-1438.2003.13202.x; WEI LJ, 1978, J AM STAT ASSOC, V73, P840; Xie F, 2012, CONTEMP CLIN TRIALS, V33, P739, DOI 10.1016/j.cct.2012.03.001; Yin GS, 2006, BIOMETRICS, V62, P777, DOI 10.1111/j.1541-0420.2006.00534.x; Yin GS, 2009, J AM STAT ASSOC, V104, P954, DOI 10.1198/jasa.2009.ap08425; Yuan BY, 2011, ANN APPL STAT, V5, P924, DOI 10.1214/10-AOAS433; Yuan Y, 2011, STAT MED, V30, P2098, DOI 10.1002/sim.4164; ZELEN M, 1969, J AM STAT ASSOC, V64, P131, DOI 10.2307/2283724; Zhang W, 2006, STAT MED, V25, P2365, DOI 10.1002/sim.2325	17	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73060	10.1371/journal.pone.0073060	http://dx.doi.org/10.1371/journal.pone.0073060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023809	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600064
J	Rossi, S; Colazza, A; Petrarca, M; Castelli, E; Cappa, P; Krebs, HI				Rossi, Stefano; Colazza, Alessandra; Petrarca, Maurizio; Castelli, Enrico; Cappa, Paolo; Krebs, Hermano Igo			Feasibility Study of a Wearable Exoskeleton for Children: Is the Gait Altered by Adding Masses on Lower Limbs?	PLOS ONE			English	Article							CEREBRAL-PALSY; REHABILITATION; EPIDEMIOLOGY; WALKING; ROBOT; IMPAIRMENTS; ORTHOSES; DESIGN; SYSTEM	We are designing a pediatric exoskeletal ankle robot (pediatric Anklebot) to promote gait habilitation in children with Cerebral Palsy (CP). Few studies have evaluated how much or whether the unilateral loading of a wearable exoskeleton may have the unwanted effect of altering significantly the gait. The purpose of this study was to evaluate whether adding masses up to 2.5 kg, the estimated overall added mass of the mentioned device, at the knee level alters the gait kinematics. Ten healthy children and eight children with CP, with light or mild gait impairment, walked wearing a knee brace with several masses. Gait parameters and lower-limb joint kinematics were analyzed with an optoelectronic system under six conditions: without brace (natural gait) and with masses placed at the knee level (0.5, 1.0, 1.5, 2.0, 2.5 kg). T-tests and repeated measures ANOVA tests were conducted in order to find noteworthy differences among the trial conditions and between loaded and unloaded legs. No statistically significant differences in gait parameters for both healthy children and children with CP were observed in the five "with added mass" conditions. We found significant differences among "natural gait" and "with added masses" conditions in knee flexion and hip extension angles for healthy children and in knee flexion angle for children with CP. This result can be interpreted as an effect of the mechanical constraint induced by the knee brace rather than the effect associated with load increase. The study demonstrates that the mechanical constraint induced by the brace has a measurable effect on the gait of healthy children and children with CP and that the added mass up to 2.5 kg does not alter the lower limb kinematics. This suggests that wearable devices weighing 25 N or less will not noticeably modify the gait patterns of the population examined here.	[Rossi, Stefano] Univ Tuscia, DEIM Dept Econ & Management Ind Engn, Viterbo, Italy; [Rossi, Stefano; Colazza, Alessandra; Petrarca, Maurizio; Castelli, Enrico; Cappa, Paolo] Bambino Gesu Pediat Hosp, MARLab Movement Anal & Robot Lab, Neurosci & Neurorehabil Dept, Rome, Italy; [Cappa, Paolo] Univ Roma La Sapienza, Dept Mech & Aerosp Engn, I-00185 Rome, Italy; [Krebs, Hermano Igo] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Krebs, Hermano Igo] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Krebs, Hermano Igo] Univ Maryland, Sch Med, Div Rehabil Med, Baltimore, MD 21201 USA	Tuscia University; IRCCS Bambino Gesu; Sapienza University Rome; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Rossi, S (corresponding author), Univ Tuscia, DEIM Dept Econ & Management Ind Engn, Viterbo, Italy.	stefano.rossi@unitus.it	Petrarca, Maurizio/B-4181-2019; Petrarca, Maurizio/GWZ-3714-2022; Rossi, Stefano/AAB-9111-2020	Petrarca, Maurizio/0000-0002-7330-3569; ROSSI, Stefano/0000-0003-0006-7013; Cappa, Paolo/0000-0002-4898-9589	Italian Institute of Technology (IIT); Italian Health Ministry; CPIRF-Niarchos Foundation	Italian Institute of Technology (IIT)(Istituto Italiano di Tecnologia - IIT); Italian Health Ministry(Ministry of Health, Italy); CPIRF-Niarchos Foundation	This project was sponsored by a grant from the Italian Institute of Technology (IIT) - Project Seed ("ITINERE - Interactive Technology: an Instrumented Novel Exoskeleton for Rehabilitation" 2009) and by a grant from Italian Health Ministry (Grant "Pilot study on a novel typology of medical devices: robotic exoskeletons for knee rehabilitation" 2009) to PC. HIK is supported in part by the CPIRF-Niarchos Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila H, 2008, PEDIATRICS, V8; Arpino C, 2010, INT J REHABIL RES, V33, P165, DOI 10.1097/MRR.0b013e328332f617; Banala SK, 2009, IEEE T NEUR SYS REH, V17, P2, DOI 10.1109/TNSRE.2008.2008280; BARNETT SL, 1993, ORTHOPEDICS, V16, P1127, DOI 10.3928/0147-7447-19931001-08; Beckung E, 2008, PEDIATRICS, V121, pE187, DOI 10.1542/peds.2007-0068; Blair E, 2006, SEMIN FETAL NEONAT M, V11, P117, DOI 10.1016/j.siny.2005.10.010; Blundell SW, 2003, CLIN REHABIL, V17, P48, DOI 10.1191/0269215503cr584oa; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Gordon KE, 2006, J BIOMECH, V39, P1832, DOI 10.1016/j.jbiomech.2005.05.018; Herr H, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-21; Jezernik S, 2003, NEUROMODULATION, V6, P108, DOI 10.1046/j.1525-1403.2003.03017.x; Jimenez-Fabian R, 2012, MED ENG PHYS, V34, P397, DOI 10.1016/j.medengphy.2011.11.018; Khanna I, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-23; Kim CM, 2003, GAIT POSTURE, V18, P23, DOI 10.1016/S0966-6362(02)00122-4; Krebs HI, 2011, IEEE INT C REH ROB P; Low KH, 2007, INT J ROBOT AUTOM, V22, P32; Meyer-Heim A, 2009, ARCH DIS CHILD, V94, P615, DOI 10.1136/adc.2008.145458; Nelson KB, 2002, MENT RETARD DEV D R, V8, P146, DOI 10.1002/mrdd.10037; Noble JW, 2006, EXP BRAIN RES, V169, P482, DOI 10.1007/s00221-005-0162-3; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Patritti BL, 2010, PM&R, V2, P71, DOI 10.1016/j.pmrj.2009.10.012; Reddihough DS, 2003, AUST J PHYSIOTHER, V49, P7, DOI 10.1016/S0004-9514(14)60183-5; Regnaux JP, 2008, CLIN BIOMECH, V23, P762, DOI 10.1016/j.clinbiomech.2008.01.011; Roy A, 2009, IEEE T ROBOT, V25, P569, DOI 10.1109/TRO.2009.2019783; Sawicki GS, 2009, J EXP BIOL, V212, P21, DOI 10.1242/jeb.017269; Shepherd RB, 1995, PHYSIOTHERAPY PAEDIA; Veneman JF, 2007, IEEE T NEUR SYS REH, V15, P379, DOI 10.1109/TNSRE.2007.903919; WINTER DA, 1989, J MOTOR BEHAV, V21, P337; Woltring H, 1995, THREE DIMENSIONAL AN; WOLTRING HJ, 1985, HUM MOVEMENT SCI, V4, P229, DOI 10.1016/0167-9457(85)90004-1; Wu YN, 2010, IEEE ENG MED BIO, P4481, DOI 10.1109/IEMBS.2010.5626043; Wu YN, 2011, NEUROREHAB NEURAL RE, V25, P378, DOI 10.1177/1545968310388666	33	28	29	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73139	10.1371/journal.pone.0073139	http://dx.doi.org/10.1371/journal.pone.0073139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023822	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600071
J	Chino, A; Makanae, K; Moriya, H				Chino, Ayako; Makanae, Koji; Moriya, Hisao			Relationships between Cell Cycle Regulator Gene Copy Numbers and Protein Expression Levels in Schizosaccharomyces pombe	PLOS ONE			English	Article							FISSION YEAST; CYTOKINESIS; TRANSCRIPTION; COMPLEX; GTPASE; DOSAGE	We previously determined the copy number limits of overexpression for cell division cycle (cdc) regulatory genes in the fission yeast Schizosaccharomyces pombe using the "genetic tug-of-war" (gTOW) method. In this study, we measured the levels of tandem affinity purification (TAP)-tagged target proteins when their copy numbers are increased in gTOW. Twenty analyzed genes showed roughly linear correlations between increased protein levels and gene copy numbers, which suggested a general lack of compensation for gene dosage in S. pombe. Cdc16 and Sid2 protein levels but not their mRNA levels were much lower than that expected by their copy numbers, which suggested the existence of a post-transcriptional down regulation of these genes. The cyclin Cig1 protein level and its mRNA level were much higher than that expected by its copy numbers, which suggested a positive feedback mechanism for its expression. A higher Cdc10 protein level and its mRNA level, probably due to cloning its gene into a plasmid, indicated that Cdc10 regulation was more robust than that previously predicted.	[Chino, Ayako] Okayama Univ, Grad Sch Sci & Technol, Kita Ku, Okayama 7008530, Japan; [Chino, Ayako; Makanae, Koji; Moriya, Hisao] Okayama Univ, Res Core Interdisciplinary Sci, Kita Ku, Okayama 7008530, Japan	Okayama University; Okayama University	Moriya, H (corresponding author), Okayama Univ, Res Core Interdisciplinary Sci, Kita Ku, Okayama 7008530, Japan.	hisaom@cc.okayama-u.ac.jp	Moriya, Hisao/B-2424-2011	Moriya, Hisao/0000-0001-7638-3640; Makanae, Koji/0000-0002-8560-4561	Strategic International Cooperative Program of Japan Science and Technology Agency; Special Coordination Fund for Promoting Sciences and Technology; Ministry of Education, Culture, Sports, Science and Technology; Okayama University	Strategic International Cooperative Program of Japan Science and Technology Agency; Special Coordination Fund for Promoting Sciences and Technology; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Okayama University	This work was supported in part by the Strategic International Cooperative Program of Japan Science and Technology Agency; the Special Coordination Fund for Promoting Sciences and Technology; Grant-in-Aid for Scientific Research on Innovative Areas "The Physicochemical Field for Genetic Activities" of the Ministry of Education, Culture, Sports, Science and Technology; and Grants in aid for strategic research promotion by Okayama University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chino A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009652; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; Furge KA, 1998, CURR BIOL, V8, P947, DOI 10.1016/S0960-9822(98)70394-X; Gomez-Escoda B, 2011, EMBO REP, V12, P84, DOI 10.1038/embor.2010.187; Hou MC, 2004, MOL CELL BIOL, V24, P3262, DOI 10.1128/MCB.24.8.3262-3276.2004; Johnson AE, 2012, CYTOSKELETON, V69, P686, DOI 10.1002/cm.21044; Kaizu K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000919; KOHRER K, 1991, METHODS ENZYMOL, V194, P398; Krapp A, 2008, J CELL SCI, V121, P601, DOI 10.1242/jcs.022772; Moriya H, 2012, MOL BIOSYST; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Moriya H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.91; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Preker PJ, 2002, RNA, V8, P969, DOI 10.1017/S1355838202020046; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; Watson A, 2011, J PHASE EQUILIB DIFF, V32, P1, DOI 10.1007/s11669-010-9844-z; Zhu Y, 1997, EMBO J, V16, P1023, DOI 10.1093/emboj/16.5.1023	22	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73319	10.1371/journal.pone.0073319	http://dx.doi.org/10.1371/journal.pone.0073319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019917	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200059
J	Howard, JB; Kechris, KJ; Rees, DC; Glazer, AN				Howard, James B.; Kechris, Katerina J.; Rees, Douglas C.; Glazer, Alexander N.			Multiple Amino Acid Sequence Alignment Nitrogenase Component 1: Insights into Phylogenetics and Structure-Function Relationships	PLOS ONE			English	Article							IRON-MOLYBDENUM COFACTOR; AZOTOBACTER-VINELANDII; MOFE-PROTEIN; FEMO-COFACTOR; ACTIVE-SITE; CLOSTRIDIUM-PASTEURIANUM; INDEPENDENT NITROGENASES; EVOLUTIONARY HISTORY; SELENOPROTEIN GENES; ANGSTROM RESOLUTION	Amino acid residues critical for a protein's structure-function are retained by natural selection and these residues are identified by the level of variance in co-aligned homologous protein sequences. The relevant residues in the nitrogen fixation Component 1 alpha- and beta-subunits were identified by the alignment of 95 protein sequences. Proteins were included from species encompassing multiple microbial phyla and diverse ecological niches as well as the nitrogen fixation genotypes, anf, nif, and vnf, which encode proteins associated with cofactors differing at one metal site. After adjusting for differences in sequence length, insertions, and deletions, the remaining >85% of the sequence co-aligned the subunits from the three genotypes. Six Groups, designated Anf, Vnf, and Nif I-IV, were assigned based upon genetic origin, sequence adjustments, and conserved residues. Both subunits subdivided into the same groups. Invariant and single variant residues were identified and were defined as "core" for nitrogenase function. Three species in Group Nif-III, Candidatus Desulforudis audaxviator, Desulfotomaculum kuznetsovii, and Thermodesulfatator indicus, were found to have a seleno-cysteine that replaces one cysteinyl ligand of the 8Fe:7S, P-cluster. Subsets of invariant residues, limited to individual groups, were identified; these unique residues help identify the gene of origin (anf, nif, or vnf) yet should not be considered diagnostic of the metal content of associated cofactors. Fourteen of the 19 residues that compose the cofactor pocket are invariant or single variant; the other five residues are highly variable but do not correlate with the putative metal content of the cofactor. The variable residues are clustered on one side of the cofactor, away from other functional centers in the three dimensional structure. Many of the invariant and single variant residues were not previously recognized as potentially critical and their identification provides the bases for new analyses of the three-dimensional structure and for mutagenesis studies.	[Howard, James B.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Howard, James B.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Kechris, Katerina J.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Glazer, Alexander N.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Minnesota System; University of Minnesota Twin Cities; California Institute of Technology; Colorado School of Public Health; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Howard, JB (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	howar001@umn.edu; Katerina.Kechris@ucdenver.edu; dcrees@caltech.edu; glazer@berkeley.edu		Kechris, Katerina/0000-0002-3725-5459	National Institutes of Health [GM45162]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045162, R37GM045162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM45162 to DCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barney BM, 2009, J BIOL INORG CHEM, V14, P1015, DOI 10.1007/s00775-009-0544-2; Benton PMC, 2003, BIOCHEMISTRY-US, V42, P9102, DOI 10.1021/bi034595x; Betancourt DA, 2008, APPL ENVIRON MICROB, V74, P3471, DOI 10.1128/AEM.02694-07; Bickel PJ, 2002, P NATL ACAD SCI USA, V99, P14764, DOI 10.1073/pnas.222508899; BISHOP PE, 1982, J BACTERIOL, V150, P1244, DOI 10.1128/JB.150.3.1244-1251.1982; BISHOP PE, 1986, BIOCHEM J, V238, P437, DOI 10.1042/bj2380437; BISHOP PE, 1986, SCIENCE, V232, P92, DOI 10.1126/science.232.4746.92; Blumer-Schuette SE, 2011, J BACTERIOL, V193, P1483, DOI 10.1128/JB.01515-10; Boyd ES, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00205; BRILL WJ, 1980, MICROBIOL REV, V44, P449, DOI 10.1128/MMBR.44.3.449-467.1980; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; CHISNELL JR, 1988, J BACTERIOL, V170, P27, DOI 10.1128/jb.170.1.27-33.1988; Dance I, 2012, DALTON T, V41, P7647, DOI 10.1039/c2dt30518f; Dekas AE, 2009, SCIENCE, V326, P422, DOI 10.1126/science.1178223; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; Dos Santos PC, 2005, ACCOUNTS CHEM RES, V38, P208, DOI 10.1021/ar040050z; Durrant MC, 2001, BIOCHEM J, V355, P569, DOI 10.1042/bj3550569; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fani R, 2000, J MOL EVOL, V51, P1; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Gladyshev VN, 1996, J BIOL CHEM, V271, P8095, DOI 10.1074/jbc.271.14.8095; Glazer AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006136; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; HALES BJ, 1986, BIOCHEMISTRY-US, V25, P7253, DOI 10.1021/bi00371a001; Hu YL, 2012, DALTON T, V41, P1118, DOI 10.1039/c1dt11535a; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; JOERGER RD, 1990, J BACTERIOL, V172, P3400, DOI 10.1128/jb.172.6.3400-3408.1990; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; Kechris KJ, 2006, P NATL ACAD SCI USA, V103, P9584, DOI 10.1073/pnas.0603534103; KIM J, 1993, BIOCHEMISTRY-US, V32, P7104, DOI 10.1021/bi00079a006; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Li Mingfeng, 2009, Genomics Proteomics & Bioinformatics, V7, P62, DOI 10.1016/S1672-0229(08)60034-0; Masukawa H, 2010, APPL ENVIRON MICROB, V76, P6741, DOI 10.1128/AEM.01056-10; Mayer SM, 1999, J MOL BIOL, V292, P871, DOI 10.1006/jmbi.1999.3107; McGlynn SE, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00419; Mehta MP, 2006, SCIENCE, V314, P1783, DOI 10.1126/science.1134772; Nakamoto M, 1999, B CHEM SOC JPN, V72, P407, DOI 10.1246/bcsj.72.407; Nauser T, 2012, AMINO ACIDS, V42, P39, DOI 10.1007/s00726-010-0602-7; Parkin A, 2008, J AM CHEM SOC, V130, P13410, DOI 10.1021/ja803657d; PAU RN, 1993, BIOCHEM J, V293, P101, DOI 10.1042/bj2930101; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schmid B, 2002, BIOCHEMISTRY-US, V41, P15557, DOI 10.1021/bi026642b; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; Siemann S, 2003, BIOCHEMISTRY-US, V42, P3846, DOI 10.1021/bi0270790; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; WANG SZ, 1988, BIOCHEMISTRY-US, V27, P2800, DOI 10.1021/bi00408a021; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WINTER HC, 1976, ANNU REV BIOCHEM, V45, P409, DOI 10.1146/annurev.bi.45.070176.002205; Zhang Y, 2005, BIOINFORMATICS, V21, P2580, DOI 10.1093/bioinformatics/bti400; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	62	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72751	10.1371/journal.pone.0072751	http://dx.doi.org/10.1371/journal.pone.0072751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019874	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000324338200016
J	Mathewson, PD; Porter, WP				Mathewson, Paul D.; Porter, Warren P.			Simulating Polar Bear Energetics during a Seasonal Fast Using a Mechanistic Model	PLOS ONE			English	Article							CLIMATE-CHANGE; HUDSON-BAY; BODY-COMPOSITION; URSUS-MARITIMUS; SERUM UREA; IMPACTS; TEMPERATURE; MASS; THERMOREGULATION; REPRODUCTION	In this study we tested the ability of a mechanistic model (Niche Mapper (TM)) to accurately model adult, non-denning polar bear (Ursus maritimus) energetics while fasting during the ice-free season in the western Hudson Bay. The model uses a steady state heat balance approach, which calculates the metabolic rate that will allow an animal to maintain its core temperature in its particular microclimate conditions. Predicted weight loss for a 120 day fast typical of the 1990s was comparable to empirical studies of the population, and the model was able to reach a heat balance at the target metabolic rate for the entire fast, supporting use of the model to explore the impacts of climate change on polar bears. Niche Mapper predicted that all but the poorest condition bears would survive a 120 day fast under current climate conditions. When the fast extended to 180 days, Niche Mapper predicted mortality of up to 18% for males. Our results illustrate how environmental conditions, variation in animal properties, and thermoregulation processes may impact survival during extended fasts because polar bears were predicted to require additional energetic expenditure for thermoregulation during a 180 day fast. A uniform 3 degrees C temperature increase reduced male mortality during a 180 day fast from 18% to 15%. Niche Mapper explicitly links an animal's energetics to environmental conditions and thus can be a valuable tool to help inform predictions of climate-related population changes. Since Niche Mapper is a generic model, it can make energetic predictions for other species threatened by climate change.	[Mathewson, Paul D.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Porter, Warren P.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mathewson, PD (corresponding author), Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA.	mathewson@wisc.edu			University of Wisconsin-Madison Zoology Department; University of Wisconsin-Madison Libraries	University of Wisconsin-Madison Zoology Department; University of Wisconsin-Madison Libraries	PDM was supported by summer research awards from the University of Wisconsin-Madison Zoology Department's Emlen Fund and Lowell E. & Ruth Chase Noland Memorial Fund. Additional funding for publication came from the University of Wisconsin-Madison Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SN, 1996, PHYSIOL ZOOL, V69, P304, DOI 10.1086/physzool.69.2.30164186; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; BEST RC, 1982, J COMP PHYSIOL, V146, P63, DOI 10.1007/BF00688718; Best RC, 1976, THESIS U GUELPH GUEL; Bird R. B., 2002, INTERPHASE TRANSPORT; Chao BT, 1969, ADV HEAT TRANSFER; Cherry SG, 2009, POLAR BIOL, V32, P383, DOI 10.1007/s00300-008-0530-0; Clark DA, 1998, URSUS-SERIES, V10, P243; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; DEROCHER AE, 1995, CAN J ZOOL, V73, P1657, DOI 10.1139/z95-197; Derocher AE, 1998, J ZOOL, V245, P65, DOI 10.1111/j.1469-7998.1998.tb00072.x; DEROCHER AE, 1990, MAR MAMMAL SCI, V6, P196, DOI 10.1111/j.1748-7692.1990.tb00243.x; Environment Canada, CLIMATE CHANGE 2007; Gagnon AS, 2005, ARCTIC, V58, P370, DOI 10.14430/arctic451; Gagnon AS, 2005, CLIMATIC CHANGE, V69, P269, DOI 10.1007/s10584-005-1815-8; Hannah L, 2002, GLOBAL ECOL BIOGEOGR, V11, P485, DOI 10.1046/j.1466-822X.2002.00306.x; HART J. S., 1956, CANADIAN JOUR ZOOL, V34, P53, DOI 10.1139/z56-007; Hobson KA, 2009, CAN J ZOOL, V87, P50, DOI 10.1139/Z08-137; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; HURST RJ, 1982, J THERM BIOL, V7, P201, DOI 10.1016/0306-4565(82)90025-0; HURST RJ, 1982, CAN J ZOOL, V60, P40, DOI 10.1139/z82-005; IDSO SB, 1969, J GEOPHYS RES, V74, P5397, DOI 10.1029/JC074i023p05397; IUCN, 2011, IUCN REDL THREAT SPE; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kreith F., 1980, BASIC HEAT TRANSFER; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Larcombe A, 2002, PHYSIOL BIOCHEM ZOOL, V75, P405, DOI 10.1086/342255; LUNN NJ, 1985, CAN J ZOOL, V63, P2291, DOI 10.1139/z85-340; Molnar PK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1183; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Molnar PK, 2009, J EXP BIOL, V212, P2313, DOI 10.1242/jeb.026146; Natori Y, 2007, ECOL APPL, V17, P1441, DOI 10.1890/06-1785.1; NRC, 1981, EFF ENV NUTR REQ DOM; ORITSLAND NA, 1970, COMP BIOCHEM PHYSIOL, V37, P225, DOI 10.1016/0010-406X(70)90547-5; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Polischuk SC, 2002, ENVIRON POLLUT, V118, P29, DOI 10.1016/S0269-7491(01)00278-0; POND CM, 1992, CAN J ZOOL, V70, P326, DOI 10.1139/z92-049; Porter WP, 2006, INTEGR COMP BIOL, V46, P1143, DOI 10.1093/icb/icl051; Porter WP, 2010, PHYSIOL BIOCHEM ZOOL, V83, P705, DOI 10.1086/656181; Porter W.P., 2006, METHOD SYSTEM CALCUL; Porter WP, 2009, P NATL ACAD SCI USA, V106, P19666, DOI 10.1073/pnas.0907321106; PORTER WP, 1994, AUST J ZOOL, V42, P125, DOI 10.1071/ZO9940125; Porter WP, 2002, INTEGR COMP BIOL, V42, P431, DOI 10.1093/icb/42.3.431; Porter WP, 2000, AM ZOOL, V40, P597, DOI 10.1668/0003-1569(2000)040[0597:CCEOBA]2.0.CO;2; RAMSAY MA, 1991, OECOLOGIA, V86, P598, DOI 10.1007/BF00318328; RAMSAY MA, 1991, CAN J ZOOL, V69, P298, DOI 10.1139/z91-048; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Sahanatien V, 2012, ANIM CONSERV, V15, P397, DOI 10.1111/j.1469-1795.2012.00529.x; SCHOLANDER PF, 1950, BIOL BULL, V99, P225, DOI 10.2307/1538740; Serreze MC, 2007, SCIENCE, V315, P1533, DOI 10.1126/science.1139426; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Solomon S., 2007, PHYS SCI BASIS WORKI; Stewart D, 2005, OVERVIEW HUDSON BAY; Stirling I, 1999, ARCTIC, V52, P294; Stirling I, 1988, HUMAN BODY COMPOSITI; Stirling I, 2006, ARCTIC, V59, P261; Stirling I, 2012, GLOBAL CHANGE BIOL, V18, P2694, DOI 10.1111/j.1365-2486.2012.02753.x; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; SWINBANK WC, 1963, Q J ROY METEOR SOC, V89, P339, DOI 10.1002/qj.49708938105; Thiemann GW, 2011, J WILDLIFE MANAGE, V75, P580, DOI 10.1002/jwmg.112; Watts P.D., 1983, DISSERTATION; WATTS PD, 1987, PHYSIOL ZOOL, V60, P687, DOI 10.1086/physzool.60.6.30159983; Wiig Oystein, 2008, Science Progress, V91, P151, DOI 10.3184/003685008X324506; 2008, FED REG, V73, P28212	69	30	30	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72863	10.1371/journal.pone.0072863	http://dx.doi.org/10.1371/journal.pone.0072863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019883	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200025
J	Yin, FX; Li, GP; Bai, CL; Liu, Y; Wei, ZY; Liang, CG; Bunch, TD; Zan, LS				Yin, Feng-Xia; Li, Guang-Peng; Bai, Chun-Ling; Liu, Yang; Wei, Zhu-Ying; Liang, Cheng-Guang; Bunch, Thomas D.; Zan, Lin-Sen			SGO1 Maintains Bovine Meiotic and Mitotic Centromeric Cohesions of Sister Chromatids and Directly Affects Embryo Development	PLOS ONE			English	Article							CHROMOSOME MIS-SEGREGATION; MEIOSIS-I; DROSOPHILA MEI-S332; OOCYTE MEIOSIS; SHUGOSHIN; MITOSIS; ANEUPLOIDY; CANCER; LOCALIZATION; MICROTUBULES	Shugoshin (SGO) is a critical factor that enforces cohesion from segregation of paired sister chromatids during mitosis and meiosis. It has been studied mainly in invertebrates. Knowledge of SGO(s) in a mammalian system has only been reported in the mouse and Hela cells. In this study, the functions of SGO1 in bovine oocytes during meiotic maturation, early embryonic development and somatic cell mitosis were investigated. The results showed that SGO1 was expressed from germinal vesicle (GV) to the metaphase II stage. SGO1 accumulated on condensed and scattered chromosomes from pre-metaphase I to metaphase II. The over-expression of SGO1 did not interfere with the process of homologous chromosome separation, although once separated they were unable to move to the opposing spindle poles. This often resulted in the formation of oocytes with 60 replicated chromosomes. Depletion of SGO1 in GV oocytes affected chromosomal separation resulting in abnormal chromosome alignment at a significantly higher proportion than in control oocytes. Knockdown of SGO1 expression significantly decreased the embryonic developmental rate and quality. To further confirm the function(s) of SGO1 during mitosis, bovine embryonic fibroblast cells were transfected with SGO1 siRNAs. SGO1 depletion induced the premature dissociation of chromosomal cohesion at the centromere and along the chromosome arm giving rise to abnormal appearing mitotic patterns. The results of this study infer that SGO1 is involved in the centromeric cohesion of sister chromatids and chromosomal movement towards the spindle poles. Depletion of SGO1 causes arrestment of cell division in meiosis and mitosis.	[Yin, Feng-Xia; Li, Guang-Peng; Bai, Chun-Ling; Wei, Zhu-Ying; Liang, Cheng-Guang] Inner Mongolia Univ, Key Lab Natl Educ Minist Mammalian Reprod Biol &, Hohhot, Peoples R China; [Liu, Yang; Zan, Lin-Sen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Bunch, Thomas D.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA	Inner Mongolia University; Northwest A&F University - China; Utah System of Higher Education; Utah State University	Li, GP (corresponding author), Inner Mongolia Univ, Key Lab Natl Educ Minist Mammalian Reprod Biol &, Hohhot, Peoples R China.	gpengli@imu.edu.cn	liang, chengguang/E-4837-2011	liang, chengguang/0000-0003-4407-7766	National Basic Research Program of China [2012CB722306]; Key Lab Researches of China Education Ministry and Inner Mongolian	National Basic Research Program of China(National Basic Research Program of China); Key Lab Researches of China Education Ministry and Inner Mongolian	This study was funded by the National Basic Research Program of China [2012CB722306]; and Key Lab Researches of China Education Ministry and Inner Mongolian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Clift D, 2009, GENE DEV, V23, P766, DOI 10.1101/gad.507509; Dai W, 2009, J FORMOS MED ASSOC, V108, P904, DOI 10.1016/S0929-6646(10)60002-2; Dudas A, 2011, CELL CYCLE, V10, P951, DOI 10.4161/cc.10.6.15032; Gutierrez-Caballero C, 2012, TRENDS GENET, V28, P351, DOI 10.1016/j.tig.2012.03.003; Hamant O, 2005, CURR BIOL, V15, P948, DOI 10.1016/j.cub.2005.04.049; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Iwaizumi M, 2009, GUT, V58, P249, DOI 10.1136/gut.2008.149468; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; KERREBROCK AW, 1992, GENETICS, V130, P827; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kiburz BM, 2008, MOL BIOL CELL, V19, P1199, DOI 10.1091/mbc.E07-06-0584; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Li GP, 2005, MOL REPROD DEV, V71, P220, DOI 10.1002/mrd.20255; Li GP, 2004, MOL REPROD DEV, V68, P189, DOI 10.1002/mrd.20071; Liu Y, 2008, MOL REPROD DEV, V75, P801, DOI 10.1002/mrd.20774; Liu Y, 2007, MOL REPROD DEV, V74, P1473, DOI 10.1002/mrd.20717; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Mailhes JB, 2003, CHROMOSOME RES, V11, P619, DOI 10.1023/A:1024909119593; Malmanche N, 2006, FEBS LETT, V580, P2888, DOI 10.1016/j.febslet.2006.03.081; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pouwels J, 2007, CELL CYCLE, V6, P1579, DOI 10.4161/cc.6.13.4442; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Rivera T, 2009, CHROMOSOMA, V118, P223, DOI 10.1007/s00412-008-0190-4; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Scanlan M J, 2001, Cancer Immun, V1, P4; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Suzuki H, 2006, CELL CYCLE, V5, P1094, DOI 10.4161/cc.5.10.2747; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Vanoosthuyse V, 2007, MOL BIOL CELL, V18, P1657, DOI 10.1091/mbc.E06-10-0890; Wang M, 2011, PLANT J, V67, P583, DOI 10.1111/j.1365-313X.2011.04615.x; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Yamada HY, 2012, CELL CYCLE, V11, P479, DOI 10.4161/cc.11.3.18994; Yang YL, 2006, CELL CYCLE, V5, P896, DOI 10.4161/cc.5.8.2691; Yin S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003516	46	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73636	10.1371/journal.pone.0073636	http://dx.doi.org/10.1371/journal.pone.0073636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019931	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200073
J	Zhang, J; Wu, LF				Zhang, Jiang; Wu, Lingfei			Allometry and Dissipation of Ecological Flow Networks	PLOS ONE			English	Article							FOOD WEBS; TRANSPORTATION NETWORKS; SCALING LAWS; ECOSYSTEMS; ORGANIZATION; ENERGETICS; DYNAMICS; ENVIRONS; BIOLOGY; ORIGIN	Background: An ecological flow network is a weighted directed graph in which the nodes are species, the edges are "who eats whom" relationships and the weights are rates of energy or nutrient transferred between species. Allometric scaling is a ubiquitous feature for flow systems such as river basins, vascular networks and food webs. Methodology: The "ecological network analysis" can serve to reveal hidden allometries, the power law relationship between the throughflux and the indirect impact of node i, directly from the original flow networks without any need to cut edges in the network. The dissipation law, which is another significant scaling relationship between the energy dissipation (respiration) and the throughflow of any species, is also obtained from an analysis of the empirical flow networks. Interestingly, the exponents of the allometric law (eta) and the dissipation law (gamma) show a strong relationship for both empirical and simulated flow networks. The dissipation law exponent c, rather than the topology of the network, is the most important factors that affect the allometric exponent eta. Conclusions: The exponent eta can be interpreted as the degree of centralization of the network, i. e., the concentration of impacts (direct and indirect influences on the entire network along all energy flow pathways) on hubs (the nodes with large throughflows). As a result, we find that as gamma increases, the relative energy loss of large nodes increases, eta decreases, i. e., the relative importance of large species decreases. Moreover, the entire flow network is more decentralized. Therefore, network flow structure (allometry) and thermodynamic constraints (dissipation) are linked.	[Zhang, Jiang] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Wu, Lingfei] City Univ Hong Kong, Dept Media & Commun, Hong Kong, Hong Kong, Peoples R China	Beijing Normal University; City University of Hong Kong	Wu, LF (corresponding author), City Univ Hong Kong, Dept Media & Commun, Hong Kong, Hong Kong, Peoples R China.	zhangjiang@bnu.edu.cn			National Natural Science Foundation of China [61004107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China under Grant No. 61004107, www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2004, J THEOR BIOL, V230, P351, DOI 10.1016/j.jtbi.2004.05.009; Almunia J, 1999, ESTUAR COAST SHELF S, V49, P363, DOI 10.1006/ecss.1999.0503; BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; Baird D, 1998, ESTUAR COAST SHELF S, V47, P329, DOI 10.1006/ecss.1998.0360; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Brown J., 2000, SCALING BIOL; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; Camacho J, 2005, NATURE, V435, pE3, DOI 10.1038/nature03839; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Cohen J. E., 1990, BIOMATHEMATICS, V20; Dreyer O, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.038101; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Fath BD, 1999, ECOSYSTEMS, V2, P167, DOI 10.1007/s100219900067; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Frank F, 2005, ECOLOGY, V86, P3258; Garlaschelli D, 2003, NATURE, V423, P165, DOI 10.1038/nature01604; Hagy J. D., 2002, THESIS U MARYLAND CO; Hechinger RF, 2011, SCIENCE, V333, P445, DOI 10.1126/science.1204337; HIGASHI M, 1993, ECOL MODEL, V66, P1, DOI 10.1016/0304-3800(93)90037-S; HIGASHI M, 1986, ECOL MODEL, V32, P137, DOI 10.1016/0304-3800(86)90022-0; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Monaco ME, 1997, MAR ECOL PROG SER, V161, P239, DOI 10.3354/meps161239; ODUM HT, 1988, SCIENCE, V242, P1132, DOI 10.1126/science.242.4882.1132; ODUM HT, 1983, SYSTEM ECOLOGY; Pascual M., 2005, ECOLOGICAL NETWORKS; PATTEN BC, 1981, AM ZOOL, V21, P845; PATTEN BC, 1982, AM NAT, V119, P179, DOI 10.1086/283903; Pimm SL, 2002, FOOD WEBS; Rodriguez-Iturbe I., 1997, FRACTAL RIVER BASINS; Straskraba M, 1999, ECOL MODEL, V117, P3, DOI 10.1016/S0304-3800(98)00194-X; SZYRMER J, 1987, ECOL MODEL, V35, P123, DOI 10.1016/0304-3800(87)90094-9; Ulanowicz R.E., 1997, ECOLOGY ASCENDENT PE; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Zhang JA, 2010, J THEOR BIOL, V264, P760, DOI 10.1016/j.jtbi.2010.03.024	41	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72525	10.1371/journal.pone.0072525	http://dx.doi.org/10.1371/journal.pone.0072525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019871	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200013
J	Graham, ES; Woo, KK; Aalderink, M; Fry, S; Greenwood, JM; Glass, M; Dragunow, M				Graham, E. Scott; Woo, Kerhan K.; Aalderink, Miranda; Fry, Sandie; Greenwood, Jeffrey M.; Glass, Michelle; Dragunow, Mike			M1 Muscarinic Receptor Activation Mediates Cell Death in M1-HEK293 Cells	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; M-3-MUSCARINIC RECEPTOR; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; GROWTH-FACTOR; APOPTOSIS; PROTEIN; PHOSPHORYLATION; EXPRESSION; INDUCTION	HEK293 cells have been used extensively to generate stable cell lines to study G protein-coupled receptors, such as muscarinic acetylcholine receptors (mAChRs). The activation of M1 mAChRs in various cell types in vitro has been shown to be protective. To further investigate M1 mAChR-mediated cell survival, we generated stable HEK293 cell-lines expressing the human M1 mAChR. M1 mAChRs were efficiently expressed at the cell surface and efficiently internalised within 1 h by carbachol. Carbachol also induced early signalling cascades similar to previous reports. Thus, ectopically expressed M1 receptors behaved in a similar fashion to the native receptor over short time periods of analysis. However, substantial cell death was observed in HEK293-M1 cells within 24 h after carbachol application. Death was only observed in HEK cells expressing M1 receptors and fully blocked by M1 antagonists. M1 mAChR-stimulation mediated prolonged activation of the MEK-ERK pathway and resulted in prolonged induction of the transcription factor EGR-1 (> 24 h). Blockade of ERK signalling with U0126 did not reduce M1 mAChR-mediated cell-death significantly but inhibited the acute induction of EGR-1. We investigated the time-course of cell death using time-lapse microscopy and xCELLigence technology. Both revealed the M1 mAChR cytotoxicity occurs within several hours of M1 activation. The xCELLigence assay also confirmed that the ERK pathway was not involved in cell-death. Interestingly, the MEK blocker did reduce carbachol-mediated cleaved caspase 3 expression in HEK293-M1 cells. The HEK293 cell line is a widely used pharmacological tool for studying G-protein coupled receptors, including mAChRs. Our results highlight the importance of investigating the longer term fate of these cells in short term signalling studies. Identifying how and why activation of the M1 mAChR signals apoptosis in these cells may lead to a better understanding of how mAChRs regulate cell-fate decisions.	[Graham, E. Scott; Woo, Kerhan K.; Aalderink, Miranda; Fry, Sandie; Greenwood, Jeffrey M.; Glass, Michelle; Dragunow, Mike] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Pharmacol & Clin Pharmacol,Ctr Brain Res, Auckland 1, New Zealand	University of Auckland	Dragunow, M (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Pharmacol & Clin Pharmacol,Ctr Brain Res, Auckland 1, New Zealand.	m.dragunow@auckland.ac.nz	Glass, Michelle/AAE-7799-2019	Glass, Michelle/0000-0002-5997-6898; Graham, Scott/0000-0002-2925-9126	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Health Research Council of New Zealand (http://www.hrc.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2000, J BIOL CHEM, V275, P28929, DOI 10.1074/jbc.M003053200; Budd DC, 2004, BIOCHEM J, V381, P43, DOI 10.1042/BJ20031705; Budd DC, 2003, J BIOL CHEM, V278, P19565, DOI 10.1074/jbc.M211670200; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Cheng KR, 2003, CANCER RES, V63, P6744; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Daigle TL, 2008, J NEUROCHEM, V106, P70, DOI 10.1111/j.1471-4159.2008.05336.x; De Sarno P, 2003, J BIOL CHEM, V278, P11086, DOI 10.1074/jbc.M212157200; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; Dragunow M, 2008, NAT REV NEUROSCI, V9, P779, DOI 10.1038/nrn2492; Dragunow M, 2008, NAT REV DRUG DISCOV, V7, DOI 10.1038/nrd2506-c1; Fisher A, 2000, JPN J PHARMACOL, V84, P101, DOI 10.1254/jjp.84.101; FISHER A, 1993, ANN NY ACAD SCI, V695, P300, DOI 10.1111/j.1749-6632.1993.tb23070.x; Fisher A, 2000, ANN NY ACAD SCI, V920, P315; Fisher A, 2012, J NEUROCHEM, V120, P22, DOI 10.1111/j.1471-4159.2011.07507.x; Giordano G, 2009, J NEUROCHEM, V109, P525, DOI 10.1111/j.1471-4159.2009.05969.x; Graham ES, 2006, J BIOL CHEM, V281, P29085, DOI 10.1074/jbc.M602516200; Greenwood JM, 2002, J NEUROCHEM, V82, P389, DOI 10.1046/j.1471-4159.2002.00992.x; Grimsey NL, 2008, CLIN EXP PHARMACOL P, V35, P1377, DOI 10.1111/j.1440-1681.2008.04991.x; Grimsey NL, 2008, J NEUROSCI METH, V171, P78, DOI 10.1016/j.jneumeth.2008.02.014; Hirota K, 2004, J BIOL CHEM, V279, P41521, DOI 10.1074/jbc.M405164200; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; Leloup C, 2000, CELL DEATH DIFFER, V7, P825, DOI 10.1038/sj.cdd.4400713; Limke TL, 2004, TOXICOL SCI, V80, P60, DOI 10.1093/toxsci/kfh131; Luo J, 2008, MOL PHARM; Moodley K, 2011, J NEUROSCI METH, V200, P173, DOI 10.1016/j.jneumeth.2011.07.005; Pereira SPF, 2001, INT J DEV NEUROSCI, V19, P559, DOI 10.1016/S0736-5748(01)00043-0; Rayford W, 1997, PROSTATE, V30, P160, DOI 10.1002/(SICI)1097-0045(19970215)30:3<160::AID-PROS3>3.0.CO;2-Q; Reina S, 2010, J CELL PHYSIOL, V222, P640, DOI 10.1002/jcp.21981; Rossler OG, 2008, ARCH BIOCHEM BIOPHYS, V470, P93, DOI 10.1016/j.abb.2007.11.008; SANDMANN J, 1991, J BIOL CHEM, V266, P6031; Shafer SH, 2004, MOL PHARMACOL, V65, P1080, DOI 10.1124/mol.65.5.1080; Slack BE, 2008, J CELL BIOCH; Song PF, 2003, CANCER RES, V63, P214; Stope MB, 2003, BIOCHEM PHARMACOL, V66, P2099, DOI 10.1016/S0006-2952(03)00580-X; Suriyo T, 2008, J TOXICOL ENV HEAL A, V71, P1109, DOI 10.1080/15287390802114725; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; von der Kammer H, 1998, J BIOL CHEM, V273, P14538, DOI 10.1074/jbc.273.23.14538; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Yagle K, 2001, GLIA, V35, P111, DOI 10.1002/glia.1076; Yamada T, 1997, JPN J PHARMACOL, V73, P311, DOI 10.1254/jjp.73.311; YAN GM, 1995, MOL PHARMACOL, V47, P248; Zhou W, 2008, CELL MOL NEUROBIOL, V28, P263, DOI 10.1007/s10571-007-9251-0	44	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72011	10.1371/journal.pone.0072011	http://dx.doi.org/10.1371/journal.pone.0072011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023725	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400009
J	Huang, JH; Kim, J; Ding, YF; Jayaraman, A; Ugaz, VM				Huang, Jen-Huang; Kim, Jeongyun; Ding, Yufang; Jayaraman, Arul; Ugaz, Victor M.			Embedding Synthetic Microvascular Networks in Poly(Lactic Acid) Substrates with Rounded Cross-Sections for Cell Culture Applications	PLOS ONE			English	Article							MICROFLUIDIC APPLICATIONS; SHEAR RATE; CHANNELS; FABRICATION; FLOW; MICROCHANNELS; MORPHOLOGY; ADHESION; DEVICES	Synthetic microvascular networks are essential to enable in vitro studies of cell biology, biophysics, hemodynamics, and drug discovery, as well as in applications involving tissue engineering and artificial vasculature. But current limitations make it challenging to construct networks incorporating a hierarchy of microchannel diameters that possess cell-favored circular cross-sectional topographies. We report a new approach that overcomes these limitations by employing pressure-assisted expansion of biocompatible degradable poly(lactic acid) (PLA) substrates. This single-step process is straightforward and highly controllable, making it possible to simultaneously shape the interior topology of branched 3D and pseudo-3D microchannel networks across wide range of diameters. We further demonstrate in vitro culture of confluent endothelial cell monolayers in microchannel networks treated by this process, suggesting potential as a tool to help generate biomimicking vascular-like environments.	[Huang, Jen-Huang; Kim, Jeongyun; Jayaraman, Arul; Ugaz, Victor M.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA; [Ding, Yufang; Jayaraman, Arul; Ugaz, Victor M.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Jayaraman, A (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.	arulj@tamu.edu; ugaz@tamu.edu		Huang, Jen-Huang/0000-0002-3086-5094	US National Science Foundation [DMR-1106005]; Texas AM University; Division Of Materials Research [1106005] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Texas AM University; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by the US National Science Foundation under grant DMR-1106005 monitored by Dr. Joseph Akkara. J.-H.H. acknowledges support from a Texas A&M University Dissertation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate AR, 2008, LAB CHIP, V8, P516, DOI 10.1039/b800001h; Abdelgawad M, 2011, LAB CHIP, V11, P545, DOI [10.1039/c0lc00093k, 10.1039/c01c00093k]; Bellan LM, 2009, SOFT MATTER, V5, P1354, DOI 10.1039/b819905a; Borenstein JT, 2010, BIOMED MICRODEVICES, V12, P71, DOI 10.1007/s10544-009-9361-1; Camp JP, 2008, BIOMED MICRODEVICES, V10, P179, DOI 10.1007/s10544-007-9123-x; Esser-Kahn AP, 2011, ADV MATER, V23, P3654, DOI 10.1002/adma.201100933; Fiddes LK, 2010, BIOMATERIALS, V31, P3459, DOI 10.1016/j.biomaterials.2010.01.082; Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302; Green JV, 2009, LAB CHIP, V9, P677, DOI 10.1039/b813516a; HELMLINGER G, 1991, J BIOMECH ENG-T ASME, V113, P123, DOI 10.1115/1.2891226; Huang JH, 2012, ANGEW CHEM INT EDIT, V51, P9619, DOI 10.1002/anie.201204600; Huang JH, 2009, ADV MATER, V21, P3567, DOI 10.1002/adma.200900584; Huang JH, 2012, MICROFLUIDIC CELL CU; IVES CL, 1986, IN VITRO CELL DEV B, V22, P500; Jain A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007104; Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739; Kam DH, 2008, J LASER APPL, V20, P185, DOI 10.2351/1.2955485; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Khan OF, 2011, BIOMED MICRODEVICES, V13, P69, DOI 10.1007/s10544-010-9472-8; King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522; Lee SH, 2010, LAB CHIP, V10, P3300, DOI 10.1039/c0lc00127a; Lima R, 2008, BIOMED MICRODEVICES, V10, P153, DOI 10.1007/s10544-007-9121-z; Lu H, 2004, ANAL CHEM, V76, P5257, DOI 10.1021/ac049837t; Malek AM, 1996, J CELL SCI, V109, P713; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Runyon MK, 2008, J AM CHEM SOC, V130, P3458, DOI 10.1021/ja076301r; Shen F, 2008, ARTERIOSCL THROM VAS, V28, P2035, DOI 10.1161/ATVBAHA.108.173930; Shevkoplyas SS, 2006, LAB CHIP, V6, P914, DOI 10.1039/b601554a; Shevkoplyas SS, 2003, MICROVASC RES, V65, P132, DOI 10.1016/S0026-2862(02)00034-1; Song SH, 2010, MICROFLUID NANOFLUID, V9, P533, DOI 10.1007/s10404-010-0570-y; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Tsai M, 2012, J CLIN INVEST, V122, P408, DOI 10.1172/JCI58753; Wang GJ, 2007, BIOMED MICRODEVICES, V9, P657, DOI 10.1007/s10544-007-9067-1; Wilson ME, 2011, LAB CHIP, V11, P1550, DOI 10.1039/c0lc00561d; Wu W, 2011, ADV MATER, V23, pH178, DOI 10.1002/adma.201004625	35	14	14	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73188	10.1371/journal.pone.0073188	http://dx.doi.org/10.1371/journal.pone.0073188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023829	gold, Green Published, Green Submitted			2022-12-27	WOS:000324238400049
J	Liu, GH; Sun, XZ; Bian, J; Wu, RP; Guan, X; Ouyang, B; Huang, YP; Xiao, HP; Luo, DS; Atala, A; Zhang, YY; Deng, CH				Liu, Guihua; Sun, Xiangzhou; Bian, Jun; Wu, Rongpei; Guan, Xuan; Ouyang, Bin; Huang, Yanping; Xiao, Haipeng; Luo, Daosheng; Atala, Anthony; Zhang, Yuanyuan; Deng, Chunhua			Correction of Diabetic Erectile Dysfunction with Adipose Derived Stem Cells Modified with the Vascular Endothelial Growth Factor Gene in a Rodent Diabetic Model	PLOS ONE			English	Article							RAT MODEL; INSULIN-RESISTANT; TISSUE; VEGF; ANGIOGENESIS; EXPRESSION; RECEPTORS; SURVIVAL; THERAPY; PROTEIN	The aim of this study was to determine whether adipose derived stem cells (ADSCs) expressing vascular endothelial growth factor (VEGF) gene can improve endothelial function, recover the impaired VEGF signaling pathway and enhance smooth muscle contents in a rat diabetic erectile dysfunction (DED) model. DED rats were induced via intraperitoneal injection of streptozotocin (40 mg/kg), and then screened by apomorphine (100 mg/kg). Five groups were used (n = 12/group)-Group 1 (G1): intracavernous injection of lentivirus-VEGF; G2: ADSCs injection; G3: VEGF-expressing ADSCs injection; G4: Phosphate buffered saline injection; G1-G4 were DED rats; G5: normal rats. The mean arterial pressure (MAP) and intracavernosal pressure (ICP) were measured at days 7 and 28 after the injections. The components of the VEGF system, endothelial, smooth muscle, pericytes markers in cavernoursal tissue were assessed. On day 28 after injection, the group with intracavernosum injection of ADSCs expressing VEGF displayed more efficiently and significantly raised ICP and ICP/MAP (p<0.01) than those with ADSCs or lentivirus-VEGF injection. Western blot and immunofluorescent analysis demonstrated that improved erectile function by ADSCs-VEGF was associated with increased expression of endothelial markers (VEGF, VEGF R1, VEGF R2, eNOS, CD31 and vWF), smooth muscle markers (a-actin and smoothelin), and pericyte markers (CD146 and NG2). ADSCs expressing VEGF produced a therapeutic effect and restored erectile function in diabetic rats by enhancing VEGF-stimulated endothelial function and increasing the contents of smooth muscle and pericytes.	[Liu, Guihua; Sun, Xiangzhou; Wu, Rongpei; Ouyang, Bin; Huang, Yanping; Deng, Chunhua] Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Guihua; Wu, Rongpei; Guan, Xuan; Atala, Anthony; Zhang, Yuanyuan] Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA; [Bian, Jun] Southern Med Univ, Affiliated Hosp 3, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Xiao, Haipeng] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Daosheng] Dongguan Peoples Hosp, Dept Urol, Dongguan, Peoples R China	Sun Yat Sen University; Wake Forest University; Southern Medical University - China; Sun Yat Sen University	Xiao, HP (corresponding author), Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	xiaohp@mail.sysu.edu.cn; yzhang@wakehealth.edu; dch0313@163.com	guihua, liu/B-1060-2012; zhang, yuanyuan/GYA-4428-2022; Guan, Xuan/H-5766-2015	Guan, Xuan/0000-0002-6558-5332; Huang, Yan-Ping/0000-0002-3301-2847; Atala, Anthony/0000-0001-8186-2160	National Natural Science Foundation of China [30872571, 81070488, 30901487, 81270696]; grant of Research Fund for the Doctoral Program of Higher Education of China [20100171110060]; Guangdong Natural Science Fund [S2011010005282, 10251008901000005]; Guangdong Province Science & Technology Project [2011B031800115, 2011B032000003, 20101051500032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); grant of Research Fund for the Doctoral Program of Higher Education of China; Guangdong Natural Science Fund; Guangdong Province Science & Technology Project	This work was funded by the grant from the National Natural Science Foundation of China (30872571,81070488, 30901487 and 81270696)(http://www.nsfc.gov.cn/Portal0/default152.htm), the grant of Research Fund for the Doctoral Program of Higher Education of China (20100171110060)(http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm), the Guangdong Natural Science Fund (S2011010005282, 10251008901000005)(http://gdsf.gdstc.gov.cn/); and the Guangdong Province Science & Technology Project(2011B031800115, 2011B032000003, 20101051500032)(http://pro.gdstc.gov.cn/stms/main.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bouacida A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048648; Chou E, 2002, CIRCULATION, V105, P373, DOI 10.1161/hc0302.102143; Das H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007325; de Tejada IS, 2005, J SEX MED, V2, P26, DOI 10.1111/j.1743-6109.2005.20103.x; De Young LX, 2008, EUR UROL, V54, P213, DOI 10.1016/j.eururo.2008.02.034; Fakhrejahani E, 2012, J ONCOL, V2012, DOI 10.1155/2012/261750; Fandel TM, 2012, EUR UROL, V61, P201, DOI 10.1016/j.eururo.2011.07.061; Garcia MM, 2010, J SEX MED, V7, P89, DOI 10.1111/j.1743-6109.2009.01541.x; GIULIANO F, 1993, J UROLOGY, V150, P519, DOI 10.1016/S0022-5347(17)35539-8; Hall AP, 2006, TOXICOL PATHOL, V34, P763, DOI 10.1080/01926230600936290; HEATON JPW, 1991, J UROLOGY, V145, P1099, DOI 10.1016/S0022-5347(17)38543-9; Huang YP, 2011, J SEX MED, V8, P840, DOI 10.1111/j.1743-6109.2010.02141.x; Jesmin S, 2003, J MOL ENDOCRINOL, V31, P401, DOI 10.1677/jme.0.0310401; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lee RH, 2011, J CELL BIOCHEM, V112, P3073, DOI 10.1002/jcb.23250; Li WJ, 2011, J SEX MED, V8, P1072, DOI 10.1111/j.1743-6109.2010.02176.x; Liakouli V, 2011, AUTOIMMUN REV, V10, P590, DOI 10.1016/j.autrev.2011.04.019; Lin CS, 2008, ASIAN J ANDROL, V10, P171, DOI 10.1111/j.1745-7262.2008.00389.x; Lin CS, 2012, STEM CELLS DEV, V21, P343, DOI 10.1089/scd.2011.0303; Liu GH, 2010, J SEX MED, V7, P3868, DOI 10.1111/j.1743-6109.2010.01844.x; Liu SY, 2011, TISSUE ENG PT A, V17, P725, DOI [10.1089/ten.tea.2010.0331, 10.1089/ten.TEA.2010.0331]; Long T, 2012, J SEX MED, V9, P1801, DOI 10.1111/j.1743-6109.2012.02739.x; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; Morizono K, 2003, HUM GENE THER, V14, P59, DOI 10.1089/10430340360464714; Obrosova IG, 2005, DIABETES, V54, P3435, DOI 10.2337/diabetes.54.12.3435; Pons J, 2008, BIOCHEM BIOPH RES CO, V376, P419, DOI 10.1016/j.bbrc.2008.09.003; Portalska KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046842; Potenza MA, 2009, CURR MED CHEM, V16, P94, DOI 10.2174/092986709787002853; Prakash R, 2012, DIABETES, V61, P1533, DOI 10.2337/db11-1528; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; Reinmuth N, 2001, FASEB J, V15, P1239, DOI 10.1096/fj.00-0693fje; Ribatti D, 2000, GEN PHARMACOL-VASC S, V35, P227, DOI 10.1016/S0306-3623(01)00112-4; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Stuckey BGA, 2003, DIABETES CARE, V26, P279, DOI 10.2337/diacare.26.2.279; Sun XZ, 2011, CHINESE MED J-PEKING, V124, P3093, DOI 10.3760/cma.j.issn.0366-6999.2011.19.026; Thorve VS, 2011, J DIABETES COMPLICAT, V25, P129, DOI 10.1016/j.jdiacomp.2010.03.003; Wespes E, 2002, INT J IMPOT RES, V14, pS17, DOI 10.1038/sj.ijir.3900792; Zhang HY, 2010, BIOCHEM BIOPH RES CO, V402, P560, DOI 10.1016/j.bbrc.2010.10.090	42	72	78	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72790	10.1371/journal.pone.0072790	http://dx.doi.org/10.1371/journal.pone.0072790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023647	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200043
J	Zoppellaro, C; Bin, A; Brun, P; Banzato, S; Macchi, V; Castagliuolo, I; Giron, MC				Zoppellaro, Chiara; Bin, Anna; Brun, Paola; Banzato, Serena; Macchi, Veronica; Castagliuolo, Ignazio; Giron, Maria Cecilia			Adenosine-Mediated Enteric Neuromuscular Function Is Affected during Herpes Simplex Virus Type 1 Infection of Rat Enteric Nervous System	PLOS ONE			English	Article							LONGITUDINAL MUSCLE; MYENTERIC MOTONEURONS; ORAL INOCULATION; GENE-EXPRESSION; MOUSE ILEUM; ECTO-ATPASE; RECEPTORS; A(1); A(2A); MODULATION	Adenosine plays an important role in regulating intestinal motility and inflammatory processes. Previous studies in rodent models have demonstrated that adenosine metabolism and signalling are altered during chronic intestinal inflammatory diseases. However, the involvement of the adenosinergic system in the pathophysiology of gut dysmotility associated to a primary neurodysfunction is still unclear. Recently, we showed that the neurotropic Herpes simplex virus type-1 (HSV-1), orally inoculated to rodents, infects the rat enteric nervous system (ENS) and affects gut motor function without signs of systemic infection. In this study we examined whether changes in purinergic metabolism and signaling occur during permanent HSV-1 infection of rat ENS. Using isolated organ bath assays, we found that contraction mediated by adenosine engagement of A(1) or A(2A) receptors was impaired at 1 and 6 weeks post-viral administration. Immunofluorescence studies revealed that viral infection of ENS led to a marked redistribution of adenosine receptors: A(1) and A(2B) receptors were confined to the muscle layers whereas A(2A) and A(3) receptors were expressed mainly in the myenteric plexus. Viral-induced ENS neurodysfunction influenced adenosine metabolism by increasing adenosine deaminase and CD73 levels in longitudinal muscle-myenteric plexus with no sign of frank inflammation. This study provides the first evidence for involvement of the adenosinergic system during HSV-1 infection of the ENS. As such, this may represent a valid therapeutic target for modulating gut contractility associated to a primary neurodysfunction.	[Zoppellaro, Chiara; Bin, Anna; Banzato, Serena; Giron, Maria Cecilia] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Brun, Paola; Macchi, Veronica; Castagliuolo, Ignazio] Univ Padua, Dept Mol Med, Padua, Italy	University of Padua; University of Padua	Giron, MC (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	cecilia.giron@unipd.it	Giron, Maria Cecilia/K-7557-2019; castagliuolo, ignazio/K-9963-2016; Macchi, Veronica/AAV-4514-2020	Giron, Maria Cecilia/0000-0002-0825-7965; castagliuolo, ignazio/0000-0001-9888-7030; Macchi, Veronica/0000-0003-2335-6897	Italian Ministry of University and Research [2007EN8F7T_002, 2009HLNNRL_002]; University of Padova [CPDA095223]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); University of Padova	This work was supported by grants from the Italian Ministry of University and Research (2007EN8F7T_002 to M. C. G. and 2009HLNNRL_002 to I. C., M. C. G.) and from University of Padova (CPDA095223 to M. C. G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioli L, 2010, BRIT J PHARMACOL, V161, P856, DOI 10.1111/j.1476-5381.2010.00917.x; Antonioli L, 2012, CURR DRUG TARGETS, V13, P842, DOI 10.2174/138945012800564095; Antonioli L, 2011, EUR J PHARMACOL, V650, P639, DOI 10.1016/j.ejphar.2010.10.041; Antonioli L, 2010, J PHARMACOL EXP THER, V335, P434, DOI 10.1124/jpet.110.171223; Antonioli L, 2008, PHARMACOL THERAPEUT, V120, P233, DOI 10.1016/j.pharmthera.2008.08.010; Auli M, 2008, AUTON NEUROSCI-BASIC, V141, P10, DOI 10.1016/j.autneu.2008.04.005; Bornstein JC, 2008, PURINERG SIGNAL, V4, P197, DOI 10.1007/s11302-007-9081-z; Brun P, 2010, GASTROENTEROLOGY, V138, P1790, DOI 10.1053/j.gastro.2010.01.036; Chandrasekharan BP, 2009, FASEB J, V23, P2727, DOI 10.1096/fj.09-129544; Christofi FL, 2001, J COMP NEUROL, V439, P46, DOI 10.1002/cne.1334; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Colgan SP, 2013, J MOL MED, V91, P157, DOI 10.1007/s00109-012-0990-0; Correia-de-Sa P, 2006, AUTON NEUROSCI-BASIC, V126, P211, DOI 10.1016/j.autneu.2006.02.004; Coupar IM, 1999, BRIT J PHARMACOL, V126, P1269, DOI 10.1038/sj.bjp.0702411; De Giorgio R, 2004, GASTROENTEROLOGY, V126, P1872, DOI 10.1053/j.gastro.2004.02.024; De Giorgio R, 2004, NEUROGASTROENT MOTIL, V16, P143, DOI 10.1111/j.1743-3150.2004.00491.x; De Giorgio R, 2010, TRANSPL P, V42, P9, DOI 10.1016/j.transproceed.2009.12.014; De Man JG, 2003, BRIT J PHARMACOL, V139, P172, DOI 10.1038/sj.bjp.0705218; Di Nardo G, 2008, ALIMENT PHARM THER, V28, P25, DOI 10.1111/j.1365-2036.2008.03707.x; Duarte-Araujo M, 2004, BRIT J PHARMACOL, V141, P925, DOI 10.1038/sj.bjp.0705697; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Gershon AA, 2008, J INFECT DIS, V197, pS61, DOI 10.1086/522149; Gesser RM, 1995, LAB INVEST, V73, P880; GESSER RM, 1994, J GEN VIROL, V75, P2379, DOI 10.1099/0022-1317-75-9-2379; Gesser RM, 1997, J VIROL, V71, P4103, DOI 10.1128/JVI.71.5.4103-4106.1997; Gesser RM, 1996, J VIROL, V70, P4097, DOI 10.1128/JVI.70.6.4097-4102.1996; Giron MC, 2008, GASTROENTEROLOGY, V134, P1116, DOI 10.1053/j.gastro.2008.01.030; Kadowaki M, 2000, BRIT J PHARMACOL, V129, P871, DOI 10.1038/sj.bjp.0703123; Kan YJ, 2012, J VIROL, V86, P10338, DOI 10.1128/JVI.01196-12; Kas-Deelen AM, 2001, FEBS LETT, V491, P21, DOI 10.1016/S0014-5793(01)02085-3; Kolachala VL, 2008, GASTROENTEROLOGY, V135, P861, DOI 10.1053/j.gastro.2008.05.049; Kolachala VL, 2008, AM J PHYSIOL-GASTR L, V294, pG401, DOI 10.1152/ajpgi.00454.2007; MURTHY KS, 1995, J PHARMACOL EXP THER, V274, P300; Nicholls J, 1996, BRIT J PHARMACOL, V117, P170, DOI 10.1111/j.1476-5381.1996.tb15170.x; Nicholls J, 1997, EUR J PHARMACOL, V338, P143, DOI 10.1016/S0014-2999(97)81942-5; NITAHARA K, 1995, NEUROSCIENCE, V67, P159, DOI 10.1016/0306-4522(94)00585-S; Roizman B, 2001, FIELDS VIROLOGY, P2399; Schwiebert EM, 2008, PURINERG SIGNAL, V4, P89, DOI 10.1007/s11302-007-9091-x; Vieira C, 2011, NEUROCHEM INT, V59, P1043, DOI 10.1016/j.neuint.2011.08.016; Volonte C, 2008, PROG NEUROBIOL, V86, P61, DOI 10.1016/j.pneurobio.2008.07.001; Voltan S, 2008, GASTROENTEROLOGY, V135, P1216, DOI 10.1053/j.gastro.2008.07.007; Zizzo MG, 2011, BRIT J PHARMACOL, V164, P1580, DOI 10.1111/j.1476-5381.2011.01498.x; Zizzo MG, 2006, BRIT J PHARMACOL, V148, P956, DOI 10.1038/sj.bjp.0706808; Zizzo MG, 2009, LIFE SCI, V84, P772, DOI 10.1016/j.lfs.2009.03.006	44	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72648	10.1371/journal.pone.0072648	http://dx.doi.org/10.1371/journal.pone.0072648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015268	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200052
J	Drgonova, J; Jacobsson, JA; Han, JC; Yanovski, JA; Fredriksson, R; Marcus, C; Schioth, HB; Uhl, GR				Drgonova, Jana; Jacobsson, Josefin A.; Han, Joan C.; Yanovski, Jack A.; Fredriksson, Robert; Marcus, Claude; Schioth, Helgi B.; Uhl, George R.			Involvement of the Neutral Amino Acid Transporter SLC6A15 and Leucine in Obesity-Related Phenotypes	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GENOME-WIDE ASSOCIATION; HIGH-PROTEIN DIET; ORPHAN TRANSPORTERS; INSULIN-RESISTANCE; V7-3 SLC6A15; ENERGY; HYPOTHALAMUS; SUPPLEMENTATION; PREVALENCE	Brain pathways, including those in hypothalamus and nucleus of the solitary tract, influence food intake, nutrient preferences, metabolism and development of obesity in ways that often differ between males and females. Branched chain amino acids, including leucine, can suppress food intake, alter metabolism and change vulnerability to obesity. The SLC6A15 (v7-3) gene encodes a sodium-dependent transporter of leucine and other branched chain amino acids that is expressed by neurons in hypothalamus and nucleus of the solitary tract. We now report that SLC6A15 knockout attenuates leucine's abilities to reduce both: a) intake of normal chow and b) weight gain produced by access to a high fat diet in gender-selective fashions. We identify SNPs in the human SLC6A15 that are associated with body mass index and insulin resistance in males. These observations in mice and humans support a novel, gender-selective role for brain amino acid compartmentalization mediated by SLC6A15 in diet and obesity-associated phenotypes.	[Drgonova, Jana; Uhl, George R.] NIDA, Mol Neurobiol Branch, NIH, IRP, Baltimore, MD USA; [Jacobsson, Josefin A.; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Unit Funct Pharmacol, Dept Neurosci, Uppsala, Sweden; [Han, Joan C.; Yanovski, Jack A.] NICHD, Sect Growth & Obes, Program Dev Endocrinol & Genet, IRP,NIH,CRC 10, Bethesda, MD USA; [Marcus, Claude] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Uppsala University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Karolinska Institutet	Uhl, GR (corresponding author), NIDA, Mol Neurobiol Branch, NIH, IRP, Baltimore, MD USA.	guhl@intra.nida.nih.gov	Schioth, Helgi/AAQ-7239-2020; Fredriksson, Robert/AAH-3921-2019; Marcus, Claude/ABE-1177-2020	Fredriksson, Robert/0000-0002-2810-3226; Marcus, Claude/0000-0003-0890-2650; Yanovski, Jack/0000-0001-8542-1637; Han, Joan/0000-0003-4252-2678	National Institute on Drug Abuse; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/DHHS); National Institute on Minority and Health Disparities (NIMHD), National Institutes of Health (NIH); Department of Health and Human Services; Swedish Medical Research foundation; Swedish Research Council; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF13OC0005723] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641, ZIAHD008898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000165] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority and Health Disparities (NIMHD), National Institutes of Health (NIH); Department of Health and Human Services; Swedish Medical Research foundation(Swedish Medical Research Council (SMRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support came from the Intramural Research Programs of the National Institute on Drug Abuse, the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/DHHS), supplementary funding from National Institute on Minority and Health Disparities (NIMHD), National Institutes of Health (NIH) (to JY), Department of Health and Human Services, the Swedish Medical Research foundation, Swedish Research Council and the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009; Broer A, 2006, BIOCHEM J, V393, P421, DOI 10.1042/BJ20051273; Choi YH, 2001, BRAIN RES, V892, P320, DOI 10.1016/S0006-8993(00)03267-4; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Collaku A, 2004, AM J CLIN NUTR, V79, P881; CORPELEIJN E, 2009, OBESITY; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; CURRIE PJ, 1995, LIFE SCI, V57, P1911, DOI 10.1016/0024-3205(95)02178-L; Dardevet D, 2002, J NUTR, V132, P95, DOI 10.1093/jn/132.1.95; Drgonova J, 2007, BRAIN RES, V1183, P10, DOI 10.1016/j.brainres.2007.09.001; Durand E, 2004, DIABETES, V53, P2483, DOI 10.2337/diabetes.53.9.2483; Farmer MK, 2000, GENOMICS, V70, P241, DOI 10.1006/geno.2000.6387; Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FOSTER KG, 2010, J BIOL CHEM; FREUDENBERG A, 2012, AMINO ACIDS; Freudenberg A, 2012, J NUTR BIOCHEM, V23, P1524, DOI 10.1016/j.jnutbio.2011.10.005; Guo KY, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-57; Gustafson JK, 2009, J CLIN ENDOCR METAB, V94, P4828, DOI 10.1210/jc.2008-2665; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Inoue K, 1996, MOL BRAIN RES, V37, P217, DOI 10.1016/0169-328X(95)00298-7; Johnston CS, 2002, J AM COLL NUTR, V21, P55, DOI 10.1080/07315724.2002.10719194; Kohli MA, 2011, NEURON, V70, P252, DOI 10.1016/j.neuron.2011.04.005; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lejeune MPGM, 2006, AM J CLIN NUTR, V83, P89; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; MAY ME, 1990, AM J CLIN NUTR, V52, P770, DOI 10.1093/ajcn/52.5.770; Nairizi A, 2009, J NUTR, V139, P715, DOI 10.3945/jn.108.100081; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; ROLLANDCACHERA MF, 1982, AM J CLIN NUTR, V36, P178, DOI 10.1093/ajcn/36.1.178; Sanchez-Lasheras C, 2010, FRONT NEUROENDOCRIN, V31, P4, DOI 10.1016/j.yfrne.2009.08.002; Suviolahti E, 2003, J CLIN INVEST, V112, P1762, DOI 10.1172/JCI200317491; Takanaga H, 2005, BIOCHEM BIOPH RES CO, V337, P892, DOI 10.1016/j.bbrc.2005.09.128; TAPPY L, 1993, AM J CLIN NUTR, V57, P912, DOI 10.1093/ajcn/57.6.912; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; UHL GR, 1992, TRENDS PHARMACOL SCI, V13, P421, DOI 10.1016/0165-6147(92)90133-Q; UHL GR, 1992, MOL BRAIN RES, V16, P353, DOI 10.1016/0169-328X(92)90246-8; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Veldhorst MAB, 2009, PHYSIOL BEHAV, V96, P675, DOI 10.1016/j.physbeh.2009.01.004; Veldhorst MAB, 2009, BRIT J NUTR, V101, P295, DOI 10.1017/S0007114508003061; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	52	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e68245	10.1371/journal.pone.0068245	http://dx.doi.org/10.1371/journal.pone.0068245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023709	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600003
J	Fan, LC; Lu, HW; Cheng, KB; Li, HP; Xu, JF				Fan, Li-Chao; Lu, Hai-Wen; Cheng, Ke-Bin; Li, Hui-Ping; Xu, Jin-Fu			Evaluation of PCR in Bronchoalveolar Lavage Fluid for Diagnosis of Pneumocystis jirovecii Pneumonia: A Bivariate Meta-Analysis and Systematic Review	PLOS ONE			English	Review							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; TEST ACCURACY; CARINII; ASSAY; DNA; SPUTUM; SPECIFICITY; SENSITIVITY; PERFORMANCE	Background: As a promising tool, PCR in bronchoalveolar lavage fluid (BALF) has not been accepted as a diagnostic criterion for PJP. Objective: We undertook a systematic review of published studies to evaluate the diagnostic accuracy of PCR assays in BALF for PJP. Methods: Eligible studies from PubMed, Embase and Web of Science reporting PCR assays in BALF for diagnosing PJP were identified. A bivariate meta-analysis of the method's sensitivity, specificity, and positive and negative likelihood ratios with a 95% confidence interval (CI) were analyzed. The post-test probability was performed to evaluate clinical usefulness. A summary receiver operating characteristics (SROC) curve was used to evaluate overall performance. Subgroup analyses were carried out to analysis the potential heterogeneity. Results: Sixteen studies published between 1994 and 2012 were included. The summary sensitivity and specificity values (95% CI) of PCR in BALF for diagnosis of PJP were 98.3% (91.3%-99.7%) and 91.0% (82.7%-95.5%), respectively. The positive and negative likelihood ratios were 10.894 (5.569-21.309) and 0.018 (0.003-0.099), respectively. In a setting of 20% prevalence of PJP, the probability of PJP would be over 3-fold if the BALF-PCR test was positive, and the probability of PJP would be less than 0.5% if it was negative. The area under the SROC curve was 0.98 (0.97-0.99). Conclusions: The method of PCR in BALF shows high sensitivity and good specificity for the diagnosis of PJP. However, clinical practice for the diagnosis of PJP should consider the consistent respiratory symptoms, radiographic changes and laboratory findings of the suspected patients.	[Fan, Li-Chao; Lu, Hai-Wen; Cheng, Ke-Bin; Li, Hui-Ping; Xu, Jin-Fu] Tongji Univ, Dept Resp Med, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China	Tongji University	Xu, JF (corresponding author), Tongji Univ, Dept Resp Med, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China.	jfxucn@gmail.com	Xu, Jin-fu/AAC-6980-2020	Xu, Jin-fu/0000-0002-8039-8973	National Science Foundation of China [NSFC81170003]; Shanghai Pujiang Project [12PJD004]; Shanghai Elite Medical Talent Project [XYQ2011006]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Project(Shanghai Pujiang Program); Shanghai Elite Medical Talent Project	This work was supported by the National Science Foundation of China [NSFC81170003]; Shanghai Pujiang Project [12PJD004] and Shanghai Elite Medical Talent Project [XYQ2011006]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni F, 2000, INT J ANTIMICROB AG, V16, P549, DOI 10.1016/S0924-8579(00)00292-2; Alvarez-Martinez MJ, 2006, DIAGN MICR INFEC DIS, V56, P153, DOI 10.1016/j.diagmicrobio.2006.03.010; Azoulay E, 2009, CHEST, V135, P655, DOI 10.1378/chest.08-1309; Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967; Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI [10.1586/eri.10.42, 10.1586/eri.10.11, 10.1586/ERI.10.42]; da Silva RM, 2007, BRAZ J INFECT DIS, V11, P549, DOI 10.1590/S1413-86702007000600005; de Oliveira A, 2007, DIAGN MICR INFEC DIS, V57, P169, DOI 10.1016/j.diagmicrobio.2006.08.015; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Flori P, 2004, J MED MICROBIOL, V53, P603, DOI 10.1099/jmm.0.45528-0; GILL VJ, 1987, J CLIN MICROBIOL, V25, P1837, DOI 10.1128/JCM.25.10.1837-1840.1987; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hauser PM, 2000, AIDS, V14, P461, DOI 10.1097/00002030-200003100-00022; Helweg-Larsen J, 1998, J CLIN MICROBIOL, V36, P2068, DOI 10.1128/JCM.36.7.2068-2072.1998; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huggett JF, 2008, THORAX, V63, P154, DOI 10.1136/thx.2007.081687; KIM YK, 1990, DIAGN MICR INFEC DIS, V13, P307, DOI 10.1016/0732-8893(90)90022-N; Kovacs JA, 2009, JAMA-J AM MED ASSOC, V301, P2578, DOI 10.1001/jama.2009.880; Lee SH, 2013, J KOREAN MED SCI, V28, P67, DOI 10.3346/jkms.2013.28.1.67; Linssen CFM, 2006, J MED MICROBIOL, V55, P1229, DOI 10.1099/jmm.0.46552-0; LIPSCHIK GY, 1992, LANCET, V340, P203, DOI 10.1016/0140-6736(92)90469-J; Lu Y, 2011, J CLIN MICROBIOL, V49, P4361, DOI 10.1128/JCM.06066-11; Maini R, 2013, EMERG INFECT DIS, V19, P386, DOI 10.3201/eid1903.121151; Matsumura Y, 2012, CLIN MICROBIOL INFEC, V18, P591, DOI 10.1111/j.1469-0691.2011.03605.x; MOONENS F, 1995, SCAND J INFECT DIS, V27, P358, DOI 10.3109/00365549509032731; Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12; Mu XD, 2011, CHINESE MED J-PEKING, V124, P2683, DOI 10.3760/cma.j.issn.0366-6999.2011.17.021; OLSSON M, 1993, J CLIN MICROBIOL, V31, P221, DOI 10.1128/JCM.31.2.221-226.1993; Ortona E, 1997, J CLIN MICROBIOL, V35, P1589, DOI 10.1128/JCM.35.6.1589-1591.1997; Pinlaor S, 2004, PARASITOL RES, V94, P213, DOI 10.1007/s00436-004-1200-y; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rohner P, 2009, INFECTION, V37, P261, DOI 10.1007/s15010-008-8027-x; ROUX P, 1994, J CLIN MICROBIOL, V32, P2324, DOI 10.1128/JCM.32.9.2324-2326.1994; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Savoia D, 1997, DIAGN MICR INFEC DIS, V29, P61, DOI 10.1016/S0732-8893(97)00126-0; Tamburrini E, 1996, J EUKARYOT MICROBIOL, V43, pS20, DOI 10.1111/j.1550-7408.1996.tb04958.x; Tia T, 2012, CLIN MICROBIOL INFEC, V18, P598, DOI 10.1111/j.1469-0691.2011.03656.x; Weig M, 1997, J CLIN MICROBIOL, V35, P1445, DOI 10.1128/JCM.35.6.1445-1449.1997; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	41	83	89	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73099	10.1371/journal.pone.0073099	http://dx.doi.org/10.1371/journal.pone.0073099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023814	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600067
J	Herbstman, JB; Wang, S; Perera, FP; Lederman, SA; Vishnevetsky, J; Rundle, AG; Hoepner, LA; Qu, LR; Tang, DL				Herbstman, Julie B.; Wang, Shuang; Perera, Frederica P.; Lederman, Sally A.; Vishnevetsky, Julia; Rundle, Andrew G.; Hoepner, Lori A.; Qu, Lirong; Tang, Deliang			Predictors and Consequences of Global DNA Methylation in Cord Blood and at Three Years	PLOS ONE			English	Article							EPIGENETIC GENE-REGULATION; DEVELOPMENTAL ORIGINS; PERIPHERAL-BLOOD; DISEASE; OBESITY; EPIGENOMICS; ENVIRONMENT; PREGNANCY; EXPOSURE; OUTCOMES	DNA methylation changes have been implicated in many common chronic diseases leading to the hypothesis that environmental and age-related DNA methylation changes within individuals are involved in disease etiology. Few studies have examined DNA methylation changes within an individual over time and all of these studies have been conducted in adults. Here, we aim to characterize how global DNA methylation changes from birth to age three within a longitudinal birth cohort study and to determine whether there are consistent predictors of DNA methylation levels measured three years apart. We measured global DNA methylation in the same children at birth (cord blood) and again at three years of age among 165 children, using an immunoassay. We found that on average, DNA methylation was significantly higher in blood at age 3-years than in cord blood (p<0.01). However, for any individual child, the difference was less than would be expected by chance. We found that pre-pregnancy BMI was negatively predictive of both cord and three-year DNA methylation, even after statistical adjustment to account for the correlation between cord blood and three-year DNA methylation. The biologic implications of small changes in global DNA methylation are unknown. However, the observation that global DNA methylation levels persist within an individual from birth to age three supports the belief that factors that influence global DNA methylation, including pre-pregnancy BMI, may confer long-term effects.	[Herbstman, Julie B.; Perera, Frederica P.; Vishnevetsky, Julia; Hoepner, Lori A.; Qu, Lirong; Tang, Deliang] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA; [Wang, Shuang] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Lederman, Sally A.] Columbia Univ, Inst Human Nutr, Med Ctr, New York, NY 10032 USA; [Rundle, Andrew G.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Herbstman, JB (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	jh2678@columbia.edu	Rundle, Andrew G/A-5282-2009	Rundle, Andrew G/0000-0003-0211-7707; Hoepner, Lori/0000-0002-4404-8140	John and Wendy Neu Family Foundation; Trustees of the Blanchette Hooker Rockefeller Fund; New York Community Trust;  [P01 ES09600/EPA RD-83450901];  [R01 ES08977R03];  [R03 CA150140-01];  [R00 ES017051-04];  [P01 ES009089]; NATIONAL CANCER INSTITUTE [R03CA150140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009600, P30ES009089, R00ES017051, R01ES008977] Funding Source: NIH RePORTER	John and Wendy Neu Family Foundation; Trustees of the Blanchette Hooker Rockefeller Fund; New York Community Trust; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	P01 ES09600/EPA RD-83450901, R01 ES08977R03, R03 CA150140-01, R00 ES017051-04, P01 ES009089, and private foundations including John and Wendy Neu Family Foundation, the Trustees of the Blanchette Hooker Rockefeller Fund, and the New York Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; [CDC Department of Health and Human Services], 2011, PREV CFDCA; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Herbstman JB, 2012, ENVIRON HEALTH PERSP, V120, P733, DOI 10.1289/ehp.1104056; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; HOALVANHELDEN EG, 1989, MUTAT RES, V219, P263, DOI 10.1016/0921-8734(89)90027-1; Huda SS, 2010, SEMIN FETAL NEONAT M, V15, P70, DOI 10.1016/j.siny.2009.09.006; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lillycrop KA, 2011, INT J OBESITY, V35, P72, DOI 10.1038/ijo.2010.122; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lopez MC, 2009, CYTOM PART B-CLIN CY, V76B, P37, DOI 10.1002/cyto.b.20441; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Michels KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025254; Nathan DG, 2009, HEMATOLOGY INFANCY C, V7th; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Pranke P, 2001, ACTA HAEMATOL-BASEL, V105, P71, DOI 10.1159/000046537; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Shanmugam MK, 2012, SUBCELL BIOCH, V61, P627; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; WHO (World Health Organization), 2009, GLOB DAT BOD MASS IN; Whyatt RM, 2002, ENVIRON HEALTH PERSP, V110, P507, DOI 10.1289/ehp.02110507; WILSON VL, 1987, J BIOL CHEM, V262, P9948; WILSON VL, 1983, SCIENCE, V220, P1054; Wu HC, 2012, CANCER EPIDEM BIOMAR, V21, P1314, DOI 10.1158/1055-9965.EPI-12-0300	37	56	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72824	10.1371/journal.pone.0072824	http://dx.doi.org/10.1371/journal.pone.0072824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023780	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600048
J	Wang, HD; Li, CH; Hu, JJ; Xu, HB; Ji, X; Wang, XF; Wang, XD; Luo, YK; Li, HL; Xu, KS; Ye, S; Zhang, AQ; Dong, JH				Wang, Hongdong; Li, Chonghui; Hu, Jianjun; Xu, Hongbin; Ji, Xu; Wang, Xiaofeng; Wang, Xuedong; Luo, Yukun; Li, Hailin; Xu, Kesen; Ye, Sheng; Zhang, Aiqun; Dong, Jiahong			Effect of Different Suprahepatic Vena Cava Reconstruction Methods on the Hemodynamics of Rats after Liver Transplantation	PLOS ONE			English	Article							TIME TISSUE ELASTOGRAPHY; CUFF TECHNIQUE; SPLANCHNIC HEMODYNAMICS; NONINVASIVE ASSESSMENT; CIRRHOTIC RATS; FIBROSIS; ANASTOMOSIS; HEPATITIS; DIAGNOSIS	Background: There are few studies on the hemodynamic changes after orthotopic liver transplantation in rats. In this study, we aimed to evaluate the effect of different suprahepatic vena cava (SHVC) reconstruction methods on the hemodynamics of rats after liver transplantation. Materials and Methods: Three rat liver transplantation groups were created according to the SHVC reconstruction method: Kamada's two-cuff technique, a modified veno-lined stent technique, and Harihara's three-cuff technique. Ten rats of similar weight were grouped as the control. Anatomical, ultrasonic, and hemodynamic parameters and the microcirculation of the liver were measured after transplantation. The detailed operation time, operative complications, and animal survival were recorded. Results: All the recipients showed portal hypertension one month after transplantation. The portal hypertension in the group with the modified veno-lined stent technique was the most severe. The value measured with real-time elastography was significantly higher in the recipients using the modified veno-lined stent technique than in the other two groups (P<0.01). There was no difference in the graft microcirculation after reperfusion among the three groups. The survival rate of the three groups displayed no difference, but the modified veno-lined stent technique led to more venous complications than the other two techniques. Conclusions: The hemodynamics after liver transplantation in rats is determined not only by the cuff used for portal vein reconstruction but also by the cuff or stent for the SHVC. Some SHVC reconstruction methods, such as the modified veno-lined stent technique, Miyata's or Settaf's three-cuff techniques, significantly affect the hemodynamics.	[Wang, Hongdong; Li, Hailin; Xu, Kesen; Dong, Jiahong] Shandong Univ, Qilu Hosp, Dept Hepatobiliary Surg, Jinan 250100, Shandong, Peoples R China; [Li, Chonghui; Hu, Jianjun; Xu, Hongbin; Wang, Xiaofeng; Wang, Xuedong; Ye, Sheng; Zhang, Aiqun; Dong, Jiahong] Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Beijing, Peoples R China; [Ji, Xu] PLA, Hosp 302, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Luo, Yukun] Peoples Liberat Army Gen Hosp, Dept Ultrasound, Beijing, Peoples R China	Shandong University; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital	Dong, JH (corresponding author), Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Beijing, Peoples R China.	dongjh301@163.com	xu, hong/GSD-8903-2022		National Natural Science Foundation of China [81070383, 30972950, 81271588]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Grants from National Natural Science Foundation of China, No. (81070383), No. (30972950), and No. (81271588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blain B, 2001, MICROSURG, V21, P80, DOI 10.1002/micr.1014; Cao H, 2003, CHINESE MED J-PEKING, V116, P405; Cao H, 2000, CHINESE MED J-PEKING, V113, P1108; Colombo S, 2012, J GASTROENTEROL, V47, P461, DOI 10.1007/s00535-011-0509-4; Delriviere L, 1998, MICROSURG, V18, P12, DOI 10.1002/(SICI)1098-2752(1998)18:1<12::AID-MICR4>3.0.CO;2-W; Delriviere Luc, 1996, Microsurgery, V17, P690, DOI 10.1002/(SICI)1098-2752(1996)17:12<690::AID-MICR6>3.0.CO;2-R; Friedrich-Rust M, 2009, ULTRASCHALL MED, V30, P478, DOI 10.1055/s-0028-1109488; Friedrich-Rust M, 2007, AM J ROENTGENOL, V188, P758, DOI 10.2214/AJR.06.0322; HARIHARA Y, 1992, TRANSPLANTATION, V53, P707; Higgins GM, 1931, ARCH PATHOL, V12, P186; Holzen JP, 2005, MICROSURG, V25, P614, DOI 10.1002/micr.20174; Hori T, 2010, WORLD J GASTROENTERO, V16, P3120, DOI 10.3748/wjg.v16.i25.3120; Imamura H, 1997, HEPATOLOGY, V26, P198; Ishii E, 2013, J NIPPON MED SCH, V80, P4, DOI 10.1272/jnms.80.4; KAMADA N, 1983, SURGERY, V93, P64; Kanamoto M, 2009, J HEPATO-BILIARY-PAN, V16, P463, DOI 10.1007/s00534-009-0075-9; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koizumi Y, 2011, RADIOLOGY, V258, P610, DOI 10.1148/radiol.10100319; KUZNETSOVA LV, 1995, AM J PHYSIOL-GASTR L, V269, pG153, DOI 10.1152/ajpgi.1995.269.1.G153; McGuire PG, 2010, J SURG RES, V164, pE201, DOI 10.1016/j.jss.2010.07.059; MIYATA M, 1980, TRANSPLANTATION, V30, P335, DOI 10.1097/00007890-198011000-00005; Ochi H, 2012, HEPATOLOGY, V56, P1271, DOI 10.1002/hep.25756; SETTAF A, 1986, TRANSPLANTATION, V42, P330; Tan FQ, 2005, MICROSURG, V25, P556, DOI 10.1002/micr.20161; TSUCHIMOTO S, 1988, TRANSPLANTATION, V45, P1153; Wong J, 2001, CAN J GASTROENTEROL, V15, P435, DOI 10.1155/2001/190508; ZHAO DL, 1993, HEPATOLOGY, V17, P310, DOI 10.1002/hep.1840170224	27	2	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72695	10.1371/journal.pone.0072695	http://dx.doi.org/10.1371/journal.pone.0072695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023763	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600036
J	Li, F; Zhao, WZ; Liu, H				Li, Fang; Zhao, Wenzhi; Liu, Hu			The Response of Aboveground Net Primary Productivity of Desert Vegetation to Rainfall Pulse in the Temperate Desert Region of Northwest China	PLOS ONE			English	Article							PRECIPITATION PULSES; SUMMER PRECIPITATION; SOIL RESPIRATION; EVENT SIZE; WATER; GRASSLAND; DYNAMICS; VARIABILITY; PATTERNS; MOISTURE	Rainfall events can be characterized as "pulses", which are discrete and variable episodes that can significantly influence the structure and function of desert ecosystems, including shifts in aboveground net primary productivity (ANPP). To determine the threshold and hierarchical response of rainfall event size on the Normalized Difference Vegetation Index (NDVI, a proxy for ANPP) and the difference across a desert area in northwestern China with two habitats - dune and desert - we selected 17 independent summer rainfall events from 2005 to 2012, and obtained a corresponding NDVI dataset extracted from MODIS images. Based on the threshold-delay model and statistical analysis, the results showed that the response of NDVI to rainfall pulses began at about a 5 mm event size. Furthermore, when the rainfall event size was more than 30 mm, NDVI rapidly increased 3- to 6-fold compared with the response to events of less than 30 mm, suggesting that 30 mm was the threshold for a large NDVI response. These results revealed the importance of the 5 mm and 30 mm rainfall events for plant survival and growth in desert regions. There was an 8- to 16-day lag time between the rainfall event and the NDVI response, and the response duration varied with rainfall event size, reaching a maximum of 32 days. Due to differences in soil physical and mineralogical properties, and to biodiversity structure and the root systems' abilities to exploit moisture, dune and desert areas differed in precipitation responses: dune habitats were characterized by a single, late summer productivity peak; in contrast, deserts showed a multi-peak pattern throughout the growing season.	[Li, Fang; Zhao, Wenzhi; Liu, Hu] Chinese Acad Sci, Linze Inland River Basin Res Stn, Key Lab Inland River Basin Ecohydrol Cold & Arid, Environm & Engn Res Inst, Lanzhou, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Zhao, WZ (corresponding author), Chinese Acad Sci, Linze Inland River Basin Res Stn, Key Lab Inland River Basin Ecohydrol Cold & Arid, Environm & Engn Res Inst, Lanzhou, Peoples R China.	zhaowzh@lzb.ac.cn			National Science Fund for Distinguished Young Scholars of China [41125002]; National Natural Science Foundation of China [41071019]	National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Fund for Distinguished Young Scholars of China (41125002) and the National Natural Science Foundation of China (41071019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger KA, 2013, INT J REMOTE SENS, V34, P73, DOI 10.1080/01431161.2012.705447; Burgess SSO, 2006, PHYSIOL PLANTARUM, V127, P404, DOI 10.1111/j.1399-3054.2006.00669.x; Cherwin K, 2012, OECOLOGIA, V169, P845, DOI 10.1007/s00442-011-2235-2; Emmerich WE, 2008, WATER RESOUR RES, V44, DOI 10.1029/2006WR005690; Fay PA, 2011, BIOGEOSCIENCES, V8, P3053, DOI 10.5194/bg-8-3053-2011; Fay PA, 2003, OECOLOGIA, V137, P245, DOI 10.1007/s00442-003-1331-3; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Gamon JA, 2013, REMOTE SENS ENVIRON, V129, P144, DOI 10.1016/j.rse.2012.10.030; Gao YZ, 2011, OECOLOGIA, V165, P855, DOI 10.1007/s00442-010-1890-z; Hamerlynck EP, 2012, ECOHYDROLOGY, V5, P297, DOI 10.1002/eco.214; He ZB, 2012, J HYDROL, V420, P183, DOI 10.1016/j.jhydrol.2011.11.056; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Heisler-White JL, 2009, GLOBAL CHANGE BIOL, V15, P2894, DOI 10.1111/j.1365-2486.2009.01961.x; Horion S, 2013, INT J APPL EARTH OBS, V20, P20, DOI 10.1016/j.jag.2011.12.010; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Huxman TE, 2004, OECOLOGIA, V141, P295, DOI 10.1007/s00442-003-1389-y; Jankju M, 2008, ARID LAND RES MANAG, V22, P123, DOI 10.1080/15324980801957986; Jenerette GD, 2008, FUNCT ECOL, V22, P924, DOI 10.1111/j.1365-2435.2008.01450.x; Kinugasa T, 2012, OECOLOGIA, V170, P857, DOI 10.1007/s00442-012-2354-4; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Knapp AK, 2006, OECOLOGIA, V149, P456, DOI 10.1007/s00442-006-0468-2; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; [刘冰 LIU Bing], 2011, [中国沙漠, Journal of Desert Research], V31, P716; Loik ME, 2007, PLANT ECOL, V191, P95, DOI 10.1007/s11258-006-9217-1; Misson L, 2006, TREE PHYSIOL, V26, P833, DOI 10.1093/treephys/26.7.833; Morales MS, 2012, OECOLOGIA, V168, P381, DOI 10.1007/s00442-011-2087-9; Muldavin EH, 2008, OECOLOGIA, V155, P123, DOI 10.1007/s00442-007-0880-2; Nippert JB, 2006, PLANT ECOL, V184, P65, DOI 10.1007/s11258-005-9052-9; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Ogle K, 2004, OECOLOGIA, V141, P282, DOI 10.1007/s00442-004-1507-5; Ospina S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035555; Parton W, 2012, GLOBAL CHANGE BIOL, V18, P915, DOI 10.1111/j.1365-2486.2011.02611.x; Polley HW, 2012, GLOBAL CHANGE BIOL, V18, P2813, DOI 10.1111/j.1365-2486.2012.02735.x; Potts DL, 2006, NEW PHYTOL, V170, P849, DOI 10.1111/j.1469-8137.2006.01732.x; Reichmann LG, 2012, ECOLOGY; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; Robertson TR, 2009, NEW PHYTOL, V181, P230, DOI 10.1111/j.1469-8137.2008.02643.x; SALA OE, 1982, OECOLOGIA, V53, P301, DOI 10.1007/BF00389004; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sponseller RA, 2012, FUNCT ECOL, V26, P750, DOI 10.1111/j.1365-2435.2012.01979.x; Svoray T, 2011, ECOHYDROLOGY, V4, P56, DOI 10.1002/eco.123; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Thomey ML, 2011, GLOBAL CHANGE BIOL, V17, P1505, DOI 10.1111/j.1365-2486.2010.02363.x; Walter, 1971, NATURAL SAVANNAHS TR; [王蕙 WANG Hui], 2009, [中国沙漠, Journal of Desert Research], V29, P1109; Wang J, 2003, INT J REMOTE SENS, V24, P2345, DOI 10.1080/01431160210154812; Williams DG, 2000, ECOL MONOGR, V70, P517, DOI 10.1890/0012-9615(2000)070[0517:IAIVFS]2.0.CO;2; Yahdjian L, 2006, ECOLOGY, V87, P952, DOI 10.1890/0012-9658(2006)87[952:VSCPPR]2.0.CO;2; Zeppel M, 2008, PLANT SOIL, V305, P121, DOI 10.1007/s11104-007-9349-7; Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110; Zhao Wen-zhi, 2011, Yingyong Shengtai Xuebao, V22, P243; Zhao WZ, 2010, AGR FOREST METEOROL, V150, P1297, DOI 10.1016/j.agrformet.2010.05.012	54	36	44	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73003	10.1371/journal.pone.0073003	http://dx.doi.org/10.1371/journal.pone.0073003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019888	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200030
J	Li, R; You, S; Hu, ZL; Chen, ZG; Sica, GL; Khuri, FR; Curran, WJ; Shin, DM; Deng, XM				Li, Rui; You, Shuo; Hu, Zhongliang; Chen, Zhuo G.; Sica, Gabriel L.; Khuri, Fadlo R.; Curran, Walter J.; Shin, Dong M.; Deng, Xingming			Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; SIGNAL TRANSDUCER; LUNG-CANCER; PANCREATIC-CANCER; MYELOMA CELLS; IN-VIVO; ACTIVATION; RESISTANCE; APOPTOSIS	Epidermal growth factor receptor (EGFR) is extensively expressed in head and neck cancer. However, EGFR-targeted therapy has only modest efficacy in head and neck cancer, through mechanisms that are not fully understood. Here, we found that inhibition of EGFR by erlotinib stimulated phosphorylation and activation of STAT3 leading to increased Bcl2/Bcl-XL expression in head and neck cancer cells, which may dampen the therapeutic efficacy of erlotinib against head and neck cancer. Erlotinib-enhanced STAT3 phosphorylation results, at least in part, from suppression of its physiological phosphatase, PTPMeg2. Specific knockdown of STAT3 by RNA interference significantly sensitized head and neck cancer cells to erlotinib treatment. Pharmacological inhibition of STAT3 by niclosamide not only blocked erlotinib-stimulated STAT3 phosphorylation but also synergistically repressed head and neck cancer growth in vitro and in vivo. Combined inhibition of EGFR and STAT3 by erlotinib and niclosamide more effectively induced apoptosis in tumor tissues without toxicity for normal tissues. Based on our findings, treatment with erlotinib combined with niclosamide may offer an effective therapeutic approach to improve the prognosis of head and neck cancer.	[Li, Rui; You, Shuo; Curran, Walter J.; Deng, Xingming] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Li, Rui; You, Shuo; Hu, Zhongliang; Chen, Zhuo G.; Sica, Gabriel L.; Khuri, Fadlo R.; Curran, Walter J.; Shin, Dong M.; Deng, Xingming] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Hu, Zhongliang; Chen, Zhuo G.; Khuri, Fadlo R.; Shin, Dong M.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Sica, Gabriel L.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Deng, XM (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.	xdeng4@emory.edu	Shin, Dong Moon/G-9649-2013; Li, Zhaohui/E-4750-2013; Khuri, Fadlo R./AAU-4942-2020; li, zh/HII-5698-2022	Shin, Dong Moon/0000-0002-8245-4174; Li, Zhaohui/0000-0003-3746-6130; Khuri, Fadlo R./0000-0002-8638-7618; 	 [R01CA136534];  [NCI P50 CA128613];  [R33 CA161873]; NATIONAL CANCER INSTITUTE [P50CA128613, R33CA161873, R01CA136534] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01CA136534 (XD), NCI P50 CA128613 (DMS) and R33 CA161873 (ZGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alas S, 2001, CANCER RES, V61, P5137; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Boehm AL, 2008, MOL PHARMACOL, V73, P1632, DOI 10.1124/mol.107.044636; Boisvert H, 2010, INFECT IMMUN, V78, P3616, DOI 10.1128/IAI.00187-10; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Carbonaro M, 2012, J BIOL CHEM, V287, P11859, DOI 10.1074/jbc.M112.345587; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chen ZG, 2004, CLIN CANCER RES, V10, P5930, DOI 10.1158/1078-0432.CCR-03-0677; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Fan WW, 2011, CANCER RES, V71, P4494, DOI 10.1158/0008-5472.CAN-10-2668; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Huang DH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225102; Huang DH, 2010, NANO RES, V3, P61, DOI 10.1007/s12274-010-1009-1; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Lai SY, 2010, DRUG RESIST UPDATE, V13, P67, DOI 10.1016/j.drup.2010.04.001; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Leeman-Neill RJ, 2010, CLIN CANCER RES, V16, P2571, DOI 10.1158/1078-0432.CCR-10-0333; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Liu AW, 2011, CLIN CANCER RES, V17, P710, DOI 10.1158/1078-0432.CCR-10-0331; Liu Y, 2012, MOL CANCER THER, V11, P45, DOI 10.1158/1535-7163.MCT-11-0578; Nie SM, 2007, ANNU REV BIOMED ENG, V9, P257, DOI 10.1146/annurev.bioeng.9.060906.152025; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Quesnelle KM, 2012, CANCER BIOL THER, V13, P935, DOI 10.4161/cbt.20846; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Sano D, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-32; Sen M, 2012, CLIN CANCER RES, V18, P4986, DOI 10.1158/1078-0432.CCR-12-0792; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Su FQ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3134; Wang XR, 2008, CANCER BIOL THER, V7, P1952, DOI 10.4161/cbt.7.12.6944; Xi SC, 2005, ONCOGENE, V24, P970, DOI 10.1038/sj.onc.1208316; Xing Y, 2007, NAT PROTOC, V2, P1152, DOI 10.1038/nprot.2007.107; Xu J, 2012, EUR J CANCER, V48, P1682, DOI 10.1016/j.ejca.2011.12.029; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	40	61	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74670	10.1371/journal.pone.0074670	http://dx.doi.org/10.1371/journal.pone.0074670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019973	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200116
J	Morrison, SF; Biciloa, P; Harlow, PS; Keogh, JS				Morrison, Suzanne F.; Biciloa, Pita; Harlow, Peter S.; Keogh, J. Scott			Spatial Ecology of the Critically Endangered Fijian Crested Iguana, Brachylophus vitiensis, in an Extremely Dense Population: Implications for Conservation	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; LIZARD HOME RANGES; MALE GREEN IGUANAS; BODY-SIZE; LACERTA-MONTICOLA; POLYGYNOUS LIZARD; SELECTION; EVOLUTION; HABITAT; DOMINANCE	The Critically Endangered Fijian crested iguana, Brachylophus vitiensis, occurs at extreme density at only one location, with estimates of >10,000 iguanas living on the 70 hectare island of Yadua Taba in Fiji. We conducted a mark and recapture study over two wet seasons, investigating the spatial ecology and intraspecific interactions of the strictly arboreal Fijian crested iguana. This species exhibits moderate male-biased sexual size dimorphism, which has been linked in other lizard species to territoriality, aggression and larger male home ranges. We found that male Fijian crested iguanas exhibit high injury levels, indicative of frequent aggressive interactions. We did not find support for larger home range size in adult males relative to adult females, however male and female residents were larger than roaming individuals. Males with established home ranges also had larger femoral pores relative to body size than roaming males. Home range areas were small in comparison to those of other iguana species, and we speculate that the extreme population density impacts considerably on the spatial ecology of this population. There was extensive home range overlap within and between sexes. Intersexual overlap was greater than intrasexual overlap for both sexes, and continuing male-female pairings were observed among residents. Our results suggest that the extreme population density necessitates extensive home range overlap even though the underlying predictors of territoriality, such as male biased sexual size dimorphism and high aggression levels, remain. Our findings should be factored in to conservation management efforts for this species, particularly in captive breeding and translocation programs.	[Morrison, Suzanne F.; Keogh, J. Scott] Australian Natl Univ, Div Evolut Ecol & Genet, Res Sch Biol, Canberra, ACT, Australia; [Biciloa, Pita] Natl Trust Fiji Isl, Suva, Fiji; [Harlow, Peter S.] Taronga Conservat Soc Australia, Mosman, NSW, Australia	Australian National University	Keogh, JS (corresponding author), Australian Natl Univ, Div Evolut Ecol & Genet, Res Sch Biol, Canberra, ACT, Australia.	Scott.Keogh@anu.edu.au	Keogh, Scott/C-8441-2009	Keogh, Scott/0000-0002-1373-6186	International Iguana Foundation; Australian National University; Federation of Australian Women; Ecological Society of Australia; Taronga Foundation	International Iguana Foundation; Australian National University(Australian National University); Federation of Australian Women; Ecological Society of Australia; Taronga Foundation	This work was supported by the International Iguana Foundation, the Australian National University (field work grant), the Federation of Australian Women (Georgina Sweet fellowship), the Ecological Society of Australia (student research award) and the Taronga Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AJ, 1999, AMPHIBIA-REPTILIA, V20, P185; ALBERTS AC, 1992, J CHEM ECOL, V18, P703, DOI 10.1007/BF00994608; ALBERTS AC, 1994, ZOO BIOL, V13, P479, DOI 10.1002/zoo.1430130510; Alberts AC, 2002, BEHAV ECOL SOCIOBIOL, V51, P324, DOI 10.1007/s00265-001-0445-z; ALBERTS AC, 1993, HERPETOLOGICA, V49, P469; Baird TA, 1997, BEHAV ECOL, V8, P506, DOI 10.1093/beheco/8.5.506; BOYLAN T, 1989, International Zoo Yearbook, V28, P126; CAROTHERS JH, 1984, AM NAT, V124, P244, DOI 10.1086/284266; Censky JE, 1997, BEHAV ECOL SOCIOBIOL, V40, P221; Cooper WE, 2002, J ZOOL, V257, P487, DOI 10.1017/S0952836902001085; COOPER WE, 1989, AM NAT, V133, P729, DOI 10.1086/284948; Cox RM, 2003, EVOLUTION, V57, P1653, DOI 10.1554/02-227; Cox Robert M., 2007, P38; Dugan B., 1982, P303; Dugan B., 1982, P320; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Gibbons J., 1984, Oryx, V18, P82; GIBBONS JRH, 1981, J HERPETOL, V15, P255, DOI 10.2307/1563429; GIBBONS JRH, 1982, IGUANAS WORLD THEIR, P419; Goodman RM, 2005, J HERPETOL, V39, P402, DOI 10.1670/159-04A.1; Harlow P.S., 2008, FIJIAN CRESTED IGUAN; Harlow PS, 2007, ORYX, V41, P44, DOI 10.1017/S0030605307001639; Harlow PS, 2001, BIOL CONSERV, V98, P223, DOI 10.1016/S0006-3207(00)00157-9; Keogh JS, 2008, PHILOS T R SOC B, V363, P3413, DOI 10.1098/rstb.2008.0120; Kerr GD, 2006, BEHAV ECOL, V17, P380, DOI 10.1093/beheco/arj041; Knapp CR, 2000, CARIBB J SCI, V36, P250; Kwiatkowski MA, 2002, BEHAV ECOL, V13, P201, DOI 10.1093/beheco/13.2.201; LAURIE WA, 1987, DOMODOMO, V5, P16; Lopez P, 2006, J CHEM ECOL, V32, P473, DOI 10.1007/s10886-005-9012-9; Moreira PL, 2006, BEHAV ECOL SOCIOBIOL, V60, P166, DOI 10.1007/s00265-005-0153-1; Morrison C, 2007, AUST J ZOOL, V55, P341, DOI 10.1071/ZO07062; Morrison C, 2009, PAC SCI, V63, P223, DOI 10.2984/049.063.0205; Morrison SF, 2002, MOL ECOL, V11, P535, DOI 10.1046/j.0962-1083.2002.01450.x; Morrison SF, 2009, PACIFIC CON BIOL, V15, P115; NUNNEY L, 1993, TRENDS ECOL EVOL, V8, P234, DOI 10.1016/0169-5347(93)90197-W; OLSSON M, 1995, BEHAV ECOL SOCIOBIOL, V36, P179, DOI 10.1007/BF00177794; Ord TJ, 2002, BIOL J LINN SOC, V76, P145, DOI 10.1046/j.1095-8312.2002.00058.x; Ord TJ, 2001, P ROY SOC B-BIOL SCI, V268, P737, DOI 10.1098/rspb.2000.1417; Perry G, 2002, ECOLOGY, V83, P1870, DOI 10.2307/3071771; PRATT NC, 1992, ZOO BIOL, V11, P153, DOI 10.1002/zoo.1430110304; RODDA G. H., 1992, SMITHSONIAN CONTRIBU, V534, P1; ROSE B, 1982, J HERPETOL, V16, P253, DOI 10.2307/1563718; STAMPS JA, 1977, ECOLOGY, V58, P349, DOI 10.2307/1935609; Stamps JA, 1983, LIZARD ECOLOGY, P169; Whiting MJ, 2009, P ROY SOC B-BIOL SCI, V276, P1585, DOI 10.1098/rspb.2008.1822; Wikelski M, 1997, EVOLUTION, V51, P922, DOI 10.1111/j.1558-5646.1997.tb03673.x; Wikelski M, 1996, ANIM BEHAV, V52, P581, DOI 10.1006/anbe.1996.0199; [No title captured]	48	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73127	10.1371/journal.pone.0073127	http://dx.doi.org/10.1371/journal.pone.0073127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019902	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200044
J	Reishofer, G; Koschutnig, K; Langkammer, C; Porter, D; Jehna, M; Enzinger, C; Keeling, S; Ebner, F				Reishofer, Gernot; Koschutnig, Karl; Langkammer, Christian; Porter, David; Jehna, Margit; Enzinger, Christian; Keeling, Stephen; Ebner, Franz			Time-Optimized High-Resolution Readout-Segmented Diffusion Tensor Imaging	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CONSTRAINED VARIATIONAL PRINCIPLE; WHITE-MATTER; MRI; CONTRAST; TRACTOGRAPHY; TRACKING; ALGORITHMS; SCLEROSIS; HUMANS	Readout-segmented echo planar imaging with 2D navigator-based reacquisition is an uprising technique enabling the sampling of high-resolution diffusion images with reduced susceptibility artifacts. However, low signal from the small voxels and long scan times hamper the clinical applicability. Therefore, we introduce a regularization algorithm based on total variation that is applied directly on the entire diffusion tensor. The spatially varying regularization parameter is determined automatically dependent on spatial variations in signal-to-noise ratio thus, avoiding over-or under-regularization. Information about the noise distribution in the diffusion tensor is extracted from the diffusion weighted images by means of complex independent component analysis. Moreover, the combination of those features enables processing of the diffusion data absolutely user independent. Tractography from in vivo data and from a software phantom demonstrate the advantage of the spatially varying regularization compared to un-regularized data with respect to parameters relevant for fiber-tracking such as Mean Fiber Length, Track Count, Volume and Voxel Count. Specifically, for in vivo data findings suggest that tractography results from the regularized diffusion tensor based on one measurement (16 min) generates results comparable to the un-regularized data with three averages (48 min). This significant reduction in scan time renders high resolution (1x1x2.5 mm(3)) diffusion tensor imaging of the entire brain applicable in a clinical context.	[Reishofer, Gernot] Med Univ Graz, Dept Radiol, MR Phys, Graz, Austria; [Koschutnig, Karl] Graz Univ, Dept Psychol, Graz, Austria; [Langkammer, Christian; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Porter, David] Siemens AG, Healthcare Sect, MR R&D, Erlangen, Germany; [Jehna, Margit; Enzinger, Christian; Ebner, Franz] Med Univ Graz, Div Neuroradiol, Dept Radiol, Graz, Austria; [Keeling, Stephen] Graz Univ, Inst Math & Sci Comp, Graz, Austria	Medical University of Graz; University of Graz; Medical University of Graz; Siemens AG; Siemens Germany; Medical University of Graz; University of Graz	Reishofer, G (corresponding author), Med Univ Graz, Dept Radiol, MR Phys, Graz, Austria.	gernot.reishofer@medunigraz.at	Reishofer, Gernot/E-9215-2011; Porter, David A/AAN-8501-2020; Langkammer, Christian/AAC-9044-2020; Koschutnig, Karl/W-3106-2019; Jehna, Margit/M-9873-2017	Reishofer, Gernot/0000-0002-3068-6475; Porter, David A/0000-0001-8436-6904; Koschutnig, Karl/0000-0001-6234-0498; Langkammer, Christian/0000-0002-7097-9707; Jehna, Margit/0000-0003-3376-7753	Siemens AG; Austrian Science Fund (FWF) [F 3203] Funding Source: researchfish	Siemens AG(Siemens AG); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	lDr. David Andrew Porter is an employee and shareholder of Siemens AG, and is the developer of the resolve pulse sequence. Given the fact that the used high-resolution DTI sequence is not available at our site (even though it is a commercial product) a cooperation with Dr. Porter was established for sequence support. There are two relevant patents in Dr. Porter's name (Patent No.: US 7,205,763 B2; Apr. 17, 2007 and Patent No.: US 7,417,427 B2; Aug. 26, 2008). The first patent covers the combination of readout-segmented EPI and 2D navigator correction. The second patent concerns the use of 2D navigator data to control the data reacquisition process. The patents are owned by Siemens AG, but he has received financial compensation for submitting them. The diffusion-weighted, readout-segmented EPI technique is a commercial product on some Siemens MR systems and is marketed under the under the product name 'syngo RESOLVE'. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Arfanakis K, 2002, MAGNET RESON MED, V47, P354, DOI 10.1002/mrm.10046; Avants BB, 2010, NEUROIMAGE, V50, P1004, DOI 10.1016/j.neuroimage.2010.01.041; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Blomgren P, 1998, IEEE T IMAGE PROCESS, V7, P304, DOI 10.1109/83.661180; Bodini B, 2009, HUM BRAIN MAPP, V30, P2852, DOI 10.1002/hbm.20713; Calamante F, 2004, MAGN RESON MED, V52, P789, DOI 10.1002/mrm.20227; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Carroll TJ, 2002, AM J NEURORADIOL, V23, P1007; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chambolle A, 2011, J MATH IMAGING VIS, V40, P120, DOI 10.1007/s10851-010-0251-1; Chan TF, 1999, SIAM J SCI COMPUT, V20, P1964, DOI 10.1137/S1064827596299767; Chefd'hotel C, 2002, LECT NOTES COMPUT SC, V2350, P251; Christiansen O, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/27432; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Cloutman LL, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00034; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Coulon O, 2004, MED IMAGE ANAL, V8, P47, DOI 10.1016/j.media.2003.06.002; Frost R, 2012, MAGN RESON MED, V68, P441, DOI 10.1002/mrm.23242; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Heidemann RM, 2012, NEUROIMAGE, V60, P967, DOI 10.1016/j.neuroimage.2011.12.081; Heidemann RM, 2010, MAGN RESON MED, V64, P9, DOI 10.1002/mrm.22480; Hintermuller M, 2006, SIAM J SCI COMPUT, V28, P1, DOI 10.1137/040613263; Holdsworth SJ, 2011, AM J NEURORADIOL, V32, P1274, DOI 10.3174/ajnr.A2481; Holdsworth SJ, 2008, EUR J RADIOL, V65, P36, DOI 10.1016/j.ejrad.2007.09.016; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Iwata NK, 2011, BRAIN, V134, P2642, DOI 10.1093/brain/awr178; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Keil B, 2012, MAGN RESON MED; Koay CG, 2006, MAGN RESON MED, V55, P930, DOI 10.1002/mrm.20832; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Leclercq D, 2011, NEUROSURG CLIN N AM, V22, P253, DOI 10.1016/j.nec.2010.11.004; Li XL, 2010, IEEE T CIRCUITS-I, V57, P1417, DOI 10.1109/TCSI.2010.2046207; Malick J, 2006, SET-VALUED ANAL, V14, P273, DOI 10.1007/s11228-005-0005-1; Martel AL, 2008, MAGN RESON MED, V59, P874, DOI 10.1002/mrm.21552; McGraw T, 2004, MED IMAGE ANAL, V8, P95, DOI 10.1016/j.media.2003.12.001; Miller KL, 2003, MAGN RESON MED, V50, P343, DOI 10.1002/mrm.10531; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Naganawa S, 2011, MAGN RESON MED SCI, V10, P269, DOI 10.2463/mrms.10.269; Nakai T, 2004, NEUROIMAGE, V21, P251, DOI 10.1016/j.neuroimage.2003.08.036; Nguyen Q, 1999, ISOTROPIC DIFFUSION, P559; Oishi K, 2011, J ALZHEIMERS DIS, V26, P287, DOI 10.3233/JAD-2011-0007; Pock T, 2010, SIAM J IMAGING SCI, V3, P1122, DOI 10.1137/090757617; Porter D, 2004, MULTISHOT DIFFUSION, P442; Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; Reishofer G, 2007, MAGN RESON MED, V57, P278, DOI 10.1002/mrm.21154; Reishofer G, 2011, MAGN RESON MED, V65, P848, DOI 10.1002/mrm.22660; Robson MD, 1997, MAGNET RESON MED, V38, P82, DOI 10.1002/mrm.1910380113; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; van Eimeren L, 2010, NEUROIMAGE, V52, P358, DOI 10.1016/j.neuroimage.2010.04.001; Wang Z, 2003, LECT NOTES COMPUT SC, V2732, P660; Wang ZZ, 2004, IEEE T MED IMAGING, V23, P930, DOI 10.1109/TMI.2004.831218; Wei XE, 2011, NEUROL INDIA, V59, P839, DOI 10.4103/0028-3886.91361; Wu XY, 2007, MED IMAGE ANAL, V11, P254, DOI 10.1016/j.media.2007.03.005; Wu Y, 2007, J CEREBR BLOOD F MET, V27, P632, DOI 10.1038/sj.jcbfm.9600374	61	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74156	10.1371/journal.pone.0074156	http://dx.doi.org/10.1371/journal.pone.0074156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019951	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200094
J	Lin, KH; Liu, JW; Chen, CL; Wang, SH; Lin, CC; Liu, YW; Yong, CC; Lin, TL; Li, WF; Hu, TH; Wang, CC				Lin, Kuo-Hua; Liu, Jien-Wei; Chen, Chao-Long; Wang, Shih-Hor; Lin, Chih-Che; Liu, Yueh-Wei; Yong, Chee-Chien; Lin, Ting-Lung; Li, Wei-Feng; Hu, Tsung-Hui; Wang, Chih-Chi			Impacts of Pretransplant Infections on Clinical Outcomes of Patients with Acute-On-Chronic Liver Failure Who Received Living-Donor Liver Transplantation	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; ETIOLOGIC AGENTS; BACTEREMIA; PNEUMONIA	Background: Liver transplantation is the only therapeutic modality for patients with acute-on chronic liver failure (ACLF). These patients are at high risk for bacterial infections while awaiting transplantation. The aim of this study was to elucidate whether an adequately treated bacterial infection influences the outcomes after transplantation in this patient population. Methodology/Principal Findings: 54 recipients (median age, 49.5 years [range, 22-60]) of adult-to-adult living donor liver transplant (LDLT) for ACLF were categorized as those with pretransplant infection (Group 1, n = 34) or without pretransplant infection (Group 2, n = 20) for retrospective analyses. With the exception of a higher male-female ratio (P = 0.046) and longer length of pretransplant hospital stay (P = 0.026) in Group 1, similar demographic, laboratory and clinical features were found in both groups. Patients in Group 1 (totally 42 pretransplant infection episodes) were adequately treated with effective antibiotic(s) before receiving LDLT. All included patients were followed up until one year after transplantation or death. Sixty-one posttransplant infection episodes were found in an overall of 44 ACLF patients (27 in Group 1 vs. 15 in Group 2; P = 0.352). Frequently encountered posttransplant infections were intraabdominal infection, pneumonia, bloodstream infection and urinary tract infection. Two patients died in each group (P = 0.622). No significant difference was found in the length of posttransplant ICU stay, and in one-year survival, graft rejection, and posttransplant infection rate between both groups. The longer overall hospital stay (mean day, 89.0 vs. 65.5, P = 0.024) found in Group 1 resulted from a longer pretransplant hospital stay receiving treatment for pretransplant infection(s) and/or awaiting transplantation. Conclusions: These data suggested that an adequately treated pretransplant infection do not pose a significant risk for clinical outcomes including posttransplant fatality in recipients in adult-to-adult LDLT for ACLF.	[Lin, Kuo-Hua; Chen, Chao-Long; Wang, Shih-Hor; Lin, Chih-Che; Liu, Yueh-Wei; Yong, Chee-Chien; Lin, Ting-Lung; Li, Wei-Feng; Wang, Chih-Chi] Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Kuo-Hua; Chen, Chao-Long; Wang, Shih-Hor; Lin, Chih-Che; Liu, Yueh-Wei; Yong, Chee-Chien; Lin, Ting-Lung; Li, Wei-Feng; Wang, Chih-Chi] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Kuo-Hua] Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan; [Liu, Jien-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Liu, Jien-Wei; Chen, Chao-Long; Hu, Tsung-Hui; Wang, Chih-Chi] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hu, Tsung-Hui] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Changhua Christian Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Wang, CC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Dept Internal Med, Kaohsiung, Taiwan.	ufel4996@ms26.hinet.net						Beck KD, 2003, AM J INFECT CONTROL, V31, P331, DOI 10.1016/S0196-6553(02)48203-X; Berg CL, 2007, GASTROENTEROLOGY, V133, P1806, DOI 10.1053/j.gastro.2007.09.004; Bert F, 2010, LIVER TRANSPLANT, V16, P393, DOI 10.1002/lt.21991; Blei AT, 2001, AM J GASTROENTEROL, V96, P168; Bonnel AR, 2011, CLIN GASTROENTEROL H, V9, P727, DOI 10.1016/j.cgh.2011.02.031; Chan AC, 2009, HEPATOL INT, V3, P571, DOI 10.1007/s12072-009-9148-8; Chen CL, 2000, TRANSPLANTATION, V69, P2580, DOI 10.1097/00007890-200006270-00018; Chen TC, 2011, J MICROBIOL IMMUNOL, V44, P303, DOI 10.1016/j.jmii.2011.01.030; Clinical and Laboratory Standards Institute, 2007, M100S16 CLIN LAB STA; de Gouvea EF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-351; de Villa VH, 2003, ANN SURG, V238, P275, DOI 10.1097/01.SLA.0000081093.73347.28; de Villa VH, 2000, TRANSPLANTATION, V70, P1604, DOI 10.1097/00007890-200012150-00011; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Garcia-Tsao G, 2004, CAN J GASTROENTEROL, V18, P405, DOI 10.1155/2004/769615; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hindler J, 1998, ESSENTIAL PROCEDURES, P205; Huprikar Shirish, 2007, Clin Liver Dis, V11, P337, DOI 10.1016/j.cld.2007.04.006; Iida T, 2010, LIVER TRANSPLANT, V16, P1379, DOI 10.1002/lt.22165; Ikegami T, 2012, LIVER TRANSPLANT, V18, P1060, DOI 10.1002/lt.23483; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kawecki D, 2007, TRANSPL P, V39, P2816, DOI 10.1016/j.transproceed.2007.08.048; Linares L, 2009, TRANSPL P, V41, P2262, DOI 10.1016/j.transproceed.2009.06.079; Liu JW, 2012, ANTIMICROB AGENTS CH, V56, P1414, DOI 10.1128/AAC.05879-11; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mrzljak A, 2010, LIVER TRANSPLANT, V16, P1217, DOI 10.1002/lt.22137; Patel G, 2012, SEMIN RESP CRIT CARE, V33, P111, DOI 10.1055/s-0032-1301739; Patel G, 2010, CURR OPIN ORGAN TRAN, V15, P676, DOI 10.1097/MOT.0b013e3283404373; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Sganga G, 2012, TRANSPL P, V44, P1973, DOI 10.1016/j.transproceed.2012.06.055; Singh N, 2000, LIVER TRANSPLANT, V6, P54, DOI 10.1016/S1527-6465(00)80033-7; Sun HY, 2010, LIVER TRANSPLANT, V16, P222, DOI 10.1002/lt.21982; Varghese J, 2012, J CLIN EXP HEPATOL, V2, P286, DOI [10.1016/j.jceh.2012.06.002, 10.1016/S0973-6883(12)60081-4]; Vincent JL, 2003, INTENS CARE MED, V29, pS74; Xu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058738	34	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72893	10.1371/journal.pone.0072893	http://dx.doi.org/10.1371/journal.pone.0072893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023787	Green Submitted, Green Published, gold			2022-12-27	WOS:000324238400031
J	Nishida, N; Kudo, M; Nishimura, T; Arizumi, T; Takita, M; Kitai, S; Yada, N; Hagiwara, S; Inoue, T; Minami, Y; Ueshima, K; Sakurai, T; Yokomichi, N; Nagasaka, T; Goel, A				Nishida, Naoshi; Kudo, Masatoshi; Nishimura, Takafumi; Arizumi, Tadaaki; Takita, Masahiro; Kitai, Satoshi; Yada, Norihisa; Hagiwara, Satoru; Inoue, Tatsuo; Minami, Yasunori; Ueshima, Kazuomi; Sakurai, Toshiharu; Yokomichi, Naosuke; Nagasaka, Takeshi; Goel, Ajay			Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; HUMAN HEPATOCARCINOGENESIS; LINE-1 HYPOMETHYLATION; ABERRANT METHYLATION; COLORECTAL-CANCER; CHRONIC HEPATITIS; INSTABILITY; MUTATIONS; INDUCTION; PATHWAYS	Global DNA hypomethylation is a characteristic feature of cancer cells that closely associates with chromosomal instability (CIN). However, the association between these characteristics during hepatocarcinogenesis remains unclear. Herein, we determined the relationship between hypomethylation and CIN in human hepatocellular carcinoma (HCC) by analyzing 179 HCCs, 178 matched non-tumor livers and 23 normal liver tissues. Hypomethylation at three different repetitive DNA (rDNA) sequences and hypermethylation of 12 CpG loci, including 11 tumor suppressor gene (TSG) promoters, were quantified using MethyLight or combined bisulfite restriction analysis. Fractional allelic loss (FAL) was used as a marker for CIN, calculated by analyzing 400 microsatellite markers. Gains and losses at each chromosome were also determined using semi-quantitative microsatellite analysis. The associations between rDNA hypomethylation and FAL, as well as between TSG hypermethylation and FAL were investigated. Significantly more hypomethylation was observed in HCC tissues than in normal liver samples. Progression of hypomethylation during carcinogenesis was more prominent in hepatitis C virus (HCV)-negative cases, which was in contrast to our previous reports of significantly increased TSG methylation levels in HCV-positive tumors. Absence of liver cirrhosis and higher FAL scores were identified as independent contributors to significant hypomethylation of rDNA in HCC. Among the chromosomal alterations frequently observed in HCC, loss of 8p, which was unique in the earliest stages of hepatocarcinogenesis, was significantly associated with hypomethylation of rDNA by multivariable analysis (p = 0.0153). rDNA hypomethylation was also associated with a high FAL score regardless of tumor differentiation (p = 0.0011, well-differentiated; p = 0.0089, moderately/poorly-differentiated HCCs). We conclude that DNA hypomethylation is an important cause of CIN in the earliest step of HCC, especially in a background of non-cirrhotic liver.	[Nishida, Naoshi; Kudo, Masatoshi; Arizumi, Tadaaki; Takita, Masahiro; Kitai, Satoshi; Yada, Norihisa; Hagiwara, Satoru; Inoue, Tatsuo; Minami, Yasunori; Ueshima, Kazuomi; Sakurai, Toshiharu] Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka, Japan; [Nishida, Naoshi] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Nishimura, Takafumi] Kyoto Univ Hosp, Outpatient Oncol Unit, Kyoto 606, Japan; [Yokomichi, Naosuke; Nagasaka, Takeshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol Surg & Surg Oncol, Okayama 7008530, Japan; [Goel, Ajay] Baylor Univ, Med Ctr, Dept Internal Med, Div Gastroenterol, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Charles Sammons Canc Ctr, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX USA	Kindai University (Kinki University); Kyoto University; Kyoto University; Okayama University; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; Baylor Scott & White Health; Baylor University; Baylor University Medical Center	Nishida, N (corresponding author), Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka, Japan.	naoshi@med.kindai.ac.jp	Kudo, Masatoshi/AAA-9744-2019	Kudo, Masatoshi/0000-0002-4102-3474; Goel, Ajay/0000-0003-1396-6341; Nagasaka, Takeshi/0000-0002-4236-350X	Japanese Society for the Promotion of Science [KAKENHI: 24590997]; Smoking Research Foundation	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI: 24590997; http://www.jsps.go.jp/j-grantsinaid/) from the Japanese Society for the Promotion of Science (N. Nishida) and a grant from the Smoking Research Foundation (http://www.srf.or.jp) (N. Nishida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Martinez JG, 2012, CELL ONCOL, V35, P259, DOI 10.1007/s13402-012-0085-5; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kawada N, 2009, J GASTROENTEROL, V44, P1190, DOI 10.1007/s00535-009-0112-0; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Kim MJ, 2009, MODERN PATHOL, V22, P442, DOI 10.1038/modpathol.2008.203; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Lachenmayer A, 2012, J HEPATOL, V56, P1343, DOI 10.1016/j.jhep.2012.01.009; Lin KT, 2012, CLIN CANCER RES, V18, P4691, DOI 10.1158/1078-0432.CCR-12-0633; Moore HM, 2011, CANCER CYTOPATHOL, V119, P92, DOI 10.1002/cncy.20147; Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110; Nishida N, 2007, CANCER RES, V67, P4586, DOI 10.1158/0008-5472.CAN-06-3464; Nishida N, 2012, HEPATOLOGY, V56, P994, DOI 10.1002/hep.25706; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; Nishimura T, 2002, GENE CHROMOSOME CANC, V35, P329, DOI 10.1002/gcc.10126; Nohara K, 2011, ARCH TOXICOL, V85, P653, DOI 10.1007/s00204-010-0611-z; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Saito Y, 2002, P NATL ACAD SCI USA, V99, P10060, DOI 10.1073/pnas.152121799; Shen LL, 2002, J NATL CANCER I, V94, P755, DOI 10.1093/jnci/94.10.755; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wu HC, 2012, CARCINOGENESIS, V33, P1340, DOI 10.1093/carcin/bgs160	30	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72312	10.1371/journal.pone.0072312	http://dx.doi.org/10.1371/journal.pone.0072312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023736	Green Submitted, gold, Green Published			2022-12-27	WOS:000324238400013
J	Pang, JH; Zhu, Y; Li, Q; Liu, JZ; Tian, YC; Liu, YL; Wu, JH				Pang, Jinhuan; Zhu, Yue; Li, Qing; Liu, Jinzhi; Tian, Yingchuan; Liu, Yule; Wu, Jiahe			Development of Agrobacterium-Mediated Virus-Induced Gene Silencing and Performance Evaluation of Four Marker Genes in Gossypium barbadense	PLOS ONE			English	Article							EXPRESSION; RESISTANCE; VECTORS	Gossypium barbadense is a cultivated cotton species and possesses many desirable traits, including high fiber quality and resistance to pathogens, especially Verticillium dahliae (a devastating pathogen of Gossypium hirsutum, the main cultivated species). These elite traits are difficult to be introduced into G. hirsutum through classical breeding methods. In addition, genetic transformation of G. barbadense has not been successfully performed. It is therefore important to develop methods for evaluating the function and molecular mechanism of genes in G. barbadense. In this study, we had successfully introduced a virus-induced gene silencing (VIGS) system into three cultivars of G. barbadense by inserting marker genes into the tobacco rattle virus (TRV) vector. After we optimized the VIGS conditions, including light intensity, photoperiod, seedling age and Agrobacterium strain, 100% of plants agroinfiltrated with the GaPDS silencing vector showed white colored leaves. Three other marker genes, GaCLA1, GaANS and GaANR, were employed to further test this VIGS system in G. barbadense. The transcript levels of the endogenous genes in the silenced plants were reduced by more than 99% compared to control plants; these plants presented phenotypic symptoms 2 weeks after inoculation. We introduced a fusing sequence fragment of GaPDS and GaANR gene silencing vectors into a single plant, which resulted in both photobleaching and brownish coloration. The extent of silencing in plants agroinfiltrated with fusing two-gene-silencing vector was consistent with plants harboring a single gene silencing vector. The development of this VIGS system should promote analysis of gene function in G. barbadense, and help to contribute desirable traits for breeding of G. barbadense and G. hirsutum.	[Pang, Jinhuan; Zhu, Yue; Liu, Jinzhi; Wu, Jiahe] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Pang, Jinhuan; Li, Qing; Liu, Jinzhi; Tian, Yingchuan; Wu, Jiahe] CAAS, State Key Lab Cotton Biol CRI, Anyang, Henan, Peoples R China; [Liu, Yule] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Agricultural Sciences; Tsinghua University	Wu, JH (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	wujiahe@im.ac.cn	Liu, Yule/E-5700-2010	Liu, Yule/0000-0002-4423-6045	State Key Laboratory of Cotton Biology Open Fund [CB2013B03]	State Key Laboratory of Cotton Biology Open Fund	Sponsored by State Key Laboratory of Cotton Biology Open Fund CB2013B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, SAS SYST WIND SOFTW; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Estevez JM, 2000, PLANT PHYSIOL, V124, P95, DOI 10.1104/pp.124.1.95; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Gao XQ, 2011, JOVE-J VIS EXP, DOI 10.3791/2938; Gao XQ, 2011, PLANT J, V66, P293, DOI 10.1111/j.1365-313X.2011.04491.x; Gronlund M, 2008, VIRUS RES, V135, P345, DOI 10.1016/j.virusres.2008.04.005; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Li YG, 1996, J SCI FOOD AGR, V70, P89, DOI 10.1002/(SICI)1097-0010(199601)70:1&lt;89::AID-JSFA470&gt;3.0.CO;2-N; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Liu Y, 2004, PLANT MOL BIOL, V54, P701, DOI 10.1023/B:PLAN.0000040899.53378.83; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Peele C, 2001, PLANT J, V27, P357, DOI 10.1046/j.1365-313x.2001.01080.x; Qu J, 2012, PLANT PHYSIOL, V160, P738, DOI 10.1104/pp.112.198564; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Senthil-Kumar M, 2007, NEW PHYTOL, V176, P782, DOI 10.1111/j.1469-8137.2007.02225.x; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tang DQ, 2005, J BIOSCIENCE, V30, P101; Turnage MA, 2002, PLANT J, V30, P107, DOI 10.1046/j.1365-313X.2002.01261.x; Tuttle JR, 2008, PLANT PHYSIOL, V148, P41, DOI 10.1104/pp.108.123869; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Ye J, 2009, PLANT BIOTECHNOL J, V7, P964, DOI 10.1111/j.1467-7652.2009.00457.x; Zhang CQ, 2006, VIROLOGY, V344, P401, DOI 10.1016/j.virol.2005.08.046; Zhang H, 2008, LECT NOTES ENG COMP, P1, DOI 10.1155/2008/742304	37	54	62	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73211	10.1371/journal.pone.0073211	http://dx.doi.org/10.1371/journal.pone.0073211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023833	gold, Green Published, Green Submitted			2022-12-27	WOS:000324238400052
J	Bouchet, S; Servin, B; Bertin, P; Madur, D; Combes, V; Dumas, F; Brunel, D; Laborde, J; Charcosset, A; Nicolas, S				Bouchet, Sophie; Servin, Bertrand; Bertin, Pascal; Madur, Delphine; Combes, Valerie; Dumas, Fabrice; Brunel, Dominique; Laborde, Jacques; Charcosset, Alain; Nicolas, Stephane			Adaptation of Maize to Temperate Climates: Mid-Density Genome-Wide Association Genetics and Diversity Patterns Reveal Key Genomic Regions, with a Major Contribution of the Vgt2 (ZCN8) Locus	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; RABBIT ORYCTOLAGUS-CUNICULUS; POST-DOMESTICATION SELECTION; POPULATION-STRUCTURE; FLOWERING-TIME; LINKAGE DISEQUILIBRIUM; QUANTITATIVE TRAIT; ASSISTED PREDICTION; ANOPHELES-GAMBIAE; STARCH PATHWAY	The migration of maize from tropical to temperate climates was accompanied by a dramatic evolution in flowering time. To gain insight into the genetic architecture of this adaptive trait, we conducted a 50K SNP-based genome-wide association and diversity investigation on a panel of tropical and temperate American and European representatives. Eighteen genomic regions were associated with flowering time. The number of early alleles cumulated along these regions was highly correlated with flowering time. Polymorphism in the vicinity of the ZCN8 gene, which is the closest maize homologue to Arabidopsis major flowering time (FT) gene, had the strongest effect. This polymorphism is in the vicinity of the causal factor of Vgt2 QTL. Diversity was lower, whereas differentiation and LD were higher for associated loci compared to the rest of the genome, which is consistent with selection acting on flowering time during maize migration. Selection tests also revealed supplementary loci that were highly differentiated among groups and not associated with flowering time in our panel, whereas they were in other linkage-based studies. This suggests that allele fixation led to a lack of statistical power when structure and relatedness were taken into account in a linear mixed model. Complementary designs and analysis methods are necessary to unravel the architecture of complex traits. Based on linkage disequilibrium (LD) estimates corrected for population structure, we concluded that the number of SNPs genotyped should be at least doubled to capture all QTLs contributing to the genetic architecture of polygenic traits in this panel. These results show that maize flowering time is controlled by numerous QTLs of small additive effect and that strong polygenic selection occurred under cool climatic conditions. They should contribute to more efficient genomic predictions of flowering time and facilitate the dissemination of diverse maize genetic resources under a wide range of environments.	[Bouchet, Sophie; Bertin, Pascal; Madur, Delphine; Combes, Valerie; Dumas, Fabrice; Charcosset, Alain; Nicolas, Stephane] Univ Paris 11, CNRS, INRA, UMR Genet Vegetale, Gif Sur Yvette, France; [Servin, Bertrand] INRA, Lab Genet Cellulaire, UMR444, F-31326 Castanet Tolosan, France; [Brunel, Dominique] Ctr Natl Genotypage, Inst Genom, Commissariat Energie Atom, INRA,UR1279, Evry, France; [Laborde, Jacques] INRA, Stn Expt Mais, St Martin De Hinx, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; CEA; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; INRAE	Charcosset, A (corresponding author), Univ Paris 11, CNRS, INRA, UMR Genet Vegetale, Gif Sur Yvette, France.	alain.charcosset@moulon.inra.fr	Servin, Bertrand/B-2206-2008; Nicolas, Stéphane/D-4980-2009; Nicolas, Stephane/N-6886-2017	Servin, Bertrand/0000-0001-5141-0913; Nicolas, Stephane/0000-0003-0758-9930; Charcosset, Alain/0000-0001-6125-503X	INRA; Genoplante; Gabi-Genoplante; French ANR; German BMBF; Spanish MICINN; ANR project Hypermaize; ANR project CornFed	INRA; Genoplante; Gabi-Genoplante; French ANR(French National Research Agency (ANR)); German BMBF(Federal Ministry of Education & Research (BMBF)); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ANR project Hypermaize(French National Research Agency (ANR)); ANR project CornFed(French National Research Agency (ANR))	Phenotyping experimentations were funded by INRA, Genoplante, and Gabi-Genoplante projects. Genotyping was funded by INRA and CornFed trilateral project (jointly funded by French ANR, German BMBF and Spanish MICINN). Sophie Bouchet was funded by ANR projects Hypermaize and CornFed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Anderson Edgar, 1952, AGR HIST, V26, P2; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; Banfield MJ, 2000, J MOL BIOL, V297, P1159, DOI 10.1006/jmbi.2000.3619; Bolanos J, 1996, FIELD CROP RES, V48, P65, DOI 10.1016/0378-4290(96)00036-6; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Carneiro M, 2010, EVOLUTION, V64, P3443, DOI 10.1111/j.1558-5646.2010.01092.x; Carneiro M, 2009, GENETICS, V181, P593, DOI 10.1534/genetics.108.096826; Charcosset A, 1996, THEOR APPL GENET, V93, P1193, DOI 10.1007/BF00223450; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Chardon F, 2005, THEOR APPL GENET, V112, P1, DOI 10.1007/s00122-005-0050-z; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Corbi J, 2011, THEOR APPL GENET, V122, P705, DOI 10.1007/s00122-010-1480-9; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; DOEBLEY J, 1988, ECON BOT, V42, P120, DOI 10.1007/BF02859042; Dubreuil P, 2006, MAYDICA, V51, P281; Ducrocq S, 2008, GENETICS, V178, P2433, DOI 10.1534/genetics.107.084830; Ducrocq S, 2009, GENETICS, V183, P1555, DOI 10.1534/genetics.109.106922; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ersoz E.S., 2007, GENOMICS ASSISTED CR, P97, DOI DOI 10.1007/978-1-4020-6295-7_5; Falush D, 2003, GENETICS, V164, P1567; Fan LJ, 2008, MOL BREEDING, V22, P329, DOI 10.1007/s11032-008-9178-2; Fan LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007612; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Frascaroli E, 2012, THEOR APPL GENET, P1; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gilmour A, 2006, ASREML USER GUIDE RE, P320; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hamblin M, 2007, PLOS ONE, V2; Haseneyer G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-5; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jeffrey S, 1961, THEORY PROBABILITY; Jung M, 2004, THEOR APPL GENET, V109, P681, DOI 10.1007/s00122-004-1695-8; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; KULESHOV N. N., 1933, JOUR AMER SOC AGRON, V25, P688; Lazakis CM, 2011, J EXP BOT, V62, P4833, DOI 10.1093/jxb/err129; LIN YR, 1995, GENETICS, V141, P391; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Maenhout S, 2009, BIOINFORMATICS, V25, P2753, DOI 10.1093/bioinformatics/btp499; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meuwissen THE, 2001, GENETICS, V157, P1819; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; Navarro A, 2003, SCIENCE, V300, P321, DOI 10.1126/science.1080600; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rebourg C, 2003, THEOR APPL GENET, V106, P895, DOI 10.1007/s00122-002-1140-9; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Ritchie J, 1991, TEMPERATURE CROP DEV; Rogers J. S., 1972, U TEXAS PUBL, V7213, P145; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Salvi S, 2009, MAYDICA, V54, P501; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; SMITH BD, 1989, SCIENCE, V246, P1566, DOI 10.1126/science.246.4937.1566; Steinhoff J, 2012, THEOR APPL GENET, P1; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; SVED J A, 1971, Theoretical Population Biology, V2, P125; Tenaillon MI, 2011, CR BIOL, V334, P221, DOI 10.1016/j.crvi.2010.12.015; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Thompson RG, 2004, NE ANTHR, V68, P25; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Truntzler M, 2012, THEOR APPL GENET, P1; Tsuji H, 2008, RICE, V1, P25, DOI 10.1007/s12284-008-9005-8; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; van Heerwaarden J, 2012, P NATL ACAD SCI USA, V109, P12420, DOI 10.1073/pnas.1209275109; Van Inghelandt D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-56; Van Inghelandt D, 2011, THEOR APPL GENET, V123, P11, DOI 10.1007/s00122-011-1562-3; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Veyrieras JB, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-49; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yano M, 1997, THEOR APPL GENET, V95, P1025, DOI 10.1007/s001220050658; Yu J, 2012, GENOME RES; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541; Zeevaart JAD, 2006, PLANT CELL, V18, P1783, DOI 10.1105/tpc.106.043513	113	52	56	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e71377	10.1371/journal.pone.0071377	http://dx.doi.org/10.1371/journal.pone.0071377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023610	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200004
J	Gheorghiu, E; Bell, J; Kingdom, FAA				Gheorghiu, Elena; Bell, Jason; Kingdom, Frederick A. A.			Line Orientation Adaptation: Local or Global?	PLOS ONE			English	Article							SHAPE-FREQUENCY; COLOR SELECTIVITY; VISUAL-CORTEX; TILT; CONTRAST; CONTOURS; MECHANISMS; V1; INTEGRATION; INHIBITION	Prolonged exposure to an oriented line shifts the perceived orientation of a subsequently observed line in the opposite direction, a phenomenon known as the tilt aftereffect (TAE). Here we consider whether the TAE for line stimuli is mediated by a mechanism that integrates the local parts of the line into a single global entity prior to the site of adaptation, or the result of the sum of local TAEs acting separately on the parts of the line. To test between these two alternatives we used the fact the TAE transfers almost completely across luminance contrast polarity [1]. We measured the TAE using adaptor and test lines that (1) either alternated in luminance polarity or were of a single polarity, and (2) either alternated in local orientation or were of a single orientation. We reasoned that if the TAE was agnostic to luminance polarity and was parts-based, we should obtain large TAEs using alternating-polarity adaptors with single-polarity tests. However we found that (i) TAEs using one-alternating-polarity adaptors with all-white tests were relatively small, increased slightly for two-alternating-polarity adaptors, and were largest with all-white or all-black adaptors. (ii) however TAEs were relatively large when the test was one-alternating polarity, irrespective of the adaptor type. (iii) The results with orientation closely mirrored those obtained with polarity with the difference that the TAE transfer across orthogonal orientations was weak. Taken together, our results demonstrate that the TAE for lines is mediated by a global shape mechanism that integrates the parts of lines into whole prior to the site of orientation adaptation. The asymmetry in the magnitude of TAE depending on whether the alternating-polarity lines was the adaptor or test can be explained by an imbalance in the population of neurons sensitive to 1st-and 2nd-order lines, with the 2nd-order lines being encoded by a subset of the mechanisms sensitive to 1st-order lines.	[Gheorghiu, Elena] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Bell, Jason] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [Bell, Jason] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Kingdom, Frederick A. A.] McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada	University of Stirling; Australian National University; University of Western Australia; McGill University	Gheorghiu, E (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.	elena.gheorghiu@stir.ac.uk		Gheorghiu, Elena/0000-0002-9459-1969; Bell, Jason/0000-0002-1583-5292	Natural Sciences and Engineering Research Council of Canada (NSERC) grant [RGPIN 121713-11]; Australian Research Council grant [DP110101511]	Natural Sciences and Engineering Research Council of Canada (NSERC) grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council grant(Australian Research Council)	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant #RGPIN 121713-11 given to FK and Australian Research Council grant DP110101511 to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Bair W, 2003, J NEUROSCI, V23, P7690; Bell J, 2011, VISION RES, V51, P1760, DOI 10.1016/j.visres.2011.06.003; Bell J, 2009, VISION RES, V49, P1702, DOI 10.1016/j.visres.2009.04.012; Boynton GM, 2003, J NEUROSCI, V23, P8781; Brincat SL, 2000, J NEUROPHYSIOL, V83, P1900, DOI 10.1152/jn.2000.83.4.1900; BROERSE J, 1975, PERCEPT PSYCHOPHYS, V17, P333, DOI 10.3758/BF03199342; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; COLTHEAR.M, 1971, NATURE-NEW BIOL, V231, P256, DOI 10.1038/newbio231256a0; COLTHEART M, 1971, PSYCHOL REV, V78, P114, DOI 10.1037/h0030639; Dragoi V, 2000, J NEUROPHYSIOL, V83, P1019, DOI 10.1152/jn.2000.83.2.1019; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; ELSNER A, 1978, PERCEPT PSYCHOPHYS, V24, P451, DOI 10.3758/BF03199743; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Fang F, 2005, J NEUROPHYSIOL, V94, P4188, DOI 10.1152/jn.00378.2005; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; GANZ L, 1966, PSYCHOL REV, V73, P128, DOI 10.1037/h0022952; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; Georgeson MA, 2002, SPATIAL VISION, V16, P59, DOI 10.1163/15685680260433913; Gheorghiu E., 2012, J VIS, V12; Gheorghiu E, 2007, VISION RES, V47, P1935, DOI 10.1016/j.visres.2007.03.010; Gheorghiu E, 2007, VISION RES, V47, P834, DOI 10.1016/j.visres.2006.11.023; Gheorghiu E, 2006, VISION RES, V46, P3603, DOI 10.1016/j.visres.2006.04.021; Gheorghiu E, 2009, VISION RES, V49, P2518, DOI 10.1016/j.visres.2009.08.009; Gheorghiu E, 2009, J VISION, V9, DOI 10.1167/9.2.23; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Graham NV, 2011, VISION RES, V51, P1397, DOI 10.1016/j.visres.2011.02.007; Hancock S, 2008, J VISION, V8, DOI 10.1167/8.7.11; Jin DZ, 2005, J NEUROPHYSIOL, V94, P4038, DOI 10.1152/jn.00571.2004; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kavadellas A, PERCEPTION PSYCHOPHY, V21, P12; Knapen T, 2010, J VISION, V10, DOI 10.1167/10.1.8; Kohler Wolfgang, 1944, PROC AMER PHIL SOC, V88, P269; Landy M. S., 2003, VISUAL NEUROSCIENCES; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; LOVEGROVE W, 1981, VISION RES, V21, P355, DOI 10.1016/0042-6989(81)90163-2; LOVEGROVE WJ, 1973, VISION RES, V13, P895, DOI 10.1016/0042-6989(73)90069-2; MAGNUSSEN S, 1980, SCIENCE, V207, P908, DOI 10.1126/science.7355271; MAGNUSSEN S, 1986, VISION RES, V26, P661, DOI 10.1016/0042-6989(86)90014-3; MAGNUSSEN S, 1979, PERCEPTION, V8, P523, DOI 10.1068/p080523; MAGNUSSEN S, 1980, VISION RES, V20, P39, DOI 10.1016/0042-6989(80)90139-X; Meese TS, 1996, PERCEPTION, V25, P255, DOI 10.1068/p250255; MITCHELL DE, 1976, VISION RES, V16, P609, DOI 10.1016/0042-6989(76)90007-9; Motoyoshi I, 2007, VISION RES, V47, P2047, DOI 10.1016/j.visres.2007.03.015; PARADISO MA, 1989, VISION RES, V29, P1205, DOI 10.1016/0042-6989(89)90066-7; PETERHANS E, 1989, J NEUROSCI, V9, P1749; REGAN D, 1992, VISION RES, V32, P1845, DOI 10.1016/0042-6989(92)90046-L; Rhodes G, 2004, CURR BIOL, V14, P2119, DOI 10.1016/j.cub.2004.11.053; ROSNESS R, 1994, VISION RES, V34, P2021, DOI 10.1016/0042-6989(94)90029-9; Schofield AJ, 2007, J VISION, V7, DOI 10.1167/7.8.1; SHATTUCK S, 1975, VISION RES, V15, P309, DOI 10.1016/0042-6989(75)90225-4; SMITH AT, 1976, PERCEPT PSYCHOPHYS, V20, P305, DOI 10.3758/BF03199457; Suzuki S, 2003, VISION RES, V43, P549, DOI 10.1016/S0042-6989(02)00683-1; Suzuki S, 2001, VISION RES, V41, P3883, DOI 10.1016/S0042-6989(01)00249-8; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; WENDEROTH P, 1988, VISION RES, V28, P301, DOI 10.1016/0042-6989(88)90158-7	59	5	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73307	10.1371/journal.pone.0073307	http://dx.doi.org/10.1371/journal.pone.0073307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023677	Green Submitted, gold, Green Published			2022-12-27	WOS:000323880200073
J	Nagy, LH; Grishina, I; Macal, M; Hirao, LA; Hu, WK; Sankaran-Walters, S; Gaulke, CA; Pollard, R; Brown, J; Suni, M; Baumler, AJ; Ghanekar, S; Marco, ML; Dandekar, S				Nagy, Lauren H.; Grishina, Irina; Macal, Monica; Hirao, Lauren A.; Hu, William K.; Sankaran-Walters, Sumathi; Gaulke, Christopher A.; Pollard, Richard; Brown, Jennifer; Suni, Maria; Baumler, Andreas J.; Ghanekar, Smita; Marco, Maria L.; Dandekar, Satya			Chronic HIV Infection Enhances the Responsiveness of Antigen Presenting Cells to Commensal Lactobacillus	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; IMMUNE ACTIVATION; T-CELLS; MICROBIAL TRANSLOCATION; ANTIRETROVIRAL THERAPY; INCREASED EXPRESSION; RHAMNOSUS-GG; KAPPA-B; HLA-DR; RESTORATION	Chronic immune activation despite long-term therapy poses an obstacle to immune recovery in HIV infection. The role of antigen presenting cells (APCs) in chronic immune activation during HIV infection remains to be fully determined. APCs, the frontline of immune defense against pathogens, are capable of distinguishing between pathogens and non-pathogenic, commensal bacteria. We hypothesized that HIV infection induces dysfunction in APC immune recognition and response to some commensal bacteria and that this may promote chronic immune activation. Therefore we examined APC inflammatory cytokine responses to commensal lactobacilli. We found that APCs from HIV-infected patients produced an enhanced inflammatory response to Lactobacillus plantarum WCFS1 as compared to APCs from healthy, HIV-negative controls. Increased APC expression of TLR2 and CD36, signaling through p38-MAPK, and decreased expression of MAP kinase phosphatase-1 (MKP-1) in HIV infection was associated with this heightened immune response. Our findings suggest that chronic HIV infection enhances the responsiveness of APCs to commensal lactobacilli, a mechanism that may partly contribute to chronic immune activation.	[Nagy, Lauren H.; Grishina, Irina; Macal, Monica; Hirao, Lauren A.; Hu, William K.; Sankaran-Walters, Sumathi; Gaulke, Christopher A.; Pollard, Richard; Baumler, Andreas J.; Dandekar, Satya] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Brown, Jennifer] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Marco, Maria L.] Univ Calif Davis, Davis, CA 95616 USA; [Suni, Maria; Ghanekar, Smita] Becton Dickinson Biosci, San Jose, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Becton Dickinson	Dandekar, S (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	sdandekar@ucdavis.edu	Gaulke, Christopher/M-7308-2019; Baumler, Andreas J/H-2301-2011; Marco, Maria/H-2322-2014	Gaulke, Christopher/0000-0001-7741-7822; Baumler, Andreas J/0000-0001-9152-7809; 	NIH [DK61297, AI43274]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061297] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH grants (DK61297 and AI43274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anukam KC, 2008, J CLIN GASTROENTEROL, V42, P239, DOI 10.1097/MCG.0b013e31802c7465; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cunningham-Rundles S, 2011, NUTRIENTS, V3, P1042, DOI 10.3390/nu3121042; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fernandez S, 2011, J INFECT DIS, V204, P1927, DOI 10.1093/infdis/jir659; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Giahi L, 2012, BENEF MICROBES, V3, P91, DOI 10.3920/BM2011.0052; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Hand TW, 2012, SCIENCE; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; Hemarajata P, 2013, THER ADV GASTROENTER, V6, P39, DOI 10.1177/1756283X12459294; Hernandez JC, 2012, AIDS RES HUM RETROVI; Jan RL, 2012, BRIT J NUTR, V108, P130, DOI 10.1017/S0007114511005265; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Klatt NR, 2013, J CLIN INVEST; Lenkei R, 1998, CYTOMETRY, V33, P115, DOI 10.1002/(SICI)1097-0320(19981001)33:2<115::AID-CYTO5>3.0.CO;2-I; Lerner P, 2011, J VIROL, V85, P4772, DOI 10.1128/JVI.02409-10; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mendez-Lagares G, 2013, J INFECT DIS; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Meroni L, 2005, JAIDS-J ACQ IMM DEF, V38, P310; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Price P, 2001, J CLIN VIROL, V22, P279, DOI 10.1016/S1386-6532(01)00200-1; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Rochat T, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-22; Salminen MK, 2004, HIV CLIN TRIALS, V5, P183, DOI 10.1310/6F83-N39Q-9PPP-LMVV; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Suni MA, 2011, METHODS MOL BIOL, V717, P155, DOI 10.1007/978-1-61779-024-9_9; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; TRIAL JA, 1995, J CLIN INVEST, V95, P1690, DOI 10.1172/JCI117845; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Watterlot L, 2010, INT J FOOD MICROBIOL, V144, P35, DOI 10.1016/j.ijfoodmicro.2010.03.037; Xiao J, 2011, CHINESE MED J-PEKING, V124, P2340, DOI 10.3760/cma.j.issn.0366-6999.2011.15.017	48	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72789	10.1371/journal.pone.0072789	http://dx.doi.org/10.1371/journal.pone.0072789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023646	Green Published, gold			2022-12-27	WOS:000323880200042
J	van Toor, ML; Hedenstrom, A; Waldenstrom, J; Fiedler, W; Holland, RA; Thorup, K; Wikelski, M				van Toor, Marielle L.; Hedenstrom, Anders; Waldenstrom, Jonas; Fiedler, Wolfgang; Holland, Richard A.; Thorup, Kasper; Wikelski, Martin			Flexibility of Continental Navigation and Migration in European Mallards	PLOS ONE			English	Article							CLIMATE-CHANGE; ORIENTATION; WATERFOWL; BEHAVIOR; VIRUS; SIZE	The ontogeny of continent-wide navigation mechanisms of the individual organism, despite being crucial for the understanding of animal movement and migration, is still poorly understood. Several previous studies, mainly conducted on passerines, indicate that inexperienced, juvenile birds may not generally correct for displacement during fall migration. Waterbirds such as the mallard (Anas platyrhynchos, Linnaeus 1758) are more flexible in their migration behavior than most migratory songbirds, but previous experiments with waterbirds have not yet allowed clear conclusions about their navigation abilities. Here we tested whether immature mallard ducks correct for latitudinal displacement during fall migration within Europe. During two consecutive fall migration periods, we caught immature females on a stopover site in southeast Sweden, and translocated a group of them ca. 1,000 km to southern Germany. We followed the movements of the ducks via satellite GPS-tracking and observed their migration decisions during the fall and consecutive spring migration. The control animals released in Ottenby behaved as expected from banding recoveries: they continued migration during the winter and in spring returned to the population's breeding grounds in the Baltics and Northwest Russia. Contrary to the control animals, the translocated mallards did not continue migration and stayed at Lake Constance. In spring, three types of movement tactics could be observed: 61.5% of the ducks (16 of 26) stayed around Lake Constance, 27% (7 of 26) migrated in a northerly direction towards Sweden and 11.5% of the individuals (3 of 26) headed east for ca. 1,000 km and then north. We suggest that young female mallards flexibly adjust their migration tactics and develop a navigational map that allows them to return to their natal breeding area.	[van Toor, Marielle L.; Fiedler, Wolfgang; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [van Toor, Marielle L.; Wikelski, Martin] Univ Konstanz, Dept Biol, Constance, Germany; [Hedenstrom, Anders] Lund Univ, Dept Biol, Lund, Sweden; [Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden; [Holland, Richard A.] Queens Univ Belfast, Sch Biol Sci, Belfast BT7 1NN, Antrim, North Ireland; [Thorup, Kasper] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	Max Planck Society; University of Konstanz; Lund University; Linnaeus University; Queens University Belfast; University of Copenhagen	van Toor, ML (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.	mvantoor@orn.mpg.de	Holland, Richard A/A-6107-2010; Fiedler, Wolfgang/AAG-4510-2021; Thorup, Kasper/A-4835-2013; Waldenström, Jonas/E-4460-2013; Hedenström, Anders/F-5377-2010	Holland, Richard A/0000-0003-4495-8061; Fiedler, Wolfgang/0000-0003-1082-4161; Thorup, Kasper/0000-0002-0320-0601; Waldenström, Jonas/0000-0002-1152-4235; Hedenström, Anders/0000-0002-1757-0945; van Toor, Marielle L./0000-0002-2254-5779	Max-Planck Society; Baden-Wuerttemberg Foundation; Swedish Science Foundation; Direct For Biological Sciences [0744704] Funding Source: National Science Foundation	Max-Planck Society(Max Planck Society); Baden-Wuerttemberg Foundation; Swedish Science Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the Max-Planck Society and the Baden-Wuerttemberg Foundation to MW, as well as by the Swedish Science Foundation to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2005, CURR BIOL, V15, P1591, DOI 10.1016/j.cub.2005.07.027; Atkinson P, 2006, REPORT EUROPEAN COMI; Baker K, 1993, IDENTIFICATION GUIDE; Bauer H.G., 2005, KOMPENDIUM VOGEL MIT; Bellrose F. C., 1958, Wilson Bulletin, V70, P20; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Berthold P., 2001, BIRD MIGRATION; Bingman VP, 2005, ETHOL ECOL EVOL, V17, P295; BINGMAN VP, 1984, BEHAV ECOL SOCIOBIOL, V15, P77, DOI 10.1007/BF00310220; Chernetsov N, 2004, J EXP BIOL, V207, P937, DOI 10.1242/jeb.00853; Clarke A, OIKOS, V79, P429; Dickens MJ, 2009, P R SOC B, V276, P2051, DOI 10.1098/rspb.2008.1778; Fransson T, 2001, SWEDISH BIRD RINGING, V1; Griswold CK, 2011, OIKOS, V120, P1847, DOI 10.1111/j.1600-0706.2011.19435.x; Gunnarsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035679; Gunnarsson G, 2012, IBIS, V154, P307, DOI 10.1111/j.1474-919X.2011.01206.x; Hochachka WM, 1999, CONDOR, V101, P195, DOI 10.2307/1369983; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Keller I, 2009, J ORNITHOL, V150, P483, DOI 10.1007/s10336-008-0367-x; Koenig WD, 2001, J ANIM ECOL, V70, P609, DOI 10.1046/j.1365-2656.2001.00516.x; Kraus RHS, 2013, MOL ECOL, V22, P41, DOI 10.1111/mec.12098; Kraus RHS, 2011, JOVE-J VIS EXP, DOI 10.3791/2832; Kraus RHS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-99; Kullberg C, 2003, P ROY SOC B-BIOL SCI, V270, P373, DOI 10.1098/rspb.2002.2273; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Moller AP, 2011, P ROY SOC B-BIOL SCI, V278, P733, DOI 10.1098/rspb.2010.1592; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; NICHOLS JD, 1983, AUK, V100, P932, DOI 10.1093/auk/100.4.932; Nilsson ALK, 2006, GLOBAL CHANGE BIOL, V12, P2014, DOI 10.1111/j.1365-2486.2006.01237.x; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; PERDECK A. C., 1958, ARDEA, V46, P1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rao JS., 2001, TOPICS CIRCULAR STAT; Roshier DA, 2009, MAR FRESHWATER RES, V60, P299, DOI 10.1071/MF08152; Saino N, 2009, BIOL LETTERS, V5, P539, DOI 10.1098/rsbl.2009.0312; Sauter A, 2010, IBIS, V152, P600, DOI 10.1111/j.1474-919X.2010.01028.x; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; STEPHENS MA, 1970, J ROY STAT SOC B, V32, P115; Streich WJ, 2005, EUROPEAN J WILDLIFE, V52, P48; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; Thorup K, 2007, BEHAV ECOL SOCIOBIOL, V61, P825, DOI 10.1007/s00265-006-0306-x; Tottrup AP, 2010, INTEGR COMP BIOL, V50, P293, DOI 10.1093/icb/icq028; Valikangas J, 1933, VOGELZUG, P159; van Toor ML, 2013, DATA FLEXIBILITY CON; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wiltschko R, 2003, ANIM BEHAV, V65, P257, DOI 10.1006/anbe.2003.2054; WOLFF WJ, 1970, ARDEA, V58, P131	49	16	16	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72629	10.1371/journal.pone.0072629	http://dx.doi.org/10.1371/journal.pone.0072629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023629	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200024
J	Wu, HC; Chou, FHC; Tsai, KY; Su, CY; Shen, SP; Chung, TC				Wu, Hung-Chi; Chou, Frank Huang-Chih; Tsai, Kuan-Yi; Su, Chao-Yueh; Shen, Shih-Pei; Chung, Tieh-Chi			The Incidence and Relative Risk of Stroke among Patients with Bipolar Disorder: A Seven-Year Follow-Up Study	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; PSYCHIATRIC COMORBIDITY; MEDICAL COMORBIDITY; SEX-DIFFERENCES; SCHIZOPHRENIA; MORTALITY; POPULATION; PREVALENCE; LITHIUM; TAIWAN	Objective: This study aimed to estimate the incidence and relative risk of stroke and post-stroke all-cause mortality among patients with bipolar disorder. Methods: This study identified a study population from the National Health Insurance Research Database (NHIRD) between 1999 and 2003 that included 16,821 patients with bipolar disorder and 67,284 age- and sex-matched control participants without bipolar disorder. The participants who had experienced a stroke between 1999 and 2003 were excluded and were randomly selected from the NHIRD. The incidence of stroke (ICD-9-CM code 430-438) and patient survival after stroke were calculated for both groups using data from the NIHRD between 2004 and 2010. A Cox proportional-hazards model was used to compare the seven-year stroke-free survival rate and all-cause mortality rate across the two cohorts after adjusting for confounding risk factors. Results: A total of 472 (2.81%) patients with bipolar disorder and 1,443 (2.14%) controls had strokes over seven years. Patients with bipolar disorder were 1.24 times more likely to have a stroke (95% CI = 1.12-1.38; p < 0.0001) after adjusting for demographic characteristics and comorbid medical conditions. In addition, 513 (26.8%) patients who had a stroke died during the follow-up period. The all-cause mortality hazard ratio for patients with bipolar disorder was 1.28 (95% CI = 1.06-1.55; p = 0.012) after adjusting for patient, physician and hospital variables. Conclusions: The likelihood of developing a stroke was greater among patients with bipolar disorder than controls, and the all-cause mortality rate was higher among patients with bipolar disorder than controls during a seven-year follow-up period.	[Wu, Hung-Chi; Shen, Shih-Pei] Kai Syuan Psychiat Hosp, Dept Addict Sci, Kaohsiung, Taiwan; [Chou, Frank Huang-Chih; Tsai, Kuan-Yi] Kai Syuan Psychiat Hosp, Dept Community Psychiat, Kaohsiung, Taiwan; [Su, Chao-Yueh] I Shou Univ, Dept Nursing, Kaohsiung, Taiwan	I Shou University		x00002149@meiho.edu.tw			Kai-Syuan Psychiatric Hospital	Kai-Syuan Psychiatric Hospital	This research was supported by grants from Kai-Syuan Psychiatric Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YM, 2013, J AFFECT DISORD; Beyer J, 2005, NEUROPSYCHOPHARMACOL, V30, P401, DOI 10.1038/sj.npp.1300608; Boden-Albala B, 2000, Curr Atheroscler Rep, V2, P160, DOI 10.1007/s11883-000-0111-3; Bos MJ, 2008, J NEUROL NEUROSUR PS, V79, P997, DOI 10.1136/jnnp.2007.134965; Cadilhac DA, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-49; Capasso RM, 2008, SCHIZOPHR RES, V98, P287, DOI 10.1016/j.schres.2007.10.005; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Chou FHC, 2011, SCHIZOPHR RES, V129, P97, DOI 10.1016/j.schres.2011.02.018; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Druss BG, 2000, JAMA-J AM MED ASSOC, V283, P506, DOI 10.1001/jama.283.4.506; Evans-Lacko SE, 2009, J CLIN PSYCHIAT, V70, P1461, DOI 10.4088/JCP.08m04871; Everson SA, 1998, ARCH INTERN MED, V158, P1133, DOI 10.1001/archinte.158.10.1133; George EL, 2003, BIPOLAR DISORD, V5, P115, DOI 10.1034/j.1399-5618.2003.00028.x; Gold AB, 2011, CURR DRUG TARGETS, V12, P243; Hsieh MH, 2012, BIPOLAR DISORD, V14, P677, DOI 10.1111/j.1399-5618.2012.01039.x; Kang JH, 2011, PSYCHOSOM MED, V73, P106, DOI 10.1097/PSY.0b013e3181fdc2c9; Kapral MK, 2005, STROKE, V36, P809, DOI 10.1161/01.STR.0000157662.09551.e5; Kemp DE, 2010, BIPOLAR DISORD, V12, P404, DOI 10.1111/j.1399-5618.2010.00823.x; Kisely S, 2009, BRIT J PSYCHIAT, V195, P545, DOI 10.1192/bjp.bp.109.067082; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; LEE TK, 1995, STROKE, V26, P790, DOI 10.1161/01.STR.26.5.790; Leys D, 2002, J NEUROL, V249, P507, DOI 10.1007/s004150200057; Lin HC, 2008, SCHIZOPHR RES, V101, P234, DOI 10.1016/j.schres.2007.12.485; Lin HC, 2007, J AFFECT DISORDERS, V100, P49, DOI 10.1016/j.jad.2006.09.016; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; McElroy SL, 2001, AM J PSYCHIAT, V158, P420, DOI 10.1176/appi.ajp.158.3.420; McFadden E, 2009, STROKE, V40, P1070, DOI 10.1161/STROKEAHA.108.533414; Mogensen UB, 2012, J STROKE CEREBROVASC; Newcomer JW, 2002, ARCH GEN PSYCHIAT, V59, P337, DOI 10.1001/archpsyc.59.4.337; Nilsson FM, 2004, EUR ARCH PSY CLIN N, V254, P387, DOI 10.1007/s00406-004-0519-9; Ohira T, 2001, STROKE, V32, P903, DOI 10.1161/01.STR.32.4.903; Pham TM, 2007, PREV MED, V44, P526, DOI 10.1016/j.ypmed.2007.02.016; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Salaycik KJ, 2007, STROKE, V38, P16, DOI 10.1161/01.STR.0000251695.39877.ca; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; Tsai KY, 2012, SCHIZOPHR RES, V138, P41, DOI 10.1016/j.schres.2012.02.013; Vieta E, 2001, BIPOLAR DISORD, V3, P253, DOI 10.1034/j.1399-5618.2001.030504.x; Wang ZF, 2011, ACTA PHARMACOL SIN, V32, P1433, DOI 10.1038/aps.2011.140; Xu JH, 2005, J HYPERTENS, V23, P2277, DOI 10.1097/01.hjh.0000189868.48290.d8	39	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73037	10.1371/journal.pone.0073037	http://dx.doi.org/10.1371/journal.pone.0073037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023667	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200063
J	Zhang, CL; Wang, GZ; Wang, JM; Ji, ZB; Liu, ZH; Pi, XS; Chen, CX				Zhang, Chunlan; Wang, Guizhi; Wang, Jianmin; Ji, Zhibin; Liu, Zhaohuan; Pi, Xiushuang; Chen, Cunxian			Characterization and Comparative Analyses of Muscle Transcriptomes in Dorper and Small-Tailed Han Sheep Using RNA-Seq Technique	PLOS ONE			English	Article							GLOBAL VIEW; MODEL; DISCOVERY; SURVIVAL; GENES; TOOL	The sheep is an important domestic animal and model for many types of medically relevant research. An investigation of gene expression in ovine muscle would significantly advance our understanding of muscle growth. RNA-seq is a recently developed analytical approach for transcriptome profiling via high-throughput sequencing. Although RNA-seq has been recently applied to a wide variety of organisms, few RNA-seq studies have been conducted in livestock, particularly in sheep. In this study, two cDNA libraries were constructed from the biceps brachii of one Small-tailed Han sheep (SH) and one Dorper sheep (DP). The Illumina high-throughput sequencing technique and bioinformatics were used to determine transcript abundances and characteristics. For the SH and DP libraries, we obtained a total of 50,264,608 and 52,794,216 high quality reads, respectively. Approximately two-thirds of the reads could be mapped to the sheep genome. In addition, 40,481 and 38,851 potential coding single nucleotide polymorphisms (cSNPs) were observed, respectively, of which a total of 59,139 cSNP coordinates were different between the two samples. Up to 5,116 and 5,265 respective reference genes had undergone 13,827 and 15,684 alternative splicing events. A total of 6,989 reference genes were extended at the 5', 3' or both ends, and 123,678 novel transcript units were found. A total of 1,300 significantly differentially expressed genes were identified between the two libraries. These results suggest that there are many differences in the muscle transcriptomes between these two animals. This study addresses a preliminary analysis and offers a foundation for future genomic research in the sheep.	[Zhang, Chunlan; Wang, Guizhi; Wang, Jianmin; Ji, Zhibin; Liu, Zhaohuan; Pi, Xiushuang; Chen, Cunxian] Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University	Wang, JM (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China.	wangjm@sdau.edu.cn	WANG, Jianmin/M-2002-2016	WANG, Jianmin/0000-0001-5678-8202	Innovation Research of Agriculture and Biology Resources [2011186125]; Shandong Provincial Modern Agriculture Industry Technology System Sheep Industry Innovation Team [SATS2012263]	Innovation Research of Agriculture and Biology Resources; Shandong Provincial Modern Agriculture Industry Technology System Sheep Industry Innovation Team	This work was financially supported by the Innovation Research of Agriculture and Biology Resources (No. 2011186125) and Shandong Provincial Modern Agriculture Industry Technology System Sheep Industry Innovation Team No. SATS2012263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Bonnet A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-417; Byrne K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-378; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Dhorne-Pollet S, 2012, ANIM GENET, V43, P199, DOI 10.1111/j.1365-2052.2011.02237.x; Du L, 2011, ANIMAL GENETIC RESOU, V62; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Faulconnier Y, 2011, COMP BIOCHEM PHYS D, V6, P139, DOI 10.1016/j.cbd.2010.12.002; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Graham NS, 2011, ANIMAL, V5, P861, DOI 10.1017/S1751731110002533; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Huang W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-711; Jager M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-158; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lister R, 2008, CELL, V3, P395; Matsuzaki K, 2010, ANN THORAC SURG, V90, P788, DOI 10.1016/j.athoracsur.2010.04.008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nie QH, 2011, DNA RES, V18, P343, DOI 10.1093/dnares/dsr021; Ollier S, 2007, J NUTR, V137, P560, DOI 10.1093/jn/137.3.560; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Ren HX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-411; Schmalstieg FC, 2007, ANN SURG, V246, P512, DOI 10.1097/SLA.0b013e318148c6e6; Shofti R, 2004, LAB ANIM-UK, V38, P149, DOI 10.1258/002367704322968821; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xiong J, 2012, PLOS ONE, V2; Yamagami T, 2010, REPROD SCI, V17, P679, DOI 10.1177/1933719110369010; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhou XQ, 2010, ANN THORAC SURG, V90, P419, DOI 10.1016/j.athoracsur.2010.04.052	39	42	46	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72686	10.1371/journal.pone.0072686	http://dx.doi.org/10.1371/journal.pone.0072686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023632	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200027
J	Yang, CH; Chan, PC; Liao, ST; Cheng, SH; Wong, WW; Huang, LM; Hsueh, PR; Chiou, HY				Yang, Chin-Hui; Chan, Pei-Chun; Liao, Say-Tsung; Cheng, Shu-Hsing; Wong, Wing-Wai; Huang, Li-Min; Hsueh, Po-Ren; Chiou, Hung-Yi			Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population	PLOS ONE			English	Article							GAMMA RELEASE ASSAY; ISONIAZID PREVENTIVE THERAPY; TUBERCULIN SKIN-TEST; CELL-BASED ASSAYS; ACTIVE TUBERCULOSIS; ANTIRETROVIRAL THERAPY; PREDICTIVE-VALUE; SOUTH-AFRICA; DIAGNOSIS; TAIWAN	Objective: To evaluate the T-SPOT. TB interferon-gamma releasing assay and the tuberculin skin test (TST), for the diagnosis of latent tuberculosis infection(LTBI) and the development of subsequent active tuberculosis, in BCG-vaccinated HIV-infected individuals. Methods: HIV-infected individuals without clinical suspicion of active TB or a past history of TB were enrolled from 1 January 2008 to 30 November 2010. Both T-SPOT. TB test and TST were offered to the participants whom were followed up prospectively until April 30, 2012 for development of TB. Results: Among the 909 participants, 25% had positive TST reactions with cut-off point of 5 mm and 15% had positive T-SPOT. TB results. After a median follow-up of 2.97 years, there were 5 cases developed culture-confirmed active TB (all had dual positive TST and T-SPOT. TB results), and the incidence was 0.17 per 100 person-years. The relative risks (RRs) for subsequent active TB in HIV-infected individuals with positive TST results, positive T-SPOT. TB results and dual positive results compared with the risk for individuals with negative results were 40.6 (95% CI 2.1-767.9), 73.9 (95% CI 3.9-1397.7) and 226.5 (95% CI 12.0-4284), respectively. The number needed to treat to prevent one subsequent TB case among patients with a positive TST, a positive T-SPOT. TB and dual positive results was 35, 22 and 8 respectively. Conclusions: Adopting positive results of the TST and T-SPOT. TB to screen LTBI among BCG-vaccinated HIV-infected individuals might be feasible. Number needed to treat for isoniazid preventive therapy could be reduced significantly by using dual positive strategy.	[Yang, Chin-Hui; Chan, Pei-Chun] Ctr Dis Control, Dept Hlth, Taipei, Taiwan; [Yang, Chin-Hui] Taipei Med Univ, Sch Publ Hlth, PhD Program, Taipei, Taiwan; [Yang, Chin-Hui] Taipei Med Univ, Taipei Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan; [Liao, Say-Tsung] Taipei Med Univ, Taipei Med Univ Hosp, Dept Internal Med, Div Rheumatol, Taipei, Taiwan; [Cheng, Shu-Hsing] Taoyuan Gen Hosp, Dept Internal Med, Div Infect Dis, Tao Yuan, Taiwan; [Wong, Wing-Wai] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Huang, Li-Min] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Dept Lab Med, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chiou, Hung-Yi] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan	Centers For Disease Control - Taiwan; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Chiou, HY (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.	hychiou@tmu.edu.tw	Hsueh, Po-Ren/ABE-1594-2021	Chiou, Hung Yi/0000-0002-4545-9697; HSUEH, PO-REN/0000-0002-7502-9225; HUANG, LI-MIN/0000-0002-9291-260X	Centers for Disease Control, Taiwan [DOH97-DC-1502]	Centers for Disease Control, Taiwan	This study was supported by the Centers for Disease Control, Taiwan (grant DOH97-DC-1502), to which interim progress reports were submitted. The funding body had no role in the study design, data analysis, data interpretation or writing of the report but was involved in data collection.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Black GF, 2001, J INFECT DIS, V184, P322, DOI 10.1086/322042; Chan PC, 2008, J FORMOS MED ASSOC, V107, P195, DOI 10.1016/S0929-6646(08)60137-0; Chan PC, 2013, THORAX, V68, P263, DOI 10.1136/thoraxjnl-2012-202208; Dheda K, 2005, AIDS, V19, P2038, DOI 10.1097/01.aids.0000191923.08938.5b; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Elzi L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-319; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; GUELAR A, 1993, AIDS, V7, P1345, DOI 10.1097/00002030-199310000-00007; Hawken MP, 1997, AIDS, V11, P875, DOI 10.1097/00002030-199707000-00006; Hoffmann M, 2007, AIDS, V21, P390, DOI 10.1097/QAD.0b013e328012164b; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Jiang WM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-31; Jonnalagadda S, 2010, J INFECT DIS, V202, P1826, DOI 10.1086/657411; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509; Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Leidl L, 2010, EUR RESPIR J, V35, P619, DOI 10.1183/09031936.00045509; Lo HY, 2011, J FORMOS MED ASSOC, V110, P501, DOI 10.1016/S0929-6646(11)60076-4; Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; National Institute of Health and Clinical Excellence, 2011, NEW NICE GUID UPD RE; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Sun HY, 2006, JPN J INFECT DIS, V59, P311; Sun HY, 2009, AM J GASTROENTEROL, V104, P877, DOI 10.1038/ajg.2008.159; Taiwan Centers for Disease Control, 2010, GUID DIAGN TREATM HI; Taiwan Centers for Disease Control, 2011, TAIW GUID TB DIAGN T; Taiwan Centers for Disease Control, 2013, TAIW HIV AIDS MONTHL; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; World Health Organization, 2011, US TUB INT GAMM REL; Yang CH, 2008, INT J DRUG POLICY, V19, P317, DOI 10.1016/j.drugpo.2006.11.016	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73069	10.1371/journal.pone.0073069	http://dx.doi.org/10.1371/journal.pone.0073069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015285	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200064
J	Rosell, A; Morancho, A; Navarro-Sobrino, M; Martinez-Saez, E; Hernandez-Guillamon, M; Lope-Piedrafita, S; Barcelo, V; Borras, F; Penalba, A; Garcia-Bonilla, L; Montaner, J				Rosell, Anna; Morancho, Anna; Navarro-Sobrino, Miriam; Martinez-Saez, Elena; Hernandez-Guillamon, Mar; Lope-Piedrafita, Silvia; Barcelo, Veronica; Borras, Francesc; Penalba, Anna; Garcia-Bonilla, Lidia; Montaner, Joan			Factors Secreted by Endothelial Progenitor Cells Enhance Neurorepair Responses after Cerebral Ischemia in Mice	PLOS ONE			English	Article							STEM-CELLS; STROKE; NEUROGENESIS; ANGIOGENESIS; INJURY; TRANSPLANTATION	Cell therapy with endothelial progenitor cells (EPCs) has emerged as a promising strategy to regenerate the brain after stroke. Here, we aimed to investigate if treatment with EPCs or their secreted factors could potentiate angiogenesis and neurogenesis after permanent focal cerebral ischemia in a mouse model of ischemic stroke. BALB/C male mice were subjected to distal occlusion of the middle cerebral artery, and EPCs, cell-free conditioned media (CM) obtained from EPCs, or vehicle media were administered one day after ischemia. Magnetic resonance imaging (MRI) was performed at baseline to confirm that the lesions were similar between groups. Immunohistochemical and histological evaluation of the brain was performed to evaluate angio-neurogenesis and neurological outcome at two weeks. CM contained growth factors, such as VEGF, FGF-b and PDGF-bb. A significant increase in capillary density was noted in the peri-infarct areas of EPC- and CM-treated animals. Bielschowsky's staining revealed a significant increase in axonal rewiring in EPC-treated animals compared with shams, but not in CM-treated mice, in close proximity with DCX-positive migrating neuroblasts. At the functional level, post-ischemia forelimb strength was significantly improved in animals receiving EPCs or CM, but not in those receiving vehicle media. In conclusion, we demonstrate for the first time that the administration of EPC-secreted factors could become a safe and effective cell-free option to be considered in future therapeutic strategies for stroke.	[Rosell, Anna; Morancho, Anna; Navarro-Sobrino, Miriam; Hernandez-Guillamon, Mar; Barcelo, Veronica; Penalba, Anna; Garcia-Bonilla, Lidia; Montaner, Joan] Univ Autonoma Barcelona, Neurovasc Res Lab, Dept Neurol, Vall dHebron Res Inst, E-08193 Barcelona, Catalonia, Spain; [Rosell, Anna; Morancho, Anna; Navarro-Sobrino, Miriam; Hernandez-Guillamon, Mar; Barcelo, Veronica; Penalba, Anna; Garcia-Bonilla, Lidia; Montaner, Joan] Univ Autonoma Barcelona, Dept Internal Med, Vall dHebron Res Inst, E-08193 Barcelona, Catalonia, Spain; [Martinez-Saez, Elena; Borras, Francesc] Hosp Valle De Hebron, Dept Pathol, Neuropathol Unit, Barcelona, Catalonia, Spain; [Lope-Piedrafita, Silvia] Univ Autonoma Barcelona, Serv RMN, Cerdanyola Del Valles, Catalonia, Spain; [Lope-Piedrafita, Silvia] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Cerdanyola Del Valles, Catalonia, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Rosell, A (corresponding author), Univ Autonoma Barcelona, Neurovasc Res Lab, Dept Neurol, Vall dHebron Res Inst, E-08193 Barcelona, Catalonia, Spain.	anna.rosell@vhir.org	Lope-Piedrafita, Silvia/I-4808-2012; Montaner, Joan/D-3063-2015; Borràs, Francesc E/P-2287-2017; Retana, Anna Morancho/K-8804-2014; Martinez-Saez, Elena/E-9097-2018	Lope-Piedrafita, Silvia/0000-0002-8127-6425; Montaner, Joan/0000-0003-4845-2279; Borràs, Francesc E/0000-0003-4038-1912; Retana, Anna Morancho/0000-0001-9059-3206; Martinez-Saez, Elena/0000-0001-6004-5364; Hernandez Guillamon, Maria Mar/0000-0001-8844-0091; Rosell Novel, Anna/0000-0003-1082-3599	Miguel Servetprogramme from the Spanish Ministry of Health (Instituto de Salud Carlos III) [CP09/00265]; Spanish Ministry of Health (Instituto de Salud Carlos III); Fondo de InvestigacionesSanitarias [PI10/00694]; Spanish stroke research network RENEVAS [RD06/0026/0010]; EUROSALUD programme (MICCIN); European Union [201024, 202213]	Miguel Servetprogramme from the Spanish Ministry of Health (Instituto de Salud Carlos III); Spanish Ministry of Health (Instituto de Salud Carlos III)(Instituto de Salud Carlos IIISpanish Government); Fondo de InvestigacionesSanitarias(Instituto de Salud Carlos III); Spanish stroke research network RENEVAS; EUROSALUD programme (MICCIN); European Union(European Commission)	AR is supported by the Miguel Servetprogramme (CP09/00265) from the Spanish Ministry of Health (Instituto de Salud Carlos III). LGB holds a Sara Borrell grant, and EMS holds a Rio Ortega grant from the Spanish Ministry of Health (Instituto de Salud Carlos III). This work has been supported by research grants from the Fondo de InvestigacionesSanitarias (PI10/00694), the Spanish stroke research network RENEVAS (RD06/0026/0010) and EUROSALUD programme (MICCIN). The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement numbers 201024 and 202213 (European Stroke Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Battistella V, 2011, REGEN MED, V6, P45, DOI 10.2217/RME.10.97; Carmichael ST, 2008, STROKE, V39, P1380, DOI 10.1161/STROKEAHA.107.499962; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Guo QM, 2009, BRAIN RES, V1279, P121, DOI 10.1016/j.brainres.2009.04.055; Hayakawa K, 2012, P NATL ACAD SCI USA, V109, P7505, DOI 10.1073/pnas.1121146109; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Kim JY, 2010, CELL TRANSPLANT, V19, P1635, DOI 10.3727/096368910X516637; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Lodi D, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-9; Molina CA, 2011, STROKE, V42, pS16, DOI 10.1161/STROKEAHA.110.598763; Moniche F, 2012, STROKE, V43, P2242, DOI 10.1161/STROKEAHA.112.659409; Morancho A, 2012, NEUROPATH APPL NEURO, V38, P617, DOI 10.1111/j.1365-2990.2012.01252.x; Moubarik C, 2011, STEM CELL REV REP, V7, P208, DOI 10.1007/s12015-010-9157-y; Navarro-Sobrino M, 2010, MICROVASC RES, V80, P317, DOI 10.1016/j.mvr.2010.05.008; Ohab JJ, 2008, NEUROSCIENTIST, V14, P369, DOI 10.1177/1073858407309545; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ohta T, 2006, NEUROSURGERY, V59, P679, DOI 10.1227/01.NEU.0000229058.08706.88; Pepper MS, 1997, ARTERIOSCL THROM VAS, V17, P605, DOI 10.1161/01.ATV.17.4.605; Rosell A, 2013, TRANSL STROKE RES, V4, P297, DOI 10.1007/s12975-012-0234-1; Rosell A, 2009, J CEREBR BLOOD F MET, V29, P933, DOI 10.1038/jcbfm.2009.17; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shimamura M, 2004, CIRCULATION, V109, P424, DOI 10.1161/01.CIR.0000109496.82683.49; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Ward NL, 2007, J APPL PHYSIOL, V102, P1927, DOI 10.1152/japplphysiol.00909.2006; Yan R, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13314; Yanamoto H, 1996, BRAIN RES, V718, P207, DOI 10.1016/0006-8993(96)00122-9; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	35	79	82	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73244	10.1371/journal.pone.0073244	http://dx.doi.org/10.1371/journal.pone.0073244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023842	Green Submitted, gold, Green Published			2022-12-27	WOS:000324515600083
J	Bennett, SE; McPeake, J; McCance, DR; Manderson, JG; Johnston, P; McGalliard, R; McGinty, A				Bennett, Sarah E.; McPeake, Jennifer; McCance, David R.; Manderson, John G.; Johnston, Philip; McGalliard, Rachel; McGinty, Ann			Maternal Vitamin D Status in Type 1 Diabetic Pregnancy: Impact on Neonatal Vitamin D Status and Association with Maternal Glycaemic Control	PLOS ONE			English	Article							D SUPPLEMENTATION; INSULIN-RESISTANCE; CORD BLOOD; SERUM; MELLITUS; CHILDREN; OBESITY; WEIGHT	Objective: The first aim of this study was to assess 25-hydroxy vitamin D (25OHD) concentrations in women with type 1 diabetes (T1DM) during pregnancy, post-delivery and also foetal (cord blood) 25OHD concentrations and to examine relationships between these. The second aim of the study was to investigate potential interactions between maternal body mass index (BMI) and foetal vitamin D status. A further study aim was to examine potential relationships between maternal 25OHD and glycosylated haemoglobin (HbA(1c)) throughout pregnancy. Research Design and Methods: This was an observational study of 52 pregnant controls without diabetes and 65 pregnant women with T1DM in a university teaching hospital. Maternal serum 25OHD was measured serially throughout the pregnancy and post-delivery. Cord blood 25OHD was measured at delivery. 25OHD was measured by liquid chromatography tandem mass spectrometry (LC-MS/MS). Results: Vitamin D deficiency (25OHD <25 nmol/L) was apparent in both the T1DM subjects and controls at all 3 pregnancy trimesters. Vitamin D levels in all cord blood were <50 nmol/L. Maternal 25OHD correlated positively with cord 25OHD at all 3 trimesters in the T1DM group (p = 0.02; p<0.001; p<0.001). 25OHD levels within cord blood were significantly lower for women with diabetes classified as obese vs. normal weight at booking [normal weight BMI <25 kg/m(2) vs. obese BMI >30 kg/m(2) (nmol/L +/- SD); 19.93 +/- 11.15 vs. 13.73 +/- 4.74, p = 0.026]. In the T1DM group, HbA(1c) at booking was significantly negatively correlated with maternal 25OHD at all 3 trimesters (p = 0.004; p = 0.001; p = 0.05). Conclusion: In T1DM pregnancy, low vitamin D levels persist throughout gestation and post-delivery. Cord blood vitamin D levels correlate with those of the mother, and are significantly lower in obese women than in their normal weight counterparts. Maternal vitamin D levels exhibit a significant negative relationship with HbA1c levels, supporting a potential role for this vitamin in maintaining glycaemic control.	[Bennett, Sarah E.; McPeake, Jennifer; Johnston, Philip; McGalliard, Rachel; McGinty, Ann] Queens Univ Belfast, Nutr & Metab Grp, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [McCance, David R.; Manderson, John G.; Johnston, Philip] Royal Victoria Hosp, Reg Ctr Endocrinol & Diabet, Belfast BT12 6BA, Antrim, North Ireland	Queens University Belfast	McGinty, A (corresponding author), Queens Univ Belfast, Nutr & Metab Grp, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	a.mcginty@qub.ac.uk						Aghajafari F., 2013, BMJ-BRIT MED J, V346, DOI [DOI 10.1136/BMJ.F1169, 10.1136/bmj.f1169]; Aljabri KS, 2010, ANN SAUDI MED, V30, P454, DOI 10.4103/0256-4947.72265; Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385; [Anonymous], 2013, BMJ, V346, pf1926, DOI 10.1136/bmj.f1926; Azar M, 2011, DIABETES CARE, V34, P1258, DOI 10.2337/dc10-2145; Bodnar LM, 2007, J NUTR, V137, P2437, DOI 10.1093/jn/137.11.2437; Brannon PM, 2011, ANNU REV NUTR, V31, P89, DOI 10.1146/annurev.nutr.012809.104807; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1368, DOI 10.1111/aogs.12006; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1357, DOI 10.1111/aogs.12000; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; DAVEY DA, 1988, AM J OBSTET GYNECOL, V158, P892, DOI 10.1016/0002-9378(88)90090-7; Department of Health, 2012, VIT D ADV SUPPL RISK; Dixon Brian M, 2012, BMC Res Notes, V5, P575, DOI 10.1186/1756-0500-5-575; George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Greenbaum CJ, 2002, DIABETES-METAB RES, V18, P192, DOI 10.1002/dmrr.291; Hearty RT, 2000, ULSTER MED J, V69, P35; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2010, ENDOCRIN METAB CLIN, V39, P381, DOI [10.1016/j.rdc.2012.03.013, 10.1016/j.ecl.2010.02.016]; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Josefson JL, 2013, J CLIN ENDOCR METAB, V98, P114, DOI 10.1210/jc.2012-2882; Lawlor DA, 2013, LANCET, V381, P2176, DOI 10.1016/S0140-6736(12)62203-X; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Magon N, 2012, N AM J MED SCI, V4, P250, DOI 10.4103/1947-2714.97202; Manderson JG, 2003, AM J OBSTET GYNECOL, V188, P1326, DOI 10.1067/mob.2003.276; MARKESTAD T, 1984, AM J CLIN NUTR, V40, P1057, DOI 10.1093/ajcn/40.5.1057; Munns CF, 2012, MED J AUSTRALIA, V196, P466, DOI 10.5694/mja11.10662; Parker J, 2010, MATURITAS, V65, P225, DOI 10.1016/j.maturitas.2009.12.013; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Salle BL, 2000, AM J CLIN NUTR, V71, p1317S, DOI 10.1093/ajcn/71.5.1317s; Schwalfenberg G, 2008, CAN FAM PHYSICIAN, V54, P864; Scientific Advisory Committee on Nutrition (SACN), 2011, UPD VIT D; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Vimaleswaran Karani S, 2013, PLoS Med, V10, pe1001383, DOI 10.1371/journal.pmed.1001383; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74068	10.1371/journal.pone.0074068	http://dx.doi.org/10.1371/journal.pone.0074068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019947	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200090
J	Kuling, IA; Brenner, E; Smeets, JBJ				Kuling, Irene A.; Brenner, Eli; Smeets, Jeroen B. J.			Proprioception Is Robust under External Forces	PLOS ONE			English	Article							VISUAL POSITION-INFORMATION; SENSORY INTEGRATION; MOTOR; PERCEPTION; MOVEMENTS; MODEL; TASK	Information from cutaneous, muscle and joint receptors is combined with efferent information to create a reliable percept of the configuration of our body (proprioception). We exposed the hand to several horizontal force fields to examine whether external forces influence this percept. In an end-point task subjects reached visually presented positions with their unseen hand. In a vector reproduction task, subjects had to judge a distance and direction visually and reproduce the corresponding vector by moving the unseen hand. We found systematic individual errors in the reproduction of the end-points and vectors, but these errors did not vary systematically with the force fields. This suggests that human proprioception accounts for external forces applied to the hand when sensing the position of the hand in the horizontal plane.	[Kuling, Irene A.; Brenner, Eli; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Kuling, IA (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands.	i.a.kuling@vu.nl	Kuling, Irene/ABC-4022-2021; Smeets, Jeroen/B-4198-2008	Kuling, Irene/0000-0003-3556-0393; Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843	Dutch Technology Foundation STW, part of the Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs, Agriculture and Innovation; STW [12160]	Dutch Technology Foundation STW, part of the Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs, Agriculture and Innovation; STW(Technologiestichting STW)	This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs, Agriculture and Innovation. STW grant 12160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boessenkool H, 2013, IEEE T HAPTICS, V6, P2, DOI [10.1109/ToH.2012.22, 10.1109/TOH.2012.22]; CORDO PJ, 1989, TRENDS NEUROSCI, V12, P110, DOI 10.1016/0166-2236(89)90167-7; de Grave DDJ, 2004, EXP BRAIN RES, V155, P56, DOI 10.1007/s00221-003-1708-x; Debats NB, 2010, LECT NOTES COMPUT SC, V6192, P392, DOI 10.1007/978-3-642-14075-4_58; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; Hudson TE, 2012, J NEUROPHYSIOL, V108, P2708, DOI 10.1152/jn.00355.2012; Kistemaker DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019568; Maij F, 2011, EXP BRAIN RES, V213, P223, DOI 10.1007/s00221-011-2680-5; MATTHEWS PB, 1964, PHYSIOL REV, V44, P219, DOI 10.1152/physrev.1964.44.2.219; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; Mulder M, 2012, J HUM FACTORS ERGON, V54, P681, DOI [10.1177/0018720812461374, DOI 10.1177/0018720812461374]; Mulder M, 2012, COGN TECHNOL WORK, V14, P1, DOI [10.1007/s10111-011-0197-0, DOI 10.1007/S10111-011-0197-0]; POLIT A, 1978, SCIENCE, V201, P1235, DOI 10.1126/science.99813; Reuschel J, 2010, EXP BRAIN RES, V201, P853, DOI 10.1007/s00221-009-2099-4; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Smith JL, 2009, J APPL PHYSIOL, V106, P950, DOI 10.1152/japplphysiol.91365.2008; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Sousa R, 2010, VISION RES, V50, P1786, DOI 10.1016/j.visres.2010.05.035; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van Beers RJ, 2011, J VISION, V11, DOI 10.1167/11.10.20; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851; YOUNG MJ, 1993, VISION RES, V33, P2685, DOI 10.1016/0042-6989(93)90228-O	28	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74236	10.1371/journal.pone.0074236	http://dx.doi.org/10.1371/journal.pone.0074236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019959	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200102
J	Leonetti, D; Reimund, JM; Tesse, A; Viennot, S; Martinez, MC; Bretagne, AL; Andriantsitohaina, R				Leonetti, Daniela; Reimund, Jean-Marie; Tesse, Angela; Viennot, Stephanie; Martinez, Maria Carmen; Bretagne, Anne-Laure; Andriantsitohaina, Ramaroson			Circulating Microparticles from Crohn's Disease Patients Cause Endothelial and Vascular Dysfunctions	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SHED MEMBRANE MICROPARTICLES; INCREASED THROMBIN GENERATION; MESENTERIC-ARTERIES; HYPOREACTIVITY; ANGIOGENESIS; FIBRINOLYSIS; PATHOGENESIS	Background: Microparticles (MPs) are small vesicles released during cell activation or apoptosis. They are involved in coagulation, inflammation and vascular dysfunction in several diseases. We characterized circulating MPs from Crohn's Disease (CD) patients and evaluated their effects on endothelial function and vascular reactivity after in vivo injection into mice. Methods: Circulating MPs and their cellular origins were examined by flow cytometry from blood samples from healthy subjects (HS) and inactive or active CD patients. MPs were intravenously injected into mice. After 24 hours, endothelial function and vascular reactivity were assessed. Results: Circulating MP levels did not differ between HS and inactive CD patients except for an increase in leukocyte-derived MPs in CD. Active CD patients compared to HS displayed increased total circulating MPs, pro-coagulant MPs and those from platelets, endothelium, erythrocytes, leukocytes, activated leukocytes and activated platelets. A significant correlation was found between total levels of MPs, those from platelets and endothelial cells, and the Harvey-Bradshaw clinical activity index. MPs from CD, but not from HS, impaired endothelium-dependent relaxation in mice aorta and flow-induced dilation in mice small mesenteric arteries, MPs from inactive CD patients being more effective than those from active patients. CDMPs induced vascular hypo-reactivity in aorta that was prevented by a nitric oxide (NO)-synthase inhibitor, and was associated with a subtle alteration of the balance between NO, reactive oxygen species and the release of COX metabolites. Conclusions: We provide evidence that MPs from CD patients significantly alter endothelial and vascular function and therefore, may play a role in CD pathophysiology, at least by contributing to uncontrolled vascular-dependent intestinal damage.	[Leonetti, Daniela; Tesse, Angela; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson] LUNAM Univ, Angers, France; [Leonetti, Daniela; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson] INSERM, U1063, Angers, France; [Reimund, Jean-Marie] Univ Caen Basse Normandie, UFR Med, SF ICORE 4206, Lab Microenvironm Cellulaire & Pathol,EA 4652, Caen, France; [Reimund, Jean-Marie; Viennot, Stephanie; Bretagne, Anne-Laure] CHU Caen, Serv Hepatogastroenterol & Nutr, Pole Med Organes & Cancerol, F-14000 Caen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Andriantsitohaina, R (corresponding author), LUNAM Univ, Angers, France.	ramaroson.andriantsitohaina@univ-angers.fr	Tesse, Angela/D-4803-2015; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018	Tesse, Angela/0000-0002-2153-4357; Martinez, M Carmen/0000-0003-3897-7397; andriantsitohaina, ramaroson/0000-0002-4770-3585	Association Francois Aupetit, Ferring France Laboratories (Paris, France); Fondation DigestScience (Lille, France); Programme Hospitalier de Recherche Clinique (PHRC) from inter-region universitaire Nord Ouest, France; "Contrat d'Interface" INSERM; Centre Hospitalier Universitaire d'Angers; Institut de Recherche des Maladies de l'Appareil Digestif (IRMAD); AstraZeneca France Laboratories	Association Francois Aupetit, Ferring France Laboratories (Paris, France); Fondation DigestScience (Lille, France); Programme Hospitalier de Recherche Clinique (PHRC) from inter-region universitaire Nord Ouest, France; "Contrat d'Interface" INSERM; Centre Hospitalier Universitaire d'Angers; Institut de Recherche des Maladies de l'Appareil Digestif (IRMAD); AstraZeneca France Laboratories	This work was supported by grants from the Association Francois Aupetit, Ferring France Laboratories (Paris, France), the Fondation DigestScience (Lille, France), and by a Programme Hospitalier de Recherche Clinique (PHRC) from inter-region universitaire Nord Ouest, France, all attributed to JMR. RA was supported by a "Contrat d'Interface" INSERM. LD was supported by Centre Hospitalier Universitaire d'Angers. ALB was supported by a research grant from the Institut de Recherche des Maladies de l'Appareil Digestif (IRMAD, sponsored by AstraZeneca France Laboratories). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Agouni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027809; Andoh A, 2005, AM J GASTROENTEROL, V100, P2042, DOI 10.1111/j.1572-0241.2005.50381.x; Andriantsitohaina R, 2012, TRENDS CARDIOVAS MED, V22, P88, DOI 10.1016/j.tcm.2012.07.001; Anthony A, 1997, J CLIN PATHOL, V50, P1013, DOI 10.1136/jcp.50.12.1013; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Chamouard P, 2005, DIGEST DIS SCI, V50, P574, DOI 10.1007/s10620-005-2477-0; Chirinos JA, 2005, J AM COLL CARDIOL, V45, P1467, DOI 10.1016/j.jacc.2004.12.075; Cleynen I, 2013, GUT, V62, P1556, DOI 10.1136/gutjnl-2011-300777; Deutschmann A, 2013, J PEDIATR GASTR NUTR, V56, P401, DOI 10.1097/MPG.0b013e31827daf72; Diehl P, 2011, J THROMB THROMBOLYS, V31, P173, DOI 10.1007/s11239-010-0507-z; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; HARVEY RF, 1980, LANCET, V1, P514; Hatoum OA, 2005, INFLAMM BOWEL DIS, V11, P304, DOI 10.1097/01.MIB.0000160772.78951.61; Hatoum OA, 2003, GASTROENTEROLOGY, V125, P58, DOI 10.1016/S0016-5085(03)00699-1; Koutroubakis IE, 2008, EUR J GASTROEN HEPAT, V20, P912, DOI 10.1097/MEG.0b013e3282faa759; Lebuffe G, 2000, ALIMENT PHARM THER, V14, P1279, DOI 10.1046/j.1365-2036.2000.00838.x; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Leroyer AS, 2010, THROMB HAEMOSTASIS, V104, P456, DOI 10.1160/TH10-02-0111; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; Martinez MC, 2011, CIRC RES, V109, P110, DOI 10.1161/CIRCRESAHA.110.233049; Martinez MC, 2011, TRENDS PHARMACOL SCI, V32, P659, DOI 10.1016/j.tips.2011.06.005; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Meziani F, 2006, AM J PATHOL, V169, P1473, DOI 10.2353/ajpath.2006.051304; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Owczarek D, 2010, INFLAMM BOWEL DIS, V16, P52, DOI 10.1002/ibd.20994; Palkovits J, 2013, J CROHNS COLITIS, V7, P222, DOI 10.1016/j.crohns.2012.05.016; Papa A, 2008, DIGEST DIS, V26, P149, DOI 10.1159/000116773; Priou P, 2010, AM J PATHOL, V177, P974, DOI 10.2353/ajpath.2010.091252; Reimund JM, 1996, GUT, V39, P684, DOI 10.1136/gut.39.5.684; Roifman I, 2009, CLIN GASTROENTEROL H, V7, P175, DOI 10.1016/j.cgh.2008.10.021; Sabatier F, 2002, DIABETES, V51, P2840, DOI 10.2337/diabetes.51.9.2840; Saibeni S, 2010, THROMB RES, V125, P278, DOI 10.1016/j.thromres.2009.10.012; SANKEY EA, 1993, GUT, V34, P375, DOI 10.1136/gut.34.3.375; Shen J, 2009, THROMB RES, V123, P604, DOI 10.1016/j.thromres.2008.04.004; Tabernero A, 2003, CIRCULATION, V107, P1407, DOI 10.1161/01.CIR.0000055321.13957.17; Tesse A, 2005, ARTERIOSCL THROM VAS, V25, P2522, DOI 10.1161/01.ATV.0000189298.62240.5d; Tesse A, 2007, AM J PHYSIOL-HEART C, V293, pH520, DOI 10.1152/ajpheart.01094.2006; Tual-Chalot S, 2011, MOL INTERV, V11, P88, DOI 10.1124/mi.11.2.5; WAKEFIELD AJ, 1991, GASTROENTEROLOGY, V100, P1279	44	30	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73088	10.1371/journal.pone.0073088	http://dx.doi.org/10.1371/journal.pone.0073088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019899	Green Published, gold			2022-12-27	WOS:000324338200041
J	Rozwadowska, N; Kolanowski, T; Wiland, E; Siatkowski, M; Pawlak, P; Malcher, A; Mietkiewski, T; Olszewska, M; Kurpisz, M				Rozwadowska, Natalia; Kolanowski, Tomasz; Wiland, Ewa; Siatkowski, Marcin; Pawlak, Piotr; Malcher, Agnieszka; Mietkiewski, Tomasz; Olszewska, Marta; Kurpisz, Maciej			Characterisation of Nuclear Architectural Alterations during In Vitro Differentiation of Human Stem Cells of Myogenic Origin	PLOS ONE			English	Article							HUMAN TRANSCRIPTOME MAP; EXPRESSED GENES; MUSCLE; MYOBLASTS; CHROMOSOMES; PLASTICITY; THERAPY; DOMAINS	Cell differentiation is based on a synchronised orchestra of complex pathways of intrinsic and extrinsic signals that manifest in the induced expression of specific transcription factors and pivotal genes within the nucleus. One cannot ignore the epigenetic status of differentiating cells, comprising not only histones and DNA modifications but also the spatial and temporal intranuclear chromatin organisation, which is an important regulator of nuclear processes. In the present study, we investigated the nuclear architecture of human primary myoblasts and myocytes in an in vitro culture, with reference to global changes in genomic expression. Repositioning of the chromosomal centromeres, along with alterations in the nuclear shape and volume, was observed as a consequence of myotube formation. Moreover, the microarray data showed that during in vitro myogenesis cells tend to silence rather than induce gene expression. The creation of a chromosome map marked with gene expression changes that were at least 2-fold confirmed the observation. Additionally, almost all of the chromosomal centromeres in the differentiated cells preferentially localised near the nuclear periphery when compared to the undifferentiated cells. The exceptions were chromosomes 7 and 11, in which we were unable to confirm the centromere repositioning. In our opinion, this is the first reported observation of the movement of chromosomal centromeres along differentiating myogenic cells. Based on these data we can conclude that the myogenic differentiation with global gene expression changes is accompanied by the spatial repositioning of chromosomes and chromatin remodelling, which are important processes that regulate cell differentiation.	[Rozwadowska, Natalia; Kolanowski, Tomasz; Wiland, Ewa; Malcher, Agnieszka; Olszewska, Marta; Kurpisz, Maciej] Polish Acad Sci, Inst Human Genet, Dept Reprod Biol & Stem Cells, PL-60479 Poznan, Poland; [Siatkowski, Marcin] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Fac Med, D-18055 Rostock, Germany; [Pawlak, Piotr] Poznan Univ Life Sci, Fac Anim Breeding Biol, Poznan, Poland; [Mietkiewski, Tomasz] Dist Hosp Wielkopolska, Traumatol & Orthopaed Dept, Poznan, Poland; [Siatkowski, Marcin] German Ctr Neurodegenerat Dis, Rostock, Germany	Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; University of Rostock; Poznan University of Life Sciences; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kurpisz, M (corresponding author), Polish Acad Sci, Inst Human Genet, Dept Reprod Biol & Stem Cells, PL-60479 Poznan, Poland.	kurpimac@man.poznan.pl	Olszewska, Marta/ABD-3226-2020; Pawlak, Piotr/AAX-7094-2020	Olszewska, Marta/0000-0002-2337-4545; Pawlak, Piotr/0000-0003-3489-1684; Rozwadowska, Natalia/0000-0002-5111-0870; Malcher, Agnieszka/0000-0002-3433-6990; Kurpisz, Maciej/0000-0003-3275-3245; Kolanowski, Tomasz Jan/0000-0003-3898-8272; Wiland, Ewa/0000-0003-0143-4516	Ministry of Science [NN 401 097937, R13 006506]	Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea)	A study was supported by Ministry of Science, No NN 401 097937, R13 006506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Bartova E, 2008, DEV DYNAM, V237, P3690, DOI 10.1002/dvdy.21773; Bigot A, 2008, BIOL CELL, V100, P189, DOI 10.1042/BC20070085; Bin Sun H, 2000, BIOPHYS J, V79, P184, DOI 10.1016/S0006-3495(00)76282-5; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chaly N, 1996, EXP CELL RES, V223, P274, DOI 10.1006/excr.1996.0082; Dilworth FJ, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt59; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Grefte S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/055004; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; Ichinoseki-Sekine N, 2012, BIOCHEM BIOPH RES CO, V419, P401, DOI 10.1016/j.bbrc.2012.02.034; Kociucka B, 2012, CYTOGENET GENOME RES, V136, P295, DOI 10.1159/000338255; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lin CS, 2012, STEM CELLS DEV, V21, P834, DOI 10.1089/scd.2011.0621; Meng JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017454; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikolajczak B, 2009, FOLIA HISTOCHEM CYTO, V47, P377, DOI 10.2478/v10042-009-0037-8; Portilho DM, 2012, EUR J PHARMACOL, V694, P1, DOI 10.1016/j.ejphar.2012.07.035; Scharner J, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-28; Seidel M, 2009, CELL TRANSPLANT, V18, P695, DOI 10.3727/096368909X470810; Stejskal S, 2010, EPIGENETICS-US, V5, P758, DOI 10.4161/epi.5.8.13183; Szczerbal I, 2009, CHROMOSOMA, V118, P647, DOI 10.1007/s00412-009-0225-5; Tedesco FS, 2012, CURR OPIN NEUROL, V25, P597, DOI 10.1097/WCO.0b013e328357f288; Terranova R, 2005, EXP CELL RES, V310, P344, DOI 10.1016/j.yexcr.2005.07.031; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Watanabe TM, 2012, BIOCHEM BIOPH RES CO, V418, P742, DOI 10.1016/j.bbrc.2012.01.091	30	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73231	10.1371/journal.pone.0073231	http://dx.doi.org/10.1371/journal.pone.0073231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019912	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200054
J	Shuai, L; Gong, T; Wu, YC				Shuai, Lan; Gong, Tao; Wu, Yicheng			Who Is Who? Interpretation of Multiple Occurrences of the Chinese Reflexive: Evidence from Real-Time Sentence Processing	PLOS ONE			English	Article							BINDING; ZIJI	Theoretical linguists claim that the notorious reflexive ziji 'self' in Mandarin Chinese, if occurring more than once in a single sentence, can take distinct antecedents. This study tackles possibly the most interesting puzzle in the linguistic literature, investigating how two occurrences of ziji in a single sentence are interpreted and whether or not there are mixed readings, i.e., these zijis are interpretively bound by distinct antecedents. Using 15 Chinese sentences each having two zijis, we conducted two sentence reading experiments based on a modified self-paced reading paradigm. The general interpretation patterns observed showed that the majority of participants associated both zijis with the same local antecedent, which was consistent with Principle A of the Standard Binding Theory and previous experimental findings involving a single ziji. In addition, mixed readings also occurred, but did not pattern as claimed in the theoretical linguistic literature (i.e., one ziji is bound by a long-distance antecedent and the other by a local antecedent). Based on these results, we argue that: (i) mixed readings were due to manifold, interlocking and conflicting perspectives taken by the participants; and (ii) cases of multiple occurrences of ziji taking distinct antecedents are illicit in Chinese syntax, since the speaker, when expressing a sentence, can select only one P(erspective)-Center that referentially denotes the psychological perspective in which the sentence is situated.	[Shuai, Lan] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MA USA; [Gong, Tao] Univ Hong Kong, Dept Linguist, Hong Kong, Hong Kong, Peoples R China; [Wu, Yicheng] Zhejiang Univ, Ctr Study Language & Cognit, Hangzhou 310003, Zhejiang, Peoples R China	Johns Hopkins University; University of Hong Kong; Zhejiang University	Wu, YC (corresponding author), Zhejiang Univ, Ctr Study Language & Cognit, Hangzhou 310003, Zhejiang, Peoples R China.	wuyicheng@zju.edu.cn	Tao, Gong/H-9685-2014		University of Hong Kong; Chinese Ministry of Education [12YJA740079]; National Social Science Fund [12BYY091]	University of Hong Kong(University of Hong Kong); Chinese Ministry of Education(Ministry of Education, China); National Social Science Fund	The work was supported by the Seed Fund for Basic Research from the University of Hong Kong, the Humanities and Social Sciences Fund of Chinese Ministry of Education (No.12YJA740079), and the National Social Science Fund (No.12BYY091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand Pranav, 2006, THESIS MIT; BATTISTELLA E, 1990, LINGUISTICS, V28, P205, DOI 10.1515/ling.1990.28.2.205; Chen E, 2005, J MEM LANG, V52, P144, DOI 10.1016/j.jml.2004.10.001; Chen P., 1992, RES CHINESE LINGUIST, P1; Chomsky Noam, 1981, LECT GOVT BINDING; Gao L., 2005, LING SCI, V2, P39, DOI [10.1037/a0015251, DOI 10.1037/A0015251]; Grodner D, 2005, COGNITIVE SCI, V29, P261, DOI 10.1207/s15516709cog0000_7; Hellan L., 1991, LONG DISTANCE ANAPHO, P27; Hsiao F, 2003, COGNITION, V90, P3, DOI 10.1016/S0010-0277(03)00124-0; Huang CTJ, 2001, SYNTAX SEMANTICS, V33, P141; Huang J, 2009, SYNTAX SEMANTICS; Huang James, 1982, THESIS MIT; HUANG Y, 1991, J LINGUIST, V27, P301, DOI 10.1017/S0022226700012706; Huang Y., 1994, SYNTAX PRAGMATICS AN; Huang Yan, 2000, ANAPHORA CROSS LINGU; LEVINSON SC, 1991, J LINGUIST, V27, P107, DOI 10.1017/S0022226700012433; Li XQ, 2010, BRAIN RES, V1331, P96, DOI 10.1016/j.brainres.2010.03.050; Liu ZJ, 2009, J CHINESE LINGUIST, V37, P1; Pan Haihua, 1997, CONSTRAINTS REFLEXIV; Pollard C, 1998, J EAST ASIAN LINGUIS, V7, P287, DOI 10.1023/A:1008388024532; Schumacher Petra B., 2011, ANAPHORA PROCESSING, V709, P119, DOI [DOI 10.1007/978-3-642-25917-3_11, 10.1007/978-3-642-25917-3, DOI 10.1007/978-3-642-25917-3]; SELLS P, 1987, LINGUIST INQ, V18, P445; Wang J.-L., 1984, P 1 HARB C GEN GRAMM, P100; XU LJ, 1994, J CHINESE LINGUIST, V22, P115; XU LJ, 1993, J CHINESE LINGUIST, V21, P123; Xue P, 2002, J LINGUIST, V38, P71, DOI 10.1017/S0022226701001244	26	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73226	10.1371/journal.pone.0073226	http://dx.doi.org/10.1371/journal.pone.0073226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	217DY	24019911	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200053
J	Strobel, S; Roswag, A; Becker, NI; Trenczek, TE; Encarnacao, JA				Strobel, Sara; Roswag, Anna; Becker, Nina I.; Trenczek, Tina E.; Encarnacao, Jorge A.			Insectivorous Bats Digest Chitin in the Stomach Using Acidic Mammalian Chitinase	PLOS ONE			English	Article							MOUSE; EXPRESSION; EVOLUTION; LYSOZYME; MYOTIS; TRACT	The gastrointestinal tract of animals is adapted to their primary source of food to optimize resource use and energy intake. Temperate bat species mainly feed on arthropods. These contain the energy-rich carbohydrate chitin, which is indigestible for the endogenous enzymes of a typical mammalian gastrointestinal tract. However, the gastrointestinal tract of bat species should be adapted to their diet and be able to digest chitin. We hypothesized that (i) European vespertilionid bat species have the digestive enzyme chitinase and that (ii) the chitinolytic activity is located in the intestine, as has been found for North American bat species. The gastrointestinal tracts of seven bat species (Pipistrellus pipistrellus, Plecotus auritus, Myotis bechsteinii, Myotis nattereri, Myotis daubentonii, Myotis myotis, and Nyctalus leisleri) were tested for chitinolytic activity by diffusion assay. Gastrointestinal tracts of P. pipistrellus, P. auritus, M. nattereri, M. myotis, and N. leisleri were examined for acidic mammalian chitinase by western blot analysis. Tissue sections of the gastrointestinal tract of P. pipistrellus were immunohistochemically analyzed to locate the acidic mammalian chitinase. Chitinolytic activity was detected in the stomachs of all bat species. Western blot analysis confirmed the acidic mammalian chitinase in stomach samples. Immunohistochemistry of the P. pipistrellus gastrointestinal tract indicated that acidic mammalian chitinase is located in the stomach chief cells at the base of the gastric glands. In conclusion, European vespertilionid bat species have acidic mammalian chitinase that is produced in the gastric glands of the stomach. Therefore, the gastrointestinal tracts of insectivorous bat species evolved an enzymatic adaptation to their diet.	[Strobel, Sara; Roswag, Anna; Becker, Nina I.; Encarnacao, Jorge A.] Univ Giessen, Dept Anim Ecol & Systemat, Mammalian Ecol Grp, D-35390 Giessen, Germany; [Strobel, Sara; Trenczek, Tina E.] Univ Giessen, Dept Gen Zool & Dev Biol, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Encarnacao, JA (corresponding author), Univ Giessen, Dept Anim Ecol & Systemat, Mammalian Ecol Grp, D-35390 Giessen, Germany.	J.Encarnacao@bio.uni-giessen.de	Encarnação, Jorge A./I-8644-2018	Encarnação, Jorge A./0000-0001-8766-0607				Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; Becker NI, 2012, COMP BIOCHEM PHYS A, V162, P386, DOI 10.1016/j.cbpa.2012.04.021; BERGER LR, 1957, BIOCHIM BIOPHYS ACTA, V26, P517, DOI 10.1016/0006-3002(57)90098-7; Boot RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1283, DOI 10.1369/jhc.4A6547.2005; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Buchholz R. H., 1958, Journal of Mammalogy, V39, P452, DOI 10.2307/1376175; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CASPARY WF, 1992, AM J CLIN NUTR, V55, P299, DOI 10.1093/ajcn/55.1.299s; Cohen-Kupiec R, 1998, CURR OPIN BIOTECH, V9, P270, DOI 10.1016/S0958-1669(98)80058-X; Cornelius C., 1975, Biochemical Syst Ecol, V3, P121, DOI 10.1016/0305-1978(75)90051-4; Donnelly LE, 2004, TRENDS PHARMACOL SCI, V25, P509, DOI 10.1016/j.tips.2004.08.002; Eurich K, 2009, WORLD J GASTROENTERO, V15, P5249, DOI 10.3748/wjg.15.5249; Goto M, 2003, ARCH ORAL BIOL, V48, P701, DOI 10.1016/S0003-9969(03)00150-X; HACKMAN RH, 1962, AUST J BIOL SCI, V15, P526, DOI 10.1071/BI9620526; Hutson A., 2008, PIPISTRELLUS PIPISTR; ISHIKAWA K, 1985, J ANAT, V142, P141; ITO S, 1963, J CELL BIOL, V16, P541, DOI 10.1083/jcb.16.3.541; JEUNIAUX C, 1961, NATURE, V192, P135, DOI 10.1038/192135a0; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Krykbaev R, 2010, GENE, V452, P63, DOI 10.1016/j.gene.2009.12.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NAUMOVA EI, 1984, DOKL AKAD NAUK SSSR+, V275, P1256; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Phillips CJ, 1998, EUR J MORPHOL, V36, P19; Ramirez MG, 2004, J MICROBIOL METH, V56, P213, DOI 10.1016/j.mimet.2003.10.011; Robbins C. T, 2001, WILDLIFE FEEDING NUT; Roswag A, 2012, J ZOOL, V288, P85, DOI 10.1111/j.1469-7998.2012.00927.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scillitani G, 2005, ACTA CHIROPTEROL, V7, P301, DOI 10.3161/1733-5329(2005)7[301:HAIEFA]2.0.CO;2; Scurlock H C, 1924, J Natl Med Assoc, V16, P5; Sibly R.M., 1981, P109; Simunek J, 2001, FOLIA MICROBIOL, V46, P76, DOI 10.1007/BF02825892; Speakman JR, 2003, BAT ECOLOGY, P430; Stevens CE., 1988, COMP PHYSL VERTEBRAT; Suzuki M, 2002, J HISTOCHEM CYTOCHEM, V50, P1081, DOI 10.1177/002215540205000810; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Whitaker JO, 2004, J MAMMAL, V85, P15, DOI 10.1644/1545-1542(2004)085<0015:CIIB>2.0.CO;2; Zou XH, 2002, MOL BIOTECHNOL, V22, P19, DOI 10.1385/MB:22:1:019	40	38	41	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72770	10.1371/journal.pone.0072770	http://dx.doi.org/10.1371/journal.pone.0072770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019876	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200018
J	Rafei, M; Dumont-Lagace, M; Rouette, A; Perreault, C				Rafei, Moutih; Dumont-Lagace, Maude; Rouette, Alexandre; Perreault, Claude			Interleukin-21 Accelerates Thymic Recovery from Glucocorticoid-Induced Atrophy	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; INDUCED THYMOCYTE APOPTOSIS; CENTER B-CELLS; EPITHELIAL-CELLS; METASTATIC MELANOMA; T-CELLS; PHASE-I; CYTOKINES; STRESS; BCL-6	Both physiological and psychological stress cause thymic atrophy via glucocorticoid (GC)-dependent apoptosis of double-positive (DP) thymocytes. Given the pervasiveness of stress, GC-induced thymic atrophy is arguably the most common type of acquired immunodeficiency. We recently reported that interleukin-21 (IL-21) has a unique ability to expand the small subset of DP thymocytes (CD69(+)) which are ongoing positive selection, and that administration of IL-21 increases thymic output in aged mice. The goal of this study was to evaluate whether IL-21 could mitigate GC-induced thymic atrophy. In contrast to double-negative (DN) and single-positive (SP) thymocytes, most DP thymocytes (CD69(-)) do not constitutively express the IL-21 receptor (IL-21R). Accordingly, CD69(-) DP thymocytes from PBS-treated mice were unresponsive to IL-21 administration. However, following GC injection, surviving CD69(-) DP thymocytes up-regulated IL-21R and responded to IL-21 treatment as evidenced by enhancement of Bcl6 expression and phosphorylation of STAT1, STAT3 and STAT5. Consequently, IL-21 administration to GC-treated mice accelerated thymic recovery by expanding considerably DP thymocytes and, to a lesser extent, DN thymocytes. However, IL-21-induced expansion of DN/DP thymocytes did not alter the diversity of the intrathymic or peripheral T-cell receptor (TCR) repertoire. We conclude that IL-21 dramatically accelerates recovery from GC-induced thymic atrophy.	[Rafei, Moutih] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Dumont-Lagace, Maude; Rouette, Alexandre; Perreault, Claude] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Perreault, Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Rafei, M (corresponding author), Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.	moutih.rafei@umontreal.ca	Perreault, Claude/A-7220-2008	Perreault, Claude/0000-0001-9453-7383; Dumont-Lagace, Maude/0000-0002-6452-0975	Canadian Institutes of Health Research (CIHR) [MOP 42384]; Canadian Center of Excellence in Commercialization and Research; Canada Foundation for Innovation; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Center of Excellence in Commercialization and Research; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grant MOP 42384 from the Canadian Institutes of Health Research (CIHR). Moutih Rafei holds a CIHR fellowship and Claude Perreault holds a Canada Research Chair in Immunobiology. The Institute for Research in Immunology and Cancer (IRIC) is supported in part by the Canadian Center of Excellence in Commercialization and Research, the Canada Foundation for Innovation, and the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Belkaya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027580; Billard MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017940; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Cifone MG, 1999, BLOOD, V93, P2282, DOI 10.1182/blood.V93.7.2282.407a23_2282_2296; DARDENNE M, 1986, CELL IMMUNOL, V100, P112, DOI 10.1016/0008-8749(86)90011-0; Davis ID, 2007, CLIN CANCER RES, V13, P3630, DOI 10.1158/1078-0432.CCR-07-0410; Dooley J, 2012, EUR J IMMUNOL, V42, P1073, DOI 10.1002/eji.201142305; Felmet KA, 2005, J IMMUNOL, V174, P3765, DOI 10.4049/jimmunol.174.6.3765; Frawley R, 2011, ENVIRON HEALTH PERSP, V119, P371, DOI 10.1289/ehp.1002358; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; GRODY WW, 1985, AM J CLIN PATHOL, V84, P85, DOI 10.1093/ajcp/84.1.85; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Hartman ML, 2013, CANCER LETT, V331, P24, DOI 10.1016/j.canlet.2013.01.010; Heinonen KM, 2011, BLOOD, V118, P5163, DOI 10.1182/blood-2011-04-350553; Heinonen KM, 2008, CRIT REV IMMUNOL, V28, P441, DOI 10.1615/CritRevImmunol.v28.i5.40; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Iannello A, 2010, J LEUKOCYTE BIOL, V87, P857, DOI 10.1189/jlb.1009701; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Leonard WJ, 2008, J LEUKOCYTE BIOL, V84, P348, DOI 10.1189/jlb.0308149; Lu Z, 2013, BLOOD; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2006, INT J HEMATOL, V84, P224, DOI 10.1532/IJH97.06036; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pedersen A, 2010, PSYCHOSOM MED, V72, P823, DOI 10.1097/PSY.0b013e3181f1d003; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Rafei M, 2013, BLOOD, V121, P107, DOI 10.1182/blood-2012-05-433508; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; ROCKLIN RE, 1979, ANNU REV MED, V30, P375, DOI 10.1146/annurev.me.30.020179.002111; Sanchez-Beato M, 2003, BLOOD, V101, P1220, DOI 10.1182/blood-2002-07-2009; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Smith LK, 2010, J BIOL CHEM, V285, P36698, DOI 10.1074/jbc.M110.162123; Sommershof A, 2011, BRAIN BEHAV IMMUN, V25, P340, DOI 10.1016/j.bbi.2010.10.016; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Szabo S, 2012, STRESS, V15, P472, DOI 10.3109/10253890.2012.710919; Talaber G, 2011, REJUV RES, V14, P241, DOI 10.1089/rej.2010.1110; Thompson JA, 2008, J CLIN ONCOL, V26, P2034, DOI 10.1200/JCO.2007.14.5193; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; WANG SD, 1994, J IMMUNOL, V152, P5014; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Zediak VP, 2007, BLOOD, V110, P1161, DOI 10.1182/blood-2007-01-071605; Zubkova I, 2005, J IMMUNOL, V175, P2321, DOI 10.4049/jimmunol.175.4.2321	51	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72801	10.1371/journal.pone.0072801	http://dx.doi.org/10.1371/journal.pone.0072801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023776	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400024
J	Teloh, JK; Ferenz, KB; Petrat, F; Mayer, C; de Groot, H				Teloh, Johanna K.; Ferenz, Katja B.; Petrat, Frank; Mayer, Christian; de Groot, Herbert			Acid-Base and Electrolyte Status during Normovolemic Hemodilution with Succinylated Gelatin or HES-Containing Volume Replacement Solutions in Rats	PLOS ONE			English	Article							6-PERCENT HYDROXYETHYL STARCH; MODIFIED FLUID GELATIN; OSMOTIC-NEPHROSIS; 4-PERCENT GELATIN; 5-PERCENT ALBUMIN; RESUSCITATION; COLLOIDS; COAGULATION; ISOFLURANE; VOLUVEN	Background: In the past, several studies have compared different colloidal replacement solutions, whereby the focus was usually on the respective colloid. We therefore systematically studied the influence of the carrier solution's composition of five approved colloidal volume replacement solutions (Gelafundin, Gelafusal, Geloplasma, Voluven and Volulyte) on acid-base as well as electrolyte status during and following acute severe normovolemic hemodilution. The solutions differed in the colloid used (succinylated gelatin vs. HES) and in the presence and concentration of metabolizable anions as well as in their electrolyte composition. Methods: Anesthetized Wistar rats were subjected to a stepwise normovolemic hemodilution with one of the solutions until a final hematocrit of 10%. Subsequent to dilution (162 min), animals were observed for an additional period (150 min). During dilution and observation time blood gas analyses were performed eight times in total. Additionally, in the Voluven and Volulyte groups as well as in 6 Gelafundin animals, electrolyte concentrations, glucose, pH and succinylated gelatin were measured in urine and histopathological evaluation of the kidney was performed. Results: All animals survived without any indications of injury. Although the employed solutions differed in their respective composition, comparable results in all plasma acid-base and electrolyte parameters studied were obtained. Plasma pH increased from approximately 7.28 to 7.39, the plasma K+ concentration decreased from circa 5.20 mM to 4.80-3.90 mM and the plasma Cl- concentration rose from approximately 105 mM to 111-120 mM. Urinary analysis revealed increased excretion of K+, H+ and Cl-. Conclusions: The present data suggest that the carrier solution's composition with regard to metabolizable anions as well as K+, Ca2+ only has a minor impact on acid-base and electrolyte status after application of succinylated gelatin or HES-containing colloidal volume replacement solutions.	[Teloh, Johanna K.; Ferenz, Katja B.; Petrat, Frank; de Groot, Herbert] Univ Duisburg Essen, Univ Hosp Essen, Inst Physiol Chem, Essen, Germany; [Mayer, Christian] Univ Duisburg Essen, Inst Phys Chem, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	de Groot, H (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Physiol Chem, Essen, Germany.	herbert.de-groot@uni-duisburg-essen.de	Ferenz, Katja/AAX-4076-2020; Mayer, Christian/D-2144-2019	Ferenz, Katja/0000-0001-6011-2467; 				Aksu U, 2012, SHOCK, V37, P205, DOI 10.1097/SHK.0b013e31823ca89c; Almac E, 2012, RESUSCITATION, V83, P1166, DOI 10.1016/j.resuscitation.2012.02.011; ALPERT NR, 1954, AM J PHYSIOL, V177, P455, DOI 10.1152/ajplegacy.1954.177.3.455; [Anonymous], COCHRANE DATABASE SY; Base EM, 2011, J CARDIOTHOR VASC AN, V25, P407, DOI 10.1053/j.jvca.2010.12.005; Casutt M, 2010, BRIT J ANAESTH, V105, P273, DOI 10.1093/bja/aeq173; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; DARDAI E, 1987, METHOD FIND EXP CLIN, V9, P717; Dickenmann M, 2008, AM J KIDNEY DIS, V51, P491, DOI 10.1053/j.ajkd.2007.10.044; Dubniks M, 2007, INTENS CARE MED, V33, P293, DOI 10.1007/s00134-006-0454-5; EDWARDS JD, 1989, CRIT CARE MED, V17, P996, DOI 10.1097/00003246-198910000-00006; Forster H, 1997, Krankenpfl J, V35, P497; Forster HAF, 1998, J ANAESTH INTENSIVBE, V5, P2; Freyburger G, 1996, BRIT J ANAESTH, V76, P519, DOI 10.1093/bja/76.4.519; FROHLICH ED, 1965, AM J PHYSIOL, V208, P149, DOI 10.1152/ajplegacy.1965.208.1.149; Godier A, 2010, ACTA ANAESTH SCAND, V54, P1241, DOI 10.1111/j.1399-6576.2010.02306.x; Haas T, 2008, ANESTH ANALG, V106, P1078, DOI 10.1213/ane.0b013e318165df18; Hauet T, 1998, TRANSPLANT P, V30, P2796, DOI 10.1016/S0041-1345(98)00812-4; Imai A, 1999, AM J VET RES, V60, P1577; JANSSEN CW, 1968, ACTA CHIR SCAND, V134, P481; Johannes T, 2007, AM J PHYSIOL-RENAL, V292, pF796, DOI 10.1152/ajprenal.00206.2006; KIEF H, 1968, VIRCHOWS ARCH B, V1, P240; LEGENDRE C, 1993, LANCET, V342, P248, DOI 10.1016/0140-6736(93)92345-T; Lehmann L, 2013, NEUROCRIT CARE, V18, P5, DOI 10.1007/s12028-012-9764-3; Levi M, 2007, SEMIN THROMB HEMOST, V33, P810, DOI 10.1055/s-2007-1000370; Lobo DN, 2010, CRIT CARE MED, V38, P464, DOI 10.1097/CCM.0b013e3181bc80f1; Margarido CB, 2007, SHOCK, V27, P390, DOI 10.1097/01.shk.0000245026.01365.55; Mitra S, 2009, INDIAN J ANAESTH, V53, P592; Mizzi Anna, 2011, Anesthesiol Clin, V29, P547, DOI 10.1016/j.anclin.2011.05.012; MORRIS M, 1982, HYPERTENSION, V4, P161, DOI 10.1161/01.HYP.4.1.161; MORTELMANS YJ, 1995, ANESTH ANALG, V81, P1235, DOI 10.1097/00000539-199512000-00020; Nolan J, 1999, BRIT MED BULL, V55, P821, DOI 10.1258/0007142991902808; OBERLEITHNER H, 1987, P NATL ACAD SCI USA, V84, P1464, DOI 10.1073/pnas.84.5.1464; Rehm M, 2000, ANESTHESIOLOGY, V93, P1174, DOI 10.1097/00000542-200011000-00007; Sirtl C, 2008, ANASTHESIOLOGIE, P384; Wiedermann CJ, 2004, WIEN KLIN WOCHENSCHR, V116, P583, DOI 10.1007/s00508-004-0237-3; Winkelmayer WC, 2003, KIDNEY INT, V64, P1046, DOI 10.1046/j.1523-1755.2003.00186.x; Yang ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002010; Zander R., 2006, EJHP PRACT, V12, P60; Zander R, 2009, FLUID MANAGEMENT, P15	41	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72848	10.1371/journal.pone.0072848	http://dx.doi.org/10.1371/journal.pone.0072848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023785	Green Submitted, Green Published, gold			2022-12-27	WOS:000324238400029
J	Wang, Z; Jiang, YH; Guan, DX; Li, JJ; Yin, HK; Pan, Y; Xie, D; Chen, Y				Wang, Zheng; Jiang, Yuhui; Guan, Dongxian; Li, Jingjing; Yin, Hongkun; Pan, Yi; Xie, Dong; Chen, Yan			Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							CADHERIN GENE-EXPRESSION; BREAST-CANCER CELLS; BETA-CATENIN; TUMOR PROGRESSION; TGF-BETA; MUTATION; PROTEINS; INHIBITION; PATHWAY; SNAIL	Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the biggest obstacle in curing HCC is its high metastasis potential. Alteration of p53 is the most frequent genetic change found in HCC. Although the biological function of p53 in tumor initiation and progression has been well characterized, whether or not p53 is implicated in metastasis of HCC is largely unknown. In this study, we analyzed the potential functions of p53 in epithelial-mesenchymal transition (EMT) and metastasis of HCC cells. Both insulin-and TGF-beta 1-induced changes of critical EMT markers were greatly enhanced by p53 knockdown in HCC cells. The insulin- and TGF-beta 1-stimulated migration of HCC cells were enhanced by p53 knockdown. Furthermore, in vivo metastasis of HCC cells using different mouse models was robustly enhanced by p53 knockdown. In addition, we found that p53 regulation on EMT and metastasis involves beta-catenin signaling. The nuclear accumulation and transcriptional activity of beta-catenin was modulated by p53. The enhanced EMT phenotype, cell migration and tumor metastasis of HCC cells by p53 knockdown were abrogated by inhibiting beta-catenin signal pathway. In conclusion, this study reveals that p53 plays a pivotal role in EMT and metastasis of HCC cells via its regulation on beta-catenin signaling.	[Wang, Zheng; Jiang, Yuhui; Guan, Dongxian; Li, Jingjing; Yin, Hongkun; Pan, Yi; Xie, Dong; Chen, Yan] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Chen, Y (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China.	ychen3@sibs.ac.cn		yin, hongkun/0000-0002-8595-4270; Xie, Dong/0000-0002-1150-8657	National Natural Science Foundation of China [81021002, 81130077, 30971660]; Ministry of Science and Technology of China [2012CB524900, 2010CB529506]; Chinese Academy of Sciences [KSCX2-EW-R-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by research grants from National Natural Science Foundation of China (81021002 and 81130077 to YC and 30971660 to YP), Ministry of Science and Technology of China (2012CB524900 to YC and 2010CB529506 to YP and ZW), and Chinese Academy of Sciences (KSCX2-EW-R-08 to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Cadoret A, 2001, CANCER RES, V61, P3245; Cagatay T, 2002, ONCOGENE, V21, P7971, DOI 10.1038/sj.onc.1205919; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Fan FJ, 2008, CARCINOGENESIS, V29, P1157, DOI 10.1093/carcin/bgn119; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Feng L, 2007, P NATL ACAD SCI USA, V104, P14348, DOI 10.1073/pnas.0701298104; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng YX, 2011, HEPATOLOGY, V53, P483, DOI 10.1002/hep.24075; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gilles C, 2003, CANCER RES, V63, P2658; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jiang YH, 2011, CANCER RES, V71, P2959, DOI 10.1158/0008-5472.CAN-10-4077; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; ODA T, 1992, CANCER RES, V52, P6358; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZTURK M, 1991, LANCET, V338, P1356, DOI 10.1016/0140-6736(91)92236-U; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pinho AV, 2011, CELL CYCLE, V10, P1312, DOI 10.4161/cc.10.8.15363; Ponchel F, 1998, BRIT J CANCER, V77, P1555, DOI 10.1038/bjc.1998.256; Sadot E, 2001, MOL CELL BIOL, V21, P6768, DOI 10.1128/MCB.21.20.6768-6781.2001; Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Tago K, 2000, GENE DEV, V14, P1741; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wang T, 2010, BRIT J CANCER, V102, P1618, DOI 10.1038/sj.bjc.6605689; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhang Y, 2010, ONCOGENE, V29, P5404, DOI 10.1038/onc.2010.270; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443	47	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72846	10.1371/journal.pone.0072846	http://dx.doi.org/10.1371/journal.pone.0072846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023784	gold, Green Submitted, Green Published			2022-12-27	WOS:000324238400028
J	Di, X; Biswal, BB				Di, Xin; Biswal, Bharat B.			Modulatory Interactions of Resting-State Brain Functional Connectivity	PLOS ONE			English	Article							DEFAULT MODE NETWORK; BASAL GANGLIA; CORTICAL INTERACTIONS; PREFRONTAL CORTEX; VISUAL PATHWAYS; GLOBAL SIGNAL; FMRI; ORGANIZATION; CIRCUITS; MULTISTABILITY	The functional brain connectivity studies are generally based on the synchronization of the resting-state functional magnetic resonance imaging (fMRI) signals. Functional connectivity measures usually assume a stable relationship over time; however, accumulating studies have reported time-varying properties of strength and spatial distribution of functional connectivity. The present study explored the modulation of functional connectivity between two regions by a third region using the physiophysiological interaction (PPI) technique. We first identified eight brain networks and two regions of interest (ROIs) representing each of the networks using a spatial independent component analysis. A voxel-wise analysis was conducted to identify regions that showed modulatory interactions (PPI) with the two ROIs of each network. Mostly, positive modulatory interactions were observed within regions involved in the same system. For example, the two regions of the dorsal attention network revealed modulatory interactions with the regions related to attention, while the two regions of the extrastriate network revealed modulatory interactions with the regions in the visual cortex. In contrast, the two regions of the default mode network (DMN) revealed negative modulatory interactions with the regions in the executive network, and vice versa, suggesting that the activities of one network may be associated with smaller within network connectivity of the competing network. These results validate the use of PPI analysis to study modulation of resting-state functional connectivity by a third region. The modulatory effects may provide a better understanding of complex brain functions.	[Di, Xin; Biswal, Bharat B.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA	New Jersey Institute of Technology	Biswal, BB (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	bbiswal@yahoo.com	Di, Xin/B-2009-2009	Di, Xin/0000-0002-2422-9016	NIH grant [5R01AG032088]; NATIONAL INSTITUTE ON AGING [R01AG032088] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by NIH grant 5R01AG032088 (to BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Anticevic A, 2012, P NATL ACAD SCI USA, V109, P16720, DOI 10.1073/pnas.1208494109; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chang C, 2013, NEUROIMAGE, V72, P227, DOI 10.1016/j.neuroimage.2013.01.049; Chang C, 2010, FILM COMMENT, V46, P81; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Dauvermann MR, 2013, NEUROIMAGE, V73, P16, DOI 10.1016/j.neuroimage.2013.01.063; Deco G, 2013, TRENDS NEUROSCI, V36, P268, DOI 10.1016/j.tins.2013.03.001; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di X, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00118; Dimitriadis SI, 2012, NONLIN DYNAM PSYCHOL, V16, P5; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Friston KJ, 1997, NEUROIMAGE, V5, P164, DOI 10.1006/nimg.1997.0259; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gattass R, 2005, PHILOS T R SOC B, V360, P709, DOI 10.1098/rstb.2005.1629; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Golland Y, 2008, NEUROPSYCHOLOGIA, V46, P540, DOI 10.1016/j.neuropsychologia.2007.10.003; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; Kang J, 2011, NEUROIMAGE, V56, P1222, DOI 10.1016/j.neuroimage.2011.03.033; Kapogiannis D, 2013, NEUROIMAGE, V64, P112, DOI 10.1016/j.neuroimage.2012.09.029; Keller CJ, 2013, J NEUROSCI, V33, P6333, DOI 10.1523/JNEUROSCI.4837-12.2013; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Kiviniemi V, 2011, BRAIN CONNECT, V1, P339, DOI 10.1089/brain.2011.0036; Kolachana BS, 1997, SYNAPSE, V25, P285; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; McIntosh A. R., 1994, Human Brain Mapping, V2, P2; McIntosh AR, 2000, NEURAL NETWORKS, V13, P861, DOI 10.1016/S0893-6080(00)00059-9; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rao H, 2008, NEUROIMAGE, V41, P1345, DOI 10.1016/j.neuroimage.2008.04.026; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Stamatakis EA, 2005, NEUROIMAGE, V28, P115, DOI 10.1016/j.neuroimage.2005.06.012; Stephan KE, 2004, J ANAT, V205, P443, DOI 10.1111/j.0021-8782.2004.00359.x; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; van Schouwenburg MR, 2010, J NEUROSCI, V30, P9910, DOI 10.1523/JNEUROSCI.1111-10.2010; Yan CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023460; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	69	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e71163	10.1371/journal.pone.0071163	http://dx.doi.org/10.1371/journal.pone.0071163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023609	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200003
J	Kadota, K; Mori, M; Yanagimachi, M; Miyamae, T; Hara, T; Kanetaka, T; Nozawa, T; Kikuchi, M; Hara, R; Imagawa, T; Kaneko, T; Yokota, S				Kadota, Keisuke; Mori, Masaaki; Yanagimachi, Masakatsu; Miyamae, Takako; Hara, Takuma; Kanetaka, Taichi; Nozawa, Tomo; Kikuchi, Masako; Hara, Ryoki; Imagawa, Tomoyuki; Kaneko, Tetsuji; Yokota, Shumpei			Analysis of Gender Differences in Genetic Risk: Association of TNFAIP3 Polymorphism with Male Childhood-Onset Systemic Lupus Erythematosus in the Japanese Population	PLOS ONE			English	Article							REVISED CRITERIA; OSTEOPONTIN; SUSCEPTIBILITY; CLASSIFICATION; C8ORF13-BLK; REGION; TNIP1	Background: Systemic lupus erythematosus (SLE) is a systemic multisystem autoimmune disorder influenced by genetic background and environmental factors. Our aim here was to replicate findings of associations between 7 of the implicated single nucleotide polymorphisms (SNPs) in IRF5, BLK, STAT4, TNFAIP3, SPP1, TNIP1 and ETS1 genes with susceptibility to childhood-onset SLE in the Japanese population. In particular, we focused on gender differences in allelic frequencies. Methodology/Principal Findings: The 7 SNPs were genotyped using TaqMan assays in 75 patients with childhood-onset SLE and in 190 healthy controls. The relationship between the cumulative number of risk alleles and SLE manifestations was explored in childhood-onset SLE. Logistic regression was used to test the effect of each polymorphism on susceptibility to SLE, and Wilcoxon rank sum testing was used for comparison of total risk alleles. Data on rs7574865 in the STAT4 gene and rs9138 in SPP1 were replicated for associations with SLE when comparing cases and controls (corrected P values ranging from 0.0043 to 0.027). The rs2230926 allele of TNFAIP3 was associated with susceptibility to SLE in males, but after Bonferroni correction there were no significant associations with any of the other four SNPs in IRF5, BLK, TNIP1 and ETS1 genes. The cumulative number of risk alleles was significantly increased in childhood-onset SLE relative to healthy controls (P = 0.0000041). Male SLE patients had a slightly but significantly higher frequency of the TNFAIP3 (rs2230926G) risk allele than female patients (odds ratio [OR] = 4.05, 95% confidence interval [95%CI] = 1.46-11.2 P<0.05). Conclusions: Associations of polymorphisms in STAT4 and SPP1 with childhood-onset SLE were confirmed in a Japanese population. Although these are preliminary results for a limited number of cases, TNFAIP3 rs2230926G may be an important predictor of disease onset in males. We also replicated findings that the cumulative number of risk alleles was significantly increased in childhood-onset SLE.	[Kadota, Keisuke; Mori, Masaaki; Yanagimachi, Masakatsu; Miyamae, Takako; Hara, Takuma; Kanetaka, Taichi; Nozawa, Tomo; Kikuchi, Masako; Hara, Ryoki; Imagawa, Tomoyuki; Yokota, Shumpei] Yokohama City Univ, Sch Med, Dept Pediat, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Kaneko, Tetsuji] Yokohama City Univ, Adv Med Res Ctr, Dept Res Support & Coordinat, Biobank,Kanazawa Ku, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University	Yanagimachi, M (corresponding author), Yokohama City Univ, Sch Med, Dept Pediat, Kanazawa Ku, Yokohama, Kanagawa 232, Japan.	myanagi@yokohama-cu.ac.jp	Kaneko, Tetsuji/GPF-6130-2022	Kaneko, Tetsuji/0000-0001-6041-1731	Japan Society for the Promotion of Science [16790583]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 16790583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Brunner HI, 2008, ARTHRITIS RHEUM-US, V58, P556, DOI 10.1002/art.23204; Chiocchetti A, 2004, BLOOD, V103, P1376, DOI 10.1182/blood-2003-05-1748; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Han SZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001757; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hughes T, 2012, ANN RHEUM DIS, V71, P694, DOI 10.1136/annrheumdis-2011-200385; Ito I, 2009, ARTHRITIS RHEUM-US, V60, P553, DOI 10.1002/art.24246; Kamphuis S, 2010, NAT REV RHEUMATOL, V6, P538, DOI 10.1038/nrrheum.2010.121; Kariuki SN, 2009, GENES IMMUN, V10, P487, DOI 10.1038/gene.2009.15; Kawasaki A, 2008, ARTHRITIS RHEUM-US, V58, P826, DOI 10.1002/art.23216; Kawasaki A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3134; Kawasaki A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/207578; Kawasaki A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2516; Koga M, 2011, J HUM GENET, V56, P503, DOI 10.1038/jhg.2011.49; Leng RX, 2011, AUTOIMMUN REV, V10, P439, DOI 10.1016/j.autrev.2011.01.007; Lu LJ, 2010, LUPUS, V19, P119, DOI 10.1177/0961203309350755; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Seligman VA, 2002, AM J MED, V112, P726, DOI 10.1016/S0002-9343(02)01118-X; Stefanidou S, 2011, LUPUS, V20, P1090, DOI 10.1177/0961203311403640; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Taylor KE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000084; Trivedi T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/802581; Tsuchiya N, 2002, IMMUNOL REV, V190, P169, DOI 10.1034/j.1600-065X.2002.19013.x; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Webb R, 2011, ANN RHEUM DIS, V70, P151, DOI 10.1136/ard.2010.141697; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Yacoub Wasef Sherif Z, 2004, Gend Med, V1, P12, DOI 10.1016/S1550-8579(04)80006-8; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Zhong H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3514	35	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72551	10.1371/journal.pone.0072551	http://dx.doi.org/10.1371/journal.pone.0072551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023622	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200017
J	Lu, CH; Lee, RKK; Hwu, YM; Lin, MH; Yeh, LY; Chen, YJ; Lin, SP; Li, SH				Lu, Chung-Hao; Lee, Robert Kuo-Kuang; Hwu, Yuh-Ming; Lin, Ming-Huei; Yeh, Ling-Yu; Chen, Ying-Jie; Lin, Shau-Ping; Li, Sheng-Hsiang			Involvement of the Serine Protease Inhibitor, SERPINE2, and the Urokinase Plasminogen Activator in Cumulus Expansion and Oocyte Maturation	PLOS ONE			English	Article							CELLS IN-VITRO; GRANULOSA-CELLS; SPATIOTEMPORAL EXPRESSION; OVULATION EFFICIENCY; DEFICIENT MICE; COMPLEX; MATRIX; HYALURONAN; GENE; FERTILIZATION	The serpin peptidase inhibitor, clade E, member 2 (SERPINE2) inhibits urokinase-type plasminogen activator (PLAU) and tissue-type plasminogen activator. Higher SERPINE2 expression levels were detected in cumulus cells of human immature oocytes than in those of mature oocytes. The objective of this study was to evaluate whether high SERPINE2 levels in cumulus cells are associated with oocyte immaturity. Using the mouse cumulus-oocyte complex as an experimental model, the effects of elimination and overexpression of SERPINE2 in cumulus cells on cumulus expansion and oocyte maturation were assayed by in vitro maturation. Serpine2 and PLAU transcripts were the most highly expressed serpins and plasminogen activators, respectively. Their expression was coordinately regulated in cumulus cells during gonadotropin-induced oocyte maturation. Silencing of Serpine2 expression using small interfering RNAs or blockage of SERPINE2 protein using a specific antibody had no effect on oocyte maturation. However, overexpression of Serpine2 or exogenous supplementation with high levels of SERPINE2 impaired cumulus expansion and oocyte maturation, probably by decreasing hyaluronan synthase 2 (Has2) and versican (Vcan) mRNA expression. Amiloride, a specific PLAU inhibitor, also suppressed these processes. PLAU supplementation of the oocyte in vitro maturation medium caused earlier and more extensive expansion of cumulus cells and oocyte maturation that may be mediated by increased Has2 mRNA expression. However, these effects were neutralized by coincubation with SERPINE2 or amiloride and PLAU. In conclusion, SERPINE2 and PLAU are involved in cumulus expansion and oocyte maturation. High SERPINE2 levels impair these processes, probably by decreasing cumulus matrix gene expression as well as reducing cumulus hyaluronan contents and inhibiting PLAU activity. These findings may explain why cumulus cells surrounding immature human oocytes express high SERPINE2 levels.	[Lu, Chung-Hao; Lee, Robert Kuo-Kuang; Hwu, Yuh-Ming; Lin, Ming-Huei; Yeh, Ling-Yu; Li, Sheng-Hsiang] Mackay Mem Hosp, Dept Med Res, New Taipei City, Taiwan; [Lu, Chung-Hao; Lin, Shau-Ping] Natl Taiwan Univ, Inst Biotechnol, Coll Bioresources & Agr, Taipei 10764, Taiwan; [Lee, Robert Kuo-Kuang; Hwu, Yuh-Ming; Lin, Ming-Huei; Chen, Ying-Jie] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Lee, Robert Kuo-Kuang] Taipei Med Univ, Dept Obstet & Gynecol, Taipei, Taiwan; [Hwu, Yuh-Ming; Lin, Ming-Huei; Li, Sheng-Hsiang] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Lin, Shau-Ping] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, Shau-Ping] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan	Mackay Memorial Hospital; National Taiwan University; Mackay Memorial Hospital; Taipei Medical University; Mackay Junior College of Medicine, Nursing & Management; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Lin, SP (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Coll Bioresources & Agr, Taipei 10764, Taiwan.	shaupinglin@ntu.edu.tw; lsh@ms1.mmh.org.tw	Li, Sheng-hsiang/AAT-8939-2021	Li, Sheng-hsiang/0000-0002-0549-3516; Lin, Shau-Ping/0000-0003-3423-991X	National Science Council [NSC99-2314-B-195-006-MY3, NSC100-2321-B-002-074, NSC 101-2314-B-195-009-MY3]; Mackay Memorial Hospital, Taipei, Taiwan [MMH10013, MMH10029]	National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital, Taipei, Taiwan	This work was supported by grants from the National Science Council (NSC99-2314-B-195-006-MY3 to SHL, NSC100-2321-B-002-074 to SPL, and NSC 101-2314-B-195-009-MY3 to RKL) and the Mackay Memorial Hospital (MMH10013 and MMH10029 to SHL), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; Cao MJ, 2006, MATRIX BIOL, V25, P342, DOI 10.1016/j.matbio.2006.05.005; Cao MJ, 2004, BIOL REPROD, V71, P887, DOI 10.1095/biolreprod.104.029702; Cha KY, 1998, HUM REPROD UPDATE, V4, P103, DOI 10.1093/humupd/4.2.103; Chen LM, 2004, PROSTATE, V59, P1, DOI 10.1002/pros.10346; Chern SR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-106; Chern SR, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-127; D'Alessandris C, 2001, ENDOCRINOLOGY, V142, P3033, DOI 10.1210/en.142.7.3033; Devjak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047106; Dragovic RA, 2007, BIOL REPROD, V76, P848, DOI 10.1095/biolreprod.106.057471; Dunning KR, 2007, HUM REPROD, V22, P2842, DOI 10.1093/humrep/dem277; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gui UM, 2005, BIOL REPROD, V72, P195, DOI 10.1095/biolreprod.104.033357; Hagglund AC, 1996, ENDOCRINOLOGY, V137, P5671, DOI 10.1210/en.137.12.5671; HOFMANN GE, 1994, AM J OBSTET GYNECOL, V170, P671, DOI 10.1016/S0002-9378(94)70246-2; Jankun J, 1999, Cancer Biochem Biophys, V17, P109; Lee R, 2011, RUNNING THE WORLDS MARKETS: THE GOVERNANCE OF FINANCIAL INFRASTRUCTURE, P9; Leonardsson G, 1995, P NATL ACAD SCI USA, V92, P12446, DOI 10.1073/pnas.92.26.12446; Liu K, 2006, DEV BIOL, V295, P615, DOI 10.1016/j.ydbio.2006.03.046; Liu YX, 2004, ENDOCRINOLOGY, V145, P1767, DOI 10.1210/en.2003-1327; LIU YX, 1987, BIOL REPROD, V36, P1055, DOI 10.1095/biolreprod36.4.1055; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CH, 2011, BIOL REPROD, V84, P514, DOI 10.1095/biolreprod.110.085100; Mahmodi R, 2009, YAKHTEH, V11, P299; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; Ny A, 1997, EUR J BIOCHEM, V244, P487, DOI 10.1111/j.1432-1033.1997.00487.x; PENG XR, 1993, EUR J BIOCHEM, V214, P147, DOI 10.1111/j.1432-1033.1993.tb17907.x; Richards JS, 2005, MOL CELL ENDOCRINOL, V234, P75, DOI 10.1016/j.mce.2005.01.004; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; SAPPINO AP, 1991, J CLIN INVEST, V87, P962, DOI 10.1172/JCI115104; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; SCOTT RW, 1985, J BIOL CHEM, V260, P7029; Su YQ, 2004, DEV BIOL, V276, P64, DOI 10.1016/j.ydbio.2004.08.020; Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051; TSAFRIRI A, 1989, ENDOCRINOLOGY, V124, P415, DOI 10.1210/endo-124-1-415; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; VASSALLI JD, 1993, EMBO J, V12, P1871, DOI 10.1002/j.1460-2075.1993.tb05835.x; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Yokoo M, 2004, INT REV CYTOL, V235, P251, DOI 10.1016/S0074-7696(04)35006-0; YOSHIMURA Y, 1987, AM J OBSTET GYNECOL, V157, P468, DOI 10.1016/S0002-9378(87)80197-7; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	46	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e74602	10.1371/journal.pone.0074602	http://dx.doi.org/10.1371/journal.pone.0074602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023701	gold, Green Submitted, Green Published			2022-12-27	WOS:000323880200099
J	Ferrarelli, F; Smith, R; Dentico, D; Riedner, BA; Zennig, C; Benca, RM; Lutz, A; Davidson, RJ; Tononi, G				Ferrarelli, Fabio; Smith, Richard; Dentico, Daniela; Riedner, Brady A.; Zennig, Corinna; Benca, Ruth M.; Lutz, Antoine; Davidson, Richard J.; Tononi, Giulio			Experienced Mindfulness Meditators Exhibit Higher Parietal-Occipital EEG Gamma Activity during NREM Sleep	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; REM-SLEEP; TRANSCENDENTAL-MEDITATION; PSYCHOMETRIC EVALUATION; SLOW; BRAIN; OSCILLATIONS; ATTENTION; SCHIZOPHRENIA; INCREASES	Over the past several years meditation practice has gained increasing attention as a non-pharmacological intervention to provide health related benefits, from promoting general wellness to alleviating the symptoms of a variety of medical conditions. However, the effects of meditation training on brain activity still need to be fully characterized. Sleep provides a unique approach to explore the meditation-related plastic changes in brain function. In this study we performed sleep high-density electroencephalographic (hdEEG) recordings in long-term meditators (LTM) of Buddhist meditation practices (approximately 8700 mean hours of life practice) and meditation naive individuals. We found that LTM had increased parietal-occipital EEG gamma power during NREM sleep. This increase was specific for the gamma range (25-40 Hz), was not related to the level of spontaneous arousal during NREM and was positively correlated with the length of lifetime daily meditation practice. Altogether, these findings indicate that meditation practice produces measurable changes in spontaneous brain activity, and suggest that EEG gamma activity during sleep represents a sensitive measure of the long-lasting, plastic effects of meditative training on brain function.	[Ferrarelli, Fabio; Smith, Richard; Dentico, Daniela; Riedner, Brady A.; Zennig, Corinna; Benca, Ruth M.; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Lutz, Antoine; Davidson, Richard J.] Univ Wisconsin, Waisman Ctr Brain Imaging & Behav, Madison, WI 53706 USA; [Davidson, Richard J.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Lutz, Antoine] Univ Lyon 1, Lyon Neurosci Res Ctr, F-69365 Lyon, France	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.	gtononi@wisc.edu	Dentico, Daniela/AAP-6736-2020; Ferrarelli, Fabio/D-3219-2019; LUTZ, Antoine/AAE-5114-2020	Dentico, Daniela/0000-0003-1050-0327; Ferrarelli, Fabio/0000-0003-0560-0227; LUTZ, Antoine/0000-0002-0258-3233; Davidson, Richard/0000-0002-8506-4964	National Center for Complementary and Alternative Medicine (NCCAM) [P01AT004952]; National Institute of Mental Health (NIMH) [R01-MH43454, P50-MH084051]; Fetzer Institute; John Templeton Foundation; National Institute of Child Health and Human Development [P30 HD003352-449015]; International Reintegration Grants (IRG) [FP7-PEOPLE-2009-RG]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084051, R01MH043454] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fetzer Institute; John Templeton Foundation; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); International Reintegration Grants (IRG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Center for Complementary and Alternative Medicine (NCCAM) P01AT004952 to TG, RJD and AL, grants from the National Institute of Mental Health (NIMH) R01-MH43454, P50-MH084051 to RJD, grants from the Fetzer Institute and the John Templeton Foundation to RJD, a core grant to the Waisman Center from the National Institute of Child Health and Human Development [P30 HD003352-449015], and a International Reintegration Grants (IRG), FP7-PEOPLE-2009-RG for AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Berkovich-Ohana A, 2012, CLIN NEUROPHYSIOL, V123, P700, DOI 10.1016/j.clinph.2011.07.048; Born AP, 2002, NEUROIMAGE, V17, P1325, DOI 10.1006/nimg.2002.1249; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Cohen J., 1988, STAT POWER ANANLYSIS; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corsi-Cabrera M, 2008, BRAIN RES, V1235, P82, DOI 10.1016/j.brainres.2008.06.052; Czisch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006749; Davidson RJ, 2008, IEEE SIGNAL PROC MAG, V25, P176, DOI 10.1109/MSP.2008.4431873; DEROGATIS LR, 1977, BRIT J SOC CLIN PSYC, V16, P347, DOI 10.1111/j.2044-8260.1977.tb00241.x; Engell AD, 2010, J NEUROSCI, V30, P8780, DOI 10.1523/JNEUROSCI.1575-10.2010; Ermis U, 2010, J SLEEP RES, V19, P400, DOI 10.1111/j.1365-2869.2010.00831.x; FABER PA, 1978, J ANAL PSYCHOL, V23, P1, DOI 10.1111/j.1465-5922.1978.00001.x; Feige B, 2007, ALCOHOL CLIN EXP RES, V31, P19, DOI 10.1111/j.1530-0277.2006.00260.x; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Ferrarelli F, 2010, AM J PSYCHIAT, V167, P1339, DOI 10.1176/appi.ajp.2010.09121731; Finelli LA, 2001, NEUROPSYCHOPHARMACOL, V25, pS57, DOI 10.1016/S0893-133X(01)00320-7; Gold AR, 2003, CHEST, V123, P87, DOI 10.1378/chest.123.1.87; Guntekin B, 2007, INT J PSYCHOPHYSIOL, V65, P294, DOI 10.1016/j.ijpsycho.2007.03.009; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hollingshead AB, 1957, 2 FACTOR INDEX UNPUB; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000276; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Jausovec N, 2007, INT J PSYCHOPHYSIOL, V66, P215, DOI 10.1016/j.ijpsycho.2007.07.005; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Kaul P, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-47; Kinsey K, 2011, INT J PSYCHOPHYSIOL, V79, P392, DOI 10.1016/j.ijpsycho.2010.12.007; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu CB, 2011, NEUROBIOL AGING, V32, P956, DOI 10.1016/j.neurobiolaging.2009.05.006; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; MacLean, 1992, J Sleep Res, V1, P35; Mainy N, 2007, HUM BRAIN MAPP, V28, P183, DOI 10.1002/hbm.20264; Martinez D, 2010, CLIN NEUROPHYSIOL, V121, P704, DOI 10.1016/j.clinph.2010.01.005; Mason LI, 1997, SLEEP, V20, P102, DOI 10.1093/sleep/20.2.102; Massimini M, 2010, COGN NEUROSCI-UK, V1, P176, DOI 10.1080/17588921003731578; Miller KJ, 2009, P NATL ACAD SCI USA, V106, P12174, DOI 10.1073/pnas.0902071106; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nagendra Ravindra P, 2012, Front Neurol, V3, P54, DOI 10.3389/fneur.2012.00054; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Ossandon T, 2011, J NEUROSCI, V31, P14521, DOI 10.1523/JNEUROSCI.2483-11.2011; Pattanashetty R, 2010, SLEEP BIOL RHYTHMS, V8, P34, DOI 10.1111/j.1479-8425.2009.00416.x; Perlis ML, 2001, SLEEP MED REV, V5, P365, DOI 10.1053/smrv.2001.0151; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Sarasso S, 2010, ARCH ITAL BIOL, V148, P271; SASKIN P, 1985, SLEEP, V8, P319, DOI 10.1093/sleep/8.4.319; Schadow J, 2009, NEUROIMAGE, V47, P651, DOI 10.1016/j.neuroimage.2009.04.074; Schoormans D, 2011, J ALTERN COMPLEM MED, V17, P629, DOI 10.1089/acm.2010.0332; Sederberg PB, 2010, MEM COGNITION, V38, P689, DOI 10.3758/MC.38.6.689; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Siegel M, 2003, J NEUROSCI, V23, P4251; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; STIGSBY B, 1981, ELECTROEN CLIN NEURO, V51, P434, DOI 10.1016/0013-4694(81)90107-3; Takahara M, 2002, PSYCHIAT CLIN NEUROS, V56, P257, DOI 10.1046/j.1440-1819.2002.00999.x; Tekell JL, 2005, CLIN EEG NEUROSCI, V36, P25, DOI 10.1177/155005940503600107; Valderrama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033477; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601	74	56	57	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73417	10.1371/journal.pone.0073417	http://dx.doi.org/10.1371/journal.pone.0073417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015304	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800099
J	Leysath, CE; Phillips, DD; Crown, D; Fattah, RJ; Moayeri, M; Leppla, SH				Leysath, Clinton E.; Phillips, Damilola D.; Crown, Devorah; Fattah, Rasem J.; Moayeri, Mahtab; Leppla, Stephen H.			Anthrax Edema Factor Toxicity Is Strongly Mediated by the N-end Rule	PLOS ONE			English	Article							LETHAL TOXIN; BINDING; PEPTIDASE; PROLINE; CYCLASE; PROTEIN	Anthrax edema factor (EF) is a calmodulin-dependent adenylate cyclase that converts adenosine triphosphate (ATP) into 3'-5'-cyclic adenosine monophosphate (cAMP), contributing to the establishment of Bacillus anthracis infections and the resulting pathophysiology. We show that EF adenylate cyclase toxin activity is strongly mediated by the N-end rule, and thus is dependent on the identity of the N-terminal amino acid. EF variants having different N-terminal residues varied by more than 100-fold in potency in cultured cells and mice. EF variants having unfavorable, destabilizing N-terminal residues showed much greater activity in cells when the E1 ubiquitin ligase was inactivated or when proteasome inhibitors were present. Taken together, these results show that EF is uniquely affected by ubiquitination and/or proteasomal degradation.	[Leysath, Clinton E.; Phillips, Damilola D.; Crown, Devorah; Fattah, Rasem J.; Moayeri, Mahtab; Leppla, Stephen H.] Natl Inst Allergy & Infect Dis, NIH, Parasit Dis Lab, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Leppla, SH (corresponding author), Natl Inst Allergy & Infect Dis, NIH, Parasit Dis Lab, Bethesda, MD USA.	sleppla@niaid.nih.gov		Moayeri, Mahtab/0000-0002-4448-8883; Phillips, Damilola/0000-0002-3643-7111	Intramural Research Program of the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001031] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKOCYGALLAGHER GA, 1992, J BIOL CHEM, V267, P1231; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Dumetz F, 2011, AM J PATHOL, V178, P2523, DOI 10.1016/j.ajpath.2011.02.027; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; Gupta PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003130; Hellmich KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049741; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; KULKA RG, 1988, J BIOL CHEM, V263, P15726; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Leysath CE, 2011, INFECT IMMUN, V79, P4609, DOI 10.1128/IAI.05314-11; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Newman ZL, 2010, BIOCHEM BIOPH RES CO, V398, P785, DOI 10.1016/j.bbrc.2010.07.039; Newman ZL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000906; NILSSON I, 1992, FEBS LETT, V299, P243, DOI 10.1016/0014-5793(92)80124-Y; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Varshavsky A, 2008, NAT STRUCT MOL BIOL, V15, P1238, DOI 10.1038/nsmb1208-1238; Wickliffe KE, 2008, CELL MICROBIOL, V10, P1352, DOI 10.1111/j.1462-5822.2008.01131.x; XIA ZG, 1990, J BIOL CHEM, V265, P6517; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	27	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e74474	10.1371/journal.pone.0074474	http://dx.doi.org/10.1371/journal.pone.0074474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015319	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800114
J	Vogelweith, F; Moret, Y; Thiery, D; Moreau, J				Vogelweith, Fanny; Moret, Yannick; Thiery, Denis; Moreau, Jerome			Lobesia botrana Larvae Develop Faster in the Presence of Parasitoids	PLOS ONE			English	Article							FECUNDITY	To combat parasitism hosts often rely on their immune system, which is the last line of defense. However, the immune system may not always be effective, and other non-immunological defenses might be favored to reduce the cost of parasite infection. Here we report that larvae of the moth Lobesia botrana can rapidly accelerate their development and reach maturity earlier in response to cues perceived at a distance from parasitoids. Such a phenotypically plastic life history shift, induced by the perception of deadly enemies in the environment, is likely to be an adaptive defensive strategy to prevent parasitoid attack, and has important implications in host-parasite dynamics.	[Vogelweith, Fanny; Moret, Yannick; Moreau, Jerome] Univ Bourgogne, Equipe Ecol Evolut, UMR Biogeosci 6282, Dijon, France; [Thiery, Denis] INRA, UMR Sante & Agroecol Vignoble 1065, Inst Sci Vigne & du Vin, Villenave Dornon, France; [Thiery, Denis] Univ Bordeaux, INRA, UMR 1065, Bordeaux Sci Agro, Villenave Dornon, France	Universite de Bourgogne; INRAE; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Vogelweith, F (corresponding author), Univ Bourgogne, Equipe Ecol Evolut, UMR Biogeosci 6282, Dijon, France.	fanny.vogelweith@u-bourgogne.fr	Vogelweith, Fanny/H-7765-2019; Moret, Yannick/I-9282-2012; moreau, jerome/A-3496-2013	Vogelweith, Fanny/0000-0002-3595-6702; 	CNRS; ANR [ANR07-JCJC-0134, ANR08-JCJC-0006]; ANR (Conseil Regional de Bourgogne)	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); ANR (Conseil Regional de Bourgogne)(French National Research Agency (ANR)Region Bourgogne-Franche-Comte)	Funding was provided by the CNRS and the ANR (ANR07-JCJC-0134 and ANR08-JCJC-0006 and the Conseil Regional de Bourgogne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606; Fred MS, 2010, ANIM BEHAV, V79, P313, DOI 10.1016/j.anbehav.2009.11.001; Guedes RNC, 2012, J COMP PHYSIOL A, V198, P325, DOI 10.1007/s00359-012-0711-8; Hawkins BA, 1997, ECOLOGY, V78, P2145, DOI 10.1890/0012-9658(1997)078[2145:PPAPAM]2.0.CO;2; Kraaijeveld AR, 2002, PARASITOLOGY, V125, pS71, DOI 10.1017/S0031182002001750; MINCHELLA DJ, 1985, PARASITOLOGY, V90, P205, DOI 10.1017/S0031182000049143; MINCHELLA DJ, 1981, AM NAT, V118, P876, DOI 10.1086/283879; Moreau J, 2010, BIOL CONTROL, V54, P300, DOI 10.1016/j.biocontrol.2010.05.019; Moret Y, 2004, ECOL LETT, V7, P146, DOI 10.1046/j.1461-0248.2003.00561.x; Nespolo RF, 2009, ECOL RES, V24, P997, DOI 10.1007/s11284-008-0570-5; Roff Derek A., 1992; Roth O, 2008, J EVOLUTION BIOL, V21, P1703, DOI 10.1111/j.1420-9101.2008.01584.x; Stearns S.C., 1992, pi; Thiery D, 2005, OECOLOGIA, V143, P548, DOI 10.1007/s00442-005-0022-7; Thiery D., 2008, RAVAGEURS VIGNE; Togashi K, 2009, APPL ENTOMOL ZOOL, V44, P249, DOI 10.1303/aez.2009.249; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	19	7	7	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72568	10.1371/journal.pone.0072568	http://dx.doi.org/10.1371/journal.pone.0072568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015260	Green Published, gold			2022-12-27	WOS:000323733800065
J	Kjelstrup, S; Hansen, PMP; Thomsen, LE; Hansen, PR; Lobner-Olesen, A				Kjelstrup, Susanne; Hansen, Paula Melo Paulon; Thomsen, Line E.; Hansen, Paul Robert; Lobner-Olesen, Anders			Cyclic Peptide Inhibitors of the beta-Sliding Clamp in Staphylococcus aureus	PLOS ONE			English	Article							DNA-POLYMERASE-III; ANTIMICROBIAL PEPTIDES; SPLIT-INTEIN; REPLICATION; PROTEIN; CYCLIZATION; MECHANISMS; INITIATOR; HELICASE; ORIGIN	Interaction between pairs of Staphylococcus aureus replication proteins was detected in an Escherichia coli based two-hybrid analysis. A reverse two-hybrid system was constructed for selection of compounds that hindered interaction between interacting protein pairs. A number of cyclic peptides, from a library generated by the split intein-mediated circular ligation of peptides and proteins technology, were found to interfere with dimerization of the beta-sliding clamp of the replisome. Two 8-mer peptides were analyzed in more detail. Both inhibited DNA replication, led to SOS induction, altered cell morphology and cell death. The peptides were active when added to bacterial cultures indicating that they could traverse the bacterial membrane to find their intracellular target. Peptide specificity was confirmed by overproduction of the putative target (DnaN) which resulted in resistance. The minimum inhibitory concentration was similar to 50 mu g/ml for S. aureus cells. These compounds may serve as lead candidates for future development into novel classes of antibiotics as well as provide information on the function of the S. aureus replication process.	[Kjelstrup, Susanne; Hansen, Paula Melo Paulon; Lobner-Olesen, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Thomsen, Line E.] Univ Copenhagen, Dept Vet Dis Biol, Copenhagen, Denmark; [Hansen, Paul Robert] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Lobner-Olesen, A (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	lobner@bio.ku.dk	Kjelstrup, Signe/N-6448-2019; Løbner-Olesen, Anders/K-4344-2014; Kjelstrup, Signe/F-9346-2014	Kjelstrup, Signe/0000-0003-1235-5709; Løbner-Olesen, Anders/0000-0002-0344-6417; Kjelstrup, Signe/0000-0003-1235-5709; Thomsen, Line Elnif/0000-0001-5460-9178; Hansen, Paul Robert/0000-0001-9357-8001	The Danish Medical Research Council [09-063428]; The Lundbeck Foundation [R32-A2889]; The Novo Nordic Foundation [R144-A]; Danish Center for Antibiotic Research and Development (DanCARD); The Danish Council for Strategic Research [09-067075]; Lundbeck Foundation [R32-2008-2889] Funding Source: researchfish	The Danish Medical Research Council(Danish Medical Research Council); The Lundbeck Foundation(Lundbeckfonden); The Novo Nordic Foundation(Novo Nordisk Foundation); Danish Center for Antibiotic Research and Development (DanCARD); The Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by: Grant 09-063428 from The Danish Medical Research Council, Grant R32-A2889 from The Lundbeck Foundation, Grant R144-A from The Novo Nordic Foundation, Danish Center for Antibiotic Research and Development (DanCARD) financed by The Danish Council for Strategic Research. Grant no. 09-067075. The funders had no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Cherkasov A, 2009, ACS CHEM BIOL, V4, P65, DOI 10.1021/cb800240j; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Dathe M, 2004, BIOCHEMISTRY-US, V43, P9140, DOI 10.1021/bi035948v; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Elleuche S, 2010, APPL MICROBIOL BIOT, V87, P479, DOI 10.1007/s00253-010-2628-x; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Fossum S, 2008, FEMS MICROBIOL LETT, V281, P210, DOI 10.1111/j.1574-6968.2008.01103.x; Georgescu RE, 2008, P NATL ACAD SCI USA, V105, P11116, DOI 10.1073/pnas.0804754105; GOTTSCHALK S, 2013, BMC MICROBIOLO UNPUB; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Gunderson CW, 2006, MOL MICROBIOL, V59, P1129, DOI 10.1111/j.1365-2958.2005.05009.x; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Hiron A, 2007, J BACTERIOL, V189, P5119, DOI 10.1128/JB.00274-07; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Horswill AR, 2004, P NATL ACAD SCI USA, V101, P15591, DOI 10.1073/pnas.0406999101; Jensen RB, 1999, EMBO J, V18, P4076, DOI 10.1093/emboj/18.14.4076; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Klemm M, 2000, J MOL BIOL, V299, P1203, DOI 10.1006/jmbi.2000.3829; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kongsuwan K, 2006, J BACTERIOL, V188, P5501, DOI 10.1128/JB.00231-06; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; McHenry CS, 2011, EMBO REP, V12, P408, DOI 10.1038/embor.2011.51; Nielsen SL, 2007, PROTEIN SCI, V16, P1969, DOI 10.1110/ps.072966007; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; ODONNELL M, 1992, MOL BIOL CELL, V3, P953, DOI 10.1091/mbc.3.9.953; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Rannou O, 2013, NUCLEIC ACIDS RES, V41, P5303, DOI 10.1093/nar/gkt207; Robinson A, 2012, CURR DRUG TARGETS, V13, P352, DOI 10.2174/138945012799424598; Rybak MJ, 2000, ANTIMICROB AGENTS CH, V44, P1062, DOI 10.1128/AAC.44.4.1062-1066.2000; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Shinabarger DL, 1997, ANTIMICROB AGENTS CH, V41, P2132, DOI 10.1128/AAC.41.10.2132; SIMMONS LA, 2008, ECOSAL ESCHERICHIA C; Smits WK, 2010, MOL MICROBIOL, V75, P452, DOI 10.1111/j.1365-2958.2009.06999.x; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Sutton MD, 2004, J BACTERIOL, V186, P6738, DOI 10.1128/JB.186.20.6738-6748.2004; Tavassoli A, 2007, NAT PROTOC, V2, P1126, DOI 10.1038/nprot.2007.152; Weigel C, 1999, MOL MICROBIOL, V34, P53, DOI 10.1046/j.1365-2958.1999.01568.x; White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062; Wijffels G, 2004, BIOCHEMISTRY-US, V43, P5661, DOI 10.1021/bi036229j; Wijffels G, 2011, J MED CHEM, V54, P4831, DOI 10.1021/jm2004333; Williams NK, 2002, J BIOL CHEM, V277, P7790, DOI 10.1074/jbc.M110303200; Wolff P, 2011, J MED CHEM, V54, P4627, DOI 10.1021/jm200311m; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	62	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72273	10.1371/journal.pone.0072273	http://dx.doi.org/10.1371/journal.pone.0072273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023733	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600016
J	Baron, R; Mannien, J; de Jonge, A; Heymans, MW; Klomp, T; Hutton, EK; Brug, J				Baron, Ruth; Mannien, Judith; de Jonge, Ank; Heymans, Martijn W.; Klomp, Trudy; Hutton, Eileen K.; Brug, Johannes			Socio-Demographic and Lifestyle-Related Characteristics Associated with Self-Reported Any, Daily and Occasional Smoking during Pregnancy	PLOS ONE			English	Article							MATERNAL SMOKING; CIGARETTE-SMOKING; RISK-FACTORS; CESSATION; HEALTH; GROWTH; WOMEN; DETERMINANTS; INEQUALITIES; RELIGIOSITY	Smoking during pregnancy is a risk factor for various adverse birth outcomes. In order to develop effective interventions, insight is needed into the characteristics associated with pregnant women who smoke. Unknown is whether these characteristics differ for women who smoke daily and women who smoke occasionally. Our study sample, drawn from the DELIVER study (Sept 2009-March 2011), consisted of 6107 pregnant women in primary care in the Netherlands who were up to 34 weeks pregnant. The associations of thirteen socio-demographic or lifestyle-related characteristics with 'any smoking', 'daily smoking' and 'occasional smoking' during pregnancy were tested using multiple binary logistic regression with general estimating equations (GEE). Characteristics most strongly associated with any smoking were low education (OR 10.3; 95% confidence interval (CI) 7.0-15.4), being of Turkish ethnicity (OR 3.9; 95% CI 2.3-6.7) and having no partner (OR 3.7; 95% CI 2.3-6.0). Women of Dutch ethnicity were three times more likely to smoke than those from Dutch-speaking Caribbean countries and non-religious women were much more likely to smoke than religious women. Low education was markedly more strongly associated with daily smoking than with occasional smoking (OR 20.3; 95% CI 13.2-31.3 versus OR 6.0; 95% CI 3.4-10.5). Daily smokers were more likely to be associated with other unfavorable lifestyle-related characteristics, such as not taking folic acid, being underweight, and having had an unplanned pregnancy. There is still much potential for health gain with respect to smoking during pregnancy in the Netherlands. Daily and occasional smokers appear to differ in characteristics, and therefore possibly require different interventions.	[Baron, Ruth] Free Univ Amsterdam, Med Ctr, Dept Midwifery Sci, AVAG EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Mannien, Judith; de Jonge, Ank; Klomp, Trudy; Hutton, Eileen K.] Vrije Univ Amsterdam, Med Ctr, Dept Midwifery Sci, AVAG EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Heymans, Martijn W.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Heymans, Martijn W.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Methodol & Appl Biostat, Amsterdam, Netherlands; [Hutton, Eileen K.] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; [Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; McMaster University; Vrije Universiteit Amsterdam	Baron, R (corresponding author), Free Univ Amsterdam, Med Ctr, Dept Midwifery Sci, AVAG EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	r.baron@vumc.nl	de Jonge, Ank/F-6475-2013; Brug, Johannes/A-8242-2018	Brug, Johannes/0000-0002-1904-7349; Mannien, Judith/0000-0003-1698-9979; Heymans, Martijn/0000-0002-3889-0921; Hutton, Eileen/0000-0003-0895-7395	Academy of Midwifery Amsterdam-Groningen (AVAG, the Netherlands)	Academy of Midwifery Amsterdam-Groningen (AVAG, the Netherlands)(Netherlands Government)	The study was funded by the Academy of Midwifery Amsterdam-Groningen (AVAG, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker R, 2011, J NUTR, V141, P2172, DOI 10.3945/jn.111.142976; Buka SL, 2003, AM J PSYCHIAT, V160, P1978, DOI 10.1176/appi.ajp.160.11.1978; Centers for Disease Control and Prevention, 2007, PREV SMOK EXP SEC SM; Dietz PM, 2011, AM J EPIDEMIOL, V173, P355, DOI 10.1093/aje/kwq381; Durmus B, 2011, AM J CLIN NUTR, V94, P164, DOI 10.3945/ajcn.110.009225; Ebert Lyn Maxine, 2007, Women Birth, V20, P161, DOI 10.1016/j.wombi.2007.08.002; el Marroun H, 2008, DRUG ALCOHOL DEPEN, V98, P218, DOI 10.1016/j.drugalcdep.2008.05.010; Elsenbruch S, 2007, HUM REPROD, V22, P869, DOI 10.1093/humrep/del432; Ergin I, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-325; Erickson AC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-102; Evers ACC, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5639; Gage JD, 2007, JOGNN-J OBST GYN NEO, V36, P574, DOI [10.1111/j.1552-6909.2007.00188.x, 10.1111/J.1552-6909.2007.00188.x]; Gillum RF, 2008, SOUTH MED J, V101, P686, DOI 10.1097/SMJ.0b013e31817a76cc; Haight J, 2012, ADDICT BEHAV, V37, P234, DOI 10.1016/j.addbeh.2011.10.006; Haslam C, 2004, HEALTH PSYCHOL, V23, P486, DOI 10.1037/0278-6133.23.5.486; Hemsing N, 2012, NICOTINE TOB RES, V14, P767, DOI 10.1093/ntr/ntr278; Hogberg L, 2007, BJOG-INT J OBSTET GY, V114, P699, DOI 10.1111/j.1471-0528.2007.01340.x; Horta BL, 1997, PAEDIATR PERINAT EP, V11, P140, DOI 10.1046/j.1365-3016.1997.d01-17.x; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P136, DOI 10.2105/AJPH.94.1.136; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Koshy G, 2011, EUR J PUBLIC HEALTH, V21, P286, DOI 10.1093/eurpub/ckq173; Kuciene R, 2009, MEDICINA-LITHUANIA, V45, P904, DOI 10.3390/medicina45110116; Lanting CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008363; Lanting Caren I, 2012, Ned Tijdschr Geneeskd, V156, pA5092; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Mann JR, 2007, SOUTH MED J, V100, P867, DOI 10.1097/SMJ.0b013e318137a422; Mannien J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-69; Maxson PJ, 2012, ADDICT BEHAV, V37, P153, DOI 10.1016/j.addbeh.2011.08.011; McCowan L, 2009, BEST PRACT RES CL OB, V23, P779, DOI 10.1016/j.bpobgyn.2009.06.003; Nagelhout GE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-303; National Institute for Health and Clinical Excellence (NICE), 2010, UITT SMOK PREGN FOLL; Page RL, 2009, MATERN CHILD HLTH J, V13, P621, DOI 10.1007/s10995-008-0394-5; Passey ME, 2012, DRUG ALCOHOL REV, V31, P608, DOI 10.1111/j.1465-3362.2012.00448.x; Russell TV, 2004, NICOTINE TOB RES, V6, pS141, DOI 10.1080/14622200410001669141; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; Siahpush M, 2004, AUST NZ J PUBL HEAL, V28, P37, DOI 10.1111/j.1467-842X.2004.tb00630.x; Stuurgroep Advies Zwangerschap en Geboorte, 2009, GOED BEG VEIL ZORG R; Thakur GA, 2013, NICOTINE TOB RES, V15, P149, DOI 10.1093/ntr/nts102; Turrell G, 2012, DRUG ALCOHOL REV, V31, P645, DOI 10.1111/j.1465-3362.2012.00452.x	39	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74197	10.1371/journal.pone.0074197	http://dx.doi.org/10.1371/journal.pone.0074197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019956	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200099
J	Kristanto, W; van Ooijen, PMA; Jansen-van der Weide, MC; Vliegenthart, R; Oudkerk, M				Kristanto, Wisnumurti; van Ooijen, Peter M. A.; Jansen-van der Weide, Marijke C.; Vliegenthart, Rozemarijn; Oudkerk, Matthijs			A Meta Analysis and Hierarchical Classification of HU-Based Atherosclerotic Plaque Characterization Criteria	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; CORONARY ARTERIAL PLAQUE; EX-VIVO MODEL; HIGH-RESOLUTION; NONINVASIVE CHARACTERIZATION; DIAGNOSTIC-ACCURACY; VASCULAR-LESIONS; CAROTID PLAQUE; CT ATTENUATION; MULTISLICE CT	Background: Many computed tomography (CT) studies have reported that lipid-rich, presumably rupture-prone atherosclerotic plaques can be characterized according to their Hounsfield Unit (HU) value. However, the published HU-based characterization criteria vary considerably. The present study aims to systematically analyze these values and empirically derive a hierarchical classification of the HU-based criteria which can be referred in clinical situation. Material and Methods: A systematic search in PubMed and Embase for publications with HU-criteria to characterize lipid-rich and fibrous atherosclerotic plaques resulted in 36 publications, published between 1998 and 2011. The HU-criteria were systematically analyzed based on the characteristics of the reporting study. Significant differences between HU-criteria were checked using Student's t-test. Subsequently, a hierarchical classification of HU-criteria was developed based on the respective study characteristics. Results: No correlation was found between HU-criteria and the reported lumen contrast-enhancement. Significant differences were found for HU-criteria when pooled according to the respective study characteristics: examination type, vessel type, CT-vendor, detector-rows, voltage-setting, and collimation-width. The hierarchical classification resulted in 21 and 22 CT attenuation value categories, for lipid-rich and fibrous plaque, respectively. More than 50% of the hierarchically classified HU-criteria were significantly different. Conclusion: In conclusion, variations in the reported CT attenuation values for lipid-rich and fibrous plaque are so large that generalized values are unreliable for clinical use. The proposed hierarchical classification can be used to determine reference CT attenuation values of lipid-rich and fibrous plaques for the local setting.	[Kristanto, Wisnumurti; van Ooijen, Peter M. A.; Jansen-van der Weide, Marijke C.; Vliegenthart, Rozemarijn; Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Ctr Med Imaging North East, Groningen, Netherlands	University of Groningen	van Ooijen, PMA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Ctr Med Imaging North East, Groningen, Netherlands.	p.m.a.van.ooijen@umcg.nl	van Ooijen, Peter/B-9150-2008	van Ooijen, Peter/0000-0002-8995-1210; Oudkerk, Matthijs/0000-0003-2800-4110				Achenbach S, 2010, J CARDIOVASC COMPUT, V4, P110, DOI 10.1016/j.jcct.2010.01.013; Becker CR, 2003, EUR RADIOL, V13, P2094, DOI 10.1007/s00330-003-1889-5; Brodoefel H, 2008, EUR RADIOL, V18, P2466, DOI 10.1007/s00330-008-1019-5; BRODOEFEL H, 2009, BR J RADIOL; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Cademartiri F, 2005, EUR RADIOL, V15, P1426, DOI 10.1007/s00330-005-2697-x; Cademartiri F, 2007, EUR RADIOL, V17, P1842, DOI 10.1007/s00330-006-0548-z; Carrascosa PM, 2006, AM J CARDIOL, V97, P598, DOI 10.1016/j.amjcard.2005.09.096; Carrascosa PM, 2003, HERZ, V28, P44, DOI 10.1007/s00059-003-2443-6; Caussin C, 2004, AM J CARDIOL, V94, P99, DOI 10.1016/j.amjcard.2004.03.036; Chopard R, 2010, INT J CARDIOVAS IMAG, V26, P373, DOI 10.1007/s10554-009-9562-y; de Weert TT, 2006, ARTERIOSCL THROM VAS, V26, P2366, DOI 10.1161/01.ATV.0000240518.90124.57; de Weert TT, 2005, EUR RADIOL, V15, P1906, DOI 10.1007/s00330-005-2712-2; Estes JM, 1998, J CARDIOVASC SURG, V39, P527; Fei XL, 2008, AM J ROENTGENOL, V191, P43, DOI 10.2214/AJR.07.2653; Ferencik M, 2006, RADIOLOGY, V240, P708, DOI 10.1148/radiol.2403051204; Foster Gary, 2009, Expert Rev Cardiovasc Ther, V7, P57, DOI 10.1586/14779072.7.1.57; Galonska M, 2008, ACAD RADIOL, V15, P222, DOI 10.1016/j.acra.2007.09.007; Gao TL, 2009, CEREBROVASC DIS, V27, P345, DOI 10.1159/000202011; Gaudio C, 2009, INT J CARDIOL, V135, P280, DOI 10.1016/j.ijcard.2008.03.091; Halliburton SS, 2006, CORONARY ARTERY DIS, V17, P553, DOI 10.1097/00019501-200609000-00009; Hammer-Hansen S, 2009, AM HEART J, V157, P481, DOI 10.1016/j.ahj.2008.10.011; Horiguchi J, 2007, AM J ROENTGENOL, V189, P981, DOI 10.2214/AJR.07.2296; Horiguchi J, 2011, EUR J RADIOL, V77, P294, DOI 10.1016/j.ejrad.2009.08.002; Hur J, 2009, J COMPUT ASSIST TOMO, V33, P186, DOI 10.1097/RCT.0b013e31817c420f; Iriart X, 2007, EUR RADIOL, V17, P2581, DOI 10.1007/s00330-007-0665-3; JIN S, 2006, CHIN J CONT NEUROL N, V6, P398; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Kim So Yeon, 2009, Korean Circ J, V39, P95, DOI 10.4070/kcj.2009.39.3.95; Kinohira Y, 2007, INT HEART J, V48, P25, DOI 10.1536/ihj.48.25; Kitagawa T, 2007, AM HEART J, V154, P1191, DOI 10.1016/j.ahj.2007.07.020; Kitagawa T, 2009, JACC-CARDIOVASC IMAG, V2, P153, DOI 10.1016/j.jcmg.2008.09.015; Kopp AF, 2001, EUR RADIOL, V11, P1607, DOI 10.1007/s003300100850; Korosoglou G, 2010, EUR RADIOL, V20, P1841, DOI 10.1007/s00330-010-1753-3; Kunita E, 2009, CIRC J, V73, P772, DOI 10.1253/circj.CJ-08-0333; Leber AW, 2007, EUR HEART J, V28, P2354, DOI 10.1093/eurheartj/ehm294; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Leber AW, 2004, J AM COLL CARDIOL, V43, P1241, DOI 10.1016/j.jacc.2003.10.059; Leschka S, 2010, J CARDIOVASC COMPUT, V4, P301, DOI 10.1016/j.jcct.2010.05.016; Marwan M, 2011, ATHEROSCLEROSIS, V215, P110, DOI 10.1016/j.atherosclerosis.2010.12.006; Miralles M, 2006, EUR J VASC ENDOVASC, V32, P561, DOI 10.1016/j.ejvs.2006.02.019; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Motoyama S, 2007, CIRC J, V71, P363, DOI 10.1253/circj.71.363; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Nikolaou K, 2004, ATHEROSCLEROSIS, V174, P243, DOI 10.1016/j.atherosclerosis.2004.01.041; Nikolaou K, 2004, RADIOLOGE, V44, P130, DOI 10.1007/s00117-003-1004-6; Oudkerk M, 2008, INT J CARDIOVAS IMAG, V24, P645, DOI 10.1007/s10554-008-9319-z; Pohle K, 2007, ATHEROSCLEROSIS, V190, P174, DOI 10.1016/j.atherosclerosis.2006.01.013; Qiu Jian-xing, 2006, Chinese Journal of Medical Imaging Technology, V22, P1456; Rozie S, 2009, EUR RADIOL, V19, P2294, DOI 10.1007/s00330-009-1394-6; Saba L, 2009, CLIN RADIOL, V64, P767, DOI 10.1016/j.crad.2009.03.009; Sakakura K, 2006, ANGIOLOGY, V57, P155, DOI 10.1177/000331970605700204; Sato Y, 2003, HEART VESSELS, V18, P224, DOI 10.1007/s00380-003-0712-1; Schmid M, 2008, ATHEROSCLEROSIS, V197, P457, DOI 10.1016/j.atherosclerosis.2007.07.003; Schoenhagen P, 2003, CORONARY ARTERY DIS, V14, P459, DOI 10.1097/00019501-200309000-00007; Schroeder S, 2001, J AM COLL CARDIOL, V37, P1430, DOI 10.1016/S0735-1097(01)01115-9; Schroeder S, 2004, HEART, V90, P1471, DOI 10.1136/hrt.2004.037861; Schroeder S, 2004, J COMPUT ASSIST TOMO, V28, P449, DOI 10.1097/00004728-200407000-00003; Shen Y, 2010, CHINESE MED J-PEKING, V123, P827, DOI 10.3760/cma.j.issn.0366-6999.2010.07.012; Soeda T, 2011, INT J CARDIOL, V148, P313, DOI 10.1016/j.ijcard.2009.11.019; Springer I, 2009, EUR J RADIOL, V71, P275, DOI 10.1016/j.ejrad.2008.04.035; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Sun JY, 2008, AM J ROENTGENOL, V190, P748, DOI 10.2214/AJR.07.2763; Suzuki S, 2006, INVEST RADIOL, V41, P510, DOI 10.1097/01.rli.0000209662.24569.c7; Tanami Y, 2010, J COMPUT ASSIST TOMO, V34, P58, DOI 10.1097/RCT.0b013e3181b66c41; Taylor AJ, 2010, J CARDIOVASC COMPUT, V4, P1, DOI 10.1016/j.jcct.2010.01.010; Varnava AM, 2002, CIRCULATION, V105, P939, DOI 10.1161/hc0802.104327; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wintermark M, 2008, AM J NEURORADIOL, V29, P875, DOI 10.3174/ajnr.A0950; [吴文辉 WU Wenhui], 2007, [中华放射学杂志, Chinese Journal of Radiology], V41, P1027; Xiao Xi-Gang, 2007, Zhonghua Yi Xue Za Zhi, V87, P3247	72	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73460	10.1371/journal.pone.0073460	http://dx.doi.org/10.1371/journal.pone.0073460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019924	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200066
J	Trikha, S; Jeremic, AM				Trikha, Saurabh; Jeremic, Aleksandar M.			Distinct Internalization Pathways of Human Amylin Monomers and Its Cytotoxic Oligomers in Pancreatic Cells	PLOS ONE			English	Article							ISLET AMYLOID POLYPEPTIDE; INSULIN-SECRETION; CALCITONIN-RECEPTOR; A-BETA; PHOSPHOINOSITIDE 3-KINASE; FIBRIL FORMATION; PROTEIN; RAT; TYPE-2; MEMBRANE	Toxic human amylin oligomers and aggregates are implicated in the pathogenesis of type 2 diabetes mellitus (TTDM). Although recent studies have shown that pancreatic cells can recycle amylin monomers and toxic oligomers, the exact uptake mechanism and trafficking routes of these molecular forms and their significance for amylin toxicity are yet to be determined. Using pancreatic rat insulinoma (RIN-m5F) beta (beta)-cells and human islets as model systems we show that monomers and oligomers cross the plasma membrane (PM) through both endocytotic and non-endocytotic (translocation) mechanisms, the predominance of which is dependent on amylin concentrations and incubation times. At low (<= 100 nM) concentrations, internalization of amylin monomers in pancreatic cells is completely blocked by the selective amylin-receptor (AM-R) antagonist, AC-187, indicating an AM-R dependent mechanism. In contrast at cytotoxic (mu M) concentrations monomers initially (1 hour) enter pancreatic cells by two distinct mechanisms: translocation and macropinocytosis. However, during the late stage (24 hours) monomers internalize by a clathrin-dependent but AM-R and macropinocytotic independent pathway. Like monomers a small fraction of the oligomers initially enter cells by a non-endocytotic mechanism. In contrast a majority of the oligomers at both early (1 hour) and late times (24 hours) traffic with a fluid-phase marker, dextran, to the same endocytotic compartments, the uptake of which is blocked by potent macropinocytotic inhibitors. This led to a significant increase in extra-cellular PM accumulation, in turn potentiating amylin toxicity in pancreatic cells. Our studies suggest that macropinocytosis is a major but not the only clearance mechanism for both amylin's molecular forms, thereby serving a cyto-protective role in these cells.	[Trikha, Saurabh; Jeremic, Aleksandar M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	George Washington University	Jeremic, AM (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	jerema@gwu.edu			National Institutes of Health (NIH) [R01-DK091845]; George Washington University UFCC research grant; Islet Cell Resource Center Basic Science and Pilot Islet Distribution Programs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091845] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Washington University UFCC research grant; Islet Cell Resource Center Basic Science and Pilot Islet Distribution Programs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant R01-DK091845 from the National Institutes of Health (NIH), by the George Washington University UFCC research grant, and by the Islet Cell Resource Center Basic Science and Pilot Islet Distribution Programs (to AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken JF, 2003, BIOCHEM J, V374, P779, DOI 10.1042/BJ20030422; Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Bailey RJ, 2012, BRIT J PHARMACOL, V166, P151, DOI 10.1111/j.1476-5381.2011.01717.x; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Brender JR, 2008, BIOCHEMISTRY-US, V47, P12680, DOI 10.1021/bi801427c; Bronsky J, 2002, Cesk Fysiol, V51, P176; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Cho WJ, 2009, J MOL BIOL, V393, P765, DOI 10.1016/j.jmb.2009.08.055; Cho WJ, 2008, METHOD CELL BIOL, V90, P267, DOI 10.1016/S0091-679X(08)00813-3; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Clark A, 2004, DIABETOLOGIA, V47, P157, DOI 10.1007/s00125-003-1304-4; Clementi G, 1996, EXPERIENTIA, V52, P677, DOI 10.1007/BF01925572; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; DEGANO P, 1993, REGUL PEPTIDES, V43, P91, DOI 10.1016/0167-0115(93)90411-Z; Domanov YA, 2008, J MOL BIOL, V376, P42, DOI 10.1016/j.jmb.2007.11.077; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Gold S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011360; Green JD, 2004, J MOL BIOL, V342, P877, DOI 10.1016/j.jmb.2004.07.052; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Haataja L, 2008, ENDOCR REV; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; INOUE K, 1993, HORM METAB RES, V25, P135, DOI 10.1055/s-2007-1002062; Janciauskiene S, 2000, BIOCHEM BIOPH RES CO, V267, P619, DOI 10.1006/bbrc.1999.1989; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jhamandas JH, 2012, APOPTOSIS, V17, P37, DOI 10.1007/s10495-011-0656-3; Jhamandas JH, 2011, AM J PATHOL, V178, P140, DOI 10.1016/j.ajpath.2010.11.022; Jhamandas JH, 2004, J NEUROSCI, V24, P5579, DOI 10.1523/JNEUROSCI.1051-04.2004; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Khemtemourian L, 2008, EXP DIABETES RES, DOI 10.1155/2008/421287; Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x; Konno M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-38; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Kuwasako K, 2004, MOL PHARMACOL, V65, P207, DOI 10.1124/mol.65.1.207; LAI AY, 2011, INT J ALZHEIMERS DIS; Lee EC, 2013, PHYS CHEM CHEM PHYS, V15, P12558, DOI 10.1039/c3cp44542a; Llorente A, 1998, J CELL BIOL, V140, P553, DOI 10.1083/jcb.140.3.553; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; MacArthur DLA, 1999, DIABETOLOGIA, V42, P1219, DOI 10.1007/s001250051295; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Magzoub M, 2012, FASEB J, V26, P1228, DOI 10.1096/fj.11-194613; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; MOORE CX, 1991, BIOCHEM BIOPH RES CO, V179, P1, DOI 10.1016/0006-291X(91)91325-7; Morfis M, 2008, ENDOCRINOLOGY, V149, P5423, DOI 10.1210/en.2007-1735; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; OHSAWA H, 1989, BIOCHEM BIOPH RES CO, V160, P961, DOI 10.1016/0006-291X(89)92529-1; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reidelberger RD, 2004, AM J PHYSIOL-REG I, V287, pR568, DOI 10.1152/ajpregu.00213.2004; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Saafi EL, 2001, CELL BIOL INT, V25, P339, DOI 10.1006/cbir.2000.0643; Sandgren KJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000866; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Stavrou I, 2006, MOL BIOL CELL, V17, P5381, DOI 10.1091/mbc.E06-06-0531; SUZUKI S, 1992, DIABETES RES CLIN PR, V15, P77, DOI 10.1016/0168-8227(92)90071-X; Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61; Trikha S, 2011, J BIOL CHEM, V286, P36086, DOI 10.1074/jbc.M111.240762; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Yu CJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-19; Zhang SP, 2002, J MOL BIOL, V324, P271, DOI 10.1016/S0022-2836(02)01044-6; Zhao HL, 2003, DIABETES, V52, P2759, DOI 10.2337/diabetes.52.11.2759; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x; Zraika S, 2007, DIABETES, V56, P304, DOI 10.2337/db06-0430	78	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73080	10.1371/journal.pone.0073080	http://dx.doi.org/10.1371/journal.pone.0073080			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019897	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200039
J	Zeitz, MJ; Ay, F; Heidmann, JD; Lerner, PL; Noble, WS; Steelman, BN; Hoffman, AR				Zeitz, Michael J.; Ay, Ferhat; Heidmann, Julia D.; Lerner, Paula L.; Noble, William S.; Steelman, Brandon N.; Hoffman, Andrew R.			Genomic Interaction Profiles in Breast Cancer Reveal Altered Chromatin Architecture	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; GROWTH; GENE; RECEPTOR; TRANSCRIPTION; PROXIMITY; RISK; EXPRESSION; COLOCALIZATION; AMPLIFICATION	Gene transcription can be regulated by remote enhancer regions through chromosome looping either in cis or in trans. Cancer cells are characterized by wholesale changes in long-range gene interactions, but the role that these long-range interactions play in cancer progression and metastasis is not well understood. In this study, we used IGFBP3, a gene involved in breast cancer pathogenesis, as bait in a 4C-seq experiment comparing normal breast cells (HMEC) with two breast cancer cell lines (MCF7, an ER positive cell line, and MDA-MB-231, a triple negative cell line). The IGFBP3 long-range interaction profile was substantially altered in breast cancer. Many interactions seen in normal breast cells are lost and novel interactions appear in cancer lines. We found that in HMEC, the breast carcinoma amplified sequence gene family (BCAS) 1-4 were among the top 10 most significantly enriched regions of interaction with IGFBP3. 3D-FISH analysis indicated that the translocation-prone BCAS genes, which are located on chromosomes 1, 17, and 20, are in close physical proximity with IGFBP3 and each other in normal breast cells. We also found that epidermal growth factor receptor (EGFR), a gene implicated in tumorigenesis, interacts significantly with IGFBP3 and that this interaction may play a role in their regulation. Breakpoint analysis suggests that when an IGFBP3 interacting region undergoes a translocation an additional interaction detectable by 4C is gained. Overall, our data from multiple lines of evidence suggest an important role for long-range chromosomal interactions in the pathogenesis of cancer.	[Zeitz, Michael J.; Heidmann, Julia D.; Lerner, Paula L.; Steelman, Brandon N.; Hoffman, Andrew R.] Stanford Univ, Sch Med, Dept Med, Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Ay, Ferhat; Noble, William S.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Noble, William S.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zeitz, MJ (corresponding author), Stanford Univ, Sch Med, Dept Med, Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	mjzeitz@stanford.edu	Ay, Ferhat/J-7800-2019	Ay, Ferhat/0000-0002-0708-6914; Hoffman, Andrew/0000-0002-0145-1917	DOD [BC102122]; Research Service of the Department of Veterans Affairs	DOD(United States Department of Defense); Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a DOD Breast Cancer Research Program Idea Award (BC102122) and the Research Service of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Baglietto L, 2007, CANCER EPIDEM BIOMAR, V16, P763, DOI 10.1158/1055-9965.EPI-06-0960; Barlund M, 2002, GENE CHROMOSOME CANC, V35, P311, DOI 10.1002/gcc.10121; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Butt AJ, 2004, J CLIN ENDOCR METAB, V89, P1950, DOI 10.1210/jc.2003-030914; Cope NF, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-204; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gheldof N, 2012, METHODS MOL BIOL, V786, P211, DOI 10.1007/978-1-61779-292-2_13; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Grkovic S, 2013, ONCOGENE, V32, P2412, DOI 10.1038/onc.2012.264; Gururaj AE, 2006, CELL CYCLE, V5, P1407, DOI 10.4161/cc.5.13.2924; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuo PC, 2009, CANCER RES, V69, P8877, DOI 10.1158/0008-5472.CAN-09-2023; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Meaburn KJ, 2008, J CELL BIOL, V180, P39, DOI 10.1083/jcb.200708204; Meaburn KJ, 2009, J CELL BIOL, V187, P801, DOI 10.1083/jcb.200909127; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; OH Y, 1993, J BIOL CHEM, V268, P26045; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qi C, 2005, BIOCHEM BIOPH RES CO, V328, P393, DOI 10.1016/j.bbrc.2004.12.187; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Rickman DS, 2012, P NATL ACAD SCI US; Rinaldi S, 2006, ENDOCR-RELAT CANCER, V13, P593, DOI 10.1677/erc.1.01150; Rocha PP, 2012, MOL CELL, V47, P873, DOI 10.1016/j.molcel.2012.06.036; Rocha RL, 1997, CLIN CANCER RES, V3, P103; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Sproul D, 2011, P NATL ACAD SCI USA, V108, P4364, DOI 10.1073/pnas.1013224108; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Sugumar A, 2004, INT J CANCER, V111, P293, DOI 10.1002/ijc.20253; Takaoka M, 2004, CANCER RES, V64, P7711, DOI 10.1158/0008-5472.CAN-04-0715; Tanner MM, 1995, CLIN CANCER RES, V1, P1455; Tomii K, 2007, INT J CANCER, V120, P566, DOI 10.1002/ijc.22341; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vu TH, 2010, HUM MOL GENET, V19, P901, DOI 10.1093/hmg/ddp558; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yu H, 1998, INT J CANCER, V79, P624, DOI 10.1002/(SICI)1097-0215(19981218)79:6<624::AID-IJC12>3.0.CO;2-9; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	66	31	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73974	10.1371/journal.pone.0073974	http://dx.doi.org/10.1371/journal.pone.0073974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019942	Green Published, gold			2022-12-27	WOS:000324338200085
J	Khalaf-Nazzal, R; Bruel-Jungerman, E; Rio, JP; Bureau, J; Irinopoulou, T; Sumia, I; Roumegous, A; Martin, E; Olaso, R; Parras, C; Cifuentes-Diaz, C; Francis, F				Khalaf-Nazzal, Reham; Bruel-Jungerman, Elodie; Rio, Jean-Paul; Bureau, Jocelyne; Irinopoulou, Theano; Sumia, Iffat; Roumegous, Audrey; Martin, Elodie; Olaso, Robert; Parras, Carlos; Cifuentes-Diaz, Carmen; Francis, Fiona			Organelle and Cellular Abnormalities Associated with Hippocampal Heterotopia in Neonatal Doublecortin Knockout Mice	PLOS ONE			English	Article							SUBCORTICAL LAMINAR HETEROTOPIA; MICROTUBULE-ASSOCIATED PROTEIN; ELECTRON-MICROSCOPIC ANALYSIS; NEURONAL MIGRATION; INTERNEURON DIVERSITY; ENHANCED EXCITABILITY; POSTNATAL-DEVELOPMENT; PYRAMIDAL CELLS; FAMILY PROTEINS; CEREBRAL-CORTEX	Heterotopic or aberrantly positioned cortical neurons are associated with epilepsy and intellectual disability. Various mouse models exist with forms of heterotopia, but the composition and state of cells developing in heterotopic bands has been little studied. Dcx knockout (KO) mice show hippocampal CA3 pyramidal cell lamination abnormalities, appearing from the age of E17.5, and mice suffer from spontaneous epilepsy. The Dcx KO CA3 region is organized in two distinct pyramidal cell layers, resembling a heterotopic situation, and exhibits hyperexcitability. Here, we characterized the abnormally organized cells in postnatal mouse brains. Electron microscopy confirmed that the Dcx KO CA3 layers at postnatal day (P) 0 are distinct and separated by an intermediate layer devoid of neuronal somata. We found that organization and cytoplasm content of pyramidal neurons in each layer were altered compared to wild type (WT) cells. Less regular nuclei and differences in mitochondria and Golgi apparatuses were identified. Each Dcx KO CA3 layer at P0 contained pyramidal neurons but also other closely apposed cells, displaying different morphologies. Quantitative PCR and immunodetections revealed increased numbers of oligodendrocyte precursor cells (OPCs) and interneurons in close proximity to Dcx KO pyramidal cells. Immunohistochemistry experiments also showed that caspase-3 dependent cell death was increased in the CA1 and CA3 regions of Dcx KO hippocampi at P2. Thus, unsuspected ultrastructural abnormalities and cellular heterogeneity may lead to abnormal neuronal function and survival in this model, which together may contribute to the development of hyperexcitability.	[Khalaf-Nazzal, Reham; Bruel-Jungerman, Elodie; Rio, Jean-Paul; Bureau, Jocelyne; Irinopoulou, Theano; Sumia, Iffat; Roumegous, Audrey; Cifuentes-Diaz, Carmen; Francis, Fiona] INSERM, UMRS 839, Paris, France; [Khalaf-Nazzal, Reham; Bruel-Jungerman, Elodie; Rio, Jean-Paul; Bureau, Jocelyne; Irinopoulou, Theano; Sumia, Iffat; Roumegous, Audrey; Martin, Elodie; Parras, Carlos; Cifuentes-Diaz, Carmen; Francis, Fiona] Univ Paris 06, Paris, France; [Khalaf-Nazzal, Reham; Bruel-Jungerman, Elodie; Rio, Jean-Paul; Bureau, Jocelyne; Irinopoulou, Theano; Sumia, Iffat; Roumegous, Audrey; Cifuentes-Diaz, Carmen; Francis, Fiona] Inst Fer Moulin, Paris, France; [Martin, Elodie; Parras, Carlos] Inst Cerveau & Moelle Epiniere, Ctr Rech, Paris, France; [Martin, Elodie; Parras, Carlos] INSERM, UMRS 975, Paris, France; [Martin, Elodie; Parras, Carlos] CNRS, UMR 7225, Paris, France; [Olaso, Robert] CEA DSV IG Ctr Natl Genotypage, Lab Rech Translat, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CEA; UDICE-French Research Universities; Universite Paris Saclay	Cifuentes-Diaz, C (corresponding author), INSERM, UMRS 839, Paris, France.	carmen.diaz@inserm.fr; fiona.francis@inserm.fr	Francis, Fiona/B-5854-2016; Parras, Carlos/G-6611-2017; Olaso, Robert/AAC-4162-2019	Parras, Carlos/0000-0003-0248-1752; Cifuentes Diaz, Carmen/0000-0003-2563-2082; Martin, Elodie/0000-0001-5668-7516; Francis, Fiona/0000-0001-8542-7537	Inserm Avenir program; French Agence National de la Recherche [ANR-08-MNP-013]; Bettencourt Schueller Foundation; Jerome Lejeune Foundation; Ile de France region through the Neuropole (Nerf)	Inserm Avenir program(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Agence National de la Recherche(French National Research Agency (ANR)); Bettencourt Schueller Foundation; Jerome Lejeune Foundation; Ile de France region through the Neuropole (Nerf)(Region Ile-de-France)	The authors thank the Inserm Avenir program, the French Agence National de la Recherche (ANR-08-MNP-013), the Bettencourt Schueller Foundation and the Jerome Lejeune Foundation for grant support to FF, and Paris 6 and An-Najah universities for support to RKN. The authors thank the Ile de France region through the Neuropole (Nerf) for support of EBJ and animal house facilities, and the FRC Rotary for confocal microscope equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman JB, 2009, J NEUROSCI, V29, P313, DOI 10.1523/JNEUROSCI.4093-08.2009; ALTMAN J, 1990, J COMP NEUROL, V301, P343, DOI 10.1002/cne.903010303; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319; Bahi-Buisson N, 2013, BRAIN, V136, P223, DOI 10.1093/brain/aws323; BALLYCUIF L, 1994, DEVELOPMENT, V120, P3379; BARKOVICH AJ, 1994, ANN NEUROL, V36, P609, DOI 10.1002/ana.410360409; Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; Bazelot M, 2012, EUR J NEUROSCI, V35, P244, DOI 10.1111/j.1460-9568.2011.07962.x; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen PH, 2008, BRAIN RES, V1243, P27, DOI 10.1016/j.brainres.2008.09.029; Chevassus-au-Louis N, 1999, CELL MOL LIFE SCI, V55, P1206, DOI 10.1007/s000180050367; Colacitti C, 1999, J NEUROPATH EXP NEUR, V58, P92, DOI 10.1097/00005072-199901000-00010; Corbo JC, 2002, J NEUROSCI, V22, P7548; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Deller T, 1999, EXP NEUROL, V156, P254, DOI 10.1006/exnr.1999.7021; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; des Portes V, 1998, CELL, V92, P51; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FARRELL MA, 1992, ACTA NEUROPATHOL, V83, P246, DOI 10.1007/BF00296786; Fleck MW, 2000, J NEUROSCI, V20, P2439; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; GOFFINET AM, 1980, ANAT EMBRYOL, V159, P199, DOI 10.1007/BF00304978; Gomez-Lopez S, 2011, GLIA, V59, P1588, DOI 10.1002/glia.21201; Guerrini R, 2006, EXP BRAIN RES, V173, P322, DOI 10.1007/s00221-006-0501-z; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hannan AJ, 1999, BRAIN, V122, P219, DOI 10.1093/brain/122.2.219; Harding B, 1996, DYSPLASIAS OF CEREBRAL CORTEX AND EPILEPSY, P81; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Jones DL, 2007, J NEUROPHYSIOL, V98, P2737, DOI 10.1152/jn.00938.2007; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Knuesel I, 2005, EUR J NEUROSCI, V21, P611, DOI 10.1111/j.1460-9568.2005.03908.x; Kukley M, 2010, J NEUROSCI, V30, P8320, DOI 10.1523/JNEUROSCI.0854-10.2010; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu JP, 2008, MICROSC RES TECHNIQ, V71, P633, DOI 10.1002/jemt.20600; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; MADEIRA MD, 1992, J COMP NEUROL, V322, P501, DOI 10.1002/cne.903220405; Manent JB, 2006, J NEUROSCI, V26, P5901, DOI 10.1523/JNEUROSCI.1033-06.2006; Markham A, 2012, EUR J NEUROSCI, V35, P366, DOI 10.1111/j.1460-9568.2011.07965.x; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; MOURELATOS Z, 1990, P NATL ACAD SCI USA, V87, P4393, DOI 10.1073/pnas.87.11.4393; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Napolioni V, 2011, MOL NEUROBIOL, V44, P83, DOI 10.1007/s12035-011-8192-2; Nosten-Bertrand M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002473; NOWAKOWSKI RS, 1979, J NEUROCYTOL, V8, P697, DOI 10.1007/BF01206671; Oettinghaus B, 2012, ACTA NEUROPATHOL, V123, P189, DOI 10.1007/s00401-011-0930-z; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Ono-Yagi K, 2000, ACTA NEUROPATHOL, V100, P403, DOI 10.1007/s004010000205; Picardo MA, 2011, NEURON, V71, P695, DOI 10.1016/j.neuron.2011.06.018; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; PRIVAT A, 1972, J COMP NEUROL, V146, P277, DOI 10.1002/cne.901460302; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Slomianka L, 2011, BRAIN STRUCT FUNCT, V216, P301, DOI 10.1007/s00429-011-0322-0; STANFIELD BB, 1979, J COMP NEUROL, V185, P423, DOI 10.1002/cne.901850303; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Tole S, 1997, DEVELOPMENT, V124, P4959; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Zhang JZ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-158	77	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72622	10.1371/journal.pone.0072622	http://dx.doi.org/10.1371/journal.pone.0072622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023755	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400017
J	Li, YF; Kwok, AHY; Jiang, JW; Zou, Y; Zheng, FY; Chen, P; Hou, CC; Leung, FC; Jiang, P				Li, Yufeng; Kwok, Amy H. Y.; Jiang, Jingwei; Zou, Yao; Zheng, Fangyuan; Chen, Pan; Hou, Chengcai; Leung, Frederick C.; Jiang, Ping			Complete Genome Analysis of a Haemophilus parasuis Serovar 12 Strain from China	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY; PATHOGENICITY ISLANDS; PIGS; DATABASE; PROTECTION; RESISTANCE; ALIGNMENT; SEQUENCE; MUTANT; GENES	Haemophilus parasuis is the etiological agent of Glasser's disease in pigs and 15 standard serovars were identified. The widespread disease causes great economic loss in the swine industry worldwide. Aiming to investigate the differences in genome composition and functions among various strains, a highly virulent strain ZJ0906 of H. parasuis serovar 12 from China was analyzed and compared with serovar 5 SH0165. Strain ZJ0906 genome is 2,324,740 base pairs with 40.06% genomic GC content. It contains 2,484 open reading frames (ORF) predicted by Glimmer 3.02, of which 2,352 (similar to 94.7%) were annotated by NCBI nr blast, 1,745 by COG database and 1,829 by KEGG database. 109 potential virulence factors were annotated in strain ZJ0906 and 3 of which are potentially related to antibiotic resistance. Strain ZJ0906 genome is,55 kilobases longer than SH0165 genome, with an extra 211 predicted ORFs. VFDB, ARDB, and PAIDB blast searches showed that ZJ0906 and SH0165 shared a nearly identical panel of potential virulence factors, drug resistant genes and four PAI-like regions which showed high homology to Enterococcus, Escherichia and Salmonella. Synteny analysis showed that gene rearrangements are frequent between the two strains, which may lead to variations in pathogenicity and cross-protection among serovars. KEGG pathway analyses showed strain ZJ0906 shared similar metabolic pathways to strain SH0165. Molecular identification of these genomic elements and potential virulence factors pave the way to the better understanding of mechanisms underlying metabolic capabilities and pathogenicity of H. parasuis and prospective vaccine targets besides the widely used method of inactivated bacteria.	[Li, Yufeng; Zou, Yao; Zheng, Fangyuan; Chen, Pan; Hou, Chengcai; Jiang, Ping] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Kwok, Amy H. Y.; Jiang, Jingwei; Leung, Frederick C.] Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China; [Leung, Frederick C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; University of Hong Kong	Jiang, P (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	fcleung.njau@gmail.com; jiangp@njau.edu.cn			Jiangsu province [BE2012368]; China agricultural research system foundation [CARS-36]; special fund for agro-scientific research in the public interest [201203039, 200903036-4]; priority academic program development of Jiangsu higher education institutions (PAPD)	Jiangsu province; China agricultural research system foundation; special fund for agro-scientific research in the public interest; priority academic program development of Jiangsu higher education institutions (PAPD)	This work was supported by the grants of agriculture from Jiangsu province (BE2012368), China agricultural research system foundation (CARS-36), special fund for agro-scientific research in the public interest (201203039, 200903036-4), and priority academic program development of Jiangsu higher education institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul M, 1997, J SMALL ANIM PRACT, V38, P286, DOI 10.1111/j.1748-5827.1997.tb03466.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bak H, 2002, VET REC, V151, P502, DOI 10.1136/vr.151.17.502; Barnes HA, 2007, MICROB PATHOGENESIS, V43, P198, DOI 10.1016/j.micpath.2007.05.007; Cai XW, 2005, VET MICROBIOL, V111, P231, DOI 10.1016/j.vetmic.2005.07.007; Castilla KS, 2012, RES VET SCI, V92, P366, DOI 10.1016/j.rvsc.2011.04.006; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Del Rio ML, 2003, J CLIN MICROBIOL, V41, P880, DOI 10.1128/JCM.41.2.880-882.2003; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fu SL, 2013, CLIN VACCINE IMMUNOL, V20, P134, DOI 10.1128/CVI.00458-12; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Jiang XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027757; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Lagergard Teresa, 1995, Trends in Microbiology, V3, P87, DOI 10.1016/S0966-842X(00)88888-5; Leplae R, 2004, NUCLEIC ACIDS RES, V32, pD45, DOI 10.1093/nar/gkh084; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; de la Fuente AJM, 2007, VET MICROBIOL, V120, P184, DOI 10.1016/j.vetmic.2006.10.014; MINIATS OP, 1991, CAN J VET RES, V55, P37; Mullins MA, 2011, STAND GENOMIC SCI, V5, P61, DOI 10.4056/sigs.2245029; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Ostblom A, 2011, APPL ENVIRON MICROB, V77, P2303, DOI 10.1128/AEM.02405-10; Que F, 2013, CURR MICROBIOL; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rafiee M, 2000, AUST VET J, V78, P172, DOI 10.1111/j.1751-0813.2000.tb10586.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Smirnova GV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P973, DOI 10.1023/A:1012361323992; Takahashi H, 2004, J BACTERIOL, V186, P244, DOI 10.1128/JB.186.1.244-247.2004; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Xu CG, 2011, J VET MED SCI, V73, P1061, DOI 10.1292/jvms.10-0515; Yoon SH, 2007, NUCLEIC ACIDS RES, V35, pD395, DOI 10.1093/nar/gkl790; Zhang J, 2011, LETT APPL MICROBIOL, V52, P589, DOI 10.1111/j.1472-765X.2011.03048.x; Zhou SM, 2013, VET J, V196, P111, DOI 10.1016/j.tvjl.2012.09.007; Zou Y, 2013, VET MICROBIOL, V162, P278, DOI 10.1016/j.vetmic.2012.08.006	36	4	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e68350	10.1371/journal.pone.0068350	http://dx.doi.org/10.1371/journal.pone.0068350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023711	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400002
J	Chang, CJ; Kuo, HC; Chang, JS; Lee, JK; Tsai, FJ; Khor, CC; Chang, LC; Chen, SP; Ko, TM; Liu, YM; Chen, YJ; Hong, YM; Jang, GY; Hibberd, ML; Kuijpers, T; Burgner, D; Levin, M; Burns, JC; Davila, S; Chen, YT; Chen, CH; Wu, JY; Lee, YC				Chang, Chia-Jung; Kuo, Ho-Chang; Chang, Jeng-Sheng; Lee, Jong-Keuk; Tsai, Fuu-Jen; Khor, Chiea Chuen; Chang, Li-Ching; Chen, Shih-Ping; Ko, Tai-Ming; Liu, Yi-Min; Chen, Ying-Ju; Hong, Young Mi; Jang, Gi Young; Hibberd, Martin L.; Kuijpers, Taco; Burgner, David; Levin, Michael; Burns, Jane C.; Davila, Sonia; Chen, Yuan-Tsong; Chen, Chien-Hsiun; Wu, Jer-Yuarn; Lee, Yi-Ching		Int Kawasaki Dis Genetics Consorti; Korean Kawasaki Dis Genetics Conso; Taiwan Kawasaki Dis Genetics Conso	Replication and Meta-Analysis of GWAS Identified Susceptibility Loci in Kawasaki Disease Confirm the Importance of B Lymphoid Tyrosine Kinase (BLK) in Disease Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; B10 CELLS; AUTOIMMUNITY; YOUNG	The BLK and CD40 loci have been associated with Kawasaki disease (KD) in two genome-wide association studies (GWAS) conducted in a Taiwanese population of Han Chinese ancestry (Taiwanese) and in Japanese cohorts. Here we build on these findings with replication studies of the BLK and CD40 loci in populations of Korean and European descent. The BLK region was significantly associated with KD susceptibility in both populations. Within the BLK gene the rs2736340-located linkage disequilibrium (LD) comprising the promoter and first intron was strongly associated with KD, with the combined results of Asian studies including Taiwanese, Japanese, and Korean populations (2,539 KD patients and 7,021 controls) providing very compelling evidence of association (rs2736340, OR = 1.498, 1.354-1.657; P = 4.74 x 10(-31)). We determined the percentage of B cells present in the peripheral blood mononuclear cell (PBMC) population and the expression of BLK in the peripheral blood leukocytes (leukocytes) of KD patients during the acute and convalescent stages. The percentage of B cells in the PBMC population and the expression of BLK in leukocytes were induced in patients in the acute stage of KD. In B cell lines derived from KD patients, and in purified B cells from KD patients obtained during the acute stage, those with the risk allele of rs2736340 expressed significantly lower levels of BLK. These results suggest that peripheral B cells play a pathogenic role during the acute stage of KD. Decreased BLK expression in peripheral blood B cells may alter B cell function and predispose individuals to KD. These associative data suggest a role for B cells during acute KD. Understanding the functional implications may facilitate the development of B cell-mediated therapy for KD.	[Chang, Chia-Jung; Chen, Yuan-Tsong] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Chang, Chia-Jung; Chang, Li-Ching; Chen, Shih-Ping; Ko, Tai-Ming; Liu, Yi-Min; Chen, Ying-Ju; Chen, Yuan-Tsong; Chen, Chien-Hsiun; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Chang, Jeng-Sheng] China Med Univ & Hosp, Dept Pediat, Taichung, Taiwan; [Lee, Jong-Keuk; Chen, Chien-Hsiun; Wu, Jer-Yuarn] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea; [Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Khor, Chiea Chuen; Davila, Sonia] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Khor, Chiea Chuen] Natl Univ Singapore, Sch Med, Dept Ophthalmol, Singapore 117548, Singapore; [Khor, Chiea Chuen] Natl Univ Singapore, Sch Med, Dept Paediat, Singapore 117548, Singapore; [Hong, Young Mi] Ewha Womans Univ Hosp, Dept Pediat, Seoul, South Korea; [Jang, Gi Young] Univ Korea Hosp, Dept Pediat, Ansan, South Korea; [Hibberd, Martin L.] Genome Inst Singapore, Div Infect Dis, Singapore, Singapore; [Kuijpers, Taco] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Burgner, David] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Burgner, David] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Pediat, London, England; [Burns, Jane C.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Davila, Sonia] Natl Univ Singapore, Sch Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Lee, Yi-Ching] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Lee, Yi-Ching] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Ulsan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Ewha Womans University; Korea University; Korea University Medicine (KU Medicine); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Imperial College London; University of California System; University of California San Diego; National University of Singapore; Duke University; National Tsing Hua University; Academia Sinica - Taiwan	Chen, YT (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan.	chen0010@ibms.sinica.edu.tw; chchen@ibms.sinica.edu.tw; jywu@ibms.sinica.edu.tw; yiching@gate.sinica.edu.tw	Wu, Jer-Yuarn/S-7010-2018; Tsai, Fuu-Jen/J-4140-2015; Kuo, Ho-Chang/AAQ-6644-2020; Curtis, Nigel/B-3491-2012; Ko, Tai-Ming/ABB-3384-2020; Chen, Chien Hsiun/Q-3826-2018; Lee, Yi-Ching/AAE-6900-2022	Kuo, Ho-Chang/0000-0002-3295-2984; Curtis, Nigel/0000-0003-3446-4594; Lee, Yi-Ching/0000-0002-7734-5619; HUANG, LI-MIN/0000-0002-9291-260X; Tulloh, Robert/0000-0002-3180-6993; Hibberd, Martin/0000-0001-8587-1849; Khor, Chiea Chuen/0000-0002-1128-4729; Levin, Michael/0000-0003-2767-6919; Burgner, David/0000-0002-8304-4302	Academia Sinica Genomic Medicine Multicenter Study, Taiwan [40-05-GMM]; National Science Council, Taiwan [NSC 100-2314-B-182-061-MY3]; National Institute for Health Research [NF-SI-0611-10230] Funding Source: researchfish	Academia Sinica Genomic Medicine Multicenter Study, Taiwan(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Institute for Health Research(National Institute for Health Research (NIHR))	This work is supported by the Academia Sinica Genomic Medicine Multicenter Study, Taiwan (40-05-GMM) and the National Science Council, Taiwan (NSC 100-2314-B-182-061-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; DYMECKI SM, 1990, SCIENCE, V247, P332, DOI 10.1126/science.2404338; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jacob A, 2002, J BIOL CHEM, V277, P23420, DOI 10.1074/jbc.M202485200; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kawasaki T, 1967, Arerugi, V16, P178; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kim S, 2005, CURR OPIN PEDIATR, V17, P695, DOI 10.1097/01.mop.0000187190.97166.83; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Lemoine S, 2011, J AUTOIMMUN, V36, P228, DOI 10.1016/j.jaut.2011.01.005; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; WASSERMAN R, 1995, J IMMUNOL, V155, P644; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385	20	37	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72037	10.1371/journal.pone.0072037	http://dx.doi.org/10.1371/journal.pone.0072037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023612	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000323880200007
J	Grant, CW; Moran-Paul, CM; Duclos, SK; Guberski, DL; Arreaza-Rubin, G; Spain, LM				Grant, Christian W.; Moran-Paul, Catherine M.; Duclos, Shane K.; Guberski, Dennis L.; Arreaza-Rubin, Guillermo; Spain, Lisa M.			Testing Agents for Prevention or Reversal of Type 1 Diabetes in Rodents	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; REGULATORY T-CELLS; NOD MICE; AUTOIMMUNE; ANTI-CD3; LISOFYLLINE; THERAPY; REMISSION; BETA; CYCLOSPORINE	We report the results of an independent laboratory's tests of novel agents to prevent or reverse type 1 diabetes (T1D) in the non-obese diabetic (NOD) mouse, BioBreeding diabetes prone (BBDP) rat, and multiple autoimmune disease prone (MAD) rat models. Methods were developed to better mimic human clinical trials, including: prescreening, randomization, blinding, and improved glycemic care of the animals. Agents were suggested by the research community in an open call for proposals, and selected for testing by an NIDDK appointed independent review panel. Agents selected for testing to prevent diabetes at later stages of progression in a rodent model were a STAT4 antagonist (DT22669), alpha(1) anti-trypsin (Aralast NP), celastrol (a natural product with anti-inflammatory properties), and a Macrophage Inflammatory Factor inhibitor (ISO-092). Agents tested for reversal of established T1D in rodent models were: alpha(1) anti-trypsin (Aralast NP), tolerogenic peptides (Tregitopes), and a long-acting formulation of GLP-1 (PGC-GLP-1). None of these agents were seen to prevent or reverse type 1 diabetes, while the positive control interventions were effective: anti-CD3 treatment provided disease reversal in the NOD mouse, dexamethasone prevented T1D induction in the MAD rat, and cyclosporin prevented T1D in the BBDP rat. For some tested agents, details of previous formulation, delivery, or dosing, as well as laboratory procedure, availability of reagents and experimental design, could have impacted our ability to confirm prior reports of efficacy in preclinical animal models. In addition, the testing protocols utilized here provided detection of effects in a range commonly used in placebo controlled clinical trials (for example, 50% effect size), and thus may have been underpowered to observe more limited effects. That said, we believe the results compiled here, showing good control and repeatability, confirm the feasibility of screening diverse test agents in an independent laboratory.	[Arreaza-Rubin, Guillermo; Spain, Lisa M.] NIDDK, NIH, Bethesda, MD USA; [Grant, Christian W.; Moran-Paul, Catherine M.; Duclos, Shane K.; Guberski, Dennis L.] Biomed Res Models BRM Inc, Worcester, MA USA; [Grant, Christian W.; Moran-Paul, Catherine M.; Duclos, Shane K.; Guberski, Dennis L.] Biomed Res Models BRM Inc, Springfield, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Spain, LM (corresponding author), NIDDK, NIH, Bethesda, MD USA.	spainL@niddk.nih.gov			National Institutes of Health [N01-DK-62909]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health under a contract N01-DK-62909. NIH staff were involved in study design, data analysis, decision to publish, and preparation of the manuscript.	Ablamunits V, 2012, DIABETES, V61, P145, DOI 10.2337/db11-1033; Atkinson MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002757; Bojunga J, 2003, CYTOKINE, V21, P179, DOI 10.1016/S1043-4666(03)00076-0; Cascao R, 2012, AUTOIMMUN REV, V11, P856, DOI 10.1016/j.autrev.2012.02.022; Castillo GM, 2012, PHARM RES-DORDR, V29, P306, DOI 10.1007/s11095-011-0542-2; Chen GJ, 2008, J LEUKOCYTE BIOL, V83, P280, DOI 10.1189/jlb.0707498; Dagia NM, 2009, EUR J PHARMACOL, V607, P201, DOI 10.1016/j.ejphar.2009.02.031; Davalli AM, 2012, ACTA DIABETOL, V49, P75, DOI 10.1007/s00592-011-0268-y; Davoodi-Semiromi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036079; De Groot AS, 2008, BLOOD, V112, P3303, DOI 10.1182/blood-2008-02-138073; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Grant CW, 2012, COMPARATIVE MED, V62, P381; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Hu CY, 2013, DIABETES, V62, P2849, DOI 10.2337/db12-1175; Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; JAWORSKI MA, 1986, DIABETES RES CLIN EX, V3, P1; Kosiewicz MM, 2011, EUR J PHARMACOL, V658, P257, DOI 10.1016/j.ejphar.2011.02.016; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Kusy S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035733, DOI 10.1371/J0URNAL.P0NE.0035733.PUBMED:22545133]; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Lewis EC, 2012, MOL MED, V18, P957, DOI 10.2119/molmed.2011.00196; Londono P, 2010, CLIN IMMUNOL, V135, P401, DOI 10.1016/j.clim.2010.01.007; Lu YQ, 2006, HUM GENE THER, V17, P625, DOI 10.1089/hum.2006.17.625; Ma H, 2010, DIABETOLOGIA, V53, P2198, DOI 10.1007/s00125-010-1829-2; Makino S, 1980, Jikken Dobutsu, V29, P1; McGuire HM, 2011, DIABETES, V60, P867, DOI 10.2337/db10-1157; Mehta DS, 2010, IMMUNOLOGY, V130, P103, DOI 10.1111/j.1365-2567.2009.03217.x; Moore DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013235; Mordes JP, 2005, DIABETES, V54, P2727, DOI 10.2337/diabetes.54.9.2727; NAKHOODA AF, 1978, DIABETOLOGIA, V14, P199, DOI 10.1007/BF00429781; *OLAW, 2002, PUBL HLTH SERV POL H; Perone MJ, 2009, J IMMUNOL, V182, P2641, DOI 10.4049/jimmunol.0800839; Phillips JM, 2007, DIABETES, V56, P634, DOI 10.2337/db06-0832; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Sarikonda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054712; Sherry NA, 2007, ENDOCRINOLOGY, V148, P5136, DOI 10.1210/en.2007-0358; Skyler JS, 2008, ANN NY ACAD SCI, V1150, P14, DOI 10.1196/annals.1447.054; Sobel D, 2010, ACTA DIABETOL, V47, P243, DOI 10.1007/s00592-010-0188-2; Sosenko JM, 2012, DIABETES, V61, P1331, DOI 10.2337/db11-1660; Stojanovic I, 2012, CLIN EXP IMMUNOL, V169, P156, DOI 10.1111/j.1365-2249.2012.04607.x; Subramanian L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037771; Takiishi T, 2012, J CLIN INVEST, V122, P1717, DOI 10.1172/JCI60530; Tian B, 2009, TRANSPLANTATION, V87, P198, DOI 10.1097/TP.0b013e3181933261; Tirabassi RS, 2010, DIABETES, V59, P110, DOI 10.2337/db09-0255; Vaidya HB, 2008, CURR DRUG TARGETS, V9, P911, DOI 10.2174/138945008785909284; van der Marel S, 2012, WORLD J GASTROENTERO, V18, P4288, DOI 10.3748/wjg.v18.i32.4288; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Wan X, 2013, DIABETES; Wang M, 2012, SCI TRANSL MED, V4; Xue S, 2010, J DIABETES COMPLICAT, V24, P163, DOI 10.1016/j.jdiacomp.2008.12.004; Yamada A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012894; Yang ZD, 2006, BIOCHEM BIOPH RES CO, V344, P1017, DOI 10.1016/j.bbrc.2006.03.177; Yang ZD, 2003, ANN NY ACAD SCI, V1005, P409, DOI 10.1196/annals.1288.069; Yang ZD, 2004, TRANSPLANTATION, V77, P55, DOI 10.1097/01.TP.0000104844.48064.81; Yang ZD, 2002, DIABETOLOGIA, V45, P1307, DOI 10.1007/s00125-002-0901-y; Yi ZA, 2012, DIABETES, V61, P2871, DOI 10.2337/db12-0098; Zhao Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004226	61	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72989	10.1371/journal.pone.0072989	http://dx.doi.org/10.1371/journal.pone.0072989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023664	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200060
J	Lansner, A; Marklund, P; Sikstrom, S; Nilsson, LG				Lansner, Anders; Marklund, Petter; Sikstrom, Sverker; Nilsson, Lars-Goran			Reactivation in Working Memory: An Attractor Network Model of Free Recall	PLOS ONE			English	Article							SHORT-TERM-MEMORY; NEURAL-NETWORK; PROSPECTIVE COHORT; RECENCY; CORTEX; PRIMACY; CONTEXT; ORGANIZATION; REPRESENTATION; VARIABILITY	The dynamic nature of human working memory, the general-purpose system for processing continuous input, while keeping no longer externally available information active in the background, is well captured in immediate free recall of supraspan word-lists. Free recall tasks produce several benchmark memory phenomena, like the U-shaped serial position curve, reflecting enhanced memory for early and late list items. To account for empirical data, including primacy and recency as well as contiguity effects, we propose here a neurobiologically based neural network model that unifies short- and long-term forms of memory and challenges both the standard view of working memory as persistent activity and dual-store accounts of free recall. Rapidly expressed and volatile synaptic plasticity, modulated intrinsic excitability, and spike-frequency adaptation are suggested as key cellular mechanisms underlying working memory encoding, reactivation and recall. Recent findings on the synaptic and molecular mechanisms behind early LTP and on spiking activity during delayed-match-to-sample tasks support this view.	[Lansner, Anders] Stockholm Univ, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden; [Lansner, Anders] KTH Royal Inst Technol, Dept Computat Biol, Sch Comp Sci & Commun, Stockholm, Sweden; [Lansner, Anders; Marklund, Petter; Sikstrom, Sverker; Nilsson, Lars-Goran] Stockholm Brain Inst, Stockholm, Sweden; [Marklund, Petter; Nilsson, Lars-Goran] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Sikstrom, Sverker] Lund Univ, Dept Psychol, Lund, Sweden	Stockholm University; Royal Institute of Technology; Stockholm University; Lund University	Lansner, A (corresponding author), Stockholm Univ, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden.	ala@kth.se	; Lansner, Anders/E-4824-2016	Sikstrom, Sverker/0000-0003-2644-9626; Lansner, Anders/0000-0002-2358-7815	Swedish Research Council [80212103, 2009-5329, 315-2004-6977]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was supported by grants from the Swedish Research Council (www.vr.se, numbers 80212103, 2009-5329, and 315-2004-6977). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akrami A, 2012, BRAIN RES, V1434, P4, DOI 10.1016/j.brainres.2011.07.030; Atkinson R. L, 1968, PSYCHOL LEARNING MOT; Baddeley A.D., 1974, RECENT ADV LEARNING, V8; Brown GDA, 2007, PSYCHOL REV, V114, P539, DOI 10.1037/0033-295X.114.3.539; BURGESS N, 1991, NETWORK-COMP NEURAL, V2, P399, DOI 10.1088/0954-898X/2/4/005; Buxhoeveden DP, 2002, BRAIN, V125, P935, DOI 10.1093/brain/awf110; Cowan N., 1999, MODELS WORKING MEMOR; Davelaar EJ, 2005, PSYCHOL REV, V112, P3, DOI 10.1037/0033-295X.112.1.3; DeFelipe J, 2006, PROG BRAIN RES, V154, P15, DOI 10.1016/S0079-6123(06)54002-6; Farrell S, 2010, J EXP PSYCHOL LEARN, V36, P324, DOI 10.1037/a0018042; FAVOROV OV, 1994, CEREB CORTEX, V4, P408, DOI 10.1093/cercor/4.4.408; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Fuentemilla L, 2010, CURR BIOL, V20, P606, DOI 10.1016/j.cub.2010.01.057; GLENBERG AM, 1986, J EXP PSYCHOL LEARN, V12, P3, DOI 10.1037/0278-7393.12.1.3; Greene AJ, 2000, LEARN MEMORY, V7, P48, DOI 10.1101/lm.7.1.48; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Howard MW, 2006, PSYCHON B REV, V13, P439, DOI 10.3758/BF03193867; Howard MW, 1999, J EXP PSYCHOL LEARN, V25, P923, DOI 10.1037/0278-7393.25.4.923; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Jacobs J, 2009, J NEUROSCI, V29, P10203, DOI 10.1523/JNEUROSCI.2187-09.2009; Johansson C, 2007, NEURAL NETWORKS, V20, P48, DOI 10.1016/j.neunet.2006.05.029; Jung SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006549; Kahana MJ, 1996, MEMORY COGNITION, V24; KANTER I, 1988, PHYS REV A, V37, P2739, DOI 10.1103/PhysRevA.37.2739; Kropff E, 2006, NATURAL COMPUTING, V6, P169; Kruse MS, 2009, EUR NEUROPSYCHOPHARM, V19, P296, DOI 10.1016/j.euroneuro.2008.12.006; Laming D, 2006, J EXP PSYCHOL LEARN, V32, P1146, DOI 10.1037/0278-7393.32.5.1146; Laming D, 2010, PSYCHOL REV, V117, P93, DOI 10.1037/a0017839; Lansner A, 1996, INT J NEURAL SYST, V7, P115, DOI 10.1142/S0129065796000816; Lansner A, 2009, TRENDS NEUROSCI, V32, P178, DOI 10.1016/j.tins.2008.12.002; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lewis-Peacock JA, 2012, J COGNITIVE NEUROSCI, V24, P61, DOI 10.1162/jocn_a_00140; Lu CB, 2009, NEUROBIOL AGING; Lundqvist M, 2006, NETWORK-COMP NEURAL, V17, P253, DOI 10.1080/09548980600774619; Lundqvist M, 2011, J COGNITIVE NEUROSCI, V23, P3008, DOI 10.1162/jocn_a_00029; Lundqvist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000803; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; MENSINK GJM, 1989, J MATH PSYCHOL, V33, P172, DOI 10.1016/0022-2496(89)90029-1; MODIGLIANI V, 1987, J EXP PSYCHOL LEARN, V13, P426, DOI 10.1037/0278-7393.13.3.426; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Muir DR, 2011, CEREB CORTEX; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Murdock BB, 1997, PSYCHOL REV, V104, P839, DOI 10.1037/0033-295X.104.4.839; MURDOCK BB, 1982, PSYCHOL REV, V89, P609, DOI 10.1037/0033-295X.89.6.609; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Polyn SM, 2009, PSYCHOL REV, V116, P129, DOI 10.1037/a0014420; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rockland KS, 2004, EXP BRAIN RES, V158, P265, DOI 10.1007/s00221-004-2024-9; Sandberg A, 2003, NETWORK-COMP NEURAL, V14, P789, DOI 10.1088/0954-898X/14/4/309; Sandberg A, 2002, NETWORK-COMP NEURAL, V13, P179, DOI 10.1088/0954-898X/13/2/302; Sandberg A, 2001, NEUROCOMPUTING; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sederberg PB, 2008, PSYCHOL REV, V115, P893, DOI 10.1037/a0013396; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Sikstrom S, 2006, COGNITIVE SCI, V30, P243, DOI 10.1207/s15516709cog0000_55; Tan L, 2000, J EXP PSYCHOL LEARN, V26, P1589, DOI 10.1037/0278-7393.26.6.1589; Treves A, 2005, COGN NEUROPSYCHOL, V22, P276, DOI 10.1080/02643290442000329; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Verduzco-Flores SO, 2012, J COMPUT NEUROSCI, V32, P403, DOI 10.1007/s10827-011-0360-x; VonderMalsburg C, 1986, BRAIN THEORY, P161; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WONG KYM, 1991, J PHYS A-MATH GEN, V24, P1119, DOI 10.1088/0305-4470/24/5/025; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	71	20	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73776	10.1371/journal.pone.0073776	http://dx.doi.org/10.1371/journal.pone.0073776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211BX	24023690	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200087
J	Ueda, Y; Takeda, M; Mori, K; Dansako, H; Wakita, T; Kim, HS; Sato, A; Wataya, Y; Ikeda, M; Kato, N				Ueda, Youki; Takeda, Midori; Mori, Kyoko; Dansako, Hiromichi; Wakita, Takaji; Kim, Hye-Sook; Sato, Akira; Wataya, Yusuke; Ikeda, Masanori; Kato, Nobuyuki			New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication	PLOS ONE			English	Article							CELL-CULTURE; EFFICIENT REPLICATION; INFECTION; GENOME; SYSTEM; INTERFERON; LINES; EPIDEMIOLOGY; ENDOPEROXIDE; COMBINATION	Background: Persistent hepatitis C virus (HCV) infection causes chronic liver diseases and is a global health problem. Although new triple therapy (pegylated-interferon, ribavirin, and telaprevir/boceprevir) has recently been started and is expected to achieve a sustained virologic response of more than 70% in HCV genotype 1 patients, there are several problems to be resolved, including skin rash/ageusia and advanced anemia. Thus a new type of anti-HCV drug is still needed. Methodology/Principal Findings: Recently developed HCV drug assay systems using HCV-RNA-replicating cells (e.g., HuH-7-derived OR6 and Li23-derived ORL8) were used to evaluate the anti-HCV activity of drug candidates. During the course of the evaluation of anti-HCV candidates, we unexpectedly found that two preclinical antimalarial drugs (N-89 and its derivative N-251) showed potent anti-HCV activities at tens of nanomolar concentrations irrespective of the cell lines and HCV strains of genotype 1b. We confirmed that replication of authentic HCV-RNA was inhibited by these drugs. Interestingly, however, this anti-HCV activity did not work for JFH-1 strain of genotype 2a. We demonstrated that HCV-RNA-replicating cells were cured by treatment with only N-89. A comparative time course assay using N-89 and interferon-alpha demonstrated that N-89-treated ORL8 cells had more rapid anti-HCV kinetics than did interferon-alpha-treated cells. This anti-HCV activity was largely canceled by vitamin E. In combination with interferon-alpha and/or ribavirin, N-89 or N-251 exhibited a synergistic inhibitory effect. Conclusions/Significance: We found that the preclinical antimalarial drugs N-89 and N-251 exhibited very fast and potent anti-HCV activities using cell-based HCV-RNA-replication assay systems. N-89 and N-251 may be useful as a new type of anti-HCV reagents when used singly or in combination with interferon and/or ribavirin.	[Ueda, Youki; Takeda, Midori; Mori, Kyoko; Dansako, Hiromichi; Ikeda, Masanori; Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Shikata, Okayama, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan; [Kim, Hye-Sook; Sato, Akira; Wataya, Yusuke] Okayama Univ, Fac Pharmaceut Sci, Dept Drug Informat, Okayama 700, Japan	Okayama University; National Institute of Infectious Diseases (NIID); Okayama University	Kato, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Shikata, Okayama, Japan.	nkato@md.okayama-u.ac.jp	Ueda, Youki/J-3529-2015; Dansako, Hiromichi/M-1421-2019; DANSAKO, Hiromichi/B-2025-2011; KIM, HYE-SOOK/B-2044-2011; Dansako, Hiromichi/N-3109-2019	Ueda, Youki/0000-0002-2627-8524; DANSAKO, Hiromichi/0000-0002-2353-3024; Dansako, Hiromichi/0000-0002-2353-3024; Sato, Akira/0000-0002-2239-6208	Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [24790216] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid for research on hepatitis from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2007, VIRUS RES, V125, P88, DOI 10.1016/j.virusres.2006.12.011; Aly NSM, 2007, PARASITOL RES, V100, P1119, DOI 10.1007/s00436-007-0460-8; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Chevaliez S, 2007, ADV DRUG DELIVER REV, V59, P1222, DOI 10.1016/j.addr.2007.07.002; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Ikeda M, 2007, ADV DRUG DELIVER REV, V59, P1277, DOI 10.1016/j.addr.2007.03.021; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Ikeda M, 2011, LIVER INT, V31, P873, DOI 10.1111/j.1478-3231.2011.02499.x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kato N, 2003, BIOCHEM BIOPH RES CO, V306, P756, DOI 10.1016/S0006-291X(03)01047-7; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kato N, 2009, VIRUS RES, V146, P41, DOI 10.1016/j.virusres.2009.08.006; Kim HS, 2003, J MED CHEM, V46, P1957, DOI 10.1021/jm020387b; Kim HS, 2001, J MED CHEM, V44, P2357, DOI 10.1021/jm010026g; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Mori K, 2013, HEPATOLOGY IN PRESS; Mori K, 2008, BIOCHEM BIOPH RES CO, V371, P104, DOI 10.1016/j.bbrc.2008.04.005; Mori K, 2012, VIRUS GENES, V44, P374, DOI 10.1007/s11262-012-0712-2; Mori K, 2011, VIRUS RES, V157, P61, DOI 10.1016/j.virusres.2011.02.005; Mori K, 2010, HEPATOL RES, V40, P1248, DOI 10.1111/j.1872-034X.2010.00730.x; Morita M, 2012, J PROTEOME RES, V11, P5704, DOI 10.1021/pr3005315; Naka K, 2005, BIOCHEM BIOPH RES CO, V330, P871, DOI 10.1016/j.bbrc.2005.03.062; Nishimura G, 2009, ANTIVIR RES, V82, P42, DOI 10.1016/j.antiviral.2009.01.007; Nozaki A, 2010, ARCH VIROL, V155, P601, DOI 10.1007/s00705-010-0624-1; Paeshuyse J, 2006, BIOCHEM BIOPH RES CO, V348, P139, DOI 10.1016/j.bbrc.2006.07.014; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Rotman Y, 2013, GUT IN PRESS; Sato A, 2011, PARASITOL INT, V60, P488, DOI 10.1016/j.parint.2011.08.017; Sato A, 2011, PARASITOL INT, V60, P270, DOI 10.1016/j.parint.2011.04.001; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Takeda M, 2012, J GEN VIROL, V93, P1422, DOI 10.1099/vir.0.040725-0; Thomas DL, 2000, CURR TOP MICROBIOL, V242, P25; Ueda Y, 2011, BIOCHEM BIOPH RES CO, V409, P663, DOI 10.1016/j.bbrc.2011.05.061; Yano M, 2007, ANTIMICROB AGENTS CH, V51, P2016, DOI 10.1128/AAC.01426-06; Yano M, 2009, HEPATOLOGY, V50, P678, DOI 10.1002/hep.23026	42	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72519	10.1371/journal.pone.0072519	http://dx.doi.org/10.1371/journal.pone.0072519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023620	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200015
J	Banko, MI; Krzyzanowski, MK; Turcza, P; Maniecka, Z; Kulis, M; Kozlowski, P				Banko, Monika I.; Krzyzanowski, Marek K.; Turcza, Paulina; Maniecka, Zuzanna; Kulis, Marta; Kozlowski, Piotr			Identification of Amino Acid Residues of ERH Required for Its Recruitment to Nuclear Speckles and Replication Foci in HeLa Cells	PLOS ONE			English	Article							RUDIMENTARY HOMOLOG ERH; DNA-POLYMERASE-DELTA; ZINC-FINGER PROTEIN; MOLECULAR PARTNER; CRYSTAL-STRUCTURE; HUMAN ENHANCER; SUBSTRATE; CLONING; CIZ1	ERH is a small, highly evolutionarily conserved nuclear protein of unknown function. Its three-dimensional structure is absolutely unique and it can form a homodimer through a beta sheet surface. ERH has been shown to interact, among others, with PDIP46/SKAR and Ciz1. When coexpressed with the latter protein, ERH accumulates in replication foci in the nucleus of HeLa cells. Here, we report that when ERH is coexpressed with PDIP46/SKAR in HeLa cells, it is recruited to nuclear speckles, and identify amino acid residues critical for targeting ERH to both these subnuclear structures. ERH H3A Q9A shows a diminished recruitment to nuclear speckles but it is recruited to replication foci. ERH E37A T51A is very poorly recruited to replication foci while still accumulating in nuclear speckles. Consequently, ERH H3A Q9A E37A T51A is recruited neither to nuclear speckles nor to replication foci. The lack of interactions of these three ERH forms with PDIP46/SKAR and/or Ciz1 was further confirmed in vitro by GST pull-down assay. The residues whose substitutions interfere with the accumulation in nuclear speckles are situated on the beta sheet surface of ERH, indicating that only the monomer of ERH can interact with PDIP46/SKAR. Substitutions affecting the recruitment to replication foci map to the other side of ERH, near a long loop between the alpha 1 and alpha 2 helices, thus both the monomer and the dimer of ERH could interact with Ciz1. The construction of the ERH mutants not recruited to nuclear speckles or replication foci will facilitate further studies on ERH actions in these subnuclear structures.	[Banko, Monika I.; Krzyzanowski, Marek K.; Turcza, Paulina; Maniecka, Zuzanna; Kulis, Marta; Kozlowski, Piotr] Univ Warsaw, Fac Biol, Dept Mol Biol, Warsaw, Poland	University of Warsaw	Kozlowski, P (corresponding author), Univ Warsaw, Fac Biol, Dept Mol Biol, Warsaw, Poland.	pkozlowski@biol.uw.edu.pl		Kulis, Marta/0000-0001-8104-9620	Ministry of Science and Higher Education, Poland [N N301 158535]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by grant N N301 158535 from the Ministry of Science and Higher Education, Poland (to P. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amente S, 2005, FEBS LETT, V579, P683, DOI 10.1016/j.febslet.2004.12.045; Arai R, 2005, PROTEIN SCI, V14, P1888, DOI 10.1110/ps.051484505; Coverley D, 2005, J CELL SCI, V118, P101, DOI 10.1242/jcs.01599; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Fujimura A, 2012, BIOCHEM BIOPH RES CO, V423, P588, DOI 10.1016/j.bbrc.2012.06.018; Gelsthorpe M, 1997, GENE, V186, P189, DOI 10.1016/S0378-1119(96)00701-9; Gelsthorpe ME, 2006, GENETICS, V174, P265, DOI 10.1534/genetics.106.061465; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Isomura M, 1996, GENOMICS, V32, P125, DOI 10.1006/geno.1996.0086; Jin TC, 2007, PROTEINS, V68, P427, DOI 10.1002/prot.21343; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Krzyzanowski MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049059; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Li H, 2005, J BIOMOL NMR, V32, P329, DOI 10.1007/s10858-005-7959-z; Liu L, 2003, J BIOL CHEM, V278, P10041, DOI 10.1074/jbc.M208694200; Lukasik A, 2008, FEBS J, V275, P332, DOI 10.1111/j.1742-4658.2007.06203.x; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mitsui K, 1999, BIOCHEM BIOPH RES CO, V264, P457, DOI 10.1006/bbrc.1999.1516; Onyango P, 2011, P NATL ACAD SCI USA, V108, P16759, DOI 10.1073/pnas.1110904108; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Smyk A, 2006, FEBS J, V273, P4728, DOI 10.1111/j.1742-4658.2006.05477.x; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tsubota SI, 2011, FLY, V5, P275, DOI 10.4161/fly.5.4.17807; von Strandmann EP, 2001, BIOL CHEM, V382, P1379; Wan C, 2005, BIOCHEMISTRY-US, V44, P5017, DOI 10.1021/bi047785w; Weng MT, 2012, P NATL ACAD SCI USA, V109, pE3659, DOI 10.1073/pnas.1207673110; WOJCIK E, 1994, GENETICS, V138, P1163; Zafrakas M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-145	30	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e74885	10.1371/journal.pone.0074885	http://dx.doi.org/10.1371/journal.pone.0074885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015320	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800115
J	Han, SS; Kim, M; Kim, H; Lee, SM; Oh, YJ; Lee, JP; Kim, S; Joo, KW; Lim, CS; Kim, YS; Kim, DK				Han, Seung Seok; Kim, Myounghee; Kim, Ho; Lee, Su Mi; Oh, Yun Jung; Lee, Jung Pyo; Kim, Sejoong; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki			Non-Linear Relationship between Serum 25-Hydroxyvitamin D and Hemoglobin in Korean Females: The Korean National Health and Nutrition Examination Survey 2010-2011	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; GLOMERULAR-FILTRATION-RATE; ANEMIA; RISK; DISEASE; ERYTHROPOIETIN; ASSOCIATION; PREVALENCE; MORTALITY; OLDER	Background: Anemia and vitamin D deficiency are both important health issues; however, the nature of the association between vitamin D and either hemoglobin or anemia remains unresolved in the general population. Methods: Data on 11,206 adults were obtained from the fifth Korean National Health and Nutritional Examination Survey. A generalized additive model was used to examine the threshold level for relationship between serum 25-hydroxyvitamin D [25(OH)D] and hemoglobin levels. A multivariate logistic regression for anemia was conducted according to 25(OH)D quintiles. All analyses were stratified according to sex and menstrual status. Results: The generalized additive model confirmed a threshold 25(OH)D level of 26.4 ng/mL (male, 27.4 ng/mL; premenopausal females, 11.8 ng/mL; postmenopausal females, 13.4 ng/mL). The threshold level affected the pattern of association between 25(OH)D and anemia risk: the odds ratio of the 1st quintile but not the 2nd, 3rd, and 4th quintiles were significantly different from the 5th quintile in both premenopausal and postmenopausal females, however there was no obvious trend in males. Conclusions: This population-based study demonstrated a non-linear relationship with a threshold effect between serum 25(OH)D and hemoglobin levels in females. Further interventional studies are warranted to determine whether the appropriate level of hemoglobin can be achieved by the correction of vitamin D deficiency.	[Han, Seung Seok; Lee, Su Mi; Oh, Yun Jung; Joo, Kwon Wook; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Myounghee] Eulji Univ, Coll Hlth Sci, Dept Dent Hyg, Gyeonggi Do, South Korea; [Kim, Ho] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Seoul 151, South Korea; [Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul 151, South Korea; [Kim, Sejoong] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Gyeonggi Do, South Korea	Seoul National University (SNU); Eulji University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, DK (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	dkkim73@gmail.com	Han, Seung Seok/HGD-2825-2022; Kim, Ho/AAS-2402-2021; Kim, Dong Ki/J-5389-2012; Kim, Sejoong/J-5356-2015	Kim, Ho/0000-0001-7472-3752; Kim, Dong Ki/0000-0002-5195-7852; Kim, Sejoong/0000-0002-7238-9962	Ministry for Health and Welfare, Republic of Korea [A102065]	Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korean Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand I, 2004, CIRCULATION, V110, P149, DOI 10.1161/01.CIR.0000134279.79571.73; ARGILES A, 1993, LANCET, V342, P378, DOI 10.1016/0140-6736(93)91528-T; Ashraf A, 2009, J CLIN ENDOCR METAB, V94, P3200, DOI 10.1210/jc.2009-0445; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Aucella F, 2003, NEPHRON CLIN PRACT, V95, pC121, DOI 10.1159/000074837; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Ben Alon D, 2002, EXP HEMATOL, V30, P403, DOI 10.1016/S0301-472X(02)00789-0; Blazsek I, 1996, CANCER DETECT PREV, V20, P31; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; de Boer IH, 2012, ANN INTERN MED, V156, P627, DOI 10.7326/0003-4819-156-9-201205010-00004; Duncan JA, 2005, EUR J CLIN INVEST, V35, P52, DOI 10.1111/j.1365-2362.2005.01531.x; Goicoechea M, 1998, NEPHRON, V78, P23, DOI 10.1159/000044877; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; HAUSSLER MR, 1986, ANNU REV NUTR, V6, P527, DOI 10.1146/annurev.nu.06.070186.002523; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kendrick J, 2009, AM J NEPHROL, V30, P64, DOI 10.1159/000202632; Kiss Z, 2011, NEPHRON CLIN PRACT, V117, pC373, DOI 10.1159/000321521; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim JS, 2012, J CLIN ENDOCR METAB, V97, P1995, DOI 10.1210/jc.2011-3098; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Meguro S, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/362981; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Patel NM, 2010, KIDNEY INT, V77, P715, DOI 10.1038/ki.2009.551; Perlstein TS, 2011, BLOOD, V117, P2800, DOI 10.1182/blood-2010-09-309708; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Shin JY, 2013, CLIN CHIM ACTA, V421, P177, DOI 10.1016/j.cca.2013.02.025; Sim JJ, 2010, ANN HEMATOL, V89, P447, DOI 10.1007/s00277-009-0850-3; Turk S, 2002, NEPHRON, V90, P188, DOI 10.1159/000049041; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, WHO TECH REP SER, V405, P5; Wood S.N., 2001, R R NEWS, V1, P20; Zadshir Ashraf, 2005, Ethn Dis, V15, pS5; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zittermann A, 2011, CLIN RES CARDIOL, V100, P781, DOI 10.1007/s00392-011-0312-5	39	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72605	10.1371/journal.pone.0072605	http://dx.doi.org/10.1371/journal.pone.0072605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015265	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800069
J	Takebayashi, K; Mekata, E; Sonoda, H; Shimizu, T; Shiomi, H; Naka, S; Endo, Y; Tani, T				Takebayashi, Katsushi; Mekata, Eiji; Sonoda, Hiromichi; Shimizu, Tomoharu; Shiomi, Hisanori; Naka, Shigeyuki; Endo, Yoshihiro; Tani, Tohru			Differences in Chemosensitivity between Primary and Metastatic Tumors in Colorectal Cancer	PLOS ONE			English	Article							DROPLET EMBEDDED-CULTURE; DRUG-SENSITIVITY TEST; THYMIDYLATE SYNTHASE; EXPRESSION LEVEL; CHEMOTHERAPY; RESECTION; PREDICTION	Purpose: We retrospectively evaluated the in vitro chemosensitivity of primary site and metastatic site tumors in colorectal cancer. Methods: Various resected tumor samples (33 from lymph nodes, 42 from liver, six from lung, and 68 primary tumors) were assessed via a collagen gel droplet-embedded culture drug sensitivity test to determine chemosensitivity to a single agent or a combination of agents. Results: Sensitivity to combination chemotherapy was significantly higher than that of monotherapy in the primary site group, lymph node group, and liver group. There was significant difference between chemosensitivity of primary site and that of liver metastasis in each agent (5-FU, p<0.001; SN38, p = 0.045; 5-FU/SN38, p<0.001; OHP, p = 0.037; 5-FU/OHP, p = 0.045). Conclusions: Tumors showed greater in vitro chemosensitivity to combination therapy when compared with monotherapy. Further, tumors that had metastasized to the liver were more resistant to chemotherapy when compared with matched primary tumors.	[Takebayashi, Katsushi; Mekata, Eiji; Sonoda, Hiromichi; Shimizu, Tomoharu; Shiomi, Hisanori; Naka, Shigeyuki; Endo, Yoshihiro; Tani, Tohru] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 52021, Japan	Shiga University of Medical Science	Mekata, E (corresponding author), Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 52021, Japan.	mekata@belle.shiga-med.ac.jp	Sonoda, Hiromichi/AAN-2617-2020		Shiga University of Medical Science, Japan	Shiga University of Medical Science, Japan(Shiga University of Medical Science)	This work was funded by Shiga University of Medical Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2003, ANN ONCOL, V14, P13, DOI 10.1093/annonc/mdg731; Akagi Y, 2012, ANTICANCER RES, V32, P2277; Gorlick R, 1998, J CLIN ONCOL, V16, P1465, DOI 10.1200/JCO.1998.16.4.1465; Hanatani Y, 2000, ONCOL REP, V7, P1027; Higashiyama M, 2001, ONCOL REP, V8, P279; Kawamura M, 2007, CANCER CHEMOTH PHARM, V59, P507, DOI 10.1007/s00280-006-0292-8; Kobayashi H, 1997, INT J ONCOL, V11, P449; Kobayashi H, 2003, RECENT RESULTS CANC, V161, P48; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Mekata E, 2013, MOL CLIN ON IN PRESS; Mentha G, 2006, BRIT J SURG, V93, P872, DOI 10.1002/bjs.5346; Midgley R, 2001, EXPERT OPIN INV DRUG, V10, P1011; Mori T, 2002, ONCOL REP, V9, P301; Ochiai T, 2005, ONCOL REP, V14, P201; Okumura K, 2006, ONCOL REP, V15, P875; Okumura K, 2008, CANCER CHEMOTH PHARM, V61, P587, DOI 10.1007/s00280-007-0511-y; Pessino A, 2008, ANN ONCOL, V19, P711, DOI 10.1093/annonc/mdm516; Poultsides GA, 2009, J CLIN ONCOL, V27, P3379, DOI 10.1200/JCO.2008.20.9817; Price TJ, 2012, ANN ONCOL, V23, P1531, DOI 10.1093/annonc/mdr488; SCHEELE J, 1995, WORLD J SURG, V19, P59, DOI 10.1007/BF00316981; Shimizu T, 2007, J GASTROENTEROL, V42, P918, DOI 10.1007/s00535-007-2105-1; Takamura Y, 2002, INT J CANCER, V98, P450, DOI 10.1002/ijc.10208; Takebayashi K, 2013, CANCER CHEMOTH PHARM, V72, P217, DOI 10.1007/s00280-013-2189-7; Yasuda H, 1998, J Hepatobiliary Pancreat Surg, V5, P261, DOI 10.1007/s005340050044	24	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73215	10.1371/journal.pone.0073215	http://dx.doi.org/10.1371/journal.pone.0073215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015297	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800094
J	Han, NY; Mu, YG				Han, Nanyu; Mu, Yuguang			Locking the 150-Cavity Open: In Silico Design and Verification of Influenza Neuraminidase Inhibitors	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; RATIONAL DESIGN; RESISTANCE; MECHANISM; POTENT; H5N1; DISCOVERY; VIRUSES; THREAT; MODEL	Neuraminidase (NA) of influenza is a key target for virus infection control and the recently discovered open 150-cavity in group-1 NA provides new opportunity for novel inhibitors design. In this study, we used a combination of theoretical methods including fragment docking, molecular linking and molecular dynamics simulations to design ligands that specifically target at the 150-cavity. Through in silico screening of a fragment compound library on the open 150-cavity of NA, a few best scored fragment compounds were selected to link with Zanamivir, one NA-targeting drug. The resultant new ligands may bind both the active site and the 150-cavity of NA simultaneously. Extensive molecular dynamics simulations in explicit solvent were applied to validate the binding between NA and the designed ligands. Moreover, two control systems, a positive control using Zanamivir and a negative control using a low-affinity ligand 3-(p-tolyl) allyl-Neu5Ac2en (ETT, abbreviation reported in the PDB) found in a recent experimental work, were employed to calibrate the simulation method. During the simulations, ETT was observed to detach from NA, on the contrary, both Zanamivir and our designed ligand bind NA firmly. Our study provides a prospective way to design novel inhibitors for controlling the spread of influenza virus.	[Han, Nanyu; Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mu, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	ygmu@ntu.edu.sg			IDA; MOE NTU Tier 1 grant [RG23/11]	IDA; MOE NTU Tier 1 grant	The authors stat that this work is partially supported by the IDA Cloud Computing Call for Project Proposals 2012 and MOE NTU Tier 1 grant RG23/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2007, J AM CHEM SOC, V129, P7764, DOI 10.1021/ja0723535; Amaro RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1390; Amaro RE, 2009, J AM CHEM SOC, V131, P4702, DOI 10.1021/ja8085643; [Anonymous], PYMOL MOL GRAPH SYST; [Anonymous], 2011, GLID VERS 5 7; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chachra R, 2008, J CHEM THEORY COMPUT, V4, P1526, DOI 10.1021/ct800068v; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Duan S, 2011, ANTIMICROB AGENTS CH, V55, P4718, DOI 10.1128/AAC.00316-11; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Fauci AS, 2006, EMERG INFECT DIS, V12, P73; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Grienke U, 2010, J MED CHEM, V53, P778, DOI 10.1021/jm901440f; Han NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060995; Han NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044057; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Landon MR, 2008, CHEM BIOL DRUG DES, V71, P106, DOI 10.1111/j.1747-0285.2007.00614.x; Li QL, 2010, CONSTRUCTIVE COMPUTATION IN STOCHASTIC MODELS WITH APPLICATIONS: THE RG-FACTORIZATION, P1; Mohan S, 2010, J MED CHEM, V53, P7377, DOI 10.1021/jm100822f; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nistal-Villan E, 2009, NAT MED, V15, P1253, DOI 10.1038/nm1109-1253; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Rudrawar S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1114; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Stacklies W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-101; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; van der Vries E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002914; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang MY, 2011, J VIROL, V85, P8431, DOI 10.1128/JVI.00638-11; Wang RX, 2000, J MOL MODEL, V6, P498, DOI 10.1007/s0089400060498; Wang SQ, 2010, BIOCHEM BIOPH RES CO, V401, P188, DOI 10.1016/j.bbrc.2010.09.020; Wen WH, 2010, BIOORGAN MED CHEM, V18, P4074, DOI 10.1016/j.bmc.2010.04.010; Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08	50	2	2	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73344	10.1371/journal.pone.0073344	http://dx.doi.org/10.1371/journal.pone.0073344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015302	gold, Green Published			2022-12-27	WOS:000323815200078
J	Begun, M; Newall, AT; Marks, GB; Wood, JG				Begun, Matt; Newall, Anthony T.; Marks, Guy B.; Wood, James G.			Contact Tracing of Tuberculosis: A Systematic Review of Transmission Modelling Studies	PLOS ONE			English	Article							REDUCING TUBERCULOSIS; DYNAMICS; VACCINES; THERAPY	The WHO recommended intervention of Directly Observed Treatment, Short-course (DOTS) appears to have been less successful than expected in reducing the burden of TB in some high prevalence settings. One strategy for enhancing DOTS is incorporating active case-finding through screening contacts of TB patients as widely used in low-prevalence settings. Predictive models that incorporate population-level effects on transmission provide one means of predicting impacts of such interventions. We aim to identify all TB transmission modelling studies addressing contact tracing and to describe and critically assess their modelling assumptions, parameter choices and relevance to policy. We searched MEDLINE, SCOPUS, COMPENDEX, Google Scholar and Web of Science databases for relevant English language publications up to February 2012. Of the 1285 studies identified, only 5 studies met our inclusion criteria of models of TB transmission dynamics in human populations designed to incorporate contact tracing as an intervention. Detailed implementation of contact processes was only present in two studies, while only one study presented a model for a high prevalence, developing world setting. Some use of relevant data for parameter estimation was made in each study however validation of the predicted impact of interventions was not attempted in any of the studies. Despite a large body of literature on TB transmission modelling, few published studies incorporate contact tracing. There is considerable scope for future analyses to make better use of data and to apply individual based models to facilitate more realistic patterns of infectious contact. Combined with a focus on high burden settings this would greatly increase the potential for models to inform the use of contract tracing as a TB control policy. Our findings highlight the potential for collaborative work between clinicians, epidemiologists and modellers to gather data required to enhance model development and validation and hence better inform future public health policy.	[Begun, Matt; Newall, Anthony T.; Wood, James G.] Univ New S Wales, Sch Publ Hlth & Community Med, Fac Med, Sydney, NSW, Australia; [Marks, Guy B.] Woolcock Inst Med Res & Liverpool Hosp, Sydney, NSW, Australia	University of New South Wales Sydney; Liverpool Hospital; University of Sydney; Woolcock Institute of Medical Research	Begun, M (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Fac Med, Sydney, NSW, Australia.	m.begun@student.unsw.edu.au	Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053; Newall, Anthony/0000-0003-0836-1065	NHMRC [630724]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	ATN holds an NHMRC Training Fellowship (630724 - Australian Based Public Health Fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Aparicio JP, 2000, J THEOR BIOL, V206, P327, DOI 10.1006/jtbi.2000.2129; Aparicio JP, 2006, CONTEMP MATH, V410, P17; Behr MA, 1998, AM J RESP CRIT CARE, V158, P465, DOI 10.1164/ajrccm.158.2.9801062; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361; CDC, 2009, NAT TB PROGR OBJ PER, P2015; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Colijn C, 2007, BIOMAT 2006, P123, DOI 10.1142/9789812708779_0008; COMSTOCK GW, 1994, CONTROL CLIN TRIALS, V15, P247, DOI 10.1016/0197-2456(94)90042-6; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Fox GJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008477.pub2; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Good PI., 2005, RESAMPLING METHODS P, V3rd ed.; Gray RT, 2010, SEX TRANSM DIS, V37, P298, DOI 10.1097/OLQ.0b013e3181ca3c0a; Guzzetta G, 2011, J THEOR BIOL, V289, P197, DOI 10.1016/j.jtbi.2011.08.032; Keeling, 2008, MODELLING INFECT DIS; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Klinkenberg D, 2006, PLOS ONE, V1, pel2, DOI [10.1371/journal.pone.0000012, DOI 10.1371/J0URNAL.-P0NE.0000012]; Mellor GR, 2011, ACM T MODEL COMPUT S, V21, DOI 10.1145/2000494.2000499; Mills HL, 2011, J R SOC INTERFACE, V8, P1510, DOI 10.1098/rsif.2011.0160; Mizumoto K, 2013, INT J ENV RES PUB HE, V10, P816, DOI 10.3390/ijerph10030816; Muller J, 2000, MATH BIOSCI, V164, P39, DOI 10.1016/S0025-5564(99)00061-9; Nair N, 2010, B WORLD HEALTH ORGAN, V88, P164, DOI 10.2471/BLT.09.073874; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Aparicio JP, 2009, MATH BIOSCI ENG, V6, P209, DOI 10.3934/mbe.2009.6.209; Rothenberg RB, 2003, INT J TUBERC LUNG D, V7, pS342; Song BJ, 2002, MATH BIOSCI, V180, P187, DOI 10.1016/S0025-5564(02)00112-8; Tian Y, 2011, WINT SIMUL C PROC, P1362, DOI 10.1109/WSC.2011.6147857; WAALER H, 1962, AM J PUBLIC HEALTH N, V56, P1002; WAALER HT, 1968, AM REV RESPIR DIS, V98, P591; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, TUB WHO FACT SHEET 1; WHO, 1997, TREATM TUB GUID NAT, V2; WHO, 2006, STOP TB STRAT; Ziv E, 2001, AM J EPIDEMIOL, V153, P381, DOI 10.1093/aje/153.4.381	37	23	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72470	10.1371/journal.pone.0072470	http://dx.doi.org/10.1371/journal.pone.0072470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023742	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600022
J	Hakkarainen, KM; Sundell, KA; Petzold, M; Hagg, S				Hakkarainen, Katja Marja; Sundell, Karolina Andersson; Petzold, Max; Hagg, Staffan			Prevalence and Perceived Preventability of Self-Reported Adverse Drug Events - A Population-Based Survey of 7099 Adults	PLOS ONE			English	Article							RISK-FACTORS; HOSPITAL ADMISSIONS; EMERGENCY-DEPARTMENT; MEDICATION ERRORS; EXPERT PANEL; MORBIDITY; INTERVENTION; DEFINITIONS; PREVENTION; HEALTH	Purpose: Adverse drug events (ADEs) are common and often preventable among inpatients, but self-reported ADEs have not been investigated in a representative sample of the general public. The objectives of this study were to estimate the 1-month prevalence of self-reported ADEs among the adult general public, and the perceived preventability of 2 ADE categories: adverse drug reactions (ADRs) and sub-therapeutic effects (STEs). Methods: In this cross-sectional study, a postal survey was sent in October 2010 to a random sample of 13 931 Swedish residents aged >= 18 years. Self-reported ADEs experienced during the past month included ADRs, STEs, drug dependence, drug intoxications and morbidity due to drug-related untreated indication. ADEs could be associated with prescription, nonprescription or herbal drugs. The respondents estimated whether ADRs and STEs could have been prevented. ADE prevalences in age groups (18-44, 45-64, or >= 65 years) were compared. Results: Of 7099 respondents (response rate 51.0%), ADEs were reported by 19.4% (95% confidence interval, 18.5-20.3%), and the prevalence did not differ by age group (p > 0.05). The prevalences of self-reported ADRs, STEs, and morbidities due to drug-related untreated indications were 7.8% (7.2-8.4%), 7.6% (7.0-8.2%) and 8.1% (7.5-8.7%), respectively. The prevalence of self-reported drug dependence was 2.2% (1.9-2.6%), and drug intoxications 0.2% (0.1-0.3%). The respondents considered 19.2% (14.8-23.6%) of ADRs and STEs preventable. Although reported drugs varied between ADE categories, most ADEs were attributable to commonly dispensed drugs. Drugs reported for all and preventable events were similar. Conclusions: One-fifth of the adult general public across age groups reported ADEs during the past month, indicating a need for prevention strategies beyond hospitalised patients. For this, the underlying causes of ADEs should increasingly be investigated. The high burden of ADEs and preventable ADEs from widely used drugs across care settings supports redesigning a safer healthcare system to adequately tackle the problem.	[Hakkarainen, Katja Marja; Sundell, Karolina Andersson; Petzold, Max; Hagg, Staffan] Nord Sch Publ Hlth NHV, Gothenburg, Sweden; [Sundell, Karolina Andersson] Univ Gothenburg, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden; [Hagg, Staffan] Linkoping Univ, Div Clin Pharmacol, Linkoping, Sweden	University of Gothenburg; University of Gothenburg; Linkoping University	Hakkarainen, KM (corresponding author), Nord Sch Publ Hlth NHV, Gothenburg, Sweden.	katja.hakkarainen@nhv.se	Hägg, Staffan/G-5612-2013; Sundell, Karolina A Andersson/E-6046-2010	Hägg, Staffan/0000-0002-5137-8420; 	National Corporation of Swedish Pharmacies (Apoteket AB)	National Corporation of Swedish Pharmacies (Apoteket AB)	The research is funded through an unrestricted grant from The National Corporation of Swedish Pharmacies (Apoteket AB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Olah YH, 2008, ANN SAUDI MED, V28, P426; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aronson JK, 2005, DRUG SAFETY, V28, P851, DOI 10.2165/00002018-200528100-00003; Avery AJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15200; Basch E, 2010, NEW ENGL J MED, V362, P865, DOI 10.1056/NEJMp0911494; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; BOSTROM G, 2009, IMPACT NONRESPONSE B; Cano FG, 2009, CAD SAUDE PUBLICA, V25, pS360, DOI 10.1590/S0102-311X2009001500003; CHRISCHILLES EA, 1992, ANN INTERN MED, V117, P634, DOI 10.7326/0003-4819-117-8-634; Chrischilles E, 2007, J AM GERIATR SOC, V55, P29, DOI 10.1111/j.1532-5415.2006.01034.x; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Cuijpers P, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-89; Danielsson M, 2012, SCAND J PUBLIC HEALT, V40, P6, DOI 10.1177/1403494812459457; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; Dequito AB, 2011, DRUG SAFETY, V34, P1089, DOI 10.2165/11592030-000000000-00000; DESOUTOBARRETO P, 2012, ARCH GERONTOL GERIAT, V55, P592, DOI DOI 10.1016/J.ARCHGER.2012.03.008; Edwards IR, 2012, DRUG SAFETY, V35, P87, DOI 10.2165/11630510-000000000-00000; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Franceschi A, 2004, PHARMACOL RES, V49, P85, DOI 10.1016/j.phrs.2003.08.001; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gibson PG, 2010, LANCET, V376, P803, DOI 10.1016/S0140-6736(10)61087-2; Goettler M, 1997, PHARMACOEPIDEM DR S, V6, pS79, DOI 10.1002/(SICI)1099-1557(199710)6:3+<S79::AID-PDS294>3.3.CO;2-F; Green Jacqueline L, 2007, Am J Geriatr Pharmacother, V5, P31, DOI 10.1016/j.amjopharm.2007.03.004; Gurwitz JH, 2000, AM J MED, V109, P87, DOI 10.1016/S0002-9343(00)00451-4; GYLLENSTEN H, 2013, BMJ OPEN, V3, P2574, DOI DOI 10.1136/BMJ0PEN-2013-002574.PRINT; Gyllensten H, 2012, INT J CLIN PHARM-NET, V34, P538, DOI 10.1007/s11096-012-9641-3; Hakkarainen KM, 2012, EUR J CLIN PHARMACOL, V68, P1309, DOI 10.1007/s00228-012-1244-3; Hakkarainen KM, 2012, DRUG SAFETY, V35, P105, DOI 10.2165/11596570-000000000-00000; HAKKARAINEN KM, 2012, PLOS ONE, V74, P33236, DOI DOI 10.1371/J0URNAL.-P0NE.0033236; HALLAS J, 1993, EUR J CLIN PHARMACOL, V45, P199, DOI 10.1007/BF00315383; HALLAS J, 1992, BRIT J CLIN PHARMACO, V33, P61, DOI 10.1111/j.1365-2125.1992.tb04001.x; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; HUTCHINSON TA, 1986, J CHRON DIS, V39, P533, DOI 10.1016/0021-9681(86)90198-0; Isacson D, 2008, ANN PHARMACOTHER, V42, P347, DOI 10.1345/aph.1K488; JOHNSON JA, 1995, ARCH INTERN MED, V155, P1949, DOI 10.1001/archinte.155.18.1949; Jonsson Anna K, 2009, BMC Clin Pharmacol, V9, P7, DOI 10.1186/1472-6904-9-7; Kanjanarat P, 2003, AM J HEALTH-SYST PH, V60, P1750, DOI 10.1093/ajhp/60.17.1750; Koneri R, 2008, J CLIN DIAGN RES, V2, P736; Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; Lau PM, 2004, SUPPORT CARE CANCER, V12, P626, DOI 10.1007/s00520-004-0622-5; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; Leape LL, 2006, MED ERRORS, P3; Leendertse AJ, 2010, DRUG SAFETY, V33, P233, DOI 10.2165/11319030-000000000-00000; Masotti P, 2010, INT J QUAL HEALTH C, V22, P115, DOI 10.1093/intqhc/mzq003; *MED DICT REG ACT, 2011, MSSODI60031400 MED D; Millar JS, 2001, BRIT J GEN PRACT, V51, P130; Ministry of Health and Social Affairs, 2011, NAT MED STRAT; Morimoto T, 2004, QUAL SAF HEALTH CARE, V13, P306, DOI 10.1136/qshc.2004.010611; Nanji KC, 2011, J AM MED INFORM ASSN, V18, P767, DOI 10.1136/amiajnl-2011-000205; Nelson KM, 1996, PHARMACOTHERAPY, V16, P701; Nolan TW, 2000, BMJ-BRIT MED J, V320, P771, DOI 10.1136/bmj.320.7237.771; Oladimeji O, 2008, ANN PHARMACOTHER, V42, P53, DOI 10.1345/aph.1K073; Paster RZ, 2010, EXPERT OPIN PHARMACO, V11, P1823, DOI 10.1517/14656566.2010.491510; Patterson ES, 2002, J AM MED INFORM ASSN, V9, P540, DOI 10.1197/jamia.M1061; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Raschetti R, 1999, EUR J CLIN PHARMACOL, V54, P959, DOI 10.1007/s002280050582; Rogers S, 2009, DRUG AGING, V26, P951, DOI 10.2165/11316750-000000000-00000; Runciman WB, 2002, QUAL SAF HEALTH CARE, V11, P224, DOI 10.1136/qhc.11.3.224; Shiyanbola OO, 2010, AM J GERIATR PHARMAC, V8, P245, DOI 10.1016/j.amjopharm.2010.06.002; *SWED NAT I PUBL H, 2010, NARC US SWED; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658; *UPPS MON CTR, 2013, GLOSS TERMS US PHARM; van Gijssel-Wiersma DG, 2005, DRUG SAFETY, V28, P1119, DOI 10.2165/00002018-200528120-00006; VINCENT C, 2010, PATIENT SAFETY, P211; Vincent C, 2010, PATIENT SAFETY, P390; Weingart SN, 2005, ARCH INTERN MED, V165, P234, DOI 10.1001/archinte.165.2.234; Weissman JS, 2008, ANN INTERN MED, V149, P100, DOI 10.7326/0003-4819-149-2-200807150-00006; Weitoft GR, 2012, SCAND J PUBLIC HEALT, V40, P293, DOI 10.1177/1403494812459623; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO, 2009, GUID ATC CLASS DDD A; Wiffen P, 2002, BANDOLIER EXTRA, P1; Winterstein AG, 2002, ANN PHARMACOTHER, V36, P1238, DOI 10.1345/aph.1A225; Woods D., 2000, HUMAN ERROR HUMAN FA; World Health Organization, 1972, WHO TECHN REP SER; World Health Organization, 2009, WHO PAT SAF RES BETT; Zargarzadeh AH, 2007, CLIN EXP PHARMACOL P, V34, P494, DOI 10.1111/j.1440-1681.2007.04600.x	81	29	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73166	10.1371/journal.pone.0073166	http://dx.doi.org/10.1371/journal.pone.0073166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023828	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600075
J	Ben Chaim, Y; Bochnik, S; Parnas, I; Parnas, H				Ben Chaim, Yair; Bochnik, Shimrit; Parnas, Itzchak; Parnas, Hanna			Voltage Affects the Dissociation Rate Constant of the m2 Muscarinic Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DOPAMINE D-2S RECEPTOR; K+ CHANNEL; NEUROTRANSMITTER RELEASE; DEACTIVATION KINETICS; ADRENERGIC-RECEPTOR; BINDING-PROPERTIES; ACTIVATION; SENSITIVITY; SELECTIVITY	G-protein coupled receptors (GPCRs) comprise the largest protein family and mediate the vast majority of signal transduction processes in the body. Until recently GPCRs were not considered to be voltage dependent. Newly it was shown for several GPCRs that the first step in GPCR activation, the binding of agonist to the receptor, is voltage sensitive: Voltage shifts the receptor between two states that differ in their binding affinity. Here we show that this shift involves the rate constant of dissociation. We used the m2 muscarinic receptor (m2R) a prototypical GPCR and measured directly the dissociation of [H-3] ACh from m2R expressed Xenopus oocytes. We show, for the first time, that the voltage dependent change in affinity is implemented by voltage shifting the receptor between two states that differ in their rate constant of dissociation. Furthermore, we provide evidence that suggest that the above shift is achieved by voltage regulating the coupling of the GPCR to its G protein.	[Ben Chaim, Yair] Open Univ Israel, Dept Nat & Life Sci, Raanana, Israel; [Bochnik, Shimrit; Parnas, Itzchak; Parnas, Hanna] Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel	Open University Israel; Hebrew University of Jerusalem	Parnas, H (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	hannap@huji.ac.il						Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Benians A, 2003, P NATL ACAD SCI USA, V100, P6239, DOI 10.1073/pnas.1037595100; Bolton Thomas B, 2003, Sci STKE, V2003, ppe52, DOI 10.1126/stke.2102003pe52; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; COHEN-ARMON M, 1986, J BIOL CHEM, V261, P2498; COHEN-ARMON M, 1993, J BIOL CHEM, V268, P9824; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Dekel N, 2012, P NATL ACAD SCI USA, V109, P285, DOI 10.1073/pnas.1119424109; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Ilouz N, 1999, J BIOL CHEM, V274, P29519, DOI 10.1074/jbc.274.41.29519; Kupchik YM, 2011, J CELL BIOL, V192, P137, DOI 10.1083/jcb.201007053; KURACHI Y, 1995, AM J PHYSIOL-CELL PH, V269, pC821, DOI 10.1152/ajpcell.1995.269.4.C821; Linial M, 1997, J PHYSIOL-LONDON, V504, P251, DOI 10.1111/j.1469-7793.1997.251be.x; Mahaut-Smith MP, 2008, TRENDS PHARMACOL SCI, V29, P421, DOI 10.1016/j.tips.2008.05.007; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; MARTY A, 1989, J PHYSIOL-LONDON, V419, P665, DOI 10.1113/jphysiol.1989.sp017892; Navarro-Polanco RA, 2011, J PHYSIOL-LONDON, V589, P1741, DOI 10.1113/jphysiol.2010.204107; Ohana L, 2006, J BIOL CHEM; Parnas H, 2005, J NEUROPHYSIOL, V93, P3257, DOI 10.1152/jn.01131.2004; Parnas H, 2000, TRENDS NEUROSCI, V23, P60, DOI 10.1016/S0166-2236(99)01498-8; Parnas H, 2007, TRENDS NEUROSCI, V30, P54, DOI 10.1016/j.tins.2006.12.001; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Rinne A, 2013, P NATL ACAD SCI USA, V110, P1536, DOI 10.1073/pnas.1212656110; Sahlholm K, 2008, BIOCHEM BIOPH RES CO, V374, P496, DOI 10.1016/j.bbrc.2008.07.052; Sahlholm K, 2008, SYNAPSE, V62, P476, DOI 10.1002/syn.20509; Sahlholm K, 2011, NEUROPHARMACOLOGY, V61, P937, DOI 10.1016/j.neuropharm.2011.06.022; Sahlholm K, 2008, BIOCHEM BIOPH RES CO, V377, P1216, DOI 10.1016/j.bbrc.2008.10.117; WESS J, 1990, MOL PHARMACOL, V38, P517; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501	36	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74354	10.1371/journal.pone.0074354	http://dx.doi.org/10.1371/journal.pone.0074354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019965	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200108
J	Jiang, JH; Mohan, P; Maxwell, CA				Jiang, Jihong; Mohan, Pooja; Maxwell, Christopher A.			The Cytoskeletal Protein RHAMM and ERK1/2 Activity Maintain the Pluripotency of Murine Embryonic Stem Cells	PLOS ONE			English	Article							MEDIATED MOTILITY RHAMM; HUMAN MITOTIC SPINDLE; HYALURONAN RECEPTOR; TUMOR; GENES; IDENTIFICATION; GENOME; CANCER; CYCLE; DIFFERENTIATION	Receptor for hyaluronan mediated motility (RHAMM, encoded by HMMR) may be a cell-surface receptor for hyaluronan that regulates embryonic stem cell pluripotency and differentiation, however, a precise mechanism for its action is not known. We examined murine embryonic stem cells with and without hemizygous genomic mutation of Hmmr/RHAMM, but we were not able to find RHAMM on the cell-surface. Rather, RHAMM localized to the microtubule cytoskeleton and along mitotic spindles. Genomic loss of Hmmr/RHAMM did not alter cell cycle progression but augmented differentiation and attenuated pluripotency in murine embryonic stem cells. Through a candidate screen of small-molecule kinase inhibitors, we identified ERK1/2 and aurora kinase A as barrier kinases whose inhibition was sufficient to rescue pluripotency in RHAMM(+/-) murine embryonic stem cells. Thus, RHAMM is not found on the cell-surface of embryonic stem cells, but it is required to maintain pluripotency and its dominant mechanism of action is through the modulation of signal transduction pathways at microtubules.	[Jiang, Jihong; Mohan, Pooja; Maxwell, Christopher A.] Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada	Child & Family Research Institute; University of British Columbia	Maxwell, CA (corresponding author), Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada.	cmaxwell@cfri.ubc.ca	Maxwell, Christopher A/B-3044-2011	Maxwell, Christopher A/0000-0002-0713-7136; Maxwell, Christopher/0000-0002-0860-4031	SickKids Foundation; Institute of Human Development Child and Youth Health-CIHR [NI11-005]; Michael Cuccione Foundation for Childhood Cancer Research	SickKids Foundation; Institute of Human Development Child and Youth Health-CIHR(Canadian Institutes of Health Research (CIHR)); Michael Cuccione Foundation for Childhood Cancer Research	These studies were supported by a Child and Youth Health, New Investigator Award from the SickKids Foundation and the Institute of Human Development Child and Youth Health-CIHR (Grant No. NI11-005), and by a Pediatric Brain Tumor grant from the Michael Cuccione Foundation for Childhood Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann V, 1999, J CELL SCI, V112, P3943; Bar-Joseph Z, 2008, P NATL ACAD SCI USA, V105, P955, DOI 10.1073/pnas.0704723105; Calloni R, 2013, STEM CELLS DEV, V22, P1455, DOI 10.1089/scd.2012.0637; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Foley JP, 2012, J BIOL CHEM, V287, P37406, DOI 10.1074/jbc.M112.360982; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Hofmann M, 1998, CELL, V95, P591, DOI 10.1016/S0092-8674(00)81628-1; Jiang JH, 2010, THESCIENTIFICWORLDJO, V10, P1244, DOI 10.1100/tsw.2010.141; Jiang XY, 2010, BLOOD, V116, P2112, DOI 10.1182/blood-2009-05-222471; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Li ZH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2059; Liska AJ, 2004, PROTEOMICS, V4, P2707, DOI 10.1002/PMIC.200300813; Liu JW, 2013, STEM CELLS DEV, V22, P1190, DOI 10.1089/scd.2012.0229; Manning AL, 2008, CELL, V134, P694, DOI 10.1016/j.cell.2008.08.001; Maxwell CA, 2005, CANCER RES, V65, P850; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; Maxwell CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001199; Mohan P, 2013, ONCOTARGET, V4, P80, DOI 10.18632/oncotarget.793; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Shaltouki A, 2013, STEM CELLS, V31, P941, DOI 10.1002/stem.1334; Sharp JA, 2011, MOL BIOL CELL, V22, P4312, DOI 10.1091/mbc.E11-07-0629; Sohr S, 2008, CELL CYCLE, V7, P3448, DOI 10.4161/cc.7.21.7014; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Stratford AL, 2012, STEM CELLS, V30, P1338, DOI 10.1002/stem.1128; Szabo AZ, 2013, STEM CELLS, V31, P786, DOI 10.1002/stem.1329; Tolg C, 2003, ONCOGENE, V22, P6873, DOI 10.1038/sj.onc.1206811; Tolg C, 2010, J BIOL CHEM, V285, P26461, DOI 10.1074/jbc.M110.121491; Washio A, 2009, EXP CELL RES, V315, P3036, DOI 10.1016/j.yexcr.2009.07.006; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; YANG BH, 1994, J CELL BIOCHEM, V56, P455, DOI 10.1002/jcb.240560406; YANG BH, 1993, J BIOL CHEM, V268, P8617; Yang YM, 2010, J TAIWAN INST CHEM E, V41, P1, DOI 10.1016/j.jtice.2009.11.002	40	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73548	10.1371/journal.pone.0073548	http://dx.doi.org/10.1371/journal.pone.0073548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019927	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200069
J	Kuan, YC; Wu, YJ; Hung, CL; Sheu, F				Kuan, Yen-Chou; Wu, Ying-Jou; Hung, Chih-Liang; Sheu, Fuu			Trametes versicolor Protein YZP Activates Regulatory B Lymphocytes - Gene Identification through De Novo Assembly and Function Analysis in a Murine Acute Colitis Model	PLOS ONE			English	Article							MUSHROOM CORIOLUS-VERSICOLOR; BOUND POLYSACCHARIDE; IMMUNOMODULATORY PROTEIN; CELL SUBSETS; T-CELLS; IN-VIVO; MACROPHAGES; IL-10; EXPRESSION; RESPONSES	Background: Trametes versicolor (Yun-Zhi) is a medicinal fungus used as a chemotherapy co-treatment to enhance antitumor immunity. Although the efficacies of T. versicolor extracts have been documented, the active ingredients and mechanisms underlying the actions of these extracts remain uncharacterized. Results: We purified a new protein, YZP, from the fruiting bodies of T. versicolor and identified the gene encoding YZP using RNA-seq and de novo assembly technologies. YZP is a 12-kDa non-glycosylated protein comprising 139 amino acids, including an 18-amino acids signal peptide. YZP induced a greater than 60-fold increase in IL-10 secretion in mice B lymphocytes; moreover, YZP specifically triggered the differentiation of CD1d(+) B cells into IL-10-producing regulatory B cells (Bregs) and enhanced the expression of CD1d. YZP-induced B cells suppressed approximately 40% of the LPS-activated macrophage production of inflammatory cytokines in a mixed leukocyte reaction and significantly alleviated the disease activity and colonic inflammation in a DSS-induced acute colitis murine model. Furthermore, YZP activated Breg function via interaction with TLR2 and TLR4 and up-regulation of the TLR-mediated signaling pathway. Conclusions: We purified a novel Breg-stimulating protein, YZP, from T. versicolor and developed an advanced approach combining RNA-seq and de novo assembly technologies. to clone its gene. We demonstrated that YZP activated CD1d+ Breg differentiation through TLR2/4-mediated signaling pathway, and the YZP-stimulated B cells exhibited anti-inflammatory efficacies in vitro and in murine acute colitis models.	[Kuan, Yen-Chou; Sheu, Fuu] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan; [Kuan, Yen-Chou; Wu, Ying-Jou; Hung, Chih-Liang; Sheu, Fuu] Natl Taiwan Univ, Dept Hort, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Sheu, F (corresponding author), Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan.	fsheu@ntu.edu.tw		Sheu, Fuu/0000-0001-9794-3483; Kuan, Yen-Chou/0000-0001-6870-0685	National Science Council of Taiwan [NSC-99-2628-B-002-003-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by a grant from the National Science Council of Taiwan (NSC-99-2628-B-002-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Anderton SM, 2008, NAT CLIN PRACT RHEUM, V4, P657, DOI 10.1038/ncprheum0950; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Chang HH, 2010, INT IMMUNOPHARMACOL, V10, P239, DOI 10.1016/j.intimp.2009.10.017; Chang HH, 2009, J AGR FOOD CHEM, V57, P6129, DOI 10.1021/jf9011399; Chu KKW, 2002, J CLIN PHARMACOL, V42, P976; Colgan SP, 1999, P NATL ACAD SCI USA, V96, P13938, DOI 10.1073/pnas.96.24.13938; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; Cui T, 2003, BIOTECHNOL ADV, V21, P109, DOI 10.1016/S0734-9750(03)00002-8; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Jeong SC, 2006, J MED FOOD, V9, P175, DOI 10.1089/jmf.2006.9.175; Kessel A, 2012, AUTOIMMUN REV, V11, P670, DOI 10.1016/j.autrev.2011.11.018; KOBAYASHI H, 1995, CANCER EPIDEM BIOMAR, V4, P275; Kuan YC, 2012, INT IMMUNOPHARMACOL, V14, P114, DOI 10.1016/j.intimp.2012.06.014; Kuan YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021004; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lim BO, 2011, PHYTOTHER RES, V25, P1257, DOI 10.1002/ptr.3378; Lin KI, 2006, J BIOL CHEM, V281, P24111, DOI 10.1074/jbc.M601106200; Lin YL, 2009, J LEUKOCYTE BIOL, V86, P877, DOI 10.1189/jlb.0708441; Liu F, 1999, LIFE SCI, V64, P1005, DOI 10.1016/S0024-3205(99)00027-2; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Maruyama S, 2009, BIOMED PHARMACOTHER, V63, P409, DOI 10.1016/j.biopha.2008.08.006; Maseda D, 2012, J IMMUNOL, V188, P1036, DOI 10.4049/jimmunol.1102500; Mauri C, 2010, NAT REV RHEUMATOL, V6, P636, DOI 10.1038/nrrheum.2010.140; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Ng TB, 1998, GEN PHARMACOL, V30, P1, DOI 10.1016/S0306-3623(97)00076-1; Ooi VEC, 2000, CURR MED CHEM, V7, P715; SAKAGAMI H, 1991, ANTICANCER RES, V11, P993; Schuetz JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031560; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sheu F, 2009, J AGR FOOD CHEM, V57, P4130, DOI 10.1021/jf900469a; Szeto MOP, 2007, CURR ONCOL, V14, P41; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; Tsang KW, 2003, RESP MED, V97, P618, DOI 10.1053/rmed.2003.1490; Wang HX, 1996, INT J BIOCHEM CELL B, V28, P601, DOI 10.1016/1357-2725(95)00157-3; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yanaba K, 2011, AM J PATHOL, V178, P735, DOI 10.1016/j.ajpath.2010.10.022; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yeh CH, 2010, J AGR FOOD CHEM, V58, P8535, DOI 10.1021/jf100914m; Zhu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041901; Zong AZ, 2012, CARBOHYD POLYM, V90, P1395, DOI 10.1016/j.carbpol.2012.07.026	50	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72422	10.1371/journal.pone.0072422	http://dx.doi.org/10.1371/journal.pone.0072422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019869	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200011
J	Mari, A; Bagger, JI; Ferrannini, E; Holst, JJ; Knop, FK; Vilsboll, T				Mari, Andrea; Bagger, Jonatan I.; Ferrannini, Ele; Holst, Jens J.; Knop, Filip K.; Vilsboll, Tina			Mechanisms of the Incretin Effect in Subjects with Normal Glucose Tolerance and Patients with Type 2 Diabetes	PLOS ONE			English	Article							BETA-CELL FUNCTION; INSULIN-SECRETION; TESTS; MEAL; SENSITIVITY; IMPACT; MODEL; GLP-1	The incretin effect on insulin secretion was investigated in 8 subjects with type 2 diabetes (T2D) and 8 with normal glucose tolerance (NGT), using 25, 75, and 125 g oral glucose tolerance tests (OGTT) and isoglycemic intravenous glucose infusions (IIGI). The beta-cell response was evaluated using a model embedding a dose-response (slope = glucose sensitivity), an early response (rate sensitivity), and potentiation (time-related secretion increase). The incretin effect, as OGTT/IIGI ratio, was calculated for each parameter. In NGT, the incretin effect on total secretion increased with dose (1.3 +/- 0.1, 1.7 +/- 0.2, 2.2 +/- 0.2 fold of IIGI, P<0.0001), mediated by a dose-dependent increase of the incretin effect on glucose sensitivity (1.9 +/- 0.4, 2.4 +/- 0.4, 3.1 +/- 0.4, P = 0.005), and a dose-independent enhancement of the incretin effect on rate sensitivity (894 [1145], 454 [516], 783 [1259] pmol m(-2) L mmol(-1) above IIGI; median [interquartile range], P<0.0001). The incretin effect on potentiation also increased (0.97 +/- 0.06, 1.45 +/- 0.20, 1.24 +/- 0.16, P<0.0001). In T2D, the incretin effect on total secretion (1.0 +/- 0.1, 1.1 +/- 0.1, 1.3 +/- 0.1, P = 0.004) and glucose sensitivity (1.2 +/- 0.2, 1.3 +/- 0.2, 2.0 +/- 0.2, P = 0.005) were impaired vs NGT; however, the incretin effect on rate sensitivity increased already at 25 g (269 [169], 284 [301], 193 [465] pmol m(-2) L mmol(-1) above IIGI; negligible IIGI rate sensitivity in T2D prevented the calculation of the fold increment). OGTT did not stimulate potentiation above IIGI (0.94 +/- 0.04, 0.89 +/- 0.06, 1.06 +/- 0.09; P<0.01 vs NGT). In the whole group, the incretin effect was inversely associated with total secretion during IIGI, although systematically lower in T2D. In conclusion, 1) In NGT, glucose sensitivity and potentiation mediate the dose-dependent incretin effect increase; 2) In T2D, the incretin effect is blunted vs NGT, but rate sensitivity is enhanced at all loads; 3) Relatively lower incretin effect in NGT is associated with higher secretion during IIGI, suggesting that the reduced incretin effect does not result from beta-cell dysfunction.	[Mari, Andrea] CNR, Inst Biomed Engn, Padua, Italy; [Bagger, Jonatan I.; Knop, Filip K.; Vilsboll, Tina] Univ Copenhagen, Gentofte Hosp, Diabet Res Div, Copenhagen, Denmark; [Ferrannini, Ele] Univ Pisa, Sch Med, Dept Internal Med, I-56100 Pisa, Italy; [Bagger, Jonatan I.; Holst, Jens J.; Knop, Filip K.; Vilsboll, Tina] Univ Copenhagen, Panum Inst, Dept Biomed Sci, NNF Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	Consiglio Nazionale delle Ricerche (CNR); University of Copenhagen; Herlev & Gentofte Hospital; University of Pisa; University of Copenhagen	Mari, A (corresponding author), CNR, Inst Biomed Engn, Padua, Italy.	andrea.mari@isib.cnr.it	Bagger, Jonatan I/H-7912-2019; Knop, Filip K/GQI-2604-2022; Vilsboll, Tina/I-6562-2016; Holst, Jens/AAA-8022-2022	Bagger, Jonatan I/0000-0003-3174-1613; Knop, Filip K/0000-0002-2495-5034; Holst, Jens Juul/0000-0001-6853-3805	MerckCo., Inc. [34851]; Novo Nordisk Fonden [NNF12OC1015904] Funding Source: researchfish	MerckCo., Inc.(Merck & Company); Novo Nordisk Fonden(Novo Nordisk Foundation)	The original study was supported by an unrestricted research grant (no. 34851) from the Investigator Initiated Studies Program of Merck&Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2003, DIABETES CARE, V26, P2860, DOI 10.2337/diacare.26.10.2860; Bagger JI, 2011, J CLIN ENDOCR METAB, V96, P737, DOI 10.1210/jc.2010-2435; Bonadonna RC, 2003, DIABETES, V52, P470, DOI 10.2337/diabetes.52.2.470; Bonuccelli S, 2009, AM J PHYSIOL-ENDOC M, V297, pE532, DOI 10.1152/ajpendo.00127.2009; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Ferrannini E, 2005, J CLIN ENDOCR METAB, V90, P493, DOI 10.1210/jc.2004-1133; Flamez D, 1999, DIABETES, V48, P1979, DOI 10.2337/diabetes.48.10.1979; Hare KJ, 2009, J CLIN ENDOCR METAB, V94, P4679, DOI 10.1210/jc.2009-0921; Kjems LL, 2003, DIABETES, V52, P380, DOI 10.2337/diabetes.52.2.380; Knop FK, 2012, DIABETES OBES METAB, V14, P500, DOI 10.1111/j.1463-1326.2011.01549.x; KRARUP T, 1984, REGUL PEPTIDES, V9, P35, DOI 10.1016/0167-0115(84)90005-3; Mari A, 2002, DIABETES, V51, pS221, DOI 10.2337/diabetes.51.2007.S221; Mari A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1159, DOI 10.1152/ajpendo.00093.2002; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; Mari A, 2008, DIABETES OBES METAB, V10, P77, DOI 10.1111/j.1463-1326.2008.00946.x; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Meier JJ, 2010, DIABETES, V59, P1117, DOI 10.2337/db09-1899; Muscelli E, 2008, DIABETES, V57, P1340, DOI 10.2337/db07-1315; Muscelli E, 2006, AM J PHYSIOL-ENDOC M, V291, pE1144, DOI 10.1152/ajpendo.00571.2005; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; NAUCK MA, 1986, J CLIN ENDOCR METAB, V63, P492, DOI 10.1210/jcem-63-2-492; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535	22	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73154	10.1371/journal.pone.0073154	http://dx.doi.org/10.1371/journal.pone.0073154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019903	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200045
J	Pickles, S; Cadieux-Dion, M; Alvarez, JI; Lecuyer, MA; Peyrard, SL; Destroismaisons, L; St-Onge, L; Terouz, S; Cossette, P; Prat, A; Vande Velde, C				Pickles, Sarah; Cadieux-Dion, Maxime; Alvarez, Jorge I.; Lecuyer, Marc-Andre; Peyrard, Sarah L.; Destroismaisons, Laurie; St-Onge, Lydia; Terouz, Simone; Cossette, Patrick; Prat, Alexandre; Vande Velde, Christine			Endo-MitoEGFP Mice: A Novel Transgenic Mouse with Fluorescently Marked Mitochondria in Microvascular Endothelial Cells	PLOS ONE			English	Article							GENE-EXPRESSION; GFP REPORTER; DIFFERENTIATION; PANCREAS; AGENESIS; ENHANCER; ISL1; HB9; CNS	Blood vessel-specific fluorescent transgenic mice are excellent tools to study the development of the vasculature and angiogenic processes. There is growing interest in the biological processes relevant to endothelial cells but limited tools exist to selectively evaluate subcellular functions of this cell type in vivo. Here, we report a novel transgenic animal model that expresses mitochondrially targeted enhanced green fluorescent protein (EGFP) via the Hb9 promoter, a homeobox transcription factor with limited known involvement in the vasculature. Random integration of the transgene, containing the entire mouse Hb9 promoter, was found to be expressed in a variety of vascularised tissues. Further inspection revealed that Mito-EGFP localizes to the endothelial cells (ECs) of a subset of microvascular blood vessels, especially in the central nervous system (CNS), heart, spleen, thymus, lymph nodes and skin. We demonstrate the utility of this novel transgenic mouse, named Endo-MitoEGFP, in the detection, imaging, and isolation of microvascular ECs and evaluation of EC mitochondrial function isolated from adult animals. These transgenic mice will be useful to studies of ECs in development, physiology, and pathology.	[Pickles, Sarah; Cadieux-Dion, Maxime; Alvarez, Jorge I.; Lecuyer, Marc-Andre; Peyrard, Sarah L.; Destroismaisons, Laurie; St-Onge, Lydia; Terouz, Simone; Cossette, Patrick; Prat, Alexandre; Vande Velde, Christine] Univ Montreal, Ctr Excellence Neur, CRCHUM, Montreal, PQ, Canada; [Pickles, Sarah] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Cossette, Patrick; Prat, Alexandre; Vande Velde, Christine] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Vande Velde, C (corresponding author), Univ Montreal, Ctr Excellence Neur, CRCHUM, Montreal, PQ, Canada.	c.vande.velde@umontreal.ca	Lécuyer, Marc-André/AAJ-2312-2021	Prat, Alexandre/0000-0001-6188-0580; Lecuyer, Marc-Andre/0000-0003-0465-6122	Canadian Institutes of Health Research Neuromuscular Research Partnership; Muscular Dystrophy Association; CHUM Research Center; Canadian Foundation for Innovation; Fonds de la Recherche du Quebec-Sante (FRQS); ALS Society of Canada; Reseau de Medecine Genetique Appliquee du FRQS	Canadian Institutes of Health Research Neuromuscular Research Partnership(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association(Muscular Dystrophy Association); CHUM Research Center; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de la Recherche du Quebec-Sante (FRQS); ALS Society of Canada; Reseau de Medecine Genetique Appliquee du FRQS	This work was supported by the Canadian Institutes of Health Research Neuromuscular Research Partnership, Muscular Dystrophy Association, CHUM Research Center, Canadian Foundation for Innovation, and Fonds de la Recherche du Quebec-Sante (FRQS) (all to CVV). AP is a Senior Research Scholars of FRQS, respectively. CVV is a CIHR New Investigator. SP and MDC are supported by the Tim Noel Studentship from the ALS Society of Canada and the Reseau de Medecine Genetique Appliquee du FRQS, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arkhipova V, 2012, DEV BIOL, V365, P290, DOI 10.1016/j.ydbio.2012.03.001; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; DEGUCHI Y, 1991, BLOOD, V78, P323; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GORSKI DH, 1993, TRENDS CARDIOVAS MED, V3, P184, DOI 10.1016/1050-1738(93)90004-P; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Iyer S, 2004, AM J PHYSIOL-LUNG C, V286, pL1143, DOI 10.1152/ajplung.00305.2003; Karsan A, 2005, MOL CELL PROTEOMICS, V4, P191, DOI 10.1074/mcp.M400152-MCP200; Keenan ID, 2012, FEBS LETT, V586, P1790, DOI 10.1016/j.febslet.2012.05.014; Li H, 1999, NAT GENET, V23, P67; Liang XQ, 2011, MOL CELL NEUROSCI, V47, P215, DOI 10.1016/j.mcn.2011.04.007; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Nakano T, 2005, DEV BIOL, V283, P474, DOI 10.1016/j.ydbio.2005.04.017; Oas RG, 2010, CIRC RES, V106, P941, DOI 10.1161/CIRCRESAHA.109.207753; Odden JP, 2002, J NEUROSCI, V22, P9143; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Vandevenne P, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016870, 10.1371/journal.pone.0022031]; Vasudevan A, 2008, CELL ADHES MIGR, V2, P167, DOI 10.4161/cam.2.3.6485; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74603	10.1371/journal.pone.0074603	http://dx.doi.org/10.1371/journal.pone.0074603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019971	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200114
J	Hottenrott, MC; Wedel, J; Gaertner, S; Stamellou, E; Kraaij, T; Mandel, L; Loesel, R; Sticht, C; Hoeger, S; Ait-Hsiko, L; Schedel, A; Hafner, M; Yard, B; Tsagogiorgas, C				Hottenrott, Maximilia C.; Wedel, Johannes; Gaertner, Sophie; Stamellou, Eleni; Kraaij, Tineke; Mandel, Linda; Loesel, Ralf; Sticht, Carsten; Hoeger, Simone; Ait-Hsiko, Lamia; Schedel, Angelika; Hafner, Mathias; Yard, Benito; Tsagogiorgas, Charalambos			N-Octanoyl Dopamine Inhibits the Expression of a Subset of kappa B Regulated Genes: Potential Role of p65 Ser276 Phosphorylation	PLOS ONE			English	Article							ENDOTHELIAL-CELL ACTIVATION; HEME OXYGENASE-1 EXPRESSION; NECROSIS-FACTOR-ALPHA; ACID PHENETHYL ESTER; ADHESION MOLECULES; IN-VITRO; TRANSCRIPTIONAL ACTIVITY; RELA PHOSPHORYLATION; CHEMOKINE PRODUCTION; MEDIATED APOPTOSIS	Background and Purpose: Catechol containing compounds have anti-inflammatory properties, yet for catecholamines these properties are modest. Since we have previously demonstrated that the synthetic dopamine derivative N-octanoyl dopamine (NOD) has superior anti-inflammatory properties compared to dopamine, we tested NOD in more detail and sought to elucidate the molecular entities and underlying mechanism by which NOD down-regulates inflammation. Experimental Approach: Genome wide gene expression profiling of human umbilical vein endothelial cells (HUVECs) was performed after stimulation with TNF-alpha or in the combination with NOD. Confirmation of these differences, NF kappa B activation and the molecular entities that were required for the anti-inflammatory properties were assessed in subsequent experiments. Key Results: Down regulation of inflammatory genes by NOD occurred predominantly for kappa B regulated genes, however not all kappa B regulated genes were affected. These findings were explained by inhibition of RelA phosphorylation at Ser276. Leukocyte adherence to TNF-alpha stimulated HUVECs was inhibited by NOD and was reflected by a diminished expression of adhesion molecules on HUVECs. NOD induced HO-1 expression, but this was not required for inhibition of NF kappa B. The anti-inflammatory effect of NOD seems to involve the redox active catechol structure, although the redox active para-dihydroxy benzene containing compounds also displayed anti-inflammatory effects, provided that they were sufficiently hydrophobic. Conclusions and Implications: The present study highlighted important mechanisms and molecular entities by which dihydroxy benzene compounds exert their potential anti-inflammatory action. Since NOD does not have hemodynamic properties, NOD seems to be a promising candidate drug for the treatment of inflammatory diseases.	[Hottenrott, Maximilia C.; Gaertner, Sophie; Tsagogiorgas, Charalambos] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Dept Anaesthesiol & Intens Care Med, Mannheim, Germany; [Wedel, Johannes; Stamellou, Eleni; Kraaij, Tineke; Mandel, Linda; Hoeger, Simone; Ait-Hsiko, Lamia; Yard, Benito] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Med Dept 5, Mannheim, Germany; [Loesel, Ralf] George Simon Ohm Hsch, Dept Appl Chem, Nurnberg, Germany; [Sticht, Carsten] Heidelberg Univ, Med Fac Mannheim, Ctr Med Res ZMF, Mannheim, Germany; [Schedel, Angelika] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, Mannheim, Germany; [Hafner, Mathias] Mannheim Univ Appl Sci, Inst Mol & Cellular Biol, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Yard, B (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Med Dept 5, Mannheim, Germany.	benito.yard@med5.ma.uni-heidelberg.de		Wedel, Johannes/0000-0002-3490-8477; Stamellou, Eleni/0000-0001-7472-4907; Losel, Ralf/0000-0001-9010-5217	German Research Foundation (DFG, Graduate School) [GRK 880]	German Research Foundation (DFG, Graduate School)(German Research Foundation (DFG))	This study was supported by a grant of the German Research Foundation (DFG, Graduate School, GRK 880). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADER R, 1995, LANCET, V345, P99, DOI 10.1016/S0140-6736(95)90066-7; Anand P, 2011, BIOCHEM PHARMACOL, V82, P1901, DOI 10.1016/j.bcp.2011.09.001; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; Beck GC, 2006, CLIN EXP IMMUNOL, V143, P523, DOI 10.1111/j.1365-2249.2006.03005.x; Beck GC, 2004, CRIT CARE, V8, P485, DOI 10.1186/cc2879; Beck GC, 2001, AM J RESP CELL MOL, V25, P636, DOI 10.1165/ajrcmb.25.5.4544; Berger SP, 2000, KIDNEY INT, V58, P2314, DOI 10.1046/j.1523-1755.2000.00415.x; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Carman CV, 2008, CURR OPIN CELL BIOL, V20, P533, DOI 10.1016/j.ceb.2008.05.007; Correnti C, 2012, J BIOL CHEM, V287, P13524, DOI 10.1074/jbc.R111.311829; Dev S, 2011, INT IMMUNOPHARMACOL; Dileep KV, 2012, CHEM BIOL DRUG DES, V79, P143, DOI 10.1111/j.1747-0285.2011.01258.x; Dinkova-Kostova AT, 2011, CHEM-BIOL INTERACT, V192, P101, DOI 10.1016/j.cbi.2010.09.010; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Ferreiro DU, 2010, BIOCHEMISTRY-US, V49, P1560, DOI 10.1021/bi901948j; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; Gottmann U, 2006, KIDNEY INT, V70, P321, DOI 10.1038/sj.ki.5001501; Hoeger S, 2007, TRANSPL INT, V20, P790, DOI 10.1111/j.1432-2277.2007.00510.x; Hommelberg PPH, 2010, CURR OPIN CLIN NUTR, V13, P647, DOI 10.1097/MCO.0b013e32833f1acd; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Jornot L, 1997, FEBS LETT, V416, P381, DOI 10.1016/S0014-5793(97)01244-1; Kapper S, 2002, TRANSPLANTATION, V74, P253, DOI 10.1097/00007890-200207270-00017; Kim AN, 2010, FREE RADICAL BIO MED, V49, P323, DOI 10.1016/j.freeradbiomed.2010.04.015; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Lee Y, 2010, EUR J PHARMACOL, V643, P21, DOI 10.1016/j.ejphar.2010.06.016; Losel RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009713; Mapesa JO, 2011, MOL NUTR FOOD RES, V55, P1850, DOI 10.1002/mnfr.201100105; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nair HB, 2010, BIOCHEM PHARMACOL, V80, P1833, DOI 10.1016/j.bcp.2010.07.021; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Raddatz A, 2006, AM J RESP CRIT CARE, V174, P198, DOI 10.1164/rccm.200508-1221OC; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rahman I, 2008, NUTR REV, V66, pS42, DOI 10.1111/j.1753-4887.2008.00067.x; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Song H, 2009, BRIT J PHARMACOL, V157, P769, DOI 10.1111/j.1476-5381.2009.00215.x; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Sundar IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031378; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Tsagogiorgas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043525; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; WRIGHT KL, 1995, J EXP MED, V181, P1459, DOI 10.1084/jem.181.4.1459; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	59	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73122	10.1371/journal.pone.0073122	http://dx.doi.org/10.1371/journal.pone.0073122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023820	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400046
J	Kemere, C; Carr, MF; Karlsson, MP; Frank, LM				Kemere, Caleb; Carr, Margaret F.; Karlsson, Mattias P.; Frank, Loren M.			Rapid and Continuous Modulation of Hippocampal Network State during Exploration of New Places	PLOS ONE			English	Article							FREELY-MOVING RATS; SYNAPTIC-TRANSMISSION; GAMMA-OSCILLATIONS; ENTORHINAL CORTEX; THETA OSCILLATIONS; CELL ASSEMBLIES; BEHAVING RAT; AWAKE STATE; CA3 OUTPUT; DYNAMICS	Hippocampal information processing is often described as two-state, with a place cell state during movement and a reactivation state during stillness. Relatively little is known about how the network transitions between these different patterns of activity during exploration. Here we show that hippocampal network changes quickly and continuously as animals explore and become familiar with initially novel places. We measured the relationship between moment-by-moment changes in behavior and information flow through hippocampal output area CA1 in rats. We examined local field potential (LFP) patterns, evoked potentials and ensemble spiking and found evidence suggestive of a smooth transition from strong CA3 drive of CA1 activity at low speeds to entorhinal cortical drive of CA1 activity at higher speeds. These changes occurred with changes in behavior on a timescale of less than a second, suggesting a continuous modulation of information processing in the hippocampal circuit as a function of behavioral state.	[Kemere, Caleb; Carr, Margaret F.; Karlsson, Mattias P.; Frank, Loren M.] Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Kemere, Caleb; Carr, Margaret F.; Karlsson, Mattias P.; Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Kemere, Caleb] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77251 USA; [Carr, Margaret F.] Stanford Univ, CNC Program, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rice University; Stanford University	Frank, LM (corresponding author), Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu		Frank, Loren/0000-0002-1752-5677; Kemere, Caleb/0000-0003-2054-0234	Sloan foundation; Swartz foundation; John Merck Fund; Helen Hay Whitney Foundation; National Science Foundation; National Institutes of Health [RO1MH077970, RO1MH080283, F31MH093067]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283, F31MH093067] Funding Source: NIH RePORTER	Sloan foundation(Alfred P. Sloan Foundation); Swartz foundation; John Merck Fund; Helen Hay Whitney Foundation; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Sloan and Swartz foundations, the John Merck Fund, a Helen Hay Whitney Foundation grant to C. K., a National Science Foundation Graduate Research Fellowship to M. F. C., and grants RO1MH077970, RO1MH080283, and F31MH093067 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OJ, 2012, J NEUROSCI, V32, P7373, DOI 10.1523/JNEUROSCI.5110-11.2012; Berke JD, 2008, HIPPOCAMPUS, V18, P519, DOI 10.1002/hipo.20435; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Carr MF, 2012, NEURON, V75, P700, DOI 10.1016/j.neuron.2012.06.014; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Chen ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021408; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Gu ZL, 2011, NEURON, V71, P155, DOI 10.1016/j.neuron.2011.04.026; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Hinman JR, 2011, J NEUROPHYSIOL, V105, P2675, DOI 10.1152/jn.00837.2010; Jeewajee A, 2008, HIPPOCAMPUS, V18, P340, DOI 10.1002/hipo.20394; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kim SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005494; King C, 1998, EUR J NEUROSCI, V10, P464, DOI 10.1046/j.1460-9568.1998.00026.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; Lever C, 2009, HIPPOCAMPUS; Logothetis NK, 2012, NATURE, V491, P547, DOI 10.1038/nature11618; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Penley SC, 2011, HIPPOCAMPUS; Schall KP, 2010, HIPPOCAMPUS, V20, P279, DOI 10.1002/hipo.20632; SEGAL M, 1978, ELECTROEN CLIN NEURO, V45, P409, DOI 10.1016/0013-4694(78)90192-X; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Singer AC, 2010, J NEUROSCI, V30, P11586, DOI 10.1523/JNEUROSCI.0926-10.2010; VANDERWOLF CH, 1975, J COMP PHYSIOL PSYCH, V88, P300, DOI 10.1037/h0076211; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WINSON J, 1978, J NEUROPHYSIOL, V41, P716, DOI 10.1152/jn.1978.41.3.716; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	64	77	77	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73114	10.1371/journal.pone.0073114	http://dx.doi.org/10.1371/journal.pone.0073114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023818	gold, Green Published, Green Submitted			2022-12-27	WOS:000324238400044
J	Gonzalez, MV; Mousel, MR; Herndon, DR; Jiang, Y; Dalrymple, BP; Reynolds, JO; Johnson, WC; Herrmann-Hoesing, LM; White, SN				Gonzalez, Michael V.; Mousel, Michelle R.; Herndon, David R.; Jiang, Yu; Dalrymple, Brian P.; Reynolds, James O.; Johnson, Wendell C.; Herrmann-Hoesing, Lynn M.; White, Stephen N.			A Divergent Artiodactyl MYADM-like Repeat Is Associated with Erythrocyte Traits and Weight of Lamb Weaned in Domestic Sheep	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HEMATOLOGICALLY IMPORTANT MUTATIONS; SICKLE-CELL-DISEASE; HEREDITARY SPHEROCYTOSIS; READ ALIGNMENT; HIGH-ALTITUDE; LOCI; DIFFERENTIATION; BLOOD; GENE	A genome-wide association study (GWAS) was performed to investigate seven red blood cell (RBC) phenotypes in over 500 domestic sheep (Ovis aries) from three breeds (Columbia, Polypay, and Rambouillet). A single nucleotide polymorphism (SNP) showed genome-wide significant association with increased mean corpuscular hemoglobin concentration (MCHC, P = 6.2x10(-14)) and genome-wide suggestive association with decreased mean corpuscular volume (MCV, P = 2.5x10(-6)). The ovine HapMap project found the same genomic region and the same peak SNP has been under extreme historical selective pressure, demonstrating the importance of this region for survival, reproduction, and/or artificially selected traits. We observed a large (>50 kb) variant haplotype sequence containing a full-length divergent artiodactyl MYADM-like repeat in strong linkage disequilibrium with the associated SNP. MYADM gene family members play roles in membrane organization and formation in myeloid cells. However, to our knowledge, no member of the MYADM gene family has been identified in development of morphologically variant RBCs. The specific RBC differences may be indicative of alterations in morphology. Additionally, erythrocytes with altered morphological structure often exhibit increased structural fragility, leading to increased RBC turnover and energy expenditure. The divergent artiodactyl MYADM-like repeat was also associated with increased ewe lifetime kilograms of lamb weaned (P = 2x10(-4)). This suggests selection for normal RBCs might increase lamb weights, although further validation is required before implementation in marker-assisted selection. These results provide clues to explain the strong selection on the artiodactyl MYADM-like repeat locus in sheep, and suggest MYADM family members may be important for RBC morphology in other mammals.	[Gonzalez, Michael V.; Herndon, David R.; Reynolds, James O.; Johnson, Wendell C.; White, Stephen N.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [Gonzalez, Michael V.; Herrmann-Hoesing, Lynn M.; White, Stephen N.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Mousel, Michelle R.] ARS, US Sheep Expt Stn, USDA, Dubois, ID USA; [Jiang, Yu; Dalrymple, Brian P.] CSIRO Anim Food & Hlth Sci, St Lucia, Qld, Australia	United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	White, SN (corresponding author), ARS, Anim Dis Res Unit, USDA, Pullman, WA USA.	Stephen.White@ars.usda.gov	Jiang, Yu/O-5114-2015; Herndon, David/AAC-3354-2020; Dalrymple, Brian P/F-8721-2010; Gonzalez, Michael/A-8146-2015; Mousel, Michelle/I-6398-2013	Jiang, Yu/0000-0003-4821-3585; Dalrymple, Brian P/0000-0003-3891-5233; Gonzalez, Michael/0000-0001-9741-475X; White, Stephen N./0000-0001-9255-6054; Mousel, Michelle/0000-0003-1367-7005	USDA-ARS [5348-32000-031-00D]; Washington State University Graduate School; ARCS Foundation; American Sheep Industry	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Washington State University Graduate School; ARCS Foundation; American Sheep Industry	This work was supported by USDA-ARS grant 5348-32000-031-00D. MVG was supported by a Distinguished Research Assistantship for Diverse Scholars from the Washington State University Graduate School, an Achievement Rewards for College Scientists fellowship from the ARCS Foundation, and a Sheep Heritage Memorial Scholarship from the American Sheep Industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda JF, 2011, MOL BIOL CELL, V22, P1252, DOI 10.1091/mbc.E10-11-0910; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; CHIEN S, 1970, J CLIN INVEST, V49, P623, DOI 10.1172/JCI106273; Cui WC, 2001, MOL BIOL REP, V28, P123, DOI 10.1023/A:1015288412047; Dannaeus K, 2005, MOL BIOL REP, V32, P149, DOI 10.1007/s11033-005-0753-x; Dong Y, 2012, NAT BIOTECH; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Fukuda MN, 2008, CELL MOL LIFE SCI, V65, P92, DOI 10.1007/s00018-007-7302-9; Gallagher PG, 1998, BLOOD CELL MOL DIS, V24, P539, DOI 10.1006/bcmd.1998.0217; Gallagher PG, 1997, BLOOD CELL MOL DIS, V23, P417, DOI 10.1006/bcmd.1997.0160; Gallagher PG, 2005, RED CELL MEMBRANE DI, P13; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Goddard ME, 2010, GENET RES, V92, P413, DOI 10.1017/S0016672310000613; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; Herrmann-Hoesing LM, 2008, IMMUNOGENETICS, V60, P749, DOI 10.1007/s00251-008-0328-9; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; KAR BC, 1986, LANCET, V2, P1198; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin JP, 2007, AM J HEMATOL, V82, P605, DOI 10.1002/ajh.20868; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mousel MR, 2010, ANIM GENET, V41, P222, DOI 10.1111/j.1365-2052.2009.01979.x; National Heart L, 2009, DIS COND IND SICKL C; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Pettersson M, 2000, J LEUKOCYTE BIOL, V67, P423, DOI 10.1002/jlb.67.3.423; PIERAGOSTINI E, 1994, SMALL RUMINANT RES, V13, P177, DOI 10.1016/0921-4488(94)90094-9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; Silva MVB, 2012, ANIM GENET, V43, P63, DOI 10.1111/j.1365-2052.2011.02202.x; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; STEINBERG MH, 1984, BLOOD, V63, P1353; Tarazona-Santos E, 2000, AM J PHYS ANTHROPOL, V111, P165, DOI 10.1002/(SICI)1096-8644(200002)111:2<165::AID-AJPA3>3.3.CO;2-7; Team R. D. C., 2008, R LANG ENV STAT COMP; Tse WT, 1999, BRIT J HAEMATOL, V104, P2, DOI 10.1111/j.1365-2141.1999.01130.x; Wang JY, 2013, ANIM GENET, V44, P34, DOI 10.1111/j.1365-2052.2012.02366.x; White SN, 2009, ANIM GENET, V40, P583, DOI 10.1111/j.1365-2052.2009.01882.x; White SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047829; WHITFIELD J B, 1985, Genetic Epidemiology, V2, P133, DOI 10.1002/gepi.1370020204; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	44	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e74700	10.1371/journal.pone.0074700	http://dx.doi.org/10.1371/journal.pone.0074700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023702	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200100
J	Li, SK; Zhu, S; Li, CB; Zhang, Z; Zhou, LZ; Wang, SJ; Wang, SQ; Zhang, YL; Wen, XB				Li, Shengkang; Zhu, Shuo; Li, Chuanbiao; Zhang, Zhao; Zhou, Lizhen; Wang, Shijia; Wang, Shuqi; Zhang, Yueling; Wen, Xiaobo			Characterization of microRNAs in Mud Crab Scylla paramamosain under Vibrio parahaemolyticus Infection	PLOS ONE			English	Article							IMMUNE-SYSTEM; RNA; IDENTIFICATION; EXPRESSION; LET-7; PREDICTION; TARGETS; PCR; BIOGENESIS; EVOLUTION	Background: Infection of bacterial Vibrio parahaemolyticus is common in mud crab farms. However, the mechanisms of the crab's response to pathogenic V. parahaemolyticus infection are not fully understood. MicroRNAs (miRNAs) are a class of small noncoding RNAs that function as regulators of gene expression and play essential roles in various biological processes. To understand the underlying mechanisms of the molecular immune response of the crab to the pathogens, high-throughput Illumina/Solexa deep sequencing technology was used to investigate the expression profiles of miRNAs in S. paramamosain under V. parahaemolyticus infection. Methodology/Principal Findings: Two mixed RNA pools of 7 tissues (intestine, heart, liver, gill, brain, muscle and blood) were obtained from V. parahaemolyticus infected crabs and the control groups, respectively. By aligning the sequencing data with known miRNAs, we characterized 421 miRNA families, and 133 conserved miRNA families in mud crab S. paramamosain were either identical or very similar to existing miRNAs in miRBase. Stem-loop qRT-PCRs were used to scan the expression levels of four randomly chosen differentially expressed miRNAs and tissue distribution. Eight novel potential miRNAs were confirmed by qRT-PCR analysis and the precursors of these novel miRNAs were verified by PCR amplification, cloning and sequencing in S. paramamosain. 161 miRNAs (106 of which up-regulated and 55 down-regulated) were significantly differentially expressed during the challenge and the potential targets of these differentially expressed miRNAs were predicted. Furthermore, we demonstrated evolutionary conservation of mud crab miRNAs in the animal evolution process. Conclusions/Significance: In this study, a large number of miRNAs were identified in S. paramamosain when challenged with V. parahaemolyticus, some of which were differentially expressed. The results show that miRNAs might play some important roles in regulating gene expression in mud crab under V. parahaemolyticus infection, providing a basis for further investigation of miRNA-modulating networks in innate immunity of mud crab.	[Li, Shengkang; Zhu, Shuo; Li, Chuanbiao; Zhang, Zhao; Zhou, Lizhen; Wang, Shuqi; Zhang, Yueling; Wen, Xiaobo] Shantou Univ, Inst Marine Biol, Guangdong Prov Key Lab Marine Biol, Shantou, Peoples R China; [Zhu, Shuo; Wang, Shijia; Zhang, Yueling] Shantou Univ, Dept Biol, Coll Sci, Shantou, Peoples R China	Shantou University; Shantou University	Wen, XB (corresponding author), Shantou Univ, Inst Marine Biol, Guangdong Prov Key Lab Marine Biol, Shantou, Peoples R China.	wenxbo@stu.edu.cn			Natural Science Foundation of China [31172424, 41176103]; Natural Science Foundation of Guangdong [S2012010009923]; Guangdong Provincial Scientific & Technological Project [2012B020308007]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Scientific & Technological Project	The work was supported by grants from the Natural Science Foundation of China (31172424, 41176103), Natural Science Foundation of Guangdong (S2012010009923) and Guangdong Provincial Scientific & Technological Project (2012B020308007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Blythe MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033784; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Garbuzov A, 2010, FLY, V4, P306, DOI 10.4161/fly.4.4.13008; Inaoka T, 2012, J BACTERIOL, V194, P5632, DOI 10.1128/JB.01147-12; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Li S, 2012, J APPL MICROBIOL, V113, P1341, DOI 10.1111/jam.12008; Li YY, 2008, DIS AQUAT ORGAN, V82, P145, DOI 10.3354/dao01988; Lin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060337; Liston A, 2012, CELL MOL LIFE SCI, V69, P3533, DOI 10.1007/s00018-012-1124-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Man MZ, 2000, BIOINFORMATICS, V16, P953, DOI 10.1093/bioinformatics/16.11.953; Meliopoulos VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037169; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pasquinelli AE, 2003, EVOL DEV, V5, P372, DOI 10.1046/j.1525-142X.2003.03044.x; Ragan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005745; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ruan LW, 2011, FISH SHELLFISH IMMUN, V31, P334, DOI 10.1016/j.fsi.2011.05.023; Saba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030832; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wang CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047001; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xia Xiao-an, 2010, Journal of Tropical Oceanography, V29, P103; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Yang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039015; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	28	32	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73392	10.1371/journal.pone.0073392	http://dx.doi.org/10.1371/journal.pone.0073392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023678	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200075
J	Linnebjerg, JF; Fort, J; Guilford, T; Reuleaux, A; Mosbech, A; Frederiksen, M				Linnebjerg, Jannie Fries; Fort, Jerome; Guilford, Tim; Reuleaux, Anna; Mosbech, Anders; Frederiksen, Morten			Sympatric Breeding Auks Shift between Dietary and Spatial Resource Partitioning across the Annual Cycle	PLOS ONE			English	Article							RAZORBILLS ALCA-TORDA; THICK-BILLED MURRES; STABLE-ISOTOPES; COMMON MURRES; URIA-AALGE; ECOLOGICAL RELATIONSHIPS; FORAGING SEGREGATION; WINTER DISTRIBUTION; OUTER BAY; SEABIRDS	When species competing for the same resources coexist, some segregation in the way they utilize those resources is expected. However, little is known about how closely related sympatric breeding species segregate outside the breeding season. We investigated the annual segregation of three closely related seabirds (razorbill Alca torda, common guillemot Uria aalge and Brunnich's guillemot U. lomvia) breeding at the same colony in Southwest Greenland. By combining GPS and geolocation (GLS) tracking with dive depth and stable isotope analyses, we compared spatial and dietary resource partitioning. During the breeding season, we found the three species to segregate in diet and/or dive depth, but less in foraging area. During both the post-breeding and pre-breeding periods, the three species had an increased overlap in diet, but were dispersed over a larger spatial scale. Dive depths were similar across the annual cycle, suggesting morphological adaptations fixed by evolution. Prey choice, on the other hand, seemed much more flexible and therefore more likely to be affected by the immediate presence of potential competitors.	[Linnebjerg, Jannie Fries; Fort, Jerome; Reuleaux, Anna; Mosbech, Anders; Frederiksen, Morten] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Guilford, Tim] Univ Oxford, Dept Zool, Oxford OX1 3PS, Oxon, England; [Mosbech, Anders] Aarhus Univ, ARC, Aarhus, Denmark	Aarhus University; University of Oxford; Aarhus University	Linnebjerg, JF (corresponding author), Aarhus Univ, Dept Biosci, Roskilde, Denmark.	jannie.linnebjerg@gmail.com	Frederiksen, Morten/A-7542-2008; Mosbech, Anders/Q-5984-2019; Fort, Jerome/F-1157-2016; Linnebjerg, Jannie/AAI-4571-2020	Frederiksen, Morten/0000-0001-5550-0537; Mosbech, Anders/0000-0002-7581-7037; Fort, Jerome/0000-0002-0860-6707; Linnebjerg, Jannie Fries/0000-0003-4043-0606	Greenlandic Bureau of Minerals and Petroleum (BMP), Nuuk, Greenland	Greenlandic Bureau of Minerals and Petroleum (BMP), Nuuk, Greenland	Funding was provided by the Greenlandic Bureau of Minerals and Petroleum (BMP), Nuuk, Greenland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken V, 2003, NORSK RINGMERKINGSAT, V1; Barger CP, 2012, BIOL LETTERS, V8, P442, DOI 10.1098/rsbl.2011.1020; Barrett RT, 1997, CAN J ZOOL, V75, P618, DOI 10.1139/z97-077; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; BIRKHEAD TR, 1987, CAN J ZOOL, V65, P1621, DOI 10.1139/z87-251; Boertmann D, 2004, BIRD CONSERV INT, V14, P87, DOI 10.1017/S0959270904000127; Boertmann D, 1996, 170 NERI; Bradstreet M. S. W., 1985, ATLANTIC ALCIDAE, P264; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Cherel Y, 2006, BIOL LETTERS, V2, P301, DOI 10.1098/rsbl.2006.0445; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Clarke TCR, 2010, WATERBIRDS, V33, P541, DOI 10.1675/063.033.0414; CROXALL JP, 1980, BIOL J LINN SOC, V14, P103, DOI 10.1111/j.1095-8312.1980.tb00101.x; Darwin C, 1859, ORIGIN SPECIES MEANS; Ekstrom P.A., 2004, MEMOIRS NATL I POLAR, P210; Elliot R.D., 1990, Studies in Avian Biology, P125; Elliott KH, 2007, CAN J ZOOL, V85, P352, DOI 10.1139/Z07-012; Forero MG, 2005, MAR ECOL PROG SER, V296, P107, DOI 10.3354/meps296107; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Frere E, 2008, IBIS, V150, P558, DOI 10.1111/j.1474-919X.2008.00824.x; Futuyma D. J., 2005, EVOLUTION; Gaston A.J., 2004, SEABIRDS NATURAL HIS; Gaston AJ, 2011, MAR BIOL, V158, P1929, DOI 10.1007/s00227-011-1704-9; Gonzalez-Solis J, 2007, AQUAT CONSERV, V17, pS22, DOI 10.1002/aqc.911; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Guilford T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033753; Guilford T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021336; Hamer KC, 2007, MAR ECOL PROG SER, V338, P295, DOI 10.3354/meps338295; Hill Roger D., 1994, P227; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Huettmann Falk, 2005, Marine Ornithology, V33, P161; Hunt G.L. Jr, 1987, P7; Ishtiaq F, 2010, WATERBIRDS, V33, P41, DOI 10.1675/063.033.0105; Kampp K, 1994, BIOSCIENCE, V42, P1; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Lavers J, 2009, BIRDS N AM ONLINE; Lewis S, 2006, OECOLOGIA, V147, P606, DOI 10.1007/s00442-005-0321-z; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Lilliendahl K, 2009, MAR BIOL RES, V5, P143, DOI 10.1080/17451000802279636; Linnebjerg JF, 2012, THESIS AARHUS U DENM; Roscales JL, 2011, MAR ECOL PROG SER, V434, P1, DOI 10.3354/meps09211; Lyngs Peter, 2003, Dansk Ornitologisk Forenings Tidsskrift, V97, P1; Merkel FR, 2002, POLAR RES, V21, P17, DOI 10.1111/j.1751-8369.2002.tb00064.x; Montevecchi WA, 2012, BIOL CONSERV, V156, P62, DOI 10.1016/j.biocon.2011.12.001; Moody Allison T., 2007, Marine Ornithology, V35, P39; Mosbech A, 2009, 749 NERI; Navarro J, 2009, BIOL LETTERS, V5, P545, DOI 10.1098/rsbl.2009.0150; NETTLESHIP D. N., 1985, ATLANTIC ALCIDAE EVO; Orians G.H., 1979, P155; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; PIANKA ER, 1969, ECOLOGY, V50, P1012, DOI 10.2307/1936893; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Thaxter CB, 2010, J EXP BIOL, V213, P1018, DOI 10.1242/jeb.037390; Thiebot JB, 2012, ECOLOGY, V93, P122, DOI 10.1890/11-0385.1; Thiebot JB, 2011, MAR ECOL PROG SER, V421, P279, DOI 10.3354/meps08907; Thompson DR, 1999, CONDOR, V101, P898, DOI 10.2307/1370085; Townsend CR., 1996, ECOLOGY INDIVIDUALS, DOI [10.1002/9781444313765, DOI 10.1002/9781444313765]; WANLESS S, 1990, COLON WATERBIRD, V13, P16, DOI 10.2307/1521416; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Wernham C., 2002, MIGRATION ATLAS MOVE; Wilson R.P., 1992, P131; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Young HS, 2010, MAR ECOL PROG SER, V416, P285, DOI 10.3354/meps08756	64	54	55	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72987	10.1371/journal.pone.0072987	http://dx.doi.org/10.1371/journal.pone.0072987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023663	Green Published, gold			2022-12-27	WOS:000323880200059
J	Marcinek, P; Jha, AN; Shinde, V; Sundaramoorthy, A; Rajkumar, R; Suryadevara, NC; Neela, SK; van Tong, H; Balachander, V; Valluri, VL; Thangaraj, K; Velavan, TP				Marcinek, Patrick; Jha, Aditya Nath; Shinde, Vidyagouri; Sundaramoorthy, Arun; Rajkumar, Raja; Suryadevara, Naveen Chandra; Neela, Sanjeev Kumar; van Tong, Hoang; Balachander, Vellingiri; Valluri, Vijaya Lakshmi; Thangaraj, Kumarasamy; Velavan, Thirumalaisamy P.			LRRK2 and RIPK2 Variants in the NOD 2-Mediated Signaling Pathway Are Associated with Susceptibility to Mycobacterium leprae in Indian Populations	PLOS ONE			English	Article							CROHNS-DISEASE; LEPROSY; GENES; LOCI	In recent years, genome wide association studies have discovered a large number of gene loci that play a functional role in innate and adaptive immune pathways associated with leprosy susceptibility. The immunological control of intracellular bacteria M. leprae is modulated by NOD2-mediated signaling of Th1 responses. In this study, we investigated 211 clinically classified leprosy patients and 230 ethnically matched controls in Indian population by genotyping four variants in NOD2 (rs9302752A/G), LRRK2 (rs1873613A/G), RIPK2 (rs40457A/G and rs42490G/A). The LRRK2 locus is associated with leprosy outcome. The LRRK2 rs1873613A minor allele and respective rs1873613AA genotypes were significantly associated with an increased risk whereas the LRRK2 rs1873613G major allele and rs1873613GG genotypes confer protection in paucibacillary and leprosy patients. The reconstructed GA haplotypes from RIPK2 rs40457A/G and rs42490G/A variants was observed to contribute towards increased risk whereas haplotypes AA was observed to confer protective role. Our results indicate that a possible shared mechanisms underlying the development of these two clinical forms of the disease as hypothesized. Our findings confirm and validates the role of gene variants involved in NOD2-mediated signalling pathways that play a role in immunological control of intracellular bacteria M. leprae.	[Marcinek, Patrick; van Tong, Hoang; Velavan, Thirumalaisamy P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Jha, Aditya Nath; Rajkumar, Raja; Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Shinde, Vidyagouri; Suryadevara, Naveen Chandra; Neela, Sanjeev Kumar; Valluri, Vijaya Lakshmi] LEPRA Blue Peter Publ Hlth & Res Ctr, Hyderabad, Andhra Pradesh, India; [Sundaramoorthy, Arun; Balachander, Vellingiri] Bharathiar Univ, Sch Life Sci, Dept Zool, Coimbatore, Tamil Nadu, India	Eberhard Karls University of Tubingen; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Bharathiar University	Velavan, TP (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	velavan@medizin.uni-tuebingen.de	Suryadevara, Naveenchandra/AAQ-7626-2021; Valluri, Vijaya Lakshmi/S-9219-2019; van Tong, Hoang/E-9448-2011; Velavan, Thirumalaisamy P/C-1223-2010	van Tong, Hoang/0000-0002-7170-8810; Velavan, Thirumalaisamy P/0000-0002-9809-9883; Jha, Aditya Nath/0000-0002-2824-7131; Thangaraj, Kumarasamy/0000-0002-0075-0106; suryadevara, naveenchandra/0000-0003-2571-1290	fortune grant [1916-1-1]; DFG [PA 1974/3-1]; BMBF [IND 10/A18]; LEPRA-BPHRC institutional grant; ICMR [5/8/3(13)/2009-ECD-I (A)]; Council of Scientific and Industrial Research, New Delhi; Deutsche Forschungsgemeinschaft (DFG); Tuebingen University	fortune grant; DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); LEPRA-BPHRC institutional grant; ICMR(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Tuebingen University	This study was funded by fortune grant (1916-1-1), DFG PA 1974/3-1 and BMBF IND 10/A18 to Velavan TP. This study was also funded by LEPRA-BPHRC institutional grant and by ICMR (5/8/3(13)/2009-ECD-I (A) grant to Valluri VL. This work was supported by the Council of Scientific and Industrial Research, New Delhi (www.csir.res.in) to KT. The authors acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P389; Assaf A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034113; Borzutzky A, 2010, CLIN IMMUNOL, V134, P251, DOI 10.1016/j.clim.2009.05.005; de Messias-Reason IJ, 2007, J INFECT DIS, V196, P1379, DOI 10.1086/521627; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Grant AV, 2012, J INFECT DIS, V206, P1763, DOI 10.1093/infdis/jis588; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jeong YJ, 2012, J MICROBIOL, V50, P489, DOI 10.1007/s12275-012-1534-6; JOHANNSEN U, 1968, Archiv fuer Experimentelle Veterinaermedizin, V22, P233; KAISER S, 1990, ADV EXP MED BIOL, V264, P117; Kang Tae Jin, 2011, Immune Netw, V11, P424, DOI 10.4110/in.2011.11.6.424; Kim BC, 2004, MEDIAT INFLAMM, V13, P51, DOI 10.1080/09629350410001664734; Lee BD, 2012, TRENDS PHARMACOL SCI, V33, P365, DOI 10.1016/j.tips.2012.04.001; Lewis PA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002680; Liu ZH, 2012, CELL RES, V22, P1092, DOI 10.1038/cr.2012.42; Madrigal AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002723; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Okafuji I, 2009, ARTHRITIS RHEUM-US, V60, P242, DOI 10.1002/art.24134; Ouf EA, 2012, J INFECT DIS; Pan H, 2012, INT J IMMUNOGENET, V39, P233, DOI 10.1111/j.1744-313X.2011.01079.x; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; RIDLEY DS, 1974, B WORLD HEALTH ORGAN, V51, P451; Schenk M, 2012, NAT MED, V18, P555, DOI 10.1038/nm.2650; Schurr E, 2009, NEW ENGL J MED, V361, P2666, DOI 10.1056/NEJMe0910690; Shinde V, 2013, HUM IMMUNOL, V74, P803, DOI 10.1016/j.humimm.2013.01.001; Sun YH, 2011, EXP DERMATOL, V20, P520, DOI 10.1111/j.1600-0625.2011.01270.x; Tigno-Aranjuez JT, 2012, BIOCH BIOPHYS ACTA; Tong HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028113; Umeno J, 2011, INFLAMM BOWEL DIS, V17, P2407, DOI 10.1002/ibd.21651; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; Velavan TP, 2012, IMMUNOGENETICS, V64, P87, DOI 10.1007/s00251-011-0563-3; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	39	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73103	10.1371/journal.pone.0073103	http://dx.doi.org/10.1371/journal.pone.0073103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015287	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800090
J	Vervaeke, P; Alen, M; Noppen, S; Schols, D; Oreste, P; Liekens, S				Vervaeke, Peter; Alen, Marijke; Noppen, Sam; Schols, Dominique; Oreste, Pasqua; Liekens, Sandra			Sulfated Escherichia coli K5 Polysaccharide Derivatives Inhibit Dengue Virus Infection of Human Microvascular Endothelial Cells by Interacting with the Viral Envelope Protein E Domain III	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CAPSULAR POLYSACCHARIDE; DENDRITIC CELLS; ENHANCEMENT; NONINTEGRIN; ACTIVATION; EXPRESSION; RECEPTOR; PROMOTES; ADHESION	Dengue virus (DENV) is an emerging mosquito-borne pathogen that causes cytokine-mediated alterations in the barrier function of the microvascular endothelium, leading to dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). We observed that DENV (serotype 2) productively infects primary (HMVEC-d) and immortalized (HMEC-1) human dermal microvascular endothelial cells, despite the absence of well-described DENV receptors, such as dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) or the mannose receptor on the cell surface. However, heparan sulfate proteoglycans (HSPGs) were highly expressed on these cells and pre-treatment of HMEC-1 cells with heparinase II or with glycosaminoglycans reduced DENV infectivity up to 90%, suggesting that DENV uses HSPGs as attachment receptor on microvascular endothelial cells. Sulfated Escherichia coli K5 derivatives, which are structurally similar to heparin/heparan sulfate but lack anticoagulant activity, were able to block DENV infection of HMEC-1 and HMVEC-d cells in the nanomolar range. The highly sulfated K5-OS(H) and K5-N, OS(H) inhibited virus attachment and subsequent entry into microvascular endothelial cells by interacting with the viral envelope (E) protein, as shown by surface plasmon resonance (SPR) analysis using the receptor-binding domain III of the E protein.	[Vervaeke, Peter; Alen, Marijke; Noppen, Sam; Schols, Dominique; Oreste, Pasqua; Liekens, Sandra] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Louvain, Belgium; [Oreste, Pasqua] Glycores 2000 Srl, Milan, Italy	KU Leuven	Liekens, S (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Louvain, Belgium.	sandra.liekens@rega.kuleuven.be	Schols, Dominique/S-9057-2017; Schols, Dominique/AAC-1309-2021; Vervaeke, Peter/F-3660-2018; Noppen, Sam/F-8681-2018	Schols, Dominique/0000-0003-3256-5850; Schols, Dominique/0000-0003-3256-5850; Vervaeke, Peter/0000-0001-8565-7391; Noppen, Sam/0000-0002-2831-5042	KU Leuven (GOA) [10/014, 10/18]	KU Leuven (GOA)(KU Leuven)	This work was supported by the KU Leuven (GOA no. 10/014 and PF no. 10/18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Alen MMF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021658; Arevalo MT, 2009, J MED VIROL, V81, P519, DOI 10.1002/jmv.21408; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bonner SM, 1998, J VIROL METHODS, V71, P159, DOI 10.1016/S0166-0934(97)00211-5; Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002; Cabello-Guterrez C, 2009, THROMB HAEMOSTASIS, V101, P916, DOI 10.1160/TH08-04-0271; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Chen LC, 2009, J INFECTION, V58, P368, DOI 10.1016/j.jinf.2009.02.018; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11; Dalrymple NA, 2012, ADV VIROL, V2012, DOI 10.1155/2012/840654; Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12; de Jong MAWP, 2008, J GEN VIROL, V89, P2398, DOI 10.1099/vir.0.2008/003129-0; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Fang SY, 2013, SCI WORLD J, DOI 10.1155/2013/684690; Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713; Huang YH, 2003, J MED VIROL, V70, P610, DOI 10.1002/jmv.10438; Huang YH, 2000, AM J TROP MED HYG, V63, P71, DOI 10.4269/ajtmh.2000.63.71; Hung SL, 1999, VIROLOGY, V257, P156, DOI 10.1006/viro.1999.9633; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Jiang Z, 2007, J INFECTION, V55, P23; Kanlaya R, 2009, J PROTEOME RES, V8, P2551, DOI 10.1021/pr900060g; Kato D, 2010, ANTIVIR RES, V88, P236, DOI 10.1016/j.antiviral.2010.09.002; KILLEN H, 1993, J VIROL METHODS, V41, P135, DOI 10.1016/0166-0934(93)90121-7; Krishnamurti C, 2002, AM J TROP MED HYG, V66, P435, DOI 10.4269/ajtmh.2002.66.435; Leali D, 2001, J BIOL CHEM, V276, P37900; Lembo D, 2008, ANTIMICROB AGENTS CH, V52, P1374, DOI 10.1128/AAC.01467-07; Lin YL, 2002, ANTIVIR RES, V56, P93, DOI 10.1016/S0166-3542(02)00095-5; Luscher-Mattli M, 2000, ANTIVIR CHEM CHEMOTH, V11, P249, DOI 10.1177/095632020001100401; Mas-Moruno C, 2010, ANTI-CANCER AGENT ME, V10, P753, DOI 10.2174/187152010794728639; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mercorelli B, 2010, ANTIMICROB AGENTS CH, V54, P4561, DOI 10.1128/AAC.00721-10; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Oreste P, 2012, Handb Exp Pharmacol, P403, DOI 10.1007/978-3-642-23056-1_18; Peyrefitte CN, 2006, J MED VIROL, V78, P229, DOI 10.1002/jmv.20532; Pinna D, 2008, ANTIMICROB AGENTS CH, V52, P3078, DOI 10.1128/AAC.00359-08; Rusnati M, 2009, PHARMACOL THERAPEUT, V123, P310, DOI 10.1016/j.pharmthera.2009.05.001; Srikiatkhachorn A, 2007, J VIROL, V81, P1592, DOI 10.1128/JVI.01642-06; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Tripathi CKM, 2012, APPL MICROBIOL BIOT, V94, P307, DOI 10.1007/s00253-012-3967-6; VANDAMME EJM, 1991, EUR J BIOCHEM, V202, P23, DOI 10.1111/j.1432-1033.1991.tb16339.x; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Vicenzi E, 2003, AIDS, V17, P177, DOI 10.1097/00002030-200301240-00006; Warke RV, 2008, J VIROL, V82, P555, DOI 10.1128/JVI.01694-06; Warke RV, 2003, J VIROL, V77, P11822, DOI 10.1128/JVI.77.21.11822-11832.2003; Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; WHO, 2022, DENG SEV DENG; Yeh TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055018; Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08; Zamudio-Meza H, 2009, J GEN VIROL, V90, P2902, DOI 10.1099/vir.0.014159-0; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004; Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051; Zhu WY, 2011, BIOMED ENVIRON SCI, V24, P81, DOI 10.3967/0895-3988.2011.01.011	67	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e74035	10.1371/journal.pone.0074035	http://dx.doi.org/10.1371/journal.pone.0074035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015314	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800109
J	Ammerpohl, O; Bens, S; Appari, M; Werner, R; Korn, B; Drop, SLS; Verheijen, F; van der Zwan, Y; Bunch, T; Hughes, I; Cools, M; Riepe, FG; Hiort, O; Siebert, R; Holterhus, PM				Ammerpohl, Ole; Bens, Susanne; Appari, Mahesh; Werner, Ralf; Korn, Bernhard; Drop, Stenvert L. S.; Verheijen, Frans; van der Zwan, Yvonne; Bunch, Trevor; Hughes, Ieuan; Cools, Martine; Riepe, Felix G.; Hiort, Olaf; Siebert, Reiner; Holterhus, Paul-Martin			Androgen Receptor Function Links Human Sexual Dimorphism to DNA Methylation	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; PRENATAL TESTOSTERONE EXCESS; PROGRAMMING WINDOW; GENE; GENDER; EXPRESSION; CANCER; STEROIDS; PATTERNS; IMPACT	Sex differences are well known to be determinants of development, health and disease. Epigenetic mechanisms are also known to differ between men and women through X-inactivation in females. We hypothesized that epigenetic sex differences may also result from sex hormone functions, in particular from long-lasting androgen programming. We aimed at investigating whether inactivation of the androgen receptor, the key regulator of normal male sex development, is associated with differences of the patterns of DNA methylation marks in genital tissues. To this end, we performed large scale array-based analysis of gene methylation profiles on genomic DNA from labioscrotal skin fibroblasts of 8 males and 26 individuals with androgen insensitivity syndrome (AIS) due to inactivating androgen receptor gene mutations. By this approach we identified differential methylation of 167 CpG loci representing 162 unique human genes. These were significantly enriched for androgen target genes and low CpG content promoter genes. Additional 75 genes showed a significant increase of heterogeneity of methylation in AIS compared to a high homogeneity in normal male controls. Our data show that normal and aberrant androgen receptor function is associated with distinct patterns of DNA-methylation marks in genital tissues. These findings support the concept that transcription factor binding to the DNA has an impact on the shape of the DNA methylome. These data which derived from a rare human model suggest that androgen programming of methylation marks contributes to sexual dimorphism in the human which might have considerable impact on the manifestation of sex-associated phenotypes and diseases.	[Ammerpohl, Ole; Bens, Susanne; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Ammerpohl, Ole; Bens, Susanne; Appari, Mahesh; Riepe, Felix G.; Siebert, Reiner; Holterhus, Paul-Martin] Univ Hosp Schleswig Holstein, Kiel, Germany; [Appari, Mahesh; Riepe, Felix G.; Holterhus, Paul-Martin] Univ Kiel, Dept Pediat, Kiel, Germany; [Werner, Ralf; Hiort, Olaf] Univ Lubeck, Dept Pediat, Lubeck, Germany; [Werner, Ralf; Hiort, Olaf] Univ Hosp Schleswig Holstein, Lubeck, Germany; [Korn, Bernhard] Inst Mol Biol gGmbH, Core Facil, Mainz, Germany; [Drop, Stenvert L. S.; van der Zwan, Yvonne] ErasmusMC Sophia, Dept Pediat, Div Pediat Endocrinol, Rotterdam, Netherlands; [Verheijen, Frans] ErasmusMC, Dept Clin Genet, Rotterdam, Netherlands; [Bunch, Trevor; Hughes, Ieuan] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England; [Cools, Martine] Univ Hosp Gent, Dept Pediat, Ghent, Belgium	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; Institute of Molecular Biology (IMB); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Ghent University; Ghent University Hospital	Holterhus, PM (corresponding author), Univ Kiel, Dept Pediat, Campus Kiel, Kiel, Germany.	holterhus@pediatrics.uni-kiel.de	Siebert, Reiner/A-8049-2010; Ammerpohl, Ole/G-2691-2010; Cools, Martine/J-4580-2012	Cools, Martine/0000-0002-9552-4899; Werner, Ralf/0000-0003-3718-3595; Appari, Mahesh/0000-0003-2269-7032	European Community [201444]; Deutsche Forschungsgemeinschaft [AM 343/2-1, HO 2073/7-1]	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement no 201444 and the Deutsche Forschungsgemeinschaft (AM 343/2-1 and HO 2073/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Achermann JC, 2008, WILLIAMS TXB ENDOCRI, V22, P783; Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Appari M, 2009, J MOL MED, V87, P623, DOI 10.1007/s00109-009-0462-3; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Bens S, 2011, SEX DEV, V5, P70, DOI 10.1159/000323807; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boerma EG, 2004, EUR J CANCER, V40, P2781, DOI 10.1016/j.ejca.2004.09.004; Brena RM, 2006, NAT GENET, V38, P1359, DOI 10.1038/ng1206-1359; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chi YY, 2011, J BIOL CHEM, V286, P1748, DOI 10.1074/jbc.M110.107367; Choi BG, 2007, ENDOCRIN METAB CLIN, V36, P365, DOI 10.1016/j.ecl.2007.03.011; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; de Medeiros F, 2008, AM J MED GENET A, V146A, P1605, DOI 10.1002/ajmg.a.32257; Decaudin D, 2000, LEUKEMIA LYMPHOMA, V37, P181, DOI 10.3109/10428190009057643; DePrimo SE, 2002, GENOME BIOL, V3; Hines M, 2003, ANN NY ACAD SCI, V1007, P272, DOI 10.1196/annals.1286.026; Hogg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024877; Holterhus PM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-292; Holterhus PM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-376; Holterhus PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r37; Holterhus PM, 2000, J CLIN ENDOCR METAB, V85, P3245, DOI 10.1210/jc.85.9.3245; Hughes IA, 2006, BEST PRACT RES CL EN, V20, P577, DOI 10.1016/j.beem.2006.11.003; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Jurgensen M, 2007, HORM BEHAV, V51, P443, DOI 10.1016/j.yhbeh.2007.01.001; Kaunisto K, 1999, BIOL REPROD, V61, P1521, DOI 10.1095/biolreprod61.6.1521; Khattri A, 2012, INT J ANDROL, V35, P810, DOI 10.1111/j.1365-2605.2012.01302.x; Konttinen YT, 2012, J AUTOIMMUN, V39, P49, DOI 10.1016/j.jaut.2012.01.004; Kreck B, 2013, LEUKEMIA IN PRESS; LAMBERT J, 1993, BIOCHIM BIOPHYS ACTA, V1172, P190, DOI 10.1016/0167-4781(93)90292-L; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Mishra DK, 2010, MOL CANCER THER, V9, P33, DOI 10.1158/1535-7163.MCT-09-0486; Nada SE, 2010, ENDOCRINOLOGY, V151, P5165, DOI 10.1210/en.2010-0666; Nohara K, 2011, ENDOCRINOLOGY, V152, P1661, DOI 10.1210/en.2010-1288; Novick RM, 2010, BIOCHEM PHARMACOL, V79, P1345, DOI 10.1016/j.bcp.2009.12.020; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; Savic I, 2010, PROG BRAIN RES, V186, P41, DOI 10.1016/B978-0-444-53630-3.00004-X; Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413; SIMARD J, 1991, CANCER RES, V51, P4336; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Soto ME, 2004, CLIN EXP RHEUMATOL, V22, P713; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trasino SE, 2007, EXP BIOL MED, V232, P762; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214	57	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73288	10.1371/journal.pone.0073288	http://dx.doi.org/10.1371/journal.pone.0073288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023855	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600092
J	Graefenhain, M; Carpenter, M; Tomasello, M				Graefenhain, Maria; Carpenter, Malinda; Tomasello, Michael			Three-Year-Olds' Understanding of the Consequences of Joint Commitments	PLOS ONE			English	Article							YOUNG-CHILDREN; INDIVIDUAL-DIFFERENCES; SHARED INTENTION; COOPERATION; FAIRNESS; PARTNER; JUSTICE; PEERS; LIES	Here we investigate the extent of children's understanding of the joint commitments inherent in joint activities. Three-year-old children either made a joint commitment to assemble a puzzle with a puppet partner, or else the child and puppet each assembled their own puzzle. Afterwards, children who had made the joint commitment were more likely to stop and wait for their partner on their way to fetch something, more likely to spontaneously help their partner when needed, and more likely to take over their partner's role when necessary. There was no clear difference in children's tendency to tattle on their partner's cheating behavior or their tendency to distribute rewards equally at the end. It thus appears that by 3 years of age making a joint commitment to act together with others is beginning to engender in children a "we"-intentionality which holds across at least most of the process of the joint activity until the shared goal is achieved, and which withstands at least some of the perturbations to the joint activity children experience.	[Graefenhain, Maria] Univ Leipzig, Dept Child & Adolescent Psychiat, D-04109 Leipzig, Germany; [Graefenhain, Maria] Univ Gottingen, Dept Dev Psychol, D-37073 Gottingen, Germany; [Carpenter, Malinda; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany	Leipzig University; University of Gottingen; Max Planck Society	Graefenhain, M (corresponding author), Univ Leipzig, Dept Child & Adolescent Psychiat, D-04109 Leipzig, Germany.	Maria.Graefenhain@medizin.uni-leipzig.de		Carpenter, Malinda/0000-0003-3983-2034				Alonso FM, 2009, ETHICS, V119, P444, DOI 10.1086/599984; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Bratman M., 2009, PHILOS SOCIAL SCI PH, P41, DOI DOI 10.1017/CB097805118:12880.005; BRATMAN ME, 1992, PHILOS REV, V101, P327, DOI 10.2307/2185537; Bratman ME, 2009, PHILOS STUD, V144, P149, DOI 10.1007/s11098-009-9375-9; BROWNELL CA, 1990, CHILD DEV, V61, P1164, DOI 10.1111/j.1467-8624.1990.tb02850.x; BROWNELL CA, 1991, PERSPECTIVES ON SOCIALLY SHARED COGNITION, P365, DOI 10.1037/10096-016; Brownell CA, 2006, CHILD DEV, V77, P803, DOI 10.1111/j.1467-8624.2006.00904.x; Brownell CA, 2011, REV PHILOS PSYCHOL, V2, P193, DOI 10.1007/s13164-011-0056-1; denBak IM, 1996, SOC DEV, V5, P292; DePaulo BM, 1998, J PERS SOC PSYCHOL, V74, P63, DOI 10.1037/0022-3514.74.1.63; DUNN J, 1991, CHILD DEV, V62, P1352, DOI 10.2307/1130811; Eckerman CO, 2001, BLACKWELL HDB INFANT, P326, DOI 10.1002/9780470996348.ch12; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; GARNER PW, 1994, DEV PSYCHOL, V30, P905, DOI 10.1037/0012-1649.30.6.905; Gilbert M., 1990, MIDWEST STUD PHILOS, V15, P1, DOI [https://doi.org/10.1111/j.1475-4975.1990.tb00202.x, DOI 10.1111/J.1475-4975.1990.TB00202.X]; Gilbert M, 2009, PHILOS STUD, V144, P167, DOI 10.1007/s11098-009-9372-z; Grafenhain M, 2009, DEV PSYCHOL, V45, P1430, DOI 10.1037/a0016122; Hamann K, 2012, CHILD DEV, V83, P137, DOI 10.1111/j.1467-8624.2011.01695.x; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; Henderson AME, 2011, COGNITION, V121, P12, DOI 10.1016/j.cognition.2011.05.008; HOWES C, 1987, DEV REV, V7, P252, DOI 10.1016/0273-2297(87)90014-1; Hughes C, 2006, BRIT J DEV PSYCHOL, V24, P53, DOI 10.1348/026151005X82893; Hunnius S., 2009, EUROPEAN J DEV SCI, V3, P368, DOI 10.3233/DEV-2009-3404; Ingram GPD, 2010, CHILD DEV, V81, P945, DOI 10.1111/j.1467-8624.2010.01444.x; Karau S. J., 1997, GROUP DYN-THEOR RES, V1, P156, DOI DOI 10.1037/1089-2699.1.2.156; Keller M, 2008, INT J DEV SCI, V2, P206, DOI [10.3233/dev-2008-2302, DOI 10.3233/DEV-2008-2302]; Kenward B, 2011, DEV PSYCHOL, V47, P1054, DOI 10.1037/a0023869; KLOCKARS CB, 1984, AM BEHAV SCI, V27, P529, DOI 10.1177/000276484027004007; LERNER MJ, 1974, J PERS SOC PSYCHOL, V29, P539, DOI 10.1037/h0036206; LINDSKOLD S, 1986, J SOC PSYCHOL, V126, P129, DOI 10.1080/00224545.1986.9713581; Michael J, 2011, REV PHILOS PSYCHOL, V2, P355, DOI 10.1007/s13164-011-0055-2; Moore C, 2009, PSYCHOL SCI, V20, P944, DOI 10.1111/j.1467-9280.2009.02378.x; Pacherie E., 2007, EXPLAINING MENTAL NA, P153; Rakoczy H, 2008, DEV PSYCHOL, V44, P1195, DOI 10.1037/0012-1649.44.4.1195; RATNER N, 1978, J CHILD LANG, V5, P391, DOI 10.1017/S0305000900002063; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; ROSS HS, 1987, DEV PSYCHOL, V23, P241, DOI 10.1037/0012-1649.23.2.241; SEARLE JR, 1990, SYS DEV FDN, P401; Steinwender J. F., 2010, INT C INF STUD BALT; Talwar V, 2004, LAW HUMAN BEHAV, V28, P411, DOI 10.1023/B:LAHU.0000039333.51399.f6; Talwar V, 2002, MERRILL PALMER QUART, V48, P160, DOI 10.1353/mpq.2002.0009; Talwar V, 2007, INT J BEHAV DEV, V31, P1, DOI 10.1177/0165025406073530; Tomasello M, 2012, CURR ANTHROPOL, V53, P673, DOI 10.1086/668207; TUOMELA R, 1990, THEOR DECIS, V28, P1, DOI 10.1007/BF00139236; Tuomela R, 2005, PHILOS STUD, V125, P327, DOI 10.1007/s11098-005-7781-1; Tuomela R, 2006, MIDWEST STUD PHILOS, V30, P35, DOI 10.1111/j.1475-4975.2006.00127.x; Vaish A, 2011, BRIT J DEV PSYCHOL, V29, P124, DOI 10.1348/026151010X532888; Warneken F, 2006, CHILD DEV, V77, P640, DOI 10.1111/j.1467-8624.2006.00895.x; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Warneken F, 2012, DEVELOPMENTAL SCI, V15, P54, DOI 10.1111/j.1467-7687.2011.01107.x; Warneken F, 2011, PSYCHOL SCI, V22, P267, DOI 10.1177/0956797610395392; WILLIAMS KD, 1991, J PERS SOC PSYCHOL, V61, P570, DOI 10.1037/0022-3514.61.4.570	53	38	37	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73039	10.1371/journal.pone.0073039	http://dx.doi.org/10.1371/journal.pone.0073039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023805	Green Published, gold			2022-12-27	WOS:000324515600059
J	Tran, ST; Renschler, JP; Le, HT; Dang, HTT; Dao, TM; Pham, AN; Nguyen, LT; Nguyen, HV; Nguyen, TTT; Le, SN; Fox, A; Caws, M; QuynhDo, NT; Horby, P; Wertheim, H				Sinh Thi Tran; Renschler, John Patrick; Hai Thanh Le; Hang Thi Thu Dang; Tuan Minh Dao; An Nhat Pham; Liem Thanh Nguyen; Hung Van Nguyen; Thuy Thi Thu Nguyen; Sy Ngoc Le; Fox, Annette; Caws, Maxine; Nhu Thi QuynhDo; Horby, Peter; Wertheim, Heiman			Diagnostic Accuracy of Microscopic Observation Drug Susceptibility (MODS) Assay for Pediatric Tuberculosis in Hanoi, Vietnam	PLOS ONE			English	Article							CHILDHOOD TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; SOUTH-AFRICA; CHILDREN; CONSENSUS	Introduction: icroscopic Observation Drug Susceptibility (MODS) has been shown to be an effective and rapid technique for early diagnosis of tuberculosis (TB). Thus far only a limited number of studies evaluating MODS have been performed in children and in extra-pulmonary tuberculosis. This study aims to assess relative accuracy and time to positive culture of MODS for TB diagnosis in children admitted to a general pediatric hospital in Vietnam. Methods/Principal Findings: Specimens from children with suspected TB were tested by smear, MODS and Lowenstein-Jensen agar (LJ). 1129 samples from 705 children were analyzed, including sputum (n = 59), gastric aspirate (n = 775), CSF (n = 148), pleural fluid (n = 33), BAL (n = 41), tracheal fluid (n = 45), other (n = 28). 113 TB cases were defined based on the "clinical diagnosis'' (confirmed and probable groups) as the reference standard, in which 26% (n = 30) were diagnosed as extra-pulmonary TB. Analysis by patient shows that the overall sensitivity and specificity of smear, LJ and MODS against "clinical diagnosis'' was 8.8% and 100%, 38.9% and 100%, 46% and 99.5% respectively with MODS significantly more sensitive than LJ culture (P = 0.02). When analyzed by sample type, the sensitivity of MODS was significantly higher than LJ for gastric aspirates (P = 0.004). The time to detection was also significantly shorter for MODS than LJ (7 days versus 32 days, P < 0.001). Conclusion: ODS is a sensitive and rapid culture technique for detecting TB in children. As MODS culture can be performed at a BSL2 facility and is inexpensive, it can therefore be recommended as a routine test for children with symptoms suggestive of TB in resource-limited settings.	[Sinh Thi Tran; Hai Thanh Le; Hang Thi Thu Dang; Tuan Minh Dao; An Nhat Pham; Liem Thanh Nguyen] Natl Hosp Pediat, Hanoi, Vietnam; [Hung Van Nguyen; Thuy Thi Thu Nguyen; Sy Ngoc Le] Natl Lung Hosp, Hanoi, Vietnam; [Sinh Thi Tran; Renschler, John Patrick; Fox, Annette; Nhu Thi QuynhDo; Horby, Peter; Wertheim, Heiman] Univ Oxford, Clin Res Unit, Hanoi, Vietnam; [Renschler, John Patrick] Princeton Univ, Grand Hlth Challenge, Princeton Environm Inst, Princeton, NJ 08544 USA; [Fox, Annette; Caws, Maxine; Horby, Peter; Wertheim, Heiman] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Caws, Maxine] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam	University of Oxford; Princeton University; University of Oxford; University of Oxford	Tran, ST (corresponding author), Natl Hosp Pediat, Hanoi, Vietnam.	ttsinh@gmail.com	Wertheim, Heiman FL/F-3338-2016	Wertheim, Heiman FL/0000-0002-5003-5565; Fox, Annette/0000-0002-0565-7146; My, Robinson/0000-0002-3602-1060; Renschler, John Patrick/0000-0002-6320-2385; Caws, Maxine/0000-0002-9109-350X; Horby, Peter/0000-0002-9822-1586	Wellcome Trust Major Overseas Program in Vietnam	Wellcome Trust Major Overseas Program in Vietnam(Wellcome Trust)	This work was funded by the Wellcome Trust Major Overseas Program in Vietnam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, AUT REAL TIM NUCL AC; Caws M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001173; Centers for Disease Control and Prevention (CDC), 2008, EP PED TUB US 1993 2, P1993; Cuevas LE, 2012, J INFECT DIS, V205, pS209, DOI 10.1093/infdis/jir879; Dang TMH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008341; de Kantor IN, 1998, WHO GLOBAL TUBERCU 2; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Gray JW, 2004, CLIN BIOCHEM, V37, P450, DOI 10.1016/j.clinbiochem.2004.03.003; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Avalos GGL, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/818219; Marais BJ, 2007, ARCH DIS CHILD, V92, P446, DOI 10.1136/adc.2006.104976; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Mukherjee A, 2011, INDIAN J PEDIATR, V78, P328, DOI 10.1007/s12098-010-0298-4; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Nicol MP, 2011, PAEDIATR RESPIR REV, V12, P16, DOI 10.1016/j.prrv.2010.09.008; Oberhelman RA, 2006, PEDIATRICS, V118, pE100, DOI 10.1542/peds.2005-2623; Oberhelman RA, 2010, LANCET INFECT DIS, V10, P612, DOI 10.1016/S1473-3099(10)70141-9; Reddy K, 2009, MATERNAL AND CHILD HEALTH: GLOBAL CHALLENGES, PROGRAMS AND POLICIES, P245, DOI 10.1007/b106524_14; Singh Sarman, 2012, J Lab Physicians, V4, P101, DOI 10.4103/0974-2727.105592; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Stevenson M., 2010, EPIR FUNCTIONS ANAL; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; Team RDC, 2010, R LANG ENV STAT COMP; Therneau T, 2010, SURVIVAL SURVIVAL AN; van Rie A, 1999, ARCH DIS CHILD, V80, P433, DOI 10.1136/adc.80.5.433; World Health Organization, 2012, WHO MON XPERT MTB RI; Zar HJ, 2012, SAMJ S AFR MED J, V102, P518, DOI 10.7196/SAMJ.5552; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2	32	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72100	10.1371/journal.pone.0072100	http://dx.doi.org/10.1371/journal.pone.0072100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023726	Green Published, gold			2022-12-27	WOS:000324515600011
J	Bonfert, T; Csaba, G; Zimmer, R; Friedel, CC				Bonfert, Thomas; Csaba, Gergely; Zimmer, Ralf; Friedel, Caroline C.			Mining RNA-Seq Data for Infections and Contaminations	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; ACCURATE; SEQUENCES; ALIGNMENT	RNA sequencing (RNA-seq) provides novel opportunities for transcriptomic studies at nucleotide resolution, including transcriptomics of viruses or microbes infecting a cell. However, standard approaches for mapping the resulting sequencing reads generally ignore alternative sources of expression other than the host cell and are little equipped to address the problems arising from redundancies and gaps among sequenced microbe and virus genomes. We show that screening of sequencing reads for contaminations and infections can be performed easily using ContextMap, our recently developed mapping software. Based on mapping-derived statistics, mapping confidence, similarities and misidentifications (e. g. due to missing genome sequences) of species/strains can be assessed. Performance of our approach is evaluated on three real-life sequencing data sets and compared to state-of-the-art metagenomics tools. In particular, ContextMap vastly outperformed GASiC and GRAMMy in terms of runtime. In contrast to MEGAN4, it was capable of providing individual read mappings to species and resolving non-unique mappings, thus allowing the identification of misalignments caused by sequence similarities between genomes and missing genome sequences. Our study illustrates the importance and potentials of routinely mining RNA-seq experiments for infections or contaminations by microbes and viruses. By using ContextMap, gene expression of infecting agents can be analyzed and novel insights in infection processes and tumorigenesis can be obtained.	[Bonfert, Thomas; Csaba, Gergely; Zimmer, Ralf; Friedel, Caroline C.] Univ Munich, Inst Informat, D-80539 Munich, Germany	University of Munich	Friedel, CC (corresponding author), Univ Munich, Inst Informat, D-80539 Munich, Germany.	caroline.friedel@bio.ifi.lmu.de	Friedel, Caroline/AAG-5017-2019; Zimmer, Ralf/L-9295-2019	Friedel, Caroline/0000-0003-3569-4877; 	DFG [FR2938/1-1]	DFG(German Research Foundation (DFG))	The study was partially supported by DFG (www.dfg.de/) grant FR2938/1-1 to CCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bonfert T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S9; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen LY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1248; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Horton M, 2010, BIOINFORMATICS, V26, P568, DOI 10.1093/bioinformatics/btp682; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; INAGAKI Y, 1988, J VIROL, V62, P1640, DOI 10.1128/JVI.62.5.1640-1646.1988; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lim YW, 2012, J CYST FIBROS; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Lindner MS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks803; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Magaldi TG, 2012, VIROLOGY, V422, P114, DOI 10.1016/j.virol.2011.10.012; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002908; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moore RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019838; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Pati A, 2011, STAND GENOMIC SCI, V5, P248, DOI 10.4056/sigs.2075298; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Schweiger MR, 2007, J VIROL, V81, P9612, DOI 10.1128/JVI.00447-07; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valles SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031828; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Xia LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027992; Xiong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036009; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	40	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73071	10.1371/journal.pone.0073071	http://dx.doi.org/10.1371/journal.pone.0073071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019895	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200037
J	Charoenkwan, P; Shoombuatong, W; Lee, HC; Chaijaruwanich, J; Huang, HL; Ho, SY				Charoenkwan, Phasit; Shoombuatong, Watshara; Lee, Hua-Chin; Chaijaruwanich, Jeerayut; Huang, Hui-Ling; Ho, Shinn-Ying			SCMCRYS: Predicting Protein Crystallization Using an Ensemble Scoring Card Method with Estimating Propensity Scores of P-Collocated Amino Acid Pairs	PLOS ONE			English	Article							SURFACE ENTROPY REDUCTION; X-RAY; BACILLUS-SUBTILIS; GENE-PRODUCT; MUTAGENESIS; OPTIMIZATION; PURIFICATION; DIFFRACTION; DOMAIN; EXPRESSION	Existing methods for predicting protein crystallization obtain high accuracy using various types of complemented features and complex ensemble classifiers, such as support vector machine (SVM) and Random Forest classifiers. It is desirable to develop a simple and easily interpretable prediction method with informative sequence features to provide insights into protein crystallization. This study proposes an ensemble method, SCMCRYS, to predict protein crystallization, for which each classifier is built by using a scoring card method (SCM) with estimating propensity scores of p-collocated amino acid (AA) pairs (p = 0 for a dipeptide). The SCM classifier determines the crystallization of a sequence according to a weighted-sum score. The weights are the composition of the p-collocated AA pairs, and the propensity scores of these AA pairs are estimated using a statistic with optimization approach. SCMCRYS predicts the crystallization using a simple voting method from a number of SCM classifiers. The experimental results show that the single SCM classifier utilizing dipeptide composition with accuracy of 73.90% is comparable to the best previously-developed SVM-based classifier, SVM_POLY (74.6%), and our proposed SVM-based classifier utilizing the same dipeptide composition (77.55%). The SCMCRYS method with accuracy of 76.1% is comparable to the state-of-the-art ensemble methods PPCpred (76.8%) and RFCRYS (80.0%), which used the SVM and Random Forest classifiers, respectively. This study also investigates mutagenesis analysis based on SCM and the result reveals the hypothesis that the mutagenesis of surface residues Ala and Cys has large and small probabilities of enhancing protein crystallizability considering the estimated scores of crystallizability and solubility, melting point, molecular weight and conformational entropy of amino acids in a generalized condition. The propensity scores of amino acids and dipeptides for estimating the protein crystallizability can aid biologists in designing mutation of surface residues to enhance protein crystallizability. The source code of SCMCRYS is available at http://iclab.life.nctu.edu.tw/SCMCRYS/.	[Charoenkwan, Phasit; Lee, Hua-Chin; Huang, Hui-Ling; Ho, Shinn-Ying] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Shoombuatong, Watshara; Chaijaruwanich, Jeerayut] Chiang Mai Univ, Dept Comp Sci, Bioinformat Res Lab, Chiang Mai 50000, Thailand; [Huang, Hui-Ling; Ho, Shinn-Ying] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Chiang Mai University; National Yang Ming Chiao Tung University	Huang, HL (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	hlhuang@mail.nctu.edu.tw; syho@mail.nctu.edu.tw	Ho, Shinn-Ying/AAE-9394-2022; Shoombuatong, Watshara/O-9986-2019; Ho, Shinn-Ying/AFD-8402-2022	Ho, Shinn-Ying/0000-0002-1901-8353; Shoombuatong, Watshara/0000-0002-3394-8709; Ho, Shinn-Ying/0000-0002-1901-8353	National Science Council of Taiwan [NSC-101-2627-B-009-003-]; "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C. [102W962]; UST-UCSD International Center of Excellence in Advanced Bioengineering; Taiwan National Science Council I-RiCE Program [NSC-101-2911-I-009-101]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan); UST-UCSD International Center of Excellence in Advanced Bioengineering; Taiwan National Science Council I-RiCE Program	This work was supported by National Science Council of Taiwan under the contract number NSC-101-2627-B-009-003-, and "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. for the project 102W962. This work was also supported in part by the UST-UCSD International Center of Excellence in Advanced Bioengineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC-101-2911-I-009-101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1993, PROTEIN SCI, V2, P859, DOI 10.1002/pro.5560020515; Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; Birtley JR, 2005, ACTA CRYSTALLOGR D, V61, P646, DOI 10.1107/S0907444905007924; Boeshans KM, 2006, PROTEIN EXPRES PURIF, V49, P235, DOI 10.1016/j.pep.2006.05.021; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Canaves JM, 2004, J MOL BIOL, V344, P977, DOI 10.1016/j.jmb.2004.09.076; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; Derewenda ZS, 2010, ACTA CRYSTALLOGR D, V66, P604, DOI 10.1107/S090744491000644X; Devedjiev Y, 2004, J MOL BIOL, V343, P395, DOI 10.1016/j.jmb.2004.08.037; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Garrard SM, 2001, PROTEIN EXPRES PURIF, V21, P412, DOI 10.1006/prep.2001.1392; Goh CS, 2004, J MOL BIOL, V336, P115, DOI 10.1016/j.jmb.2003.11.053; Guo Y, 2006, ACTA CRYSTALLOGR F, V62, P238, DOI 10.1107/S1744309106003691; Gustin SE, 2001, EUR J BIOCHEM, V268, P2905, DOI 10.1046/j.1432-1327.2001.02178.x; Hibi T, 2002, ACTA CRYSTALLOGR D, V58, P316, DOI 10.1107/S0907444901019886; Ho SY, 2004, IEEE T EVOLUT COMPUT, V8, P522, DOI 10.1109/TEVC.2004.835176; Honjo E, 2008, J SYNCHROTRON RADIAT, V15, P285, DOI 10.1107/S0909049508004470; Huang HL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S3; Hui R, 2003, J STRUCT BIOL, V142, P154, DOI 10.1016/S1047-8477(03)00046-7; Jahandideh S, 2012, J THEOR BIOL, V306, P115, DOI 10.1016/j.jtbi.2012.04.028; Janda I, 2004, ACTA CRYSTALLOGR D, V60, P1101, DOI 10.1107/S0907444904007188; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P423, DOI 10.2174/092986610790963726; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kessler D, 2004, J MOL BIOL, V342, P183, DOI 10.1016/j.jmb.2004.07.028; KLEIN C, 1990, PROTEIN ENG, V4, P65, DOI 10.1093/protein/4.1.65; Kurgan L, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-50; Longenecker KL, 2001, ACTA CRYSTALLOGR D, V57, P679, DOI 10.1107/S0907444901003122; MartinezHackert E, 1996, PROTEIN SCI, V5, P1429, DOI 10.1002/pro.5560050722; Mateja A, 2002, ACTA CRYSTALLOGR D, V58, P1983, DOI 10.1107/S090744490201394X; Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229; Munshi S, 2003, ACTA CRYSTALLOGR D, V59, P1725, DOI 10.1107/S0907444903015415; Nickerson D, 1998, ACTA CRYSTALLOGR D, V54, P470, DOI 10.1107/S0907444997012195; Norin M, 2001, Curr Opin Drug Discov Devel, V4, P284; Overton IM, 2008, BIOINFORMATICS, V24, P901, DOI 10.1093/bioinformatics/btn055; Overton IM, 2006, FEBS LETT, V580, P4005, DOI 10.1016/j.febslet.2006.06.015; Patel SB, 2004, BBA-PROTEINS PROTEOM, V1696, P67, DOI 10.1016/j.bbapap.2003.09.009; PICKETT SD, 1993, J MOL BIOL, V231, P825, DOI 10.1006/jmbi.1993.1329; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; Schwede TF, 1999, PROTEIN ENG, V12, P151, DOI 10.1093/protein/12.2.151; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Smialowski P, 2006, PROTEINS, V62, P343, DOI 10.1002/prot.20789; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554	47	68	71	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72368	10.1371/journal.pone.0072368	http://dx.doi.org/10.1371/journal.pone.0072368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019868	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200010
J	Chen, K; Yang, XY; Wu, LQ; Yu, ML; Li, XY; Li, N; Wang, SH; Li, GC				Chen, Kan; Yang, Xinyan; Wu, Liqin; Yu, Meilan; Li, Xiaoyan; Li, Na; Wang, Shuanghui; Li, Gongchu			Pinellia pedatisecta Agglutinin Targets Drug Resistant K562/ADR Leukemia Cells through Binding with Sarcolemmal Membrane Associated Protein and Enhancing Macrophage Phagocytosis	PLOS ONE			English	Article							CANCER STEM-CELLS; MULTIDRUG-RESISTANCE; MOLECULAR-MECHANISMS; BREAST CANCERS; LECTIN; POLARIZATION; EXPRESSION; BIOMARKERS; MICROENVIRONMENT; IDENTIFICATION	Pinellia pedatisecta agglutinin (PPA) has previously been used in labeling fractions of myeloid leukemia cells in our laboratory. We report here that a bacterial expressed recombinant PPA domain b tagged with soluble coxsackie and adenovirus receptor (sCAR-PPAb) preferentially recognized drug resistant cancer cells K562/ADR and H460/5Fu, as compared to their parental cell lines. Pretreatment of K562/ADR cells with sCAR-PPAb significantly enhanced phagocytosis of K562/ADR by macrophages in vivo. Meanwhile, in a K562/ADR xenograft model, intratumoral injection of sCAR-PPAb induced macrophage infiltration and phagocytosis. Furthermore, immunoprecipitation, mass spectrometry and Western blot identified the membrane target of PPA on K562/ADR as sarcolemmal membrane associated protein (SLMAP). An antibody against SLMAP significantly promoted the phagocytosis of K562/ADR by macrophages in vitro. These findings suggest that PPA not only could be developed into a novel agent that can detect drug resistant cancer cells and predict chemotherapy outcome, but also it has potential value in immunotherapy against drug resistant cancer cells through inducing the tumoricidal activity of macrophages.	[Chen, Kan; Yang, Xinyan; Wu, Liqin; Yu, Meilan; Li, Xiaoyan; Li, Na; Wang, Shuanghui; Li, Gongchu] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Li, GC (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	lgc@zstu.edu.cn	yang, xin/HGU-9981-2022; 俞, 梅兰/GXZ-9889-2022					Ahn YH, 2012, J PROTEOMICS, V75, P5507, DOI 10.1016/j.jprot.2012.06.027; Batabyal SK, 2009, NEOPLASMA, V56, P68, DOI 10.4149/neo_2009_01_68; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chen XL, 2011, EXP DIABETES RES, DOI 10.1155/2011/421982; Clark D, 2012, DIS MARKERS, V33, P1, DOI 10.3233/DMA-2012-0904; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Drake PM, 2012, J PROTEOME RES, V11, P2508, DOI 10.1021/pr201206w; Fry SA, 2011, GLYCOBIOLOGY, V21, P1060, DOI 10.1093/glycob/cwr045; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Gangemi R, 2009, CURR MED CHEM, V16, P1688, DOI 10.2174/092986709788186147; Guzzo RM, 2004, J CELL SCI, V117, P2271, DOI 10.1242/jcs.01079; He JT, 2010, J PROTEOME RES, V9, P2565, DOI 10.1021/pr100012p; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Ishikawa T, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1098, DOI 10.1161/CIRCEP.111.969972; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kashentseva EA, 2002, CANCER RES, V62, P609; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kudo T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-32; Lei HY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-10; Li C, 2009, J PROTEOME RES, V8, P483, DOI 10.1021/pr8007013; Li GC, 2009, INT J HEMATOL, V89, P611, DOI 10.1007/s12185-009-0308-3; Liu B, 2009, AUTOPHAGY, V5, P253, DOI 10.4161/auto.5.2.7561; Lu Q, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.30; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mony U, 2008, LEUKEMIA, V22, P1395, DOI 10.1038/leu.2008.125; Nader M, 2012, AM J PHYSIOL-HEART C, V302, pH1138, DOI 10.1152/ajpheart.00872.2011; Ochoa-Alvarez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041845; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sica A, 2010, EUR J IMMUNOL, V40, P2131, DOI 10.1002/eji.201040736; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; Tucker-Burden C, 2012, STEM CELLS DEV, V21, P2374, DOI 10.1089/scd.2011.0369; Upham JP, 2010, J VIROL, V84, P3730, DOI 10.1128/JVI.02148-09; Wielowieyski PA, 2000, J BIOL CHEM, V275, P38474, DOI 10.1074/jbc.M007682200; Wigle JT, 1997, J BIOL CHEM, V272, P32384, DOI 10.1074/jbc.272.51.32384; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n; Wu J, 2012, J PROTEOME RES, V11, P4541, DOI 10.1021/pr300330z; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311	41	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74363	10.1371/journal.pone.0074363	http://dx.doi.org/10.1371/journal.pone.0074363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019967	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200110
J	Jones, HN; Crombleholme, T; Habli, M				Jones, Helen N.; Crombleholme, Timothy; Habli, Mounira			Adenoviral-Mediated Placental Gene Transfer of IGF-1 Corrects Placental Insufficiency via Enhanced Placental Glucose Transport Mechanisms	PLOS ONE			English	Article							EXPRESSION; FETAL; DEFICIENCY; GLUT8; MICE	Previous work in our laboratory demonstrated that over-expression of human insulin-like growth factor -1 (hIGF-1) in the placenta corrects fetal weight deficits in mouse, rat, and rabbit models of intrauterine growth restriction without changes in placental weight. The underlying mechanisms of this effect have not been elucidated. To investigate the effect of intra-placental IGF-1 over-expression on placental function we examined glucose transporter expression and localization in both a mouse model of IUGR and a model of human trophoblast, the BeWo Choriocarcinoma cell line. Methods: At gestational day 18, animals were divided into four groups; sham-operated controls, uterine artery branch ligation (UABL), UABL+Ad-hIGF-1 (10(8) PFU), UABL+Ad-LacZ (10(8) PFU). At gestational day 20, pups and placentas were harvested by C-section. For human studies, BeWo choriocarcinoma cells were grown in F12 complete medium + 10% FBS. Cells were incubated in serum-free control media +/- Ad-IGF-1 or Ad-LacZ for 48 hours. MOIs of 10: 1 and 100:1 were utilized. The RNA, protein expression and localization of glucose transporters GLUT1, 3, 8, and 9 were analyzed by RT-PCR, Western blot and immunohistochemistry. Results: In both the mouse placenta and BeWo, GLUT1 regulation was linked to altered protein localization. GLUT3, localized to the mouse fetal endothelial cells, was reduced in placental insufficiency but maintained with Ad-I GF-1 treatment. Interestingly, GLUT8 expression was reduced in the UABL placenta but up-regulated following Ad-IGF-1 in both mouse and human systems. GLUT9 expression in the mouse was increased by Ad-IGF-1 but this was not reflected in the BeWo, where Ad-IGF-1 caused moderate membrane relocalization. Conclusion: Enhanced GLUT isoform transporter expression and relocalization to the membrane may be an important mechanism in Ad-hIGF-1mediated correction of placental insufficiency.	[Jones, Helen N.; Habli, Mounira] Cincinnati Childrens Hosp Med Ctr, Ctr Fetal Cellular & Mol Therapy, Cincinnati, OH 45229 USA; [Crombleholme, Timothy] Childrens Hosp Colorado, Colorado Fetal Care Ctr, Aurora, CO USA	Cincinnati Children's Hospital Medical Center; Children's Hospital Colorado	Jones, HN (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Fetal Cellular & Mol Therapy, Cincinnati, OH 45229 USA.	Helen.jones@cchmc.org	Crombleholme, Timothy/Y-1477-2019		Eunice Kennedy Shriver NICHD [K99HD068504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD068504, R00HD068504] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	HNJ is funded by a Eunice Kennedy Shriver NICHD grant K99HD068504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adastra KL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097675; Baumann MU, 2007, AM J PHYSIOL-CELL PH, V293, pC477, DOI 10.1152/ajpcell.00075.2007; Bibee KP, 2011, REPROD SCI, V18, P20, DOI 10.1177/1933719110380276; Brown K, 2011, PLACENTA, V32, P1041, DOI 10.1016/j.placenta.2011.09.014; Chung J, 2010, FETAL DIAGNOSIS THER; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; Eremia SC, 2007, ENDOCRINOLOGY, V148, P2963, DOI 10.1210/en.2006-1701; Ganguly A, 2012, ENDOCRINOLOGY, V153, P3995, DOI 10.1210/en.2011-1973; Gao L, 2012, ENDOCRINOLOGY, V153, P1464, DOI 10.1210/en.2011-1673; Hahn T, 1999, J CLIN ENDOCR METAB, V84, P1445, DOI 10.1210/jc.84.4.1445; HaugueldeMouzon S, 1997, J CLIN ENDOCR METAB, V82, P2689, DOI 10.1210/jc.82.8.2689; Illsley NP, 2000, PLACENTA, V21, P14, DOI 10.1053/plac.1999.0448; Jansson T, 2002, PLACENTA, V23, P392, DOI 10.1053/plac.2002.0826; Jansson T, 1999, AM J OBSTET GYNECOL, V180, P163, DOI 10.1016/S0002-9378(99)70169-9; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; KALHAN SC, 1979, J CLIN INVEST, V63, P388, DOI 10.1172/JCI109314; Kamei Y, 1999, ENDOCRINOLOGY, V140, P4236, DOI 10.1210/en.140.9.4236; Katz AB, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.029; Langdown ML, 2001, MOL CELL ENDOCRINOL, V185, P109, DOI 10.1016/S0303-7207(01)00629-3; Limesand SW, 2004, PLACENTA, V25, P70, DOI 10.1016/j.placenta.2003.08.012; Osmond DTD, 2000, DIABETOLOGIA, V43, P576, DOI 10.1007/s001250051346; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schmidt S, 2009, AM J PHYSIOL-ENDOC M, V296, pE614, DOI 10.1152/ajpendo.91019.2008	23	46	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74632	10.1371/journal.pone.0074632	http://dx.doi.org/10.1371/journal.pone.0074632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019972	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200115
J	Tuncay, H; Findinier, J; Duchene, T; Cogez, V; Cousin, C; Peltier, G; Ball, SG; Dauvillee, D				Tuncay, Hande; Findinier, Justin; Duchene, Thierry; Cogez, Virginie; Cousin, Charlotte; Peltier, Gilles; Ball, Steven G.; Dauvillee, David			A Forward Genetic Approach in Chlamydomonas reinhardtii as a Strategy for Exploring Starch Catabolism	PLOS ONE			English	Article							BIOCHEMICAL-CHARACTERIZATION; ARABIDOPSIS LEAVES; PROTEIN; METABOLISM; BREAKDOWN; MUTANTS; IDENTIFICATION; PHOSPHATASE; PHOSPHOGLUCAN; BIOSYNTHESIS	A screen was recently developed to study the mobilization of starch in the unicellular green alga Chlamydomonas reinhardtii. This screen relies on starch synthesis accumulation during nitrogen starvation followed by the supply of nitrogen and the switch to darkness. Hence multiple regulatory networks including those of nutrient starvation, cell cycle control and light to dark transitions are likely to impact the recovery of mutant candidates. In this paper we monitor the specificity of this mutant screen by characterizing the nature of the genes disrupted in the selected mutants. We show that one third of the mutants consisted of strains mutated in genes previously reported to be of paramount importance in starch catabolism such as those encoding beta-amylases, the maltose export protein, and branching enzyme I. The other mutants were defective for previously uncharacterized functions some of which are likely to define novel proteins affecting starch mobilization in green algae.	[Tuncay, Hande; Findinier, Justin; Duchene, Thierry; Cogez, Virginie; Cousin, Charlotte; Ball, Steven G.; Dauvillee, David] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct UMR 8576, CNRS, Villeneuve Dascq, France; [Cousin, Charlotte] INRA, Inst Micalis UMR1319, F-78850 Thiverval Grignon, France; [Peltier, Gilles] Aix Marseille Univ, UMR Biol Vegetale & Microbiol Environm, Lab Bioenerget & Biotechnol Bacteries & Microlagu, CEA CNRS, St Paul Les Durance, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Aix-Marseille Universite	Dauvillee, D (corresponding author), Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct UMR 8576, CNRS, Villeneuve Dascq, France.	David.Dauvillee@univ-lille1.fr	Dauvillée, David/A-2174-2009; PELTIER, Gilles/ABD-4484-2021	Dauvillée, David/0000-0002-0751-9193; PELTIER, Gilles/0000-0002-2226-3931; Ball, Steven/0000-0003-1629-1650	Centre National de la Recherche Scientifique (CNRS); Universite des Sciences et Technologies de Lille (USTL); Institut Francais des Materiaux Agro-Sources (IFMAS); Ministere de la recherche et de l'enseignement superieur; Region Nord Pas de Calais and the Universite des Sciences et technologies de Lille	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite des Sciences et Technologies de Lille (USTL); Institut Francais des Materiaux Agro-Sources (IFMAS); Ministere de la recherche et de l'enseignement superieur; Region Nord Pas de Calais and the Universite des Sciences et technologies de Lille(Region Hauts-de-France)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Universite des Sciences et Technologies de Lille (USTL) and the Institut Francais des Materiaux Agro-Sources (IFMAS). pHD grants from the Ministere de la recherche et de l'enseignement superieur (HT) and the Region Nord Pas de Calais and the Universite des Sciences et technologies de Lille (JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANKS W, 1971, CARBOHYD RES, V17, P25, DOI 10.1016/S0008-6215(00)81539-6; BELLANGER F, 1994, THESIS U TECHNOLOGIE; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Chochois V, 2010, INT J HYDROGEN ENERG, V35, P10731, DOI 10.1016/j.ijhydene.2010.03.052; Colleoni C, 1999, PLANT PHYSIOL, V120, P993, DOI 10.1104/pp.120.4.993; Colombo SL, 2002, FUNCT PLANT BIOL, V29, P231, DOI 10.1071/PP01189; Comparot-Moss S, 2010, PLANT PHYSIOL, V152, P685, DOI 10.1104/pp.109.148981; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1723, DOI 10.1104/pp.125.4.1723; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; DELRUE B, 1992, J BACTERIOL, V174, P3612, DOI 10.1128/JB.174.11.3612-3620.1992; Deschamps P, 2008, GENETICS, V178, P2373, DOI 10.1534/genetics.108.087205; Fettke J, 2005, PLANT J, V43, P568, DOI 10.1111/j.1365-313X.2005.02475.x; FINCHER GB, 1989, ANNU REV PLANT PHYS, V40, P305, DOI 10.1146/annurev.pp.40.060189.001513; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; HAMILTON BS, 1992, BIOCHEM CELL BIOL, V70, P255, DOI 10.1139/o92-039; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hejazi M, 2008, PLANT J, V55, P323, DOI [10.1111/j.1365-313X.2008.03513.x, 10.1111/j.0960-7412.2008.03513.x]; Hejazi M, 2010, PLANT PHYSIOL, V152, P711, DOI 10.1104/pp.109.149914; Hennen-Bierwagen TA, 2008, PLANT PHYSIOL, V146, P1892, DOI 10.1104/pp.108.116285; Hicks GR, 2001, PLANT PHYSIOL, V127, P1334; KAKEFUDA G, 1984, PLANT PHYSIOL, V75, P278, DOI 10.1104/pp.75.1.278; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; LIBESSART N, 1995, PLANT CELL, V7, P1117; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Merendino L, 2003, PLANT MOL BIOL, V53, P371, DOI 10.1023/B:PLAN.0000006941.56233.42; Mouille G, 1996, PLANT CELL, V8, P1353; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; OCHMAN H, 1988, GENETICS, V120, P621; Razem FA, 1999, PROTOPLASMA, V206, P57, DOI 10.1007/BF01279253; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; ROCHAIX JD, 1991, PLANT MOL BIOL PRACT, P253; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Weise SE, 2006, PLANT PHYSIOL, V141, P879, DOI 10.1104/pp.106.081174; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Xia H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-95; Yu TS, 2005, J BIOL CHEM, V280, P9773, DOI 10.1074/jbc.M413638200	45	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74763	10.1371/journal.pone.0074763	http://dx.doi.org/10.1371/journal.pone.0074763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019981	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200124
J	Lloyd, SM; Stott, DJ; de Craen, AJM; Kearney, PM; Sattar, N; Perry, I; Packard, CJ; Briggs, A; Marchbank, L; Comber, H; Jukema, JW; Westendorp, RGJ; Trompet, S; Buckley, BM; Ford, I				Lloyd, Suzanne M.; Stott, David J.; de Craen, Anton J. M.; Kearney, Patricia M.; Sattar, Naveed; Perry, Ivan; Packard, Christopher J.; Briggs, Andrew; Marchbank, Laura; Comber, Harry; Jukema, J. Wouter; Westendorp, Rudi G. J.; Trompet, Stella; Buckley, Brendan M.; Ford, Ian			Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)	PLOS ONE			English	Article							MORTALITY; DISEASE; MEN	Background: The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-controlled trial of pravastatin, demonstrated a 19% reduction in coronary outcomes (p = 0.006) after a mean of 3.2 years, with no impact on stroke outcomes or all-cause mortality. However, there was a suggestion of increased cancer risk. Our aim is to determine the long-term benefits and safety of pravastatin treatment in older people using post-trial follow-up of the PROSPER participants. Methods: 5,804 (2,520 Scottish) men and women aged 70-82 years with either pre-existing vascular disease or increased risk of such disease because of smoking, hypertension or diabetes, were randomised to 40 mg pravastatin or matching placebo. Using record linkage to routinely collected health records, all participants (full cohort) were linked to death and cancer registries, and the Scottish cohort additionally to hospital admissions, to provide composite fatal/non-fatal cardiovascular outcomes (total mean follow-up 8.6 years). Results: Pravastatin treatment for 3.2 years reduced CHD death in the full cohort, hazard ratio (HR) 0.80, 95% confidence interval (CI) 0.68-0.95, p = 0.0091 and fatal coronary events or coronary hospitalisations in the Scottish cohort (HR 0.81, 95% CI 0.69-0.95, p = 0.0081) over 8.6 years. There was no reduction in stroke or all-cause mortality. Cancer risk was not increased in the full cohort (HR 1.08, 95% CI 0.96-1.21, p = 0.22). Conclusions: Pravastatin treatment of elderly high-risk subjects for 3.2 years provided long-term protection against CHD events and CHD mortality. However, this was not associated with any increase in life expectancy, possibly due to competing mortality with deaths from other causes. There was no evidence of long-term increased risk of cancer. Trial registration: http://www.controlled-trials.com/ISRCTN40976937.	[Lloyd, Suzanne M.; Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Stott, David J.; Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [de Craen, Anton J. M.; Westendorp, Rudi G. J.; Trompet, Stella] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Kearney, Patricia M.; Perry, Ivan] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Packard, Christopher J.] Greater Glasgow & Clyde Hlth Board, Res & Dev Directorate, Natl Hlth Serv, Glasgow, Lanark, Scotland; [Briggs, Andrew] Univ Glasgow, Glasgow, Lanark, Scotland; [Marchbank, Laura] Natl Hlth Serv Scotland, Informat Serv Div Scotland, Paisley, Renfrew, Scotland; [Comber, Harry] Natl Canc Registry, Cork, Ireland; [Jukema, J. Wouter; Trompet, Stella] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Buckley, Brendan M.] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland	University of Glasgow; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University College Cork; NHS Blood & Transplant (NHSBT); University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University College Cork	Ford, I (corresponding author), Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland.	ian.ford@glasgow.ac.uk	Jukema, J. Wouter/ABD-6503-2021; Kearney, Patricia M/AAE-8501-2020; Ford, Ian/ABE-6145-2020	Jukema, J. Wouter/0000-0002-3246-8359; Kearney, Patricia/0000-0001-9599-3540; Perry, Ivan/0000-0002-4965-9792; Briggs, Andrew/0000-0002-0777-1997	Wellcome Trust; Chief Scientist Office, Scotland; Chief Scientist Office [CZH/4/637] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Chief Scientist Office, Scotland; Chief Scientist Office	Funding provided by the Wellcome Trust for the Scottish Health Informatics Programme and a project grant from the Chief Scientist Office, Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bulbulia R, 2011, LANCET, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Deedwania P, 2007, CIRCULATION, V115, P700, DOI 10.1161/CIRCULATIONAHA.106.654756; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Ford I, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-8; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Ford I, 2009, PLOS MED, V6, P76, DOI 10.1371/journal.pmed.1000016; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Redberg RF, 2012, JAMA-J AM MED ASSOC, V307, P1491, DOI 10.1001/jama.2012.423; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sever PS, 2011, EUR HEART J, V32, P2525, DOI 10.1093/eurheartj/ehr333; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; Simes RJ, 2002, LANCET, V359, P1379; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5	18	42	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72642	10.1371/journal.pone.0072642	http://dx.doi.org/10.1371/journal.pone.0072642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023757	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000324238400019
J	Mathew, D; Zhou, P; Pywell, CM; van der Veen, DR; Shao, JP; Xi, Y; Bonar, NA; Hummel, AD; Chapman, S; Leevy, WM; Duffield, GE				Mathew, Deepa; Zhou, Peng; Pywell, Cameron M.; van der Veen, Daan R.; Shao, Jinping; Xi, Yang; Bonar, Nicolle A.; Hummel, Alyssa D.; Chapman, Sarah; Leevy, W. Matthew; Duffield, Giles E.			Ablation of the Id2 Gene Results in Altered Circadian Feeding Behavior, and Sex-Specific Enhancement of Insulin Sensitivity and Elevated Glucose Uptake in Skeletal Muscle and Brown Adipose Tissue	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; REGULATES ADIPOGENESIS; EXPRESSION PROFILES; METABOLIC SYNDROME; MOLECULAR CLOCK; MICE LACKING; AGED RATS; RESISTANCE; OBESITY; FAT	Inhibitor of DNA binding 2 (ID2) is a helix-loop-helix transcriptional repressor rhythmically expressed in many adult tissues. Our earlier studies have demonstrated a role for ID2 in the input pathway, core clock function and output pathways of the mouse circadian system. We have also reported that Id2 null (Id2-/-) mice are lean with low gonadal white adipose tissue deposits and lower lipid content in the liver. These results coincided with altered or disrupted circadian expression profiles of liver genes including those involved in lipid metabolism. In the present phenotypic study we intended to decipher, on a sex-specific basis, the role of ID2 in glucose metabolism and in the circadian regulation of activity, important components of energy balance. We find that Id2-/- mice exhibited altered daily and circadian rhythms of feeding and locomotor activity; activity profiles extended further into the late night/dark phase of the 24-hr cycle, despite mice showing reduced total locomotor activity. Also, male Id2-/- mice consumed a greater amount of food relative to body mass, and displayed less weight gain. Id2-/- females had smaller adipocytes, suggesting sexual-dimorphic programing of adipogenesis. We observed increased glucose tolerance and insulin sensitivity in male Id2-/- mice, which was exacerbated in older animals. FDG-PET analysis revealed increased glucose uptake by skeletal muscle and brown adipose tissue of male Id2-/- mice, suggesting increased glucose metabolism and thermogenesis in these tissues. Reductions in intramuscular triacylglycerol and diacylglycerol were detected in male Id2-/- mice, highlighting its possible mechanistic role in enhanced insulin sensitivity in these mice. Our findings indicate a role for ID2 as a regulator of glucose and lipid metabolism, and in the circadian control of feeding/locomotor behavior; and contribute to the understanding of the development of obesity and diabetes, particularly in shift work personnel among whom incidence of such metabolic disorders is elevated.	[Mathew, Deepa; Zhou, Peng; Pywell, Cameron M.; van der Veen, Daan R.; Shao, Jinping; Xi, Yang; Bonar, Nicolle A.; Hummel, Alyssa D.; Leevy, W. Matthew; Duffield, Giles E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Chapman, Sarah; Leevy, W. Matthew] Univ Notre Dame, Notre Dame Integrated Imaging Facil, Notre Dame, IN 46556 USA; [Duffield, Giles E.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Duffield, GE (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	duffield.2@nd.edu	Mathew, Deepa/AAW-4435-2020; van der Veen, Daan R/T-1013-2017	van der Veen, Daan R/0000-0001-8037-1407; Xi, Yang/0000-0002-5990-2549	NIGMS [R01-GM087508]; American Heart Association [10SDG4030011]; University of Notre Dame College of Science Summer Undergraduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087508] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); University of Notre Dame College of Science Summer Undergraduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported from grants to GED from the NIGMS (R01-GM087508) and American Heart Association (10SDG4030011), and from a University of Notre Dame College of Science Summer Undergraduate Research Fellowship (to CMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfeldt MC, 2011, DIABETES, V60, P2506, DOI 10.2337/db11-0083; Alway SE, 2002, AM J PHYSIOL-REG I, V282, pR411, DOI 10.1152/ajpregu.00332.2001; ARMARIO A, 1990, PSYCHONEUROENDOCRINO, V15, P341, DOI 10.1016/0306-4530(90)90059-I; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Belden WJ, 2013, CELL, V153, P1421, DOI 10.1016/j.cell.2013.05.055; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151; Chen HC, 2002, J LIPID RES, V43, P986; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Cutchins A, 2012, ARTERIOSCL THROM VAS, V32, P317, DOI 10.1161/ATVBAHA.111.234856; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Devi SS, 2006, TOXICOL APPL PHARM, V212, P69, DOI 10.1016/j.taap.2005.09.004; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; Ge HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033603; Gomez-Perez Y, 2011, REJUV RES, V14, P153, DOI 10.1089/rej.2010.1107; Gomez-Perez Y, 2008, CELL PHYSIOL BIOCHEM, V22, P539, DOI 10.1159/000185538; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guo BY, 2012, FASEB J, V26, P3453, DOI 10.1096/fj.12-205781; Gupte AA, 2008, J APPL PHYSIOL, V105, P839, DOI 10.1152/japplphysiol.00148.2008; Haddad F, 2006, J APPL PHYSIOL, V100, P1188, DOI 10.1152/japplphysiol.01227.2005; Hong J, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-11; Hou TY, 2009, J BIOL CHEM, V284, P31735, DOI 10.1074/jbc.M109.013961; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Karaya K, 2005, NUCLEIC ACIDS RES, V33, P1924, DOI 10.1093/nar/gki339; Kim H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1227, DOI 10.1152/ajpendo.00344.2005; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lan H, 2003, DIABETES, V52, P688, DOI 10.2337/diabetes.52.3.688; Lefta M, 2011, CURR TOP DEV BIOL, V96, P231, DOI 10.1016/B978-0-12-385940-2.00009-7; Lightfoot JT, 2010, J APPL PHYSIOL, V109, P623, DOI 10.1152/japplphysiol.00525.2010; Link JC, 2013, ADIPOCYTE, V2, P74, DOI 10.4161/adip.23320; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Mirbolooki MR, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-30; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moldes M, 1997, MOL CELL BIOL, V17, P1796, DOI 10.1128/MCB.17.4.1796; Moldes M, 1999, BIOCHEM J, V344, P873, DOI 10.1042/0264-6021:3440873; Murad JM, 2010, J BIOL CHEM, V285, P24164, DOI 10.1074/jbc.M110.128744; Norton JD, 2000, J CELL SCI, V113, P3897; Park KW, 2008, MOL ENDOCRINOL, V22, P2038, DOI 10.1210/me.2007-0454; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8; Reitman ML, 2002, ANNU REV NUTR, V22, P459, DOI 10.1146/annurev.nutr.22.010402.102849; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Satyanarayana A, 2012, FASEB J, V26, P309, DOI 10.1096/fj.11-190892; Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shostak A, 2013, DIABETES, V62, P2195, DOI 10.2337/db12-1449; Siddals KW, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740289; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van der Veen DR, 2012, OBESITY, V20, P1527, DOI 10.1038/oby.2012.78; van der Veen DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031792; Ward SM, 2010, J BIOL CHEM, V285, P38987, DOI 10.1074/jbc.M110.175182; Wheatcroft SB, 2007, DIABETES, V56, P285, DOI 10.2337/db06-0436; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yakar S, 2006, ENDOCRINOLOGY, V147, P5826, DOI 10.1210/en.2006-0311; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Zhu X, 2003, CELL MOL LIFE SCI, V60, P212, DOI 10.1007/s000180300015; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	65	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73064	10.1371/journal.pone.0073064	http://dx.doi.org/10.1371/journal.pone.0073064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023810	gold, Green Published			2022-12-27	WOS:000324238400041
J	Yoshikawa, T; Otsuka, M; Kishikawa, T; Takata, A; Ohno, M; Shibata, C; Kang, YJ; Yoshida, H; Koike, K				Yoshikawa, Takeshi; Otsuka, Motoyuki; Kishikawa, Takahiro; Takata, Akemi; Ohno, Motoko; Shibata, Chikako; Kang, Young Jun; Yoshida, Haruhiko; Koike, Kazuhiko			Unique Haploinsufficient Role of the MicroRNA-Processing Molecule Dicer1 in a Murine Colitis-Associated Tumorigenesis Model	PLOS ONE			English	Article							POOR-PROGNOSIS; CANCER; EXPRESSION; MUTATIONS; COLON; TRANSFORMATION; BIOGENESIS; EPITHELIUM; DNA	A widespread downregulated expression of microRNAs (miRNAs) is commonly observed in human cancers. Similarly, deregulated expression of miRNA-processing pathway components, which results in the reduction of global miRNA expression, may also be associated with tumorigenesis. Here, we show that specific ablation of Dicer1 in intestinal epithelial cells accelerates intestinal inflammation-associated tumorigenesis. This effect was apparent only when a single copy of Dicer1 was deleted, but not with complete Dicer1 ablation. DICER expression and subsequent mature miRNA levels were inversely correlated with the number of intact Dicer1 alleles. Because the expression levels of DICER were retained in tumors and its surrounding tissues even after induction of colitis-associated tumors, the effects of Dicer1 deletion were cell-autonomous. Although the expression levels of representative oncogenes and tumor suppressor genes were in most cases inversely correlated with the expression levels of DICER, some genes were not affected by Dicer1 deletion. Thus, deregulating the delicate balance between the expression levels of tumor-promoting and - suppressive genes may be crucial for tumorigenesis in this unique haploinsufficient case.	[Yoshikawa, Takeshi; Otsuka, Motoyuki; Kishikawa, Takahiro; Takata, Akemi; Ohno, Motoko; Shibata, Chikako; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Otsuka, Motoyuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Kang, Young Jun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Tokyo; Japan Science & Technology Agency (JST); Scripps Research Institute	Otsuka, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	otsukamo-tky@umin.ac.jp	Kishikawa, Takahiro/ABD-7420-2020; Otsuka, Motoyuki/H-9067-2019	Kishikawa, Takahiro/0000-0002-8602-5916; Otsuka, Motoyuki/0000-0003-2869-2881; Kang, Young Jun/0000-0001-9778-1963	Ministry of Education, Culture, Sports, Science and Technology, Japan [22390058, 2529307, 24390183]; Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan; Japan Foundation for Applied Enzymology; Sagawa Foundation for Promotion of Cancer Research; Cell Science Research Foundation; Japanese Society of Gastroenterology	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan; Japan Foundation for Applied Enzymology; Sagawa Foundation for Promotion of Cancer Research; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Japanese Society of Gastroenterology(Japanese Society of Gastroenterology)	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (#22390058 and #2529307 to M. Otsuka, and #24390183 to K. Koike), by Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (to K. Koike), grants from the Japan Foundation for Applied Enzymology, the Sagawa Foundation for Promotion of Cancer Research, the Cell Science Research Foundation, and the Japanese Society of Gastroenterology (to M. Otsuka.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrate MP, 2010, CANCER RES, V70, P6083, DOI 10.1158/0008-5472.CAN-09-4736; Bahubeshi A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002493; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davalos V, 2012, CANCER CELL, V21, P717, DOI 10.1016/j.ccr.2012.05.030; FLINT N, 1991, BIOCHEM J, V280, P331, DOI 10.1042/bj2800331; Frio TR, 2011, JAMA-J AM MED ASSOC, V305, P68, DOI 10.1001/jama.2010.1910; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Heravi-Moussavi A, 2012, NEW ENGL J MED, V366, P234, DOI 10.1056/NEJMoa1102903; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kitagawa N, 2013, CANCER SCI, V104, P543, DOI 10.1111/cas.12126; Kojima K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1345; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Otsuka M, 2010, GASTROENTEROLOGY, V138, P1255, DOI 10.1053/j.gastro.2010.01.005; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; Sekine S, 2009, GASTROENTEROLOGY, V136, P2304, DOI 10.1053/j.gastro.2009.02.067; Takata A, 2013, HEPATOLOGY, V57, P162, DOI 10.1002/hep.26011; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Yoshikawa T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00637; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhu DX, 2012, CANCER SCI, V103, P875, DOI 10.1111/j.1349-7006.2012.02234.x	36	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e71969	10.1371/journal.pone.0071969	http://dx.doi.org/10.1371/journal.pone.0071969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023722	gold, Green Submitted, Green Published			2022-12-27	WOS:000324238400007
J	Zettler, J; Eppmann, S; Busche, A; Dikovskaya, D; Dotsch, V; Mootz, HD; Sonntag, T				Zettler, Joachim; Eppmann, Simone; Busche, Alena; Dikovskaya, Dina; Doetsch, Volker; Mootz, Henning D.; Sonntag, Tim			SPLICEFINDER - A Fast and Easy Screening Method for Active Protein Trans-Splicing Positions	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; III C-METHYLTRANSFERASE; SPLIT INTEINS; DNAE INTEIN; MULTIDOMAIN PROTEIN; ESCHERICHIA-COLI; HIGHLY EFFICIENT; NOSTOC-PUNCTIFORME; NMR-SPECTROSCOPY; LIGATION	Split intein enabled protein trans-splicing (PTS) is a powerful method for the ligation of two protein fragments, thereby paving the way for various protein modification or protein function control applications. PTS activity is strongly influenced by the amino acids directly flanking the splice junctions. However, to date no reliable prediction can be made whether or not a split intein is active in a particular foreign extein context. Here we describe SPLICEFINDER, a PCR-based method, allowing fast and easy screening for active split intein insertions in any target protein. Furthermore we demonstrate the applicability of SPLICEFINDER for segmental isotopic labeling as well as for the generation of multi-domain and enzymatically active proteins.	[Zettler, Joachim; Eppmann, Simone; Mootz, Henning D.; Sonntag, Tim] TU Dortmund Univ, Dept Chem & Chem Biol, Dortmund, Germany; [Busche, Alena; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60054 Frankfurt, Germany; [Busche, Alena; Doetsch, Volker] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60054 Frankfurt, Germany; [Dikovskaya, Dina] Univ Glasgow, CRUK Beatson Labs, Glasgow, Lanark, Scotland	Dortmund University of Technology; Goethe University Frankfurt; Goethe University Frankfurt; University of Glasgow	Sonntag, T (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tsonntag@salk.edu		Dotsch, Volker/0000-0001-5720-212X	Cancer Research UK; German Research Foundation [MO 1073/2]; Human Frontier Science Program [RGP0031/2010]; Fonds der Chemischen Industrie	Cancer Research UK(Cancer Research UK); German Research Foundation(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	DD was funded by the Cancer Research UK Programme grant to Prof. Inke Nathke. HDM acknowledges financial support from the German Research Foundation (MO 1073/2), Human Frontier Science Program (RGP0031/2010) and Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Apgar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037355; Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Brachmann CB, 1998, YEAST, V14, P115; Brenzel S, 2006, BIOCHEMISTRY-US, V45, P1571, DOI 10.1021/bi051697+; Buchinger E, 2010, PROTEIN SCI, V19, P1534, DOI 10.1002/pro.432; Busche AEL, 2009, ANGEW CHEM INT EDIT, V48, P6128, DOI 10.1002/anie.200901488; Carvajal-Vallejos P, 2012, J BIOL CHEM, V287, P28686, DOI 10.1074/jbc.M112.372680; Cheriyan M, 2013, J BIOL CHEM, V288, P6202, DOI 10.1074/jbc.M112.433094; Cowburn D, 2001, METHOD ENZYMOL, V339, P41, DOI 10.1016/S0076-6879(01)39308-4; Durek T, 2007, P NATL ACAD SCI USA, V104, P4846, DOI 10.1073/pnas.0610630104; Feliciano J, 2006, BIOTECHNOL BIOENG, V93, P989, DOI 10.1002/bit.20808; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Iwai Hideo, 2007, Biotechnol Genet Eng Rev, V24, P129; Koglin A, 2009, NAT PROD REP, V26, P987, DOI 10.1039/b904543k; Kurpiers T, 2008, CHEMBIOCHEM, V9, P2317, DOI 10.1002/cbic.200800319; Lee YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043820; Linne U, 2003, BIOCHEMISTRY-US, V42, P5114, DOI 10.1021/bi034223o; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Minato Y, 2012, J BIOMOL NMR, V53, P191, DOI 10.1007/s10858-012-9628-3; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Muona M, 2010, NAT PROTOC, V5, P574, DOI 10.1038/nprot.2009.240; Muona M, 2008, CHEMBIOCHEM, V9, P2958, DOI 10.1002/cbic.200800604; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Oeemig JS, 2012, J MOL BIOL, V421, P85, DOI 10.1016/j.jmb.2012.04.029; Otomo T, 1999, BIOCHEMISTRY-US, V38, P16040, DOI 10.1021/bi991902j; Rehse PH, 2005, ACTA CRYSTALLOGR D, V61, P913, DOI 10.1107/S0907444905008838; SATTLER I, 1995, J BACTERIOL, V177, P1564, DOI 10.1128/jb.177.6.1564-1569.1995; Schwartz EC, 2007, NAT CHEM BIOL, V3, P50, DOI 10.1038/nchembio832; Shah NH, 2012, J AM CHEM SOC, V134, P11338, DOI 10.1021/ja303226x; Shah NH, 2013, J AM CHEM SOC; Shi JX, 2005, J AM CHEM SOC, V127, P6198, DOI 10.1021/ja042287w; Skrisovska L, 2008, J MOL BIOL, V375, P151, DOI 10.1016/j.jmb.2007.09.030; Sonntag T, 2011, MOL BIOSYST, V7, P2031, DOI 10.1039/c1mb05025g; Southworth MW, 1999, BIOTECHNIQUES, V27, P110, DOI 10.2144/99271st04; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vevodova J, 2004, J MOL BIOL, V344, P419, DOI 10.1016/j.jmb.2004.09.020; Volkmann G, 2010, MOL BIOSYST, V6, P2110, DOI 10.1039/c0mb00034e; WARREN MJ, 1990, BIOCHEM J, V265, P725, DOI 10.1042/bj2650725; Wasmuth A, 2013, BIOORG MED CHEM; Weber T, 2001, STRUCTURE, V9, pR3, DOI 10.1016/S0969-2126(00)00560-8; Wider G, 1999, CURR OPIN STRUC BIOL, V9, P594, DOI 10.1016/S0959-440X(99)00011-1; Wildt S, 1999, NAT BIOTECHNOL, V17, P1175, DOI 10.1038/70713; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Xu R, 1999, P NATL ACAD SCI USA, V96, P388, DOI 10.1073/pnas.96.2.388; Yagi H, 2004, J AM CHEM SOC, V126, P16632, DOI 10.1021/ja045279o; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	51	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72925	10.1371/journal.pone.0072925	http://dx.doi.org/10.1371/journal.pone.0072925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023792	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000324238400034
J	Cahill, F; Amini, P; Wadden, D; Khalili, S; Randell, E; Vasdev, S; Gulliver, W; Sun, G				Cahill, Farrell; Amini, Peyvand; Wadden, Danny; Khalili, Sammy; Randell, Edward; Vasdev, Sudesh; Gulliver, Wayne; Sun, Guang			Short-Term Overfeeding Increases Circulating Adiponectin Independent of Obesity Status	PLOS ONE			English	Article							ADIPOSE-SPECIFIC PROTEIN; BETA-CELL FUNCTION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; NORMAL-WEIGHT; PLASMA; GLUCOSE; TISSUE; LEPTIN; SENSITIVITY	Background: Adiponectin is an adipose tissue derived hormone which strengthens insulin sensitivity. However, there is little data available regarding the influence of a positive energy challenge (PEC) on circulating adiponectin and the role of obesity status on this response. Objective: The purpose of this study was to investigate how circulating adiponectin will respond to a short-term PEC and whether or not this response will differ among normal-weight(NW), overweight(OW) and obese(OB). Design: We examined adiponectin among 64 young men (19-29 yr) before and after a 7-day overfeeding (70% above normal energy requirements). The relationship between adiponectin and obesity related phenotypes including; weight, percent body fat (%BF), percent trunk fat (%TF), percent android fat (%AF), body mass index (BMI), total cholesterol, HDLc, LDLc, glucose, insulin, homeostatic model assessment insulin resistance (HOMA-IR) and beta-cell function (HOMA-beta) were analyzed before and after overfeeding. Results: Analysis of variance (ANOVA) and partial correlations were used to compute the effect of overfeeding on adiponectin and its association with adiposity measurements, respectively. Circulating Adiponectin levels significantly increased after the 7-day overfeeding in all three adiposity groups. Moreover, adiponectin at baseline was not significantly different among NW, OW and OB subjects defined by either %BF or BMI. Baseline adiponectin was negatively correlated with weight and BMI for the entire cohort and %TF, glucose, insulin and HOMA-IR in OB. However, after controlling for insulin resistance the correlation of adiponectin with weight, BMI and %TF were nullified. Conclusion: Our study provides evidence that the protective response of adiponectin is preserved during a PEC regardless of adiposity. Baseline adiponectin level is not directly associated with obesity status and weight gain in response to short-term overfeeding. However, the significant increase of adiponectin in response to overfeeding indicates the physiological potential for adiponectin to attenuate insulin resistance during the development of obesity.	[Cahill, Farrell; Amini, Peyvand; Wadden, Danny; Khalili, Sammy; Vasdev, Sudesh; Gulliver, Wayne; Sun, Guang] Mem Univ Newfoundland, Fac Med, Div Med, St John, NF, Canada; [Randell, Edward] Mem Univ Newfoundland, Discipline Lab Med, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Sun, G (corresponding author), Mem Univ Newfoundland, Fac Med, Div Med, St John, NF, Canada.	gsun@mun.ca			Canadian Institutes of Health Research (CIHR) [MOP192552]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research (CIHR), grant number: MOP192552 to GS; URL:http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Astrand O, 2010, EUR J ENDOCRINOL, V163, P879, DOI 10.1530/EJE-10-0763; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bray GA., 2003, CONT DIAGNOSIS MANAG; Brinc D, 2012, CLIN BIOCHEM, V45, P816, DOI 10.1016/j.clinbiochem.2012.03.029; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; Cahill F, 2011, AM J CLIN NUTR; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Christiansen T, 2010, J CLIN ENDOCR METAB, V95, P911, DOI 10.1210/jc.2008-2505; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Cote M, 2005, J CLIN ENDOCR METAB, V90, P1434, DOI 10.1210/jc.2004-1711; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Hajri T, 2011, AM J PHYSIOL-ENDOC M, V300, pE350, DOI 10.1152/ajpendo.00307.2010; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lou PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011669; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MAURIEGE P, 1992, INT J OBESITY, V16, P219; Moreno-Aliaga MJ, 2010, P NUTR SOC, V69, P324, DOI 10.1017/S0029665110001801; Pellme F, 2003, DIABETES, V52, P1182, DOI 10.2337/diabetes.52.5.1182; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; Shea J, 2007, AM J CLIN NUTR, V86, P1310, DOI 10.1093/ajcn/86.5.1310; Steinberg GR, 2002, AM J PHYSIOL-ENDOC M, V283, pE187, DOI 10.1152/ajpendo.00542.2001; Sun G, 2005, DIABETES, V54, P3336, DOI 10.2337/diabetes.54.11.3336; Sun G, 2007, AM J CLIN NUTR, V85, P399, DOI 10.1093/ajcn/85.2.399; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Ukkola O, 2008, J ENDOCRINOL INVEST, V31, P132, DOI 10.1007/BF03345579; Varady KA, 2009, METABOLISM, V58, P1096, DOI 10.1016/j.metabol.2009.04.010; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815	45	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e74215	10.1371/journal.pone.0074215	http://dx.doi.org/10.1371/journal.pone.0074215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023698	Green Published, gold, Green Accepted			2022-12-27	WOS:000323880200096
J	Carmeli, C; Donati, A; Antille, V; Viceic, D; Ghika, J; von Gunten, A; Clarke, S; Meuli, R; Frackowiak, RS; Knyazeva, MG				Carmeli, Cristian; Donati, Alessia; Antille, Valerie; Viceic, Dragana; Ghika, Joseph; von Gunten, Armin; Clarke, Stephanie; Meuli, Reto; Frackowiak, Richard S.; Knyazeva, Maria G.			Demyelination in Mild Cognitive Impairment Suggests Progression Path to Alzheimer's Disease	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; MINI-MENTAL-STATE; MAGNETIZATION-TRANSFER; HIPPOCAMPAL VOLUME; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; CORPUS-CALLOSUM; MRI; DEFICITS	The preclinical Alzheimer's disease (AD) - amnestic mild cognitive impairment (MCI) - is manifested by phenotypes classified into exclusively memory (single-domain) MCI (sMCI) and multiple-domain MCI (mMCI). We suggest that typical MCI-to-AD progression occurs through the sMCI-to-mMCI sequence as a result of the extension of initial pathological processes. To support this hypothesis, we assess myelin content with a Magnetization Transfer Ratio (MTR) in 21 sMCI and 21 mMCI patients and in 42 age-, sex-, and education-matched controls. A conjunction analysis revealed MTR reduction shared by sMCI and mMCI groups in the medial temporal lobe and posterior structures including white matter (WM: splenium, posterior corona radiata) and gray matter (GM: hippocampus; parahippocampal and lingual gyri). A disjunction analysis showed the spread of demyelination to prefrontal WM and insula GM in executive mMCI. Our findings suggest that demyelination starts in the structures affected by neurofibrillary pathology; its presence correlates with the clinical picture and indicates the method of MCI-to-AD progression. In vivo staging of preclinical AD can be developed in terms of WM/GM demyelination.	[Carmeli, Cristian; Frackowiak, Richard S.; Knyazeva, Maria G.] CHU Vaudois, Dept Clin Neurosci, LREN, CH-1011 Lausanne, Switzerland; [Carmeli, Cristian; Donati, Alessia; Antille, Valerie; Viceic, Dragana; Ghika, Joseph; von Gunten, Armin; Clarke, Stephanie; Meuli, Reto; Frackowiak, Richard S.; Knyazeva, Maria G.] Univ Lausanne, Lausanne, Switzerland; [Donati, Alessia; von Gunten, Armin] CHU Vaudois, Dept Psychiat, Serv Old Age Psychiat, CH-1011 Lausanne, Switzerland; [Antille, Valerie; Clarke, Stephanie] CHU Vaudois, Neuropsychol & Neurorehabil Serv, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland; [Viceic, Dragana; Ghika, Joseph] CHU Vaudois, Neurol Serv, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland; [Meuli, Reto] CIBM Ctr Imagerie Biomed, CHUV Unit, Lausanne, Switzerland; [Meuli, Reto; Knyazeva, Maria G.] CHU Vaudois, Dept Radiol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Knyazeva, MG (corresponding author), CHU Vaudois, Dept Clin Neurosci, LREN, CH-1011 Lausanne, Switzerland.	Maria.Knyazeva@chuv.ch	Frackowiak, Richard/H-4383-2011; Clarke, Stephanie/A-2845-2009	Frackowiak, Richard/0000-0002-3151-822X; Clarke, Stephanie/0000-0001-9393-5718; Carmeli, Cristian/0000-0002-1463-4587; von Gunten, Armin/0000-0001-7852-3803	Swiss National Foundation [320030-127538/1, 3200B0-122263]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation Grants No 320030-127538/1 and 3200B0-122263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Adam S., 2004, EVALUATION TROUBLES; Ahdesmaki M, 2010, ANN APPL STAT, V4, P503, DOI 10.1214/09-AOAS277; Albert M, 2007, NEUROPSYCHOLOGY, V21, P158, DOI 10.1037/0894-4105.21.2.158; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Backman L, 2004, J INTERN MED, V256, P195, DOI 10.1111/j.1365-2796.2004.01386.x; Baddeley AD, 2004, DOORS PEOPLE TEST VI; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Bobinski M, 1998, BRAIN RES, V799, P156, DOI 10.1016/S0006-8993(98)00441-7; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2012, HUM BRAIN MAPP, V33, P1295, DOI 10.1002/hbm.21287; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Brambati SM, 2009, DEMENT GERIATR COGN, V28, P541, DOI 10.1159/000255240; Braskie MN, 2011, J NEUROSCI, V31, P6764, DOI 10.1523/JNEUROSCI.5794-10.2011; Chen PJ, 2001, ARCH GEN PSYCHIAT, V58, P853, DOI 10.1001/archpsyc.58.9.853; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Cho H, 2008, J KOREAN MED SCI, V23, P477, DOI 10.3346/jkms.2008.23.3.477; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Corsi P.M., 1972, THESIS MCGILL U MONT; Csernansky JG, 2004, ALZ DIS ASSOC DIS, V18, P190; Davis HS, 2004, INT J GERIATR PSYCH, V19, P313, DOI 10.1002/gps.1049; De Partz MP, 2002, LEXIS TESTS DIAGNOST; de Souza LC, 2012, NEUROBIOL AGING, V33, P1253, DOI 10.1016/j.neurobiolaging.2011.02.022; de Souza LC, 2013, J ALZHEIMERS DIS, V36, P57, DOI 10.3233/JAD-122293; den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq048; Derouesne C, 1999, PRESSE MED, V28, P1141; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Di Paola M, 2010, NEUROIMAGE, V49, P141, DOI 10.1016/j.neuroimage.2009.07.050; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Filippi M, 2011, J ALZHEIMERS DIS, V24, P455, DOI 10.3233/JAD-2011-101854; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fornari E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.014; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Funnell MG, 2000, ARCH NEUROL-CHICAGO, V57, P185, DOI 10.1001/archneur.57.2.185; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Han JW, 2012, ALZHEIMERS DEMENT, V8, P553, DOI 10.1016/j.jalz.2011.08.007; Hebb D.O., 1961, BRAIN MECH LEARNING, P37, DOI DOI 10.5962/BHL.TITLE.7220; Helms G, 2009, J MAGN RESON IMAGING, V29, P198, DOI 10.1002/jmri.21629; Helms G, 2008, MAGN RESON MED, V60, P1396, DOI 10.1002/mrm.21732; Higgins J.J., 2004, INTRO MODERN NONPARA; Holland PR, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.11.009; Huang JB, 2007, ANN NY ACAD SCI, V1097, P259, DOI 10.1196/annals.1379.021; Jack CR, 2012, ARCH NEUROL-CHICAGO, V69, P856, DOI 10.1001/archneurol.2011.3405; Jacobson MW, 2009, BEHAV NEUROL, V21, P29, DOI [10.3233/BEN-2009-0229, 10.1155/2009/617312]; Jha AP, 1997, J COGNITIVE NEUROSCI, V9, P143, DOI 10.1162/jocn.1997.9.1.143; Johns EK, 2012, J INT NEUROPSYCH SOC, V18, P541, DOI 10.1017/S1355617712000069; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Knyazeva MG, 2013, NEUROBIOL AGING, V34, P694, DOI 10.1016/j.neurobiolaging.2012.07.012; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Mahieux-Laurent F, 2009, REV NEUROL-FRANCE, V165, P560, DOI 10.1016/j.neurol.2008.11.016; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Miller MB, 2002, J COGNITIVE NEUROSCI, V14, P702, DOI 10.1162/08989290260138609; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Moretti D V, 2012, Int J Alzheimers Dis, V2012, P917537, DOI 10.1155/2012/917537; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; Mortimer JA, 2008, ANN NEUROL, V64, P479, DOI 10.1002/ana.21552; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nierenberg J, 2005, NEUROREPORT, V16, P1369, DOI 10.1097/01.wnr.0000174058.49521.16; Palmer K, 2008, AM J GERIAT PSYCHIAT, V16, P603, DOI 10.1097/JGP.0b013e3181753a64; Parente DB, 2008, AM J ROENTGENOL, V190, P1369, DOI 10.2214/AJR.07.2617; Persson J, 2006, NEUROLOGY, V66, P1029, DOI 10.1212/01.wnl.0000204180.25361.48; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Preti MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035856; Rapp MA, 2005, AM J GERIAT PSYCHIAT, V13, P134, DOI 10.1176/appi.ajgp.13.2.134; Reisberg Barry, 2002, Am J Alzheimers Dis Other Demen, V17, P202, DOI 10.1177/153331750201700411; Rose SE, 2006, J NEUROL NEUROSUR PS, V77, P1122, DOI 10.1136/jnnp.2005.074336; Rousseaux M, 2001, REV NEUROL-FRANCE, V157, P1385; Rytsar R, 2011, NEUROIMAGE, V57, P1131, DOI 10.1016/j.neuroimage.2011.05.029; Salat DH, 2011, BRAIN CONNECT, V1, P279, DOI 10.1089/brain.2011.0056; Salimi-Khorshidi G, 2011, NEUROIMAGE, V54, P2006, DOI 10.1016/j.neuroimage.2010.09.088; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schmierer K, 2007, J MAGN RESON IMAGING, V26, P41, DOI 10.1002/jmri.20984; Schroeter ML, 2012, BRAIN, V135, P201, DOI 10.1093/brain/awr311; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Smith CD, 2010, NEUROBIOL AGING, V31, P1122, DOI 10.1016/j.neurobiolaging.2008.08.006; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stanisz GJ, 1999, MAGN RESON MED, V42, P1128, DOI 10.1002/(SICI)1522-2594(199912)42:6<1128::AID-MRM18>3.0.CO;2-9; Stebbins GT, 2009, BEHAV NEUROL, V21, P39, DOI [10.3233/BEN-2009-0234, 10.1155/2009/915041]; Storandt M, 2008, CURR DIR PSYCHOL SCI, V17, P198, DOI 10.1111/j.1467-8721.2008.00574.x; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sugihara S, 2004, ACTA RADIOL, V45, P658, DOI 10.1080/02841850410008388; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ukmar M, 2008, RADIOL MED, V113, P915, DOI 10.1007/s11547-008-0286-1; Wang PJ, 2006, NEUROBIOL AGING, V27, P1613, DOI 10.1016/j.neurobiolaging.2005.09.035; Wechsler D., 1997, WECHSLER ADULT INTEL; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Whitwell JL, 2007, ARCH NEUROL-CHICAGO, V64, P1130, DOI 10.1001/archneur.64.8.1130; Wiest R, 2013, AM J NEURORADIOL, V34, P740, DOI 10.3174/ajnr.A3307; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003; Zhang HB, 2012, J NEUROL SCI, V315, P26, DOI 10.1016/j.jns.2011.12.011; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	114	39	39	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72759	10.1371/journal.pone.0072759	http://dx.doi.org/10.1371/journal.pone.0072759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023644	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200040
J	Clarke, RT; Liley, D; Sharp, JM; Green, RE				Clarke, Ralph T.; Liley, Durwyn; Sharp, Joanna M.; Green, Rhys E.			Building Development and Roads: Implications for the Distribution of Stone Curlews across the Brecks	PLOS ONE			English	Article							BURHINUS-OEDICNEMUS; DISTURBANCE; PREDATION; IMPACT; URBANIZATION; SELECTION; NUMBERS; PORTON; BIRDS	Background: Substantial new housing and infrastructure development planned within England has the potential to conflict with the nature conservation interests of protected sites. The Breckland area of eastern England (the Brecks) is designated as a Special Protection Area for a number of bird species, including the stone curlew (for which it holds more than 60% of the UK total population). We explore the effect of buildings and roads on the spatial distribution of stone curlew nests across the Brecks in order to inform strategic development plans to avoid adverse effects on such European protected sites. Methodology: Using data across all years (and subsets of years) over the period 1988-2006 but restricted to habitat areas of arable land with suitable soils, we assessed nest density in relation to the distances to nearest settlements and to major roads. Measures of the local density of nearby buildings, roads and traffic levels were assessed using normal kernel distance-weighting functions. Quasi-Poisson generalised linear mixed models allowing for spatial autocorrelation were fitted. Results: Significantly lower densities of stone curlew nests were found at distances up to 1500m from settlements, and distances up to 1000m or more from major (trunk) roads. The best fitting models involved optimally distance-weighted variables for the extent of nearby buildings and the trunk road traffic levels. Significance: The results and predictions from this study of past data suggests there is cause for concern that future housing development and associated road infrastructure within the Breckland area could have negative impacts on the nesting stone curlew population. Given the strict legal protection afforded to the SPA the planning and conservation bodies have subsequently agreed precautionary restrictions on building development within the distances identified and used the modelling predictions to agree mitigation measures for proposed trunk road developments.	[Clarke, Ralph T.] Bournemouth Univ, Sch Appl Sci, Poole BH12 5BB, Dorset, England; [Clarke, Ralph T.; Liley, Durwyn; Sharp, Joanna M.] Footprint Ecol, Wareham, Dorset, England; [Green, Rhys E.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Green, Rhys E.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England	Bournemouth University; University of Cambridge; Royal Society for Protection of Birds	Clarke, RT (corresponding author), Bournemouth Univ, Sch Appl Sci, Poole BH12 5BB, Dorset, England.	rclarke@bourneouth.ac.uk	Sharp, Joanna/C-1167-2011; Clarke, Ralph T/B-3859-2009; Liley, Durwyn/GXG-6398-2022	Sharp, Joanna/0000-0001-5849-868X; 	Breckland District Council, UK	Breckland District Council, UK	Funding towards this research was provided by Breckland District Council, UK. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript (other than minor factual comments on a final draft).	Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Bealey CE, 1999, BIRD STUDY, V46, P145, DOI 10.1080/00063659909461126; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clarke RT, 2009, IMPACT STONE CURLEWS; Day TCF, 2003, EFFECTS DISTURBANCE, P228; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Frid A, 2002, CONSERV ECOL, V6; Green R. E., 1997, Ringing and Migration, V18, P102; Green R.E., 1995, P138; GREEN RE, 1995, BIRD STUDY, V42, P177, DOI 10.1080/00063659509477166; Green RE, 2000, J ZOOL, V250, P161, DOI 10.1111/j.1469-7998.2000.tb01067.x; Green RE, 1994, J ZOOL LOND, V233, P257; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; HARRIS S, 1986, J ANIM ECOL, V55, P575, DOI 10.2307/4740; Haskins Lesley, 2000, British Wildlife, V11, P229; Liley D, 2003, BIOL CONSERV, V114, P219, DOI 10.1016/S0006-3207(03)00042-9; Mallord JW, 2007, J APPL ECOL, V44, P185, DOI 10.1111/j.1365-2664.2006.01242.x; Marzluff John M., 2001, P19; McCullagh P, 1989, GEN LINEAR MODELS; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Palomino D, 2006, LANDSCAPE URBAN PLAN, V77, P276, DOI 10.1016/j.landurbplan.2005.04.003; Reijnen R, 1997, BIODIVERS CONSERV, V6, P567, DOI 10.1023/A:1018385312751; Scharlemann JPW, 2005, BIOL CONSERV, V123, P317, DOI 10.1016/j.biocon.2004.11.019; Sharp J, 2008, HE EFFECT HOUSING DE; Summers PD, 2011, J APPL ECOL, V48, P1527, DOI 10.1111/j.1365-2664.2011.02041.x; Taylor EC, 2007, IBIS, V149, P37, DOI 10.1111/j.1474-919X.2007.00645.x; Underhill-Day JC, 2005, 624 ENGL NAT; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Wallander J, 2006, BIOL CONSERV, V132, P343, DOI 10.1016/j.biocon.2006.04.026; Whittingham MJ, 2002, J AVIAN BIOL, V33, P184, DOI 10.1034/j.1600-048X.2002.330210.x; Woods M, 2003, MAMMAL REV, V33, P174, DOI 10.1046/j.1365-2907.2003.00017.x; Yasue M, 2006, J APPL ECOL, V43, P978, DOI 10.1111/j.1365-2664.2006.01204.x	37	10	11	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72984	10.1371/journal.pone.0072984	http://dx.doi.org/10.1371/journal.pone.0072984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023662	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000323880200058
J	Phillips, JB; Youmans, PW; Muheim, R; Sloan, KA; Landler, L; Painter, MS; Anderson, CR				Phillips, John B.; Youmans, Paul W.; Muheim, Rachel; Sloan, Kelly A.; Landler, Lukas; Painter, Michael S.; Anderson, Christopher R.			Rapid Learning of Magnetic Compass Direction by C57BL/6 Mice in a 4-Armed 'Plus' Water Maze	PLOS ONE			English	Article							RADICAL-PAIR MECHANISM; NEWT NOTOPHTHALMUS-VIRIDESCENS; HEAD DIRECTION; EUROPEAN ROBINS; SUBTERRANEAN RODENT; ANIMAL NAVIGATION; GEOMAGNETIC-FIELD; PATH-INTEGRATION; MIGRATORY BIRDS; PLACE CELLS	Magnetoreception has been demonstrated in all five vertebrate classes. In rodents, nest building experiments have shown the use of magnetic cues by two families of molerats, Siberian hamsters and C57BL/6 mice. However, assays widely used to study rodent spatial cognition (e.g. water maze, radial arm maze) have failed to provide evidence for the use of magnetic cues. Here we show that C57BL/6 mice can learn the magnetic direction of a submerged platform in a 4-armed (plus) water maze. Naive mice were given two brief training trials. In each trial, a mouse was confined to one arm of the maze with the submerged platform at the outer end in a predetermined alignment relative to magnetic north. Between trials, the training arm and magnetic field were rotated by 180 degrees so that the mouse had to swim in the same magnetic direction to reach the submerged platform. The directional preference of each mouse was tested once in one of four magnetic field alignments by releasing it at the center of the maze with access to all four arms. Equal numbers of responses were obtained from mice tested in the four symmetrical magnetic field alignments. Findings show that two training trials are sufficient for mice to learn the magnetic direction of the submerged platform in a plus water maze. The success of these experiments may be explained by: (1) absence of alternative directional cues (2), rotation of magnetic field alignment, and (3) electromagnetic shielding to minimize radio frequency interference that has been shown to interfere with magnetic compass orientation of birds. These findings confirm that mice have a well-developed magnetic compass, and give further impetus to the question of whether epigeic rodents (e.g., mice and rats) have a photoreceptor-based magnetic compass similar to that found in amphibians and migratory birds.	[Phillips, John B.; Youmans, Paul W.; Landler, Lukas; Painter, Michael S.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Muheim, Rachel] Lund Univ, Dept Funct Zool, Lund, Sweden; [Sloan, Kelly A.] South Carolina Dept Nat Resources, Charleston, SC USA; [Anderson, Christopher R.] US Naval Acad, Annapolis, MD USA	Virginia Polytechnic Institute & State University; Lund University; United States Department of Defense; United States Navy; United States Naval Academy	Phillips, JB (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	jphillip@vt.edu	Landler, Lukas/D-6428-2013	Landler, Lukas/0000-0002-5638-7924; Muheim, Rachel/0000-0002-2079-6443	National Science Foundation [IOS 07-48175]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by the National Science Foundation IOS 07-48175 (to JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batschelet E, 1981, CIRCULAR STAT BIOL; Beason RC, 1996, J EXP BIOL, V199, P1241; Begall S, 2008, P NATL ACAD SCI USA, V105, P13451, DOI 10.1073/pnas.0803650105; BINGMAN VP, 1987, AUK, V104, P523, DOI 10.2307/4087555; Binhi VN, 2006, BIOELECTROMAGNETICS, V27, P58, DOI 10.1002/bem.20178; Brown JE, 2002, PHYSIOL BEHAV, V77, P743, DOI 10.1016/S0031-9384(02)00928-9; BURDA H, 1990, EXPERIENTIA, V46, P528, DOI 10.1007/BF01954256; Burda H, 2009, P NATL ACAD SCI USA, V106, P5708, DOI 10.1073/pnas.0811194106; Burger T, 2010, J R SOC INTERFACE, V7, P1275, DOI 10.1098/rsif.2009.0551; Calhoun ME, 1998, NEUROBIOL AGING, V19, P599, DOI 10.1016/S0197-4580(98)00098-0; Cerveny J, 2011, BIOL LETTERS, V7, P355, DOI 10.1098/rsbl.2010.1145; Cheung A, 2008, BIOL CYBERN, V99, P197, DOI 10.1007/s00422-008-0251-z; Cheung A, 2007, BIOL CYBERN, V97, P47, DOI 10.1007/s00422-007-0158-0; Derdikman D, 2010, TRENDS COGN SCI, V14, P561, DOI 10.1016/j.tics.2010.09.004; Deutschlander ME, 2012, WILSON J ORNITHOL, V124, P467, DOI 10.1676/11-043.1; Deutschlander ME, 2003, ANIM BEHAV, V65, P779, DOI 10.1006/anbe.2003.2111; Dudchenko PA, 2002, ANIM COGN, V5, P115, DOI 10.1007/s10071-002-0134-y; Gauger EM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.040503; Henbest KB, 2004, J AM CHEM SOC, V126, P8102, DOI 10.1021/ja048220q; Holland RA, 2006, NATURE, V444, P702, DOI 10.1038/444702b; Holland RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001676; Iivonen H, 2003, BEHAV BRAIN RES, V141, P207, DOI 10.1016/S0166-4328(02)00369-8; Diego-Rasilla FJ, 2010, NATURWISSENSCHAFTEN, V97, P1077, DOI 10.1007/s00114-010-0730-7; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kimchi T, 2004, P NATL ACAD SCI USA, V101, P1105, DOI 10.1073/pnas.0307560100; Kimchi T, 2001, J EXP BIOL, V204, P751; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Kishkinev D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065847; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Lau JCS, 2012, J R SOC INTERFACE, V9, P3329, DOI 10.1098/rsif.2012.0374; Lauwers M, 2013, CURR BIOL, V23, P924, DOI 10.1016/j.cub.2013.04.025; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; MERRITT R, 1983, REV SCI INSTRUM, V54, P879, DOI 10.1063/1.1137480; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Muheim R, 2002, J EXP BIOL, V205, P3845; Muheim R, 2006, LEARN BEHAV, V34, P366, DOI 10.3758/BF03193201; Munro U, 1997, NATURWISSENSCHAFTEN, V84, P26, DOI 10.1007/s001140050343; Niessner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020091; OLCESE J, 1988, BRAIN RES, V448, P325, DOI 10.1016/0006-8993(88)91271-1; OLCESE J, 1985, BRAIN RES, V333, P382, DOI 10.1016/0006-8993(85)91598-7; OLCESE J, 1988, LIFE SCI, V42, P605, DOI 10.1016/0024-3205(88)90451-1; Oliveriusova L, 2012, J EXP BIOL, V215, P3649, DOI 10.1242/jeb.069625; Painter MS, 2013, J EXP BIOL, V216, P1307, DOI 10.1242/jeb.077404; PHILLIPS JB, 1986, SCIENCE, V233, P765, DOI 10.1126/science.3738508; PHILLIPS JB, 1994, J EXP BIOL, V188, P275; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; PHILLIPS JB, 1986, J COMP PHYSIOL A, V158, P103, DOI 10.1007/BF00614524; Phillips JB, 2010, J EXP BIOL, V213, P3247, DOI 10.1242/jeb.020792; Phillips JB, 2010, J R SOC INTERFACE, V7, pS241, DOI 10.1098/rsif.2009.0459.focus; RITZ DA, 1991, J EXP MAR BIOL ECOL, V154, P245, DOI 10.1016/0022-0981(91)90167-U; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; SEMM P, 1984, J COMP PHYSIOL, V155, P283, DOI 10.1007/BF00610581; Sharp PE, 2006, BEHAV BRAIN RES, V174, P206, DOI 10.1016/j.bbr.2006.05.034; Solov'yov IA, 2012, J AM CHEM SOC; Solovyov I., 2011, QUANTUM EFFECTS BIOL; Stackman RW, 2003, J NEUROPHYSIOL, V90, P2862, DOI 10.1152/jn.00346.2003; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Stackman RW, 1998, J NEUROSCI, V18, P9020; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; Thalau P, 2006, J R SOC INTERFACE, V3, P583, DOI 10.1098/rsif.2006.0130; Tryon VL, 2012, BEHAV NEUROSCI, V126, P835, DOI 10.1037/a0030248; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075; Vacha M, 2009, J EXP BIOL, V212, P3473, DOI 10.1242/jeb.028670; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2006, BIOESSAYS, V28, P157, DOI 10.1002/bies.20363; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko R, 2010, J R SOC INTERFACE, V7, pS163, DOI 10.1098/rsif.2009.0367.focus; WILTSCHKO W, 1975, Zeitschrift fuer Tierpsychologie, V37, P337; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Wiltschko W, 2002, J EXP BIOL, V205, P3031; Winklhofer M, 2010, J R SOC INTERFACE, V7, pS273, DOI 10.1098/rsif.2009.0435.focus; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Wu LQ, 2011, CURR BIOL, V21, P418, DOI 10.1016/j.cub.2011.01.058	79	25	26	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73112	10.1371/journal.pone.0073112	http://dx.doi.org/10.1371/journal.pone.0073112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023673	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200069
J	Saha, D; Pal, A; Biswas, A; Panigrahi, R; Sarkar, N; Sarkar, J; Pal, M; Guha, SK; Saha, B; Chakrabarti, S; Chakravarty, R				Saha, Debraj; Pal, Ananya; Biswas, Avik; Panigrahi, Rajesh; Sarkar, Neelakshi; Sarkar, Jayeeta; Pal, Manisha; Guha, Subhasish Kamal; Saha, Bibhuti; Chakrabarti, Sekhar; Chakravarty, Runu			Characterization of Treatment-Naive HIV/HBV Co-Infected Patients Attending ART Clinic of a Tertiary Healthcare Centre in Eastern India	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS; VIRAL-HEPATITIS; BLOOD-DONORS; LIVER-DISEASE; GENOTYPES; HBV; ASSOCIATION; PREVALENCE	Objective: The study was designed to assess the hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infection scenario among the human immunodeficiency virus (HIV) infected patients attending a tertiary healthcare unit in eastern India. Additionally, clinical and virological characterization of these viruses, prior to antiretroviral therapy (ART) initiation was also done for better understanding of the disease profile. Methods: Pool of ART-naive HIV/HBV co-infected and HIV mono-infected patients, participating in two different studies, were included in this study. HBV DNA was detected by nested-PCR amplification followed by HBV genotype determination and HBV reverse transcriptase (RT) region amplification and direct sequencing for detecting drug resistance. Results: The prevalence of HBsAg (11.3%) was higher compared to anti-HCV (1.9%) among the HIV infected ART-naive patients. Moreover, majority of the HBeAg positive HIV/HBV co-infected patients (87.7%) had HBV DNA >= 20,000 IU/ml with median HBV DNA significantly higher than that of HBeAg negative subjects (5.7 log(10) IU/ml vs. 4.2 log(10) IU/ml; p<0.0001). Multivariate analysis also showed that HBeAg-positive status was independently associated with higher HBV DNA level (p = <0.001). Notably, 60.9% of the HBeAg negative co-infected subjects had HBV DNA >= 2,000 IU/ml of which 37.0% had HBV DNA >= 20,000 IU/ml. Genotype HBV/D (68.2%) was the predominant genotype followed by HBV/A (24.3%) and HBV/C (7.5%). Anti-HBV drug resistant mutations were detected in two (3.8%) of the ART-naive patients. Conclusion: The prevalence of HIV/HBV co-infection was relatively higher in our study subjects. HBeAg testing might provide clue for early treatment initiation. Furthermore, HBeAg negative patients are also associated with high HBV DNA levels and therefore require appropriate medical attention. Pre-treatment screening for anti-HBV drug resistant mutations is not necessary before ART initiation.	[Saha, Debraj; Pal, Ananya; Biswas, Avik; Panigrahi, Rajesh; Sarkar, Neelakshi; Chakravarty, Runu] ICMR Virus Unit, Kolkata, India; [Sarkar, Jayeeta; Guha, Subhasish Kamal; Saha, Bibhuti] Calcutta Sch Trop Med, Kolkata, India; [Chakrabarti, Sekhar] Natl Inst Cholera & Enter Dis, Kolkata, India; [Pal, Manisha] Univ Calcutta, Dept Stat, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; Calcutta School of Tropical Medicine (CSTM); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of Calcutta	Chakravarty, R (corresponding author), ICMR Virus Unit, ID & BG Hosp Campus, Kolkata, India.	runugc@gmail.com	PAL, MRINAL/ABG-9676-2020	PAL, MRINAL/0000-0002-1032-272X; Panigrahi, Rajesh/0000-0002-6704-0029	Department of Biotechnology, Government of India [BT/PR14485/Med/29/203/2010]; Indian Council of Medical Research [HIV/50/128/2010-ECD-II, 29/3/11]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	Funded by Department of Biotechnology, Government of India (No. BT/PR14485/Med/29/203/2010), and the part of clinical trial (IRIS ID No. 200905630) was funded by Indian Council of Medical Research (No. HIV/50/128/2010-ECD-II, 29/3/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SK, 2006, NATL MED J INDIA, V19, P203; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Banerjee A, 2005, INTERVIROLOGY, V48, P389, DOI 10.1159/000086066; Banerjee A, 2006, WORLD J GASTROENTERO, V12, P5964, DOI 10.3748/wjg.v12.i37.5964; Biswas A, 2009, HEPATOL RES, V39, P53, DOI 10.1111/j.1872-034X.2008.00403.x; Biswas A, 2011, J MED VIROL, V83, P253, DOI 10.1002/jmv.21979; Chandra PK, 2007, INTERVIROLOGY, V50, P173, DOI 10.1159/000098960; Chauhan R, 2006, J MED VIROL, V78, P1047, DOI 10.1002/jmv.20661; Chelleng PK, 2008, INDIAN J MED RES, V128, P640; Clements CJ, 2010, B WORLD HEALTH ORGAN, V88, P66, DOI 10.2471/BLT.08.065722; Corbet S, 2003, J CLIN MICROBIOL, V41, P1091, DOI 10.1128/JCM.41.3.1091-1100.2003; Datta S, 2006, EMERG INFECT DIS, V12, P1954; de Vries-Sluijs TEMS, 2010, GASTROENTEROLOGY, V139, P1934, DOI 10.1053/j.gastro.2010.08.045; Gandhe SS, 2003, J MED VIROL, V69, P324, DOI 10.1002/jmv.10292; Gupta S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-53; Idoko J, 2007, CLIN INFECT DIS, V49, P1268; Iser D. M., 2009, HIV Therapy, V3, P405, DOI 10.2217/HIV.09.19; Jobarteh M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-230; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Locarnini S, 2008, HEPATOL INT, V2, P147, DOI 10.1007/s12072-008-9048-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; National AIDS Control Organization (NACO), 2012, NACO ANN REP 2011 20, P2011; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Pal A, 2013, VIROLOGY, V436, P134, DOI 10.1016/j.virol.2012.11.003; Panigrahi R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-204; Rockstroh JK, 2008, HIV MED, V9, P82, DOI 10.1111/j.1468-1293.2007.00535.x; Saha MK, 2000, INDIAN J MED RES, V111, P37; Sellier P, 2010, J CLIN VIROL, V47, P13, DOI 10.1016/j.jcv.2009.10.010; Sheldon J, 2008, J ANTIMICROB CHEMOTH, V61, P766, DOI 10.1093/jac/dkn014; Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021; Soriano V, 2010, J ANTIMICROB CHEMOTH, V65, P548, DOI 10.1093/jac/dkp479; Thibault V, 2002, AIDS, V16, P131, DOI 10.1097/00002030-200201040-00020; Thio CL, 2013, AIDS, V27, P191, DOI 10.1097/QAD.0b013e32835a9984; Trevino A, 2009, AIDS RES HUM RETROV, V25, P1273, DOI 10.1089/aid.2009.0119; Tuma P, 2011, ANTIVIR THER, V16, P585, DOI 10.3851/IMP1778; Vivekanandan P, 2004, CLIN INFECT DIS, V38, pE81, DOI 10.1086/383144; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Yan YX, 2011, EPIDEMIOL INFECT, V139, P354, DOI 10.1017/S0950268810001597	39	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73613	10.1371/journal.pone.0073613	http://dx.doi.org/10.1371/journal.pone.0073613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023688	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200085
J	Meyer, JP; McAvoy, KE; Jiang, J				Meyer, Jacob P.; McAvoy, Kieran E.; Jiang, Jack			Rehydration Capacities and Rates for Various Porcine Tissues after Dehydration	PLOS ONE			English	Article							HUMAN PATELLAR TENDON; VOCAL FOLD TISSUES; WATER-CONTENT; ARTICULAR-CARTILAGE; STRESS-RELAXATION; HYDRATION; COMPRESSION; BEHAVIOR; LIGAMENT; CREEP	The biphasic effects of liquid on tissue biomechanics are well known in cartilage and vocal folds, yet not extensively in other tissue types. Past studies have shown that tissue dehydration significantly impacts biomechanical properties and that rehydration can restore these properties in certain tissue types. However, these studies failed to consider how temporal exposure to dehydrating or rehydrating agents may alter tissue rehydration capacity, as overexposure to dehydration may permanently prevent rehydration to the initial liquid volume. Select porcine tissues were dehydrated until they reached between 100% and 40% of their initial mass. Each sample was allowed to rehydrate for 5 hours in a 0.9% saline solution, and the percent change between the initial and rehydrated mass values was calculated. Spearman correlation tests indicated a greater loss in mass despite rehydration when tissues were previously exposed to greater levels of dehydration. Additionally, Pearson correlation tests indicated the total liquid mass of samples after complete rehydration decreased when previously exposed to higher levels of dehydration. Rehydration rates were found by dehydrating tissues to 40% of their initial mass followed by rehydration in a 0.9% saline solution for 60 minutes, with mass measurements occurring in 15 minute intervals. All tissues rehydrated nonlinearly, most increasing significantly in mass up to 30 minutes after initial soaking. This study suggests the ability for tissues to rehydrate is dependent on the level of initial dehydration exposure. In vitro rehydration experiments therefore require controlled dosage and temporal exposure to dehydrating and rehydrating agents to avoid incomplete rehydration, and caution should be taken when combining different tissue types in models of hydration.	[Meyer, Jacob P.; McAvoy, Kieran E.; Jiang, Jack] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Jiang, J (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53706 USA.	jjjiang@wisc.edu		Jiang, Jack J./0000-0002-3070-4952	NIH from the National Institute on Deafness and other Communicative Disorders [R01 DC05522]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005522] Funding Source: NIH RePORTER	NIH from the National Institute on Deafness and other Communicative Disorders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by NIH grant number R01 DC05522 from the National Institute on Deafness and other Communicative Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013; Atkinson TS, 1999, J BIOMECH, V32, P907, DOI 10.1016/S0021-9290(99)00089-5; Chan RW, 2003, ANN BIOMED ENG, V31, P482, DOI 10.1114/1.1561287; Chan RW, 2002, OTOLARYNG HEAD NECK, V126, P528, DOI 10.1067/mhn.2002.124936; CHIMICH D, 1992, J BIOMECH, V25, P831, DOI 10.1016/0021-9290(92)90223-N; HAJI T, 1992, ACTA OTO-LARYNGOL, V112, P151, DOI 10.3109/00016489209100797; Hanson KP, 2011, J VOICE, V25, P657, DOI 10.1016/j.jvoice.2010.06.005; Haut TL, 1997, J BIOMECH, V30, P79, DOI 10.1016/S0021-9290(96)00108-X; Hendriks FM, 2004, SKIN RES TECHNOL, V10, P231, DOI 10.1111/j.1600-0846.2004.00077.x; Hoffman AH, 2005, J BIOMECH, V38, P1636, DOI 10.1016/j.jbiomech.2004.07.032; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5; Thornton GM, 2001, J ORTHOPAED RES, V19, P845, DOI 10.1016/S0736-0266(01)00005-5; Vargas O, 1999, LASER SURG MED, V24, P133	14	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72573	10.1371/journal.pone.0072573	http://dx.doi.org/10.1371/journal.pone.0072573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023753	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600031
J	Csupor, D; Boros, K; Hohmann, J				Csupor, Dezso; Boros, Klara; Hohmann, Judit			Low Potency Homeopathic Remedies and Allopathic Herbal Medicines: Is There an Overlap?	PLOS ONE			English	Article							VITEX-AGNUS-CASTUS; PREMENSTRUAL-SYNDROME; CYCLICAL MASTALGIA; EXTRACTS	Classical homeopathy is based on the therapeutic application of highly diluted homeopathic stocks. The indications of such medicines are determined by proving, i.e. by applying the remedies in healthy subjects. However, there are several complex homeopathic medicinal products on the market with approved therapeutic indications. The efficacy of these medicines has been assessed in clinical trials on patients. There is no upper limit of dosing for such homeopathic remedies, and these products often contain undiluted mother tincture. The aim of our study was to compare an allopathic herbal medicine and a homeopathic product containing undiluted mother tincture based on the same plant. Two products (an allopathic herbal medicine and a homeopathic product) containing Vitex agnus-castus extract were analyzed by HPLC-DAD for their agnuside and casticin contents. The agnuside content of the allopathic product was approximately four times higher, while the amount of casticin was in the same order of magnitude. Our experiments revealed the presence of active ingredients in allopathic quantity in a homeopathic preparation, highlighting the controversy between the principles of classical and practice of contemporary homeopathy. According to the principles of classical homeopathy these remedies cannot be considered as homeopathic remedies but rather as (allopathic) herbal ones. This phenomenon necessitates a case-by-case approach towards the possible adverse effects and drug interactions of homeopathics in the daily medical practice. Homeopathic products containing active agents in allopathic doses should be treated the same way as allopathic medicines from the point of view of quality assurance and pharmacovigilance.	[Csupor, Dezso; Boros, Klara; Hohmann, Judit] Univ Szeged, Dept Pharmacognosy, Szeged, Hungary	Szeged University	Csupor, D (corresponding author), Univ Szeged, Dept Pharmacognosy, Szeged, Hungary.	csupor.dezso@pharmacognosy.hu	Csupor, Dezső/ABE-1830-2021	Csupor, Dezső/0000-0002-4088-3333; Hohmann, Judit/0000-0002-2887-6392	New Hungary Development Plan projects [TAMOP-4.2.2.A-11/1/KONV-2012-0047, TAMOP-4.2.2.A-11/1/KONV-2012-0035]	New Hungary Development Plan projects	This work was supported by the New Hungary Development Plan projects TAMOP-4.2.2.A-11/1/KONV-2012-0047 and TAMOP-4.2.2.A-11/1/KONV-2012-0035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ALTERN MED REV, V14, P67; Falch B, 2003, THERAPIEWOCHE, V19, P287; Hajdu Z, 2007, PHYTOTHER RES, V21, P391, DOI 10.1002/ptr.2021; Halaska M, 1999, BREAST, V8, P175, DOI 10.1054/brst.1999.0039; He Z, 2009, MATURITAS, V63, P99, DOI 10.1016/j.maturitas.2009.01.006; Jutte R, 2005, COMPLEMENT THER MED, V13, P291, DOI 10.1016/j.ctim.2005.10.003; Kayne SB., 2006, HOMEOPATHIC PHARM TH; Meier B, 2000, PHYTOMEDICINE, V7, P373, DOI 10.1016/S0944-7113(00)80058-6; Schellenberg R, 2001, BRIT MED J, V322, P134, DOI 10.1136/bmj.322.7279.134; Sharma A, 2012, J ANAL METHODS CHEM, V2012, DOI 10.1155/2012/109058; Sharma A, 2010, MED CHEM RES, V19, P643, DOI 10.1007/s00044-009-9219-3; van Die MD, 2009, J ALTERN COMPLEM MED, V15, P853, DOI 10.1089/acm.2008.0447; Webster DE, 2006, J ETHNOPHARMACOL, V106, P216, DOI 10.1016/j.jep.2005.12.025; Webster DE, 2011, BIOCHEM PHARMACOL, V81, P170, DOI 10.1016/j.bcp.2010.09.013; Wuttke W, 2003, PHYTOMEDICINE, V10, P348, DOI 10.1078/094471103322004866; Wuttke W, 1997, GEBURTSH FRAUENHEILK, V57, P569, DOI 10.1055/s-2007-1023139	16	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74181	10.1371/journal.pone.0074181	http://dx.doi.org/10.1371/journal.pone.0074181			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019954	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200097
J	Fu, SS; Li, FJ; Wang, YY; You, AB; Qie, YL; Meng, X; Li, JR; Li, BC; Zhang, Y; Li, QD				Fu, Shen Shen; Li, Fu Ji; Wang, Yuan Yuan; You, An Bei; Qie, Yi Liang; Meng, Xiao; Li, Jian Rui; Li, Bao Chuan; Zhang, Yun; Li, Qing Da			Kallikrein Gene-Modified EPCs Induce Angiogenesis in Rats with Ischemic Hindlimb and Correlate with Integrin alpha v beta 3 Expression	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; NITRIC-OXIDE-SYNTHASE; GROWTH-FACTOR; THERAPEUTIC NEOVASCULARIZATION; VASCULAR DEVELOPMENT; DISEASE; TRANSPLANTATION; VASCULOGENESIS; VEGF; RECRUITMENT	Background: Human tissue kallikrein (hTK) plays an essential role in the physiological and pathological mechanisms of blood vessels. This study aimed to determine whether angiogenesis induced by endothelial progenitor cells (EPCs) transduced with the adenovirus-mediated hTK gene could improve blood flow in rat hindlimb ischemia in vivo and to establish a promising mechanism in vitro. Methods: EPCs transduced with adenovirus encoding hTK-162 (i.e., Ad/hTK-transduced EPCs or Ad/GFP-transduced EPCs) were administered to Wister rats with hindlimb ischemia through therapeutic neovascularization. Muscular capillary density (MCD), blood flow (BF), and the number of myofibers were measured at days 7, 14, and 21 after treatment. Expressions of integrin alpha v beta 3 and endothelial nitric oxide synthase (eNOS) were detected on the surface of EPCs. Results: MCD, BF, and the number of myofibers in rats with Ad/hTK-transduced EPCs remarkably increased at day 21 after treatment compared with rats with Ad/GFP-transduced EPCs or the control group (P<0.01). Expressions of integrin alpha v beta 3 and eNOS protein on the surface of EPCs also increased in rats with Ad/hTK-transduced EPCs. The levels of integrin alpha v beta 3 expression were reduced by PI3K and eNOS blockade, and the inhibitor of integrin alpha v beta 3 abrogated the migration and adhesion of hTK-transduced EPCs (P<0.05). Conclusion: hTK gene delivery in vivo improves the natural angiogenic response to ischemia. The ability of hTK gene-transduced EPCs can be enhanced in vitro, in which integrin alpha v beta 3 plays a role in the process.	[Fu, Shen Shen; Li, Fu Ji; Wang, Yuan Yuan; You, An Bei; Qie, Yi Liang; Meng, Xiao; Li, Jian Rui; Li, Bao Chuan; Zhang, Yun; Li, Qing Da] Shandong Univ, Dept Med, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University	Li, QD (corresponding author), Shandong Univ, Dept Med, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	qingdali611@163.com	Lv, Yuanjie/AER-0767-2022		Natural Science Foundation of Shandong Province [Y2007C042]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This project was supported by Natural Science Foundation of Shandong Province (No. Y2007C042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Caiado F, 2012, CAIADO DIAS FIBROGEN; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Estrada R, 2008, J BIOL CHEM, V283, P30363, DOI 10.1074/jbc.M804392200; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Fang ST, 2012, ANGIOGENESIS, V15, P511, DOI 10.1007/s10456-012-9278-9; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Hildbrand P, 2004, BLOOD, V104, P2010, DOI 10.1182/blood-2003-12-4219; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Jiao LF, 2008, THESIS TIANJIN MED U; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lange S, 2009, CARDIOVASC RES, V81, P159, DOI 10.1093/cvr/cvn258; Lara-Hernandez R, 2008, MED CLIN-BARCELONA, V131, P665, DOI 10.1157/13128727; Liu XL, 2010, AM J PATHOL, V176, P504, DOI 10.2353/ajpath.2010.081152; Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Morbidelli L, 1998, BRIT J PHARMACOL, V124, P1286, DOI 10.1038/sj.bjp.0701943; Morishita R, 2004, HYPERTENSION, V44, P203, DOI 10.1161/01.HYP.0000136394.08900.ed; Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156, DOI 10.1161/01.ATV.19.5.1156; Nakamura T, 2007, GASTROENTEROLOGY, V133, P91, DOI 10.1053/j.gastro.2007.03.110; Rossig L, 2005, J EXP MED, V201, P1825, DOI 10.1084/jem.20042097; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Spinetti G, 2011, CIRC RES, V108, P284, DOI 10.1161/CIRCRESAHA.110.236786; Stipic-Markovic A., 2012, Acta Medica Croatica, V66, P19; Stone OA, 2009, ARTERIOSCL THROM VAS, V29, P657, DOI 10.1161/ATVBAHA.108.182139; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Torsney E, 2007, ATHEROSCLEROSIS, V191, P259, DOI 10.1016/j.atherosclerosis.2006.05.033; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wu Y, 2010, J THROMB HAEMOST, V8, P185, DOI 10.1111/j.1538-7836.2009.03662.x; Yoshida H, 2000, HYPERTENSION, V35, P25, DOI 10.1161/01.HYP.35.1.25; Young PP, 2002, P NATL ACAD SCI USA, V99, P11951, DOI 10.1073/pnas.182215799; Zhang JJ, 1999, STROKE, V30, P1925, DOI 10.1161/01.STR.30.9.1925	38	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73035	10.1371/journal.pone.0073035	http://dx.doi.org/10.1371/journal.pone.0073035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019890	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200032
J	Ren, Q; Riquelme, MA; Xu, J; Yan, X; Nicholson, BJ; Gu, SM; Jiang, JX				Ren, Qian; Riquelme, Manuel A.; Xu, Ji; Yan, Xiang; Nicholson, Bruce J.; Gu, Sumin; Jiang, Jean X.			Cataract-Causing Mutation of Human Connexin 46 Impairs Gap Junction, but Increases Hemichannel Function and Cell Death	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; LENS DEVELOPMENT; CHANNELS; GJA3; PHOSPHORYLATION; CALCIUM; DISEASE; VOLTAGE; PROTEIN; MUTANT	Connexin channels play a critical role in maintaining metabolic homeostasis and transparency of the lens. Mutations in connexin genes are linked to congenital cataracts in humans. The G143R missense mutation on connexin (Cx) 46 was recently reported to be associated with congenital Coppock cataracts. Here, we showed that the G143R mutation decreased Cx46 gap junctional coupling in a dominant negative manner; however, it significantly increased gap junctional plaques. The G143R mutant also increased hemichannel activity, inversely correlated with the level of Cx46 protein on the cell surface. The interaction between cytoplasmic loop domain and C-terminus has been shown to be involved in gating of connexin channels. Interestingly, the G143R mutation enhanced the interaction between intracellular loop and Cx46. Furthermore, this mutation decreased cell viability and the resistance of the cells to oxidative stress, primarily due to the increased hemichannel function. Together, these results suggest that mutation of this highly conserved residue on the cytoplasmic loop domain of Cx46 enhances its interaction with the C-terminus, resulting in a reduction of gap junction channel function, but increased hemichannel function. This combination leads to the development of human congenital cataracts.	[Ren, Qian; Yan, Xiang] Lanzhou Univ, Hosp 1, Lanzhou 730000, Peoples R China; [Ren, Qian; Riquelme, Manuel A.; Xu, Ji; Nicholson, Bruce J.; Gu, Sumin; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	Lanzhou University; University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Riquelme, Manuel/B-1082-2015	Riquelme, Manuel/0000-0002-1915-0434; Jiang, Jean/0000-0002-2185-5716; Nicholson, Bruce/0000-0003-1649-7173	Institutes of Health [EY012085]; Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R01EY012085, R29EY012085] Funding Source: NIH RePORTER	Institutes of Health(National Health Research Institutes - Taiwan); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by Institutes of Health Grant EY012085 and Welch Foundation Grant AQ-1507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beahm DL, 2006, J BIOL CHEM, V281, P7994, DOI 10.1074/jbc.M506533200; Bennett TM, 2011, MOL VIS, V17, P2255; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Dobrowolski R, 2007, J MEMBRANE BIOL, V219, P9, DOI 10.1007/s00232-007-9055-7; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Ebihara L, 2003, BIOPHYS J, V84, P277, DOI 10.1016/S0006-3495(03)74848-6; Ebihara L, 2011, INVEST OPHTH VIS SCI, V52, P882, DOI 10.1167/iovs.10-6200; Forrester JVDA., 1996, EYE BASIC SCI PRACTI; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough D.A., 1992, SEMINARS CELL BIOL; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Jiang JX, 2010, CURR MOL MED, V10, P851; Krutovskikh VA, 1998, MOL CARCINOGEN, V23, P254, DOI 10.1002/(SICI)1098-2744(199812)23:4<254::AID-MC9>3.0.CO;2-4; Lai A, 2006, J CELL SCI, V119, P532, DOI 10.1242/jcs.02770; Liu JL, 2011, J BIOL CHEM, V286, P16914, DOI 10.1074/jbc.M111.218735; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nettleship E, 1906, T OPHTHAL SOC UK, V26, P191; Pal JD, 2000, AM J PHYSIOL-CELL PH, V279, pC596, DOI 10.1152/ajpcell.2000.279.3.C596; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Pfahnl A, 1999, PFLUG ARCH EUR J PHY, V437, P345, DOI 10.1007/s004240050788; Pfenniger A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/j.1365-2362.2010.02378.x; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Roscoe W, 2005, J BIOL CHEM, V280, P11458, DOI 10.1074/jbc.M409564200; Seki A, 2004, CIRC RES, V95, P22, DOI 10.1161/01.RES.0000140737.62245.c5; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Xu J, 2013, BBA-BIOMEMBRANES, V1828, P167, DOI 10.1016/j.bbamem.2012.06.024; Zhang L, 2012, MOL VIS, V18, P2114; Zhou Z, 2011, MOL VIS, V17, P621	36	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74732	10.1371/journal.pone.0074732	http://dx.doi.org/10.1371/journal.pone.0074732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019978	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200121
J	Bai, J; Zhang, N; Hua, Y; Wang, BJ; Ling, L; Ferro, A; Xu, B				Bai, Jian; Zhang, Na; Hua, Ying; Wang, Bingjian; Ling, Lin; Ferro, Albert; Xu, Biao			Metformin Inhibits Angiotensin II-Induced Differentiation of Cardiac Fibroblasts into Myofibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAY; OXIDATIVE STRESS; HEART-FAILURE; ENDOTHELIAL-CELLS; NAD(P)H OXIDASE; PROTEIN-KINASE; FIBROSIS; ACTIVATION; EXPRESSION	Differentiation of cardiac fibroblasts into myofibroblasts is a critical event in the progression of cardiac fibrosis that leads to pathological cardiac remodeling. Metformin, an antidiabetic agent, exhibits a number of cardioprotective properties. However, much less is known regarding the effect of metformin on cardiac fibroblast differentiation. Thus, in the present study, we examined the effect of metformin on angiotensin (Ang) II-induced differentiation of cardiac fibroblasts into myofibroblasts and its underlying mechanism. Adult rat cardiac fibroblasts were stimulated with Ang II (100 nM) in the presence or absence of metformin (10-200 mu M). Ang II stimulation induced the differentiation of cardiac fibroblasts into myofibroblasts, as indicated by increased expression of alpha-smooth muscle actin (alpha-SMA) and collagen types I and III, and this effect of Ang II was inhibited by pretreatment of cardiac fibroblasts with metformin. Metformin also decreased Ang II-induced reactive oxygen species (ROS) generation in cardiac fibroblasts via inhibiting the activation of the PKC-NADPH oxidase pathway. Further experiments using PKC inhibitor calphostin C and NADPH oxidase inhibitor apocynin confirmed that inhibition of the PKC-NADPH oxidase pathway markedly attenuated Ang II-induced ROS generation and myofibroblast differentiation. These data indicate that metformin inhibits Ang II-induced myofibroblast differentiation by suppressing ROS generation via the inhibition of the PKC-NADPH oxidase pathway in adult rat cardiac fibroblasts. Our results provide new mechanistic insights regarding the cardioprotective effects of metformin and provide an efficient therapeutic strategy to attenuate cardiac fibrosis.	[Bai, Jian; Zhang, Na; Hua, Ying; Wang, Bingjian; Ling, Lin; Xu, Biao] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China; [Ferro, Albert] Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London, England	Nanjing University; University of London; King's College London	Ferro, A (corresponding author), Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London, England.	albert.ferro@kcl.ac.uk; xubiao@medmail.com.cn		Ferro, Albert/0000-0002-5486-9145	National Natural Science Foundation of China [81000055, 81070195]; Natural Science Foundation of Jiangsu Province [BK2009036, BK2010107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (81000055 and 81070195) and Natural Science Foundation of Jiangsu Province (BK2009036 and BK2010107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Ceolotto G, 2007, ARTERIOSCL THROM VAS, V27, P2627, DOI 10.1161/ATVBAHA.107.155762; Chen J, 2006, AM J PHYSIOL-HEART C, V291, pH1738, DOI 10.1152/ajpheart.00341.2006; Cheng TH, 2003, J AM COLL CARDIOL, V42, P1845, DOI 10.1016/j.jacc.2003.06.010; Choi SS, 2006, HEPATOLOGY, V44, P1267, DOI 10.1002/hep.21375; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; HOLTZ J, 1993, BASIC RES CARDIOL, V88, P183; Lijnen PJ, 2000, METHOD FIND EXP CLIN, V22, P709, DOI 10.1358/mf.2000.22.10.802287; Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x; Mahrouf M, 2006, BIOCHEM PHARMACOL, V72, P176, DOI 10.1016/j.bcp.2006.04.027; Mahrouf-Yorgov M, 2009, METABOLISM, V58, P525, DOI 10.1016/j.metabol.2008.11.012; Manoury B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-11; Matsui Y, 2004, HYPERTENSION, V43, P1195, DOI 10.1161/01.HYP.0000128621.68160.dd; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Naugle JE, 2006, AM J PHYSIOL-HEART C, V290, pH323, DOI 10.1152/ajpheart.00321.2005; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Takahashi M, 2008, AM J PHYSIOL-HEART C, V294, pH2879, DOI 10.1152/ajpheart.91406.2007; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Tang M, 2008, CELL MOL LIFE SCI, V65, P2924, DOI 10.1007/s00018-008-8255-3; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tsai KL, 2011, MOL NUTR FOOD RES, V55, pS227, DOI 10.1002/mnfr.201100147; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P854; Vasquez C, 2011, J CARDIOVASC PHARM, V57, P380, DOI 10.1097/FJC.0b013e31820cda19; Weber KT, 2004, J HYPERTENS, V22, P47, DOI 10.1097/00004872-200401000-00011; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; Wu ML, 2009, EUR J PHARMACOL, V616, P155, DOI 10.1016/j.ejphar.2009.05.016; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Yin MM, 2011, AM J PHYSIOL-HEART C, V301, pH459, DOI 10.1152/ajpheart.00054.2011	40	50	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72120	10.1371/journal.pone.0072120	http://dx.doi.org/10.1371/journal.pone.0072120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023727	Green Submitted, Green Published, gold			2022-12-27	WOS:000324238400010
J	Yu, GF; Jing, YY; Kou, XR; Ye, F; Gao, L; Fan, QM; Yang, Y; Zhao, QD; Li, R; Wu, MC; Wei, LX				Yu, Guofeng; Jing, Yingying; Kou, Xingrui; Ye, Fei; Gao, Lu; Fan, Qingmin; Yang, Yang; Zhao, Qiudong; Li, Rong; Wu, Mengchao; Wei, Lixin			Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; HGF/MET SIGNALING PATHWAY; TUMOR MICROENVIRONMENT; THERAPY; INVASION; CATENIN	As the main source of extracellular matrix proteins in tumor stroma, hepatic stellate cells (HSCs) have a great impact on biological behaviors of hepatocellular carcinoma (HCC). In the present study, we have investigated a mechanism whereby HSCs modulate the chemoresistance of hepatoma cells. We used human HSC line lx-2 and chemotherapeutic agent cisplatin to investigate their effects on human HCC cell line Hep3B. The results showed that cisplatin resistance in Hep3B cells was enhanced with LX-2 CM (cultured medium) exposure in vitro as well as co-injection with LX-2 cells in null mice. Meanwhile, in presence of LX-2 CM, Hep3B cells underwent epithelial to mesenchymal transition (EMT) and upregulation of cancer stem cell (CSC) -like properties. Besides, LX-2 cells synthesized and secreted hepatic growth factor (HGF) into the CM. HGF receptor tyrosine kinase mesenchymal-epithelial transition factor (Met) was activated in Hep3B cells after LX-2 CM exposure. The HGF level of LX-2 CM could be effectively reduced by using HGF neutralizing antibody. Furthermore, depletion of HGF in LX-2 CM abolished its effects on activation of Met as well as promotion of the EMT, CSC-like features and cisplatin resistance in Hep3B cells. Collectively, secreting HGF into tumor milieu, HSCs may decrease hepatoma cells sensitization to chemotherapeutic agents by promoting EMT and CSC-like features via HGF/Met signaling.	[Yu, Guofeng; Jing, Yingying; Kou, Xingrui; Ye, Fei; Gao, Lu; Fan, Qingmin; Yang, Yang; Zhao, Qiudong; Li, Rong; Wei, Lixin] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai, Peoples R China; [Wu, Mengchao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Comprehens Treatment, Shanghai, Peoples R China; [Yu, Guofeng; Kou, Xingrui] Soochow Univ, Suzhou, Jiangsu, Peoples R China	Naval Medical University; Naval Medical University; Soochow University - China	Wu, MC (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Comprehens Treatment, Shanghai, Peoples R China.	wuyuz@yahoo.com.cn; weilixin@yahoo.com		Wei, Lixin/0000-0002-9526-5348	Key Basic Research Project of China [2012CBA01303, 2011CB966200, 2010CB945600, 2011CB965100]; Key project of National Natural Science Foundation of China [81030041]; National Natural Science Foundation of China [31171321, 81101622?81201584]; Special Funds for National key Sci-Tech Special Project of China [2012ZX10002-016, 2012ZX10002011-011]; Shanghai Science and Technology Committee [11ZR1449500, 12ZR1454200, 12ZR1439800, 11nm0504700]; Shanghai Municipal Health Bureau [XYQ2011044, 20114004]; Science Fund for Creative Research Groups, NSFC, China [81221061]	Key Basic Research Project of China; Key project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds for National key Sci-Tech Special Project of China; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Municipal Health Bureau; Science Fund for Creative Research Groups, NSFC, China(Science Fund for Creative Research GroupsNational Natural Science Foundation of China (NSFC))	Key Basic Research Project of China (Grant NO. 2012CBA01303, 2011CB966200, 2010CB945600, 2011CB965100); Key project of National Natural Science Foundation of China(Grant NO. 81030041); National Natural Science Foundation of China (Grant NO. 31171321, 81101622?81201584); Special Funds for National key Sci-Tech Special Project of China (Grant NO. 2012ZX10002-016, 2012ZX10002011-011); Shanghai Science and Technology Committee (Grant NO. 11ZR1449500, 12ZR1454200, 12ZR1439800, 11nm0504700); Shanghai Municipal Health Bureau (Grant NO. XYQ2011044, 20114004) and Science Fund for Creative Research Groups, NSFC, China (Grant NO. 81221061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Castells M, 2012, INT J MOL SCI, V13, P9545, DOI 10.3390/ijms13089545; Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957; Cecchi F, 2010, EUR J CANCER, V46, P1260, DOI 10.1016/j.ejca.2010.02.028; Dayan D, 2012, CANCER MED-US, V1, P128, DOI 10.1002/cam4.24; De Giorgio M, 2007, DIGEST DIS, V25, P279, DOI 10.1159/000103902; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim H, 2013, KOREAN J PATHOL, V47, P44, DOI 10.4132/KoreanJPathol.2013.47.1.44; Li XL, 2008, EUR J PHARM BIOPHARM, V70, P726, DOI 10.1016/j.ejpb.2008.06.016; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Mizuno S, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/909350; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363; Stavrovskaya AA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P95; Stuart KA, 2000, INT J EXP PATHOL, V81, P17, DOI 10.1046/j.1365-2613.2000.00138.x; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329; Wang BB, 2010, ANAT REC, V293, P1492, DOI 10.1002/ar.21173; Wu KJ, 2011, BIOSCIENCE REP, V31, P449, DOI 10.1042/BSR20100114; Wu Kou-Juey, 2011, Chang Gung Med J, V34, P229; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yu ZR, 2012, INT J BIOCHEM CELL B, V44, P2144, DOI 10.1016/j.biocel.2012.08.022; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang Linlin, 2013, Zhongguo Fei Ai Za Zhi, V16, P54, DOI 10.3779/j.issn.1009-3419.2013.01.10; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	36	53	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73312	10.1371/journal.pone.0073312	http://dx.doi.org/10.1371/journal.pone.0073312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023859	Green Submitted, Green Published, gold			2022-12-27	WOS:000324238400060
J	Hu, LY; Shen, CC; Hu, YW; Chen, MH; Tsai, CF; Chiang, HL; Yeh, CM; Wang, WS; Chen, PM; Hu, TM; Chen, TJ; Su, TP; Liu, CJ				Hu, Li-Yu; Shen, Cheng-Che; Hu, Yu-Wen; Chen, Mu-Hong; Tsai, Chia-Fen; Chiang, Huey-Ling; Yeh, Chiu-Mei; Wang, Wei-Shu; Chen, Pan-Ming; Hu, Tsung-Ming; Chen, Tzeng-Ji; Su, Tung-Ping; Liu, Chia-Jen			Hyperthyroidism and Risk for Bipolar Disorders: A Nationwide Population-Based Study	PLOS ONE			English	Article							PREVALENCE; ASTHMA; ONSET	Background: Thyroid disorders have long been associated with psychiatric illness, often with symptoms suggestive of mood disorders. The most common clinical features associated with hyperthyroidism are anxiety and depression. The risk of bipolar disorders, especially bipolar mania, among patients with thyroid disorders has not been well characterized. Objective: We explored the relationship of hyperthyroidism and the subsequent development of bipolar disorders, and examined the risk factors for bipolar disorders in patients with hyperthyroidism. Methods: We identified patients who were diagnosed with hyperthyroidism between 2000 and 2010 in the Taiwan National Health Insurance Research Database. A comparison cohort without hyperthyroidism was matched based on age, sex, and comorbidities. The occurrence of bipolar disorders was evaluated in both cohorts based on diagnosis and the use of mood stabilizer drugs. Results: The hyperthyroidism cohort consisted of 21, 574 patients, and the comparison cohort consisted of 21, 574 matched control patients without hyperthyroidism. The incidence of bipolar disorders (incidence rate ratio [IRR], 2.31, 95% CI 1.80-2.99, P = .001) was higher for the hyperthyroidism patients than the control patients. Multivariate, matched regression models showed that women (HR 2.02, 95% CI 1.34-3.05, P = .001), patients with alcohol use disorders (HR 3.03, 95% CI 1.58-5.79, P = .001), and those with asthma (HR 1.70, 95% CI 1.18-2.43, P = .004) were independent risk factors for the development of bipolar disorders in hyperthyroidism patients. Conclusions: Although a possibility that the diagnosis of bipolar disorders in this study actually includes "bipolar disorders due to hyperthyroidism" cannot be excluded, this study suggests that hyperthyroidism may increase the risk of developing bipolar disorders.	[Hu, Li-Yu; Hu, Tsung-Ming] Yuli Vet Hosp, Dept Psychiat, Hualien, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Chiayi, Taiwan; [Hu, Yu-Wen; Tsai, Chia-Fen; Wang, Wei-Shu; Chen, Tzeng-Ji; Su, Tung-Ping; Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Chen, Mu-Hong; Tsai, Chia-Fen; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chiang, Huey-Ling] Far Eastern Mem Hosp, Dept Psychiat, New Taipei City, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Wang, Wei-Shu] Natl Yang Ming Univ Hosp, Dept Internal Med, Yilan, Taiwan; [Chen, Pan-Ming] Dept Psychiat, Su Ao, Taiwan; [Chen, Pan-Ming] Taipei Vet Gen Hosp, Yuanshan Branch, Yilan, Taiwan; [Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Far Eastern Memorial Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Liu, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	chiajenliu@gmail.com	Chen, MuHong/ACJ-6131-2022; Chen, TJ/AAH-8430-2021	Chen, MuHong/0000-0001-6516-1073; CHIANG, HUEY-LING/0000-0002-2979-6108; Shen, Cheng-Che/0000-0003-1587-5590; Hu, Yu-Wen/0000-0002-7983-415X	Taipei Veterans General Hospital [V102D-001-1, V102D-001-2]; Yuli Veterans Hospital [VHYL-102-08]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Yuli Veterans Hospital	This study was supported by grants from Taipei Veterans General Hospital (V102D-001-1 and V102D-001-2) and Yuli Veterans Hospital (VHYL-102-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canonica GW, 2006, CHEST, V130, p21S, DOI 10.1378/chest.130.1_suppl.21S; Chakrabarti S, 2011, J THROID RES, V2011, DOI 10.4061/2011/306367; Fahrenfort JJ, 2000, PSYCHONEUROENDOCRINO, V25, P201, DOI 10.1016/S0306-4530(99)00050-5; Farren CK, 2012, CURR PSYCHIAT REP, V14, P659, DOI 10.1007/s11920-012-0320-9; Faustino LC, 2012, AM J PHYSIOL-ENDOC M, V303, pE787, DOI 10.1152/ajpendo.00223.2012; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; Graae L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032304; KATHOL RG, 1986, PSYCHOSOMATICS, V27, P501, DOI 10.1016/S0033-3182(86)72656-X; Kennedy N, 2005, AM J PSYCHIAT, V162, P257, DOI 10.1176/appi.ajp.162.2.257; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Kroon JS, 2013, BIPOLAR DISORD, V15, P306, DOI 10.1111/bdi.12058; Lee Catherine See-Ning, 2008, Ann Gen Psychiatry, V7, P3, DOI 10.1186/1744-859X-7-3; Lu C L, 1995, Zhonghua Yi Xue Za Zhi (Taipei), V56, P393; Lucas K, 2013, MOL NEUROBIOL; Mouhamed DH, 2012, ANN BIOL CLIN-PARIS, V70, P199, DOI 10.1684/abc.2012.0689; Nath J, 2001, ACTA PSYCHIAT SCAND, V104, P72, DOI 10.1034/j.1600-0447.2001.00303.x; Pettinati HM, 2013, AM J PSYCHIAT, V170, P23, DOI 10.1176/appi.ajp.2012.12010112; Placidi GPA, 1998, NEUROPSYCHOBIOLOGY, V38, P222, DOI 10.1159/000026545; Post RM, 2013, J AFFECT DISORD; Thomsen AF, 2005, EUR J ENDOCRINOL, V152, P535, DOI 10.1530/eje.1.01894; WALLACE JE, 1980, J ABNORM PSYCHOL, V89, P519, DOI 10.1037/0021-843X.89.4.519; Waxmonsky JA, 2005, GEN HOSP PSYCHIAT, V27, P321, DOI 10.1016/j.genhosppsych.2005.05.003; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	23	30	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73057	10.1371/journal.pone.0073057	http://dx.doi.org/10.1371/journal.pone.0073057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211BX	24023669	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200065
J	Johnson, TL; Tulis, DA; Keeler, BE; Virag, JA; Lust, RM; Clemens, S				Johnson, Tracy L.; Tulis, David A.; Keeler, Benjamin E.; Virag, Jitka A.; Lust, Robert M.; Clemens, Stefan			The Dopamine D3 Receptor Knockout Mouse Mimics Aging-Related Changes in Autonomic Function and Cardiac Fibrosis	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; PROTEIN-COUPLED RECEPTOR; HEART-RATE-VARIABILITY; PROXIMAL TUBULE CELLS; MATRIX METALLOPROTEINASES; KINASE 4; HYPERTENSION; COLLAGEN; GENE; MECHANISMS	Blood pressure increases with age, and dysfunction of the dopamine D3 receptor has been implicated in the pathogenesis of hypertension. To evaluate the role of the D3 receptor in aging-related hypertension, we assessed cardiac structure and function in differently aged (2 mo, 1 yr, 2 yr) wild type (WT) and young (2 mo) D3 receptor knockout mice (D3KO). In WT, systolic and diastolic blood pressures and rate-pressure product (RPP) significantly increased with age, while heart rate significantly decreased. Blood pressure values, heart rate and RPP of young D3KO were significantly elevated over age-matched WT, but similar to those of the 2 yr old WT. Echocardiography revealed that the functional measurements of ejection fraction and fractional shortening decreased significantly with age in WT and that they were significantly smaller in D3KO compared to young WT. Despite this functional change however, cardiac morphology remained similar between the age-matched WT and D3KO. Additional morphometric analyses confirmed an aging-related increase in left ventricle (LV) and myocyte cross-sectional areas in WT, but found no difference between age-matched young WT and D3KO. In contrast, interstitial fibrosis, which increased with age in WT, was significantly elevated in the D3KO over age-matched WT, and similar to 2 yr old WT. Western analyses of myocardial homogenates revealed significantly increased levels of pro- and mature collagen type I in young D3KO. Column zymography revealed that activities of myocardial MMP-2 and MMP-9 increased with age in WTs, but in D3KO, only MMP-9 activity was significantly increased over age-matched WTs. Our data provide evidence that the dopamine D3 receptor has a critical role in the emergence of aging-related cardiac fibrosis, remodeling, and dysfunction.	[Johnson, Tracy L.; Tulis, David A.; Keeler, Benjamin E.; Virag, Jitka A.; Lust, Robert M.; Clemens, Stefan] E Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Clemens, S (corresponding author), E Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA.	clemenss@ecu.edu	Clemens, Stefan/B-9872-2011; Virag, Jitka Amira Ismail/AAW-7427-2020; Virag, Jitka/AAW-6690-2020	Clemens, Stefan/0000-0003-2616-0558; Virag, Jitka Amira Ismail/0000-0003-3321-9861; 	Brody School of Medicine; National Institutes of Health National Heart, Lung, and Blood Institute [R01HL081720]; Brody School of Medicine and the Department of Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081720] Funding Source: NIH RePORTER	Brody School of Medicine; National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Brody School of Medicine and the Department of Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported in part by Start-up Awards of the Brody School of Medicine (SC, DAT) and by the National Institutes of Health National Heart, Lung, and Blood Institute award R01HL081720 (DAT). TLJ was funded in part by a Graduate School Scholarship of the Brody School of Medicine and the Department of Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 1996, P NATL ACAD SCI USA, V93, P1945, DOI 10.1073/pnas.93.5.1945; Asico LD, 1998, J CLIN INVEST, V102, P493, DOI 10.1172/JCI3685; Banday AA, 2008, CURR HYPERTENS REP, V10, P268, DOI 10.1007/s11906-008-0051-9; Biernacka A, 2011, AGING DIS, V2, P158; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Chen-Izu Y, 2007, AM J PHYSIOL-HEART C, V293, pH3301, DOI 10.1152/ajpheart.00259.2007; Chiao YA, 2012, CARDIOVASC RES; Chiao YA, 2011, CIRC-CARDIOVASC GENE, V4, P455, DOI 10.1161/CIRCGENETICS.111.959981; Clemens S, 2006, NEUROLOGY, V67, P125, DOI 10.1212/01.wnl.0000223316.53428.c9; de Leeuw PW, 2001, CARDIOVASC DRUG THER, V15, P263, DOI 10.1023/A:1011924508599; de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486; Dering MA, 1998, BRAIN RES, V780, P245, DOI 10.1016/S0006-8993(97)01199-2; Dries JL, 2011, J PHYSIOL-LONDON, V589, P1725, DOI 10.1113/jphysiol.2010.202366; Felder RA, 2000, ACTA PHYSIOL SCAND, V168, P245; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Freel EM, 2004, J AM SOC NEPHROL, V15, P1993, DOI 10.1097/01.ASN.0000132473.50966.14; Giorelli M, 2005, J INTERF CYTOK RES, V25, P395, DOI 10.1089/jir.2005.25.395; GOLDBERG LI, 1984, AM J MED, V77, P37, DOI 10.1016/S0002-9343(84)80036-4; Gomez MD, 2002, CAN J PHYSIOL PHARM, V80, P578, DOI 10.1139/Y02-081; Hardwick JC, 2012, AM J PHYSIOL-REG I, V303, pR950, DOI 10.1152/ajpregu.00223.2012; Hartman RP, 2003, RADIOL CLIN N AM, V41, P909, DOI 10.1016/S0033-8389(03)00071-X; Horn MA, 2012, J MOL CELL CARDIOL, V53, P82, DOI 10.1016/j.yjmcc.2012.03.011; Innes KE, 2012, SLEEP MED REV, V16, P309, DOI 10.1016/j.smrv.2011.04.001; Jose PA, 2002, CURR OPIN NEPHROL HY, V11, P87, DOI 10.1097/00041552-200201000-00013; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Joshi CN, 2011, J PHARMACOL EXP THER, V339, P394, DOI 10.1124/jpet.111.183400; JULIUS S, 1988, AM HEART J, V116, P600, DOI 10.1016/0002-8703(88)90557-1; JULIUS S, 1971, CIRCULATION, V44, P413, DOI 10.1161/01.CIR.44.3.413; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Latini R, 1998, J CARDIOVASC PHARM, V31, P601, DOI 10.1097/00005344-199804000-00020; Laurent Stephane, 2002, Am J Geriatr Cardiol, V11, P34, DOI 10.1111/j.1076-7460.2002.00857.x; Lekakis JP, 2004, INT J CARDIOL, V97, P29, DOI 10.1016/j.ijcard.2003.06.011; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Lundberg J, 1990, J Cardiothorac Anesth, V4, P348, DOI 10.1016/0888-6296(90)90044-G; Manconi M, 2011, NEUROLOGY, V77, P110, DOI 10.1212/WNL.0b013e3182242d91; Manconi M, 2010, SLEEP MED; Manconi M, 2011, SLEEP MED, V12, P47, DOI 10.1016/j.sleep.2010.03.019; McCain ML, 2011, PFLUG ARCH EUR J PHY, V462, P89, DOI 10.1007/s00424-011-0951-4; Morley ME, 2007, BIOCHEM SOC T, V35, P905, DOI 10.1042/BST0350905; Muhlbauer B, 2000, ACTA PHYSIOL SCAND, V168, P219; Mukhopadhyay Somnath, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P311, DOI 10.2174/187152507782109917; Nakashioya H, 2011, MOD RHEUMATOL, V21, P260, DOI 10.1007/s10165-010-0387-2; Novak V, 2004, PRIMER AUTONOMIC NER, P191; Palatini P, 2009, CURR HYPERTENS REP, V11, P199, DOI 10.1007/s11906-009-0035-4; Parati Gianfranco, 1996, Clinical Science (London), V91, P129; Priebe HJ, 2000, BRIT J ANAESTH, V85, P763, DOI 10.1093/bja/85.5.763; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Safar ME, 2005, HYPERTENSION, V46, P205, DOI 10.1161/01.HYP.0000167992.80876.26; Schlesinger I, 2009, MOVEMENT DISORD, V24, P1587, DOI 10.1002/mds.22486; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Tayebati SK, 2011, CURR NEUROVASC RES, V8, P246; Torok T, 1997, CAN J ANAESTH, V44, P677; Tulis DA, 2001, CIRCULATION, V104, P2710, DOI 10.1161/hc4701.099585; Tulis DA, 2008, AM J THER, V15, P551, DOI 10.1097/MJT.0b013e318140052f; Vassiliadis E, 2011, BMC DERMATOL, V11, DOI 10.1186/1471-5945-11-6; Villar VM, 2009, J BIOL CHEM, V284, P21425, DOI 10.1074/jbc.M109.003665; Virag JAI, 2007, AM J PATHOL, V171, P1431, DOI 10.2353/ajpath.2007.070003; Virag JAI, 2010, AM J PHYSIOL-HEART C, V298, pH1088, DOI 10.1152/ajpheart.01280.2008; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Yu CQ, 2009, AM J HYPERTENS, V22, P877, DOI 10.1038/ajh.2009.80; Zeng CY, 2008, AM J PHYSIOL-HEART C, V294, pH551, DOI 10.1152/ajpheart.01036.2007; Zeng Chunyu, 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P369, DOI 10.2174/187152506778520727; Zeng CY, 2004, HYPERTENSION, V43, P654, DOI 10.1161/01.HYP.0000114601.30306.bf; Zeng CY, 2003, HYPERTENSION, V41, P724, DOI 10.1161/01.HYP.0000047880.78462.0E; Zhang Y, 2007, AM J PHYSIOL-HEART C, V292, pH1187, DOI 10.1152/ajpheart.00895.2006	66	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e74116	10.1371/journal.pone.0074116	http://dx.doi.org/10.1371/journal.pone.0074116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023697	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200095
J	Warelow, TP; Oke, M; Schoepp-Cothenet, B; Dahl, JU; Bruselat, N; Sivalingam, GN; Leimkuhler, S; Thalassinos, K; Kappler, U; Naismith, JH; Santini, JM				Warelow, Thomas P.; Oke, Muse; Schoepp-Cothenet, Barbara; Dahl, Jan U.; Bruselat, Nicole; Sivalingam, Ganesh N.; Leimkuehler, Silke; Thalassinos, Konstantinos; Kappler, Ulrike; Naismith, James H.; Santini, Joanne M.			The Respiratory Arsenite Oxidase: Structure and the Role of Residues Surrounding the Rieske Cluster	PLOS ONE			English	Article							IRON-SULFUR PROTEIN; ALCALIGENES-FAECALIS; 2FE-2S CLUSTER; BC(1) COMPLEX; OXIDATION; REFINEMENT; REDUCTASE; SITE	The arsenite oxidase (Aio) from the facultative autotrophic Alphaproteobacterium Rhizobium sp. NT-26 is a bioenergetic enzyme involved in the oxidation of arsenite to arsenate. The enzyme from the distantly related heterotroph, Alcaligenes faecalis, which is thought to oxidise arsenite for detoxification, consists of a large alpha subunit (AioA) with bis-molybdopterin guanine dinucleotide at its active site and a 3Fe-4S cluster, and a small beta subunit (AioB) which contains a Rieske 2Fe-2S cluster. The successful heterologous expression of the NT-26 Aio in Escherichia coli has resulted in the solution of its crystal structure. The NT-26 Aio, a heterotetramer, shares high overall similarity to the heterodimeric arsenite oxidase from A. faecalis but there are striking differences in the structure surrounding the Rieske 2Fe-2S cluster which we demonstrate explains the difference in the observed redox potentials (+225 mV vs. +130/160 mV, respectively). A combination of site-directed mutagenesis and electron paramagnetic resonance was used to explore the differences observed in the structure and redox properties of the Rieske cluster. In the NT-26 AioB the substitution of a serine (S126 in NT-26) for a threonine as in the A. faecalis AioB explains a -20 mV decrease in redox potential. The disulphide bridge in the A. faecalis AioB which is conserved in other betaproteobacterial AioB subunits and the Rieske subunit of the cytochrome bc(1) complex is absent in the NT-26 AioB subunit. The introduction of a disulphide bridge had no effect on Aio activity or protein stability but resulted in a decrease in the redox potential of the cluster. These results are in conflict with previous data on the betaproteobacterial AioB subunit and the Rieske of the bc(1) complex where removal of the disulphide bridge had no effect on the redox potential of the former but a decrease in cluster stability was observed in the latter.	[Warelow, Thomas P.; Bruselat, Nicole; Sivalingam, Ganesh N.; Thalassinos, Konstantinos; Santini, Joanne M.] UCL, Inst Struct & Mol Biol, London, England; [Oke, Muse; Naismith, James H.] Univ St Andrews, Ctr Biomol Sci, St Andrews, Fife, Scotland; [Schoepp-Cothenet, Barbara] Aix Marseille Univ, BIP CNRS, Lab Bioenerget & Ingn Prot, UMR7281, Marseille, France; [Dahl, Jan U.; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Kappler, Ulrike] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia	University of London; Birkbeck University London; University College London; University of St Andrews; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Potsdam; University of Queensland	Naismith, JH (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews, Fife, Scotland.	naismith@st-andrews.ac.uk; j.santini@ucl.ac.uk	Kappler, Ulrike/A-9483-2013; Schoepp-Cothenet, Barbara/AAH-8911-2021; Dahl, Jan-Ulrik/J-4970-2017; Naismith, James Henderson/AAB-8614-2020; Dahl, Jan-Ulrik/J-1893-2019; Naismith, James Henderson/H-3408-2012	Kappler, Ulrike/0000-0002-2642-1319; Schoepp-Cothenet, Barbara/0000-0002-6820-4478; Dahl, Jan-Ulrik/0000-0002-4164-6129; Naismith, James Henderson/0000-0001-6744-5061; Dahl, Jan-Ulrik/0000-0001-8597-7416; Naismith, James Henderson/0000-0001-6744-5061; Thalassinos, Konstantinos/0000-0001-5072-8428; Oke, Muse/0000-0002-0169-752X; Leimkuhler, Silke/0000-0003-3238-2122	Biotechnology and Biological Sciences Research Council [BB/F016948/1]; Medical Research Council - National Institute of Medical Research studentship; Deutsche Forschungsgemeinschaft [LE1171/6-1]; Australian Research Council Australian Research Fellowship [DP0870525]; Scottish Funding Council [SULSA]; BBSRC [BB/S/B14450]; MC2 ANR; Biotech-IgG AB; Biotechnology and Biological Sciences Research Council [BBS/B/14426] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council - National Institute of Medical Research studentship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Australian Research Council Australian Research Fellowship(Australian Research Council); Scottish Funding Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MC2 ANR(French National Research Agency (ANR)); Biotech-IgG AB(HOGANAS ABStatisticon AB); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	TPW is supported by a Biotechnology and Biological Sciences Research Council (BB/F016948/1) CASE award with Biotech-IgG AB as the industrial partner. GS is supported by a Medical Research Council - National Institute of Medical Research studentship. SL was supported by a Deutsche Forschungsgemeinschaft grant LE1171/6-1 and UK by an Australian Research Council Australian Research Fellowship (DP0870525). Structural work was supported by grants from The Scottish Funding Council [grant number SULSA (to JHN)] and BBSRC [grant number BB/S/B14450 (to JHN)]. BSC's contribution to this publication was supported by MC2 ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GL, 1992, J BIOL CHEM, V267, P23674; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIDSON E, 1992, BIOCHEMISTRY-US, V31, P3342, DOI 10.1021/bi00128a006; Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085; DUTTON PL, 1971, BIOCHIM BIOPHYS ACTA, V226, P63, DOI 10.1016/0005-2728(71)90178-2; Duval S, 2010, J BIOL CHEM, V285, P20442, DOI 10.1074/jbc.M110.113811; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Ellis PJ, 2001, STRUCTURE, V9, P125, DOI 10.1016/S0969-2126(01)00566-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P.R., 1997, JOINT CCP4 ESF EACBM, V33, P22; Guergova-Kuras M, 2000, BIOCHEMISTRY-US, V39, P7436, DOI 10.1021/bi992491+; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hilton JC, 1999, J BIOL CHEM, V274, P8428, DOI 10.1074/jbc.274.13.8428; Hoke KR, 2004, BIOCHEMISTRY-US, V43, P1667, DOI 10.1021/bi0357154; Kolling DJ, 2007, STRUCTURE, V15, P29, DOI 10.1016/j.str.2006.11.012; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Lebrun E, 2003, MOL BIOL EVOL, V20, P686, DOI 10.1093/molbev/msg071; Leggate EJ, 2005, BIOCHEMISTRY-US, V44, P7048, DOI 10.1021/bi050189x; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, P1; Lett MC, 2012, J BACTERIOL, V194, P207, DOI 10.1128/JB.06391-11; Lhee S, 2010, J BIOL CHEM, V285, P9233, DOI 10.1074/jbc.M109.043505; Liebl U, 1997, BIOCHEMISTRY-US, V36, P11675, DOI 10.1021/bi970776l; Lieutaud A, 2010, J BIOL CHEM, V285, P20433, DOI 10.1074/jbc.M110.113761; Lis van R, 2012, METABOLISM ARSENITE, P125; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mertitz-Zahradnik T, 2003, BIOCHEMISTRY-US, V42, P13637; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osborne TH, 2013, METALLOMICS, V5, P318, DOI 10.1039/c2mt20180a; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; Romao MJ, 2009, DALTON T, P4053, DOI 10.1039/b821108f; Santini JM, 2004, J BACTERIOL, V186, P1614, DOI 10.1128/JB.186.6.1614-1619.2004; Santini JM, 2000, APPL ENVIRON MICROB, V66, P92, DOI 10.1128/AEM.66.1.92-97.2000; Santini JM, 2007, BBA-BIOENERGETICS, V1767, P189, DOI 10.1016/j.bbabio.2007.01.009; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Temple CA, 2000, BIOCHEMISTRY-US, V39, P4046, DOI 10.1021/bi9921541; van Lis R, 2012, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbabio.2012.08.007, DOI 10.1016/J.BBA-BI0.2012.08.007]; van Lis R, 2012, BBA-BIOENERGETICS, V1817, P1701, DOI 10.1016/j.bbabio.2012.06.001; vanden Hoven RN, 2004, BBA-BIOENERGETICS, V1656, P148, DOI 10.1016/j.bbabio.2004.03.001; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	45	41	42	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72535	10.1371/journal.pone.0072535	http://dx.doi.org/10.1371/journal.pone.0072535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023621	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200016
J	Lai, YC; Ruan, SY; Huang, CT; Kuo, PH; Yu, CJ				Lai, Yi-Chun; Ruan, Sheng-Yuan; Huang, Chun-Ta; Kuo, Ping-Hung; Yu, Chong-Jen			Hemoglobin Levels and Weaning Outcome of Mechanical Ventilation in Difficult-To-Wean Patients: A Retrospective Cohort Study	PLOS ONE			English	Article							BLOOD-TRANSFUSION; CRITICALLY-ILL; ANEMIA	Introduction: The effect of hemoglobin levels on the weaning outcomes of mechanically ventilated patients remains under debate, particularly for the patients with difficult weaning. This study aims to evaluate the effect of hemoglobin levels on weaning outcomes in difficult-to-wean patients. Methods: This retrospective cohort study was conducted in a university-affiliated teaching hospital in Taiwan. Patients who fulfilled the criteria of difficult weaning were enrolled. Medical records were reviewed to obtain data on hemograms, biochemistry tests, transfusion records, comorbidities and weaning outcome. The association between hemoglobin levels and 30-day weaning outcomes was evaluated using a logistic regression model. Results: A total of 751 patients received mechanical ventilation during the study period, 138 of whom fulfilled the criteria of difficult weaning. Compared with the patients whose hemoglobin was <8 g/dL, those with higher hemoglobin levels were more likely to be successfully weaned (odds ratio [OR], 3.69; 95% CI, 1.22-11.15 for hemoglobin 8-10 g/dL and OR, 4.16, 95% CI, 1.30-13.29 for hemoglobin >10 g/dL). Multivariate analysis showed that the odds ratio for weaning success remained significant for hemoglobin levels of 8-10 g/dL (adjusted OR, 3.3; 95% CI, 1.07-10.15) with borderline significance for hemoglobin level > 10 g/dL (adjusted OR, 2.95, 95% CI, 0.88-9.96). Conclusions: Hemoglobin level is independently associated with weaning outcome in difficult-to-wean patients. Further studies are needed to evaluate whether a restrictive transfusion trigger for acute critical illness is also appropriate for such patients.	[Lai, Yi-Chun; Ruan, Sheng-Yuan; Huang, Chun-Ta; Kuo, Ping-Hung; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lai, Yi-Chun] Natl Yang Ming Univ Hosp, Dept Med, Taipei, Taiwan; [Lai, Yi-Chun] Sch Med, Taipei, Taiwan; [Ruan, Sheng-Yuan] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Ruan, SY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	syruan@ntu.edu.tw		HUANG, CHUN-TA/0000-0002-5234-4986; RUAN, SHENG-YUAN/0000-0002-7949-7253; Yu, Chong-Jen/0000-0001-5664-9392; KUO, PING-HUNG/0000-0003-3756-3395	National Taiwan University Hospital Yun-Lin Branch [NTUHYL 97.N008]	National Taiwan University Hospital Yun-Lin Branch	This study was supported by a grant from the National Taiwan University Hospital Yun-Lin Branch (NTUHYL 97.N008). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Estenssoro E, 2005, CHEST, V127, P598, DOI 10.1378/chest.127.2.598; Hebert PC, 2007, CHEST, V131, P1583, DOI 10.1378/chest.06-1055; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 2001, CHEST, V119, P1850, DOI 10.1378/chest.119.6.1850; Khamiees M, 2001, CHEST, V120, P1262, DOI 10.1378/chest.120.4.1262; Leach RM, 2002, THORAX, V57, P170, DOI 10.1136/thorax.57.2.170; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Ouellette DR, 2005, CHEST, V128, p576S, DOI 10.1378/chest.128.5_suppl_2.576S; Ruan SY, 2013, ANAESTH INTENS CARE, V41, P41, DOI 10.1177/0310057X1304100108; Schonhofer B, 1998, ANAESTHESIA, V53, P181, DOI 10.1046/j.1365-2044.1998.00275.x; Schonhofer B, 1998, CRIT CARE MED, V26, P1824, DOI 10.1097/00003246-199811000-00022; Silver MR, 2005, CHEST, V128, p568S, DOI 10.1378/chest.128.5_suppl_2.568S; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Vamvakas EC, 2001, TRANSFUSION, V41, P691, DOI 10.1046/j.1537-2995.2001.41050691.x; Vamvakas EC, 2007, BLOOD REV, V21, P327, DOI 10.1016/j.blre.2007.07.003; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809	20	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73743	10.1371/journal.pone.0073743	http://dx.doi.org/10.1371/journal.pone.0073743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015310	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800105
J	Fang, Y; Feng, YJ; Wu, TJ; Srinivas, S; Yang, WQ; Fan, J; Yang, C; Wang, SH				Fang, Yi; Feng, Youjun; Wu, Tongjin; Srinivas, Swaminath; Yang, Weiqiang; Fan, Jue; Yang, Chi; Wang, Shihua			Aflatoxin B-1 Negatively Regulates Wnt/beta-Catenin Signaling Pathway through Activating miR-33a	PLOS ONE			English	Article							BETA-CATENIN; HEPATOCELLULAR-CARCINOMA; TRANSLATIONAL REPRESSION; CELL-PROLIFERATION; MICRORNA; RNA; EXPRESSION; GENE; EXPOSURE; CANCER	MicroRNAs are known to play an important role in modulating gene expression in various diseases including cancers and cardiovascular disorders, but only a few of them are associated with the pathology of aflatoxin B-1 (AFB(1)), a potent mycotoxin. Here, we discovered a novel regulatory network between AFB(1), miR-33a and beta-catenin in human carcinoma cells. The level of miR-33a was up-regulated in hepatocellular carcinoma (HCC) cells treated with AFB(1), while in the same cells causing the decrease in beta-catenin expression when treated at their IC50 values. miR-33a, specifically miR-33a-5p, was demonstrated to down-regulate the expression of beta-catenin, affect the beta-catenin pathway, and inhibit cell growth. Also, by employing a luciferase assay, we found that miR-33a down-regulated beta-catenin by directly binding to the 3'-UTR of beta-catenin. These results suggested that AFB(1) might down-regulate beta-catenin by up-regulating miR-33a. This understanding opens new lines of thought in the potential role of miR-33a in the clinical therapy of cancer.	[Fang, Yi; Wu, Tongjin; Yang, Weiqiang; Fan, Jue; Yang, Chi; Wang, Shihua] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Fang, Yi; Wu, Tongjin; Yang, Weiqiang; Fan, Jue; Yang, Chi; Wang, Shihua] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Fang, Yi] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou, Peoples R China; [Fang, Yi] Fujian Univ Tradit Chinese Med, Fujian Key Lab Integrat Med Geriatr, Fuzhou, Peoples R China; [Feng, Youjun] Univ Illinois, Dept Microbiol, Champaign, IL USA; [Srinivas, Swaminath] Univ Illinois, Dept Biochem, Champaign, IL USA	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian University of Traditional Chinese Medicine; Fujian University of Traditional Chinese Medicine; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wang, SH (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China.	wshyyl@sina.com	yang, chi/AHB-9343-2022; Srinivas, Swaminath/AAK-7213-2021	yang, chi/0000-0002-8617-3820; Srinivas, Swaminath/0000-0002-7210-5122; Wu, Tongjin/0000-0002-1233-4994	National Natural Science Foundation of China [31000961, 31172297]; Natural Science Foundation of Fujian Province [2013J01081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China ( No. 31000961 and No. 31172297), and the Natural Science Foundation of Fujian Province (No. 2013J01081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL RW, 1995, TOXICOL LETT, V75, P119, DOI 10.1016/0378-4274(94)03169-8; Ban KC, 2004, J SURG ONCOL, V86, P157, DOI 10.1002/jso.20051; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bianco G, 2012, TOXICON, V59, P644, DOI 10.1016/j.toxicon.2012.02.010; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Burge CB, 2008, MAMMALIAN GENE REGUL; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Devereux TR, 2001, MOL CARCINOGEN, V31, P68, DOI 10.1002/mc.1041; EATON DL, 1994, ANNU REV PHARMACOL, V34, P135, DOI 10.1146/annurev.pa.34.040194.001031; Gallagher EP, 1996, TOXICOL APPL PHARM, V141, P595, DOI 10.1006/taap.1996.0326; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guengerich FP, 1998, MUTAT RES-FUND MOL M, V402, P121, DOI 10.1016/S0027-5107(97)00289-3; Herrera-Merchan A, 2010, CELL CYCLE, V9, P3277, DOI 10.4161/cc.9.16.12598; Ho PC, 2011, FASEB J, V25, P1758, DOI 10.1096/fj.10-179267; Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80; Huang K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-252; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001; Fuster JJ, 2010, CELL CYCLE, V9, P3397, DOI 10.4161/cc.9.17.13070; Kumar M, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-5; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ma YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047961; Magrelli A, 2009, TRANSL ONCOL, V2, P157, DOI 10.1593/tlo.09124; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Mejia-Teniente L, AFLATOXINS BIOCH MOL; Montesano R, 1997, JNCI-J NATL CANCER I, V89, P1844, DOI 10.1093/jnci/89.24.1844; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Peterson S, 2006, FOOD CHEM TOXICOL, V44, P1474, DOI 10.1016/j.fct.2006.04.010; Pineau P, 2007, DIGEST LIVER DIS, V39, P671, DOI 10.1016/j.dld.2007.03.012; Pineau P, 2008, MUTAT RES-GEN TOX EN, V653, P6, DOI 10.1016/j.mrgentox.2008.01.012; PRINCE LO, 1982, CANCER RES, V42, P5053; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; RANEY VM, 1993, CHEM RES TOXICOL, V6, P64, DOI 10.1021/tx00031a010; Rossi JJ, 2011, EMBO J, V30, P4340, DOI 10.1038/emboj.2011.373; Sareddy GR, 2009, NEUROCHEM INT, V55, P307, DOI 10.1016/j.neuint.2009.03.016; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Strosnider H, 2006, ENVIRON HEALTH PERSP, V114, P1898, DOI 10.1289/ehp.9302; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Veronese A, 2011, P NATL ACAD SCI USA, V108, P4840, DOI 10.1073/pnas.1101734108; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wuchty S, 2012, NUCLEIC ACIDS RES, V40, P8219, DOI 10.1093/nar/gks627; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Yang XJ, 2012, TOXICOLOGY, V300, P138, DOI 10.1016/j.tox.2012.06.010; Yunus AW, 2011, TOXINS, V3, P566, DOI 10.3390/toxins3060566; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	54	50	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73004	10.1371/journal.pone.0073004	http://dx.doi.org/10.1371/journal.pone.0073004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015284	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200062
J	Azzam, G; Wang, XT; Bell, D; Murphy, ME				Azzam, Gregory; Wang, Xuting; Bell, Douglas; Murphy, Maureen E.			CSF1 Is a Novel p53 Target Gene Whose Protein Product Functions in a Feed-Forward Manner to Suppress Apoptosis and Enhance p53-Mediated Growth Arrest	PLOS ONE			English	Article							CODON 72 POLYMORPHISM; STIMULATING FACTOR-I; DNA-DAMAGE; REGULATORY ELEMENTS; RECEPTOR EXPRESSION; ULCERATIVE-COLITIS; R72P POLYMORPHISM; BREAST-CANCER; MICE; BINDING	The p53 tumor suppressor gene has a common polymorphism at codon 72 that alters its function. We previously reported that the proline 72 polymorphic variant of p53 (P72) demonstrates increased ability to transactivate a subset of genes, relative to arginine 72 (R72); one of these genes is macrophage colony stimulating factor (CSF1). At present, the mechanism(s) underlying the increased transcriptional activity of P72 toward genes like CSF1 have not been completely elucidated. Additionally, the consequences of increased transcription of genes like CSF1 by the P72 variant to the downstream p53 pathway are unknown. In this report, we address these issues. We show that the CSF1 gene contains a conserved binding site for p53, and interestingly that the P72 variant shows increased ability to bind to this site. Moreover, we show that increased CSF1/CSF1R signaling in P72 cells feeds back on the p53 pathway to enhance p53 phosphorylation, levels, and transactivation of target genes, particularly the cyclin-dependent kinase inhibitor p21 (CDKN1A). This leads to an increase in p53-mediated growth arrest, along with a concomitant decrease in apoptosis. Notably, the CSF1/CSF1R signaling axis is overexpressed in several epithelial cancers, and there is clinical evidence that this pathway plays a role in radioresistance of some cancers. We show that cells expressing CSF1 and CSF1R are indeed radio-resistant, and further, that this effect requires p53. These combined data are the first to implicate the CSF1/CSF1R pathway in the decision between p53-mediated growth arrest and apoptosis. They are also the first to highlight a cytokine as influential in cell fate determined by p53 in epithelial cells. Finally, these data may explain the association of the P72 variant and the CSF1/CSF1R pathway with increased senescence and radio-resistance in some epithelial tumor types.	[Azzam, Gregory; Murphy, Maureen E.] Wistar Inst Anat & Biol, Program Mol & Cellular Oncogenesis, Philadelphia, PA USA; [Wang, Xuting; Bell, Douglas] NIEHS, Mol Genet Lab, Intramural Res Program, NIH, Res Triangle Pk, NC 27709 USA	The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Murphy, ME (corresponding author), Wistar Inst Anat & Biol, Program Mol & Cellular Oncogenesis, Philadelphia, PA USA.	mmurphy@wistar.org	Bell, Douglas/HGE-6048-2022; Bell, Douglas A/C-7687-2019	Bell, Douglas A/0000-0001-7700-0840; Wang, Xuting/0000-0001-6781-8008; Murphy, Maureen/0000-0001-7644-7296	National Institute of Environmental Health Sciences-National Institutes of Health [Z01ES100475, Z01ES065079]; NATIONAL CANCER INSTITUTE [R01CA102184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100475, Z01ES100475, Z01ES065079, ZIAES046008] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences-National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded in part by the Intramural Research Program of the National Institute of Environmental Health Sciences-National Institutes of Health (projects: Z01ES100475 and Z01ES065079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzam GA, 2011, CELL CYCLE, V10, P1352, DOI 10.4161/cc.10.9.15344; Bandele OJ, 2011, NUCLEIC ACIDS RES, V39, P178, DOI 10.1093/nar/gkq764; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Bonafe M, 1999, AM J HUM GENET, V65, P1782, DOI 10.1086/302664; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burgdorf KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015813; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; Cattelani S, 2012, NEOPLASIA, V14, P634, DOI 10.1593/neo.12594; Chambers SK, 1997, CLIN CANCER RES, V3, P999; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Den Reijer PM, 2008, MECH AGEING DEV, V129, P175, DOI 10.1016/j.mad.2007.12.006; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Eren F, 2010, PATHOL ONCOL RES, V16, P563, DOI 10.1007/s12253-010-9255-9; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Gaulton KJ, 2008, DIABETES, V57, P3136, DOI 10.2337/db07-1731; Gottlieb TM, 1996, BBA-REV CANCER, V1287, P77, DOI 10.1016/0304-419X(95)00019-C; GUILLOUF C, 1995, BLOOD, V85, P2691, DOI 10.1182/blood.V85.10.2691.bloodjournal85102691; Jaworski M, 2005, CARCINOGENESIS, V26, P1829, DOI 10.1093/carcin/bgi142; Jeong BS, 2010, FASEB J, V24, P1347, DOI 10.1096/fj.09-146001; Kacinski BM, 1999, INT J RADIAT ONCOL, V45, P969, DOI 10.1016/S0360-3016(99)00269-2; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kluger HM, 2004, CLIN CANCER RES, V10, P173, DOI 10.1158/1078-0432.CCR-0699-3; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Liu ZP, 2005, CANCER RES, V65, P2583, DOI 10.1158/0008-5472.CAN-04-3675; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; Luo JL, 2001, CANCER RES, V61, P8158; MacCallum DE, 1996, ONCOGENE, V13, P2575; Maher MG, 1998, CLIN CANCER RES, V4, P1851; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Pietsch EC, 2006, ONCOGENE, V25, P1602, DOI 10.1038/sj.onc.1209367; Salvioli S, 2005, CELL CYCLE, V4, P1264, DOI 10.4161/cc.4.9.1978; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vaji S, 2011, INT J COLORECTAL DIS, V26, P235, DOI 10.1007/s00384-010-1021-7; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Vietri MT, 2007, J GASTROENTEROL, V42, P456, DOI 10.1007/s00535-007-2026-z; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74297	10.1371/journal.pone.0074297	http://dx.doi.org/10.1371/journal.pone.0074297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019961	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200104
J	Kelsey, TW; Dodwell, SK; Wilkinson, AG; Greve, T; Andersen, CY; Anderson, RA; Wallace, WHB				Kelsey, Thomas W.; Dodwell, Sarah K.; Wilkinson, A. Graham; Greve, Tine; Andersen, Claus Y.; Anderson, Richard A.; Wallace, W. Hamish B.			Ovarian Volume throughout Life: A Validated Normative Model	PLOS ONE			English	Article							INTERNAL GENITALIA; GIRLS; HORMONE; RESERVE; CANCER; AGE; POPULATION; MENOPAUSE; DECLINE; PUBERTY	The measurement of ovarian volume has been shown to be a useful indirect indicator of the ovarian reserve in women of reproductive age, in the diagnosis and management of a number of disorders of puberty and adult reproductive function, and is under investigation as a screening tool for ovarian cancer. To date there is no normative model of ovarian volume throughout life. By searching the published literature for ovarian volume in healthy females, and using our own data from multiple sources (combined n = 59,994) we have generated and robustly validated the first model of ovarian volume from conception to 82 years of age. This model shows that 69% of the variation in ovarian volume is due to age alone. We have shown that in the average case ovarian volume rises from 0.7 mL (95% CI 0.4-1.1 mL) at 2 years of age to a peak of 7.7 mL (95% CI 6.5-9.2 mL) at 20 years of age with a subsequent decline to about 2.8 mL (95% CI 2.7-2.9 mL) at the menopause and smaller volumes thereafter. Our model allows us to generate normal values and ranges for ovarian volume throughout life. This is the first validated normative model of ovarian volume from conception to old age; it will be of use in the diagnosis and management of a number of diverse gynaecological and reproductive conditions in females from birth to menopause and beyond.	[Kelsey, Thomas W.] Univ St Andrews, Sch Comp Sci, St Andrews, Fife, Scotland; [Dodwell, Sarah K.] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Wilkinson, A. Graham] Royal Hosp Sick Children, Dept Paediat Radiol, Edinburgh EH9 1LF, Midlothian, Scotland; [Greve, Tine; Andersen, Claus Y.] Univ Copenhagen, Univ Copenhagen Hosp, Juliane Marie Ctr Women Children & Reprod, Lab Reprod Biol,Sect 5712, Copenhagen, Denmark; [Anderson, Richard A.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Wallace, W. Hamish B.] Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland	University of St Andrews; University of Edinburgh; University of Copenhagen; University of Edinburgh	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458; wallace, william, hamish/0000-0001-8080-5674; Andersen, Claus Yding/0000-0001-7681-253X	UK EPSRC (Engineering and Physical Sciences Research Council) [EP/H004092/1]; EPSRC [EP/H004092/1] Funding Source: UKRI; MRC [G1100357, G1002033, G1002118] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H004092/1] Funding Source: researchfish; Medical Research Council [G1100357, G1002118, G1002033] Funding Source: researchfish	UK EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by UK EPSRC (Engineering and Physical Sciences Research Council) grant EP/H004092/1 (http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/H004092/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badouraki M, 2008, J CLIN ULTRASOUND, V36, P539, DOI 10.1002/jcu.20522; Brett S, 2009, REPROD BIOMED ONLINE, V18, P348, DOI 10.1016/S1472-6483(10)60092-2; BRIDGES NA, 1993, FERTIL STERIL, V60, P456; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broekmans FJ, 1998, MATURITAS, V30, P205, DOI 10.1016/S0378-5122(98)00075-9; Brougham MFH, 2012, J CLIN ENDOCR METAB, V97, P2059, DOI 10.1210/jc.2011-3180; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Davison AC, 1997, BOOTSTRAP METHODS TH; Faddy MJ, 1996, HUM REPROD, V11, P1484; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fleming R, 2012, FERTIL STERIL, V98, P1097, DOI 10.1016/j.fertnstert.2012.07.1114; GRIFFIN IJ, 1995, ACTA PAEDIATR, V84, P536, DOI 10.1111/j.1651-2227.1995.tb13689.x; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Herter LD, 1996, J CLIN ULTRASOUND, V24, P243, DOI 10.1002/(SICI)1097-0096(199606)24:5<243::AID-JCU3>3.0.CO;2-E; HOLM K, 1995, ULTRASOUND OBST GYN, V6, P175, DOI 10.1046/j.1469-0705.1995.06030175.x; Jensen AMB, 1998, J PEDIATR-US, V132, P105, DOI 10.1016/S0022-3476(98)70493-7; Kelsey TW, 2012, MOL HUM REPROD, V18, P79, DOI 10.1093/molehr/gar059; Kelsey TW, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/305025; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Lass A, 1999, HUM REPROD UPDATE, V5, P256, DOI 10.1093/humupd/5.3.256; LINTERNMOORE S, 1974, J REPROD FERTIL, V39, P53; Lujan ME, 2013, HUM REPROD, V28, P1361, DOI 10.1093/humrep/det062; Pavlik EJ, 2000, GYNECOL ONCOL, V77, P410, DOI 10.1006/gyno.2000.5783; Razzaghy-Azar M, 2011, J CLIN ULTRASOUND, V39, P64, DOI 10.1002/jcu.20723; Rosendahl M, 2010, FERTIL STERIL, V93, P995, DOI 10.1016/j.fertnstert.2008.10.055; SALARDI S, 1985, ARCH DIS CHILD, V60, P120, DOI 10.1136/adc.60.2.120; Seth Anju, 2002, Indian Journal of Pediatrics, V69, P869, DOI 10.1007/BF02723710; Sforza C, 2004, EARLY HUM DEV, V80, P7, DOI 10.1016/j.earlhumdev.2004.05.005; Simkins CS, 1932, AM J ANAT, V51, P465, DOI 10.1002/aja.1000510208; TRELOAR AE, 1981, MATURITAS, V3, P249, DOI 10.1016/0378-5122(81)90032-3; TSE WY, 1989, ACTA PAEDIATR SCAND, P38; van Nagell JR, 2007, CANCER-AM CANCER SOC, V109, P1887, DOI 10.1002/cncr.22594; VANNAGELL JR, 1995, CANCER, V76, P2086, DOI 10.1002/1097-0142(19951115)76:10+<2086::AID-CNCR2820761330>3.0.CO;2-L; vanNoord PAH, 1997, FERTIL STERIL, V68, P95, DOI 10.1016/S0015-0282(97)81482-3; Wallace WHB, 2012, J CLIN ONCOL, V30, P3, DOI 10.1200/JCO.2011.38.3877; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Ziereisen F, 2001, PEDIATR RADIOL, V31, P712, DOI 10.1007/s002470100463	38	55	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e71465	10.1371/journal.pone.0071465	http://dx.doi.org/10.1371/journal.pone.0071465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019863	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200005
J	Minassian, C; Thomas, SL; Williams, DJ; Campbell, O; Smeeth, L				Minassian, Caroline; Thomas, Sara L.; Williams, David J.; Campbell, Oona; Smeeth, Liam			Acute Maternal Infection and Risk of Pre-Eclampsia: A Population-Based Case-Control Study	PLOS ONE			English	Article							HELICOBACTER-PYLORI SEROPOSITIVITY; PRACTICE RESEARCH DATABASE; PREGNANCY; ASSOCIATION; CYTOMEGALOVIRUS; INFLAMMATION; PNEUMONIAE; ANTIBODIES; WOMEN	Background: Infection in pregnancy may be involved in the aetiology of pre-eclampsia. However, a clear association between acute maternal infection and pre-eclampsia has not been established. We assessed whether acute urinary tract infection, respiratory tract infection, and antibiotic drug prescriptions in pregnancy (a likely proxy for maternal infection) are associated with an increased risk of pre-eclampsia. Methods and Findings: We used a matched nested case-control design and data from the UK General Practice Research Database to examine the association between maternal infection and pre-eclampsia. Primiparous women aged at least 13 years and registered with a participating practice between January 1987 and October 2007 were eligible for inclusion. We selected all cases of pre-eclampsia and a random sample of primiparous women without pre-eclampsia (controls). Cases (n = 1533) were individually matched with up to ten controls (n = 14236) on practice and year of delivery. We calculated odds ratios and 95% confidence intervals for pre-eclampsia comparing women exposed and unexposed to infection using multivariable conditional logistic regression. After adjusting for maternal age, pre-gestational hypertension, diabetes, renal disease and multifetal gestation, the odds of pre-eclampsia were increased in women prescribed antibiotic drugs (adjusted odds ratio 1.28; 1.14-1.44) and in women with urinary tract infection (adjusted odds ratio 1.22; 1.03-1.45). We found no association with maternal respiratory tract infection (adjusted odds ratio 0.91; 0.72-1.16). Further adjustment for maternal smoking and pre-pregnancy body mass index made no difference to our findings. Conclusions: Women who acquire a urinary infection during pregnancy, but not those who have a respiratory infection, are at an increased risk of pre-eclampsia. Maternal antibiotic prescriptions are also associated with an increased risk. Further research is required to elucidate the underlying mechanism of this association and to determine whether, among women who acquire infections in pregnancy, prompt treatment or prophylaxis against infection might reduce the risk of pre-eclampsia.	[Minassian, Caroline; Thomas, Sara L.; Campbell, Oona; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Williams, David J.] Univ Coll London Hosp, Inst Womens Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; University College London	Minassian, C (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	caroline.minassian@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; Campbell, Oona/0000-0002-9311-0115; Minassian, Caroline/0000-0001-9406-1928	Wellcome Trust Senior Research Fellowship in Clinical Science [098504/Z/12/Z]; UCL/UCLH Biomedical Research Centre; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); UCL/UCLH Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by a Wellcome Trust Senior Research Fellowship in Clinical Science awarded to Professor LS (grant number 098504/Z/12/Z). Dr DJW receives part of his funding from UCL/UCLH Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, 2002, ACOG PRACTICE B, V77, P67; Aksoy H, 2009, J CLIN LAB ANAL, V23, P219, DOI 10.1002/jcla.20330; [Anonymous], 2000, AM J OBSTET GYNECOL, V183, pS1, DOI [10.1067/mob.2000.107928, DOI 10.1067/M0B.2000.107928]; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; Heine RP, 2003, OBSTET GYNECOL, V101, P221, DOI 10.1016/S0029-7844(02)02591-7; Hernandez-Diaz S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2255; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Lawrenson R, 1999, J PUBLIC HEALTH MED, V21, P299, DOI 10.1093/pubmed/21.3.299; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Mazor-Dray E, 2009, J MATERN-FETAL NEO M, V22, P124, DOI 10.1080/14767050802488246; Cota LOM, 2006, J PERIODONTOL, V77, P2063, DOI 10.1902/jop.2006.060061; Munkhaugen J, 2009, NEPHROL DIAL TRANSPL, V24, P2964, DOI 10.1093/ndt/gfp341; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Petersen I, 2010, J ANTIMICROB CHEMOTH, V65, P2238, DOI 10.1093/jac/dkq307; Pugliese A, 2008, CELL BIOCHEM FUNCT, V26, P817, DOI 10.1002/cbf.1503; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Ruma M, 2008, AM J OBSTET GYNECOL, V198, DOI [10.1016/j.ajog.2007.12.002, DOI 10.1016/J.AJ0G.2007.12.002]; Schnarr J, 2008, EUR J CLIN INVEST, V38, P50, DOI 10.1111/j.1365-2362.2008.02009.x; Shamsi U, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-14; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Trogstad L, 2011, BEST PRACTICE RES CL, DOI [10.1016/j.bpobgyn.2011.01.007, DOI 10.1016/J.BP0BGYN.2011.01.007]; Trogstad LIS, 2001, INT J EPIDEMIOL, V30, P1317, DOI 10.1093/ije/30.6.1317; Ustun Y, 2010, J MATERN-FETAL NEO M, V23, P311, DOI 10.3109/14767050903121456; von Dadelszen P, 2003, BJOG-INT J OBSTET GY, V110, P725, DOI 10.1111/j.1471-0528.2003.02481.x; von Dadelszen P, 2002, ACTA OBSTET GYN SCAN, V81, P642, DOI 10.1034/j.1600-0412.2002.810710.x; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Xie F, 2010, ACTA OBSTET GYN SCAN, V89, P1162, DOI 10.3109/00016349.2010.499449; Xiong X, 2006, BJOG-INT J OBSTET GY, V113, P135, DOI 10.1111/j.1471-0528.2005.00827.x	29	41	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73047	10.1371/journal.pone.0073047	http://dx.doi.org/10.1371/journal.pone.0073047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019891	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000324338200033
J	Ammitzboll, CG; Steffensen, R; Nielsen, HJ; Thiel, S; Stengaard-Pedersen, K; Bogsted, M; Jensenius, JC				Ammitzboll, Christian Gytz; Steffensen, Rudi; Nielsen, Hans Jorgen; Thiel, Steffen; Stengaard-Pedersen, Kristian; Bogsted, Martin; Jensenius, Jens Christian			Polymorphisms in the MASP1 Gene Are Associated with Serum Levels of MASP-1, MASP-3, and MAp44	PLOS ONE			English	Article							MANNAN-BINDING LECTIN; PATTERN-RECOGNITION MOLECULES; POLYMERASE-CHAIN-REACTION; SERINE-PROTEASE (MASP)-1; PATHWAY ACTIVATION; MUTATIONS; MBL; HAPLOTYPES; FICOLIN; PHASE	Introduction: MASP-1 is the first protein in the activation of the lectin pathway and MASP-1 is, like its isoforms MASP-3 and MAp44, encoded by the MASP1 gene. Our aim was to explore associations between polymorphisms in MASP1 and corresponding concentrations of MASP-1, MASP-3, and MAp44 in plasma as well as the genetic contribution to the equilibrium between the three proteins. Methods: Fifteen SNPs were genotyped in the MASP1 gene in 350 blood donors. Corresponding plasma concentrations of MASP-1, MASP-3, and MAp44 were measured. Results: A total of 10 different SNPs showed associations with the concentration of one or some of the three proteins (rs113938200, rs190590338, rs35089177, rs3774275, rs67143992, rs698090, rs72549154, rs72549254, rs75284004, rs7625133), and several of these were in strong linkage. SNPs located in the mutually exclusive splice region had opposite effects on the protein concentrations. Being e. g. homozygote for the minor allele of rs3774275 was associated with an increase in median concentration of 13% in MASP-1(P=0.03), 29% in MAp44 (P<0.001), and a decrease in MASP-3 of 26% (P<0.001) compared to homozygosis for the major allele. Heterozygosis of rs113938200 (p. Asn368Asp in MAp44) was associated with a reduced MAp44 concentration of 61% (P=0.005). Rs190590338 located in the promoter region was associated in the heterozygote form with an increased MASP-1 concentration of 35% (P = 0.002). A multivariate linear regression model including sex, age, M-and H-ficolin, MBL, and the 15 SNPs explained 20-48% of the variation in the concentration of the three proteins and the SNPs investigated contributed with the most explanatory power (12-23%). Discussion: The present study described 10 SNPs, which were associated with the concentration of one or some of the three proteins originating from the MASP1 gene and in a multivariate model it was shown that the SNPs contributed with the most explanatory power to the protein concentrations.	[Ammitzboll, Christian Gytz; Stengaard-Pedersen, Kristian] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark; [Steffensen, Rudi] Aalborg Univ Hosp, Dept Clin Immunol, Aalborg, Denmark; [Nielsen, Hans Jorgen] Hvidovre Univ Hosp, Dept Surg Gastroenterol, DK-2650 Hvidovre, Denmark; [Thiel, Steffen; Jensenius, Jens Christian] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Bogsted, Martin] Aalborg Univ Hosp, Dept Haematol, Aarhus, Denmark; [Bogsted, Martin] Aalborg Univ, Dept Math Sci, Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; University of Copenhagen; Aarhus University; Aalborg University; Aalborg University Hospital; Aalborg University	Ammitzboll, CG (corresponding author), Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark.	c.ammitz@gmail.com		Ammitzboll, Christian/0000-0002-8535-1613; Bogsted, Martin/0000-0001-9192-1814; Thiel, Steffen/0000-0002-4817-155X	Danish Rheumatism Association; Hede Nielsen Foundation; Aase and Ejnar Danielsen Foundation; Fonden til Laegevidenskabens Fremme; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102923, UC2HL103010, UC2HL102924, RC2HL103010, UC2HL102925, RC2HL102924, UC2HL102923, UC2HL102926, RC2HL102926, RC2HL102925] Funding Source: NIH RePORTER	Danish Rheumatism Association; Hede Nielsen Foundation; Aase and Ejnar Danielsen Foundation; Fonden til Laegevidenskabens Fremme; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors have recieved grant support from The Danish Rheumatism Association, The Fonden til Laegevidenskabens Fremme, The Hede Nielsen Foundation and The Aase and Ejnar Danielsen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammitzboll CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050585; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boldt ABW, 2011, HUM IMMUNOL, V72, P753, DOI 10.1016/j.humimm.2011.05.015; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Degn SE, 2011, AM J HUM GENET, V88, P689, DOI 10.1016/j.ajhg.2011.05.011; Degn SE, 2011, CURR OPIN ORGAN TRAN, V16, P21, DOI 10.1097/MOT.0b013e32834253df; Degn SE, 2010, J IMMUNOL METHODS, V361, P37, DOI 10.1016/j.jim.2010.07.006; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Iwaki D, 2011, J IMMUNOL, V187, P3751, DOI 10.4049/jimmunol.1100280; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; NHLBI GO Exome Sequencing Project (ESP), EX VAR SERV; PORTER RR, 1978, NATURE, V275, P699, DOI 10.1038/275699a0; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Skjoedt MO, 2011, IMMUNOBIOLOGY, V216, P625, DOI 10.1016/j.imbio.2010.09.011; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; Ytting H, 2007, SCAND J IMMUNOL, V66, P458, DOI 10.1111/j.1365-3083.2007.01991.x	30	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73317	10.1371/journal.pone.0073317	http://dx.doi.org/10.1371/journal.pone.0073317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023860	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400061
J	Wolun-Cholewa, M; Langer, K; Szymanowski, K; Glodek, A; Jankowska, A; Warchol, W; Langer, J				Wolun-Cholewa, Maria; Langer, Krzysztof; Szymanowski, Krzysztof; Glodek, Aleksandra; Jankowska, Anna; Warchol, Wojciech; Langer, Jerzy			An Efficient 3D Cell Culture Method on Biomimetic Nanostructured Grids	PLOS ONE			English	Article							TISSUE; SCAFFOLDS; NANOFIBER; BIOMATERIALS; CANCER; FIBER	Current techniques of in vitro cell cultures are able to mimic the in vivo environment only to a limited extent, as they enable cells to grow only in two dimensions. Therefore cell culture approaches should rely on scaffolds that provide support comparable to the extracellular matrix. Here we demonstrate the advantages of novel nanostructured three-dimensional grids fabricated using electro-spinning technique, as scaffolds for cultures of neoplastic cells. The results of the study show that the fibers allow for a dynamic growth of HeLa cells, which form multi-layer structures of symmetrical and spherical character. This indicates that the applied scaffolds are nontoxic and allow proper flow of oxygen, nutrients, and growth factors. In addition, grids have been proven to be useful in in situ examination of cells ultrastructure.	[Wolun-Cholewa, Maria; Glodek, Aleksandra; Jankowska, Anna] Poznan Univ Med Sci, Dept Cell Biol, Poznan, Poland; [Langer, Krzysztof; Langer, Jerzy] Adam Mickiewicz Univ, Lab Mat Physicochem & Nanotechnol, Srem, Poland; [Szymanowski, Krzysztof] Poznan Univ Med Sci, Dept Mothers & Childs Hlth, Poznan, Poland; [Warchol, Wojciech] Poznan Univ Med Sci, Dept Biophys, Poznan, Poland	Poznan University of Medical Sciences; Adam Mickiewicz University; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Wolun-Cholewa, M (corresponding author), Poznan Univ Med Sci, Dept Cell Biol, Poznan, Poland.	doskon@ump.edu.pl	Szymanowski, Krzysztof/GQP-2680-2022	Wolun-Cholewa, Maria/0000-0002-2182-9219; Langer, Jerzy J./0000-0003-0329-748X	polish National Committee for Scientific Research [NN 407 084 836]	polish National Committee for Scientific Research(Polish State Committee for Scientific Research)	The study was supported in part by the polish National Committee for Scientific Research, grant no. NN 407 084 836. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2007, MOL CELL BIOCHEM, V301, P241, DOI 10.1007/s11010-007-9417-6; Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043; Cai YZ, 2012, J BIOMED MATER RES A, V100A, P1187, DOI 10.1002/jbm.a.34063; Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005; Fik E, 2001, FOLIA HISTOCHEM CYTO, V39, P215; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Garg K, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3567097; Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093; Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008; Jeong SI, 2010, MACROMOL BIOSCI, V10, P934, DOI 10.1002/mabi.201000046; Jo JH, 2009, J BIOMED MATER RES B, V91B, P213, DOI 10.1002/jbm.b.31392; Kim JH, 2012, J BIOMED MATER RES A, V100A, P3287, DOI 10.1002/jbm.a.34274; Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221; Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671; Lee JJ, 2009, J MATER SCI-MATER M, V20, P1927, DOI 10.1007/s10856-009-3743-z; Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041; Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306; Rnjak-Kovacina J, 2011, TISSUE ENG PART B-RE, V17, P365, DOI 10.1089/ten.teb.2011.0235; Rodrigues MT, 2012, J TISSUE ENG REGEN M, V6, pe24, DOI 10.1002/term.499; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8; Wolun-Cholewa M, 2011, PHOTODIAGN PHOTODYN, V8, P58, DOI 10.1016/j.pdpdt.2010.12.003; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zhang S, 2008, ADV CANCER RES, V99, P335, DOI 10.1016/S0065-230X(07)99005-3	25	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72936	10.1371/journal.pone.0072936	http://dx.doi.org/10.1371/journal.pone.0072936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023793	Green Published, gold, Green Submitted			2022-12-27	WOS:000324238400035
J	Novoselov, SS; Mustill, WJ; Gray, AL; Dick, JR; Kanuga, N; Kalmar, B; Greensmith, L; Cheetham, ME				Novoselov, Sergey S.; Mustill, Wendy J.; Gray, Anna L.; Dick, James R.; Kanuga, Naheed; Kalmar, Bernadett; Greensmith, Linda; Cheetham, Michael E.			Molecular Chaperone Mediated Late-Stage Neuroprotection in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							DELAYS DISEASE PROGRESSION; HEAT-SHOCK PROTEINS; SUPEROXIDE-DISMUTASE; MUTANT SOD1; HSP70 CHAPERONE; WILD-TYPE; AGGREGATION; MICE; DEGENERATION; ARIMOCLOMOL	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the selective loss of motor neurons in the spinal cord, brain stem, and motor cortex. Mutations in superoxide dismutase (SOD1) are associated with familial ALS and lead to SOD1 protein misfolding and aggregation. Here we show that the molecular chaperone, HSJ1 (DNAJB2), mutations in which cause distal hereditary motor neuropathy, can reduce mutant SOD1 aggregation and improve motor neuron survival in mutant SOD1 models of ALS. Overexpression of human HSJ1a (hHSJ1a) in vivo in motor neurons of SOD1(G93A) transgenic mice ameliorated disease. In particular, there was a significant improvement in muscle force, increased motor unit number and enhanced motor neuron survival. hHSJ1a was present in a complex with SOD1(G93A) and led to reduced SOD1 aggregation at late stages of disease progression. We also observed altered ubiquitin immunoreactivity in the double transgenic animals, suggesting that ubiquitin modification might be important for the observed improvements. In a cell model of SOD1(G93A) aggregation, HSJ1a preferentially bound to mutant SOD1, enhanced SOD1 ubiquitylation and reduced SOD1 aggregation in a J-domain and ubiquitin interaction motif (UIM) dependent manner. Collectively, the data suggest that HSJ1a acts on mutant SOD1 through a combination of chaperone, co-chaperone and pro-ubiquitylation activity. These results show that targeting SOD1 protein misfolding and aggregation in vivo can be neuroprotective and suggest that manipulation of DnaJ molecular chaperones might be useful in the treatment of ALS.	[Novoselov, Sergey S.; Mustill, Wendy J.; Kanuga, Naheed; Cheetham, Michael E.] UCL Inst Ophthalmol, London, England; [Mustill, Wendy J.; Gray, Anna L.; Dick, James R.; Kalmar, Bernadett; Greensmith, Linda] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Gray, Anna L.; Greensmith, Linda] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Greensmith, L (corresponding author), UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	l.greensmith@ucl.ac.uk; michael.cheetham@ucl.ac.uk		Novoselov, Sergey/0000-0002-5491-7522; Kalmar, Bernadett/0000-0003-3747-4843; Gray, Anna Lindsay/0000-0003-0182-8355; Cheetham, Michael/0000-0001-6429-654X	MRC; Motor Neurone Disease Association; Brain Research Trust; European Community; Medical Research Council [MR/K000608/1, G0700412] Funding Source: researchfish; MRC [MR/K000608/1, G0700412] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association; Brain Research Trust; European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the MRC and Motor Neurone Disease Association. LG is the Graham Watts Senior Research Fellow, funded by The Brain Research Trust and the European Community's Seventh Framework Programme (FP7/2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batulan Z, 2006, NEUROBIOL DIS, V24, P213, DOI 10.1016/j.nbd.2006.06.017; Blumen SC, 2012, ANN NEUROL, V71, P509, DOI 10.1002/ana.22684; Borrell-Pages M, 2006, J CLIN INVEST, V116, P1410, DOI 10.1172/JCI27607; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bryson JB, 2012, HUM MOL GENET, V21, P3871, DOI 10.1093/hmg/dds215; Chapple JP, 2003, J BIOL CHEM, V278, P19087, DOI 10.1074/jbc.M212349200; CHEETHAM ME, 1992, BIOCHEM J, V284, P469, DOI 10.1042/bj2840469; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Gao XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019763; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Howarth JL, 2007, MOL THER, V15, P1100, DOI 10.1038/sj.mt.6300163; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kalmar B, 2008, J NEUROCHEM, V107, P339, DOI 10.1111/j.1471-4159.2008.05595.x; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Krishnan J, 2008, J NEUROCHEM, V106, P2170, DOI 10.1111/j.1471-4159.2008.05545.x; Labbadia J, 2012, BRAIN, V135, P1180, DOI 10.1093/brain/aws022; LEIGH PN, 1988, NEUROSCI LETT, V93, P197, DOI 10.1016/0304-3940(88)90081-X; Lemaire-Vieille C, 2000, P NATL ACAD SCI USA, V97, P5422, DOI 10.1073/pnas.080081197; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; LOWE J, 1988, NEUROSCI LETT, V94, P203, DOI 10.1016/0304-3940(88)90296-0; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Patel YJK, 2005, MOL BRAIN RES, V134, P256, DOI 10.1016/j.molbrainres.2004.10.028; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Rohde G, 2008, NEUROSCIENCE, V157, P844, DOI 10.1016/j.neuroscience.2008.09.055; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rossor AM, 2012, J NEUROL NEUROSUR PS, V83, P6, DOI 10.1136/jnnp-2011-300952; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Sharp PS, 2005, NEUROSCIENCE, V130, P897, DOI 10.1016/j.neuroscience.2004.09.069; Takeuchi H, 2002, BRAIN RES, V949, P11, DOI 10.1016/S0006-8993(02)02568-4; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Westhoff B, 2005, CURR BIOL, V15, P1058, DOI 10.1016/j.cub.2005.04.058; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3	40	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73944	10.1371/journal.pone.0073944	http://dx.doi.org/10.1371/journal.pone.0073944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023695	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200092
J	Ruokolainen, L				Ruokolainen, Lasse			Spatio-Temporal Environmental Correlation and Population Variability in Simple Metacommunities	PLOS ONE			English	Article							PREDATOR-PREY MODELS; FOOD-WEB DYNAMICS; EXTINCTION RISK; COMPETITIVE COMMUNITIES; ECOLOGICAL COMMUNITIES; SPATIAL HETEROGENEITY; COLORED ENVIRONMENTS; DISPERSAL STRATEGIES; PATCHY ENVIRONMENTS; PHASE-LOCKING	Natural populations experience environmental conditions that vary across space and over time. This variation is often correlated between localities depending on the geographical separation between them, and different species can respond to local environmental fluctuations similarly or differently, depending on their adaptation. How this emerging structure in environmental correlation (between-patches and between-species) affects spatial community dynamics is an open question. This paper aims at a general understanding of the interactions between the environmental correlation structure and population dynamics in spatial networks of local communities (metacommunities), by studying simple two-patch, two-species systems. Three different pairs of interspecific interactions are considered: competition, consumer-resource interaction, and host-parasitoid interaction. While the results paint a relatively complex picture of the effect of environmental correlation, the interaction between environmental forcing, dispersal, and local interactions can be understood via two mechanisms. While increasing between-patch environmental correlation couples immigration and local densities (destabilising effect), the coupling between local populations under increased between-species environmental correlation can either amplify or dampen population fluctuations, depending on the patterns in density dependence. This work provides a unifying framework for modelling stochastic metacommunities, and forms a foundation for a better understanding of population responses to environmental fluctuations in natural systems.	Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki	Ruokolainen, L (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	lasse.ruokolainen@helsinki.fi		Ruokolainen, Lasse/0000-0003-0951-9100	Academy of Finland	Academy of Finland(Academy of Finland)	The work was funded by the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; Abrams PA, 2012, ECOLOGY, V93, P281, DOI 10.1890/11-0011.1; Abrams PA, 2011, J THEOR BIOL, V277, P99, DOI 10.1016/j.jtbi.2011.02.019; Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Amarasekare P, 2007, AM NAT, V170, P819, DOI 10.1086/522837; Avgar T, 2013, J ANIM ECOL, V82, P96, DOI 10.1111/j.1365-2656.2012.02035.x; BEDDINGTON JR, 1975, NATURE, V255, P58, DOI 10.1038/255058a0; Blowes SA, 2012, ECOL APPL, V22, P311, DOI 10.1890/11-0952.1; Bocedi G, 2012, AM NAT, V179, P606, DOI 10.1086/665004; Borrvall C, 2008, ECOL COMPLEX, V5, P99, DOI 10.1016/j.ecocom.2008.02.004; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Cohen AE, 1998, P ROY SOC B-BIOL SCI, V265, P11, DOI 10.1098/rspb.1998.0257; Engen S, 2002, AM NAT, V160, P439, DOI 10.1086/342072; Fontaine C, 2005, ECOLOGY, V86, P1463, DOI 10.1890/04-1400; Fowler MS, 2013, J THEOR BIOL, V324, P32, DOI 10.1016/j.jtbi.2013.01.016; Fox JW, 2011, ECOL LETT, V14, P163, DOI 10.1111/j.1461-0248.2010.01567.x; FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; Gonzalez A, 2004, OIKOS, V106, P105, DOI 10.1111/j.0030-1299.2004.12925.x; Gouhier TC, 2010, AM NAT, V175, pE16, DOI 10.1086/649579; Gouhier TC, 2013, ECOL APPL IN PRESS; Greenman JV, 2005, THEOR POPUL BIOL, V68, P217, DOI 10.1016/j.tpb.2005.06.007; Greenman JV, 2001, OIKOS, V93, P343, DOI 10.1034/j.1600-0706.2001.930217.x; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Heino M, 1997, P ROY SOC B-BIOL SCI, V264, P481, DOI 10.1098/rspb.1997.0069; Johansson J, 2010, THEOR POPUL BIOL, V77, P95, DOI 10.1016/j.tpb.2009.10.007; Kallimanis AS, 2005, CONSERV BIOL, V19, P534, DOI 10.1111/j.1523-1739.2005.00418.x; Koelle K, 2005, ECOL LETT, V8, P167, DOI 10.1111/j.1461-0248.2004.00703.x; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Lindstrom T, 2011, P ROY SOC B-BIOL SCI, V278, P1564, DOI 10.1098/rspb.2010.1902; Long ZT, 2007, ECOL LETT, V10, P574, DOI 10.1111/j.1461-0248.2007.01049.x; Maser GL, 2007, J THEOR BIOL, V247, P337, DOI 10.1016/j.jtbi.2007.03.003; Matthews DP, 2007, ECOLOGY, V88, P2848, DOI 10.1890/06-1107.1; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; McCann KS, 2009, PHILOS T R SOC B, V364, P1789, DOI 10.1098/rstb.2008.0273; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Palmqvist E, 1998, OIKOS, V83, P359, DOI 10.2307/3546850; PERSSON L, 1986, ECOLOGY, V67, P355, DOI 10.2307/1938578; Petchey OL, 1997, P ROY SOC B-BIOL SCI, V264, P1841, DOI 10.1098/rspb.1997.0254; Petchey OL, 2000, P ROY SOC B-BIOL SCI, V267, P747, DOI 10.1098/rspb.2000.1066; Ranta E, 2008, P ROY SOC B-BIOL SCI, V275, P435, DOI 10.1098/rspb.2007.1546; Reed DH, 2004, ANIM CONSERV, V7, P181, DOI 10.1017/S1367943004001313; Rip JMK, 2011, ECOL LETT, V14, P733, DOI 10.1111/j.1461-0248.2011.01636.x; Ripa J, 2000, OIKOS, V89, P175, DOI 10.1034/j.1600-0706.2000.890119.x; Ripa J, 1999, ECOL LETT, V2, P219; Ripa J, 2003, THEOR POPUL BIOL, V64, P369, DOI 10.1016/S0040-5809(03)00089-3; Roy M, 2005, AM NAT, V166, P246, DOI 10.1086/431286; Ruokolainen L, 2008, P ROY SOC B-BIOL SCI, V275, P1775, DOI 10.1098/rspb.2008.0193; Ruokolainen L, 2007, OIKOS, V116, P439, DOI 10.1111/j.2006.0030-1299.15586.x; Ruokolainen L, 2012, J THEOR BIOL, V310, P199, DOI 10.1016/j.jtbi.2012.06.035; Ruokolainen L, 2011, J THEOR BIOL, V291, P76, DOI 10.1016/j.jtbi.2011.09.004; Ruokolainen L, 2009, J THEOR BIOL, V261, P379, DOI 10.1016/j.jtbi.2009.08.010; Ruokolainen L, 2009, TRENDS ECOL EVOL, V24, P555, DOI 10.1016/j.tree.2009.04.009; Ruokolainen L, 2009, ECOL LETT, V12, P909, DOI 10.1111/j.1461-0248.2009.01346.x; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Schwager M, 2006, AM NAT, V167, P879, DOI 10.1086/503609; Steiner CF, 2013, OIKOS IN PRESS; Stomp M, 2004, NATURE, V432, P104, DOI 10.1038/nature03044; Travis JMJ, 2001, ECOL RES, V16, P157, DOI 10.1046/j.1440-1703.2001.00381.x; van Nouhuys S, 2002, J ANIM ECOL, V71, P639, DOI 10.1046/j.1365-2656.2002.00627.x; Vasseur DA, 2004, ECOLOGY, V85, P1146, DOI 10.1890/02-3122; Vasseur DA, 2007, ECOL LETT, V10, P1066, DOI 10.1111/j.1461-0248.2007.01099.x; Vasseur DA, 2007, THEOR POPUL BIOL, V72, P186, DOI 10.1016/j.tpb.2007.06.002; Vasseur DA, 2009, NATURE, V460, P1007, DOI 10.1038/nature08208; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508	69	9	10	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72325	10.1371/journal.pone.0072325	http://dx.doi.org/10.1371/journal.pone.0072325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023615	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200010
J	Venturelli, S; Berger, A; Bocker, A; Busch, C; Weiland, T; Noor, S; Leischner, C; Schleicher, S; Mayer, M; Weiss, TS; Bischoff, SC; Lauer, UM; Bitzer, M				Venturelli, Sascha; Berger, Alexander; Boecker, Alexander; Busch, Christian; Weiland, Timo; Noor, Seema; Leischner, Christian; Schleicher, Sabine; Mayer, Mascha; Weiss, Thomas S.; Bischoff, Stephan C.; Lauer, Ulrich M.; Bitzer, Michael			Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; INDUCED APOPTOSIS; CANCER; QUERCETIN; ARREST; GROWTH; CYCLE; TIME; ACTIVATORS; INDUCTION	The polyphenolic alcohol resveratrol has demonstrated promising activities for the prevention and treatment of cancer. Different modes of action have been described for resveratrol including the activation of sirtuins, which represent the class III histone deacetylases (HDACs). However, little is known about the activity of resveratrol on the classical HDACs of class I, II and IV, although these classes are involved in cancer development or progression and inhibitors of HDACs (HDACi) are currently under investigation as promising novel anticancer drugs. We could show by in silico docking studies that resveratrol has the chemical structure to inhibit the activity of different human HDAC enzymes. In vitro analyses of overall HDAC inhibition and a detailed HDAC profiling showed that resveratrol inhibited all eleven human HDACs of class I, II and IV in a dose-dependent manner. Transferring this molecular mechanism into cancer therapy strategies, resveratrol treatment was analyzed on solid tumor cell lines. Despite the fact that hepatocellular carcinoma (HCC) is known to be particularly resistant against conventional chemotherapeutics, treatment of HCC with established HDACi already has shown promising results. Testing of resveratrol on hepatoma cell lines HepG2, Hep3B and HuH7 revealed a dose-dependent antiproliferative effect on all cell lines. Interestingly, only for HepG2 cells a specific inhibition of HDACs and in turn a histone hyperacetylation caused by resveratrol was detected. Additional testing of human blood samples demonstrated a HDACi activity by resveratrol ex vivo. Concluding toxicity studies showed that primary human hepatocytes tolerated resveratrol, whereas in vivo chicken embryotoxicity assays demonstrated severe toxicity at high concentrations. Taken together, this novel pan-HDACi activity opens up a new perspective of resveratrol for cancer therapy alone or in combination with other chemotherapeutics. Moreover, resveratrol may serve as a lead structure for chemical optimization of bioavailability, pharmacology or HDAC inhibition.	[Venturelli, Sascha; Berger, Alexander; Weiland, Timo; Leischner, Christian; Lauer, Ulrich M.; Bitzer, Michael] Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany; [Boecker, Alexander] Evotec AG, Hamburg, Germany; [Noor, Seema] Univ Tubingen, Sect Dermatooncol, Dept Dermatol & Allergol, Tubingen, Germany; [Schleicher, Sabine] Univ Tubingen, Univ Childrens Hosp, Dept Hematol Oncol, Tubingen, Germany; [Mayer, Mascha; Bischoff, Stephan C.] Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany; [Weiss, Thomas S.] Univ Regensburg Hosp, Dept Pediat & Adolescent Med, Ctr Liver Cell Res, Regensburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Evotec; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; University Hohenheim; University of Regensburg	Bitzer, M (corresponding author), Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany.	michael.bitzer@uni-tuebingen.de	Weiss, Thomas S./G-3989-2012	Weiss, Thomas S./0000-0003-0336-0581; Venturelli, Sascha/0000-0001-5585-6701	Deutsche Forschungsgemeinschaft [SFB 773]; Zentrum fuer Ernaehrungsmedizin Tuebingen - Hohenheim (ZEM); fortuene program of the University Clinic Tuebingen [1966-0-0]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Zentrum fuer Ernaehrungsmedizin Tuebingen - Hohenheim (ZEM); fortuene program of the University Clinic Tuebingen	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (SFB 773), from the Zentrum fuer Ernaehrungsmedizin Tuebingen - Hohenheim (ZEM) and the fortuene program of the University Clinic Tuebingen (1966-0-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Acharya MR, 2005, MOL PHARMACOL, V68, P917, DOI 10.1124/mol.105.014167; Ahmad N, 2001, CLIN CANCER RES, V7, P1466; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Armeanu S, 2005, J HEPATOL, V42, P210, DOI 10.1016/j.jhep.2004.10.020; Berger A, 2012, J NUTR BIOC IN PRESS; Billard C, 2002, LEUKEMIA LYMPHOMA, V43, P1991, DOI 10.1080/1042819021000015952; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Busch C, 2008, INT J CANCER, V122, P526, DOI 10.1002/ijc.23139; Campas-Moya C, 2009, DRUG TODAY, V45, P787, DOI 10.1358/dot.2009.45.11.1437052; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Clement MV, 1998, BLOOD, V92, P996; Colin D, 2008, BIOCHIMIE, V90, P1674, DOI 10.1016/j.biochi.2008.06.006; Collins MA, 2009, ALCOHOL CLIN EXP RES, V33, P206, DOI 10.1111/j.1530-0277.2008.00828.x; Colom H, 2011, PHARM RES-DORDR, V28, P1606, DOI 10.1007/s11095-011-0395-8; CREASY LL, 1988, J AM SOC HORTIC SCI, V113, P230; Dashwood RH, 2006, CARCINOGENESIS, V27, P344, DOI 10.1093/carcin/bgi253; Dayangac-Erden D, 2009, CHEM BIOL DRUG DES, V73, P355, DOI 10.1111/j.1747-0285.2009.00781.x; Ding Xian-Zhong, 2002, Pancreas, V25, pe71, DOI 10.1097/00006676-200211000-00024; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; ElAttar TMA, 1999, ANTI-CANCER DRUG, V10, P187, DOI 10.1097/00001813-199902000-00007; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fechner S, 2008, ULTRASOUND OBST GYN, V31, P277, DOI 10.1002/uog.5244; Fulda S, 2010, DRUG DISCOV TODAY, V15, P757, DOI 10.1016/j.drudis.2010.07.005; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Ho E, 2010, WORLD REV NUTR DIET, V101, P95, DOI 10.1159/000314514; Holian O, 2002, AM J PHYSIOL-GASTR L, V282, pG809, DOI 10.1152/ajpgi.00193.2001; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu Y, 2011, FREE RADICAL BIO MED, V51, P250, DOI 10.1016/j.freeradbiomed.2011.04.034; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kampa M, 2000, NUTR CANCER, V37, P223, DOI 10.1207/S15327914NC372_16; Kawada N, 1998, HEPATOLOGY, V27, P1265, DOI 10.1002/hep.510270512; Kelly WK, 2002, EXPERT OPIN INV DRUG, V11, P1695, DOI 10.1517/13543784.11.12.1695; Kim YA, 2003, INT J ONCOL, V23, P1143; Kopp P, 1998, EUR J ENDOCRINOL, V138, P619, DOI 10.1530/eje.0.1380619; Kozuki Y, 2001, CANCER LETT, V167, P151, DOI 10.1016/S0304-3835(01)00476-1; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; LANGCAKE P, 1976, PHYSIOL PLANT PATHOL, V9, P77, DOI 10.1016/0048-4059(76)90077-1; Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4; Leiro J, 2004, DIS AQUAT ORGAN, V59, P171, DOI 10.3354/dao059171; Liao PC, 2010, J MED FOOD, V13, P1415, DOI 10.1089/jmf.2010.1126; Liu BH, 2012, CELL METAB, V16, P738, DOI 10.1016/j.cmet.2012.11.007; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Meeran SM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0011-5; Menegola Elena, 2006, Birth Defects Research, V78, P345, DOI 10.1002/bdrc.20082; Mgbonyebi OP, 1998, INT J ONCOL, V12, P865; Ndiaye M, 2011, ANN NY ACAD SCI, V1215, P144, DOI 10.1111/j.1749-6632.2010.05851.x; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park L. K., 2011, P NUTR SOC, V4, P1; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Soleas GJ, 1997, CLIN BIOCHEM, V30, P91, DOI 10.1016/S0009-9120(96)00155-5; Spallotta F, 2013, J BIOL CHEM, V288, P11004, DOI 10.1074/jbc.M112.441816; Sun AY, 2002, FREE RADICAL BIO MED, V32, P314, DOI 10.1016/S0891-5849(01)00803-6; Thasler WE, 2006, ATLA-ALTERN LAB ANIM, V34, P387, DOI 10.1177/026119290603400411; Thasler Wolfgang E., 2003, Cell and Tissue Banking, V4, P49, DOI 10.1023/A:1026392429112; Tinhofer I, 2001, FASEB J, V15, P1613, DOI 10.1096/fj.00-0675fje; Venturelli S, 2007, CANCER, V109, P2132, DOI 10.1002/cncr.22652; Venturelli S, 2011, GUT, V60, P156, DOI 10.1136/gut.2010.208041; Wadsworth TL, 1999, BIOCHEM PHARMACOL, V57, P941, DOI 10.1016/S0006-2952(99)00002-7; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Weiland T, 2012, ASSAY DRUG DEV TECHN, V10, P289, DOI 10.1089/adt.2011.0402; Wolter F, 2001, J NUTR, V131, P2197, DOI 10.1093/jn/131.8.2197	67	121	121	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73097	10.1371/journal.pone.0073097	http://dx.doi.org/10.1371/journal.pone.0073097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023672	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200068
J	Collins, SH; Kuo, AD				Collins, Steven H.; Kuo, Arthur D.			Two Independent Contributions to Step Variability during Over-Ground Human Walking	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; OLDER-ADULTS; FRACTAL DYNAMICS; STRIDE-INTERVAL; KINEMATIC VARIABILITY; WIDTH VARIABILITY; GAIT; TREADMILL; BALANCE; STABILIZATION	Human walking exhibits small variations in both step length and step width, some of which may be related to active balance control. Lateral balance is thought to require integrative sensorimotor control through adjustment of step width rather than length, contributing to greater variability in step width. Here we propose that step length variations are largely explained by the typical human preference for step length to increase with walking speed, which itself normally exhibits some slow and spontaneous fluctuation. In contrast, step width variations should have little relation to speed if they are produced more for lateral balance. As a test, we examined hundreds of overground walking steps by healthy young adults (N = 14, age < 40 yrs.). We found that slow fluctuations in self-selected walking speed (2.3% coefficient of variation) could explain most of the variance in step length (59%, P < 0.01). The residual variability not explained by speed was small (1.5% coefficient of variation), suggesting that step length is actually quite precise if not for the slow speed fluctuations. Step width varied over faster time scales and was independent of speed fluctuations, with variance 4.3 times greater than that for step length (P < 0.01) after accounting for the speed effect. That difference was further magnified by walking with eyes closed, which appears detrimental to control of lateral balance. Humans appear to modulate fore-aft foot placement in precise accordance with slow fluctuations in walking speed, whereas the variability of lateral foot placement appears more closely related to balance. Step variability is separable in both direction and time scale into balance-and speed-related components. The separation of factors not related to balance may reveal which aspects of walking are most critical for the nervous system to control.	[Collins, Steven H.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Collins, Steven H.] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Kuo, Arthur D.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Kuo, Arthur D.] Univ Michigan, Dept Biomech Engn, Ann Arbor, MI 48109 USA	Carnegie Mellon University; Carnegie Mellon University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Collins, SH (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	stevecollins@cmu.edu	Kuo, Arthur/L-3359-2013	Kuo, Arthur/0000-0001-5233-9709; Collins, Steve/0000-0002-3997-3374	U.S. NIH [DC6466]; U.S. Department of Defense [DR081177 296]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC006466] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by U.S. NIH (nih.gov) grant DC6466 (ADK) and the U.S. Department of Defense (www.defense.gov) grant DR081177 296 (ADK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2009, EXP BRAIN RES, V199, P39, DOI 10.1007/s00221-009-1968-1; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; Brach JS, 2008, GAIT POSTURE, V27, P431, DOI 10.1016/j.gaitpost.2007.05.016; Dean JC, 2007, IEEE T BIO-MED ENG, V54, P1919, DOI 10.1109/TBME.2007.901031; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Donelan JM, 2002, J EXP BIOL, V205, P3717; ELFTMAN H, 1966, J BONE JOINT SURG AM, VA 48, P363, DOI 10.2106/00004623-196648020-00017; Frenkel-Toledo Silvi, 2005, J Neuroeng Rehabil, V2, P23, DOI 10.1186/1743-0003-2-23; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; Glantz S. A., 2005, PRIMER BIOSTATISTICS; Grabiner PC, 2001, ARCH PHYS MED REHAB, V82, P31, DOI 10.1053/apmr.2001.18219; Grieve D.W., 1968, BIOMED ENG, V3, P119; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hof AL, 2010, J EXP BIOL, V213, P2655, DOI 10.1242/jeb.042572; Kito T, 2006, HUM MOVEMENT SCI, V25, P383, DOI 10.1016/j.humov.2006.01.001; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; MANCHESTER D, 1989, J GERONTOL, V44, pM118; McAndrew PM, 2010, J BIOMECH, V43, P1470, DOI 10.1016/j.jbiomech.2010.02.003; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; O'Connor SM, 2009, J NEUROPHYSIOL, V102, P1411, DOI 10.1152/jn.00131.2009; Owings TM, 2004, J BIOMECH, V37, P935, DOI 10.1016/j.jbiomech.2003.11.012; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; SNATERSE M, 2010, J APPL PHYS IN PRESS; Terrier P, 2005, HUM MOVEMENT SCI, V24, P97, DOI 10.1016/j.humov.2005.03.002; ZARRUGH MY, 1974, EUR J APPL PHYSIOL O, V33, P293, DOI 10.1007/BF00430237	35	66	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73597	10.1371/journal.pone.0073597	http://dx.doi.org/10.1371/journal.pone.0073597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015308	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800103
J	Manca, C; Koo, MS; Peixoto, B; Fallows, D; Kaplan, G; Subbian, S				Manca, Claudia; Koo, Mi-Sun; Peixoto, Blas; Fallows, Dorothy; Kaplan, Gilla; Subbian, Selvakumar			Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; CYCLIC-AMP; HUMAN MONOCYTES; CYTOKINE RESPONSE; NUCLEAR RECEPTORS; LIPID-METABOLISM; PPAR-GAMMA; BIOMARKERS; PHOSPHODIESTERASE; INFLAMMATION	Pyrazinamide (PZA) is one of the first line antibiotics used for the treatment of tuberculosis (TB). In the present study, we have used in vitro and in vivo systems to investigate whether PZA, in addition to its known anti-mycobacterial properties, modulate the host immune response during Mycobacterium tuberculosis (Mtb) infection. In vitro we have examined the effect of PZA on cytokine and chemokine release by Mtb-infected or Toll-like receptor (TLR) -stimulated primary human monocytes. In vivo, we have investigated at the transcriptional levels using genome-wide microarray gene expression analysis, whether PZA treatment of Mtb-infected mice alters the host immune response to Mtb infection in the lungs. Here, we report that PZA treatment of Mtb-infected human monocytes and mice significantly reduces the release of pro-inflammatory cytokines and chemokines, including IL-1 beta, IL-6, TNF-alpha and MCP-1 at the protein and at the gene transcription levels, respectively. Data from microarray analysis also reveal that PZA treatment of Mtb-infected mice significantly alters the expression level of genes involved in the regulation of the pro-inflammatory mediators, lung inflammatory response and TLR signaling networks. Specifically, genes coding for adenylate cyclase and Peroxisome-Proliferator Activated Receptor (PPAR), molecules known for their anti-inflammatory effect, were found to be up-regulated in the lungs of PZA-treated Mtb-infected mice. Based on the microarray findings, we propose that PZA treatment modulates the host immune response to Mtb infection by reducing pro-inflammatory cytokine production, probably through PPAR-and NF-kB- dependent pathways. In addition, our results suggest that inclusion or exclusion of PZA in the TB treatment regimen could potentially affect the biomarker signature detected in the circulation of TB patients.	[Manca, Claudia; Koo, Mi-Sun; Peixoto, Blas; Fallows, Dorothy; Kaplan, Gilla; Subbian, Selvakumar] Rutgers State Univ, Rutgers Biomed & Hlth Sci, New Jersey Med Sch, PHRI,Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kaplan, G (corresponding author), Rutgers State Univ, Rutgers Biomed & Hlth Sci, New Jersey Med Sch, PHRI,Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07102 USA.	kaplangi@njms.rutgers.edu		Subbian, Selvakumar/0000-0003-2021-8632	NIH [R01 AI80737]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080737] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from NIH (R01 AI80737 awarded to GK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2011, ANTIMICROB AGENTS CH, V55, P1527, DOI 10.1128/AAC.01524-10; Almeida D, 2009, ANTIMICROB AGENTS CH, V53, P4178, DOI 10.1128/AAC.00830-09; Araujo FG, 2002, CLIN MICROBIOL INFEC, V8, P26, DOI 10.1046/j.1469-0691.2002.00374.x; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; CAMPBELL PI, 1989, AM J PHYSIOL, V257, pF1021, DOI 10.1152/ajprenal.1989.257.6.F1021; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Conte JE, 1999, ANTIMICROB AGENTS CH, V43, P1329, DOI 10.1128/AAC.43.6.1329; Dalhoff A, 2003, LANCET INFECT DIS, V3, P359, DOI 10.1016/S1473-3099(03)00658-3; De Groote MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061002; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Donald PR, 2012, TUBERCULOSIS, V92, P1, DOI 10.1016/j.tube.2011.05.006; Gil D, 2003, TOXICOL APPL PHARM, V190, P111, DOI 10.1016/S0041-008X(03)00162-5; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Heifets L, 2000, INT J TUBERC LUNG D, V4, P491; Heysell SK, 2010, EMERG INFECT DIS, V16, P1546, DOI 10.3201/eid1610.100374; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Kim JJ, 2012, CELL HOST MICROBE, V11, P457, DOI 10.1016/j.chom.2012.03.008; Koo MS, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-2; Koo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017091; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Manca C, 1999, J IMMUNOL, V162, P6740; Manca C, 2012, J INTERF CYTOK RES, V32, P27, DOI 10.1089/jir.2011.0044; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Melhus A, 2001, J ANTIMICROB CHEMOTH, V48, P397, DOI 10.1093/jac/48.3.397; Mendez S, 2009, ANTIMICROB AGENTS CH, V53, P5114, DOI 10.1128/AAC.01146-09; Michalik L, 1999, CURR OPIN BIOTECH, V10, P564, DOI 10.1016/S0958-1669(99)00030-0; Mitchison D, 2012, INT J TUBERC LUNG D, V16, P724, DOI 10.5588/ijtld.12.0083; Nahid P, 2011, AM J RESP CRIT CARE, V184, P972, DOI 10.1164/rccm.201105-0827WS; Pahlevan AA, 2002, J ANTIMICROB CHEMOTH, V49, P531, DOI 10.1093/jac/49.3.531; Peloquin CA, 2002, DRUGS, V62, P2169, DOI 10.2165/00003495-200262150-00001; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; RASTOGI N, 1988, ANTIMICROB AGENTS CH, V32, P287, DOI 10.1128/AAC.32.2.287; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Shalit I, 2002, ANTIMICROB AGENTS CH, V46, P2442, DOI 10.1128/AAC.46.8.2442-2449.2002; Sharma SK, 2004, INDIAN J MED RES, V120, P316; SHIMOYAMA M, 1975, PHYSIOL CHEM PHYS M, V7, P125; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Sinsimer D, 2010, INFECT IMMUN, V78, P293, DOI 10.1128/IAI.00816-09; Souness JE, 2000, IMMUNOPHARMACOLOGY, V47, P127, DOI 10.1016/S0162-3109(00)00185-5; Souness JE, 1996, BRIT J PHARMACOL, V118, P649, DOI 10.1111/j.1476-5381.1996.tb15450.x; Subbian S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002262; Um SW, 2007, INT J TUBERC LUNG D, V11, P972; Ungerstedt JS, 2003, CLIN EXP IMMUNOL, V131, P48, DOI 10.1046/j.1365-2249.2003.02031.x; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Weiss T, 2004, ANTIMICROB AGENTS CH, V48, P1974, DOI 10.1128/AAC.48.6.1974-1982.2004; WHO, 2012, TUB FACT SHEET; Yamazaki R, 2002, J PHARMACOL EXP THER, V302, P18, DOI 10.1124/jpet.302.1.18; Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065; Yuhas Y, 2006, ANTIMICROB AGENTS CH, V50, P396, DOI 10.1128/AAC.50.1.396-398.2006; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zhang Y, 2012, J APPL TOXICOL; Zidek Z, 1999, EUR CYTOKINE NETW, V10, P319; Ziglam HM, 2004, J CHEMOTHERAPY, V16, P357, DOI 10.1179/joc.2004.16.4.357	69	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e74082	10.1371/journal.pone.0074082	http://dx.doi.org/10.1371/journal.pone.0074082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015316	Green Submitted, gold, Green Published			2022-12-27	WOS:000323733800111
J	Beckert, U; Aw, WY; Burhenne, H; Forsterling, L; Kaever, V; Timmons, L; Seifert, R				Beckert, Ulrike; Aw, Wen Yih; Burhenne, Heike; Foersterling, Lisa; Kaever, Volkhard; Timmons, Lisa; Seifert, Roland			The Receptor-Bound Guanylyl Cyclase DAF-11 Is the Mediator of Hydrogen Peroxide-Induced Cgmp Increase in Caenorhabditis elegans	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE RELEASE; C-ELEGANS; GUANOSINE 3',5'-MONOPHOSPHATE; SIGNALING PATHWAY; BODY-SIZE; LIFE-SPAN; TISSUES; RAT; SUPERFAMILY	Adenosine 3', 5'-cyclic monophosphate (cAMP) and guanosine 3', 5'-cyclic monophosphate (cGMP) are well-studied second messengers that transmit extracellular signals into mammalian cells, with conserved functions in various other species such as Caenorhabditis elegans (C. elegans). cAMP is generated by adenylyl cyclases, and cGMP is generated by guanylyl cyclases, respectively. Studies using C. elegans have revealed additional roles for cGMP signaling in lifespan extension. For example, mutants lacking the function of a specific receptor-bound guanylyl cyclase, DAF-11, have an increased life expectancy. While the daf-11 phenotype has been attributed to reductions in intracellular cGMP concentrations, the actual content of cyclic nucleotides has not been biochemically determined in this system. Similar assumptions were made in studies using phosphodiesterase loss-of-function mutants or using adenylyl cyclase overexpressing mutants. In the present study, cyclic nucleotide regulation in C. elegans was studied by establishing a special nematode protocol for the simultaneous detection and quantitation of cyclic nucleotides. We also examined the influence of reactive oxygen species (ROS) on cyclic nucleotide metabolism and lifespan in C. elegans using highly specific HPLC-coupled tandem mass-spectrometry and behavioral assays. Here, we show that the relation between cGMP and survival is more complex than previously appreciated.	[Beckert, Ulrike; Aw, Wen Yih; Burhenne, Heike; Foersterling, Lisa; Kaever, Volkhard; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Aw, Wen Yih; Timmons, Lisa] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Mass Spectrometry Metabol, Hannover, Germany	Hannover Medical School; University of Kansas; Hannover Medical School	Seifert, R (corresponding author), Hannover Med Sch, Inst Pharmacol, Hannover, Germany.	seifert.roland@mh-hannover.de	Kaever, Volkhard/G-3280-2013; Seifert, Roland/G-3189-2013; Bähre, Heike/AAL-7873-2021; Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; Aw, Wen Yih/0000-0002-1724-412X	Fulbright graduate student fellowship; German Academic Exchange Service RISE fellowship	Fulbright graduate student fellowship; German Academic Exchange Service RISE fellowship	This work was supported by a Fulbright graduate student fellowship to Ulrike Beckert and a German Academic Exchange Service RISE fellowship to Wen Yih Aw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMAN DF, 1963, BIOCHEM BIOPH RES CO, V11, P330, DOI 10.1016/0006-291X(63)90566-7; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI [DOI 10.1126/SCIENCE.282.5396.2028, DOI 10.1126/science.282.5396.2028]; Baude EJ, 1997, J BIOL CHEM, V272, P16035, DOI 10.1074/jbc.272.25.16035; Behrends S, 2003, CURR MED CHEM, V10, P291, DOI 10.2174/0929867033368286; BERTHET J, 1957, J Biol Chem, V224, P463; BERTHET J, 1957, J BIOL CHEM, V229, P351; Birnby DA, 2000, GENETICS, V155, P85; BOHME E, 1969, N-S ARCH PHARMAKOL, V264, P220, DOI 10.1007/BF02431417; BRENNER S, 1974, GENETICS, V77, P71; Burhenne H, 2011, N-S ARCH PHARMACOL, V383, P33; Cheng FC, 2002, J CHROMATOGR B, V781, P481, DOI 10.1016/S1570-0232(02)00620-7; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Ghosh SR, 2010, EUR J CELL BIOL, V89, P437, DOI 10.1016/j.ejcb.2009.11.027; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hahm JH, 2009, AGING CELL, V8, P473, DOI 10.1111/j.1474-9726.2009.00495.x; HARDMAN JG, 1969, J BIOL CHEM, V244, P6363; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hope IA., 1999, C ELEGANS PRACTICAL; ISHIKAWA E, 1969, J BIOL CHEM, V244, P6371; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Schaap P, 2005, FRONT BIOSCI-LANDMRK, V10, P1485, DOI 10.2741/1633; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Seifert R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003466; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VOWELS JJ, 1994, GENETICS, V138, P303; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; WHITE AA, 1969, BIOCHIM BIOPHYS ACTA, V191, P686, DOI 10.1016/0005-2744(69)90362-3; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]	48	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72569	10.1371/journal.pone.0072569	http://dx.doi.org/10.1371/journal.pone.0072569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015261	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200048
J	Davis, AJ; Smith, TO; Hing, CB; Sofat, N				Davis, Alison J.; Smith, Toby O.; Hing, Caroline B.; Sofat, Nidhi			Are Bisphosphonates Effective in the Treatment of Osteoarthritis Pain? A Meta-Analysis and Systematic Review	PLOS ONE			English	Review							KNEE OSTEOARTHRITIS; RISEDRONATE; ALENDRONATE; SYMPTOMS; BONE; ELECTROALGOMETRY; BACK; ETIDRONATE; CLODRONATE; FALL	Objective: Osteoarthritis (OA) is the most common form of arthritis worldwide. Pain and reduced function are the main symptoms in this prevalent disease. There are currently no treatments for OA that modify disease progression; therefore analgesic drugs and joint replacement for larger joints are the standard of care. In light of several recent studies reporting the use of bisphosphonates for OA treatment, our work aimed to evaluate published literature to assess the effectiveness of bisphosphonates in OA treatment. Methods: Literature databases were searched from inception to the 30th June 2012 for clinical trials of bisphosphonates to treat OA pain. Data was appraised and levels of evidence determined qualitatively using best evidence synthesis from the Cochrane Collaboration. The two largest studies were conducted with risedronate in the treatment of knee OA, for which meta-analyses were performed for pain and functional outcomes. Results: Our searches found 13/297 eligible studies, which included a total of 3832 participants. The trials recruited participants with OA of the hand (n = 1), knee (n = 8), knee and spine (n = 3), or hip (n = 1). Our meta-analysis of the two largest knee studies using risedronate 15 mg showed odds ratios favouring placebo interventions for the Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain (1.73), WOMAC function (2.03), and WOMAC stiffness (1.82). However, 8 trials (61.5%) reported that bisphosphonates improve pain assessed by VAS scores and 2 (38.5%) reported significant improvement in WOMAC pain scores compared to control groups. Conclusions: There is limited evidence that bisphosphonates are effective in the treatment of OA pain. Limitations of the studies we analysed included the differences in duration of bisphosphonate use, the dose and route of administration and the lack of long-term data on OA joint structure modification post-bisphosphonate therapy. Future more targeted studies are required to appreciate the value of bisphosphonates in treating osteoarthritis pain.	[Davis, Alison J.; Sofat, Nidhi] Univ London, Div Biomed Sci, Dept Rheumatol, London, England; [Smith, Toby O.] Univ E Anglia, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Hing, Caroline B.] St George Hosp, Dept Orthopaed, London, England	University of London; University of East Anglia; St Georges University London	Sofat, N (corresponding author), Univ London, Div Biomed Sci, Dept Rheumatol, London, England.	nsofat@sgul.ac.uk	Sofat, Nidhi/AAQ-7358-2020; Hing, Caroline/AAH-6777-2021	Sofat, Nidhi/0000-0002-6963-6475; Hing, Caroline/0000-0003-0836-2885; Smith, Toby/0000-0003-1673-2954	Rosetrees' Trust; National Institute for Health Research (NIHR) Comprehensive Local Research Network (CLRN); Wellcome Trust; Rosetrees Trust [M11-F1] Funding Source: researchfish	Rosetrees' Trust(Rosetrees Trust); National Institute for Health Research (NIHR) Comprehensive Local Research Network (CLRN)(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Rosetrees Trust(Rosetrees Trust)	This work was supported by The Rosetrees' Trust, the National Institute for Health Research (NIHR) Comprehensive Local Research Network (CLRN), and The Wellcome Trust Value in People Award to Alison Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bingham CO, 2006, ARTHRITIS RHEUM-US, V54, P3494, DOI 10.1002/art.22160; Buckland-Wright JC, 2007, RHEUMATOLOGY, V46, P257, DOI 10.1093/rheumatology/kel213; Carbone LD, 2004, ARTHRITIS RHEUM-US, V50, P3516, DOI 10.1002/art.20627; Chen A, 2012, ARTHRITIS, DOI 10.1155/2012/698709; Fujita T, 2008, J INT MED RES, V36, P932, DOI 10.1177/147323000803600509; Fujita T, 2001, J BONE MINER METAB, V19, P251, DOI 10.1007/s007740170028; Fujita T, 2011, J BONE MINER METAB, V29, P588, DOI 10.1007/s00774-011-0259-7; Fujita T, 2009, J BONE MINER METAB, V27, P234, DOI 10.1007/s00774-009-0035-0; Haugen IK, 2010, ANN RHEUM DIS, V69, P1436, DOI 10.1136/ard.2008.100156; Hunter DJ, 2011, OSTEOARTHR CARTILAGE, V19, P990, DOI 10.1016/j.joca.2011.05.004; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jokar M, 2010, IRAN J MED SCI, V35, P9; Kawasaki T, 2008, J BONE MINER METAB, V26, P279, DOI 10.1007/s00774-007-0813-5; Laslett LL, 2012, ANN RHEUM DIS, V71, P1322, DOI 10.1136/annrheumdis-2011-200970; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lievense AM, 2002, RHEUMATOLOGY, V41, P1155, DOI 10.1093/rheumatology/41.10.1155; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moreau M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3373; Nishii T, 2012, OSTEOARTHR CARTILAGE, V20, pS284, DOI 10.1016/j.joca.2012.02.489; Reilly KA, 2006, KNEE, V13, P177, DOI 10.1016/j.knee.2006.02.003; Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722; Rossini M, 2009, RHEUMATOLOGY, V48, P773, DOI 10.1093/rheumatology/kep084; SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539; Saviola G, 2012, MOD RHEUMATOL, V22, P256, DOI 10.1007/s10165-011-0506-8; Smith TO, 2007, KNEE SURG SPORT TR A, V15, P1301, DOI 10.1007/s00167-007-0390-0; Sofat N, 2011, RHEUMATOLOGY, V50, P2157, DOI 10.1093/rheumatology/ker283; Spector TD, 2005, ARTHRITIS RES THER, V7, pR625, DOI 10.1186/ar1716; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Walsh DA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3448; Walsh DA, 2010, RHEUMATOLOGY, V49, P1852, DOI 10.1093/rheumatology/keq188; Yoneda T, 2011, BONE, V48, P100, DOI 10.1016/j.bone.2010.07.009; Yusuf E, 2011, ANN RHEUM DIS, V70, P60, DOI 10.1136/ard.2010.131904	34	32	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72714	10.1371/journal.pone.0072714	http://dx.doi.org/10.1371/journal.pone.0072714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023766	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000324515600039
J	Okoturo-Evans, O; Dybowska, A; Valsami-Jones, E; Cupitt, J; Gierula, M; Boobis, AR; Edwards, RJ				Okoturo-Evans, Odu; Dybowska, Agnieszka; Valsami-Jones, Eugenia; Cupitt, John; Gierula, Magdalena; Boobis, Alan R.; Edwards, Robert J.			Elucidation of Toxicity Pathways in Lung Epithelial Cells Induced by Silicon Dioxide Nanoparticles	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CONSUMER PRODUCTS; OXIDATIVE STRESS; APOPTOSIS; CYTOTOXICITY; NANOMATERIALS; EXPOSURE; SIZE; NANOTECHNOLOGY; PULMONARY	A study into the effects of amorphous nano-SiO2 particles on A549 lung epithelial cells was undertaken using proteomics to understand the interactions that occur and the biological consequences of exposure of lung to nanoparticles. Suitable conditions for treatment, where A549 cells remained viable for the exposure period, were established by following changes in cell morphology, flow cytometry, and MTT reduction. Label-free proteomics was used to estimate the relative level of proteins from their component tryptic peptides detected by mass spectrometry. It was found that A549 cells tolerated treatment with 100 mu g/ml nano-SiO2 in the presence of 1.25% serum for at least 4 h. After this time detrimental changes in cell morphology, flow cytometry, and MTT reduction were evident. Proteomics performed after 4 h indicated changes in the expression of 47 proteins. Most of the proteins affected fell into four functional groups, indicating that the most prominent cellular changes were those that affected apoptosis regulation (e.g. UCP2 and calpain-12), structural reorganisation and regulation of actin cytoskeleton (e.g. PHACTR1), the unfolded protein response (e.g. HSP 90), and proteins involved in protein synthesis (e.g. ribosomal proteins). Treatment with just 10 mg/ml nano-SiO2 particles in serum-free medium resulted in a rapid deterioration of the cells and in medium containing 10% serum the cells were resistant to up to 1000 mu g/ml nano-SiO2 particles, suggesting interaction of serum components with the nanoparticles. A variety of serum proteins were found which bound to nano-SiO2 particles, the most prominent of which were albumin, apolipoprotein A-I, hemoglobin, vitronectin and fibronectin. The use of a proteomics platform, with appropriately designed experimental conditions, enabled the early biological perturbations induced by nano-SiO2 in a model target cell system to be identified. The approach facilitates the design of more focused test systems for use in tiered evaluations of nanomaterials.	[Okoturo-Evans, Odu; Cupitt, John; Gierula, Magdalena; Boobis, Alan R.; Edwards, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Dept Med, London, England; [Dybowska, Agnieszka; Valsami-Jones, Eugenia] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Valsami-Jones, Eugenia] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England	Imperial College London; Natural History Museum London; University of Birmingham	Edwards, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Dept Med, London, England.	r.edwards@imperial.ac.uk	Boobis, Alan/E-1536-2018; Valsami-Jones, Eva/I-1736-2016	Boobis, Alan/0000-0003-3371-386X; Valsami-Jones, Eva/0000-0002-8850-7556; Dybowska, Agnieszka/0000-0002-8927-0159	MRC [G0801880]; Medical Research Council [G0801880] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the MRC. Title: "Pathway analysis in characterising the toxicological properties of nanomaterials''. Principal investigator: Professor A.R. Boobis with Professor S. Grimm, Professor T. Tetley and Dr R.J. Edwards. Grant code: G0801880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Salam VB, 2010, CIRCULATION, V122, P2058, DOI 10.1161/CIRCULATIONAHA.110.972745; Ahamed M, 2013, HUM EXP TOXICOL, V32, P186, DOI 10.1177/0960327112459206; Al-Jawad M, 2009, EUR PHYS J E, V30, P175, DOI 10.1140/epje/i2009-10472-0; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Bakand S, 2012, INHAL TOXICOL, V24, P125, DOI 10.3109/08958378.2010.642021; Becker H, 2011, INT J HYG ENVIR HEAL, V214, P231, DOI 10.1016/j.ijheh.2010.11.004; Berg JM, 2013, TOXICOL IN VITRO, V27, P24, DOI 10.1016/j.tiv.2012.09.002; Bitar A, 2012, DRUG DISCOV TODAY, V17, P1147, DOI 10.1016/j.drudis.2012.06.014; Calzolai L, 2012, FOOD ADDIT CONTAM A, V29, P1183, DOI 10.1080/19440049.2012.689777; Card JW, 2011, CRIT REV TOXICOL, V41, P20, DOI 10.3109/10408444.2010.524636; Chen Z, 2008, ENVIRON SCI TECHNOL, V42, P8985, DOI 10.1021/es800975u; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Deng SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030714; Deng ZJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455101; Drescher D, 2011, ANAL BIOANAL CHEM, V400, P1367, DOI 10.1007/s00216-011-4893-7; Editorial, 2013, NATURE NANOTECHNOLOG, P8; EFSA, 2011, EFSA J, V9, P36; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Ge Y, 2011, PROTEOMICS, V11, P2406, DOI 10.1002/pmic.201000741; Gorbunov B, 2009, ANN OCCUP HYG, V53, P225, DOI 10.1093/annhyg/mep002; Haniu H, 2011, J PROTEOMICS, V74, P2703, DOI 10.1016/j.jprot.2011.03.004; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Kerbiriou M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008436; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuhlbusch TAJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-22; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Lee J, 2010, ACS NANO, V4, P3580, DOI 10.1021/nn100866w; Lesniak A, 2012, ACS NANO, V6, P5845, DOI 10.1021/nn300223w; Liberda EN, 2010, INHAL TOXICOL, V22, P95, DOI 10.3109/08958378.2010.515269; Lu X, 2011, INT J NANOMED, V6, P1889, DOI 10.2147/IJN.S24005; Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g; Maynard AD, 2011, TOXICOL SCI, V120, pS109, DOI 10.1093/toxsci/kfq372; McCarthy J, 2012, CHEM RES TOXICOL, V25, P2227, DOI 10.1021/tx3002884; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Morimoto Yasuo, 2008, Sangyo Eiseigaku Zasshi, V50, P37, DOI 10.1539/sangyoeisei.50.37; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nasir A, 2010, CLIN DERMATOL, V28, P581, DOI 10.1016/j.clindermatol.2009.06.006; Nel A, 2012, ACC CHEM RES; Ozgen U, 2000, CYTOMETRY, V42, P74, DOI 10.1002/(SICI)1097-0320(20000215)42:1<74::AID-CYTO11>3.0.CO;2-6; Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005; Priestly BG, 2007, MED J AUSTRALIA, V186, P187, DOI 10.5694/j.1326-5377.2007.tb00859.x; Rabolli V, 2011, TOXICOL LETT, V206, P197, DOI 10.1016/j.toxlet.2011.07.013; Rivera-Gil P, 2012, ACC CHEM RES; Sandford F, 2003, MICROSC RES TECHNIQ, V62, P336, DOI 10.1002/jemt.10400; Sayes CM, 2009, WIRES NANOMED NANOBI, V1, P660, DOI 10.1002/wnan.58; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22; Srivastava RK, 2013, HUM EXP TOXICOL, V32, P153, DOI 10.1177/0960327112462725; Stamm H, 2012, FOOD ADDIT CONTAM A, V29, P1175, DOI 10.1080/19440049.2012.689778; Stoehr LC, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-36; Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116; Tsuda H, 2009, ASIAN PAC J CANCER P, V10, P975; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wisniowski PE, 2000, AM J RESP CRIT CARE, V162, P733, DOI 10.1164/ajrccm.162.2.9808015; Yang XF, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-1; Ye YY, 2010, TOXICOL IN VITRO, V24, P751, DOI 10.1016/j.tiv.2010.01.001; Yuan JF, 2012, TOXICOL SCI, V126, P149, DOI 10.1093/toxsci/kfr332; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001; Zhu ZY, 2008, PROTEOMICS, V8, P1987, DOI 10.1002/pmic.200700901	62	34	34	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72363	10.1371/journal.pone.0072363	http://dx.doi.org/10.1371/journal.pone.0072363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023737	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600018
J	Tijdink, JK; Vergouwen, ACM; Smulders, YM				Tijdink, Joeri K.; Vergouwen, Anton C. M.; Smulders, Yvo M.			Publication Pressure and Burn Out among Dutch Medical Professors: A Nationwide Survey	PLOS ONE			English	Article							ASSOCIATION; CHAIRS; DISTRESS; SCIENCE; LIFE	Background: Publication of scientific research papers is important for professionals working in academic medical centres. Quantitative measures of scientific output determine status and prestige, and serve to rank universities as well as individuals. The pressure to generate maximum scientific output is high, and quantitative aspects may tend to dominate over qualitative ones. How this pressure influences professionals' perception of science and their personal well-being is unknown. Methods and Findings: We performed an online survey inviting all medical professors (n = 1206) of the 8 academic medical centres in The Netherlands to participate. They were asked to fill out 2 questionnaires; a validated Publication Pressure Questionnaire and the Maslach Burnout Inventory. In total, 437 professors completed the questionnaires. among them, 54% judge that publication pressure 'has become excessive', 39% believe that publication pressure 'affects the credibility of medical research' and 26% judge that publication pressure has a 'sickening effect on medical science'. The burn out questionnaire indicates that 24% of medical professors have signs of burn out. The number of years of professorship was significantly related with experiencing less publication pressure. Significant and strong associations between burn out symptoms and the level of perceived publication pressure were found. The main limitation is the possibility of response bias. Conclusion: A substantial proportion of medical professors believe that publication pressure has become excessive, and have a cynical view on the validity of medical science. These perceptions are statistically correlated to burn out symptoms. Further research should address the effects of publication pressure in more detail and identify alternative ways to stimulate the quality of medical science.	[Tijdink, Joeri K.; Smulders, Yvo M.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Tijdink, Joeri K.] Tergooi Hosp, Dept Psychiat, Blaricum, Netherlands; [Vergouwen, Anton C. M.] St Lucas Andreas Hosp, Dept Psychiat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Tergooi Blaricum; Sint Lucas Andreas Hospital	Tijdink, JK (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands.	j.tijdink@vumc.nl	Smulders, YM/AAG-7506-2021	Tijdink, Joeri/0000-0002-1826-2274				Adler NJ, 2009, ACAD MANAG LEARN EDU, V8, P72, DOI 10.5465/AMLE.2009.37012181; Anderson MS, 2007, SCI ENG ETHICS, V13, P387, DOI 10.1007/s11948-007-9047-0; Anderson MS, 2007, J EMPIR RES HUM RES, V2, P3, DOI 10.1525/jer.2007.2.4.3; Bedeian AG, 2009, ORGAN RES METHODS, V12, P238; Benedetti A, 2004, STAT MED, V23, P3781, DOI 10.1002/sim.2073; Bird SJ, 2006, SCI ENG ETHICS, V12, P411, DOI 10.1007/s11948-006-0040-9; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Cruz OA, 2007, OPHTHALMOLOGY, V114, P2350, DOI 10.1016/j.ophtha.2007.04.058; Davis MS, 2007, SCI ENG ETHICS, V13, P395, DOI 10.1007/s11948-007-9045-2; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1060, DOI 10.1001/jama.292.9.1060; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Feller I, 1996, COMPETITIVENESS ACAD; Gabbe SG, 2002, AM J OBSTET GYNECOL, V186, P601, DOI 10.1067/mob.2002.122391; Gannon F, 2000, EMBO REP, V1, P293, DOI 10.1093/embo-reports/kvd081; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Glick WH, 2007, J ORGAN BEHAV, V28, P817, DOI 10.1002/job.455; Hessels LK, 2010, THESIS UTRECHT U; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Johns MM, 2005, LARYNGOSCOPE, V115, P2056, DOI 10.1097/01.MLG.0000181492.36179.8B; Joinson A, 1999, BEHAV RES METH INS C, V31, P433, DOI 10.3758/BF03200723; Klein DB, 2005, CRIT REV, V17, P257; Louis KS, 2013, REV HIGH EDUC, V18, P393; Maslach C., 1996, MASLACH BURNOUT INVE; Miller AN, 2011, CAREER DEV INT, V16, P422, DOI 10.1108/13620431111167751; Prins JT, 2010, MED EDUC, V44, P236, DOI 10.1111/j.1365-2923.2009.03590.x; Retzer V, 2009, BASIC APPL ECOL, V10, P393, DOI 10.1016/j.baae.2008.09.001; Saleh KJ, 2007, J BONE JOINT SURG AM, V89A, P896, DOI 10.2106/JBJS.F.00987; Schaufeli WB, 2000, UTRECHTSE BURNOUT SC; Shapin S., 2008, SCI LIFE MORAL HIST; Sheldon T, 2012, BMJ-BRIT MED J, V344, P2898; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tijdink JK, 2013, ASSESSMENT  IN PRESS; van Dalen HP, 2012, J AM SOC INF SCI TEC, V63, P1282, DOI 10.1002/asi.22636; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	37	54	55	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73381	10.1371/journal.pone.0073381	http://dx.doi.org/10.1371/journal.pone.0073381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023865	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600097
J	Wegrzyn, JL; Lin, BY; Zieve, JJ; Dougherty, WM; Martinez-Garcia, PJ; Koriabine, M; Holtz-Morris, A; deJong, P; Crepeau, M; Langley, CH; Puiu, D; Salzberg, SL; Neale, DB; Stevens, KA				Wegrzyn, Jill L.; Lin, Brian Y.; Zieve, Jacob J.; Dougherty, William M.; Martinez-Garcia, Pedro J.; Koriabine, Maxim; Holtz-Morris, Ann; deJong, Pieter; Crepeau, Marc; Langley, Charles H.; Puiu, Daniela; Salzberg, Steven L.; Neale, David B.; Stevens, Kristian A.			Insights into the Loblolly Pine Genome: Characterization of BAC and Fosmid Sequences	PLOS ONE			English	Article							GYPSY-LIKE RETROTRANSPOSON; CUCUMBER CUCUMIS-SATIVUS; TRANSPOSABLE ELEMENTS; HUMAN DNA; EVOLUTION; REPEATS; FAMILIES; GENES; MICROSATELLITES; CLASSIFICATION	Despite their prevalence and importance, the genome sequences of loblolly pine, Norway spruce, and white spruce, three ecologically and economically important conifer species, are just becoming available to the research community. Following the completion of these large assemblies, annotation efforts will be undertaken to characterize the reference sequences. Accurate annotation of these ancient genomes would be aided by a comprehensive repeat library; however, few studies have generated enough sequence to fully evaluate and catalog their non-genic content. In this paper, two sets of loblolly pine genomic sequence, 103 previously assembled BACs and 90,954 newly sequenced and assembled fosmid scaffolds, were analyzed. Together, this sequence represents 280 Mbp (roughly 1% of the loblolly pine genome) and one of the most comprehensive studies of repetitive elements and genes in a gymnosperm species. A combination of homology and de novo methodologies were applied to identify both conserved and novel repeats. Similarity analysis estimated a repetitive content of 27% that included both full and partial elements. When combined with the de novo investigation, the estimate increased to almost 86%. Over 60% of the repetitive sequence consists of full or partial LTR (long terminal repeat) retrotransposons. Through de novo approaches, 6,270 novel, full-length transposable element families and 9,415 sub-families were identified. Among those 6,270 families, 82% were annotated as single-copy. Several of the novel, high-copy families are described here, with the largest, PtPiedmont, comprising 133 full-length copies. In addition to repeats, analysis of the coding region reported 23 full-length eukaryotic orthologous proteins (KOGS) and another 29 novel or orthologous genes. These discoveries, along with other genomic resources, will be used to annotate conifer genomes and address long-standing questions about gymnosperm evolution.	[Wegrzyn, Jill L.; Lin, Brian Y.; Zieve, Jacob J.; Martinez-Garcia, Pedro J.; Neale, David B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Dougherty, William M.; Crepeau, Marc; Langley, Charles H.; Stevens, Kristian A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Koriabine, Maxim; Holtz-Morris, Ann; deJong, Pieter] Childrens Hosp Oakland Res Inst, Oakland, CA USA; [Puiu, Daniela; Salzberg, Steven L.] Johns Hopkins Univ, Ctr Computat Biol, McKusick Nathans Inst Genet Med, Baltimore, MD USA	University of California System; University of California Davis; University of California System; University of California Davis; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Johns Hopkins University	Wegrzyn, JL (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jlwegrzyn@ucdavis.edu; kastevens@ucdavis.edu	Salzberg, Steven L/F-6162-2011; Martinez-Garcia, Pedro Jose/AAK-1814-2020; Wegrzyn, Jill/H-3745-2019; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Martinez-Garcia, Pedro Jose/0000-0002-7647-5235; Wegrzyn, Jill/0000-0001-5923-0888; Salzberg, Steven/0000-0002-8859-7432; Crepeau, Marc/0000-0002-3639-3921	USDA/NIFA [2011-67009-30030]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG008345] Funding Source: NIH RePORTER	USDA/NIFA(United States Department of Agriculture (USDA)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding for this project was made available through the USDA/NIFA (2011-67009-30030) award to DBN at University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Aronesty E., 2011, EA UTILS COMMAND LIN; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bautista R, 2007, ANN FOREST SCI, V64, P855, DOI 10.1051/forest:2007060; Bennett MD, 2004, PLANT DNA C VALUES D; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Burleigh J. G., 2012, Journal of Botany, V2012, P292857; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Civan P., 2011, Journal of Botany, V2011, P893546, DOI 10.1155/2011/893546; Davis TM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-81; Dondoshansky I, 2002, BLASTCLUST NCBI SOFT; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Elsik CG, 2001, MOL GENET GENOMICS, V265, P535, DOI 10.1007/s004380100443; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Frederick WJ, 2008, BIORESOURCE TECHNOL, V99, P5051, DOI 10.1016/j.biortech.2007.08.086; Friesen N, 2001, MOL BIOL EVOL, V18, P1176, DOI 10.1093/oxfordjournals.molbev.a003905; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hamberger B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-106; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Hao DC, 2011, MOL GENET GENOMICS, V285, P197, DOI 10.1007/s00438-010-0598-4; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeffreys AJ, 1998, EMBO J, V17, P4147, DOI 10.1093/emboj/17.14.4147; Jiang N, 2001, PLANT CELL, V13, P2553, DOI 10.1105/tpc.13.11.2553; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kamm A, 1996, P NATL ACAD SCI USA, V93, P2708, DOI 10.1073/pnas.93.7.2708; Kejnovsky E, 2012, PLANT GENOME DIVERSI, V1, P17; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kossack DS, 1999, PLANT MOL BIOL, V39, P417, DOI 10.1023/A:1006115732620; Kovach A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-420; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kumekawa N, 2001, MOL GENET GENOMICS, V265, P480, DOI 10.1007/s004380000436; Kuykendall David, 2009, Int J Plant Genomics, V2009, P576742, DOI 10.1155/2009/576742; L'Homme Y, 2000, GENOME, V43, P1084, DOI 10.1139/gen-43-6-1084; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lange C, 2008, GENOME, V51, P948, DOI 10.1139/G08-071; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li XG, 2011, GENE, V487, P62, DOI 10.1016/j.gene.2011.07.028; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liu WX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-553; Lorenz WW, 2012, TREE GENET GENOMES, V8, P1477, DOI 10.1007/s11295-012-0547-y; Mackay J, 2012, PLANT MOL BIOL, V80, P555, DOI 10.1007/s11103-012-9961-7; Magbanua ZV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016214; McKeand S, 2003, J FOREST, V101, P32; Meyer JDF, 2008, MOL GENET GENOMICS, V279, P473, DOI 10.1007/s00438-008-0326-5; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Nagarajan N, 2008, TROPICAL PLANT BIOL, V1, P191; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Noma K, 1999, MOL GEN GENET, V261, P71, DOI 10.1007/s004380050943; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Peterson D. G., 2000, Journal of Agricultural Genomics, V5, P1; Peterson DG, 2002, TRENDS GENET, V18, P547, DOI 10.1016/S0168-9525(02)02764-6; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Quesneville H, 2003, J MOL EVOL, V57, pS50, DOI 10.1007/s00239-003-0007-2; Raj M, 2005, SILVAE GENET, V54, P126, DOI 10.1515/sg-2005-0020; Rampant PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-292; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; RICHARDS EJ, 1988, CELL, V53, P127, DOI 10.1016/0092-8674(88)90494-1; Rocheta M, 2007, PLANTA, V225, P551, DOI 10.1007/s00425-006-0370-5; Rocheta Margarida, 2012, BMC Res Notes, V5, P432, DOI 10.1186/1756-0500-5-432; Schmidt A, 2000, THEOR APPL GENET, V101, P7, DOI 10.1007/s001220051442; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; SMITH DN, 1994, GENOME, V37, P977, DOI 10.1139/g94-138; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Steinbiss S, 2009, NUCLEIC ACIDS RES, V37, P7002, DOI 10.1093/nar/gkp759; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vitte C, 2006, P NATL ACAD SCI USA, V103, P17638, DOI 10.1073/pnas.0605618103; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wegrzyn Jill L, 2008, Int J Plant Genomics, V2008, P412875, DOI 10.1155/2008/412875; Wei LJ, 2013, MOL PLANT, V6, P470, DOI 10.1093/mp/sss081; Wicker T, 2005, PLANT J, V41, P184, DOI 10.1111/j.1365-313X.2004.02285.x; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu JJ, 2012, PLANT MOL BIOL, V78, P95, DOI 10.1007/s11103-011-9849-y	92	38	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72439	10.1371/journal.pone.0072439	http://dx.doi.org/10.1371/journal.pone.0072439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023741	Green Submitted, gold, Green Published			2022-12-27	WOS:000324515600021
J	Cheong, H; Kim, CY; Jeon, JS; Lee, BM; Moon, JS; Hwang, I				Cheong, Hoon; Kim, Chi-Yeol; Jeon, Jong-Seong; Lee, Byoung-Moo; Moon, Jae Sun; Hwang, Ingyu			Xanthomonas oryzae pv. oryzae Type III Effector XopN Targets OsVOZ2 and a Putative Thiamine Synthase as a Virulence Factor in Rice	PLOS ONE			English	Article							BACTERIAL-BLIGHT PATHOGEN; PROTEIN SECRETION SYSTEM; ONE-ZINC-FINGER; TAL EFFECTORS; TRANSCRIPTION FACTORS; TRIGGERED IMMUNITY; CAMPESTRIS; RESISTANCE; DISEASE; GENES	Xanthomonas oryzae pv. oryzae (Xoo) is spread systemically through the xylem tissue and causes bacterial blight in rice. We evaluated the roles of Xanthomonas outer proteins (Xop) in the Xoo strain KXO85 in a Japonica-type rice cultivar, Dongjin. Five xop gene knockout mutants (xopQ(KXO85), xop(XKXO85), xopP1(KXO85), xopP2(KXO85), and xopN(KXO85)) were generated by EZ-Tn5 mutagenesis, and their virulence was assessed in 3-month-old rice leaves. Among these mutants, the xopN(KXO85) mutant appeared to be less virulent than the wild-type KXO85; however, the difference was not statistically significant. In contrast, the xopN(KXO85) mutant exhibited significantly less virulence in flag leaves after flowering than the wild-type KXO85. These observations indicate that the roles of Xop in Xoo virulence are dependent on leaf stage. We chose the xopN gene for further characterization because the xopN(KXO85) mutant showed the greatest influence on virulence. We confirmed that XopN(KXO85) is translocated into rice cells, and its gene expression is positively regulated by HrpX. Two rice proteins, OsVOZ2 and a putative thiamine synthase (OsXNP), were identified as targets of XopN(KXO85) by yeast two-hybrid screening. Interactions between XopN(KXO85) and OsVOZ2 and OsXNP were further confirmed in planta by bimolecular fluorescence complementation and in vivo pull-down assays. To investigate the roles of OsVOZ2 in interactions between rice and Xoo, we evaluated the virulence of the wild-type KXO85 and xopN(KXO85) mutant in the OsVOZ2 mutant line PFG_3A-07565 of Dongjin. The wild-type KXO85 and xopN(KXO85) mutant were significantly less virulent in the mutant rice line. These results indicate that XopN(KXO85) and OsVOZ2 play important roles both individually and together for Xoo virulence in rice.	[Cheong, Hoon; Hwang, Ingyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Chi-Yeol; Jeon, Jong-Seong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin, South Korea; [Kim, Chi-Yeol; Jeon, Jong-Seong] Kyung Hee Univ, Crop Biotech Inst, Yongin, South Korea; [Lee, Byoung-Moo] Natl Acad Agr Sci, Rural Dev Adm, Suwon, South Korea; [Moon, Jae Sun] Korea Res Inst Biosci & Biotechnol, Plant Syst Engn Res Ctr, Daejeon, South Korea	Seoul National University (SNU); Kyung Hee University; Kyung Hee University; Rural Development Administration (RDA); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Hwang, I (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	ingyu@snu.ac.kr	Jeon, Jong-Seong/AAJ-2161-2020	Jeon, Jong-Seong/0000-0001-6221-4993	National Research Foundation of Korea [2010-0018280]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was partially supported by the Creative Research Initiatives Programmes (2010-0018280) of the National Research Foundation of Korea (http://www.nrf.re.kr). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IP, 2007, PLANT PHYSIOL, V143, P838, DOI 10.1104/pp.106.092627; Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; Akimoto-Tomiyama C, 2012, MOL PLANT MICROBE IN, V25, P505, DOI 10.1094/MPMI-06-11-0167; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Bai JF, 2000, MOL PLANT MICROBE IN, V13, P1322, DOI 10.1094/MPMI.2000.13.12.1322; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Boureau T, 2011, MOL PLANT MICROBE IN, V24, P577, DOI 10.1094/MPMI-09-10-0212; Buttner D, 2009, PLANT PHYSIOL, V150, P1656, DOI 10.1104/pp.109.139089; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Canonne J, 2011, PLANT CELL, V23, P3498, DOI 10.1105/tpc.111.088815; Cho JI, 2009, PLANT PHYSIOL, V149, P745, DOI 10.1104/pp.108.131227; Crabill E, 2012, MOL MICROBIOL, V85, P225, DOI 10.1111/j.1365-2958.2012.08097.x; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; GOEL RK, 1990, TROP AGR, V67, P368; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Hossain MA, 2010, J PLANT PHYSIOL, V167, P1512, DOI 10.1016/j.jplph.2010.05.008; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Hwang IS, 2012, PLANTA, V236, P1191, DOI 10.1007/s00425-012-1672-4; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jiang BL, 2008, RES MICROBIOL, V159, P216, DOI 10.1016/j.resmic.2007.12.004; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529; Kim JG, 2013, CELL HOST MICROBE, V13, P143, DOI 10.1016/j.chom.2013.01.006; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Metz M, 2005, PLANT J, V41, P801, DOI 10.1111/j.1365-313X.2005.02338.x; MEW TW, 1987, ANNU REV PHYTOPATHOL, V25, P359, DOI 10.1146/annurev.py.25.090187.002043; Meyer D, 2006, J BACTERIOL, V188, P4903, DOI 10.1128/JB.00180-06; Mitsuda N, 2004, PLANT CELL PHYSIOL, V45, P845, DOI 10.1093/pcp/pch101; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Nakai Y, 2013, PLANT J, V73, P761, DOI 10.1111/tpj.12069; Petnicki-Ocwieja T, 2005, J BACTERIOL, V187, P649, DOI 10.1128/JB.187.2.649-663.2005; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; SAMBROOK J, 1997, MOL CLONING LAB MANU; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Song CF, 2010, MOL PLANT MICROBE IN, V23, P893, DOI 10.1094/MPMI-23-7-0893; Sugio A, 2005, MOL PLANT MICROBE IN, V18, P546, DOI 10.1094/MPMI-18-0546; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Tsuge Seiji, 2002, Journal of General Plant Pathology, V68, P363, DOI 10.1007/PL00013104; Verdier V, 2012, NEW PHYTOL, V196, P1197, DOI 10.1111/j.1469-8137.2012.04367.x; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Yamaguchi K, 2013, CELL HOST MICROBE, V13, P347, DOI 10.1016/j.chom.2013.02.007; Yasui Y, 2012, PLANT CELL, V24, P3248, DOI 10.1105/tpc.112.101915; Yu YH, 2011, MOL PLANT MICROBE IN, V24, P1102, DOI 10.1094/MPMI-11-10-0254; ZHANG Q, 1985, PLANT DIS, V69, P896; Zhao S, 2013, WORLD J MICROB BIOT, V29, P733, DOI 10.1007/s11274-012-1229-5; Zhu WG, 2000, J BACTERIOL, V182, P1844, DOI 10.1128/JB.182.7.1844-1853.2000	57	29	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73346	10.1371/journal.pone.0073346	http://dx.doi.org/10.1371/journal.pone.0073346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019919	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200061
J	Cun, YP; Frohlich, H				Cun, Yupeng; Froehlich, Holger			Network and Data Integration for Biomarker Signature Discovery via Network Smoothed T-Statistics	PLOS ONE			English	Article							BREAST-CANCER; PROSTATE-CANCER; ANDROGEN RECEPTOR; PATHWAY KNOWLEDGE; SIGNALING PATHWAY; GENE SELECTION; R-PACKAGE; EXPRESSION; CLASSIFICATION; GROWTH	Predictive, stable and interpretable gene signatures are generally seen as an important step towards a better personalized medicine. During the last decade various methods have been proposed for that purpose. However, one important obstacle for making gene signatures a standard tool in clinics is the typical low reproducibility of signatures combined with the difficulty to achieve a clear biological interpretation. For that purpose in the last years there has been a growing interest in approaches that try to integrate information from molecular interaction networks. We here propose a technique that integrates network information as well as different kinds of experimental data (here exemplified by mRNA and miRNA expression) into one classifier. This is done by smoothing t-statistics of individual genes or miRNAs over the structure of a combined protein-protein interaction (PPI) and miRNA-target gene network. A permutation test is conducted to select features in a highly consistent manner, and subsequently a Support Vector Machine (SVM) classifier is trained. Compared to several other competing methods our algorithm reveals an overall better prediction performance for early versus late disease relapse and a higher signature stability. Moreover, obtained gene lists can be clearly associated to biological knowledge, such as known disease genes and KEGG pathways. We demonstrate that our data integration strategy can improve classification performance compared to using a single data source only. Our method, called stSVM, is available in R-package netClass on CRAN (http://cran.r-project.org).	[Cun, Yupeng; Froehlich, Holger] Bonn Aachen Int Ctr IT, Bonn, Germany		Frohlich, H (corresponding author), Bonn Aachen Int Ctr IT, Bonn, Germany.	frohlich@bit.uni-bonn.de	Fröhlich, Holger/H-1976-2017; Cun, Yupeng/B-5864-2011	Fröhlich, Holger/0000-0002-5328-1243; Cun, Yupeng/0000-0002-4241-8099	state of NRW via the B-IT research school	state of NRW via the B-IT research school	YC was supported by the state of NRW via the B-IT research school. HF is a member of the excellence cluster ImmunoSensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-18; Blazadonakis ME, 2011, IEEE T INF TECHNOL B, V15, P155, DOI 10.1109/TITB.2010.2072964; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brys M, 2004, ONCOL REP, V11, P219; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Ceccarelli C, 1998, J CLIN PATHOL, V51, P818, DOI 10.1136/jcp.51.11.818; Cerami Ethan G, 2011, Nucleic Acids Res, V39, pD685, DOI 10.1093/nar/gkq1039; Chapelle O, 2002, MACH LEARN, V46, P131, DOI 10.1023/A:1012450327387; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Chung F, 2007, P NATL ACAD SCI USA, V104, P19735, DOI 10.1073/pnas.0708838104; Clement JH, 1999, INT J CANCER, V80, P250, DOI 10.1002/(SICI)1097-0215(19990118)80:2<250::AID-IJC14>3.0.CO;2-D; Correa-Cerro L, 1999, EUR J HUM GENET, V7, P357, DOI 10.1038/sj.ejhg.5200298; Cun Yupeng, 2012, Biology (Basel), V1, P5, DOI 10.3390/biology1010005; Cun YP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-69; De Bie T, 2007, BIOINFORMATICS, V23, pI125, DOI 10.1093/bioinformatics/btm187; Fiorentino M, 2010, CANCER RES, V70, P3136, DOI 10.1158/0008-5472.CAN-09-4100; Gade S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-488; Gao CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S19; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Goncalves JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049634; Gonen Mithat, 2009, Gastrointest Cancer Res, V3, pS19; Gonzalez R, 1999, BRIT J CANCER, V81, P503, DOI 10.1038/sj.bjc.6690722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo Z, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-58; Gutierrez NC, 2010, LEUKEMIA, V24, P629, DOI 10.1038/leu.2009.274; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Johannes M, 2011, BIOINFORMATICS, V27, P1442, DOI 10.1093/bioinformatics/btr157; Johannes M, 2010, BIOINFORMATICS, V26, P2136, DOI 10.1093/bioinformatics/btq345; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Marsh KL, 1998, BRIT J CANCER, V77, P1460, DOI 10.1038/bjc.1998.240; Moreau Y, 2012, NATURE REV GENETICS; Morrison JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-233; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Papp J, 1996, BRIT J CANCER, V74, P1592, DOI 10.1038/bjc.1996.594; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Scholkopf B., 2002, LEARNING KERNELS; Shaw G, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-3; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Staiger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034796; Sukhtankar D, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-81; Sun YJ, 2009, PROSTATE, V69, P1119, DOI 10.1002/pros.20961; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Terasawa K, 1999, CANCER LETT, V142, P207, DOI 10.1016/S0304-3835(99)00170-6; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tran B, 2012, J CLIN ONCOL, V30, P647, DOI 10.1200/JCO.2011.39.2316; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Winter C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002511; Yardy GW, 2006, BJU INT, V98, P719, DOI 10.1111/j.1464-410X.2006.06339.x; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77; Zhu YN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S21	66	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73074	10.1371/journal.pone.0073074	http://dx.doi.org/10.1371/journal.pone.0073074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019896	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200038
J	Dumaual, CM; Steere, BA; Walls, CD; Wang, M; Zhang, ZY; Randall, SK				Dumaual, Carmen M.; Steere, Boyd A.; Walls, Chad D.; Wang, Mu; Zhang, Zhong-Yin; Randall, Stephen K.			Integrated Analysis of Global mRNA and Protein Expression Data in HEK293 Cells Overexpressing PRL-1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REGENERATING LIVER 1; TANDEM MASS-SPECTRA; LUNG-CANCER CELLS; LARGE GENE LISTS; TYROSINE-PHOSPHATASE; LINKED KINASE; MATRICELLULAR PROTEIN; DOWN-REGULATION; BREAST-CANCER	Background: The protein tyrosine phosphatase PRL-1 represents a putative oncogene with wide-ranging cellular effects. Overexpression of PRL-1 can promote cell proliferation, survival, migration, invasion, and metastasis, but the underlying mechanisms by which it influences these processes remain poorly understood. Methodology: To increase our comprehension of PRL-1 mediated signaling events, we employed transcriptional profiling (DNA microarray) and proteomics (mass spectrometry) to perform a thorough characterization of the global molecular changes in gene expression that occur in response to stable PRL-1 overexpression in a relevant model system (HEK293). Principal Findings: Overexpression of PRL-1 led to several significant changes in the mRNA and protein expression profiles of HEK293 cells. The differentially expressed gene set was highly enriched in genes involved in cytoskeletal remodeling, integrin-mediated cell-matrix adhesion, and RNA recognition and splicing. In particular, members of the Rho signaling pathway and molecules that converge on this pathway were heavily influenced by PRL-1 overexpression, supporting observations from previous studies that link PRL-1 to the Rho GTPase signaling network. In addition, several genes not previously associated with PRL-1 were found to be significantly altered by its expression. Most notable among these were Filamin A, RhoGDI alpha, SPARC, hnRNPH2, and PRDX2. Conclusions and Significance: This systems-level approach sheds new light on the molecular networks underlying PRL-1 action and presents several novel directions for future, hypothesis-based studies.	[Dumaual, Carmen M.; Randall, Stephen K.] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA; [Steere, Boyd A.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Walls, Chad D.; Wang, Mu; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Eli Lilly; Indiana University System; Indiana University Bloomington	Dumaual, CM (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA.	czambran@iupui.edu; steere_boyd_a@lilly.com; srandal@iupui.edu		Randall, Stephen/0000-0002-8637-9407	IUPUI RSFG grant; National Institutes of Health Grant [CA69202]; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER	IUPUI RSFG grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by an IUPUI RSFG grant awarded to SKR and a National Institutes of Health Grant CA69202 awarded to ZYZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; [Anonymous], [No title captured]; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Aranda JF, 2011, MOL BIOL CELL, V22, P1252, DOI 10.1091/mbc.E10-11-0910; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bai YP, 2011, J BIOL CHEM, V286, P42316, DOI 10.1074/jbc.M111.286302; Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Baldini G, 2008, J CELL BIOCHEM, V104, P2310, DOI 10.1002/jcb.21789; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Basu A, 2011, PROSTATE, V71, P755, DOI 10.1002/pros.21292; Beck KF, 2001, LIFE SCI, V69, P2945, DOI 10.1016/S0024-3205(01)01403-5; Benelli D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032047; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhoopathi P, 2011, CELL SIGNAL, V23, P1978, DOI 10.1016/j.cellsig.2011.07.008; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boissan M, 2010, CANCER RES, V70, P7710, DOI 10.1158/0008-5472.CAN-10-1887; Boulter E, 2006, EUR J CELL BIOL, V85, P255, DOI 10.1016/j.ejcb.2005.09.002; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Busch A, 2012, WIRES RNA, V3, P1, DOI 10.1002/wrna.100; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Chlenski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023880; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Cho William C. S., 2007, Genomics Proteomics & Bioinformatics, V5, P77, DOI 10.1016/S1672-0229(07)60018-7; Choi MS, 2011, BIOCHEM BIOPH RES CO, V406, P305, DOI 10.1016/j.bbrc.2011.02.037; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; Chua CEL, 2010, FEBS LETT, V584, P1, DOI 10.1016/j.febslet.2009.11.051; Clark CJ, 2008, J CELL BIOCHEM, V104, P721, DOI 10.1002/jcb.21688; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Daouti S, 2008, CANCER RES, V68, P1162, DOI 10.1158/0008-5472.CAN-07-2349; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Diamond RH, 1996, AM J PHYSIOL-GASTR L, V271, pG121, DOI 10.1152/ajpgi.1996.271.1.G121; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Dumaual CM, 2012, AM J TRANSL RES, V4, P83; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fenouille N, 2011, ONCOGENE, V30, P4887, DOI 10.1038/onc.2011.198; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Fielding A, 2009, CANCER METAST REV, V28, P99, DOI 10.1007/s10555-008-9177-0; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Germann S, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/269570; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Goldman RD, 2012, J STRUCT BIOL, V177, P14, DOI 10.1016/j.jsb.2011.11.017; Goo K, 2006, CANCER RES, V66, P9625, DOI 10.1158/0008-5472.CAN-06-0726; Gooden MD, 1999, J CELL BIOCHEM, V74, P152, DOI 10.1002/(SICI)1097-4644(19990801)74:2<152::AID-JCB2>3.0.CO;2-4; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Guo SC, 2003, INT J ONCOL, V23, P933; Hale JE, 2004, ANAL BIOCHEM, V333, P174, DOI 10.1016/j.ab.2004.04.013; Helvering LM, 2005, BIOL REPROD, V72, P830, DOI 10.1095/biolreprod.104.034595; Higgs RE, 2005, J PROTEOME RES, V4, P1442, DOI 10.1021/pr050109b; Higgs RE, 2007, J PROTEOME RES, V6, P1758, DOI 10.1021/pr0605320; Higgs Richard E., 2008, V428, P209; Ho TTG, 2011, MOL BIOL CELL, V22, P3263, DOI 10.1091/mbc.E11-01-0020; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ishii T, 2012, J CLIN BIOCHEM NUTR, V50, P91, DOI 10.3164/jcbn.11-109; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Jackson WM, 2008, AM J PHYSIOL-CELL PH, V295, pC1007, DOI 10.1152/ajpcell.00509.2007; Kanakkanthara A, 2012, PHARM RES; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Liu Y, 2012, BLOOD, V119, P445, DOI 10.1182/blood-2011-07-368860; Liu YQ, 2008, ARCH PATHOL LAB MED, V132, P1307, DOI 10.1043/1543-2165(2008)132[1307:EOPORL]2.0.CO;2; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; McClung HM, 2007, NEUROSCI LETT, V419, P172, DOI 10.1016/j.neulet.2007.04.037; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Min SH, 2009, ONCOGENE, V28, P545, DOI 10.1038/onc.2008.409; MOHN KL, 1991, MOL CELL BIOL, V11, P381, DOI 10.1128/MCB.11.1.381; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nakashima Masanao, 2010, J Pharmacol Exp Ther, V334, P627, DOI 10.1124/jpet.110.167809; Noh DY, 2001, ANTICANCER RES, V21, P2085; Parr C, 2010, ANTI-CANCER AGENT ME, V10, P47, DOI 10.2174/1871520611009010047; Pavasant P, 2008, ORAL DIS, V14, P335, DOI 10.1111/j.1601-0825.2007.01383.x; Penuelas S, 2005, FEBS J, V272, P696, DOI 10.1111/j.1742-4658.2004.04504.x; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; Piruzian E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-41; Polanski R, 2011, CARCINOGENESIS, V32, P1133, DOI 10.1093/carcin/bgr070; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Reich R, 2011, INT J MOL SCI, V12, P1133, DOI 10.3390/ijms12021133; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rivera LB, 2011, CELL MOL LIFE SCI, V68, P3165, DOI 10.1007/s00018-011-0781-8; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Rodriguez IR, 2000, INVEST OPHTH VIS SCI, V41, P2438; Schwartz MA, 2001, J CELL SCI, V114, P2553; Scime A, 2010, MECH AGEING DEV, V131, P9, DOI 10.1016/j.mad.2009.11.001; Simard JP, 2011, J CELL SCI, V124, P2367, DOI 10.1242/jcs.081745; Skinner AL, 2009, BIOCHEMISTRY-US, V48, P4262, DOI 10.1021/bi900241k; Stephens B, 2008, MOL CANCER THER, V7, P202, DOI 10.1158/1535-7163.MCT-07-0542; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sun JP, 2007, J BIOL CHEM, V282, P29043, DOI 10.1074/jbc.M703537200; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Takano S, 1996, MOL BRAIN RES, V40, P105, DOI 10.1016/0169-328X(96)00035-6; Vial E, 2000, ONCOGENE, V19, P5020, DOI 10.1038/sj.onc.1203867; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; Wang J, 2002, J BIOL CHEM, V277, P46659, DOI 10.1074/jbc.M206407200; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Weighardt F, 1996, BIOESSAYS, V18, P747, DOI 10.1002/bies.950180910; Werner SR, 2003, CANCER LETT, V202, P201, DOI 10.1016/S0304-3835(03)00517-2; Wheldon LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010264; Wilson KS, 2002, AM J PATHOL, V161, P1171, DOI 10.1016/S0002-9440(10)64394-5; Yan Q, 1998, J HISTOCHEM CYTOCHEM, V46, P3, DOI 10.1177/002215549804600102; Yarovinsky TO, 2000, MOL BRAIN RES, V77, P95, DOI 10.1016/S0169-328X(00)00045-0; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yu L, 2007, BBA-MOL CELL RES, V1773, P1473, DOI 10.1016/j.bbamcr.2007.06.005; Zeng Q, 2003, CANCER RES, V63, P2716; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	120	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72977	10.1371/journal.pone.0072977	http://dx.doi.org/10.1371/journal.pone.0072977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019887	Green Submitted, gold, Green Published			2022-12-27	WOS:000324338200029
J	Gupte, M; Tuck, AN; Sharma, VP; Williams, KJ				Gupte, Maithili; Tuck, Andrew N.; Sharma, Vishal P.; Williams, Kandace J.			Major Differences between Tumor and Normal Human Cell Fates after Exposure to Chemotherapeutic Monofunctional Alkylator	PLOS ONE			English	Article							DNA MISMATCH REPAIR; DAMAGE-RESPONSE; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; TEMOZOLOMIDE RESISTANCE; MOLECULAR-MECHANISMS; MSH6 MUTATIONS; MUTL-ALPHA; CYCLE; PARP; THERAPY	The major dilemma of cancer chemotherapy has always been a double-edged sword, producing resistance in tumor cells and life-threatening destruction of nontumorigenic tissue. Glioblastoma is the most common form of primary brain tumor, with median survival at 14 months after surgery, radiation and temozolomide (monofunctional alkylator) therapy. Treatment failure is most often due to temozolomide-resistant tumor growth. The underlying basis for development of tumor cell resistance to temozolomide instead of death is not understood. Our current results demonstrate that both cervical carcinoma (HeLa MR) and glioblastoma (U251) tumor cells exposed to an equivalent chemotherapeutic concentration of a monofunctional alkylator undergo multiple cell cycles, maintenance of metabolic activity, and a prolonged time to death that involves accumulation of Apoptosis Inducing Factor (AIF) within the nucleus. A minority of the tumor cell population undergoes senescence, with minimal caspase cleavage. Surviving tumor cells are comprised of a very small subpopulation of individual cells that eventually resume proliferation, out of which resistant cells emerge. In contrast, normal human cells (MCF12A) exposed to a monofunctional alkylator undergo an immediate decrease in metabolic activity and subsequent senescence. A minority of the normal cell population undergoes cell death by the caspase cleavage pathway. All cytotoxic events occur within the first cell cycle in nontumorigenic cells. In summation, we have demonstrated that two different highly malignant tumor cell lines slowly undergo very altered cellular and temporal responses to chemotherapeutic monofunctional alkylation, as compared to rapid responses of normal cells. In the clinic, this produces resistance and growth of tumor cells, cytotoxicity of normal cells, and death of the patient.	[Williams, Kandace J.] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43606 USA; [Gupte, Maithili] Amgen Inc, Seattle, WA USA; [Tuck, Andrew N.] Univ Michigan, Ann Arbor, MI 48109 USA; [Sharma, Vishal P.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA	University of Toledo; Amgen; University of Michigan System; University of Michigan; Bowling Green State University	Williams, KJ (corresponding author), Univ Toledo, Coll Med, Dept Biochem & Canc Biol, 2801 W Bancroft St, Toledo, OH 43606 USA.	Kandace.williams@utoledo.edu			NIH [CA106575]; University of Toledo College of Medicine SURF undergraduate program; NATIONAL CANCER INSTITUTE [R01CA106575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toledo College of Medicine SURF undergraduate program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH grant CA106575, University of Toledo College of Medicine SURF undergraduate program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvino E, 2006, INT J ONCOL, V29, P785; Arko L, 2010, PHARMACOL THERAPEUT, V128, P1, DOI 10.1016/j.pharmthera.2010.04.015; Auger N, 2006, MOL CANCER THER, V5, P2182, DOI 10.1158/1535-7163.MCT-05-0428; Bartek J, 2012, J NEUROL NEUROSUR PS, V83, P753, DOI 10.1136/jnnp-2011-300709; de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866; Bhakat KK, 2003, CARCINOGENESIS, V24, P1337, DOI 10.1093/carcin/bgg086; Bignami M, 2000, MUTAT RES-REV MUTAT, V462, P71, DOI 10.1016/S1383-5742(00)00016-8; Borovski T, 2013, ONCOGENE, V32, P1539, DOI 10.1038/onc.2012.172; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Casorelli I, 2012, INT J ENV RES PUB HE, V9, P2636, DOI 10.3390/ijerph9082636; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Clarke MJ, 2009, MOL CANCER THER, V8, P407, DOI 10.1158/1535-7163.MCT-08-0854; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Do K, 2013, CLIN CANCER RES, V19, P977, DOI 10.1158/1078-0432.CCR-12-0163; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Fojo T, 2013, CANCER DISCOV, V3, P20, DOI 10.1158/2159-8290.CD-12-0514; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Genschel J, 2009, J BIOL CHEM, V284, P21536, DOI 10.1074/jbc.M109.021287; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Hangen E, 2010, TRENDS BIOCHEM SCI, V35, P278, DOI 10.1016/j.tibs.2009.12.008; Happold C, 2012, J NEUROCHEM, V122, P444, DOI 10.1111/j.1471-4159.2012.07781.x; HAWN MT, 1995, CANCER RES, V55, P3721; Horton JK, 2013, MOL CANCER RES, V11, P13, DOI 10.1158/1541-7786.MCR-12-0512; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Jascur T, 2011, J BIOL CHEM, V286, P29531, DOI 10.1074/jbc.M111.221341; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lalezari S, 2013, NEUROONCOLOGY; Lea JS, 2007, REPROD SCI, V14, P20, DOI 10.1177/1933719106298189; Lin DP, 2004, CANCER RES, V64, P517, DOI 10.1158/0008-5472.CAN-03-2957; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Margison GP, 2003, CARCINOGENESIS, V24, P625, DOI 10.1093/carcin/bgg005; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mo Wei, 2012, Int J Biochem Mol Biol, V3, P1; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Overmeyer JH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-69; Pabla N, 2011, J BIOL CHEM, V286, P10411, DOI 10.1074/jbc.M110.210989; Reid JM, 1997, CLIN CANCER RES, V3, P2393; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Schroering AG, 2008, DNA REPAIR, V7, P951, DOI 10.1016/j.dnarep.2008.03.023; Schroering AG, 2007, EXP CELL RES, V313, P292, DOI 10.1016/j.yexcr.2006.10.018; Schroering AG, 2009, CANCER RES, V69, P6307, DOI 10.1158/0008-5472.CAN-09-0899; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Sharma S, 2009, ANTICANCER RES, V29, P3759; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Umar A, 1997, CANCER RES, V57, P3949; VAN MEIR EG, 1994, CANCER RES, V54, P649; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Yasaei H, 2013, ONCOGENE, V32, P171, DOI 10.1038/onc.2012.45; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103	65	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74071	10.1371/journal.pone.0074071	http://dx.doi.org/10.1371/journal.pone.0074071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019948	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200091
J	Gurusinghe, S; Brown, RD; Cai, XC; Samuel, CS; Ricardo, SD; Thomas, MC; Kett, MM				Gurusinghe, Seshini; Brown, Russell D.; Cai, Xiaochu; Samuel, Chrishan S.; Ricardo, Sharon D.; Thomas, Merlin C.; Kett, Michelle M.			Does a Nephron Deficit Exacerbate the Renal and Cardiovascular Effects of Obesity?	PLOS ONE			English	Article							MICE LACKING GDNF; DIET-INDUCED OBESITY; KIDNEY DONORS; INDUCED HYPERTENSION; HETEROZYGOUS MICE; RESERVE CAPACITY; BLOOD-PRESSURE; DISEASE; ENDOWMENT; NUMBER	It has been hypothesized that a reduced nephron endowment exacerbates the hypertensive and renal effects of obesity. We therefore examined the impact of diet-induced obesity on renal structure and function, and arterial pressure in a genetic model of reduced nephron endowment, the GDNF Heterozygous (HET) mouse. 6wk-old male GDNF WT and HET mice were placed on control or high fat (HFF) diet for 20 weeks. 24 hr arterial pressure, heart rate and activity (radiotelemetry), creatinine clearance and albumin excretion were measured, and kidneys collected (histopathology, collagen content). Bodyweights of HFF WT (50.6 +/- 1.2 g) and HET (48.8 +/- 1.4 g) mice were similar to 14 g greater than control mice (37.3 +/- 1.3 g, 36.4 +/- 1.1 g respectively; Pdiet<0.001). Obesity led to significantly greater 24 hr MAP (Pdiet<0.001), heart rate (Pdiet<0.01) and lower locomotor activity (Pdiet<0.01) in HET and WT mice. Whilst there was no significant impact of genotype on 24 hr MAP response to obesity, night-time MAP of obese HET mice was significantly greater than obese WT mice (122.3 +/- 1.6 vs 116.9 +/- 1.3 mmHg; P<0.05). 24 hr creatinine clearance was 50%, and albumin excretion 180% greater in obese WT and HET mice compared to controls (Pdiet<0.05) but this response did not differ between genotypes. Obesity induced glomerulomegaly, glomerulosclerosis, tubulointerstitial expansion and increased collagen accumulation (total, collagen I, V and IV; Pdiet<0.001). Obese GDNF HET mice had exacerbated total renal collagen (P<0.01), and greater levels of the collagen I subtype compared to kidneys of obese WT mice. In summary, obese nephron-deficient GDNF HET mice were able to maintain the high creatinine clearances of obese WT mice but at the expense of higher MAP and greater renal fibrosis. Whilst modest, our findings support the hypothesis that a reduced nephron endowment increases the susceptibility to obesity-induced kidney disease and hypertension.	[Gurusinghe, Seshini; Brown, Russell D.; Cai, Xiaochu] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Samuel, Chrishan S.] Univ Melbourne, Howard Florey Inst, Parkville, Vic 3052, Australia; [Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Ricardo, Sharon D.; Kett, Michelle M.] Monash Univ, Dept Anat & Cell Biol, Clayton, Vic, Australia; [Thomas, Merlin C.] Baker IDI Heart & Diabet Inst, Prahran, Vic, Australia	Monash University; Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Monash University; Baker Heart and Diabetes Institute	Kett, MM (corresponding author), Monash Univ, Dept Anat & Cell Biol, Clayton, Vic, Australia.	Michelle.Kett@monash.edu		Thomas, Merlin/0000-0003-0694-8743; Ricardo, Sharon/0000-0003-1724-3669	NHMRC [491042]; Monash University; National Heart Foundation of Australia	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by NHMRC (Project Grant 491042). CS Samuel was supported by a Mid-Career Fellowship from Monash University and MM Kett was supported by a Fellowship from the National Heart Foundation of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan MA, 2011, AM J PATHOL, V179, P1243, DOI 10.1016/j.ajpath.2011.05.037; Benz K, 2011, AM J PHYSIOL-RENAL, V300, pF521, DOI 10.1152/ajprenal.00490.2009; Carroll JF, 2002, MED SCI SPORT EXER, V34, P596, DOI 10.1097/00005768-200204000-00006; Cochrane AL, 2005, J AM SOC NEPHROL, V16, P3623, DOI 10.1681/ASN.2004090771; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Cullen-McEwen LA, 2001, KIDNEY INT, V60, P31, DOI 10.1046/j.1523-1755.2001.00767.x; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Dunn SR, 2004, KIDNEY INT, V65, P1959, DOI 10.1111/j.1523-1755.2004.00600.x; GALLOP PM, 1975, PHYSIOL REV, V55, P418, DOI 10.1152/physrev.1975.55.3.418; Gonzalez E, 2005, KIDNEY INT, V68, P263, DOI 10.1111/j.1523-1755.2005.00401.x; Goumenos DS, 2009, NEPHROL DIAL TRANSPL, V24, P3732, DOI 10.1093/ndt/gfp329; Griffin KA, 2008, AM J PHYSIOL-RENAL, V294, pF695, DOI 10.1152/ajprenal.00324.2007; HALL JE, 1993, HYPERTENSION, V22, P292, DOI 10.1161/01.HYP.22.3.292; Hall JE, 1999, ANN NY ACAD SCI, V892, P91, DOI 10.1111/j.1749-6632.1999.tb07788.x; Howitt L, 2011, AM J PHYSIOL-HEART C, V301, pH29, DOI 10.1152/ajpheart.00134.2011; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Jordan J, 2011, J HYPERTENS, V29, P437, DOI 10.1097/HJH.0b013e3283435af0; Maric C, 2011, CONTRIB NEPHROL, V170, P28, DOI 10.1159/000324941; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nenov VD, 2000, CURR OPIN NEPHROL HY, V9, P85, DOI 10.1097/00041552-200003000-00001; Nogueira JM, 2010, TRANSPLANTATION, V90, P993, DOI 10.1097/TP.0b013e3181f6a058; OLIVER JR, 1990, AM J PHYSIOL, V258, pH221, DOI 10.1152/ajpheart.1990.258.1.H221; PERELSTEIN EM, 1990, ARCH DIS CHILD, V65, P728, DOI 10.1136/adc.65.7.728; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Praga M, 2005, NEPHROL DIAL TRANSPL, V20, P2594, DOI 10.1093/ndt/gfi201; Praga M, 2000, KIDNEY INT, V58, P2111, DOI 10.1046/j.1523-1755.2000.00384.x; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; Rook M, 2008, AM J TRANSPLANT, V8, P2077, DOI 10.1111/j.1600-6143.2008.02355.x; Rook M, 2006, AM J TRANSPLANT, V6, P1653, DOI 10.1111/j.1600-6143.2006.01359.x; Ruta LAM, 2010, AM J PHYSIOL-RENAL, V298, pF1384, DOI 10.1152/ajprenal.00049.2010; Samuel CS, 1996, ENDOCRINOLOGY, V137, P3884, DOI 10.1210/en.137.9.3884; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Shweta A, 2009, AM J PHYSIOL-RENAL, V296, pF583, DOI 10.1152/ajprenal.90359.2008; Tavakol MM, 2009, CLIN J AM SOC NEPHRO, V4, P1230, DOI 10.2215/CJN.01350209; Walker KA, 2012, AM J PHYSIOL-RENAL, V303, pF253, DOI 10.1152/ajprenal.00028.2012; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x; Woods LL, 2001, HYPERTENSION, V38, P337, DOI 10.1161/01.HYP.38.3.337	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73095	10.1371/journal.pone.0073095	http://dx.doi.org/10.1371/journal.pone.0073095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019901	Green Published, gold			2022-12-27	WOS:000324338200043
J	Huang, C; Yu, QB; Lv, RH; Yin, QQ; Chen, GY; Xu, L; Yang, ZN				Huang, Chao; Yu, Qing-Bo; Lv, Ruo-Hong; Yin, Qian-Qian; Chen, Gen-Yun; Xu, Ling; Yang, Zhong-Nan			The Reduced Plastid-Encoded Polymerase-Dependent Plastid Gene Expression Leads to the Delayed Greening of the Arabidopsis fln2 Mutant	PLOS ONE			English	Article							TRANSCRIPTIONALLY ACTIVE CHROMOSOME; CHLOROPLAST DEVELOPMENT; RNA-POLYMERASE; HIGHER-PLANTS; PROTEIN; GROWTH; LIGHT; BIOGENESIS; REGULATORS; MATURATION	In Arabidopsis leaf coloration mutants, the delayed greening phenomenon is common. Nonetheless, the mechanism remains largely elusive. Here, a delayed greening mutant fln2-4 of FLN2 (Fructokinase-Like Protein2) was studied. FLN2 is one component of Transcriptionally Active Chromosome (TAC) complex which is thought to contain the complete plastiden-coded polymerase (PEP). fln2-4 displayed albino phenotype on medium without sucrose. The PEP-dependent plastid gene expression and chloroplast development were inhibited in fln2-4. Besides interacting with thioredoxin z (TRX z), we identified that FLN2 interacted with another two members of TAC complex in yeast including its homologous protein FLN1 (Fructokinase-Like Protein1) and pTAC5. This indicates that FLN2 functions in regulation of PEP activity associated with these TAC components. fln2-4 exhibited delayed greening on sucrose-containing medium. Comparison of the PEP-dependent gene expression among two complete albino mutants (trx z and ptac14), two yellow mutants (ecb2-2 and ys1) and the fln2-4 showed that fln2-4 remains partial PEP activity. FLN2 and FLN1 are the target proteins of TRX z involved in affecting the PEP activity. Together with the data that FLN1 could interact with itself in yeast, FLN1 may form a homodimer to replace FLN1-FLN2 as the TRX z target in redox pathway for maintaining partial PEP activity in fln2-4. We proposed the partial PEP activity in the fln2 mutant allowed plastids to develop into fully functional chloroplasts when exogenous sucrose was supplied, and finally the mutants exhibited green phenotype.	[Huang, Chao; Yu, Qing-Bo; Lv, Ruo-Hong; Yin, Qian-Qian; Yang, Zhong-Nan] Shanghai Normal Univ, Dept Biol, Coll Life & Environm Sci, Shanghai, Peoples R China; [Huang, Chao; Xu, Ling] E China Normal Univ, Dept Biol, Sch Life Sci, Shanghai 200062, Peoples R China; [Chen, Gen-Yun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China	Shanghai Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, ZN (corresponding author), Shanghai Normal Univ, Dept Biol, Coll Life & Environm Sci, Shanghai, Peoples R China.	znyang@shnu.edu.cn	Yang, Zhong-Nan/F-5570-2012; yu, qing/HGC-4611-2022	Yang, Zhong-Nan/0000-0002-5918-2385; 	National Basic Research Program of China [2009CB118504]; National Science Foundation of China [31100965]; Shanghai Municipal Natural Science Foundation [10ZR1421800]; Leading Academic Discipline Project of the Shanghai Municipal Education Commission [J50401]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; Leading Academic Discipline Project of the Shanghai Municipal Education Commission	This work was supported by grants from the National Basic Research Program of China (grant number 2009CB118504), National Science Foundation of China (grant number 31100965), the Shanghai Municipal Natural Science Foundation (grant number 10ZR1421800) and the Leading Academic Discipline Project of the Shanghai Municipal Education Commission (grant number J50401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2010, PLANT CELL, V22, P3423, DOI 10.1105/tpc.110.074781; Allison LA, 1996, EMBO J, V15, P2802, DOI 10.1002/j.1460-2075.1996.tb00640.x; Arsova B, 2010, PLANT CELL, V22, P1498, DOI 10.1105/tpc.109.071001; Barnes SA, 1996, PLANT CELL, V8, P601, DOI 10.1105/tpc.8.4.601; Cao ZL, 2011, J INTEGR PLANT BIOL, V53, P258, DOI 10.1111/j.1744-7909.2011.01030.x; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Chi W, 2010, PLANT J, V64, P14, DOI 10.1111/j.1365-313X.2010.04304.x; Dietz KJ, 2011, PLANT PHYSIOL, V155, P1477, DOI 10.1104/pp.110.170043; Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4; Gao ZP, 2011, PLANT PHYSIOL, V157, P1733, DOI 10.1104/pp.111.184762; Gilkerson J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-102; Hajdukiewicz PTJ, 1997, EMBO J, V16, P4041, DOI 10.1093/emboj/16.13.4041; HALLICK RB, 1976, BIOCHEMISTRY-US, V15, P3039, DOI 10.1021/bi00659a016; Hudson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026765; IGLOI GL, 1992, CRIT REV PLANT SCI, V10, P525, DOI 10.1080/07352689209382326; Inaba T, 2010, PLANT CELL PHYSIOL, V51, P1847, DOI 10.1093/pcp/pcq147; Kobayashi K, 2012, PLANT CELL, V24, P1081, DOI 10.1105/tpc.111.092254; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Link G, 2003, ANTIOXID REDOX SIGN, V5, P79, DOI 10.1089/152308603321223568; Motohashi R, 2001, P NATL ACAD SCI USA, V98, P10499, DOI 10.1073/pnas.181304598; Myouga F, 2008, PLANT CELL, V20, P3148, DOI 10.1105/tpc.108.061341; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Ogawa T, 2009, PLANT PHYSIOL, V151, P114, DOI 10.1104/pp.109.139683; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Pogson BJ, 2011, PLANT PHYSIOL, V155, P1545, DOI 10.1104/pp.110.170365; REISS T, 1985, EUR J BIOCHEM, V148, P207, DOI 10.1111/j.1432-1033.1985.tb08826.x; Rushlow KE, 1982, ISOLATION PURIFICATI, P543; Shiina T, 2005, INT REV CYTOL, V244, P1, DOI 10.1016/S0074-7696(05)44001-2; Shimada H, 2007, PLANT CELL, V19, P3157, DOI 10.1105/tpc.107.051714; Shipman-Roston RL, 2010, PLANT PHYSIOL, V152, P1297, DOI 10.1104/pp.109.151977; Steiner S, 2011, PLANT PHYSIOL, V157, P1043, DOI 10.1104/pp.111.184515; Suck R, 1996, CURR GENET, V30, P515, DOI 10.1007/s002940050164; Tang WJ, 2012, PLANT CELL, V24, P1984, DOI 10.1105/tpc.112.097022; vonArnim A, 1996, ANNU REV PLANT PHYS, V47, P215, DOI 10.1146/annurev.arplant.47.1.215; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Yagi Y, 2012, P NATL ACAD SCI USA, V109, P7541, DOI 10.1073/pnas.1119403109; Yamamoto YY, 2000, PLANT CELL PHYSIOL, V41, P68, DOI 10.1093/pcp/41.1.68; Yu QB, 2013, PHYSIOL PLANTARUM, V148, P408, DOI 10.1111/j.1399-3054.2012.01718.x; Zhelyazkova P, 2012, PLANT CELL, V24, P123, DOI 10.1105/tpc.111.089441; Zhong SW, 2009, P NATL ACAD SCI USA, V106, P21431, DOI 10.1073/pnas.0907670106; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	41	20	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73092	10.1371/journal.pone.0073092	http://dx.doi.org/10.1371/journal.pone.0073092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019900	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200042
J	Khan, W; Duffy, F; Pollastri, G; Shields, DC; Mooney, C				Khan, Waqasuddin; Duffy, Fergal; Pollastri, Gianluca; Shields, Denis C.; Mooney, Catherine			Predicting Binding within Disordered Protein Regions to Structurally Characterised Peptide-Binding Domains	PLOS ONE			English	Article							SHORT LINEAR MOTIFS; WEB SERVER; DATABASE; DOCKING; NETWORKS; COMPLEX; CONTEXT; SYSTEMS; FUTURE; SITES	Disordered regions of proteins often bind to structured domains, mediating interactions within and between proteins. However, it is difficult to identify a priori the short disordered regions involved in binding. We set out to determine if docking such peptide regions to peptide binding domains would assist in these predictions. We assembled a redundancy reduced dataset of SLiM (Short Linear Motif) containing proteins from the ELM database. We selected 84 sequences which had an associated PDB structures showing the SLiM bound to a protein receptor, where the SLiM was found within a 50 residue region of the protein sequence which was predicted to be disordered. First, we investigated the Vina docking scores of overlapping tripeptides from the 50 residue SLiM containing disordered regions of the protein sequence to the corresponding PDB domain. We found only weak discrimination of docking scores between peptides involved in binding and adjacent non-binding peptides in this context (AUC 0.58). Next, we trained a bidirectional recurrent neural network (BRNN) using as input the protein sequence, predicted secondary structure, Vina docking score and predicted disorder score. The results were very promising (AUC 0.72) showing that multiple sources of information can be combined to produce results which are clearly superior to any single source. We conclude that the Vina docking score alone has only modest power to define the location of a peptide within a larger protein region known to contain it. However, combining this information with other knowledge (using machine learning methods) clearly improves the identification of peptide binding regions within a protein sequence. This approach combining docking with machine learning is primarily a predictor of binding to peptide-binding sites, and is not intended as a predictor of specificity of binding to particular receptors.	[Khan, Waqasuddin; Duffy, Fergal; Pollastri, Gianluca; Shields, Denis C.; Mooney, Catherine] Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 2, Ireland; [Khan, Waqasuddin] Univ Karachi, Int Ctr Chem & Biol Sci, Hussain Ebrahim Jamal Res Inst Chem, Karachi, Pakistan; [Duffy, Fergal; Shields, Denis C.; Mooney, Catherine] Univ Coll Dublin, Conway Inst Biomol & Biomed Sci, Dublin 2, Ireland; [Duffy, Fergal; Shields, Denis C.; Mooney, Catherine] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Pollastri, Gianluca] Univ Coll Dublin, Sch Comp Sci & Informat, Dublin 2, Ireland	University College Dublin; University of Karachi; University College Dublin; University College Dublin; University College Dublin	Shields, DC (corresponding author), Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 2, Ireland.	denis.shields@ucd.ie	Duffy, Fergal/AAN-6743-2020; Khan, Waqasuddin/AAF-7771-2019	Duffy, Fergal/0000-0002-4675-0937; Khan, Waqasuddin/0000-0001-7995-8163; Pollastri, Gianluca/0000-0002-5825-4949; Mooney, Catherine/0000-0002-7696-1364; Shields, Denis/0000-0003-4015-2474	Science Foundation Ireland [08/IN.1/B1864]; European Commission (EC) Erasmus Mundus Europe Asia (EMEA) Split-Doctoral Scholarship Scheme in University College Dublin (UCD), Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Commission (EC) Erasmus Mundus Europe Asia (EMEA) Split-Doctoral Scholarship Scheme in University College Dublin (UCD), Ireland	This work was supported by Science Foundation Ireland principal investigator grant [grant number 08/IN.1/B1864] to D. C. Shields. W. Khan gratefully acknowledges the award of a European Commission (EC) Erasmus Mundus Europe Asia (EMEA) Split-Doctoral Scholarship Scheme in University College Dublin (UCD), Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Baldi P, 1999, BIOINFORMATICS, V15, P937, DOI 10.1093/bioinformatics/15.11.937; Bau D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-402; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blanchevoye C, 2013, J BIOL CHEM, V288, P1317, DOI 10.1074/jbc.M112.419929; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cross JB, 2009, J CHEM INF MODEL, V49, P1455, DOI 10.1021/ci900056c; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Davey NE, 2011, NUCLEIC ACIDS RES, V39, pW56, DOI 10.1093/nar/gkr402; Davey NE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-14; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Duffy FJ, 2011, J CHEM INF MODEL, V51, P829, DOI 10.1021/ci100431r; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Haslam NJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-104; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Khan W, 2013, UCDCSI201301; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Lee SH, 2012, CURR PROTEIN PEPT SC, V13, P34, DOI 10.2174/138920312799277974; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mi T, 2012, NUCLEIC ACIDS RES, V40, pD252, DOI 10.1093/nar/gkr1189; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mosca R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000490; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Norris R, 2012, FOOD CHEM, V133, P1349, DOI 10.1016/j.foodchem.2012.02.023; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; R Development Core Team, 2008, R LANG ENV STAT COMP; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Stein A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000789; Stein A, 2009, FEBS J, V276, P5390, DOI 10.1111/j.1742-4658.2009.07251.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334	53	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72838	10.1371/journal.pone.0072838	http://dx.doi.org/10.1371/journal.pone.0072838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019881	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200023
J	Reychler, G; Caty, G; Vincent, A; Billo, S; Yombi, JC				Reychler, Gregory; Caty, Gilles; Vincent, Anne; Billo, Simon; Yombi, Jean-Cyr			Validation of the French Version of the World Health Organization Quality of Life HIV Instrument	PLOS ONE			English	Article							WHOQOL-HIV; SURVEY SF-36; INFECTION; IMPACT; ADULTS; COST; BREF	Purpose: Quality of life is a key element in the follow-up of people living with HIV/AIDS. The main purpose of this study was to validate the French version of the WHOQOL-HIV instrument by comparing this instrument to a generic questionnaire. The second objective was to test the reproducibility of this questionnaire. Method: The WHOQOL-HIV and SF-36 questionnaires were filled out by 50 patients on two separate occasions with a time interval of 2 weeks. The internal consistency, validity and reliability of the WHOQOL-HIV were evaluated. Results: The internal consistency was acceptable for the different domains, with Cronbach's alpha ranging from 0.937 to 0.944. The facet-domain correlations were all statistically significant (p<0.001). There was a correlation between the domains from the WHOQOL-HIV and SF-36 questionnaires, with coefficients ranging from 0.349 to 0.763 (p<0.05 for all), except for the Spirituality domain. The test-retest reliability was suitable for all domains and facets, with statistically significant intra-class coefficients between 0.615 and 0.931. Conclusion: This study demonstrated that the French translation of the WHOQOL-HIV instrument is a valid and reproducible tool for the evaluation of the quality of life for HIV-infected patients.	[Reychler, Gregory] Catholic Univ Louvain, IREC, Pole Pneumol ENT & Dermatol, B-1200 Brussels, Belgium; [Reychler, Gregory] Clin Univ St Luc, Serv Pneumol, B-1200 Brussels, Belgium; [Reychler, Gregory; Caty, Gilles; Billo, Simon] Clin Univ St Luc, Dept Med Phys & Readaptat, B-1200 Brussels, Belgium; [Vincent, Anne; Yombi, Jean-Cyr] Clin Univ St Luc, Ctr Prise Charge VIH, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Reychler, G (corresponding author), Catholic Univ Louvain, IREC, Pole Pneumol ENT & Dermatol, B-1200 Brussels, Belgium.	gregory.reychler@uclouvain.be						Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Bachmann MO, 2006, AIDS CARE, V18, P109, DOI 10.1080/09540120500159334; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Belgian Scientific Institute of Public Health, 2011, EP AIDS HIV INF BELG; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Campsmith Michael L, 2003, Health Qual Life Outcomes, V1, P12, DOI 10.1186/1477-7525-1-12; Canavarro MC, 2011, AIDS CARE, V23, P187, DOI 10.1080/09540121.2010.498870; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Hays RD, 2000, AM J MED, V108, P714, DOI 10.1016/S0002-9343(00)00387-9; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Hsiung PC, 2005, QUAL LIFE RES, V14, P141, DOI 10.1007/s11136-004-6252-z; Hsiung PC, 2011, AIDS CARE, V23, P1035, DOI 10.1080/09540121.2010.543881; Mahalakshmy T, 2011, Indian J Community Med, V36, P203, DOI 10.4103/0970-0218.86521; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Mrus JM, 2006, QUAL LIFE RES, V15, P503, DOI 10.1007/s11136-005-1946-4; Mweemba P, 2011, J ASSOC NURSE AIDS C, V22, P53, DOI 10.1016/j.jana.2010.04.006; Nickerson CAE, 1997, BIOMETRICS, V53, P1503, DOI 10.2307/2533516; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; O'Connell K, 2003, SOC SCI MED, V57, P1259, DOI 10.1016/S0277-9536(02)00506-3; O'Connell KA, 2004, AIDS CARE, V16, P882, DOI 10.1080/09540120412331290194; Ogbuji Q C, 2010, Afr J Med Med Sci, V39, P127; Oguntibeju OO, 2012, HIV AIDS-RES PALLIAT, V4, P117, DOI 10.2147/HIV.S32321; Olsen M, 2012, QUAL LIFE RES; PERNEGER TV, 1995, J CLIN EPIDEMIOL, V48, P1051, DOI 10.1016/0895-4356(94)00227-H; Razavi Pedram, 2012, AIDS Res Treat, V2012, P849406, DOI 10.1155/2012/849406; Reis RK, 2012, AIDS CARE, V24, P626, DOI 10.1080/09540121.2011.630345; Saxena S, 2003, AIDS CARE, V15, P347, DOI 10.1080/0954012031000105405; Saxena Shekhar, 2002, Gerontologist, V42 Spec No 3, P81; Sherbourne CD, 2000, AM J PSYCHIAT, V157, P248, DOI 10.1176/appi.ajp.157.2.248; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Skevington SM, 2012, AIDS CARE, V24, P1219, DOI 10.1080/09540121.2012.661838; Skevington SM, 2010, AIDS CARE, V22, P614, DOI 10.1080/09540120903311466; Starace F, 2002, AIDS CARE, V14, P405, DOI 10.1080/09540120220123793a; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; UNAIDS, 2012, DEC POINT FRANC NO N; Walters Stephen J, 2004, Health Qual Life Outcomes, V2, P26, DOI 10.1186/1477-7525-2-26; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zimpel RR, 2007, AIDS CARE, V19, P923, DOI 10.1080/09540120701213765	43	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73180	10.1371/journal.pone.0073180	http://dx.doi.org/10.1371/journal.pone.0073180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019904	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200046
J	Das, KC				Das, Kumuda C.			Hyperoxia Decreases Glycolytic Capacity, Glycolytic Reserve and Oxidative Phosphorylation in MLE-12 Cells and Inhibits Complex I and II Function, but Not Complex IV in Isolated Mouse Lung Mitochondria	PLOS ONE			English	Article							HAMSTER OVARY CELLS; ELECTRON-TRANSPORT; NORMOBARIC HYPEROXIA; GROWTH ARREST; RAT LUNGS; OXYGEN; METABOLISM; EXPRESSION; ATP	High levels of oxygen (hyperoxia) are frequently used in critical care units and in conditions of respiratory insufficiencies in adults, as well as in infants. However, hyperoxia has been implicated in a number of pulmonary disorders including bronchopulmonary dysplasia (BPD) and adult respiratory distress syndrome (ARDS). Hyperoxia increases the generation of reactive oxygen species (ROS) in the mitochondria that could impair the function of the mitochondrial electron transport chain. We analyzed lung mitochondrial function in hyperoxia using the XF24 analyzer (extracellular flux) and optimized the assay for lung epithelial cells and mitochondria isolated from lungs of mice. Our data show that hyperoxia decreases basal oxygen consumption rate (OCR), spare respiratory capacity, maximal respiration and ATP turnover in MLE-12 cells. There was significant decrease in glycolytic capacity and glycolytic reserve in MLE-12 cells exposed to hyperoxia. Using mitochondria isolated from lungs of mice exposed to hyperoxia or normoxia we have shown that hyperoxia decreased the basal, state 3 and state3 m (respiration in an uncoupled state) respirations. Further, using substrate or inhibitor of a specific complex we show that the OCR via complex I and II, but not complex IV was decreased, demonstrating that complexes I and II are specific targets of hyperoxia. Further, the activities of complex I (NADH dehydrogenase, NADH-DH) and complex II (succinate dehydrogenase, SDH) were decreased in hyperoxia, but the activity of complex IV (cytochrome oxidase, COX) remains unchanged. Taken together, our study show that hyperoxia impairs glycolytic and mitochondrial energy metabolism in in tact cells, as well as in lungs of mice by selectively inactivating components of electron transport system.	Texas Tech Univ, Hlth Sci Ctr, Dept Anesthesiol, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Das, KC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Anesthesiol, Lubbock, TX 79430 USA.	kumuda.das@ttuhsc.edu			National Institutes of Health [HL 1R01HL107885-01, 1R01HL109397-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107885, R01HL109397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work presented here is supported by National Institutes of Health grants HL 1R01HL107885-01 and 1R01HL109397-01 to KCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABMAN SH, 1984, J PEDIATR-US, V104, P928, DOI 10.1016/S0022-3476(84)80501-6; Ahmad S, 2001, AM J PHYSIOL-LUNG C, V280, pL779, DOI 10.1152/ajplung.2001.280.4.L779; Allen CB, 1998, AM J PHYSIOL-LUNG C, V274, pL320, DOI 10.1152/ajplung.1998.274.3.L320; Allen CB, 1998, AM J PHYSIOL-LUNG C, V274, pL159, DOI 10.1152/ajplung.1998.274.1.L159; BALIN AK, 1976, J CELL PHYSIOL, V89, P235, DOI 10.1002/jcp.1040890207; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Campian JL, 2004, J BIOL CHEM, V279, P46580, DOI 10.1074/jbc.M406685200; Carlson DE, 2005, J BIOENERG BIOMEMBR, V37, P327, DOI 10.1007/s10863-005-8644-3; CARNEY DN, 1981, P NATL ACAD SCI-BIOL, V78, P3185, DOI 10.1073/pnas.78.5.3185; de Duve C, 1971, J Cell Biol, V50, P20; DERVARTANIAN DV, 1964, BIOCHIM BIOPHYS ACTA, V92, P233, DOI 10.1016/0926-6569(64)90182-8; Dos Santos CC, 2007, CRIT CARE, V11, DOI 10.1186/cc5733; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; McGrath-Morrow SA, 2001, BBA-MOL CELL RES, V1538, P90, DOI 10.1016/S0167-4889(00)00142-7; Ratner V, 2009, AM J RESP CELL MOL, V40, P511, DOI 10.1165/rcmb.2008-0341RC; REISS OK, 1966, J CELL BIOL, V30, P45, DOI 10.1083/jcb.30.1.45; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; SANDERS SP, 1993, J CLIN INVEST, V91, P46, DOI 10.1172/JCI116198; Scatena R, 2004, J BIOCHEM MOL BIOL, V37, P454; Schober P, 2012, J CLIN MONIT COMPUT, V26, P255, DOI 10.1007/s10877-012-9350-4; SCHOONEN WGEJ, 1990, J BIOL CHEM, V265, P11118; Shenberger JS, 1999, AM J RESP CELL MOL, V21, P395, DOI 10.1165/ajrcmb.21.3.3604; SIMON LM, 1979, J APPL PHYSIOL, V47, P98, DOI 10.1152/jappl.1979.47.1.98; SUAREZ MD, 1984, J BIOL CHEM, V259, P3791; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; VANDERVALK P, 1988, FREE RADICAL BIO MED, V4, P345, DOI 10.1016/0891-5849(88)90086-X	29	62	63	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73358	10.1371/journal.pone.0073358	http://dx.doi.org/10.1371/journal.pone.0073358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023862	Green Submitted, Green Published, gold			2022-12-27	WOS:000324238400063
J	Sharifahmadian, M; Sarker, M; Palleboina, D; Waring, AJ; Walther, FJ; Morrow, MR; Booth, V				Sharifahmadian, Mahzad; Sarker, Muzaddid; Palleboina, Dharamaraju; Waring, Alan J.; Walther, Frans J.; Morrow, Michael R.; Booth, Valerie			Role of the N-Terminal Seven Residues of Surfactant Protein B (SP-B)	PLOS ONE			English	Article							RESPIRATORY-DISTRESS SYNDROME; MAGNETIC-RESONANCE-SPECTROSCOPY; CIRCULAR-DICHROISM SPECTRA; PULMONARY SURFACTANT; SECONDARY STRUCTURE; DETERGENT MICELLES; SYNTHETIC PEPTIDES; INSERTION-SEQUENCE; LIPID-BILAYERS; MINI-B	Breathing is enabled by lung surfactant, a mixture of proteins and lipids that forms a surface-active layer and reduces surface tension at the air-water interface in lungs. Surfactant protein B (SP-B) is an essential component of lung surfactant. In this study we probe the mechanism underlying the important functional contributions made by the N-terminal 7 residues of SP-B, a region sometimes called the "insertion sequence". These studies employed a construct of SP-B, SP-B (1-25,63-78), also called Super Mini-B, which is a 41-residue peptide with internal disulfide bonds comprising the N-terminal 7-residue insertion sequence and the N- and C-terminal helices of SP-B. Circular dichroism, solution NMR, and solid state H-2 NMR were used to study the structure of SP-B (1-25,63-78) and its interactions with phospholipid bilayers. Comparison of results for SP-B (8-25,63-78) and SP-B (1-25,63-78) demonstrates that the presence of the 7-residue insertion sequence induces substantial disorder near the centre of the lipid bilayer, but without a major disruption of the overall mechanical orientation of the bilayers. This observation suggests the insertion sequence is unlikely to penetrate deeply into the bilayer. The 7-residue insertion sequence substantially increases the solution NMR linewidths, most likely due to an increase in global dynamics.	[Sharifahmadian, Mahzad; Booth, Valerie] Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada; [Waring, Alan J.] Harbor UCLA, Dept Med, Div Mol Med, Torrance, CA USA; [Sarker, Muzaddid; Palleboina, Dharamaraju; Morrow, Michael R.; Booth, Valerie] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada; [Walther, Frans J.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Walther, Frans J.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands	Memorial University Newfoundland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Memorial University Newfoundland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Booth, V (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada.	vbooth@mun.ca	Booth, Valerie/AAH-5932-2019	Booth, Valerie/0000-0001-9342-9217; Walther, Frans/0000-0003-1931-159X	Canadian Institutes of Health Research (CIHR); NSERC; National Institutes of Health (NIH) [HL-092158, ES-015330, HL-080775]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL080775, R01HL092158, R43HL080775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015330] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by a Canadian Institutes of Health Research (CIHR) (http://www.cihr-irsc.gc.ca) Operating Grant to Valerie Booth (Structure-Function Based Molecular Design of Inactivation Resistant Lung Surfactants) and an NSERC (http://www.nserc-crsng.gc.ca) Discovery Grant to Michael Morrow (Lipid bilayer interactions and organization at ambient and high pressure). Alan J. Waring and Frans J. Walther were supported by National Institutes of Health (NIH) HL-092158, ES-015330, HL-080775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Antharam VC, 2009, BIOPHYS J, V96, P4085, DOI 10.1016/j.bpj.2008.12.3966; AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; BAATZ JE, 1991, CHEM PHYS LIPIDS, V60, P163, DOI 10.1016/0009-3084(91)90039-E; Baoukina S, 2010, BIOPHYS J, V99, P2134, DOI 10.1016/j.bpj.2010.07.049; Booth V, 2004, BIOCHEMISTRY-US, V43, P15187, DOI 10.1021/bi0481895; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; CLEMENTS JA, 1957, P SOC EXP BIOL MED, V95, P170; CREUWELS LAJM, 1995, J BIOL CHEM, V270, P16225, DOI 10.1074/jbc.270.27.16225; Crouch EC, 1998, BBA-MOL BASIS DIS, V1408, P278, DOI 10.1016/S0925-4439(98)00073-8; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Farver RS, 2010, BIOPHYS J, V99, P1773, DOI 10.1016/j.bpj.2010.06.076; Frey SL, 2010, AM J PHYSIOL-LUNG C, V298, pL335, DOI 10.1152/ajplung.00190.2009; Goddard T. D., SPARKY 3; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; Hallman M, 2001, COMP BIOCHEM PHYS A, V129, P287, DOI 10.1016/S1095-6433(01)00324-5; Hartog A, 1995, Monaldi Arch Chest Dis, V50, P372; Hawgood S, 1998, BBA-MOL BASIS DIS, V1408, P150, DOI 10.1016/S0925-4439(98)00064-7; HILDEBRAN JN, 1979, J APPL PHYSIOL, V47, P604, DOI 10.1152/jappl.1979.47.3.604; Johansson J, 1998, BBA-MOL BASIS DIS, V1408, P161, DOI 10.1016/S0925-4439(98)00065-9; Kang JH, 1996, BIOCHEM MOL BIOL INT, V40, P617; Kurutz JW, 2002, BIOCHEMISTRY-US, V41, P9627, DOI 10.1021/bi016077x; LAFLEUR M, 1989, BIOPHYS J, V56, P1037, DOI 10.1016/S0006-3495(89)82749-3; Lang CJ, 2005, AM J PHYSIOL-REG I, V289, pR1426, DOI 10.1152/ajpregu.00496.2004; Lewis JF, 2006, SEMIN RESP CRIT CARE, V27, P377, DOI 10.1055/s-2006-948291; McCormack FX, 1998, BBA-MOL BASIS DIS, V1408, P109, DOI 10.1016/S0925-4439(98)00062-3; MORRIS KF, 1992, J AM CHEM SOC, V114, P3139, DOI 10.1021/ja00034a071; MUNFORD RS, 1995, J LIPID RES, V36, P1653; Nilsson M, 2009, J MAGN RESON, V200, P296, DOI 10.1016/j.jmr.2009.07.022; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEMISTRY-US, V30, P10965, DOI 10.1021/bi00109a022; Palleboina D, 2012, EUR BIOPHYS J BIOPHY, V41, P755, DOI 10.1007/s00249-012-0850-4; PATTLE RE, 1955, NATURE, V175, P1125, DOI 10.1038/1751125b0; Perez-Gil J, 2002, BIOL NEONATE, V81, P6, DOI 10.1159/000056765; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Petsko G., 2004, PROTEIN STRUCTURE FU; POSSMAYER F, 1988, AM REV RESPIR DIS, V138, P990, DOI 10.1164/ajrccm/138.4.990; Possmayer F, 2010, RESP PHYSIOL NEUROBI, V173, pS55, DOI 10.1016/j.resp.2010.02.014; Postle AD, 2001, COMP BIOCHEM PHYS A, V129, P65, DOI 10.1016/S1095-6433(01)00306-3; PROSSER RS, 1991, BIOCHEMISTRY-US, V30, P4687, DOI 10.1021/bi00233a008; Pujals S, 2008, ADV DRUG DELIVER REV, V60, P473, DOI 10.1016/j.addr.2007.09.012; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; REVAK SD, 1991, PEDIATR RES, V29, P460, DOI 10.1203/00006450-199105010-00010; Ross M, 2002, EUR BIOPHYS J BIOPHY, V31, P52, DOI 10.1007/s002490100181; Salnikov ES, 2009, BIOCHIMIE; Sarker M, 2007, BIOCHEMISTRY-US, V46, P11047, DOI 10.1021/bi7011756; Sarker M, 2011, BIOCHEMISTRY-US, V50, P4867, DOI 10.1021/bi200167d; SCHWARTZ RM, 1994, NEW ENGL J MED, V330, P1476, DOI 10.1056/NEJM199405263302102; SEEGER W, 1993, CLIN INVESTIGATOR, V71, P177; Serrano AG, 2006, BIOPHYS J, V90, P238, DOI 10.1529/biophysj.105.073403; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stevens TP, 2007, CHEST, V131, P1577, DOI 10.1378/chest.06-2371; TANNER JE, 1970, J CHEM PHYS, V52, P2523, DOI 10.1063/1.1673336; Veldhuizen EJA, 2000, BIOPHYS J, V79, P377, DOI 10.1016/S0006-3495(00)76299-0; Walther FJ, 2002, EXP LUNG RES, V28, P623, DOI 10.1080/01902140260426733; Walther FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008672; Wang YD, 2003, BIOCHEMISTRY-US, V42, P4015, DOI 10.1021/bi027344h; Waring AJ, 2005, J PEPT RES, V66, P364, DOI 10.1111/j.1399-3011.2005.00300.x; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WHITSETT JA, 1995, PHYSIOL REV, V75, P749, DOI 10.1152/physrev.1995.75.4.749; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang TC, 2009, BIOPHYS J, V96, P3762, DOI 10.1016/j.bpj.2009.02.027; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	66	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72821	10.1371/journal.pone.0072821	http://dx.doi.org/10.1371/journal.pone.0072821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023779	Green Published, Green Accepted, gold			2022-12-27	WOS:000324238400026
J	Anand, S; Bitton, A; Gaziano, T				Anand, Shuchi; Bitton, Asaf; Gaziano, Thomas			The Gap between Estimated Incidence of End-Stage Renal Disease and Use of Therapy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PERITONEAL-DIALYSIS; DEVELOPING-WORLD; LATIN-AMERICA; PREVALENCE; TRENDS; MEN; PROGRESSION; COUNTRY; MRFIT	Background: Relatively few data exist on the burden of end-stage renal disease (ESRD) and use of renal replacement therapy (RRT)-a life-saving therapy-in developing regions. No study has quantified the proportion of patients who develop ESRD but are unable to access RRT. Methods: We performed a comprehensive literature search to estimate use and annual initiation of RRT worldwide, and present these estimates according to World Bank regions. We also present estimates of survival and of etiology of diseases in patients undergoing RRT. Using data on prevalence of diabetes and hypertension, we modeled the incidence of ESRD related to these risk factors in order to quantify the gap between ESRD and use of RRT in developing regions. Results: We find that 1.9 million patients are undergoing RRT worldwide, with continued use and annual initiation at 316 and 73 per million population respectively. RRT use correlates directly (Pearson's r = 0.94) with regional income. Hemodialysis remains the dominant form of RRT but there is wide regional variation in its use. With the exception of the Latin American and Caribbean region, it appears that initiation of RRT in developing regions is restricted to fewer than a quarter of patients projected to develop ESRD. This results in at least 1.2 million premature deaths each year due to lack of access to RRT as a result of diabetes and elevated blood pressure and as many as 3.2 million premature deaths due to all causes of ESRD. Conclusion: Thus, the majority of patients projected to reach ESRD due to diabetes or hypertension in developing regions are unable to access RRT; this gap will increase with rising prevalence of these risk factors worldwide.	[Anand, Shuchi] Stanford Univ, Dept Med, Sch Med, Div Nephrol, Stanford, CA 94305 USA; [Bitton, Asaf] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Med, Boston, MA 02115 USA; [Gaziano, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Stanford University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gaziano, T (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.	tgaziano@partners.org			 [F32 DK 084697]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007357, F32DK084697] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Anand is supported by F32 DK 084697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Aisha H, 2010, PERITON DIALYSIS INT, V30, P23, DOI 10.3747/pdi.2008.00226; Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Aea El Matri, 2008, ARAB J NEPHROLOGY TR, V1, P9; [Anonymous], 2007, TREATM END STAG ORG; Australia and New Zealand Dialysis and Transplant Registry, 2006, 29 AUSTR NZ DIAL TRA; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Barsoum RS, 2002, ARTIF ORGANS, V26, P737, DOI 10.1046/j.1525-1594.2002.07061.x; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; Cusumano A, 2006, RENAL FAILURE, V28, P631, DOI 10.1080/08860220600925693; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Egyptian Society of Nephrology and Transplantation, 2004, EG SOC NEPHR TRANSPL; European Renal Association-European Dialysis and Transplant Association, 2005, EUR REN ASS EUR DIAL; Finkelstein FO, 2009, PERITON DIALYSIS INT, V29, P618; Goyal M, 2002, JAMA-J AM MED ASSOC, V288, P1589, DOI 10.1001/jama.288.13.1589; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Jha V, 2004, RENAL FAILURE, V26, P201, DOI 10.1081/JDI-120039516; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Mahmoud KM, 2010, PERITON DIALYSIS INT, V30, P269, DOI 10.3747/pdi.2009.00001; Moosa MR, 2006, KIDNEY INT, V70, P1107, DOI 10.1038/sj.ki.5001750; Najafi I, 2009, PERITON DIALYSIS INT, V29, pS217; National Disease Registry Office and Health Promotion Board, 2000, 3 NAT DIS REG OFF HL; National Renal Registry and Malaysian Society of Nephrology, 2006, 14 NAT REN REG MAL S; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Riella MC, 2007, PERITON DIALYSIS INT, V27, P322; Saudi Arabia Center for Organ Transplantation, 2008, ANN DAT REP; Sesso R, 2007, INT J TECHNOL ASSESS, V23, P126, DOI 10.1017/S0266462307051665; Sitprija V, 2003, KIDNEY INT, V63, P128, DOI 10.1046/j.1523-1755.63.s83.27.x; The Kidney Foundation, 2006, DIAL REG PAK 2005 20; The World Bank, 2011, WE CLASS COUNTR WORL; United States Renal Data System, 2008, ANN DAT REP 2005; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	37	93	95	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72860	10.1371/journal.pone.0072860	http://dx.doi.org/10.1371/journal.pone.0072860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023651	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200047
J	Elmore, AJ; Julian, JP; Guinn, SM; Fitzpatrick, MC				Elmore, Andrew J.; Julian, Jason P.; Guinn, Steven M.; Fitzpatrick, Matthew C.			Potential Stream Density in Mid-Atlantic US Watersheds	PLOS ONE			English	Article							CHANNEL HEAD LOCATIONS; SPECIES DISTRIBUTIONS; UNITED-STATES; HEADWATER STREAMS; LIDAR DATA; PREDICTION; MODELS; THRESHOLDS; DRAINAGE; EXTENT	Stream network density exerts a strong influence on ecohydrologic processes in watersheds, yet existing stream maps fail to capture most headwater streams and therefore underestimate stream density. Furthermore, discrepancies between mapped and actual stream length vary between watersheds, confounding efforts to understand the impacts of land use on stream ecosystems. Here we report on research that predicts stream presence from coupled field observations of headwater stream channels and terrain variables that were calculated both locally and as an average across the watershed upstream of any location on the landscape. Our approach used maximum entropy modeling (MaxEnt), a robust method commonly implemented to model species distributions that requires information only on the presence of the entity of interest. In validation, the method correctly predicts the presence of 86% of all 10-m stream segments and errors are low (<1%) for catchments larger than 10 ha. We apply this model to the entire Potomac River watershed (37,800 km(2)) and several adjacent watersheds to map stream density and compare our results with the National Hydrography Dataset (NHD). We find that NHD underestimates stream density by up to 250%, with errors being greatest in the densely urbanized cities of Washington, DC and Baltimore, MD and in regions where the NHD has never been updated from its original, coarse-grain mapping. This work is the most ambitious attempt yet to map stream networks over a large region and will have lasting implications for modeling and conservation efforts.	[Elmore, Andrew J.; Guinn, Steven M.; Fitzpatrick, Matthew C.] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD USA; [Julian, Jason P.] Texas State Univ, Dept Geog, San Marcos, TX USA	University System of Maryland; University of Maryland Center for Environmental Science; Texas State University System; Texas State University San Marcos	Elmore, AJ (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD USA.	aelmore@umces.edu	Fitzpatrick, Matthew/ABC-1930-2020; Fitzpatrick, Matt/F-7620-2010; Elmore, Andrew James/D-4341-2012	Fitzpatrick, Matthew/0000-0003-1911-8407; Fitzpatrick, Matt/0000-0003-1911-8407; Elmore, Andrew James/0000-0002-9697-9457	Maryland Sea Grant, National Oceanic and Atmospheric Administration, United States Department of Commerce [NA05OAR4171042]	Maryland Sea Grant, National Oceanic and Atmospheric Administration, United States Department of Commerce	This manuscript was prepared under award (NA05OAR4171042) from Maryland Sea Grant, National Oceanic and Atmospheric Administration, United States Department of Commerce. The statements, findings, conclusions and recommendations are those of the authors' and do not necessarily reflect the views of their funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson P, 1998, EARTH SURF PROC LAND, V23, P1185, DOI 10.1002/(SICI)1096-9837(199812)23:13&lt;1185::AID-ESP928&gt;3.0.CO;2-W; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Baker ME, 2007, LANDSCAPE ECOL, V22, P973, DOI 10.1007/s10980-007-9080-z; Brakebill JW, 2011, J AM WATER RESOUR AS, V47, P916, DOI 10.1111/j.1752-1688.2011.00578.x; Brooks RT, 2011, J AM WATER RESOUR AS, V47, P158, DOI 10.1111/j.1752-1688.2010.00499.x; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Daniels MH, 2011, J HYDROL ENG, V16, P677, DOI 10.1061/(ASCE)HE.1943-5584.0000340; Dietrich W.E., 1993, CHANNEL NETWORK HYDR, P175; Doyle MW, 2011, ENVIRON SCI TECHNOL, V45, P354, DOI 10.1021/es101273f; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Elmore AJ, 2008, FRONT ECOL ENVIRON, V6, P308, DOI 10.1890/070101; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Heine RA, 2004, ANN ASSOC AM GEOGR, V94, P477, DOI 10.1111/j.1467-8306.2004.00409.x; Henkle JE, 2011, GEOMORPHOLOGY, V129, P309, DOI 10.1016/j.geomorph.2011.02.026; Hollister JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025764; IJJASZVASQUEZ EJ, 1995, GEOMORPHOLOGY, V12, P299, DOI 10.1016/0169-555X(95)00012-T; Imaizumi F, 2010, GEOMORPHOLOGY, V115, P32, DOI 10.1016/j.geomorph.2009.09.026; James LA, 2007, CATENA, V71, P132, DOI 10.1016/j.catena.2006.10.010; Jantz CA, 2004, ENVIRON PLANN B, V31, P251, DOI 10.1068/b2983; JAWORSKI NA, 1992, ESTUARIES, V15, P83, DOI 10.2307/1352713; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Jones KB, 2010, LANDSCAPE ECOL, V25, P1261, DOI 10.1007/s10980-010-9510-1; Jones KB, 2001, ECOSYST HEALTH, V7, P229, DOI 10.1046/j.1526-0992.2001.01047.x; Julian JP, 2012, GEOMORPHOLOGY, V177, P194, DOI 10.1016/j.geomorph.2012.07.029; Kaushal SS, 2012, URBAN ECOSYST, V15, P409, DOI 10.1007/s11252-012-0226-7; Lashermes B, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031140; Leopold L.B., 1992, FLUVIAL PROCESSES GE; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lookingbill TR, 2009, ECOL SOC, V14; Luoto M, 2004, PERMAFROST PERIGLAC, V15, P327, DOI 10.1002/ppp.482; Marmion M, 2009, COMPUT GEOSCI-UK, V35, P615, DOI 10.1016/j.cageo.2008.02.024; Martinez C, 2010, INT J REMOTE SENS, V31, P6239, DOI 10.1080/01431160903403060; McNamara JP, 2006, FOREST ECOL MANAG, V224, P147, DOI 10.1016/j.foreco.2005.12.014; MONTGOMERY DR, 1994, WATER RESOUR RES, V30, P1925, DOI 10.1029/94WR00538; MONTGOMERY DR, 1993, WATER RESOUR RES, V29, P3925, DOI 10.1029/93WR02463; MONTGOMERY DR, 1989, WATER RESOUR RES, V25, P1907, DOI 10.1029/WR025i008p01907; MONTGOMERY DR, 1988, NATURE, V336, P232, DOI 10.1038/336232a0; NRCS, 2011, SOIL SURV GEOGR SSUR; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Passalacqua P, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001254; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Petroselli A, 2012, GISCI REMOTE SENS, V49, P139, DOI 10.2747/1548-1603.49.1.139; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Roy AH, 2009, J N AM BENTHOL SOC, V28, P911, DOI 10.1899/08-178.1; Steward AL, 2012, FRONT ECOL ENVIRON, V10, P202, DOI 10.1890/110136; Svoray T, 2009, EARTH SURF PROC LAND, V34, P1970, DOI 10.1002/esp.1873; Tarboton DG, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P2000; Tarboton D. G., 2008, REPRESENTING MODELIN; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; Utz RM, 2011, J N AM BENTHOL SOC, V30, P25, DOI 10.1899/10-007.1; Weller DE, 2011, ECOL APPL, V21, P1679, DOI 10.1890/10-0789.1; Xian G, 2009, REMOTE SENS ENVIRON, V113, P1133, DOI 10.1016/j.rse.2009.02.004	61	31	31	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e74819	10.1371/journal.pone.0074819	http://dx.doi.org/10.1371/journal.pone.0074819			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023704	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200102
J	Federau, C; Hagmann, P; Maeder, P; Muller, M; Meuli, R; Stuber, M; O'Brien, K				Federau, Christian; Hagmann, Patric; Maeder, Philippe; Mueller, Markus; Meuli, Reto; Stuber, Matthias; O'Brien, Kieran			Dependence of Brain Intravoxel Incoherent Motion Perfusion Parameters on the Cardiac Cycle	PLOS ONE			English	Article							BLOOD-FLOW; DIFFUSION; PULSATILE; VELOCITY; NETWORK; PULSE; IVIM; MICROCIRCULATION; HEMODYNAMICS; PRESSURE	Measurement of microvascular perfusion with Intravoxel Incoherent Motion (IVIM) MRI is gaining interest. Yet, the physiological influences on the IVIM perfusion parameters ("pseudo-diffusion" coefficient D*, perfusion fraction f, and flow related parameter fD*) remain insufficiently characterized. In this article, we hypothesize that D* and fD*, which depend on blood speed, should vary during the cardiac cycle. We extended the IVIM model to include time dependence of D* = D*(t), and demonstrate in the healthy human brain that both parameters D* and fD* are significantly larger during systole than diastole, while the diffusion coefficient D and f do not vary significantly. The results non-invasively demonstrate the pulsatility of the brain's microvasculature.	[Federau, Christian; Hagmann, Patric; Maeder, Philippe; Meuli, Reto; Stuber, Matthias] CHU Vaudois, Lausanne, Switzerland; [Federau, Christian; Hagmann, Patric; Maeder, Philippe; Meuli, Reto; Stuber, Matthias] Univ Lausanne, Lausanne, Switzerland; [Mueller, Markus] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy; [Stuber, Matthias] Univ Lausanne, Ctr Biomed Imaging CIBM, Lausanne, Switzerland; [O'Brien, Kieran] Univ Geneva, Ctr Biomed Imaging CIBM, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Abdus Salam International Centre for Theoretical Physics (ICTP); University of Lausanne; University of Geneva	Federau, C (corresponding author), CHU Vaudois, Lausanne, Switzerland.	christian.federau@gmail.com	Muller, Markus/Q-4756-2019; Müller, Markus/L-5058-2013; O'Brien, Kieran/B-7276-2016; Stuber, Matthias/B-2949-2010	Muller, Markus/0000-0002-0299-952X; Müller, Markus/0000-0002-0299-952X; O'Brien, Kieran/0000-0003-1996-3563; Stuber, Matthias/0000-0001-9843-2028	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; Centre d'Imagerie BioMedicale (CIBM) of the UNIGE; Centre d'Imagerie BioMedicale (CIBM) of the HUG; Centre d'Imagerie BioMedicale (CIBM) of the CHUV; Centre d'Imagerie BioMedicale (CIBM) of the EPFL; Leenaards and Jeantet Foundations; Facultede biologie et de medecine of the University of Lausanne; Leenaards Foundation	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; Centre d'Imagerie BioMedicale (CIBM) of the UNIGE; Centre d'Imagerie BioMedicale (CIBM) of the HUG; Centre d'Imagerie BioMedicale (CIBM) of the CHUV; Centre d'Imagerie BioMedicale (CIBM) of the EPFL; Leenaards and Jeantet Foundations; Facultede biologie et de medecine of the University of Lausanne; Leenaards Foundation	This work was supported by the Centre d'Imagerie BioMedicale (CIBM) of the UNIL, UNIGE, HUG, CHUV, EPFL and the Leenaards and Jeantet Foundations. CF was supported by the Facultede biologie et de medecine of the University of Lausanne. PH was supported by Leenaards Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN CB, 1987, MED PHYS, V14, P43, DOI 10.1118/1.596093; Callaghan P., 1991, PRINCIPLES NUCL MAGN; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; CHAMPSAUR G, 1994, CIRCULATION, V90, P47; Conturo TE, 1995, NMR BIOMED, V8, P307, DOI 10.1002/nbm.1940080706; Federau C, 2013, J MAGN RESO IN PRESS; Federau C, 2012, RADIOLOGY, V265, P874, DOI 10.1148/radiol.12120584; Fung YC., 1997, BIOMECHANICS CIRCULA, DOI [10.1007/978-1-4757-2696-1, DOI 10.1007/978-1-4757-2696-1]; GAEHTGENS P, 1970, Microvascular Research, V2, P151, DOI 10.1016/0026-2862(70)90003-8; GROSS JF, 1974, AM J PHYSIOL, V226, P1117, DOI 10.1152/ajplegacy.1974.226.5.1117; Hahn M, 1996, J INVEST DERMATOL, V106, P1256, DOI 10.1111/1523-1747.ep12348955; Harris C.R.S., 1973, HEART VASCULAR SYSTE; HENKELMAN RM, 1994, MAGNET RESON MED, V32, P464, DOI 10.1002/mrm.1910320407; KENNAN RP, 1994, MED PHYS, V21, P539, DOI 10.1118/1.597170; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Koutsiaris AG, 2010, MICROVASC RES, V80, P202, DOI 10.1016/j.mvr.2010.05.001; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Le Bihan D, 2012, NEUROIMAGE, V62, P1131, DOI 10.1016/j.neuroimage.2011.09.058; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1992, MAGNET RESON MED, V27, P171, DOI 10.1002/mrm.1910270116; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1989, MAGNET RESON MED, V10, P324; Lemke A, 2010, MAGN RESON MED, V64, P1580, DOI 10.1002/mrm.22565; MAVROUDIS C, 1978, ANN THORAC SURG, V25, P259, DOI 10.1016/S0003-4975(10)63539-4; McAllister J, 2009, CEREBROSPINAL FLU S2, pS10; Murphy GS, 2009, ANESTH ANALG, V108, P1394, DOI 10.1213/ane.0b013e3181875e2e; Reynolds O, 1895, PHIL T ROY SOC LON A, V186, P123, DOI 10.1098/rsta.1895.0004; ROSENBLUM WI, 1969, CIRC RES, V24, P887, DOI 10.1161/01.RES.24.6.887; SALOTTO AG, 1986, MICROVASC RES, V32, P152, DOI 10.1016/0026-2862(86)90051-8; Santisakultarm TP, 2012, AM J PHYSIOL-HEART C, V302, pH1367, DOI 10.1152/ajpheart.00417.2011; Seki J, 2006, CLIN HEMORHEOL MICRO, V34, P233; SEKI J, 1994, AM J PHYSIOL, V266, pH811, DOI 10.1152/ajpheart.1994.266.2.H811; SHEPARD RB, 1966, ARCH SURG-CHICAGO, V93, P730; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; TURNER R, 1990, RADIOLOGY, V177, P407, DOI 10.1148/radiology.177.2.2217777; WEDEEN VJ, 1985, SCIENCE, V230, P946, DOI 10.1126/science.4059917; WIEDERHIELM CA, 1964, AM J PHYSIOL, V207, P173, DOI 10.1152/ajplegacy.1964.207.1.173; Wittsack HJ, 2012, INVEST RADIOL, V47, P226, DOI 10.1097/RLI.0b013e3182396410	40	66	75	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72856	10.1371/journal.pone.0072856	http://dx.doi.org/10.1371/journal.pone.0072856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023649	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200045
J	Hoffmann, M; Mueller, MA; Drexler, JF; Glende, J; Erdt, M; Gutzkow, T; Losemann, C; Binger, T; Deng, HK; Schwegmann-Wessels, C; Esser, KH; Drosten, C; Herrler, G				Hoffmann, Markus; Mueller, Marcel Alexander; Drexler, Jan Felix; Glende, Joerg; Erdt, Meike; Guetzkow, Tim; Losemann, Christoph; Binger, Tabea; Deng, Hongkui; Schwegmann-Wessels, Christel; Esser, Karl-Heinz; Drosten, Christian; Herrler, Georg			Differential Sensitivity of Bat Cells to Infection by Enveloped RNA Viruses: Coronaviruses, Paramyxoviruses, Filoviruses, and Influenza Viruses	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-LIKE CORONAVIRUS; SPIKE-PROTEIN; S PROTEIN; C VIRUS; RECEPTOR DETERMINANT; PROTEOLYTIC CLEAVAGE; FUNCTIONAL RECEPTOR; BOVINE CORONAVIRUS; AMINOPEPTIDASE-N	Bats (Chiroptera) host major human pathogenic viruses including corona-, paramyxo, rhabdo- and filoviruses. We analyzed six different cell lines from either Yinpterochiroptera (including African flying foxes and a rhinolophid bat) or Yangochiroptera (genera Carollia and Tadarida) for susceptibility to infection by different enveloped RNA viruses. None of the cells were sensitive to infection by transmissible gastroenteritis virus (TGEV), a porcine coronavirus, or to infection mediated by the Spike (S) protein of SARS-coronavirus (SARS-CoV) incorporated into pseudotypes based on vesicular stomatitis virus (VSV). The resistance to infection was overcome if cells were transfected to express the respective cellular receptor, porcine aminopeptidase N for TGEV or angiotensin-converting enzyme 2 for SARS-CoV. VSV pseudotypes containing the S proteins of two bat SARS-related CoV (Bg08 and Rp3) were unable to infect any of the six tested bat cell lines. By contrast, viral pseudotypes containing the surface protein GP of Marburg virus from the family Filoviridae infected all six cell lines though at different efficiency. Notably, all cells were sensitive to infection by two paramyxoviruses (Sendai virus and bovine respiratory syncytial virus) and three influenza viruses from different subtypes. These results indicate that bat cells are more resistant to infection by coronaviruses than to infection by paramyxoviruses, filoviruses and influenza viruses. Furthermore, these results show a receptor-dependent restriction of the infection of bat cells by CoV. The implications for the isolation of coronaviruses from bats are discussed.	[Hoffmann, Markus; Glende, Joerg; Erdt, Meike; Guetzkow, Tim; Losemann, Christoph; Schwegmann-Wessels, Christel; Herrler, Georg] Univ Vet Med Hannover, Inst Virol, Hannover, Germany; [Mueller, Marcel Alexander; Drexler, Jan Felix; Binger, Tabea; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Esser, Karl-Heinz] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Deng, Hongkui] Peking Univ, Coll Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China	University of Veterinary Medicine Hannover, Foundation; University of Bonn; University of Veterinary Medicine Hannover, Foundation; Peking University	Herrler, G (corresponding author), Univ Vet Med Hannover, Inst Virol, Hannover, Germany.	georg.herrler@tiho-hannover.de	Müller, Marcel A./O-2425-2019; Drexler, Jan Felix/GMW-5098-2022; Drexler, Jan Felix/C-1004-2014; Hoffmann, Markus/J-7836-2018	Müller, Marcel A./0000-0003-2242-5117; Hoffmann, Markus/0000-0003-4603-7696; Drexler, Jan Felix/0000-0002-3509-0232	Deutsche Forschungsgemeinschaft [SFB621 TP B7, SFB587 TP A1]; Bundesministerium fur Bildung und Forschung [01KI1005B, 01KI1006D, 01KIO701]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by grants to GH from Deutsche Forschungsgemeinschaft (SFB621 TP B7, SFB587 TP A1) and Bundesministerium fur Bildung und Forschung (Ecology and Pathogenesis of SARS, an Archetypical Zoonosis, project code 01KI1005B and FluResearchNet, project code 01KI1006D). CD was supported by a grant from Bundesministerium fur Bildung und Forschung (Ecology and Pathogenesis of SARS, an Archetypical Zoonosis, project code 01KIO701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105; Belouzard S, 2010, J BIOL CHEM, V285, P22756, DOI 10.1074/jbc.M110.103275; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chu DKW, 2006, J GEN VIROL, V87, P2461, DOI 10.1099/vir.0.82203-0; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; de Groot RJ, 2012, VIRUS TAXONOMY, P806; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Fraser GC, 1996, EMERG INFECT DIS, V2, P327, DOI 10.3201/eid0204.960408; Frentzen A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002029; Fukushi S, 2005, J GEN VIROL, V86, P2269, DOI 10.1099/vir.0.80955-0; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Glende J, 2008, VIROLOGY, V381, P215, DOI 10.1016/j.virol.2008.08.026; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Goris K, 2009, J VIROL, V83, P1962, DOI 10.1128/JVI.01271-08; Gouilh MA, 2011, INFECT GENET EVOL, V11, P1690, DOI 10.1016/j.meegid.2011.06.021; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; Harris SL, 2007, VET REC, V161, P384, DOI 10.1136/vr.161.11.384; HERRLER G, 1985, VIROLOGY, V141, P144, DOI 10.1016/0042-6822(85)90190-4; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hou YX, 2010, ARCH VIROL, V155, P1563, DOI 10.1007/s00705-010-0729-6; KELKAR SD, 1981, INDIAN J MED RES, V74, P147; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; LVOV DK, 1979, VOP VIRUSOL+, P338; Mackenzie JS, 2004, ARCH VIROL, P97; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Nie YC, 2004, BIOCHEM BIOPH RES CO, V321, P994, DOI 10.1016/j.bbrc.2004.07.060; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Philbey AW, 1998, EMERG INFECT DIS, V4, P269, DOI 10.3201/eid0402.980214; Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Ren XF, 2006, J GEN VIROL, V87, P1691, DOI 10.1099/vir.0.81749-0; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; SCHULTZE B, 1992, J GEN VIROL, V73, P901, DOI 10.1099/0022-1317-73-4-901; Schultze B, 1996, J GEN VIROL, V77, P2507, DOI 10.1099/0022-1317-77-10-2507; Schwegmann-Wessels C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-435; Schwegmann-Wessels C, 2009, J GEN VIROL, V90, P1724, DOI 10.1099/vir.0.009704-0; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Simmons G, 2011, VIROLOGY, V413, P265, DOI 10.1016/j.virol.2011.02.020; STURMAN LS, 1985, J VIROL, V56, P904, DOI 10.1128/JVI.56.3.904-911.1985; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Vijaykrishna D, 2007, J VIROL, V81, P4012, DOI 10.1128/JVI.02605-06; VLASAK R, 1988, J VIROL, V62, P4686, DOI 10.1128/JVI.62.12.4686-4690.1988; Wang PG, 2004, BIOCHEM BIOPH RES CO, V315, P439, DOI 10.1016/j.bbrc.2004.01.076; Watanabe R, 2008, J VIROL, V82, P11985, DOI 10.1128/JVI.01412-08; Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; Winter C, 2006, J GEN VIROL, V87, P1209, DOI 10.1099/vir.0.81651-0; Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315; Zhang H, 2004, J VIROL, V78, P6938, DOI 10.1128/JVI.78.13.6938-6945.2004; Zimmer G, 2005, J VIROL, V79, P10467, DOI 10.1128/JVI.79.16.10467-10477.2005	74	74	76	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72942	10.1371/journal.pone.0072942	http://dx.doi.org/10.1371/journal.pone.0072942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023659	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200055
J	Lanzen, A; Simachew, A; Gessesse, A; Chmolowska, D; Jonassen, I; Ovreas, L				Lanzen, Anders; Simachew, Addis; Gessesse, Amare; Chmolowska, Dominika; Jonassen, Inge; Ovreas, Lise			Surprising Prokaryotic and Eukaryotic Diversity, Community Structure and Biogeography of Ethiopian Soda Lakes	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; EXTREMELY HALOALKALINE CONDITIONS; AMMONIA-OXIDIZING ARCHAEA; RIFT-VALLEY LAKES; BACTERIAL DIVERSITY; GEN. NOV.; MICROBIAL DIVERSITY; MOLECULAR DIVERSITY; SALINITY GRADIENT; GOLD MINE	Soda lakes are intriguing ecosystems harboring extremely productive microbial communities in spite of their extreme environmental conditions. This makes them valuable model systems for studying the connection between community structure and abiotic parameters such as pH and salinity. For the first time, we apply high-throughput sequencing to accurately estimate phylogenetic richness and composition in five soda lakes, located in the Ethiopian Rift Valley. The lakes were selected for their contrasting pH, salinities and stratification and several depths or spatial positions were covered in each lake. DNA was extracted and analyzed from all lakes at various depths and RNA extracted from two of the lakes, analyzed using both amplicon- and shotgun sequencing. We reveal a surprisingly high biodiversity in all of the studied lakes, similar to that of freshwater lakes. Interestingly, diversity appeared uncorrelated or positively correlated to pH and salinity, with the most "extreme'' lakes showing the highest richness. Together, pH, dissolved oxygen, sodium- and potassium concentration explained approximately 30% of the compositional variation between samples. A diversity of prokaryotic and eukaryotic taxa could be identified, including several putatively involved in carbon-, sulfur- or nitrogen cycling. Key processes like methane oxidation, ammonia oxidation and 'nitrifier denitrification' were also confirmed by mRNA transcript analyses.	[Lanzen, Anders; Ovreas, Lise] Univ Bergen, Dept Biol, Bergen, Norway; [Lanzen, Anders; Ovreas, Lise] Univ Bergen, Ctr Geobiol, Bergen, Norway; [Lanzen, Anders; Jonassen, Inge] Uni Res AS, Uni Comp, Computat Biol Unit, Bergen, Norway; [Simachew, Addis; Gessesse, Amare] Univ Addis Ababa, Inst Biotechnol, Addis Ababa, Ethiopia; [Chmolowska, Dominika] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Jonassen, Inge] Univ Bergen, Dept Informat, N-5008 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Addis Ababa University; Jagiellonian University; University of Bergen	Lanzen, A (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	alanzen@neiker.net	Jonassen, Inge/AAC-7035-2020; Chmolowska, Dominika/AAB-7940-2020; Øvreås, Lise/H-8651-2016; Lanzén, Anders/F-3818-2016; Lanzén, Anders/AAG-5048-2019	Chmolowska, Dominika/0000-0002-2156-4791; Lanzén, Anders/0000-0002-7138-6364; Lanzén, Anders/0000-0002-7138-6364; Jonassen, Inge/0000-0003-4110-0748	Norwegian Research Council [179560]; L. Meltzers hoyskolefond [805372]; Norwegian Agency for Development Cooperation (NUFU) [802779]	Norwegian Research Council(Research Council of NorwayEuropean Commission); L. Meltzers hoyskolefond; Norwegian Agency for Development Cooperation (NUFU)	This work was supported by the Norwegian Research Council (project no. 179560), L. Meltzers hoyskolefond (project no. 805372) and the Norwegian Agency for Development Cooperation (NUFU project no. 802779: "Biotechnology and Diversity of Ethiopian Soda Lakes''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony CP, 2012, INT J SYST EVOL MICR, V62, P1613, DOI 10.1099/ijs.0.035089-0; Antony CP, 2012, FEMS MICROBIOL ECOL, V81, P43, DOI 10.1111/j.1574-6941.2011.01274.x; Asao M, 2011, ENVIRON MICROBIOL, V26, P925; Ayenew T, 2007, J AFR EARTH SCI, V48, P222, DOI 10.1016/j.jafrearsci.2006.05.010; Ballot A, 2004, J PLANKTON RES, V26, P925, DOI 10.1093/plankt/fbh084; Barberan A, 2011, MICROB ECOL, V61, P465, DOI 10.1007/s00248-010-9775-6; Bartossek R, 2010, ENVIRON MICROBIOL, V12, P1075, DOI 10.1111/j.1462-2920.2010.02153.x; Baxter RM, 2002, BIO INL WAT, P45; Bendif E, 2011, PROTIST, V162, P738, DOI 10.1016/j.protis.2011.05.001; Bengtsson MM, 2010, AQUAT MICROB ECOL, V60, P71, DOI 10.3354/ame01409; Bengtsson MM, 2012, ISME J; Benvenuti M, 2002, J AFR EARTH SCI, V35, P247, DOI 10.1016/S0899-5362(02)00036-2; Carini SA, 2008, LIMNOL OCEANOGR, V53, P2546, DOI 10.4319/lo.2008.53.6.2546; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Dillon JG, 2009, HYDROBIOLOGIA, V632, P49, DOI 10.1007/s10750-009-9827-4; Dirnitriu PA, 2008, APPL ENVIRON MICROB, V74, P4877, DOI 10.1128/AEM.00455-08; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Fuchsman CA, 2012, FEMS MICROBIOL ECOL, V80, P402, DOI 10.1111/j.1574-6941.2012.01306.x; Fukunaga Y, 2009, J GEN APPL MICROBIOL, V55, P267, DOI 10.2323/jgam.55.267; Gardner Paul P, 2011, Nucleic Acids Res, V39, pD141, DOI 10.1093/nar/gkq1129; Gebre-Mariam Z, 1998, HUMAN INTERACTIONS W; Girma MB, 2012, LIMNOLOGICA, V42, P212, DOI 10.1016/j.limno.2011.12.002; Glatz RE, 2006, GEOBIOLOGY, V4, P53, DOI 10.1111/j.1472-4669.2006.00057.x; Goerner A, 2009, J ARID ENVIRON, V73, P287, DOI 10.1016/j.jaridenv.2008.09.015; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grant WD, 2006, METHOD MICROBIOL, V35, P439, DOI 10.1016/S0580-9517(05)35018-5; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Humayoun SB, 2003, APPL ENVIRON MICROB, V69, P1030, DOI 10.1128/AEM.69.2.1030-1042.2003; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; Klepac-Ceraj V, 2012, GEOBIOLOGY, V10, P223, DOI 10.1111/j.1472-4669.2012.00317.x; Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35; Lanzen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049334; Lanzen A, 2011, FEMS MICROBIOL ECOL, V77, P577, DOI 10.1111/j.1574-6941.2011.01138.x; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lin JL, 2004, ENVIRON MICROBIOL, V6, P1049, DOI 10.1111/j.1462-2920.2004.00635.x; Loscher CR, 2012, BIOGEOSCIENCES, V9, P2419, DOI 10.5194/bg-9-2419-2012; Logue JB, 2012, ISME J, V6, P1127, DOI 10.1038/ismej.2011.184; Medova H, 2011, FEMS MICROBIOL ECOL, V76, P393, DOI 10.1111/j.1574-6941.2011.01059.x; MELACK JM, 1974, LIMNOL OCEANOGR, V19, P743, DOI 10.4319/lo.1974.19.5.0743; Mesbah NM, 2007, MICROB ECOL, V54, P598, DOI 10.1007/s00248-006-9193-y; Milford AD, 2000, ARCH MICROBIOL, V174, P18, DOI 10.1007/s002030000166; Mosier AC, 2012, MICROB ECOL, V64, P955, DOI 10.1007/s00248-012-0075-1; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nelson KA, 2009, APPL ENVIRON MICROB, V75, P4211, DOI 10.1128/AEM.00201-09; Nunoura T, 2005, ENVIRON MICROBIOL, V7, P1967, DOI 10.1111/j.1462-2920.2005.00881.x; O'Malley MA, 2008, STUD HIST PHI PART C, V39, P314, DOI 10.1016/j.shpsc.2008.06.005; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ollivier B, 1998, INT J SYST BACTERIOL, V48, P821, DOI 10.1099/00207713-48-3-821; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Owino AO, 2001, HYDROBIOLOGIA, V458, P45, DOI 10.1023/A:1013115724138; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Peura S, 2012, ISME J, V6, P1640, DOI 10.1038/ismej.2012.21; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2021, R LANGUAGE ENV STAT; Radax R, 2012, ENVIRON MICROBIOL, V14, P1308, DOI 10.1111/j.1462-2920.2012.02714.x; Rastogi G, 2009, J MICROBIOL, V47, P371, DOI 10.1007/s12275-008-0249-1; Rees HC, 2004, EXTREMOPHILES, V8, P63, DOI 10.1007/s00792-003-0361-4; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Sorokin DY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00044; Sorokin DY, 2010, FEMS MICROBIOL ECOL, V73, P278, DOI 10.1111/j.1574-6941.2010.00901.x; Sorokin DY, 2009, INT J SYST EVOL MICR, V59, P248, DOI 10.1099/ijs.0.002204-0; Surakasi VP, 2010, J BASIC MICROB, V50, P465, DOI 10.1002/jobm.201000001; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Terrat S, 2012, MICROB BIOTECHNOL, V5, P135, DOI 10.1111/j.1751-7915.2011.00307.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027597; Wani AA, 2006, RES MICROBIOL, V157, P928, DOI 10.1016/j.resmic.2006.08.005; Wu QL, 2006, APPL ENVIRON MICROB, V72, P5478, DOI 10.1128/AEM.00767-06; Wu QLL, 2009, MICROB ECOL, V58, P569, DOI 10.1007/s00248-009-9526-8; Xiong JB, 2012, ENVIRON MICROBIOL, V14, P2457, DOI 10.1111/j.1462-2920.2012.02799.x; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Yousuf B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-150; Zavarzin GA, 2000, JOURNEY DIVERSE MICR, P191; Zhang Xianhui, 2010, Weishengwu Xuebao, V50, P334; Zhilina TN, 2012, INT J SYST EVOL MICR, V62, P1666, DOI 10.1099/ijs.0.034363-0; Zinabu GM, 1997, J PLANKTON RES, V19, P647, DOI 10.1093/plankt/19.5.647	85	70	74	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72577	10.1371/journal.pone.0072577	http://dx.doi.org/10.1371/journal.pone.0072577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023625	Green Published, gold			2022-12-27	WOS:000323880200020
J	Zeng, XF; Sunkara, LT; Jiang, WY; Bible, M; Carter, S; Ma, X; Qiao, SY; Zhang, GL				Zeng, Xiangfang; Sunkara, Lakshmi T.; Jiang, Weiyu; Bible, Megan; Carter, Scott; Ma, Xi; Qiao, Shiyan; Zhang, Guolong			Induction of Porcine Host Defense Peptide Gene Expression by Short-Chain Fatty Acids and Their Analogs	PLOS ONE			English	Article							CATHELICIDIN ANTIMICROBIAL PEPTIDE; BETA-DEFENSINS; 1,25-DIHYDROXYVITAMIN D-3; BUTYRATE; CELLS; LL-37; BETA-DEFENSIN-2; SHIGELLOSIS; TISSUES; PIGS	Dietary modulation of the synthesis of endogenous host defense peptides (HDPs) represents a novel antimicrobial approach for disease control and prevention, particularly against antibiotic-resistant infections. However, HDP regulation by dietary compounds such as butyrate is species-dependent. To examine whether butyrate could induce HDP expression in pigs, we evaluated the expressions of a panel of porcine HDPs in IPEC-J2 intestinal epithelial cells, 3D4/31 macrophages, and primary monocytes in response to sodium butyrate treatment by real-time PCR. We revealed that butyrate is a potent inducer of multiple, but not all, HDP genes. Porcine beta-defensin 2 (pBD2), pBD3, epididymis protein 2 splicing variant C (pEP2C), and protegrins were induced markedly in response to butyrate, whereas pBD1 expression remained largely unaltered in any cell type. Additionally, a comparison of the HDP-inducing efficacy among saturated free fatty acids of different aliphatic chain lengths revealed that fatty acids containing 3-8 carbons showed an obvious induction of HDP expression in IPEC-J2 cells, with butyrate being the most potent and long-chain fatty acids having only a marginal effect. We further investigated a panel of butyrate analogs for their efficacy in HDP induction, and found glyceryl tributyrate, benzyl butyrate, and 4-phenylbutyrate to be comparable with butyrate. Identification of butyrate and several analogs with a strong capacity to induce HDP gene expression in pigs provides attractive candidates for further evaluation of their potential as novel alternatives to antibiotics in augmenting innate immunity and disease resistance of pigs.	[Zeng, Xiangfang; Sunkara, Lakshmi T.; Jiang, Weiyu; Bible, Megan; Carter, Scott; Zhang, Guolong] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA; [Zeng, Xiangfang; Ma, Xi; Qiao, Shiyan] China Agr Univ, State Key Lab Anim Nutr, Beijing 100094, Peoples R China; [Zhang, Guolong] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Zhang, Guolong] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; China Agricultural University; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Zhang, GL (corresponding author), Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA.	zguolon@okstate.edu	Sunkara, Lakshmi/B-8108-2014; Zhang, Guolong/HCI-5587-2022; Zhang, Guolong/AAU-8197-2020; Ma, Xi/J-4625-2019	Sunkara, Lakshmi/0000-0003-2023-5010; Zhang, Guolong/0000-0003-4781-5816; Ma, Xi/0000-0003-4562-9331; jiang, weiyu/0000-0001-6199-4289	United States Department of Agriculture/National Institute of Food and Agriculture grant [2008-35204-04544]; Oklahoma Center for the Advancement of Science and Technology [AR12.2-077, HR12-051]; Oklahoma State University Technology Business Development Program grant; Oklahoma Agricultural Experiment Station project [H-2811]	United States Department of Agriculture/National Institute of Food and Agriculture grant; Oklahoma Center for the Advancement of Science and Technology; Oklahoma State University Technology Business Development Program grant; Oklahoma Agricultural Experiment Station project	This work was supported by a United States Department of Agriculture/National Institute of Food and Agriculture grant (2008-35204-04544), Oklahoma Center for the Advancement of Science and Technology grants AR12.2-077 and HR12-051, Oklahoma State University Technology Business Development Program grant, and Oklahoma Agricultural Experiment Station project H-2811. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta M, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-15; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Bommineni YR, 2010, PEPTIDES, V31, P1225, DOI 10.1016/j.peptides.2010.03.037; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cederlund A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053876; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Fehlbaum P, 2000, P NATL ACAD SCI USA, V97, P12723, DOI 10.1073/pnas.220424597; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Heidor R, 2012, CURR DRUG TARGETS, V13, P1720, DOI 10.2174/138945012804545443; Huehnken C, 2009, THESIS U IRELAND REY; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; Mao XB, 2013, MOL BIOL REP, V40, P1547, DOI 10.1007/s11033-012-2200-0; Mao XB, 2012, LIVEST SCI, V148, P103, DOI 10.1016/j.livsci.2012.05.016; McDermott PF, 2002, ANIM BIOTECHNOL, V13, P71, DOI 10.1081/ABIO-120005771; McGinty D, 2012, FOOD CHEM TOXICOL, V50, pS407, DOI 10.1016/j.fct.2012.02.063; Nakatsuji T, 2010, J INVEST DERMATOL, V130, P985, DOI 10.1038/jid.2009.384; Ochoa-Zarzosa A, 2009, MICROB PATHOGENESIS, V47, P1, DOI 10.1016/j.micpath.2009.04.006; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Pulido D, 2012, J INNATE IMMUN, V4, P327, DOI 10.1159/000336713; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Raqib R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-111; Sang YM, 2006, MAMM GENOME, V17, P332, DOI 10.1007/s00335-005-0158-0; Sang YM, 2009, DEV COMP IMMUNOL, V33, P334, DOI 10.1016/j.dci.2008.05.006; Schauber J, 2004, MOL IMMUNOL, V41, P847, DOI 10.1016/j.molimm.2004.05.005; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schauber J, 2008, J INVEST DERMATOL, V128, P816, DOI 10.1038/sj.jid.5701102; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schlee M, 2008, CLIN EXP IMMUNOL, V151, P528, DOI 10.1111/j.1365-2249.2007.03587.x; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Schwab M, 2007, MOL IMMUNOL, V44, P2107, DOI 10.1016/j.molimm.2006.09.016; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Sherman H, 2006, MOL IMMUNOL, V43, P1617, DOI 10.1016/j.molimm.2005.09.013; Smith DL, 2005, PLOS MED, V2, P731, DOI 10.1371/journal.pmed.0020232; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Sunkara LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049558; Sunkara LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027225; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Talukder P, 2011, INT IMMUNOPHARMACOL, V11, P141, DOI 10.1016/j.intimp.2010.10.010; van der Does AM, 2012, J LEUKOCYTE BIOL, V92, P735, DOI 10.1189/jlb.0412178; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Xiao YJ, 2006, FEBS J, V273, P2581, DOI 10.1111/j.1742-4658.2006.05261.x; Xiao YJ, 2009, J INNATE IMMUN, V1, P268, DOI 10.1159/000174822; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zhang GL, 1998, FEBS LETT, V424, P37, DOI 10.1016/S0014-5793(98)00134-3; Zhang GL, 2000, VET RES, V31, P277, DOI 10.1051/vetres:2000121; Zhang JH, 2011, LIVEST SCI, V138, P259, DOI 10.1016/j.livsci.2011.01.001	50	86	96	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72922	10.1371/journal.pone.0072922	http://dx.doi.org/10.1371/journal.pone.0072922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023657	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200053
J	Bouatra, S; Aziat, F; Mandal, R; Guo, AC; Wilson, MR; Knox, C; Bjorndahl, TC; Krishnamurthy, R; Saleem, F; Liu, P; Dame, ZT; Poelzer, J; Huynh, J; Yallou, FS; Psychogios, N; Dong, E; Bogumil, R; Roehring, C; Wishart, DS				Bouatra, Souhaila; Aziat, Farid; Mandal, Rupasri; Guo, An Chi; Wilson, Michael R.; Knox, Craig; Bjorndahl, Trent C.; Krishnamurthy, Ramanarayan; Saleem, Fozia; Liu, Philip; Dame, Zerihun T.; Poelzer, Jenna; Huynh, Jessica; Yallou, Faizath S.; Psychogios, Nick; Dong, Edison; Bogumil, Ralf; Roehring, Cornelia; Wishart, David S.			The Human Urine Metabolome	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; MASS-SPECTROMETRY; ORGANIC-ACIDS; AMINO-ACIDS; CEREBROSPINAL-FLUID; QUANTITATIVE-ANALYSIS; BIOLOGICAL SAMPLES; PROLINE BETAINE; INBORN-ERRORS	Urine has long been a "favored" biofluid among metabolomics researchers. It is sterile, easy-to-obtain in large volumes, largely free from interfering proteins or lipids and chemically complex. However, this chemical complexity has also made urine a particularly difficult substrate to fully understand. As a biological waste material, urine typically contains metabolic breakdown products from a wide range of foods, drinks, drugs, environmental contaminants, endogenous waste metabolites and bacterial by-products. Many of these compounds are poorly characterized and poorly understood. In an effort to improve our understanding of this biofluid we have undertaken a comprehensive, quantitative, metabolome-wide characterization of human urine. This involved both computer-aided literature mining and comprehensive, quantitative experimental assessment/validation. The experimental portion employed NMR spectroscopy, gas chromatography mass spectrometry (GC-MS), direct flow injection mass spectrometry (DFI/LC-MS/MS), inductively coupled plasma mass spectrometry (ICP-MS) and high performance liquid chromatography (HPLC) experiments performed on multiple human urine samples. This multi-platform metabolomic analysis allowed us to identify 445 and quantify 378 unique urine metabolites or metabolite species. The different analytical platforms were able to identify (quantify) a total of: 209 (209) by NMR, 179 (85) by GC-MS, 127 (127) by DFI/LC-MS/MS, 40 (40) by ICP-MS and 10 (10) by HPLC. Our use of multiple metabolomics platforms and technologies allowed us to identify several previously unknown urine metabolites and to substantially enhance the level of metabolome coverage. It also allowed us to critically assess the relative strengths and weaknesses of different platforms or technologies. The literature review led to the identification and annotation of another 2206 urinary compounds and was used to help guide the subsequent experimental studies. An online database containing the complete set of 2651 confirmed human urine metabolite species, their structures (3079 in total), concentrations, related literature references and links to their known disease associations are freely available at http://www.urinemetabolome.ca.	[Bouatra, Souhaila; Aziat, Farid; Mandal, Rupasri; Bjorndahl, Trent C.; Krishnamurthy, Ramanarayan; Saleem, Fozia; Liu, Philip; Dame, Zerihun T.; Poelzer, Jenna; Huynh, Jessica; Yallou, Faizath S.; Dong, Edison; Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Guo, An Chi; Wilson, Michael R.; Knox, Craig; Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Psychogios, Nick] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [Bogumil, Ralf; Roehring, Cornelia] BIOCRATES Life Sci AG, Innsbruck, Austria; [Wishart, David S.] Natl Inst Nanotechnol, Edmonton, AB, Canada	University of Alberta; University of Alberta; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Research Council Canada	Wishart, DS (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	david.wishart@ualberta.ca	Knox, Craig/AAG-1019-2022; Knox, Craig/AFK-2712-2022; Wishart, David Scott/ABI-3181-2020	Dame, Zerihun T./0000-0003-3862-1067; Wishart, David S/0000-0002-3207-2434; Psychogios, Nikolaos/0000-0002-2747-6012	Genome Canada; Genome Alberta; Canadian Institutes of Health Research; Alberta Innovates BioSolutions; Alberta Innovates Health Solutions; National Research Council; National Institute of Nanotechnology; Alberta Innovates [201201143] Funding Source: researchfish	Genome Canada(Genome Canada); Genome Alberta; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates BioSolutions; Alberta Innovates Health Solutions; National Research Council; National Institute of Nanotechnology; Alberta Innovates	Funding for this research has been provided by Genome Canada, Genome Alberta, The Canadian Institutes of Health Research, Alberta Innovates BioSolutions, Alberta Innovates Health Solutions, The National Research Council, The National Institute of Nanotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Atkinson W, 2007, EUR J NUTR, V46, P446, DOI 10.1007/s00394-007-0684-5; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Benkhedda K, 2000, J ANAL ATOM SPECTROM, V15, P1349, DOI 10.1039/b003997g; Bollard ME, 2005, NMR BIOMED, V18, P143, DOI 10.1002/nbm.935; Brindle JT, 2003, NAT MED, V9, P477, DOI 10.1038/nm0403-477c; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Cava-Montesinos P, 2005, TALANTA, V66, P895, DOI 10.1016/j.talanta.2004.12.042; Cheng Y, 2012, J PROTEOME RES, V11, P1354, DOI 10.1021/pr201001a; CORSO G, 1993, BIOL MASS SPECTROM, V22, P698, DOI 10.1002/bms.1200221205; David F.P., 1971, COMPOSITION CONCENTR; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; DITTRICH P, 1988, PHYTOCHEMISTRY, V27, P935, DOI 10.1016/0031-9422(88)84125-6; Dunne VG, 2005, NMR BIOMED, V18, P24, DOI 10.1002/nbm.918; Dutton GJ, 1966, GLUCURONIC ACID, P629; Echeverry G, 2010, METHODS MOL BIOL, V641, P1, DOI 10.1007/978-1-60761-711-2_1; Engelke UFH, 2004, CLIN CHEM, V50, P58, DOI 10.1373/clinchem.2003.020214; FISKERSTRAND T, 1993, CLIN CHEM, V39, P263; Franke AA, 1998, P SOC EXP BIOL MED, V217, P263, DOI 10.3181/00379727-217-44231; FRANKE AA, 1994, J CHROMATOGR B, V662, P47, DOI 10.1016/0378-4347(94)00390-4; Frolkis A, 2010, NUCLEIC ACIDS RES, V38, pD480, DOI 10.1093/nar/gkp1002; Garrod AE, 1996, MOL MED, V2, P274, DOI 10.1007/BF03401625; GATES SC, 1978, CLIN CHEM, V24, P1680; Goulle JP, 2005, FORENSIC SCI INT, V153, P39, DOI 10.1016/j.forsciint.2005.04.020; GUNERAL F, 1994, CLIN CHEM, V40, P862; Guo K, 1218, J CHROMATOGR A, P3689; Guo K, 2009, ANAL CHEM, V81, P3919, DOI 10.1021/ac900166a; Hao J, 2012, BIOINFORMATICS, V28, P2088, DOI 10.1093/bioinformatics/bts308; Harborne J. B., 1988, FLAVONOIDS; Heitland P, 2006, J TRACE ELEM MED BIO, V20, P253, DOI 10.1016/j.jtemb.2006.08.001; HOFFMANN G, 1989, CLIN CHEM, V35, P587; Holmes E, 2007, ANAL CHEM, V79, P2629, DOI 10.1021/ac062305n; HUCKER HB, 1967, J PHARMACOL EXP THER, V155, P309; Issaq HJ, 2008, J UROLOGY, V179, P2422, DOI 10.1016/j.juro.2008.01.084; Jia CR, 1998, J MICROCOLUMN SEP, V10, P167, DOI 10.1002/(SICI)1520-667X(1998)10:2<167::AID-MCS1>3.0.CO;2-E; Giron AJ, 2012, ANAL CHIM ACTA, V721, P137, DOI 10.1016/j.aca.2012.02.002; Kaddurah-Daouk R, 2004, PHARMAGENOMICS, V4, P46; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kang SM, 2011, CLIN BIOCHEM, V44, P293, DOI 10.1016/j.clinbiochem.2010.11.010; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Kern SM, 2003, J AGR FOOD CHEM, V51, P6050, DOI 10.1021/jf0302299; Kim H, 2008, ANALYST, V133, P1656, DOI 10.1039/b804715d; Kim K, 2009, MOL CELL PROTEOMICS, V8, P558, DOI 10.1074/mcp.M800165-MCP200; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; Kouba E, 2007, J UROLOGY, V177, P50, DOI 10.1016/j.juro.2006.08.111; Kuimierek K, 2008, BIOMED CHROMATOGR, V22, P441, DOI 10.1002/bmc.959; Kumari K, 2007, J ETHNOPHARMACOL, V109, P367, DOI 10.1016/j.jep.2006.07.045; Kusmierek K, 2006, ANAL BIOANAL CHEM, V385, P855, DOI 10.1007/s00216-006-0454-x; Kusmierek K, 2008, CHROMATOGRAPHIA, V68, pS91, DOI 10.1365/s10337-008-0582-x; Kvitvang HFN, 2011, ANAL CHEM, V83, P2705, DOI 10.1021/ac103245b; Law WS, 2008, RAPID COMMUN MASS SP, V22, P2436, DOI 10.1002/rcm.3629; LAWSON AM, 1976, CLIN CHEM, V22, P1283; LIEBICH HM, 1990, J CHROMATOGR-BIOMED, V525, P1, DOI 10.1016/S0378-4347(00)83375-7; Lim C, 2010, J MICROBIOL BIOTECHN, V20, P494, DOI 10.4014/jmb.0909.09026; Lindon JC, 2005, PHARMACOGENOMICS, V6, P691, DOI 10.2217/14622416.6.7.691; Lloyd AJ, 2011, BRIT J NUTR, V106, P812, DOI 10.1017/S0007114511001164; Luo JL, 1997, J PHARMACEUT BIOMED, V15, P1289, DOI 10.1016/S0731-7085(96)01971-1; MACCARONE MC, 1993, SOFTWARE PRACT EXPER, V23, P55, DOI 10.1002/spe.4380230105; Mandal R, 2012, GENOME MED, V4, DOI 10.1186/gm337; Matsumoto I, 1996, MASS SPECTROM REV, V15, P43, DOI 10.1002/(SICI)1098-2787(1996)15:1<43::AID-MAS3>3.0.CO;2-B; Mendrick DL, 2009, BIOMARK MED, V3, P605, DOI 10.2217/BMM.09.43; Metz TO, 2007, BIOMARK MED, V1, P159, DOI 10.2217/17520363.1.1.159; MINKLER PE, 1993, J CHROMATOGR-BIOMED, V613, P203, DOI 10.1016/0378-4347(93)80135-Q; Montoliu I, 2013, GENES NUTR, V8, P19, DOI 10.1007/s12263-012-0313-7; Moure A, 2001, FOOD CHEM, V72, P145, DOI 10.1016/S0308-8146(00)00223-5; Myint T, 2000, AM J EPIDEMIOL, V152, P752, DOI 10.1093/aje/152.8.752; Navarro-Munoz M, 2012, KIDNEY BLOOD PRESS R, V35, P314, DOI 10.1159/000335383; Ng DJY, 2011, METABOLOMICS, V7, P155, DOI 10.1007/s11306-010-0250-7; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Nielen MWF, 2006, ANAL CHEM, V78, P424, DOI 10.1021/ac051317q; Ouellette BFF, 1998, METHOD BIOCHEM ANAL, V39, P16; Pardalidis N, 2008, J UROLOGY, V179, P1271, DOI 10.1016/j.juro.2007.11.046; Pasikanti KK, 2008, RAPID COMMUN MASS SP, V22, P2984, DOI 10.1002/rcm.3699; Pasikanti KK, 2010, J PROTEOME RES, V9, P2988, DOI 10.1021/pr901173v; Pechlivanis A, 2010, J PROTEOME RES, V9, P6405, DOI 10.1021/pr100684t; Psihogios NG, 2008, NMR BIOMED, V21, P195, DOI 10.1002/nbm.1176; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rezzi S, 2008, J CHROMATOGR B, V871, P271, DOI 10.1016/j.jchromb.2008.04.001; Rigby D, 2005, UNDERSTANDING URINE; Rios LY, 2003, AM J CLIN NUTR, V77, P912, DOI 10.1093/ajcn/77.4.912; Rocha SM, 2012, J CHROMATOGR A, V1252, P155, DOI 10.1016/j.chroma.2012.06.067; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rohring C, 10031 BIOCR LIF SCI; Rousu T, 2009, RAPID COMMUN MASS SP, V23, P843, DOI 10.1002/rcm.3953; Roux A, 2012, ANAL CHEM, V84, P6429, DOI 10.1021/ac300829f; RUBIN D, 1979, CLIN CHEM, V25, P1867; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Saude EJ, 2006, METABOLOMICS, V2, P113, DOI 10.1007/s11306-006-0023-5; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Shaykhutdinov RA, 2009, METABOLOMICS, V5, P307, DOI 10.1007/s11306-009-0155-5; SHOEMAKER JD, 1991, J CHROMATOGR-BIOMED, V562, P125, DOI 10.1016/0378-4347(91)80571-S; Silva CL, 2011, BRIT J CANCER, V105, P1894, DOI 10.1038/bjc.2011.437; SJOLIN J, 1989, AM J CLIN NUTR, V49, P62; SJOLIN J, 1987, METABOLISM, V36, P1175, DOI 10.1016/0026-0495(87)90245-9; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Smith LM, 2007, ANAL CHEM, V79, P5682, DOI 10.1021/ac0703754; Takeda I, 2009, NMR BIOMED, V22, P577, DOI 10.1002/nbm.1369; Taylor E. H, 1989, CLIN CHEM; van der Kloet FM, 2012, METABOLOMICS, V8, P109, DOI 10.1007/s11306-011-0291-6; Viant MR, 2008, MOL BIOSYST, V4, P980, DOI 10.1039/b805354e; Wadhier MC, 2011, J CHROMATOGR A, V1218, P4537, DOI 10.1016/j.chroma.2011.05.039; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Winning H, 2009, ANALYST, V134, P2344, DOI 10.1039/b918259d; Wishart DS, 2008, DRUGS R&D, V9, P307, DOI 10.2165/00126839-200809050-00002; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; WOO KL, 1995, J CHROMATOGR B, V665, P15, DOI 10.1016/0378-4347(94)00515-7; Yanamandra Ramesh, 2012, Sci Pharm, V80, P101, DOI 10.3797/scipharm.1110-14; Yang WJ, 2008, SCI CHINA SER B, V51, P218, DOI 10.1007/s11426-008-0031-6; Zhang QF, 2005, J AM SOC MASS SPECTR, V16, P1192, DOI 10.1016/j.jasms.2005.03.052; Zhang SC, 2012, METABOLOMICS, V8, P323, DOI 10.1007/s11306-011-0315-2; Zhang W, 2010, J CHROMATOGR A, V1217, P5785, DOI 10.1016/j.chroma.2010.07.045; Zhang Y, 2011, DRUG TEST ANAL, V3, P857, DOI 10.1002/dta.380; Zuppi C, 1997, CLIN CHIM ACTA, V265, P85, DOI 10.1016/S0009-8981(97)00110-1	120	863	881	20	467	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73076	10.1371/journal.pone.0073076	http://dx.doi.org/10.1371/journal.pone.0073076			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023812	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600066
J	Pescaretti, MD; Farizano, JV; Morero, R; Delgado, MA				de las Mercedes Pescaretti, Maria; Farizano, Juan V.; Morero, Roberto; Delgado, Monica A.			A Novel Insight on Signal Transduction Mechanism of RcsCDB System in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEMS; ESCHERICHIA-COLI K-12; PHOSPHORELAY SYSTEM; MULTISTEP PHOSPHORELAY; RESPONSE REGULATOR; CAPSULE SYNTHESIS; UGD GENE; EXPRESSION; VIRULENCE; PROTEIN	The RcsCDB system of Salmonella enterica serovar Typhimurium is implicated in the control of capsule and flagella synthesis. The hybrid sensor RcsC, the phosphotransferase RcsD and the RcsB regulator, constitute the main components of the RcsCDB system. The proposed Rcs signaling cascade involves the autophosphorylation of RcsC and the transfer of the phosphate group to RcsB, mediated by RcsD. We previously reported that the overexpression of rcsB repress the transcription of rcsD by an autoregulation mechanism. Moreover, we demonstrated that during the rcsD repression, the RcsB-dependent flagellar modulation remained active. These results suggest that the Rcs phosphorelay mechanism occurs even in the absence of RcsD. In this work, we established the existence of two alternative phosphorelay pathways driving activation of this system. We demonstrated that RcsC and RcsD can act as histidine kinase proteins which, after autophosphorylated, are able to independently transfer the phosphate to RcsB. Our results suggest that these pathways could be activated by different environmental signals, leading different levels of RcsB-phosphorylated to produce a differential gene modulation. These findings contribute to a better understanding of the complexity and importance of the Rcs system activation, where more than one phosphate flow pathway increases the possibilities to exert gene regulation for a quick environmental changes response.	[Delgado, Monica A.] Univ Nacl Tucuman, Inst Super Invest Biol, Consejo Nacl Invest Cient & Tecn, RA-4000 San Miguel De Tucuman, Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman	Delgado, MA (corresponding author), Univ Nacl Tucuman, Inst Super Invest Biol, Consejo Nacl Invest Cient & Tecn, RA-4000 San Miguel De Tucuman, Tucuman, Argentina.	monicad@fbqf.unt.edu.ar	Delgado, Monica Alejandra/H-2740-2019	Delgado, Monica Alejandra/0000-0002-4283-6979; Pescaretti, Maria de las Mercedes/0000-0002-9299-2080; Farizano, Juan Vicente/0000-0003-0180-4927	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2518]; Consejo de Investigaciones de la Universidad Nacional de Tucuman [26/D439]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo de Investigaciones de la Universidad Nacional de Tucuman	This work was supported by grants PIP 2518 from Consejo Nacional de Investigaciones Cientificas y Tecnicas (www.conicet.gov.ar) and Consejo de Investigaciones de la Universidad Nacional de Tucuman 26/D439 (www.ct.unt.edu.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulencia A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.242003; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Aiso T, 2003, GENES CELLS, V8, P179, DOI 10.1046/j.1365-2443.2003.00624.x; Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Cano DA, 2002, GENETICS, V162, P1513; Castanie-Cornet MP, 2007, MICROBIOL-SGM, V153, P238, DOI 10.1099/mic.0.29278-0; Costa CS, 2001, FEMS MICROBIOL LETT, V200, P201, DOI 10.1111/j.1574-6968.2001.tb10716.x; Cotter PD, 2002, ANTIMICROB AGENTS CH, V46, P2784, DOI 10.1128/AAC.46.9.2784-2790.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Pescaretti MD, 2010, MICROBIOL-SGM, V156, P3513, DOI 10.1099/mic.0.041319-0; Pescaretti MD, 2009, FEMS MICROBIOL LETT, V300, P165, DOI 10.1111/j.1574-6968.2009.01771.x; Delgado MA, 2006, MOL MICROBIOL, V60, P39, DOI 10.1111/j.1365-2958.2006.05069.x; Detweiler CS, 2003, MOL MICROBIOL, V48, P385, DOI 10.1046/j.1365-2958.2003.03455.x; Erickson KD, 2006, MOL MICROBIOL, V62, P883, DOI 10.1111/j.1365-2958.2006.05420.x; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Garcia-Calderon CB, 2005, MICROBIOL-SGM, V151, P579, DOI 10.1099/mic.0.27520-0; Garcia-Calderon CB, 2007, J BACTERIOL, V189, P6635, DOI 10.1128/JB.00640-07; Hsu JL, 2008, J BIOL CHEM, V283, P9933, DOI 10.1074/jbc.M708836200; Jones AM, 2006, J BACTERIOL, V188, P5077, DOI 10.1128/JB.00206-06; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Miller J.H., 1972, EXPT MOL GENETICS; Mouslim C, 2004, MOL MICROBIOL, V54, P386, DOI 10.1111/j.1365-2958.2004.04293.x; Mouslim C, 2003, J BIOL CHEM, V278, P50588, DOI 10.1074/jbc.M309433200; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Rogov VV, 2004, J MOL BIOL, V343, P1035, DOI 10.1016/j.jmb.2004.08.096; Sambrook J., 2002, MOL CLONING LAB MANU; SANDERSON KE, 1995, MICROBIOL REV, V59, P241, DOI 10.1128/MMBR.59.2.241-303.1995; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; STOUT V, 1990, J BACTERIOL, V172, P659, DOI 10.1128/jb.172.2.659-669.1990; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Takeda S, 2001, MOL MICROBIOL, V40, P440, DOI 10.1046/j.1365-2958.2001.02393.x; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200	41	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72527	10.1371/journal.pone.0072527	http://dx.doi.org/10.1371/journal.pone.0072527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023746	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600025
J	Rizzato, C; Kato, I; Plummer, M; Munoz, N; Canzian, F				Rizzato, Cosmeri; Kato, Ikuko; Plummer, Martyn; Munoz, Nubia; Canzian, Federico			Genetic Variation in PSCA and Risk of Gastric Advanced Preneoplastic Lesions and Cancer in Relation to Helicobacter pylori Infection	PLOS ONE			English	Article							STEM-CELL ANTIGEN; GENOME-WIDE ASSOCIATION; STOMACH-CANCER; SUSCEPTIBILITY; POLYMORPHISMS; STRAINS; CAGA; EPIDEMIOLOGY; MARKER; VACA	SNPs in the Prostate Stem Cell Antigen (PSCA) gene have been found associated with gastric cancer (GC) risk in a genome-wide association study. This association has been replicated in several populations. In this study we assessed the impact of PSCA genotype on the risk of advanced gastric precancerous lesions and GC. We used baseline gastric histopathology data and DNA from frozen gastric biopsies of 2045 subjects enrolled in a chemoprevention trial for gastric precancerous lesions in Venezuela, and 180 cases of GC from the same area. We analyzed 3 SNPs in the PSCA gene (rs2294008, rs9297976 and rs12155758) which were previously found to be associated with GC risk in Europeans. The T allele of rs2294008 was found to be associated with a higher prevalence of atrophic gastritis (OR = 1.44; 95% CI 1.03-2.01 for the dominant model) and intestinal metaplasia (OR = 1.50; 95% CI 1.13-1.98 for the dominant model). We also confirmed the association with higher risk of gastric cancer (OR = 2.34; 95% CI 1.36-4.01 for the allele carriers). SNP rs12155758 was not associated with risk of gastric preneoplastic lesions, but we confirmed its association with higher GC risk (OR 1.95; 95% CI 1.29-2.97 for dominant model). We tested the relevance of the presence of the Helicobacter pylori cagA gene, which is known to increase the risk of more severe gastric lesions, but we did not find any clearcut interaction with PSCA SNPs in defining risk of gastric precancerous lesions or cancer.	[Rizzato, Cosmeri; Canzian, Federico] German Canc Res Ctr, Heidelberg, Germany; [Kato, Ikuko] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Kato, Ikuko] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Plummer, Martyn] IARC, Lyon, France; [Munoz, Nubia] Natl Canc Inst Colombia, Bogota, Colombia	Helmholtz Association; German Cancer Research Center (DKFZ); Wayne State University; Wayne State University; World Health Organization; International Agency for Research on Cancer (IARC)	Canzian, F (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	f.canzian@dkfz.de	Rizzato, Cosmeri/AAI-1261-2020; Canzian, Federico/I-2804-2014	Plummer, Martyn/0000-0001-5130-6497; Canzian, Federico/0000-0002-4261-4583	European Community [CT90-0555]; US National Cancer Institute [CA 98309]; NATIONAL CANCER INSTITUTE [R01CA098309] Funding Source: NIH RePORTER	European Community(European Commission); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the European Community (CT90-0555 to I.K.) and the US National Cancer Institute (CA 98309 to I.K.)DOI: 10.1002/ijc.28019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Chiurillo MA, 2011, DIGEST DIS SCI, V56, P449, DOI 10.1007/s10620-010-1316-0; [Anonymous], 2011, J CLIN GASTROENTEROL, V45, P383, DOI 10.1097/MCG.0b013e31820fb8f6; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Bevan S, 1999, QJM-MON J ASSOC PHYS, V92, P5, DOI 10.1093/qjmed/92.1.5; CORREA P, 1990, CANCER RES, V50, P4731; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; El-Etr SH, 2004, J INFECT DIS, V190, P1516, DOI 10.1086/424526; Ghose C, 2005, J CLIN MICROBIOL, V43, P2635, DOI 10.1128/JCM.43.6.2635-2641.2005; Kato I, 2004, CANCER EPIDEM BIOMAR, V13, P468; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Lochhead P, 2011, GASTROENTEROLOGY, V140, P435, DOI 10.1053/j.gastro.2010.11.001; Lunet N, 2003, INT J CANCER, V106, P953, DOI 10.1002/ijc.11306; Matsuo K, 2009, INT J CANCER, V125, P1961, DOI 10.1002/ijc.24519; Mbulaiteye SM, 2009, FRONT BIOSCI-LANDMRK, V14, P1490, DOI 10.2741/3320; Munoz N, 2001, INT J CANCER, V93, P417, DOI 10.1002/ijc.1333; Plummer M, 2000, CANCER EPIDEM BIOMAR, V9, P961; Plummer M, 2007, J NATL CANCER I, V99, P1328, DOI 10.1093/jnci/djm120; Qiao L, 2012, GENE, V493, P83, DOI 10.1016/j.gene.2011.11.017; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Rizzato C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029605; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Sala N, 2012, INT J CANC; Shi DN, 2012, J CANCER RES CLIN, V138, P1339, DOI 10.1007/s00432-012-1210-6; Song HR, 2011, MOL CARCINOGEN, V50, P871, DOI 10.1002/mc.20796; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Torres J, 2013, CANCER CAUSE CONTROL, V24, P249, DOI 10.1007/s10552-012-0114-8; Tran CP, 2002, MOL CANCER RES, V1, P113; van Doorn LJ, 1998, J CLIN MICROBIOL, V36, P1271, DOI 10.1128/JCM.36.5.1271-1276.1998; van Doorn NEM, 1999, J CLIN MICROBIOL, V37, P2348, DOI 10.1128/JCM.37.7.2348-2349.1999; Wang ML, 2011, INT J CANCER, V129, P1207, DOI 10.1002/ijc.25740; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Zeng ZR, 2011, MOL CARCINOGEN, V50, P353, DOI 10.1002/mc.20718; Zhang QH, 2012, ASIAN PAC J CANCER P, V13, P2867, DOI 10.7314/APJCP.2012.13.6.2867; Zhang T, 2012, EXP THER MED, V4, P158, DOI 10.3892/etm.2012.563	38	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73100	10.1371/journal.pone.0073100	http://dx.doi.org/10.1371/journal.pone.0073100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023815	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600068
J	Venail, PA; Vives, MJ				Venail, Patrick A.; Vives, Martha J.			Positive Effects of Bacterial Diversity on Ecosystem Functioning Driven by Complementarity Effects in a Bioremediation Context	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; CRUDE-OIL; PLANT DIVERSITY; BIODIVERSITY; BIOAUGMENTATION; SELECTION; RICHNESS; BIODEGRADATION; PRODUCTIVITY; SOIL	Despite their importance as ecosystem drivers, our understanding of the influence of bacterial diversity on ecosystem functioning is limited. After identifying twelve bacterial strains from two petroleum-contaminated sites, we experimentally explored the impact of biodiversity on total density by manipulating the number of strains in culture. Irrespective of the origin of the bacteria relative to the contaminant, biodiversity positively influenced total density. However, bacteria cultured in the crude oil of their origin (autochthonous) reached higher densities than bacteria from another origin (allochthonous) and the relationship between diversity and density was stronger for autochthonous bacteria. By measuring the relative contribution of each strain to total density we showed that the observed positive effect of increasing diversity on total density was mainly due to positive interactions among species and not the presence of a particular species. Our findings can be explained by the complex chemical composition of crude oil and the necessity of a diverse array of organisms with complementary enzymatic capacities to achieve its degradation. The long term exposure to a contaminant may have allowed different bacteria to become adapted to the use of different fractions of the crude, resulting in higher complementarity in resource use in autochthonous bacteria compared to allochthonous ones. Our results could help improve the success of bioaugmentation as a bioremediation technique by suggesting the use of a diversified set of autochthonous organisms.	[Venail, Patrick A.; Vives, Martha J.] Univ Los Andes, Dept Ciencias Biol, Ctr Invest Microbiol, Bogota, Colombia	Universidad de los Andes (Colombia)	Venail, PA (corresponding author), Univ Geneva, Fac Sci, Inst Francois Alphonse Forel, Versoix, Switzerland.	patrickvenail@hotmail.com	Venail, Patrick/D-2968-2018	Venail, Patrick/0000-0003-1126-280X; Vives, Martha/0000-0001-7795-1494				Alisi C, 2009, SCI TOTAL ENVIRON, V407, P3024, DOI 10.1016/j.scitotenv.2009.01.011; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Becker J, 2012, ECOL LETT, V15, P468, DOI 10.1111/j.1461-0248.2012.01759.x; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Boopathy R, 2000, BIORESOURCE TECHNOL, V74, P63, DOI 10.1016/S0960-8524(99)00144-3; Bouvier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037620; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Dejonghe W, 2001, ENVIRON MICROBIOL, V3, P649, DOI 10.1046/j.1462-2920.2001.00236.x; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Gentry TJ, 2004, CRIT REV ENV SCI TEC, V34, P447, DOI 10.1080/10643380490452362; Gravel D, 2011, NATURE, V469, P89, DOI 10.1038/nature09592; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jiang L, 2007, ECOLOGY, V88, P1075, DOI 10.1890/06-1556; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Li H, 2007, FEMS MICROBIOL ECOL, V60, P74, DOI 10.1111/j.1574-6941.2006.00266.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Machin-Ramirez C, 2008, CHEMOSPHERE, V70, P737, DOI 10.1016/j.chemosphere.2007.06.017; Magot M, 2000, ANTON LEEUW INT J G, V77, P103, DOI 10.1023/A:1002434330514; McKew BA, 2007, ENVIRON MICROBIOL, V9, P1562, DOI 10.1111/j.1462-2920.2007.01277.x; Mishra S, 2001, APPL ENVIRON MICROB, V67, P1675, DOI 10.1128/AEM.67.4.1675-1681.2001; Rahman KSM, 2002, J BASIC MICROB, V42, P284, DOI 10.1002/1521-4028(200208)42:4&lt;284::AID-JOBM284&gt;3.0.CO;2-M; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Singer AC, 2005, TRENDS BIOTECHNOL, V23, P74, DOI 10.1016/j.tibtech.2004.12.012; Swannell RPJ, 1996, MICROBIOL REV, V60, P342, DOI 10.1128/MMBR.60.2.342-365.1996; Thompson IP, 2005, ENVIRON MICROBIOL, V7, P909, DOI 10.1111/j.1462-2920.2005.00804.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; Venail PA, 2010, P ROY SOC B-BIOL SCI, V277, P2339, DOI 10.1098/rspb.2009.2104; Vinas M, 2002, J IND MICROBIOL BIOT, V28, P252, DOI 10.1038/sj/jim/7000236	38	14	14	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72561	10.1371/journal.pone.0072561	http://dx.doi.org/10.1371/journal.pone.0072561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023751	gold, Green Submitted, Green Published			2022-12-27	WOS:000324515600030
J	Hirjak, D; Breyer, T; Thomann, PA; Fuchs, T				Hirjak, Dusan; Breyer, Thiemo; Thomann, Philipp Arthur; Fuchs, Thomas			Disturbance of Intentionality: A Phenomenological Study of Body-Affecting First-Rank Symptoms in Schizophrenia	PLOS ONE			English	Article							1ST RANK SYMPTOMS; ANOMALOUS SELF-EXPERIENCE; AUDITORY VERBAL HALLUCINATIONS; ULTRA-HIGH RISK; PSYCHOSIS ONSET; PLASTICITY; DYSCONNECTIVITY; SCHNEIDER; FREQUENCY; DEFICIT	Objectives: In 1950, Kurt Schneider proposed that a considerable number of schizophrenia patients develop first-rank symptoms (FRS). In such cases, patients report made experiences, replaced control of will, thought insertion, broadcast or withdrawal and delusional perception, respectively. Although a number of recent studies tend to explain FRS in terms of neurobiological and neuropsychological processes, the origin of these symptoms still remains unknown. In this paper, we explore the subjective experience of patients with the following two FRS: (1) "made" impulses and (2) "made" volitional acts. Method: The method applied for the study of two FRS consists first in the overview of psychiatric and philosophical literature and second in the further investigation of subjective experience in patients with FRS. Psychopathological and phenomenological aspects of FRS are discussed by means of patient cases. Results: We discovered a profound transformation of intentionality and agency in schizophrenia patients with body-affecting FRS. This concept offers an insight into the interrelatedness between particular FRS. Conclusion: We propose that the subjective experience of schizophrenia patients with body-affecting FRS is rooted in the disturbance of intentionality and diminished sense of agency. This theoretical account of body-affecting FRS will open up new directions in both phenomenological and neurobiological psychiatric research.	[Hirjak, Dusan; Breyer, Thiemo; Fuchs, Thomas] Heidelberg Univ, Ctr Psychosocial Med, Dept Gen Psychiat, Sect Phenomenol Psychopathol & Psychotherapy, Heidelberg, Germany; [Hirjak, Dusan; Thomann, Philipp Arthur] Heidelberg Univ, Ctr Psychosocial Med, Dept Gen Psychiat, Struct Neuroimaging Grp, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hirjak, D (corresponding author), Heidelberg Univ, Ctr Psychosocial Med, Dept Gen Psychiat, Sect Phenomenol Psychopathol & Psychotherapy, Heidelberg, Germany.	dusan.hirjak@med.uni-heidelberg.de	Hirjak, Dusan/P-2777-2018; Hirjak, Dusan/W-2126-2019; Fuchs, Thomas/AAY-1696-2020	Fuchs, Thomas/0000-0001-9466-4956				Andreasen NC, 2007, SCHIZOPHRENIA BULL, V33, P108, DOI 10.1093/schbul/sbl054; Angyal A, 1936, ARCH NEURO PSYCHIATR, V35, P1029, DOI 10.1001/archneurpsyc.1936.02260050103007; [Anonymous], 2010, HDB PHENOMENOLOGY CO, DOI DOI 10.1007/978-90-481-2646-0_28; [Anonymous], 2008, PHILOS ISSUES PSYCHI; Beringer K, 1926, Z GESAMTE NEUROL PSY, V103, P185, DOI 10.1007/BF02909807; Beringer K, 1924, Z GESAMTE NEUROL PSY, V93, P55, DOI 10.1007/BF02900045; Berze J, 1929, PSYCHOL SCHIZOPHRENI, DOI DOI 10.1007/978-3-7091-6005-3; Blakemore SJ, 2003, SELF IN NEUROSCIENCE AND PSYCHIATRY, P407, DOI 10.1017/CBO9780511543708.020; Blankenburg W., 1971, VERLUST NATURLICHEN; Carroy J, 2000, J HIST BEHAV SCI, V36, P231, DOI 10.1002/1520-6696(200022)36:3<231::AID-JHBS2>3.0.CO;2-I; Ceccherini-Nelli A, 2007, SCHIZOPHR RES, V90, P203, DOI 10.1016/j.schres.2006.09.017; CHAPMAN J, 1966, BRIT J PSYCHIAT, V112, P225, DOI 10.1192/bjp.112.484.225; CLOS M, 2013, BRAIN STRUCT FUNCT; CONRAD K, 1971, BEGINNENDE SCHIZOPHR; Davidsen KA, 2009, PSYCHOPATHOLOGY, V42, P361, DOI 10.1159/000236907; de Haan S, 2010, PSYCHOPATHOLOGY, V43, P327, DOI 10.1159/000319402; DESCARTES R, 1969, MENSCHEN SOWIE BESCH; Descartes Rene, 1994, MEDITATIONEN GRUNDLA; Faget-Agius C, 2012, J PSYCHIATR NEUROSCI, V37, P297, DOI 10.1503/jpn.110125; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Fuchs T, 2005, PSYCHOPATHOLOGY, V38, P133, DOI 10.1159/000085843; Fuchs T, 2002, PSYCHOPATHOLOGY, V35, P319, DOI 10.1159/000068593; FUCHS T, 2013, ONE CENTURY K JASPER; Fuchs T, 2010, PSYCHOPATHOLOGY, V43, P268, DOI 10.1159/000315126; Gaebel W, 2008, EUR ARCH PSY CLIN N, V258, P41, DOI 10.1007/s00406-008-2009-y; Gallagher S., 2000, EXPLORING SELF PHILO; Gallagher Shaun., 2021, PHENOMENOLOGICAL MIN, V3rd ed., DOI 10.4324/9780203086599; GURWITSCH A, 1974, PHENOMENOLOGY THEORY, P210; Gurwitsch A., 1964, FIELD CONSCIOUSNESS; Hirjak D, 2010, PSYCHOPATHOLOGY, V43, P96, DOI 10.1159/000274178; Homan P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00304; HOWARD RJ, 1992, BRIT J PSYCHIAT, V160, P108, DOI 10.1192/bjp.160.1.108; Husserl E., 1982, GEN INTRO PURE PHENO; HUSSERL E., 1950, CARTESIANISCHE MEDIT, VI; Husserl E., 2001, ANAL PASSIVE ACTIVE, V9; Ihara K, 2009, PSYCHOPATHOLOGY, V42, P81, DOI 10.1159/000203340; Kean C, 2009, SCHIZOPHRENIA BULL, V35, P1034, DOI 10.1093/schbul/sbp043; Kendler KS, 2009, PSYCHOL MED, V39, P1935, DOI 10.1017/S0033291709005753; KLOSTERKOTTER J, 1992, NERVENARZT, V63, P675; KLOSTERKOTTER J, 1988, MONOGR GESAMTGEB PSY, P1; KOEHLER K, 1979, BRIT J PSYCHIAT, V134, P236, DOI 10.1192/bjp.134.3.236; Kompus K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00144; Kong L, 2012, SCHIZOPHR RES, V134, P27, DOI 10.1016/j.schres.2011.09.015; Leube D, 2008, EUR ARCH PSY CLIN N, V258, P22, DOI 10.1007/s00406-008-5017-z; Lysaker Paul H, 2010, Schizophr Bull, V36, P331, DOI 10.1093/schbul/sbn077; MARNEROS A, 1988, BRIT J PSYCHIAT, V152, P625, DOI 10.1192/bjp.152.5.625; MATUSSEK P, 1952, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V189, P279, DOI 10.1007/BF00351194; Matussek P, 1953, SCHWEIZ ARCH NEUROL, V71, P189; MELLOR CS, 1970, BRIT J PSYCHIAT, V117, P15, DOI 10.1192/S0007125000192116; Merleau-Ponty M., 1962, PHENOMENOLOGY PERCEP; Mishara AL, 2013, SCHIZOPHRENIA BULL, V39, P278, DOI 10.1093/schbul/sbs155; Mullen PE, 2007, SCHIZOPHRENIA BULL, V33, P113, DOI 10.1093/schbul/sbl043; Mundt C, 2005, PSYCHOPATHOLOGY, V38, P231, DOI 10.1159/000088440; MUNDT C, 1984, NERVENARZT, V55, P582; MUNDT C, 1990, PHILOS PSYCHOPATHOLO; MUNDT C, 1985, APATHIESYNDROM SCHIZ; Nelson B, 2009, NEUROSCI BIOBEHAV R, V33, P807, DOI 10.1016/j.neubiorev.2009.01.002; Nelson B, 2012, SCHIZOPHRENIA BULL, V38, P1277, DOI 10.1093/schbul/sbs007; Nelson B, 2009, PSYCHOPATHOLOGY, V42, P283, DOI 10.1159/000228837; Nordgaard J, 2008, SCHIZOPHRENIA BULL, V34, P137, DOI 10.1093/schbul/sbm044; Nordgaard J, 2013, EUR ARCH PSY CLIN N, V263, P353, DOI 10.1007/s00406-012-0366-z; Palaniyappan L, 2012, J PSYCHIATR RES, V46, P1249, DOI 10.1016/j.jpsychires.2012.06.007; Parnas J, 2005, PSYCHOPATHOLOGY, V38, P236, DOI 10.1159/000088441; Parnas J, 2003, ACTA PSYCHIAT SCAND, V108, P126, DOI 10.1034/j.1600-0447.2003.00105.x; Parnas J, 2003, COMPR PSYCHIAT, V44, P121, DOI 10.1053/comp.2003.50017; Parnas J, 1998, NEUROL PSYCHIAT BR, V6, P97; Parnas J, 2000, ADV CONSC RES, V23, P115; PARNAS J, 2011, EMBODIED SELF DIMENS, P227; Parnas J, 2013, SCHIZOPHRENIA BULL, V39, P270, DOI 10.1093/schbul/sbs153; Parnas J, 2012, WORLD PSYCHIATRY, V11, P67, DOI 10.1016/j.wpsyc.2012.05.002; Parnas J, 2011, SCHIZOPHRENIA BULL, V37, P1121, DOI 10.1093/schbul/sbr081; Plessner H, 2020, STUFEN ORG MENSCH EI, DOI DOI 10.1515/9783110845341; Raballo A, 2011, SCHIZOPHRENIA BULL, V37, P344, DOI 10.1093/schbul/sbp056; Raballo A, 2011, SCHIZOPHRENIA BULL, V37, P1017, DOI 10.1093/schbul/sbq008; Rosen C, 2011, COMPR PSYCHIAT, V52, P126, DOI 10.1016/j.comppsych.2010.06.005; Sass L, 2000, ADV CONSC RES, V23, P149; Sass L., 2010, HDB PHENOMENOLOGY CO, P635, DOI DOI 10.1007/978-90-481-2646-0_31; Sass LA, 2003, SELF IN NEUROSCIENCE AND PSYCHIATRY, P242, DOI 10.1017/CBO9780511543708.013; Sass LA, 2003, SCHIZOPHRENIA BULL, V29, P427, DOI 10.1093/oxfordjournals.schbul.a007017; Sass LA., 1994, PARADOXES DELUSION W; Sass Louis A., 1994, MADNESS MODERNISM IN; Schmicking D., 2010, HDB PHENOMENOLOGY CO, P35; Schmid-Siegel B, 2004, PSYCHOPATHOLOGY, V37, P84, DOI 10.1159/000077584; Schneider K., 1959, CLIN PSYCHOPATHOLOGY; SPIEGELBERG H, 1975, PHENOMENOLOGICAL MOV; Stanghellini G., 2004, DISEMBODIED SPIRITS; Stanghellini G, 2012, CURR PHARM DESIGN, V18, P392, DOI 10.2174/138161212799316181; Stanghellini G, 2009, WORLD PSYCHIATRY, V8, P56; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stompe T, 2003, PSYCHOPATHOLOGY, V36, P6, DOI 10.1159/000069658; Suzuki M, 2005, PSYCHOL MED, V35, P549, DOI 10.1017/S0033291704003885; Taylor MA, 2010, ACTA PSYCHIAT SCAND, V122, P173, DOI 10.1111/j.1600-0447.2010.01589.x; Thompson Evan, 2007, MIND LIFE BIOL PHENO; Thorup A, 2007, SCHIZOPHR RES, V97, P60, DOI 10.1016/j.schres.2007.06.018; Triarhou LC, 2012, J NEUROL, V259, P2012, DOI 10.1007/s00415-012-6461-2; TRIMBLE MR, 1990, BRIT J PSYCHIAT, V156, P195, DOI 10.1192/bjp.156.2.195; UEHLEIN F, 1992, PHENOMENOLOGY LANGUA, P70; Uhlhaas PJ, 2007, SCHIZOPHRENIA BULL, V33, P142, DOI 10.1093/schbul/sbl047; van Swam C, 2012, J PSYCHIATR RES, V46, P1015, DOI 10.1016/j.jpsychires.2012.03.016; Voineskos AN, 2013, JAMA PSYCHIAT, V70, P472, DOI 10.1001/jamapsychiatry.2013.786; Volpe U, 2012, PROG NEURO-PSYCHOPH, V37, P264, DOI 10.1016/j.pnpbp.2012.02.003; Waters F, 2009, PSYCHIAT RES, V170, P140, DOI 10.1016/j.psychres.2008.10.033; Waters F, 2009, PSYCHIAT RES, V167, P12, DOI 10.1016/j.psychres.2008.04.004; Waters FAV, 2010, SCHIZOPHRENIA BULL, V36, P510, DOI 10.1093/schbul/sbn112; WIGGINS OP, 1989, PHILOS PSYCHOPATHOLO; Wolf ND, 2011, J PSYCHIATR NEUROSCI, V36, P366, DOI 10.1503/jpn.110008; Zahavi D., 2003, HUSSERLS PHENOMENOLO	107	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73662	10.1371/journal.pone.0073662	http://dx.doi.org/10.1371/journal.pone.0073662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019932	Green Submitted, gold, Green Published			2022-12-27	WOS:000324338200074
J	Peters, KE; Chubb, SAP; Davis, WA; Davis, TME				Peters, Kirsten E.; Chubb, S. A. Paul; Davis, Wendy A.; Davis, Timothy M. E.			The Relationship between Hypomagnesemia, Metformin Therapy and Cardiovascular Disease Complicating Type 2 Diabetes: The Fremantle Diabetes Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DIETARY MAGNESIUM; SERUM MAGNESIUM; RISK; INSULIN; HYPERTENSION; METAANALYSIS; DEFICIENCY; MORTALITY; EXCRETION	Background: Low serum magnesium concentrations have been associated with cardiovascular disease risk and outcomes in some general population studies but there are no equivalent studies in diabetes. Metformin may have cardiovascular benefits beyond blood glucose lowering in type 2 diabetes but its association with hypomagnesemia appears paradoxical. The aim of this study was to examine relationships between metformin therapy, magnesium homoeostasis and cardiovascular disease in well-characterized type 2 patients from the community. Methods and Findings: We studied 940 non-insulin-treated patients (mean +/- SD age 63.4 +/- 11.6 years, 49.0% males) from the longitudinal observational Fremantle Diabetes Study Phase I (FDS1) who were followed for 12.3 +/- 5.3 years. Baseline serum magnesium was measured using stored sera. Multivariate methods were used to determine associates of prevalent and incident coronary heart disease (CHD) and cerebrovascular disease (CVD) as ascertained from self-report and linked morbidity/mortality databases. 19% of patients were hypomagnesemic (serum magnesium <0.70 mmol/L). Patients on metformin, alone or combined with a sulfonylurea, had lower serum magnesium concentrations than those on diet alone (P<0.05). There were no independent associations between serum magnesium or metformin therapy and either CHD or CVD at baseline. Incident CVD, but not CHD, was independently and inversely associated with serum magnesium (hazard ratio (95% CI) 0.28 (0.11-0.74); P=0.010), but metformin therapy was not a significant variable in these models. Conclusions: Since hypomagnesemia appears to be an independent risk factor for CVD complicating type 2 diabetes, the value of replacement therapy should be investigated further, especially in patients at high CVD risk.	[Peters, Kirsten E.; Davis, Wendy A.; Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA, Australia; [Chubb, S. A. Paul] Fremantle Hosp, Dept Biochem, PathWest Lab Med, Fremantle, WA, Australia	University of Western Australia	Davis, TME (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA, Australia.	tim.davis@uwa.edu.au	Davis, Timothy ME/M-5144-2014	Davis, Timothy/0000-0003-0749-7411; Peters, Kirsten/0000-0003-1406-8797; Davis, Wendy/0000-0002-5709-8235	Raine Foundation; University of Western Australia; Fremantle Hospital Medical Research Foundation; National Health and Medical Research Council of Australia	Raine Foundation; University of Western Australia; Fremantle Hospital Medical Research Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The Fremantle Diabetes Study Phase I was supported by the Raine Foundation, University of Western Australia, and the present sub-study by the Fremantle Hospital Medical Research Foundation. TMED is supported by a National Health and Medical Research Council of Australia Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altura BM, 1995, CELL MOL BIOL RES, V41, P347; Amighi J, 2004, STROKE, V35, P22, DOI 10.1161/01.STR.0000105928.95124.1F; Azoulay A, 2001, J GEN INTERN MED, V16, P168, DOI 10.1046/j.1525-1497.2001.04189.x; Belin RJ, 2007, MAGNESIUM RES, V20, P107; Bo S, 2008, CURR OPIN LIPIDOL, V19, P50, DOI 10.1097/MOL.0b013e3282f33ccc; Boussageon R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001204; Chaudhary DP, 2010, BIOL TRACE ELEM RES, V134, P119, DOI 10.1007/s12011-009-8465-z; Davis TME, 2013, INT J EPIDEMIOL, V42, P412, DOI 10.1093/ije/dys065; de Jager J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2181; DJURHUUS MS, 1995, DIABETIC MED, V12, P664, DOI 10.1111/j.1464-5491.1995.tb00566.x; Dosa MD, 2011, BIOL TRACE ELEM RES, V142, P36, DOI 10.1007/s12011-010-8751-9; Elisaf M, 1997, MAGNESIUM RES, V10, P315; Gorelik O, 2007, BIOL TRACE ELEM RES, V120, P102, DOI 10.1007/s12011-007-8024-4; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; JAEGER P, 1986, KIDNEY INT, V29, P563, DOI 10.1038/ki.1986.35; Khan AM, 2010, AM HEART J, V160, P715, DOI 10.1016/j.ahj.2010.06.036; KROLL MH, 1985, CLIN CHEM, V31, P244; Kupetsky-Rincon EA, 2012, ANN NUTR METAB, V61, P102, DOI 10.1159/000339380; Lamanna C, 2011, DIABETES OBES METAB, V13, P221, DOI 10.1111/j.1463-1326.2010.01349.x; Lameris AL, 2012, CLIN SCI, V123, P1, DOI 10.1042/CS20120045; Larsson SC, 2012, AM J CLIN NUTR, V95, P362, DOI 10.3945/ajcn.111.022376; Liao FZ, 1998, AM HEART J, V136, P480, DOI 10.1016/S0002-8703(98)70224-8; MA J, 1995, J CLIN EPIDEMIOL, V48, P927, DOI 10.1016/0895-4356(94)00200-A; MATHER HM, 1979, CLIN CHIM ACTA, V95, P235, DOI 10.1016/0009-8981(79)90364-4; Mathers TW, 2009, J AM ACAD NURSE PRAC, V21, P651, DOI 10.1111/j.1745-7599.2009.00460.x; MCBAIN AM, 1988, J CLIN PATHOL, V41, P933, DOI 10.1136/jcp.41.9.933; Norman PE, 2006, DIABETES CARE, V29, P575, DOI 10.2337/diacare.29.03.06.dc05-1567; Ohira T, 2009, AM J EPIDEMIOL, V169, P1437, DOI 10.1093/aje/kwp071; Reffelmann T, 2011, ATHEROSCLEROSIS, V219, P280, DOI 10.1016/j.atherosclerosis.2011.05.038; Sillars B, 2010, DIABETES OBES METAB, V12, P757, DOI 10.1111/j.1463-1326.2010.01230.x; STUTZMAN FL, 1953, J LAB CLIN MED, V41, P215; Svare Anders, 2009, Cases J, V2, P156, DOI 10.1186/1757-1626-2-156; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Walti MK, 2003, SWISS MED WKLY, V133, P289; Witkowski M, 2011, MAGNESIUM RES, V24, P163, DOI 10.1684/mrh.2011.0292; World Health Organisation, 2009, CALC MAGN DRINK WAT	38	38	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74355	10.1371/journal.pone.0074355	http://dx.doi.org/10.1371/journal.pone.0074355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019966	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200109
J	Takeuchi, A; Okubo, K				Takeuchi, Akio; Okubo, Kataaki			Post-Proliferative Immature Radial Glial Cells Female-Specifically Express Aromatase in the Medaka Optic Tectum	PLOS ONE			English	Article							NEURAL STEM-CELLS; ORYZIAS-LATIPES; SEXUAL-DIFFERENTIATION; ADULT NEUROGENESIS; MESSENGER-RNA; PREOPTIC AREA; TELEOST FISH; SPINAL-CORD; BRAIN; ESTROGEN	Aromatase, the key enzyme responsible for estrogen biosynthesis, is present in the brain of all vertebrates. Much evidence has accumulated that aromatase is highly and exclusively expressed in proliferating mature radial glial cells in the brain of teleost fish even in adulthood, unlike in other vertebrates. However, the physiological significance of this expression remains unknown. We recently found that aromatase is female-specifically expressed in the optic tectum of adult medaka fish. In the present study, we demonstrated that, contrary to the accepted view of the teleost brain, female-specific aromatase-expressing cells in the medaka optic tectum represent a transient subset of post-proliferative immature radial glial cells in the neural stem cell lineage. This finding led us to hypothesize that female-specific aromatase expression and consequent estrogen production causes some sex difference in the life cycle of tectal cells. As expected, the female tectum exhibited higher expression of genes indicative of cell proliferation and radial glial maturation and lower expression of an anti-apoptotic gene than did the male tectum, suggesting a female-biased acceleration of the cell life cycle. Complicating the interpretation of this result, however, is the additional observation that estrogen administration masculinized the expression of these genes in the optic tectum, while simultaneously stimulating aromatase expression. Taken together, these results provide evidence that a unique subpopulation of neural stem cells female-specifically express aromatase in the optic tectum and suggest that this aromatase expression and resultant estrogen synthesis have an impact on the life cycle of tectal cells, whether stimulatory or inhibitory.	[Takeuchi, Akio; Okubo, Kataaki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Okubo, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo, Japan.	okubo@marine.fs.a.u-tokyo.ac.jp		Okubo, Kataaki/0000-0002-4178-3094	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [23132505]; Japan Society for the Promotion of Science (JSPS) [22688015, 247421]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by The Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan (grant number 23132505) and Japan Society for the Promotion of Science (JSPS) (grant numbers 22688015 and 247421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunni A, 2010, DEV NEUROBIOL, V70, P693, DOI 10.1002/dneu.20799; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bakker J, 2003, ANN NY ACAD SCI, V1007, P251, DOI 10.1196/annals.1286.024; Bowers J Michael, 2010, Biol Sex Differ, V1, P8, DOI 10.1186/2042-6410-1-8; Candal E, 2005, DEV BRAIN RES, V154, P101, DOI 10.1016/j.devbrainres.2004.10.008; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; CULICAN SM, 1990, J NEUROSCI, V10, P684; Diotel N, 2013, HORM BEHAV, V63, P193, DOI 10.1016/j.yhbeh.2012.04.003; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Foran CM, 2004, ARCH ENVIRON CON TOX, V46, P511, DOI 10.1007/s00244-003-3042-5; Foran CM, 2002, TOXICOL SCI, V68, P389, DOI 10.1093/toxsci/68.2.389; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; Fowler CD, 2003, J NEUROBIOL, V57, P257, DOI 10.1002/neu.10273; GEORGE FW, 1982, ENDOCRINOLOGY, V111, P522, DOI 10.1210/endo-111-2-522; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; Jeng SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044750; Kawabata Y, 2012, NEUROSCIENCE, V218, P65, DOI 10.1016/j.neuroscience.2012.05.021; Kim H, 2008, DEV DYNAM, V237, P2081, DOI 10.1002/dvdy.21620; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Martinez-Cerdeno V, 2006, EUR J NEUROSCI, V24, P3475, DOI 10.1111/j.1460-9568.2006.05239.x; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; Melo AC, 2001, ENVIRON HEALTH PERSP, V109, P257, DOI 10.2307/3434694; Mong JA, 1999, J NEUROSCI, V19, P1464; Monteiro SM, 2009, AQUAT TOXICOL, V94, P219, DOI 10.1016/j.aquatox.2009.07.008; Nakasone K, 2013, ENDOCRINOLOGY, V154, P920, DOI 10.1210/en.2012-2000; Nguyen V, 1999, J COMP NEUROL, V413, P385, DOI 10.1002/(SICI)1096-9861(19991025)413:3<385::AID-CNE3>3.0.CO;2-P; Okubo K, 2011, J NEUROENDOCRINOL, V23, P412, DOI 10.1111/j.1365-2826.2011.02120.x; PASMANIK M, 1985, GEN COMP ENDOCR, V60, P244, DOI 10.1016/0016-6480(85)90320-X; Patil JG, 2008, GEN COMP ENDOCR, V158, P131, DOI 10.1016/j.ygcen.2008.05.016; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Petersen SL, 2012, FRONT NEUROENDOCRIN, V33, P36, DOI 10.1016/j.yfrne.2011.06.002; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; RAYMOND PA, 1983, J NEUROSCI, V3, P1077; Saravia F, 2007, PSYCHONEUROENDOCRINO, V32, P480, DOI 10.1016/j.psyneuen.2007.02.012; Strobl-Mazzulla PH, 2010, BRAIN BEHAV EVOLUT, V76, P20, DOI 10.1159/000316022; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tilton SC, 2003, COMP BIOCHEM PHYS C, V136, P265, DOI 10.1016/j.cca.2003.09.009; Tong SK, 2009, GENESIS, V47, P67, DOI 10.1002/dvg.20459; Tsukahara S, 2008, NEUROSCI LETT, V432, P58, DOI 10.1016/j.neulet.2007.12.006; Tsukahara S, 2006, J NEUROBIOL, V66, P1411, DOI 10.1002/neu.20276; Tsukahara S, 2011, NEUROENDOCRINOLOGY, V94, P137, DOI 10.1159/000327541; VANEGAS H, 1983, BRAIN RES REV, V6, P117, DOI 10.1016/0165-0173(83)90036-X; Xu Q, 2008, NEUROSCI LETT, V436, P35, DOI 10.1016/j.neulet.2008.02.054	47	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73663	10.1371/journal.pone.0073663	http://dx.doi.org/10.1371/journal.pone.0073663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019933	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200075
J	Dick, JM; Shock, EL				Dick, Jeffrey M.; Shock, Everett L.			A Metastable Equilibrium Model for the Relative Abundances of Microbial Phyla in a Hot Spring	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; PARTIAL MOLAL PROPERTIES; HIGH-PRESSURES; THERMODYNAMIC PROPERTIES; TRANSPORT-PROPERTIES; COMMUNITY STRUCTURE; STANDARD; TEMPERATURES; STATE; ELECTROLYTES	Many studies link the compositions of microbial communities to their environments, but the energetics of organism-specific biomass synthesis as a function of geochemical variables have rarely been assessed. We describe a thermodynamic model that integrates geochemical and metagenomic data for biofilms sampled at five sites along a thermal and chemical gradient in the outflow channel of the hot spring known as "Bison Pool" in Yellowstone National Park. The relative abundances of major phyla in individual communities sampled along the outflow channel are modeled by computing metastable equilibrium among model proteins with amino acid compositions derived from metagenomic sequences. Geochemical conditions are represented by temperature and activities of basis species, including pH and oxidation-reduction potential quantified as the activity of dissolved hydrogen. By adjusting the activity of hydrogen, the model can be tuned to closely approximate the relative abundances of the phyla observed in the community profiles generated from BLAST assignments. The findings reveal an inverse relationship between the energy demand to form the proteins at equal thermodynamic activities and the abundance of phyla in the community. The distance from metastable equilibrium of the communities, assessed using an equation derived from energetic considerations that is also consistent with the information-theoretic entropy change, decreases along the outflow channel. Specific divergences from metastable equilibrium, such as an underprediction of the relative abundances of phototrophic organisms at lower temperatures, can be explained by considering additional sources of energy and/or differences in growth efficiency. Although the metabolisms used by many members of these communities are driven by chemical disequilibria, the results support the possibility that higher-level patterns of chemotrophic microbial ecosystems are shaped by metastable equilibrium states that depend on both the composition of biomass and the environmental conditions.	[Dick, Jeffrey M.] Curtin Univ, Dept Chem, Perth, WA 6845, Australia; [Dick, Jeffrey M.] Curtin Univ, Dept Appl Geol, Perth, WA 6845, Australia; [Shock, Everett L.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Shock, Everett L.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Curtin University; Curtin University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Dick, JM (corresponding author), Curtin Univ, Dept Chem, Perth, WA 6845, Australia.	Jeffrey.Dick@curtin.edu.au	Dick, Jeffrey M/K-1619-2013	Dick, Jeffrey M/0000-0002-0687-5890; Shock, Everett/0000-0002-4283-0163	National Science Foundation [EAR-0847616]; Directorate For Geosciences [1123649] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This material is based upon work supported by the National Science Foundation under grant EAR-0847616. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson G., 2005, THERMODYNAMICS NATUR, DOI DOI 10.1017/CBO9780511840258; Bjornsdottir SH, 2006, EXTREMOPHILES, V10, P1, DOI 10.1007/s00792-005-0466-z; Boyd ES, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00221; Boyd ES, 2010, ISME J, V4, P1485, DOI 10.1038/ismej.2010.76; COMETTA S, 1982, EUR J APPL MICROBIOL, V15, P69, DOI 10.1007/BF00499509; Costas AMG, 2012, ENVIRON MICROBIOL, V14, P177, DOI 10.1111/j.1462-2920.2011.02592.x; Cox A, 2011, CHEM GEOL, V280, P344, DOI 10.1016/j.chemgeo.2010.11.022; de Donder Th., 1936, THERMODYNAMIC THEORY; Dick JM, 2006, BIOGEOSCIENCES, V3, P311, DOI 10.5194/bg-3-311-2006; Dick JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022782; Dick JM, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-10; Doncaster CP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007460; Garcia HG, 2011, METHOD ENZYMOL, V492, P27, DOI 10.1016/B978-0-12-381268-1.00014-8; Hamilton TL, 2012, GEOBIOLOGY, V10, P236, DOI 10.1111/j.1472-4669.2011.00296.x; Havig JR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001415; HELGESON HC, 1981, AM J SCI, V281, P1249, DOI 10.2475/ajs.281.10.1249; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Jorgensen SE., 2004, THERMODYNAMIC THEORY, V1; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; LaRowe DE, 2012, GEOCHIM COSMOCHIM AC, V80, P70, DOI 10.1016/j.gca.2011.11.041; Larsen P, 2012, J BIOTECHNOL, V160, P17, DOI 10.1016/j.jbiotec.2012.03.009; Larsen PE, 2012, NAT METHODS, V9, P621, DOI [10.1038/NMETH.1975, 10.1038/nmeth.1975]; Ludovisi A, 2009, ECOL MODEL, V220, P1566, DOI 10.1016/j.ecolmodel.2009.04.009; McCollom TM, 2005, GEOBIOLOGY, V3, P135, DOI 10.1111/j.1472-4669.2005.00045.x; Meyer-Dombard DR, 2011, ENVIRON MICROBIOL, V13, P2216, DOI 10.1111/j.1462-2920.2011.02476.x; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qian H, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.042103; R Core Team, 2012, R LANG ENV STAT COMP; Schulte MD, 2001, GEOCHIM COSMOCHIM AC, V65, P3919, DOI 10.1016/S0016-7037(01)00717-7; Sella G, 2005, P NATL ACAD SCI USA, V102, P9541, DOI 10.1073/pnas.0501865102; SHOCK EL, 1988, GEOCHIM COSMOCHIM AC, V52, P2009, DOI 10.1016/0016-7037(88)90181-0; SHOCK EL, 1989, GEOCHIM COSMOCHIM AC, V53, P2157, DOI 10.1016/0016-7037(89)90341-4; Shock EL, 2007, ASTROBIOLOGY, V7, P839, DOI 10.1089/ast.2007.0137; Shock EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4005, DOI 10.1016/j.gca.2009.08.036; Sloan WT, 2007, MICROB ECOL, V53, P443, DOI 10.1007/s00248-006-9141-x; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Swingley WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038108; TANGER JC, 1988, AM J SCI, V288, P19, DOI 10.2475/ajs.288.1.19; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	41	11	11	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72395	10.1371/journal.pone.0072395	http://dx.doi.org/10.1371/journal.pone.0072395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023738	Green Submitted, Green Published, gold			2022-12-27	WOS:000324238400014
J	Bullman, S; Lucid, A; Corcoran, D; Sleator, RD; Lucey, B				Bullman, Susan; Lucid, Alan; Corcoran, Daniel; Sleator, Roy D.; Lucey, Brigid			Genomic Investigation into Strain Heterogeneity and Pathogenic Potential of the Emerging Gastrointestinal Pathogen Campylobacter ureolyticus	PLOS ONE			English	Article							BACTEROIDES-UREOLYTICUS; NEISSERIA-MENINGITIDIS; TRANSCELLULAR TRANSLOCATION; PROTEIN SECRETION; ESCHERICHIA-COLI; BINDING PROTEIN; JEJUNI; VIRULENCE; INVASION; IDENTIFICATION	The recent detection and isolation of C. ureolyticus from patients with diarrhoeal illness and inflammatory bowel diseases warrants further investigation into its role as an emerging pathogen of the human gastrointestinal tract. Regarding the pathogenic mechanisms employed by this species we provide the first whole genome analysis of two C. ureolyticus isolates including the type strain. Comparative analysis, subtractive hybridisation and gene ontology searches against other Campylobacter species identifies the high degree of heterogenicity between C. ureolyticus isolates, in addition to the identification of 106 putative virulence associated factors, 52 of which are predicted to be secreted. Such factors encompass each of the known virulence tactics of pathogenic Campylobacter spp. including adhesion and colonisation (CadF, PEB1, IcmF and FlpA), invasion (ciaB and 16 virB-virD4 genes) and toxin production (S-layer RTX and ZOT). Herein, we provide the first virulence catalogue for C. ureolyticus, the components of which theoretically provide this emerging species with sufficient arsenal to establish pathology.	[Bullman, Susan; Lucid, Alan; Sleator, Roy D.; Lucey, Brigid] Cork Inst Technol, Dept Biol Sci, Cork, Ireland; [Corcoran, Daniel; Lucey, Brigid] Cork Univ Hosp, Dept Med Microbiol, Cork, Ireland	Cork Institute of Technology; University College Cork	Sleator, RD (corresponding author), Cork Inst Technol, Dept Biol Sci, Cork, Ireland.	roy.sleator@cit.ie		Lucey, Brigid/0000-0002-0872-202X; Sleator, Roy/0000-0001-5846-3938; Bullman, Susan/0000-0002-7713-0810	Irish Research Council for Science, Engineering and Technology [RS/2009/1670, RS/2012/219]; Serosep Ltd, Ireland	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Serosep Ltd, Ireland	SB and AL are supported by scholarships from the Irish Research Council for Science, Engineering and Technology (RS/2009/1670 and RS/2012/219 respectively). RDS is an ESCMID Fellow and Coordinator of the EU FP7 IAPP project ClouDx-i. Funding was provided by Serosep Ltd, Ireland. The authors would like to thank Dr Nikos Kyrpides (DOE Joint Genome Institute) for his insightful discussion on the area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bacon DJ, 2002, INFECT IMMUN, V70, P6242, DOI 10.1128/IAI.70.11.6242-6250.2002; Bacon DJ, 2000, INFECT IMMUN, V68, P4384, DOI 10.1128/IAI.68.8.4384-4390.2000; Bahar O, 2009, MOL PLANT MICROBE IN, V22, P909, DOI 10.1094/MPMI-22-8-0909; Bardy SL, 2003, MICROBIOL-SGM, V149, P295, DOI 10.1099/mic.0.25948-0; BASTYNS K, 1995, MOL CELL PROBE, V9, P247, DOI 10.1016/S0890-8508(95)90114-0; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Biswas D, 2011, INT MICROBIOL, V14, P25, DOI 10.2436/20.1501.01.132; Bras AM, 1999, FEMS MICROBIOL LETT, V179, P209, DOI 10.1016/S0378-1097(99)00413-9; Bullman S, 2012, EPIDEMIOL INFECT, V140, P684, DOI 10.1017/S0950268811000859; Bullman S, 2012, EMERG INFECT DIS, V18, P1709, DOI 10.3201/eid1810.120369; Bullman S, 2012, BIOENGINEERED, V3, P1, DOI 10.4161/bbug.3.1.19011; Bullman S, 2011, FEMS IMMUNOL MED MIC, V63, P248, DOI 10.1111/j.1574-695X.2011.00847.x; Bullman S, 2011, FEMS IMMUNOL MED MIC, V61, P228, DOI 10.1111/j.1574-695X.2010.00760.x; Burgos-Portugal JA, 2012, INFECT IMMUN, V80, P883, DOI 10.1128/IAI.06031-11; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Cabrita P, 2010, TALANTA, V83, P457, DOI 10.1016/j.talanta.2010.09.039; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Christensen JE, 2009, MOL MICROBIOL, V73, P650, DOI 10.1111/j.1365-2958.2009.06797.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Croinin TO, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00025; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; de Pace F, 2011, MICROBIOL-SGM, V157, P2954, DOI 10.1099/mic.0.050005-0; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deshpande NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022170; Douidah L, 2012, J CLIN MICROBIOL, V50, P735, DOI 10.1128/JCM.05872-11; DUERDEN B, 1982, J CLIN PATHOL, V35, P309, DOI 10.1136/jcp.35.3.309; DUERDEN BI, 1987, J MED MICROBIOL, V24, P133, DOI 10.1099/00222615-24-2-133; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; Engberg J, 2006, DAN MED BULL, V53, P361; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Eucker TP, 2012, CELL MICROBIOL, V14, P226, DOI 10.1111/j.1462-5822.2011.01714.x; FASANO A, 1995, J CLIN INVEST, V96, P710, DOI 10.1172/JCI118114; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Fraczek M, 2012, ANDROLOGIA, V44, P315, DOI 10.1111/j.1439-0272.2012.01283.x; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Godlewska R, 2009, FEMS MICROBIOL LETT, V298, P1, DOI 10.1111/j.1574-6968.2009.01659.x; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Gorkiewicz G, 2010, J BACTERIOL, V192, P502, DOI 10.1128/JB.00803-09; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Holz C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178104; Hu L, 2008, INFECT IMMUN, V76, P5294, DOI 10.1128/IAI.01408-07; Huizinga R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034416; Istivan TS, 2008, FEMS IMMUNOL MED MIC, V54, P224, DOI 10.1111/j.1574-695X.2008.00467.x; JACKSON FL, 1978, INT J SYST BACTERIOL, V28, P197, DOI 10.1099/00207713-28-2-197; Johnston C, 2010, Bioeng Bugs, V1, P155, DOI 10.4161/bbug.1.3.10408; Joseph B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018441; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Kaakoush NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029045; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; Kakinuma Y, 2007, J APPL MICROBIOL, V103, P252, DOI 10.1111/j.1365-2672.2006.03212.x; Kakinuma Y, 2011, FOLIA MICROBIOL, V56, P159, DOI 10.1007/s12223-011-0020-6; Kale A, 2011, J BIOL CHEM, V286, P21254, DOI 10.1074/jbc.M111.220442; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Kalischuk LD, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-2; Kamal N, 2007, INFECT IMMUN, V75, P6008, DOI 10.1128/IAI.01995-06; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katz J, 2000, INFECT IMMUN, V68, P1441, DOI 10.1128/IAI.68.3.1441-1449.2000; Kienesberger S, 2011, J BACTERIOL, V193, P744, DOI 10.1128/JB.00798-10; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; KONKEL ME, 1992, J INFECT DIS, V166, P308, DOI 10.1093/infdis/166.2.308; Konkel ME, 2010, J BACTERIOL, V192, P68, DOI 10.1128/JB.00969-09; Koziel M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-14; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Kulkarni R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004752; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leon-Kempis MD, 2006, MOL MICROBIOL, V60, P1262, DOI 10.1111/j.1365-2958.2006.05168.x; Lertpiriyapong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042842; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Lioy VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030282; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Lux R, 2004, CRIT REV ORAL BIOL M, V15, P207, DOI 10.1177/154411130401500404; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; McCormick BA, 1997, INFECT IMMUN, V65, P1414, DOI 10.1128/IAI.65.4.1414-1421.1997; Meinersmann RJ, 2009, SYST APPL MICROBIOL, V32, P91, DOI 10.1016/j.syapm.2008.12.004; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Monteville MR, 2002, INFECT IMMUN, V70, P6665, DOI 10.1128/IAI.70.12.6665-6671.2002; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Moore JE, 2001, INT J FOOD SCI TECH, V36, P593, DOI 10.1046/j.1365-2621.2001.00508.x; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021490; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nielsen LN, 2012, CLIN VACCINE IMMUNOL, V19, P113, DOI 10.1128/CVI.05161-11; Nishimura K, 2010, J MOL MED, V88, P451, DOI 10.1007/s00109-010-0600-y; Osicka R, 2001, INFECT IMMUN, V69, P5509; Park HSM, 2002, INFECT IMMUN, V70, P3891, DOI 10.1128/IAI.70.7.3891-3903.2002; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PEI ZH, 1993, J BIOL CHEM, V268, P18717; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Prochazkova K, 2005, J BIOL CHEM, V280, P3251, DOI 10.1074/jbc.M411232200; RAWLINSON A, 1993, J DENT, V21, P179, DOI 10.1016/0300-5712(93)90029-P; Rivera-Amill V, 2001, J INFECT DIS, V183, P1607, DOI 10.1086/320704; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Selbach M, 2002, INFECT IMMUN, V70, P665, DOI 10.1128/IAI.70.2.665-671.2002; Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Sleator RD, 2011, ARCH MICROBIOL, V193, P235, DOI 10.1007/s00203-011-0677-x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Souza RC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-172; Stack HM, 2005, APPL ENVIRON MICROB, V71, P4241, DOI 10.1128/AEM.71.8.4241-4247.2005; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; TAYLOR AJ, 1986, J MED MICROBIOL, V21, P109, DOI 10.1099/00222615-21-2-109; Tracz DM, 2005, EMERG INFECT DIS, V11, P838; VANDAMME P, 1991, INT J SYST BACTERIOL, V41, P88, DOI 10.1099/00207713-41-1-88; VANDAMME P, 1995, INT J SYST BACTERIOL, V45, P145, DOI 10.1099/00207713-45-1-145; Vandamme P, 2010, INT J SYST EVOL MICR, V60, P2016, DOI 10.1099/ijs.0.017152-0; VANDAMME P, 1989, J CLIN MICROBIOL, V27, P1775, DOI 10.1128/JCM.27.8.1775-1781.1989; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wassenaar TM, 1997, CLIN MICROBIOL REV, V10, P466, DOI 10.1128/CMR.10.3.466; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	127	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e71515	10.1371/journal.pone.0071515	http://dx.doi.org/10.1371/journal.pone.0071515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023611	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200005
J	Henry, KM; Pase, L; Ramos-Lopez, CF; Lieschke, GJ; Renshaw, SA; Reyes-Aldasoro, CC				Henry, Katherine M.; Pase, Luke; Ramos-Lopez, Carlos Fernando; Lieschke, Graham J.; Renshaw, Stephen A.; Reyes-Aldasoro, Constantino Carlos			PhagoSight: An Open-Source MATLAB (R) Package for the Analysis of Fluorescent Neutrophil and Macrophage Migration in a Zebrafish Model	PLOS ONE			English	Article							IMAGE SEGMENTATION; CELL; TRACKING; PERMEABILITY; VOLUME; LOCALIZATION; INFLAMMATION; RESOLUTION; THRESHOLD; SELECTION	Neutrophil migration in zebrafish larvae is increasingly used as a model to study the response of these leukocytes to different determinants of the cellular inflammatory response. However, it remains challenging to extract comprehensive information describing the behaviour of neutrophils from the multi-dimensional data sets acquired with widefield or confocal microscopes. Here, we describe PhagoSight, an open-source software package for the segmentation, tracking and visualisation of migrating phagocytes in three dimensions. The algorithms in PhagoSight extract a large number of measurements that summarise the behaviour of neutrophils, but that could potentially be applied to any moving fluorescent cells. To derive a useful panel of variables quantifying aspects of neutrophil migratory behaviour, and to demonstrate the utility of PhagoSight, we evaluated changes in the volume of migrating neutrophils. Cell volume increased as neutrophils migrated towards the wound region of injured zebrafish. PhagoSight is openly available as MATLAB (R) m-files under the GNU General Public License. Synthetic data sets and a comprehensive user manual are available from http://www.phagosight.org.	[Henry, Katherine M.; Renshaw, Stephen A.] Univ Sheffield, MRC Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Pase, Luke; Lieschke, Graham J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic 3050, Australia; [Pase, Luke] KIT, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Lieschke, Graham J.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Lieschke, Graham J.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Reyes-Aldasoro, Constantino Carlos] City Univ London, Informat Engn & Med Imaging Grp, London EC1V 0HB, England	University of Sheffield; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Helmholtz Association; Karlsruhe Institute of Technology; University of Melbourne; Australian Regenerative Medicine Institute; Monash University; City University London	Henry, KM (corresponding author), Univ Sheffield, MRC Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England.	k.henry@sheffield.ac.uk; reyes@city.ac.uk	Renshaw, Steve/E-6192-2010; Reyes-Aldasoro, Constantino/S-5093-2019	Renshaw, Steve/0000-0003-1790-1641; Reyes-Aldasoro, Constantino/0000-0002-9466-2018; Lieschke, Graham/0000-0003-0325-798X	MRC Senior Clinical Fellowship [G0701932]; MRC centre grant [G0700091]; Wellcome Trust [GR077544AIA]; State Government of Victoria; Australian Government; MRC [G108/595, G0701932] Funding Source: UKRI; Medical Research Council [G108/595, G0700091B, G0701932] Funding Source: researchfish	MRC Senior Clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); State Government of Victoria; Australian Government(Australian GovernmentCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a MRC Senior Clinical Fellowship (Reference Number G0701932) to SAR and an MRC centre grant (Reference Number G0700091). Microscopy was supported by a Wellcome Trust grant to the Molecular Biology and Biotechnology/Biomedical Science Light Microscopy Facility, University of Sheffield (Reference Number GR077544AIA). The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT METHODS, V8, P885; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; Calvo CF, 2011, GENE DEV, V25, P831, DOI 10.1101/gad.615311; COLEMAN GB, 1979, P IEEE, V67, P773, DOI 10.1109/PROC.1979.11327; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cui J, 2006, MED IMAGE ANAL, V10, P598, DOI 10.1016/j.media.2006.05.006; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; Domon B, 2006, MOL CELL PROTEOMICS, V5, P1921, DOI 10.1074/mcp.R600012-MCP200; Elks PM, 2011, BLOOD, V118, P712, DOI 10.1182/blood-2010-12-324186; Fiole D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039831; Grau V, 2004, IEEE T MED IMAGING, V23, P447, DOI 10.1109/TMI.2004.824224; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Hellriegel C, 2009, J R SOC INTERFACE, V6, pS3, DOI 10.1098/rsif.2008.0313.focus; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Kadirkamanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035182; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; Karlsson T, 2011, J LEUKOCYTE BIOL, V90, P963, DOI 10.1189/jlb.0910540; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Liepe J, 2012, INTEGR BIOL-UK, V4, P335, DOI 10.1039/c2ib00175f; Loitto VM, 2002, J LEUKOCYTE BIOL, V71, P212; Luisier F, 2010, THESIS ECOLE POLYTEC; Lunt SJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3281674; Mandl JN, 2012, P NATL ACAD SCI USA, V109, P18036, DOI 10.1073/pnas.1211717109; Masters BR, 2004, MICROSC RES TECHNIQ, V63, P3, DOI 10.1002/jemt.10418; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Moreau HD, 2012, IMMUNITY, V37, P351, DOI 10.1016/j.immuni.2012.05.014; Murphy CT, 2010, CLIN EXP IMMUNOL, V162, P188, DOI 10.1111/j.1365-2249.2010.04234.x; Nielsen TA, 2012, J R SOC INTERFACE, V9, P1040, DOI 10.1098/rsif.2011.0616; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pase L, 2012, CURR BIOL, V22, P1818, DOI 10.1016/j.cub.2012.07.060; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Reyes-Aldasoro CC, 2008, J MICROSC-OXFORD, V229, P162, DOI 10.1111/j.1365-2818.2007.01877.x; Reyes-Aldasoro C.C, 2009, 4 IAPR INT C PATT RE; Reyes-Aldasoro CC, 2006, PATTERN RECOGN, V39, P812, DOI 10.1016/j.patcog.2005.12.003; Reyes-Aldasoro CC, 2008, MICROCIRCULATION, V15, P65, DOI 10.1080/10739680701436350; Ritter M, 1998, BRIT J PHARMACOL, V124, P627, DOI 10.1038/sj.bjp.0701864; ROSENGREN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1623, DOI 10.1152/ajpcell.1994.267.6.C1623; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHMIDSCHONBEIN GW, 1980, BLOOD, V56, P866; Schmitt OH., 1938, J SCI INSTRUM, V15, P24, DOI DOI 10.1088/0950-7671/15/1/305; Sirakov NM, 2010, IEEE IM AN INT SSIAI, DOI DOI 10.1109/SSIAI.2010.5483933; Tam J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548880; Taylor HB, 2012, IMMUNOL CELL BIOL; Textor J, 2011, P NATL ACAD SCI USA, V108, P12401, DOI 10.1073/pnas.1102288108; Theruvath TP, 2008, HEPATOLOGY, V47, P236, DOI 10.1002/hep.21912; TINGBEALL HP, 1993, BLOOD, V81, P2774; Tozer GM, 2008, CANCER RES, V68, P2301, DOI 10.1158/0008-5472.CAN-07-2011; Walters KB, 2009, DEV DYNAM, V238, P86, DOI 10.1002/dvdy.21821; Winter M, 2011, NAT PROTOC, V6, P1942, DOI 10.1038/nprot.2011.422; Xu NJ, 2011, JOVE-J VIS EXP, DOI 10.3791/3296; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Zhang B, 2007, THESIS ECOLE NATL SU; Zhong Z, 2007, AM J TRANSPLANT, V7, P1103, DOI 10.1111/j.1600-6143.2007.01770.x	58	31	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72636	10.1371/journal.pone.0072636	http://dx.doi.org/10.1371/journal.pone.0072636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023630	Green Published, Green Accepted, gold			2022-12-27	WOS:000323880200025
J	Muenchmeier, N; Boecker, S; Bankel, L; Hinz, L; Rieth, N; Lapa, C; Mendler, AN; Noessner, E; Mocikat, R; Nelson, PJ				Muenchmeier, Niklas; Boecker, Sophia; Bankel, Lorenz; Hinz, Laura; Rieth, Nicole; Lapa, Constantin; Mendler, Anna N.; Noessner, Elfriede; Mocikat, Ralph; Nelson, Peter J.			A Novel CXCL10-Based GPI-Anchored Fusion Protein as Adjuvant in NK-Based Tumor Therapy	PLOS ONE			English	Article							CELL-ADHESION; IN-VIVO; TRANSENDOTHELIAL MIGRATION; ADOPTIVE IMMUNOTHERAPY; ENDOTHELIAL-CELLS; MONOCYTE ARREST; T-CELLS; EXPRESSION; CANCER; ANGIOGENESIS	Background: Cellular therapy is a promising therapeutic strategy for malignant diseases. The efficacy of this therapy can be limited by poor infiltration of the tumor by immune effector cells. In particular, NK cell infiltration is often reduced relative to T cells. A novel class of fusion proteins was designed to enhance the recruitment of specific leukocyte subsets based on their expression of a given chemokine receptor. The proteins are composed of an N-terminal chemokine head, the mucin domain taken from the membrane-anchored chemokine CX3CL1, and a C-terminal glycosylphosphatidylinositol (GPI) membrane anchor replacing the normal transmembrane domain allowing integration of the proteins into cell membranes when injected into a solid tumor. The mucin domain in conjunction with the chemokine head acts to specifically recruit leukocytes expressing the corresponding chemokine receptor. Methodology/Principal Findings: A fusion protein comprising a CXCL10 chemokine head (CXCL10-mucin-GPI) was used for proof of concept for this approach and expressed constitutively in Chinese Hamster Ovary cells. FPLC was used to purify proteins. The recombinant proteins efficiently integrated into cell membranes in a process dependent upon the GPI anchor and were able to activate the CXCR3 receptor on lymphocytes. Endothelial cells incubated with CXCL10-mucin-GPI efficiently recruited NK cells in vitro under conditions of physiologic flow, which was shown to be dependent on the presence of the mucin domain. Experiments conducted in vivo using established tumors in mice suggested a positive effect of CXCL10-mucin-GPI on the recruitment of NK cells. Conclusions: The results suggest enhanced recruitment of NK cells by CXCL10-mucin-GPI. This class of fusion proteins represents a novel adjuvant in cellular immunotherapy. The underlying concept of a chemokine head fused to the mucin domain and a GPI anchor signal sequence may be expanded into a broader family of reagents that will allow targeted recruitment of cells in various settings.	[Muenchmeier, Niklas; Boecker, Sophia; Hinz, Laura; Rieth, Nicole; Lapa, Constantin; Nelson, Peter J.] Klinikum Univ Munchen, AG Klin Biochem, Med Klin & Poliklin 4, Munich, Germany; [Bankel, Lorenz; Mendler, Anna N.; Noessner, Elfriede; Mocikat, Ralph; Nelson, Peter J.] Helmholtz Zentrum Munchen, Deutsch Forschungszentrum Gesundheit & Umwelt, Inst Mol Immunol, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Nelson, PJ (corresponding author), Helmholtz Zentrum Munchen, Deutsch Forschungszentrum Gesundheit & Umwelt, Inst Mol Immunol, Munich, Germany.	peter.nelson@med.uni-muenchen.de	Lapa, Constantin/GLV-0441-2022	Lapa, Constantin/0000-0001-7536-2207	Deutsche Forschungsgemeinschaft (DFG) [SFB-TR36]; Deutsche Krebshilfe	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	The work was funded by the Deutsche Forschungsgemeinschaft (DFG) SFB-TR36. ANM is supported by a grant from the Deutsche Krebshilfe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner CD, 2010, EUR J IMMUNOL, V40, P494, DOI 10.1002/eji.200939937; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Dirkx AEM, 2003, CANCER RES, V63, P2322; Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781; Fregni G, 2012, ONCOIMMUNOLOGY, V1, P38, DOI 10.4161/onci.1.1.18312; Fruci D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-30; GAMBLE JR, 1988, SCIENCE, V242, P97; Griffioen AW, 1996, CANCER RES, V56, P1111; Griffioen AW, 1999, INT J CANCER, V80, P315, DOI 10.1002/(SICI)1097-0215(19990118)80:2<315::AID-IJC23>3.0.CO;2-L; Griffioen AW, 1996, BLOOD, V88, P667, DOI 10.1182/blood.V88.2.667.bloodjournal882667; Grone HJ, 1999, FASEB J, V13, P1371, DOI 10.1096/fasebj.13.11.1371; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Huang H, 2002, CELL IMMUNOL, V217, P12, DOI 10.1016/S0008-8749(02)00508-7; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Kukreti S, 1997, BLOOD, V89, P4104, DOI 10.1182/blood.V89.11.4104; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; LAWRENCE MB, 1987, BLOOD, V70, P1284; Manes TD, 2006, TRANSPLANTATION, V82, pS9, DOI 10.1097/01.tp.0000231356.57576.82; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; Milani V, 2005, INT IMMUNOL, V17, P257, DOI 10.1093/intimm/dxh203; Mukai S, 1999, CANCER RES, V59, P5245; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Pietra G, 2012, CANCER RES, V72, P1407, DOI 10.1158/0008-5472.CAN-11-2544; POCKAJ BA, 1994, CANCER, V73, P1731, DOI 10.1002/1097-0142(19940315)73:6<1731::AID-CNCR2820730630>3.0.CO;2-H; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2010, EXPERT OPIN INV DRUG, V19, P345, DOI 10.1517/13543780903535867; Ranjbaran H, 2006, CIRCULATION, V114, P1293, DOI 10.1161/CIRCULATIONAHA.106.631457; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Sconocchia G, 2012, CANCER RES, V72, P5428, DOI 10.1158/0008-5472.CAN-12-1181; Senovilla L, 2012, ONCOIMMUNOLOGY, V1, P1323, DOI 10.4161/onci.22009; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Stachel G, 2013, STEM CELLS IN PRESS; Tromp SC, 2000, INT IMMUNOL, V12, P671, DOI 10.1093/intimm/12.5.671; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; WU NZ, 1992, CANCER RES, V52, P4265	44	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72749	10.1371/journal.pone.0072749	http://dx.doi.org/10.1371/journal.pone.0072749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023642	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200038
J	Uomini, NT; Meyer, GF				Uomini, Natalie Thais; Meyer, Georg Friedrich			Shared Brain Lateralization Patterns in Language and Acheulean Stone Tool Production: A Functional Transcranial Doppler Ultrasound Study	PLOS ONE			English	Article							HEMISPHERIC LATERALIZATION; CEREBRAL LATERALIZATION; SONOGRAPHY; EVOLUTION; ACTIVATION; COGNITION; NETWORK; COMPLEX; SPEECH; COMMUNICATION	Background: The popular theory that complex tool-making and language co-evolved in the human lineage rests on the hypothesis that both skills share underlying brain processes and systems. However, language and stone tool-making have so far only been studied separately using a range of neuroimaging techniques and diverse paradigms. Methodology/Principal Findings: We present the first-ever study of brain activation that directly compares active Acheulean tool-making and language. Using functional transcranial Doppler ultrasonography (fTCD), we measured brain blood flow lateralization patterns (hemodynamics) in subjects who performed two tasks designed to isolate the planning component of Acheulean stone tool-making and cued word generation as a language task. We show highly correlated hemodynamics in the initial 10 seconds of task execution. Conclusions/Significance: Stone tool-making and cued word generation cause common cerebral blood flow lateralization signatures in our participants. This is consistent with a shared neural substrate for prehistoric stone tool-making and language, and is compatible with language evolution theories that posit a co-evolution of language and manual praxis. In turn, our results support the hypothesis that aspects of language might have emerged as early as 1.75 million years ago, with the start of Acheulean technology.	[Uomini, Natalie Thais] Univ Liverpool, Dept Archaeol Class & Egyptol, Liverpool L69 3BX, Merseyside, England; [Meyer, Georg Friedrich] Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Meyer, GF (corresponding author), Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England.	georg@liv.ac.uk	Uomini, Natalie T./A-7904-2012	Uomini, Natalie T./0000-0002-9898-6415; Meyer, Georg/0000-0002-3739-1653	ESRC award [North West DTC ES/J500094/1]; British Academy centenary project "Lucy to Language: the Archaeology of the Social Brain"; Leverhulme Early Career Fellowship [0298]	ESRC award(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); British Academy centenary project "Lucy to Language: the Archaeology of the Social Brain"; Leverhulme Early Career Fellowship(Leverhulme Trust)	This work was partially supported by an ESRC award (North West DTC ES/J500094/1). N. Uomini was supported by a postdoctoral fellowship from the British Academy centenary project "Lucy to Language: the Archaeology of the Social Brain" and a Leverhulme Early Career Fellowship number 0298. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LC, 1998, MEM CALIF ACAD SCI, P21; Arbib MA, 2008, CURR ANTHROPOL, V49, P1052, DOI 10.1086/593015; Beevor CE, 1907, BRAIN, V30, P403; BELFERCOHEN A, 1994, WORLD ARCHAEOL, V26, P144, DOI 10.1080/00438243.1994.9980269; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; Bishop DVM, 2009, NEUROPSYCHOLOGIA, V47, P587, DOI 10.1016/j.neuropsychologia.2008.09.013; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Bradshaw J.L., 1982, CURR PSYCHOL, V2, P171, DOI [DOI 10.1007/BF02684498, 10.1007/BF02684498]; BRADSHAW JL, 1988, J HUM EVOL, V17, P615, DOI 10.1016/0047-2484(88)90088-7; Bruner E., 2010, HUMAN BRAIN EVOLVING, P83; Callow P., 1986, STONE AGE PREHISTORY, P243; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Coolidge FL, 2005, CAMB ARCHAEOL J, V15, P5, DOI 10.1017/S0959774305000016; Corballis MC, 2002, HAND MOUTH ORIGINS L; Corballis MC, 2012, GESTURE, V12, P200, DOI 10.1075/gest.12.2.04cor; Darwin C., 2004, DESCENT MAN SELECTIO; Deppe M, 2004, NEUROIMAGE, V21, P1124, DOI 10.1016/j.neuroimage.2003.10.016; Deppe M, 1997, J NEUROSCI METH, V75, P147, DOI 10.1016/S0165-0270(97)00067-8; Deppe M, 2000, J CEREBR BLOOD F MET, V20, P263, DOI 10.1097/00004647-200002000-00006; Faisal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013718; Floel A, 2000, NEUROIMAGE 2, V11, pS276, DOI DOI 10.1016/S1053-8119(00)91208-4; Frey SH, 2008, PHILOS T R SOC B, V363, P1951, DOI 10.1098/rstb.2008.0008; FROST GT, 1980, J HUM EVOL, V9, P447, DOI 10.1016/0047-2484(80)90002-0; GIBSON KR, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P251; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Goren-Inbar N, 2011, PHILOS T R SOC B, V366, P1038, DOI 10.1098/rstb.2010.0365; Gowlett J. A. J., 1984, HOMINID EVOLUTION CO, P167; Gowlett J.A.J., 2006, AXE AGE ACHEULIAN TO, P203; GOWLETT JAJ, 1979, NATURE, V278, P14, DOI 10.1038/278014b0; Gowlett JAJ, 2011, CASTING NET WIDE PAP, P93; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Higuchi S, 2009, NEUROREPORT, V20, P1376, DOI 10.1097/WNR.0b013e3283315570; Hobaiter C, 2011, MULTIMODAL COMMUNICA; Hodgson D, 2005, CURR ANTHROPOL, V46, P647, DOI 10.1086/432749; HOLLOWAY RL, 1969, CURR ANTHROPOL, V10, P395, DOI 10.1086/201036; Isaac G, 1976, ORIGINS EVOLUTION LA, V280, P275; Jansen A, 2006, NEUROIMAGE, V33, P204, DOI 10.1016/j.neuroimage.2006.06.019; Jansen A, 2004, HUM BRAIN MAPP, V23, P168, DOI 10.1002/hbm.20055; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kempe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048333; Kleindienst MR, 1961, S AFRICAN ARCHAEOLOG, V16, P35, DOI DOI 10.2307/3886868; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Knecht S, 1998, STROKE, V29, P82, DOI 10.1161/01.STR.29.1.82; Knecht S, 1998, STROKE, V29, P1155, DOI 10.1161/01.STR.29.6.1155; Kroliczak G, 2009, CEREB CORTEX, V19, P2396, DOI 10.1093/cercor/bhn261; Lust JM, 2011, NEUROPSYCHOLOGIA, V49, P2375, DOI 10.1016/j.neuropsychologia.2011.04.011; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P3; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Meador KJ, 1999, NEUROLOGY, V53, P2028, DOI 10.1212/WNL.53.9.2028; Meyer GF, 2013, NEUROPSYCHOLOGIA, V51, P1716, DOI 10.1016/j.neuropsychologia.2013.05.014; Meyer GF, 2011, J COGNITIVE NEUROSCI, V23, P2291, DOI 10.1162/jocn.2010.21593; Normile D, 2012, SCIENCE, V336, P408, DOI 10.1126/science.336.6080.408; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Regolin, 2013, BEHAV LATERALIZATION, P125, DOI [10.1007/978-3-642-30203-9_9, DOI 10.1007/978-3-642-30203-9_9]; RINGELSTEIN EB, 1990, ULTRASOUND MED BIOL, V16, P745, DOI 10.1016/0301-5629(90)90039-F; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Rosch RE, 2012, NEUROPSYCHOLOGIA, V50, P810, DOI 10.1016/j.neuropsychologia.2012.01.015; Sabri O, 2003, J NUCL MED, V44, P671; Schuepbach D, 2007, CLIN NEUROPHYSIOL, V118, P2254, DOI 10.1016/j.clinph.2007.07.013; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Sharon G., 2007, ACHEULIAN LARGE FLAK; Sharon G, 2011, J HUM EVOL, V60, P387, DOI 10.1016/j.jhevol.2009.11.012; Shipton C, 2010, VERTEBR PALEOBIOL PA, P49, DOI 10.1007/978-90-481-9094-2_5; Shipton C, 2010, CAMB ARCHAEOL J, V20, P197, DOI 10.1017/S0959774310000235; Somers M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00031; Steele J, 1995, CAMB ARCHAEOL J, V5, P245; Steele J, 2005, STONE KNAPPING NECES, P217; Steele J, 2009, CAMB ARCHAEOL J, V19, P97, DOI 10.1017/S0959774309000067; Sterelny K, 2012, PHILOS T R SOC B, V367, P2141, DOI 10.1098/rstb.2012.0116; Stout D, 2000, J ARCHAEOL SCI, V27, P1215, DOI 10.1006/jasc.2000.0595; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; Stout D, 2007, NEUROPSYCHOLOGIA, V45, P1091, DOI 10.1016/j.neuropsychologia.2006.09.014; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Stout D, 2011, PHILOS T R SOC B, V366, P1050, DOI 10.1098/rstb.2010.0369; Stout D, 2009, CAMB ARCHAEOL J, V19, P85, DOI 10.1017/S0959774309000055; Stroobant N, 2001, ULTRASOUND MED BIOL, V27, P509, DOI 10.1016/S0301-5629(00)00325-2; Tallerman M., 2011, OXFORD HDB LANGUAGE; TOTH N, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P346; Uomini N., 2009, EMERGENCE COGNITIVE, P37; Uomini NT, 2009, J HUM EVOL, V57, P411, DOI 10.1016/j.jhevol.2009.02.012; Vaesen K, 2012, BEHAV BRAIN SCI, V35, P203, DOI 10.1017/S0140525X11001452; Whitehouse AJO, 2009, J INT NEUROPSYCH SOC, V15, P1028, DOI 10.1017/S1355617709990555; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Wynn T., 1991, CAMB ARCHAEOL J, V1, P191, DOI [DOI 10.1017/S0959774300000354), 10.1017/S0959774300000354, DOI 10.1017/S0959774300000354]	88	70	72	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72693	10.1371/journal.pone.0072693	http://dx.doi.org/10.1371/journal.pone.0072693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	211BX	24023634	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200029
J	Zhu, L; Zhang, QX; Shi, SF; Liu, LJ; Lv, JC; Zhang, H				Zhu, Li; Zhang, Qingxian; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong			Synergistic Effect of Mesangial Cell-Induced CXCL1 and TGF-beta 1 in Promoting Podocyte Loss in IgA Nephropathy	PLOS ONE			English	Article							IMMUNE-COMPLEXES; GRO-ALPHA; IN-VITRO; URINARY PODOCYTES; KIDNEY-DISEASE; POLYMERIC IGA; INJURY; EXPRESSION; RECEPTORS; TRANSPLANTATION	Podocyte loss has been reported to relate to disease severity and progression in IgA nephropathy (IgAN). However, the underlying mechanism for its role in IgAN remain unclear. Recent evidence has shown that IgA1 complexes from patients with IgAN could activate mesangial cells to induce soluble mediator excretion, and further injure podocytes through mesangial-podocytic cross-talk. In the present study, we explored the underlying mechanism of mesangial cell-induced podocyte loss in IgAN. We found that IgA1 complexes from IgAN patients significantly up-regulated the expression of CXCL1 and TGF-beta 1 in mesangial cells compared with healthy controls. Significantly higher urinary levels of CXCL1 and TGF-beta 1 were also observed in patients with IgAN compared to healthy controls. Moreover, IgAN patients with higher urinary CXCL1 and TGF-beta 1 presented with severe clinical and pathological manifestations, including higher 24-hour urine protein excretion, lower eGFR and higher cresentic glomeruli proportion. Further in vitro experiments showed that increased podocyte death and reduced podocyte adhesion were induced by mesangial cell conditional medium from IgAN (IgAN-HMCM), as well as rhCXCL1 together with rhTGF-beta 1. In addition, the over-expression of CXCR2, the receptor for CXCL1, by podocytes was induced by IgAN-HMCM and rhTGF-beta 1, but not by rhCXCL1. Furthermore, the effect of increased podocyte death and reduced podocyte adhesion induced by IgAN-HMCM and rhCXCL1 and rhTGF-beta 1 was rescued partially by a blocking antibody against CXCR2. Moreover, we observed the expression of CXCR2 in urine exfoliated podocytes in IgAN patients. Our present study implied that IgA1 complexes from IgAN patients could up-regulate the secretion of CXCL1 and TGF-beta 1 in mesangial cells. Additionally, the synergistic effect of CXCL1 and TGF-beta 1 further induced podocyte death and adhesion dysfunction in podocytes via CXCR2. This might be a potential mechanism for podocyte loss observed in IgAN.	[Zhu, Li; Zhang, Qingxian; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China; [Zhu, Li; Zhang, Qingxian; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Zhu, Li; Zhang, Qingxian; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Zhu, Li; Zhang, Qingxian; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong] Peking Univ, Minist Educ, Key Lab Chron Kidney Dis Prevent & Treatment, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Zhang, H (corresponding author), Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China.	hongzh@bjmu.edu.cn	deng, qiongxia/A-3206-2017		National Science Foundation for Youths of China [81000297]; Major State Basic Research Development Program of China (973 program) [2012CB517700]; National Natural Science Foundation for Innovative Research Groups of China [81021004]; Beijing Natural Science Foundation [7131016]	National Science Foundation for Youths of China; Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation for Innovative Research Groups of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Science Foundation for Youths of China (Grant No. 81000297); the Major State Basic Research Development Program of China (973 program, No. 2012CB517700); the National Natural Science Foundation for Innovative Research Groups of China (Grant No. 81021004); and the Beijing Natural Science Foundation (Grant No. 7131016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asao R, 2012, CLIN J AM SOC NEPHRO, V7, P1385, DOI 10.2215/CJN.08110811; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Barratt J, 2004, SEMIN NEPHROL, V24, P197, DOI 10.1016/j.semnephrol.2004.01.002; Bechara C, 2007, MED SCI MONITOR, V13, pRA87; CHEN A, 1994, J PATHOL, V173, P119, DOI 10.1002/path.1711730208; Chung ACK, 2011, J AM SOC NEPHROL, V22, P802, DOI 10.1681/ASN.2010050510; Coppo R, 2010, KIDNEY INT, V77, P417, DOI 10.1038/ki.2009.473; CUEVAS X, 1987, TRANSPL P, V19, P2208; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Dessapt C, 2009, NEPHROL DIAL TRANSPL, V24, P2645, DOI 10.1093/ndt/gfp204; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Duque N, 1997, J IMMUNOL, V159, P3474; Fimmel S, 2007, ANN NY ACAD SCI, V1119, P176, DOI 10.1196/annals.1404.016; Floege J, 1998, NEPHROL DIAL TRANSPL, V13, P1933, DOI 10.1093/ndt/13.8.1933; FUJII K, 1990, AM J KIDNEY DIS, V16, P207, DOI 10.1016/S0272-6386(12)81019-5; Gao YH, 2007, CLIN EXP IMMUNOL, V148, P507, DOI 10.1111/j.1365-2249.2007.03374.x; Han Sang-Youb, 2005, Korean Journal of Internal Medicine, V20, P40; Hara M, 1998, PEDIATR NEPHROL, V12, P43, DOI 10.1007/s004670050401; Hara M, 2007, CLIN J AM SOC NEPHRO, V2, P231, DOI 10.2215/CJN.01470506; Huber TB, 2002, J IMMUNOL, V168, P6244, DOI 10.4049/jimmunol.168.12.6244; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lai KN, 2011, ADV OTO-RHINO-LARYNG, V72, P40, DOI 10.1159/000324593; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; Lai KN, 2003, J AM SOC NEPHROL, V14, P3127, DOI 10.1097/01.ASN.0000095639.56212.BF; Lemley KV, 2002, KIDNEY INT, V61, P1475, DOI 10.1046/j.1523-1755.2002.00269.x; Leung JCK, 2003, NEPHROL DIAL TRANSPL, V18, P36, DOI 10.1093/ndt/18.1.36; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Migliorini A, 2013, J NEPHROL, V26, P437, DOI 10.5301/jn.5000247; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Novak J, 2011, NEPHROL DIAL TRANSPL, V26, P3451, DOI 10.1093/ndt/gfr448; Reterink TJF, 1996, MEDIAT INFLAMM, V5, P191, DOI 10.1155/S0962935196000269; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; SANFILIPPO F, 1982, TRANSPLANTATION, V33, P370, DOI 10.1097/00007890-198204000-00006; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Tam KY, 2009, KIDNEY INT, V75, P1330, DOI 10.1038/ki.2009.71; Taniguchi Y, 1999, NEPHRON, V81, P94, DOI 10.1159/000045254; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Wang C, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13304; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159	41	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73425	10.1371/journal.pone.0073425	http://dx.doi.org/10.1371/journal.pone.0073425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023680	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200077
J	Xiong, XW; Tao, RY; DePinho, RA; Dong, XC				Xiong, Xiwen; Tao, Rongya; DePinho, Ronald A.; Dong, X. Charlie			Deletion of Hepatic FoxO1/3/4 Genes in Mice Significantly Impacts on Glucose Metabolism through Downregulation of Gluconeogenesis and Upregulation of Glycolysis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO1; TRANSGENIC MICE; CELL HOMEOSTASIS; LIPID-METABOLISM; INSULIN ACTION; GLUCOKINASE; LIVER; EXPRESSION; PATHWAYS; OVEREXPRESSION	Forkhead transcription factors FoxO1/3/4 have pleiotrophic functions including anti-oxidative stress and metabolism. With regard to glucose metabolism, most studies have been focused on FoxO1. To further investigate their hepatic functions, we generated liver-specific FoxO1/3/4 knockout mice (LTKO) and examined their collective impacts on glucose homeostasis under physiological and pathological conditions. As compared to wild-type mice, LTKO mice had lower blood glucose levels under both fasting and non-fasting conditions and they manifested better glucose and pyruvate tolerance on regular chow diet. After challenged by a high-fat diet, wild-type mice developed type 2 diabetes, but LTKO mice remained euglycemic and insulin-sensitive. To understand the underlying mechanisms, we examined the roles of SIRT6 (Sirtuin 6) and Gck (glucokinase) in the FoxO-mediated glucose metabolism. Interestingly, ectopic expression of SIRT6 in the liver only reduced gluconeogenesis in wild-type but not LTKO mice whereas knockdown of Gck caused glucose intolerance in both wild-type and LTKO mice. The data suggest that both decreased gluconeogenesis and increased glycolysis may contribute to the overall glucose phenotype in the LTKO mice. Collectively, FoxO1/3/4 transcription factors play important roles in hepatic glucose homeostasis.	[Xiong, Xiwen; Tao, Rongya; Dong, X. Charlie] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; UTMD Anderson Cancer Center	Dong, XC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	xcdong@iu.edu	Xiong, Xiwen/GSN-0686-2022; tao, rongya/B-8042-2014	tao, rongya/0000-0002-3316-5587; DePinho, Ronald/0000-0002-5625-577X	National Institute of Diabetes And Digestive And Kidney Diseases [R00DK077505]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK077505, K99DK077505] Funding Source: NIH RePORTER	National Institute of Diabetes And Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes And Digestive And Kidney Diseases grant R00DK077505 (to XCD). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; An BS, 2010, MOL CELL BIOL, V30, P4890, DOI 10.1128/MCB.00180-10; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Ferre T, 1996, P NATL ACAD SCI USA, V93, P7225, DOI 10.1073/pnas.93.14.7225; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; Ganjam GK, 2009, J BIOL CHEM, V284, P30783, DOI 10.1074/jbc.M109.045260; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Jackerott M, 2002, DIABETOLOGIA, V45, P1292, DOI 10.1007/s00125-002-0881-y; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Kim DH, 2011, DIABETES, V60, P2763, DOI 10.2337/db11-0548; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Naimi M, 2007, ENDOCRINOLOGY, V148, P2424, DOI 10.1210/en.2006-1411; Nakae J, 2001, BIOCHEMISTRY-US, V40, P11768, DOI 10.1021/bi015532m; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; Onuma H, 2006, MOL ENDOCRINOL, V20, P2831, DOI 10.1210/me.2006-0085; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Senokuchi T, 2008, DIABETES, V57, P2967, DOI 10.2337/db08-0520; Shiota M, 2001, DIABETES, V50, P622, DOI 10.2337/diabetes.50.3.622; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; Xiong XW, 2012, J BIOL CHEM, V287, P39107, DOI 10.1074/jbc.M112.412569; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	45	66	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e74340	10.1371/journal.pone.0074340	http://dx.doi.org/10.1371/journal.pone.0074340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015318	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800113
J	Yang, L; Jue, DW; Li, W; Zhang, RJ; Chen, M; Yang, Q				Yang, Liu; Jue, Dengwei; Li, Wang; Zhang, Ruijie; Chen, Min; Yang, Qing			Identification of MiRNA from Eggplant (Solanum melongena L.) by Small RNA Deep Sequencing and Their Response to Verticillium dahliae Infection	PLOS ONE			English	Article							SIRNA BIOGENESIS; INNATE IMMUNITY; MICRORNAS; ARABIDOPSIS; RESISTANCE; STRESS; GENE; PLANTS; REPRESSION; EXPRESSION	MiRNAs are a class of non-coding small RNAs that play important roles in the regulation of gene expression. Although plant miRNAs have been extensively studied in model systems, less is known in other plants with limited genome sequence data, including eggplant (Solanum melongena L.). To identify miRNAs in eggplant and their response to Verticillium dahliae infection, a fungal pathogen for which clear understanding of infection mechanisms and effective cure methods are currently lacking, we deep-sequenced two small RNA (sRNA) libraries prepared from mock-infected and infected seedlings of eggplants. Specifically, 30,830,792 reads produced 7,716,328 unique miRNAs representing 99 known miRNA families that have been identified in other plant species. Two novel putative miRNAs were predicted with eggplant ESTs. The potential targets of the identified known and novel miRNAs were also predicted based on sequence homology search. It was observed that the length distribution of obtained sRNAs and the expression of 6 miRNA families were obviously different between the two libraries. These results provide a framework for further analysis of miRNAs and their role in regulating plant response to fungal infection and Verticillium wilt in particular.	[Yang, Liu; Jue, Dengwei; Li, Wang; Zhang, Ruijie; Chen, Min; Yang, Qing] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	qyang19@njau.edu.cn			Jiangsu Agricultural Science and Technology Innovation Fund [cx (11)1020]; National '863' High-tech Program [2010AA10A108]; National Pear Industry Technology System [CARS-29]; Priority Academic Program Development of Jiangsu Higher Education Institutions: Modern horticultural science (PAPD)	Jiangsu Agricultural Science and Technology Innovation Fund; National '863' High-tech Program; National Pear Industry Technology System; Priority Academic Program Development of Jiangsu Higher Education Institutions: Modern horticultural science (PAPD)	This study was supported financially by grants from the Jiangsu Agricultural Science and Technology Innovation Fund (NO. cx (11)1020), the National '863' High-tech Program (NO. 2010AA10A108), the National Pear Industry Technology System (NO. CARS-29) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions: Modern horticultural science (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio A, 2007, PLANT CELL, V19, P3778, DOI 10.1105/tpc.107.054494; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen L, 2012, PLANT SCI, V184, P14, DOI 10.1016/j.plantsci.2011.11.007; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Ellendorff U, 2009, J EXP BOT, V60, P591, DOI 10.1093/jxb/ern306; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gunaratne Preethi H, 2012, Methods Mol Biol, V822, P273, DOI 10.1007/978-1-61779-427-8_19; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; He XF, 2008, FEBS LETT, V582, P2445, DOI 10.1016/j.febslet.2008.06.011; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Liu SP, 2012, PLANT MOL BIOL REP, V30, P1032, DOI 10.1007/s11105-012-0413-y; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Lu XY, 2008, BIOCHEM BIOPH RES CO, V368, P458, DOI 10.1016/j.bbrc.2008.02.007; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Ori N, 1997, PLANT CELL, V9, P521, DOI 10.1105/tpc.9.4.521; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Reddy DCL, 2012, J HORTIC SCI BIOTECH, V87, P186; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sara M., 2012, American Journal of Plant Sciences, V3, P283, DOI 10.4236/ajps.2012.32034; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Yi H, 2007, PLANT CELL, V19, P2929, DOI 10.1105/tpc.107.051821; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Yin ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035765; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	65	52	54	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72840	10.1371/journal.pone.0072840	http://dx.doi.org/10.1371/journal.pone.0072840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015279	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200060
J	Hocking, J; Dzafic, I; Kazovsky, M; Copland, DA				Hocking, Julia; Dzafic, Ilvana; Kazovsky, Maria; Copland, David A.			NESSTI: Norms for Environmental Sound Stimuli	PLOS ONE			English	Article							OBJECT RECOGNITION; WORD-FREQUENCY; IDENTIFICATION; PICTURES; CATEGORIZATION; REPRESENTATION; FAMILIARITY; AGE; ACQUISITION; DEMENTIA	In this paper we provide normative data along multiple cognitive and affective variable dimensions for a set of 110 sounds, including living and manmade stimuli. Environmental sounds are being increasingly utilized as stimuli in the cognitive, neuropsychological and neuroimaging fields, yet there is no comprehensive set of normative information for these type of stimuli available for use across these experimental domains. Experiment 1 collected data from 162 participants in an on-line questionnaire, which included measures of identification and categorization as well as cognitive and affective variables. A subsequent experiment collected response times to these sounds. Sounds were normalized to the same length (1 second) in order to maximize usage across multiple paradigms and experimental fields. These sounds can be freely downloaded for use, and all response data have also been made available in order that researchers can choose one or many of the cognitive and affective dimensions along which they would like to control their stimuli. Our hope is that the availability of such information will assist researchers in the fields of cognitive and clinical psychology and the neuroimaging community in choosing well-controlled environmental sound stimuli, and allow comparison across multiple studies.	[Hocking, Julia; Dzafic, Ilvana; Kazovsky, Maria] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia; [Copland, David A.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia; [Copland, David A.] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Hocking, J (corresponding author), Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia.	j.hocking@uq.edu.au	Dzafic, Ilvana/H-5503-2019; Copland, David/AAE-5334-2020; Dzafic, Ilvana/C-8596-2016; Hocking, Julia/D-2504-2009; Copland, David A/F-1409-2010	Dzafic, Ilvana/0000-0002-1101-0736; Copland, David/0000-0002-2257-4270; Dzafic, Ilvana/0000-0002-1101-0736; Hocking, Julia/0000-0001-9153-905X; Copland, David A/0000-0002-2257-4270	Australian Research Council [DP110101567]; Australian Research Council; Australian National Health and Medical Research Council	Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by an Australian Research Council (www.arc.gov.au) Discovery Project grant DP110101567 to JH and an Australian Research Council Future Fellowship to DA. JH is supported by an Australian National Health and Medical Research Council fellowship (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; BALLAS JA, 1993, J EXP PSYCHOL HUMAN, V19, P250, DOI 10.1037/0096-1523.19.2.250; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Bramao I, 2011, ACTA PSYCHOL, V138, P244, DOI 10.1016/j.actpsy.2011.06.010; Brodeur MB, 2012, BEHAV RES METHODS, V44, P961, DOI 10.3758/s13428-011-0184-7; Bunn EM, 1998, NEUROPSYCHOLOGY, V12, P367, DOI 10.1037/0894-4105.12.3.367; Catling JC, 2008, ACTA PSYCHOL, V129, P130, DOI 10.1016/j.actpsy.2008.05.005; DEWHURST SA, 1994, J EXP PSYCHOL LEARN, V20, P1088, DOI 10.1037/0278-7393.20.5.1088; Fabiani M, 1996, PSYCHOPHYSIOLOGY, V33, P462, DOI 10.1111/j.1469-8986.1996.tb01072.x; FUNNELL E, 1992, COGNITIVE NEUROPSYCH, V9, P135, DOI 10.1080/02643299208252056; GAFFAN D, 1993, J COGNITIVE NEUROSCI, V5, P118, DOI 10.1162/jocn.1993.5.1.118; Gerlach C, 2009, COGNITION, V111, P281, DOI 10.1016/j.cognition.2009.02.005; Giordano BL, 2010, BRAIN COGNITION, V73, P7, DOI 10.1016/j.bandc.2010.01.005; Goll JC, 2012, NEUROIMAGE, V61, P170, DOI 10.1016/j.neuroimage.2012.02.045; Guastavino C, 2007, CAN J EXP PSYCHOL, V61, P54, DOI 10.1037/cjep2007006; Gygi B, 2004, J ACOUST SOC AM, V115, P1252, DOI 10.1121/1.1635840; Gygi B, 2007, PERCEPT PSYCHOPHYS, V69, P839, DOI 10.3758/BF03193921; Hocking J, 2011, HUM BRAIN MAPP, V32, P688, DOI 10.1002/hbm.21040; Hocking J, 2010, NEUROIMAGE, V50, P796, DOI 10.1016/j.neuroimage.2009.12.067; Kirmse U, 2012, NEUROREPORT, V23, P320, DOI 10.1097/WNR.0b013e328351760b; LACHMAN R, 1973, J EXP PSYCHOL, V99, P199, DOI 10.1037/h0034633; LASS NJ, 1982, PERCEPT MOTOR SKILL, V55, P75, DOI 10.2466/pms.1982.55.1.75; Lewis JW, 2011, J COGNITIVE NEUROSCI, V23, P2079, DOI 10.1162/jocn.2010.21570; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Liu Y, 2011, PLOS ONE, V6; Liu YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016505; Lund K, 1996, BRAIN COGNITION, V30, P5; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Manoiloff L, 2010, BEHAV RES METHODS, V42, P452, DOI 10.3758/BRM.42.2.452; Marcell ME, 2000, J CLIN EXP NEUROPSYC, V22, P830, DOI 10.1076/jcen.22.6.830.949; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Mecklinger A, 1997, NEUROSCI LETT, V235, P65, DOI 10.1016/S0304-3940(97)00712-X; MORRISON CM, 1992, MEM COGNITION, V20, P705, DOI 10.3758/BF03202720; Nielsen JM., 1946, AGNOSIA APRAXIA APHA; O'Neill W, 2005, PERCEPT MOTOR SKILL, V100, P716, DOI 10.2466/PMS.100.3.716-722; Overath T, 2010, J NEUROSCI, V30, P2070, DOI 10.1523/JNEUROSCI.5378-09.2010; PRICE CJ, 1989, Q J EXP PSYCHOL-A, V41, P797, DOI 10.1080/14640748908402394; Robson MD, 1998, NEUROIMAGE, V7, P185, DOI 10.1006/nimg.1998.0322; Saygin AP, 2005, BEHAV RES METHODS, V37, P99, DOI 10.3758/BF03206403; Schneider TR, 2008, EXP PSYCHOL, V55, P121, DOI 10.1027/1618-3169.55.2.121; Shafiro V, 2004, BEHAV RES METH INS C, V36, P590, DOI 10.3758/BF03206539; Shafiro V, 2008, EAR HEARING, V29, P401, DOI 10.1097/AUD.0b013e31816a0cf1; Shatzman KB, 2004, BRAIN LANG, V90, P160, DOI 10.1016/S0093-934X(03)00429-2; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; STEWART F, 1992, Q J EXP PSYCHOL-A, V44, P261, DOI 10.1080/02724989243000037; Szekely A, 2005, CORTEX, V41, P7, DOI 10.1016/S0010-9452(08)70174-6; UYEDA KM, 1980, BEHAV RES METH INSTR, V12, P587, DOI 10.3758/BF03201848; VITKOVITCH M, 1995, Q J EXP PSYCHOL-A, V48, P822, DOI 10.1080/14640749508401419; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	49	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73382	10.1371/journal.pone.0073382	http://dx.doi.org/10.1371/journal.pone.0073382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023866	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600098
J	Lanata, CF; Fischer-Walker, CL; Olascoaga, AC; Torres, CX; Aryee, MJ; Black, RE				Lanata, Claudio F.; Fischer-Walker, Christa L.; Olascoaga, Ana C.; Torres, Carla X.; Aryee, Martin J.; Black, Robert E.		World Hlth Org; UNICEF	Global Causes of Diarrheal Disease Mortality in Children < 5 Years of Age: A Systematic Review	PLOS ONE			English	Review							DEVELOPING-COUNTRIES; ENTERIC MULTICENTER; ROTAVIRUS DISEASE; GIARDIA-LAMBLIA; YOUNG-CHILDREN; GASTROENTERITIS; INFECTION; INFANTS; ILLNESS; DEATHS	Estimation of pathogen-specific causes of child diarrhea deaths is needed to guide vaccine development and other prevention strategies. We did a systematic review of articles published between 1990 and 2011 reporting at least one of 13 pathogens in children <5 years of age hospitalized with diarrhea. We included 2011 rotavirus data from the Rotavirus Surveillance Network coordinated by WHO. We excluded studies conducted during diarrhea outbreaks that did not discriminate between inpatient and outpatient cases, reporting nosocomial infections, those conducted in special populations, not done with adequate methods, and rotavirus studies in countries where the rotavirus vaccine was used. Age-adjusted median proportions for each pathogen were calculated and applied to 712 000 deaths due to diarrhea in children under 5 years for 2011, assuming that those observed among children hospitalized for diarrhea represent those causing child diarrhea deaths. 163 articles and WHO studies done in 31 countries were selected representing 286 inpatient studies. Studies seeking only one pathogen found higher proportions for some pathogens than studies seeking multiple pathogens (e.g. 39% rotavirus in 180 single-pathogen studies vs. 20% in 24 studies with 5-13 pathogens, p<0.0001). The percentage of episodes for which no pathogen could be identified was estimated to be 34%; the total of all age-adjusted percentages for pathogens and no-pathogen cases was 138%. Adjusting all proportions, including unknowns, to add to 100%, we estimated that rotavirus caused 197 000 [Uncertainty range (UR) 110 000-295 000], enteropathogenic E. coli 79 000 (UR 31 000-146 000), calicivirus 71 000 (UR 39 000-113 000), and enterotoxigenic E. coli 42 000 (UR 20 000-76 000) deaths. Rotavirus, calicivirus, enteropathogenic and enterotoxigenic E. coli cause more than half of all diarrheal deaths in children <5 years in the world.	[Lanata, Claudio F.; Olascoaga, Ana C.; Torres, Carla X.] Inst Invest Nutr, Lima, Peru; [Lanata, Claudio F.] US Navy Med Res Unit 6, Callao, Peru; [Lanata, Claudio F.] Univ Peruana Ciencias Aplicadas, Sch Med, Lima, Peru; [Fischer-Walker, Christa L.; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Aryee, Martin J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Biostat, Baltimore, MD USA	Universidad Peruana de Ciencias Aplicadas (UPC); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Lanata, CF (corresponding author), Inst Invest Nutr, Lima, Peru.	clanata@iin.sld.pe	Aryee, Martin/AAC-8113-2020; Lanata, Claudio F./N-7997-2018	Lanata, Claudio F./0000-0002-6994-7425	Bill & Melinda Gates Foundation for the Child Health Epidemiology Reference Group of World Health Organization; UNICEF; Prof. Lanatas Institutional Research Funds	Bill & Melinda Gates Foundation for the Child Health Epidemiology Reference Group of World Health Organization; UNICEF; Prof. Lanatas Institutional Research Funds	The work was supported by a grant to the US Fund for United Nations Children's Fund (UNICEF) from the Bill & Melinda Gates Foundation for the Child Health Epidemiology Reference Group of World Health Organization and UNICEF and by Prof. Lanatas Institutional Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-88; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P174; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; Barletta F, 2011, CLIN INFECT DIS, V53, P1223, DOI 10.1093/cid/cir730; BRANDT CD, 1981, J CLIN MICROBIOL, V13, P976, DOI 10.1128/JCM.13.5.976-981.1981; Desai R, 2011, MEM I OSWALDO CRUZ, V106, P907, DOI 10.1590/S0074-02762011000800002; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Garcia LS, 2010, CLIN MICROBIOLOGY PR; Hollm-Delgado MG, 2008, AM J EPIDEMIOL, V168, P647, DOI 10.1093/aje/kwn177; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lindstrom M, 2011, FOOD MICROBIOL, V28, P192, DOI 10.1016/j.fm.2010.03.020; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Muhsen K, 2012, CLIN INFECT DIS, V55, pS271, DOI 10.1093/cid/cis762; Ochoa TJ, 2009, CLIN INFECT DIS, V49, P1694, DOI 10.1086/648069; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pinchuk IV, 2010, TOXINS, V2, P2177, DOI 10.3390/toxins2082177; SULLIVAN PS, 1988, AM J EPIDEMIOL, V127, P1272, DOI 10.1093/oxfordjournals.aje.a114919; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tennant SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-117; United Nations, 2011, STESASERA308 UN; van Maarseveen NM, 2010, J CLIN VIROL, V49, P205, DOI 10.1016/j.jcv.2010.07.019; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Yori PP, 2009, PEDIATR INFECT DIS J, V28, P844, DOI 10.1097/INF.0b013e3181a24730	32	403	434	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72788	10.1371/journal.pone.0072788	http://dx.doi.org/10.1371/journal.pone.0072788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023773	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600044
J	Wang, Q; Cai, J; Cai, XH; Chen, L				Wang, Qing; Cai, Jie; Cai, Xian-hua; Chen, Lei			miR-346 Regulates Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by Targeting the Wnt/beta-Catenin Pathway	PLOS ONE			English	Article							IN-VIVO; PROTEIN EXPRESSION; GENE-EXPRESSION; MICRORNAS; OSTEOBLASTS; INHIBITION; DISEASE; MIRNAS; MASS	Osteogenic differentiation of human mesenchymal stem cells (hMSCs) is regulated by multiple transcription factors and signaling molecules. However, the molecular mechanisms underlying this process remain to be fully elucidated. MicroRNAs (miRNAs) act as key regulators in various biological processes by mediating mRNA degradation or translational inhibition of target genes. In this study, we report that miR-346 plays critical roles in regulating osteogenic differentiation of hBMSCs. The expression of endogenous miR-346 was increased during osteogenic differentiation of hBMSCs. Overexpression of miR-346 significantly promoted osteogenic differentiation, whereas miR-346 depletion suppressed this process. Further studies confirmed that miR-346 directly targeted the 3'-UTR of the glycogen synthase kinase-3 beta (GSK-3 beta) gene so as to suppress the expression of GSK-3 beta protein. Similar to miR-346 overexpression, GSK-3 beta depletion promoted osteogenic differentiation, whereas GSK-3 beta overexpression reversed the promotional effect of miR-346. We further found that miR-346 overexpression activated the Wnt/beta-catenin pathway and increased the expression of several downstream genes including CyclinD1, c-Myc, TCF-1 and LEF-1. Depletion of beta-catenin almost completely blocked the positive role of miR-346 on osteogenic differentiation. Taken together, our data indicate that miR-346 positively regulates hBMSC osteogenic differentiation by targeting GSK-3 beta and activating the Wnt/beta-catenin pathway.	[Wang, Qing; Cai, Jie; Cai, Xian-hua; Chen, Lei] Wuhan Gen Hosp Guangzhou Command, Dept Orthopaed Surg, Wuhan, Peoples R China		Chen, L (corresponding author), Wuhan Gen Hosp Guangzhou Command, Dept Orthopaed Surg, Wuhan, Peoples R China.	webberchen@foxmail.com	Cai, Xian-Hua/ABA-2969-2021	Cai, Xian-Hua/0000-0002-2080-6656				Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gambardella A, 2011, J BONE MINER RES, V26, P811, DOI 10.1002/jbmr.266; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Jang HD, 2011, J BIOL CHEM, V286, P39043, DOI 10.1074/jbc.M111.256768; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kulkarni NH, 2006, J BONE MINER RES, V21, P910, DOI 10.1359/JBMR.060316; Laine SK, 2012, J CELL BIOCHEM, V113, P2687, DOI 10.1002/jcb.24144; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Zeng Y, 2012, FEBS LETT, V586, P2375, DOI 10.1016/j.febslet.2012.05.049; Zhang JF, 2011, RNA BIOL, V8, P829, DOI 10.4161/rna.8.5.16043	24	74	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72266	10.1371/journal.pone.0072266	http://dx.doi.org/10.1371/journal.pone.0072266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023731	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600015
J	Dagenais, A; Tessier, MC; Tatur, S; Brochiero, E; Grygorczyk, R; Berthiaume, Y				Dagenais, Andre; Tessier, Marie-Claude; Tatur, Sabina; Brochiero, Emmanuelle; Grygorczyk, Ryszard; Berthiaume, Yves			Hypotonic Shock Modulates Na+ Current via a Cl- and Ca2(+)/Calmodulin Dependent Mechanism in Alveolar Epithelial Cells	PLOS ONE			English	Article							CONDUCTANCE CHLORIDE CHANNELS; ATP RELEASE; ALPHA-ENAC; II CELLS; EXTRACELLULAR NUCLEOTIDES; FLUID ABSORPTION; TYROSINE KINASE; SODIUM-CHANNELS; A6 CELLS; TRANSPORT	Alveolar epithelial cells are involved in Na+ absorption via the epithelial Na+ channel (ENaC), an important process for maintaining an appropriate volume of liquid lining the respiratory epithelium and for lung oedema clearance. Here, we investigated how a 20% hypotonic shock modulates the ionic current in these cells. Polarized alveolar epithelial cells isolated from rat lungs were cultured on permeant filters and their electrophysiological properties recorded. A 20% bilateral hypotonic shock induced an immediate, but transient 52% rise in total transepithelial current and a 67% increase in the amiloride-sensitive current mediated by ENaC. Amiloride pre-treatment decreased the current rise after hypotonic shock, showing that ENaC current is involved in this response. Since Cl- transport is modulated by hypotonic shock, its contribution to the basal and hypotonic-induced transepithelial current was also assessed. Apical NPPB, a broad Cl-channel inhibitor and basolateral DIOA a potassium chloride co-transporter (KCC) inhibitor reduced the total and ENaC currents, showing that transcellular Cl- transport plays a major role in that process. During hypotonic shock, a basolateral Cl- influx, partly inhibited by NPPB is essential for the hypotonic-induced current rise. Hypotonic shock promoted apical ATP secretion and increased intracellular Ca2+. While apyrase, an ATP scavenger, did not inhibit the hypotonic shock current response, W7 a calmodulin antagonist completely prevented the hypotonic current rise. These results indicate that a basolateral Cl- influx as well as Ca2+/calmodulin, but not ATP, are involved in the acute transepithelial current rise elicited by hypotonic shock.	[Dagenais, Andre; Tessier, Marie-Claude; Berthiaume, Yves] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Dagenais, Andre; Brochiero, Emmanuelle; Grygorczyk, Ryszard; Berthiaume, Yves] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Tatur, Sabina; Brochiero, Emmanuelle; Grygorczyk, Ryszard] Univ Montreal, CRCHUM, Ctr Hosp, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universite de Montreal	Dagenais, A (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	andre.dagenais@ircm.qc.ca	Berthiaume, Yves/K-7588-2012	Grygorczyk, Ryszard/0000-0002-9798-7651	Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research	Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Cystic Fibrosis Foundation (www.cysticfibrosis.ca) and the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopova I, 2012, PURINERG SIGNAL, V8, P59, DOI 10.1007/s11302-011-9259-2; Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Bachhuber T, 2005, J BIOL CHEM, V280, P31587, DOI 10.1074/jbc.M504347200; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Boncoeur E, 2010, AM J PHYSIOL-LUNG C, V298, pL417, DOI 10.1152/ajplung.00170.2009; Boudreault F, 2002, AM J PHYSIOL-CELL PH, V282, pC219, DOI 10.1152/ajpcell.00317.2001; Boudreault F, 2004, J MICROSC-OXFORD, V215, P302, DOI 10.1111/j.0022-2720.2004.01378.x; Bove PF, 2010, J BIOL CHEM, V285, P34939, DOI 10.1074/jbc.M110.162933; Brochiero E, 2004, AM J PHYSIOL-LUNG C, V287, pL382, DOI 10.1152/ajplung.00320.2002; BROCHIERO E, 1995, PFLUG ARCH EUR J PHY, V431, P32, DOI 10.1007/BF00374375; Butterworth MB, 2010, BBA-MOL BASIS DIS, V1802, P1166, DOI 10.1016/j.bbadis.2010.03.010; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chow YH, 1999, PEDIATR RES, V46, P208, DOI 10.1203/00006450-199908000-00014; CLERICI C, 1995, J MEMBRANE BIOL, V147, P295; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Comellas AP, 2010, J CELL SCI, V123, P1343, DOI 10.1242/jcs.066464; Dagenais A, 2001, AM J PHYSIOL-LUNG C, V281, pL217, DOI 10.1152/ajplung.2001.281.1.L217; Dagenais A, 2006, AM J PHYSIOL-LUNG C, V291, pL1220, DOI 10.1152/ajplung.00511.2005; Davis IC, 2007, ADV EXP MED BIOL, V618, P127; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Egli M, 2004, J PHYSIOL-LONDON, V560, P857, DOI 10.1113/jphysiol.2004.066704; EHRENFELD J, 1994, J MEMBRANE BIOL, V138, P181; Fang X, 2002, J GEN PHYSIOL, V119, P199, DOI 10.1085/jgp.119.2.199; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; FENG ZP, 1993, AM J RESP CELL MOL, V9, P248, DOI 10.1165/ajrcmb/9.3.248; Fujii T, 2008, J BIOL CHEM, V283, P6869, DOI 10.1074/jbc.M708429200; Fujii T, 2010, BIOCHEM BIOPH RES CO, V399, P683, DOI 10.1016/j.bbrc.2010.08.002; Gu YC, 2008, J EXP BIOL, V211, P3167, DOI 10.1242/jeb.019646; Gu Y, 2008, J CELL PHYSIOL, V216, P453, DOI 10.1002/jcp.21413; Guyot A, 2002, J PHYSIOL-LONDON, V545, P199, DOI 10.1113/jphysiol.2002.030148; Hazama A, 1999, J GEN PHYSIOL, V114, P525, DOI 10.1085/jgp.114.4.525; Helve O, 2009, NEONATOLOGY, V95, P347, DOI 10.1159/000209300; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Ingbar DH, 2009, AM J PHYSIOL-LUNG C, V297, pL813, DOI 10.1152/ajplung.00324.2009; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Itani OA, 2002, AM J PHYSIOL-LUNG C, V282, pL631, DOI 10.1152/ajplung.00085.2001; Jain L, 2001, AM J PHYSIOL-LUNG C, V280, pL646, DOI 10.1152/ajplung.2001.280.4.L646; Jain L, 1999, AM J PHYSIOL-LUNG C, V276, pL1046, DOI 10.1152/ajplung.1999.276.6.L1046; Ji HL, 1998, AM J PHYSIOL-CELL PH, V275, pC1182; Jiang XP, 1998, AM J PHYSIOL-CELL PH, V275, pC1610, DOI 10.1152/ajpcell.1998.275.6.C1610; Johnson M, 2009, AM J PHYSIOL-LUNG C, V297, pL816, DOI 10.1152/ajplung.90466.2008; KEMP PJ, 1993, AM J PHYSIOL, V265, pL323, DOI 10.1152/ajplung.1993.265.4.L323; Kunzelmann K, 2004, FASEB J, V18, P142, DOI 10.1096/fj.04-2314fje; Kunzelmann K, 2002, PFLUG ARCH EUR J PHY, V444, P220, DOI 10.1007/s00424-002-0796-y; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Lee SY, 2003, J MEMBRANE BIOL, V191, P133, DOI 10.1007/s00232-002-1049-x; Leroy C, 2004, AM J PHYSIOL-LUNG C, V286, pL1027, DOI 10.1152/ajplung.00249.2003; Leroy C, 2006, AM J PHYSIOL-LUNG C, V291, pL1207, DOI 10.1152/ajplung.00376.2005; Mace OJ, 2008, J PHYSIOL-LONDON, V586, P4541, DOI 10.1113/jphysiol.2008.158253; Mall M, 2000, AM J RESP CELL MOL, V23, P755, DOI 10.1165/ajrcmb.23.6.4207; Marunaka Y, 2001, J MEMBRANE BIOL, V180, P91, DOI 10.1007/s002320010061; Miyazaki H, 2007, AM J PHYSIOL-RENAL, V292, pF1411, DOI 10.1152/ajprenal.00244.2006; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Nielsen VG, 1998, AM J PHYSIOL-LUNG C, V275, pL1127, DOI 10.1152/ajplung.1998.275.6.L1127; Niisato N, 2004, AM J PHYSIOL-RENAL, V287, pF932, DOI 10.1152/ajprenal.00131.2004; Niisato N, 1999, J PHYSIOL-LONDON, V518, P417, DOI 10.1111/j.1469-7793.1999.0417p.x; Niisato N, 2000, J MEMBRANE BIOL, V175, P63, DOI 10.1007/s002320001055; O'Grady SM, 2003, AM J PHYSIOL-LUNG C, V284, pL689, DOI 10.1152/ajplung.00256.2002; O'Grady SM, 2000, AM J PHYSIOL-LUNG C, V278, pL239, DOI 10.1152/ajplung.2000.278.2.L239; O'Mullane LM, 2009, CLIN EXP PHARMACOL P, V36, P1016, DOI 10.1111/j.1440-1681.2009.05256.x; Olson JE, 2004, GLIA, V46, P391, DOI 10.1002/glia.20014; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Ramminger SJ, 1999, BRIT J PHARMACOL, V128, P293, DOI 10.1038/sj.bjp.0702767; Reid JM, 2000, BIOCHEM BIOPH RES CO, V271, P429, DOI 10.1006/bbrc.2000.2638; SCHNEIDER GT, 1985, PFLUG ARCH EUR J PHY, V404, P354, DOI 10.1007/BF00585348; Schreiber R, 2003, J MEMBRANE BIOL, V192, P101, DOI 10.1007/s00232-002-1067-8; Taruno A, 2008, AM J PHYSIOL-RENAL, V294, pF177, DOI 10.1152/ajprenal.00250.2007; Taruno A, 2010, CELL PHYSIOL BIOCHEM, V26, P925, DOI 10.1159/000324001; Tatur S, 2008, PURINERG SIGNAL, V4, P139, DOI 10.1007/s11302-007-9059-x; Tatur S, 2007, J PHYSIOL-LONDON, V584, P419, DOI 10.1113/jphysiol.2007.133314; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Tokuda S, 2002, BIOCHEM BIOPH RES CO, V298, P619, DOI 10.1016/S0006-291X(02)02514-7; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Venkatesh VC, 1997, AM J PHYSIOL-LUNG C, V273, pL227, DOI 10.1152/ajplung.1997.273.1.L227; Wang XF, 2000, BIOL REPROD, V63, P1918, DOI 10.1095/biolreprod63.6.1918; WILLS NK, 1991, J MEMBRANE BIOL, V121, P79, DOI 10.1007/BF01870653; Xie Y, 2004, AM J PHYSIOL-RENAL, V287, pF722, DOI 10.1152/ajprenal.00135.2004; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yip KP, 2002, J PHYSIOL-LONDON, V538, P891, DOI 10.1113/jphysiol.2001.012606	85	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74565	10.1371/journal.pone.0074565	http://dx.doi.org/10.1371/journal.pone.0074565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019969	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200112
J	Tian, SZ; Wang, Y; Ning, TY; Zhao, HX; Wang, BW; Li, N; Li, ZJ; Chi, SY				Tian, Shenzhong; Wang, Yu; Ning, Tangyuan; Zhao, Hongxiang; Wang, Bingwen; Li, Na; Li, Zengjia; Chi, Shuyun			Greenhouse Gas Flux and Crop Productivity after 10 Years of Reduced and No Tillage in a Wheat-Maize Cropping System	PLOS ONE			English	Article							AGRICULTURAL SOILS; NITROUS-OXIDE; CARBON-DIOXIDE; METHANE OXIDATION; LAND-USE; EMISSIONS; TEMPERATURE; RESIDUE; WATER; CORN	Appropriate tillage plays an important role in mitigating the emissions of greenhouse gases (GHG) in regions with higher crop yields, but the emission situations of some reduced tillage systems such as subsoiling, harrow tillage and rotary tillage are not comprehensively studied. The objective of this study was to evaluate the emission characteristics of GHG (CH4 and N2O) under four reduced tillage systems from October 2007 to August 2009 based on a 10-yr tillage experiment in the North China Plain, which included no-tillage (NT) and three reduced tillage systems of subsoil tillage (ST), harrow tillage (HT) and rotary tillage (RT), with the conventional tillage (CT) as the control. The soil under the five tillage systems was an absorption sink for CH4 and an emission source for N2O. The soil temperature positive impacted on the CH4 absorption by the soils of different tillage systems, while a significant negative correlation was observed between the absorption and soil moisture. The main driving factor for increased N2O emission was not the soil temperature but the soil moisture and the content of nitrate. In the two rotation cycle of wheat-maize system (10/2007-10/2008 and 10/2008-10/2009), averaged cumulative uptake fluxes of CH4 under CT, ST, HT, RT and NT systems were approximately 1.67, 1.72, 1.63, 1.77 and 1.17 t ha(-1) year(-1), respectively, and meanwhile, approximately 4.43, 4.38, 4.47, 4.30 and 4.61 t ha(-1) year(-1) of N2O were emitted from soil of these systems, respectively. Moreover, they also gained 33.73, 34.63, 32.62, 34.56 and 27.54 t ha(-1) yields during two crop-rotation periods, respectively. Based on these comparisons, the rotary tillage and subsoiling mitigated the emissions of CH4 and N2O as well as improving crop productivity of a wheat-maize cropping system.	[Tian, Shenzhong; Ning, Tangyuan; Zhao, Hongxiang; Wang, Bingwen; Li, Na; Li, Zengjia] Shandong Agr Univ, State Key Lab Crop Biol, Shandong Key Lab Crop Biol, Natl Engn Lab Efficient Utilizat Soil & Fertilize, Tai An, Shandong, Peoples R China; [Wang, Yu] Shandong Rice Res Inst, Jinan, Shandong, Peoples R China; [Chi, Shuyun] Shandong Agr Univ, Coll Mech & Elect Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Ning, TY (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Shandong Key Lab Crop Biol, Natl Engn Lab Efficient Utilizat Soil & Fertilize, Tai An, Shandong, Peoples R China.	ningty@163.com; chishujun1955@163.com	Tian, Shenzhong/AAA-6890-2020	, TIAN/0000-0002-6264-5758	National Science and Technology Research Projects of China [2012BAD14B07]; Special Research Funding for Public Benefit Industries (Agriculture) of China [201103001]; Nature Science Fund of China [30900876, 31101127]	National Science and Technology Research Projects of China; Special Research Funding for Public Benefit Industries (Agriculture) of China; Nature Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was financial supported by Financial supported by the National Science and Technology Research Projects of China (2012BAD14B07), the Special Research Funding for Public Benefit Industries (Agriculture) of China (201103001), and the Nature Science Fund of China (30900876 and 31101127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2009, SOIL TILL RES, V106, P54, DOI 10.1016/j.still.2009.09.005; Bai XiaoLin, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P282; Bao S.D, 2000, SOIL AGR CHEM ANAL; Bhatia A, 2010, AGR ECOSYST ENVIRON, V136, P247, DOI 10.1016/j.agee.2010.01.004; Boomsma CR, 2010, SOIL TILL RES, V106, P227, DOI 10.1016/j.still.2009.12.006; BOUWMAN AF, 1990, SOILS AND THE GREENHOUSE EFFECT, P61; Chatskikh D, 2007, SOIL TILL RES, V97, P5, DOI 10.1016/j.still.2007.08.004; Cui RY, 2001, ACTA ECOLOGICA SINIC, V21, P315; Dijkstra FA, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001288; Dong Yuhong, 2005, Ying Yong Sheng Tai Xue Bao, V16, P1303; DUNFIELD P, 1993, SOIL BIOL BIOCHEM, V25, P321, DOI 10.1016/0038-0717(93)90130-4; Elder JW, 2008, SOIL TILL RES, V98, P45, DOI 10.1016/j.still.2007.10.003; Forster P., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1103/PHYSREVB.77.220407; FORTIN MC, 1990, AGRON J, V82, P710, DOI 10.2134/agronj1990.00021962008200040013x; FORTIN MC, 1993, AGRON J, V85, P571, DOI 10.2134/agronj1993.00021962008500030010x; [宫秀杰 GONG Xiu-jie], 2009, [玉米科学, Maize Science], V17, P134; Gregorich EG, 2005, SOIL TILL RES, V83, P53, DOI 10.1016/j.still.2005.02.009; Groffman PM, 2006, GLOBAL CHANGE BIOL, V12, P1748, DOI 10.1111/j.1365-2486.2006.01194.x; HASSINK J, 1995, SOIL BIOL BIOCHEM, V27, P1099, DOI 10.1016/0038-0717(95)00027-C; He Jin, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P62; He J, 2011, SOIL TILL RES, V113, P48, DOI 10.1016/j.still.2011.01.005; He J, 2009, SOIL TILL RES, V104, P198, DOI 10.1016/j.still.2008.08.015; Huang Ming, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P50; Hutsch BW, 1998, BIOL FERT SOILS, V27, P284, DOI 10.1007/s003740050435; Kessavalou A, 1998, J ENVIRON QUAL, V27, P1094, DOI 10.2134/jeq1998.00472425002700050015x; 郑循华, 1998, Advances in Atmospheric Sciences, V15, P569; Koponen HT, 2004, SOIL BIOL BIOCHEM, V36, P757, DOI 10.1016/j.soilbio.2003.12.011; KOVAR JL, 1992, SOIL TILL RES, V24, P11, DOI 10.1016/0167-1987(92)90069-N; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lee J, 2006, J ENVIRON QUAL, V35, P714, DOI 10.2134/jeq2005.0337; Li DM, 2011, SOIL TILL RES, V113, P77, DOI 10.1016/j.still.2011.02.006; Liang W, 2007, PEDOSPHERE, V17, P630, DOI 10.1016/S1002-0160(07)60075-7; LUND MG, 1993, J PROD AGRIC, V6, P207, DOI 10.2134/jpa1993.0207; [马静 MA Jing], 2007, [土壤, Soils], V39, P859; MOCK JJ, 1977, AGRON J, V69, P337, DOI 10.2134/agronj1977.00021962006900030001x; Omonode RA, 2007, SOIL TILL RES, V95, P182, DOI 10.1016/j.still.2006.12.004; Paustian K, 1997, SOIL USE MANAGE, V13, P230, DOI 10.1111/j.1475-2743.1997.tb00594.x; [齐玉春 Qi Yuchun], 2002, [农村生态环境, Rural Eco-Environment], V18, P56; Robertson G. Philip, 1993, V55, P95; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Six J, 2004, GLOBAL CHANGE BIOL, V10, P155, DOI 10.1111/j.1529-8817.2003.00730.x; Smith P, 2001, NUTR CYCL AGROECOSYS, V60, P237, DOI 10.1023/A:1012617517839; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SWAN JB, 1994, AGRON J, V86, P711, DOI 10.2134/agronj1994.00021962008600040024x; Tian SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051206; [田慎重 Tian Shenzhong], 2012, [生态学报, Acta Ecologica Sinica], V32, P879; von Fischer JC, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000731; Wan YF, 2005, CHIN J AGROMETEOROL, V27, P122; WILLISON TW, 1995, CHEMOSPHERE, V30, P539, DOI 10.1016/0045-6535(94)00416-R; Zhang HaiLin, 2005, Journal of China Agricultural University, V10, P16; Zhang XueSong, 2006, Journal of Nanjing Institute of Meteorology, V29, P181	52	16	17	6	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73450	10.1371/journal.pone.0073450	http://dx.doi.org/10.1371/journal.pone.0073450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019923	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200065
J	Gouni-Berthold, I; Berthold, HK; Huh, JY; Berman, R; Spenrath, N; Krone, W; Mantzoros, CS				Gouni-Berthold, Ioanna; Berthold, Heiner K.; Huh, Joo Young; Berman, Reena; Spenrath, Nadine; Krone, Wilhelm; Mantzoros, Christos S.			Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo	PLOS ONE			English	Article							EZETIMIBE AND/OR SIMVASTATIN; CIRCULATING ADIPONECTIN; RANDOMIZED-TRIAL; HEALTHY-MEN; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; LDL-CHOLESTEROL; STATIN THERAPY; MESSENGER-RNA; LEPTIN LEVELS	Context and Objective: The myokine irisin has been proposed to regulate energy homeostasis. Little is known about its association with metabolic parameters and especially with parameters influencing pathways of lipid metabolism. In the context of a clinical trial, an exploratory post hoc analysis has been performed in healthy subjects to determine whether simvastatin and/or ezetimibe influence serum irisin levels. The direct effects of simvastatin on irisin were also examined in primary human skeletal muscle cells (HSKMCs). Design and Participants: A randomized, parallel 3-group study was performed in 72 men with mild hypercholesterolemia and without apparent cardiovascular disease. Each group of 24 subjects received a 14-day treatment with either simvastatin 40 mg, ezetimibe 10 mg, or their combination. Results: Baseline irisin concentrations were not significantly correlated with age, BMI, estimated GFR, thyroid parameters, glucose, insulin, lipoproteins, non-cholesterol sterols, adipokines, inflammation markers and various molecular markers of cholesterol metabolism. Circulating irisin increased significantly in simvastatin-treated but not in ezetimibe-treated subjects. The changes were independent of changes in LDL-cholesterol and were not correlated with changes in creatine kinase levels. In HSKMCs, simvastatin significantly increased irisin secretion as well as mRNA expression of its parent peptide hormone FNDC5. Simvastatin significantly induced cellular reactive oxygen species levels along with expression of pro-and anti-oxidative genes such as Nox2, and MnSOD and catalase, respectively. Markers of cellular stress such as atrogin-1 mRNA and Bax protein expression were also induced by simvastatin. Decreased cell viability and increased irisin secretion by simvastatin was reversed by antioxidant mito-TEMPO, implying in part that irisin is secreted as a result of increased mitochondrial oxidative stress and subsequent myocyte damage. Conclusions: Simvastatin increases irisin concentrations in vivo and in vitro. It remains to be determined whether this increase is a result of muscle damage or a protective mechanism against simvastatin-induced cellular stress. Trial Registration: ClinicalTrials.gov NCT00317993 http://clinicaltrials.gov/ct2/show/NCT00317993.	[Gouni-Berthold, Ioanna; Spenrath, Nadine; Krone, Wilhelm] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, D-50931 Cologne, Germany; [Berthold, Heiner K.] Charite, EGZB, D-13353 Berlin, Germany; [Berthold, Heiner K.] Interdisciplinary Metab Ctr, Lipid Clin, Virchow Clin Campus, Berlin, Germany; [Huh, Joo Young; Berman, Reena; Mantzoros, Christos S.] Boston VA Healthcare Syst, Endocrinol Sect, Boston, MA USA; [Huh, Joo Young; Berman, Reena; Mantzoros, Christos S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Gouni-Berthold, I (corresponding author), Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, D-50931 Cologne, Germany.	ioanna.berthold@uni-koeln.de	Mantzoros, Christos/Y-2902-2019; Berthold, Heiner/E-6017-2011	Berthold, Heiner/0000-0002-1457-2216	MSD Sharp & Dohme (Munich, Germany); Wilhelm-Doerenkamp Foundation (Cologne, Germany)	MSD Sharp & Dohme (Munich, Germany); Wilhelm-Doerenkamp Foundation (Cologne, Germany)	The parent trial (1) was supported in part by an investigator-initiated grant from MSD Sharp & Dohme (Munich, Germany) and the Wilhelm-Doerenkamp Foundation (Cologne, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axsom K, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0299-z; Baer AN, 2007, CURR OPIN RHEUMATOL, V19, P67; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Becker DJ, 2008, MAYO CLIN PROC, V83, P758, DOI 10.4065/83.7.758; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Berneis K, 2010, EUR HEART J, V31, P1633, DOI 10.1093/eurheartj/ehq181; Berthold HK, 2008, EXP CLIN ENDOCR DIAB, V116, P262, DOI 10.1055/s-2007-993144; Berthold HK, 2006, DRUG SAFETY, V29, P703, DOI 10.2165/00002018-200629080-00007; Bluher M, 2007, DIABETES CARE, V30, P280, DOI 10.2337/dc06-1362; Boaz M, 2009, DIABETIC MED, V26, P708, DOI 10.1111/j.1464-5491.2009.02747.x; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Cao PR, 2009, FASEB J, V23, P2844, DOI 10.1096/fj.08-128843; Castillo-Quan JI, 2012, DIS MODEL MECH, V5, P293, DOI 10.1242/dmm.009894; Chan JL, 2007, CLIN ENDOCRINOL, V66, P49, DOI 10.1111/j.1365-2265.2006.02684.x; Choi YK, 2013, DIABETES RES CLIN PR; Danaei G, 2012, DIABETES CARE; Eckel RH, 2010, J CLIN ENDOCR METAB, V95, P2015, DOI 10.1210/jc.2009-2689; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Galtier F, 2012, TOXICOL APPL PHARM, V263, P281, DOI 10.1016/j.taap.2012.06.020; Goodpaster BH, 2013, DIABETES, V62, P1032, DOI 10.2337/db12-1612; Gouni-Berthold I, 2008, CLIN ENDOCRINOL, V68, P536, DOI 10.1111/j.1365-2265.2007.03080.x; Gouni-Berthold I, 2008, ATHEROSCLEROSIS, V198, P198, DOI 10.1016/j.atherosclerosis.2007.09.034; Gouni-Berthold I, 2012, EXPERT OPIN PHARMACO, V13, P1985, DOI 10.1517/14656566.2012.720974; Howles PN, 2012, J LIPID RES, V53, P2253, DOI 10.1194/jlr.E031823; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Iwayanagi Y, 2011, PHARM RES-DORDR, V28, P405, DOI 10.1007/s11095-010-0294-4; Jeong JH, 2009, EXP MOL MED, V41, P406, DOI 10.3858/emm.2009.41.6.046; Kelly DP, 2012, SCIENCE, V336, P42, DOI 10.1126/science.1221688; Kokkinos PF, 2013, LANCET, V381, P394, DOI 10.1016/S0140-6736(12)61426-3; Kwak HB, 2012, FREE RADICAL BIO MED, V52, P198, DOI 10.1016/j.freeradbiomed.2011.10.449; Labonte ED, 2008, AM J PHYSIOL-GASTR L, V295, pG776, DOI 10.1152/ajpgi.90275.2008; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu JJ, 2013, J DIABETES COMPLICAT; Liu WZ, 2012, J BIOL CHEM, V287, P7213, DOI 10.1074/jbc.M111.286724; Mantzoros CS, 2005, J CLIN ENDOCR METAB, V90, P4542, DOI 10.1210/jc.2005-0372; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Mikus C.R., 2013, J AM COLL CARDIOL, DOI 10.1016/j.jacc.2013.02.074; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rallidis LS, 2012, INT J CARDIOL, V159, P169, DOI 10.1016/j.ijcard.2011.07.048; Rizzo M, 2009, ATHEROSCLEROSIS, V204, P330, DOI 10.1016/j.atherosclerosis.2008.10.005; Roberts MD, 2013, METABOLISM, V62, P1052, DOI 10.1016/j.metabol.2013.02.002; Sathasivam S, 2012, EUR J INTERN MED, V23, P317, DOI 10.1016/j.ejim.2012.01.004; Shetty GK, 2004, DIABETES CARE, V27, P2450, DOI 10.2337/diacare.27.10.2450; Swick AG, 2013, METABOLISM, V62, P1070, DOI 10.1016/j.metabol.2013.02.012; Wang LJ, 2012, BBA-MOL CELL BIOL L, V1821, P964, DOI 10.1016/j.bbalip.2012.03.004	48	92	96	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72858	10.1371/journal.pone.0072858	http://dx.doi.org/10.1371/journal.pone.0072858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023786	gold, Green Submitted, Green Published			2022-12-27	WOS:000324238400030
J	Pessi, G; Braunwalder, R; Grunau, A; Omasits, U; Ahrens, CH; Eberl, L				Pessi, Gabriella; Braunwalder, Rubina; Grunau, Alexander; Omasits, Ulrich; Ahrens, Christian H.; Eberl, Leo			Response of Burkholderia cenocepacia H111 to Micro-Oxia	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA PAO1; DEPENDENT UP-REGULATION; CYSTIC-FIBROSIS; BIOFILM FORMATION; PHYSIOLOGICAL HETEROGENEITY; MASS-SPECTROMETRY; CBB(3) OXIDASE; CEPACIA; STRAINS; PROTEIN	B. cenocepacia is an opportunistic human pathogen that is particularly problematic for patients suffering from cystic fibrosis (CF). In the CF lung bacteria grow to high densities within the viscous mucus that is limited in oxygen. Pseudomonas aeruginosa, the dominant pathogen in CF patients, is known to grow and survive under oxygen-limited to anaerobic conditions by using micro-oxic respiration, denitrification and fermentative pathways. In contrast, inspection of the genome sequences of available B. cenocepacia strains suggested that B. cenocepacia is an obligate aerobic and non-fermenting bacterium. In accordance with the bioinformatics analysis we observed that B. cenocepacia H111 is able to grow with as little as 0.1% O-2 but not under strictly anoxic conditions. Phenotypic analyses revealed that H111 produced larger amounts of biofilm, pellicle and proteases under micro-oxic conditions (0.5%-5% O-2, i.e. conditions that mimic those encountered in CF lung infection), and was more resistant to several antibiotics. RNA-Seq and shotgun proteomics analyses of cultures of B. cenocepacia H111 grown under micro-oxic and aerobic conditions showed up-regulation of genes involved in the synthesis of the exopolysaccharide (EPS) cepacian as well as several proteases, two isocitrate lyases and other genes potentially important for life in micro-oxia. Data deposition: RNA-Seq raw data files are accessible through the GEO Series accession number GSE48585. MS data have been deposited in the ProteomeXchange database (PXD000270).	[Pessi, Gabriella; Braunwalder, Rubina; Grunau, Alexander; Eberl, Leo] Univ Zurich, Dept Microbiol, Zurich, Switzerland; [Omasits, Ulrich; Ahrens, Christian H.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich; University of Zurich	Pessi, G (corresponding author), Univ Zurich, Dept Microbiol, Zurich, Switzerland.	gabriella.pessi@botinst.uzh.ch	Pessi, Gabriella/AGW-2342-2022; Eberl, Leo/A-8380-2012; Ahrens, Christian H./F-4656-2011; Eberl, Leo/AAE-8165-2019	Eberl, Leo/0000-0002-7241-0864; Ahrens, Christian H./0000-0002-8148-7257; Goldmann, Ulrich/0000-0003-1120-6912; Pessi, Gabriella/0000-0002-8138-5541	Swiss National Science Foundation [31003A-143773]; Swiss SystemsX.ch initiative [IPP 2011/121]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss SystemsX.ch initiative	This work was financially supported by the Swiss National Science Foundation (Project 31003A-143773) to LE and the Swiss SystemsX.ch initiative (grant IPP 2011/121) to CHA and LE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoli K, 2012, MOL MICROBIOL, V83, P362, DOI 10.1111/j.1365-2958.2011.07937.x; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; BAYER AS, 1990, INFECT IMMUN, V58, P1344, DOI 10.1128/IAI.58.5.1344-1349.1990; Burns JL, 2007, ANTIBIOTIC RESISTANC; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Comolli JC, 2004, MOL MICROBIOL, V51, P1193, DOI 10.1046/j.1365-2958.2003.03904.x; Cosseau C, 2004, ARCH MICROBIOL, V181, P89, DOI 10.1007/s00203-003-0641-5; Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710; Doring G, 2011, FEMS MICROBIOL REV, V35, P124, DOI 10.1111/j.1574-6976.2010.00237.x; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Ferreira AS, 2010, APPL ENVIRON MICROB, V76, P441, DOI 10.1128/AEM.01828-09; GALIMAND M, 1991, J BACTERIOL, V173, P1598, DOI 10.1128/jb.173.5.1598-1606.1991; Geisenberger O, 2000, FEMS MICROBIOL LETT, V184, P273, DOI 10.1111/j.1574-6968.2000.tb09026.x; Gotschlich A, 2001, SYST APPL MICROBIOL, V24, P1, DOI 10.1078/0723-2020-00013; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Herasimenka Y, 2007, J CYST FIBROS, V6, P145, DOI 10.1016/j.jcf.2006.06.004; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Inhulsen S, 2012, MICROBIOLOGYOPEN, V1, P225, DOI 10.1002/mbo3.24; Kristensen DB, 2004, MOL CELL PROTEOMICS, V3, P1023, DOI 10.1074/mcp.T400004-MCP200; Leitao JH, 1997, RES MICROBIOL, V148, P37, DOI 10.1016/S0923-2508(97)81898-0; LEITAO JH, 1993, J GEN MICROBIOL, V139, P441, DOI 10.1099/00221287-139-3-441; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; LIPUMA JJ, 1990, LANCET, V336, P1094, DOI 10.1016/0140-6736(90)92571-X; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Modis K, 2013, INT J MOL MED, V31, P437, DOI 10.3892/ijmm.2012.1203; MUIR ME, 1984, J GEN MICROBIOL, V130, P2015; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Pett-Ridge J, 2005, APPL ENVIRON MICROB, V71, P6998, DOI 10.1128/AEM.71.11.6998-7007.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitcher RS, 2002, BIOCHEM SOC T, V30, P653, DOI 10.1042/bst0300653; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qeli E, 2010, NAT BIOTECHNOL, V28, P647, DOI 10.1038/nbt0710-647; ROMLING U, 1994, J INFECT DIS, V170, P1616, DOI 10.1093/infdis/170.6.1616; Sabra W, 2002, MICROBIOL-SGM, V148, P3195, DOI 10.1099/00221287-148-10-3195; Sass AM, 2013, ISME J, DOI [10.1038/ismej.2013.1036, DOI 10.1038/ISMEJ.2013.1036]; Savoia D, 2007, CURR MICROBIOL, V54, P440, DOI 10.1007/s00284-006-0601-9; SAWERS RG, 1991, MOL MICROBIOL, V5, P1469, DOI 10.1111/j.1365-2958.1991.tb00793.x; Schmid N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049966; Schobert M, 2010, INT J MED MICROBIOL, V300, P549, DOI 10.1016/j.ijmm.2010.08.007; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; STACHEL SE, 1985, EMBO J, V4, P891, DOI 10.1002/j.1460-2075.1985.tb03715.x; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Tandhavanant S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-303; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Van Acker H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058943; VANDERWAUVEN C, 1984, J BACTERIOL, V160, P928, DOI 10.1128/JB.160.3.928-934.1984; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Wongwanich Siripan, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P111; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; Yang L, 2011, ENVIRON MICROBIOL, V13, P1682, DOI 10.1111/j.1462-2920.2011.02459.x; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	64	36	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72939	10.1371/journal.pone.0072939	http://dx.doi.org/10.1371/journal.pone.0072939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023794	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000324238400036
J	Brunye, TT; Hayes, JF; Mahoney, CR; Gardony, AL; Taylor, HA; Kanarek, RB				Brunye, Tad T.; Hayes, Jackie F.; Mahoney, Caroline R.; Gardony, Aaron L.; Taylor, Holly A.; Kanarek, Robin B.			Get in My Belly: Food Preferences Trigger Approach and Avoidant Postural Asymmetries	PLOS ONE			English	Article							SELECTIVE ATTENTION; DRUG-ADDICTION; HEDONIC IMPACT; EMOTION; REWARD; BRAIN; RESPONSES; PICTURES; STIMULI; HUNGER	Appetitive motivational states are fundamental neural and behavioral mechanisms underlying healthy and abnormal eating behavior, though their dynamic influence on food-related behavior is unknown. The present study examined whether personal food-related preferences would activate approach and avoidance systems, modulating spontaneous postural sway toward and away from food items. Participants stood on a balance board that collected real-time data regarding postural sway along two axes (x, y) while they viewed a series of images depicting food items varying in nutritional value and individual preferences. Overall, participants showed reliable postural sway toward highly preferred and away from highly non-preferred items. This effect became more pronounced over time; sway along the mediolateral axis showed no reliable variation by preference. Results carry implications for two-factor (homeostatic versus hedonic) neurobehavioral theories of hunger and appetitive motivation, and carry applied clinical implications for the measurement and management of abnormal eating behavior.	[Brunye, Tad T.; Hayes, Jackie F.; Mahoney, Caroline R.; Gardony, Aaron L.; Taylor, Holly A.; Kanarek, Robin B.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Kanarek, Robin B.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Brunye, Tad T.; Hayes, Jackie F.; Mahoney, Caroline R.; Gardony, Aaron L.] US Army Natick Soldier Res, Ctr Dev & Engn, Natick, MA USA	Tufts University; Tufts University; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM)	Brunye, TT (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	tbrunye@alumni.tufts.edu		Hayes, Jacqueline/0000-0002-6241-1839; Brunye, Tad/0000-0002-8788-8764	United States Army [W911QY-09-C-0219]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007456] Funding Source: NIH RePORTER	United States Army(United States Department of DefenseUnited States Army); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Parts of this work were supported by United States Army contract #W911QY-09-C-0219 to author HAT. The opinions expressed herein are those of the authors and not necessarily of the United States Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; [Anonymous], AM SOC BIOMECH; Azevedo TM, 2005, PSYCHOPHYSIOLOGY, V42, P255, DOI 10.1111/j.1469-8986.2005.00287.x; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berthoud HR, 2007, PHYSIOL BEHAV, V91, P486, DOI 10.1016/j.physbeh.2006.12.016; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; Cardello AV, 2005, APPETITE, V44, P1, DOI 10.1016/j.appet.2004.05.007; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; CHANNON S, 1990, INT J EAT DISORDER, V9, P447, DOI 10.1002/1098-108X(199007)9:4&lt;447::AID-EAT2260090411&gt;3.0.CO;2-0; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Damasio A.R., 2005, DESCARTES ERROR EMOT; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DelParigi A, 2007, INT J OBESITY, V31, P440, DOI 10.1038/sj.ijo.0803431; Duarte M, 1999, MOTOR CONTROL, V3, P12, DOI 10.1123/mcj.3.1.12; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Facchinetti LD, 2006, NEUROSCI LETT, V410, P52, DOI 10.1016/j.neulet.2006.09.063; Ford BQ, 2010, PSYCHOL SCI, V21, P1098, DOI 10.1177/0956797610375450; Forster J, 2003, EUR J SOC PSYCHOL, V33, P339, DOI 10.1002/ejsp.150; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Frijda NH, 2009, EMOT REV, V1, P264, DOI 10.1177/1754073909103595; Gable P, 2008, PSYCHOPHYSIOLOGY, V45, P275, DOI 10.1111/j.1469-8986.2007.00627.x; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Harmon-Jones E, 2011, PSYCHOL BULL, V137, P508, DOI 10.1037/a0022744; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; HARMONJONES E, EMOT REV; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Hillman CH, 2004, BIOL PSYCHOL, V66, P51, DOI 10.1016/j.biopsycho.2003.07.005; Johnston Craig A, 2007, Curr Atheroscler Rep, V9, P448, DOI 10.1007/s11883-007-0060-1; Kemps E, 2013, J EXP PSYCHOL-APPL, V19, P30, DOI 10.1037/a0031626; Kringelbach ML, 2004, NEUROSCIENCE, V126, P807, DOI 10.1016/j.neuroscience.2004.04.035; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lang PJ, 2000, J SPORT EXERCISE PSY, V22, pS122, DOI 10.1123/jsep.22.s1.s122; Lattimore Paul, 2004, Eat Behav, V5, P315, DOI 10.1016/j.eatbeh.2004.04.009; Lowe MR, 2007, PHYSIOL BEHAV, V91, P432, DOI 10.1016/j.physbeh.2007.04.006; Lowe MR, 2005, OBES RES, V13, P797, DOI 10.1038/oby.2005.90; Maxwell JS, 2007, PSYCHOL SCI, V18, P1113, DOI 10.1111/j.1467-9280.2007.02033.x; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; Mogg K, 1998, BEHAV RES THER, V36, P227, DOI 10.1016/S0005-7967(97)00062-4; Murray EA, 2007, ANN NY ACAD SCI, V1121, P273, DOI 10.1196/annals.1401.021; Naugle KM, 2010, J BIOMECH, V43, P3099, DOI 10.1016/j.jbiomech.2010.08.008; Norgren R, 2006, PHYSIOL BEHAV, V89, P531, DOI 10.1016/j.physbeh.2006.05.024; NORMAN GJ, 2011, OXFORD HDB SOCIAL NE, P164; OVERDUIN J, 1995, INT J EAT DISORDER, V18, P277, DOI 10.1002/1098-108X(199511)18:3&lt;277::AID-EAT2260180310&gt;3.0.CO;2-3; Papies EK, 2008, PERS SOC PSYCHOL B, V34, P1290, DOI 10.1177/0146167208320063; Pecina S, 2005, J NEUROSCI, V25, P11777, DOI 10.1523/JNEUROSCI.2329-05.2005; Pinel JPJ, 2000, AM PSYCHOL, V55, P1105, DOI 10.1037//0003-066X.55.10.1105; Price TF, 2012, BIOL PSYCHOL, V90, P211, DOI 10.1016/j.biopsycho.2012.04.001; Price TF, 2011, PSYCHOPHYSIOLOGY, V48, P718, DOI 10.1111/j.1469-8986.2010.01127.x; RISKIND J H, 1982, Motivation and Emotion, V6, P273, DOI 10.1007/BF00992249; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Sedikides C., 2011, HDB SELF ENHANCEMENT, P23; Seibt B, 2007, EUR J SOC PSYCHOL, V37, P359, DOI 10.1002/ejsp.365; Speakman JR, 2004, J NUTR, V134, p2090S, DOI 10.1093/jn/134.8.2090S; Stins JF, 2011, EXP BRAIN RES, V212, P603, DOI 10.1007/s00221-011-2767-z; Stins JF, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-83; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Todorovic A, 2012, J NEUROSCI, V32, P13389, DOI 10.1523/JNEUROSCI.2227-12.2012; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 2011, NEURON, V69, P599, DOI 10.1016/j.neuron.2011.01.027; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wilbertz G, 2012, NEUROIMAGE, V60, P353, DOI 10.1016/j.neuroimage.2011.12.011; Woods SC, 2000, ANNU REV PSYCHOL, V51, P255, DOI 10.1146/annurev.psych.51.1.255; Yeomans MR, 2004, BRIT J NUTR, V92, pS3, DOI 10.1079/BJN20041134	73	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72432	10.1371/journal.pone.0072432	http://dx.doi.org/10.1371/journal.pone.0072432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211BX	24023618	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200013
J	Lambers, C; Roth, M; Zhong, J; Campregher, C; Binder, P; Burian, B; Petkov, V; Block, LH				Lambers, Christopher; Roth, Michael; Zhong, Jun; Campregher, Christoph; Binder, Petra; Burian, Bernhard; Petkov, Ventzislav; Block, Lutz-Henning			The Interaction of Endothelin-1 and TGF-beta 1 Mediates Vascular Cell Remodeling	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; SMOOTH-MUSCLE-CELLS; HUMAN LUNG FIBROBLASTS; TISSUE GROWTH-FACTOR; EXTRACELLULAR-MATRIX; ETA-RECEPTOR; MAP KINASES; CROSS-TALK; PROLIFERATION; DISEASE	Background: Pulmonary arterial hypertension is characterized by increased thickness of pulmonary vessel walls due to both increased proliferation of pulmonary arterial smooth muscle cell (PASMC) and deposition of extracellular matrix. In patients suffering from pulmonary arterial hypertension, endothelin-1 (ET-1) synthesis is up-regulated and may increase PASMC activity and vessel wall remodeling through transforming growth factor beta-1 (TGF-beta 1) and connective tissue growth factor. Objective: To assess the signaling pathway leading to ET-1 induced proliferation and extracellular matrix deposition by human PASMC. Methods: PASMC were serum starved for 24 hours before stimulation with either ET-1 and/or TGF-beta 1. ET-1 was inhibited by Bosentan, ERK1/2 mitogen activated protein kinase (MAPK) was inhibited by U0126 and p38 MAPK was inhibited by SB203580. Results: ET-1 increased PASMC proliferation when combined with serum. This effect involved the mitogen activated protein kinases (MAPK) ERK1/2 MAPK and was abrogated by Bosentan which caused a G1- arrest through activation of p27((Kip)). Regarding the contribution of extracellular matrix deposition in vessel wall remodeling, TGF-beta 1 increased the deposition of collagen type-I and fibronectin, which was further increased when ET-1 was added mainly through ERK1/2 MAPK. In contrast, collagen type-IV was not affected by ET-1. Bosentan dose-dependently reduced the stimulatory effect of ET-1 on collagen type-I and fibronectin, but had no effect on TGF-beta 1. Conclusion and Clinical Relevance: ET-1 alone does not induce PASMC proliferation and extracellular matrix deposition. However, ET-1 significantly up-regulates serum induced proliferation and TGF-beta 1 induced extracellular matrix deposition, specifically of collagen type-I and fibronectin. The synergistic effects of ET-1 on serum and TGF-beta 1 involve ERK1/2 MAPK and may thus present a novel mode of action in the pathogenesis of pulmonary arterial hypertension.	[Lambers, Christopher; Binder, Petra; Burian, Bernhard; Petkov, Ventzislav; Block, Lutz-Henning] Med Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, Austria; [Roth, Michael; Zhong, Jun] Univ Basel, Univ Hosp, Dept Biomed Internal Med, Basel, Switzerland; [Campregher, Christoph] Med Univ Vienna, Dept Med, Div Gastroenterol & Hepatol, Christian Doppler Lab Mol Canc Chemoprevent, Vienna, Austria	Medical University of Vienna; University of Basel; Medical University of Vienna	Block, LH (corresponding author), Med Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, Austria.	lutz-henning.block@meduniwien.ac.at	Roth, Michael/H-8657-2019	Roth, Michael/0000-0002-8139-2821	Actelion Pharmaceuticals; G & J Bangerter-Rhyner Stiftung [8427/HEG-DSV]	Actelion Pharmaceuticals; G & J Bangerter-Rhyner Stiftung	This study was supported by an unrestricted grant of Actelion Pharmaceuticals to L.-H. B. and by an unrestricted research grant by the G & J Bangerter-Rhyner Stiftung (#8427/HEG-DSV) to M. R. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbera JA, 2009, DRUGS, V69, P1153, DOI 10.2165/00003495-200969090-00002; Budd DC, 2012, PHARMACOL THERAPEUT, V135, P279, DOI 10.1016/j.pharmthera.2012.06.001; Castro C, 2003, J BIOL CHEM, V278, P4482, DOI 10.1074/jbc.M204716200; Choudhary G, 2011, J HEART LUNG TRANSPL, V30, P827, DOI 10.1016/j.healun.2011.03.010; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; Deacon K, 2010, J BIOL CHEM, V285, P25913, DOI 10.1074/jbc.M110.139485; Dorfmuller P, 2003, SARCOIDOSIS VASC DIF, V20, P9; Egito EST, 2003, PATHOL RES PRACT, V199, P521, DOI 10.1078/0344-0338-00457; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Fouty BW, 2001, AM J RESP CELL MOL, V25, P652, DOI 10.1165/ajrcmb.25.5.4592; FUKURODA T, 1994, J APPL PHYSIOL, V76, P1976, DOI 10.1152/jappl.1994.76.5.1976; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Gallelli L, 2005, J CELL BIOCHEM, V96, P858, DOI 10.1002/jcb.20608; Goulet S, 2007, J CELL PHYSIOL, V210, P167, DOI 10.1002/jcp.20836; Horstmeyer A, 2005, FEBS J, V272, P6297, DOI 10.1111/j.1742-4658.2005.05016.x; Humbert M, 2008, VASC PHARMACOL, V49, P113, DOI 10.1016/j.vph.2008.06.003; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Jonigk D, 2011, AM J PATHOL, V179, P167, DOI 10.1016/j.ajpath.2011.03.040; Lambers C, 2010, INT J CLIN PHARM TH, V48, P419; Li M, 2005, J NANOSCI NANOTECHNO, V5, P1809, DOI 10.1166/jnn.2005.436; Liu AJ, 2011, CHINESE MED J-PEKING, V124, P3098, DOI 10.3760/cma.j.issn.0366-6999.2011.19.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma WL, 2011, J CLIN INVEST, V121, P4548, DOI 10.1172/JCI57734; Olenych SG, 2005, BIOMACROMOLECULES, V6, P3252, DOI 10.1021/bm050298r; Panettieri RA, 1996, BRIT J PHARMACOL, V118, P191, DOI 10.1111/j.1476-5381.1996.tb15385.x; Rodriguez-Vita J, 2005, CIRC RES, V97, P125, DOI 10.1161/01.RES.0000174614.74469.83; Rubens C, 2001, CHEST, V120, P1562, DOI 10.1378/chest.120.5.1562; Schiffrin EL, 1998, J CARDIOVASC PHARM, V32, pS2; Tabima DM, 2012, J BIOMECH, V45, P799, DOI 10.1016/j.jbiomech.2011.11.020; Wei L, 2012, AM J PHYSIOL-LUNG C, V302, pL1273, DOI 10.1152/ajplung.00082.2012; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; West J, 2010, ADV EXP MED BIOL, V661, P265, DOI 10.1007/978-1-60761-500-2_17; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang JQ, 2008, AM J RESP CELL MOL, V38, P414, DOI 10.1165/rcmb.2007-0079OC; Yang ZH, 1999, CIRCULATION, V100, P5, DOI 10.1161/01.CIR.100.1.5; Yogi A, 2007, ARTERIOSCL THROM VAS, V27, P1960, DOI 10.1161/ATVBAHA.107.146746	38	31	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73399	10.1371/journal.pone.0073399	http://dx.doi.org/10.1371/journal.pone.0073399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015303	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800098
J	Shajib, MS; Wang, HQ; Kim, JJ; Sunjic, I; Ghia, JE; Denou, E; Collins, M; Denburg, JA; Khan, WI				Shajib, Md. Sharif; Wang, Huaqing; Kim, Janice J.; Sunjic, Ivana; Ghia, Jean-Eric; Denou, Emmanuel; Collins, Matthew; Denburg, Judah A.; Khan, Waliul I.			Interleukin 13 and Serotonin: Linking the Immune and Endocrine Systems in Murine Models of Intestinal Inflammation	PLOS ONE			English	Article							NK-T-CELLS; ULCERATIVE-COLITIS; ENTEROCHROMAFFIN CELL; OXAZOLONE COLITIS; BOWEL-DISEASE; IL-13; RESPONSES; SULFATE; MUCOSA; MICE	Objective: Infiltration of activated immune cells and increased cytokine production define the immunophenotype of gastrointestinal (GI) inflammation. In addition, intestinal inflammation is accompanied by alteration in the numbers of serotonin (5-hydroxytryptamine; 5-HT) synthesizing enterochromaffin (EC) cells and in 5-HT amount. It has been established that EC cells express interleukin (IL)-13 receptor, additionally IL-13 has been implicated in the pathogenesis of ulcerative colitis. In this study, we investigated the role of IL-13 mediated 5-HT signaling in pathogenesis of colitis. Methodology: Colitis was induced in IL-13 deficient (IL-13-/-) and wild-type (WT) mice with dextran sulfate sodium (DSS) and dinitrobenzene sulfonic acid (DNBS), as well as in IL-13-/- mice given recombinant mouse IL-13 (rmIL-13) and 5-hydroxytryptamine (5-HTP), the direct precursor of 5-HT. Principal Findings and Conclusion: Elevated colonic IL-13 levels were observed in WT mice receiving DSS in comparison to control. IL-13-/- mice administered DSS exhibited significantly reduced severity of colitis compared to WT mice as reflected by macroscopic and histological damage assessments. Following DSS administration, significantly lower pro-inflammatory cytokine production and fewer infiltrating macrophages were observed in IL-13-/- mice compared to WT. The reduced severity of colitis observed in IL-13-/- mice was also accompanied by down-regulation of EC cell numbers and colonic 5-HT content. In addition, increasing colonic 5-HT content by administration of rmIL-13 or 5-HTP exacerbated severity of DSS colitis in IL-13-/- mice. IL-13-/- mice also exhibited reduced severity of DNBS-induced colitis. These results demonstrate that IL-13 plays a critical role in the pathogenesis of experimental colitis and 5-HT is an important mediator of IL-13 driven intestinal inflammation. This study revealed important information on immune-endocrine axis in gut in relation to inflammation which may ultimately lead to better strategy in managing various intestinal inflammatory conditions including inflammatory bowel disease.	[Shajib, Md. Sharif; Wang, Huaqing; Kim, Janice J.; Sunjic, Ivana; Collins, Matthew; Khan, Waliul I.] Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Shajib, Md. Sharif; Wang, Huaqing; Kim, Janice J.; Sunjic, Ivana; Denou, Emmanuel; Collins, Matthew; Khan, Waliul I.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Ghia, Jean-Eric] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Denou, Emmanuel; Denburg, Judah A.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Khan, Waliul I.] Hamilton Hlth Sci, Hamilton Reg Lab Med Program, Hamilton, ON, Canada	McMaster University; McMaster University; University of Manitoba; McMaster University; McMaster University	Khan, WI (corresponding author), Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.	khanwal@mcmaster.ca		Ghia, Jean-Eric/0000-0002-3018-9719; Kim, Janice/0000-0001-5096-4068	Canadian Institutes of Health Research (CIHR); Crohn's and Colitis Foundation of Canada (CCFC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada (CCFC)	This work is funded by Canadian Institutes of Health Research (CIHR) and by Crohn's and Colitis Foundation of Canada (CCFC) grants awarded to Dr. Waliul I. Khan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamias G, 2011, DISCOV MED, V11, P459; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; COOPER HS, 1993, LAB INVEST, V69, P238; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Khan WI, 2006, AM J PHYSIOL-GASTR L, V291, pG803, DOI 10.1152/ajpgi.00069.2006; Khan WI, 2010, CLIN EXP IMMUNOL, V161, P19, DOI 10.1111/j.1365-2249.2010.04150.x; Khan WI, 2002, INFECT IMMUN, V70, P5931, DOI 10.1128/IAI.70.11.5931-5937.2002; Kim J.J., 2012, J VISUALIZED EXPT, V60; Kim JJ, 2013, J IMMUNOL, V190, P4795, DOI 10.4049/jimmunol.1201887; Kiser D, 2012, NEUROSCI BIOBEHAV R, V36, P786, DOI 10.1016/j.neubiorev.2011.12.009; Li N, 2011, AM J PATHOL, V178, P662, DOI 10.1016/j.ajpath.2010.10.028; Linden DR, 2003, AM J PHYSIOL-GASTR L, V285, pG207, DOI 10.1152/ajpgi.00488.2002; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mannon PJ, 2011, GUT, V60, P449, DOI 10.1136/gut.2010.226860; Manocha M, 2013, MUCOSAL IMMUNOL, V6, P146, DOI 10.1038/mi.2012.58; Manocha MM, 2012, CLIN TRANSLATIONAL G, V3, pe13; Matos I, 2013, MOL IMMUNOL, V54, P482, DOI 10.1016/j.molimm.2013.01.018; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; Mentink-Kane MM, 2004, IMMUNOL REV, V202, P191, DOI 10.1111/j.0105-2896.2004.00210.x; Miller L.J., 1999, TXB GASTROENTEROLOGY, P35; Motomura Y, 2008, GUT, V57, P475, DOI 10.1136/gut.2007.129296; Nelson DL, 2006, ENDOCRINE, V29, P49, DOI 10.1385/ENDO:29:1:49; Oshima S, 1999, HISTOCHEM CELL BIOL, V112, P257, DOI 10.1007/s004180050445; Qiu BS, 1999, NAT MED, V5, P1178, DOI 10.1038/13503; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Thoreson R, 2007, SURG CLIN N AM, V87, P575, DOI 10.1016/j.suc.2007.03.001; Wang HQ, 2007, GUT, V56, P949, DOI 10.1136/gut.2006.103226; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yang GB, 2004, J NEUROIMMUNOL, V146, P46, DOI 10.1016/j.jneuroim.2003.10.044	34	39	40	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72774	10.1371/journal.pone.0072774	http://dx.doi.org/10.1371/journal.pone.0072774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015275	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800079
J	Abaid, N; Cappa, P; Palermo, E; Petrarca, M; Porfiri, M				Abaid, Nicole; Cappa, Paolo; Palermo, Eduardo; Petrarca, Maurizio; Porfiri, Maurizio			Gait Detection in Children with and without Hemiplegia Using Single-Axis Wearable Gyroscopes	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; ELECTRICAL-STIMULATION; EVENT DETECTION; WALKING; DISCRIMINATION; REHABILITATION; ANKLE	In this work, we develop a novel gait phase detection algorithm based on a hidden Markov model, which uses data from foot-mounted single-axis gyroscopes as input. We explore whether the proposed gait detection algorithm can generate equivalent results as a reference signal provided by force sensitive resistors (FSRs) for typically developing children (TD) and children with hemiplegia (HC). We find that the algorithm faithfully reproduces reference results in terms of high values of sensitivity and specificity with respect to FSR signals. In addition, the algorithm distinguishes between TD and HC and is able to assess the level of gait ability in patients. Finally, we show that the algorithm can be adapted to enable real-time processing with high accuracy. Due to the small, inexpensive nature of gyroscopes utilized in this study and the ease of implementation of the developed algorithm, this work finds application in the on-going development of active orthoses designed for therapy and locomotion in children with gait pathologies.	[Abaid, Nicole] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA; [Cappa, Paolo; Palermo, Eduardo] Univ Roma La Sapienza, Dept Mech & Aerosp Engn, I-00185 Rome, Italy; [Cappa, Paolo; Palermo, Eduardo; Petrarca, Maurizio] Bambino Gesu Pediat Hosp, Dept Neurosci & Neurorehabil, MARlab Movement Anal & Robot Lab, Rome, Italy; [Porfiri, Maurizio] New York Univ, Polytech Inst, Dept Mech & Aerosp Engn, Brooklyn, NY USA	Virginia Polytechnic Institute & State University; Sapienza University Rome; IRCCS Bambino Gesu; New York University; New York University Tandon School of Engineering	Abaid, N (corresponding author), Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA.	nabaid@vt.edu	Petrarca, Maurizio/B-4181-2019; Petrarca, Maurizio/GWZ-3714-2022; Palermo, Eduardo/AAX-8426-2021	Petrarca, Maurizio/0000-0002-7330-3569; Palermo, Eduardo/0000-0002-3213-8261; Cappa, Paolo/0000-0002-4898-9589; Porfiri, Maurizio/0000-0002-1480-3539	Italian Health Ministry; Italian Institute of Technology; "Sapienza" University of Rome	Italian Health Ministry(Ministry of Health, Italy); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); "Sapienza" University of Rome	This work was supported by a grant from the Italian Health Ministry (Grant 2009 'Pilot study on a novel typology of medical devices: exoskeleton for pediatric rehabilitation', PC) and a grant from the Italian Institute of Technology (Project Seed 2009 'ITINERE - Interactive Technology: an Instrumented Novel Exoskeleton for REhabilitation', PC). Nicole Abaid gratefully acknowledges the support of "Sapienza" University of Rome through a didactic fellowship in academic year 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NB, 2005, CLEV CLIN J MED, V72, P586, DOI 10.3949/ccjm.72.7.586; Aminian K, 2002, J BIOMECH, V35, P689, DOI 10.1016/S0021-9290(02)00008-8; Andersen JB, 2003, IEEE T BIO-MED ENG, V50, P1208, DOI 10.1109/TBME.2003.816073; Bae J, 2011, MECHATRONICS, V21, P961, DOI 10.1016/j.mechatronics.2011.03.003; Bamberg SJM, 2008, IEEE T INF TECHNOL B, V12, P413, DOI 10.1109/TITB.2007.899493; Banala SK, 2009, IEEE T NEUR SYS REH, V17, P2, DOI 10.1109/TNSRE.2008.2008280; Ceccato JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008193; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; Chen M, 2008, IEEE INT CONF ROBOT, P2019, DOI 10.1109/ROBOT.2008.4543503; Dalton A, 2013, GAIT POSTURE, V37, P49, DOI 10.1016/j.gaitpost.2012.05.028; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Durham S., 2004, PHYSIOTHERAPY, V90, P82, DOI DOI 10.1016/j.physio.2004.02.003; Gonzalez RC, 2010, GAIT POSTURE, V31, P322, DOI 10.1016/j.gaitpost.2009.11.014; Hanlon M, 2009, GAIT POSTURE, V30, P523, DOI 10.1016/j.gaitpost.2009.07.128; Hansen M, 2004, IEEE T NEUR SYS REH, V12, P81, DOI 10.1109/TNSRE.2003.819890; Holt RL, 2011, PEDIATR NEUROL, V44, P239, DOI 10.1016/j.pediatrneurol.2010.11.009; Klucken J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056956; Lee H, 2011, J BIOMECH, V44, P1901, DOI 10.1016/j.jbiomech.2011.04.028; Lee JK, 2011, MED BIOL ENG COMPUT, V49, P707, DOI 10.1007/s11517-011-0736-0; Lopez-Meyer P, 2011, IEEE T INF TECHNOL B, V15, P594, DOI 10.1109/TITB.2011.2112773; Mannini A, 2012, GAIT POSTURE, V36, P657, DOI 10.1016/j.gaitpost.2012.06.017; Mannini A, 2011, IEEE ENG MED BIO, P4369, DOI 10.1109/IEMBS.2011.6091084; Mannini A, 2010, SENSORS-BASEL, V10, P1154, DOI 10.3390/s100201154; McGregor SJ, 2009, CHAOS, V19, DOI 10.1063/1.3147423; Mickey R., 2004, APPL STAT ANAL VARIA; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Panahandeh G, 2013, IEEE T INSTRUM MEAS, V62, P1073, DOI 10.1109/TIM.2012.2236792; Pastor PN, 2009, FUNCTIONAL DIFFICULT; Petrarca M, 2011, EUR J PHYS REHAB MED, V47, P35; Pfau T, 2008, J BIOMECH, V41, P216, DOI 10.1016/j.jbiomech.2007.08.004; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rueterbories J, 2013, GAIT POSTURE, V37, P183, DOI 10.1016/j.gaitpost.2012.06.029; Rushton DN, 2003, MED ENG PHYS, V25, P75, DOI 10.1016/S1350-4533(02)00040-1; Sipahi R, 2011, IEEE CONTR SYST MAG, V31, P38, DOI 10.1109/MCS.2010.939135; Skelly MM, 2001, IEEE T NEUR SYS REH, V9, P59, DOI 10.1109/7333.918277; Smith BT, 2002, IEEE T NEUR SYS REH, V10, P22, DOI 10.1109/TNSRE.2002.1021583; Spittle AJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub2; Venkat I, 2011, INT J COMPUT VISION, V91, P7, DOI 10.1007/s11263-010-0362-6; Wilson AD, 1999, IEEE T PATTERN ANAL, V21, P884, DOI 10.1109/34.790429; Xu YF, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000955; Zwick EB, 2004, GAIT POSTURE, V20, P273, DOI 10.1016/j.gaitpost.2003.10.002	41	57	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73152	10.1371/journal.pone.0073152	http://dx.doi.org/10.1371/journal.pone.0073152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023825	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600074
J	Gan, XT; Zhao, GJ; Huang, CX; Rowe, AC; Purdham, DM; Karmazyn, M				Gan, Xiaohong Tracey; Zhao, Ganjian; Huang, Cathy X.; Rowe, Adrianna C.; Purdham, Daniel M.; Karmazyn, Morris			Identification of Fat Mass and Obesity Associated (FTO) Protein Expression in Cardiomyocytes: Regulation by Leptin and Its Contribution to Leptin-Induced Hypertrophy	PLOS ONE			English	Article							ADULT OBESITY; FOOD-INTAKE; GENE; HEART; CHILDHOOD; TARGET	The recently-identified fat mass and obesity-associated (FTO) protein is associated with various physiological functions including energy and body weight regulation. Ubiquitously expressed, FTO was identified in heart homogenates although its function is unknown. We studied whether FTO is specifically expressed within the cardiac myocyte and its potential role pertaining to the hypertrophic effect of the adipokine leptin. Most experiments were performed using cultured neonatal rat cardiomyocytes which showed nuclei-specific FTO expression. Leptin significantly increased FTO expression which was associated with myocyte hypertrophy although both events were abrogated by FTO knockdown with siRNA. Administration of a leptin receptor antibody to either normal or obese rats significant reduced myocardial FTO protein expression. Responses in cardiomyocytes were accompanied by JAK2/STAT3 activation whereas JAK2/STAT3 inhibition abolished these effects. Expression of the cut-like homeobox 1(CUX1) transcriptional factor was significantly increased by leptin although this was restricted to the cathepsin L-dependent, proteolytically-derived shorter p110CUX1 isoform whereas the longer p200CUX1 protein was not significantly affected. Cathepsin L expression and activity were both significantly increased by leptin whereas a cathepsin L peptide inhibitor or siRNA specific for CUX1 completely prevented the leptin-induced increase in FTO expression. The cathepsin L peptide inhibitor or siRNA-induced knockdown of either CUX1 or FTO abrogated the hypertrophic response to leptin. Two other pro-hypertrophic factors, endothelin-1 or angiotensin II had no effect on FTO expression and FTO knockdown did not alter the hypertrophic response to either agent. This study demonstrates leptin-induced FTO upregulation in cardiomyocytes via JAK2/STAT3-dependent CUX1 upregulation and suggests an FTO regulatory function of leptin. It also demonstrates for the first time a functional role of FTO in the cardiomyocyte.	[Gan, Xiaohong Tracey; Zhao, Ganjian; Huang, Cathy X.; Rowe, Adrianna C.; Purdham, Daniel M.; Karmazyn, Morris] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario)	Karmazyn, M (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	Morris.Karmazyn@schulich.uwo.ca			Canadian Institutes of Health Research [62764]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant # 62764 from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). M. Karmazyn holds a Tier 1 Canada Research Chair in Experimental Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2010, AM HEART J, V160, P1163, DOI 10.1016/j.ahj.2010.08.002; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hou N, 2011, CLIN EXP PHARMACOL P, V38, P905, DOI 10.1111/j.1440-1681.2011.05619.x; Hulea L, GENE, V497, P18; Karmazyn M, 2008, CARDIOVASC RES, V79, P279, DOI 10.1093/cvr/cvn115; Karmazyn M, 2007, TRENDS CARDIOVAS MED, V17, P206, DOI 10.1016/j.tcm.2007.06.001; Larder R, 2011, TRENDS ENDOCRIN MET, V22, P53, DOI 10.1016/j.tem.2010.11.001; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Martinez-Abundis E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041612; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Purdham DM, 2008, AM J PHYSIOL-HEART C, V295, pH441, DOI 10.1152/ajpheart.91537.2007; Rajapurohitam V, 2012, CELL SIGNAL, V24, P2283, DOI 10.1016/j.cellsig.2012.07.025; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Sweeney G, 2010, NAT REV CARDIOL, V7, P22, DOI 10.1038/nrcardio.2009.224; Tung YCL, 2011, ANN NY ACAD SCI, V1220, P162, DOI 10.1111/j.1749-6632.2010.05903.x; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Villanueva EC, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.232; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; Wauman J, 2011, FRONT BIOSCI-LANDMRK, V16, P2771, DOI 10.2741/3885	26	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74235	10.1371/journal.pone.0074235	http://dx.doi.org/10.1371/journal.pone.0074235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019958	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200101
J	Kelly, MA; Zieba, AP; Buttemer, WA; Hulbert, AJ				Kelly, Megan A.; Zieba, Adam P.; Buttemer, William A.; Hulbert, A. J.			Effect of Temperature on the Rate of Ageing: An Experimental Study of the Blowfly Calliphora stygia	PLOS ONE			English	Article							LIFE-SPAN; METABOLIC-RATE; DIETARY-RESTRICTION; MORTALITY-RATES; DROSOPHILA-MELANOGASTER; FUNCTIONAL SENESCENCE; LIPID-PEROXIDATION; AGE PIGMENT; LIPOFUSCIN; LONGEVITY	All organisms age, the rate of which can be measured by demographic analysis of mortality rates. The rate of ageing is thermally sensitive in ectothermic invertebrates and we examined the effects of temperature on both demographic rates of ageing and on cellular senescence in the blowfly, Calliphora stygia. The short lifespan of these flies is advantageous for demographic measurements while their large body size permits individual-based biochemical characterisation. Blowflies maintained at temperatures from 12 degrees C to 34 degrees C had a five to six-fold decrease in maximum and average longevity, respectively. Mortality rates were best described by a two-phase Gompertz relation, which revealed the first-phase of ageing to be much more temperature sensitive than the second stage. Flies held at low temperatures had both a slower first-phase rate of ageing and a delayed onset of second-phase ageing, which significantly extended their longevity compared with those at high temperatures. Blowflies that were transferred from 29 degrees C to 15 degrees C had higher first-phase mortality rates than those of flies held at constant 15 degrees C, but their onset of second-phase ageing was deferred beyond that of flies held constantly at this temperature. The accumulation of fluorescent AGE pigment, a measure of cellular oxidative damage, increased steadily over time in all blowflies, irrespective of the temporal pattern of mortality. Pigment accumulated steadily during periods of 'negligible senescence', as measured by minimal rate of mortality, and the rate of accumulation was significantly affected by temperature. Thus accumulation of AGE pigment is more representative of chronological age than a reflection of biological age or a cause of mortality.	[Kelly, Megan A.; Zieba, Adam P.; Hulbert, A. J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Zieba, Adam P.] Univ Wollongong, Sch Hlth Sci, Wollongong, NSW, Australia; [Buttemer, William A.] Deakin Univ, Ctr Integrat Ecol, Geelong, Vic 3217, Australia	University of Wollongong; University of Wollongong; Deakin University	Kelly, MA (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	maj02@uowmail.edu.au	Buttemer, William A/F-9573-2019; Kelly, Megan/D-6686-2014	Buttemer, William A/0000-0003-3176-4452; Kelly, Megan/0000-0002-0877-126X	Australian Research Council	Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council Grant to AJH and WAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Carens Joseph, 1998, MIGRATION ADMISSIONS, P3; CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; Clancy DJ, 2012, AGEING RES REV, DOI [doi.org/10.1016/j.arr.2012.1003.1011, DOI 10.1016/J.ARR.2012.1003.1011]; Clarke A, 2004, FUNCT ECOL, V18, P243, DOI 10.1111/j.0269-8463.2004.00841.x; CLARKE JM, 1961, J EXP BIOL, V38, P679; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; DEREGGI ML, 1975, EXP GERONTOL, V10, P333, DOI 10.1016/0531-5565(75)90023-6; DONATO H, 1978, EXP GERONTOL, V13, P171, DOI 10.1016/0531-5565(78)90010-4; Ettershank G, 1993, AUSTR J ZOOLOGY, V31, P131; Finch CE, 2009, GERONTOLOGY, V55, P307, DOI 10.1159/000215589; FUKUI HH, 1993, EXP GERONTOL, V28, P585, DOI 10.1016/0531-5565(93)90048-I; Garcia AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000950; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Girardot F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-69; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Haddad LS, 2007, EXP GERONTOL, V42, P601, DOI 10.1016/j.exger.2007.02.008; Hohn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006; Hohn A, 2012, FREE RADICAL BIO MED, V53, P1760, DOI 10.1016/j.freeradbiomed.2012.08.591; Hohn A, 2010, FREE RADICAL BIO MED, V48, P1100, DOI 10.1016/j.freeradbiomed.2010.01.030; Hollingsworth MJ, 1966, EXP GERONTOL, V1, P251, DOI 10.1016/0531-5565(66)90010-6; HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826; Hsu CY, 2009, AGING CELL, V8, P726, DOI 10.1111/j.1474-9726.2009.00525.x; Huey RB, 2011, P NATL ACAD SCI USA, V108, P10377, DOI 10.1073/pnas.1107430108; Hulbert AJ, 2004, EXP GERONTOL, V39, P1137, DOI 10.1016/j.exger.2004.04.006; Jacobson J, 2010, AGING CELL, V9, P466, DOI 10.1111/j.1474-9726.2010.00573.x; Jolly RD, 2002, ARCH GERONTOL GERIAT, V34, P205, DOI 10.1016/S0167-4943(01)00219-9; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Loeb J, 1916, P NATL ACAD SCI USA, V2, P456, DOI 10.1073/pnas.2.8.456; Loeb J, 1917, J BIOL CHEM, V32, P103; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; MCARTHUR MC, 1982, J GERONTOL, V37, P268, DOI 10.1093/geronj/37.3.268; MCCARTER R, 1985, AM J PHYSIOL, V248, pE488; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Melvin RG, 2007, J INSECT PHYSIOL, V53, P1300, DOI 10.1016/j.jinsphys.2007.07.006; Pujol-Lereis LM, 2012, EXP GERONTOL, V47, P465, DOI 10.1016/j.exger.2012.04.001; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Munch SB, 2009, P NATL ACAD SCI USA, V106, P13860, DOI 10.1073/pnas.0900300106; Oudes AJ, 1998, MECH AGEING DEV, V100, P221, DOI 10.1016/S0047-6374(97)00146-2; Pearl R., 1928, RATE LIVING BEING AC; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Promislow DEL, 2002, AGING CELL, V1, P66, DOI 10.1046/j.1474-9728.2002.00009.x; Shahrestani P, 2012, REJUV RES, V15, P49, DOI 10.1089/rej.2011.1201; SHELDAHL JA, 1974, EXP GERONTOL, V9, P33, DOI 10.1016/0531-5565(74)90005-9; Simm A, 2010, EXP GERONTOL, V45, P731, DOI 10.1016/j.exger.2010.08.006; SMITH JM, 1958, J EXP BIOL, V35, P832; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Terman A, 1998, APMIS, V106, P265, DOI 10.1111/j.1699-0463.1998.tb01346.x; Ujvari B, 2009, COMP BIOCHEM PHYS A, V154, P383, DOI 10.1016/j.cbpa.2009.07.012; Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x; Van Voorhies WA, 2003, J APPL PHYSIOL, V95, P2605, DOI 10.1152/japplphysiol.00448.2003; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Ward WF, 2000, BIOGERONTOLOGY, V1, P195, DOI 10.1023/A:1010076818119; Yen K, 2004, EXP GERONTOL, V39, P947, DOI 10.1016/j.exger.2004.03.016; Yen K, 2010, AGE, V32, P39, DOI 10.1007/s11357-009-9110-7; Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X	60	12	14	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73781	10.1371/journal.pone.0073781	http://dx.doi.org/10.1371/journal.pone.0073781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019937	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200080
J	Osborn, M; Rustom, N; Clarke, M; Litteljohn, D; Rudyk, C; Anisman, H; Hayley, S				Osborn, Meagan; Rustom, Nazneen; Clarke, Melanie; Litteljohn, Darcy; Rudyk, Chris; Anisman, Hymie; Hayley, Shawn			Antidepressant-Like Effects of Erythropoietin: A Focus on Behavioural and Hippocampal Processes	PLOS ONE			English	Article							ADULT BRAIN NEUROGENESIS; GRANULE CELL PRECURSORS; NEUROTROPHIC FACTOR; PERMANENT OCCLUSION; CHRONIC FLUOXETINE; SIGNALING PATHWAY; MAMMALIAN TARGET; PROTECTS NEURONS; STRESS; VOLUME	Depression is a chronic and debilitating condition with a significant degree of relapse and treatment resistance that could stem, at least in part, from disturbances of neuroplasticity. This has led to an increased focus on treatment strategies that target brain derived neurotrophic factor (BDNF), synaptic plasticity and adult neurogenesis. In the current study we aimed to assess whether erythropoietin (EPO) would have antidepressant-like effects given its already established pro-trophic actions. In particular, we assessed whether EPO would diminish the deleterious effects of a social stressor in mice. Indeed, EPO induced anxiolytic and antidepressant-like responses in a forced swim test, open field, elevated-plus maze, and a novelty test, and appeared to blunt some of the negative behavioural effects of a social stressor. Furthermore, EPO promoted adult hippocampal neurogenesis, an important feature of effective antidepressants. Finally, a separate study using the mTOR inhibitor rapamycin revealed that antagonizing this pathway prevented the impact of EPO upon forced swim performance. These data are consistent with previous findings showing that the mTOR pathway and its neurogenic and synaptogenic effects might mediate the behavioral consequences of antidepressant agents. Our findings further highlight EPO as a possible adjunct treatment for affective disorders, as well as other stressor associated disorders of impaired neuroplasticity.	[Osborn, Meagan; Rustom, Nazneen; Clarke, Melanie; Litteljohn, Darcy; Rudyk, Chris; Anisman, Hymie; Hayley, Shawn] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Hayley, S (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	sp.hayley@gmail.com		Rudyk, Christopher Rudyk/0000-0003-4302-518X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Caetano SC, 2004, PSYCHIAT RES-NEUROIM, V132, P141, DOI 10.1016/j.psychresns.2004.08.002; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Constandil L, 2011, BRAIN RES BULL, V86, P454, DOI 10.1016/j.brainresbull.2011.08.008; D'Sa C, 2002, BIPOLAR DISORD, V4, P183, DOI 10.1034/j.1399-5618.2002.01203.x; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Dremencov E, 2003, PROG NEURO-PSYCHOPH, V27, P729, DOI 10.1016/S0278-5846(03)00123-4; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2012, NEUROPHARMACOLOGY, V62, P35, DOI 10.1016/j.neuropharm.2011.08.044; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; Elsayed M, 2012, BIOL PSYCHIAT, V72, P258, DOI 10.1016/j.biopsych.2012.03.003; Estanislau C, 2011, BEHAV PROCESS, V86, P46, DOI 10.1016/j.beproc.2010.08.008; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Geslain R, 2013, CYTOKINE, V61, P329, DOI 10.1016/j.cyto.2012.10.017; Girgenti MJ, 2009, BIOL PSYCHIAT, V66, P267, DOI 10.1016/j.biopsych.2008.12.005; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003; Hengemihle John M., 1996, Physiology and Behavior, V59, P153, DOI 10.1016/0031-9384(95)02046-2; Hinojosa FR, 2006, BEHAV BRAIN RES, V168, P127, DOI 10.1016/j.bbr.2005.10.019; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Huang GJ, 2008, MOL PSYCHIATR, V13, P119, DOI 10.1038/sj.mp.4002104; Jacobs BL, 2002, BRAIN BEHAV IMMUN, V16, P602, DOI 10.1016/S0889-1591(02)00015-6; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Leconte C, 2012, BEHAV BRAIN RES, V230, P78, DOI 10.1016/j.bbr.2012.01.054; Leconte C, 2011, NEUROPHARMACOLOGY, V60, P354, DOI 10.1016/j.neuropharm.2010.09.025; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Litteljohn D, 2010, BRAIN BEHAV IMMUN, V24, P462, DOI 10.1016/j.bbi.2009.12.001; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Matayoshi S, 2005, J PHYSIOL-LONDON, V569, P685, DOI 10.1113/jphysiol.2005.095331; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Merali Z, 2004, EUR J NEUROSCI, V20, P229, DOI 10.1111/j.1460-9568.2004.03468.x; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Miskowiak K, 2008, NEUROPSYCHOPHARMACOL, V33, P611, DOI 10.1038/sj.npp.1301439; Miskowiak K, 2007, BIOL PSYCHIAT, V62, P1244, DOI 10.1016/j.biopsych.2007.01.011; Miskowiak K, 2007, J NEUROSCI, V27, P2788, DOI 10.1523/JNEUROSCI.5013-06.2007; Miskowiak KW, 2012, PSYCHOPHARMACOLOGY, V219, P687, DOI 10.1007/s00213-011-2511-1; Miskowiak KW, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-97; Miskowiak KW, 2010, PSYCHOPHARMACOLOGY, V210, P419, DOI 10.1007/s00213-010-1842-7; Miskowiak KW, 2009, PSYCHOPHARMACOLOGY, V207, P133, DOI 10.1007/s00213-009-1641-1; Pandey GN, 2010, PROG NEURO-PSYCHOPH, V34, P645, DOI 10.1016/j.pnpbp.2010.03.003; Pardridge WM, 1998, PHARMACEUT RES, V15, P576, DOI 10.1023/A:1011981927620; Qian L, 2006, J PHARMACOL EXP THER, V319, P44, DOI 10.1124/jpet.106.106351; Sadamoto Y, 1998, BIOCHEM BIOPH RES CO, V253, P26, DOI 10.1006/bbrc.1998.9748; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sanchez PE, 2009, J COMP NEUROL, V514, P403, DOI 10.1002/cne.22020; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Schmidt HD, 2010, NEUROPSYCHOPHARMACOL, V35, P2378, DOI 10.1038/npp.2010.114; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; STEINBEHRENS B, 1994, J NEUROSCI, V14, P5373; Tanapat P, 1998, INT J DEV NEUROSCI, V16, P235, DOI 10.1016/S0736-5748(98)00029-X; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yamashita K, 1997, METAB BRAIN DIS, V12, P271, DOI 10.1007/BF02674671; Yan HC, 2011, CURR MED CHEM, V18, P4359, DOI 10.2174/092986711797200471; Yis U, 2008, NEUROSCI LETT, V448, P245, DOI 10.1016/j.neulet.2008.10.060; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang F, 2007, NEUROBIOL DIS, V25, P45, DOI 10.1016/j.nbd.2006.08.007	74	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72813	10.1371/journal.pone.0072813	http://dx.doi.org/10.1371/journal.pone.0072813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019878	gold, Green Submitted, Green Published			2022-12-27	WOS:000324338200020
J	Phillips, O; Sanchez-Castaneda, C; Elifani, F; Maglione, V; Di Pardo, A; Caltagirone, C; Squitieri, F; Sabatini, U; Di Paola, M				Phillips, Owen; Sanchez-Castaneda, Cristina; Elifani, Francesca; Maglione, Vittorio; Di Pardo, Alba; Caltagirone, Carlo; Squitieri, Ferdinando; Sabatini, Umberto; Di Paola, Margherita			Tractography of the Corpus Callosum in Huntington's Disease	PLOS ONE			English	Article							CEREBRAL WHITE-MATTER; MAGNETIC-RESONANCE; DIFFUSION; BRAIN; MORPHOLOGY; DYSMYELINATION; CONNECTIVITY; EXPRESSION; ANISOTROPY; PATHOLOGY	White matter abnormalities have been shown in presymptomatic and symptomatic Huntington's disease (HD) subjects using Magnetic Resonance Imaging (MRI) and Diffusion Tensor Imaging (DTI) methods. The largest white matter tract, the corpus callosum (CC), has been shown to be particularly vulnerable; however, little work has been done to investigate the regional specificity of tract abnormalities in the CC. Thus, this study examined the major callosal tracts by applying DTI-based tractography. Using TrackVis, a previously defined region of interest tractography method parcellating CC into seven major tracts based on target region was applied to 30 direction DTI data collected from 100 subjects: presymptomatic HD (Pre-HD) subjects (n = 25), HD patients (n = 25) and healthy control subjects (n = 50). Tractography results showed decreased fractional anisotropy (FA) and increased radial diffusivity (RD) across broad regions of the CC in Pre-HD subjects. Similar though more severe deficits were seen in HD patients. In Pre-HD and HD, callosal FA and RD were correlated with Disease Burden/CAG repeat length as well as motor (UHDRSI) and cognitive (URDRS2) assessments. These results add evidence that CC pathways are compromised prior to disease onset with possible demyelination occurring early in the disease and suggest that CAG repeat length is a contributing factor to connectivity deficits. Furthermore, disruption of these callosal pathways potentially contributes to the disturbances of motor and cognitive processing that characterize HD.	[Phillips, Owen; Caltagirone, Carlo; Di Paola, Margherita] Ist Ricovero & Cura Carattere Sci Santa Lucia Fdn, Clin & Behav Neurol Dept, Rome, Italy; [Sanchez-Castaneda, Cristina; Sabatini, Umberto] Ist Ricovero & Cura Carattere Sci Santa Lucia Fdn, Dept Radiol, Rome, Italy; [Elifani, Francesca; Maglione, Vittorio; Di Pardo, Alba; Squitieri, Ferdinando] Ist Ricovero & Cura Carattere Sci Neuromed, Ctr Neurogenet & Rare Dis, Pozzilli, Italy; [Caltagirone, Carlo] Univ Roma Tor Vergata, Neurosci Dept, Rome, Italy; [Di Paola, Margherita] Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy	IRCCS Neuromed; University of Rome Tor Vergata; University of L'Aquila	Di Paola, M (corresponding author), Ist Ricovero & Cura Carattere Sci Santa Lucia Fdn, Clin & Behav Neurol Dept, Rome, Italy.	m.dipaola@hsantalucia.it	Maglione, Vittorio/AAA-5455-2019; Sabatini, Umberto/K-4659-2016; Squitieri, Ferdinando/N-1852-2019; Sanchez-Castañeda, Cristina/J-2303-2015; phillips, owen/J-3651-2017; Elifani, Francesca/AAE-2509-2020; Di Pardo, Alba/AAC-9393-2020	Maglione, Vittorio/0000-0002-6906-7372; Sabatini, Umberto/0000-0001-5321-8626; Squitieri, Ferdinando/0000-0002-7397-1727; Sanchez-Castañeda, Cristina/0000-0002-6827-9146; phillips, owen/0000-0002-5391-707X; Elifani, Francesca/0000-0002-0824-9543; Di Pardo, Alba/0000-0002-9514-0086	Italian Ministry of Health [204/GR-2009-1606835]; European Commission [FP7-PEOPLE-2011-IEF]; Italian Ministry of Health (Ricerca Corrente); Telethon [GGP12218]	Italian Ministry of Health(Ministry of Health, Italy); European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); Telethon(Fondazione Telethon)	This work was supported by the Italian Ministry of Health GRANT 204/GR-2009-1606835. Also, support was provided by the European Commission: Marie Curie Fellowship for career development to CS (FP7-PEOPLE-2011-IEF). The authors are grateful for the support they received from the Italian Ministry of Health (Ricerca Corrente), by Telethon [GGP12218], European Huntington's Disease Network for the Registry Study, by the Italian Association Huntington Research "Lega Italiana Ricerca Huntington" and by the Italian Association of HD Families "Associazione Italiana Corea di Huntington - Neuromed." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to all patients for contributing to the work.	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bohanna I, 2011, BRAIN IMAGING BEHAV, V5, P171, DOI 10.1007/s11682-011-9121-8; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Di Paola M, 2010, NEUROIMAGE, V49, P141, DOI 10.1016/j.neuroimage.2009.07.050; Duff Kevin, 2008, Handb Clin Neurol, V89, P589, DOI 10.1016/S0072-9752(07)01255-9; Dumas EM, 2012, HUM BRAIN MAPP, V33, P203, DOI 10.1002/hbm.21205; Esmaeilzadeh M, 2011, CNS NEUROSCI THER, V17, P368, DOI 10.1111/j.1755-5949.2010.00157.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hasan KM, 2007, NEUROREPORT, V18, P1735, DOI 10.1097/WNR.0b013e3282f0d40c; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jones DK, 2012, NEUROIMAGE; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kochunov P, 2011, NEUROIMAGE, V58, P41, DOI 10.1016/j.neuroimage.2011.05.050; Konrad A, 2008, SCHIZOPHRENIA BULL, V34, P72, DOI 10.1093/schbul/sbm034; Luders E, 2012, CEREB CORTEX; Luders E, 2007, NEUROREPORT, V18, P203, DOI 10.1097/WNR.0b013e3280115942; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Muller H.P., 2011, PLOS CURR, V3; Nopoulos PC, 2011, BRAIN, V134, P137, DOI 10.1093/brain/awq280; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Persichetti F, 1996, NEUROBIOL DIS, V3, P183, DOI 10.1006/nbdi.1996.0018; Phillips OR, 2011, HUM BRAIN MAPP, V32, P1788, DOI 10.1002/hbm.21147; Phillips OR, 2009, SCHIZOPHR RES, V107, P30, DOI 10.1016/j.schres.2008.10.019; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2010, NEUROIMAGE, V49, P2995, DOI 10.1016/j.neuroimage.2009.10.015; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Rosas HD, 2005, NEUROLOGY, V65, P745, DOI 10.1212/01.wnl.0000174432.87383.87; Sach M, 2004, BRAIN, V127, P340, DOI 10.1093/brain/awh041; Schmierer K, 2008, MAGN RESON MED, V59, P268, DOI 10.1002/mrm.21487; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stoffers D, 2010, NEUROLOGY, V74, P1208, DOI 10.1212/WNL.0b013e3181d8c20a; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Takahashi M, 2000, RADIOLOGY, V216, P881, DOI 10.1148/radiology.216.3.r00se41881; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Weinstein M, 2011, HUM BRAIN MAPP, V32, P534, DOI 10.1002/hbm.21042; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Xiang ZM, 2011, J NEUROSCI, V31, P9544, DOI 10.1523/JNEUROSCI.1291-11.2011	50	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73280	10.1371/journal.pone.0073280	http://dx.doi.org/10.1371/journal.pone.0073280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019913	Green Submitted, gold, Green Published			2022-12-27	WOS:000324338200055
J	Regis, S; Corsolini, F; Grossi, S; Tappino, B; Cooper, DN; Filocamo, M				Regis, Stefano; Corsolini, Fabio; Grossi, Serena; Tappino, Barbara; Cooper, David N.; Filocamo, Mirella			Restoration of the Normal Splicing Pattern of the PLP1 Gene by Means of an Antisense Oligonucleotide Directed against an Exonic Mutation	PLOS ONE			English	Article							PELIZAEUS-MERZBACHER-DISEASE; SPASTIC PARAPLEGIA TYPE-2; PROTEOLIPID PROTEIN; DISORDERS; OLIGODENDROCYTES; IDENTIFICATION; ENHANCERS; FAMILY; MYELIN	An exonic missense mutation, c.436C>G, in the PLP1 gene of a patient affected by the hypomyelinating leukodystrophy, Pelizaeus-Merzbacher disease, has previously been found to be responsible for the alteration of the canonical alternative splicing profile of the PLP1 gene leading to the loss of the longer PLP isoform. Here we show that the presence of the c. 436C>G mutation served to introduce regulatory motifs that appear to be responsible for the perturbed splicing pattern that led to loss of the major PLP transcript. With the aim of disrupting the interaction between the PLP1 splicing regulatory motifs and their cognate splicing factors, we designed an antisense oligonucleotide-based in vitro correction protocol that successfully restored PLP transcript production in oligodendrocyte precursor cells.	[Regis, Stefano; Corsolini, Fabio; Grossi, Serena; Tappino, Barbara; Filocamo, Mirella] Ist Giannina Gaslini, Ctr Diagnost Genet & Biochim Malattie Metab, I-16148 Genoa, Italy; [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF10 3AX, S Glam, Wales	University of Genoa; IRCCS Istituto Giannina Gaslini; Cardiff University	Filocamo, M (corresponding author), Ist Giannina Gaslini, Ctr Diagnost Genet & Biochim Malattie Metab, I-16148 Genoa, Italy.	mirellafilocamo@ospedale-gaslini.ge.it	Cooper, David N/H-4384-2011; Tappino, Barbara/AAB-7494-2020; Corsolini, Fabio/AAC-6663-2020; Regis, Stefano/AAA-7794-2020; Filocamo, Mirella/AAG-3948-2021	Cooper, David N/0000-0002-8943-8484; Tappino, Barbara/0000-0002-5971-0926; Corsolini, Fabio/0000-0003-0016-3400; Regis, Stefano/0000-0002-7723-2294; Filocamo, Mirella/0000-0001-5505-8507	Italian Health Department 'Finanziamento Cinque per mille e Ricerca Corrente'; FP7-HEALTH, LeukoTreat [241622]	Italian Health Department 'Finanziamento Cinque per mille e Ricerca Corrente'; FP7-HEALTH, LeukoTreat	This work was supported by grants from the Italian Health Department 'Finanziamento Cinque per mille e Ricerca Corrente' and FP7-HEALTH, LeukoTreat no.241622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dhaunchak AS, 2011, J NEUROSCI, V31, P14961, DOI 10.1523/JNEUROSCI.2097-11.2011; Garbern JY, 2007, CELL MOL LIFE SCI, V64, P50, DOI 10.1007/s00018-006-6182-8; Garbern JY, 1993, GENEREVIEWS; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; Grossi S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-40; Hobson GM, 2002, ANN NEUROL, V52, P477, DOI 10.1002/ana.10320; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; Schweitzer M, 2006, MOL CELL NEUROSCI, V31, P161, DOI 10.1016/j.mcn.2005.10.007; Sivakumar K, 1999, ANN NEUROL, V45, P680, DOI 10.1002/1531-8249(199905)45:5<680::AID-ANA23>3.0.CO;2-H; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Southwood C, 2007, J NEUROSCI RES, V85, P471, DOI 10.1002/jnr.21153; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Wang EM, 2006, J CELL BIOCHEM, V97, P999, DOI 10.1002/jcb.20692; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wolf NI, 2005, BRAIN, V128, P743, DOI 10.1093/brain/awh409	24	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73633	10.1371/journal.pone.0073633	http://dx.doi.org/10.1371/journal.pone.0073633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019930	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000324338200072
J	Takahashi, M; Shirayama, Y; Muneoka, K; Suzuki, M; Sato, K; Hashimoto, K				Takahashi, Michio; Shirayama, Yukihiko; Muneoka, Katsumasa; Suzuki, Masatoshi; Sato, Koichi; Hashimoto, Kenji			Low Openness on the Revised NEO Personality Inventory as a Risk Factor for Treatment-Resistant Depression	PLOS ONE			English	Article							MAJOR DEPRESSION; 5-FACTOR MODEL; PSYCHOBIOLOGICAL MODEL; TREATMENT RESPONSE; SELF; TEMPERAMENT; DYSFUNCTION; NEUROTICISM; RESILIENCE; RECOVERY	Background: Recently, we reported that low reward dependence, and to a lesser extent, low cooperativeness in the Temperature and Character Inventory (TCI) may be risk factors for treatment-resistant depression. Here, we analyzed additional psychological traits in these patients. Methods: We administered Costa and McCrae's five-factor model personality inventory, NEO Personality Inventory-Revised (NEO-PI-R), to antidepressant-treatment resistant depressed patients (n = 35), remitted depressed patients (n = 27), and healthy controls (n = 66). We also evaluated the relationships between scores on NEO and TCI, using the same cohort of patients with treatment-resistant depression, as our previous study. Results: Patients with treatment-resistant depression showed high scores for neuroticism, low scores for extraversion, openness and conscientiousness, without changes in agreeableness, on the NEO. However, patients in remitted depression showed no significant scores on NEO. Patients with treatment-resistant depression and low openness on NEO showed positive relationships with reward dependence and cooperativeness on the TCI. Conclusions: Many studies have reported that depressed patients show high neuroticism, low extraversion and low conscientiousness on the NEO. Our study highlights low openness on the NEO, as a risk mediator in treatment-resistant depression. This newly identified trait should be included as a risk factor in treatment-resistant depression.	[Takahashi, Michio; Shirayama, Yukihiko; Muneoka, Katsumasa; Suzuki, Masatoshi; Sato, Koichi] Teikyo Univ, Chiba Med Ctr, Dept Psychiat, Ichihara, Chiba, Japan; [Takahashi, Michio; Shirayama, Yukihiko; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Teikyo University; Chiba University	Shirayama, Y (corresponding author), Teikyo Univ, Chiba Med Ctr, Dept Psychiat, Ichihara, Chiba, Japan.	shirayama@rapid.ocn.ne.jp	Takahashi, Michio/R-2889-2019; Hashimoto, Kenji/I-5800-2015	Takahashi, Michio/0000-0002-7151-1364; Hashimoto, Kenji/0000-0002-8892-0439	Teikyo University Chiba Medical Center, Ichihara, Japan	Teikyo University Chiba Medical Center, Ichihara, Japan	Funding for this study was provided by Teikyo University Chiba Medical Center, Ichihara, Japan. The funder of this study had no role in the data collection, analysis, interpretation or reporting of this paper.	Alim TN, 2008, AM J PSYCHIAT, V165, P1566, DOI 10.1176/appi.ajp.2008.07121939; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BAGBY RM, 1995, J PERS DISORD, V9, P224, DOI 10.1521/pedi.1995.9.3.224; Bagby RM, 1998, AM J PSYCHIAT, V155, P437, DOI 10.1176/ajp.155.3.437; Chopra KK, 2005, PSYCHIAT RES, V134, P161, DOI 10.1016/j.psychres.2005.02.002; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Costa PT, 2005, J AFFECT DISORDERS, V89, P45, DOI 10.1016/j.jad.2005.06.010; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; De Fruyt F, 2000, PERS INDIV DIFFER, V29, P441, DOI 10.1016/S0191-8869(99)00204-4; Du LS, 2002, J AFFECT DISORDERS, V71, P235, DOI 10.1016/S0165-0327(01)00370-6; Duberstein PR, 2007, J AFFECT DISORDERS, V103, P165, DOI 10.1016/j.jad.2007.01.025; Elliott R, 2012, ARCH GEN PSYCHIAT, V69, P37, DOI 10.1001/archgenpsychiatry.2011.139; Enns MW, 2000, J AFFECT DISORDERS, V60, P33, DOI 10.1016/S0165-0327(99)00156-1; Fava GA, 2007, PSYCHOL MED, V37, P307, DOI 10.1017/S0033291706008981; Fekadu A, 2012, BRIT J PSYCHIAT, V201, P369, DOI 10.1192/bjp.bp.111.102665; Gorwood P, 2010, BRIT J PSYCHIAT, V196, P139, DOI 10.1192/bjp.bp.109.067058; Karsten J, 2012, J PSYCHIATR RES, V46, P644, DOI 10.1016/j.jpsychires.2012.01.024; Kijima N, 2000, PSYCHOL REP, V86, P1050, DOI 10.2466/PR0.86.3.1050-1058; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; Ong AD, 2006, J PERS SOC PSYCHOL, V91, P730, DOI 10.1037/0022-3514.91.4.730; Petersen T, 2001, COMPR PSYCHIAT, V42, P488, DOI 10.1053/comp.2001.27897; Quilty LC, 2008, J AFFECT DISORDERS, V111, P67, DOI 10.1016/j.jad.2008.02.006; Rector NA, 2012, PSYCHIAT RES, V199, P131, DOI 10.1016/j.psychres.2012.04.027; SCOTT J, 1995, J AFFECT DISORDERS, V33, P167, DOI 10.1016/0165-0327(94)00085-N; Shea MT, 1996, AM J PSYCHIAT, V153, P1404; Souery D, 2007, J CLIN PSYCHIAT, V68, P1062, DOI 10.4088/JCP.v68n0713; Spinhoven P, 2011, ACTA PSYCHIAT SCAND, V124, P462, DOI 10.1111/j.1600-0447.2011.01753.x; Takahashi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063756; Takeuchi M, 2011, COMPR PSYCHIAT, V52, P109, DOI 10.1016/j.comppsych.2010.04.002; Tang TZ, 2009, ARCH GEN PSYCHIAT, V66, P1322, DOI 10.1001/archgenpsychiatry.2009.166; Thase Michael E., 1995, P1081; Wiersma JE, 2011, J CLIN PSYCHIAT, V72, P288, DOI 10.4088/JCP.09m05735blu	32	33	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e71964	10.1371/journal.pone.0071964	http://dx.doi.org/10.1371/journal.pone.0071964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019864	Green Submitted, gold, Green Published			2022-12-27	WOS:000324338200006
J	Liang, ZS; Ma, YN; Xu, T; Cui, BM; Liu, Y; Guo, ZX; Yang, DF				Liang, Zongsuo; Ma, Yini; Xu, Tao; Cui, Beimi; Liu, Yan; Guo, Zhixin; Yang, Dongfeng			Effects of Abscisic Acid, Gibberellin, Ethylene and Their Interactions on Production of Phenolic Acids in Salvia miltiorrhiza Bunge Hairy Roots	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; METHYL JASMONATE; PAL ACTIVITY; ABA; BIOSYNTHESIS; GROWTH; FRUIT; METABOLISM; SEEDLINGS; HORMONES	Salvia miltiorrhiza is one of the most important traditional Chinese medicinal plants because of its excellent performance in treating coronary heart disease. Phenolic acids mainly including caffeic acid, rosmarinic acid and salvianolic acid B are a group of active ingredients in S. miltiorrhiza. Abscisic acid (ABA), gibberellin (GA) and ethylene are three important phytohormones. In this study, effects of the three phytohormones and their interactions on phenolic production in S. miltiorrhiza hairy roots were investigated. The results showed that ABA, GA and ethylene were all effective to induce production of phenolic acids and increase activities of PAL and TAT in S. miltiorrhiza hairy roots. Effects of phytohormones were reversed by their biosynthetic inhibitors. Antagonistic actions between the three phytohormones played important roles in the biosynthesis of phenolic acids. GA signaling is necessary for ABA and ethylene-induced phenolic production. Yet, ABA and ethylene signaling is probably not necessary for GA3-induced phenolic production. The complex interactions of phytohormones help us reveal regulation mechanism of secondary metabolism and scale-up production of active ingredients in plants.	[Liang, Zongsuo; Ma, Yini; Xu, Tao; Yang, Dongfeng] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Cui, Beimi] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Liu, Yan] Tianjin Tasly Modern TCM Resources Co Ltd, Tianjin, Peoples R China; [Guo, Zhixin] Tasly Inst, Tianjin, Peoples R China	Zhejiang Sci-Tech University; Northwest A&F University - China	Yang, DF (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	ydf807@163.com			Specialized Research Fund for the Doctoral Program of Higher Education [20110204110028]; Science Foundation of Zhejiang Sci-Tech University (ZSTU) [1204806-Y, 1204822-Y]; Zhejiang Provincial Natural Science Foundation of China [LQ13C020003]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Foundation of Zhejiang Sci-Tech University (ZSTU); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This material is based upon work funded by Specialized Research Fund for the Doctoral Program of Higher Education (20110204110028), Science Foundation of Zhejiang Sci-Tech University (ZSTU) under grant numbers 1204806-Y and 1204822-Y, and Zhejiang Provincial Natural Science Foundation of China under grant number LQ13C020003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; BEEVERS L, 1970, PLANTA, V90, P286, DOI 10.1007/BF00387180; Benschop JJ, 2007, PLANT PHYSIOL, V143, P1013, DOI 10.1104/pp.106.092700; Cui B, 2012, ZHONGGUO ZHONG YAO Z, V37, P754; Dubois V, 2011, PLANT SIGNAL BEHAV, V6, P134, DOI 10.4161/psb.6.1.14268; FUCHS Y, 1968, PLANT PHYSIOL, V43, P2029, DOI 10.1104/pp.43.12.2029; Ghassemian M, 2000, PLANT CELL, V12, P1117, DOI 10.1105/tpc.12.7.1117; Gil-Amado JA, 2012, PLANTA, V235, P1221, DOI 10.1007/s00425-011-1570-1; GOLDSCHMIDT EE, 1977, PLANT PHYSIOL, V59, P193, DOI 10.1104/pp.59.2.193; Gomez-Cadenas A, 2001, PLANT CELL, V13, P667, DOI 10.1105/tpc.13.3.667; He X, 2008, CHINESE J EXPT TRADI, V14, P1; Heredia JB, 2009, POSTHARVEST BIOL TEC, V51, P242, DOI 10.1016/j.postharvbio.2008.07.001; Jiang YM, 2003, PLANT GROWTH REGUL, V39, P171, DOI 10.1023/A:1022539901044; LI HC, 1970, PHYSIOL PLANTARUM, V23, P928, DOI 10.1111/j.1399-3054.1970.tb06490.x; Liang ZS, 2012, PLANT CELL REP, V31, P873, DOI 10.1007/s00299-011-1208-6; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Steffens B, 2006, PLANTA, V223, P604, DOI 10.1007/s00425-005-0111-1; Vriezen WH, 2004, PLANT J, V37, P505, DOI 10.1046/j.1365-313X.2003.01975.x; Wang JW, 2010, APPL MICROBIOL BIOT, V88, P437, DOI 10.1007/s00253-010-2797-7; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Wilmowicz E, 2008, J PLANT PHYSIOL, V165, P1917, DOI 10.1016/j.jplph.2008.04.009; Xu L., 2011, PLOS ONE, V6; Yang DF, 2012, J PLANT GROWTH REGUL, V31, P579, DOI 10.1007/s00344-012-9268-6; Yang DF, 2012, PHYSIOL PLANTARUM, V146, P173, DOI 10.1111/j.1399-3054.2012.01603.x; ZEEVAART JAD, 1983, PLANT PHYSIOL, V71, P477, DOI 10.1104/pp.71.3.477; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	30	84	88	2	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72806	10.1371/journal.pone.0072806	http://dx.doi.org/10.1371/journal.pone.0072806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023778	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400025
J	Xue, J; Cong, Z; Xiong, J; Wang, W; Jiang, H; Chen, T; Wu, FX; Liu, KJ; Su, AH; Ju, B; Chen, ZW; Couto, MA; Wei, Q; Qin, C				Xue, Jing; Cong, Zhe; Xiong, Jing; Wang, Wei; Jiang, Hong; Chen, Ting; Wu, Fangxin; Liu, Kejian; Su, Aihua; Ju, Bin; Chen, Zhiwei; Couto, Marcelo A.; Wei, Qiang; Qin, Chuan			Repressive Effect of Primary Virus Replication on Superinfection Correlated with Gut-Derived Central Memory CD4(+) T Cells in SHIV-Infected Chinese Rhesus Macaques	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL REPLICATION; SUBTYPE-C; HIV-1 SUPERINFECTION; IMMUNE-RESPONSES; DEPLETION; LIVE; CHALLENGE; AIDS; IMMUNIZATION	A possible mechanism of susceptibility to superinfection with simian-human immunodeficiency virus (SHIV)-1157ipd3N4 was explored in twelve SHIVSF162P3-infected Chinese rhesus macaques. Based on the kinetics of viral replication for the second infecting virus following SHIV-1157ipd3N4 inoculation, the monkeys were divided into two groups: those relatively resistant to superinfection (SIR) and those relatively sensitive to superinfection (SIS). We found that superinfection-resistant macaques had high primary viremia, whereas superinfection-sensitive macaques had low primary viremia, suggesting that primary SHIVSF162P3 infection with a high viral-replication level would repress superinfection with a heterologous SHIV-1157ipd3N4. Although no correlation of protection against superinfection with virus-specific CD4(+) T cell or CD8(+) T cell immune responses from gut was observed prior to superinfection, superinfection susceptibility was strongly correlated with CD4(+) Tcm cells from gut both prior to the second infecting virus inoculation and on day 7 after superinfection, but not with CD4(+) Tem cells from gut or with CD4(+) Tcm cells from peripheral blood and lymph node. These results point to the important roles of gut-derived CD4(+) Tcm cells for the study of the mechanisms of protection against superinfection and the evaluation of the safety and efficacy of vaccines and therapies against acquired immune deficiency syndrome (AIDS).	[Xue, Jing; Cong, Zhe; Xiong, Jing; Wang, Wei; Jiang, Hong; Chen, Ting; Wu, Fangxin; Liu, Kejian; Su, Aihua; Ju, Bin; Wei, Qiang; Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Xue, Jing; Cong, Zhe; Xiong, Jing; Wang, Wei; Jiang, Hong; Chen, Ting; Wu, Fangxin; Liu, Kejian; Su, Aihua; Ju, Bin; Wei, Qiang; Qin, Chuan] Peking Union Med Coll, Comparat Med Ctr, Key Lab Human Dis Comparat Med, Beijing 100021, Peoples R China; [Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Hong Kong, Peoples R China; [Couto, Marcelo A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Hong Kong; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wei, Q (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, 5 Panjiayuan Nanli, Beijing, Peoples R China.	weiqiang@cnilas.pumc.edu.cn; qinchuan@pumc.edu.cn	Chen, Zhiwei/B-7793-2019	Chen, Zhiwei/0000-0002-4511-2888	National Science and Technology Major Projects of Infectious Disease [2012ZX10004501-001, 2012ZX10001007-008, 2012ZX10001006-003, 2013ZX10004608-003]	National Science and Technology Major Projects of Infectious Disease	This work was supported by grants (2012ZX10004501-001, 2012ZX10001007-008, 2012ZX10001006-003 and 2013ZX10004608-003) from the National Science and Technology Major Projects of Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose Z, 2001, J VIROL, V75, P8589, DOI 10.1128/JVI.75.18.8589-8596.2001; Angel JB, 2004, AIDS, V18, P331, DOI 10.1097/00002030-200401230-00027; Basu D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-76; Berry N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023092; Biesinger T, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-88; Blish CA, 2012, AIDS, V26, P643, DOI 10.1097/QAD.0b013e3283509a0b; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chase A, 2006, TRENDS PHARMACOL SCI, V27, P4, DOI 10.1016/j.tips.2005.11.005; Chen ZW, 2000, J VIROL, V74, P6501, DOI 10.1128/JVI.74.14.6501-6510.2000; Chen ZW, 2002, J ACQ IMMUN DEF SYND, V30, P133, DOI 10.1097/01.QA1.0000017963.22053.47; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; Cornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849; Davenport MP, 2006, JAIDS-J ACQ IMM DEF, V41, P259, DOI 10.1097/01.qai.0000199232.31340.d3; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; FULTZ PN, 1987, J VIROL, V61, P4026, DOI 10.1128/JVI.61.12.4026-4029.1987; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Horton H, 2002, J VIROL, V76, P7187, DOI 10.1128/JVI.76.14.7187-7202.2002; Hsu M, 2003, J MED PRIMATOL, V32, P211, DOI 10.1034/j.1600-0684.2003.00027.x; Kersh EN, 2012, J INFECT DIS, V206, P770, DOI 10.1093/infdis/jis422; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Lay MDH, 2009, J VIROL, V83, P7517, DOI 10.1128/JVI.00552-09; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Li Y, 2012, CURR HIV RES; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Mason RD, 2008, VIROLOGY, V381, P11, DOI 10.1016/j.virol.2008.08.042; Mattapallil JJ, 1998, J VIROL, V72, P6421, DOI 10.1128/JVI.72.8.6421-6429.1998; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mayr LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038989; Pahar B, 2009, VIROLOGY, V387, P273, DOI 10.1016/j.virol.2009.02.014; Peng M, 2010, IMMUNOLOGY, V130, P83, DOI 10.1111/j.1365-2567.2009.03215.x; Redd AD, 2011, J CLIN MICROBIOL, V49, P2859, DOI 10.1128/JCM.00804-11; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Salha MD, 2008, VIROLOGY, V377, P239, DOI 10.1016/j.virol.2008.04.031; Shakirzyanova M, 2012, J VIROL, V86, P9432, DOI 10.1128/JVI.00852-12; Sharpe SA, 2004, J GEN VIROL, V85, P2591, DOI 10.1099/vir.0.80050-0; Singer R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003936; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Stebbings R, 2005, J VIROL, V79, P12264, DOI 10.1128/JVI.79.19.12264-12272.2005; Stevceva L, 2001, BMC INFECT DIS, V1, part. no., DOI 10.1186/1471-2334-1-9; Stranford SA, 1999, P NATL ACAD SCI USA, V96, P1030, DOI 10.1073/pnas.96.3.1030; Sun CJ, 2010, J INFECTION, V60, P371, DOI 10.1016/j.jinf.2010.03.005; Tsukamoto T, 2007, J VIROL, V81, P11640, DOI 10.1128/JVI.01475-07; van der Kuyl AC, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-60; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Waters L, 2012, CURR OPIN INFECT DIS, V25, P42, DOI 10.1097/QCO.0b013e32834ef5af; Xue J, 2010, GLYCOBIOLOGY, V20, P905, DOI 10.1093/glycob/cwq048; Yang GB, 2012, J GEN VIROL, V93, P1506, DOI 10.1099/vir.0.041061-0; Yeh WW, 2009, J VIROL, V83, P2686, DOI 10.1128/JVI.02237-08; Yu K, 2010, BRAIN BEHAV IMMUN, V24, P298, DOI 10.1016/j.bbi.2009.10.008; Zhao CC, 2013, ARCH VIROL, V158, P853, DOI 10.1007/s00705-012-1534-1	56	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72295	10.1371/journal.pone.0072295	http://dx.doi.org/10.1371/journal.pone.0072295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023734	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400012
J	Chen, GQ; Zhuang, QY; Wang, KC; Liu, S; Shao, JZ; Jiang, WM; Hou, GY; Li, JP; Yu, JM; Li, YP; Chen, JM				Chen, Gui-Qian; Zhuang, Qing-Ye; Wang, Kai-Cheng; Liu, Shuo; Shao, Jian-Zhong; Jiang, Wen-Ming; Hou, Guang-Yu; Li, Jin-Ping; Yu, Jian-Min; Li, Yi-Ping; Chen, Ji-Ming			Identification and Survey of a Novel Avian Coronavirus in Ducks	PLOS ONE			English	Article							INFECTIOUS-BRONCHITIS VIRUS; LIBRARY PREPARATION PROTOCOL; COMPLETE GENOME SEQUENCE; RNA VIRUS; TURKEY; DISCOVERY; BETACORONAVIRUS; DIVERSITY; EVOLUTION; REVEALS	The rapid discovery of novel viruses using next generation sequencing (NGS) technologies including DNA-Seq and RNA-Seq, has greatly expanded our understanding of viral diversity in recent years. The timely identification of novel viruses using NGS technologies is also important for us to control emerging infectious diseases caused by novel viruses. In this study, we identified a novel duck coronavirus (CoV), distinct with chicken infectious bronchitis virus (IBV), using RNA-Seq. The novel duck-specific CoV was a potential novel species within the genus Gammacoronavirus, as indicated by sequences of three regions in the viral 1b gene. We also performed a survey of CoVs in domestic fowls in China using reverse-transcription polymerase chain reaction (RT-PCR), targeting the viral nucleocapsid (N) gene. A total of 102 CoV positives were identified through the survey. Phylogenetic analysis of the viral N sequences suggested that CoVs in domestic fowls have diverged into several region-specific or host-specific clades or subclades in the world, and IBVs can infect ducks, geese and pigeons, although they mainly circulate in chickens. Moreover, this study provided novel data supporting the notion that some host-specific CoVs other than IBVs circulate in ducks, geese and pigeons, and indicated that the novel duck-specific CoV identified through RNA-Seq in this study is genetically closer to some CoVs circulating in wild water fowls. Taken together, this study shed new insight into the diversity, distribution, evolution and control of avian CoVs.	[Chen, Gui-Qian; Shao, Jian-Zhong; Li, Yi-Ping] Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Gui-Qian; Zhuang, Qing-Ye; Wang, Kai-Cheng; Liu, Shuo; Jiang, Wen-Ming; Hou, Guang-Yu; Li, Jin-Ping; Yu, Jian-Min; Chen, Ji-Ming] China Anim Hlth & Epidemiol Ctr, Lab Avian Dis Surveillance, Qingdao, Peoples R China	Zhejiang University; China Animal Health & Epidemiology Center	Li, YP (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Hangzhou 310003, Zhejiang, Peoples R China.	ypli@uab.edu; jmchen678@qq.com	Chen, Ji-Ming/AHD-7398-2022; Chen, Jiming/AAA-3575-2020	Chen, Jiming/0000-0003-3155-3145; Chen, Jiming/0000-0002-0404-0830	Avian Influenza Surveillance Program of the Ministry of Agriculture; Sci-tech Basic Work Project of the Ministry of Science and Technology in China [SQ2012FY3260033]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044741] Funding Source: NIH RePORTER	Avian Influenza Surveillance Program of the Ministry of Agriculture; Sci-tech Basic Work Project of the Ministry of Science and Technology in China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Avian Influenza Surveillance Program of the Ministry of Agriculture, and the Sci-tech Basic Work Project of the Ministry of Science and Technology (SQ2012FY3260033) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2013, ARCH VIROL, V158, P909, DOI 10.1007/s00705-012-1546-x; Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Borderia AV, 2011, CURR OPIN VIROL, V1, P643, DOI 10.1016/j.coviro.2011.09.012; Borodina T, 2011, METHOD ENZYMOL, V500, P79, DOI 10.1016/B978-0-12-385118-5.00005-0; Buisine N, 2004, BIOTECHNIQUES, V37, P987, DOI 10.2144/04376BIN01; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Chen JM, 2000, GUIDELINES EPIDEMILO; Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432; DEA S, 1989, AM J VET RES, V50, P226; DEA S, 1991, AVIAN DIS, V35, P767, DOI 10.2307/1591609; DEA S, 1990, J VIROL, V64, P3112, DOI 10.1128/JVI.64.6.3112-3118.1990; Dillies MA, 2012, BRIEF BIOINFORM; Giovannoni SJ, 1996, P NATL ACAD SCI USA, V93, P7979, DOI 10.1073/pnas.93.15.7979; Gouilh MA, 2011, INFECT GENET EVOL, V11, P1690, DOI 10.1016/j.meegid.2011.06.021; Guy JS, 2000, AVIAN PATHOL, V29, P207, DOI 10.1080/03079450050045459; Huang YP, 2006, VACCINE, V24, P785, DOI 10.1016/j.vaccine.2005.08.081; Hudson C B, 1932, Science, V76, P34, DOI 10.1126/science.76.1958.34-a; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jackwood MW, 2012, INFECT GENET EVOL, V12, P1305, DOI 10.1016/j.meegid.2012.05.003; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; King A.M., 2012, VIRUS TAXONOMY, V9; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kumar R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00202; Kuo SM, 2013, VET MICROBIOL, V162, P408, DOI 10.1016/j.vetmic.2012.10.020; Li M, 2012, ARCH VIROL, V157, P467, DOI 10.1007/s00705-011-1206-6; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Mihindukulasuriya KA, 2008, J VIROL, V82, P5084, DOI 10.1128/JVI.02722-07; Muradrasoli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013640; Nei M., 2000, MOL EVOLUTION PHYLOG; Orilio AF, 2013, ARCH VIROL, V158, P291, DOI 10.1007/s00705-012-1473-x; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Rosseel T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-463; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Routh A, 2012, J MOL BIOL, V424, P257, DOI 10.1016/j.jmb.2012.10.005; Ruan YJ, 2004, TRENDS BIOTECHNOL, V22, P23, DOI 10.1016/j.tibtech.2003.11.002; Sapats SI, 1996, VIROLOGY, V226, P412, DOI 10.1006/viro.1996.0670; Sultan M, 2012, BIOCHEM BIOPH RES CO, V422, P643, DOI 10.1016/j.bbrc.2012.05.043; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan S. L., 2006, HEPATITIS C VIRUSES; Tarnagda Z, 2011, J INFECT DEV COUNTR, V5, P565, DOI 10.3855/jidc.1441; Tregenza T, 2002, GENETICA, V116, P291, DOI 10.1023/A:1021257114996; Wang CH, 1996, ARCH VIROL, V141, P1677, DOI 10.1007/BF01718291; Wang KC, 2013, GENOME ANNOUNC, V1; Williams LJS, 2012, GENOME RES, V22, P2241, DOI 10.1101/gr.138925.112; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08; World Organization for Animal Health, 2011, TERR AN HLTH COD; Yu JM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-39	48	38	41	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72918	10.1371/journal.pone.0072918	http://dx.doi.org/10.1371/journal.pone.0072918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023656	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200052
J	Morato, PN; Lollo, PCB; Moura, CS; Batista, TM; Camargo, RL; Carneiro, EM; Amaya-Farfan, J				Morato, Priscila Neder; Barboza Lollo, Pablo Christiano; Moura, Carolina Soares; Batista, Thiago Martins; Camargo, Rafael Ludemann; Carneiro, Everardo Magalhaes; Amaya-Farfan, Jaime			Whey Protein Hydrolysate Increases Translocation of GLUT-4 to the Plasma Membrane Independent of Insulin in Wistar Rats	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER EXPRESSION; SKELETAL-MUSCLE; GLYCOGEN; EXERCISE; INGESTION; MECHANISMS; NUTRITION; LIVER	Whey protein (WP) and whey protein hydrolysate (WPH) have the recognized capacity to increase glycogen stores. The objective of this study was to verify if consuming WP and WPH could also increase the concentration of the glucose transporters GLUT-1 and GLUT-4 in the plasma membrane (PM) of the muscle cells of sedentary and exercised animals. Forty-eight Wistar rats were divided into 6 groups (n = 8 per group), were treated and fed with experimental diets for 9 days as follows: a) control casein (CAS); b) WP; c) WPH; d) CAS exercised; e) WP exercised; and f) WPH exercised. After the experimental period, the animals were sacrificed, muscle GLUT-1 and GLUT-4, p85, Akt and phosphorylated Akt were analyzed by western blotting, and the glycogen, blood amino acids, insulin levels and biochemical health indicators were analyzed using standard methods. Consumption of WPH significantly increased the concentrations of GLUT-4 in the PM and glycogen, whereas the GLUT-1 and insulin levels and the health indicators showed no alterations. The physical exercise associated with consumption of WPH had favorable effects on glucose transport into muscle. These results should encourage new studies dealing with the potential of both WP and WPH for the treatment or prevention of type II diabetes, a disease in which there is reduced translocation of GLUT-4 to the plasma membrane.	[Morato, Priscila Neder; Barboza Lollo, Pablo Christiano; Moura, Carolina Soares; Amaya-Farfan, Jaime] Univ Estadual Campinas, UNICAMP, Fac Food Engn FEA, Campinas, SP, Brazil; [Batista, Thiago Martins; Camargo, Rafael Ludemann; Carneiro, Everardo Magalhaes] Univ Estadual Campinas, UNICAMP, Inst Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Morato, PN (corresponding author), Univ Estadual Campinas, UNICAMP, Fac Food Engn FEA, Campinas, SP, Brazil.	primorato@gmail.com	Camargo, Rafael/G-8330-2015; Carneiro, Everardo/D-4758-2012; Morato, Priscila Neder/AAN-6178-2021; Batista, Thiago M/C-9816-2014	Camargo, Rafael/0000-0001-9971-5900; Batista, Thiago M/0000-0001-6971-1191	FAPESP [Proc. 2012/05859-7]; CNPq; CAPES	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPESP (Proc. 2012/05859-7), CNPq and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lollo PCB, 2011, J HUM KINET, V30, P49, DOI 10.2478/v10078-011-0072-3; Batista TM, 2012, J NUTR BIOCHEM, V23, P306, DOI 10.1016/j.jnutbio.2010.12.012; Brancaccio P, 2008, CLIN SPORT MED, V27, P1, DOI 10.1016/j.csm.2007.09.005; Carneiro EA, 2009, J NUTR BIOCHEM, V20, P503, DOI 10.1016/j.jnutbio.2008.05.008; Christ-Roberts CY, 2004, EXERC SPORT SCI REV, V32, P90, DOI 10.1097/00003677-200407000-00003; de Moura CS, 2013, FOOD CHEM, V136, P1350, DOI 10.1016/j.foodchem.2012.09.070; Faria I. C., 2012, African Journal of Biotechnology, V11, P2402; Gaster M, 2000, AM J PHYSIOL-ENDOC M, V279, pE529, DOI 10.1152/ajpendo.2000.279.3.E529; Jeukendrup AE, 2011, J SPORT SCI, V29, pS91, DOI 10.1080/02640414.2011.610348; Kuo C.-H., 1999, Acta Physiologica Scandinavica, V165, P193, DOI 10.1046/j.1365-201x.1999.00489.x; Kuo CH, 2004, J APPL PHYSIOL, V96, P621, DOI 10.1152/japplphysiol.00830.2003; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Lollo PCB, 2012, FOOD RES INT, V49, P416, DOI 10.1016/j.foodres.2012.07.024; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLean P S, 2000, Exerc Sport Sci Rev, V28, P148; Meisel H, 2005, CURR MED CHEM, V12, P1905, DOI 10.2174/0929867054546618; Morifuji M, 2005, NUTRITION, V21, P1052, DOI 10.1016/j.nut.2005.01.010; Morifuji M, 2005, BRIT J NUTR, V93, P439, DOI 10.1079/BJN20051373; Morifuji M, 2011, NUTRITION, V27, P833, DOI 10.1016/j.nut.2010.08.021; Morifuji M, 2009, J NUTR SCI VITAMINOL, V55, P81, DOI 10.3177/jnsv.55.81; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Nery-Diez ACC, 2010, J MED FOOD, V13, P992, DOI 10.1089/jmf.2009.0149; Okamoto MM, 2011, J ENDOCRINOL, V211, P55, DOI 10.1530/JOE-11-0105; Pal S, 2010, BRIT J NUTR, V104, P1241, DOI 10.1017/S0007114510001911; Power O, 2009, AMINO ACIDS, V37, P333, DOI 10.1007/s00726-008-0156-0; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Tassi EMM, 1998, NUTR RES, V18, P875, DOI 10.1016/S0271-5317(98)00072-4; Pimenta FMV, 2006, INT DAIRY J, V16, P984, DOI 10.1016/j.idairyj.2005.12.006; WHITE JA, 1986, J AUTOM CHEM, V8, P170, DOI 10.1155/S1463924686000330; Zorzano A, 2005, ACTA PHYSIOL SCAND, V183, P43, DOI 10.1111/j.1365-201X.2004.01380.x	30	33	33	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							SICI e71134	10.1371/journal.pone.0071134	http://dx.doi.org/10.1371/journal.pone.0071134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023607	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200001
J	Saldova, R; Piccard, H; Perez-Garay, M; Harvey, DJ; Struwe, WB; Galligan, MC; Berghmans, N; Madden, SF; Peracaula, R; Opdenakker, G; Rudd, PM				Saldova, Radka; Piccard, Helene; Perez-Garay, Marta; Harvey, David J.; Struwe, Weston B.; Galligan, Marie C.; Berghmans, Nele; Madden, Stephen F.; Peracaula, Rosa; Opdenakker, Ghislain; Rudd, Pauline M.			Increase in Sialylation and Branching in the Mouse Serum N-glycome Correlates with Inflammation and Ovarian Tumour Progression	PLOS ONE			English	Article							CHLORITE-OXIDIZED OXYAMYLOSE; LASER-DESORPTION IONIZATION; STRUCTURAL-ANALYSIS; LINKED OLIGOSACCHARIDES; GLYCANS; CANCER; GLYCOPROTEINS; INHIBITION; INDUCTION; PROTEINS	Ovarian cancer is the most lethal gynaecological cancer and is often diagnosed in late stage, often as the result of the unavailability of sufficiently sensitive biomarkers for early detection, tumour progression and tumour-associated inflammation. Glycosylation is the most common posttranslational modification of proteins; it is altered in cancer and therefore is a potential source of biomarkers. We investigated the quantitative and qualitative effects of anti-inflammatory (acetylsalicylic acid) and pro-inflammatory (thioglycolate and chlorite-oxidized oxyamylose) drugs on glycosylation in mouse cancer serum. A significant increase in sialylation and branching of glycans in mice treated with an inflammation-inducing compound was observed. Moreover, the increases in sialylation correlated with increased tumour sizes. Increases in sialylation and branching were consistent with increased expression of sialyltransferases and the branching enzyme MGAT5. Because the sialyltransferases are highly conserved among species, the described changes in the ovarian cancer mouse model are relevant to humans and serum N-glycome analysis for monitoring disease treatment and progression might be a useful biomarker.	[Saldova, Radka; Harvey, David J.; Struwe, Weston B.; Rudd, Pauline M.] Natl Inst Bioproc Res & Training, GlycoSci Grp, Dublin, Ireland; [Piccard, Helene; Berghmans, Nele; Opdenakker, Ghislain] Univ Louvain, Rega Inst Med Res, Immunobiol Lab, Louvain, Belgium; [Perez-Garay, Marta; Peracaula, Rosa] Univ Girona, Dept Biol, Unitat Bioquim & Biol Mol, Girona, Spain; [Harvey, David J.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Galligan, Marie C.] Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland; [Madden, Stephen F.] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland	KU Leuven; Universitat de Girona; University of Oxford; University College Dublin; Dublin City University	Rudd, PM (corresponding author), Natl Inst Bioproc Res & Training, GlycoSci Grp, Dublin, Ireland.	pauline.rudd@nibrt.ie	Harvey, David/A-5579-2013; Opdenakker, Ghislain/Q-3130-2017; Struwe, Weston/D-6180-2018; Opdenakker, Ghislain/V-8562-2019	Opdenakker, Ghislain/0000-0003-1714-2294; Struwe, Weston/0000-0003-0594-226X; Opdenakker, Ghislain/0000-0003-1714-2294; Harvey, David/0000-0003-0544-771X; Madden, Stephen/0000-0002-0489-4588; Peracaula, Rosa/0000-0003-3513-524X; Fahey (Saldova), Radka/0000-0001-5085-5080	European Union Seventh Framework Programme (FP7) [260600]; Science Foundation Ireland, Strategic Research Cluster; "Geconcerteerde OnderzoeksActies (GOA)" from the KU Leuven; Fund for Scientific Research of Flanders (FWO-Vlaanderen); Wellcome Trust; Spanish Ministry of Science and Innovation [BIO 2010-16922]	European Union Seventh Framework Programme (FP7); Science Foundation Ireland, Strategic Research Cluster(Science Foundation Ireland); "Geconcerteerde OnderzoeksActies (GOA)" from the KU Leuven; Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Wellcome Trust(Wellcome Trust); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	R.S. acknowledges funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no260600 ("GlycoHIT"). S.F.M. acknowledges funding from Science Foundation Ireland, Strategic Research Cluster, award to Molecular Therapeutics for Cancer Ireland. The G.O. group thanks for support from the "Geconcerteerde OnderzoeksActies (GOA)" from the KU Leuven and the Fund for Scientific Research of Flanders (FWO-Vlaanderen). We thank the Wellcome Trust for an equipment grant to purchase the electrospray mass spectrometer. R.P. acknowledges funding from the Spanish Ministry of Science and Innovation [grants BIO 2010-16922]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 2008, CANCER CHEMOTH PHARM, V61, P203, DOI 10.1007/s00280-007-0462-3; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; BILLIAU A, 1971, LIFE SCI 2-BIOCH GEN, V10, P643, DOI 10.1016/0024-3205(71)90060-9; BORNSEN KO, 1995, RAPID COMMUN MASS SP, V9, P1031, DOI 10.1002/rcm.1290091112; CLAES P, 1970, J VIROL, V5, P313, DOI 10.1128/JVI.5.3.313-320.1970; Coddeville B, 2000, BBA-GEN SUBJECTS, V1475, P321, DOI 10.1016/S0304-4165(00)00083-0; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DECLERCQ E, 1972, EUR J CANCER, V8, P535, DOI 10.1016/0014-2964(72)90106-5; Dhingra VK, 2012, WOMENS HEALTH, V8, P191, DOI 10.2217/whe.11.91; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Duffy MJ, 2005, INT J GYNECOL CANCER, V15, P679, DOI 10.1111/j.1525-1438.2005.00130.x; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lattova E, 2008, J AM SOC MASS SPECTR, V19, P671, DOI 10.1016/j.jasms.2008.01.016; Li S, 2008, BIOCHEM PHARMACOL, V76, P831, DOI 10.1016/j.bcp.2008.07.022; Li S, 2010, J LEUKOCYTE BIOL, V88, P1017, DOI 10.1189/jlb.1109724; Lin SY, 2008, J PROTEOME RES, V7, P3293, DOI 10.1021/pr800093b; Llop E, 2008, ANAL BIOCHEM, V383, P243, DOI 10.1016/j.ab.2008.08.027; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marino K, 2012, CARBOHYDRATE CHEM CH; Montesino R, 2010, ARCH BIOCHEM BIOPHYS, V500, P169, DOI 10.1016/j.abb.2010.05.006; Peracaula R, 2010, PROTEOM CLIN APPL, V4, P426, DOI 10.1002/prca.200900170; Piccard H, 2012, CRIT REV ONCOL HEMAT, V82, P296, DOI 10.1016/j.critrevonc.2011.06.004; Piccard H, 2012, INT J CANCER, V131, pE425, DOI 10.1002/ijc.26465; Robinson-Smith TM, 2007, CANCER RES, V67, P5708, DOI 10.1158/0008-5472.CAN-06-4375; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Royle Louise, 2006, V347, P125; VanDamme J, 1997, J LEUKOCYTE BIOL, V62, P563, DOI 10.1002/jlb.62.5.563; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068	36	33	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e71159	10.1371/journal.pone.0071159	http://dx.doi.org/10.1371/journal.pone.0071159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023608	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200002
J	Broadbent, E; Kumar, V; Li, XY; Sollers, J; Stafford, RQ; MacDonald, BA; Wegner, DM				Broadbent, Elizabeth; Kumar, Vinayak; Li, Xingyan; Sollers, John, III; Stafford, Rebecca Q.; MacDonald, Bruce A.; Wegner, Daniel M.			Robots with Display Screens: A Robot with a More Humanlike Face Display Is Perceived To Have More Mind and a Better Personality	PLOS ONE			English	Article							UNCANNY VALLEY; PERCEPTION; BEHAVIOR	It is important for robot designers to know how to make robots that interact effectively with humans. One key dimension is robot appearance and in particular how humanlike the robot should be. Uncanny Valley theory suggests that robots look uncanny when their appearance approaches, but is not absolutely, human. An underlying mechanism may be that appearance affects users' perceptions of the robot's personality and mind. This study aimed to investigate how robot facial appearance affected perceptions of the robot's mind, personality and eeriness. A repeated measures experiment was conducted. 30 participants (14 females and 16 males, mean age 22.5 years) interacted with a Peoplebot healthcare robot under three conditions in a randomized order: the robot had either a humanlike face, silver face, or no-face on its display screen. Each time, the robot assisted the participant to take his/her blood pressure. Participants rated the robot's mind, personality, and eeriness in each condition. The robot with the humanlike face display was most preferred, rated as having most mind, being most humanlike, alive, sociable and amiable. The robot with the silver face display was least preferred, rated most eerie, moderate in mind, humanlikeness and amiability. The robot with the no-face display was rated least sociable and amiable. There was no difference in blood pressure readings between the robots with different face displays. Higher ratings of eeriness were related to impressions of the robot with the humanlike face display being less amiable, less sociable and less trustworthy. These results suggest that the more humanlike a healthcare robot's face display is, the more people attribute mind and positive personality characteristics to it. Eeriness was related to negative impressions of the robot's personality. Designers should be aware that the face on a robot's display screen can affect both the perceived mind and personality of the robot.	[Broadbent, Elizabeth; Kumar, Vinayak; Sollers, John, III; Stafford, Rebecca Q.] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand; [Li, Xingyan; MacDonald, Bruce A.] Univ Auckland, Dept Elect & Comp Engn, Auckland 1, New Zealand; [Wegner, Daniel M.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Auckland; University of Auckland; Harvard University	Broadbent, E (corresponding author), Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand.	e.broadbent@auckland.ac.nz		Broadbent, Elizabeth/0000-0003-3626-9100	University of Auckland Research Excellence award	University of Auckland Research Excellence award	This research was funded by a University of Auckland Research Excellence award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH SE, 1946, J ABNORM SOC PSYCH, V41, P258, DOI 10.1037/h0055756; Bartneck Christoph, 2007, 16th IEEE International Conference on Robot and Human Interactive Communication, P368; Broadbent E, 2009, INT J SOC ROBOT, V1, P319, DOI 10.1007/s12369-009-0030-6; Broadbent E, 2012, AUSTRALAS J AGEING, V31, P115, DOI 10.1111/j.1741-6612.2011.00551.x; Broadbent E, 2011, INT J SOC ROBOT, V3, P291, DOI 10.1007/s12369-011-0096-9; Broadbent E, 2010, TELEMED J E-HEALTH, V16, P608, DOI 10.1089/tmj.2009.0171; Broekens Joost, 2009, Gerontechnology, V8, P94, DOI 10.4017/gt.2009.08.02.002.00; Cheetham M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00126; Chin-Chang Ho, 2008, 2008 3rd ACM/IEEE International Conference on Human-Robot Interaction (HRI 2008), P169; DiSalvo C. F., 2002, P 4 C DESIGNING INTE, P321, DOI [10.1145/778712.778756, DOI 10.1145/778712.778756]; Eyssel F., 2012, 2012 RO-MAN: The 21st IEEE International Symposium on Robot and Human Interactive Communication, P851, DOI 10.1109/ROMAN.2012.6343858; Eyssel F, 2011, EFFECTS ANTICIPATED, P61; Eyssel F, 2010, 2010 IEEE RO-MAN, P646, DOI 10.1109/ROMAN.2010.5598687; Floridi L, 2004, MIND MACH, V14, P349, DOI 10.1023/B:MIND.0000035461.63578.9d; Graf B., 2009, IEEE WORKSH ADV ROB, P139, DOI [10.1109/ARSO.2009.5587059, DOI 10.1109/ARSO.2009.5587059, DOI 10.1109/ARS0.2009.5587059]; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Gray K, 2012, COGNITION, V125, P125, DOI 10.1016/j.cognition.2012.06.007; Hanson D, 2006, P ICCS COGSCI 2006 L, P16; Jayawardena C, 2012, P IEEE RAS-EMBS INT, P1837, DOI 10.1109/BioRob.2012.6290890; Kaneko K, 2011, IEEE INT C INT ROBOT, P4400, DOI 10.1109/IROS.2011.6048074; Kramer NC, 2008, LECT NOTES ARTIF INT, V4930, P222; Lewkowicz DJ, 2012, DEV PSYCHOBIOL, V54, P124, DOI 10.1002/dev.20583; MacDorman KF, 2006, INTERACT STUD, V7, P297, DOI 10.1075/is.7.3.03mac; MacDorman KF, 2009, COMPUT HUM BEHAV, V25, P695, DOI 10.1016/j.chb.2008.12.026; MacDorman KF, 2005, P ICCS COGSCI 2006 L, P26; Mitchell WJ, 2011, I-PERCEPTION, V2, P10, DOI 10.1068/i0415; Moore RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00864; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Niculescu A., 2011, Proceedings of the 2011 International Conference on User Science and Engineering (i-USEr 2011), P18, DOI 10.1109/iUSEr.2011.6150529; Paepcke S, 2010, ACMIEEE INT CONF HUM, P45, DOI 10.1109/HRI.2010.5453268; Pollick F. E., 2010, SOCIAL INFORM TELECO, P69, DOI DOI 10.1007/978-3-642-12630-7_8; Powers A., 2006, P 1 ACM SIGCHI SIGAR, DOI [10.1145/1121241.1121280, DOI 10.1145/1121241.1121280]; Saygin AP, 2012, SOC COGN AFFECT NEUR, V7, P413, DOI 10.1093/scan/nsr025; Shibata T, 2011, GERONTOLOGY, V57, P378, DOI 10.1159/000319015; Steckenfinger SA, 2009, P NATL ACAD SCI USA, V106, P18362, DOI 10.1073/pnas.0910063106; Tamagawa R, 2011, INT J SOC ROBOT, V3, P253, DOI 10.1007/s12369-011-0100-4; Thompson JC, 2011, PERCEPTION, V40, P695, DOI 10.1068/p6900; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; von der Putten AM, 2011, ACMIEEE INT CONF HUM, P283, DOI 10.1145/1957656.1957772; von der Putten AM, 2010, COMPUT HUM BEHAV, V26, P1641, DOI 10.1016/j.chb.2010.06.012; Walters ML, 2008, AUTON ROBOT, V24, P159, DOI 10.1007/s10514-007-9058-3; Waytz A, 2010, TRENDS COGN SCI, V14, P383, DOI 10.1016/j.tics.2010.05.006; Woods S, 2004, RO-MAN 2004: 13TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P47, DOI 10.1109/ROMAN.2004.1374728	43	94	94	9	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72589	10.1371/journal.pone.0072589	http://dx.doi.org/10.1371/journal.pone.0072589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015263	Green Submitted, gold, Green Published			2022-12-27	WOS:000323733800067
J	Kushwaha, S; Singh, PK; Rana, AK; Misra-Bhattacharya, S				Kushwaha, Susheela; Singh, Prashant Kumar; Rana, Ajay Kumar; Misra-Bhattacharya, Shailja			Immunization of Mastomys coucha with Brugia malayi Recombinant Trehalose-6-Phosphate Phosphatase Results in Significant Protection against Homologous Challenge Infection	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI; IMMUNE-RESPONSES; ANTHELMINTIC RESISTANCE; DENDRITIC CELLS; NITRIC-OXIDE; HIGH-LEVEL; NEMATODE; VACCINATION; ANTIGEN; LARVAE	Development of a vaccine to prevent or reduce parasite development in lymphatic filariasis would be a complementary approach to existing chemotherapeutic tools. Trehalose-6-phosphate phosphatase of Brugia malayi (Bm-TPP) represents an attractive vaccine target due to its absence in mammals, prevalence in the major life stages of the parasite and immunoreactivity with human bancroftian antibodies, especially from endemic normal subjects. We have recently reported on the cloning, expression, purification and biochemical characterization of this vital enzyme of B. malayi. In the present study, immunoprophylactic evaluation of Bm-TPP was carried out against B. malayi larval challenge in a susceptible host Mastomys coucha and the protective ability of the recombinant protein was evaluated by observing the adverse effects on microfilarial density and adult worm establishment. Immunization caused 78.4% decrease in microfilaremia and 71.04% reduction in the adult worm establishment along with sterilization of 70.06% of the recovered live females. The recombinant protein elicited a mixed Th1/Th2 type of protective immune response as evidenced by the generation of both pro-and anti-inflammatory cytokines IL-2, IFN-gamma, TNF-alpha, IL-4 and an increased production of antibody isotypes IgG1, IgG2a, IgG2b and IgA. Thus immunization with Bm-TPP conferred considerable protection against B. malayi establishment by engendering a long-lasting effective immune response and therefore emerges as a potential vaccine candidate against lymphatic filariasis (LF).	[Kushwaha, Susheela; Singh, Prashant Kumar; Rana, Ajay Kumar; Misra-Bhattacharya, Shailja] CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Misra-Bhattacharya, S (corresponding author), CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India.	Shailja_cdri@rediffmail.com		Rana, Ajay/0000-0003-3954-5887; SINGH, PRASHANT/0000-0002-6704-277X	NET fellowships by University Grants Commission, New Delhi, India; Council for Industrial and Scientific Research, New Delhi, India; CSIR network project 'SPLenDID'	NET fellowships by University Grants Commission, New Delhi, India; Council for Industrial and Scientific Research, New Delhi, India; CSIR network project 'SPLenDID'	The financial supports in the form of NET fellowships by University Grants Commission, New Delhi, India (SK) and Council for Industrial and Scientific Research, New Delhi, India (PKS) are gratefully acknowledged. The authors also acknowledge the financial assistance in the form of CSIR network project 'SPLenDID'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND NM, 1986, PARASITE IMMUNOL, V8, P391, DOI 10.1111/j.1365-3024.1986.tb00855.x; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P377; Babayan SA, 2006, INT J PARASITOL, V36, P903, DOI 10.1016/j.ijpara.2006.04.013; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Benoit JB, 2009, COMP BIOCHEM PHYS A, V152, P518, DOI 10.1016/j.cbpa.2008.12.009; Bottazzi ME, 2006, EXPERT REV VACCINES, V5, P189, DOI 10.1586/14760584.5.2.189; CHANDRASHEKAR R, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P15; CHANDRASHEKAR R, 1985, PARASITE IMMUNOL, V7, P633, DOI 10.1111/j.1365-3024.1985.tb00107.x; Chenthamarakshan V, 1997, J BIOSCIENCE, V22, P91, DOI 10.1007/BF02703621; Coles GC, 2006, VET PARASITOL, V136, P167, DOI 10.1016/j.vetpar.2005.11.019; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Diemert DJ, 2008, CLIN INFECT DIS, V46, P282, DOI 10.1086/524070; Dimock KA, 1996, INFECT IMMUN, V64, P2962, DOI 10.1128/IAI.64.8.2962-2967.1996; ELSON LH, 1995, J INFECT DIS, V171, P652, DOI 10.1093/infdis/171.3.652; Gal TZ, 2001, J PARASITOL, V87, P725, DOI 10.1645/0022-3395(2001)087[0725:AITLOG]2.0.CO;2; Gregory WF, 2000, INFECT IMMUN, V68, P4174, DOI 10.1128/IAI.68.7.4174-4179.2000; GRZYCH JM, 1993, J IMMUNOL, V150, P527; Hoerauf A, 2003, CURR OPIN INFECT DIS, V16, P403, DOI 10.1097/00001432-200310000-00006; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Jenson JS, 2002, EUR J IMMUNOL, V32, P858, DOI 10.1002/1521-4141(200203)32:3<858::AID-IMMU858>3.0.CO;2-E; Johnston Kelly L, 2007, Curr Infect Dis Rep, V9, P55, DOI 10.1007/s11908-007-0023-2; Kalyanasundaram R, 2011, RES REP TROP MED, V2, P45, DOI 10.2147/RRTM.S13679; Khalil Hamed M., 1999, Journal of the Egyptian Society of Parasitology, V29, P395; Kushwaha S, 2011, PARASITE IMMUNOL; Kushwaha S, 2012, MICROBES INFECT, V14, P1330, DOI 10.1016/j.micinf.2012.08.006; Kushwaha S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001770; Kushwaha S, 2011, ACTA TROP, V119, P151, DOI 10.1016/j.actatropica.2011.05.008; Le Goff L, 1997, TROP MED INT HEALTH, V2, P1170, DOI 10.1046/j.1365-3156.1997.d01-218.x; Liu LX, 1996, NEW ENGL J MED, V334, P1178, DOI 10.1056/NEJM199605023341808; LLOYD S, 1978, IMMUNOLOGY, V34, P939; Loke P, 2000, EUR J IMMUNOL; MABBOTT NA, 1995, PARASITE IMMUNOL, V17, P143, DOI 10.1111/j.1365-3024.1995.tb01016.x; MacDonald AS, 1998, J IMMUNOL, V160, P1304; Makepeace BL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000544; Molyneux DH, 2009, T ROY SOC TROP MED H, V103, P338, DOI 10.1016/j.trstmh.2008.12.016; Molyneux DH, 2002, ANN TROP MED PARASIT, V96, pS15, DOI 10.1179/000349802125002374; NANDURI J, 1989, CLIN MICROBIOL REV, V2, P39, DOI 10.1128/CMR.2.1.39-50.1989; Osborne J, 1996, INFECT IMMUN, V64, P3461, DOI 10.1128/IAI.64.9.3461-3466.1996; Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2; OTTESEN EA, 1992, PARASITOLOGY, V104, pS71, DOI 10.1017/S0031182000075259; Pokharel DR, 2006, VACCINE, V24, P6208, DOI 10.1016/j.vaccine.2006.05.103; Prichard RK, 2007, EXPERT OPIN DRUG DIS, V2, pS41, DOI 10.1517/17460441.2.S1.S41; Richard-Lenoble D, 2003, FUND CLIN PHARMACOL, V17, P199, DOI 10.1046/j.1472-8206.2003.00170.x; ROM WN, 1990, AM REV RESPIR DIS, V142, P1088, DOI 10.1164/ajrccm/142.5.1088; Saeftel M, 2003, INFECT IMMUN, V71, P6978, DOI 10.1128/IAI.71.12.6978-6985.2003; Sahu BR, 2008, J INFECT DIS, V198, P434, DOI 10.1086/589881; Schwab AE, 2007, PARASITOLOGY, V134, P1025, DOI 10.1017/S0031182007002363; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; Semnani RT, 2001, INFECT IMMUN, V69, P5813, DOI 10.1128/IAI.69.9.5813-5822.2001; Shakya S, 2009, PARASITOL INT, V58, P346, DOI 10.1016/j.parint.2009.07.007; SIM BKL, 1982, T ROY SOC TROP MED H, V76, P362, DOI 10.1016/0035-9203(82)90191-2; Solomon A, 2000, PARASITOLOGY, V121, P409, DOI 10.1017/S0031182099006563; Thirugnanam S, 2007, EXP PARASITOL, V116, P483, DOI 10.1016/j.exppara.2007.02.017; Townson S, 2007, EXPERT OPIN DRUG DIS, V2, pS63, DOI 10.1517/17460441.2.S1.S63; Vanam U, 2009, AM J TROP MED HYG, V80, P319, DOI 10.4269/ajtmh.2009.80.319; Vedi S, 2008, VACCINE, V26, P5997, DOI 10.1016/j.vaccine.2008.08.073; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457; VICKERY AC, 1984, PARASITE IMMUNOL, V6, P545, DOI 10.1111/j.1365-3024.1984.tb00824.x; Volkmann L, 2001, INFECT IMMUN, V69, P2950, DOI 10.1128/IAI.69.5.2950-2956.2001; Wharton DA, 2002, CRYOLETTERS, V23, P5; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; YATES JA, 1985, AM J TROP MED HYG, V34, P1132, DOI 10.4269/ajtmh.1985.34.1132	63	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72585	10.1371/journal.pone.0072585	http://dx.doi.org/10.1371/journal.pone.0072585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015262	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800066
J	Tilburt, JC; James, KM; Jenkins, SM; Antiel, RM; Curlin, FA; Rasinski, KA				Tilburt, Jon C.; James, Katherine M.; Jenkins, Sarah M.; Antiel, Ryan M.; Curlin, Farr A.; Rasinski, Kenneth A.			"Righteous Minds" in Health Care: Measurement and Explanatory Value of Social Intuitionism in Accounting for the Moral Judgments in a Sample of US Physicians	PLOS ONE			English	Article							RELIGIOSITY; CONSCIENCE; ATTITUDES	The broad diversity in physicians' judgments on controversial health care topics may reflect differences in religious characteristics, political ideologies, and moral intuitions. We tested an existing measure of moral intuitions in a new population (U. S. physicians) to assess its validity and to determine whether physicians' moral intuitions correlate with their views on controversial health care topics as well as other known predictors of these intuitions such as political affiliation and religiosity. In 2009, we mailed an 8-page questionnaire to a random sample of 2000 practicing U. S. physicians from all specialties. The survey included the Moral Foundations Questionnaire (MFQ30), along with questions on physicians' judgments about controversial health care topics including abortion and euthanasia (no moral objection, some moral objection, strong moral objection). A total of 1032 of 1895 (54%) physicians responded. Physicians' overall mean moral foundations scores were 3.5 for harm, 3.3 for fairness, 2.8 for loyalty, 3.2 for authority, and 2.7 for sanctity on a 0-5 scale. Increasing levels of religious service attendance, having a more conservative political ideology, and higher sanctity scores remained the greatest positive predictors of respondents objecting to abortion (beta = 0.12, 0.23, 0.14, respectively, each p < 0.001) as well as euthanasia (beta = 0.08, 0.17, and 0.17, respectively, each p < 0.001), even after adjusting for demographics. Higher authority scores were also significantly negatively associated with objection to abortion (beta = -0.12, p < 0.01), but not euthanasia. These data suggest that the relative importance physicians place on the different categories of moral intuitions may predict differences in physicians' judgments about morally controversial topics and may interrelate with ideology and religiosity. Further examination of the diversity in physicians' moral intuitions may prove illustrative in describing and addressing moral differences that arise in medical practice.	[Tilburt, Jon C.] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA; [Tilburt, Jon C.; James, Katherine M.] Mayo Clin, Biomed Eth Res Unit, Rochester, MN USA; [Tilburt, Jon C.] Mayo Clin, Mayo Program Professionalism & Eth, Rochester, MN USA; [Jenkins, Sarah M.] Mayo Clin, Rochester, MN USA; [Antiel, Ryan M.] Mayo Clin, Dept Surg, Rochester, MN USA; [Curlin, Farr A.] Univ Chicago, Dept Med, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; [Rasinski, Kenneth A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Chicago; University of Chicago	Tilburt, JC (corresponding author), Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA.	tilburt.jon@mayo.edu	FORETZ, Marc/O-7334-2017	FORETZ, Marc/0000-0001-7017-9032	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [1 KL2 RR024151]; NIH Roadmap for Medical Research; Mayo Clinic Program in Professionalism and Ethics and Department of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Program in Professionalism and Ethics and Department of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was made possible by Grant Number 1 KL2 RR024151 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research, as well as funds from the Mayo Clinic Program in Professionalism and Ethics and Department of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghababaei N, 2013, AM J HOSP PALLIAT ME, V30, P781, DOI 10.1177/1049909112472721; American Medical Association, 2013, AMA PHYS MAST; Antiel RM, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0907876; Bulow HH, 2012, INTENS CARE MED, V38, P1126, DOI 10.1007/s00134-012-2554-8; Combs MP, 2011, J MED ETHICS, V37, P397, DOI 10.1136/jme.2010.041194; Craig A, 2007, J MED ETHICS, V33, P400, DOI 10.1136/jme.2006.018713; Curlin FA, 2007, NEW ENGL J MED, V356, P593, DOI 10.1056/NEJMsa065316; Haidt J., 2012, RIGHTEOUS MIND WHY G; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Koleva SP, 2012, J RES PERS, V46, P184, DOI 10.1016/j.jrp.2012.01.006; Krosnick JA, 1999, ANNU REV PSYCHOL, V50, P537, DOI 10.1146/annurev.psych.50.1.537; Lawrence RE, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.051; Lawrence RE, 2009, ACAD MED, V84, P1276, DOI 10.1097/ACM.0b013e3181b18dc5; Pawlikowski J, 2012, ANN AGR ENV MED, V19, P503; Smyth JD, 2006, PUBLIC OPIN QUART, V70, P66, DOI 10.1093/poq/nfj007; The American Association for Public Opinion Research, 2011, STAND DEF FIN DISP C	16	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73379	10.1371/journal.pone.0073379	http://dx.doi.org/10.1371/journal.pone.0073379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219OE	24023864	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600096
J	Citerne, HL; Le Guilloux, M; Sannier, J; Nadot, S; Damerval, C				Citerne, Helene L.; Le Guilloux, Martine; Sannier, Julie; Nadot, Sophie; Damerval, Catherine			Combining Phylogenetic and Syntenic Analyses for Understanding the Evolution of TCP ECE Genes in Eudicots	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL SYMMETRY; EXPRESSION DIVERGENCE; COROLLA MONOSYMMETRY; GENOME DUPLICATIONS; PISTILLATA LINEAGES; FLOWER DEVELOPMENT; CORE EUDICOTS; DIVERSIFICATION; ZYGOMORPHY	TCP ECE genes encode transcription factors which have received much attention for their repeated recruitment in the control of floral symmetry in core eudicots, and more recently in monocots. Major duplications of TCP ECE genes have been described in core eudicots, but the evolutionary history of this gene family is unknown in basal eudicots. Reconstructing the phylogeny of ECE genes in basal eudicots will help set a framework for understanding the functional evolution of these genes. TCP ECE genes were sequenced in all major lineages of basal eudicots and Gunnera which belongs to the sister clade to all other core eudicots. We show that in these lineages they have a complex evolutionary history with repeated duplications. We estimate the timing of the two major duplications already identified in the core eudicots within a timeframe before the divergence of Gunnera and after the divergence of Proteales. We also use a synteny-based approach to examine the extent to which the expansion of TCP ECE genes in diverse eudicot lineages may be due to genome-wide duplications. The three major core-eudicot specific clades share a number of collinear genes, and their common evolutionary history may have originated at the gamma event. Genomic comparisons in Arabidopsis thaliana and Solanum lycopersicum highlight their separate polyploid origin, with syntenic fragments with and without TCP ECE genes showing differential gene loss and genomic rearrangements. Comparison between recently available genomes from two basal eudicots Aquilegia coerulea and Nelumbo nucifera suggests that the two TCP ECE paralogs in these species are also derived from large-scale duplications. TCP ECE loci from basal eudicots share many features with the three main core eudicot loci, and allow us to infer the makeup of the ancestral eudicot locus.	[Citerne, Helene L.; Le Guilloux, Martine; Damerval, Catherine] Paris South Univ, Plant Genet Res Unit, Natl Ctr Sci Res, Natl Inst Agron Res, Gif Sur Yvette, France; [Sannier, Julie; Nadot, Sophie] Paris South Univ, Ecol Systemat & Evolut Lab, Natl Ctr Sci Res AgroParisTech, Orsay, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech	Citerne, HL (corresponding author), Paris South Univ, Plant Genet Res Unit, Natl Ctr Sci Res, Natl Inst Agron Res, Gif Sur Yvette, France.	h_citerne@hotmail.com			Agence Nationale de la Recherche program [ANR-07-BLAN-0112-02]	Agence Nationale de la Recherche program(French National Research Agency (ANR))	The project was funded by the Agence Nationale de la Recherche program ANR-07-BLAN-0112-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; Airoldi CA, 2012, J GENET GENOMICS, V39, P157, DOI 10.1016/j.jgg.2012.02.008; Almeida J, 2005, INT J DEV BIOL, V49, P527, DOI 10.1387/ijdb.041967ja; Almeida J, 1997, DEVELOPMENT, V124, P1387; Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; Bartlett ME, 2011, AM J BOT, V98, P227, DOI 10.3732/ajb.1000246; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; Busch A, 2007, P NATL ACAD SCI USA, V104, P16714, DOI 10.1073/pnas.0705338104; Busch A, 2012, MOL BIOL EVOL, V29, P1241, DOI 10.1093/molbev/msr297; Cantino PD, 2007, TAXON, V56, P822, DOI 10.2307/25065865; Causier B, 2010, MOL BIOL EVOL, V27, P2651, DOI 10.1093/molbev/msq156; Cenci A, 2010, MOL GENET GENOMICS, V283, P493, DOI 10.1007/s00438-010-0534-7; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; Chapman MA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002628; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Citerne H, 2010, ADV BOT RES, V54, P85, DOI 10.1016/S0065-2296(10)54003-5; Citerne HL, 2006, P NATL ACAD SCI USA, V103, P12017, DOI 10.1073/pnas.0600986103; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Cubas P, 2001, CURR BIOL, V11, P1050, DOI 10.1016/S0960-9822(01)00295-0; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Damerval C, 2007, ANN BOT-LONDON, V100, P631, DOI 10.1093/aob/mcm041; Damerval C, 2007, PLANT PHYSIOL, V143, P759, DOI 10.1104/pp.106.090324; Damerval C, 2013, AM J BOT, V100, P391, DOI 10.3732/ajb.1200376; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endress PK, 2006, ADV BOT RES, V44, P1, DOI 10.1016/S0065-2296(06)44001-5; Endress PK, 1999, INT J PLANT SCI, V160, pS3, DOI 10.1086/314211; Fambrini M, 2011, GENETICA, V139, P1521, DOI 10.1007/s10709-012-9652-y; Feng XZ, 2006, P NATL ACAD SCI USA, V103, P4970, DOI 10.1073/pnas.0600681103; Force A, 1999, GENETICS, V151, P1531; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hileman LC, 2003, P NATL ACAD SCI USA, V100, P12814, DOI 10.1073/pnas.1835725100; Howarth DG, 2006, P NATL ACAD SCI USA, V103, P9101, DOI 10.1073/pnas.0602827103; Howarth DG, 2011, ANN BOT-LONDON, V107, P1521, DOI 10.1093/aob/mcr049; Howarth DG, 2009, MOL BIOL EVOL, V26, P1245, DOI 10.1093/molbev/msp051; Hubbard L, 2002, GENETICS, V162, P1927; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Kim M, 2008, SCIENCE, V322, P1116, DOI 10.1126/science.1164371; Kolsch A, 2006, PLANT BIOLOGY, V8, P680, DOI 10.1055/s-2006-924286; Kramer EM, 1998, GENETICS, V149, P765; Kramer EM, 2003, INT J PLANT SCI, V164, P1, DOI 10.1086/344694; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Litt A, 2003, GENETICS, V165, P821; Liu CJ, 2010, MOL BIOL EVOL, V27, P1598, DOI 10.1093/molbev/msq044; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Mondragon-Palomino M, 2011, ANN BOT-LONDON, V107, P1533, DOI 10.1093/aob/mcr059; Neal PR, 1998, ANNU REV ECOL SYST, V29, P345, DOI 10.1146/annurev.ecolsys.29.1.345; OCHMAN H, 1988, GENETICS, V120, P621; Paterson AH, 2010, ANNU REV PLANT BIOL, V61, P349, DOI 10.1146/annurev-arplant-042809-112235; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Preston JC, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-6; Preston JC, 2011, P NATL ACAD SCI USA, V108, P2343, DOI 10.1073/pnas.1011361108; Preston JC, 2009, NEW PHYTOL, V182, P751, DOI 10.1111/j.1469-8137.2009.02794.x; Rasmussen DA, 2009, AM J BOT, V96, P96, DOI 10.3732/ajb.0800038; Sargent RD, 2004, P ROY SOC B-BIOL SCI, V271, P603, DOI 10.1098/rspb.2003.2644; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shan HY, 2007, MOL PHYLOGENET EVOL, V44, P26, DOI 10.1016/j.ympev.2007.02.016; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Soltis D, 2005, PHYLOGENY EVOLUTION; Soltis DE, 2003, AM J BOT, V90, P461, DOI 10.3732/ajb.90.3.461; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Song CF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-244; Specht CD, 2009, ANNU REV ECOL EVOL S, V40, P217, DOI 10.1146/annurev.ecolsys.110308.120203; Stellari GM, 2004, MOL BIOL EVOL, V21, P506, DOI 10.1093/molbev/msh044; Tahtiharju S, 2012, MOL BIOL EVOL, V29, P1155, DOI 10.1093/molbev/msr283; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Vekemans D, 2012, MOL BIOL EVOL, V29, P3793, DOI 10.1093/molbev/mss183; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wang YP, 2012, ANN NY ACAD SCI, V1256, P1, DOI 10.1111/j.1749-6632.2011.06384.x; Wang Z, 2008, P NATL ACAD SCI USA, V105, P10414, DOI 10.1073/pnas.0803291105; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Xu SL, 2013, J INTEGR PLANT BIOL, V55, P221, DOI 10.1111/j.1744-7909.2012.01169.x; Yang Zhang, 2009, Proceedings of the 2009 International Conference on Computational Intelligence and Security (CIS 2009), P1, DOI 10.1109/CIS.2009.263; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan Z, 2009, PLANT PHYSIOL, V149, P235, DOI 10.1104/pp.108.128231; Zhang WH, 2010, P NATL ACAD SCI USA, V107, P6388, DOI 10.1073/pnas.0910155107; Zhou XR, 2008, NEW PHYTOL, V178, P532, DOI 10.1111/j.1469-8137.2008.02384.x	90	27	31	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74803	10.1371/journal.pone.0074803	http://dx.doi.org/10.1371/journal.pone.0074803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019982	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200125
J	Pakula, A; Schneider, J; Janke, J; Zacharias, U; Schulz, H; Hubner, N; Mahler, A; Spuler, A; Spuler, S; Carlier, P; Boschmann, M				Pakula, Anna; Schneider, Joanna; Janke, Juergen; Zacharias, Ute; Schulz, Herbert; Huebner, Norbert; Maehler, Anja; Spuler, Andreas; Spuler, Simone; Carlier, Pierre; Boschmann, Michael			Altered Expression of Cyclin A 1 In Muscle of Patients with Facioscapulohumeral Muscle Dystrophy (FSHD-1)	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; INDUCED APOPTOSIS; CELLS; DISEASE; PROTEIN; MODEL; GENE; PATHOGENESIS; HYPERTROPHY; DUCHENNE	Objectives: Cyclin A1 regulates cell cycle activity and proliferation in somatic and germ-line cells. Its expression increases in G1/S phase and reaches a maximum in G2 and M phases. Altered cyclin A1 expression might contribute to clinical symptoms in facioscapulohumeral muscular dystrophy (FSHD). Methods: Muscle biopsies were taken from the Vastus lateralis muscle for cDNA microarray, RT-PCR, immunohistochemistry and Western blot analyses to assess RNA and protein expression of cyclin A1 in human muscle cell lines and muscle tissue. Muscle fibers diameter was calculated on cryosections to test for hypertrophy. Results: cDNA microarray data showed specifically elevated cyclin A1 levels in FSHD vs. other muscular disorders such as caveolinopathy, dysferlinopathy, four and a half LIM domains protein 1 deficiency and healthy controls. Data could be confirmed with RT-PCR and Western blot analysis showing up-regulated cyclin A1 levels also at protein level. We found also clear signs of hypertrophy within the Vastus lateralis muscle in FSHD-1 patients. Conclusions: In most somatic human cell lines, cyclin A1 levels are low. Overexpression of cyclin A1 in FSHD indicates cell cycle dysregulation in FSHD and might contribute to clinical symptoms of this disease.	[Pakula, Anna; Maehler, Anja; Boschmann, Michael] Charite Univ Med & Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Franz Volhard Ctr Clin Res, Berlin, Germany; [Schneider, Joanna; Zacharias, Ute; Spuler, Simone] Charite Univ Med & Max Delbruck Ctr Mol Med, Muscle Res Unit, Expt & Clin Res Ctr, Berlin, Germany; [Janke, Juergen] Max Delbruck Ctr Mol Med, Dept Mol Epidemiol, Berlin, Germany; [Schulz, Herbert; Huebner, Norbert] Max Delbruck Ctr Mol Med, Dept Expt Genet Cardiovasc Dis, Berlin, Germany; [Spuler, Andreas] HELIOS Klinikum Berlin Buch, Klin Neurochirurg, Berlin, Germany; [Carlier, Pierre] Pitie Salpetriere Univ Hosp, Inst Myol, AIM CEA NMR Lab, Inst Myol, Paris, France	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helios Kliniken; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; CEA; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Boschmann, M (corresponding author), Charite Univ Med & Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Franz Volhard Ctr Clin Res, Berlin, Germany.	michael.boschmann@charite.de	Zacharias, Ute/AAS-4998-2020	Mahler, Anja/0000-0002-3904-5789; Spuler, Simone/0000-0002-0155-1117; Schneider, Joanna/0000-0001-8810-0492; Spuler, Andreas/0000-0001-6031-179X	Deutsche Forschungsgemeinschaft [DFG KFO 192/2, DFG GRK 1631]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The project is supported by Deutsche Forschungsgemeinschaft (DFG KFO 192/2 and DFG GRK 1631. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barat-Houari M, 2010, EUR J HUM GENET, V18, P533, DOI 10.1038/ejhg.2009.207; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekberg J, 2006, INT J BIOCHEM CELL B, V38, P1330, DOI 10.1016/j.biocel.2006.01.011; Ekberg J, 2009, MOL CELL BIOCHEM, V320, P115, DOI 10.1007/s11010-008-9913-3; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Homma S, 2012, EUR J HUM GENET, V20, P404, DOI 10.1038/ejhg.2011.213; Jacobs HW, 2001, EMBO J, V20, P2376, DOI 10.1093/emboj/20.10.2376; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Ji P, 2007, INT J CANCER, V121, P706, DOI 10.1002/ijc.22634; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kornegay JN, 2012, PHYS MED REH CLIN N, V23, P149, DOI 10.1016/j.pmr.2011.11.014; Krom YD, 2012, AM J PATHOL, V181, P1387, DOI 10.1016/j.ajpath.2012.07.007; Lefkowitz DL, 2005, MED HYPOTHESES, V65, P716, DOI 10.1016/j.mehy.2005.04.035; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lu YM, 2012, STRENGTH FUNCTIONAL; Marg A, 2012, TRAFFIC, V13, P1286, DOI 10.1111/j.1600-0854.2012.01386.x; Meikrantz W, 1996, J BIOL CHEM, V271, P10205, DOI 10.1074/jbc.271.17.10205; Muller C, 2000, MOL CELL BIOL, V20, P3316, DOI 10.1128/MCB.20.9.3316-3329.2000; Philippi Susanne, 2012, PLoS Curr, V4, pRRN1298, DOI 10.1371/currents.RRN1298; R Core Team, 2012, R LANG ENV STAT COMP; Reutenauer J, 2008, BRIT J PHARMACOL, V155, P574, DOI 10.1038/bjp.2008.285; Rivera A, 2006, CELL MOL LIFE SCI, V63, P1425, DOI 10.1007/s00018-006-5521-5; Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; SLIPETZ DM, 1991, AM J HUM GENET, V48, P502; Spuler S, 2007, NEUROLOGY, V68, P677, DOI 10.1212/01.wnl.0000255939.73424.f8; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tupler R, 2004, CELL MOL LIFE SCI, V61, P557, DOI 10.1007/s00018-003-3285-3; van der Meer T, 2004, REPRODUCTION, V127, P503, DOI 10.1530/rep.1.00131; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	40	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73573	10.1371/journal.pone.0073573	http://dx.doi.org/10.1371/journal.pone.0073573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019929	gold, Green Published, Green Accepted			2022-12-27	WOS:000324338200071
J	Holtfreter, S; Radcliff, FJ; Grumann, D; Read, H; Johnson, S; Monecke, S; Ritchie, S; Clow, F; Goerke, C; Broker, BM; Fraser, JD; Wiles, S				Holtfreter, Silva; Radcliff, Fiona J.; Grumann, Dorothee; Read, Hannah; Johnson, Sarah; Monecke, Stefan; Ritchie, Stephen; Clow, Fiona; Goerke, Christiane; Broeker, Barbara M.; Fraser, John D.; Wiles, Siouxsie			Characterization of a Mouse-Adapted Staphylococcus aureus Strain	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; HORIZONTAL GENE-TRANSFER; IMMUNE EVASION; NASAL CARRIAGE; COMPLEMENT INHIBITOR; MICE; INFECTIONS; RESISTANCE; MODEL; BACTERIOPHAGES	More effective antibiotics and a protective vaccine are desperately needed to combat the 'superbug' Staphylococcus aureus. While in vivo pathogenicity studies routinely involve infection of mice with human S. aureus isolates, recent genetic studies have demonstrated that S. aureus lineages are largely host-specific. The use of such animal-adapted S. aureus strains may therefore be a promising approach for developing more clinically relevant animal infection models. We have isolated a mouse-adapted S. aureus strain (JSNZ) which caused a severe outbreak of preputial gland abscesses among male C57BL/6J mice. We aimed to extensively characterize this strain on a genomic level and determine its virulence potential in murine colonization and infection models. JSNZ belongs to the MLST type ST88, rare among human isolates, and lacks an hlb-converting phage encoding human-specific immune evasion factors. Naive mice were found to be more susceptible to nasal and gastrointestinal colonization with JSNZ than with the human-derived Newman strain. Furthermore, naive mice required antibiotic pre-treatment to become colonized with Newman. In contrast, JSNZ was able to colonize mice in the absence of antibiotic treatment suggesting that this strain can compete with the natural flora for space and nutrients. In a renal abscess model, JSNZ caused more severe disease than Newman with greater weight loss and bacterial burden. In contrast to most other clinical isolates, JSNZ can also be readily genetically modified by phage transduction and electroporation. In conclusion, the mouse-adapted strain JSNZ may represent a valuable tool for studying aspects of mucosal colonization and for screening novel vaccines and therapies directed at preventing colonization.	[Holtfreter, Silva; Radcliff, Fiona J.; Read, Hannah; Johnson, Sarah; Ritchie, Stephen; Clow, Fiona; Fraser, John D.; Wiles, Siouxsie] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Grumann, Dorothee; Broeker, Barbara M.] Ernst Moritz Arndt Univ Greifswald, Dept Immunol, Greifswald, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Monecke, Stefan] Alere Technol, Jena, Germany; [Goerke, Christiane] Univ Klinikum Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany	University of Auckland; Ernst Moritz Arndt Universitat Greifswald; Technische Universitat Dresden; Alere; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wiles, S (corresponding author), Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand.	s.wiles@auckland.ac.nz	Bröker, Barbara M/O-4850-2015; Wiles, Siouxsie/E-1690-2011; Radcliff, Fiona/R-4010-2019	Bröker, Barbara M/0000-0002-5020-8542; Wiles, Siouxsie/0000-0002-0467-0015; Holtfreter, Silva/0000-0002-2672-8230; Read, Hannah/0000-0002-9540-5224; Ritchie, Stephen/0000-0001-5001-8899; Radcliff, Fiona/0000-0003-2679-6927	German Research Foundation [HO4345/1-1]; Health Research Council of New Zealand [09/099]	German Research Foundation(German Research Foundation (DFG)); Health Research Council of New Zealand(Health Research Council of New Zealand)	S.H. was supported by a Research fellowship (grant HO4345/1-1) from the German Research Foundation (http://www.dfg.de/en/) and S.W. by a Sir Charles Hercus Fellowship (09/099) from the Health Research Council of New Zealand (http://www.hrc.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Baker D. G., 2003, NATURAL PATHOGENS LA; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; BLACKMORE DK, 1970, J COMP PATHOL, V80, P645, DOI 10.1016/0021-9975(70)90064-2; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; BREMELL T, 1990, ARTHRITIS RHEUM, V33, P1739, DOI 10.1002/art.1780331120; Capparelli R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028377; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fluit AC, 2001, EUR J CLIN MICROBIOL, V20, P617; FORD CW, 1989, J MED MICROBIOL, V28, P259, DOI 10.1099/00222615-28-4-259; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; HONG CC, 1978, LAB ANIM SCI, V28, P153; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Kiank C, 2006, BRAIN BEHAV IMMUN, V20, P359, DOI 10.1016/j.bbi.2005.10.151; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; MARKHAM NP, 1966, J COMP PATHOL, V76, P49, DOI 10.1016/0021-9975(66)90047-8; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Mertz D, 2007, CLIN INFECT DIS, V45, P475, DOI 10.1086/520016; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Monecke S, 2009, EUR J CLIN MICROBIOL, V198, P1166; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2013, VET MICROBIOL, V162, P806, DOI 10.1016/j.vetmic.2012.10.018; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; Percy DH, 2007, PATHOLOGY LAB RODENT; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Rojas IG, 2002, BRAIN BEHAV IMMUN, V16, P74, DOI 10.1006/brbi.2000.0619; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Tavakkol Z, 2010, J AM ASSOC LAB ANIM, V49, P588; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P343, DOI 10.1111/j.1469-0691.2010.03227.x; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Xu SY, 2011, NUCLEIC ACIDS RES, V39, P5597, DOI 10.1093/nar/gkr098; Zhang W, 2009, EUR J CLIN MICROBIOL, V28, P861, DOI 10.1007/s10096-009-0706-8	52	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e71142	10.1371/journal.pone.0071142	http://dx.doi.org/10.1371/journal.pone.0071142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023720	gold, Green Published, Green Submitted			2022-12-27	WOS:000324238400006
J	Fu, CY; Wang, F; Sun, BR; Liu, WG; Li, JH; Deng, RF; Liu, DL; Liu, ZR; Zhu, MS; Liao, YL; Chen, JW				Fu, Chong-Yun; Wang, Feng; Sun, Bing-Rui; Liu, Wu-Ge; Li, Jin-Hua; Deng, Ru-Fang; Liu, Di-Lin; Liu, Zhen-Rong; Zhu, Man-Shan; Liao, Yi-Long; Chen, Jian-Wei			Genetic and Cytological Analysis of a Novel Type of Low Temperature-Dependent Intrasubspecific Hybrid Weakness in Rice	PLOS ONE			English	Article							CALMODULIN-BINDING PROTEIN; RESISTANCE GENE; FIELD-RESISTANCE; CELL-DIVISION; ARABIDOPSIS; BLAST; PLANT; EXPRESSION; NECROSIS; WHEAT	Hybrid weakness (HW) is an important postzygotic isolation which occurs in both intra-and inter-specific crosses. In this study, we described a novel low temperature-dependent intrasubspecific hybrid weakness in the F-1 plants derived from the cross between two indica rice varieties Taifeng A and V1134. HW plants showed growth retardation, reduced panicle number and pale green leaves with chlorotic spots. Cytological assay showed that there were reduced cell numbers, larger intercellular spaces, thicker cell walls, and abnormal development of chloroplast and mitochondria in the mature leaves from HW F-1 plants in comparison with that from both of the parental lines. Genetic analysis revealed that HW was controlled by two complementary dominant genes Hw3 from V1134 and Hw4 from Taifeng A. Hw3 was mapped in a 136 kb interval between the markers Indel1118 and Indel1117 on chromosome 11, and Hw4 was mapped in the region of about 15 cM between RM182 and RM505 on chromosome 7, respectively. RT-PCR analysis revealed that only LOC_Os11g44310, encoding a putative calmodulin-binding protein (OsCaMBP), differentially expressed among Taifeng A, V1134 and their HW F-1. No recombinant was detected using the markers designed based on the sequence of LOC_Os11g44310 in the BC1F2 (Taifeng A//Taifeng A/V1134) population. Hence, LOC_Os11g44310 was probably the candidate gene of Hw3. Gene amplification suggested that LOC_Os11g44310 was present in V1134 and absent in Taifeng A. BLAST search revealed that LOC_Os11g44310 had one copy in the japonica genomic sequence of Nipponbare, and no homologous sequence in the indica reference sequence of 9311. Our results indicate that Hw3 is a novel gene for inducing hybrid weakness in rice.	[Fu, Chong-Yun; Wang, Feng; Sun, Bing-Rui; Liu, Wu-Ge; Li, Jin-Hua; Liu, Di-Lin; Liu, Zhen-Rong; Zhu, Man-Shan; Liao, Yi-Long; Chen, Jian-Wei] Guangdong Acad Agr Sci, Rice Res Inst, Guangzhou, Guangdong, Peoples R China; [Fu, Chong-Yun; Wang, Feng; Sun, Bing-Rui; Liu, Wu-Ge; Li, Jin-Hua; Liu, Di-Lin; Liu, Zhen-Rong; Zhu, Man-Shan; Liao, Yi-Long; Chen, Jian-Wei] Guangdong Prov Key Lab New Technol Rice Breeding, Guangzhou, Guangdong, Peoples R China; [Deng, Ru-Fang] Chinese Acad Sci, South China Bot Garden, Publ Lab, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences; Chinese Academy of Sciences; South China Botanical Garden, CAS	Wang, F (corresponding author), Guangdong Acad Agr Sci, Rice Res Inst, Guangzhou, Guangdong, Peoples R China.	fwang1631@163.com			earmarked fund for Modern Agro-industry Technology Research System; National "863" project [2011AA 10A 101]; Key Programme of Guangdong Province, China [2009A 020102003, 2011A 020201004]; Special project for public welfare on Agriculture [201303007]	earmarked fund for Modern Agro-industry Technology Research System; National "863" project(National High Technology Research and Development Program of China); Key Programme of Guangdong Province, China; Special project for public welfare on Agriculture	This work was supported in part by grants from the earmarked fund for Modern Agro-industry Technology Research System and the National "863" project (2011AA 10A 101), the Key Programme of Guangdong Province, China (2009A 020102003, 2011A 020201004), and the Special project for public welfare on Agriculture(201303007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Ali GS, 2003, PLANT MOL BIOL, V51, P803, DOI 10.1023/A:1023001403794; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Bussemer J, 2009, FEBS J, V276, P4294, DOI 10.1111/j.1742-4658.2009.07102.x; Chen C, 2013, MOL PLANT, V6, P716, DOI 10.1093/mp/sss146; Coyne J.A., 2004, SPECIATION; Cui YL, 2011, PLANT PHYSIOL, V155, P130, DOI 10.1104/pp.110.165589; Dobzhansky T., 1937; DROPKIN VH, 1969, PHYTOPATHOLOGY, V59, P1632; Dymek EE, 2006, J CELL SCI, V119, P3107, DOI 10.1242/jcs.03028; Hatano H, 2012, NEW PHYTOL, V194, P1143, DOI 10.1111/j.1469-8137.2012.04125.x; He Q, 2006, MOL BREEDING, V17, P1, DOI 10.1007/s11032-005-8698-2; HERMSEN JGT, 1963, EUPHYTICA, V12, P147, DOI 10.1007/BF00022351; Hola D, 2008, PHOTOSYNTHETICA, V46, P329, DOI 10.1007/s11099-008-0061-5; Hua LX, 2012, THEOR APPL GENET, V125, P1047, DOI 10.1007/s00122-012-1894-7; Ichitani K, 2007, THEOR APPL GENET, V114, P1407, DOI 10.1007/s00122-007-0526-0; Ichitani K, 2011, RICE, V4, P29, DOI 10.1007/s12284-011-9062-2; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Kuboyama T, 2009, RICE, V2, P93, DOI 10.1007/s12284-009-9026-y; Li YH, 2010, PHOTOSYNTHETICA, V48, P457, DOI 10.1007/s11099-010-0060-1; Mallet J, 2006, TRENDS ECOL EVOL, V21, P386, DOI 10.1016/j.tree.2006.05.004; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mirouze M, 2006, PLANT J, V47, P329, DOI 10.1111/j.1365-313X.2006.02788.x; Muller HJ, 1942, BIOL S, V6, P71; OKA HIKO-ICHI, 1957, JAPANESE JOUR GENETICS, V32, P83, DOI 10.1266/jjg.32.83; Preuss ML, 2003, PLANT PHYSIOL, V132, P154, DOI 10.1104/pp.103.020339; Reddy VS, 2003, PLANT MOL BIOL, V52, P143, DOI 10.1023/A:1023993713849; Reddy VS, 2002, J BIOL CHEM, V277, P9840, DOI 10.1074/jbc.M111626200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Saito T, 2007, BREEDING SCI, V57, P281, DOI 10.1270/jsbbs.57.281; Sardesai N, 2002, THEOR APPL GENET, V105, P691, DOI 10.1007/s00122-002-1035-9; SHII C T, 1980, Journal of Heredity, V71, P219; SINGH RP, 1993, CROP SCI, V33, P633, DOI 10.2135/cropsci1993.0011183X003300030041x; Smith LM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002164; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Terashima T, 2008, PLANT BREEDING, V127, P485, DOI 10.1111/j.1439-0523.2007.01451.x; Tezuka T, 2007, PLANTA, V226, P753, DOI 10.1007/s00425-007-0522-2; Van Wees SC, 2008, COLD SPRING HARD PRO, V3, DOI [10.1101/pdb.prot4982, DOI 10.1101/PDB.PR0T4982]; Wang L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000301; Wright KM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001497; Wulff BBH, 2004, PLANT J, V40, P942, DOI 10.1111/j.1365-313X.2004.02268.x; Xu X, 2008, THEOR APPL GENET, V117, P997, DOI 10.1007/s00122-008-0839-7; Yang TB, 2000, BIOCHEM BIOPH RES CO, V275, P601, DOI 10.1006/bbrc.2000.3335; Yin GK, 2009, PLANT CELL PHYSIOL, V50, P1305, DOI 10.1093/pcp/pcp074	51	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73886	10.1371/journal.pone.0073886	http://dx.doi.org/10.1371/journal.pone.0073886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023693	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200090
J	Taylor, N; Grabmeier-Pfistershammer, K; Egle, A; Greil, R; Rieger, A; Ledergerber, B; Oberkofler, H				Taylor, Ninon; Grabmeier-Pfistershammer, Katharina; Egle, Alexander; Greil, Richard; Rieger, Armin; Ledergerber, Bruno; Oberkofler, Hannes			Cobas Ampliprep/Cobas TaqMan HIV-1 v2.0 Assay: Consequences at the Cohort Level	PLOS ONE			English	Article							PLASMA PREPARATION TUBES; VIRAL LOAD BLIPS; TIME PCR ASSAYS; ABBOTT REALTIME; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; TYPE-1 LOAD; RNA LEVELS; VIREMIA; QUANTIFICATION	Background: High-sensitive real-time PCR assays are routinely used to monitor HIV-1 infected subjects. Inter-assay discrepancies have been described at the low viral load (VL) end, where clinical decisions regarding possible virological rebound are based. Methods: A retrospective study was performed to analyze frequencies of viral blips after transition to the COBAS Ampliprep/COBAS TaqMan v2.0 HIV-1 assay (Taqman v2.0) in patients with prior undetectable VLs as measured with the Roche Cobas Ampliprep Amplicor HIV-1 Monitor Test, v1.5 (Amplicor) and was evaluated in comparison to a group of patients monitored with the Abbott Real-time HIV-1 assay (Abbott RT) during the same period of time. Results: 85 of 373 patients with VLs below the limit of quantification with Amplicor had VLs >50 copies/mL after transition to the TaqMan v2.0 assay. Among these 74.1% had VLs ranging from 50-499 copies/mL, 22.9% had VLs >500 copies/mL. From 22 patients with initial Taqman v2.0 based VLs exceeding 500 copies/mL, 6 patients had VLs <20 copies/mL after novel VL measurement on a next visit. In our control group with VL quantification using the Abbott RT assay, only 1 patient became detectable and showed a VL of <40 copies/mL after new measurement. Conclusions: Transition to the Taqman v2.0 assay was accompanied by an increase of quantifiable HIV-1 VLs in patients with long term viral suppression under antiretroviral therapy that might be attributed to technical shortcomings of the Taqman v2.0 assay. A high test variability at the low VL end but also beyond was observed, making meaningful clinical interpretation of viral blips derived from different assays difficult.	[Taylor, Ninon; Egle, Alexander; Greil, Richard] Paracelsus Med Univ, Dept Internal Med 3, Salzburg, Austria; [Grabmeier-Pfistershammer, Katharina; Rieger, Armin] Vienna Med Univ, Dept Dermatol, Vienna, Austria; [Ledergerber, Bruno] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Zurich Hosp, Zurich, Switzerland; [Oberkofler, Hannes] Paracelsus Med Univ, Dept Lab Med, Salzburg, Austria	Paracelsus Private Medical University; Medical University of Vienna; University of Zurich; University Zurich Hospital; Paracelsus Private Medical University	Taylor, N (corresponding author), Paracelsus Med Univ, Dept Internal Med 3, Salzburg, Austria.	n.taylor@salk.at; katharina.pfistershammer@meduniwien.ac.at	Ledergerber, Bruno/B-5656-2009; Greil, Richard F/C-7673-2017; Egle, Alexander/AAC-3787-2020	Ledergerber, Bruno/0000-0002-6881-4401; Greil, Richard F/0000-0002-4462-3694; Egle, Alexander/0000-0003-0648-4416; Grabmeier-Pfistershammer, Katharina/0000-0003-0665-5414				[Anonymous], 2011, GUID US ANT AG HIV 1, P1; Bourlet T, 2011, J CLIN MICROBIOL, V49, P292, DOI 10.1128/JCM.01688-10; Damond F, 2007, J CLIN MICROBIOL, V45, P3436, DOI 10.1128/JCM.00973-07; Doyle T, 2012, CLIN INFECT DIS, V54, P724, DOI 10.1093/cid/cir936; Foulongne V, 2006, J CLIN MICROBIOL, V44, P2963, DOI 10.1128/JCM.00341-06; Garrett NJ, 2012, J CLIN VIROL, V53, P354, DOI 10.1016/j.jcv.2011.12.024; Gatanaga H, 2009, CLIN INFECT DIS, V48, P260, DOI 10.1086/595707; Giordano M, 2006, J CLIN VIROL, V35, P420, DOI 10.1016/j.jcv.2005.10.011; Grennan JT, 2012, J INFECT DIS, V205, P1230, DOI 10.1093/infdis/jis104; Griffith BP, 2006, J CLIN VIROL, V35, P197, DOI 10.1016/j.jcv.2005.08.008; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Ho DD, 1998, SCIENCE, V280, P1866, DOI 10.1126/science.280.5371.1866; Korn K, 2009, J CLIN MICROBIOL, V47, P1238, DOI 10.1128/JCM.02204-08; Kran AMB, 2009, J CLIN MICROBIOL, V47, P2170, DOI 10.1128/JCM.00519-09; Lima V, 2009, JAIDS-J ACQ IMM DEF, V51, P3, DOI 10.1097/QAI.0b013e31819e721b; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Naeth G, 2012, MED MICROBIOL IMMUNO; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Nettles RE, 2006, CURR OPIN HIV AIDS, V1, P157, DOI 10.1097/01.COH.0000203834.24221.13; Ruelle J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-100; Sloma CR, 2009, J CLIN MICROBIOL, V47, P889, DOI 10.1128/JCM.02231-08; Stosor V, 2005, CLIN INFECT DIS, V41, P1671, DOI 10.1086/498025; Taylor N, 2009, ANTIVIR THER, V14, P1189, DOI 10.3851/IMP1427; Willig JH, 2010, JAIDS-J ACQ IMM DEF, V54, P442, DOI 10.1097/QAI.0b013e3181d01d1d; Wirden M, 2009, J CLIN MICROBIOL, V47, P1543, DOI 10.1128/JCM.02134-08; Wojewoda CM, 2013, J VIROL METHODS, V187, P1, DOI 10.1016/j.jviromet.2012.10.004	26	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e74024	10.1371/journal.pone.0074024	http://dx.doi.org/10.1371/journal.pone.0074024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023696	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000323880200093
J	Westphal, C; Spallek, B; Konkel, A; Marko, L; Qadri, F; DeGraff, LM; Schubert, C; Bradbury, JA; Regitz-Zagrosek, V; Falck, JR; Zeldin, DC; Muller, DN; Schunck, WH; Fischer, R				Westphal, Christina; Spallek, Bastian; Konkel, Anne; Marko, Lajos; Qadri, Fatimunnisa; DeGraff, Laura M.; Schubert, Carola; Bradbury, J. Alyce; Regitz-Zagrosek, Vera; Falck, John R.; Zeldin, Darryl C.; Mueller, Dominik N.; Schunck, Wolf-Hagen; Fischer, Robert			CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; SENSITIVE K+ CHANNELS; EPOXYEICOSATRIENOIC ACIDS; MOLECULAR-CLONING; GAP-JUNCTIONS; CYTOCHROME-P450; EXPRESSION; INHIBITION; MECHANISMS; MODEL	Maladaptive cardiac hypertrophy predisposes one to arrhythmia and sudden death. Cytochrome P450 (CYP)-derived epoxyeicosatrienoic acids (EETs) promote anti-inflammatory and antiapoptotic mechanisms, and are involved in the regulation of cardiac Ca2+-, K+- and Na+-channels. To test the hypothesis that enhanced cardiac EET biosynthesis counteracts hypertrophy-induced electrical remodeling, male transgenic mice with cardiomyocyte-specific overexpression of the human epoxygenase CYP2J2 (CYP2J2-TG) and wildtype littermates (WT) were subjected to chronic pressure overload (transverse aortic constriction, TAC) or beta-adrenergic stimulation (isoproterenol infusion, ISO). TAC caused progressive mortality that was higher in WT (42% over 8 weeks after TAC), compared to CYP2J2-TG mice (6%). In vivo electrophysiological studies, 4 weeks after TAC, revealed high ventricular tachyarrhythmia inducibility in WT (47% of the stimulation protocols), but not in CYP2J2-TG mice (0%). CYP2J2 overexpression also enhanced ventricular refractoriness and protected against TAC-induced QRS prolongation and delocalization of left ventricular connexin-43. ISO for 14 days induced high vulnerability for atrial fibrillation in WT mice (54%) that was reduced in CYP-TG mice (17%). CYP2J2 overexpression also protected against ISO-induced reduction of atrial refractoriness and development of atrial fibrosis. In contrast to these profound effects on electrical remodeling, CYP2J2 overexpression only moderately reduced TAC-induced cardiac hypertrophy and did not affect the hypertrophic response to beta-adrenergic stimulation. These results demonstrate that enhanced cardiac EET biosynthesis protects against electrical remodeling, ventricular tachyarrhythmia, and atrial fibrillation susceptibility during maladaptive cardiac hypertrophy.	[Westphal, Christina; Konkel, Anne; Mueller, Dominik N.; Schunck, Wolf-Hagen] Max Delbruck Ctr Mol Med, Berlin, Germany; [Spallek, Bastian; Marko, Lajos; Qadri, Fatimunnisa; Mueller, Dominik N.] Expt & Clin Res Ctr, Berlin, Germany; [DeGraff, Laura M.; Bradbury, J. Alyce; Zeldin, Darryl C.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Schubert, Carola; Regitz-Zagrosek, Vera] Charite, Inst Gender Med, D-13353 Berlin, Germany; [Falck, John R.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Mueller, Dominik N.] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Expt Med 1, Nurnberg, Germany; [Fischer, Robert] Charite, Clin Cardiol & Pulmonol, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schunck, WH (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	schunck@mdc-berlin.de	Falck, John R/B-3030-2011; Zeldin, Darryl C/Y-7091-2018; Bader, Michael/K-2124-2013	Falck, John R/0000-0002-9219-7845; Zeldin, Darryl C/0000-0002-2087-7307; Muller, Dominik N/0000-0003-3650-5644; Schubert, Carola/0000-0002-9116-9105; Regitz-Zagrosek, Vera/0000-0002-3566-3467; Marko, Lajos/0000-0003-1888-5575	Deutsche Forschungsgemeinschaft, (DFG) [Schu822/5, FOR 1054]; PreGoBio-Program of the MDC; German Competence Network Heart Failure; Intramural Research Division of the NIH; National Institute of Environmental Health Sciences [Z01 ES025034]; NIH [GM31278]; Robert A. Welch Foundation [GL625910]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft, (DFG)(German Research Foundation (DFG)); PreGoBio-Program of the MDC; German Competence Network Heart Failure; Intramural Research Division of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft, (DFG); Schu822/5; FOR 1054. CW received a grant from the PreGoBio-Program of the MDC and BS from the German Competence Network Heart Failure. This work was also supported, in part, by the Intramural Research Division of the NIH, National Institute of Environmental Health Sciences (Z01 ES025034), NIH GM31278 and the Robert A. Welch Foundation (GL625910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchu SN, 2009, J MOL CELL CARDIOL, V46, P67, DOI 10.1016/j.yjmcc.2008.09.711; Bolognesi M, 2011, LIVER INT, V31, P883, DOI 10.1111/j.1478-3231.2011.02509.x; Boulaksil M, 2010, NETH HEART J, V18, P509, DOI 10.1007/BF03091824; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Falk RH, 2001, NEW ENGL J MED, V344, P1067, DOI 10.1056/NEJM200104053441407; Fischer R, 2008, HYPERTENSION, V51, P540, DOI 10.1161/HYPERTENSIONAHA.107.103143; Fliegner D, 2010, AM J PHYSIOL-REG I, V298, pR1597, DOI 10.1152/ajpregu.00825.2009; Gauthier KM, 2003, HYPERTENSION, V42, P555, DOI 10.1161/01.HYP.0000091265.94045.C7; Gross GJ, 2008, AM J PHYSIOL-HEART C, V294, pH2838, DOI 10.1152/ajpheart.00186.2008; Gross GJ, 2007, J MOL CELL CARDIOL, V42, P687, DOI 10.1016/j.yjmcc.2006.11.020; Gross GJ, 2009, AM J PHYSIOL-HEART C, V297, pH47, DOI 10.1152/ajpheart.01084.2008; Gross GJ, 2005, CARDIOVASC RES, V68, P18, DOI 10.1016/j.cardiores.2005.06.007; Gross GJ, 2011, CARDIOVASC DRUGS THE; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Jain SK, 2003, CIRC RES, V92, P1138, DOI 10.1161/01.RES.0000074883.66422.C5; Ke QG, 2007, MOL PHARMACOL, V72, P1063, DOI 10.1124/mol.107.035881; Lee HC, 1999, J PHYSIOL-LONDON, V519, P153, DOI 10.1111/j.1469-7793.1999.0153o.x; Lu T, 2001, J PHYSIOL-LONDON, V537, P811; Monti J, 2008, NAT GENET, V40, P529, DOI 10.1038/ng.129; Nithipatikom K, 2004, CIRC RES, V95, pE65, DOI 10.1161/01.RES.0000146277.62128.6f; Nithipatikom K, 2010, J CARDIOVASC PHARM T, V15, P112, DOI 10.1177/1074248409358408; Popp R, 2002, CIRC RES, V90, P800, DOI 10.1161/01.RES.0000015328.20581.D6; Qiu H, 2011, CARDIOVASC THER, V29, P99, DOI 10.1111/j.1755-5922.2010.00150.x; Quindry JC, 2010, AM J PHYSIOL-HEART C, V299, pH175, DOI 10.1152/ajpheart.01211.2009; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Wang YG, 2010, J MOL CELL CARDIOL, V48, P619, DOI 10.1016/j.yjmcc.2010.01.009; Workman AJ, 2010, N-S ARCH PHARMACOL, V381, P235, DOI 10.1007/s00210-009-0474-0; Wu S, 1996, J BIOL CHEM, V271, P3460; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; Xiao YF, 2004, MOL PHARMACOL, V66, P1607, DOI 10.1124/mol.104.004150; Xiao YF, 1998, J PHYSIOL-LONDON, V508, P777, DOI 10.1111/j.1469-7793.1998.777bp.x; Xu D, 2006, P NATL ACAD SCI USA, V103, P18733, DOI 10.1073/pnas.0609158103; Yu GG, 2011, CLIN EXP PHARMACOL P, V38, P63, DOI 10.1111/j.1440-1681.2010.05464.x	40	43	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73490	10.1371/journal.pone.0073490	http://dx.doi.org/10.1371/journal.pone.0073490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023684	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000323880200081
J	Xiao, YJ; Peng, CQ; Huang, W; Zhang, JZ; Xia, M; Zhang, Y; Ling, WH				Xiao, Yunjun; Peng, Chaoqiong; Huang, Wei; Zhang, Jinzhou; Xia, Min; Zhang, Yuan; Ling, Wenhua			Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INTRAVASCULAR ULTRASOUND; CARDIOVASCULAR-DISEASE; SPOTTY CALCIFICATION; PARATHYROID-HORMONE; ATHEROSCLEROSIS; PLASMA; MORTALITY; COMMUNITY; FGF23	Objective: Fibroblast growth factor 23 (FGF23) is a circulating regulator of phosphate and vitamin D metabolism and is associated with coronary artery calcification, and has been implicated in the pathogenesis of cardiovascular disease. The aim of this study was to determine whether circulating FGF23 concentration is independently associated with the severity and extent of coronary artery disease in patients undergoing coronary angiography. Method: A cross-sectional design was used to examine the relationship between serum FGF23 and the severity and extent of coronary artery stenosis in 2076 patients undergoing coronary angiography (1263 male and 813 female, mean aged 62.5 years). Subgroup analyses were performed to assess the associations between FGF23 and coronary arterial plaque characteristics evaluated by intravascular ultrasound and 12-month incidence of target vessel revascularization (TVR) and target lesion revascularization (TLR). Findings: We found a stepwise increase of serum FGF23 concentrations in patients with mild, moderate, severe stenosis or with increased number of stenotic vessels compared with those without stenosis (P < 0.001). Serum FGF23 concentration was positively correlated with stenosis scores as the global index of the severity and extent of coronary artery stenosis in both male and female (r = 0.315 and r = 0.291, P < 0.001). In multiple regression analyses, serum FGF23 concentration was a significant determinant of the stenosis scores independent of other traditional risk factors (standardized b = 0.326, P < 0.001). Furthermore, subgroup analyses found FGF23 was significantly associated with plaque and dense calcium volumes. Multiple logistic regression analyses showed that serum FGF23 levels were significantly independent predictors of TVR and TLR. Conclusions: We report an independent association between circulating FGF23 concentration and the severity and extent of coronary artery stenosis in the coronary angiographic patients. Future studies are needed to elucidate the potential biological mechanisms and whether FGF23 is a modifiable cardiovascular risk factor.	[Xiao, Yunjun; Peng, Chaoqiong; Huang, Wei; Zhang, Jinzhou] Shenzhen Ctr Dis Control & Prevent, Dept Nutr & Food Hyg, Shenzhen, Guangdong, Peoples R China; [Xiao, Yunjun; Xia, Min; Ling, Wenhua] Sun Yat Sen Univ, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Xiao, Yunjun; Xia, Min; Ling, Wenhua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yuan] Guangzhou Mil Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Sun Yat Sen University; Sun Yat Sen University; Southern Theater Command General Hospital	Xiao, YJ (corresponding author), Shenzhen Ctr Dis Control & Prevent, Dept Nutr & Food Hyg, Shenzhen, Guangdong, Peoples R China.	xyjszcdc@163.com; lingwenhua2012@163.com			National Natural Science Foundation of China [81130052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant from the Key Project of National Natural Science Foundation of China (81130052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Austen W G, 1975, Circulation, V51, P5; Bhattacharyya N, 2012, TRENDS ENDOCRIN MET, V23, P610, DOI 10.1016/j.tem.2012.07.002; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; BUDDE T, 1994, ARTERIOSCLER THROMB, V14, P1730, DOI 10.1161/01.ATV.14.11.1730; Dalal M, 2011, EUR J ENDOCRINOL, V165, P797, DOI 10.1530/EJE-11-0577; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Desjardins L, 2012, OSTEOPOROSIS INT, V23, P2017, DOI 10.1007/s00198-011-1838-0; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRINK RJ, 1970, AM J CARDIOL, V26, P241, DOI 10.1016/0002-9149(70)90790-3; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; JENKINS PJ, 1978, BMJ-BRIT MED J, V2, P388, DOI 10.1136/bmj.2.6134.388; Kataoka Y, 2012, J AM COLL CARDIOL, V59, P1592, DOI 10.1016/j.jacc.2012.03.012; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Masai H, 2012, ATHEROSCLEROSIS, DOI [10.1016/j.atherosclerosis.2012.1010.1045, DOI 10.1016/J.ATHER0SCLER0SIS.2012.1010.1045]; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Neeland IJ, 2012, AM HEART J, V164, P547, DOI 10.1016/j.ahj.2012.07.007; Pajunen P, 1997, AM J CARDIOL, V80, P550, DOI 10.1016/S0002-9149(97)00420-7; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Roos M, 2008, CLIN ENDOCRINOL, V68, P660, DOI 10.1111/j.1365-2265.2007.03074.x; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Taylor EN, 2011, AM HEART J, V161, P956, DOI 10.1016/j.ahj.2011.02.012; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105	34	22	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72545	10.1371/journal.pone.0072545	http://dx.doi.org/10.1371/journal.pone.0072545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015259	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800064
J	Xu, Y; Duan, CH; Kuang, ZZ; Hao, YH; Jeffries, JL; Lau, GW				Xu, Ying; Duan, Chaohui; Kuang, Zhizhou; Hao, Yonghua; Jeffries, Jayme L.; Lau, Gee W.			Pseudomonas aeruginosa Pyocyanin Activates NRF2-ARE-Mediated Transcriptional Response via the ROS-EGFR-PI3K-AKT/MEK-ERK MAP Kinase Signaling in Pulmonary Epithelial Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; CYSTIC-FIBROSIS; RESPIRATORY-TRACT; A549 CELLS; HYPEROXIA; INFECTION; NRF2; GLUTATHIONE; MECHANISMS; EXPRESSION	The redox-active pyocyanin (PCN) secreted by the respiratory pathogen Pseudomonas aeruginosa generates reactive oxygen species (ROS) and causes oxidative stress to pulmonary epithelial cells. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) confers protection against ROS-mediated cell death by inducing the expression of detoxifying enzymes and proteins via its binding to the cis-acting antioxidant response element (ARE). However, a clear relationship between NRF2 and PCN-mediated oxidative stress has not been established experimentally. In this study, we investigated the induction of NRF2-ARE response by PCN in the pulmonary epithelial cells. We analyzed the effect of PCN on NRF2 expression and nuclear translocation in cultured human airway epithelial cells, and in a mouse model of chronic PCN exposure. NRF2-dependent transcription of antioxidative enzymes was also assessed. Furthermore, we used inhibitors to examine the involvement of EGFR and its downstream signaling components that mediate NRF2-ARE-activation in response to PCN. PCN enhances the nuclear NRF2 accumulation and activates the transcription of ARE-mediated antioxidant genes. Furthermore, PCN activates NRF2 by inducing the EGFR-phosphoinositide-3-kinase (PI3K) signaling pathway and its main downstream effectors, AKT and MEK1/2-ERK1/2 MAP kinases. Inhibition of the EGFR-PI3K signaling markedly attenuates PCN-stimulated NRF2 accumulation in the nucleus. We demonstrate for the first time that PCN-mediated oxidative stress activates the EGFR-PI3K-AKT/MEK1/2-ERK1/2 MAP kinase signaling pathway, leading to nuclear NRF2 translocation and ARE responsiveness in pulmonary epithelial cells.	[Xu, Ying; Kuang, Zhizhou; Hao, Yonghua; Jeffries, Jayme L.; Lau, Gee W.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Xu, Ying; Duan, Chaohui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Clin Immunol Lab, Guangzhou 510275, Guangdong, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; Sun Yat Sen University	Lau, GW (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA.	geelau@illinois.edu	Lau, Gee W/H-4073-2018		American Lung Association DeSouza Research Award [DS-192835-N]; NIH [HL090699]; Research Facilities Improvement Program from the National Center for Research Resources, National Institutes of Health [C06 RR 16515-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016515] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090699] Funding Source: NIH RePORTER	American Lung Association DeSouza Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program from the National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Lung Association DeSouza Research Award (DS-192835-N) and NIH (HL090699) to GW Lau. This investigation was conducted in a facility constructed with the support from Research Facilities Improvement Program Grant Number C06 RR 16515-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Deng XB, 2013, CELL BIOL TOXICOL, V29, P143, DOI 10.1007/s10565-013-9242-5; Farrell PM, 2009, RADIOLOGY, V252, P534, DOI 10.1148/radiol.2522081882; Gardner PR, 1996, ARCH BIOCHEM BIOPHYS, V333, P267, DOI 10.1006/abbi.1996.0390; Gloyne LS, 2011, TOXICOL IN VITRO, V25, P1353, DOI 10.1016/j.tiv.2011.05.004; Hao YH, 2012, CELL MICROBIOL, V14, P401, DOI 10.1111/j.1462-5822.2011.01727.x; Ho YS, 1998, AM J RESP CELL MOL, V18, P538, DOI 10.1165/ajrcmb.18.4.2959; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kong FS, 2006, CELL MICROBIOL, V8, P1121, DOI 10.1111/j.1462-5822.2006.00696.x; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Look DC, 2005, J IMMUNOL, V175, P4017, DOI 10.4049/jimmunol.175.6.4017; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Muller M, 2002, FREE RADICAL BIO MED, V33, P1527, DOI 10.1016/S0891-5849(02)01087-0; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; Ojeniyi B, 2000, PEDIATR PULM, V29, P177, DOI 10.1002/(SICI)1099-0496(200003)29:3<177::AID-PPUL4>3.0.CO;2-U; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Rada B, 2011, MUCOSAL IMMUNOL, V4, P158, DOI 10.1038/mi.2010.62; Ran HM, 2003, P NATL ACAD SCI USA, V100, P14315, DOI 10.1073/pnas.2332354100; Reimer A, 2000, ACTA OTO-LARYNGOL, P86; Ricciardolo FLM, 2006, EUR J PHARMACOL, V533, P240, DOI 10.1016/j.ejphar.2005.12.057; Roper JM, 2004, AM J PHYSIOL-LUNG C, V286, pL1045, DOI 10.1152/ajplung.00376.2003; Tirumalai R, 2002, TOXICOL LETT, V132, P27, DOI 10.1016/S0378-4274(02)00055-3; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988	36	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72528	10.1371/journal.pone.0072528	http://dx.doi.org/10.1371/journal.pone.0072528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015256	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200047
J	Banerjee, A; Benjamin, R; Banerjee, S				Banerjee, Atoshi; Benjamin, Ronald; Banerjee, Sharmistha			Impact of Viral Factors on Subcellular Distribution and RNA Export Activity of HIV-1 Rev in Astrocytes 1321N1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; CELL-LINE; SITU HYBRIDIZATION; BLOOD MONOCYTES; HOST PROTEINS; BRAIN-CELLS; INFECTION; REPLICATION	CNS associated cells are permissive to HIV-1 infection, but poor in virus production due to attenuated Rev activity. The temporal and the spatial distribution of Rev in human astrocyte 1321N1 and glioblastoma GO-G-CCM were monitored for explaining the reduced Rev activity and low viral production during HIV-1 infection. Rev remained localized to the nuclei of these cells upon infection, attenuating its export activity, as manifested by low copy number of RRE-containing viral-mRNA in the cytoplasm of these cells. In contrast to infection, when Rev alone was transiently expressed, it localized in the cytoplasm of 1321N1. The localization changed to the nucleus when Rev was expressed in the presence of other viral proteins through pro-viral DNA pNL4-3. This study, for the first time, revealed the impact of other HIV-1 proteins apart from host factors in regulating the subcellular localization of Rev in astrocytes and hence the fate of HIV-1 infection in these cells.	[Banerjee, Atoshi; Benjamin, Ronald; Banerjee, Sharmistha] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Banerjee, S (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	sbanerjee.uohyd@gmail.com	Banerjee, Atoshi/M-6404-2018; Banerjee, Atoshi/AAU-9256-2020; Babu, Ronald/AAT-6101-2020	Banerjee, Atoshi/0000-0002-3134-1268; Banerjee, Atoshi/0000-0002-3134-1268; Babu, Ronald/0000-0003-2622-9359	Department of Biotechnology, Government of India [BT/PR10092/BRB/10/585/2007, BT/01/CoE/07/02]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The project was financially supported by Department of Biotechnology, Government of India,(http://dbtindia.nic.in/index.asp) grants DBT-Rev grant: BT/PR10092/BRB/10/585/2007 letter-I and DBT-CoE grant: BT/01/CoE/07/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SF, 1999, ACTA NEUROPATHOL, V98, P481, DOI 10.1007/s004010051113; Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002; Benjamin R, 2013, PLOS ONE IN PRESS; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Bieniasz PD, 2012, AIDS, V26, P1243, DOI 10.1097/QAD.0b013e328353bd04; Borjabad A, 2010, J NEUROIMMUNE PHARM, V5, P44, DOI 10.1007/s11481-009-9167-1; BRACKWERNER R, 1992, AIDS, V6, P273, DOI 10.1097/00002030-199203000-00003; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chompre G, 2013, NEUROBIOL DIS, V49, P128, DOI 10.1016/j.nbd.2012.08.007; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; Dash PK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-25; Dayton Andrew I, 2004, Retrovirology, V1, P35, DOI 10.1186/1742-4690-1-35; ERFLE V, 1991, RES VIROLOGY, V142, P139, DOI 10.1016/0923-2516(91)90050-D; Fang JH, 2005, VIROLOGY, V336, P299, DOI 10.1016/j.virol.2005.03.017; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Friedrich B, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-354; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Gorry PR, 2003, CURR HIV RES, V1, P463, DOI 10.2174/1570162033485122; Gorry PR, 1999, J VIROL, V73, P352, DOI 10.1128/JVI.73.1.352-361.1999; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; Haedicke J, 2009, P NATL ACAD SCI USA, V106, P14040, DOI 10.1073/pnas.0900502106; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; INNOCENTI P, 1992, AIDS RES HUM RETROV, V8, P261, DOI 10.1089/aid.1992.8.261; Karyala P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014408; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lawrence DMP, 2004, J VIROL, V78, P7319, DOI 10.1128/JVI.78.14.7319-7328.2004; Lever AML, 2011, BIOCHEMISTRY-US, V50, P920, DOI 10.1021/bi101805f; Levin A, 2009, PROTEIN ENG DES SEL, V22, P753, DOI 10.1093/protein/gzp060; Levy J A, 2011, Adv Dent Res, V23, P13, DOI 10.1177/0022034511398874; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Ludwig E, 1999, J VIROL, V73, P8279, DOI 10.1128/JVI.73.10.8279-8289.1999; MCELRATH MJ, 1991, J CLIN INVEST, V87, P27, DOI 10.1172/JCI114981; Naji S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015313; NEUMANN M, 1995, J VIROL, V69, P2159, DOI 10.1128/JVI.69.4.2159-2167.1995; Neumann M, 2001, J CELL SCI, V114, P1717; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; RANKI A, 1994, ARCH VIROL, V139, P365, DOI 10.1007/BF01310798; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; Santos S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-65; Schweighardt B, 2011, PROG BRAIN RES, V132, P721; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; SYLWESTER A, 1993, J CELL SCI, V106, P941; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; TORNATORE C, 1994, J VIROL, V68, P93, DOI 10.1128/JVI.68.1.93-102.1994; TRONO D, 1990, EMBO J, V9, P4155, DOI 10.1002/j.1460-2075.1990.tb07638.x; Vincendeau M, 2010, AIDS, V24, P2432, DOI 10.1097/QAD.0b013e32833e8758; WEBER J, 1989, J GEN VIROL, V70, P2653, DOI 10.1099/0022-1317-70-10-2653; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Yi R, 2002, J VIROL, V76, P2036, DOI 10.1128/JVI.76.5.2036-2042.2002; Yu Z, 2005, P NATL ACAD SCI USA, V102, P4027, DOI 10.1073/pnas.0408889102; Zhang JZ, 2005, GENE, V363, P67, DOI 10.1016/j.gene.2005.06.043; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	56	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72905	10.1371/journal.pone.0072905	http://dx.doi.org/10.1371/journal.pone.0072905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023789	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600051
J	Hadrevi, J; Ghafouri, B; Larsson, B; Gerdle, B; Hellstrom, F				Hadrevi, Jenny; Ghafouri, Bijar; Larsson, Britt; Gerdle, Bjorn; Hellstrom, Fredrik			Multivariate Modeling of Proteins Related to Trapezius Myalgia, a Comparative Study of Female Cleaners with or without Pain	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; CEREBROSPINAL-FLUID PROTEOME; RAGGED-RED FIBERS; SKELETAL-MUSCLE; EXERCISE INTENSITY; METABOLISM; DISORDERS; LACTATE; STRESS; MICRODIALYSIS	The prevalence of chronic trapezius myalgia is high in women with high exposure to awkward working positions, repetitive movements and movements with high precision demands. The mechanisms behind chronic trapezius myalgia are not fully understood. The purpose of this study was to explore the differences in protein content between healthy and myalgic trapezius muscle using proteomics. Muscle biopsies from 12 female cleaners with work-related trapezius myalgia and 12 pain free female cleaners were obtained from the descending part of the trapezius. Proteins were separated with two-dimensional differential gel electrophoresis (2D-DIGE) and selected proteins were identified with mass spectrometry. In order to discriminate the two groups, quantified proteins were fitted to a multivariate analysis: partial least square discriminate analysis. The model separated 28 unique proteins which were related to glycolysis, the tricaboxylic acid cycle, to the contractile apparatus, the cytoskeleton and to acute response proteins. The results suggest altered metabolism, a higher abundance of proteins related to inflammation in myalgic cleaners compared to healthy, and a possible alteration of the contractile apparatus. This explorative proteomic screening of proteins related to chronic pain in the trapezius muscle provides new important aspects of the pathophysiology behind chronic trapezius myalgia.	[Hadrevi, Jenny] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Hadrevi, Jenny; Hellstrom, Fredrik] Univ Gavle, Fac Hlth & Occupat Studies, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Umea, Sweden; [Ghafouri, Bijar; Larsson, Britt; Gerdle, Bjorn] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Linkoping, Sweden; [Ghafouri, Bijar; Larsson, Britt; Gerdle, Bjorn] Cty Council Ostergotland, Pain & Rehabil Ctr, Linkoping, Sweden; [Ghafouri, Bijar] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Ghafouri, Bijar] Cty Council Ostergotland, Ctr Occupat & Environm Med, Linkoping, Sweden	Umea University; University of Gavle; Linkoping University; City Council Ostergotland; Linkoping University; City Council Ostergotland	Hadrevi, J (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	jhi@hig.se	Hellström, Fredrik/A-1562-2010; Hadrevi, Jenny/E-4758-2017; Ghafouri, Bijar/H-8257-2014	Hellström, Fredrik/0000-0002-4556-2846; Hadrevi, Jenny/0000-0003-4864-7842; 	Swedish Research Council [K2011-69X-21874-01-6]; Swedish Council for Working life and Social research [2009-1761, 2010-0913]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working life and Social research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by the Swedish Research Council (K2011-69X-21874-01-6) and the Swedish Council for Working life and Social research (2009-1761, 2010-0913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2009, J SEP SCI, V32, P771, DOI 10.1002/jssc.200800622; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Andersen LL, 2008, PAIN, V139, P588, DOI 10.1016/j.pain.2008.06.013; Blanco I, 2004, J RHEUMATOL, V31, P2082; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Brocca L, 2012, J PHYSL, P6; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Capitanio D, 2005, PROTEOMICS, V5, P2577, DOI 10.1002/pmic.200401183; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Erlandsen H, 2000, CURR OPIN STRUC BIOL, V10, P719, DOI 10.1016/S0959-440X(00)00154-8; Ferrero S, 2008, GYNECOL ENDOCRINOL, V24, P433, DOI 10.1080/09513590802173824; Finehout EJ, 2004, ELECTROPHORESIS, V25, P2564, DOI 10.1002/elps.200406012; Flodgren G, 2010, J BIOMED BIOTECHNOL, V2010, P9; Gerdle B, 2012, POTENTIAL MUSCLE BIO; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Hadrevi J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-181; Hagg GM, 2000, EUR J APPL PHYSIOL, V83, P159, DOI 10.1007/s004210000274; Holloway KV, 2009, PROTEOMICS, V9, P5155, DOI 10.1002/pmic.200900068; Howlett RA, 1998, AM J PHYSIOL-REG I, V275, pR418, DOI 10.1152/ajpregu.1998.275.2.R418; Hunt JM, 2012, CURR MOL MED, V12, P827; IWAKI K, 1993, CIRCULATION, V87, P2023, DOI 10.1161/01.CIR.87.6.2023; Kadi F, 1998, PAIN, V78, P191, DOI 10.1016/S0304-3959(98)00126-2; Kadi F, 1998, ACTA NEUROPATHOLOGIC, V95, P362; Larsson B, 2000, PAIN, V84, P379, DOI 10.1016/S0304-3959(99)00237-7; Larsson B, 2002, EUR J APPL PHYSIOL, V87, P481, DOI 10.1007/s00421-002-0667-4; Larsson B, 2001, EUR J APPL PHYSIOL, V84, P492, DOI 10.1007/s004210100409; Larsson B, 2012, EUR J PAIN, P1532; Larsson B, 2007, BEST PRACT RES CL RH, V21, P447, DOI 10.1016/j.berh.2007.02.015; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; LINDMAN R, 1991, AM J ANAT, V190, P385, DOI 10.1002/aja.1001900406; Liu J, 2009, J INT MED RES, V37, P1913, DOI 10.1177/147323000903700629; Mackey AL, 2010, J APPL PHYSIOL, V109, P1920, DOI 10.1152/japplphysiol.00789.2010; Malm C, 2008, SCAND J CLIN LAB INV, V68, P793, DOI 10.1080/00365510802277464; Maughan DW, 2005, MOL CELL PROTEOMICS, V4, P1541, DOI 10.1074/mcp.M500053-MCP200; Moriggi M, 2010, PROTEOMICS, V10, P3756, DOI 10.1002/pmic.200900817; Morton JP, 2009, SPORTS MED, V39, P643, DOI 10.2165/00007256-200939080-00003; OHLSSON K, 1994, ERGONOMICS, V37, P891, DOI 10.1080/00140139408963698; Oki G, 2012, PAIN, V153, P532, DOI 10.1016/j.pain.2011.11.008; Olausson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052560; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Rosendal L, 2004, PAIN, V112, P324, DOI 10.1016/j.pain.2004.09.017; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Seeber B, 2010, FERTIL STERIL, V93, P2137, DOI 10.1016/j.fertnstert.2008.12.121; Sjogaard G, 2010, EUR J APPL PHYSIOL, V108, P657, DOI 10.1007/s00421-009-1268-2; SKIDMORE R, 1995, AM J PHYSIOL-REG I, V268, pR92, DOI 10.1152/ajpregu.1995.268.1.R92; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Unge J, 2007, INT ARCH OCC ENV HEA, V81, P209, DOI 10.1007/s00420-007-0208-x; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x; Vigano A, 2008, PROTEOMICS, V8, P4668, DOI 10.1002/pmic.200800232; Visser B, 2006, J ELECTROMYOGR KINES, V16, P1, DOI 10.1016/j.jelekin.2005.06.005; Wallen ES, 1997, INT J HYPERTHER, V13, P517, DOI 10.3109/02656739709023550; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Yuan XL, 2002, ELECTROPHORESIS, V23, P1185, DOI 10.1002/1522-2683(200204)23:7/8<1185::AID-ELPS1185>3.0.CO;2-G; Zimmerman UJP, 2004, IUBMB LIFE, V56, P343, DOI 10.1080/1521-6540400000850	60	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73285	10.1371/journal.pone.0073285	http://dx.doi.org/10.1371/journal.pone.0073285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023854	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600091
J	Maesako, M; Uemura, K; Iwata, A; Kubota, M; Watanabe, K; Uemura, M; Noda, Y; Asada-Utsugi, M; Kihara, T; Takahashi, R; Shimohama, S; Kinoshita, A				Maesako, Masato; Uemura, Kengo; Iwata, Ayana; Kubota, Masakazu; Watanabe, Kiwamu; Uemura, Maiko; Noda, Yasuha; Asada-Utsugi, Megumi; Kihara, Takeshi; Takahashi, Ryosuke; Shimohama, Shun; Kinoshita, Ayae			Continuation of Exercise Is Necessary to Inhibit High Fat Diet-Induced beta-Amyloid Deposition and Memory Deficit in Amyloid Precursor Protein Transgenic Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; INSULIN-RESISTANCE; SYNAPTIC PLASTICITY; PHYSICAL-ACTIVITY; RISK; IMPAIRMENT; DEMENTIA	High fat diet (HFD) is prevalent in many modern societies and HFD-induced metabolic condition is a growing concern worldwide. It has been previously reported that HFD clearly worsens cognitive function in amyloid precursor protein (APP) transgenic mice. On the other hand, we have demonstrated that voluntary exercise in an enriched environment is an effective intervention to rescue HFD-induced beta-amyloid (A beta) deposition and memory deficit. However, it had been unclear whether consumption of HFD after exercising abolished the beneficial effect of exercise on the inhibition of Alzheimer's disease (AD) pathology. To examine this question, we exposed wild type (WT) and APP mice fed with HFD to exercise conditions at different time periods. In our previous experiment, we gave HFD to mice for 20 weeks and subjected them to exercise during weeks 10-20. In the present study, mice were subjected to exercise conditions during weeks 0-10 or weeks 5-15 while being on HFD. Interestingly, we found that the effect of exercise during weeks 0-10 or weeks 5-15 on memory function was not abolished in WT mice even if they kept having HFD after finishing exercise. However, in APP transgenic mice, HFD clearly disrupted the effect of exercise during weeks 0-10 or weeks 5-15 on memory function. Importantly, we observed that the level of A beta oligomer was significantly elevated in the APP mice that exercised during weeks 0-10: this might have been caused by the up-regulation of A beta production. These results provide solid evidence that continuation of exercise is necessary to rescue HFD-induced aggravation of cognitive decline in the pathological setting of AD.	[Maesako, Masato; Iwata, Ayana; Kubota, Masakazu; Noda, Yasuha; Asada-Utsugi, Megumi; Kihara, Takeshi; Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Kyoto, Japan; [Uemura, Kengo; Watanabe, Kiwamu; Uemura, Maiko; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Uemura, Kengo] Ishiki Hosp, Kagoshima, Japan; [Shimohama, Shun] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido, Japan	Kyoto University; Kyoto University; Sapporo Medical University	Uemura, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan.	ueken@kuhp.kyoto-u.ac.jp	Uemura, Maiko/L-7293-2016	Uemura, Maiko/0000-0001-8356-1409	Ministry of Education, Culture, Sports, Science and Technology [24111524, 23591243]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	The work was financially supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (24111524(AK), 23591243(KU)) and the Research Grant from Takeda Science Foundation (KU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hiltunen M, 2012, J CELL MOL MED, V16, P1206, DOI 10.1111/j.1582-4934.2011.01384.x; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2013, NEURON, V77, P929, DOI 10.1016/j.neuron.2012.12.040; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Maesako M, 2012, J BIOL CHEM, V287, P23024, DOI 10.1074/jbc.M112.367011; Maesako M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.028; Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Moreno-Gonzalez I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2494; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Rose JB, 2009, J NEUROSCI, V29, P1115, DOI 10.1523/JNEUROSCI.4220-08.2009; Serlin Yonatan, 2011, Cardiovasc Psychiatry Neurol, V2011, P609202, DOI 10.1155/2011/609202; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013463; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Verret L, 2013, NEUROBIOL AGING, V34, P211, DOI 10.1016/j.neurobiolaging.2012.05.013; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P117, DOI 10.2174/156720507780362065; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09	34	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72796	10.1371/journal.pone.0072796	http://dx.doi.org/10.1371/journal.pone.0072796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023774	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600045
J	Monteiro, F; Sebastiana, M; Pais, MS; Figueiredo, A				Monteiro, Filipa; Sebastiana, Monica; Pais, Maria Salome; Figueiredo, Andreia			Reference Gene Selection and Validation for the Early Responses to Downy Mildew Infection in Susceptible and Resistant Vitis vinifera Cultivars	PLOS ONE			English	Article							TIME RT-PCR; FUNGAL DISEASE RESISTANCE; REAL-TIME; RELATIVE QUANTIFICATION; ARABIDOPSIS-THALIANA; PLASMOPARA-VITICOLA; SERINE PROTEASES; QUANTITATIVE PCR; CYCLOPHILIN GENE; EXPRESSION	The pivotal role of cultivated grapevine (Vitis vinifera L.) in many countries economy is compromised by its high susceptibility to Plasmopara viticola, the causal agent of downy mildew disease. Recent research has identified a set of genes related to resistance which may be used to track downy mildew infection. Quantification of the expression of these resistance genes requires normalizing qPCR data using reference genes with stable expression in the system studied. In this study, a set of eleven genes (VATP16, 60 S, UQCC, SMD3, EF1 alpha, UBQ, SAND, GAPDH, ACT, PsaB, PTB2) was evaluated to identify reference genes during the first hours of interaction (6, 12, 18 and 24 hpi) between two V. vinifera genotypes and P. viticola. Two analyses were used for the selection of reference genes: direct comparison of susceptible, Trincadeira, and resistant, Regent, V. vinifera cultivars at 0 h, 6, 12, 18 and 24 hours post inoculation with P. viticola (genotype effect); and comparison of each genotype with mock inoculated samples during inoculation time-course (biotic stress effect). Three statistical methods were used, GeNorm, NormFinder, and BestKeeper, allowing to identify UBQ, EF1 alpha and GAPDH as the most stable genes for the genotype effect. For the biotic stress effect, EF1a, SAND and SMD3 were the most constant for the susceptible cultivar Trincadeira and EF1 alpha, GAPDH, UBQ for the resistant cultivar Regent. In addition, the expression of three defense-related transcripts, encoding for subtilisin-like protein, CYP and PR10, was analysed, for both datasets, during inoculation time-course. Taken together, our results provide guidelines for reference gene(s) selection towards a more accurate and widespread use of qPCR to study the first hours of interaction between different grapevine cultivars and P. viticola.	[Monteiro, Filipa; Sebastiana, Monica; Pais, Maria Salome; Figueiredo, Andreia] Univ Lisbon, Fac Sci, Ctr Biodivers Funct & Integrat Genom BioFIG, Plant Syst Biol Lab, P-1699 Lisbon, Portugal	Universidade de Lisboa	Monteiro, F (corresponding author), Univ Lisbon, Fac Sci, Ctr Biodivers Funct & Integrat Genom BioFIG, Plant Syst Biol Lab, P-1699 Lisbon, Portugal.	fimonteiro@fc.ul.pt; aafigueiredo@fc.ul.pt	Monteiro, Filipa/I-6116-2012; Figueiredo, Andreia/G-2887-2014; Sebastiana, Monica/M-7415-2015	Monteiro, Filipa/0000-0002-1505-2140; Figueiredo, Andreia/0000-0001-8156-7700; Sebastiana, Monica/0000-0001-8735-7632; Pais, Maria Salome/0000-0002-3068-5851	Portuguese Foundation for Science and Technology [PTDC/AGR-GPC/119753/2010, SFRH/BPD/25661/2005, SFRH/BPD/63641/2009, BIOFIG PEst-OE/BIA/UI4046/2011]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology within the frame of the project PTDC/AGR-GPC/119753/2010, with the fellowship SFRH/BPD/25661/2005 to MS and SFRH/BPD/63641/2009 to AF and BIOFIG PEst-OE/BIA/UI4046/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkurt M, 2007, MOL BREEDING, V19, P103, DOI 10.1007/s11032-006-9047-9; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2000, DESCR LIST VAR GRAP; Bellin D, 2009, THEOR APPL GENET, V120, P163, DOI 10.1007/s00122-009-1167-2; Blasi P, 2011, THEOR APPL GENET, V123, P43, DOI 10.1007/s00122-011-1565-0; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin Stephen A, 2010, Expert Rev Mol Diagn, V10, P713, DOI 10.1586/erm.10.65; Castro P, 2012, MOL BREEDING, V29, P261, DOI 10.1007/s11032-010-9544-8; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; Coito Joao L, 2012, BMC Res Notes, V5, P220, DOI 10.1186/1756-0500-5-220; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dalbo MA, 2000, GENOME, V43, P333, DOI 10.1139/gen-43-2-333; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Figueiredo A, 2008, J EXP BOT, V59, P3371, DOI 10.1093/jxb/ern187; Figueiredo A, 2012, FUNCT INTEGR GENOMIC, V12, P379, DOI 10.1007/s10142-012-0261-8; Fischer BM, 2004, THEOR APPL GENET, V108, P501, DOI 10.1007/s00122-003-1445-3; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Godoy AV, 2000, PLANT SCI, V152, P123, DOI 10.1016/S0168-9452(99)00211-3; Golldack D, 2003, PHYSIOL PLANTARUM, V118, P64, DOI 10.1034/j.1399-3054.2003.00087.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jorda L, 2000, PLANT PHYSIOL, V122, P67, DOI 10.1104/pp.122.1.67; Jurges G, 2009, PLANT BIOLOGY, V11, P886, DOI 10.1111/j.1438-8677.2008.00182.x; Kong HY, 2001, PHYSIOL MOL PLANT P, V59, P189, DOI 10.1006/pmpp.2001.0356; Kortekamp A, 2003, J PLANT PHYSIOL, V160, P1393, DOI 10.1078/0176-1617-01021; Kortekamp A, 2008, MOL BREEDING, V22, P421, DOI 10.1007/s11032-008-9186-2; Lee JR, 2007, BIOCHEM BIOPH RES CO, V353, P672, DOI 10.1016/j.bbrc.2006.12.102; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malacarne G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-114; Merdinoglu D, 2003, ACTA HORTIC, P451, DOI 10.17660/ActaHortic.2003.603.57; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Peressotti E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-147; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Polesani M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-117; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schwander F, 2012, THEOR APPL GENET, V124, P163, DOI 10.1007/s00122-011-1695-4; Selim M, 2012, PLANT CELL REP, V31, P205, DOI 10.1007/s00299-011-1156-1; Tornero P, 1996, P NATL ACAD SCI USA, V93, P6332, DOI 10.1073/pnas.93.13.6332; Tornero P, 1997, J BIOL CHEM, V272, P14412, DOI 10.1074/jbc.272.22.14412; Trouvelot S, 2008, MOL PLANT MICROBE IN, V21, P232, DOI 10.1094/MPMI-21-2-0232; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Welter LJ, 2007, MOL BREEDING, V20, P359, DOI 10.1007/s11032-007-9097-7; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Xie YR, 2010, J PLANT PHYSIOL, V167, P121, DOI 10.1016/j.jplph.2009.07.004	56	66	73	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72998	10.1371/journal.pone.0072998	http://dx.doi.org/10.1371/journal.pone.0072998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023800	Green Submitted, gold, Green Published			2022-12-27	WOS:000324515600057
J	Boss, L; Labudda, L; Wegrzyn, G; Hayes, F; Kedzierska, B				Boss, Lidia; Labudda, Lukasz; Wegrzyn, Grzegorz; Hayes, Finbarr; Kedzierska, Barbara			The Axe-Txe Complex of Enterococcus faecium Presents a Multilayered Mode of Toxin-Antitoxin Gene Expression Regulation	PLOS ONE			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; YOEB TOXIN; YEFM-YOEB; CONDITIONAL COOPERATIVITY; VIBRIO-CHOLERAE; PLASMID R1; SYSTEMS; RESISTANT; PAR	Multidrug-resistant variants of human pathogens from the genus Enterococcus represent a significant health threat as leading agents of nosocomial infections. The easy acquisition of plasmid-borne genes is intimately involved in the spread of antibiotic resistance in enterococci. Toxin-antitoxin (TA) systems play a major role in both maintenance of mobile genetic elements that specify antibiotic resistance, and in bacterial persistence and virulence. Expression of toxin and antitoxin genes must be in balance as inappropriate levels of toxin can be dangerous to the host. The controlled production of toxin and antitoxin is usually achieved by transcriptional autoregulation of TA operons. One of the most prevalent TA modules in enterococcal species is axe-txe which is detected in a majority of clinical isolates. Here, we demonstrate that the axe-txe cassette presents a complex pattern of gene expression regulation. Axe-Txe cooperatively autorepress expression from a major promoter upstream of the cassette. However, an internal promoter that drives the production of a newly discovered transcript from within axe gene combined with a possible modulation in mRNA stability play important roles in the modulation of Axe: Txe ratio to ensure controlled release of the toxin.	[Boss, Lidia; Labudda, Lukasz; Wegrzyn, Grzegorz; Kedzierska, Barbara] Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland; [Hayes, Finbarr] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Hayes, Finbarr] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	Fahrenheit Universities; University of Gdansk; University of Manchester; University of Manchester	Kedzierska, B (corresponding author), Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland.	barbara.kedzierska@biol.ug.edu.pl	Wegrzyn, Grzegorz/AAL-1179-2020; Boss, Lidia/ACW-3955-2022; Wegrzyn, Grzegorz/ABD-6699-2020; Kedzierska, Barbara/ABI-1438-2020	Boss, Lidia/0000-0002-0748-4429; Wegrzyn, Grzegorz/0000-0003-4042-7466; Kedzierska, Barbara/0000-0002-5236-7539; Hayes, Finbarr/0000-0003-3212-4326	Polish Ministry of Science and Higher Education [N N301 251936]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish Ministry of Science and Higher Education (project grant no N N301 251936 to BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Bailey SES, 2009, J BACTERIOL, V191, P762, DOI 10.1128/JB.01331-08; Bjorkeng E, 2011, APMIS, V119, P247, DOI 10.1111/j.1600-0463.2011.02724.x; Brinkman CL, 2013, J BACTERIOL, V195, P156, DOI 10.1128/JB.01597-12; Bukowski M, 2011, ACTA BIOCHIM POL, V58, P1; Cataudella I, 2012, NUCLEIC ACIDS RES, V40, P6424, DOI 10.1093/nar/gks297; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Donegan NP, 2009, J BACTERIOL, V191, P2795, DOI 10.1128/JB.01713-08; EBERL L, 1992, MOL MICROBIOL, V6, P1969, DOI 10.1111/j.1365-2958.1992.tb01370.x; Elliott S, 1984, CELL, V36, P211; Gao JJ, 2006, MOL MICROBIOL, V61, P394, DOI 10.1111/j.1365-2958.2006.05246.x; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Greenfield TJ, 2001, MOL MICROBIOL, V42, P527, DOI 10.1046/j.1365-2958.2001.02663.x; Hallez R, 2010, MOL MICROBIOL, V76, P719, DOI 10.1111/j.1365-2958.2010.07129.x; Halvorsen EM, 2011, MICROBIOL-SGM, V157, P387, DOI 10.1099/mic.0.045492-0; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hayes F, 1998, J BACTERIOL, V180, P6415; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Jasiecki J, 2003, EMBO REP, V4, P172, DOI 10.1038/sj.embor.embor733; Kak V., 2002, ACQUIRED ANTIBIOTIC, P355; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kopfmann S, 2013, J BIOL CHEM, V288, P7399, DOI 10.1074/jbc.M112.434100; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Monti MC, 2007, NUCLEIC ACIDS RES, V35, P1737, DOI 10.1093/nar/gkm073; Moritz EM, 2007, P NATL ACAD SCI USA, V104, P311, DOI 10.1073/pnas.0601168104; Mutschler H, 2011, J MOL MED, V89, P1183, DOI 10.1007/s00109-011-0797-4; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Prud'homme-Genereux A, 2004, MOL MICROBIOL, V54, P1409, DOI 10.1111/j.1365-2958.2004.04360.x; Rosvoll TCS, 2010, FEMS IMMUNOL MED MIC, V58, P254, DOI 10.1111/j.1574-695X.2009.00633.x; RUIZECHEVARRIA MJ, 1995, MOL GEN GENET, V248, P599, DOI 10.1007/BF02423456; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Schuster CF, 2013, J BACTERIOL, V195, P115, DOI 10.1128/JB.00400-12; Sevillano L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032977; Silva IJ, 2011, WIRES RNA, V2, P818, DOI 10.1002/wrna.94; Weaver KE, 1996, MOL MICROBIOL, V20, P53, DOI 10.1111/j.1365-2958.1996.tb02488.x; Weaver KE, 2012, RNA BIOL, V9, P1498, DOI 10.4161/rna.22311; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412	46	13	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73569	10.1371/journal.pone.0073569	http://dx.doi.org/10.1371/journal.pone.0073569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019928	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200070
J	Chen, X; Qiu, JD; Shi, SP; Suo, SB; Liang, RP				Chen, Xiang; Qiu, Jian-Ding; Shi, Shao-Ping; Suo, Sheng-Bao; Liang, Ru-Ping			Systematic Analysis and Prediction of Pupylation Sites in Prokaryotic Proteins	PLOS ONE			English	Article							COMPUTATIONAL PREDICTION; UBIQUITIN; DEGRADATION; PUP; IDENTIFICATION; UBIQUITYLATION; ANNOTATION; DATABASE; PROTEOME; PATHWAY	Prokaryotic ubiquitin-like protein (Pup) is the first identified prokaryotic protein that is functionally analogous to ubiquitin. Recent studies have shed light on the Pup activation and conjugation to target proteins to be a signal for the selective degradation proteins in Mycobacterium tuberculosis (Mtb). By covalently conjugating the Pup, pupylation functions as a critical post-translational modification (PTM) conserved in actinomycetes. Detecting pupylation sites is crucial and fundamental for understanding the molecular mechanisms of Pup. Yet comparative studies with other PTM suggest that the development of accurate and complete repertories of pupylation is still in its early stages. Unbiased screening for pupylation sites by experimental methods is time consuming and expensive; in silico prediction can provide highly potential candidates and reduce the number of potential candidates that require further in vivo or in vitro confirmation. Here, we present an effective classifier of PupPred for predicting pupylation sites, which shows better performance than existing classifiers. Importantly, this work not only investigates the sequential, structural and evolutionary hallmarks around pupylation sites but also compares the differences of pupylation and ubiquitylation from the environmental, conservative and functional characterization of substrates. These prediction and analysis results may be helpful for further experimental investigation of degradation proteins in prokaryotes. Finally, the PupPred server is available at http://bioinfo.ncu.edu.cn/PupPred.aspx.	[Chen, Xiang; Qiu, Jian-Ding; Shi, Shao-Ping; Suo, Sheng-Bao; Liang, Ru-Ping] Nanchang Univ, Dept Chem, Nanchang, Peoples R China; [Qiu, Jian-Ding] Pingxiang Coll, Dept Mat & Chem Engn, Pingxiang, Peoples R China; [Shi, Shao-Ping] Nanchang Univ, Dept Math, Nanchang, Peoples R China	Nanchang University; Pingxiang University; Nanchang University	Qiu, JD (corresponding author), Nanchang Univ, Dept Chem, Nanchang, Peoples R China.	jdqiu@ncu.edu.cn	Qiu, Jianding/A-2259-2012; Shi, Shaoping/AAV-9122-2020	Qiu, Jianding/0000-0002-6793-9499; Shi, Shaoping/0000-0003-0045-868X	National Natural Science Foundation of China [20605010, 21175064]; Program for New Century Excellent Talents in University [NCET-11-1002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (20605010 and 21175064), and Program for New Century Excellent Talents in University (NCET-11-1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; Burns KE, 2010, CELL MICROBIOL, V12, P424, DOI 10.1111/j.1462-5822.2010.01447.x; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Cerda-Maira FA, 2011, EMBO REP, V12, P863, DOI 10.1038/embor.2011.109; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen X, 2013, BIOINFORMATICS, V29, P1614, DOI 10.1093/bioinformatics/btt196; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeMartino GN, 2009, TRENDS BIOCHEM SCI, V34, P155, DOI 10.1016/j.tibs.2008.12.005; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; Farriol-Mathis N, 2004, PROTEOMICS, V4, P1537, DOI 10.1002/pmic.200300764; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Goldberg AL, 2005, NEURON, V45, P339, DOI 10.1016/j.neuron.2005.01.019; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Lin C-J, 2003, NIPS 2003 FEATURE SE, P1; Liu ZX, 2011, MOL BIOSYST, V7, P2737, DOI 10.1039/c1mb05217a; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Poulsen C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.39; Provost F, 2000, AAAI 2000 WORKSH IMB; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Reinstein E, 2006, ANN INTERN MED, V145, P676, DOI 10.7326/0003-4819-145-9-200611070-00010; Sanders WS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002101; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Tumminello M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031123; Tung CW, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-40; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Watrous J, 2010, MOL BIOSYST, V6, P376, DOI 10.1039/b916104j	40	28	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74002	10.1371/journal.pone.0074002	http://dx.doi.org/10.1371/journal.pone.0074002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019945	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200088
J	Dyer, J; Sossin, WS				Dyer, John; Sossin, Wayne S.			Characterization of the Role of eIF4G in Stimulating Cap- and IRES-Dependent Translation in Aplysia Neurons	PLOS ONE			English	Article							INITIATION; PHOSPHORYLATION; EUKARYOTES; MECHANISMS; PLASTICITY; HELICASE; KINASE; CANCER; SITES; 4G	The rate-limiting step(s) of translation in the nervous system have not been clearly identified. We have been examining this question in the cell body of the Aplysia sensory neuron, where translational regulation is important for the regulation of synaptic strength. In the present study, we examined the role of the adaptor protein eIF4G. We cloned Aplysia eIF4G (Ap4G) and Ap4G contains all the standard metazoan eIF4G protein-protein interaction domains. Overexpressing Ap4G in Aplysia sensory neurons caused an increase in both cap-dependent and internal ribosome entry site (IRES)-dependent translation using a previously characterized bicistronic fluorescent reporter. Unexpectedly, measurement of overall translation using the methionine analog, L-azidohomoalanine, revealed that overexpression of Ap4G did not lead to an increase in overall translation rates. Indeed, the effect of Ap4G on the bicistronic reporter depended on the presence of an upstream open reading frame (uORF) in the 5' UTR encoded by the vector. We have previously shown that Mnk strongly decreased cap-dependent translation and this depended on a putative 4G binding domain. Here we extend these results showing that even in the absence of the uORF, overexpression of Mnk strongly decreases cap-dependent translation and this depends on the Mnk binding site in eIF4G. Similarly, an increase in cap-dependent translation seen with overexpression of elongation factor 2 kinase did not depend on the uORF. Overall, we show that eIF4G is rate limiting for translation of an mRNA encoding an uORF, but is not generally a rate-limiting step for translation.	[Dyer, John; Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Sossin, WS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	wayne.sossin@mcgill.ca			CIHR [MOP 119286]	CIHR(Canadian Institutes of Health Research (CIHR))	CIHR MOP 119286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carroll M, 2006, MOL CELL BIOL, V26, P8586, DOI 10.1128/MCB.00955-06; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dobrikov MI, 2013, MOL CELL BIOL, V33, P937, DOI 10.1128/MCB.01441-12; Dyer JR, 2003, NAT NEUROSCI, V6, P219, DOI 10.1038/nn1018; Dyer JR, 2000, J NEUROCHEM, V75, P872, DOI 10.1046/j.1471-4159.2000.0750872.x; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Kaang BK, 1996, NEUROSCI LETT, V221, P29, DOI 10.1016/S0304-3940(96)13279-1; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Livingstone M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/021001; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Ran I, 2013, J NEUROSCI, V33, P1872, DOI 10.1523/JNEUROSCI.3264-12.2013; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Ross G, 2006, J NEUROCHEM, V97, P79, DOI 10.1111/j.1471-4159.2006.03704.x; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sossin WS, 2010, CURR OPIN NEUROBIOL, V20, P450, DOI 10.1016/j.conb.2010.03.011; Watanabe R, 2010, J BIOL CHEM, V285, P21922, DOI 10.1074/jbc.M110.132027; Weatherill DB, 2011, J NEUROCHEM, V117, P841, DOI 10.1111/j.1471-4159.2011.07251.x	23	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74085	10.1371/journal.pone.0074085	http://dx.doi.org/10.1371/journal.pone.0074085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019950	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200093
J	Katz, IT; Nkala, B; Dietrich, J; Wallace, M; Bekker, LG; Pollenz, K; Bogart, LM; Wright, AA; Tsai, AC; Bangsberg, DR; Gray, GE				Katz, Ingrid T.; Nkala, Busisiwe; Dietrich, Janan; Wallace, Melissa; Bekker, Linda-Gail; Pollenz, Kathryn; Bogart, Laura M.; Wright, Alexi A.; Tsai, Alexander C.; Bangsberg, David R.; Gray, Glenda E.			A Qualitative Analysis of Factors Influencing HPV Vaccine Uptake in Soweto, South Africa among Adolescents and Their Caregivers	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; CERVICAL-CANCER PREVENTION; DECISION-MAKING; WOMEN; ACCEPTABILITY; ACCEPTANCE; VIRUS; RISK; IMMUNOGENICITY; JOHANNESBURG	Background: In South Africa, the prevalence of oncogenic Human Papillomavirus (HPV) may be as high as 64%, and cervical cancer is the leading cause of cancer-related death among women. The development of efficacious prophylactic vaccines has provided an opportunity for primary prevention. Given the importance of psycho-social forces in vaccine uptake, we sought to elucidate factors influencing HPV vaccination among a sample of low-income South African adolescents receiving the vaccine for the first time in Soweto. Methods: The HPV vaccine was introduced to adolescents in low-income townships throughout South Africa as part of a nationwide trial to understand adolescent involvement in future vaccine research targeting human immunodeficiency virus (HIV). We performed in-depth semi-structured interviews with purposively-sampled adolescents and their care providers to understand what forces shaped HPV vaccine uptake. Interviews were recorded, transcribed, translated, and examined using thematic analysis. Results: Of 224 adolescents recruited, 201 initiated the vaccine; 192 (95.5%) received a second immunization; and 164 (81.6%) completed three doses. In our qualitative study of 39 adolescent-caregiver dyads, we found that factors driving vaccine uptake reflected a socio-cultural backdrop of high HIV endemnicity, sexual violence, poverty, and an abundance of female-headed households. Adolescents exercised a high level of autonomy and often initiated decision-making. Healthcare providers and peers provided support and guidance that was absent at home. The impact of the HIV epidemic on decision-making was substantial, leading participants to mistakenly conflate HPV and HIV. Conclusions: In a setting of perceived rampant sexual violence and epidemic levels of HIV, adolescents and caregivers sought to decrease harm by seeking a vaccine targeting a sexually transmitted infection (STI). Despite careful consenting, there was confusion regarding the vaccine's target. Future interventions promoting STI vaccines will need to provide substantial information for participants, particularly adolescents who may exercise a significant level of autonomy in decision-making.	[Katz, Ingrid T.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Katz, Ingrid T.; Pollenz, Kathryn; Bogart, Laura M.; Wright, Alexi A.; Tsai, Alexander C.; Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA; [Katz, Ingrid T.; Tsai, Alexander C.; Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Nkala, Busisiwe; Dietrich, Janan; Gray, Glenda E.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Wallace, Melissa; Bekker, Linda-Gail] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Bogart, Laura M.] Childrens Hosp Boston, Boston, MA USA; [Wright, Alexi A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bangsberg, David R.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Bangsberg, David R.] Harvard Univ, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Witwatersrand; University of Cape Town; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Katz, IT (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	ikatz2@partners.org	Bekker, Linda-Gail/AAZ-8929-2020; Tsai, Alexander C./F-4247-2015; Wright, Alexi/T-5793-2019	Tsai, Alexander C./0000-0001-6397-7917; Dietrich, Janan/0000-0002-1949-3138; Katz, Ingrid/0000-0002-3014-238X; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Wallace, Melissa/0000-0001-7007-1910	KL2 MeRIT program of Harvard Catalyst \ The Harvard Clinical and Translational Science Center [UL1 RR 025758]; Harvard University; National Institute of Mental Health [1K23MH097667-01, K23 MH-096620, 5K24AA015287-06]; Harvard University Center for AIDS Research (HU CFAR HIV/NIAID) [5P30A1060354-08]; European & Developing Countries Clinical Trials Partnership; South African AIDS Vaccine Initiative (SAAVI); NATIONAL CANCER INSTITUTE [K07CA166210] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH096620, K23MH097667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K24AA015287] Funding Source: NIH RePORTER	KL2 MeRIT program of Harvard Catalyst \ The Harvard Clinical and Translational Science Center; Harvard University; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Harvard University Center for AIDS Research (HU CFAR HIV/NIAID); European & Developing Countries Clinical Trials Partnership; South African AIDS Vaccine Initiative (SAAVI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This qualitative study was funded by a grant to Dr. Katz, MD, MHS, from the KL2 MeRIT program of Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (Award #UL1 RR 025758), and by financial contributions from Harvard University and its affiliated academic health care centers. Dr. Katz currently receives salary support through the National Institute of Mental Health (1K23MH097667-01) and the Harvard University Center for AIDS Research (HU CFAR HIV/NIAID, Fund 5P30A1060354-08. Ms. Nkala received support from The European & Developing Countries Clinical Trials Partnership. Ms. Dietrich receives partial salary support through The South African AIDS Vaccine Initiative (SAAVI). Dr. Tsai receives salary support through The National Institute of Mental Health (K23 MH-096620). Dr. Bangsberg receives salary support through The National Institute of Mental Health (5K24AA015287-06). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar J, 2000, S AFRICAN HLTH REV, P411; Alexander AB, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-192; [Anonymous], 2004, LANCET, DOI DOI 10.1016/S0140-6736(04)17398-4; Bartolini RM, 2010, SALUD PUBLICA MEXICO, V52, P226, DOI 10.1590/S0036-36342010000300007; Bekker LG, 2009, COMMUNITY ATTITUDES; Bingham A, 2009, ARCH PEDIAT ADOL MED, V163, P455, DOI 10.1001/archpediatrics.2009.50; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Botha MH, 2012, VACCINE, V30, pC28, DOI 10.1016/j.vaccine.2012.03.032; Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048; Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Cover JK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-629; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; Creswell J.W., 2018, QUAL INQ, V4; Crime Information Analysis Center, 2001, REP SER CRIM SIT S A; De Vuyst H, 2012, INT J CANCER, V131, P949, DOI 10.1002/ijc.26470; Denny L, 2006, INT J GYNECOL OBSTET, V95, pS211, DOI 10.1016/S0020-7292(06)60036-2; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Denny L, 2008, REPROD HEALTH MATTER, V16, P18, DOI 10.1016/S0968-8080(08)32397-0; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Department of Health, 2011, NAT ANT SENT HIV SYP; Fazekas KI, 2008, J WOMENS HEALTH, V17, P539, DOI 10.1089/jwh.2007.0489; Fife KH, 2004, VACCINE, V22, P2943, DOI 10.1016/j.vaccine.2003.11.058; Firnhaber C, 2010, CANCER CAUSE CONTROL, V21, P433, DOI 10.1007/s10552-009-9475-z; Forster AS, 2012, VACCINE, V30, P4505, DOI 10.1016/j.vaccine.2012.04.066; Francis SA, 2012, MATERN CHILD HLTH J; Francis SA, 2011, VACCINE, V29, P8760, DOI 10.1016/j.vaccine.2011.07.116; Francis SA, 2010, VACCINE, V28, P8026, DOI 10.1016/j.vaccine.2010.08.090; Gerend MA, 2013, SEX TRANSM DIS, V40, P401, DOI 10.1097/OLQ.0b013e318283c8a8; Gerend MA, 2013, HEALTH PSYCHOL, V32, P361, DOI 10.1037/a0026248; Harries J, 2009, VACCINE, V27, P38, DOI 10.1016/j.vaccine.2008.10.033; Hilton S, 2013, VACCINE; HUMAN RIGHTS WATCH, 1995, VIOL WOM S AFR STAT; Hung KJ, 2012, OBSTET GYNECOL, V119, P975, DOI 10.1097/AOG.0b013e31824fc9a0; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Jones HE, 2007, J CLIN MICROBIOL, V45, P1679, DOI 10.1128/JCM.02369-06; Katz IT, 2010, SEX HEALTH, V7, P279, DOI 10.1071/SH09130; Katz IT, 2006, NEW ENGL J MED, V354, P1110, DOI 10.1056/NEJMp068031; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laz TH, 2013, CANCER-AM CANCER SOC, V119, P1386, DOI 10.1002/cncr.27894; Mosavel M, 2005, SOC SCI MED, V61, P2577, DOI 10.1016/j.socscimed.2005.04.041; Motsoaledi A., 2013, COMMUNICATION; Nelson JA, 2010, SEX REPROD HEALTHC, V1, P195, DOI 10.1016/j.srhc.2010.07.004; Nguyen QN, 2010, SEX HEALTH, V7, P262, DOI 10.1071/SH09123; Omar T, 2011, AIDS, V25, P87, DOI 10.1097/QAD.0b013e328340fd99; Otwombe KN, 2011, JAIDS-J ACQ IMM DEF, V58, P211, DOI 10.1097/QAI.0b013e31822b7702; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; PATH National AIDS Research Institute (NARI), 2008, ASS INTR HPV VACC IN; Population Reference Bureau PATH, 2004, PREV CERV CANC WORLD; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Reiter PL, 2010, VACCINE, V28, P6292, DOI 10.1016/j.vaccine.2010.06.114; Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1; Shisana O, 2010, J WOMENS HEALTH, V19, P39, DOI 10.1089/jwh.2008.1200; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Smith K, 2010, J CHILD SEX ABUS, V19, P255, DOI 10.1080/10538711003781269; Statistics South Africa, 2011, DAT MET SET VICT CRI; Tsai AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001440; Tsai AC, 2012, AIDS, V26, P381, DOI 10.1097/QAD.0b013e32834e1ccb; UNAIDS, 2011, S AFRICA; WILLMS DG, 1990, MED ANTHROPOL Q, V4, P391, DOI 10.1525/maq.1990.4.4.02a00020; Wong CA, 2011, CANCER-AM CANCER SOC, V117, P5612, DOI 10.1002/cncr.26246; World Health Organization, 2010, PREV INT PARTN VIOL; Wright TC, 2006, VACCINE, V24, P251, DOI 10.1016/j.vaccine.2006.06.064; [No title captured]	64	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72094	10.1371/journal.pone.0072094	http://dx.doi.org/10.1371/journal.pone.0072094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211BX	24023613	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200008
J	Allen, DB; Conklin, K				Allen, David B.; Conklin, Kathy			Cross-Linguistic Similarity and Task Demands in Japanese-English Bilingual Processing	PLOS ONE			English	Article							SCRIPT TRANSLATION; WORD RECOGNITION; ORTHOGRAPHY; AMBIGUITY; PHONOLOGY; SPANISH; MEMORY	Even in languages that do not share script, bilinguals process cognates faster than matched noncognates in a range of tasks. The current research more fully explores what underpins the cognate 'advantage' in different script bilinguals (Japanese-English). To do this, instead of the more traditional binary cognate/noncognate distinction, the current study uses continuous measures of phonological and semantic overlap, L2 (second language) proficiency and lexical variables (e. g., frequency). An L2 picture naming (Experiment 1) revealed a significant interaction between phonological and semantic similarity and demonstrates that degree of overlap modulates naming times. In lexical decision (Experiment 2), increased phonological similarity (e. g., bus/basu/vs. radio/rajio/) lead to faster response times. Interestingly, increased semantic similarity slowed response times in lexical decision. The studies also indicate how L2 proficiency and lexical variables modulate L2 word processing. These findings are explained in terms of current models of bilingual lexical processing.	[Allen, David B.; Conklin, Kathy] Univ Nottingham, Sch English, Nottingham NG7 2RD, England	University of Nottingham	Allen, DB (corresponding author), Univ Nottingham, Sch English, Nottingham NG7 2RD, England.	david.allen@nottingham.ac.uk		Conklin, Kathy/0000-0003-2347-8018	Japanese Ministry of Education, Culture, Sports, Science Technology	Japanese Ministry of Education, Culture, Sports, Science Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Global Studies grant, Japanese Ministry of Education, Culture, Sports, Science & Technology (www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2000, NIHONGONO GOITOKUSEI, V7; [Anonymous], 2010, R LANG ENV STAT COMP; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; BNC, 2007, BRIT NAT CORP VERS 3; Christoffels IK, 2006, J MEM LANG, V54, P324, DOI 10.1016/j.jml.2005.12.004; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Costa A, 2005, BRAIN LANG, V94, P94, DOI 10.1016/j.bandl.2004.12.002; DEGROOT AMB, 1991, J MEM LANG, V30, P90, DOI 10.1016/0749-596X(91)90012-9; DEGROOT AMB, 1994, J MEM LANG, V33, P600, DOI 10.1006/jmla.1994.1029; Dijkstra T, 1999, J MEM LANG, V41, P496, DOI 10.1006/jmla.1999.2654; Dijkstra T, 2002, BILING-LANG COGN, V5, P175, DOI 10.1017/S1366728902003012; Dijkstra T, 2010, J MEM LANG, V62, P284, DOI 10.1016/j.jml.2009.12.003; Dimitropoulou M, 2011, MEM COGNITION, V39, P260, DOI 10.3758/s13421-010-0004-9; Dunabeitia JA, 2010, EXP PSYCHOL, V57, P98, DOI 10.1027/1618-3169/a000013; Duyck W, 2007, J EXP PSYCHOL LEARN, V33, P663, DOI 10.1037/0278-7393.33.4.663; Ferrand L, 1996, J MEM LANG, V35, P708, DOI 10.1006/jmla.1996.0037; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Gollan TH, 1997, J EXP PSYCHOL LEARN, V23, P1122, DOI 10.1037/0278-7393.23.5.1122; Hernandez AE, 2000, BRAIN LANG, V73, P421, DOI 10.1006/brln.1999.2278; Hino Y, 2002, J EXP PSYCHOL LEARN, V28, P686, DOI 10.1037//0278-7393.28.4.686; Hoshino N, 2008, COGNITION, V106, P501, DOI 10.1016/j.cognition.2007.02.001; Kilgarriff A., 2004, P 11 EURALEX INT C, V1, P105; Kim J, 2003, J MEM LANG, V49, P484, DOI 10.1016/S0749-596X(03)00093-7; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Nakayama M, 2012, LANG COGNITIVE PROC, V27, P1563, DOI 10.1080/01690965.2011.606669; Nishimoto T, 2005, BEHAV RES METHODS, V37, P398, DOI 10.3758/BF03192709; Perfetti C.A., 1999, NEUROCOGNITION LANGU, P167, DOI DOI 10.1093/ACPROF:OSO/9780198507932.0006; Princeton University, 2010, WORDNET; Rodd J, 2002, J MEM LANG, V46, P245, DOI 10.1006/jmla.2001.2810; SANCHEZCASAS RM, 1992, EUR J COGN PSYCHOL, V4, P293; Schwartz AI, 2007, LANG COGNITIVE PROC, V22, P106, DOI 10.1080/01690960500463920; SHOLL A, 1995, PSYCHOL SCI, V6, P45, DOI 10.1111/j.1467-9280.1995.tb00303.x; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; Taft M, 2002, BRAIN LANG, V81, P532, DOI 10.1006/brln.2001.2545; Tokowicz N, 2002, BEHAV RES METH INS C, V34, P435, DOI 10.3758/BF03195472; Tremblay A, 2012, PACK LMERCONVENICEFU; Van Assche E, 2011, J MEM LANG, V64, P88, DOI 10.1016/j.jml.2010.08.006; Van Assche E, 2009, PSYCHOL SCI, V20, P923, DOI 10.1111/j.1467-9280.2009.02389.x; VANORDEN GC, 1987, MEM COGNITION, V15, P181, DOI 10.3758/BF03197716; Voga M, 2007, MEM COGNITION, V35, P938, DOI 10.3758/BF03193467	41	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72631	10.1371/journal.pone.0072631	http://dx.doi.org/10.1371/journal.pone.0072631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015266	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800071
J	Ukwaja, KN; Alobu, I; Igwenyi, C; Hopewell, PC				Ukwaja, Kingsley N.; Alobu, Isaac; Igwenyi, Chika; Hopewell, Philip C.			The High Cost of Free Tuberculosis Services: Patient and Household Costs Associated with Tuberculosis Care in Ebonyi State, Nigeria	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ECONOMIC BURDEN; DIAGNOSIS; POVERTY; COUNTRIES; BARRIERS; IMPACT	Objective: Poverty is both a cause and consequence of tuberculosis. The objective of this study is to quantify patient/household costs for an episode of tuberculosis (TB), its relationships with household impoverishment, and the strategies used to cope with the costs by TB patients in a resource-limited high TB/HIV setting. Methods: A cross-sectional study was conducted in three rural hospitals in southeast Nigeria. Consecutive adults with newly diagnosed pulmonary TB were interviewed to determine the costs each incurred in their care-seeking pathway using a standardised questionnaire. We defined direct costs as out-of-pocket payments, and indirect costs as lost income. Results: Of 452 patients enrolled, majority were male 55% (249), and rural residents 79% (356), with a mean age of 34 (+/- 11.6) years. Median direct pre-diagnosis/diagnosis cost was $49 per patient. Median direct treatment cost was $36 per patient. Indirect pre-diagnostic and treatment costs were $416, or 79% of total patient costs, $528. The median total cost of TB care per household was $592; corresponding to 37% of median annual household income pre-TB. Most patients reported having to borrow money 212(47%), sell assets 42(9%), or both 144(32%) to cope with the cost of care. Following an episode of TB, household income reduced increasing the proportion of households classified as poor from 54% to 79%. Before TB illness, independent predictors of household poverty were; rural residence (adjusted odds ratio [ aOR] 2.8), HIV-positive status (aOR 4.8), and care-seeking at a private facility (aOR 5.1). After TB care, independent determinants of household poverty were; younger age (<= 35 years; aOR 2.4), male gender (aOR 2.1), and HIV-positive status (aOR 2.5). Conclusion: Patient and household costs for TB care are potentially catastrophic even where services are provided free-of-charge. There is an urgent need to implement strategies for TB care that are affordable for the poor.	[Ukwaja, Kingsley N.; Igwenyi, Chika] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria; [Hopewell, Philip C.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Int TB Ctr, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Ukwaja, KN (corresponding author), Fed Teaching Hosp, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria.	ukwajakingsley@yahoo.co.uk	Ukwaja, Kingsley N./A-7794-2013	Ukwaja, Kingsley N./0000-0002-1974-8735	Pan African Thoracic Society (PATS) through its - Methods in Epidemiologic, Clinical and Operations Research (PATS-MECOR)	Pan African Thoracic Society (PATS) through its - Methods in Epidemiologic, Clinical and Operations Research (PATS-MECOR)	This work was supported in part by the Pan African Thoracic Society (PATS) through its 2010 - Methods in Epidemiologic, Clinical and Operations Research (PATS-MECOR) small grant award (UKN). (http://africanthoracic.org/patsmecor/2009_awards.htm.) No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspler A, 2008, INT J TUBERC LUNG D, V12, P928; Aye R, 2011, TROP MED INT HEALTH, V16, P307, DOI 10.1111/j.1365-3156.2010.02710.x; Benatar SR, 2010, INT J TUBERC LUNG D, V14, P1215; Dahlgren G, 2006, LEVELING 1; Datiko DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009158; Ebonyi State Ministry of Health, 2011, NTBLCP STAT RET ACC; Federal Ministry of Health, 2015, NATL TUBER LEPR CONT, V6th, P1; Federal Ministry of Health Department of Public Health, 2010, 2010 NAT HIV SER PRE; Fox-Rushby J, 2005, EC EVALUATION; Gyapong M, 2011, P 18 C INT UN TUB LU; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Ifebunandu Ngozi A, 2012, J Infect Public Health, V5, P340, DOI 10.1016/j.jiph.2012.06.002; Ifebunandu NA, 2012, TROP DOCT, V42, P74, DOI 10.1258/td.2011.110421; Kamineni VV, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-17; Kamolratanakul P, 1999, INT J TUBERC LUNG D, V3, P596; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Marais BJ, 2009, EUR RESPIR J, V33, P943, DOI 10.1183/09031936.00173608; Mauch V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-43; Mesfin MM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-173; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Office S.I.N.S, 2009, REPORT 2009 POPULATI; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; SPENCE DPS, 1993, BRIT MED J, V307, P759, DOI 10.1136/bmj.307.6907.759; Stop TB Partnership DOTS Expansion Working Group (TB and Poverty subgroup), TOOLS EST PAT COSTS; The World Bank, WORLD DEV IND GNI PE; Ukwaja KN, 2012, INT J TUBERC LUNG D, V16, P733, DOI 10.5588/ijtld.11.0193; Ukwaja Kingsley, 2011, Pan Afr Med J, V9, P12; Umar NA, 2012, INT J TUBERC LUNG D, V16, P835, DOI 10.5588/ijtld.10.0774; Vassall A, 2010, INT J TUBERC LUNG D, V14, P604; World Health Organisation, 2005, ADD POV TB CONTR; World Health Organisation, 2011, WHOHTMTB201116; Wyss K, 2001, TROP MED INT HEALTH, V6, P60, DOI 10.1046/j.1365-3156.2001.00677.x	32	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73134	10.1371/journal.pone.0073134	http://dx.doi.org/10.1371/journal.pone.0073134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015293	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200068
J	Kogelberg, H; Miranda, E; Burnet, J; Ellison, D; Tolner, B; Foster, J; Picon, C; Thomas, GJ; Meyer, T; Marshall, JF; Mather, SJ; Chester, K				Kogelberg, Heide; Miranda, Enrique; Burnet, Jerome; Ellison, David; Tolner, Berend; Foster, Julie; Picon, Carmen; Thomas, Gareth J.; Meyer, Tim; Marshall, John F.; Mather, Stephen J.; Chester, Kerry			Generation and Characterization of a Diabody Targeting the alpha(v)beta(6) Integrin	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; COLORECTAL-CANCER PROGRESSION; MESENCHYMAL-TRANSITION EMT; LATENT TGF-BETA; ALPHA-V-BETA-6 INTEGRIN; IN-VIVO; ANTIBODY FRAGMENTS; GASTRIC-CARCINOMA; UP-REGULATION; CELLS	The alpha(v)beta(6) integrin is up-regulated in cancer and wound healing but it is not generally expressed in healthy adult tissue. There is increasing evidence that it has a role in cancer progression and will be a useful target for antibody-directed cancer therapies. We report a novel recombinant diabody antibody fragment that targets specifically alpha(v)beta(6) and blocks its function. The diabody was engineered with a C-terminal hexahistidine tag (His tag), expressed in Pichia pastoris and purified by IMAC. Surface plasmon resonance (SPR) analysis of the purified diabody showed affinity in the nanomolar range. Pre-treatment of alpha(v)beta(6)-expressing cells with the diabody resulted in a reduction of cell migration and adhesion to LAP, demonstrating biological function-blocking activity. After radio-labeling, using the His-tag for site-specific attachment of Tc-99m, the diabody retained affinity and targeted specifically to alpha(v)beta(6)-expressing tumors in mice bearing isogenic alpha(v)beta(6) +/- xenografts. Furthermore, the diabody was specifically internalized into alpha(v)beta(6)-expressing cells, indicating warhead targeting potential. Our results indicate that the new alpha(v)beta(6) diabody has a range of potential applications in imaging, function blocking or targeted delivery/internalization of therapeutic agents.	[Kogelberg, Heide; Miranda, Enrique; Tolner, Berend; Picon, Carmen; Meyer, Tim; Chester, Kerry] UCL, UCL Canc Inst, London, England; [Burnet, Jerome; Ellison, David; Foster, Julie; Mather, Stephen J.] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, John Vane Sci Ctr, London, England; [Thomas, Gareth J.] Univ Southampton, Canc Sci Unit, Southampton, Hants, England; [Marshall, John F.] Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, Tumor Biol Ctr, London, England	University of London; University College London; University of London; Queen Mary University London; University of Southampton; University of London; Queen Mary University London	Chester, K (corresponding author), UCL, UCL Canc Inst, London, England.	k.chester@ucl.ac.uk	Miranda, Enrique/AAD-4621-2020; Chester, Kerry/AAE-2856-2020	Miranda, Enrique/0000-0003-3361-3957; Marshall, John/0000-0002-0494-2295	Debbie Fund; UCL Cancer Institute Research Trust; Cancer Research UK [C34/A5149]; Department of Health; Cancer Research UK Experimental Cancer Medicine Centre [C34/A7279]; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) [UCLH.BW.mn.10161]	Debbie Fund; UCL Cancer Institute Research Trust; Cancer Research UK(Cancer Research UK); Department of Health; Cancer Research UK Experimental Cancer Medicine Centre; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR))	This study was supported by Debbie Fund and the UCL Cancer Institute Research Trust, Cancer Research UK (grant number C34/A5149), the Department of Health and Cancer Research UK Experimental Cancer Medicine Centre (grant number C34/A7279) (www.cancerresearchuk.org) (www.ecmcnetwork.org.uk) and the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) (ref. UCLH.BW.mn.10161 (http://www.uclhospitals.brc.nihr.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 1998, BRIT J CANCER, V77, P1405, DOI 10.1038/bjc.1998.233; Bandyopadhyay A, 2009, CURR DRUG TARGETS, V10, P645, DOI 10.2174/138945009788680374; Bates RC, 2005, CELL CYCLE, V4, P1350, DOI 10.4161/cc.4.10.2053; Bates RC, 2005, CANCER BIOL THER, V4, P365; DiCara D, 2007, J BIOL CHEM, V282, P9657, DOI 10.1074/jbc.M610461200; Eberlein C, 2012, ONCOGENE; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Giacomini MM, 2012, EXP CELL RES, V318, P716, DOI 10.1016/j.yexcr.2012.01.020; Graff CP, 2004, PROTEIN ENG DES SEL, V17, P293, DOI 10.1093/protein/gzh038; Hazelbag S, 2007, J PATHOL, V212, P316, DOI 10.1002/path.2168; He J, 2010, J NUCL MED, V51, P427, DOI 10.2967/jnumed.109.069492; Hezel AF, 2012, CANCER RES, V72, P4840, DOI 10.1158/0008-5472.CAN-12-0634; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444; Kogelberg H, 2008, J MOL BIOL, V382, P385, DOI 10.1016/j.jmb.2008.07.013; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Li L, 2010, J NUCL MED, V51, P1139, DOI 10.2967/jnumed.109.074153; Mamuya FA, 2012, J CELL MOL MED, V16, P445, DOI 10.1111/j.1582-4934.2011.01419.x; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Patsenker E, 2010, J HEPATOL, V52, P362, DOI 10.1016/j.jhep.2009.12.006; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sipos B, 2004, HISTOPATHOLOGY, V45, P226, DOI 10.1111/j.1365-2559.2004.01919.x; Sundaresan G, 2003, J NUCL MED, V44, P1962; Thomas GJ, 2006, J ORAL PATHOL MED, V35, P1, DOI 10.1111/j.1600-0714.2005.00374.x; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; Tolner B, 2006, NAT PROTOC, V1, P1006, DOI 10.1038/nprot.2006.126; Tolner B, 2006, NAT PROTOC, V1, P1213, DOI 10.1038/nprot.2006.127; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Wu AM, 2000, Q J NUCL MED, V44, P268; Wu AM, 2008, CANCER J, V14, P191, DOI 10.1097/PPO.0b013e31817b07ae; Yang GY, 2008, CANCER SCI, V99, P879, DOI 10.1111/j.1349-7006.2008.00762.x; Yang SB, 2012, CANCER IMMUNOL IMMUN, V61, P335, DOI 10.1007/s00262-011-1108-1; Zhang ZY, 2008, CLIN ONCOL-UK, V20, P61, DOI 10.1016/j.clon.2007.09.008	38	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73260	10.1371/journal.pone.0073260	http://dx.doi.org/10.1371/journal.pone.0073260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023846	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000324515600086
J	Krystal, AD; Schopler, B; Kobbe, S; Williams, C; Rakatondrainibe, H; Yoder, AD; Klopfer, P				Krystal, Andrew D.; Schopler, Bobby; Kobbe, Susanne; Williams, Cathy; Rakatondrainibe, Hajanirina; Yoder, Anne D.; Klopfer, Peter			The Relationship of Sleep with Temperature and Metabolic Rate in a Hibernating Primate	PLOS ONE			English	Article							EUROPEAN GROUND-SQUIRRELS; SLOW-WAVE ACTIVITY; REM-SLEEP; BODY-TEMPERATURE; AROUSAL EPISODES; POWER-DENSITY; PRIOR WAKING; DEPRIVATION; EEG; HOMEOSTASIS	Study Objectives: It has long been suspected that sleep is important for regulating body temperature and metabolic-rate. Hibernation, a state of acute hypothermia and reduced metabolic-rate, offers a promising system for investigating those relationships. Prior studies in hibernating ground squirrels report that, although sleep occurs during hibernation, it manifests only as non-REM sleep, and only at relatively high temperatures. In our study, we report data on sleep during hibernation in a lemuriform primate, Cheirogaleus medius. As the only primate known to experience prolonged periods of hibernation and as an inhabitant of more temperate climates than ground squirrels, this animal serves as an alternative model for exploring sleep temperature/metabolism relationships that may be uniquely relevant to understanding human physiology. Measurements and Results: We find that during hibernation, non-REM sleep is absent in Cheirogaleus. Rather, periods of REM sleep occur during periods of relatively high ambient temperature, a pattern opposite of that observed in ground squirrels. Like ground squirrels, however, EEG is marked by ultra-low voltage activity at relatively low metabolic-rates. Conclusions: These findings confirm a sleep-temperature/metabolism link, though they also suggest that the relationship of sleep stage with temperature/metabolism is flexible and may differ across species or mammalian orders. The absence of non-REM sleep suggests that during hibernation in Cheirogaleus, like in the ground squirrel, the otherwise universal non-REM sleep homeostatic response is greatly curtailed or absent. Lastly, ultra-low voltage EEG appears to be a cross-species marker for extremely low metabolic-rate, and, as such, may be an attractive target for research on hibernation induction.	[Krystal, Andrew D.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Schopler, Bobby; Williams, Cathy; Yoder, Anne D.; Klopfer, Peter] Duke Univ, Lemur Ctr, Durham, NC USA; [Kobbe, Susanne] Univ Hamburg, Dept Anim Ecol & Conservat, Hamburg, Germany; [Rakatondrainibe, Hajanirina] Mineral Soc Anonym, Lemurs Biomed Monitoring Environm Dept, Biodivers Sect, Ambatovy, Antananarivo, Madagascar; [Yoder, Anne D.; Klopfer, Peter] Duke Univ, Dept Biol, Durham, NC USA; [Yoder, Anne D.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	Duke University; Duke University; University of Hamburg; Duke University; Duke University	Krystal, AD (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27706 USA.	kryst001@mc.duke.edu	Krystal, Andrew D/J-7109-2013	Krystal, Andrew D/0000-0002-6702-781X	The Provost's Common Fund, Duke University; The Lemur Center, Duke University; The Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine; Duke Institute for Genome Sciences and Policy	The Provost's Common Fund, Duke University; The Lemur Center, Duke University; The Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine; Duke Institute for Genome Sciences and Policy	The authors acknowledge the following sources of funding: The Provost's Common Fund, Duke University; The Lemur Center, Duke University; The Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine; Duke Institute for Genome Sciences and Policy. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; Aslami H, 2010, NETH J MED, V68, P190; Aslami H, 2009, CURR MED CHEM, V16, P1295, DOI 10.2174/092986709787846631; Baird BJ, 2011, MUTAT RES-FUND MOL M, V711, P142, DOI 10.1016/j.mrfmmm.2010.12.006; Barf RP, 2012, AM J PHYSIOL-REG I, V302, pR112, DOI 10.1152/ajpregu.00326.2011; BENINGTON JH, 1995, BRAIN RES, V692, P79, DOI 10.1016/0006-8993(95)00590-M; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; BRUNNER DP, 1990, ELECTROEN CLIN NEURO, V75, P492, DOI 10.1016/0013-4694(90)90136-8; Cirelli C, 2006, SLEEP MED REV, V10, P307, DOI 10.1016/j.smrv.2006.04.001; DAAN S, 1991, NEUROSCI LETT, V128, P265, DOI 10.1016/0304-3940(91)90276-Y; Dausmann KH, 2009, J COMP PHYSIOL B, V179, P345, DOI 10.1007/s00360-008-0318-0; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; DEBOER T, 1995, BRAIN RES, V670, P153, DOI 10.1016/0006-8993(94)01299-W; Deboer T, 1998, J SLEEP RES, V7, P254, DOI 10.1046/j.1365-2869.1998.00125.x; DIJK DJ, 1990, SLEEP, V13, P430, DOI 10.1093/sleep/13.5.430; ERWIN CW, 1984, J CLIN NEUROPHYSIOL, V1, P253, DOI 10.1097/00004691-198407000-00001; Fredholm BB, 2011, ADV PHARMACOL, V61, P77, DOI 10.1016/B978-0-12-385526-8.00003-5; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Hornung OP, 2006, EXP NEUROL, V197, P486, DOI 10.1016/j.expneurol.2005.10.013; Iaizzo PA, 2012, INTEGR ZOOL, V7, P48, DOI [10.1111/j.1749-4877.2012.00275.x, 10.1111/j.1749-4877.2011.00280.x]; Iber C., 2007, AASM MANUAL SCORING; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Koban M, 2005, AM J PHYSIOL-ENDOC M, V289, pE68, DOI 10.1152/ajpendo.00543.2004; Krauchi K, 2010, FRONT BIOSCI-LANDMRK, V15, P604, DOI 10.2741/3636; Krystal AD, 2002, SLEEP, V25, P630; Krystal AD, 2010, SLEEP, V33, P669, DOI 10.1093/sleep/33.5.669; Larkin JE, 1996, AM J PHYSIOL-REG I, V270, pR777, DOI 10.1152/ajpregu.1996.270.4.R777; Larkin JE, 1999, AM J PHYSIOL-REG I, V276, pR522, DOI 10.1152/ajpregu.1999.276.2.R522; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Lu W, 2012, SLEEP MED REV, V16, P389, DOI 10.1016/j.smrv.2011.08.001; Parmeggiani PL, 2003, FRONT BIOSCI, V8, pS557, DOI 10.2741/1054; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Porkka-Heiskanen T, 2011, SLEEP MED REV, V15, P123, DOI 10.1016/j.smrv.2010.06.005; Rechtschaffen A, 2002, SLEEP, V25, p68B, DOI 10.1093/sleep/25.1.68; RUIZPRIMO E, 1982, ELECTROEN CLIN NEURO, V53, P559, DOI 10.1016/0013-4694(82)90068-2; Schmid SM, 2008, J SLEEP RES, V17, P331, DOI 10.1111/j.1365-2869.2008.00662.x; Siegel JM, 2011, SLEEP MED REV, V15, P139, DOI 10.1016/j.smrv.2011.01.001; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Strijkstra AM, 1997, J SLEEP RES, V6, P36, DOI 10.1046/j.1365-2869.1997.00024.x; Strijkstra AM, 1998, AM J PHYSIOL-REG I, V275, pR1110, DOI 10.1152/ajpregu.1998.275.4.R1110; Strijkstra AM, 1997, NEUROSCI LETT, V221, P177, DOI 10.1016/S0304-3940(96)13321-8; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vaara J, 2009, EUR J APPL PHYSIOL, V105, P439, DOI 10.1007/s00421-008-0921-5; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; WALKER JM, 1977, AM J PHYSIOL, V233, pR213, DOI 10.1152/ajpregu.1977.233.5.R213; WALKER JM, 1981, EXPERIENTIA, V37, P726, DOI 10.1007/BF01967947; Wurts SW, 2000, J NEUROSCI, V20, P4300	50	21	21	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e69914	10.1371/journal.pone.0069914	http://dx.doi.org/10.1371/journal.pone.0069914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023713	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600005
J	Ravani, P; Maas, R; Malberti, F; Pecchini, P; Mieth, M; Quinn, R; Tripepi, G; Mallamaci, F; Zoccali, C				Ravani, Pietro; Maas, Renke; Malberti, Fabio; Pecchini, Paola; Mieth, Maren; Quinn, Robert; Tripepi, Giovanni; Mallamaci, Francesca; Zoccali, Carmine			Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients	PLOS ONE			English	Article							MASS-SPECTROMETRIC DETERMINATION; ASYMMETRIC DIMETHYLARGININE; RENAL-DISEASE; RISK-FACTOR; PLASMA; ARGININE; MODELS; TARGET; ADMA	Background and Aims: Homoarginine, a precursor of nitric oxide, is an inverse predictor of death in dialysis patients and in subjects with cardiovascular disease and normal kidney function but its relationship with clinical outcomes in chronic kidney disease (CKD) patients not yet on dialysis is unknown. Design, setting, participants and measurements: We enrolled 168 consecutive predialysis CKD patients (Age: 70 +/- 11 yrs; 26% Diabetics; eGFR 34 +/- 18 ml/min/1.73 m(2)) referred to a tertiary care centre and measured laboratory data on kidney function and cardiovascular risk factors. We modeled progression to dialysis or death as a function of homoarginine, using Cox's regression, accounting for clinical characteristics, baseline levels of kidney function, and markers of inflammation. Results: On crude and adjusted analyses homoarginine was directly associated with the eGFR and patients with more compromised renal function exhibited lower homoarginine levels. Furthermore homoarginine was also independently related to L-arginine, serum albumin and body mass index, and inversely related to proteinuria, C-reactive protein and age. During the study (follow up median time 4 years, inter-quartile range 1.7 to 7.0 years) 56 patients started dialysis and 103 died and homoarginine was a strong inverse predictor of the incidence rate of both outcomes (P = 0.002 and P = 0.017). Conclusions: Homoarginine declines with advancing renal disease and is inversely related to progression to dialysis and mortality. The nature of the link between homoarginine and clinical outcomes is amenable to testing in clinical trials.	[Ravani, Pietro; Quinn, Robert] Univ Calgary, Dept Med, Calgary, AB, Canada; [Ravani, Pietro; Quinn, Robert] Univ Calgary, Fac Med, Calgary, AB, Canada; [Maas, Renke; Mieth, Maren] Univ Erlangen Nurnberg, Inst Clin & Expt Pharmacol & Toxicol, Nurnberg, Germany; [Malberti, Fabio; Pecchini, Paola] Azienda Ist Ospitalieri Cremona, Div Nefrol, Cremona, Italy; [Tripepi, Giovanni; Mallamaci, Francesca; Zoccali, Carmine] Osped Riuniti Reggio Calabria, Div Nefrol, Reggio Di Calabria, Italy; [Tripepi, Giovanni; Mallamaci, Francesca; Zoccali, Carmine] CNR IBIM, Reggio Di Calabria, Italy	University of Calgary; University of Calgary; University of Erlangen Nuremberg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Zoccali, C (corresponding author), Osped Riuniti Reggio Calabria, Div Nefrol, Reggio Di Calabria, Italy.	carmine.zoccali@tin.it	Ravani, Pietro/J-3050-2015; Quinn, Robert R/E-7017-2011	Ravani, Pietro/0000-0001-6973-8570; Zoccali, Carmine/0000-0002-6616-1996	National Research Council	National Research Council(Consiglio Nazionale delle Ricerche (CNR))	No current external funding sources for this study. The institutional funder (National Research Council) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzler D, 2011, J CHROMATOGR B, V879, P2294, DOI 10.1016/j.jchromb.2011.06.016; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Curtis BM, 2005, NEPHROL DIAL TRANSPL, V20, P147, DOI 10.1093/ndt/gfh585; Drechsler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063560; Fliser D, 2010, J NEPHROL, V23, P369; Kielstein JT, 2008, CURR OPIN NEPHROL HY, V17, P609, DOI 10.1097/MNH.0b013e328314b6ca; LEVILLAIN O, 1995, KIDNEY INT, V47, P464, DOI 10.1038/ki.1995.59; Marz W, 2010, CIRCULATION, V122, P967, DOI 10.1161/CIRCULATIONAHA.109.908988; Meinitzer A, 2007, CLIN CHIM ACTA, V384, P141, DOI 10.1016/j.cca.2007.07.006; Pilz S, 2011, HEART, V97, P1222, DOI 10.1136/hrt.2010.220731; Ravani P, 2008, NEPHROL DIAL TRANSPL, V23, P1484, DOI 10.1093/ndt/gfn138; Schwedhelm E, 2007, J CHROMATOGR B, V851, P211, DOI 10.1016/j.jchromb.2006.11.052; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; Valtonen P, 2008, CIRC J, V72, P1879, DOI 10.1253/circj.CJ-08-0240; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Zoccali C, 2006, J HYPERTENS, V24, P611, DOI 10.1097/01.hjh.0000217839.26971.8d	17	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72694	10.1371/journal.pone.0072694	http://dx.doi.org/10.1371/journal.pone.0072694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023762	gold, Green Submitted, Green Published			2022-12-27	WOS:000324515600035
J	Phan, TG; Vo, NP; Boros, A; Pankovics, P; Reuter, G; Li, OTW; Wang, CL; Deng, XT; Poon, LLM; Delwart, E				Tung Gia Phan; Nguyen Phung Vo; Boros, Akos; Pankovics, Peter; Reuter, Gabor; Li, Olive T. W.; Wang, Chunling; Deng, Xutao; Poon, Leo L. M.; Delwart, Eric			The Viruses of Wild Pigeon Droppings	PLOS ONE			English	Article							WEST-NILE-VIRUS; PATHOGENIC AVIAN INFLUENZA; COMPLETE GENOME SEQUENCE; NEWCASTLE-DISEASE; VIRAL-INFECTIONS; ROTAVIRUS GENOME; ENTERIC DISEASE; HUMAN GYROVIRUS; CHICKEN; PICORNAVIRUS	Birds are frequent sources of emerging human infectious diseases. Viral particles were enriched from the feces of 51 wild urban pigeons (Columba livia) from Hong Kong and Hungary, their nucleic acids randomly amplified and then sequenced. We identified sequences from known and novel species from the viral families Circoviridae, Parvoviridae, Picornaviridae, Reoviridae, Adenovirus, Astroviridae, and Caliciviridae (listed in decreasing number of reads), as well as plant and insect viruses likely originating from consumed food. The near full genome of a new species of a proposed parvovirus genus provisionally called Aviparvovirus contained an unusually long middle ORF showing weak similarity to an ORF of unknown function from a fowl adenovirus. Picornaviruses found in both Asia and Europe that are distantly related to the turkey megrivirus and contained a highly divergent 2A1 region were named mesiviruses. All eleven segments of a novel rotavirus subgroup related to a chicken rotavirus in group G were sequenced and phylogenetically analyzed. This study provides an initial assessment of the enteric virome in the droppings of pigeons, a feral urban species with frequent human contact.	[Tung Gia Phan; Nguyen Phung Vo; Deng, Xutao; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Tung Gia Phan; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Nguyen Phung Vo] Ho Chi Minh City Univ Med & Pharm, Dept Pharmacol, Sch Pharm, Ho Chi Minh City, Vietnam; [Boros, Akos; Pankovics, Peter; Reuter, Gabor] ANTSZ Reg Inst, State Publ Hlth Serv, Natl Reference Lab Gastroenter Viruses, Reg Lab Virol, Pecs, Hungary; [Wang, Chunling] Stanford Genome Technol Ctr, Stanford, CA USA; [Li, Olive T. W.; Poon, Leo L. M.] Univ Hong Kong, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Li, Olive T. W.; Poon, Leo L. M.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Hochiminh City University of Medicine & Pharmacy; Stanford University; University of Hong Kong; University of Hong Kong	Delwart, E (corresponding author), Blood Syst Res Inst, San Francisco, CA USA.	delwarte@medicine.ucsf.edu	Poon, Leo/AAP-6887-2020; Reuter, Gábor/I-7412-2013; Poon, Leo Lit Man/C-4382-2009	Reuter, Gábor/0000-0002-5857-4934; Poon, Leo Lit Man/0000-0002-9101-7953; Phan, Tung/0000-0003-3517-3078; Delwart, Eric/0000-0002-6296-4484; Boros, Akos/0000-0001-5843-4360	NHLBI [R01HL083254]; BSRI; EMPERIE [EU FP7 223498]; Hungarian Scientific Research Fund (OTKA) [K83013, PD108482]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; National Excellence Program TAMOP [4.2.4. A/2-11-1-2012-0001]; European Social Fund; European Union; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083254] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BSRI; EMPERIE; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); National Excellence Program TAMOP; European Social Fund(European Social Fund (ESF)); European Union(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge NHLBI R01HL083254 and support from BSRI to ED, EMPERIE grant EU FP7 223498 to L.LMP. Grants from the Hungarian Scientific Research Fund (OTKA, K83013 and PD108482) and support from the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences to GR. AB was supported by the National Excellence Program TAMOP 4.2.4. A/2-11-1-2012-0001 subsidized by the European Union and co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Elzein EME, 1999, J VET MED B, V46, P689, DOI 10.1046/j.1439-0450.1999.00296.x; Adair BM, 2000, DEV COMP IMMUNOL, V24, P247, DOI 10.1016/S0145-305X(99)00076-2; Alexander DJ, 2012, AVIAN PATHOL, V41, P329, DOI 10.1080/03079457.2012.697991; Alexander DJ, 2011, AVIAN PATHOL, V40, P547, DOI 10.1080/03079457.2011.618823; Alexander DJ, 2000, REV SCI TECH OIE, V19, P197, DOI 10.20506/rst.19.1.1220; Allison AB, 2004, EMERG INFECT DIS, V10, P2252, DOI 10.3201/eid1012.040511; Amendola A, 2011, J Prev Med Hyg, V52, P107; [Anonymous], 1952, AM J PUBLIC HEALTH; Balamurugan V, 2006, VET RES COMMUN, V30, P541, DOI 10.1007/s11259-006-3278-4; Bengis RH, 2004, REV SCI TECH OIE, V23, P497; Biagini P, 2013, EMERG INFECT DIS, V19, P1014, DOI 10.3201/eid1906.130228; BISHOP RF, 1973, NEW ENGL J MED, V289, P1096; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Boros A, 2013, J GEN VIROL; Boros A, 2012, J GEN VIROL, V93, P2171, DOI 10.1099/vir.0.043224-0; Brown KE, 2010, REV MED VIROL, V20, P231, DOI 10.1002/rmv.648; Cann AJ, 2005, VIRUS GENES, V30, P151, DOI 10.1007/s11262-004-5624-3; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Capua I, 2010, AVIAN DIS, V54, P176, DOI 10.1637/8870-041009-Reg.1; Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X; Cattoli G, 2011, J VET DIAGN INVEST, V23, P637, DOI 10.1177/1040638711407887; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; Chu DKW, 2012, J CLIN VIROL, V55, P209, DOI 10.1016/j.jcv.2012.07.001; Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11; Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; Day JM, 2010, VIROLOGY, V399, P59, DOI 10.1016/j.virol.2009.12.027; Dennehy Penelope H, 2012, Adv Pediatr, V59, P47, DOI 10.1016/j.yapd.2012.04.002; Dortmans JCFM, 2011, AVIAN PATHOL, V40, P125, DOI 10.1080/03079457.2010.542131; Duchatel JP, 2009, AVIAN PATHOL, V38, P143, DOI 10.1080/03079450902737805; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; GORBALENYA AE, 1989, FEBS LETT, V243, P103, DOI 10.1016/0014-5793(89)80109-7; Griffin BD, 2011, J GEN VIROL, V92, P1260, DOI 10.1099/vir.0.030064-0; Gronesova P, 2009, ACTA VIROL, V53, P213, DOI 10.4149/av_2009_03_213; Guo HD, 2010, INT J DIGIT EARTH, V3, P1, DOI 10.1080/17538941003650702; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; Hofmeister EK, 2011, INTEGR ZOOL, V6, P279, DOI 10.1111/j.1749-4877.2011.00251.x; Honkavuori KS, 2011, EMERG INFECT DIS, V17, P480, DOI 10.3201/eid1703.101410; Hughes PJ, 2000, J GEN VIROL, V81, P201, DOI 10.1099/0022-1317-81-1-201; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; Ito H, 2001, VIRUS RES, V75, P123, DOI 10.1016/S0168-1702(01)00234-9; Johne R, 2011, VIROLOGY, V412, P384, DOI 10.1016/j.virol.2011.01.031; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kindler E, 2013, INFECT GENET EVOL, V14, P58, DOI 10.1016/j.meegid.2012.11.015; Knowles NJ, 2012, EMERG INFECT DIS, V18, P499, DOI 10.3201/eid1803.110908; Kohls A, 2011, AVIAN DIS, V55, P447, DOI 10.1637/9567-100710-ResNote.1; Kozdrun W, 2012, POL J VET SCI, V15, P525, DOI 10.2478/v10181-012-0080-9; Krapez U, 2012, AVIAN DIS, V56, P432, DOI 10.1637/9929-091211-Case.1; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Lindsey Nicole P., 2012, Morbidity and Mortality Weekly Report, V61, P510; Lubroth J, 2007, DEV BIOLOGICALS, V130, P13; Mackenzie JS, 2013, CURR OPIN VIROL; Maggi F, 2012, EMERG INFECT DIS, V18, P956, DOI 10.3201/eid1806.120179; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marlier D, 2006, VET J, V172, P40, DOI 10.1016/j.tvjl.2005.02.026; Martin V, 2006, ANN NY ACAD SCI, V1081, P153, DOI 10.1196/annals.1373.017; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; MCNULTY MS, 1984, ARCH VIROL, V81, P113, DOI 10.1007/BF01309301; Miguel E, 2012, EPIDEMIOL INFECT, P1; MINAMOTO N, 1988, EPIDEMIOL INFECT, V100, P481, DOI 10.1017/S0950268800067212; MITCHELL DB, 1990, VIROLOGY, V174, P618, DOI 10.1016/0042-6822(90)90117-A; Monaco F, 2010, ZOONOSES PUBLIC HLTH, V57, P476, DOI 10.1111/j.1863-2378.2009.01245.x; Murgia MV, 2012, AVIAN DIS, V56, P744, DOI 10.1637/10076-020812-ResNote.1; Murray KO, 2011, EPIDEMIOL INFECT, V139, P807, DOI 10.1017/S0950268811000185; Ong A, 2008, ANN ACAD MED SINGAP, V37, P477; Palade EA, 2011, AVIAN DIS, V55, P468, DOI 10.1637/9688-021711-ResNote.1; Pankovics P, 2012, ARCH VIROL, V157, P525, DOI 10.1007/s00705-011-1192-8; Patton JT, 2006, CURR TOP MICROBIOL, V309, P169; PATTON JT, 1993, VIROLOGY, V192, P438, DOI 10.1006/viro.1993.1059; Pchelkina IP, 2013, AVIAN DIS, V57, P2, DOI 10.1637/10246-051112-Reg.1; Pesavento JB, 2006, CURR TOP MICROBIOL, V309, P189; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Phan TG, 2012, J GEN VIROL, V93, P1356, DOI 10.1099/vir.0.041731-0; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3; Reuter G, 2012, J VIROL, V86, P13295, DOI 10.1128/JVI.01142-12; Rijsewijk FAM, 2011, ARCH VIROL, V156, P1097, DOI 10.1007/s00705-011-0971-6; Rumschlag-Booms E, 2013, ADV VIROL, V2013, DOI 10.1155/2013/121924; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schat KA, 2009, CURR TOP MICROBIOL, V331, P151; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Shortridge KF, 2003, J APPL MICROBIOL, V94, p70S; Simmonds Peter, 2012, BMC Res Notes, V5, P50, DOI 10.1186/1756-0500-5-50; Stenzel TA, 2012, VET REC, V171, P562, DOI 10.1136/vr.100932; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; Trojnar E, 2009, VIROLOGY, V386, P325, DOI 10.1016/j.virol.2009.01.034; TROTT DG, 1965, BMJ-BRIT MED J, V2, P1514, DOI 10.1136/bmj.2.5477.1514; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wei CY, 2012, J VIROL, V86, P10247, DOI 10.1128/JVI.01643-12; Woo PCY, 2012, J VIROL, V86, P2797, DOI 10.1128/JVI.05481-11; Woo PCY, 2010, J GEN VIROL, V91, P2433, DOI 10.1099/vir.0.021717-0; WOODS LW, 1994, J VET DIAGN INVEST, V6, P156, DOI 10.1177/104063879400600205; Xu Y, 2013, J VIROL, V87, P3760, DOI 10.1128/JVI.02497-12; Yamamoto Y, 2012, J VET MED SCI, V74, P205, DOI 10.1292/jvms.11-0312; Zanetti F, 2001, AVIAN DIS, V45, P567, DOI 10.2307/1592896; Zsak L, 2008, AVIAN PATHOL, V37, P435, DOI 10.1080/03079450802210648	103	85	89	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72787	10.1371/journal.pone.0072787	http://dx.doi.org/10.1371/journal.pone.0072787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023772	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600043
J	Wang, XQ; Ng, RK; Ming, XY; Zhang, W; Chen, L; Chu, ACY; Pang, R; Lo, CM; Tsao, SW; Liu, XQ; Poon, RTP; Fan, ST				Wang, Xiao Qi; Ng, Ray Kit; Ming, Xiaoyan; Zhang, Wu; Chen, Lin; Chu, Andrew C. Y.; Pang, Roberta; Lo, Chung Mau; Tsao, Sai Wah; Liu, Xuqing; Poon, Ronnie T. P.; Fan, Sheung Tat			Epigenetic Regulation of Pluripotent Genes Mediates Stem Cell Features in Human Hepatocellular Carcinoma and Cancer Cell Lines	PLOS ONE			English	Article							COLORECTAL-CANCER; EXPRESSION; HYPOMETHYLATION; DIFFERENTIATION; GENERATION; RESISTANCE; SIGNATURE; NANOGP8; NETWORK; PATHWAY	Activation of the stem cell transcriptional circuitry is an important event in cancer development. Although cancer cells demonstrate a stem cell-like gene expression signature, the epigenetic regulation of pluripotency-associated genes in cancers remains poorly understood. In this study, we characterized the epigenetic regulation of the pluripotency-associated genes NANOG, OCT4, c-MYC, KLF4, and SOX2 in a variety of cancer cell lines and in primary tumor samples, and investigated the re-activation of pluripotency regulatory circuits in cancer progression. Differential patterns of DNA methylation, histone modifications, and gene expression of pluripotent genes were demonstrated in different types of cancers, which may reflect their tissue origins. NANOG promoter hypomethylation and gene upregulation were found in metastatic human liver cancer cells and human hepatocellular carcinoma (HCC) primary tumor tissues. The upregulation of NANOG, together with p53 depletion, was significantly associated with clinical late stage of HCC. A pro-metastatic role of NANOG in colon cancer cells was also demonstrated, using a NANOG-overexpressing orthotopic tumor implantation mouse model. Demethylation of NANOG promoter was observed in CD133+(high) cancer cells. In accordance, overexpression of NANOG resulted in an increase in the population of CD133+(high) cells. In addition, we demonstrated a cross-regulation between OCT4 and NANOG in cancer cells via reprogramming of promoter methylation. Taken together, epigenetic reprogramming of NANOG can lead to the acquisition of stem cell-like properties. These results underscore the restoration of pluripotency circuits in cancer cells as a potential mechanism for cancer progression.	[Wang, Xiao Qi; Ming, Xiaoyan; Zhang, Wu; Chen, Lin; Pang, Roberta; Lo, Chung Mau; Liu, Xuqing; Poon, Ronnie T. P.; Fan, Sheung Tat] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Wang, Xiao Qi; Poon, Ronnie T. P.; Fan, Sheung Tat] Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China; [Ng, Ray Kit] Univ Hong Kong, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Ng, Ray Kit] Univ Hong Kong, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China; [Chu, Andrew C. Y.] Univ Hong Kong, Ctr Canc Res, Pokfulam, Hong Kong, Peoples R China; [Tsao, Sai Wah] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Fan, ST (corresponding author), Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China.	stfan@hku.hk			Seed Funding Program for Basic Research at the University of Hong Kong [11159149]; General Research Fund of Hong Kong Research Grant Council [HKU778809M]	Seed Funding Program for Basic Research at the University of Hong Kong; General Research Fund of Hong Kong Research Grant Council	This work was supported by Seed Funding Program for Basic Research at the University of Hong Kong (11159149) and General Research Fund of Hong Kong Research Grant Council (HKU778809M) to Wang XQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio O, 2005, CURR PROTOC MOL BIO, V21; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Greene FL, 2002, AJCC CANC STAGING MA, pC22; HANADA M, 1993, BLOOD, V82, P1820; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Ishiguro T, 2012, BIOCHEM BIOPH RES CO, V418, P199, DOI 10.1016/j.bbrc.2011.10.123; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orkin SH, 2005, CELL, V122, P828, DOI 10.1016/j.cell.2005.09.002; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Wang Y, 2008, CELL STEM CELL, V2, P297, DOI 10.1016/j.stem.2008.03.014; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wong DJ, 2008, CELL CYCLE, V7, P3622, DOI 10.4161/cc.7.23.7104; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x; Zwaka TP, 2010, NATURE, V467, P280, DOI 10.1038/467280a	37	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72435	10.1371/journal.pone.0072435	http://dx.doi.org/10.1371/journal.pone.0072435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023739	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600019
J	Karimi, R; Frisk, MG; Fisher, NS				Karimi, Roxanne; Frisk, Michael G.; Fisher, Nicholas S.			Contrasting Food Web Factor and Body Size Relationships with Hg and Se Concentrations in Marine Biota	PLOS ONE			English	Article							SELENIUMMERCURY MOLAR RATIOS; NEW-JERSEY; CONTAMINANT BIOACCUMULATION; MULTIELEMENT STOICHIOMETRY; MERCURY ASSIMILATION; TROPHIC POSITION; CHAIN STRUCTURE; SALTWATER FISH; CHEMICAL FORM; METHYLMERCURY	Marine fish and shellfish are primary sources of human exposure to mercury, a potentially toxic metal, and selenium, an essential element that may protect against mercury bioaccumulation and toxicity. Yet we lack a thorough understanding of Hg and Se patterns in common marine taxa, particularly those that are commercially important, and how food web and body size factors differ in their influence on Hg and Se patterns. We compared Hg and Se content among marine fish and invertebrate taxa collected from Long Island, NY, and examined associations between Hg, Se, body length, trophic level (measured by delta N-15) and degree of pelagic feeding (measured by delta C-13). Finfish, particularly shark, had high Hg content whereas bivalves generally had high Se content. Both taxonomic differences and variability were larger for Hg than Se, and Hg content explained most of the variation in Hg: Se molar ratios among taxa. Finally, Hg was more strongly associated with length and trophic level across taxa than Se, consistent with a greater degree of Hg bioaccumulation in the body over time, and biomagnification through the food web, respectively. Overall, our findings indicate distinct taxonomic and ecological Hg and Se patterns in commercially important marine biota, and these patterns have nutritional and toxicological implications for seafood-consuming wildlife and humans.	[Karimi, Roxanne; Frisk, Michael G.; Fisher, Nicholas S.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Karimi, R (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	roxanne.karimi@stonybrook.edu	Karimi, Roxanne/GXZ-6386-2022	Karimi, Roxanne/0000-0002-9298-1197	NY SeaGrant [R/SHH-17]; Gelfond Fund for Mercury Research and Outreach	NY SeaGrant; Gelfond Fund for Mercury Research and Outreach	Funding for this research was provided by NY SeaGrant R/SHH-17 (http://www.seagrant.sunysb.edu/) and the Gelfond Fund for Mercury Research and Outreach (http://www.stonybrook.edu/commcms/gelfond/about/fund.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcom PH, 2004, MAR CHEM, V90, P53, DOI 10.1016/j.marchem.2004.02.020; Belzile N, 2006, CAN J FISH AQUAT SCI, V63, P1, DOI 10.1139/F05-202; BLOOM NS, 1992, CAN J FISH AQUAT SCI, V49, P1010, DOI 10.1139/f92-113; Brix H., 1985, Symposia Biologica Hungarica, V29, P253; Burger J, 2001, ENVIRON RES, V87, P108, DOI 10.1006/enrs.2001.4294; Burger J, 2013, SCI TOTAL ENVIRON, V443, P278, DOI 10.1016/j.scitotenv.2012.10.040; Burger J, 2012, ECOHEALTH, V9, P171, DOI 10.1007/s10393-012-0761-y; Burger J, 2012, SCI TOTAL ENVIRON, V431, P46, DOI 10.1016/j.scitotenv.2012.05.024; Burger J, 2012, ENVIRON RES, V114, P12, DOI 10.1016/j.envres.2012.02.004; Burger J, 2011, SCI TOTAL ENVIRON, V409, P1418, DOI 10.1016/j.scitotenv.2010.12.034; Burger J, 2009, J TOXICOL ENV HEAL A, V72, P853, DOI 10.1080/15287390902953485; CABANA G, 1994, CAN J FISH AQUAT SCI, V51, P381, DOI 10.1139/f94-039; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Cabanero AI, 2005, BIOL TRACE ELEM RES, V103, P17, DOI 10.1385/BTER:103:1:017; CAPPON CJ, 1984, J GREAT LAKES RES, V10, P429, DOI 10.1016/S0380-1330(84)71859-4; Chen CY, 2009, ENVIRON SCI TECHNOL, V43, P1804, DOI 10.1021/es8017122; Chen CY, 2000, LIMNOL OCEANOGR, V45, P1525, DOI 10.4319/lo.2000.45.7.1525; Chen YW, 2001, LIMNOL OCEANOGR, V46, P1814, DOI 10.4319/lo.2001.46.7.1814; Chetelat J, 2011, ENVIRON POLLUT, V159, P10, DOI 10.1016/j.envpol.2010.09.034; CUTSHALL NH, 1978, SCIENCE, V200, P1489, DOI 10.1126/science.663631; Dang F, 2011, ENVIRON SCI TECHNOL, V45, P3116, DOI 10.1021/es103705a; Evans DW, 2005, B MAR SCI, V77, P321; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; France RL, 1995, LIMNOL OCEANOGR, V40, P1310, DOI 10.4319/lo.1995.40.7.1310; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Gerber LR, 2012, FRONT ECOL ENVIRON, V10, P487, DOI 10.1890/120003; Gochfeld M, 2012, ENVIRON RES, V112, P8, DOI 10.1016/j.envres.2011.12.007; Greenfield BK, 2010, ENVIRON POLLUT, V158, P2716, DOI 10.1016/j.envpol.2010.04.010; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI 10.1007/BF02289162; Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019; Hammerschmidt CR, 2006, ARCH ENVIRON CON TOX, V51, P416, DOI 10.1007/s00244-005-0265-7; Hammerschmidt CR, 2004, MAR CHEM, V90, P31, DOI 10.1016/j.marchem.2004.02.024; Hong Y, 2013, ENV TOXICOL IN PRESS; Jarman WM, 1996, ENVIRON SCI TECHNOL, V30, P654, DOI 10.1021/es950392n; KAISER HF, 1961, BRIT J STATIST PSYCH, V14, P1, DOI 10.1111/j.2044-8317.1961.tb00061.x; Kaneko JJ, 2007, BIOL TRACE ELEM RES, V119, P242, DOI 10.1007/s12011-007-8004-8; Karimi R, 2012, QUANTITATIVE SYNTHES; Karimi R, 2006, ECOL LETT, V9, P1273, DOI 10.1111/j.1461-0248.2006.00979.x; Karimi R, 2012, ENVIRON HEALTH PERSP, V120, P1512, DOI 10.1289/ehp.1205122; Karimi R, 2010, AM NAT, V176, P699, DOI 10.1086/657046; Kehrig HD, 2009, ENVIRON SCI POLLUT R, V16, P10, DOI 10.1007/s11356-008-0038-8; Khan MAK, 2009, ENVIRON TOXICOL CHEM, V28, P1567, DOI 10.1897/08-375.1; LUOMA SN, 1992, ENVIRON SCI TECHNOL, V26, P485, DOI 10.1021/es00027a005; MAGG DD, 1967, SELENIUM BIOMEDICINE, P127; Mathews T, 2008, MAR ECOL PROG SER, V367, P23, DOI 10.3354/meps07536; National Oceanic and Atmospheric Administration, 1994, 80 NOAA NOS ORCA; New York State Department of Environmental Conservation, 2010, STUD STRIP BASS MAR; Nuttall MA, 2011, ECOL MODEL, V222, P3335, DOI 10.1016/j.ecolmodel.2011.07.004; PARIZEK J, 1971, J REPROD FERTIL, V25, P157, DOI 10.1530/jrf.0.0250157; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pickhardt PC, 2006, ENVIRON TOXICOL CHEM, V25, P2132, DOI 10.1897/05-595R.1; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Presser Theresa S., 2010, Integrated Environmental Assessment and Management, V6, P685, DOI 10.1002/ieam.101; PRICE NM, 1987, J PHYCOL, V23, P1; Ralston NVC, 2008, NEUROTOXICOLOGY, V29, P802, DOI 10.1016/j.neuro.2008.07.007; Ralston NVC, 2008, ECOHEALTH, V5, P442, DOI 10.1007/s10393-008-0202-0; Rasmussen JB, 2004, FOOD WEBS LANDSCAPE, P548; Roditi HA, 2000, NATURE, V407, P78, DOI 10.1038/35024069; Sackett DK, 2010, ECOTOXICOLOGY, V19, P1601, DOI 10.1007/s10646-010-0545-5; Sagarese SR, 2011, NORTHEAST NAT, V18, P291; Scheuhammer AM, 1998, ENVIRON TOXICOL CHEM, V17, P197, DOI 10.1002/etc.5620170209; STEINNES E, 1990, ENVIRON TOXICOL CHEM, V9, P825, DOI 10.1002/etc.5620090702; Stemberger RS, 1998, CAN J FISH AQUAT SCI, V55, P339, DOI 10.1139/cjfas-55-2-339; Stewart AR, 2004, ENVIRON SCI TECHNOL, V38, P4519, DOI 10.1021/es0499647; STEWART R., 2010, ECOLOGICAL ASSESSMEN, P93, DOI [10.1201/EBK1439826775-c5, DOI 10.1201/EBK1439826775-C5]; U.S. Environmental Protection Agency, 1995, 821R95034 USEPA OFF; Underwood EJ., 1977, TRACE ELEMENTS HUMAN, P545; [USFDA] US Food & Drug Administration, 2004, WHAT YOU NEED KNOW M; VANBUSKIRK J, 1988, ECOLOGY, V69, P857, DOI 10.2307/1941035; Vander Zanden MJ, 1996, ECOL MONOGR, V66, P451, DOI 10.2307/2963490; Wang WX, 2004, AQUAT TOXICOL, V68, P39, DOI 10.1016/j.aquatox.2004.02.003; Wang WX, 1997, MAR ECOL PROG SER, V161, P103, DOI 10.3354/meps161103; Watras CJ, 1998, SCI TOTAL ENVIRON, V219, P183, DOI 10.1016/S0048-9697(98)00228-9; Wiener James G., 1996, P297; WIENER JG, 1990, ENVIRON TOXICOL CHEM, V9, P909, DOI 10.1002/etc.5620090709; Williams JJ, 2010, ENVIRON TOXICOL CHEM, V29, P1755, DOI 10.1002/etc.207; Xu Y, 2002, MAR ECOL PROG SER, V238, P173, DOI 10.3354/meps238173	77	37	37	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74695	10.1371/journal.pone.0074695	http://dx.doi.org/10.1371/journal.pone.0074695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019976	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200119
J	Olivotto, E; Otero, M; Astolfi, A; Platano, D; Facchini, A; Pagani, S; Flamigni, F; Facchini, A; Goldring, MB; Borzi, RM; Marcu, KB				Olivotto, Eleonora; Otero, Miguel; Astolfi, Annalisa; Platano, Daniela; Facchini, Annalisa; Pagani, Stefania; Flamigni, Flavio; Facchini, Andrea; Goldring, Mary B.; Borzi, Rosa Maria; Marcu, Kenneth B.			IKK alpha/CHUK Regulates Extracellular Matrix Remodeling Independent of Its Kinase Activity to Facilitate Articular Chondrocyte Differentiation	PLOS ONE			English	Article							NF-KAPPA-B; METALLOPROTEINASE 13-DEFICIENT MICE; HUMAN OSTEOARTHRITIC CHONDROCYTES; HELIX-LOOP-HELIX; GENE-EXPRESSION; GROWTH-PLATE; TRANSCRIPTIONAL CONTROL; II COLLAGEN; CARTILAGE DEGENERATION; CELL-DIFFERENTIATION	Background: The non-canonical NF-kappa B activating kinase IKK alpha, encoded by CHUK (conserved-helix-loop-helix-ubiquitous-kinase), has been reported to modulate pro- or anti-inflammatory responses, cellular survival and cellular differentiation. Here, we have investigated the mechanism of action of IKK alpha as a novel effector of human and murine chondrocyte extracellular matrix (ECM) homeostasis and differentiation towards hypertrophy. Methodology/Principal Findings: IKK alpha expression was ablated in primary human osteoarthritic (OA) chondrocytes and in immature murine articular chondrocytes (iMACs) derived from IKK alpha(f/f):CreERT2 mice by retroviral-mediated stable shRNA transduction and Cre recombinase-dependent Lox P site recombination, respectively. MMP-10 was identified as a major target of IKK alpha in chondrocytes by mRNA profiling, quantitative RT-PCR analysis, immunohistochemistry and immunoblotting. ECM integrity, as assessed by type II collagen (COL2) deposition and the lack of MMP-dependent COL2 degradation products, was enhanced by IKK alpha ablation in mice. MMP-13 and total collagenase activities were significantly reduced, while TIMP-3 (tissue inhibitor of metalloproteinase-3) protein levels were enhanced in IKK alpha-deficient chondrocytes. IKK alpha deficiency suppressed chondrocyte differentiation, as shown by the quantitative inhibition of. Alizarin red staining and the reduced expression of multiple chondrocyte differentiation effectors, including Runx2, Col10a1 and Vegfa,. Importantly, the differentiation of IKK alpha-deficient chondrocytes was rescued by a kinase-dead IKK alpha protein mutant. Conclusions/Significance: IKK alpha acts independent of its kinase activity to help drive chondrocyte differentiation towards a hypertrophic-like state. IKK alpha positively modulates ECM remodeling via multiple downstream targets (including MMP-10 and TIMP-3 at the mRNA and post-transcriptional levels, respectively) to maintain maximal MMP-13 activity, which is required for ECM remodeling leading to chondrocyte differentiation. Chondrocytes are the unique cell component in articular cartilage, which are quiescent and maintain ECM integrity during tissue homeostasis. In OA, chondrocytes reacquire the capacity to proliferate and differentiate and their activation results in pronounced cartilage degeneration. T eta nu sigma, our findings are also of potential relevance for defining the onset and/or progression of OA disease.	[Olivotto, Eleonora; Platano, Daniela; Pagani, Stefania; Facchini, Andrea; Borzi, Rosa Maria; Marcu, Kenneth B.] Rizzoli Orthoped Res Inst, Lab Immunorheumatol & Tissue Regenerat RAMSES, Bologna, Italy; [Otero, Miguel; Goldring, Mary B.] Hosp Special Surg, Div Res, New York, NY 10021 USA; [Otero, Miguel; Goldring, Mary B.] Weill Cornell Med Coll, New York, NY USA; [Astolfi, Annalisa] Univ Bologna, G Prodi Canc Res Ctr, Bologna, Italy; [Facchini, Annalisa; Facchini, Andrea] Univ Bologna, Med & Surg Sci Dept, Bologna, Italy; [Facchini, Annalisa; Flamigni, Flavio] Univ Bologna, Biomed & Neuromotor Sci Dept, Bologna, Italy; [Marcu, Kenneth B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Cornell University; University of Bologna; University of Bologna; University of Bologna; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Marcu, KB (corresponding author), Rizzoli Orthoped Res Inst, Lab Immunorheumatol & Tissue Regenerat RAMSES, Bologna, Italy.	kenneth.marcu@stonybrook.edu	Olivotto, Eleonora/AAE-5763-2020; Olivotto, Eleonora/C-6938-2019; Pagani, Stefania/C-7151-2019; Astolfi, Annalisa/K-3034-2016; Borzì, Rosa Maria/ABI-2279-2020	Olivotto, Eleonora/0000-0002-6726-3177; Pagani, Stefania/0000-0002-4055-3828; Astolfi, Annalisa/0000-0002-2732-0747; Borzì, Rosa Maria/0000-0003-4133-4894	National Institutes of Health (NIH) [GM066882, RC4-AR060546]; CARISBO Foundation of Bologna, Italy; FIRB-MIUR of Italy [RBAP10KCNS]; Fondi cinque per mille (Ministero della Salute, Italy); POS-FESR, Emilia Romagna Region; Arthritis Foundation; Osteoarthritis Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC4AR060546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066882] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CARISBO Foundation of Bologna, Italy; FIRB-MIUR of Italy; Fondi cinque per mille (Ministero della Salute, Italy); POS-FESR, Emilia Romagna Region; Arthritis Foundation; Osteoarthritis Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health (NIH) grants GM066882 (KBM) and RC4-AR060546 (MBG and KBM); the CARISBO Foundation of Bologna, Italy (EO, SP and Andrea Facchini); FIRB-MIUR of Italy grant RBAP10KCNS (Andrea Facchini, FF, DP, Annalisa Facchini and RMB); Fondi cinque per mille (Ministero della Salute, Italy) (Andrea Faccchini, DP and RMB); POS-FESR 2007-2013, Emilia Romagna Region (EO); and also in part by an Arthritis Foundation postdoctoral fellowship (MO) and an Osteoarthritis Research Society International scholarship (EO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2007, CURR DRUG TARGETS, V8, P377, DOI 10.2174/138945007779940052; Aigner T, 2004, CLIN ORTHOP RELAT R, pS138, DOI 10.1097/01.blo.0000143838.53434.b8; Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P3244, DOI 10.1002/art.22167; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bobick BE, 2007, J CELL PHYSIOL, V211, P233, DOI 10.1002/jcp.20923; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Borzi RM, 2010, ARTHRITIS RHEUM-US, V62, P2370, DOI 10.1002/art.27512; Bos SD, 2008, CURR OPIN RHEUMATOL, V20, P553, DOI 10.1097/BOR.0b013e32830aba48; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Connelly MA, 1995, CELL MOL BIOL RES, V41, P537; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Drissi Hicham, 2005, Molecular Aspects of Medicine, V26, P169, DOI 10.1016/j.mam.2005.01.003; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Fan ZY, 2006, ARTHRITIS RHEUM-US, V54, P2471, DOI 10.1002/art.21961; Gauci S. J., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P308; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; Goldring MB, 2007, BIOMED HEALTH RES, V70, P118; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Ijiri K, 2008, ARTHRITIS RHEUM-US, V58, P2075, DOI 10.1002/art.23504; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Liu ZH, 2007, DEV BIOL, V302, P80, DOI 10.1016/j.ydbio.2006.08.071; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; Massa PE, 2005, J BIOL CHEM, V280, P14057, DOI 10.1074/jbc.M414401200; McKenzie FR, 2000, MOL CELL BIOL, V20, P2635, DOI 10.1128/MCB.20.8.2635-2649.2000; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Olivotto E, 2008, ARTHRITIS RHEUM-US, V58, P227, DOI 10.1002/art.23211; Olivotto E, 2007, J CELL PHYSIOL, V210, P417, DOI 10.1002/jcp.20864; Otero M, 2012, J BIOL CHEM, V287, P3559, DOI 10.1074/jbc.M111.265744; Peng H, 2008, J CELL PHYSIOL, V215, P562, DOI 10.1002/jcp.21338; Penzo M, 2010, J IMMUNOL, V184, P4497, DOI 10.4049/jimmunol.0903131; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Sitcheran R, 2003, GENE DEV, V17, P2368, DOI 10.1101/gad.1114503; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tallheden T, 2003, J BONE JOINT SURG AM, V85A, P93, DOI 10.2106/00004623-200300002-00012; Tchetina EV, 2007, MATRIX BIOL, V26, P247, DOI 10.1016/j.matbio.2007.01.006; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Terkeltaub RA, 2007, BIOMED HEALTH RES, V70, P31; Tonelli R, 2012, CLIN CANCER RES, V18, P796, DOI 10.1158/1078-0432.CCR-11-1981; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003; Wang MN, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4133; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153	78	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73024	10.1371/journal.pone.0073024	http://dx.doi.org/10.1371/journal.pone.0073024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023802	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400039
J	Rosewell, A; Clark, G; Mabong, P; Ropa, B; Posanai, E; Man, NWY; Dutta, SR; Wickramasinghe, W; Qi, LX; Ng, JC; Mola, G; Zwi, AB; MacIntyre, CR				Rosewell, Alexander; Clark, Geoff; Mabong, Paul; Ropa, Berry; Posanai, Enoch; Man, Nicola W. Y.; Dutta, Samir R.; Wickramasinghe, Wasa; Qi, Lixia; Ng, Jack C.; Mola, Glen; Zwi, Anthony B.; MacIntyre, C. Raina			Concurrent Outbreaks of Cholera and Peripheral Neuropathy Associated with High Mortality among Persons Internally Displaced by a Volcanic Eruption	PLOS ONE			English	Article							OPTIC NEUROPATHY; ICP-MS; EPIDEMIC; EMERGENCIES; REFUGEE; URBAN; CUBA	Background: In October 2004, Manam Island volcano in Papua New Guinea erupted, causing over 10 000 villagers to flee to internally displaced person (IDP) camps, including 550 from Dugulaba village. Following violence over land access in March 2010, the IDPs fled the camps, and four months later concurrent outbreaks of acute watery diarrhea and unusual neurological complaints were reported in this population. Materials and Methods: A retrospective case-control study was conducted to identify the risk factors for peripheral neuropathy. Rectal swabs were collected from cases of acute watery diarrhea. Hair and serum metals and metalloids were analyzed by Inductively Coupled Plasma-Mass Spectrometry (ICP-MS). Results: There were 17 deaths among the 550 village inhabitants during the outbreak period at a crude mortality rate 21-fold that of a humanitarian crisis. Vibrio cholerae O1 El Tor Ogawa was confirmed among the population. Access to community-level rehydration was crucial to mortality. Peripheral neuropathy was diagnosed among cases with neurological symptoms. A balanced diet was significantly protective against neuropathy. A dose-response relationship was seen between peripheral neuropathy and a decreasing number of micronutrient-rich foods in the diet. Deficiencies in copper, iron, selenium and zinc were identified among the cases of peripheral neuropathy. Conclusions: Cholera likely caused the mostly preventable excess mortality. Peripheral neuropathy was not caused by cholera, but cholera may worsen existing nutritional deficiencies. The peripheral neuropathy was likely caused by complex micronutrient deficiencies linked to non-diversified diets that potentially increased the vulnerability of this population, however a new zinc-associated neuropathy could not be ruled out. Reoccurrence can be prevented by addressing the root cause of displacement and ensuring access to arable land and timely resettlement.	[Rosewell, Alexander; Clark, Geoff] WHO, Port Moresby, National Capita, Papua N Guinea; [Rosewell, Alexander; Man, Nicola W. Y.; Zwi, Anthony B.; MacIntyre, C. Raina] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Mabong, Paul] Prov Hlth Off, Madang, Madang Province, Papua N Guinea; [Ropa, Berry; Posanai, Enoch] Natl Dept Hlth, Port Moresby, Ncd, Papua N Guinea; [Dutta, Samir R.] Port Moresby Gen Hosp, Dept Pathol, Port Moresby, Ncd, Papua N Guinea; [Wickramasinghe, Wasa; Qi, Lixia; Ng, Jack C.] Univ Queensland, Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia; [Mola, Glen] Univ Papua New Guinea, Port Moresby, Ncd, Papua N Guinea	World Health Organization; University of New South Wales Sydney; University of Queensland; University of Papua New Guinea	Rosewell, A (corresponding author), WHO, Port Moresby, National Capita, Papua N Guinea.	arosewell@yahoo.com	Man, Nicola/AAX-7816-2020; Man, Nicola/HCG-9161-2022; Zwi, Anthony/AAP-7026-2021; Zwi, Anthony/AAP-8731-2020	Man, Nicola/0000-0003-2224-9301; Zwi, Anthony/0000-0001-6902-6602; MacIntyre, C Raina/0000-0002-3060-0555	World Health Organization Country Office	World Health Organization Country Office	The funds for these investigations were from the core budgets for outbreak response of the national and provincial health authorities and the World Health Organization Country Office. The investigation team designed the studies, data collection and analysis, decided to publish, and prepared the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoua L, 2007, FOOD NUTR BULL, V28, P283, DOI 10.1177/156482650702800304; Banerjee B, 2010, NUTR MANAGEMENT DIGE, P388; BERN C, 1995, NEW ENGL J MED, V333, P1176; Bhatia Rita, 2003, Forum Nutr, V56, P391; Bravo IDB, 2007, J TRACE ELEM MED BIO, V21, P14, DOI 10.1016/j.jtemb.2007.09.017; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; CARY SG, 1964, J BACTERIOL, V88, P96, DOI 10.1128/JB.88.1.96-98.1964; Casentini B, 2010, AQUAT GEOCHEM, V16, P373, DOI 10.1007/s10498-010-9090-3; Davidson Robert, 2008, OXFORD HDB TROPICAL; Dolin PJ, 1998, NEW ENGL J MED, V338, P1547, DOI 10.1056/NEJM199805213382115; Dunkle SE, 2011, EMERG INFECT DIS, V17, P2143, DOI [10.3201/eid1711.11110772, 10.3201/eid1711.110772]; Gellein K, 2008, BIOL TRACE ELEM RES, V123, P250, DOI 10.1007/s12011-008-8104-0; Grais RF, 2008, J R SOC INTERFACE, V5, P67, DOI 10.1098/rsif.2007.1038; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Levy BS, 1996, WAR PUBLIC HLTH, P444; London Laboratory Services Group (n.d.), LAB TEST INF GUID; Lonsdale D, 2006, EVID-BASED COMPL ALT, V3, P49, DOI 10.1093/ecam/nek009; Mateen FJ, 2010, ANN NEUROL, V68, P282, DOI 10.1002/ana.22135; McQuilty R, 2002, HDB TRACE TOXIC ELEM; Medina MT, 2007, NEUROLOGIC CONSEQUEN, P83; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Ndombi I, 2005, DEBRIEFING CURRENT S; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; ROMAN GC, 1994, J NEUROL SCI, V127, P11, DOI 10.1016/0022-510X(94)90130-9; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; Watson RR, 2010, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60761-061-8; WHO, 2004, CHOL OUTBR ASS OUTBR	30	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72566	10.1371/journal.pone.0072566	http://dx.doi.org/10.1371/journal.pone.0072566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023752	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000324238400016
J	Badole, SL; Chaudhari, SM; Bagul, PP; Mahamuni, SP; Khose, RD; Joshi, AC; Raut, CG; Zanwar, AA				Badole, Sachin L.; Chaudhari, Swapnil M.; Bagul, Pranita P.; Mahamuni, Sagar P.; Khose, Rekha D.; Joshi, Anuja C.; Raut, Chandrashekhar G.; Zanwar, Anand A.			Effect of Concomitant Administration of L-Glutamine and Cycloart-23-ene-3 beta, 25-diol (B2) with Sitagliptin in GLP-1 (7-36) Amide Secretion, Biochemical and Oxidative Stress in Streptozotocin - Nicotinamide Induced Diabetic Sprague Dawley Rats	PLOS ONE			English	Article							GLUTATHIONE; INHIBITOR; LIVER; MODEL; MICE	Previously we have reported that, cycloart-23-ene-3 beta, 25-diol (called as B2) and L-glutamine stimulated glucagon like peptide-1 (GLP-1) (7-36) amide secretion diabetic rats. The objective of present investigation was to investigate the concomitant administration of cycloart-23-ene-3 beta, 25-diol+sitagliptin and L-glutamine+sitagliptin in streptozotocin - nicotinamide induced diabetic Sprague Dawley. Type 2 diabetes was induced in overnight fasted male Sprague Dawley rats pre-treated with nicotinamide (100 mg/kg, i.p.) followed by administration of streptozotocin (55 mg/kg, i.p.) 20 min after. The rats were divided into; I-non-diabetic, II-diabetic control, III-Sitagliptin (5 mg/kg, p.o.)+cycloart-23-ene-3 beta, 25-diol (1 mg/kg, p.o.), IV-Sitagliptin (5 mg/kg, p.o.)+L-glutamine (1000 mg/kg, p.o.). The concomitant treatment of cycloart-23-ene-3 beta, 25-diol and L-glutamine with sitagliptin was 8 weeks. Plasma glucose, body weight, food and water intake were determined every week. Glycosylated haemoglobin, lipid profile, plasma and colonic active (GLP-1) (7-36) amide, plasma and pancreatic insulin, histology of pancreata and biomarkers of oxidative stress were measured after 8th week treatment. Concomitant administration of cycloart-23-ene-3 beta, 25-diol and L-glutamine with sitagliptin significantly (p<0.001) reduced plasma glucose, glyoxylated haemoglobin, lipid profile and oxidative stress parameters compared to diabetic control groups. Both concomitant treatment increased plasma and pancreatic insulin as well as plasma and colonic active (GLP-1) (7-36) amide secretion. Histological analysis by Gomori staining observed less destruction of pancreatic beta cells. The result obtained from this study; it is concluded that concomitant administration of cycloart-23-ene-3 beta, 25-diol+sitagliptin and L-glutamine+sitagliptin showed additive antihyperglycaemic effect in diabetic rats.	[Badole, Sachin L.; Chaudhari, Swapnil M.; Bagul, Pranita P.; Mahamuni, Sagar P.; Khose, Rekha D.; Joshi, Anuja C.] PESs Modern Coll Pharm, Dept Pharmacol, Pune, Maharashtra, India; [Raut, Chandrashekhar G.] Natl Inst Virol, High Containment Lab, Pune, Maharashtra, India; [Zanwar, Anand A.] Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs, Ctr Innovat Nutr, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Bharati Vidyapeeth Deemed University	Badole, SL (corresponding author), PESs Modern Coll Pharm, Dept Pharmacol, Pune, Maharashtra, India.	sachinbadole@rediffmail.com	Bodhankar, Sunhash/AAQ-4624-2020; Zanwar, Anand/AAK-6051-2020	Zanwar, Anand/0000-0002-0858-7075; Chaudhari, Swapnil/0000-0002-6547-8596				Badole SL, 2013, CHEM-BIOL INTERACT, V203, P530, DOI 10.1016/j.cbi.2013.02.006; Badole SL, 2013, EUR J PHARMACOL, V698, P470, DOI 10.1016/j.ejphar.2012.10.002; Badole SL, 2010, EUR J PHARMACOL, V632, P103, DOI 10.1016/j.ejphar.2010.01.019; Bansal P, 2012, EXP TOXICOL PATHOL, V64, P651, DOI 10.1016/j.etp.2010.12.009; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Gallwitz B, 2007, DRUGS TODAY, V43, P13, DOI 10.1358/dot.2007.43.1.1043909; GOMORI G, 1950, AM J CLIN PATHOL, V20, P665; Green Brian D, 2006, Diab Vasc Dis Res, V3, P159, DOI 10.3132/dvdr.2006.024; Habig W H, 1981, Methods Enzymol, V77, P398; Izzo AA, 2005, FUND CLIN PHARMACOL, V19, P1, DOI 10.1111/j.1472-8206.2004.00301.x; Kameswararao B, 2003, FITOTERAPIA, V74, P7, DOI 10.1016/S0367-326X(02)00297-6; Krentz AJ, 2003, DIABETES OBES METAB, V5, pS19, DOI 10.1046/j.1462-8902.2003.0310.x; Lin YC, 2004, J CLIN ANESTH, V16, P4, DOI 10.1016/j.jclinane.2003.03.005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Masiello P, 1998, DIABETES, V47, P224, DOI 10.2337/diabetes.47.2.224; MISRA HP, 1972, J BIOL CHEM, V247, P3170; MOREL DW, 1989, J LIPID RES, V30, P1827; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Qin XF, 2005, AM J PHYSIOL-GASTR L, V288, pG943, DOI 10.1152/ajpgi.00303.2004; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Saxena R, 2005, CLIN CHIM ACTA, V359, P101, DOI 10.1016/j.cccn.2005.03.036; Shinde SN, 2011, INDIAN J CLIN BIOCHE, V26, P74, DOI 10.1007/s12291-010-0041-y; Singh M, 2005, J Vet Sci, V6, P197; SLATER TF, 1971, BIOCHEM J, V123, P805, DOI 10.1042/bj1230805; STRANDELL E, 1988, MOL CELL ENDOCRINOL, V59, P83, DOI 10.1016/0303-7207(88)90198-0; Szkudelski T, 2012, EXP BIOL MED, V237, P481, DOI 10.1258/ebm.2012.011372; Tsai PH, 2011, CLIN NUTR, V30, P124, DOI 10.1016/j.clnu.2010.07.005	28	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72817	10.1371/journal.pone.0072817	http://dx.doi.org/10.1371/journal.pone.0072817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023648	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200044
J	Dijkstra, A; Janssen, F; De Bakker, M; Bos, J; Lub, R; Van Wissen, LJG; Hak, E				Dijkstra, Aletta; Janssen, Fanny; De Bakker, Marinus; Bos, Jens; Lub, Rene; Van Wissen, Leo J. G.; Hak, Eelko			Using Spatial Analysis to Predict Health Care Use at the Local Level: A Case Study of Type 2 Diabetes Medication Use and Its Association with Demographic Change and Socioeconomic Status	PLOS ONE			English	Article							PREVALENCE; OBESITY; MELLITUS; INEQUALITIES; COMMUNITY; FUTURE	Local health status and health care use may be negatively influenced by low local socio-economic profile, population decline and population ageing. To support the need for targeted local health care, we explored spatial patterns of type 2 diabetes mellitus (T2DM) drug use at local level and determined its association with local demographic, socio-economic and access to care variables. We assessed spatial variability in these associations. We estimated the five-year prevalence of T2DM drug use (2005-2009) in persons aged 45 years and older at four-digit postal code level using the University of Groningen pharmacy database IADB.nl. Statistics Netherlands supplied data on potential predictor variables. We assessed spatial clustering, correlations and estimated a multiple linear regression model and a geographically weighted regression (GWR) model. Prevalence of T2DM medicine use ranged from 2.0% to 25.4%. The regression model included the extent of population ageing, proportion of social welfare/benefits, proportion of low incomes and proportion of pensioners, all significant positive predictors of local T2DM drug use. The GWR model demonstrated considerable spatial variability in the association between T2DM drug use and above predictors and was more accurate. The findings demonstrate the added value of spatial analysis in predicting health care use at local level.	[Dijkstra, Aletta; Janssen, Fanny; Bos, Jens; Lub, Rene; Hak, Eelko] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Janssen, Fanny; Van Wissen, Leo J. G.] Univ Groningen, Fac Spatial Sci, Populat Res Ctr, Groningen, Netherlands; [De Bakker, Marinus] Univ Groningen, Fac Spatial Sci, Groningen Ctr Spatial Informat, Groningen, Netherlands; [Van Wissen, Leo J. G.] NIDI, The Hague, Netherlands	University of Groningen; University of Groningen; University of Groningen	Dijkstra, A (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	a.dijkstra@rug.nl		Janssen, Fanny/0000-0002-3110-238X				Andreason AW, 2011, J BUSINESS EC, V2, P73; Andrulis DP, 1998, ANN INTERN MED, V129, P412, DOI 10.7326/0003-4819-129-5-199809010-00012; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 2004, EXPLORING SPATIAL DA; Bocquier A, 2011, DIABETES METAB, V37, P39, DOI 10.1016/j.diabet.2010.07.004; Booth GL, 2003, ARCH INTERN MED, V163, P101, DOI 10.1001/archinte.163.1.101; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Chen SE, 2010, J NUTR, V140, P1181, DOI 10.3945/jn.109.111336; Cheng CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-380; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173; Cooper RA, 2012, J URBAN HEALTH, P1; Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155; De Looper M, 2009, MEASURING DISPARITIE; Dutch Government council of municipalities Inter-provincial council, 2009, INT ACT BEV KRIMP ME; Eberstadt N, 2010, FOREIGN AFF, V89, P54; Espelt A, 2008, DIABETOLOGIA, V51, P1971, DOI 10.1007/s00125-008-1146-1; Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3; FESUS G., 2008, REGIONS 2020 DEMOGRA; Ford ES, 2005, OBES RES, V13, P118, DOI 10.1038/oby.2005.15; Fotheringham AS, 1999, GEOGR ANAL, V31, P340; Green C, 2003, SOC SCI MED, V57, P551, DOI 10.1016/S0277-9536(02)00380-5; Hakkinen H, 2009, HLTH CARE CHALLENGES; Hofer TP, 1998, HEALTH SERV RES, V33, P243; Jongeneel-Grimen B, 2011, HEALTH PLACE, V17, P988, DOI 10.1016/j.healthplace.2011.03.008; Lub R, 2006, BRIT J CLIN PHARMACO, V62, P660, DOI 10.1111/j.1365-2125.2006.02711.x; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Monster TBM, 2002, PHARMACOEPIDEM DR S, V11, P379, DOI 10.1002/pds.722; MORGAN BS, 1975, URBAN STUD, V12, P47, DOI 10.1080/00420987520080041; Ness RB, 2009, ACAD MED, V84, P1631, DOI 10.1097/ACM.0b013e3181bbb4ed; Rabi DM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-124; Rechel B., 2010, CAN HLTH SYSTEMS RES; Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007; Rosenshein L, 2010, SPATIAL STAT TOOLB S; Ryan Kathleen, 2005, N Z Med J, V118, pU1677; Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073; Schlossberg M., 2003, PLANNING PRACTICE RE, V18, P213, DOI DOI 10.1080/0269745032000168269; Schlundt DG, 2006, J AMBUL CARE MANAG, V29, P125, DOI 10.1097/00004479-200604000-00005; Schuurman N, 2007, J URBAN HEALTH, V84, P591, DOI 10.1007/s11524-007-9193-3; Tobi H, 2000, MED DATA ANAL, V1933, P93; Uusitupa M, 2011, NUTR METAB CARDIOVAS, V21, P380, DOI 10.1016/j.numecd.2010.12.007; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Vinks THAM, 2006, PHARM WORLD SCI, V28, P33, DOI 10.1007/s11096-005-4213-4; Westert GP, 2005, EUR J PUBLIC HEALTH, V15, P59, DOI 10.1093/eurpub/cki116; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	45	21	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72730	10.1371/journal.pone.0072730	http://dx.doi.org/10.1371/journal.pone.0072730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211BX	24023636	Green Submitted, gold, Green Published			2022-12-27	WOS:000323880200031
J	Morisaka, T; Sakai, M; Kogi, K; Nakasuji, A; Sakakibara, K; Kasanuki, Y; Yoshioka, M				Morisaka, Tadamichi; Sakai, Mai; Kogi, Kazunobu; Nakasuji, Akane; Sakakibara, Kasumi; Kasanuki, Yuria; Yoshioka, Motoi			Spontaneous Ejaculation in a Wild Indo-Pacific Bottlenose Dolphin (Tursiops aduncus)	PLOS ONE			English	Article							SPONTANEOUS SEMINAL EMISSION; SPINAL-CORD; PEPTIDE SYSTEM; SEXUAL FUNCTION; BEHAVIOR; RAT; TRUNCATUS	Spontaneous ejaculation, which is defined as the release of seminal fluids without apparent sexual stimulation, has been documented in boreoeutherian mammals. Here we report spontaneous ejaculation in a wild Indo-Pacific bottlenose dolphin (Tursiops aduncus), and present a video of this rare behavior. This is the first report of spontaneous ejaculation by an aquatic mammal, and the first video of this behavior in animals to be published in a scientific journal.	[Morisaka, Tadamichi; Sakai, Mai; Nakasuji, Akane] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Sakai, Mai] Japan Soc Promot Sci, Tokyo, Japan; [Kogi, Kazunobu] Mikura Isl Tourist Informat Ctr, Tokyo, Japan; [Sakakibara, Kasumi; Kasanuki, Yuria] Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo, Japan; [Yoshioka, Motoi] Mie Univ, Grad Sch Bioresources, Tsu, Mie, Japan	Kyoto University; Japan Society for the Promotion of Science; Tokyo University of Agriculture & Technology; Mie University	Morisaka, T (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan.	chaka@wrc.kyoto-u.ac.jp	Morisaka, Tadamichi/AAJ-7388-2021	Morisaka, Tadamichi/0000-0001-7051-3184	JSPS KAKENHI [23220006]; Grants-in-Aid for Scientific Research [12J40161] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Number 23220006 (URL: http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMO A, 1976, J REPROD FERTIL, V48, P405, DOI 10.1530/jrf.0.0480405; ARONSON LR, 1949, J COMP PHYSIOL PSYCH, V42, P226, DOI 10.1037/h0062233; Bagemihl B., 1999, BIOL EXUBERANCE ANIM; BEACH FA, 1969, PHYSIOL BEHAV, V4, P155, DOI 10.1016/0031-9384(69)90073-0; BEACH FA, 1975, PHYSIOL BEHAV, V15, P91, DOI 10.1016/0031-9384(75)90284-X; BEACH FA, 1966, PSYCHOSOM MED, V28, P749, DOI 10.1097/00006842-196609000-00006; BEACH FA, 1967, PHYSIOL REV, V47, P289, DOI 10.1152/physrev.1967.47.2.289; Carro-Juarez M, 2008, BRAIN RES REV, V58, P106, DOI 10.1016/j.brainresrev.2007.12.002; Chen Dao-quan, 2002, Acta Zoologica Sinica, V48, P611; Chen Dao-quan, 2001, Acta Hydrobiologica Sinica, V25, P467; Connor RC, 1996, BEHAVIOUR, V133, P643, DOI 10.1163/156853996X00404; Connor RC, 2000, CETACEAN SOCIETIES, P91; Defran RH., 1980, CETACEAN BEHAV MECH, P319; HARRISON RJ, 1971, J ZOOL, V165, P355; HUBER MHR, 1980, BEHAV NEURAL BIOL, V29, P390, DOI 10.1016/S0163-1047(80)90373-8; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; JOUBERT S C J, 1975, Zeitschrift fuer Tierpsychologie, V37, P182; KIHLSTRO.JE, 1966, NATURE, V209, P513, DOI 10.1038/209513a0; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kogi K, 2004, MAR MAMMAL SCI, V20, P510, DOI 10.1111/j.1748-7692.2004.tb01176.x; Kogi K, 2001, EFFECTS DOLPHIN WATC; KUHR CS, 1995, J UROLOGY, V153, P429, DOI 10.1097/00005392-199502000-00045; Levin R J, 1975, Med Hypotheses, V1, P130, DOI 10.1016/0306-9877(75)90053-5; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; Mann Janet, 2006, P107; MARTAN J, 1968, J REPROD FERTIL, V17, P161, DOI 10.1530/jrf.0.0170161; MARTAN J., 1966, Transactions of the Illinois State Academy of Science, V59, P78; MCBRIDE AF, 1948, J COMP PHYSIOL PSYCH, V41, P111, DOI 10.1037/h0057927; MCBRIDE AF, 1951, J MAMMAL, V32, P251, DOI 10.2307/1375657; MCDONNELL SM, 1990, PROCEEDINGS OF THE THIRTY-FIFTH ANNUAL CONVENTION OF THE AMERICAN ASSOCIATION OF EQUINE PRACTITIONERS, P567; Norris K.S., 1994, HAWAIIAN SPINNER DOL; ORBACH J., 1967, BRAIN RES, V5, P520, DOI 10.1016/0006-8993(67)90026-1; ORBACH J, 1961, SCIENCE, V134, P1072, DOI 10.1126/science.134.3485.1072; RIESEN AH, 1971, CHIMPANZEE, V4, P1; Sakai M, 2010, BEHAV PROCESS, V83, P48, DOI 10.1016/j.beproc.2009.10.001; Sakamoto H, 2008, NAT NEUROSCI, V11, P634, DOI 10.1038/nn.2126; Sakamoto H, 2009, ENDOCRINOLOGY, V150, P3672, DOI 10.1210/en.2008-1791; Sakamoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004276; STEFANICK ML, 1983, PHYSIOL BEHAV, V31, P737, DOI 10.1016/0031-9384(83)90268-8; VANDIS H, 1970, PHYSIOL BEHAV, V5, P1161, DOI 10.1016/0031-9384(70)90205-2; Yuen QWH, 2009, J ANDROL, V30, P432, DOI 10.2164/jandrol.108.006692	41	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72879	10.1371/journal.pone.0072879	http://dx.doi.org/10.1371/journal.pone.0072879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015280	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800083
J	Peng, R; Zhang, XM; Ji, YF; Chen, TW; Yang, L; Huang, XH; Chi, XX				Peng, Rong; Zhang, Xiao Ming; Ji, Yi Fan; Chen, Tian Wu; Yang, Lin; Huang, Xiao Hua; Chi, Xiao Xiao			Pancreatic Duct Patterns in Acute Pancreatitis: A MRI Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; COMPLICATIONS; DISRUPTION	Objectives: To study the MRI findings of the pancreatic duct in patients with acute pancreatitis. Materials and Methods: A total of 239 patients with acute pancreatitis and 125 controls were analyzed in this study. The severity of acute pancreatitis was graded using the MR severity index (MRSI) and the Acute Physiology And Chronic Healthy Evaluation II(APACHE II) scoring systems. The number of main pancreatic duct (MPD) segments visualized, and both MPD diameter and pancreatic duct disruption were noted and compared with the severity of acute pancreatitis. Results: The frequency of MPD segment visualization in the control group was higher than that in the acute pancreatitis group (p<0.05). The number of MPD segments visualized was negatively correlated with the MRSI score (p<0.05) and the APACHE II score (p<0.05). There was no difference in the MPD diameter between the acute pancreatitis and control groups or among the patients with different severities of acute pancreatitis (p>0.05). The prevalence of pancreatic duct disruption was 7.9% in the acute pancreatitis group. The prevalences of pancreatic duct disruption were 4.8% and 15.3% in the mild and severe acute pancreatitis groups based on the APACHE II score, respectively, and were 0%, 5.7% and 43.5% in the mild, moderate and severe acute pancreatitis groups according the MRSI score, respectively. The prevalence of pancreatic duct disruption was correlated with the severity of acute pancreatitis based on the APACHE II score (p<0.05) and MRSI score (p<0.05). Conclusion: The pancreatic duct in acute pancreatitis patients was of normal diameter. The number of MPD segments visualized and visible pancreatic duct disruption on MRI may be supplementary indicators for determining the severity of acute pancreatitis.	[Peng, Rong; Zhang, Xiao Ming; Ji, Yi Fan; Chen, Tian Wu; Yang, Lin; Huang, Xiao Hua; Chi, Xiao Xiao] North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China	North Sichuan Medical University	Zhang, XM (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China.	cjr.zhxm@vip.163.com	Zhang, Xiao Ming/H-7104-2019	Zhang, Xiao Ming/0000-0001-5327-8506				Akisik MF, 2006, RADIOGRAPHICS, V26, P665, DOI 10.1148/rg.263055077; Arvanitakis M, 2004, GASTROENTEROLOGY, V126, P715, DOI 10.1053/j.gastro.2003.12.006; Aube C, 2003, SURG RADIOL ANAT, V25, P64, DOI 10.1007/s00276-002-0082-x; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; De Campos T, 2008, J PANCREAS, V9, P690; Drake LM, 2012, J CLIN GASTROENTEROL, V46, P696, DOI 10.1097/MCG.0b013e31825003b3; Kim DH, 2007, SURG CLIN N AM, V87, P1341, DOI 10.1016/j.suc.2007.08.005; Larena JA, 1998, BRIT J RADIOL, V71, P1100, DOI 10.1259/bjr.71.850.10211075; Leyendecker JR, 2002, AM J ROENTGENOL, V179, P1465, DOI 10.2214/ajr.179.6.1791465; Lund H, 2006, SCAND J GASTROENTERO, V41, P234, DOI 10.1080/00365520510024133; Manfredi R, 2000, RADIOLOGY, V214, P849, DOI 10.1148/radiology.214.3.r00mr24849; Munsell MA, 2010, J HOSP MED, V5, P241, DOI 10.1002/jhm.574; Nealon WH, 2009, J AM COLL SURGEONS, V208, P790, DOI 10.1016/j.jamcollsurg.2008.12.027; NEOPTOLEMOS JP, 1993, BRIT J SURG, V80, P94, DOI 10.1002/bjs.1800800131; Pascual I, 2008, DIGEST DIS SCI, V53, P3234, DOI 10.1007/s10620-008-0284-0; Pelaez-Luna M, 2008, GASTROINTEST ENDOSC, V68, P91, DOI 10.1016/j.gie.2007.11.041; Sandrasegaran K, 2007, RADIOGRAPHICS, V27, DOI 10.1148/rg.275065163; SEIDENSTICKER F, 1995, INT J PANCREATOL, V17, P225; Sica GT, 1999, RADIOLOGY, V210, P605, DOI 10.1148/radiology.210.3.r99fe55605; Stimac D, 2007, AM J GASTROENTEROL, V102, P997, DOI 10.1111/j.1572-0241.2007.01164.x; Triester SL, 2002, J CLIN GASTROENTEROL, V34, P167, DOI 10.1097/00004836-200202000-00014; Ueno E, 1998, PANCREAS, V16, P418, DOI 10.1097/00006676-199804000-00034; Uomo G, 1998, AM J SURG, V176, P49, DOI 10.1016/S0002-9610(98)00097-X; Viremouneix L, 2007, J MAGN RESON IMAGING, V26, P331, DOI 10.1002/jmri.21037; Xiao B, 2010, WORLD J GASTROENTERO, V16, P2735, DOI 10.3748/wjg.v16.i22.2735	26	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72792	10.1371/journal.pone.0072792	http://dx.doi.org/10.1371/journal.pone.0072792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015276	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800080
J	Yu, B; Gong, M; Wang, YG; Millard, RW; Pasha, Z; Yang, YT; Ashraf, M; Xu, MF				Yu, Bin; Gong, Min; Wang, Yigang; Millard, Ronald W.; Pasha, Zeeshan; Yang, Yueting; Ashraf, Muhammad; Xu, Meifeng			Cardiomyocyte Protection by GATA-4 Gene Engineered Mesenchymal Stem Cells Is Partially Mediated by Translocation of miR-221 in Microvesicles	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ISCHEMIC-HEART; SURVIVAL; THERAPY; BCL-2; BAX; TRANSPLANTATION; MICRORNAS; MECHANISM; APOPTOSIS	Introduction: microRNAs (miRs), a novel class of small non-coding RNAs, are involved in cell proliferation, differentiation, development, and death. In this study, we found that miR-221 translocation by microvesicles (MVs) plays an important role in cardioprotection mediated by GATA-4 overexpressed mesenchymal stem cells (MSC). Methods and Results: Adult rat bone marrow MSC and neonatal rat ventricle cardiomyocytes (CM) were harvested as primary cultures. MSC were transduced with GATA-4 (MSCGATA-4) using the murine stem cell virus (pMSCV) retroviral expression system. Empty vector transfection was used as a control (MSCNull). The expression of miRs was assessed by real-time PCR and localized using in situ hybridization (ISH). MVs collected from MSC cultures were characterized by expression of CD9, CD63, and HSP70, and photographed with electron microscopy. Cardioprotection during hypoxia afforded by conditioned medium (CdM) from MSC cultures was evaluated by lactate dehydrogenase (LDH) release, MTS uptake by CM, and caspase 3/7 activity. Expression of miR-221/222 was significantly higher in MSC than in CM and miR-221 was upregulated in MSCGATA-4. MSC overexpression of miR-221 significantly enhanced cardioprotection by reducing the expression of p53 upregulated modulator of apoptosis (PUMA). Moreover, expression of PUMA was significantly decreased in CM co-cultured with MSC. MVs derived from MSC expressed high levels of miR-221, and were internalized quickly by CM as documented in images obtained from a Time-Lapse Imaging System. Conclusions: Our results demonstrate that cardioprotection by MSCGATA-4 may be regulated in part by a transfer of antiapoptotic miRs contained within MVs.	[Yu, Bin; Gong, Min; Wang, Yigang; Pasha, Zeeshan; Yang, Yueting; Ashraf, Muhammad; Xu, Meifeng] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Millard, Ronald W.] Univ Cincinnati, Med Ctr, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Xu, MF (corresponding author), Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.	meifeng.xu@uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health [HL105176, HL114654]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105176, R01HL114654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants HL105176 and HL114654 (to M. Xu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angoulvant D, 2011, J HEART LUNG TRANSPL, V30, P95, DOI 10.1016/j.healun.2010.08.023; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Boonbaichaiyapruck Sarana, 2010, Clin Cardiol, V33, pE10, DOI 10.1002/clc.20545; Burchfield JS, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-4; Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192; Chen L, 2013, BIOCH BIOPHYS RES CO; Follis AV, 2013, NAT CHEM BIOL; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Leri Annarosa, 2007, Drug Discov Today Dis Mech, V4, P197, DOI 10.1016/j.ddmec.2008.02.008; Li HX, 2010, AM J PHYSIOL-HEART C, V299, pH1772, DOI 10.1152/ajpheart.00557.2010; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374; Nguyen BK, 2010, J CARDIOVASC TRANSL, V3, P547, DOI 10.1007/s12265-010-9171-0; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Poynter JA, 2011, J AM COLL SURGEONS, V213, P253, DOI 10.1016/j.jamcollsurg.2011.04.005; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Sharma AD, 2011, HEPATOLOGY, V53, P1651, DOI 10.1002/hep.24243; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Villunger A, 2003, BLOOD, V101, P2393, DOI 10.1182/blood-2002-07-2132; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Xu MF, 2004, CIRCULATION, V110, P2658, DOI 10.1161/01.CIR.0000145609.20435.36; Yousef M, 2009, J AM COLL CARDIOL, V53, P2262, DOI 10.1016/j.jacc.2009.02.051; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007	37	84	100	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73304	10.1371/journal.pone.0073304	http://dx.doi.org/10.1371/journal.pone.0073304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015301	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800097
J	Bungum, L; Franssohn, F; Bungum, M; Humaidan, P; Giwercman, A				Bungum, Leif; Franssohn, Florencia; Bungum, Mona; Humaidan, Peter; Giwercman, Aleksander			The Circadian Variation in Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome Differs Significantly from Normally Ovulating Women	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; LUTEINIZING-HORMONE; INHIBITING SUBSTANCE; INSULIN SENSITIVITY; GONADOTROPIN-SECRETION; GRANULOSA-CELLS; THECAL CELLS; SERUM; HYPERANDROGENISM; TESTOSTERONE	Obective: To improve the biologic understanding of the Polycystic Ovarian Syndrome (PCOS) condition by examining the circadian variation and relationship between Anti Mullerian Hormone (AMH), gonadotropins and ovarian steroids in PCOS patients compared to normally ovulating and menstruating women. By comparing the pattern of co-variation between AMH and Luteinizing Hormone, two compounds closely linked to hyperandrogenism and anovulation in PCOS, the involvement of the Hypothalamic-Pituitary-Ovarian axis in PCOS pathology could be elucidated. Patients: Eight normal-weighted young, anovulatory PCOS-women as study group and ten normal menstruating and ovulating women as controls. Interventions: Observational prospective study of the circadian variation in AMH, gonadotropins, sex steroids and androgens in a study and a control group. A circadian profile was performed in each study and control subject during a 24-h period by blood sampling every second hour, starting at 8:00 a.m. and continuing until 8:00 a.m. the following day. Result(s): Significant differences in hormonal levels were found between the groups, with higher concentrations of AMH, LH and androgens in the PCOS group and lower amounts of FSH and progesterone. A distinct difference in the circadian variation pattern of AMH and LH between PCOS patients and normal controls was seen, with PCOS patients presenting a uniform pattern in serum levels of AMH and LH throughout the study period, without significant nadir late-night values as was seen in the control group. In PCOS women, a significant positive association between LH/FSH and testosterone was found opposite to controls. Main outcome measures: Circadian variation in Anti-Mullerian Hormone, gonadotropins and ovarian steroids and the covariation between them. Conclusion: A significant difference in the circadian secretion of LH and AMH in PCOS women compared to normally ovulating women indicate an increased GnRH pulse, creating high and constant LH serum concentrations. A significant covariation between LH and AMH may suggest LH as a factor involved in the control of AMH secretion.	[Bungum, Leif; Franssohn, Florencia; Bungum, Mona; Giwercman, Aleksander] Lund Univ, Reprod Med Ctr, Skane Univ Hosp, Malmo, Sweden; [Humaidan, Peter] Odense Univ Hosp, Fertil Clin, DK-5000 Odense, Denmark	Lund University; Skane University Hospital; University of Southern Denmark; Odense University Hospital	Bungum, L (corresponding author), Lund Univ, Reprod Med Ctr, Skane Univ Hosp, Malmo, Sweden.	Leif.bungum@med.lu.se	Humaidan, Peter/AAB-4788-2020	Humaidan, Peter/0000-0001-6884-5366	Merck-Serono	Merck-Serono(Merck & Company)	The study was supported by an unconditional grant from Merck-Serono. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz R, 2006, J CLIN ENDOCR METAB, V91, P781, DOI 10.1210/jc.2005-2153; Barontini M, 2001, ARCH MED RES, V32, P544, DOI 10.1016/S0188-4409(01)00325-3; Bedecarrats GY, 2003, P NATL ACAD SCI USA, V100, P9348, DOI 10.1073/pnas.1633592100; BERCU BB, 1978, PEDIATR RES, V12, P139, DOI 10.1203/00006450-197802000-00015; Blank SK, 2006, HUM REPROD UPDATE, V12, P351, DOI 10.1093/humupd/dml017; Bungum L, 2011, HUM REPROD, V26, P678, DOI 10.1093/humrep/deq380; Carlsen E, 1999, J CLIN ENDOCR METAB, V84, P1664, DOI 10.1210/jc.84.5.1664; Cook CL, 2002, FERTIL STERIL, V77, P141, DOI 10.1016/S0015-0282(01)02944-2; Dewailly D, 2003, J GYNECOL OBST BIO R, V32, pS30; Dunaif A, 1999, ENDOCRIN METAB CLIN, V28, P341, DOI 10.1016/S0889-8529(05)70073-6; DUNAIF A, 1989, J CLIN INVEST, V83, P23, DOI 10.1172/JCI113864; Eagleson CA, 2000, J CLIN ENDOCR METAB, V85, P4047, DOI 10.1210/jc.85.11.4047; EHRMANN DA, 1995, J CLIN INVEST, V96, P520, DOI 10.1172/JCI118064; Eldar-Geva T, 2005, HUM REPROD, V20, P1814, DOI 10.1093/humrep/deh873; Fallat ME, 1997, FERTIL STERIL, V67, P962, DOI 10.1016/S0015-0282(97)81417-3; FRANKS S, 1994, CURR OPIN OBSTET GYN, V6, P136; Franks S, 1998, STEROIDS, V63, P306, DOI 10.1016/S0039-128X(98)00035-X; Georgopoulos NA, 2010, FERTIL STERIL, V93, pE13, DOI 10.1016/j.fertnstert.2009.10.006; GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158; HILLIER SG, 1991, J CLIN ENDOCR METAB, V72, P1206, DOI 10.1210/jcem-72-6-1206; HOLTE J, 1995, J CLIN ENDOCR METAB, V80, P2586, DOI 10.1210/jc.80.9.2586; Jakimiuk AJ, 2001, J CLIN ENDOCR METAB, V86, P1318, DOI 10.1210/jc.86.3.1318; Jonard S, 2004, HUM REPROD UPDATE, V10, P107, DOI 10.1093/humupd/dmh010; Jonard S, 2003, HUM REPROD, V18, P598, DOI 10.1093/humrep/deg115; KURODA T, 1990, ENDOCRINOLOGY, V127, P1825, DOI 10.1210/endo-127-4-1825; Laven JSE, 2004, J CLIN ENDOCR METAB, V89, P318, DOI 10.1210/jc.2003-030932; Lawson MA, 2008, J CLIN ENDOCR METAB, V93, P2089, DOI 10.1210/jc.2007-2656; Liu NN, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-36; Long W, 2000, Zhonghua Fu Chan Ke Za Zhi, V35, P356; Lukas-Croisier C, 2003, MOL ENDOCRINOL, V17, P550, DOI 10.1210/me.2002-0186; McCartney CR, 2002, SEMIN REPROD MED, V20, P317, DOI 10.1055/s-2002-36706; Mehta RV, 2005, J CLIN ENDOCR METAB, V90, P2136, DOI 10.1210/jc.2004-1040; Moret M, 2009, NEUROENDOCRINOLOGY, V89, P131, DOI 10.1159/000160911; Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925; Nestler JE, 1998, NEW ENGL J MED, V338, P1876, DOI 10.1056/NEJM199806253382603; NESTLER JE, 1987, J CLIN ENDOCR METAB, V64, P180, DOI 10.1210/jcem-64-1-180; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; PACHE TD, 1993, FERTIL STERIL, V59, P544; Panidis D, 2005, FERTIL STERIL, V84, P538, DOI 10.1016/j.fertnstert.2005.02.017; Panidis D, 2011, MED HYPOTHESES, V77, P649, DOI 10.1016/j.mehy.2011.07.005; Panidis D, 2011, GYNECOL ENDOCRINOL, V27, P587, DOI 10.3109/09513590.2010.507283; Pigny P, 2003, J CLIN ENDOCR METAB, V88, P5957, DOI 10.1210/jc.2003-030727; Piouka A, 2009, AM J PHYSIOL-ENDOC M, V296, pE238, DOI 10.1152/ajpendo.90684.2008; Teede HJ, 2006, ENDOCRINE, V30, P45, DOI 10.1385/ENDO:30:1:45; Teede HJ, 2006, ENDOCRINE, V30, P1, DOI 10.1385/ENDO:30:1:1; TETSUKA M, 1995, J ENDOCRINOL, V145, P535, DOI 10.1677/joe.0.1450535; Tsutsumi R, 2009, ENDOCR J, V56, P729, DOI 10.1507/endocrj.K09E-185; Udoff L C, 1996, J Pediatr Adolesc Gynecol, V9, P3; Vendola KA, 1998, J CLIN INVEST, V101, P2622, DOI 10.1172/JCI2081; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529; WALDSTREICHER J, 1988, J CLIN ENDOCR METAB, V66, P165, DOI 10.1210/jcem-66-1-165; Willis D, 1996, J CLIN ENDOCR METAB, V81, P302, DOI 10.1210/jc.81.1.302	53	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e68223	10.1371/journal.pone.0068223	http://dx.doi.org/10.1371/journal.pone.0068223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023708	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600002
J	Hagl, CI; Heumuller-Klug, S; Wink, E; Wessel, L; Schafer, KH				Hagl, Cornelia Irene; Heumueller-Klug, Sabine; Wink, Elvira; Wessel, Lucas; Schaefer, Karl-Herbert			The Human Gastrointestinal Tract, a Potential Autologous Neural Stem Cell Source	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; ISCHEMIC BRAIN-INJURY; CREST-DERIVED CELLS; PARKINSONS-DISEASE; MYENTERIC PLEXUS; ALZHEIMERS-DISEASE; PRECURSOR CELLS; GLIAL-CELLS; EXPRESSION; PLASTICITY	Stem cell therapies seem to be an appropriate tool for the treatment of a variety of diseases, especially when a substantial cell loss leads to a severe clinical impact. This is the case in most neuronal cell losses. Unfortunately, adequate neural stem cell sources are hard to find and current alternatives, such as induced programmed stem cells, still have incalculable risks. Evidence of neurogenesis in the adult human enteric nervous system brought up a new perspective. In humans the appendix harbors enteric neuronal tissue and is an ideal location where the presence of neural stem cells is combined with a minimal invasive accessibility. In this study appendices from adults and children were investigated concerning their neural stem cell potential. From each appendix tissue samples were collected, and processed for immunohistochemistry or enteric neural progenitor cell generation. Free-floating enteric neurospheres (EnNS's) could be generated after 6 days in vitro. EnNS's were either used for transplantation into rat brain slices or differentiation experiments. Both transplanted spheres and control cultures developed an intricate network with glia, neurons and interconnecting fibers, as seen in primary enteric cultures before. Neuronal, glial and neural stem cell markers could be identified both in vitro and in vivo by immunostaining. The study underlines the potential of the enteric nervous system as an autologous neural stem cell source. Using the appendix as a potential target opens up a new perspective that might lead to a relatively unproblematic harvest of neural stem cells.	[Hagl, Cornelia Irene; Heumueller-Klug, Sabine; Wink, Elvira; Wessel, Lucas; Schaefer, Karl-Herbert] Univ Heidelberg Mannheim, Med Fac Mannheim, Clin Pediat Surg, Heidelberg, Germany; [Schaefer, Karl-Herbert] Univ Appl Sci, Fac Comp Sci & Microsyst Technol, Dept Life Sci, Zweibrucken, Germany	Ruprecht Karls University Heidelberg	Schafer, KH (corresponding author), Univ Heidelberg Mannheim, Med Fac Mannheim, Clin Pediat Surg, Heidelberg, Germany.	Schaefer@mst-fh-kl.de	Wessel, Lucas/AAD-6385-2020		university grant (Hochschulfonds)	university grant (Hochschulfonds)	Funding was supported by a university grant (Hochschulfonds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anlauf M, 2003, J COMP NEUROL, V459, P90, DOI 10.1002/cne.10599; Annerino DM, 2012, ACTA NEUROPATHOL, V124, P665, DOI 10.1007/s00401-012-1040-2; Azan G, 2011, CELL TISSUE RES, V344, P217, DOI 10.1007/s00441-011-1130-9; Bath KG, 2010, DEV NEUROBIOL, V70, P339, DOI 10.1002/dneu.20781; Bellenchi GC, 2012, J NEUROCHEM; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; Cavaleri F, 2003, CELL, V113, P551, DOI 10.1016/S0092-8674(03)00394-5; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Chen HC, 2010, J NEUROSCI RES, V88, P3308, DOI 10.1002/jnr.22492; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Delavaran H, 2012, EUR J NEUROL; Demir IE, 2013, ACTA NEUROPATHOL, V125, P491, DOI 10.1007/s00401-013-1099-4; Du F, 2009, NEUROGASTROENT MOTIL, V21, P1229, DOI 10.1111/j.1365-2982.2009.01379.x; Dyson SC, 2011, EXPERT REV NEUROTHER, V11, P831, DOI [10.1586/ern.11.33, 10.1586/ERN.11.33]; Eichmann A, 2012, COLD SPRING HARB PER; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fichter M, 2011, MOL NUTR FOOD RES, V55, P1592, DOI 10.1002/mnfr.201100124; Furness J.B., 2006, ENTERIC NERVOUS SYST; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Garzon-Muvdi T, 2010, ILAR J, V51, P3, DOI 10.1093/ilar.51.1.3; Gershon M.D., 1998, 2 BRAIN; Giaroni C, 1999, GASTROENTEROLOGY, V117, P1438, DOI 10.1016/S0016-5085(99)70295-7; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Grundmann D, 2013, GLIA, V61, pS53; Hanani M, 2004, AUTON NEUROSCI-BASIC, V110, P49, DOI 10.1016/j.autneu.2003.09.001; Hess PG, 2009, ACCOUNT RES, V16, P175, DOI 10.1080/08989620903065145; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; Jiang S, 2005, EXP BRAIN RES, V162, P56, DOI 10.1007/s00221-004-2119-3; Kohl A, 2003, EXP NEUROL, V181, P1, DOI 10.1016/S0014-4886(02)00049-3; Korzhevskii D E, 2011, Morfologiia, V139, P13; Landgren H, 2011, J CELL PHYSIOL, V226, P1, DOI 10.1002/jcp.22319; Lebouvier T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012728; Lebouvier T, 2009, EUR J NEUROSCI, V30, P735, DOI 10.1111/j.1460-9568.2009.06873.x; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; Lindley RM, 2009, J PEDIATR SURG, V44, P1249, DOI 10.1016/j.jpedsurg.2009.02.048; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Marlatt MW, 2010, CURR ALZHEIMER RES, V7, P113, DOI 10.2174/156720510790691362; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; MOLINOFF PB, 1971, ANNU REV BIOCHEM, V40, P465, DOI 10.1146/annurev.bi.40.070171.002341; Neunlist M, 2003, AM J PHYSIOL-GASTR L, V285, pG1028, DOI 10.1152/ajpgi.00066.2003; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pascual A, 2011, J MOL ENDOCRINOL, V46, pR83, DOI 10.1530/JME-10-0125; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prabhakaran S, 2012, STROKE, V43, P2258, DOI 10.1161/STROKEAHA.112.655910; Rauch U, 2006, J HISTOCHEM CYTOCHEM, V54, P39, DOI 10.1369/jhc.4A6495.2005; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Robinson AP, 2011, STEM CELLS DEV, V20, P289, DOI 10.1089/scd.2009.0444; Rooney GE, 2010, REGEN MED, V5, P365, DOI 10.2217/RME.10.20; RUDGE JS, 1990, J NEUROSCI, V10, P3594; Sabuncu MR, 2011, ARCH NEUROL-CHICAGO, V68, P1040, DOI 10.1001/archneurol.2011.167; Satija NK, 2009, J CELL MOL MED, V13, P4385, DOI 10.1111/j.1582-4934.2009.00857.x; Schafer KH, 2009, ANAT REC, V292, P1940, DOI 10.1002/ar.21033; Schafer KH, 1997, BRAIN RES PROTOC, V1, P109, DOI 10.1016/S1385-299X(96)00017-7; Schafer KH, 2003, PEDIATR SURG INT, V19, P340, DOI 10.1007/s00383-003-1007-4; Schafer KH, 2000, DIGEST DIS SCI, V45, P1631, DOI 10.1023/A:1005581531603; Schrenk S, 2012, NEUROGASTROENT MOTIL, V24, P118; Sidebotham EL, 2001, PEDIATR SURG INT, V17, P304, DOI 10.1007/s003830100599; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SINGARAM C, 1995, LANCET, V346, P861, DOI 10.1016/S0140-6736(95)92707-7; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Suarez-Rodriguez R, 2004, STEM CELLS, V22, P1373, DOI 10.1634/stemcells.2003-0049; Swank HA, 2011, WORLD J SURG, V35, P1221, DOI 10.1007/s00268-011-1088-5; TEW EMM, 1994, EXP NEUROL, V129, P120, DOI 10.1006/exnr.1994.1153; Van Landeghem L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-507; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; von Boyen GBT, 2002, J GASTROENTEROL, V37, P583, DOI 10.1007/s005350200093; Von Boyen G, 2010, NEURON GLIA BIOL, V6, P231, DOI 10.1017/S1740925X11000068; WAKABAYASHI K, 1988, ACTA NEUROPATHOL, V76, P217, DOI 10.1007/BF00687767; Wang L, 2010, BIOMATERIALS, V31, P1691, DOI 10.1016/j.biomaterials.2009.11.053; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yates A, 2005, BIOCHEM SOC T, V33, P1518, DOI 10.1042/BST0331518; Yenamandra SP, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.138; Yoo J, 2012, J CELL BIOCH; Young HM, 1999, DEV DYNAM, V216, P137, DOI 10.1002/(SICI)1097-0177(199910)216:2<137::AID-DVDY5>3.0.CO;2-6; Young HM, 2001, ANAT REC, V262, P1	83	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72948	10.1371/journal.pone.0072948	http://dx.doi.org/10.1371/journal.pone.0072948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023797	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600055
J	Razzaghian, HR; Forsberg, LA; Prakash, KR; Przerada, S; Paprocka, H; Zywicka, A; Westerman, MP; Pedersen, NL; O'Hanlon, TP; Rider, LG; Miller, FW; Srutek, E; Jankowski, M; Zegarski, W; Piotrowski, A; Absher, D; Dumanski, JP				Razzaghian, Hamid Reza; Forsberg, Lars A.; Prakash, Kancherla Reddy; Przerada, Szymon; Paprocka, Hanna; Zywicka, Anna; Westerman, Maxwell P.; Pedersen, Nancy L.; O'Hanlon, Terrance P.; Rider, Lisa G.; Miller, Frederick W.; Srutek, Ewa; Jankowski, Michal; Zegarski, Wojciech; Piotrowski, Arkadiusz; Absher, Devin; Dumanski, Jan P.			Post-Zygotic and Inter-Individual Structural Genetic Variation in a Presumptive Enhancer Element of the Locus between the IL10R beta and IFNAR1 Genes	PLOS ONE			English	Article							COPY-NUMBER-VARIATION; SOMATIC MOSAICISM; TANDEM REPEATS; HUMAN GENOME; TRANSCRIPTION FACTORS; HUMAN TISSUES; INS VNTR; MECHANISMS; DNA; CANCER	Although historically considered as junk-DNA, tandemly repeated sequence motifs can affect human phenotype. For example, variable number tandem repeats (VNTR) with embedded enhancers have been shown to regulate gene transcription. The post-zygotic variation is the presence of genetically distinct populations of cells in an individual derived from a single zygote, and this is an understudied aspect of genome biology. We report somatically variable VNTR with sequence properties of an enhancer, located upstream of IFNAR1. Initially, SNP genotyping of 63 monozygotic twin pairs and multiple tissues from 21 breast cancer patients suggested a frequent post-zygotic mosaicism. The VNTR displayed a repeated 32 bp core motif in the center of the repeat, which was flanked by similar variable motifs. A total of 14 alleles were characterized based on combinations of segments, which showed post-zygotic and inter-individual variation, with up to 6 alleles in a single subject. Somatic variation occurred in similar to 24% of cases. In this hypervariable region, we found a clustering of transcription factor binding sites with strongest sequence similarity to mouse Foxg1 transcription factor binding motif. This study describes a VNTR with sequence properties of an enhancer that displays post-zygotic and inter-individual genetic variation. This element is within a locus containing four related cytokine receptors: IFNAR2, IL10R beta, IFNAR1 and IFNGR2, and we hypothesize that it might function in transcriptional regulation of several genes in this cluster. Our findings add another level of complexity to the variation among VNTR-based enhancers. Further work may unveil the normal function of this VNTR in transcriptional control and its possible involvement in diseases connected with these receptors, such as autoimmune conditions and cancer.	[Razzaghian, Hamid Reza; Forsberg, Lars A.; Prakash, Kancherla Reddy; Przerada, Szymon; Paprocka, Hanna; Zywicka, Anna; Dumanski, Jan P.] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Westerman, Maxwell P.] Mt Sinai Hosp Med Ctr, Chicago, IL USA; [Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [O'Hanlon, Terrance P.; Rider, Lisa G.; Miller, Frederick W.] NIEHS, Environm Autoimmun Grp, NIH, Clin Res Ctr, Bethesda, MD USA; [Srutek, Ewa; Jankowski, Michal; Zegarski, Wojciech] Nicholas Copernicus Univ, Surg Oncol Clin, Coll Med, Ctr Oncol, Bydgoszcz, Poland; [Piotrowski, Arkadiusz] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Absher, Devin] HudsonAlpha Inst Biotechnol, Huntsville, MD USA	Uppsala University; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Nicolaus Copernicus University; Ludwik Rydygier Collegium Medicum; Fahrenheit Universities; Medical University Gdansk; HudsonAlpha Institute for Biotechnology	Dumanski, JP (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	jan.dumanski@igp.uu.se	Piotrowski, Arkadiusz/A-5484-2010; Rider, Lisa G/C-7083-2018; Zegarski, Wojciech/H-7199-2014; Miller, Frederick/D-2431-2019	Piotrowski, Arkadiusz/0000-0002-0823-0607; Rider, Lisa G/0000-0002-6912-2458; Dumanski, Jan Piotr/0000-0002-1489-1452; Forsberg, Lars/0000-0002-1701-755X; Jankowski, Michal/0000-0001-9982-842X; Miller, Frederick/0000-0003-2831-9593	Ellison Medical Foundation; Swedish Cancer Society; Swedish Research Council; Swedish Heart-Lung Foundation; Science for Life Laboratory-Uppsala; Foundation for Polish Science [FOCUS 4/2008, FOCUS 4/08/2009]; Uppsala University; Uppsala University Hospital; Swedish Research Council [80576801, 70374401]; National Institute of Environmental Health Sciences; National Institute of Health, Bethesda, Maryland, United States of America; NIH [AG 04563, AG10175]; NATIONAL INSTITUTE ON AGING [R01AG004563, R01AG010175] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Science for Life Laboratory-Uppsala; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Uppsala University; Uppsala University Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Health, Bethesda, Maryland, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was sponsored by grants from the Ellison Medical Foundation (JPD and DA), the Swedish Cancer Society, the Swedish Research Council, Swedish Heart-Lung Foundation, and the Science for Life Laboratory-Uppsala (JPD). AP acknowledges FOCUS 4/2008 and FOCUS 4/08/2009 grants from the Foundation for Polish Science. Genotyping was performed in part by the SNP&SEQ Technology Platform, which is supported by Uppsala University, Uppsala University Hospital, the Science for Life Laboratory-Uppsala, and the Swedish Research Council (contracts 80576801 and 70374401). This study was also supported in part by the intramural research program of the National Institute of Environmental Health Sciences, the National Institute of Health, Bethesda, Maryland, United States of America. SATSA study is supported in part by grants from the NIH (AG 04563, AG10175) and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesina AM, 2007, HUM PATHOL, V38, P400, DOI 10.1016/j.humpath.2006.09.003; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Cervin C, 2008, DIABETES, V57, P1433, DOI 10.2337/db07-0299; Chan DW, 2009, BRIT J CANCER, V101, P1433, DOI 10.1038/sj.bjc.6605316; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Critchley-Thorne RJ, 2009, P NATL ACAD SCI USA, V106, P9010, DOI 10.1073/pnas.0901329106; Danesin C, 2012, CURR OPIN GENET DEV, V22, P323, DOI 10.1016/j.gde.2012.05.001; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Dumanski JP, 2012, METHODS MOL BIOL, V838, P249, DOI 10.1007/978-1-61779-507-7_12; Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Ferguson LA, 2009, FEBS LETT, V583, P3181, DOI 10.1016/j.febslet.2009.08.041; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Forsberg LA, 2013, J MED GENET, V50, P1, DOI 10.1136/jmedgenet-2012-101322; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Group T. H. D. C. R., 1993, CELL, V72, P971, DOI [10.1016/0092-8674(93)90585-E8458085, DOI 10.1016/0092-8674(93)90585-E8458085]; Guerrini R, 2012, EPILEPSIA, V53, P2067, DOI 10.1111/j.1528-1167.2012.03656.x; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hellauer K, 2002, J BIOL CHEM, V277, P17671, DOI 10.1074/jbc.M201637200; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Katoh M, 2004, INT J ONCOL, V25, P1495; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Ong KKL, 1999, NAT GENET, V21, P262, DOI 10.1038/6775; Palin K, 2006, NAT PROTOC, V1, P368, DOI 10.1038/nprot.2006.56; Paquette J, 1998, J BIOL CHEM, V273, P14158, DOI 10.1074/jbc.273.23.14158; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Ronnblom L, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2884; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Smit A, 1996, REPEATMASKER OPEN 30; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, GENOMICS, V93, P509, DOI 10.1016/j.ygeno.2009.02.002; Warpeha KM, 1999, FASEB J, V13, P1825, DOI 10.1096/fasebj.13.13.1825; Waterworth DM, 1997, LANCET, V349, P986, DOI 10.1016/S0140-6736(96)08368-7; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	59	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e67752	10.1371/journal.pone.0067752	http://dx.doi.org/10.1371/journal.pone.0067752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023707	Green Submitted, gold, Green Published			2022-12-27	WOS:000324515600001
J	Vajhala, CSK; Sadumpati, VK; Nunna, HR; Puligundla, SK; Vudem, DR; Khareedu, VR				Vajhala, Chakravarthy S. K.; Sadumpati, Vijaya Kumar; Nunna, Hariprasad Rao; Puligundla, Sateesh Kumar; Vudem, Dashavantha Reddy; Khareedu, Venkateswara Rao			Development of Transgenic Cotton Lines Expressing Allium sativum Agglutinin (ASAL) for Enhanced Resistance against Major Sap-Sucking Pests	PLOS ONE			English	Article							HIGH-LEVEL RESISTANCE; TUBER LECTIN 1; LEAF AGGLUTININ; CONFERS RESISTANCE; PLANTS; GENE; PROTEINS; GNA; PERFORMANCE; RECEPTORS	Mannose-specific Allium sativum leaf agglutinin encoding gene (ASAL) and herbicide tolerance gene (BAR) were introduced into an elite cotton inbred line (NC-601) employing Agrobacterium-mediated genetic transformation. Cotton transformants were produced from the phosphinothricin (PPT)-resistant shoots obtained after co-cultivation of mature embryos with the Agrobacterium strain EHA105 harbouring recombinant binary vector pCAMBIA3300-ASAL-BAR. PCR and Southern blot analysis confirmed the presence and stable integration of ASAL and BAR genes in various transformants of cotton. Basta leaf-dip assay, northern blot, western blot and ELISA analyses disclosed variable expression of BAR and ASAL transgenes in different transformants. Transgenes, ASAL and BAR, were stably inherited and showed co-segregation in T-1 generation in a Mendelian fashion for both PPT tolerance and insect resistance. In planta insect bioassays on T-2 and T-3 homozygous ASAL-transgenic lines revealed potent entomotoxic effects of ASAL on jassid and whitefly insects, as evidenced by significant decreases in the survival, development and fecundity of the insects when compared to the untransformed controls. Furthermore, the transgenic cotton lines conferred higher levels of resistance (1-2 score) with minimal plant damage against these major sucking pests when bioassays were carried out employing standard screening techniques. The developed transgenics could serve as a potential genetic resource in recombination breeding aimed at improving the pest resistance of cotton. This study represents the first report of its kind dealing with the development of transgenic cotton resistant to two major sap-sucking insects.	[Vajhala, Chakravarthy S. K.; Sadumpati, Vijaya Kumar; Vudem, Dashavantha Reddy; Khareedu, Venkateswara Rao] Osmania Univ, Ctr Plant Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Nunna, Hariprasad Rao; Puligundla, Sateesh Kumar] Nuziveedu Seeds Ltd, Ranga Reddy, Andhra Pradesh, India	Osmania University	Khareedu, VR (corresponding author), Osmania Univ, Ctr Plant Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	rao_kv1@rediffmail.com			M/s. Swarna Bharathi Biotech Pvt., Ltd., Hyderabad, India	M/s. Swarna Bharathi Biotech Pvt., Ltd., Hyderabad, India	This work has been supported by grants from M/s. Swarna Bharathi Biotech Pvt., Ltd., Hyderabad, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldemita RR, 1996, PLANTA, V199, P612, DOI 10.1007/BF00195194; Amudha J, 2011, CURR SCI INDIA, V101, P300; Banerjee S, 2004, J BIOL CHEM, V279, P23782, DOI 10.1074/jbc.M401405200; Bharathi Y, 2011, J BIOTECHNOL, V152, P63, DOI 10.1016/j.jbiotec.2011.01.021; Chakraborti D, 2009, TRANSGENIC RES, V18, P529, DOI 10.1007/s11248-009-9242-7; Chakravarthy VSK, 2012, CRIT REV BIOTECHNOL, DOI 10 3109/07388551 2012 743502; Chougule NP, 2012, TOXINS, V4, P405, DOI 10.3390/toxins4060405; Dai S, 2001, PLANT CELL REP, V20, P738, DOI 10.1007/s002990100390; Dutta I, 2005, PLANT SCI, V169, P996, DOI 10.1016/j.plantsci.2005.05.016; FINNEGAN J, 1994, BIO-TECHNOL, V12, P883, DOI 10.1038/nbt0994-883; Gatehouse AMR, 1998, PESTIC SCI, V52, P165, DOI 10.1002/(SICI)1096-9063(199802)52:2&lt;165::AID-PS679&gt;3.0.CO;2-7; Jindal V, 2009, PHYTOPARASITICA, V37, P137, DOI 10.1007/s12600-009-0026-7; Kato T, 2010, PLANT BIOTECHNOL-NAR, V27, P141, DOI 10.5511/plantbiotechnology.27.141; Kranthi K.R., 2009, ADV COTTON IPM, P26; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawo NC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004804; LICHTENSTEIN C, 1985, DNA CLONING, V2, P67; Majumder P, 2004, GLYCOCONJUGATE J, V20, P525, DOI 10.1023/B:GLYC.0000043288.72051.7c; Mehboob-ur-Rahman, 2012, AGRON SUSTAIN DEV, V32, P419, DOI 10.1007/s13593-011-0051-z; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagadhara D, 2004, THEOR APPL GENET, V109, P1399, DOI 10.1007/s00122-004-1750-5; Nagadhara D, 2003, PLANT BIOTECHNOL J, V1, P231, DOI 10.1046/j.1467-7652.2003.00022.x; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Palle SR, 2013, PLANT BIOTECHNOL J, V11, P296, DOI 10.1111/pbi.12013; Patterson A. H., 1993, PLANT MOL BIOL REP, V11, P122; Rao KV, 1998, PLANT J, V15, P469, DOI 10.1046/j.1365-313X.1998.00226.x; Sadeghi A, 2008, TRANSGENIC RES, V17, P9, DOI 10.1007/s11248-007-9069-z; Saha P, 2006, PLANTA, V223, P1329, DOI 10.1007/s00425-005-0182-z; Sambrook J., 2001, MOL CLONING LAB MANU; Tidke PM, 1962, IND COT GROW REV, V16, P323; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Upadhyay SK, 2012, PROTEIN J, V31, P439, DOI 10.1007/s10930-012-9423-8; Upadhyay SK, 2010, PROTEOMICS, V10, P4431, DOI 10.1002/pmic.201000152; Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; Vijayan M, 1999, CURR OPIN STRUC BIOL, V9, P707, DOI 10.1016/S0959-440X(99)00034-2; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wilkins TA, 2000, CRIT REV PLANT SCI, V19, P511, DOI 10.1016/S0735-2689(01)80007-1; Wu J, 2006, PLANT BREEDING, V125, P390, DOI 10.1111/j.1439-0523.2006.01247.x; Wu JH, 2008, BIOTECHNOL LETT, V30, P547, DOI 10.1007/s10529-007-9555-7; Yao JH, 2003, TRANSGENIC RES, V12, P715, DOI 10.1023/B:TRAG.0000005146.05655.7d; Yarasi B, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-102; Yoshimura S, 2012, PLANT BIOTECHNOL-NAR, V29, P501, DOI 10.5511/plantbiotechnology.12.0726b	43	22	22	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72542	10.1371/journal.pone.0072542	http://dx.doi.org/10.1371/journal.pone.0072542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023750	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600029
J	Wang, XF; Huang, MZ; Zhang, XW; Hua, RX; Guo, WJ				Wang, Xiao-feng; Huang, Ming-zhu; Zhang, Xiao-wei; Hua, Rui-xi; Guo, Wei-jian			COX-2-765G > C Polymorphism Increases the Risk of Cancer: A Meta-Analysis	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SINGLE-NUCLEOTIDE POLYMORPHISMS; ACUTE MYELOID-LEUKEMIA; CELL LUNG-CANCER; COLORECTAL-CANCER; PROSTATE-CANCER; CYCLOOXYGENASE-2 GENE; GASTRIC-CANCER; COX-2 GENE; HEPATOCELLULAR-CARCINOMA	Background: Chronic inflammation has been regarded as an important mechanism in carcinogenesis. Inflammation-associated genetic variants have been highly associated with cancer risk. Polymorphisms in the gene cyclooxygenase-2 (COX-2), a pro-inflammation factor, have been suggested to alter the risk of multiple tumors, but the findings of various studies are not consistent. Methods: A literature search through February 2013 was performed using PubMed, EMBASE, and CNKI databases. We used odds ratios (ORs) with confidence intervals (CIs) of 95% to assess the strength of the association between the COX-2-765G>C polymorphism and cancer risk in a random-effect model. We also assessed heterogeneity and publication bias. Results: In total, 65 articles with 29,487 cancer cases and 39,212 non-cancer controls were included in this meta-analysis. The pooled OR (95% CIs) in the co-dominant model (GC vs. GG) was 1.11 (1.02-1.22), and in the dominant model ((CC+GC) vs. GG), the pooled OR was 1.12 (1.02-1.23). In the subgroup analysis, stratified by cancer type and race, significant associations were found between the-765 C allele and higher risk for gastric cancer, leukemia, pancreatic cancer, and cancer in the Asian population. Conclusion: In summary, the COX-2-765 C allele was related to increased cancer susceptibility, especially gastric cancer and cancer in the Asian population.	[Wang, Xiao-feng; Huang, Ming-zhu; Zhang, Xiao-wei; Guo, Wei-jian] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Wang, Xiao-feng; Huang, Ming-zhu; Zhang, Xiao-wei; Guo, Wei-jian] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Hua, Rui-xi] Sun Yat Sen Univ, Dept Med Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Fudan University; Fudan University; Sun Yat Sen University	Guo, WJ (corresponding author), Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	guoweijian0001@163.com		Hua, Rui-Xi/0000-0001-5319-656X	National Natural Scientific Funding [81171909]	National Natural Scientific Funding	This work was supported by grants from the National Natural Scientific Funding (81171909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Balistreri CR, 2010, CURR PHARM DESIGN, V16, P718, DOI 10.2174/138161210790883877; Ben Nasr H, 2009, MOL BIOL REP, V36, P193, DOI 10.1007/s11033-007-9166-3; Berlau J, 2004, ANAL BIOANAL CHEM, V378, P737, DOI 10.1007/s00216-003-2284-4; Bi N, 2010, CLIN CANCER RES, V16, P2383, DOI 10.1158/1078-0432.CCR-09-2793; Biramijamal F, 2010, BIOCHEM GENET, V48, P915, DOI 10.1007/s10528-010-9372-x; Bye H, 2011, CARCINOGENESIS, V32, P1855, DOI 10.1093/carcin/bgr211; Cakmakoglu BA, 2011, MOL BIOL REP, V38, P3481, DOI 10.1007/s11033-010-0458-7; Campa D, 2004, CARCINOGENESIS, V25, P229, DOI 10.1093/carcin/bgh008; Cao H, 2010, TOHOKU J EXP MED, V222, P15, DOI 10.1620/tjem.222.15; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Catsburg C, 2012, CARCINOGENESIS, V33, P1352, DOI 10.1093/carcin/bgs175; Chang ET, 2009, CANCER EPIDEM BIOMAR, V18, P976, DOI 10.1158/1055-9965.EPI-08-1130; Chang WS, 2012, CHINESE J PHYSIOL, V55, P1, DOI 10.4077/CJP.2012.AMM056; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Cheng I, 2007, BRIT J CANCER, V97, P557, DOI 10.1038/sj.bjc.6603874; Chiang SL, 2008, CANCER RES, V68, P8489, DOI 10.1158/0008-5472.CAN-08-0823; Cocos R, 2012, ARCH DERMATOL RES, V304, P335, DOI 10.1007/s00403-011-1194-0; Coskunpinar E, 2011, MED ONCOL, V28, P1436, DOI 10.1007/s12032-010-9627-8; Cox DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1635; Cox DG, 2004, BRIT J CANCER, V91, P339, DOI 10.1038/sj.bjc.6601906; Daraei A, 2012, MOL BIOL REP, V39, P5219, DOI 10.1007/s11033-011-1319-8; Dong J, 2010, J GASTROEN HEPATOL, V25, P1042, DOI 10.1111/j.1440-1746.2010.06293.x; Dossus L, 2010, CARCINOGENESIS, V31, P455, DOI 10.1093/carcin/bgp307; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Gong ZH, 2009, INT J COLORECTAL DIS, V24, P647, DOI 10.1007/s00384-009-0656-8; Gunter MJ, 2006, CANCER EPIDEM BIOMAR, V15, P1126, DOI 10.1158/1055-9965.EPI-06-0042; Haghshenas M, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-20; Hamajima Nobuyuki, 2001, Asian Pac J Cancer Prev, V2, P57; Hardbower DM, 2013, GUT MICROBES, P4; He JH, 2012, MOL BIOL REP, V39, P4163, DOI 10.1007/s11033-011-1199-y; Hoeft B, 2008, CANCER CAUSE CONTROL, V19, P163, DOI 10.1007/s10552-007-9082-9; Hoff JH, 2009, WORLD J GASTROENTERO, V15, P4561, DOI 10.3748/wjg.15.4561; Hou L, 2007, ANTICANCER RES, V27, P4243; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Iglesias D, 2009, CANCER CAUSE CONTROL, V20, P1421, DOI 10.1007/s10552-009-9368-1; Joshi AD, 2012, CARCINOGENESIS, V33, P2108, DOI 10.1093/carcin/bgs242; Ke JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062485; Koh WP, 2004, BRIT J CANCER, V90, P1760, DOI 10.1038/sj.bjc.6601797; Li YC, 2012, ONCOL LETT, V3, P107, DOI 10.3892/ol.2011.426; Liang YA, 2011, TOHOKU J EXP MED, V223, P137, DOI 10.1620/tjem.223.137; Lira MG, 2007, BRIT J DERMATOL, V157, P49, DOI 10.1111/j.1365-2133.2007.07921.x; Liu CJ, 2010, ANTICANCER RES, V30, P1195; Liu F, 2006, GASTROENTEROLOGY, V130, P1975, DOI 10.1053/j.gastro.2006.03.021; Liu JL, 2010, WORLD J GASTROENTERO, V16, P5510, DOI 10.3748/wjg.v16.i43.5510; Liu L, 2011, CANCER-AM CANCER SOC, V117, P5172, DOI 10.1002/cncr.26154; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Ma Y, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-11; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Mittal M, 2010, ORAL ONCOL, V46, P622, DOI 10.1016/j.oraloncology.2010.06.002; Monroy CM, 2011, MOL CARCINOGEN, V50, P36, DOI 10.1002/mc.20688; Moons LMG, 2007, AM J GASTROENTEROL, V102, P2373, DOI 10.1111/j.1572-0241.2007.01373.x; Murad A, 2009, PROSTATE CANCER P D, V12, P296, DOI 10.1038/pcan.2009.18; O'Byrne KJ, 2001, BRIT J CANCER, V85, P473, DOI 10.1054/bjoc.2001.1943; Pandey S, 2010, INT J GYNECOL CANCER, V20, P625, DOI 10.1111/IGC.0b013e3181c63f79; Panguluri RCK, 2004, CARCINOGENESIS, V25, P961, DOI 10.1093/carcin/bgh100; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; Pereira C, 2006, WORLD J GASTROENTERO, V12, P5473, DOI 10.3748/wjg.v12.i34.5473; Pereira C, 2010, EUR J GASTROEN HEPAT, V22, P607, DOI 10.1097/MEG.0b013e3283352cbb; Pereira C, 2009, EUR J GASTROEN HEPAT, V21, P76, DOI 10.1097/MEG.0b013e32830ce7ba; Peters WHM, 2009, HEAD NECK-J SCI SPEC, V31, P938, DOI 10.1002/hed.21058; Pinheiro SP, 2010, INT J MOL EPIDEMIOL, V1, P320; Piranda DN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-613; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Saxena A, 2008, WORLD J GASTROENTERO, V14, P1498, DOI 10.3748/wjg.14.1498; Schwartzbaum J, 2005, CANCER RES, V65, P6459, DOI 10.1158/0008-5472.CAN-04-3728; Sethi G, 2012, BIOSCIENCE REP, V32, P1, DOI 10.1042/BSR20100136; Shin WG, 2012, GUT LIVER, V6, P321, DOI 10.5009/gnl.2012.6.3.321; Sitarz R, 2008, MODERN PATHOL, V21, P685, DOI 10.1038/modpathol.2008.36; Song QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033318; Szczeklik W, 2004, J ALLERGY CLIN IMMUN, V114, P248, DOI 10.1016/j.jaci.2004.05.030; Tan W, 2007, CARCINOGENESIS, V28, P1197, DOI 10.1093/carcin/bgl242; Thompson CL, 2009, WORLD J GASTROENTERO, V15, P2240, DOI 10.3748/wjg.15.2240; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Ueda N, 2008, CANCER SCI, V99, P576, DOI 10.1111/j.1349-7006.2007.00711.x; Ulrich CM, 2005, CANCER EPIDEM BIOMAR, V14, P616, DOI 10.1158/1055-9965.EPI-04-0510; Upadhyay R, 2009, MUTAT RES-FUND MOL M, V663, P52, DOI 10.1016/j.mrfmmm.2009.01.007; Vogel U, 2007, MUTAT RES-FUND MOL M, V617, P138, DOI 10.1016/j.mrfmmm.2007.01.005; Wang CH, 2010, ANTICANCER RES, V30, P3649; Wang J, 2012, INT J CANCER, V130, P1898, DOI 10.1002/ijc.26199; Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5; Wei GQ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-46; Wu HC, 2011, ANTICANCER RES, V31, P221; Xing LL, 2008, WORLD J GASTROENTERO, V14, P1785, DOI 10.3748/wjg.14.1785; Xu Dong-kui, 2008, Zhonghua Yi Xue Za Zhi, V88, P1961; Yaghoobi M, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-28; Yu KD, 2010, BREAST CANCER RES TR, V122, P251, DOI 10.1007/s10549-009-0688-3; Zhang HT, 2012, GENET MOL RES, V11, P1642, DOI 10.4238/2012.June.15.13; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003; Zhang XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021894; Zhao D, 2009, GASTROENTEROLOGY, V136, P1659, DOI 10.1053/j.gastro.2009.01.071; Zheng J, 2011, EUR J HAEMATOL, V87, P486, DOI 10.1111/j.1600-0609.2011.01691.x; Zhu W, 2010, MOL BIOL REP, V37, P277, DOI 10.1007/s11033-009-9685-1	96	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73213	10.1371/journal.pone.0073213	http://dx.doi.org/10.1371/journal.pone.0073213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023834	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600077
J	Xing, Y; Hong, C; Cheng, B; Zhang, K				Xing, Yi; Hong, Chen; Cheng, Bei; Zhang, Kun			Preparation of Mn-Based Selective Catalytic Reduction Catalysts by Three Methods and Optimization of Process Conditions	PLOS ONE			English	Article							LOW-TEMPERATURE SCR; SUPPORTED MANGANESE; OXIDE CATALYSTS; NH3; NOX; TITANIA; TIO2	Mn-based catalysts enable high NOx conversion in the selective catalytic reduction of NOx with NH3. Three catalyst-production methods, namely, co-precipitation, impregnation, and sol-gel, were used in this study to determine the optimum method and parameters. The maximum catalytic activity was found for the catalyst prepared by sol-gel with a 0.5 Mn/Ti ratio. The denitrification efficiency using this catalyst was >90%, which was higher than those of catalysts prepared by the two other methods. The critical temperature of catalytic activity was 353 K. The optimum manganese acetate concentration and weathering time were 0.10 mol and 24 h, respectively. The gas hourly space velocity and O-2 concentration were determined to be 12000 h(-1) and 3%, respectively.	[Xing, Yi] Univ Sci & Technol Beijing, Key Lab Educ Minist High Efficient Min & Safety M, Beijing 100083, Peoples R China; [Xing, Yi; Hong, Chen; Cheng, Bei; Zhang, Kun] Univ Sci & Technol Beijing, Dept Environm Engn, Beijing 100083, Peoples R China	University of Science & Technology Beijing; University of Science & Technology Beijing	Xing, Y (corresponding author), Univ Sci & Technol Beijing, Key Lab Educ Minist High Efficient Min & Safety M, Beijing 100083, Peoples R China.	xingyiustb@163.com			Beijing Nova Program [Z111106054511043]	Beijing Nova Program(Beijing Municipal Science & Technology Commission)	The work was supported by Beijing Nova Program (No. Z111106054511043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMORES JMG, 1995, J MATER CHEM, V5, P1245, DOI 10.1039/jm9950501245; Craciun R, 2003, APPL CATAL A-GEN, V243, P67, DOI 10.1016/S0926-860X(02)00538-0; Djerad S, 2006, CATAL TODAY, V113, P208, DOI 10.1016/j.cattod.2005.11.067; Ettireddy PR, 2007, APPL CATAL B-ENVIRON, V76, P123, DOI 10.1016/j.apcatb.2007.05.010; Gao X, 2010, J HAZARD MATER, V174, P734, DOI 10.1016/j.jhazmat.2009.09.112; INOMATA M, 1982, IND ENG CHEM PROD RD, V21, P424, DOI 10.1021/i300007a014; Kim YJ, 2010, CATAL TODAY, V151, P244, DOI 10.1016/j.cattod.2010.02.074; Lei ZG, 2011, ENVIRON SCI TECHNOL, V45, P3437, DOI 10.1021/es104156j; Lindholm A, 2010, APPL CATAL B-ENVIRON, V98, P112, DOI 10.1016/j.apcatb.2010.05.019; Metkar PS, 2011, APPL CATAL B-ENVIRON, V104, P110, DOI 10.1016/j.apcatb.2011.02.022; Pena DA, 2004, J PHYS CHEM B, V108, P9927, DOI 10.1021/jp0313122; Pena DA, 2004, J CATAL, V221, P421, DOI 10.1016/j.jcat.2003.09.003; Qi GS, 2003, APPL CATAL B-ENVIRON, V44, P217, DOI 10.1016/S0926-3373(03)00100-0; Stanciulescu M, 2012, APPL CATAL B-ENVIRON, V123, P229, DOI 10.1016/j.apcatb.2012.04.012; Tang XL, 2007, CATAL COMMUN, V8, P329, DOI 10.1016/j.catcom.2006.06.025; Wu ZB, 2007, ENVIRON SCI TECHNOL, V41, P5812, DOI 10.1021/es0700350; Xie GY, 2004, J CATAL, V224, P36, DOI 10.1016/j.jcat.2004.02.015	17	2	2	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73237	10.1371/journal.pone.0073237	http://dx.doi.org/10.1371/journal.pone.0073237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023841	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600082
J	Chanakul, A; Zhang, MYH; Louw, A; Armbrecht, HJ; Miller, WL; Portale, AA; Perwad, F				Chanakul, Ankanee; Zhang, Martin Y. H.; Louw, Andrew; Armbrecht, Harvey J.; Miller, Walter L.; Portale, Anthony A.; Perwad, Farzana			FGF-23 Regulates CYP27B1 Transcription in the Kidney and in Extra-Renal Tissues	PLOS ONE			English	Article							25-HYDROXYVITAMIN D-3 1-ALPHA-HYDROXYLASE; VITAMIN-D 1-ALPHA-HYDROXYLASE; PARATHYROID-HORMONE; ALPHA-HYDROXYLASE; GENE-EXPRESSION; D METABOLISM; 1,25-DIHYDROXYVITAMIN-D3 PRODUCTION; HYPOPHOSPHATEMIC RICKETS; CARDIOVASCULAR FUNCTION; ALVEOLAR MACROPHAGES	The mitochondrial enzyme 25-hydroxyvitamin D 1 alpha-hydroxylase, which is encoded by the CYP27B1 gene, converts 25OHD to the biological active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D). Renal 1 alpha-hydroxylase activity is the principal determinant of the circulating 1,25(OH)2D concentration and enzyme activity is tightly regulated by several factors. Fibroblast growth factor-23 (FGF-23) decreases serum 1,25(OH)2D concentrations by suppressing CYP27B1 mRNA abundance in mice. In extra-renal tissues, 1 alpha-hydroxylase is responsible for local 1,25(OH)2D synthesis, which has important paracrine actions, but whether FGF-23 regulates CYP27B1 gene expression in extra-renal tissues is unknown. We sought to determine whether FGF-23 regulates CYP27B1 transcription in the kidney and whether extra-renal tissues are target sites for FGF-23-induced suppression of CYP27B1. In HEK293 cells transfected with the human CYP27B1 promoter, FGF-23 suppressed promoter activity by 70%, and the suppressive effect was blocked by CI-1040, a specific inhibitor of extracellular signal regulated kinase 1/2. To examine CYP27B1 transcriptional activity in vivo, we crossed fgf-23 null mice with mice bearing the CYP27B1 promoter-driven luciferase transgene (1 alpha-Luc). In the kidney of FGF-23 null/1 alpha-Luc mice, CYP27B1 promoter activity was increased by 3-fold compared to that in wild-type/1 alpha-Luc mice. Intraperitoneal injection of FGF-23 suppressed renal CYP27B1 promoter activity and protein expression by 26% and 60% respectively, and the suppressive effect was blocked by PD0325901, an ERK1/2 inhibitor. These findings provide evidence that FGF-23 suppresses CYP27B1 transcription in the kidney. Furthermore, we demonstrate that in FGF-23 null/1 alpha-Luc mice, CYP27B1 promoter activity and mRNA abundance are increased in several extra-renal sites. In the heart of FGF-23 null/1 alpha-Luc mice, CYP27B1 promoter activity and mRNA were 2- and 5-fold higher, respectively, than in control mice. We also observed a 3- to 10-fold increase in CYP27B1 mRNA abundance in the lung, spleen, aorta and testis of FGF-23 null/1 alpha-Luc mice. Thus, we have identified novel extra-renal target sites for FGF-23-mediated regulation of CYP27B1.	[Chanakul, Ankanee; Zhang, Martin Y. H.; Louw, Andrew; Miller, Walter L.; Portale, Anthony A.; Perwad, Farzana] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Armbrecht, Harvey J.] St Louis Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, St Louis, MO USA	University of California System; University of California San Francisco; Geriatric Research Education & Clinical Center	Perwad, F (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	perwadf@peds.ucsf.edu			National Institutes of Health [DK-073092]; Norman S. Coplon Grant, Satellite Health Care Inc; VA merit grant from the Department of Veterans Affairs; Department of Veterans Affairs; Pediatric Nephrology Innovative Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK073092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norman S. Coplon Grant, Satellite Health Care Inc; VA merit grant from the Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); Pediatric Nephrology Innovative Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK-073092 (to Farzana Perwad), Norman S. Coplon Grant, Satellite Health Care Inc (to Farzana Perwad) (http://www.satellitehealth.com/about_satellite/philanthropy/coplon_grants), a VA merit grant from the Department of Veterans Affairs (to Harvey J. Armbrecht), and the Pediatric Nephrology Innovative Research Fund (to Anthony A. Portale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided financial support for research technician, mice, lab supplies and the salary of the investigators.	ADAMS JS, 1983, J CLIN INVEST, V72, P1856, DOI 10.1172/JCI111147; Anderson PH, 2008, MOL CELL ENDOCRINOL, V285, P1, DOI 10.1016/j.mce.2007.12.018; Armbrecht HJ, 2007, J STEROID BIOCHEM, V103, P330, DOI 10.1016/j.jsbmb.2006.12.035; Armbrecht HJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P298, DOI 10.1016/S0003-9861(02)00636-7; ARMBRECHT JH, 1992, J STEROID BIOCHEM, V43, P1073, DOI 10.1016/0960-0760(92)90334-F; Bai XY, 2003, J BIOL CHEM, V278, P9843, DOI 10.1074/jbc.M210490200; Bajwa A, 2008, ARCH BIOCHEM BIOPHYS, V477, P33, DOI 10.1016/j.abb.2008.06.006; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Bikle DD, 2010, J BONE MINER METAB, V28, P117, DOI 10.1007/s00774-009-0153-8; BIKLE DD, 1986, J CLIN INVEST, V78, P557, DOI 10.1172/JCI112609; BRUNETTE MG, 1978, NATURE, V276, P287, DOI 10.1038/276287a0; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Chen S, 2008, HYPERTENSION, V52, P1106, DOI 10.1161/HYPERTENSIONAHA.108.119602; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Ebert R, 2004, MOL ENDOCRINOL, V18, P2440, DOI 10.1210/me.2002-0441; Farrow EG, 2009, J AM SOC NEPHROL, V20, P955, DOI 10.1681/ASN.2008070783; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Feldman David, 1996, P205; FRASER DR, 1970, NATURE, V228, P764, DOI 10.1038/228764a0; Fu GK, 1997, DNA CELL BIOL, V16, P1499, DOI 10.1089/dna.1997.16.1499; Fu GK, 1997, MOL ENDOCRINOL, V11, P1961, DOI 10.1210/me.11.13.1961; Gao XH, 2002, INT J BIOCHEM CELL B, V34, P921, DOI 10.1016/S1357-2725(01)00165-0; GRAY R, 1971, SCIENCE, V172, P1232, DOI 10.1126/science.172.3989.1232; GRAY RW, 1972, J BIOL CHEM, V247, P7528; GRAY RW, 1974, J CLIN ENDOCR METAB, V39, P1045, DOI 10.1210/jcem-39-6-1045; Hendrix I, 2005, J MOL ENDOCRINOL, V34, P237, DOI 10.1677/jme.1.01654; Hendrix I, 2004, J STEROID BIOCHEM, V89-90, P139, DOI 10.1016/j.jsbmb.2004.03.093; HOWARD GA, 1981, J BIOL CHEM, V256, P7738; Jensen MB, 2012, REPRODUCTION, V144, P135, DOI 10.1530/REP-12-0064; KAWASHIMA H, 1981, P NATL ACAD SCI-BIOL, V78, P1199, DOI 10.1073/pnas.78.2.1199; Kim CJ, 2007, J CLIN ENDOCR METAB, V92, P3177, DOI 10.1210/jc.2006-2664; Kong XF, 1999, P NATL ACAD SCI USA, V96, P6988, DOI 10.1073/pnas.96.12.6988; Krajisnik T, 2007, J ENDOCRINOL, V195, P125, DOI 10.1677/JOE-07-0267; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; MASON RS, 1984, ANN INTERN MED, V100, P59, DOI 10.7326/0003-4819-100-1-59; Monkawa T, 1997, BIOCHEM BIOPH RES CO, V239, P527, DOI 10.1006/bbrc.1997.7508; Morris Howard A, 2010, Clin Biochem Rev, V31, P129; Murayama A, 1998, BIOCHEM BIOPH RES CO, V249, P11, DOI 10.1006/bbrc.1998.9098; Nibbelink KA, 2007, J STEROID BIOCHEM, V103, P533, DOI 10.1016/j.jsbmb.2006.12.099; OConnell TD, 1997, AM J PHYSIOL-HEART C, V272, pH1751; PAULSON SK, 1985, J BIOL CHEM, V260, P1488; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Portale AA, 2012, PEDIATRIC BONE: BIOLOGY & DISEASES, 2ND EDITION, P679, DOI 10.1016/B978-0-12-382040-2.10025-5; Ranch D, 2011, J BONE MINER RES, V26, P1883, DOI 10.1002/jbmr.401; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; REICHEL H, 1987, J CLIN ENDOCR METAB, V65, P1201, DOI 10.1210/jcem-65-6-1201; Ritter CS, 2006, KIDNEY INT, V70, P654, DOI 10.1038/sj.ki.5000394; Ritter CS, 2012, J STEROID BIOCHEM, V130, P73, DOI 10.1016/j.jsbmb.2012.01.010; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shinki T, 1997, P NATL ACAD SCI USA, V94, P12920, DOI 10.1073/pnas.94.24.12920; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; StArnaud R, 1997, J BONE MINER RES, V12, P1552, DOI 10.1359/jbmr.1997.12.10.1552; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Turunen MM, 2007, NUCLEIC ACIDS RES, V35, P2734, DOI 10.1093/nar/gkm179; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Wang JT, 1998, AM J HUM GENET, V63, P1694, DOI 10.1086/302156; Wang XM, 2002, J CLIN ENDOCR METAB, V87, P2424, DOI 10.1210/jc.87.6.2424; WEISHAAR RE, 1990, AM J PHYSIOL, V258, pE134, DOI 10.1152/ajpendo.1990.258.1.E134; WEISHAAR RE, 1987, J CLIN INVEST, V79, P1706, DOI 10.1172/JCI113010; Xie ZJ, 2002, J BIOL CHEM, V277, P36987, DOI 10.1074/jbc.M201404200; Zhang MYH, 2012, ENDOCRINOLOGY, V153, P1806, DOI 10.1210/en.2011-1831; Zhang MYH, 2002, ENDOCRINOLOGY, V143, P587, DOI 10.1210/en.143.2.587; Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101	73	45	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72816	10.1371/journal.pone.0072816	http://dx.doi.org/10.1371/journal.pone.0072816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019880	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200022
J	Gao, RM; Wong, SM				Gao, Ruimin; Wong, Sek-Man			Basic Amino Acid Mutations in the Nuclear Localization Signal of Hibiscus Chlorotic Ringspot Virus p23 Inhibit Virus Long Distance Movement	PLOS ONE			English	Article							TURNIP-CRINKLE-VIRUS; OPEN READING FRAMES; NUCLEOTIDE-SEQUENCE; GENOME ORGANIZATION; AGROBACTERIUM-TUMEFACIENS; GENUS CARMOVIRUS; CANNABINUS L.; MOTTLE VIRUS; RNA; EXPRESSION	The p23 is a unique protein in the Hibiscus chlorotic ringspot virus which belongs to Family Tombusviridae Genus Carmovirus. Our previous results showed that the p23 is indispensable for host-specific replication and is localized in the nucleus with a novel nuclear localization signal. To investigate additional function(s) of p23, mutations of basic amino acids lysine (K), arginine (R) and histidine (H) that abolish its nuclear localization, were introduced into a biologically active full-length cDNA clone p223 of HCRSV for testing its effects on virus replication and virus movement in vivo. Primer-specific reverse transcription-PCR was conducted to detect gene transcript level of p23 and viral coat protein separately. Virus replication and its coat protein expression were detected by fluorescent in situ hybridization and Western blot, respectively. The effect of p23 was further confirmed by using artificial microRNA inoculation-mediated silencing. Results showed that the two mutants were able to replicate in protoplasts but unable to move from inoculated leaves to newly emerged leaves. Both the p23 and the CP genes of HCRSV were detected in the newly emerged leaves of infected plants but CP was not detected by Western blot and no symptom was observed on those leaves at 19 days post inoculation. This study demonstrates that when p23 is prevented from entering the nucleus, it results in restriction of virus long distance movement which in turn abrogates symptom expression in the newly emerged leaves. We conclude that the p23 protein of HCRSV is required for virus long distance movement.	[Gao, Ruimin; Wong, Sek-Man] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Wong, Sek-Man] Temasek Life Sci Lab, Singapore, Singapore; [Wong, Sek-Man] Natl Univ Singapore, Suzhou Res Inst, Suzhou Ind Pk, Jiangsu, Peoples R China	National University of Singapore; National University of Singapore	Wong, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswsm@nus.edu.sg			National University of Singapore [R-154-000-552-112]	National University of Singapore(National University of Singapore)	This work was supported by the National University of Singapore research grant R-154-000-552-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr J, 2010, J GEN VIROL, V91, P1373, DOI 10.1099/vir.0.020818-0; Berthome R, 1998, ARCH VIROL, V143, P1823, DOI 10.1007/s007050050420; CARRINGTON JC, 1989, VIROLOGY, V170, P219, DOI 10.1016/0042-6822(89)90369-3; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Gao RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048736; Gao RM, 2012, MOL PLANT MICROBE IN, V25, P1574, DOI 10.1094/MPMI-08-12-0203-R; GUILLEY H, 1985, NUCLEIC ACIDS RES, V13, P6663, DOI 10.1093/nar/13.18.6663; HACKER DL, 1992, VIROLOGY, V186, P1, DOI 10.1016/0042-6822(92)90055-T; Huang M, 2000, J VIROL, V74, P3149, DOI 10.1128/JVI.74.7.3149-3155.2000; Kojima M, 2004, J BIOSCI BIOENG, V98, P136, DOI 10.1016/S1389-1723(04)70256-X; Kojima M, 2000, BIOSCI BIOTECH BIOCH, V64, P845, DOI 10.1271/bbb.64.845; Li VZ, 1998, VIROLOGY, V244, P405, DOI 10.1006/viro.1998.9125; Liang XZ, 2002, PLANT CELL REP, V20, P982, DOI 10.1007/s00299-002-0435-2; Liang XZ, 2002, J VIROL, V76, P12312, DOI 10.1128/JVI.76.23.12312-12319.2002; Meng CY, 2008, J GEN VIROL, V89, P2349, DOI 10.1099/vir.0.2008/002170-0; Rajendran KS, 2002, J VIROL, V76, P1707, DOI 10.1128/JVI.76.4.1707-1717.2002; RIVIERE CJ, 1990, J GEN VIROL, V71, P1887, DOI 10.1099/0022-1317-71-9-1887; Weng ZM, 1997, J GEN VIROL, V78, P525, DOI 10.1099/0022-1317-78-3-525; WHITE KA, 1995, VIROLOGY, V211, P525, DOI 10.1006/viro.1995.1434; YOU XJ, 1995, J GEN VIROL, V76, P2841, DOI 10.1099/0022-1317-76-11-2841; Zenklusen D, 2010, METHOD ENZYMOL, V470, P641, DOI 10.1016/S0076-6879(10)70026-4; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhou T, 2006, MOL PLANT MICROBE IN, V19, P948, DOI 10.1094/MPMI-19-0948	23	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74000	10.1371/journal.pone.0074000	http://dx.doi.org/10.1371/journal.pone.0074000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019944	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200087
J	Marras, S; Killen, SS; Domenici, P; Claireaux, G; McKenzie, DJ				Marras, Stefano; Killen, Shaun S.; Domenici, Paolo; Claireaux, Guy; McKenzie, David J.			Relationships among Traits of Aerobic and Anaerobic Swimming Performance in Individual European Sea Bass Dicentrarchus labrax	PLOS ONE			English	Article							RAINBOW-TROUT; LOCOMOTOR PERFORMANCE; SMALLMOUTH BASS; ESCAPE RESPONSE; WHITE MUSCLE; QUANTITATIVE GENETICS; ACTIVITY METABOLISM; LACERTID LIZARDS; GARTER SNAKES; TELEOST FISH	Teleost fishes exhibit wide and temporally stable inter-individual variation in a suite of aerobic and anaerobic locomotor traits. One mechanism that could allow such variation to persist within populations is the presence of tradeoffs between aerobic and anaerobic performance, such that individuals with a high capacity for one type of performance have a reduced capacity for the other. We investigated this possibility in European seabass Dicentrarchus labrax, each measured for a battery of indicators of maximum locomotor performance. Aerobic traits comprised active metabolic rate, aerobic scope for activity, maximum aerobic swimming speed, and stride length, using a constant acceleration test. Anaerobic traits comprised maximum speed during an escape response, maximum sprint speed, and maximum anaerobic burst speed during constant acceleration. The data provided evidence of significant variation in performance among individuals, but there was no evidence of any trade-offs among any traits of aerobic versus anaerobic swimming performance. Furthermore, the anaerobic traits were not correlated significantly among each other, despite relying on the same muscular structures. Thus, the variation observed may reflect trade-offs with other morphological, physiological or behavioural traits.	[Marras, Stefano; Killen, Shaun S.; McKenzie, David J.] Univ Montpellier 2, UMR5554, Inst Sci Evolut Montpellier, Montpellier, France; [Domenici, Paolo] IAMC CNR, Torregrande, Oristano, Italy; [Claireaux, Guy] Univ Bretagne Occidentale, LEMAR UMR6539, PFOM ARN, Ctr Ifremer Brest, Plouzane, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Marras, S (corresponding author), IAMC CNR, Torregrande, Oristano, Italy.	stefano.marras@iamc.cnr.it	Domenici, Paolo/F-6958-2010; McKenzie, David J./K-3090-2012; McKenzie, David/AAA-5179-2021; Marras, Stefano/AAX-6549-2020	McKenzie, David J./0000-0003-0961-9101; McKenzie, David/0000-0003-0961-9101; Marras, Stefano/0000-0002-8386-7608; Killen, Shaun/0000-0003-4949-3988	Centre National de la Recherche Scientifique (CNRS); Universite Montpellier 2; Regione Autonoma della Sardegna (Italy); European Commission; Natural Sciences and Engineering Research Council of Canada; Davies Charitable Foundation	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Montpellier 2; Regione Autonoma della Sardegna (Italy)(Regione Sardegna); European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Davies Charitable Foundation	This research was supported by the Centre National de la Recherche Scientifique (CNRS) and the Universite Montpellier 2. SM was supported by a doctoral fellowship from the Regione Autonoma della Sardegna (Italy) and the European Commission. SSK was supported by post-doctoral research grants from the Natural Sciences and Engineering Research Council of Canada and the Davies Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SJ, 1988, BIOL J LINN SOC, V34, P175, DOI 10.1111/j.1095-8312.1988.tb01955.x; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; Becker W. A, 1984, MANUAL QUANTITATIVE; Bell W.H., 1970, J FISHERIES RES BOAR; Bennett A.F., 1987, P147; BENNETT AF, 1980, ANIM BEHAV, V28, P752, DOI 10.1016/S0003-3472(80)80135-7; BENNETT AF, 1989, AM J PHYSIOL, V256, pR1200, DOI 10.1152/ajpregu.1989.256.6.R1200; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; Blumstein DT, 2010, J EVOLUTION BIOL, V23, P879, DOI 10.1111/j.1420-9101.2010.01967.x; BOOTH RK, 1995, CAN J FISH AQUAT SCI, V52, P283, DOI 10.1139/f95-029; Chatelier A, 2006, J EXP BIOL, V209, P3429, DOI 10.1242/jeb.02347; Claireaux G, 2005, J EXP BIOL, V208, P1775, DOI 10.1242/jeb.01587; Claireaux G, 2007, PHYSIOL BIOCHEM ZOOL, V80, P186, DOI 10.1086/511143; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Dohm MR, 1996, EVOLUTION, V50, P1688, DOI 10.1111/j.1558-5646.1996.tb03940.x; Domenici P, 1997, J EXP BIOL, V200, P1165; Domenici P, 2003, EXPTL BIOL REV, P137; EATON RC, 1991, J EXP BIOL, V161, P469; Farrell AP, 2008, J FISH BIOL, V72, P693, DOI 10.1111/j.1095-8649.2007.01759.x; Farrell AP, 2007, PHILOS T R SOC B, V362, P2017, DOI 10.1098/rstb.2007.2111; FORD NB, 1986, COPEIA, P999, DOI 10.2307/1445298; GARLAND T, 1988, EVOLUTION, V42, P335, DOI 10.1111/j.1558-5646.1988.tb04137.x; GARLAND T, 1987, AM J PHYSIOL, V252, pR439, DOI 10.1152/ajpregu.1987.252.3.R439; GREERWALKER M, 1975, J FISH BIOL, V7, P295, DOI 10.1111/j.1095-8649.1975.tb04602.x; HUEY RB, 1990, PHYSIOL ZOOL, V63, P845, DOI 10.1086/physzool.63.5.30152617; HUEY RB, 1984, ANIM BEHAV, V32, P41, DOI 10.1016/S0003-3472(84)80322-X; HUNTER JR, 1971, FISH BULL NATL OC AT, V69, P253; JAYNE BC, 1990, EVOLUTION, V44, P1204, DOI 10.1111/j.1558-5646.1990.tb05226.x; Killen SS, 2012, FUNCT ECOL, V26, P134, DOI 10.1111/j.1365-2435.2011.01920.x; Killen SS, 2011, J ANIM ECOL, V80, P1024, DOI 10.1111/j.1365-2656.2011.01844.x; Komi P V, 1984, Exerc Sport Sci Rev, V12, P81; Lee CG, 2003, J EXP BIOL, V206, P3253, DOI 10.1242/jeb.00548; Lefrancois C, 2006, MAR BIOL, V149, P969, DOI 10.1007/s00227-006-0261-0; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Marras S, 2010, J EXP BIOL, V213, P26, DOI 10.1242/jeb.032136; Marras S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065784; Marras S, 2011, J EXP BIOL, V214, P3102, DOI 10.1242/jeb.056648; McFarlane WJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P250, DOI 10.1086/341815; McKenzie DJ, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1636; McKenzie D.J., 2010, P296, DOI 10.1201/b10190-11; McKenzie DJ, 2007, AQUACULTURE, V263, P280, DOI 10.1016/j.aquaculture.2006.10.022; MCLAUGHLIN RL, 1991, ENVIRON BIOL FISH, V30, P369, DOI 10.1007/BF02027980; MEYERROCHOW VB, 1993, P ROY SOC B-BIOL SCI, V252, P85, DOI 10.1098/rspb.1993.0050; Nelson JA, 2005, T AM FISH SOC, V134, P1274, DOI 10.1577/T04-087.1; Oufiero CE, 2009, FUNCT ECOL, V23, P969, DOI 10.1111/j.1365-2435.2009.01571.x; Peake S, 2004, T AM FISH SOC, V133, P1472, DOI 10.1577/T03-202.1; Peake SJ, 2006, J FISH BIOL, V68, P1742, DOI 10.1111/j.0022-1112.2006.01052.x; Peake SJ, 2004, J EXP BIOL, V207, P1563, DOI 10.1242/jeb.00927; Pickett G., 1994, SEA BASS BIOL EXPLOI; Pinch FC, 2003, J HERPETOL, V37, P671, DOI 10.1670/183-02; Prenter J, 2012, ANIM BEHAV, V83, P1195, DOI 10.1016/j.anbehav.2012.02.010; QUIGNARD JP, 1984, MANAGEMENT COASTAL L, P3; Randall, 1978, FISH PHYSIOL, P361; Reidy SP, 2000, J EXP BIOL, V203, P347; ROME LC, 1988, NATURE, V335, P824, DOI 10.1038/335824a0; ROME LC, 1993, SCIENCE, V261, P340, DOI 10.1126/science.8332898; Seebacher F, 2012, J EXP BIOL, V215, P663, DOI 10.1242/jeb.066712; SORCI G, 1995, PHYSIOL ZOOL, V68, P698, DOI 10.1086/physzool.68.4.30166352; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; Vandamm JP, 2012, PHYSIOL BIOCHEM ZOOL, V85, P704, DOI 10.1086/666463; Vanhooydonck B, 2001, EVOLUTION, V55, P1040, DOI 10.1554/0014-3820(2001)055[1040:SASTOI]2.0.CO;2; Videler J.J., 1991, Reviews in Fish Biology and Fisheries, V1, P23, DOI 10.1007/BF00042660; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; WANG YX, 1994, J EXP BIOL, V195, P227; Webb Paul W., 1998, P3; WEBB PW, 1978, J EXP BIOL, V74, P211; WEIHS D, 1973, Biorheology, V10, P343; Wilson RS, 2002, J EXP BIOL, V205, P1145	68	36	37	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72815	10.1371/journal.pone.0072815	http://dx.doi.org/10.1371/journal.pone.0072815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019879	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200021
J	Millen, SH; Schneider, OD; Miller, WE; Monaco, JJ; Weiss, AA				Millen, Scott H.; Schneider, Olivia D.; Miller, William E.; Monaco, John J.; Weiss, Alison A.			Pertussis Toxin B-Pentamer Mediates Intercellular Transfer of Membrane Proteins and Lipids	PLOS ONE			English	Article							CELL ANTIGEN RECEPTOR; WHEAT-GERM-AGGLUTININ; T-CELLS; IMMUNE-RESPONSES; MAMMALIAN-CELLS; IL-2 PRODUCTION; IDENTIFICATION; REQUIREMENT; MECHANISMS; INDUCTION	Pertussis toxin (PTx) is the major virulence factor of Bordetella pertussis. The enzymatic or active (A) subunit inactivates host G protein coupled receptor (GPCR) signaling pathways. The non-enzymatic binding (B) subunit also mediates biological effects due to lectin-like binding characteristics, including the induction of T cell receptor (TCR) signaling and subsequent down-regulation of chemokine receptor expression. Here we report another activity attributable to PTxB, facilitating transfer of membrane material between mammalian cells. This activity does not require the TCR, and does not require cell-to-cell contact or cellular aggregation. Rather, membrane vesicles are transferred from donor to recipient cells in a toxin-dependent fashion. Membrane transfer occurs in different cell types, including cultured human T cells, CHO cells, and human primary peripheral blood mononuclear cells. Transfer involves both lipid and integral membrane proteins, as evidenced by the transfer of T and B cell-specific receptor molecules to other PBMCs. Interestingly, membrane transfer activity is a property that PTx shares with some, but not all, cell-aggregating lectins that are mitogenic for human T cells, and appears to be related to the ability to bind certain host cell glycolipids. This phenomenon may represent another mechanism by which pertussis toxin disrupts mammalian intra-and inter-cellular signaling.	[Millen, Scott H.; Schneider, Olivia D.; Miller, William E.; Monaco, John J.; Weiss, Alison A.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Monaco, JJ (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	John.Monaco@uc.edu		Weiss, Alison/0000-0002-4726-8376; Millen, Scott/0000-0001-5072-6844; Miller, William/0000-0001-6900-4884	National Institutes of Health (NIH) [R56 AI023695]; University of Cincinnati; NIH [T32 AI055406]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055406, R56AI023695] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant R56 AI023695 to AAW, WEM and JJM and by start-up funds from the University of Cincinnati to WEM. ODS and SHM were supported by an NIH training grant, T32 AI055406. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro MG, 2001, CELL MICROBIOL, V3, P45, DOI 10.1046/j.1462-5822.2001.00092.x; Dong ZM, 1999, INFECT IMMUN, V67, P220, DOI 10.1128/IAI.67.1.220-229.1999; HEERZE LD, 1992, J BIOL CHEM, V267, P25810; HEWLETT EL, 1983, INFECT IMMUN, V40, P1198, DOI 10.1128/IAI.40.3.1198-1203.1983; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; KATADA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P290, DOI 10.1016/0003-9861(83)90212-6; Li H, 2000, IMMUNOLOGY, V100, P502, DOI 10.1046/j.1365-2567.2000.00064.x; Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z; Millen SH, 2004, INFECT IMMUN, V72, P615, DOI 10.1128/IAI.72.1.615-620.2004; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; MONSIGNY M, 1979, EUR J BIOCHEM, V98, P39, DOI 10.1111/j.1432-1033.1979.tb13157.x; MUNOZ JJ, 1981, INFECT IMMUN, V33, P820, DOI 10.1128/IAI.33.3.820-826.1981; Munoz JJ, 1985, PERTUSSIS TOXIN, P1; NENCIONI L, 1991, INFECT IMMUN, V59, P4732, DOI 10.1128/IAI.59.12.4732-4734.1991; Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Schneider OD, 2007, INFECT IMMUN, V75, P4040, DOI 10.1128/IAI.00414-07; Schneider OD, 2012, BIOCHEMISTRY-US, V51, P4126, DOI 10.1021/bi3002693; Smyth LA, 2013, EUR J IMMUNOL, V43, P2430, DOI 10.1002/eji.201242909; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; WEISS A, 1984, J IMMUNOL, V133, P123; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Yang CJ, 2012, EUR J IMMUNOL, V42, P1778, DOI 10.1002/eji.201141978; Zocchi MR, 2005, J IMMUNOL, V174, P6054, DOI 10.4049/jimmunol.174.10.6054	29	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72885	10.1371/journal.pone.0072885	http://dx.doi.org/10.1371/journal.pone.0072885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019885	gold, Green Published, Green Submitted			2022-12-27	WOS:000324338200027
J	Wierda, SM; Taatgen, NA; van Rijn, H; Martens, S				Wierda, Stefan M.; Taatgen, Niels A.; van Rijn, Hedderik; Martens, Sander			Word Frequency and the Attentional Blink: The Effects of Target Difficulty on Retrieval and Consolidation Processes	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; TEMPORAL ATTENTION; T1 DIFFICULTY; P300; TASK; SUPPRESSION; TIME	Background: When a second target (T2) is presented in close succession of a first target (T1) within a stream of non-targets, people often fail to detect T2-a deficit known as the attentional blink (AB). Two types of theories can be distinguished that have tried to account for this phenomenon. Whereas attentional-control theories suggest that protection of consolidation processes induces the AB, limited-resource theories claim that the AB is caused by a lack of resources. According to the latter type of theories, increasing difficulty of one or both targets should increase the magnitude of the AB. Similarly, attentional-control theories predict that a difficult T1 increases the AB due to prolonged processing. However, the prediction for T2 is not as straightforward. Prolonged processing of T2 could cause conflicts and increase the AB. However, if consolidation of T2 is postponed without loss of identity, the AB might be attenuated. Methodology/Principal Findings: Participants performed an AB task that consisted of a stream of distractor non-words and two target words. Difficulty of T1 and T2 was manipulated by varying word-frequency. Overall performance for high-frequency words was better than for low-frequency words. When T1 was highly frequent, the AB was reduced. The opposite effect was found for T2. When T2 was highly frequent, performance during the AB period was relatively worse than for a low-frequency T2. A threaded-cognition model of the AB was presented that simulated the observed pattern of behavior by taking changes in the time-course of retrieval and consolidation processes into account. Our results were replicated in a subsequent ERP study. Conclusions/Significance: The finding that a difficult low-frequency T2 reduces the magnitude of the AB is at odds with limited-resource accounts of the AB. However, it was successfully accounted for by the threaded-cognition model, thus providing an explanation in terms of attentional control.	[Wierda, Stefan M.; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Wierda, Stefan M.; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Taatgen, Niels A.] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [van Rijn, Hedderik] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Wierda, SM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands.	s.m.wierda@med.umcg.nl	van Rijn, Hedderik/L-3685-2014; Taatgen, Niels/A-3216-2008	van Rijn, Hedderik/0000-0002-0461-9850; Martens, Sander/0000-0001-8237-7984; Taatgen, Niels/0000-0001-7286-3460	Behavioural and Cognitive Neurosciences (BCN) Research School	Behavioural and Cognitive Neurosciences (BCN) Research School	This research was supported by a grant of the Behavioural and Cognitive Neurosciences (BCN) Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 2007, CAN HUMAN MIND OCCUR; Baayen R. H., 1993, CELEX LEXICAL DATABA; Bates D, 2008, LME4 LINEAR MIXED EF; Burt JS, 2011, ATTEN PERCEPT PSYCHO, V73, P751, DOI 10.3758/s13414-010-0054-x; Christmann C, 2004, Q J EXP PSYCHOL-A, V57, P357, DOI 10.1080/02724980343000350; Chua FK, 2005, PERCEPT PSYCHOPHYS, V67, P770, DOI 10.3758/BF03193532; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Frisch S, 2003, CLIN NEUROPHYSIOL, V114, P336, DOI 10.1016/S1388-2457(02)00366-8; ISREAL JB, 1980, HUM FACTORS, V22, P211, DOI 10.1177/001872088002200210; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Koelewijn T, 2008, PERCEPT PSYCHOPHYS, V70, P658, DOI 10.3758/PP.70.4.658; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kranczioch C, 2005, NEUROIMAGE, V24, P704, DOI 10.1016/j.neuroimage.2004.09.024; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Kranczioch C, 2011, NEUROREPORT, V22, P161, DOI 10.1097/WNR.0b013e3283438b76; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Martens S, 2002, J EXP PSYCHOL HUMAN, V28, P1275, DOI 10.1037//0096-1523.28.6.1275; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; McArthur G, 1999, NEUROREPORT, V10, P3691, DOI 10.1097/00001756-199911260-00042; McLaughlin EN, 2001, Q J EXP PSYCHOL-A, V54, P169, DOI 10.1080/02724980042000075; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nieuwenstein MR, 2009, J EXP PSYCHOL HUMAN, V35, P159, DOI 10.1037/0096-1523.35.1.159; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Ouimet C, 2007, VIS COGN, V15, P290, DOI 10.1080/13506280600693741; POLICH J, 1988, ELECTROEN CLIN NEURO, V70, P33, DOI 10.1016/0013-4694(88)90192-7; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Potter MC, 2010, J EXP PSYCHOL HUMAN, V36, P1486, DOI 10.1037/a0018730; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rolke B, 2001, PSYCHOPHYSIOLOGY, V38, P165, DOI 10.1017/S0048577201991504; Shapiro K, 1997, PSYCHOL SCI, V8, P95, DOI 10.1111/j.1467-9280.1997.tb00689.x; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; van Rijn H., 2003, P 5 INT C COGN MOD, P207; Visser TAW, 2007, CAN J EXP PSYCHOL, V61, P102, DOI 10.1037/cjep2007011; Visser TAW, 2007, J EXP PSYCHOL HUMAN, V33, P285, DOI 10.1037/0096-1523.33.2.285; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vogel EK, 2002, PSYCHON B REV, V9, P739, DOI 10.3758/BF03196329; Ward R, 1997, PERCEPT PSYCHOPHYS, V59, P593, DOI 10.3758/BF03211867; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wierda SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015024; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902	48	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73415	10.1371/journal.pone.0073415	http://dx.doi.org/10.1371/journal.pone.0073415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24019921	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200063
J	Black, AJ; Ross, JV				Black, Andrew J.; Ross, Joshua V.			Estimating a Markovian Epidemic Model Using Household Serial Interval Data from the Early Phase of an Epidemic	PLOS ONE			English	Article							INFLUENZA-A H1N1; PANDEMIC INFLUENZA; GENERATION TIMES; TRANSMISSION; DISEASE; STRATEGIES; PARAMETERS; VIRUS	The clinical serial interval of an infectious disease is the time between date of symptom onset in an index case and the date of symptom onset in one of its secondary cases. It is a quantity which is commonly collected during a pandemic and is of fundamental importance to public health policy and mathematical modelling. In this paper we present a novel method for calculating the serial interval distribution for a Markovian model of household transmission dynamics. This allows the use of Bayesian MCMC methods, with explicit evaluation of the likelihood, to fit to serial interval data and infer parameters of the underlying model. We use simulated and real data to verify the accuracy of our methodology and illustrate the importance of accounting for household size. The output of our approach can be used to produce posterior distributions of population level epidemic characteristics.	[Black, Andrew J.; Ross, Joshua V.] Univ Adelaide, Sch Math Sci, Adelaide, SA, Australia	University of Adelaide	Ross, JV (corresponding author), Univ Adelaide, Sch Math Sci, Adelaide, SA, Australia.	joshua.ross@adelaide.edu.au		Ross, Joshua/0000-0002-9918-8167	Australian Research Council's Discovery Projects funding scheme [DP110102893]	Australian Research Council's Discovery Projects funding scheme(Australian Research Council)	This work was supported under the Australian Research Council's Discovery Projects funding scheme (project number DP110102893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Ball F, 1997, ANN APPL PROBAB, V7, P46; Black AJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1019; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Epistruct, 2013, MATLAB ROUT EP MOD I; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Griffin JT, 2011, BIOSTATISTICS, V12, P303, DOI 10.1093/biostatistics/kxq058; House T, 2011, P ROY SOC B-BIOL SCI, V278, P2753, DOI 10.1098/rspb.2010.2688; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lipsitch M, 2012, EPIDEMIOLOGY, V23, P510, DOI 10.1097/EDE.0b013e31824f2f32; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599; Pitzer VE, 2012, EPIDEMIOLOGY, V23, P520, DOI 10.1097/EDE.0b013e31825902ab; Ross JV, 2011, J THEOR BIOL, V289, P83, DOI 10.1016/j.jtbi.2011.08.035; Ross JV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009666; Sidje RB, 1998, ACM T MATH SOFTWARE, V24, P130, DOI 10.1145/285861.285868; Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010; Tomba GS, 2010, MATH BIOSCI, V223, P24, DOI 10.1016/j.mbs.2009.10.004; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174	31	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73420	10.1371/journal.pone.0073420	http://dx.doi.org/10.1371/journal.pone.0073420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023679	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200076
J	Eaton, SL; Roche, SL; Hurtado, ML; Oldknow, KJ; Farquharson, C; Gillingwater, TH; Wishart, TM				Eaton, Samantha L.; Roche, Sarah L.; Hurtado, Maica Llavero; Oldknow, Karla J.; Farquharson, Colin; Gillingwater, Thomas H.; Wishart, Thomas M.			Total Protein Analysis as a Reliable Loading Control for Quantitative Fluorescent Western Blotting	PLOS ONE			English	Article							MOUSE MODELS; PATHOLOGY	Western blotting has been a key technique for determining the relative expression of proteins within complex biological samples since the first publications in 1979. Recent developments in sensitive fluorescent labels, with truly quantifiable linear ranges and greater limits of detection, have allowed biologists to probe tissue specific pathways and processes with higher resolution than ever before. However, the application of quantitative Western blotting (QWB) to a range of healthy tissues and those from degenerative models has highlighted a problem with significant consequences for quantitative protein analysis: how can researchers conduct comparative expression analyses when many of the commonly used reference proteins (e.g. loading controls) are differentially expressed? Here we demonstrate that common controls, including actin and tubulin, are differentially expressed in tissues from a wide range of animal models of neurodegeneration. We highlight the prevalence of such alterations through examination of published "-omics'' data, and demonstrate similar responses in sensitive QWB experiments. For example, QWB analysis of spinal cord from a murine model of Spinal Muscular Atrophy using an Odyssey scanner revealed that beta-actin expression was decreased by 19.3 +/- 2% compared to healthy littermate controls. Thus, normalising QWB data to beta-actin in these circumstances could result in 'skewing' of all data by similar to 20%. We further demonstrate that differential expression of commonly used loading controls was not restricted to the nervous system, but was also detectable across multiple tissues, including bone, fat and internal organs. Moreover, expression of these "control'' proteins was not consistent between different portions of the same tissue, highlighting the importance of careful and consistent tissue sampling for QWB experiments. Finally, having illustrated the problem of selecting appropriate single protein loading controls, we demonstrate that normalisation using total protein analysis on samples run in parallel with stains such as Coomassie blue provides a more robust approach.	[Eaton, Samantha L.; Hurtado, Maica Llavero; Wishart, Thomas M.] Univ Edinburgh, Roslin Inst, Div Neurobiol, Edinburgh, Midlothian, Scotland; [Eaton, Samantha L.; Hurtado, Maica Llavero; Oldknow, Karla J.; Farquharson, Colin; Wishart, Thomas M.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Roche, Sarah L.; Gillingwater, Thomas H.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Oldknow, Karla J.; Farquharson, Colin] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Gillingwater, Thomas H.; Wishart, Thomas M.] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Wishart, TM (corresponding author), Univ Edinburgh, Roslin Inst, Div Neurobiol, Edinburgh, Midlothian, Scotland.	T.M.Wishart@Roslin.ed.ac.uk	Suchacki, Karla Jade/AAA-4267-2021; farquharson, colin/C-2956-2011	Suchacki, Karla Jade/0000-0002-4688-4126; farquharson, colin/0000-0002-4970-4039; Gillingwater, Thomas/0000-0002-0306-5577; wishart, thomas/0000-0002-1973-6654	Biotechnology and Biological Sciences Research Council (BBSRC) UK through a studentship award (CJO); BBSRC; SMA Trust; Muscular Dystrophy Campaign; BBSRC [BBS/E/D/20251967, BBS/E/D/20251968, BBS/E/D/20251969] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251968, BBS/E/D/20251967, BBS/E/D/20251969, 1097988] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) UK through a studentship award (CJO)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SMA Trust; Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work in the authors' laboratories has been supported by grant funding from the Biotechnology and Biological Sciences Research Council (BBSRC) UK through a studentship award (CJO) and Institute Strategic Programme Grant Funding from the BBSRC (CF & TMW) and the SMA Trust and Muscular Dystrophy Campaign (TG & SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Castano Z., 2008, OPEN NEUROSCI J, V2, P36, DOI DOI 10.2174/1874082000802010036; Comley LH, 2011, HUM MOL GENET, V20, P2406, DOI 10.1093/hmg/ddr147; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Flynn JM, 2012, FREE RADICAL BIO MED, V53, P1048, DOI 10.1016/j.freeradbiomed.2012.07.004; Gebhardt FM, 2010, ALZHEIMERS DEMENT, V6, P465, DOI 10.1016/j.jalz.2009.11.002; Gingrich JC, 2000, BIOTECHNIQUES, V29, P636, DOI 10.2144/00293pf02; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Martins-de-Souza D, 2012, J PROTEOME RES, V11, P2533, DOI 10.1021/pr2012279; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Silva DNE, 2010, ACTA CIR BRAS, V25, P158, DOI 10.1590/S0102-86502010000200007; Suzuki O, 2011, EXP ANIM TOKYO, V60, P193, DOI 10.1538/expanim.60.193; Vegh MJ, 2012, J PROTEOME RES, V11, P1855, DOI 10.1021/pr201203m; Wei D, 2011, FISH SHELLFISH IMMUN, V30, P720, DOI 10.1016/j.fsi.2010.12.028; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Wishart TM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002936; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340; Wishart TM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r101; Zellner M, 2008, ELECTROPHORESIS, V29, P3621, DOI 10.1002/elps.200700935	26	256	260	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72457	10.1371/journal.pone.0072457	http://dx.doi.org/10.1371/journal.pone.0072457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023619	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200014
J	Westerdahl, H; Stjernman, M; Raberg, L; Lannefors, M; Nilsson, JA				Westerdahl, Helena; Stjernman, Martin; Raberg, Lars; Lannefors, Mimi; Nilsson, Jan-Ake			MHC-I Affects Infection Intensity but Not Infection Status with a Frequent Avian Malaria Parasite in Blue Tits	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; DISEASE RESISTANCE; MIGRATORY SONGBIRD; MYODES-GLAREOLUS; BLOOD PARASITES; VIRUS-INFECTION; BANK VOLE; POPULATION; WILD; DIVERSITY	Host resistance against parasites depends on three aspects: the ability to prevent, control and clear infections. In vertebrates the immune system consists of innate and adaptive immunity. Innate immunity is particularly important for preventing infection and eradicating established infections at an early stage while adaptive immunity is slow, but powerful, and essential for controlling infection intensities and eventually clearing infections. Major Histocompatibility Complex (MHC) molecules are central in adaptive immunity, and studies on parasite resistance and MHC in wild animals have found effects on both infection intensity (parasite load) and infection status (infected or not). It seems MHC can affect both the ability to control infection intensities and the ability to clear infections. However, these two aspects have rarely been considered simultaneously, and their relative importance in natural populations is therefore unclear. Here we investigate if MHC class I genotype affects infection intensity and infection status with a frequent avian malaria infection Haemoproteus majoris in a natural population of blue tits Cyanistes caeruleus. We found a significant negative association between a single MHC allele and infection intensity but no association with infection status. Blue tits that carry a specific MHC allele seem able to suppress H. majoris infection intensity, while we have no evidence that this allele also has an effect on clearance of the H. majoris infection, a result that is in contrast with some previous studies of MHC and avian malaria. A likely explanation could be that the clearance rate of avian malaria parasites differs between avian malaria lineages and/or between avian hosts.	[Westerdahl, Helena; Stjernman, Martin; Raberg, Lars; Lannefors, Mimi; Nilsson, Jan-Ake] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Westerdahl, H (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Helena.Westerdahl@biol.lu.se			Swedish Research Council (VR) [621-2006-4551, 621-2009-5194]	Swedish Research Council (VR)(Swedish Research Council)	The study was financed by grants from the Swedish Research Council (VR, 621-2006-4551 to HW; 621-2009-5194 to JAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello JR, 1998, NAT GENET, V18, P192, DOI 10.1038/ng0298-192; Asghar M, 2012, PARASITOLOGY, V139, P1246, DOI 10.1017/S0031182012000510; Axtner J, 2007, IMMUNOGENETICS, V59, P417, DOI 10.1007/s00251-007-0205-y; Bengsch B, 2009, VIRUSES-BASEL, V1, P104, DOI 10.3390/v1020104; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; Brouwer L, 2010, MOL ECOL, V19, P3444, DOI 10.1111/j.1365-294X.2010.04750.x; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; Guivier E, 2010, J GEN VIROL, V91, P2507, DOI 10.1099/vir.0.021600-0; Hill AVS, 1996, PARASITOLOGY, V112, pS75, DOI 10.1017/S003118200007668X; Kekalainen J, 2009, P ROY SOC B-BIOL SCI, V276, P3133, DOI 10.1098/rspb.2009.0727; KLEIN J, 1986, NATURAL HIST MAJOR H; Kloch A, 2010, MOL ECOL, V19, P255, DOI 10.1111/j.1365-294X.2009.04476.x; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Kubinak JL, 2012, P NATL ACAD SCI USA, V109, P3422, DOI 10.1073/pnas.1112633109; Loiseau C, 2008, ECOL LETT, V11, P258, DOI 10.1111/j.1461-0248.2007.01141.x; Loiseau C, 2011, P ROY SOC B-BIOL SCI, V278, P1264, DOI 10.1098/rspb.2010.1968; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Oppelt C, 2010, MOL ECOL, V19, P4155, DOI 10.1111/j.1365-294X.2010.04766.x; Palinauskas V, 2011, EXP PARASITOL, V127, P527, DOI 10.1016/j.exppara.2010.10.007; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Radwan J, 2012, MOL ECOL, V21, P2469, DOI 10.1111/j.1365-294X.2012.05547.x; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Schad J, 2005, EVOLUTION, V59, P439, DOI 10.1111/j.0014-3820.2005.tb01002.x; Schut E, 2012, THESIS U GRONINGEN N; Schut E, 2011, IMMUNOGENETICS, V63, P531, DOI 10.1007/s00251-011-0532-x; Sepil I, 2013, P ROY SOC LOND B BIO, V278, P1025; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Srithayakumar V, 2011, IMMUNOGENETICS, V63, P103, DOI 10.1007/s00251-010-0485-5; Stjernman M, 2004, P ROY SOC B-BIOL SCI, V271, P2387, DOI 10.1098/rspb.2004.2883; Stjernman M, 2004, THESIS LUND U SWEDEN; Stjernman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002463; Valkinas G., 2005, AVIAN MALARIA PARASI; Wedekind C, 2005, GENETICS, V170, P1427, DOI 10.1534/genetics.105.040683; Westerdahl H, 2005, P ROY SOC B-BIOL SCI, V272, P1511, DOI 10.1098/rspb.2005.3113; Westerdahl H, 2004, HEREDITY, V92, P534, DOI 10.1038/sj.hdy.6800450; Westerdahl H, 2007, J ORNITHOL, V148, pS469, DOI 10.1007/s10336-007-0230-5; Westerdahl H, 2012, P ROY SOC B-BIOL SCI, V279, P577, DOI 10.1098/rspb.2011.0917; Wutzler R, 2012, GENETICA, V140, P349, DOI 10.1007/s10709-012-9679-0; Zehtindjiev P, 2008, EXP PARASITOL, V119, P99, DOI 10.1016/j.exppara.2007.12.018	45	17	17	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72647	10.1371/journal.pone.0072647	http://dx.doi.org/10.1371/journal.pone.0072647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023631	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200026
J	Ng, CN; Wang, RY; Zhao, TJ				Ng, Cho Nam; Wang, Raymond Yu; Zhao, Tianjie			Joint Effects of Asymmetric Payoff and Reciprocity Mechanisms on Collective Cooperation in Water Sharing Interactions: A Game Theoretic Perspective	PLOS ONE			English	Article							SOCIAL-ECOLOGICAL SYSTEMS; EVOLUTION; EMBEDDEDNESS; FRAMEWORK; SOCIOLOGY; COMMONS	Common-pool resource (CPR) dilemmas distinguish themselves from general public good problems by encompassing both social and physical features. This paper examines how a physical mechanism, namely asymmetric payoff; and a social mechanism, reciprocity; simultaneously affect collective cooperation in theoretical water sharing interactions. We present an iterative N-person game theoretic model to investigate the joint effects of these two mechanisms in a linear fully connected river system under three information assumptions. From a simple evolutionary perspective, this paper quantitatively addresses the conditions for Nash Equilibrium in which collective cooperation might be established. The results suggest that direct reciprocity increases every actor's motivation to contribute to the collective good of the river system. Meanwhile, various upstream and downstream actors manifest individual disparities as a result of the direct reciprocity and asymmetric payoff mechanisms. More specifically, the downstream actors are less willing to cooperate unless there is a high probability that long-term interactions are ensured; however, a greater level of asymmetries is likely to increase upstream actors' incentives to cooperate even though the interactions could quickly end. The upstream actors also display weak sensitivity to an increase in the total number of actors, which generally results in a reduction in the other actors' motivation for cooperation. It is also shown that the indirect reciprocity mechanism relaxes the overall conditions for cooperative Nash Equilibrium.	[Ng, Cho Nam; Wang, Raymond Yu] Univ Hong Kong, Dept Geog, Pokfulam, Hong Kong, Peoples R China; [Zhao, Tianjie] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China	University of Hong Kong; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Wang, RY (corresponding author), Univ Hong Kong, Dept Geog, Pokfulam, Hong Kong, Peoples R China.	wangyuray@connect.hku.hk	Wang, Raymond Yu/AAV-8653-2021; Wang, Raymond Yu/AAL-2328-2020	Wang, Raymond Yu/0000-0003-0634-9492; zhao, tian jie/0000-0002-0914-599X	Research Grants Council of Hong Kong [HKU750911H]; Utrecht University	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Utrecht University	Financial support is appreciated from the General Research Fund, Research Grants Council of Hong Kong (No.HKU750911H), as well as the Short Stay Fellowship for Ph.D. candidates of Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Velez MA, 2012, ECOL ECON, V77, P185, DOI 10.1016/j.ecolecon.2012.02.030; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Coleman J., 1990, FDN SOCIAL THEORY; Friedman J.W., 1977, OLIGOPOLY THEORY GAM; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Janssen MA, 2012, J ECON BEHAV ORGAN, V81, P220, DOI 10.1016/j.jebo.2011.10.010; Janssen MA, 2011, ECOL ECON, V70, P1590, DOI 10.1016/j.ecolecon.2011.01.006; Janssen MA, 2010, SCIENCE, V328, P613, DOI 10.1126/science.1183532; Krippner GR, 2007, ANNU REV SOCIOL, V33, P219, DOI 10.1146/annurev.soc.33.040406.131647; Lindahl T, 2012, ECOL ECON, V79, P52, DOI 10.1016/j.ecolecon.2012.04.016; Madani K, 2012, ECOLOGICAL EC; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2012, J THEOR BIOL, V299, P1, DOI 10.1016/j.jtbi.2012.01.014; OLSON M., 1971, LOGIC COLLECTIVE ACT; OSTROM E, 1993, J ECON PERSPECT, V7, P93, DOI 10.1257/jep.7.4.93; Ostrom E, 1994, RULES GAMES COMMON F; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Rahman HMT, 2012, ECOL ECON, V83, P32, DOI 10.1016/j.ecolecon.2012.08.018; RAUB W, 1990, AM J SOCIOL, V96, P626, DOI 10.1086/229574; Raub W, 2011, J MATH SOCIOL, V35, P1, DOI 10.1080/0022250X.2010.532263	23	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73793	10.1371/journal.pone.0073793	http://dx.doi.org/10.1371/journal.pone.0073793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015312	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800107
J	Ronald, JA; Cusso, L; Chuang, HY; Yan, XR; Dragulescu-Andrasi, A; Gambhir, SS				Ronald, John A.; Cusso, Lorena; Chuang, Hui-Yen; Yan, Xinrui; Dragulescu-Andrasi, Anca; Gambhir, Sanjiv Sam			Development and Validation of Non-Integrative, Self-Limited, and Replicating Minicircles for Safe Reporter Gene Imaging of Cell-Based Therapies	PLOS ONE			English	Article							SCAFFOLD/MATRIX-ATTACHED REGION; EMBRYONIC STEM-CELLS; EPISOMAL VECTOR; EXPRESSION; TRANSCRIPTION; METHYLATION; ACTIVATION; DELIVERY; ORIGIN; SYSTEM	Reporter gene (RG) imaging of cell-based therapies provides a direct readout of therapeutic efficacy by assessing the fate of implanted cells. To permit long-term cellular imaging, RGs are traditionally required to be integrated into the cellular genome. This poses a potential safety risk and regulatory bottleneck for clinical translation as integration can lead to cellular transformation. To address this issue, we have developed non-integrative, replicating minicircles (MCs) as an alternative platform for safer monitoring of cells in living subjects. We developed both plasmids and minicircles containing the scaffold/matrix attachment regions (S/MAR) of the human interferon-beta gene, driven by the CMV promoter, and expressing the bioluminescence RG firefly luciferase. Constructs were transfected into breast cancer cells, and expanded S/MAR minicircle clones showed luciferase signal for greater than 3 months in culture and minicircles remained as episomes. Importantly, luciferase activity in clonal populations was slowly lost over time and this corresponded to a loss of episome, providing a way to reversibly label cells. To monitor cell proliferation in vivo, 1.5x10(6) cells carrying the S/MAR minicircle were implanted subcutaneously into mice (n = 5) and as tumors developed significantly more bioluminescence signal was noted at day 35 and 43 compared to day 7 post-implant (p<0.05). To our knowledge, this is the first work examining the use of episomal, self-limited, replicating minicircles to track the proliferation of cells using non-invasive imaging in living subjects. Continued development of S/MAR minicircles will provide a broadly applicable vector platform amenable with any of the numerous RG technologies available to allow therapeutic cell fate to be assessed in individual patients, and to achieve this without the need to manipulate the cell's genome so that safety concerns are minimized. This will lead to safe tools to assess treatment response at earlier time points and improve the precision of cell-based therapies.	[Ronald, John A.; Chuang, Hui-Yen; Yan, Xinrui; Dragulescu-Andrasi, Anca; Gambhir, Sanjiv Sam] Stanford Univ, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Ronald, John A.; Yan, Xinrui; Dragulescu-Andrasi, Anca; Gambhir, Sanjiv Sam] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Cusso, Lorena] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Inst Invest Sanitaria Gregorio Maranon, CIBERSAM, Madrid, Spain; [Chuang, Hui-Yen] Natl Yang Ming Univ, Taipei 112, Taiwan	Stanford University; Stanford University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universidad Carlos III de Madrid; National Yang Ming Chiao Tung University	Gambhir, SS (corresponding author), Stanford Univ, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	sgambhir@stanford.edu	Ronald, John A/B-7123-2008; cussó, lorena/R-6715-2019; CHUANG, HUI-YEN/GVW-2101-2022	Ronald, John A/0000-0003-3665-173X; cussó, lorena/0000-0001-9298-0015; 	National Cancer Institute [NCI ICMIC P50CA114747, NCI RO1 CA082214]; Canadian Institutes of Health Research (CIHR); NATIONAL CANCER INSTITUTE [P50CA114747, R01CA082214] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Sanjiv Sam Gambhir has grant funding from National Cancer Institute NCI ICMIC P50CA114747 (SSG), and NCI RO1 CA082214 (SSG). (http://www.cancer.gov) John Ronald was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyros O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047920; Argyros O, 2011, J MOL MED, V89, P515, DOI 10.1007/s00109-010-0713-3; Baiker A, 2000, NAT CELL BIOL, V2, P182, DOI 10.1038/35004061; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Broll S, 2010, J MOL BIOL, V395, P950, DOI 10.1016/j.jmb.2009.11.066; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Cohen B, 2007, NAT MED, V13, P498, DOI 10.1038/nm1497; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Deans AE, 2006, MAGN RESON MED, V56, P51, DOI 10.1002/mrm.20914; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Filonov GS, 2012, ANGEW CHEM INT EDIT, V51, P1448, DOI 10.1002/anie.201107026; Gambhir SS, 2000, P NATL ACAD SCI USA, V97, P2785, DOI 10.1073/pnas.97.6.2785; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Herweijer H, 2001, J GENE MED, V3, P280, DOI 10.1002/jgm.178; Hong K, 2001, BIOMOL ENG, V18, P185, DOI 10.1016/S1389-0344(01)00100-9; Jenke ACW, 2004, P NATL ACAD SCI USA, V101, P11322, DOI 10.1073/pnas.0401355101; Jenke BHC, 2002, EMBO REP, V3, P349, DOI 10.1093/embo-reports/kvf070; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Lan F, 2012, CIRCULATION, V126, pS20, DOI 10.1161/CIRCULATIONAHA.111.084913; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Manzini S, 2006, P NATL ACAD SCI USA, V103, P17672, DOI 10.1073/pnas.0604938103; Marie C, 2008, NAT P, P713; Nehlsen K, 2006, GENE THER MOL BIOL, V10B, P233; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Piechaczek C, 1999, NUCLEIC ACIDS RES, V27, P426, DOI 10.1093/nar/27.2.426; Rupprecht S, 2010, GENE, V466, P36, DOI 10.1016/j.gene.2010.07.001; Schaarschmidt D, 2004, EMBO J, V23, P191, DOI 10.1038/sj.emboj.7600029; Stehle IM, 2003, CHROMOSOME RES, V11, P413, DOI 10.1023/A:1024962308071; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Sun N, 2009, NAT PROTOC, V4, P1192, DOI 10.1038/nprot.2009.100; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Wang YM, 2012, CIRC RES, V111, P1494, DOI 10.1161/CIRCRESAHA.112.274969; Wilson J B, 1992, Curr Top Microbiol Immunol, V182, P375; Wong SP, 2011, GENE THER, V18, P82, DOI 10.1038/gt.2010.116; Wong SP, 2009, CURR OPIN MOL THER, V11, P433; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278	40	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73138	10.1371/journal.pone.0073138	http://dx.doi.org/10.1371/journal.pone.0073138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015294	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800093
J	Drago, E; Bordonaro, M; Lee, S; Atamna, W; Lazarova, DL				Drago, Eric; Bordonaro, Michael; Lee, Seon; Atamna, Wafa; Lazarova, Darina L.			Propolis Augments Apoptosis Induced by Butyrate via Targeting Cell Survival Pathways	PLOS ONE			English	Article							COLON-CANCER CELLS; C-JUN; BETA-CATENIN; CARCINOMA CELLS; ACTIVATION; JNK; PROLIFERATION; EXPRESSION; GENE; INHIBITION	Diet is one of the major lifestyle factors affecting incidence of colorectal cancer ( CC), and despite accumulating evidence that numerous diet-derived compounds modulate CC incidence, definitive dietary recommendations are not available. We propose a strategy that could facilitate the design of dietary supplements with CC-preventive properties. Thus, nutrient combinations that are a source of apoptosis-inducers and inhibitors of compensatory cell proliferation pathways (e.g., AKT signaling) may produce high levels of programmed death in CC cells. Here we report the combined effect of butyrate, an apoptosis inducer that is produced through fermentation of fiber in the colon, and propolis, a honeybee product, on CC cells. We established that propolis increases the apoptosis of CC cells exposed to butyrate through suppression of cell survival pathways such as the AKT signaling. The programmed death of CC cells by combined exposure to butyrate and propolis is further augmented by inhibition of the JNK signaling pathway. Analyses on the contribution of the downstream targets of JNK signaling, c-JUN and JAK/STAT, to the apoptosis of butyrate/propolis-treated CC cells ascertained that JAK/STAT signaling has an anti-apoptotic role; whereas, the role of cJUN might be dependent upon regulatory cell factors. Thus, our studies ascertained that propolis augments apoptosis of butyrate-sensitive CC cells and re-sensitizes butyrate-resistant CC cells to apoptosis by suppressing AKT signaling and downregulating the JAK/STAT pathway. Future in vivo studies should evaluate the CC-preventive potential of a dietary supplement that produces high levels of colonic butyrate, propolis, and diet-derived JAK/STAT inhibitors.	[Drago, Eric; Bordonaro, Michael; Lee, Seon; Atamna, Wafa; Lazarova, Darina L.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA	Geisinger Commonwealth School of Medicine	Lazarova, DL (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.	dlazarova@tcmedc.org			National Institutes of Health (NIH) [R15 CA152852-01]; NATIONAL CANCER INSTITUTE [R15CA152852] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded by National Institutes of Health (NIH) grants R15 CA152852-01 (Lazarova). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramova MV, 2010, INT J BIOCHEM CELL B, V42, P1847, DOI 10.1016/j.biocel.2010.08.001; Abramova MV, 2006, J BIOL CHEM, V281, P21040, DOI 10.1074/jbc.M511059200; Araujo JR, 2011, NUTR RES, V31, P77, DOI 10.1016/j.nutres.2011.01.006; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bergman PJ, 1999, THESIS TEXAS MED CTR; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Bestwick CS, 2006, CANCER LETT, V243, P80, DOI 10.1016/j.canlet.2005.11.025; Bhutani M, 2007, CLIN CANCER RES, V13, P3024, DOI 10.1158/1078-0432.CCR-06-2575; Bordonaro M, 2007, EXP CELL RES, V313, P1652, DOI 10.1016/j.yexcr.2007.02.008; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Bordonaro M, 2011, EXP CELL RES, V317, P1368, DOI 10.1016/j.yexcr.2011.03.019; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bradham CA, 2001, AM J PHYSIOL-GASTR L, V281, pG1279, DOI 10.1152/ajpgi.2001.281.5.G1279; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Denlinger CE, 2005, J THORAC CARDIOV SUR, V130, P1422, DOI 10.1016/j.jtcvs.2005.06.051; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Jaganathan SK, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/830616; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; KONDO S, 1988, INT J RADIAT BIOL, V53, P95, DOI 10.1080/09553008814550461; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; Kumar MAS, 2007, MOL CARCINOGEN, V46, P231, DOI 10.1002/mc.20272; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Li X, 2011, TOXICOL IN VITRO, V25, P630, DOI 10.1016/j.tiv.2010.12.013; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Markham KR, 1996, PHYTOCHEMISTRY, V42, P205, DOI 10.1016/0031-9422(96)83286-9; Meurette O, 2009, CANCER RES, V69, P5015, DOI 10.1158/0008-5472.CAN-08-3478; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Trecul A, 2012, GENES NUTR, V7, P111, DOI 10.1007/s12263-012-0281-y; Weston CR, 2003, GENE DEV, V17, P1271, DOI 10.1101/gad.1087303; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Woo KJ, 2004, BIOCHEM BIOPH RES CO, V325, P1215, DOI 10.1016/j.bbrc.2004.09.225; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Wu YZ, 2003, ONCOGENE, V22, P8891, DOI 10.1038/sj.onc.1206898; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Zagariya A, 1998, MOL CELL BIOL, V18, P2815, DOI 10.1128/MCB.18.5.2815; Zeilstra J, 2011, BIOCHEM BIOPH RES CO, V406, P1, DOI 10.1016/j.bbrc.2010.12.070; Zhang Y, 2010, CHEM-BIOL INTERACT, V185, P174, DOI 10.1016/j.cbi.2010.03.035; Zugowski C, 2011, BIOL CHEM, V392, P449, DOI 10.1515/BC.2011.038	47	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73151	10.1371/journal.pone.0073151	http://dx.doi.org/10.1371/journal.pone.0073151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023824	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600073
J	Nicolas-Chanoine, MH; Robert, J; Vigan, M; Laouenan, C; Brisse, S; Mentre, F; Jarlier, V				Nicolas-Chanoine, Marie-Helene; Robert, Jerome; Vigan, Marie; Laouenan, Cedric; Brisse, Sylvain; Mentre, France; Jarlier, Vincent		Coli Study Grp	Different Factors Associated with CTX-M-Producing ST131 and Non-ST131 Escherichia coli Clinical Isolates	PLOS ONE			English	Article							CLONAL GROUPS; CHICKEN MEAT; RESISTANCE; VIRULENCE; STRAINS; COLONIZATION; INFECTIONS; EMERGENCE; HUMANS; GENES	Objectives: To determine factors associated with CTX-M-producing ST131 Escherichia coli which is the worldwide predominant lineage among CTX-M-producing E. coli isolates. Methods: Consecutive inpatients with a clinical sample positive for CTX-M-producing E. coli and considered as cases in a previous 8-month (2008-2009) case-control study performed in ten university hospitals in the Paris area were included in the present sub-population study. Patients with a CTX-M-producing ST131 E. coli clinical isolate were compared with those with a CTX-M-producing non-ST131 E. coli clinical isolate with regard to 66 variables. Variables were first compared using univariate logistic regression, then a multivariate analysis using a backward selection with variables with p-value < 0.1 in univariate analysis was carried out. Results: Fifty-five patients with a CTX-M-producing ST131 E. coli clinical isolate were compared to 97 patients with a CTX-producing non-ST131 E. coli clinical isolate. Multivariate analysis showed that only previous residence in long term care facilities (OR = 4.4; 95% CI = 1.3-14.7) was positively associated with a CTX-M-producing ST131 E. coli isolate. However, it also showed that regular consumption of poultry products (OR = 0.2; 95% CI = 0.1-0.6), having had at least one device in the preceding 6 months (OR = 0.3; 95% CI = 0.1-0.7) and stay in ICU (OR = 0.2; 95% CI = 0.05-0.8) were negatively associated with isolation of CTX-M-producing ST131 E. coli from clinical samples. Conclusions: This study provides more insight into the epidemiological features of ST131 and non-ST131 E. coli producing CTX-M enzymes. It shows, for the first time, that isolation of CTX-M-producing ST131 E. coli from clinical samples is not linked to consumption of various foods and confirms that residence in long term care facilities is a predictor of these isolates.	[Nicolas-Chanoine, Marie-Helene] Hop Beaujon, AP HP, Microbiol Serv, Clichy, France; [Nicolas-Chanoine, Marie-Helene] Fac Med D Diderot, Paris, France; [Nicolas-Chanoine, Marie-Helene] Univ Paris Diderot, INSERM, U773, Ctr Rech Biomed Bichat Beaujon CRB3, Paris, France; [Robert, Jerome; Jarlier, Vincent] Univ Paris 06, EA 1541 ER 5, Paris, France; [Robert, Jerome; Jarlier, Vincent] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Paris, France; [Vigan, Marie; Laouenan, Cedric; Mentre, France] Univ Paris Diderot, UMR S 738, INSERM, Sorbonne Paris Cite, Paris, France; [Laouenan, Cedric; Mentre, France] Hop Bichat Claude Bernard, AP HP, Serv Biostat, F-75877 Paris, France; [Brisse, Sylvain] Inst Pasteur, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nicolas-Chanoine, MH (corresponding author), Hop Beaujon, AP HP, Microbiol Serv, Clichy, France.	mhn.chanoine@bjn.aphp.fr	Mentre, France/AFU-8218-2022; Brisse, Sylvain/M-8723-2013; Laouenan, Cedric/E-1157-2019; ROBERT, Jérôme/C-3993-2011	Mentre, France/0000-0002-7045-1275; Brisse, Sylvain/0000-0002-2516-2108; Laouenan, Cedric/0000-0002-3681-6314; ROBERT, Jérôme/0000-0002-9380-0570; Vigan, Marie/0000-0003-4267-3847	Programme Regional de Recherche Clinique AP-HP/Institut Pasteur, Direction de la Recherche Clinique AP-HP, Paris, France [PASo7010]	Programme Regional de Recherche Clinique AP-HP/Institut Pasteur, Direction de la Recherche Clinique AP-HP, Paris, France	This study was supported by a grant (PASo7010) from the Programme Regional de Recherche Clinique AP-HP/Institut Pasteur, Direction de la Recherche Clinique AP-HP, Paris, France (a publicly funded non-profit organization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2013, INFECT CONT HOSP EP, V34, P361, DOI 10.1086/669865; Brisse S, 2012, J CLIN MICROBIOL, V50, P2974, DOI 10.1128/JCM.00919-12; Cortes P, 2010, APPL ENVIRON MICROB, V76, P2799, DOI 10.1128/AEM.02421-09; Dhanji H, 2010, J ANTIMICROB CHEMOTH, V65, P2534, DOI 10.1093/jac/dkq376; Egea P, 2012, INT J FOOD MICROBIOL, V159, P69, DOI 10.1016/j.ijfoodmicro.2012.08.002; Gibreel TM, 2012, J ANTIMICROB CHEMOTH, V67, P346, DOI 10.1093/jac/dkr451; Guenther S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053039; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson JR, 2009, ANTIMICROB AGENTS CH, V53, P2733, DOI 10.1128/AAC.00297-09; Kassis-Chikhani N, 2004, EMERG INFECT DIS, V10, P1697, DOI 10.3201/eid1009.030969; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Lavigne JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034294; Leflon-Guibout V, 2004, ANTIMICROB AGENTS CH, V48, P3736, DOI 10.1128/AAC.48.10.3736-3742.2004; Manges AR, 2012, CLIN INFECT DIS, V55, P712, DOI 10.1093/cid/cis502; Mora A, 2012, VET MICROBIOL, V156, P347, DOI 10.1016/j.vetmic.2011.10.033; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; Nicolas-Chanoine MH, 2013, J ANTIMICROB CHEMOTH, V68, P562, DOI 10.1093/jac/dks429; Nicolas-Chanoine MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030498; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Stuart JC, 2012, INT J FOOD MICROBIOL, V154, P212, DOI 10.1016/j.ijfoodmicro.2011.12.034; Vimont S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046547; Vincent C, 2010, EMERG INFECT DIS, V16, P88, DOI 10.3201/eid1601.091118	24	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72191	10.1371/journal.pone.0072191	http://dx.doi.org/10.1371/journal.pone.0072191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023730	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600014
J	Villas-Boas, IM; Goncalves-de-Andrade, RM; Squaiella-Baptistao, CC; Sant'Anna, OA; Tambourgi, DV				Villas-Boas, Isadora Maria; Goncalves-de-Andrade, Rute Maria; Squaiella-Baptistao, Carla Cristina; Sant'Anna, Osvaldo Augusto; Tambourgi, Denise V.			Characterization of Phenotypes of Immune Cells and Cytokines Associated with Chronic Exposure to Premolis semirufa Caterpillar Bristles Extract	PLOS ONE			English	Article							CD44; INTERLEUKIN-17; RECEPTOR; IL-17; SYNOVIOCYTES; INFLAMMATION; EXPRESSION; ARTHRITIS; CONTACT; DISEASE	The Brazilian moth Premolis semirufa (Walker, 1856), usually called pararama, is a parasite of the rubber Hevea genus. Contact with the bristles causes symptoms of acute inflammation. A chronic inflammatory reaction frequently occurs in individuals after multiple contacts, and this reaction is characterised by articular synovial membrane thickening with joint deformities, common characteristics of chronic synovitis. Extract from the bristles has been shown to induce an intense inflammatory response in a murine model, and this reaction was characterised by the presence of neutrophils in the paw tissues of injected mice and a strong, specific antibody response. There is not yet an effective treatment for incidents involving contact with pararama. In this study, we evaluated the phenotype of the immunological response and cytokine production in BALB/c mice subcutaneously injected in the footpad with P. semirufa bristle extract or sterile saline (control) seven times at 15 day intervals. An analysis of cells from the draining lymph node by flow cytometry showed that the absolute numbers of TCD4, TCD8 and B lymphocytes, as well as the expression of activation molecules, were higher in the extract-treated group. Furthermore, immunohistochemistry and immunofluorescence analyses showed a mixed inflammatory infiltrate composed of neutrophils and macrophages at the inoculation site. In addition, an analysis of paw cytokines showed elevated levels of IL-6, IL-12, IL-10, IL-17 and IL-23 after the 7th inoculation. In conclusion, these data provide evidence of pro-inflammatory changes in the phenotypes of immune cells and cytokine production in animals subjected to injections with an extract from Premolis semirufa bristles, which may explain the intense and prolonged inflammatory response that characterises this disorder.	[Villas-Boas, Isadora Maria; Goncalves-de-Andrade, Rute Maria; Squaiella-Baptistao, Carla Cristina; Sant'Anna, Osvaldo Augusto; Tambourgi, Denise V.] Butantan Inst, Immunochem Lab, Sao Paulo, Brazil	Instituto Butantan	Tambourgi, DV (corresponding author), Butantan Inst, Immunochem Lab, Sao Paulo, Brazil.	denise.tambourgi@butantan.gov.br	Boas, Isadora Maria Villas/H-3499-2013; Squaiella-Baptistão, Carla Cristina/K-2557-2013; Tambourgi, Denise/H-7114-2016; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015	Tambourgi, Denise/0000-0003-1896-9074; Squaiella-Baptistao, Carla Cristina/0000-0002-4187-798X; Villas Boas, Isadora/0000-0001-6034-9544	FAPESP; CNPq; INCTTOX	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCTTOX	This study was supported by grants from FAPESP, CNPq and INCTTOX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini R, 2004, J PHOTOCH PHOTOBIO B, V74, P101, DOI 10.1016/j.jphotobiol.2004.03.002; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bonder CS, 2006, BLOOD, V107, P4798, DOI 10.1182/blood-2005-09-3581; Brasil, 1992, MAN DIAGN TRAT AC AN; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Castaman TA, 2001, REV SOC BRASILEIRA A, V33, P143; Chabaud M, 1998, J IMMUNOL, V161, P409; Costa R M, 1993, Rev Paul Med, V111, P462; Costa RM, 2003, ANIMAIS PECONHENTOS, P233, DOI [10.1016/j.ttbdis.2014.03.010, DOI 10.1016/J.TTBDIS.2014.03.010]; Couppie P, 1998, ANN DERMATOL VENER, V125, P489; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Davey MS, 2011, NAT IMMUNOL, V12, P1017, DOI 10.1038/ni.2111; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Dias LB, 1997, DOENCAS; Duarte AC, 1996, LANCET, V348, P1033, DOI 10.1016/S0140-6736(05)64961-6; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gaffen SL, 2006, VITAM HORM, V74, P255, DOI 10.1016/S0083-6729(06)74010-9; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Karouzakis E, 2006, IMMUNOL LETT, V106, P8, DOI 10.1016/j.imlet.2006.04.011; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; MANGAN DF, 1991, J IMMUNOL, V146, P1541; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Miga A., 2000, Immunological Investigations, V29, P111, DOI 10.3109/08820130009062292; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Neron S, 2006, INT IMMUNOL, V18, P375, DOI 10.1093/intimm/dxh377; Okumura A, 2008, ARTHRITIS RHEUM, V58, P413, DOI 10.1002/art.23215; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Puccetti P, 2002, CRIT REV IMMUNOL, V22, P373; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Shahrara S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2477; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Toes REM, 2009, PLOS MED, V6, P15, DOI 10.1371/journal.pmed.1000009; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Villas-Boas IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001531; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; WERNO J, 1991, CR ACAD SCI III-VIE, V312, P455; Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355, DOI 10.1055/s-0037-1613453; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e71938	10.1371/journal.pone.0071938	http://dx.doi.org/10.1371/journal.pone.0071938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023721	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600009
J	Ueda, N; Degnan, SM				Ueda, Nobuo; Degnan, Sandie M.			Nitric Oxide Acts as a Positive Regulator to Induce Metamorphosis of the Ascidian Herdmania momus	PLOS ONE			English	Article							MARINE-INVERTEBRATE LARVAE; CIONA-INTESTINALIS METAMORPHOSIS; PROTEIN-KINASE-C; EGF-LIKE PROTEIN; HEAT-SHOCK; GENE-EXPRESSION; CREPIDULA-FORNICATA; SIGNAL-TRANSDUCTION; SYNTHASE ACTIVITY; MESSENGER-RNA	Marine invertebrates commonly have a biphasic life cycle in which the metamorphic transition from a pelagic larva to a benthic post-larva is mediated by the nitric oxide signalling pathway. Nitric oxide (NO) is synthesised by nitric oxide synthase (NOS), which is a client protein of the molecular chaperon heat shock protein 90 (HSP90). It is notable, then, that both NO and HSP90 have been implicated in regulating metamorphosis in marine invertebrates as diverse as urochordates, echinoderms, molluscs, annelids, and crustaceans. Specifically, the suppression of NOS activity by the application of either NOS-or HSP90-inhibiting pharmacological agents has been shown consistently to induce the initiation of metamorphosis, leading to the hypothesis that a negative regulatory role of NO is widely conserved in biphasic life cycles. Further, the induction of metamorphosis by heat-shock has been demonstrated for multiple species. Here, we investigate the regulatory role of NO in induction of metamorphosis of the solitary tropical ascidian, Herdmania momus. By coupling pharmacological treatments with analysis of HmNOS and HmHSP90 gene expression, we present compelling evidence of a positive regulatory role for NO in metamorphosis of this species, in contrast to all existing ascidian data that supports the hypothesis of NO as a conserved negative regulator of metamorphosis. The exposure of competent H. momus larvae to a NOS inhibitor or an NO donor results in an up-regulation of NOS and HSP90 genes. Heat shock of competent larvae induces metamorphosis in a temperature dependent manner, up to a thermal tolerance that approaches 35 degrees C. Both larval/ post-larval survival and the appearance of abnormal morphologies in H. momus post-larvae reflect the magnitude of up-regulation of the HSP90 gene in response to heat-shock. The demonstrated role of NO as a positive metamorphic regulator in H. momus suggests the existence of inter-specific adaptations of NO regulation in ascidian metamorphosis.	[Ueda, Nobuo; Degnan, Sandie M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	University of Queensland	Degnan, SM (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	s.degnan@uq.edu.au	Degnan, Sandie/G-7338-2012	Degnan, Sandie/0000-0001-8003-0426	Australian Research Council [DP110104601]; Australian Government	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This work has been funded by grant number DP110104601 from the Australian Research Council (http://www.arc.gov.au/) to SMD, and was conducted while NU held an Endeavour International Postgraduate Research Scholarship provided by Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; Amador-Cano G, 2006, BIOL BULL-US, V210, P121, DOI 10.2307/4134601; Arnold JM, 1997, DEV DYNAM, V210, P264, DOI 10.1002/(SICI)1097-0177(199711)210:3<264::AID-AJA7>3.0.CO;2-E; BAXTER G, 1987, P NATL ACAD SCI USA, V84, P1867, DOI 10.1073/pnas.84.7.1867; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Biggers WJ, 2012, INVERTEBR REPROD DEV, V56, P1, DOI 10.1080/07924259.2011.588006; Biggers WJ, 1999, BIOL BULL, V196, P187, DOI 10.2307/1542564; Bishop CD, 2003, EVOL DEV, V5, P542, DOI 10.1046/j.1525-142X.2003.03059.x; Bishop CD, 2001, BIOL BULL, V201, P394, DOI 10.2307/1543617; Bishop CD, 2001, J EXP ZOOL, V289, P374, DOI 10.1002/jez.1019; Bishop CD, 2008, EVOL DEV, V10, P288, DOI 10.1111/j.1525-142X.2008.00238.x; Boettcher AA, 2005, J SHELLFISH RES, V24, P1123; BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5; Brown MA, 2007, BIOCHEM BIOPH RES CO, V363, P241, DOI 10.1016/j.bbrc.2007.08.054; Brune B, 2003, CELL DEATH DIFFER, V10, P864, DOI 10.1038/sj.cdd.4401261; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Chambon JP, 2007, DEVELOPMENT, V134, P1203, DOI 10.1242/dev.002220; Chambon JP, 2002, DEVELOPMENT, V129, P3105; Chung HT, 2001, BIOCHEM BIOPH RES CO, V282, P1075, DOI 10.1006/bbrc.2001.4670; CLONEY RA, 1982, AM ZOOL, V22, P817; Colasanti M, 1998, MOL NEUROBIOL, V17, P157, DOI 10.1007/BF02802029; COLASANTI M, 1995, J BIOL CHEM, V270, P26731, DOI 10.1074/jbc.270.45.26731; Comes S, 2007, DEV BIOL, V306, P772, DOI 10.1016/j.ydbio.2007.04.016; Degnan B, 1990, THESIS U QUEENSLAND; Degnan BM, 2001, BIOLOGY OF ASCIDIANS, P258; Degnan BM, 1996, MAR FRESHWATER RES, V47, P543, DOI 10.1071/MF9960543; DEGNAN BM, 1995, AM ZOOL, V35, P391; Degnan BM, 1997, DEV GENES EVOL, V206, P370, DOI 10.1007/s004270050066; Degnan BM, 1999, BIOL BULL-US, V197, P332, DOI 10.2307/1542787; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Ercolesi E, 2012, NITRIC OXIDE-BIOL CH, V27, P18, DOI 10.1016/j.niox.2012.03.012; Eri R, 1999, DEVELOPMENT, V126, P5809; Filippov G, 1997, J CLIN INVEST, V100, P942, DOI 10.1172/JCI119610; Froggett SJ, 1999, BIOL BULL, V196, P57, DOI 10.2307/1543167; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gaudette MF, 2001, J EXP MAR BIOL ECOL, V266, P151, DOI 10.1016/S0022-0981(01)00351-3; Green K, 2001, THESIS U QUEENSLAND; Grumbach IM, 2005, J MOL CELL CARDIOL, V39, P595, DOI 10.1016/j.yjmcc.2005.06.012; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; Hadfield MG, 2001, AM ZOOL, V41, P1123, DOI 10.1668/0003-1569(2001)041[1123:MCAMAC]2.0.CO;2; Hadfield MG, 2000, SEMIN CELL DEV BIOL, V11, P437, DOI 10.1006/scdb.2000.0197; Hadfield MG, 1998, BIOFOULING, V12, P9, DOI 10.1080/08927019809378343; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; Heyland A, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P29; Hinman VF, 2001, AM ZOOL, V41, P664, DOI 10.1668/0003-1569(2001)041[0664:HGRAAT]2.0.CO;2; Kashiwagi A, 1999, FREE RADICAL BIO MED, V26, P1001, DOI 10.1016/S0891-5849(98)00296-2; Kawashima T, 2005, DEV GROWTH DIFFER, V47, P187; Kim PKM, 2001, INT IMMUNOPHARMACOL, V1, P1421, DOI 10.1016/S1567-5769(01)00088-1; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; KROIHER M, 1992, ROUX ARCH DEV BIOL, V201, P169, DOI 10.1007/BF00188715; Leise EM, 2000, BIOL BULL, V199, P241, DOI 10.2307/1543180; Li CQ, 2005, CANCER LETT, V226, P1, DOI 10.1016/j.canlet.2004.10.021; LIMA GM, 1985, J EXP MAR BIOL ECOL, V90, P55, DOI 10.1016/0022-0981(85)90074-7; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lutz R. A, 1970, Proc. natn. Shellfish. Ass., V60, P68; Nakayama A, 2002, DIFFERENTIATION, V70, P429, DOI 10.1046/j.1432-0436.2002.700805.x; Nakayama A, 2001, DEV GENES EVOL, V211, P184, DOI 10.1007/s004270100133; Nakayama-Ishimura A, 2009, DEV BIOL, V326, P357, DOI 10.1016/j.ydbio.2008.11.026; Palumbo A, 2005, COMP BIOCHEM PHYS A, V142, P241, DOI 10.1016/j.cbpb.2005.05.043; PARK SK, 1994, BIOCHEM BIOPH RES CO, V201, P762, DOI 10.1006/bbrc.1994.1766; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; Pechenik JA, 2004, INVERTEBRATE REPROD, P555; Pechenik JA, 2007, BIOL BULL-US, V213, P160, DOI 10.2307/25066632; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schmidt I, 2004, J BACTERIOL, V186, P2781, DOI 10.1128/JB.186.9.2781-2788.2004; Serfozo Z, 2002, CELL TISSUE RES, V310, P119, DOI 10.1007/s00441-002-0589-9; Song Y, 2001, BIOCHEM J, V355, P357, DOI 10.1042/0264-6021:3550357; STRATHMANN RR, 1993, ANNU REV ECOL SYST, V24, P89, DOI 10.1146/annurev.es.24.110193.000513; Stuehr DJ, 2004, J NUTR, V134, p2748S, DOI 10.1093/jn/134.10.2748S; Tao YP, 1997, DEVELOPMENT, V124, P3587; Taris N, 2009, MAR GENOM, V2, P161, DOI 10.1016/j.margen.2009.08.002; Taylor BS, 1997, ARCH SURG-CHICAGO, V132, P1177; Tenu JP, 1999, NITRIC OXIDE-BIOL CH, V3, P427, DOI 10.1006/niox.1999.0255; Tomanek L, 1999, J EXP BIOL, V202, P2925; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilken M, 1999, EUR J CELL BIOL, V78, P209, DOI 10.1016/S0171-9335(99)80100-9; Woods RG, 2004, DEVELOPMENT, V131, P2921, DOI 10.1242/dev.01120; Yeyati PL, 2007, PLOS GENET, V3, P431, DOI 10.1371/journal.pgen.0030043; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhang Y, 2012, J EXP BIOL, V215, P3813, DOI 10.1242/jeb.070235	85	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e72797	10.1371/journal.pone.0072797	http://dx.doi.org/10.1371/journal.pone.0072797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019877	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200019
J	Yu, LH; Xie, B; Yin, XT; Liang, ML; Evans, AC; Wang, J; Dai, C				Yu, Longhua; Xie, Bing; Yin, Xuntao; Liang, Minglong; Evans, Alan C.; Wang, Jian; Dai, Chao			Reduced Cortical Thickness in Primary Open-Angle Glaucoma and Its Relationship to the Retinal Nerve Fiber Layer Thickness	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; LATERAL GENICULATE-NUCLEUS; AUTOMATED 3-D EXTRACTION; VISUAL-CORTEX; OPTIC-NERVE; NEURAL DEGENERATION; CLINICAL SEVERITY; MRI DATA; DISEASE; ABNORMALITIES	Objectives: To examine possible changes in cortical thickness and their relationship to retinal nerve fiber layer (RNFL) thickness in patients with primary open-angle glaucoma (POAG). Materials and Methods: Thirty-six patients with POAG and 40 matched healthy controls were enrolled in this study. All subjects underwent a comprehensive ophthalmologic examination and a high resolution structural magnetic resonance scan. Cortical thickness analysis was used to assess the changes between patients and controls. Correlations between the thickness of the visual cortex and RNFL thickness were also analyzed. Finally, the relationship between the severity of changes in the visual cortex and RNFL thickness was evaluated by comparing patients with mild and severe groups. Results: POAG patients showed significant bilateral cortical thinning in the anterior half of the visual cortex around the calcarine sulci (left BA 17 and BA 18, right BA17) and in some smaller regions located in the left middle temporal gyrus (BA37) and fusiform gyrus (BA19). The thickness of the visual cortex correlated positively with RNFL thickness (left, r = 0.44, p = 0.01; right, r = 0.38, p = 0.03). Significant differences between mild and severe groups were observed with regard to both RNFL thickness and the thickness of bilateral visual cortex (p < 0.05). Conclusion: Our findings indicate that cortical thickness analysis may be sufficiently sensitive to detect cortical alterations in POAG and that the measurement has great potential for clinical application.	[Yu, Longhua; Xie, Bing; Yin, Xuntao; Liang, Minglong; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Yu, Longhua] 401st Hosp Peoples Liberat Army, Dept Radiol, Qingdao, Shandong, Peoples R China; [Evans, Alan C.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Dai, Chao] Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Ophthalmol Res Ctr, Chongqing, Peoples R China	Army Medical University; McGill University; Army Medical University	Wang, J (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	wangjian_811@yahoo.com; daichaotom@gmail.com	Evans, Alan C/B-2373-2013	Evans, Alan C/0000-0003-3841-6098; Yin, Xuntao/0000-0002-8228-6908	Natural Science Foundation of China [30870697]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (grant no. 30870697 to Dr. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Ophthalmology, 2008, GLAUC 2008 2009, P85; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Chen ZQ, 2013, CLIN EXP OPHTHALMOL, V41, P43, DOI 10.1111/j.1442-9071.2012.02832.x; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Johansson Barbro B., 2004, Keio Journal of Medicine, V53, P231, DOI 10.2302/kjm.53.231; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Lalezary M, 2006, AM J OPHTHALMOL, V142, P576, DOI 10.1016/j.ajo.2006.05.004; Lam D, 2009, MOL VIS, V15, P2217; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Mills RP, 2006, AM J OPHTHALMOL, V141, P24, DOI 10.1016/j.ajo.2005.07.044; Nickells RW, 1996, J GLAUCOMA, V5, P345; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parikh RS, 2007, OPHTHALMOLOGY, V114, P2238, DOI 10.1016/j.ophtha.2007.03.005; Park HJ, 2009, NEUROIMAGE, V47, P98, DOI 10.1016/j.neuroimage.2009.03.076; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Shimazawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030526; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Vickers JC, 1997, AUST NZ J OPHTHALMOL, V25, P239, DOI 10.1111/j.1442-9071.1997.tb01400.x; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Wang MY, 2013, NEURORADIOLOGY, V55, P493, DOI 10.1007/s00234-013-1133-1; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Wostyn P, 2010, MED HYPOTHESES, V74, P973, DOI 10.1016/j.mehy.2009.12.019; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714	37	45	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73208	10.1371/journal.pone.0073208	http://dx.doi.org/10.1371/journal.pone.0073208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019910	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200052
J	Zhang, JY; Weng, YG; Liu, X; Wang, JH; Zhang, WW; Kim, SH; Zhang, HY; Li, RD; Kong, YH; Chen, X; Shui, W; Wang, N; Zhao, C; Wu, NN; He, YF; Nan, GX; Chen, X; Wen, S; Zhang, HM; Deng, F; Wan, LH; Luu, HH; Haydon, RC; Shi, LL; He, TC; Shi, Q				Zhang, Jiye; Weng, Yaguang; Liu, Xing; Wang, Jinhua; Zhang, Wenwen; Kim, Stephanie H.; Zhang, Hongyu; Li, Ruidong; Kong, Yuhan; Chen, Xiang; Shui, Wei; Wang, Ning; Zhao, Chen; Wu, Ningning; He, Yunfeng; Nan, Guoxin; Chen, Xian; Wen, Sheng; Zhang, Hongmei; Deng, Fang; Wan, Lihua; Luu, Hue H.; Haydon, Rex C.; Shi, Lewis L.; He, Tong-Chuan; Shi, Qiong			Endoplasmic Reticulum (ER) Stress Inducible Factor Cysteine-Rich with EGF-Like Domains 2 (Creld2) Is an Important Mediator of BMP9-Regulated Osteogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; TUMOR-GROWTH; TRANSDUCER OASIS; SITE-1 PROTEASE; BMP-9; CHOP; MAINTENANCE; SYSTEM; PLAYS	Mesenchymal stem cells (MSCs) are multipotent progenitors that can undergo osteogenic differentiation under proper stimuli. We demonstrated that BMP9 is one of the most osteogenic BMPs. However, the molecular mechanism underlying BMP9-initiated osteogenic signaling in MSCs remains unclear. Through gene expression profiling analysis we identified several candidate mediators of BMP9 osteogenic signaling. Here, we focus on one such signaling mediator and investigate the functional role of cysteine-rich with EGF-like domains 2 (Creld2) in BMP9-initiated osteogenic signaling. Creld2 was originally identified as an ER stress-inducible factor localized in the ER-Golgi apparatus. Our genomewide expression profiling analysis indicates that Creld2 is among the top up-regulated genes in BMP9-stimulated MSCs. We confirm that Creld2 is up-regulated by BMP9 in MSCs. ChIP analysis indicates that Smad1/5/8 directly binds to the Creld2 promoter in a BMP9-dependent fashion. Exogenous expression of Creld2 in MSCs potentiates BMP9-induced early and late osteogenic markers, and matrix mineralization. Conversely, silencing Creld2 expression inhibits BMP9-induced osteogenic differentiation. In vivo stem cell implantation assay reveals that exogenous Creld2 promotes BMP9-induced ectopic bone formation and matrix mineralization, whereas silencing Creld2 expression diminishes BMP9-induced bone formation and matrix mineralization. We further show that Creld2 is localized in ER and the ER stress inducers potentiate BMP9-induced osteogenic differentiation. Our results strongly suggest that Creld2 may be directly regulated by BMP9 and ER stress response may play an important role in regulating osteogenic differentiation.	[Zhang, Jiye; Weng, Yaguang; Wang, Jinhua; Zhang, Wenwen; Zhang, Hongyu; Li, Ruidong; Kong, Yuhan; Shui, Wei; Wu, Ningning; He, Yunfeng; Chen, Xian; Zhang, Hongmei; Wan, Lihua; He, Tong-Chuan; Shi, Qiong] Chongqing Med Univ, Minist Educ Key Lab Diagnost Med & Affiliated Hos, Chongqing, Peoples R China; [Liu, Xing; Wang, Jinhua; Zhang, Wenwen; Kim, Stephanie H.; Zhang, Hongyu; Li, Ruidong; Kong, Yuhan; Chen, Xiang; Shui, Wei; Wang, Ning; Zhao, Chen; Wu, Ningning; He, Yunfeng; Nan, Guoxin; Chen, Xian; Wen, Sheng; Zhang, Hongmei; Deng, Fang; Luu, Hue H.; Haydon, Rex C.; Shi, Lewis L.] Univ Chicago, Med Ctr, Dept Orthopaed Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Liu, Xing; Nan, Guoxin; Wen, Sheng; He, Tong-Chuan] Chongqing Med Univ, Stem Cell Biol & Therapy Lab, Chinese Minist Educ & Chongqing Bur Educ, Key Lab Pediat,Childrens Hosp, Chongqing, Peoples R China; [Chen, Xiang] Fourth Mil Med Univ, Affiliated Tangdu Hosp, Dept Orthopaed Surg, Xian 710032, Peoples R China; [Wang, Ning; Zhao, Chen; Deng, Fang] Third Mil Med Univ, Sch Lab Med, Chongqing, Peoples R China; [Wang, Ning; Zhao, Chen; Deng, Fang] Third Mil Med Univ, Affiliated Southwest Hosp, Chongqing, Peoples R China	Chongqing Medical University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Air Force Military Medical University; Army Medical University; Army Medical University	He, TC (corresponding author), Chongqing Med Univ, Minist Educ Key Lab Diagnost Med & Affiliated Hos, Chongqing, Peoples R China.	tche@uchicago.edu; qiong.shi@yahoo.com	wan, li/GRY-7634-2022	Chen, Xiang/0000-0001-7628-516X	National Institutes of Health; 973 Program of the Ministry of Science and Technology of China [2011CB707906]; Natural Science Foundation of China [NSFC30872770]; Chongqing Science and Technology Commission [CSTC2011BB5131]; Ministry of Education of China [KJ120327]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Program of the Ministry of Science and Technology of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC); Ministry of Education of China(Ministry of Education, China)	The reported work was supported in part by research grants from the National Institutes of Health (RCH, TCH and HHL), the 973 Program of the Ministry of Science and Technology of China (#2011CB707906 to TCH), the Natural Science Foundation of China (NSFC30872770 to QS), Chongqing Science and Technology Commission (CSTC2011BB5131 to QS), and Ministry of Education of China (KJ120327 to QS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Funamoto T, 2011, BONE, V49, P724, DOI 10.1016/j.bone.2011.06.012; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huang E, 2012, J BONE MINER RES; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luther G, 2011, CURR GENE THER, V11, P229; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Maslen CL, 2006, GENE, V382, P111, DOI 10.1016/j.gene.2006.06.016; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Murakami T, 2011, BONE, V48, P514, DOI 10.1016/j.bone.2010.10.176; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Oh-hashi K, 2011, FEBS LETT, V585, P2481, DOI 10.1016/j.febslet.2011.06.029; Oh-hashi K, 2009, BIOCHEM BIOPH RES CO, V387, P504, DOI 10.1016/j.bbrc.2009.07.047; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Ortiz JA, 2005, J NEUROCHEM, V95, P1585, DOI 10.1111/j.1471-4159.2005.03473.x; Park JES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030075; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Patra D, 2011, J BIOL CHEM, V286, P29227, DOI 10.1074/jbc.M110.208686; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pereira RC, 2007, BONE, V40, P619, DOI 10.1016/j.bone.2006.09.028; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182; Ren Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040587; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shirakawa K, 2006, MOL CELL BIOL, V26, P6105, DOI 10.1128/MCB.02429-05; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Xu DJ, 2012, BMB REP, V45, P247, DOI 10.5483/BMBRep.2012.45.4.247; Yao Y, 2012, BLOOD; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zhao YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043383; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	60	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73086	10.1371/journal.pone.0073086	http://dx.doi.org/10.1371/journal.pone.0073086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019898	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200040
J	Pais, D; Hogan, PM; Schlegel, T; Franks, NR; Leonard, NE; Marshall, JAR				Pais, Darren; Hogan, Patrick M.; Schlegel, Thomas; Franks, Nigel R.; Leonard, Naomi E.; Marshall, James A. R.			A Mechanism for Value-Sensitive Decision-Making	PLOS ONE			English	Article							NEST-SITE SELECTION; MODELS; SWARMS; CHOICE; SPEED	We present a dynamical systems analysis of a decision-making mechanism inspired by collective choice in house-hunting honeybee swarms, revealing the crucial role of cross-inhibitory 'stop-signalling' in improving the decision-making capabilities. We show that strength of cross-inhibition is a decision-parameter influencing how decisions depend both on the difference in value and on the mean value of the alternatives; this is in contrast to many previous mechanistic models of decision-making, which are typically sensitive to decision accuracy rather than the value of the option chosen. The strength of cross-inhibition determines when deadlock over similarly valued alternatives is maintained or broken, as a function of the mean value; thus, changes in cross-inhibition strength allow adaptive time-dependent decision-making strategies. Cross-inhibition also tunes the minimum difference between alternatives required for reliable discrimination, in a manner similar to Weber's law of just-noticeable difference. Finally, cross-inhibition tunes the speed-accuracy trade-off realised when differences in the values of the alternatives are sufficiently large to matter. We propose that the model, and the significant role of the values of the alternatives, may describe other decision-making systems, including intracellular regulatory circuits, and simple neural circuits, and may provide guidance in the design of decision-making algorithms for artificial systems, particularly those functioning without centralised control.	[Pais, Darren; Leonard, Naomi E.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Hogan, Patrick M.; Marshall, James A. R.] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Hogan, Patrick M.; Marshall, James A. R.] Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England; [Schlegel, Thomas; Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	Princeton University; University of Sheffield; University of Sheffield; University of Bristol	Marshall, JAR (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.	James.Marshall@sheffield.ac.uk	Franks, Nigel/AAG-8207-2019	Franks, Nigel/0000-0001-8139-9604; Marshall, James/0000-0002-1506-167X	Biotechnology and Biological Sciences Research Council [BB/G02166X/2]; Office of Naval Research [N00014-09-1-1074]; Biotechnology and Biological Sciences Research Council [E19832, BB/G02166X/1] Funding Source: researchfish; BBSRC [BB/G02166X/2, BB/G02166X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Naval Research(Office of Naval Research); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JARM and NRF acknowledge Biotechnology and Biological Sciences Research Council grant BB/G02166X/2 (www.bbsrc.ac.uk). NEL acknowledges Office of Naval Research grant N00014-09-1-1074 (http://www.onr.navy.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold V. I., 2003, CATASTROPHE THEORY, DOI DOI 10.1007/978-3-642-58124-3; Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Britton NF, 2002, P ROY SOC B-BIOL SCI, V269, P1383, DOI 10.1098/rspb.2002.2001; Brown P., 2001, STOCH DYNAM, V1, P159, DOI 10.1142/S0219493701000102; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Feng S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000284; Ferrell JE, 2009, MOL CELL, V36, P724, DOI 10.1016/j.molcel.2009.11.032; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; Hanks TD, 2011, J NEUROSCI, V31, P6339, DOI 10.1523/JNEUROSCI.5613-10.2011; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Marshall JAR, 2006, J R SOC INTERFACE, V3, P243, DOI 10.1098/rsif.2005.0075; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; Marshall JAR, 2009, CURR BIOL, V19, pR395, DOI 10.1016/j.cub.2009.03.011; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; Nene NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032779; Nicolis SC, 1999, J THEOR BIOL, V198, P575, DOI 10.1006/jtbi.1999.0934; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; Niven JE, 2012, SCIENCE, V335, P43, DOI 10.1126/science.1216563; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Passino KM, 2008, BEHAV ECOL SOCIOBIOL, V62, P401, DOI 10.1007/s00265-007-0468-1; Passino KM, 2006, BEHAV ECOL SOCIOBIOL, V59, P427, DOI 10.1007/s00265-005-0067-y; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Seeley TD, 2001, BEHAV ECOL SOCIOBIOL, V49, P416, DOI 10.1007/s002650000299; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sumpter DJT, 2012, MANAG DECIS ECON, V33, P295, DOI 10.1002/mde.2553; Tsetsos K, 2012, P NATL ACAD SCI USA, V109, P9659, DOI 10.1073/pnas.1119569109; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; van Kampen N.G., 2001, STOCHASTIC PROCESSES; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; von Frisch K., 1967, DANCE LANGUAGE ORIEN	39	76	76	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73216	10.1371/journal.pone.0073216	http://dx.doi.org/10.1371/journal.pone.0073216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215VH	24023835	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000324238400053
J	Pan, XQ; Zhu, BZ; Luo, YB; Fu, DQ				Pan, Xiaoqi; Zhu, Benzhong; Luo, Yunbo; Fu, Daqi			Unraveling the Protein Network of Tomato Fruit in Response to Necrotrophic Phytopathogenic Rhizopus nigricans	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; HEAT-SHOCK PROTEINS; ETHYLENE BIOSYNTHESIS; PROTEOMIC ANALYSIS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ENHANCES PHOTOSYNTHESIS; BORRELIA-BURGDORFERI; LOW-TEMPERATURES; STRESS; EXPRESSION	Plants are endowed with a sophisticated defense mechanism that gives signals to plant cells about the immediate danger from surroundings and protects them from pathogen invasion. In the search for the particular proteins involved in fruit defense responses, we report here a comparative analysis of tomato fruit (Solanum lycopersicum cv. Ailsa Craig) infected by Rhizopus nigricans Ehrenb, which is a significant contributor to postharvest rot disease in fresh tomato fruits. In total, four hundred forty-five tomato proteins were detected in common between the non-infected group and infected tomato fruit of mature green. Forty-nine differentially expressed spots in 2-D gels were identified, and were sorted into fifteen functional groups. Most of these proteins participate directly in the stress response process, while others were found to be involved in several equally important biological processes: protein metabolic process, carbohydrate metabolic process, ethylene biosynthesis, and cell death and so on. These responses occur in different cellular components, both intra-and extracellular spaces. The differentially expressed proteins were integrated into several pathways to show the regulation style existing in tomato fruit host. The composition of the collected proteins populations and the putative functions of the identified proteins argue for their roles in pathogen-plant interactions. Collectively results provide evidence that several regulatory pathways contribute to the resistance of tomato fruit to pathogen.	[Pan, Xiaoqi; Zhu, Benzhong; Luo, Yunbo; Fu, Daqi] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China	China Agricultural University	Fu, DQ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.	qigongzi1031@126.com			National Natural Science Foundation of China [31000925]; Doctor Innovation Project of China Agricultural University [2012YJ082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctor Innovation Project of China Agricultural University	This work was funded by National Natural Science Foundation of China (number 31000925) and Doctor Innovation Project of China Agricultural University (number 2012YJ082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; [Anonymous], 2005, PLANT TISSUE CULT LE; AVDIUSHKO SA, 1993, PHYSIOL MOL PLANT P, V42, P441, DOI 10.1006/pmpp.1993.1033; BACHMANN M, 1994, PLANT PHYSIOL, V105, P1335, DOI 10.1104/pp.105.4.1335; Bachmann M, 1996, FEBS LETT, V398, P26, DOI 10.1016/S0014-5793(96)01188-X; Banci L, 2011, J PROTEOMICS, V74, P2522, DOI 10.1016/j.jprot.2011.04.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownell SE, 2012, FRONTIERS IMMUNOLOGY; Chen SB, 2009, J EXP BOT, V60, P2005, DOI 10.1093/jxb/erp075; Clapp C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.90; CORDES S, 1989, PLANT CELL, V1, P1025, DOI 10.1105/tpc.1.10.1025; Feng LL, 2007, FUNCT PLANT BIOL, V34, P822, DOI 10.1071/FP07074; Feng LL, 2007, PLANT CELL REP, V26, P1635, DOI 10.1007/s00299-006-0299-y; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Giannakis C., 1998, Australian Journal of Grape and Wine Research, V4, P14, DOI 10.1111/j.1755-0238.1998.tb00130.x; Gusev O, 2011, CELL STRESS CHAPERON, V16, P81, DOI 10.1007/s12192-010-0223-9; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Hartwig K, 2009, GENES NUTR, V4, P59, DOI 10.1007/s12263-009-0113-x; HAVIR EA, 1987, PLANT PHYSIOL, V84, P450, DOI 10.1104/pp.84.2.450; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Kneissl ML, 1996, PLANT PHYSIOL, V112, P537, DOI 10.1104/pp.112.2.537; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Li F, 2009, J CHROMATOGR A, V1216, P4383, DOI 10.1016/j.chroma.2009.02.069; Lin ZF, 2008, PLANT J, V54, P1083, DOI 10.1111/j.1365-313X.2008.03481.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurie S, 1997, PHYSIOL MOL PLANT P, V50, P141, DOI 10.1006/pmpp.1996.0074; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; Munoz-Bertomeu J, 2010, PLANT SIGNAL BEHAV, V5, P67, DOI 10.4161/psb.5.1.10200; Munoz-Bertomeu J, 2010, PLANT PHYSIOL, V152, P1830, DOI 10.1104/pp.109.150458; Nogueira SV, 2012, INFECT IMMUN, V80, P82, DOI 10.1128/IAI.05671-11; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Pan XQ, 2013, POSTHARVEST BIOL TEC, V75, P28, DOI 10.1016/j.postharvbio.2012.07.008; Pennycooke JC, 2003, PLANT PHYSIOL, V133, P901, DOI 10.1104/pp.103.024554; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; PROMBONA A, 1995, PLANT MOL BIOL, V27, P1109, DOI 10.1007/BF00020884; Qin G., 2012, PLANT J; Raines CA, 2003, PHOTOSYNTH RES, V75, P1, DOI 10.1023/A:1022421515027; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; RIVETT AJ, 1993, CURR BIOL, V3, P127, DOI 10.1016/0960-9822(93)90173-L; Sabehat A, 1998, PLANT PHYSIOL, V117, P651, DOI 10.1104/pp.117.2.651; SANTARIUS KA, 1973, PLANTA, V113, P105, DOI 10.1007/BF00388196; SANTARIUS KA, 1977, PLANTA, V136, P163, DOI 10.1007/BF00396193; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Shah P, 2012, J PROTEOME RES, V11, P2178, DOI 10.1021/pr200965c; Soti C, 2007, J BIOSCIENCES, V32, P511, DOI 10.1007/s12038-007-0050-z; Strand A, 2003, PLANT CELL ENVIRON, V26, P523, DOI 10.1046/j.1365-3040.2003.00983.x; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Toledo A, 2012, INFECT IMMUN, V80, P359, DOI 10.1128/IAI.05836-11; Toroser D, 1998, FEBS LETT, V435, P110, DOI 10.1016/S0014-5793(98)01048-5; VAN DER STRAETEN D, 1991, PLANT CELL, V3, P719, DOI 10.2307/3869253; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yokotani N, 2009, J EXP BOT, V60, P3433, DOI 10.1093/jxb/erp185; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zegzouti H, 1999, PLANT J, V18, P589, DOI 10.1046/j.1365-313x.1999.00483.x; Zhang HY, 2008, BIOL CONTROL, V47, P60, DOI 10.1016/j.biocontrol.2008.06.012; Zhao J, 2011, 14 3 3 PROTEINS POTE	62	9	9	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73034	10.1371/journal.pone.0073034	http://dx.doi.org/10.1371/journal.pone.0073034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023804	gold, Green Submitted, Green Published			2022-12-27	WOS:000324238400040
J	Singh, JP; Grann, M; Fazel, S				Singh, Jay P.; Grann, Martin; Fazel, Seena			Authorship Bias in Violence Risk Assessment? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CONFLICT-OF-INTEREST; FINANCIAL CONFLICTS; INDUSTRY SPONSORSHIP; ROC CURVE; ALLEGIANCE; SIZE	Various financial and non-financial conflicts of interests have been shown to influence the reporting of research findings, particularly in clinical medicine. In this study, we examine whether this extends to prognostic instruments designed to assess violence risk. Such instruments have increasingly become a routine part of clinical practice in mental health and criminal justice settings. The present meta-analysis investigated whether an authorship effect exists in the violence risk assessment literature by comparing predictive accuracy outcomes in studies where the individuals who designed these instruments were study authors with independent investigations. A systematic search from 1966 to 2011 was conducted using PsycINFO, EMBASE, MEDLINE, and US National Criminal Justice Reference Service Abstracts to identify predictive validity studies for the nine most commonly used risk assessment tools. Tabular data from 83 studies comprising 104 samples was collected, information on two-thirds of which was received directly from study authors for the review. Random effects subgroup analysis and metaregression were used to explore evidence of an authorship effect. We found a substantial and statistically significant authorship effect. Overall, studies authored by tool designers reported predictive validity findings around two times higher those of investigations reported by independent authors (DOR = 6.22 [95% CI = 4.68-8.26] in designers' studies vs. DOR = 3.08 [95% CI = 2.45-3.88] in independent studies). As there was evidence of an authorship effect, we also examined disclosure rates. None of the 25 studies where tool designers or translators were also study authors published a conflict of interest statement to that effect, despite a number of journals requiring that potential conflicts be disclosed. The field of risk assessment would benefit from routine disclosure and registration of research studies. The extent to which similar conflict of interests exists in those developing risk assessment guidelines and providing expert testimony needs clarification.	[Singh, Jay P.] Dept Justice, Psychiatr Psychol Serv, Zurich, Switzerland; [Singh, Jay P.] Molde Univ Coll, Fac Hlth Sci, Molde, Norway; [Grann, Martin] Karolinska Inst, Ctr Violence Prevent, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Fazel, Seena] Univ Oxford, Dept Psychiat, Oxford, England	Molde University College; Karolinska Institutet; University of Oxford	Fazel, S (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	seena.fazel@psych.ox.ac.uk	Fazel, Seena/B-5307-2008	Fazel, Seena/0000-0002-5383-5365	Wellcome Trust; Swedish Prison and Probation Service	Wellcome Trust(Wellcome Trust); Swedish Prison and Probation Service	Dr. Fazel is funded by the Wellcome Trust. Dr. Grann is funded by Swedish Prison and Probation Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DA., 1995, LSI R LEVEL SERVICE; [Anonymous], 2010, LANCET, V375, P348, DOI 10.1016/S0140-6736(10)60148-1; Archer RP, 2006, J PERS ASSESS, V87, P84, DOI 10.1207/s15327752jpa8701_07; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Belia S, 2005, PSYCHOL METHODS, V10, P389, DOI 10.1037/1082-989X.10.4.389; Blair PR, 2008, CLIN PSYCHOL-SCI PR, V15, P346, DOI 10.1111/j.1468-2850.2008.00147.x; Boer D.P., 1997, MANUAL SEXUAL VIOLEN; Borum R., 2002, MANUAL STRUCTURED AS; Borum R, 2003, MANUAL STRUCTURED AS; Buchanan A, 2001, LANCET, V358, P1955, DOI 10.1016/S0140-6736(01)06962-8; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Cohen J.E., 1988, STAT POWER ANAL BEHA; Eaves, 1995, MANUAL SPOUSAL ASSAU; Egger M., 2001, SYSTEMATIC REV HLTH; Fava GA, 2009, J ETHICS MENT HLTH, V4, pS1; Fazel S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4692; Guy LS., 2008, THESIS; Hanson R.K., 1999, STATIC 99 IMPROVING; Hare R. D., 2003, HARE PSYCHOPATHY CHE, V2nd; Harris A, 2003, STATIC 99 CODING RUL; Harris GT, 2010, CLIN PSYCHOL-SCI PR, V17, P82, DOI 10.1111/j.1468-2850.2009.01197.x; Harris GT, 2003, ANN NY ACAD SCI, V989, P198; Khiroya R, 2009, PSYCHIATR BULL, V33, P129, DOI 10.1192/pb.bp.108.019810; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; Kropp P. R., 1999, SPOUSAL ASSAULT RISK; Kropp P. R., 1994, MANUAL SPOUSAL ASSAU; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lilienfeld SO, 2008, CLIN PSYCHOL-SCI PR, V15, P361, DOI 10.1111/j.1468-2850.2008.00148.x; Maj M, 2008, BRIT J PSYCHIAT, V193, P91, DOI 10.1192/bjp.bp.108.049361; Marzban C, 2004, WEATHER FORECAST, V19, P1106, DOI 10.1175/825.1; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Monahan John, 1981, CLIN PREDICTION VIOL; Morton SC., 2004, METAREGRESSION APPRO; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; Quinsey V. L., 2006, VIOLENT OFFENDERS AP, V2nd, DOI 10.1037/11367-000; Quinsey Vernon L., 1998, VIOLENT OFFENDERS AP; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Ruscio J, 2008, PSYCHOL METHODS, V13, P19, DOI 10.1037/1082-989X.13.1.19; Singh JP, 2012, HANDBOOK OF JUVENILE FORENSIC PSYCHOLOGY AND PSYCHIATRY, P215, DOI 10.1007/978-1-4614-0905-2_14; Singh JP, 2013, BEHAV SCI LAW, V31, P8, DOI 10.1002/bsl.2052; Singh JP, 2011, CLIN PSYCHOL REV, V31, P499, DOI 10.1016/j.cpr.2010.11.009; Singh JP, 2010, CRIM JUSTICE BEHAV, V37, P965, DOI 10.1177/0093854810374274; Sjostedt G., 2002, INT J FORENSIC MENT, V1, P179, DOI [DOI 10.1080/14999013.2002.10471172, https://doi.org/10.1080/14999013.2002.10471172]; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; Van Hauwaert SM, 2018, EUR J POLIT RES, V57, P68, DOI 10.1111/1475-6765.12216; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13; Viljoen JL, 2010, ASSESSMENT, V17, P377, DOI 10.1177/1073191109359587; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Webster C.D., 1997, HCR 20 ASSESSING RIS; Webster CD., 1995, HCR 20 SCHEME ASSESS	52	67	67	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e72484	10.1371/journal.pone.0072484	http://dx.doi.org/10.1371/journal.pone.0072484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215VH	24023744	Green Published, gold			2022-12-27	WOS:000324238400015
J	Tan, MY; Xia, SQ; Zhang, Q; Zhu, J; Bao, ED				Tan, Mingyue; Xia, Shengqiang; Zhang, Qi; Zhu, Jiang; Bao, Erdun			The-160C > A Polymorphism in e-Cadherin Is Associated with the Risk of Nephrolithiasis	PLOS ONE			English	Article							RECEPTOR GENE POLYMORPHISMS; VITAMIN-D-RECEPTOR; CELL-ADHESION; KIDNEY-STONE; EPIDEMIOLOGY	Nephrolithiasis is a common disorder worldwide. E-cadherin (CDH1) is involved in epithelial cell-cell interactions and plays important roles in the etiology of nephrolithiasis. We hypothesized that variants in the CDH1 gene are associated with risk of nephrolithiasis. In a hospital-based case-control study of 127 nephrolithiasis patients and 152 controls frequency matched by age and sex, we genotyped the functional -160C>A (rs16260) polymorphism and assessed its associations with risk of nephrolithiasis in a Chinese population. We found that the CA/AA genotypes were associated with a significantly decreased risk of nephrolithiasis (OR = 0.53, 95% CI = 0.32-0.87), compared with the CC genotype, particularly among subgroups of BMI > 24 kg/m(2) (OR = 0.38, 95% CI = 0.17-0.85), age <= 57 years (OR = 0.47, 95% CI = 0.24-0.93), and men (OR = 0.56, 95% CI = 0.29-0.99). Our results suggest that the CDH1 polymorphism is involved in the etiology of nephrolithiasis and thus may be a marker for genetic susceptibility to nephrolithiasis.	[Tan, Mingyue; Zhang, Qi; Zhu, Jiang; Bao, Erdun] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China; [Xia, Shengqiang] Tongji Univ, Shanghai Peoples Hosp 10, Dept Urol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Tongji University	Zhu, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China.	drzhujiang888@126.com; bed@medmail.com.cn						Amato M, 2004, UROL INT, V72, P1, DOI 10.1159/000076582; Chen WC, 2003, UROL RES, V31, P218, DOI 10.1007/s00240-003-0325-2; Chen WC, 2001, BJU INT, V88, P432, DOI 10.1046/j.1464-410X.2001.02319.x; Chou YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025227; Chou YH, 2007, KAOHSIUNG J MED SCI, V23, P63, DOI 10.1016/S1607-551X(09)70376-6; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; de Water R, 2000, AM J KIDNEY DIS, V36, P615, DOI 10.1053/ajkd.2000.16203; Ferreira LG, 2010, NEPHRON CLIN PRACT, V114, pC135, DOI 10.1159/000254386; Heilberg IP, 2002, NEPHRON, V90, P51, DOI 10.1159/000046314; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Jang JH, 2012, INT J MOL MED, V30, P1357, DOI 10.3892/ijmm.2012.1158; Leaf DE, 2012, CLIN J AM SOC NEPHRO, V7, P829, DOI 10.2215/CJN.11331111; Li LC, 2000, CANCER RES, V60, P873; Lu XL, 2012, GENE, V511, P127, DOI 10.1016/j.gene.2012.09.112; Nakamura A, 2002, MUTAT RES-FUND MOL M, V502, P19, DOI 10.1016/S0027-5107(02)00024-6; Ojakian GK, 2001, J CELL SCI, V114, P941; Ramello A, 2000, J NEPHROL, V13, pS45; Rendina D, 2004, UROLOGY, V64, P833, DOI 10.1016/j.urology.2004.05.013; Serio A, 1999, NEPHRON, V81, P26, DOI 10.1159/000046295; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Trinchieri A, 1999, J UROLOGY, V162, P27, DOI 10.1097/00005392-199907000-00007; Tsai FJ, 2003, UROL INT, V70, P278, DOI 10.1159/000070135; Tsujihata M, 2001, EUR UROL, V40, P458, DOI 10.1159/000049816	23	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2013	8	9							e73109	10.1371/journal.pone.0073109	http://dx.doi.org/10.1371/journal.pone.0073109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215VH	24023817	Green Published, Green Submitted, gold			2022-12-27	WOS:000324238400043
J	Chandramouli, KH; Ravasi, T; Reish, D; Qian, PY				Chandramouli, Kondethimmanahalli H.; Ravasi, Timothy; Reish, Donald; Qian, Pei-Yuan			Proteomic Changes between Male and Female Worms of the Polychaetous Annelid Neanthes arenaceodentata before and after Spawning	PLOS ONE			English	Article							MYOSIN LIGHT-CHAIN; LARVAL METAMORPHOSIS; HYDROIDS-ELEGANS; PSEUDOPOLYDORA-VEXILLOSA; PHOSPHOPROTEOME ANALYSIS; PROTEIN; TROPONIN; SYSTEM; KINASE; PHOSPHORYLATION	The Neanthes acuminata species complex (Polychaeta) are cosmopolitan in distribution. Neanthes arenaceodentata, Southern California member of the N. acuminata complex, has been widely used as toxicological test animal in the marine environment. Method of reproduction is unique in this polychaete complex. Same sexes fight and opposite sexes lie side by side until egg laying. Females lose about 75% of their weight and die after laying eggs. The male, capable of reproducing up to nine times, fertilizes the eggs and incubates the embryos for 3-4 weeks. The objective of this study was to determine if there is any set of proteins that influences this unique pattern of reproduction. Gel-based two-dimensional electrophoresis (2-DE) and gel-free quantitative proteomics methods were used to identify differential protein expression patterns before and after spawning in both male and female N. arenaceodentata. Males showed a higher degree of similarity in protein expression patterns but females showed large changes in phosphoproteme before and after spawning. There was a decrease (about 70%) in the number of detected phosphoproteins in spent females. The proteins involved in muscular development, cell signaling, structure and integrity, and translation were differentially expressed. This study provides proteomic insights of the male and female worms that may serve as a foundation for better understanding of unusual reproductive patterns in polychaete worms.	[Chandramouli, Kondethimmanahalli H.; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res, Hong Kong, Hong Kong, Peoples R China; [Chandramouli, Kondethimmanahalli H.; Ravasi, Timothy] King Abdullah Univ Sci & Technol, Div Appl Math & Comp Sci, Div Biol & Environm Sci & Engn, Integrat Syst Biol Lab, Thuwal, Saudi Arabia; [Reish, Donald] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	Hong Kong University of Science & Technology; King Abdullah University of Science & Technology; California State University System; California State University Long Beach	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Ravasi, Timothy/B-8777-2008	Ravasi, Timothy/0000-0002-9950-465X; Chandramouli, Kondethimmanahalli/0000-0002-0104-1993; Qian, Pei-Yuan/0000-0003-4074-9078	China Ocean Mineral Resources Research and Development [DY125-15-T-02]; Sanya Institute of Deep-Sea Science and Engineering [SIDSSE-201206]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]	China Ocean Mineral Resources Research and Development; Sanya Institute of Deep-Sea Science and Engineering; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This study was supported by a grant from China Ocean Mineral Resources Research and Development (DY125-15-T-02), a grant from Sanya Institute of Deep-Sea Science and Engineering (SIDSSE-201206), and an award SA-C0040/UK-C0016 from the King Abdullah University of Science and Technology to PY Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAERT JL, 1987, COMP BIOCHEM PHYS B, V88, P1191, DOI 10.1016/0305-0491(87)90023-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blank M, 2012, J PROTEOME RES, V11, P897, DOI 10.1021/pr200710z; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Chandramouli KH, 2013, J PROTEOME RES, V12, P1344, DOI 10.1021/pr3010088; Chandramouli KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038814; Chandramouli KH, 2012, J PROTEOME RES, V11, P1330, DOI 10.1021/pr200982k; Chandramouli KH, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-51; Chandramouli KH, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-31; Chen ZF, 2012, COMP BIOCHEM PHYS B, V162, P113, DOI 10.1016/j.cbpb.2012.04.001; Chen ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031337; Cheng GF, 2005, PROTEOMICS, V5, P511, DOI 10.1002/pmic.200400953; Chevalier F, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-23; DAVIS W R, 1975, Revue Internationale d'Oceanographie Medicale, V37-38, P3; Dilly GF, 2012, P ROY SOC B-BIOL SCI, V279, P3347, DOI 10.1098/rspb.2012.0098; Fischer A., 1986, Advances in Invertebrate Reproduction, V4, P195; Glasby CJ, 2005, MAR ECOL-EVOL PERSP, V26, P235, DOI 10.1111/j.1439-0485.2005.00059.x; GREASER ML, 1971, J BIOL CHEM, V246, P4226; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; HARTSHORNE DJ, 1969, BIOCHIM BIOPHYS ACTA, V175, P320, DOI 10.1016/0005-2795(69)90009-9; Issaq HJ, 2008, BIOTECHNIQUES, V44, P697, DOI 10.2144/000112823; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; Lee RF, 2005, COMP BIOCHEM PHYS B, V140, P381, DOI 10.1016/j.cbpc.2004.11.002; MARSDEN JR, 1966, CAN J ZOOLOG, V44, P377, DOI 10.1139/z66-041; Moreno Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000326; Neave MJ, 2012, J PROTEOMICS, V75, P2721, DOI 10.1016/j.jprot.2012.03.031; Reish DJ, 1997, B MAR SCI, V60, P584; Reish DJ, 2009, ZOOSYMPOSIA, V2, P391, DOI 10.11646/zoosymposia.2.1.27; REISH DONALD J., 1957, PACIFIC SCI, V11, P216; Rosen G, 2011, ENVIRON TOXICOL CHEM, V30, P730, DOI 10.1002/etc.438; SCHAUB MC, 1969, BIOCHEM J, V115, P993, DOI 10.1042/bj1150993; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SOHMA H, 1988, J BIOCHEM-TOKYO, V103, P431, DOI 10.1093/oxfordjournals.jbchem.a122287; STEVENS FC, 1983, CAN J BIOCHEM CELL B, V61, P906, DOI 10.1139/o83-115; Sun J, 2012, J PROTEOME RES, V11, P4240, DOI 10.1021/pr3003613; Takemori N, 2009, PROTEOMICS, V9, P2484, DOI 10.1002/pmic.200800795; Thiyagarajan V, 2009, J PROTEOME RES, V8, P2708, DOI 10.1021/pr800976u; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Wang H, 2010, J EXP ZOOL PART B, V314B, P390, DOI 10.1002/jez.b.21344; Winchell CJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-17; WYSOLMERSKI RB, 1990, P NATL ACAD SCI USA, V87, P16, DOI 10.1073/pnas.87.1.16; Zhang HM, 2011, J PROTEOME RES, V10, P349, DOI 10.1021/pr100817v; Zhang Y, 2010, J PROTEOME RES, V9, P4851, DOI 10.1021/pr100645z	44	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72990	10.1371/journal.pone.0072990	http://dx.doi.org/10.1371/journal.pone.0072990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023665	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200061
J	Huang, HX; Bae, C; Sachs, F; Suchyna, TM				Huang, Haixia; Bae, Chilman; Sachs, Frederick; Suchyna, Thomas M.			Caveolae Regulation of Mechanosensitive Channel Function in Myotubes	PLOS ONE			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; SKELETAL-MUSCLE MYOTUBES; ION CHANNELS; MEMBRANE CHOLESTEROL; SCAFFOLDING DOMAIN; T-TUBULE; TRPC1; CELL; STRETCH; FIBERS	Mutations that lead to muscular dystrophy often create deficiencies in cytoskeletal support of the muscle sarcolemma causing hyperactive mechanosensitive cation channel (MSC) activity and elevated intracellular Ca2+. Caveolae are cholesterol-rich microdomains that form mechanically deformable invaginations of the sarcolemma. Mutations to caveolin-3, the main scaffolding protein of caveolae in muscle, cause Limbe-Girdle muscular dystrophy. Using genetic and acute chemical perturbations of developing myotubes we investigated whether caveolae are functionally linked to MSCs. MSC sensitivity was assayed using suction application to patches and probe-induced indentation during whole-cell recordings. Membrane mechanical stress in patches was monitored using patch capacitance/impedance. Cholesterol depletion disrupted caveolae and caused a large increase in MSC current. It also decreased the membrane mechanical relaxation time, likely reflecting cytoskeleton dissociation from the bilayer. Reduction of Cav3 expression with miRNA also increased MSC current and decreased patch relaxation time. In contrast Cav3 overexpression produced a small decrease in MSC currents. To acutely and specifically inhibit Cav3 interactions, we made a chimeric peptide containing the antennapedia membrane translocation domain and the Cav3 scaffolding domain (A-CSD3). A-CSD3 action was time dependent initially producing a mild Ca2+ leak and increased MSC current, while longer exposures decreased MSC currents coinciding with increased patch stiffening. Images of GFP labeled Cav3 in patches showed that Cav3 doesn't enter the pipette, showing patch composition differed from the cell surface. However, disruption via cholesterol depletion caused Cav3 to become uniformly distributed over the sarcolemma and Cav3 appearance in the patch dome. The whole-cell indentation currents elicited under the different caveolae modifying conditions mirror the patch response supporting the role of caveolae in MSC function. These studies show that normal expression levels of Cav3 are mechanoprotective to the sarcolemma through multiple mechanisms, and Cav3 upregulation observed in some dystrophies may compensate for other mechanical deficiencies.	[Huang, Haixia] Capital Med Univ, Dept Physiol, Beijing, Peoples R China; [Bae, Chilman; Sachs, Frederick; Suchyna, Thomas M.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	Capital Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Suchyna, TM (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA.	suchyna@buffalo.edu			National Institutes of Health; Children's Guild of Buffalo	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Guild of Buffalo	Supported by grants from the National Institutes of Health and the Children's Guild of Buffalo to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2011, INT J BIOCHEM CELL B, V43, P290, DOI 10.1016/j.biocel.2010.11.005; Ayuyan AG, 2008, BIOPHYS J, V94, P2654, DOI 10.1529/biophysj.107.118596; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOPHYS J, V101, P2645, DOI 10.1016/j.bpj.2011.11.002; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Bernatchez PN, 2005, P NATL ACAD SCI USA, V102, P761, DOI 10.1073/pnas.0407224102; Bett G, JOURNAL, V72, pA268; BONILLA E, 1988, AM J PATHOL, V133, P440; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cristofaro V, 2007, NEUROUROL URODYNAM, V26, P71, DOI 10.1002/nau.20361; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Das M, 2012, ANN MED, V44, P530, DOI 10.3109/07853890.2011.577445; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Ferrari MB, 2006, CELL BIOCHEM BIOPHYS, V45, P317, DOI 10.1385/CBB:45:3:317; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Franco-Obregon A, 2002, J PHYSIOL-LONDON, V539, P391, DOI 10.1113/jphysiol.2001.013043; FRANCOOBREGON A, 1994, J PHYSIOL-LONDON, V481, P299, DOI 10.1113/jphysiol.1994.sp020440; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Galbiati F, 2001, TRENDS MOL MED, V7, P435, DOI 10.1016/S1471-4914(01)02105-0; Gazzerro E, 2010, EUR J HUM GENET, V18, P137, DOI 10.1038/ejhg.2009.103; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Gervasio OL, 2011, J CELL SCI, V124, P3581, DOI 10.1242/jcs.084376; Gil Z, 1999, BIOPHYS J, V76, P3118, DOI 10.1016/S0006-3495(99)77463-1; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Halayko AJ, 2005, CAN J PHYSIOL PHARM, V83, P877, DOI 10.1139/Y05-107; Hamill OP, 1997, BIOL BULL, V192, P121, DOI 10.2307/1542583; Hezel M, 2010, MOL BIOL CELL, V21, P302, DOI 10.1091/mbc.E09-05-0381; Ho TC, 2012, CHANNELS, V6, P246, DOI 10.4161/chan.20719; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Kwiatek AM, 2006, MOL PHARMACOL, V70, P1174, DOI 10.1124/mol.105.021741; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Nakamura TY, 2001, AM J PHYSIOL-CELL PH, V281, pC690, DOI 10.1152/ajpcell.2001.281.2.C690; Oh H, 2009, ARTERIOSCL THROM VAS, V29, P1290, DOI 10.1161/ATVBAHA.109.189571; Pan NC, 2012, PFLUG ARCH EUR J PHY, V464, P193, DOI 10.1007/s00424-012-1132-9; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; QUARTARARO N, 1988, PFLUG ARCH EUR J PHY, V411, P101, DOI 10.1007/BF00581653; Radojevic V, 2000, CELL TISSUE RES, V300, P447, DOI 10.1007/s004410000213; Sabourin J, 2009, J BIOL CHEM, V284, P36248, DOI 10.1074/jbc.M109.012872; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Smythe GM, 2006, EXP CELL RES, V312, P2816, DOI 10.1016/j.yexcr.2006.05.010; Stiber JA, 2009, J CARDIOVASC PHARM, V54, P116, DOI 10.1097/FJC.0b013e3181aa233f; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Suchyna T, 2011, CARDIAC MECHANOELECT, P57; Suchyna TM, 2007, J PHYSIOL-LONDON, V581, P369, DOI 10.1113/jphysiol.2006.125021; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Suchyna TM, 2004, PHYS BIOL, V1, P1, DOI 10.1088/1478-3967/1/1/001; Sukharev S, 2004, TRENDS NEUROSCI, V27, P345, DOI 10.1016/j.tins.2004.04.006; TANK DW, 1982, J CELL BIOL, V92, P207, DOI 10.1083/jcb.92.1.207; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Vaghy PL, 1998, FEBS LETT, V431, P125, DOI 10.1016/S0014-5793(98)00738-8; Vandebrouck A, 2007, FASEB J, V21, P608, DOI 10.1096/fj.06-6683com; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vasquez I, 2012, J PHYSIOL-LONDON, V590, P6167, DOI 10.1113/jphysiol.2012.240044; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Zanou N, 2009, FEBS LETT, V583, P3600, DOI 10.1016/j.febslet.2009.10.033	75	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72894	10.1371/journal.pone.0072894	http://dx.doi.org/10.1371/journal.pone.0072894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023653	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200049
J	Huang, YY; Matzke, AJM; Matzke, M				Huang, Ya-Yi; Matzke, Antonius J. M.; Matzke, Marjori			Complete Sequence and Comparative Analysis of the Chloroplast Genome of Coconut Palm (Cocos nucifera)	PLOS ONE			English	Article							RNA EDITING SITES; PLASTID GENOMES; PHYLOGENETIC-RELATIONSHIPS; INVERTED REPEAT; MESSENGER-RNAS; DNA; ORGANIZATION; TRANSCRIPTS; EVOLUTION; GENES	Coconut, a member of the palm family (Arecaceae), is one of the most economically important trees used by mankind. Despite its diverse morphology, coconut is recognized taxonomically as only a single species (Cocos nucifera L.). There are two major coconut varieties, tall and dwarf, the latter of which displays traits resulting from selection by humans. We report here the complete chloroplast (cp) genome of a dwarf coconut plant, and describe the gene content and organization, inverted repeat fluctuations, repeated sequence structure, and occurrence of RNA editing. Phylogenetic relationships of monocots were inferred based on 47 chloroplast protein-coding genes. Potential nodes for events of gene duplication and pseudogenization related to inverted repeat fluctuation were mapped onto the tree using parsimony criteria. We compare our findings with those from other palm species for which complete cp genome sequences are available.	[Huang, Ya-Yi; Matzke, Antonius J. M.; Matzke, Marjori] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan	Matzke, M (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	marjorimatzke@gate.sinica.edu.tw	Matzke, Marjori/H-8689-2015; Matzke, Antonius/H-8698-2015		Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	This work was funded by Academia Sinica (http://www.sinica.edu.tw/main_e.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2012, GENOME BIOL EVOL, V4, P1316, DOI 10.1093/gbe/evs110; Baker WJ, 2009, SYST BIOL, V58, P240, DOI 10.1093/sysbio/syp021; Barrett CF, 2013, CLADISTICS, V29, P65, DOI 10.1111/j.1096-0031.2012.00418.x; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Cai Z, 2008, J MOL EVOL; Cai ZQ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-77; Chen HY, 2011, J INTEGR PLANT BIOL, V53, P961, DOI 10.1111/j.1744-7909.2011.01082.x; CHEN XM, 1995, PLANT CELL, V7, P1295; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Corneille S, 2000, MOL GEN GENET, V264, P419, DOI 10.1007/s004380000295; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Donaher N, 2009, GENOME BIOL EVOL, V1, P439, DOI 10.1093/gbe/evp047; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Gray BN, 2009, TRANSGENIC RES, V18, P559, DOI 10.1007/s11248-009-9246-3; GRAY MW, 1993, FASEB J, V7, P64, DOI 10.1096/fasebj.7.1.8422976; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Gunn BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021143; Guzowska-Nowowiejska M, 2009, GENE, V434, P1, DOI 10.1016/j.gene.2008.12.017; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; HARRIES HC, 1978, BOT REV, V44, P265, DOI 10.1007/BF02957852; Hirose T, 1999, MOL GEN GENET, V262, P462, DOI 10.1007/s004380051106; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Lutz KA, 2001, CURR GENET, V40, P214, DOI 10.1007/s002940100242; Marechal A, 2009, P NATL ACAD SCI USA, V106, P14693, DOI 10.1073/pnas.0901710106; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Meerow AW, 2012, GENOMICS TREE CROPS, P299, DOI DOI 10.1007/978-1-4614-0920-5_10; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; PALMER JD, 1987, P NATL ACAD SCI USA, V84, P769, DOI 10.1073/pnas.84.3.769; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Perera L, 2003, EUPHYTICA, V132, P121, DOI 10.1023/A:1024696303261; Perry AS, 2002, J MOL EVOL, V55, P501, DOI 10.1007/s00239-002-2333-y; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Rogalski M, 2006, NUCLEIC ACIDS RES, V34, P4537, DOI 10.1093/nar/gkl634; ROHDE W, 1994, J GEN VIROL, V75, P2141, DOI 10.1099/0022-1317-75-9-2141; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sasaki T, 2003, MOL BIOL EVOL, V20, P1028, DOI 10.1093/molbev/msg098; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SHIMADA H, 1991, NUCLEIC ACIDS RES, V19, P983, DOI 10.1093/nar/19.5.983; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tillich M, 2006, MOL BIOL EVOL, V23, P1912, DOI 10.1093/molbev/msl054; Uthaipaisanwong P, 2012, GENE, V500, P172, DOI 10.1016/j.gene.2012.03.061; Wakasugi T, 1996, P NATL ACAD SCI USA, V93, P8766, DOI 10.1073/pnas.93.16.8766; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zandueta-Criado A, 2004, NUCLEIC ACIDS RES, V32, P542, DOI 10.1093/nar/gkh217; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	59	65	69	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e74736	10.1371/journal.pone.0074736	http://dx.doi.org/10.1371/journal.pone.0074736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023703	gold, Green Published, Green Submitted			2022-12-27	WOS:000323880200101
J	Geiser, J; De Lisle, RC; Finkelstein, D; Adlard, PA; Bush, AI; Andrews, GK				Geiser, Jim; De Lisle, Robert C.; Finkelstein, David; Adlard, Paul A.; Bush, Ashley I.; Andrews, Glen K.			Clioquinol Synergistically Augments Rescue by Zinc Supplementation in a Mouse Model of Acrodermatitis Enteropathica	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COPPER DEFICIENCY; BETA; ZIP4; GROWTH; PBT2; MICE; PHOSPHORYLATION; PROLIFERATION; INVOLVEMENT	Background: Zinc deficiency due to poor nutrition or genetic mutations in zinc transporters is a global health problem and approaches to providing effective dietary zinc supplementation while avoiding potential toxic side effects are needed. Methods/Principal Findings: Conditional knockout of the intestinal zinc transporter Zip4 (Slc39a4) in mice creates a model of the lethal human genetic disease acrodermatitis enteropathica (AE). This knockout leads to acute zinc deficiency resulting in rapid weight loss, disrupted intestine integrity and eventually lethality, and therefore provides a model system in which to examine novel approaches to zinc supplementation. We examined the efficacy of dietary clioquinol (CQ), a well characterized zinc chelator/ionophore, in rescuing the Zip4 (intest) (KO) phenotype. By 8 days after initiation of the knockout neither dietary CQ nor zinc supplementation in the drinking water was found to be effective at improving this phenotype. In contrast, dietary CQ in conjunction with zinc supplementation was highly effective. Dietary CQ with zinc supplementation rapidly restored intestine stem cell division and differentiation of secretory and the absorptive cells. These changes were accompanied by rapid growth and dramatically increased longevity in the majority of mice, as well as the apparent restoration of the homeostasis of several essential metals in the liver. Conclusions: These studies suggest that oral CQ (or other 8-hydroxyquinolines) coupled with zinc supplementation could provide a facile approach toward treating zinc deficiency in humans by stimulating stem cell proliferation and differentiation of intestinal epithelial cells.	[Geiser, Jim; Andrews, Glen K.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA; [De Lisle, Robert C.; Andrews, Glen K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Finkelstein, David; Adlard, Paul A.; Bush, Ashley I.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Finkelstein, David; Adlard, Paul A.; Bush, Ashley I.] Univ Melbourne, Melbourne, Vic 3010, Australia	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Andrews, GK (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA.	gandrews@kumc.edu	Bush, Ashley I/A-1186-2007; Finkelstein, David/B-9617-2009; Bush, Ashley/Y-2457-2019	Bush, Ashley I/0000-0001-8259-9069; Finkelstein, David/0000-0002-8167-4917; Bush, Ashley/0000-0001-8259-9069	National Institutes of Health [R01 DK063975, R01 AI 083479]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institutes of Health to GKA (R01 DK063975) and RCD (R01 AI 083479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2012, FRONT PSYCHIATRY, V3, P1; Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Afrin LB, 2010, AM J MED SCI, V340, P164, DOI 10.1097/MAJ.0b013e3181e3648c; AGGETT PJ, 1979, BIOCHEM BIOPH RES CO, V87, P513, DOI 10.1016/0006-291X(79)91825-4; ANDREWS RCR, 1992, LANCET, V340, P1160; Arbiser JL, 1998, MOL MED, V4, P665, DOI 10.1007/BF03401927; ATHERTON DJ, 1979, CLIN SCI, V56, P505, DOI 10.1042/cs0560505; Aydemir TB, 2012, GASTROENTEROLOGY, V142, P1536, DOI 10.1053/j.gastro.2012.02.046; Bareggi SR, 2012, CNS NEUROSCI THER, V18, P41, DOI 10.1111/j.1755-5949.2010.00231.x; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Black MM, 1998, AM J CLIN NUTR, V68, p464S, DOI 10.1093/ajcn/68.2.464S; Black RE, 2003, J NUTR, V133, p1485S, DOI 10.1093/jn/133.5.1485S; BLOOM D, 1955, J INVEST DERMATOL, V24, P167, DOI 10.1038/jid.1955.29; Bloxam DL, 1996, AM J OBSTET GYNECOL, V175, P1078, DOI 10.1016/S0002-9378(96)80062-7; Blundell R, 2013, VET REC, V172, P17, DOI 10.1136/vr.100376; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Corniola RS, 2008, BRAIN RES, V1237, P52, DOI 10.1016/j.brainres.2008.08.040; Crouch PJ, 2011, J NEUROCHEM, V119, P220, DOI 10.1111/j.1471-4159.2011.07402.x; Dhawan SS, 2008, J EMERG MED, V35, P33, DOI 10.1016/j.jemermed.2007.11.023; Di Vaira M, 2004, INORG CHEM, V43, P3795, DOI 10.1021/ic0494051; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Doherty K, 2011, BRIT DENT J, V210, P523, DOI 10.1038/sj.bdj.2011.428; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Ferrada E, 2007, NEUROTOXICOLOGY, V28, P445, DOI 10.1016/j.neuro.2007.02.004; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Hambidge KM, 2003, PEDIATRICS, V112, P1419, DOI 10.1542/peds.112.6.1419; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; JACKSON MJ, 1977, J CLIN PATHOL, V30, P284, DOI 10.1136/jcp.30.3.284; Kelleher SL, 2006, J NUTR, V136, P1185; Kilic M, 2012, JIMD REP, V2, P25, DOI 10.1007/8904_2011_38; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Li M, 2007, P NATL ACAD SCI USA, V104, P18636, DOI 10.1073/pnas.0709307104; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; MOYNAHAN EJ, 1974, LANCET, V2, P399; NEGGERS YH, 1990, AM J CLIN NUTR, V51, P678, DOI 10.1093/ajcn/51.4.678; NELDNER KH, 1974, ARCH DERMATOL, V110, P711, DOI 10.1001/archderm.110.5.711; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; Opazo C, 2006, AGING CELL, V5, P69, DOI 10.1111/j.1474-9726.2006.00196.x; Prasad AS, 2007, J NUTR, V137, P1345, DOI 10.1093/jn/137.5.1345; Prasad AS, 2012, J TRACE ELEM MED BIO, V26, P66, DOI 10.1016/j.jtemb.2012.04.004; PRASAD AS, 1984, FED PROC, V43, P2829; Ryu JM, 2009, J CELL PHYSIOL, V218, P558, DOI 10.1002/jcp.21628; Salgueiro MJ, 2004, BIOL TRACE ELEM RES, V99, P49, DOI 10.1385/BTER:99:1-3:049; Schafer S, 2007, J MOL MED, V85, P405, DOI 10.1007/s00109-006-0140-7; Seok SH, 2013, J APPL TOXI IN PRESS; Sharir H, 2010, J BIOL CHEM, V285, P26097, DOI 10.1074/jbc.M110.107490; STURTEVANT FM, 1980, PEDIATRICS, V65, P610; SUNDAL A, 1957, Ann Paediatr Fenn, V3, P486; Tamura T, 2000, AM J CLIN NUTR, V71, P109; Tang ZH, 2006, BONE, V38, P181, DOI 10.1016/j.bone.2005.08.010; Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Weaver Benjamin P, 2010, PLoS One, V5, DOI 10.1371/journal.pone.0013158; WEISMANN K, 1978, J INVEST DERMATOL, V71, P242, DOI 10.1111/1523-1747.ep12515094; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yang YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054736, 10.1371/journal.pone.0055384, 10.1371/journal.pone.0067755]; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Zhang YQ, 2010, CLIN CANCER RES, V16, P1423, DOI 10.1158/1078-0432.CCR-09-2405	67	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72543	10.1371/journal.pone.0072543	http://dx.doi.org/10.1371/journal.pone.0072543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015258	Green Published, gold			2022-12-27	WOS:000323733800063
J	Nouhin, J; Madec, Y; Ngo-Giang-Huong, N; Ferradini, L; Nerrienet, E				Nouhin, Janin; Madec, Yoann; Ngo-Giang-Huong, Nicole; Ferradini, Laurent; Nerrienet, Eric			Increased Risk of Q151M and K65R Mutations in Patients Failing Stavudine-Containing First-Line Antiretroviral Therapy in Cambodia	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE GENE; HIV-INFECTED PATIENTS; HIV-1-INFECTED PATIENTS; RESISTANCE MUTATIONS; PREVALENCE; COMBINATION; LAMIVUDINE; EMERGENCE; TENOFOVIR; CHILDREN	Background: Multi-nucleos(t)ide resistance (MNR) mutations including Q151M, K65R mutations, and insertion at codon 69 of HIV-1 reverse transcriptase coding region may confer resistance to all molecules of nucleos(t)ide reverse transcriptase inhibitors (NRTI). The presence of these mutations is an emerging problem compromising non-nucleoside reverse transcriptase inhibitors and protease inhibitors-based therapies. Furthermore, factors associated with selection of these mutations are still not well defined. The current study aimed to evaluate the frequency and to characterize factors associated with the occurrence of multi-nucleos(t)ide resistance mutations among HIV-1 infected patients failing recommended first-line antiretroviral regimens in Cambodia. Methodology/Principal Finding: This is a retrospective analysis of HIV-1 drug resistance genotyping of 520 HIV-1 infected patients in virological failure (viral load > 250 copies/mL) while on first-line antiretroviral therapy in Cambodia with at least one reverse transcriptase inhibitor resistance associated mutation. Among these 520 patients, a total of 66 subjects (66/520, 12.7%) presented >= 1 MNR mutation, including Q151M, K65R, and Insert69 for 59 (11.3%), 29 (5.6%), and 2 (0.4%) patients, respectively. In multivariate analysis, both Q151M (p = 0.039) and K65R (p = 0.029) mutations were independently associated with current stavudine-compared to zidovudine-use. Conclusion: Such selection of mutations by stavudine drastically limits the choice of antiretroviral molecules available for second-line therapy in resource-limited settings. This finding supports the World Health Organization's recommendation for stavudine phase-out.	[Nouhin, Janin; Nerrienet, Eric] Inst Pasteur Cambodia, HIV Hepatitis Unit, Phnom Penh, Cambodia; [Nouhin, Janin] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Madec, Yoann] Inst Pasteur, Emerging Dis Epidemiol Unit, Dept Infect & Epidemiol, Paris, France; [Ngo-Giang-Huong, Nicole] Inst Rech Dev IRD UMI 174, Paris, France; [Ngo-Giang-Huong, Nicole] Chiang Mai Univ, Fac Assoc Med Sci, Chiang Mai 50000, Thailand; [Ngo-Giang-Huong, Nicole] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Ferradini, Laurent] FHI 360, Phnom Penh, Cambodia; [Nerrienet, Eric] Inst Pasteur, Dept Virol, Regulat Retroviral Infect Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); Chiang Mai University; Harvard University; Harvard T.H. Chan School of Public Health; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nouhin, J (corresponding author), Inst Pasteur Cambodia, HIV Hepatitis Unit, Phnom Penh, Cambodia.	njanin@pasteur-kh.org	Ngo-Giang-Huong, Nicole/G-2860-2017; Nouhin, Janin/AAS-6946-2020; Nouhin, Janin/AAM-2322-2021	Ngo-Giang-Huong, Nicole/0000-0001-8950-3234; Nouhin, Janin/0000-0003-4985-8377; Nouhin, Janin/0000-0003-4985-8377; Madec, Yoann/0000-0002-6201-1261				ANRS, 2010, HIV 1 GEN DRUG RES I; Bulgheroni E, 2004, J CLIN VIROL, V29, P27, DOI 10.1016/S1386-6532(03)00082-9; Coakley EP, 2000, AIDS, V14, pF9, DOI 10.1097/00002030-200001280-00002; d'Ettorre G, 2011, J CHEMOTHERAPY, V23, P24, DOI 10.1179/joc.2011.23.1.24; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Garcia-Lerma JG, 2003, J VIROL, V77, P5685, DOI 10.1128/JVI.77.10.5685-5693.2003; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Isaakidis P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-11; Janssens B, 2007, PEDIATRICS, V120, pE1134, DOI 10.1542/peds.2006-3503; Larder BA, 1999, ANTIMICROB AGENTS CH, V43, P1961, DOI 10.1128/AAC.43.8.1961; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; MoH, 2005, CAMB NAT GUID US ANT; MoH, 2001, CAMB ETH GUID HLTH 3; Pellegrin I, 1999, AIDS, V13, P1705, DOI 10.1097/00002030-199909100-00014; Phan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030647; Rouet F, 2008, EXPERT REV MOL DIAGN, V8, P635, DOI 10.1586/14737159.8.5.635; Segeral O, 2011, AIDS RES HUM RETROVI; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; Sirivichayakul S, 2003, AIDS, V17, P1889, DOI 10.1097/00002030-200309050-00007; Stone C, 2004, ANTIMICROB AGENTS CH, V48, P1413, DOI 10.1128/AAC.48.4.1413-1415.2004; Sungkanuparph S, 2008, J CLIN VIROL, V41, P310, DOI 10.1016/j.jcv.2007.12.015; Trotta MP, 2006, J MED VIROL, V78, P535, DOI 10.1002/jmv.20573; WHO, 2004, SCAL ANT THER RESS L; Winters MA, 1998, J CLIN INVEST, V102, P1769, DOI 10.1172/JCI4948; World Health Organization, 2009, RAP ADV ANT THER HIV; Zaccarelli M, 2004, CLIN INFECT DIS, V38, P433, DOI 10.1086/381097	27	13	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73744	10.1371/journal.pone.0073744	http://dx.doi.org/10.1371/journal.pone.0073744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015311	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800106
J	Ahmad, S; Shahab, U; Baig, MH; Khan, MS; Khan, MS; Srivastava, AK; Saeed, M; Moinuddin				Ahmad, Saheem; Shahab, Uzma; Baig, Mohd. Hassan; Khan, Mohd. Sajid; Khan, M. Salman; Srivastava, A. K.; Saeed, Mohd; Moinuddin			Inhibitory Effect of Metformin and Pyridoxamine in the Formation of Early, Intermediate and Advanced Glycation End-Products	PLOS ONE			English	Article							DIABETES-MELLITUS; OXIDATIVE STRESS; HUMAN DNA; METHYLGLYOXAL; DIHYDROXYACETONE; ENDPRODUCTS; IMMUNOGENICITY; COMPLICATIONS; GLUCOSE; PROTEIN	Background: Non-enzymatic glycation is the addition of free carbonyl group of reducing sugar to the free amino groups of proteins, resulting in the formation of a Schiff base and an Amadori product. Dihydroxyacetone (DHA) is one of the carbonyl species which reacts rapidly with the free amino groups of proteins to form advanced glycation end products (AGEs). The highly reactive dihydroxyacetone phosphate is a derivative of dihydroxyacetone (DHA), and a product of glycolysis, having potential glycating effects to form AGEs. The formation of AGEs results in the generation of free radicals which play an important role in the pathophysiology of aging and diabetic complications. While the formation of DHA-AGEs has been demonstrated previously, no extensive studies have been performed to assess the inhibition of AGE inhibitors at all the three stages of glycation (early, intermediate and late) using metformin (MF) and pyridoxamine (PM) as a novel inhibitor. Methodology/Principal Findings: In this study we report glycation of human serum albumin (HSA) & its characterization by various spectroscopic techniques. Furthermore, inhibition of glycation products at all the stages of glycation was also studied. Spectroscopic analysis suggests structural perturbations in the HSA as a result of modification which might be due to generation of free radicals and formation of AGEs. Conclusion: The inhibition in the formation of glycation reaction reveals that Pyridoxamine is a better antiglycating agent than Metformin at all stages of the glycation (early, intermediate and late stages).	[Ahmad, Saheem; Baig, Mohd. Hassan; Khan, Mohd. Sajid; Khan, M. Salman; Srivastava, A. K.; Saeed, Mohd] Integral Univ, Dept Biotechnol, Lucknow, Uttar Pradesh, India; [Shahab, Uzma; Moinuddin] Aligarh Muslim Univ, Dept Biochem, JN Med Coll, Fac Med, Aligarh, Uttar Pradesh, India	Integral University; Aligarh Muslim University	Ahmad, S (corresponding author), Loyola Univ Chicago, Dept Surg, Cardinal Bernardin Canc Ctr, Loyola Univ Med Ctr, Maywood, IL USA.	ahmadsaheem@gmail.com	Ahmad, Saheem/T-2609-2019; Saeed, Mohd/AAG-3896-2020; Ahmad, Saheem/R-7016-2017; Shahab, Uzma/AAR-4332-2021	Ahmad, Saheem/0000-0003-1215-0279; Saeed, Mohd/0000-0003-3443-386X; Ahmad, Saheem/0000-0003-1215-0279; Khan, Mohd Sajid/0000-0002-0883-5200; Khan, M. Salman/0000-0001-9716-8165; Baig, Mohd Hassan/0000-0001-8227-4838	In-house training of the department	In-house training of the department	In-house training of the department has supported the work to be accomplished. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MI, 2011, INDIAN J BIOCHEM BIO, V48, P290; Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; Ahmad S, 2012, LIFE SCI, V90, P980, DOI 10.1016/j.lfs.2012.05.002; Akhter F, 2013, INT J BIOL MACROMOL, V58, P206, DOI 10.1016/j.ijbiomac.2013.03.036; Anderson AS, 2010, BEST PRACT RES CL RH, V24, P15, DOI 10.1016/j.berh.2009.08.006; Arif B, 2012, ARCH BIOCHEM BIOPHYS, V522, P17, DOI 10.1016/j.abb.2012.04.005; Ashraf JM, 2012, INT J BIOL MACROMOL, V51, P604, DOI 10.1016/j.ijbiomac.2012.06.013; Cervantes-Laurean D, 2006, J NUTR BIOCHEM, V17, P531, DOI 10.1016/j.jnutbio.2005.10.002; Engelen L, 2012, OBES METAB, DOI [10.1111/dom.12058, DOI 10.1111/D0M.12058]; Hashim A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/729393; HORBACH S, 1994, FEMS MICROBIOL LETT, V120, P37; Kakuta T, 2011, AM J KIDNEY DIS, V57, P422, DOI 10.1053/j.ajkd.2010.10.055; Kanazawa I, 2011, EXP CLIN ENDOCR DIAB, V119, P362, DOI 10.1055/s-0030-1267953; KAWASHIMA K, 1980, AGR BIOL CHEM TOKYO, V44, P1595, DOI 10.1080/00021369.1980.10864173; Khan M. S., 2013, Journal of Applied Pharmaceutical Science, V3, P133; Kim EJ, 2009, J THROMB HAEMOST, V7, P1172, DOI 10.1111/j.1538-7836.2009.03477.x; Lee C, 1998, J BIOL CHEM, V273, P25272, DOI 10.1074/jbc.273.39.25272; Losso JN, 2011, FOOD CHEM, V128, P55, DOI 10.1016/j.foodchem.2011.02.076; Marchetti P., 2009, MEDICOGRAPHIA, V31, P257; Metz TO, 2003, ARCH BIOCHEM BIOPHYS, V419, P41, DOI 10.1016/j.abb.2003.08.021; Mironova R, 2005, MOL MICROBIOL, V55, P1801, DOI 10.1111/j.1365-2958.2005.04504.x; Moinuddin Dixit K, 2012, ENVIRON TOXICOL, DOI [10.1002/tox.21782, DOI 10.1002/T0X.21782]; Mustafa I, 2012, DIABETES RES CLIN PR, V95, P98, DOI 10.1016/j.diabres.2011.09.018; Nagai R, 2012, DIABETES, V61, P549, DOI 10.2337/db11-1120; Nagaraj RH, 1996, J BIOL CHEM, V271, P19338, DOI 10.1074/jbc.271.32.19338; Nakamura K, 2008, DIABETES-METAB RES, V24, P109, DOI 10.1002/dmrr.766; Nascimento MM, 2006, J RENAL NUTR, V16, P119, DOI 10.1053/j.jrn.2006.01.002; Petersen AB, 2004, MUTAT RES-GEN TOX EN, V560, P173, DOI 10.1016/j.mrgentox.2004.03.002; Rahbar S, 1999, CLIN CHIM ACTA, V287, P123, DOI 10.1016/S0009-8981(99)00125-4; Rahbar S, 1999, BIOCHEM BIOPH RES CO, V262, P651, DOI 10.1006/bbrc.1999.1275; Ruggiero-Lopez D, 1999, BIOCHEM PHARMACOL, V58, P1765, DOI 10.1016/S0006-2952(99)00263-4; Schmitt A, 2005, ANAL BIOCHEM, V338, P201, DOI 10.1016/j.ab.2004.12.003; Shahab U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053205; Shahab U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031199; Shahab U, 2012, IUBMB LIFE, V64, P340, DOI 10.1002/iub.1008; Synold T, 2008, CHEM RES TOXICOL, V21, P2148, DOI 10.1021/tx800224y; Tan D, 2008, ANN NY ACAD SCI, V1126, P72, DOI 10.1196/annals.1433.027; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Voziyan PA, 2003, J BIOL CHEM, V278, P46616, DOI 10.1074/jbc.M307155200; You Wei-hua, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P622, DOI 10.3736/jcim20090705	41	78	80	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72128	10.1371/journal.pone.0072128	http://dx.doi.org/10.1371/journal.pone.0072128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023728	gold, Green Published, Green Submitted			2022-12-27	WOS:000324515600012
J	Mudaliar, MAV; Haggart, RD; Miele, G; Sellar, G; Tan, KAL; Goodlad, JR; Milne, E; Vail, DM; Kurzman, I; Crowther, D; Argyle, DJ				Mudaliar, Manikhandan A. V.; Haggart, Ross D.; Miele, Gino; Sellar, Grant; Tan, Karen A. L.; Goodlad, John R.; Milne, Elspeth; Vail, David M.; Kurzman, Ilene; Crowther, Daniel; Argyle, David J.			Comparative Gene Expression Profiling Identifies Common Molecular Signatures of NF-kappa B Activation in Canine and Human Diffuse Large B Cell Lymphoma (DLBCL)	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE; DISTINCT SUBGROUPS; KINASE; BIOINFORMATICS; CHEMOTHERAPY; MECHANISMS; SUMMARIES; NETWORKS; DOGS	We present the first comparison of global transcriptional changes in canine and human diffuse large B-cell lymphoma (DLBCL), with particular reference to the nuclear factor-kappa B (NF-kappa'B) pathway. Microarray data generated from canine DLBCL and normal lymph nodes were used for differential expression, co-expression and pathway analyses, and compared with analysis of microarray data from human healthy and DLBCL lymph nodes. The comparisons at gene level were performed by mapping the probesets in canine microarrays to orthologous genes in humans and vice versa. A considerable number of differentially expressed genes between canine lymphoma and healthy lymph node samples were also found differentially expressed between human DLBCL and healthy lymph node samples. Principal component analysis using a literature-derived NF-kappa B target gene set mapped to orthologous canine array probesets and human array probesets clearly separated the healthy and cancer samples in both datasets. The analysis demonstrated that for both human and canine DLBCL there is activation of the NF-kappa B/p65 canonical pathway, indicating that canine lymphoma could be used as a model to study NF-kappa B-targeted therapeutics for human lymphoma. To validate this, tissue arrays were generated for canine and human NHL and immunohistochemistry was employed to assess NF-kappa B activation status. In addition, human and canine B-cell lymphoma lines were assessed for NF-kB activity and the effects of NF-kappa B inhibition.	[Mudaliar, Manikhandan A. V.; Haggart, Ross D.] Univ Dundee, Ninewells Hosp, Translat Med Res Collaborat, Dundee, Scotland; [Miele, Gino; Sellar, Grant; Crowther, Daniel] Ninewells Hosp, Translat Med Res Collaborat, Pfizer Inc, Dundee DD1 9SY, Scotland; [Goodlad, John R.] Univ Edinburgh, Western Gen Hosp, Dept Pathol, Edinburgh, Midlothian, Scotland; [Tan, Karen A. L.; Milne, Elspeth; Argyle, David J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Tan, Karen A. L.; Milne, Elspeth; Argyle, David J.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Vail, David M.; Kurzman, Ilene] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA	University of Dundee; Pfizer; University of Dundee; University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Wisconsin System; University of Wisconsin Madison	Argyle, DJ (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland.	David.argyle@ed.ac.uk	Mudaliar, Manikhandan/K-1377-2014	Mudaliar, Manikhandan/0000-0003-1482-840X; Goodlad, John Robert/0000-0002-8385-8517	Translational Medicine Research Collaboration; Universities of Aberdeen, Dundee, Edinburgh and Glasgow; National Health Service Health Boards (Grampian, Tayside, Lothian and Greater Glasgow Clyde); Pfizer	Translational Medicine Research Collaboration; Universities of Aberdeen, Dundee, Edinburgh and Glasgow; National Health Service Health Boards (Grampian, Tayside, Lothian and Greater Glasgow Clyde); Pfizer(Pfizer)	This work was supported by the Translational Medicine Research Collaboration, a consortium made up of the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, the four associated National Health Service Health Boards (Grampian, Tayside, Lothian and Greater Glasgow & Clyde), Scottish Enterprise and Wyeth (now Pfizer). The funders did have a role in study design, data collection and analysis, preparation of the manuscript and decision to publish.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2009, CANC INCIDENCE WALES; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Chan WC, 2010, INT J HEMATOL, V92, P219, DOI 10.1007/s12185-010-0602-0; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; Fang C, 2010, ANN HEMATOL, V89, P1107, DOI 10.1007/s00277-010-0990-5; Frantz AM, 2013, VET PATHOL, V50, P693, DOI 10.1177/0300985812465325; Gaurnier-Hausser A, 2011, CLIN CANCER RES, V17, P4661, DOI 10.1158/1078-0432.CCR-10-3310; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Hollmann CA, 2006, CANCER RES, V66, P3550, DOI 10.1158/0008-5472.CAN-05-2498; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ingenuity, 2010, ING PATHW AN; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; MATHERLY LH, 1995, BLOOD, V85, P500; Miyoshi Y, 2010, BREAST CANCER-TOKYO, V17, P103, DOI 10.1007/s12282-009-0152-6; Molina JR, 2008, IDRUGS, V11, P508; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Parman C, 2010, AFFYQCREPORT; Partek, 2010, PART GEN SUIT REV 6; Paterson JC, 2006, HAEMATOLOGICA, V91, P772; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rutgen BC, 2010, LEUKEMIA RES, V34, P932, DOI 10.1016/j.leukres.2010.01.021; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Tagawa H, 2005, BLOOD, V106, P1770, DOI 10.1182/blood-2005-02-0542; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Vail DM, 2007, WITHROW MACEWENS SMA, P699; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000	45	60	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72591	10.1371/journal.pone.0072591	http://dx.doi.org/10.1371/journal.pone.0072591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023754	Green Published, Green Accepted, gold			2022-12-27	WOS:000324515600032
J	Nayak, AR; Shajahan, TK; Panfilov, AV; Pandit, R				Nayak, Alok Ranjan; Shajahan, T. K.; Panfilov, A. V.; Pandit, Rahul			Spiral-Wave Dynamics in a Mathematical Model of Human Ventricular Tissue with Myocytes and Fibroblasts	PLOS ONE			English	Article							ACTION-POTENTIAL PROPAGATION; CARDIAC MYOCYTES; K+ CURRENTS; MECHANOSENSITIVE FIBROBLASTS; SPATIOTEMPORAL CHAOS; IMPULSE PROPAGATION; ATRIAL FIBROBLASTS; EXCITABLE MEDIA; SINOATRIAL NODE; IONIC CURRENTS	Cardiac fibroblasts, when coupled functionally with myocytes, can modulate the electrophysiological properties of cardiac tissue. We present systematic numerical studies of such modulation of electrophysiological properties in mathematical models for (a) single myocyte-fibroblast (MF) units and (b) two-dimensional (2D) arrays of such units; our models build on earlier ones and allow for zero-, one-, and two-sided MF couplings. Our studies of MF units elucidate the dependence of the action-potential (AP) morphology on parameters such as E-f, the fibroblast resting-membrane potential, the fibroblast conductance G(f), and the MF gap-junctional coupling G(gap). Furthermore, we find that our MF composite can show autorhythmic and oscillatory behaviors in addition to an excitable response. Our 2D studies use (a) both homogeneous and inhomogeneous distributions of fibroblasts, (b) various ranges for parameters such as G(gap), G(f), and E-f, and (c) intercellular couplings that can be zero-sided, one-sided, and two-sided connections of fibroblasts with myocytes. We show, in particular, that the plane-wave conduction velocity CV decreases as a function of G(gap), for zero-sided and one-sided couplings; however, for two-sided coupling, CV decreases initially and then increases as a function of G(gap), and, eventually, we observe that conduction failure occurs for low values of G(gap). In our homogeneous studies, we find that the rotation speed and stability of a spiral wave can be controlled either by controlling G(gap) or E-f. Our studies with fibroblast inhomogeneities show that a spiral wave can get anchored to a local fibroblast inhomogeneity. We also study the efficacy of a low-amplitude control scheme, which has been suggested for the control of spiral-wave turbulence in mathematical models for cardiac tissue, in our MF model both with and without heterogeneities.	[Nayak, Alok Ranjan; Pandit, Rahul] Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India; [Shajahan, T. K.] McGill Univ, Ctr Nonlinear Dynam Physiol & Med, Montreal, PQ, Canada; [Panfilov, A. V.] Univ Ghent, Dept Phys & Astron, Ghent, Belgium; [Pandit, Rahul] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; McGill University; Ghent University; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Pandit, R (corresponding author), Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India.	rahul@physics.iisc.ernet.in	Shajahan, T K/AAG-4094-2019; Panfilov, Alexander/G-8459-2016; Nayak, Alok Ranjan/AAF-1119-2020; Nayak, Alok/E-2979-2016	Panfilov, Alexander/0000-0003-2643-642X; Nayak, Alok/0000-0003-0102-0778; Shajahan, TK/0000-0001-5551-1324	Department of Science and Technology (DST), India; University Grants Commission (UGC), India; Council for Scientific and Industrial Research (CSIR), India; Microsoft Research (India); Robert Bosch Centre for Cyber Physical Systems (IISc); Research-Foundation Flanders (FWO)	Department of Science and Technology (DST), India(Department of Science & Technology (India)); University Grants Commission (UGC), India(University Grants Commission, India); Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Microsoft Research (India); Robert Bosch Centre for Cyber Physical Systems (IISc); Research-Foundation Flanders (FWO)(FWO)	This study was supported by research grants from the Department of Science and Technology (DST), India and the University Grants Commission (UGC), India. Alok Ranjan Nayak was supported by research fellowships from the Council for Scientific and Industrial Research (CSIR), India, Microsoft Research (India), and the Robert Bosch Centre for Cyber Physical Systems (IISc). AV Panfilov also acknowledges the support of the Research-Foundation Flanders (FWO). Computational resources were also provided by the Supercomputer Education and Research Centre (SERC, IISc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKLEY D, 1990, PHYS REV A, V42, P2489, DOI 10.1103/PhysRevA.42.2489; Baudino TA, 2008, MICROSC MICROANAL, V14, P117, DOI 10.1017/S1431927608080021; Bernus O, 2002, AM J PHYSIOL-HEART C, V282, pH2296, DOI 10.1152/ajpheart.00731.2001; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V287, pH1378, DOI 10.1152/ajpheart.00185.2003; Camelliti P, 2005, MICROSC MICROANAL, V11, P249, DOI [10.1017/S1431927605050506, 10.1017/S143927605050506]; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Camelliti P, 2004, CARDIOVASC RES, V62, P415, DOI 10.1016/j.cardiores.2004.01.027; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Chen PS, 2003, CIRCULATION, V108, P2298, DOI 10.1161/01.CIR.0000094404.26004.07; Chilton L, 2005, AM J PHYSIOL-HEART C, V288, pH2931, DOI 10.1152/ajpheart.01220.2004; Chilton L, 2007, J PHYSIOL-LONDON, V583, P225, DOI 10.1113/jphysiol.2007.135038; Comtois P, 2005, EUROPACE, V7, pS10, DOI 10.1016/j.eupc.2005.05.011; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Desroches BR, 2012, AM J PHYSIOL-HEART C, V302, pH2031, DOI 10.1152/ajpheart.00743.2011; DOERR T, 1990, PFLUG ARCH EUR J PHY, V416, P230, DOI 10.1007/BF00392058; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Fink M, 2006, PHILOS T R SOC A, V364, P1207, DOI 10.1098/rsta.2006.1765; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Gray RA, 2009, CHAOS, V19, DOI 10.1063/1.3204256; Hu G, 1998, PHYS REV LETT, V80, P1884, DOI 10.1103/PhysRevLett.80.1884; Hwang SM, 2005, P NATL ACAD SCI USA, V102, P10363, DOI 10.1073/pnas.0501539102; Ideker RE, 2006, CIRCULATION, V114, P530, DOI 10.1161/CIRCULATIONAHA.106.644765; Ikeda T, 1997, CIRC RES, V81, P753; Jacquemet V, 2008, AM J PHYSIOL-HEART C, V294, pH2040, DOI 10.1152/ajpheart.01298.2007; Jacquemet V, 2007, EUROPACE, V9, P29, DOI 10.1093/europace/eum207; Jacquemet V, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011908; Janse MJ, 2007, AM J PHYSIOL-HEART C, V292, pH2561, DOI 10.1152/ajpheart.00167.2007; Kamkin A, 2005, BASIC RES CARDIOL, V100, P337, DOI 10.1007/s00395-005-0529-4; Kamkin A, 2002, AM J PHYSIOL-HEART C, V282, pH842, DOI 10.1152/ajpheart.00240.2001; Kamkin A, 1999, EXP PHYSIOL, V84, P347, DOI 10.1111/j.1469-445X.1999.01794.x; KARMA A, 1993, PHYS REV LETT, V71, P1103, DOI 10.1103/PhysRevLett.71.1103; Kenner J, 1998, MATH PHYSL; Kiseleva I, 1998, J MOL CELL CARDIOL, V30, P1083, DOI 10.1006/jmcc.1998.0673; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; KOHL P, 1992, EXP PHYSIOL, V77, P213, DOI 10.1113/expphysiol.1992.sp003576; KOHL P, 1994, EXP PHYSIOL, V79, P943, DOI 10.1113/expphysiol.1994.sp003819; Kohl P, 2007, HEART RHYTHM, V4, P233, DOI 10.1016/j.hrthm.2006.10.014; Kryukov AK, 2008, CHAOS, V18, DOI 10.1063/1.2956985; Lim ZY, 2006, CIRCULATION, V114, P2113, DOI 10.1161/CIRCULATIONAHA.105.598631; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; LUO CH, 1994, CIRC RES, V74, P1097, DOI 10.1161/01.RES.74.6.1097; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; MacCannell KA, 2007, BIOPHYS J, V92, P4121, DOI 10.1529/biophysj.106.101410; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Majumder R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045040; Majumder R, 2011, HEART RATE AND RHYTHM: MOLECULAR BASIS, PHARMACOLOGICAL MODULATION AND CLINICAL IMPLICATIONS, P269, DOI 10.1007/978-3-642-17575-6_14; Majumder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018052; Matsuoka S, 2003, JPN J PHYSIOL, V53, P105, DOI 10.2170/jjphysiol.53.105; McDowell KS, 2011, BIOPHYS J, V101, P1307, DOI 10.1016/j.bpj.2011.08.009; McSpadden LC, 2009, AM J PHYSIOL-CELL PH, V297, pC339, DOI 10.1152/ajpcell.00024.2009; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Otani NF, 2002, CHAOS, V12, P829, DOI 10.1063/1.1503921; Pandit R, 2002, PHYSICA A, V306, P211, DOI 10.1016/S0378-4371(02)00499-5; Pandit SV, 2001, BIOPHYS J, V81, P3029, DOI 10.1016/S0006-3495(01)75943-7; Panfilov AV, 2007, P NATL ACAD SCI USA, V104, P7922, DOI 10.1073/pnas.0701895104; Panfilov AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118101; Panfilov AV, 1998, CHAOS, V8, P57, DOI 10.1063/1.166287; PANFILOV AV, 1991, PHYSICA D, V49, P107, DOI 10.1016/0167-2789(91)90200-S; Panfilov AV, 1996, COMPUTATIONAL BIOL H; PERTSOV AM, 1993, CIRC RES, V72, P631, DOI 10.1161/01.RES.72.3.631; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Pumir A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208101; Qu ZL, 2000, ANN BIOMED ENG, V28, P755, DOI 10.1114/1.1289474; ROOK MB, 1992, AM J PHYSIOL, V263, pC959, DOI 10.1152/ajpcell.1992.263.5.C959; RUDENKO AN, 1983, STUD BIOPHYS, V98, P183; Sachse FB, 2008, ANN BIOMED ENG, V36, P41, DOI 10.1007/s10439-007-9405-8; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Shajahan TK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011929; Shajahan TK, 2008, THESIS INDIAN I SCI; Shibukawa Y, 2005, BIOPHYS J, V88, P3924, DOI 10.1529/biophysj.104.054429; Sinha S, 2001, PHYS REV LETT, V86, P3678, DOI 10.1103/PhysRevLett.86.3678; ten Tusscher KHWJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.062902; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Ten Tusscher KHWJ, 2003, AM J PHYSIOL-HEART C, V284, pH542, DOI 10.1152/ajpheart.00608.2002; Ten Tusscher KHWJ, 2007, EUROPACE, V9, P38, DOI 10.1093/europace/eum206; Valderrabano M, 2000, J AM COLL CARDIOL, V36, P2000, DOI 10.1016/S0735-1097(00)00941-4; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; Weise LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021934; Weiss JN, 2000, CIRC RES, V87, P1103, DOI 10.1161/01.RES.87.12.1103; Xie F, 1998, PHYS REV E, V58, P6355, DOI 10.1103/PhysRevE.58.6355; Xie FG, 2001, AM J PHYSIOL-HEART C, V280, pH535, DOI 10.1152/ajpheart.2001.280.2.H535; Xie YF, 2009, HEART RHYTHM, V6, P1641, DOI 10.1016/j.hrthm.2009.08.003; Xie YF, 2009, AM J PHYSIOL-HEART C, V297, pH775, DOI 10.1152/ajpheart.00341.2009; Zhang H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188301; Zhang H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026134; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	89	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72950	10.1371/journal.pone.0072950	http://dx.doi.org/10.1371/journal.pone.0072950			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023798	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000324515600056
J	Robert, MA; Okamoto, K; Lloyd, AL; Gould, F				Robert, Michael A.; Okamoto, Kenichi; Lloyd, Alun L.; Gould, Fred			A Reduce and Replace Strategy for Suppressing Vector-Borne Diseases: Insights from a Deterministic Model	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; LETHAL GENETIC SYSTEM; THEORETICAL-ANALYSIS; DENGUE TRANSMISSION; STERILE MALES; HUMAN BLOOD; MOSQUITO; POPULATIONS; CULICIDAE; RELEASE	Genetic approaches for controlling disease vectors have aimed either to reduce wild-type populations or to replace wildtype populations with insects that cannot transmit pathogens. Here, we propose a Reduce and Replace (R&R) strategy in which released insects have both female-killing and anti-pathogen genes. We develop a mathematical model to numerically explore release strategies involving an R&R strain of the dengue vector Aedes aegypti. We show that repeated R&R releases may lead to a temporary decrease in mosquito population density and, in the absence of fitness costs associated with the anti-pathogen gene, a long-term decrease in competent vector population density. We find that R&R releases more rapidly reduce the transient and long-term competent vector densities than female-killing releases alone. We show that releases including R&R females lead to greater reduction in competent vector density than male-only releases. The magnitude of reduction in total and competent vectors depends upon the release ratio, release duration, and whether females are included in releases. Even when the anti-pathogen allele has a fitness cost, R&R releases lead to greater reduction in competent vectors than female-killing releases during the release period; however, continued releases are needed to maintain low density of competent vectors long-term. We discuss the results of the model as motivation for more detailed studies of R&R strategies.	[Robert, Michael A.; Lloyd, Alun L.] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA; [Robert, Michael A.; Lloyd, Alun L.] N Carolina State Univ, Biomath Grad Program, Raleigh, NC 27695 USA; [Okamoto, Kenichi; Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Lloyd, Alun L.; Gould, Fred] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Robert, MA (corresponding author), N Carolina State Univ, Dept Math, Box 8205, Raleigh, NC 27695 USA.	marober5@ncsu.edu	Okamoto, Kenichi/AAA-3763-2021; Lloyd, Alun/AAN-6639-2020; Lloyd, Alun L/H-4944-2012	Okamoto, Kenichi/0000-0002-1889-4538; Lloyd, Alun/0000-0002-6389-6321; Robert, Michael/0000-0003-3705-0952	National Institutes of Health (NIH) [R01AI091980]; Foundation for the NIH through the Bill and Melinda Gates Foundation Grand Challenges in Global Health initiative; University of Pretoria North Carolina State University Strategic Collaboration Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091980] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH through the Bill and Melinda Gates Foundation Grand Challenges in Global Health initiative; University of Pretoria North Carolina State University Strategic Collaboration Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded in part by National Institutes of Health (NIH) grant R01AI091980, a grant to the Regents of the University of California from the Foundation for the NIH through the Bill and Melinda Gates Foundation Grand Challenges in Global Health initiative. This work is also funded in part by a University of Pretoria North Carolina State University Strategic Collaboration Seed Grant (to A. L. Lloyd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; BARBOSA P, 1972, Environmental Entomology, V1, P89; Barclay HJ, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P147, DOI 10.1007/1-4020-4051-2_6; BELLOWS TS, 1981, J ANIM ECOL, V50, P139, DOI 10.2307/4037; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; COLLINS FH, 1995, ANNU REV ENTOMOL, V40, P195, DOI 10.1146/annurev.en.40.010195.001211; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Facchinelli L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002001; FOSTER GG, 1988, THEOR APPL GENET, V76, P870, DOI 10.1007/BF00273675; Fouque F, 2006, J VECTOR ECOL, V31, P390, DOI 10.3376/1081-1710(2006)31[390:AASADT]2.0.CO;2; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; Gould F, 2006, AM SCI, V94, P238, DOI 10.1511/2006.3.238; Gould F, 2008, P ROY SOC B-BIOL SCI, V275, P2823, DOI 10.1098/rspb.2008.0846; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411; Heinrich JC, 2000, P NATL ACAD SCI USA, V97, P8229, DOI 10.1073/pnas.140142697; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Huang YX, 2009, EVOL APPL, V2, P143, DOI 10.1111/j.1752-4571.2008.00049.x; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2; Legros M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052235; Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301; Macia A, 2006, J VECTOR ECOL, V31, P371, DOI 10.3376/1081-1710(2006)31[371:DIPOAA]2.0.CO;2; Marshall JM, 2011, J HERED, V102, P336, DOI 10.1093/jhered/esr019; Marshall JM, 2011, GENETICS, V187, P535, DOI 10.1534/genetics.110.124479; Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; PROUT T, 1978, THEOR POPUL BIOL, V13, P40, DOI 10.1016/0040-5809(78)90035-7; Rasgon JL, 2008, ADV EXP MED BIOL, V627, P114, DOI 10.1007/978-0-387-78225-6_10; Rasgon JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005833; Robert MA, 2012, J MED ENTOMOL, V49, P1177, DOI 10.1603/ME11205; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1566, DOI 10.1603/0022-0493-93.6.1566; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Ward CM, 2011, EVOLUTION, V65, P1149, DOI 10.1111/j.1558-5646.2010.01186.x; Yakob L, 2009, J ECON ENTOMOL, V102, P50, DOI 10.1603/029.102.0108; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	50	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73233	10.1371/journal.pone.0073233	http://dx.doi.org/10.1371/journal.pone.0073233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023839	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600081
J	Tian, K; Rajendran, R; Doddananjaiah, M; Krstic-Demonacos, M; Schwartz, JM				Tian, Kun; Rajendran, Ramkumar; Doddananjaiah, Manjula; Krstic-Demonacos, Marija; Schwartz, Jean-Marc			Dynamics of DNA Damage Induced Pathways to Cancer	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; FEEDBACK LOOPS; NETWORK MODEL; P53 NETWORK; ATM KINASE; CELL-DEATH; APOPTOSIS; ACTIVATION; CHK1; BAX	Chemotherapy is commonly used in cancer treatments, however only 25% of cancers are responsive and a significant proportion develops resistance. The p53 tumour suppressor is crucial for cancer development and therapy, but has been less amenable to therapeutic applications due to the complexity of its action, reflected in 66,000 papers describing its function. Here we provide a systematic approach to integrate this information by constructing a large-scale logical model of the p53 interactome using extensive database and literature integration. The model contains 206 nodes representing genes or proteins, DNA damage input, apoptosis and cellular senescence outputs, connected by 738 logical interactions. Predictions from in silico knock-outs and steady state model analysis were validated using literature searches and in vitro based experiments. We identify an upregulation of Chk1, ATM and ATR pathways in p53 negative cells and 61 other predictions obtained by knockout tests mimicking mutations. The comparison of model simulations with microarray data demonstrated a significant rate of successful predictions ranging between 52% and 71% depending on the cancer type. Growth factors and receptors FGF2, IGF1R, PDGFRB and TGFA were identified as factors contributing selectively to the control of U2OS osteosarcoma and HCT116 colon cancer cell growth. In summary, we provide the proof of principle that this versatile and predictive model has vast potential for use in cancer treatment by identifying pathways in individual patients that contribute to tumour growth, defining a sub population of "high'' responders and identification of shifts in pathways leading to chemotherapy resistance.	[Tian, Kun; Rajendran, Ramkumar; Doddananjaiah, Manjula; Krstic-Demonacos, Marija; Schwartz, Jean-Marc] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Tian, Kun; Krstic-Demonacos, Marija] Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England; [Rajendran, Ramkumar] Int Med Univ, Kuala Lumpur 57000, Malaysia	University of Manchester; University of Salford; International Medical University Malaysia	Krstic-Demonacos, M (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	m.krstic-demonacos@salford.ac.uk; jeanmarc.schwartz@manchester.ac.uk	Schwartz, Jean-Marc/AAS-8274-2020	Schwartz, Jean-Marc/0000-0002-6472-0184; Rajendran, Ramkumar/0000-0002-3610-8430	University of Manchester Intellectual Property	University of Manchester Intellectual Property	The authors thank University of Manchester Intellectual Property for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bean LJH, 2002, J BIOL CHEM, V277, P1864, DOI 10.1074/jbc.M108881200; Blagosklonny MV, 2001, ONCOGENE, V20, P395, DOI 10.1038/sj.onc.1204055; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Calzolari D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000547; Cameron DA, 2008, NAT CLIN PRACT ONCOL, V5, P512, DOI 10.1038/ncponc1156; Chaves M, 2009, MODEL SIMUL SCI ENG, P19, DOI 10.1007/978-0-8176-4751-3_2; Chehab NH, 2000, GENE DEV, V14, P278; Chen CC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-24; Chen DWC, 2013, ONCOGENE, V32, P3039, DOI 10.1038/onc.2012.321; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chiu SM, 2003, BRIT J CANCER, V89, P1590, DOI 10.1038/sj.bjc.6601298; Choi M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003363; Christensen TS, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-7; Christmann M, 2005, ONCOGENE, V24, P8304, DOI 10.1038/sj.onc.1208994; Coffill CR, 2012, EMBO REP, V13, P638, DOI 10.1038/embor.2012.74; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Demonacos C, 2004, NAT CELL BIOL, V6, P968, DOI 10.1038/ncb1170; Edelman LB, 2010, WIRES SYST BIOL MED, V2, P438, DOI 10.1002/wsbm.75; Ge H, 2009, J COMPUT BIOL, V16, P119, DOI 10.1089/cmb.2007.0181; Ghaffari N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S10; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Huang YP, 2012, CELL CYCLE, V11, P2367, DOI 10.4161/cc.20863; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Ke HN, 2004, EXP CELL RES, V298, P329, DOI 10.1016/j.yexcr.2004.04.031; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Lesne A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-21; Lunardi A, 2010, P NATL ACAD SCI USA, V107, P6322, DOI 10.1073/pnas.1002447107; Mai ZX, 2009, J THEOR BIOL, V259, P760, DOI 10.1016/j.jtbi.2009.04.024; Manna SK, 2011, J BIOL CHEM, V286, P7339, DOI 10.1074/jbc.M110.191916; Moll UM, 2003, MOL CANCER RES, V1, P1001; Mouri K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005131; O'Prey J, 2010, CELL CYCLE, V9, P947, DOI 10.4161/cc.9.5.10872; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Poltz R, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-125; Potratz JC, 2005, INT J ONCOL, V26, P493; Prives C, 1999, J PATHOL, V187, P112; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rodriguez A, 2012, BIOINFORMATICS, V28, P858, DOI 10.1093/bioinformatics/bts036; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Rossiter HB, 2008, J CELL BIOCHEM, V104, P525, DOI 10.1002/jcb.21643; Satyanarayana A, 2008, MOL BIOL CELL, V19, P65, DOI 10.1091/mbc.E07-06-0525; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Schwartz JM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r123; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Taira N, 2010, J BIOL CHEM, V285, P4909, DOI 10.1074/jbc.M109.042341; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Taura M, 2010, CANCER SCI, V101, P1610, DOI 10.1111/j.1349-7006.2010.01567.x; Yee KS, 2005, CARCINOGENESIS, V26, P1317, DOI 10.1093/carcin/bgi122; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Zhang RR, 2008, P NATL ACAD SCI USA, V105, P16308, DOI 10.1073/pnas.0806447105; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108	63	20	21	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72303	10.1371/journal.pone.0072303	http://dx.doi.org/10.1371/journal.pone.0072303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023735	Green Published, gold, Green Submitted			2022-12-27	WOS:000324515600017
J	Bartkowska, K; Gajerska, M; Turlejski, K; Djavadian, RL				Bartkowska, Katarzyna; Gajerska, Monika; Turlejski, Kris; Djavadian, Rouzanna L.			Expression of TrkC Receptors in the Developing Brain of the Monodelphis opossum and Its Effect on the Development of Cortical Cells	PLOS ONE			English	Article							RAT TRKC; MOLECULAR-CLONING; NERVOUS-SYSTEM; MESSENGER-RNA; NEUROTROPHINS; ISOFORMS; GANGLION; DIFFERENTIATION; SURVIVAL; PROLIFERATION	In this study, we investigated the distribution, localization and several various functions of TrkC receptors during development of the Monodelphis opossum brain. Western blotting analysis showed that two different forms of the TrkC receptor, the full-length receptor and one of its truncated forms, are abundantly expressed in the opossum brain. The expression of TrkC receptors was barely detected in the brain of newborn opossums. At postnatal day (P) 3, the expression of full-length TrkC remained at low levels, while moderate expression of the TrkC truncated form was detected. The expression levels of both forms of this protein gradually increased throughout development, peaking at P35. We found that in different neocortical areas located both at the rostral and caudal regions of the cortex, up to 98% of BrdU-labeled cells forming cortical layers (II-VI) had prominently expressed TrkC. To assess which developmental processes of cortical cells are regulated by TrkC receptors, three different shRNAs were constructed. The shRNAs were individually tested in transfected cortical progenitor cells grown on culture plates for 2 days. The effects of the shRNA-TrkC constructs were similar: blockade of TrkC receptors decreased the number of Ki67-positive and apoptotic cells, and it did not change the number of TUJ-positive neurons in vitro. Thus, the lack of TrkC receptors in cultured progenitor cells provided insight on the potential role of these receptors in the regulation of proliferation and cell survival but not in the differentiation of cortical cells.	[Bartkowska, Katarzyna; Gajerska, Monika; Turlejski, Kris; Djavadian, Rouzanna L.] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Djavadian, RL (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland.	r.djavadian@nencki.gov.pl		Bartkowska, Katarzyna/0000-0002-4276-3204; Djavadian, Ruzanna/0000-0002-0416-0234; Krzysztof, Turlejski/0000-0001-6708-7815	Ministry of Science and Higher Education (Poland) [3089/B/P01/2009/37]	Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education (Poland), grant No. 3089/B/P01/2009/37. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell KWS, 2008, BRAIN BEHAV EVOLUT, V71, P216, DOI 10.1159/000119711; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bartkowska K, 2010, ACTA NEUROBIOL EXP, V70, P454; Bayer S.A., 1991, NEOCORTICAL DEV; BAYER SA, 1990, EXP NEUROL, V107, P118, DOI 10.1016/0014-4886(90)90150-Q; Bayer Shirley A., 1995, P1041; Beck G, 2004, J NEUROBIOL, V60, P12, DOI 10.1002/neu.10329; Beltaifa S, 2005, EUR J NEUROSCI, V21, P2433, DOI 10.1111/j.1460-9568.2005.04074.x; Benn B, 1998, J COMP NEUROL, V401, P47, DOI 10.1002/(SICI)1096-9861(19981109)401:1<47::AID-CNE4>3.0.CO;2-C; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Carim-Todd L, 2009, J NEUROSCI, V29, P678, DOI 10.1523/JNEUROSCI.5060-08.2009; CARMIGNOTO G, 1989, J NEUROSCI, V9, P1263; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cheung AFP, 2010, CEREB CORTEX, V20, P1071, DOI 10.1093/cercor/bhp168; Eide FF, 1996, J NEUROSCI, V16, P3123; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Eugenin J, 2000, BRAIN RES BULL, V53, P605, DOI 10.1016/S0361-9230(00)00394-4; Forooghian F, 2000, J MOL NEUROSCI, V14, P39, DOI 10.1385/JMN:14:1-2:039; GARNER AS, 1994, NEURON, V13, P457, DOI 10.1016/0896-6273(94)90360-3; GAROFALO L, 1992, P NATL ACAD SCI USA, V89, P2639, DOI 10.1073/pnas.89.7.2639; ICHIM G, 2012, J NEUROBIOL, V60, P12; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; Kahn MA, 1999, GLIA, V26, P153, DOI 10.1002/(SICI)1098-1136(199904)26:2<153::AID-GLIA6>3.3.CO;2-Q; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; Kullander K, 1997, J MOL EVOL, V45, P311, DOI 10.1007/PL00006235; LAMBALLE F, 1993, EMBO J, V12, P3083, DOI 10.1002/j.1460-2075.1993.tb05977.x; Lei L, 2007, CELL MOL LIFE SCI, V64, P522, DOI 10.1007/s00018-006-6328-8; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; MARK RF, 1992, TRENDS NEUROSCI, V15, P51, DOI 10.1016/0166-2236(92)90026-5; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; Minichiello L, 1995, DEVELOPMENT, V121, P4067; MOREST DK, 1970, Z ANAT ENTWICKLUNGS, V130, P265, DOI 10.1007/BF00520999; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Numan S, 2005, J MOL NEUROSCI, V27, P245, DOI 10.1385/JMN:27:2:245; Okuno H, 1999, J COMP NEUROL, V408, P378; Palko ME, 1999, J NEUROSCI, V19, P775; Puzzolo E, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-8; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; RAEDLER E, 1978, ANAT EMBRYOL, V154, P267, DOI 10.1007/BF00345657; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RENFREE MB, 1982, BRAIN BEHAV EVOLUT, V20, P57, DOI 10.1159/000121581; ROBINSON SR, 1990, BRAIN BEHAV EVOLUT, V36, P177, DOI 10.1159/000115306; Sanderson Ken J., 1997, Revista Brasileira de Biologia, V57, P323; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Smith KK, 2001, J ANAT, V199, P121, DOI 10.1017/S0021878201008202; TAKAHASHI T, 1995, J NEUROSCI, V15, P6058; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; Tsoulfas P, 1996, J BIOL CHEM, V271, P5691, DOI 10.1074/jbc.271.10.5691; ULINSKI PS, 1971, J COMP NEUROL, V142, P33, DOI 10.1002/cne.901420104; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; van Kesteren RE, 1998, EMBO J, V17, P2534, DOI 10.1093/emboj/17.9.2534; VandeBerg John L., 1997, ILAR J, V38, P4; Wang Q, 2011, J NEUROSCI, V31, P7938, DOI 10.1523/JNEUROSCI.1434-10.2011	63	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74346	10.1371/journal.pone.0074346	http://dx.doi.org/10.1371/journal.pone.0074346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019963	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200106
J	Manjon, JV; Coupe, P; Concha, L; Buades, A; Collins, DL; Robles, M				Manjon, Jose V.; Coupe, Pierrick; Concha, Luis; Buades, Antonio; Collins, D. Louis; Robles, Montserrat			Diffusion Weighted Image Denoising Using Overcomplete Local PCA	PLOS ONE			English	Article							RICIAN NOISE REMOVAL; FIBER-TRACKING; TENSOR; REDUCTION	Diffusion Weighted Images (DWI) normally shows a low Signal to Noise Ratio (SNR) due to the presence of noise from the measurement process that complicates and biases the estimation of quantitative diffusion parameters. In this paper, a new denoising methodology is proposed that takes into consideration the multicomponent nature of multi-directional DWI datasets such as those employed in diffusion imaging. This new filter reduces random noise in multicomponent DWI by locally shrinking less significant Principal Components using an overcomplete approach. The proposed method is compared with state-of-the-art methods using synthetic and real clinical MR images, showing improved performance in terms of denoising quality and estimation of diffusion parameters.	[Manjon, Jose V.; Robles, Montserrat] Univ Politecn Valencia, Inst Aplicac Tecnol Informac & Comunicac Avanzado, E-46071 Valencia, Spain; [Coupe, Pierrick] Unite Mixte Rech CNRS UMR 5800, Lab Bordelais Rech Informat, F-33405 Talence, France; [Concha, Luis] Univ Nacl Autonoma Mexico, Inst Neurobiol, Queretaro, Mexico; [Buades, Antonio] ENS Cachan, CMLA, F-94235 Cachan, France; [Buades, Antonio] Univ Illes Balears, Dept Matemat, Palma De Mallorca, Spain; [Collins, D. Louis] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada	Universitat Politecnica de Valencia; Centre National de la Recherche Scientifique (CNRS); Universidad Nacional Autonoma de Mexico; UDICE-French Research Universities; Universite Paris Saclay; Universitat de les Illes Balears; McGill University	Manjon, JV (corresponding author), Univ Politecn Valencia, Inst Aplicac Tecnol Informac & Comunicac Avanzado, E-46071 Valencia, Spain.	jmanjon@fis.upv.es	buades, antoni/K-6110-2014; Collins, D. Louis/ABD-7708-2021; Concha, Luis/M-5720-2019; manjon, jose/ABE-7094-2021; Concha, Luis/G-5161-2011; Robles, Montserrat/A-6722-2016	buades, antoni/0000-0001-9832-3358; Collins, D. Louis/0000-0002-8432-7021; manjon, jose/0000-0001-6640-927X; Concha, Luis/0000-0002-7842-3869; Robles, Montserrat/0000-0002-7705-1389; Coupe, Pierrick/0000-0003-2709-3350	Ministerio de Ciencia e Innovacion [TIN2011-26727]; French grant "HR-DTI" [ANR-10-LABX-57]; TRAIL from the French Agence Nationale de la Recherche within the context of the Investments for the Future program	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); French grant "HR-DTI"; TRAIL from the French Agence Nationale de la Recherche within the context of the Investments for the Future program(French National Research Agency (ANR))	This work has been supported by the Spanish grant TIN2011-26727 from Ministerio de Ciencia e Innovacion. This work has been also partially supported by the French grant "HR-DTI" ANR-10-LABX-57 funded by the TRAIL from the French Agence Nationale de la Recherche within the context of the Investments for the Future program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aja-Fernandez S, 2008, IEEE T MED IMAGING, V27, P1389, DOI 10.1109/TMI.2008.920609; Bao LJ, 2013, MED IMAGE ANAL, V17, P442, DOI 10.1016/j.media.2013.01.006; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Basu S, 2006, LECT NOTES COMPUT SC, V4190, P117; Bydder M, 2006, MAGN RESON IMAGING, V24, P849, DOI 10.1016/j.mri.2006.03.006; Chen B, 2005, MAGN RESON MED, V54, P393, DOI 10.1002/mrm.20582; Close TG, 2009, NEUROIMAGE, V47, P1288, DOI 10.1016/j.neuroimage.2009.03.077; Coifman R, 1995, SPRINGER VERLAG LECT; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Coupe P, 2010, MED IMAGE ANAL, V14, P483, DOI 10.1016/j.media.2010.03.001; Coupe P, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/590183; Deledalle C, 2011, BMVC2011; Descoteaux M, 2008, LECT NOTES COMPUT SC, V5242, P122, DOI 10.1007/978-3-540-85990-1_15; Ding ZH, 2005, MAGN RESON MED, V53, P485, DOI 10.1002/mrm.20339; Fan Lam S, 2013, MAGNETIC RESONANCE M, V69, P1; Fillard P, 2007, IEEE T MED IMAGING, V26, P1472, DOI 10.1109/TMI.2007.899173; Gering DT, 1999, LECT NOTES COMPUT SC, V1679, P809; Goh A, 2009, LECT NOTES COMPUT SC, V5761, P877, DOI 10.1007/978-3-642-04268-3_108; Gonzalez JEI, 2011, MED PHYS, V38, P4350, DOI 10.1118/1.3599724; Hamarnesh G, 2007, IEEE T IMAGE PROCESS, V16, P2463, DOI 10.1109/TIP.2007.904964; Johansen-Berg H, 2006, CURR OPIN NEUROL, V19, P379, DOI 10.1097/01.wco.0000236618.82086.01; Jolliffe IT, 1986, PRINCIPAL COMPONENT, V487; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Katkovnik V, 2010, INT J COMPUT VISION, V86, P1, DOI 10.1007/s11263-009-0272-7; Koay CG, 2006, J MAGN RESON, V179, P317, DOI 10.1016/j.jmr.2006.01.016; Landman BA, 2009, MAGN RESON IMAGING, V27, P741, DOI 10.1016/j.mri.2009.01.001; Manjon JV, 2012, MED IMAGE ANAL, V16, P18, DOI 10.1016/j.media.2011.04.003; Manjon JV, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/756897; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Martin-Fernandez M, 2009, MED IMAGE ANAL, V13, P19, DOI 10.1016/j.media.2008.05.004; McGraw T, 2004, MED IMAGE ANAL, V8, P95, DOI 10.1016/j.media.2003.12.001; McGraw T, 2009, INVERSE PROBL IMAG, V3, P625, DOI 10.3934/ipi.2009.3.625; Muresan DD, 2003, IEEE IMAGE PROC, P101; Nowak RD, 1999, IEEE T IMAGE PROCESS, V8, P1408, DOI 10.1109/83.791966; Parker GJM, 2000, J MAGN RESON IMAGING, V11, P702, DOI 10.1002/1522-2586(200006)11:6<702::AID-JMRI18>3.0.CO;2-A; Poon PK, 2009, IMAGE DENOISING SING; Reisert M, 2011, IEEE T MED IMAGING, V30, P1274, DOI 10.1109/TMI.2011.2112769; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Strang G., 1976, LINEAR ALGEBRA ITS A; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Tristan-Vega A, 2010, MED IMAGE ANAL, V14, P205, DOI 10.1016/j.media.2009.11.001; Wang ZZ, 2004, IEEE T MED IMAGING, V23, P930, DOI 10.1109/TMI.2004.831218; Weickert J, 2002, DIFFUSION REGULARIZA; Wiest-Daessle N, 2007, LECT NOTES COMPUT SC, V4792, P344; Wirestam R, 2006, MAGN RESON MED, V56, P1114, DOI 10.1002/mrm.21036; Xu Q, 2010, MAGN RESON IMAGING, V28, P200, DOI 10.1016/j.mri.2009.10.001; Zhang L, 2010, PATTERN RECOGN, V43, P1531, DOI 10.1016/j.patcog.2009.09.023	47	205	207	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73021	10.1371/journal.pone.0073021	http://dx.doi.org/10.1371/journal.pone.0073021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019889	Green Published, Green Submitted, gold			2022-12-27	WOS:000324338200031
J	Steenpass, L; Kanber, D; Hiber, M; Buiting, K; Horsthemke, B; Lohmann, D				Steenpass, Laura; Kanber, Deniz; Hiber, Michaela; Buiting, Karin; Horsthemke, Bernhard; Lohmann, Dietmar			Human PPP1R26P1 Functions as cis-Repressive Element in Mouse Rb1	PLOS ONE			English	Article							METHYLATION; EXPRESSION; ORIGIN; ESTABLISHMENT; TRANSCRIPTION; ALLELE; RETINOBLASTOMA; LANDSCAPE; PATTERNS; MUTATION	The human retinoblastoma gene (RB1) is imprinted; the mouse Rb1 gene is not. Imprinted expression of RB1 is due to differential methylation of a CpG island (CpG85), which is located in the pseudogene PPP1R26P1 in intron 2 of RB1. CpG85 serves as promoter for an alternative RB1 transcript, which is expressed from the unmethylated paternal allele only and is thought to suppress expression of the full-length RB1 transcript in cis. PPP1R26P1 contains another CpG island (CpG42), which is biallelically methylated. To determine the influence of PPP1R26P1 on RB1 expression, we generated an in vitro murine embryonic stem cell model by introducing human PPP1R26P1 into mouse Rb1. Next generation bisulfite sequencing of CpG85 and CpG42 revealed differences in their susceptibility to DNA methylation, gaining methylation at a median level of 4% and 18%, respectively. We showed binding of RNA polymerase II at and transcription from the unmethylated CpG85 in PPP1R26P1 and observed reduced expression of full-length Rb1 from the targeted allele. Our results identify human PPP1R26P1 as a cis-repressive element and support a connection between retrotransposition of PPP1R26P1 into human RB1 and the reduced expression of RB1 on the paternal allele.	[Steenpass, Laura; Kanber, Deniz; Hiber, Michaela; Buiting, Karin; Horsthemke, Bernhard; Lohmann, Dietmar] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, Essen, Germany	University of Duisburg Essen	Steenpass, L (corresponding author), Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, Essen, Germany.	laura.steenpass@uni-due.de	Lohmann, Dietmar R/B-4041-2013; Lohmann, Dietmar R./X-4895-2019	Lohmann, Dietmar R/0000-0002-2624-9889; Lohmann, Dietmar R./0000-0002-2624-9889	Deutsche Forschungsgemeinschaft [LO530/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant LO530/7-1 to DL, KB and LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JF, 1998, BRIT J CANCER, V78, P484, DOI 10.1038/bjc.1998.519; Beygo J, 2011, MOL SYNDROMOL, V2, P53, DOI 10.1159/000335545; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Cowley M, 2010, BRIEF FUNCT GENOMICS, V9, P340, DOI 10.1093/bfgp/elq015; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; Fang F, 2012, P NATL ACAD SCI USA, V109, P7332, DOI 10.1073/pnas.1201310109; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Klutz M, 2002, AM J HUM GENET, V71, P174, DOI 10.1086/341284; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Koerner MV, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002540; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kohama C, 2012, HUM MOL GENET, V21, P1391, DOI 10.1093/hmg/ddr577; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; Lohmann D, 2010, ADV EXP MED BIOL, V685, P220; Lutsik P, 2011, NUCLEIC ACIDS RES, V39, pW551, DOI 10.1093/nar/gkr312; McCole RB, 2008, EPIGENETICS-US, V3, P258, DOI 10.4161/epi.3.5.7052; Monk D, 2011, NUCLEIC ACIDS RES, V39, P4577, DOI 10.1093/nar/gkq1230; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santoro F, 2013, CELL CYCLE, V12, P711, DOI 10.4161/cc.23860; Santoro F, 2013, DEVELOPMENT, V140, P1184, DOI 10.1242/dev.088849; Schuler A, 2005, EUR J CANCER, V41, P735, DOI 10.1016/j.ejca.2004.12.022; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith EY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002422; Stricker SH, 2008, EMBO J, V27, P3116, DOI 10.1038/emboj.2008.239; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020; Wood MD, 2010, EPIGENETICS, V5	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74159	10.1371/journal.pone.0074159	http://dx.doi.org/10.1371/journal.pone.0074159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019952	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200095
J	Wu, YC; Guan, K; Wang, ZJ; Xu, B; Zhao, F				Wu, Yicheng; Guan, Kai; Wang, Zejie; Xu, Bing; Zhao, Feng			Isolation, Identification and Characterization of an Electrogenic Microalgae Strain	PLOS ONE			English	Article							CHLOROPHYCEAE; SCENEDESMUS; OXYGEN; DESMODESMUS; BIOCATHODE; BIODIESEL; HYDROGEN; REMOVAL; CULTURE; WASTE	Extracellular electron transfer involving microbes is important as it closely reflects the ability of cells to communicate with the environment. However, there are few reports on electron transfer mechanisms of pure microalgae and a lack of any model alga to study the transfer processes. In the present study, nine green microalgae species were isolated from wastewater and characterized in terms of their ability to transfer electrons between cells and an electrode. One species showed direct electron transfer via membrane-associated proteins and indirect electron transfer via secreted oxygen. The microalga was identified as Desmodesmus sp. based on phylogenetic analysis and electron microscopy. Electrochemical tests demonstrated that Desmodesmus sp. was able to act as a cathodic microorganism. Stable current densities of 20.24, 35.54 and 170 mA m(-2) were achieved at potentials of +0.2, -0.2 and -0.4 V, respectively, under illumination. Dissolved oxygen concentration measurement showed gradients within the microalgae biofilm: 18.3 mg L-1 in light decreasing to 4.29 mg L-1 in the dark. This study diversified the exoelectrogen library and provided a potential model microalga to explore the associated mechanism of extracellular electron transfer.	[Wu, Yicheng; Guan, Kai; Wang, Zejie; Xu, Bing; Zhao, Feng] Chinese Acad Sci, Inst Urban Environm, Xiamen, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS	Zhao, F (corresponding author), Chinese Acad Sci, Inst Urban Environm, Xiamen, Peoples R China.	fzhao@iue.ac.cn	Zhao, Feng/C-5293-2009; Wang, Zejie/G-5130-2010	Zhao, Feng/0000-0002-1525-042X; 	main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences [KZCXZ-EW-402]; Hundred Talents Program of the Chinese Academy of Sciences; National Natural Science Foundation of China [21177122]; Ministry of Science and Technology [2011DFB91710]	main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was sponsored by the main Direction Program of Knowledge Innovation (KZCXZ-EW-402) and the Hundred Talents Program of the Chinese Academy of Sciences, National Natural Science Foundation of China (21177122) and Ministry of Science and Technology (2011DFB91710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERK RS, 1964, APPL MICROBIOL, V12, P10, DOI 10.1128/AEM.12.1.10-12.1964; Cai PJ, 2013, BIOSENS BIOELECTRON, V39, P306, DOI 10.1016/j.bios.2012.06.058; Chen R, 2012, BIOMASS BIOENERG, V39, P128, DOI 10.1016/j.biombioe.2011.12.045; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; De Schamphelaire L, 2009, BIOTECHNOL BIOENG, V103, P296, DOI 10.1002/bit.22257; Fawley MW, 2011, PHYCOLOGIA, V50, P23, DOI 10.2216/10-16.1; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Hamelers HVM, 2010, APPL MICROBIOL BIOT, V85, P1673, DOI 10.1007/s00253-009-2357-1; Hegewald E, 2003, PLANT SYST EVOL, V241, P185, DOI 10.1007/s00606-003-0061-7; Inoue K, 2011, ENV MICROBIOL REP, V3, P211, DOI 10.1111/j.1758-2229.2010.00210.x; Kruse O, 2010, CURR OPIN BIOTECH, V21, P238, DOI 10.1016/j.copbio.2010.03.012; Li X, 2010, BIORESOURCE TECHNOL, V101, P5494, DOI 10.1016/j.biortech.2010.02.016; Liu W, 2007, J EXP MAR BIOL ECOL, V346, P76, DOI 10.1016/j.jembe.2007.03.007; Liu XW, 2013, BIOTECHNOL BIOENG, V110, P173, DOI 10.1002/bit.24628; Lovley DR, 2011, CURR OPIN BIOTECH, V22, P441, DOI 10.1016/j.copbio.2011.01.009; Lurling M, 2003, ANN LIMNOL-INT J LIM, V39, P85, DOI 10.1051/limn/2003014; Meitl LA, 2009, GEOCHIM COSMOCHIM AC, V73, P5292, DOI 10.1016/j.gca.2009.06.021; Oh SE, 2005, WATER RES, V39, P4673, DOI 10.1016/j.watres.2005.09.019; Patil S.A., 2012, BIOANAL REV, V4, P159, DOI DOI 10.1007/S12566-012-0033-X; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; Sathish A, 2012, BIORESOURCE TECHNOL, V118, P643, DOI 10.1016/j.biortech.2012.05.118; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; STAEHELIN LA, 1975, J PHYCOL, V11, P163, DOI 10.1111/j.1529-8817.1975.tb02765.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timmins M, 2009, J EXP BOT, V60, P1691, DOI 10.1093/jxb/erp052; Vanormelingen P, 2007, J PHYCOL, V43, P378, DOI 10.1111/j.1529-8817.2007.00325.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang ZJ, 2013, BIORESOURCE TECHNOL, V132, P387, DOI 10.1016/j.biortech.2012.11.026; Xiao L, 2012, ENVIRON SCI TECHNOL, V46, P11459, DOI 10.1021/es303144n; Yoon JH, 2002, INT J HYDROGEN ENERG, V27, P1265, DOI 10.1016/S0360-3199(02)00109-X	31	27	30	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73442	10.1371/journal.pone.0073442	http://dx.doi.org/10.1371/journal.pone.0073442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019922	Green Published, gold, Green Submitted			2022-12-27	WOS:000324338200064
J	Xue, WT; Batushansky, A; Toubiana, D; Botnick, I; Szymanski, J; Khozin-Goldberg, I; Nikoloski, Z; Lewinsohn, E; Fait, A				Xue, Wentao; Batushansky, Albert; Toubiana, David; Botnick, Ilan; Szymanski, Jedrzej; Khozin-Goldberg, Inna; Nikoloski, Zoran; Lewinsohn, Efraim; Fait, Aaron			The Investment in Scent: Time-Resolved Metabolic Processes in Developing Volatile-Producing Nigella sativa L. Seeds	PLOS ONE			English	Article							GALACTINOL SYNTHASE; LIPID-PEROXIDATION; FRUIT-DEVELOPMENT; PLANT DEFENSE; ACID; BIOSYNTHESIS; MATURATION; OIL; ACCUMULATION; GERMINATION	The interplay of processes in central and specialized metabolisms during seed development of Nigella sativa L. was studied by using a high-throughput metabolomics technology and network-based analysis. Two major metabolic shifts were identified during seed development: the first was characterized by the accumulation of storage lipids (estimated as total fatty acids) and N-compounds, and the second by the biosynthesis of volatile organic compounds (VOCs) and a 30% average decrease in total fatty acids. Network-based analysis identified coordinated metabolic processes during development and demonstrated the presence of five network communities. Enrichment analysis indicated that different compound classes, such as sugars, amino acids, and fatty acids, are largely separated and over-represented in certain communities. One community displayed several terpenoids and the central metabolites, shikimate derived amino acids, raffinose, xylitol and glycerol-3-phosphate. The latter are related to precursors of the mevalonate-independent pathway for VOC production in the plastid; also plastidial fatty acid 18:3n-3 abundant in "green" seeds grouped with several major terpenes. The findings highlight the interplay between the components of central metabolism and the VOCs. The developmental regulation of Nigella seed metabolism during seed maturation suggests a substantial re-allocation of carbon from the breakdown of fatty acids and from N-compounds, probably towards the biosynthesis of VOCs.	[Xue, Wentao; Batushansky, Albert; Toubiana, David; Khozin-Goldberg, Inna; Fait, Aaron] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel; [Botnick, Ilan; Lewinsohn, Efraim] Agr Res Org, Newe Yaar Res Ctr, Ramat Yishay, Israel; [Szymanski, Jedrzej; Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Ben Gurion University; Max Planck Society	Fait, A (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel.	fait@bgu.ac.il	Fait, Aaron/M-2869-2015; Khozin-Goldberg, Inna/F-2300-2012	Fait, Aaron/0000-0002-9073-8441; Khozin-Goldberg, Inna/0000-0001-8618-0687; Szymanski, Jedrzej/0000-0003-1086-0920; Toubiana, David/0000-0001-9526-1745; Nikoloski, Zoran/0000-0003-2671-6763				Angelovici R, 2010, TRENDS PLANT SCI, V15, P211, DOI 10.1016/j.tplants.2010.01.003; Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Benkaci-Ali F, 2007, FLAVOUR FRAG J, V22, P148, DOI 10.1002/ffj.1773; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Borisjuk L, 2003, J EXP BOT, V54, P503, DOI 10.1093/jxb/erg051; Botnick I, 2012, MOLECULES, V17, P10159, DOI 10.3390/molecules170910159; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenac P, 1997, J PLANT PHYSIOL, V150, P481, DOI 10.1016/S0176-1617(97)80102-2; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Burits M, 2000, PHYTOTHER RES, V14, P323, DOI 10.1002/1099-1573(200008)14:5&lt;323::AID-PTR621&gt;3.0.CO;2-Q; CASTILLO EM, 1990, J AGR FOOD CHEM, V38, P351, DOI 10.1021/jf00092a003; Chia TYP, 2005, J EXP BOT, V56, P1285, DOI 10.1093/jxb/eri129; COHEN Z, 1993, J APPL PHYCOL, V5, P109, DOI 10.1007/BF02182428; Davis EM, 2000, TOP CURR CHEM, V209, P53; DESMAISON AM, 1984, PHYTOCHEMISTRY, V23, P2453, DOI 10.1016/S0031-9422(00)84074-1; Erban A, 2006, NONSUPERVISED CONSTR, P19; Fahn A., 1982, LEAF ANATOMY, V3, P208; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Gonda I, 2013, PLANT J, V74, P458, DOI 10.1111/tpj.12149; Gonda I, 2010, J EXP BOT, V61, P1111, DOI 10.1093/jxb/erp390; Hempel S., 2013, EURO PHYS J B, V86, P1, DOI [10.1140/epjb/e2013-31111-8, DOI 10.1140/EPJB/E2013-31111-8]; Hempel S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-292; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; HOLM RE, 1972, PLANT PHYSIOL, V50, P293, DOI 10.1104/pp.50.2.293; HOUGHTON PJ, 1995, PLANTA MED, V61, P33, DOI 10.1055/s-2006-957994; Hummel Jan, 2007, V18, P75, DOI 10.1007/4735_2007_0229; Jardine K, 2012, PHOTOSYNTH RES, V113, P321, DOI 10.1007/s11120-012-9746-5; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Marcel D, 2009, NATURE CHEM BIOL, V5, P317; McKinney, 1941, J BIOL CHEM, V140, P315; Mounet F, 2007, METABOLOMICS, V3, P273, DOI 10.1007/s11306-007-0059-1; Moyes CL, 2001, P ROY SOC B-BIOL SCI, V268, P1567, DOI 10.1098/rspb.2001.1685; Newton E, OECOLOGIA, V160, P63; Pleite R, 2005, J EXP BOT, V56, P1297, DOI 10.1093/jxb/eri130; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Rosnoblet C, 2007, PLANT J, V51, P47, DOI 10.1111/j.1365-313X.2007.03116.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SARAVITZ DM, 1987, PLANT PHYSIOL, V83, P185, DOI 10.1104/pp.83.1.185; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; SOKAL RR, 1994, BIOMETRY; Spiteller P, 2001, BBA-MOL CELL BIOL L, V1531, P188, DOI 10.1016/S1388-1981(01)00100-7; Sprenger N, 2000, PLANT J, V21, P249, DOI 10.1046/j.1365-313x.2000.00671.x; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Thompson R, 2009, PLANT PHYSIOL, V151, P1023, DOI 10.1104/pp.109.143966; Toubiana D, 2013, TRENDS BIOTECHNOL, V31, P29, DOI 10.1016/j.tibtech.2012.10.011; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Urbanczyk-Wochniak E, 2006, INTEGRATING PROFILIN, P77; Weber H, 2005, ANNU REV PLANT BIOL, V56, P253, DOI 10.1146/annurev.arplant.56.032604.144201; Weichert H, 2002, PLANTA, V215, P612, DOI 10.1007/s00425-002-0779-4; Wobus U, 1999, BIOL CHEM, V380, P937, DOI 10.1515/BC.1999.116; Zhang JJ, 2011, J EXP BOT, V62, P1103, DOI 10.1093/jxb/erq343	56	3	3	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73061	10.1371/journal.pone.0073061	http://dx.doi.org/10.1371/journal.pone.0073061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24019893	Green Published, gold			2022-12-27	WOS:000324338200035
J	Caliz, R; Canet, LM; Lupianez, CB; Canhao, H; Escudero, A; Filipescu, I; Segura-Catena, J; Soto-Pino, MJ; Exposito-Ruiz, M; Ferrer, MA; Garcia, A; Romani, L; Gonzalez-Utrilla, A; Vallejo, T; Perez-Pampin, E; Hemminki, K; Forsti, A; Collantes, E; Fonseca, JE; Sainz, J				Caliz, Rafael; Maria Canet, Luz; Belen Lupianez, Carmen; Canhao, Helena; Escudero, Alejandro; Filipescu, Ileana; Segura-Catena, Juana; Jose Soto-Pino, Maria; Exposito-Ruiz, Manuela; Angel Ferrer, Miguel; Garcia, Antonio; Romani, Lurdes; Gonzalez-Utrilla, Alfonso; Vallejo, Teresa; Perez-Pampin, Eva; Hemminki, Kari; Forsti, Asta; Collantes, Eduardo; Fonseca, Joao Eurico; Sainz, Juan			Gender-Specific Effects of Genetic Variants within Th1 and Th17 Cell-Mediated Immune Response Genes on the Risk of Developing Rheumatoid Arthritis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; PATTERN-RECOGNITION RECEPTOR; TUMOR-NECROSIS-FACTOR; JOINT DESTRUCTION; DISEASE; POLYMORPHISM; EXPRESSION; DECTIN-2; ASSOCIATION; SUSCEPTIBILITY	The present study was conducted to explore whether single nucleotide polymorphisms (SNPs) in Th1 and Th17 cell-mediated immune response genes differentially influence the risk of rheumatoid arthritis (RA) in women and men. In phase one, 27 functional/tagging polymorphisms in C-type lectins and MCP-1/CCR2 axis were genotyped in 458 RA patients and 512 controls. Carriers of Dectin-2(rs4264222T) allele had an increased risk of RA (OR = 1.47, 95% CI 1.10-1.96) whereas patients harboring the DC-SIGN(rs4804803G), MCP-1(rs1024611G), MCP-1(rs13900T) and MCP-1(rs4586C) alleles had a decreased risk of developing the disease (OR = 0.66, 95% CI 0.49-0.88; OR = 0.66, 95% CI 0.50-0.89; OR = 0.73, 95% CI 0.55-0.97 and OR = 0.68, 95% CI 0.51-0.91). Interestingly, significant gender-specific differences were observed for Dectin-2(rs4264222) and Dectin-2(rs7134303): women carrying the Dectin-2(rs4264222T) and Dectin-2(rs7134303G) alleles had an increased risk of RA (OR = 1.93, 95% CI 1.34-2.79 and OR = 1.90, 95% CI 1.29-2.80). Also five other SNPs showed significant associations only with one gender: women carrying the MCP-1(rs1024611G), MCP-1(rs13900T) and MCP-1(rs4586C) alleles had a decreased risk of RA (OR = 0.61, 95% CI 0.43-0.87; OR = 0.67, 95% CI 0.47-0.95 and OR = 0.60, 95% CI 0.42-0.86). In men, carriers of the DC-SIGN(rs2287886A) allele had an increased risk of RA (OR = 1.70, 95% CI 1.03-2.78), whereas carriers of the DC-SIGN(rs4804803G) had a decreased risk of developing the disease (OR = 0.53, 95% CI 0.32-0.89). In phase 2, we genotyped these SNPs in 754 RA patients and 519 controls, leading to consistent gender-specific associations for Dectin-2(rs4264222), MCP-1(rs1024611), MCP-1(rs13900) and DC-SIGN(rs4804803) polymorphisms in the pooled sample (OR = 1.38, 95% CI 1.08-1.77; OR = 0.74, 95% CI 0.58-0.94; OR = 0.76, 95% CI 0.59-0.97 and OR = 0.56, 95% CI 0.34-0.93). SNP-SNP interaction analysis of significant SNPs also showed a significant two-locus interaction model in women that was not seen in men. This model consisted of Dectin-2(rs4264222) and Dectin-2(rs7134303) SNPs and suggested a synergistic effect between the variants. These findings suggest that Dectin-2, MCP-1 and DC-SIGN polymorphisms may, at least in part, account for gender-associated differences in susceptibility to RA.	[Caliz, Rafael; Jose Soto-Pino, Maria; Angel Ferrer, Miguel; Garcia, Antonio; Romani, Lurdes; Gonzalez-Utrilla, Alfonso; Vallejo, Teresa] Virgen de las Nieves Univ Hosp, Dept Rheumatol, Granada, Spain; [Maria Canet, Luz; Belen Lupianez, Carmen; Segura-Catena, Juana; Sainz, Juan] Univ Granada, Andalusian Reg Govt, Ctr Genom & Oncol Res, Genom Oncol Area,GENYO,Pfizer, Granada, Spain; [Canhao, Helena; Fonseca, Joao Eurico] Univ Lisbon, Fac Med, Inst Med Mol, Rheumatol Res Unit, P-1699 Lisbon, Portugal; [Canhao, Helena; Fonseca, Joao Eurico] Hosp Santa Maria, CHLN, Dept Rheumatol, Lisbon, Portugal; [Escudero, Alejandro; Filipescu, Ileana; Collantes, Eduardo] Reina Sofia Hosp, Dept Rheumatol, Cordoba, Spain; [Exposito-Ruiz, Manuela] Virgen de las Nieves Univ Hosp, FIBAO Fundat, Granada, Spain; [Perez-Pampin, Eva] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Rheumtol Unit, Santiago De Compostela, Spain; [Hemminki, Kari; Forsti, Asta; Sainz, Juan] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Hemminki, Kari; Forsti, Asta] Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden	Hospital Universitario Virgen de las Nieves; Pfizer; University of Granada; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Hospital Universitario Reina Sofia - Cordoba; Hospital Universitario Virgen de las Nieves; Complexo Hospitalario Universitario de Santiago de Compostela; Helmholtz Association; German Cancer Research Center (DKFZ)	Sainz, J (corresponding author), Univ Granada, Andalusian Reg Govt, Ctr Genom & Oncol Res, Genom Oncol Area,GENYO,Pfizer, Granada, Spain.	juan.sainz@genyo.es	Ruiz, Manuela Exposito/AAT-4629-2021; Perez-Pampin, Eva/ABF-7200-2020; canet, luz maria/F-7816-2016; Collantes-Estevez, Eduardo/M-9549-2019; Canhao, Helena/C-9611-2018; Escudero, Alejandro/AGR-5004-2022; Collantes-Estevez, Eduardo/ABI-3550-2020; Segura-Catena, Juana/G-1242-2016; Juan, Sainz/Y-6473-2019	canet, luz maria/0000-0002-2838-622X; Canhao, Helena/0000-0003-1894-4870; Collantes-Estevez, Eduardo/0000-0002-7647-6289; Segura-Catena, Juana/0000-0002-1190-0368; Juan, Sainz/0000-0002-9355-2423; Perez-Pampin, Eva/0000-0003-0319-4456; Exposito, Manuela/0000-0003-2789-9442; Fonseca, Joao/0000-0003-1432-3671; Escudero Contreras, Alejandro/0000-0001-5891-5527; Canhao, Helena/0000-0002-3239-2809	Consejeria de Salud de la Junta de Andalucia (Sevilla, Spain) [P08-CVI-4116]; Fondo de Investigaciones Sanitarias (Madrid, Spain) [PI08/1051, PI12/02688]	Consejeria de Salud de la Junta de Andalucia (Sevilla, Spain); Fondo de Investigaciones Sanitarias (Madrid, Spain)	This study was partially supported by grants P08-CVI-4116 from Consejeria de Salud de la Junta de Andalucia (Sevilla, Spain) and PI08/1051 and PI12/02688 from Fondo de Investigaciones Sanitarias (Madrid, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman LS, 2006, ARCH DERMATOL, V142, P371, DOI 10.1001/archderm.142.3.371; AKAHOSHI T, 1993, ARTHRITIS RHEUM-US, V36, P762, DOI 10.1002/art.1780360605; Aragane Y, 2003, J IMMUNOL, V171, P3801, DOI 10.4049/jimmunol.171.7.3801; Bouman A, 2004, AM J REPROD IMMUNOL, V52, P19, DOI 10.1111/j.1600-0897.2004.00177.x; Bowes J, 2008, RHEUMATOLOGY, V47, P399, DOI 10.1093/rheumatology/ken005; Burmester GR, 1997, ARTHRITIS RHEUM, V40, P5, DOI 10.1002/art.1780400104; Carter RW, 2006, CELL IMMUNOL, V239, P87, DOI 10.1016/j.cellimm.2006.05.001; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; Dieguez-Gonzalez R, 2009, J RHEUMATOL, V36, P1590, DOI 10.3899/jrheum.090022; Gabriel SE, 2001, RHEUM DIS CLIN N AM, V27, P269, DOI 10.1016/S0889-857X(05)70201-5; Gonzalez-Escribano MF, 2003, HUM IMMUNOL, V64, P741, DOI 10.1016/S0198-8859(03)00090-9; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gutierrez L, 2007, BLOOD, V110, P1933, DOI 10.1182/blood-2006-09-048322; Gutierrez-Roelens I, 2008, CURR MOL MED, V8, P551, DOI 10.2174/156652408785747906; Hussein Y, 2011, JOINT BONE SPINE; Hussein YM, 2011, RHEUMATOL INT; Hussein YM, 2011, CELL IMMUNOL, V271, P192, DOI 10.1016/j.cellimm.2011.06.023; Hwang SY, 2002, EUR J IMMUNOGENET, V29, P413, DOI 10.1046/j.1365-2370.2002.00346.x; Iikuni N, 2009, J RHEUMATOL, V36, P508, DOI 10.3899/jrheum.080724; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Karouzakis E, 2006, IMMUNOL LETT, V106, P8, DOI 10.1016/j.imlet.2006.04.011; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Lee YH, 2003, SCAND J RHEUMATOL, V32, P235; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Makarov SS, 2001, ARTHRITIS RES, V3, P200, DOI 10.1186/ar300; McDermott DH, 2005, CIRCULATION, V112, P1113, DOI 10.1161/CIRCULATIONAHA.105.543579; Miossec P, 2004, CURR OPIN RHEUMATOL, V16, P218, DOI 10.1097/00002281-200405000-00009; Miossec P, 2007, ARTHRITIS RHEUM-US, V56, P2111, DOI 10.1002/art.22733; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Muller-Ladner U, 2005, NAT CLIN PRACT RHEUM, V1, P102, DOI 10.1038/ncprheum0047; Myasoedova E, 2010, ARTHRITIS RHEUM-US, V62, P1576, DOI 10.1002/art.27425; Padyukov L, 2004, J RHEUMATOL, V31, P422; Plantinga TS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2933; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rose NR, 1997, HOSP PRACT, V32, P147, DOI 10.1080/21548331.1997.11443469; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Scrivo R, 2007, ANN NY ACAD SCI, V1108, P312, DOI 10.1196/annals.1422.033; Sokka T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2591; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; TALAL N, 1992, RHEUM DIS CLIN N AM, V18, P507; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; van Lent PLEM, 2003, ARTHRITIS RHEUM, V48, P360, DOI 10.1002/art.10786; Worthington J, 2005, J AUTOIMMUN, V25, P16, DOI 10.1016/j.jaut.2005.09.011; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	50	16	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e72732	10.1371/journal.pone.0072732	http://dx.doi.org/10.1371/journal.pone.0072732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023637	Green Submitted, Green Published, gold			2022-12-27	WOS:000323880200032
J	Currie, SM; Findlay, EG; McHugh, BJ; Mackellar, A; Man, T; Macmillan, D; Wang, HW; Fitch, PM; Schwarze, J; Davidson, DJ				Currie, Silke M.; Findlay, Emily Gwyer; McHugh, Brian J.; Mackellar, Annie; Man, Tian; Macmillan, Derek; Wang, Hongwei; Fitch, Paul M.; Schwarze, Juergen; Davidson, Donald J.			The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; HOST-DEFENSE; VITAMIN-D; EPITHELIAL-CELLS; BRONCHIOLITIS; INFECTIONS; EXPRESSION; FRAGMENTS; IMMUNITY; RECEPTOR	Respiratory syncytial virus is a leading cause of lower respiratory tract illness among infants, the elderly and immunocompromised individuals. Currently, there is no effective vaccine or disease modifying treatment available and novel interventions are urgently required. Cathelicidins are cationic host defence peptides expressed in the inflamed lung, with key roles in innate host defence against infection. We demonstrate that the human cathelicidin LL-37 has effective antiviral activity against RSV in vitro, retained by a truncated central peptide fragment. LL-37 prevented virus-induced cell death in epithelial cultures, significantly inhibited the production of new infectious particles and diminished the spread of infection, with antiviral effects directed both against the viral particles and the epithelial cells. LL-37 may represent an important targetable component of innate host defence against RSV infection. Prophylactic modulation of LL-37 expression and/or use of synthetic analogues post-infection may represent future novel strategies against RSV infection.	[Currie, Silke M.; Findlay, Emily Gwyer; McHugh, Brian J.; Mackellar, Annie; Man, Tian; Wang, Hongwei; Fitch, Paul M.; Schwarze, Juergen; Davidson, Donald J.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Man, Tian] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Macmillan, Derek] UCL, Dept Chem, London, England; [Wang, Hongwei] Nanjing Univ, Sch Med, Ctr Translat Med, Nanjing 210008, Jiangsu, Peoples R China	University of Edinburgh; Nanjing Medical University; University of London; University College London; Nanjing University	Davidson, DJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	donald.davidson@ed.ac.uk	Schwarze, Jürgen/F-7396-2011	Gwyer Findlay, Emily/0000-0002-2311-6589; McHugh, Brian/0000-0003-4747-0643; FITCH, PAUL/0000-0001-5294-3340; Schwarze, Jurgen/0000-0002-6899-748X	MRC Senior Non-clinical Research Fellowship [G1002046]; University of Edinburgh College of Medicine and Veterinary Medicine Studentship; Wellcome Trust Senior Fellowship [067454]; Natural Science Foundation of Jiangsu Province China [BK2010245]; MRC [G0901697, G1002046, G1002033] Funding Source: UKRI; Medical Research Council [G0901697, G1002046, G1002033] Funding Source: researchfish	MRC Senior Non-clinical Research Fellowship; University of Edinburgh College of Medicine and Veterinary Medicine Studentship; Wellcome Trust Senior Fellowship(Wellcome Trust); Natural Science Foundation of Jiangsu Province China(Natural Science Foundation of Jiangsu Province); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DJD is supported by a MRC (http://www.mrc.ac.uk) Senior Non-clinical Research Fellowship (G1002046), SMC is supported by a University of Edinburgh College of Medicine and Veterinary Medicine Studentship (http://www.ed.ac.uk), JS was supported by a Wellcome Trust (http://www.wellcome.ac.uk) Senior Fellowship (067454), HW is support by The Natural Science Foundation of Jiangsu Province China (No. BK2010245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Barlow PG, 2010, AM J RESP CELL MOL, V43, P692, DOI 10.1165/rcmb.2009-0250OC; Beaumont PE, 2013, ANTIMICROBIAL PEPTID, P97; Belderbos ME, 2011, PEDIATRICS, V127, pE1513, DOI 10.1542/peds.2010-3054; Bergman P, 2007, CURR HIV RES, V5, P410; Berry DJ, 2011, BRIT J NUTR, V106, P1433, DOI 10.1017/S0007114511001991; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; CANNON MJ, 1987, J VIROL METHODS, V16, P293, DOI 10.1016/0166-0934(87)90014-0; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; Gwyer Findlay E, 2013, BIODRUGS; HAMBLING MH, 1964, BRIT J EXP PATHOL, V45, P647; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lau YE, 2005, INFECT IMMUN, V73, P583, DOI 10.1128/IAI.73.1.583-591.2005; Li HN, 2009, J LEUKOCYTE BIOL, V86, P891, DOI 10.1189/jlb.0209050; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10; Mansbach JM, 2012, J ALLERGY CLIN IMMUN, V130, P1007, DOI 10.1016/j.jaci.2012.07.044; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nell MJ, 2006, PEPTIDES, V27, P649, DOI 10.1016/j.peptides.2005.09.016; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Sarker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020637; Scagnolari C, 2012, MED MICROBIOL IMMUN, V201, P311, DOI 10.1007/s00430-012-0233-6; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Singh D, 2013, J BIOL CHEM, V288, P8258, DOI 10.1074/jbc.M112.440883; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0; van der Does AM, 2012, J LEUKOCYTE BIOL, V92, P735, DOI 10.1189/jlb.0412178; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wong JH, 2011, PEPTIDES, V32, P1117, DOI 10.1016/j.peptides.2011.04.017; YIM S, 2007, J CYST FIBROS	48	112	120	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73659	10.1371/journal.pone.0073659	http://dx.doi.org/10.1371/journal.pone.0073659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24023689	Green Published, Green Submitted, gold			2022-12-27	WOS:000323880200086
J	Aerts, L; Hamelin, ME; Rheaume, C; Lavigne, S; Couture, C; Kim, W; Susan-Resiga, D; Prat, A; Seidah, NG; Vergnolle, N; Riteau, B; Boivin, G				Aerts, Laetitia; Hamelin, Marie-Eve; Rheaume, Chantal; Lavigne, Sophie; Couture, Christian; Kim, WooJin; Susan-Resiga, Delia; Prat, Annik; Seidah, Nabil G.; Vergnolle, Nathalie; Riteau, Beatrice; Boivin, Guy			Modulation of Protease Activated Receptor 1 Influences Human Metapneumovirus Disease Severity in a Mouse Model	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; IMMUNE-RESPONSE; SECONDARY PREVENTION; TRANSPLANT RECIPIENT; BALB/C MICE; INFECTION; PATHOGENESIS; PROPROTEIN; CELLS; INFLAMMATION	Human metapneumovirus (hMPV) infection causes acute respiratory tract infections (RTI) which can result in hospitalization of both children and adults. To date, no antiviral or vaccine is available for this common viral infection. Immunomodulators could represent an interesting strategy for the treatment of severe viral infection. Recently, the role of protease-activated receptors (PAR) in inflammation, coagulation and infection processes has been of growing interest. Herein, the effects of a PAR1 agonist and a PAR1 antagonist on hMPV infection were investigated in BALB/c mice. Intranasal administration of the PAR1 agonist resulted in increased weight loss and mortality of infected mice. Conversely, the PAR1 antagonist was beneficial to hMPV infection by decreasing weight loss and clinical signs and by significantly reducing pulmonary inflammation, pro-inflammatory cytokine levels (including IL-6, KC and MCP-1) and recruitment of immune cells to the lungs. In addition, a significant reduction in pulmonary viral titers was also observed in the lungs of PAR1 antagonist-treated mice. Despite no apparent direct effect on virus replication during in vitro experiments, an important role for PAR1 in the regulation of furin expression in the lungs was shown for the first time. Further experiments indicated that the hMPV fusion protein can be cleaved by furin thus suggesting that PAR1 could have an effect on viral infectivity in addition to its immunomodulatory properties. Thus, inhibition of PAR1 by selected antagonists could represent an interesting strategy for decreasing the severity of paramyxovirus infections.	[Aerts, Laetitia; Hamelin, Marie-Eve; Rheaume, Chantal; Boivin, Guy] Ctr Hosp Univ Quebec, Ctr Rech Infectiol, Quebec City, PQ, Canada; [Aerts, Laetitia; Hamelin, Marie-Eve; Rheaume, Chantal; Boivin, Guy] Univ Laval, Quebec City, PQ, Canada; [Lavigne, Sophie; Couture, Christian] Univ Laval, Dept Anatomopathol, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Kim, WooJin; Susan-Resiga, Delia; Prat, Annik; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Vergnolle, Nathalie] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, Inst Natl Sante & Rech Med, Ctr Natl Rech Sci,Univ Toulouse, F-31062 Toulouse, France; [Vergnolle, Nathalie] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada; [Riteau, Beatrice] Univ Lyon, Fac Med RTH Laennec, Lyon, France; [Riteau, Beatrice] Nouzilly Inst Natl Rech Agron, Ctr Tours, Nouzilly, France	Laval University; Laval University; Laval University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Calgary; INRAE	Boivin, G (corresponding author), Ctr Hosp Univ Quebec, Ctr Rech Infectiol, Quebec City, PQ, Canada.	Guy.Boivin@crchul.ulaval.ca	Vergnolle, Nathalie/C-7677-2018; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017; Seidah, Nabil/I-3596-2013	Vergnolle, Nathalie/0000-0003-1825-6015; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Seidah, Nabil/0000-0001-6503-9342; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes of Health Research [273261, 733598]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by grant No. 273261 from the Canadian Institutes of Health Research (to G. B.), and by grant No. 733598 from the Canadian Institutes of Health Research (to N.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2011, BRAIN, V134, P3209, DOI 10.1093/brain/awr242; Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Alvarez R, 2005, J VIROL, V79, P5971, DOI 10.1128/JVI.79.10.5971-5978.2005; Alvarez R, 2004, J VIROL, V78, P14003, DOI 10.1128/JVI.78.24.14003-14011.2004; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Antoniak S, 2013, J CLIN INVEST, V123, P1310, DOI 10.1172/JCI66125; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Atzori L, 2009, AM J RESP CELL MOL, V41, P680, DOI 10.1165/rcmb.2007-0386OC; Bar-Shavit R, 2002, IMMUNOLOGY, V105, P35, DOI 10.1046/j.0019-2805.2001.01351.x; Barik S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-104; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Berri F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003229; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; Cabello-Guterrez C, 2009, THROMB HAEMOSTASIS, V101, P916, DOI 10.1160/TH08-04-0271; Cane PA, 2003, BONE MARROW TRANSPL, V31, P309, DOI 10.1038/sj.bmt.1703849; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Cenac N, 2005, INFLAMM BOWEL DIS, V11, P792, DOI 10.1097/01.mib.0000177506.71784.bd; Chin AC, 2003, P NATL ACAD SCI USA, V100, P11104, DOI 10.1073/pnas.1831452100; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Darniot M, 2005, VACCINE, V23, P4473, DOI 10.1016/j.vaccine.2005.04.027; de Swart RL, 2007, VACCINE, V25, P8518, DOI 10.1016/j.vaccine.2007.10.022; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Di Serio C, 2007, BASIC CLIN PHARMACOL, V101, P63, DOI 10.1111/j.1742-7843.2007.00078.x; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Feuillet F, 2012, J CLIN VIROL, V53, P97, DOI 10.1016/j.jcv.2011.10.002; Foucault ML, 2011, J CLIN VIROL, V51, P155, DOI 10.1016/j.jcv.2011.04.013; Ganachari M, 2012, GENES IMMUN, V13, P605, DOI 10.1038/gene.2012.39; Hamelin ME, 2007, J GEN VIROL, V88, P3391, DOI 10.1099/vir.0.83250-0; Hamelin ME, 2006, J INFECT DIS, V193, P1634, DOI 10.1086/504262; Hamelin ME, 2006, ANTIMICROB AGENTS CH, V50, P774, DOI 10.1128/AAC.50.2.774-777.2006; Hamelin ME, 2005, J VIROL, V79, P8894, DOI 10.1128/JVI.79.14.8894-8903.2005; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Herfst S, 2008, J CLIN VIROL, V41, P45, DOI 10.1016/j.jcv.2007.10.022; Kamboj M, 2008, J INFECTION, V57, P464, DOI 10.1016/j.jinf.2008.10.003; Khoufache K, 2013, J CLIN INVEST, V123, P206, DOI 10.1172/JCI61667; Khoufache K, 2009, J IMMUNOL, V182, P7795, DOI 10.4049/jimmunol.0803743; Kuiken T, 2004, AM J PATHOL, V164, P1893, DOI 10.1016/S0002-9440(10)63750-9; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Lan RS, 2004, AM J PHYSIOL-LUNG C, V286, pL388, DOI 10.1152/ajplung.00286.2003; Li T, 2006, IMMUNOL CELL BIOL, V84, P461, DOI 10.1111/j.1440-1711.2006.01456.x; Louie JK, 2007, J INFECT DIS, V196, P705, DOI 10.1086/519846; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Mercer PF, 2009, AM J RESP CRIT CARE, V179, P414, DOI 10.1164/rccm.200712-1827OC; Min JY, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/649570; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651; Pelletier G, 2002, EMERG INFECT DIS, V8, P976, DOI 10.3201/eid0809.020238; Raza K, 2007, J HEART LUNG TRANSPL, V26, P862, DOI 10.1016/j.healun.2007.05.020; Rullier A, 2008, AM J PHYSIOL-GASTR L, V294, pG226, DOI 10.1152/ajpgi.00444.2007; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Shahda S, 2011, TRANSPL INFECT DIS, V13, P324, DOI 10.1111/j.1399-3062.2010.00575.x; Sookoian Silvia, 2004, Ann Hepatol, V3, P104; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Strande JL, 2007, BASIC RES CARDIOL, V102, P350, DOI 10.1007/s00395-007-0653-4; Sumino KC, 2005, J INFECT DIS, V192, P1052, DOI 10.1086/432728; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Sutherland MR, 2007, J THROMB HAEMOST, V5, P1055, DOI 10.1111/j.1538-7836.2007.02441.x; Sutherland MR, 2012, BLOOD, V119, P3638, DOI 10.1182/blood-2011-08-376814; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Van den Hoogen BG, 2004, PEDIATR INFECT DIS J, V23, pS25, DOI 10.1097/01.inf.0000108190.09824.e8; Vargas SO, 2004, PEDIATR DEVEL PATHOL, V7, P478, DOI 10.1007/s10024-004-1011-2; Ventre K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000181.pub3; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Wang HY, 2007, EUR J CELL BIOL, V86, P233, DOI 10.1016/j.ejcb.2006.12.003; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Williams JV, 2005, J VIROL, V79, P10944, DOI 10.1128/JVI.79.17.10944-10951.2005; Wyde PR, 2005, ANTIVIR RES, V66, P57, DOI 10.1016/j.antiviral.2004.12.009; Wyde PR, 2003, ANTIVIR RES, V60, P51, DOI 10.1016/S0166-3542(03)00153-0; Yanagita M, 2007, BIOCHEM BIOPH RES CO, V364, P318, DOI 10.1016/j.bbrc.2007.10.002; Yoshikawa Y, 2010, CYTOTECHNOLOGY, V62, P325, DOI 10.1007/s10616-010-9275-z	80	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72529	10.1371/journal.pone.0072529	http://dx.doi.org/10.1371/journal.pone.0072529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015257	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800062
J	Deng, M; Tang, HL; Lu, XH; Liu, MY; Lu, XM; Gu, YX; Liu, JF; He, ZM				Deng, Min; Tang, Hai-lin; Lu, Xi-hong; Liu, Mei-yuan; Lu, Xiao-min; Gu, Yi-xue; Liu, Ji-fang; He, Zhi-min			miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA; MICRORNA EXPRESSION; SURVIVAL; CLUSTER; GLIOMA; CELLS; EZH2	The role of miR-26a in cancer cells seemed controversial in previous studies. Until now, the role of miR-26a in gastric cancer remains undefined. In this study, we found that miR-26a was strongly downregulated in gastric cancer (GC) tissues and cell lines, and its expression levels were associated with lymph node metastasis and clinical stage, as well as overall survival and replase-free survival of GC. We also found that ectopic expression of miR-26a inhibited GC cell proliferation and GC metastasis in vitro and in vivo. We further identified a novel mechanism of miR-26a to suppress GC growth and metastasis. FGF9 was proved to be a direct target of miR-26a, using luciferase assay and western blot. FGF9 overexpression in miR-26a-expressing cells could rescue invasion and growth defects of miR-26a. In addition, miR-26a expression inversely correlated with FGF9 protein levels in GC. Taken together, our data suggest that miR-26a functions as a tumor suppressor in GC development and progression, and holds promise as a prognostic biomarker and potential therapeutic target for GC.	[Deng, Min; Liu, Mei-yuan; Gu, Yi-xue; Liu, Ji-fang; He, Zhi-min] Guangzhou Med Univ, Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Deng, Min; Liu, Mei-yuan; Gu, Yi-xue; Liu, Ji-fang; He, Zhi-min] Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Tang, Hai-lin] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Min; Tang, Hai-lin; Liu, Ji-fang] Univ South China, Canc Res Inst, Hengyang, Peoples R China; [Lu, Xi-hong] Univ South China, Affiliated Nanhua Hosp, Hengyang, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Sun Yat Sen University; University of South China; University of South China	Deng, M (corresponding author), Guangzhou Med Univ, Canc Hosp, Guangzhou, Guangdong, Peoples R China.	dengmin2006@yahoo.com.cn; hezhimin2005@yahoo.com			Nature Scientific Foundation of China [81101526, 31100936]; Guangzhou Medical College Doctor Start Foundation [2012C11]	Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Medical College Doctor Start Foundation	This work was supported by grants from the Nature Scientific Foundation of China (81101526, 31100936) and Guangzhou Medical College Doctor Start Foundation (2012C11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.64; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Cheng CJ, 2012, CANCER J, V18, P232, DOI 10.1097/PPO.0b013e318258b75b; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Deng M, 2013, TUMOR BIOL, V34, P1793, DOI 10.1007/s13277-013-0718-y; Deng M, 2011, J CELL SCI, V124, P2997, DOI 10.1242/jcs.085050; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Gao J, 2011, ONCOL LETT, V2, P1019, DOI 10.3892/ol.2011.413; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang X, 2012, P NATL ACAD SCI USA, V109, P19397, DOI 10.1073/pnas.1217519109; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Li ZG, 2008, J CLIN INVEST, V118, P2697, DOI 10.1172/JCI33093; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; Ralfkiaer U, 2011, BLOOD, V118, P5891, DOI 10.1182/blood-2011-06-358382; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Strillacci A, 2013, J PATHOL, V229, P379, DOI 10.1002/path.4097; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang H, 2013, HEPATOLOGY, V58, P205, DOI 10.1002/hep.26315; Zhang JQ, 2012, GASTROENTEROLOGY, V143, P246, DOI 10.1053/j.gastro.2012.03.045; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	37	83	96	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72662	10.1371/journal.pone.0072662	http://dx.doi.org/10.1371/journal.pone.0072662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015269	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800073
J	Guida, B; Cataldi, M; Riccio, E; Grumetto, L; Pota, A; Borrelli, S; Memoli, A; Barbato, F; Argentino, G; Salerno, G; Memoli, B				Guida, Bruna; Cataldi, Mauro; Riccio, Eleonora; Grumetto, Lucia; Pota, Andrea; Borrelli, Silvio; Memoli, Andrea; Barbato, Francesco; Argentino, Gennaro; Salerno, Giuliana; Memoli, Bruno			Plasma p-Cresol Lowering Effect of Sevelamer in Peritoneal Dialysis Patients: Evidence from a Cross-Sectional Observational Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; UREMIC TOXINS; PHOSPHATE BINDERS; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; RETENTION SOLUTE; MORTALITY RISK; URIC-ACID; HEMODIALYSIS; SERUM	p-Cresol is a by-product of the metabolism of aromatic aminoacid operated by resident intestinal bacteria. In patients with chronic kidney disease, the accumulation of p-cresol and of its metabolite p-cresyl-sulphate causes endothelial dysfunction and ultimately increases the cardiovascular risk of these patients. Therapeutic strategies to reduce plasma p-cresol levels are highly demanded but not available yet. Because it has been reported that the phosphate binder sevelamer sequesters p-cresol in vitro we hypothesized that it could do so also in peritoneal dialysis patients. To explore this hypothesis we measured total cresol plasma concentrations in 57 patients with end-stage renal disease on peritoneal dialysis, 29 receiving sevelamer for the treatment of hyperphosphatemia and 28 patients not assuming this drug. Among the patients not assuming sevelamer, 16 were treated with lanthanum whereas the remaining 12 received no drug because they were not hyperphosphatemic. Patients receiving sevelamer had plasma p-cresol and serum high sensitivity C-reactive protein concentrations significantly lower than those receiving lanthanum or no drug. Conversely, no difference was observed among the different groups either in residual glomerular filtration rate, total weekly dialysis dose, total clearance, urine volume, protein catabolic rate, serum albumin or serum phosphate levels. Multiple linear regression analysis showed that none of these variables predicted plasma p-cresol concentrations that, instead, negatively correlated with the use of sevelamer. These results suggest that sevelamer could be an effective strategy to lower p-cresol circulating levels in peritoneal dialysis patients in which it could also favorably affect cardiovascular risk because of its anti-inflammatory effect.	[Guida, Bruna] Univ Naples Federico II, Dept Clin Med & Surg, Div Physiol, Naples, Italy; [Cataldi, Mauro] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Naples, Italy; [Riccio, Eleonora; Pota, Andrea; Memoli, Andrea; Argentino, Gennaro; Memoli, Bruno] Univ Naples Federico II, Dept Nephrol, Naples, Italy; [Grumetto, Lucia; Barbato, Francesco] Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, Naples, Italy; [Salerno, Giuliana] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy; [Borrelli, Silvio] Univ Naples 2, Div Nephrol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli	Guida, B (corresponding author), Univ Naples Federico II, Dept Clin Med & Surg, Div Physiol, Naples, Italy.	bguida@unina.it	Borrelli, Silvio/AAH-8549-2019; Cataldi, Mauro/AAB-3642-2019; Barbato, Francesco/I-5863-2015	Borrelli, Silvio/0000-0002-4414-4597; Cataldi, Mauro/0000-0001-7787-3406; Barbato, Francesco/0000-0001-6709-3545; Grumetto, Lucia/0000-0002-3529-1819				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Bammens B, 2003, KIDNEY INT, V64, P2238, DOI 10.1046/j.1523-1755.2003.00310.x; Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Brandenburg VM, 2010, NEPHROL DIAL TRANSPL, V25, P2672, DOI 10.1093/ndt/gfq053; Burke SK, 2003, ADV RENAL REPLACE TH, V10, P133, DOI 10.1053/jarr.2003.50016; Caglar K, 2008, CLIN J AM SOC NEPHRO, V3, P61, DOI 10.2215/CJN.02810707; Cerini C, 2004, THROMB HAEMOSTASIS, V92, P140, DOI 10.1160/th03-07-0491; Cohen J.E., 1988, STAT POWER ANAL BEHA; CUMMINGS JH, 1983, LANCET, V1, P1206; Davenport A, 2011, HEMODIAL INT, V15, pS49, DOI 10.1111/j.1542-4758.2011.00602.x; De Smet R, 1998, CLIN CHIM ACTA, V278, P1, DOI 10.1016/S0009-8981(98)00124-7; De Smet R, 2004, J AM SOC NEPHROL, V15, p505A; Evenepoel P, 1999, AM J PHYSIOL-GASTR L, V277, pG935, DOI 10.1152/ajpgi.1999.277.5.G935; Evenepoel P, 2009, KIDNEY INT, V76, pS12, DOI 10.1038/ki.2009.402; Evenepoel P, 2009, NEPHROL DIAL TRANSPL, V24, P278, DOI 10.1093/ndt/gfn488; Ferramosca E, 2005, AM HEART J, V149, P820, DOI 10.1016/j.ahj.2004.07.023; Garg JP, 2005, ARTHRITIS RHEUM-US, V52, P290, DOI 10.1002/art.20781; Goldsmith DR, 2008, DRUGS, V68, P85, DOI 10.2165/00003495-200868010-00006; Goto S, 2011, THER APHER DIAL, V15, P132, DOI 10.1111/j.1744-9987.2010.00891.x; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Krieter DH, 2010, NEPHROL DIAL TRANSPL, V25, P212, DOI 10.1093/ndt/gfp437; Leypoldt JK, 1999, AM J KIDNEY DIS, V33, P349, DOI 10.1016/S0272-6386(99)70311-2; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lin CJ, 2011, INT J GERONTOL, V5, P80, DOI 10.1016/j.ijge.2011.04.010; Lin CJ, 2010, NEPHROL DIAL TRANSPL, V25, P3693, DOI 10.1093/ndt/gfq251; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022; Navarro-Gonzalez JF, 2011, CLIN J AM SOC NEPHRO, V6, P2272, DOI 10.2215/CJN.01650211; NIWA T, 1993, NEPHRON, V65, P82, DOI 10.1159/000187446; Ohno I, 2009, INTERNAL MED, V48, P415, DOI 10.2169/internalmedicine.48.1817; Perianayagam MC, 2008, AM J NEPHROL, V28, P802, DOI 10.1159/000135691; Phan O, 2005, CIRCULATION, V112, P2875, DOI 10.1161/CIRCULATIONAHA105.541854; Ritz E, 2011, BLOOD PURIFICAT, V31, P70, DOI 10.1159/000321848; Shantouf R, 2008, AM J NEPHROL, V28, P275, DOI 10.1159/000111061; Stinghen AEM, 2010, BLOOD PURIFICAT, V29, P352, DOI 10.1159/000302723; Sun PP, 2009, J RENAL NUTR, V19, P432, DOI 10.1053/j.jrn.2009.01.022; Takei T, 2008, NEPHRON CLIN PRACT, V108, pC278, DOI 10.1159/000127361; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Vanholder R, 2003, NEPHROL DIAL TRANSPL, V18, P463, DOI 10.1093/ndt/18.3.463; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2011, NEPHROL DIAL TRANSPL, V26, P1464, DOI 10.1093/ndt/gfr056; Vlassara H, 2012, CLIN J AM SOC NEPHRO, V7, P934, DOI 10.2215/CJN.12891211; Yamada K, 2005, RENAL FAILURE, V27, P361, DOI 10.1081/JDI-200065259; Ying Y, 2011, CIRC J, V75, P2252, DOI 10.1253/circj.CJ-11-0046; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	49	23	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e73558	10.1371/journal.pone.0073558	http://dx.doi.org/10.1371/journal.pone.0073558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015307	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800102
J	Paris, CB; Atema, J; Irisson, JO; Kingsford, M; Gerlach, G; Guigand, CM				Paris, Claire B.; Atema, Jelle; Irisson, Jean-Olivier; Kingsford, Michael; Gerlach, Gabriele; Guigand, Cedric M.			Reef Odor: A Wake Up Call for Navigation in Reef Fish Larvae	PLOS ONE			English	Article							PELAGIC STAGES; ORIENTATION; CONNECTIVITY; ABILITIES; RETENTION; MIGRATION; DISPERSAL; BEHAVIOR	The behavior of reef fish larvae, equipped with a complex toolbox of sensory apparatus, has become a central issue in understanding their transport in the ocean. In this study pelagic reef fish larvae were monitored using an unmanned open-ocean tracking device, the drifting in-situ chamber (DISC), deployed sequentially in oceanic waters and in reef-born odor plumes propagating offshore with the ebb flow. A total of 83 larvae of two taxonomic groups of the families Pomacentridae and Apogonidae were observed in the two water masses around One Tree Island, southern Great Barrier Reef. The study provides the first in-situ evidence that pelagic reef fish larvae discriminate reef odor and respond by changing their swimming speed and direction. It concludes that reef fish larvae smell the presence of coral reefs from several kilometers offshore and this odor is a primary component of their navigational system and activates other directional sensory cues. The two families expressed differences in their response that could be adapted to maintain a position close to the reef. In particular, damselfish larvae embedded in the odor plume detected the location of the reef crest and swam westward and parallel to shore on both sides of the island. This study underlines the critical importance of in situ Lagrangian observations to provide unique information on larval fish behavioral decisions. From an ecological perspective the central role of olfactory signals in marine population connectivity raises concerns about the effects of pollution and acidification of oceans, which can alter chemical cues and olfactory responses.	[Paris, Claire B.; Guigand, Cedric M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Atema, Jelle] Boston Univ, Marine Program, Boston, MA 02215 USA; [Irisson, Jean-Olivier] Observ Oceanol, Stn Zool, Lab Oceanog Villefranche Sur Mer, Villefranche Sur Mer, France; [Kingsford, Michael] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Kingsford, Michael] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Gerlach, Gabriele] Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany	University of Miami; Boston University; UDICE-French Research Universities; Sorbonne Universite; James Cook University; James Cook University; Carl von Ossietzky Universitat Oldenburg	Paris, CB (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	cparis@rsmas.miami.edu	Gerlach, Gabriele/K-5919-2012; Kingsford, Michael J/C-2015-2008	Kingsford, Michael J/0000-0003-1704-6198; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334	National Science Foundation (NSF)-SGER [OCE-0512167]; NSF-OTIC [1155698]; NSF [OCE 0452988]; Deutsche Forschungsgemeinschaft [GE842/6-1]; Australian Research Council Centre of Excellence	National Science Foundation (NSF)-SGER(National Science Foundation (NSF)); NSF-OTIC; NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Australian Research Council Centre of Excellence(Australian Research Council)	Portions of this study were funded by National Science Foundation (NSF)-SGER OCE-0512167 and NSF-OTIC 1155698 to C. B. Paris, by NSF OCE 0452988 to J. Atema and G. Gerlach, by Deutsche Forschungsgemeinschaft GE842/6-1 to G. Gerlach, and by an Australian Research Council Centre of Excellence Grant to M. J. Kingsford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Armsworth PR, 2000, MAR ECOL PROG SER, V195, P231, DOI 10.3354/meps195231; Arvedlund M, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P135, DOI 10.1007/978-90-481-2406-0_5; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; Atema J, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P1; Batschelet E, 1981, CIRCULAR STAT BIOL; Booth DJ, 2006, MAR ECOL PROG SER, V202, P219; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dittman AH, 1996, J EXP BIOL, V199, P83; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Fisher R, 2005, MAR BIOL, V147, P1201, DOI 10.1007/s00227-005-0001-x; Gagliardo A, 2001, P ROY SOC B-BIOL SCI, V268, P2065, DOI 10.1098/rspb.2001.1746; Gardiner JM, 2010, CURR BIOL, V20, P1187, DOI 10.1016/j.cub.2010.04.053; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Gomez-Marin A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00006; Irisson JO, 2010, LIMNOL OCEANOGR, V55, P909, DOI 10.4319/lo.2009.55.2.0909; Irisson JO, 2009, LIMNOL OCEANOGR-METH, V7, P664, DOI 10.4319/lom.2009.7.664; Kawamura G, 2003, BIG FISH BANG, P123; Kingsford MJ, 2002, B MAR SCI, V70, P309; Leis JM, 2007, MAR BIOL, V153, P103, DOI 10.1007/s00227-007-0794-x; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Lund U, 2007, CIRCULAR 0 3 8 CIRCU; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; Montgomery JC, 2001, FISH FISH, V2, P261, DOI 10.1046/j.1467-2960.2001.00053.x; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Paris CB, 2005, MAR ECOL PROG SER, V296, P93, DOI 10.3354/meps296093; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Paris Claire B., 2008, Marine Sanctuaries Conservation Series, V08-07, P52; Pineda J, 2010, J EXP MAR BIOL ECOL, V392, P9, DOI 10.1016/j.jembe.2010.04.008; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Smith J, 2010, SCIENCE, V328, P1497, DOI 10.1126/science.328.5985.1497; Staaterman E, 2013, ICES J MARINE SCI; Staaterman E, 2013, SOUNDSCAPES TROPICAL; Staaterman E, 2012, J THEOR BIOL, V304, P188, DOI 10.1016/j.jtbi.2012.03.016; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464; Vogel S, 2009, GLIMPSES CREATURES T	41	73	74	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72808	10.1371/journal.pone.0072808	http://dx.doi.org/10.1371/journal.pone.0072808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015278	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000323733800082
J	Saludes, V; Bascunana, E; Jordana-Lluch, E; Casanovas, S; Ardevol, M; Soler, E; Planas, R; Ausina, V; Martro, E				Saludes, Veronica; Bascunana, Elisabet; Jordana-Lluch, Elena; Casanovas, Sonia; Ardevol, Merce; Soler, Esther; Planas, Ramon; Ausina, Vicente; Martro, Elisa			Relevance of Baseline Viral Genetic Heterogeneity and Host Factors for Treatment Outcome Prediction in Hepatitis C Virus 1b-Infected Patients	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; AMINO-ACID SUBSTITUTION; PLUS RIBAVIRIN THERAPY; INFECTED PATIENTS; INTERFERON-ALPHA; PRETREATMENT PREDICTION; PEGINTERFERON ALPHA-2B; IL28B POLYMORPHISMS; TREATMENT FAILURE; CORE PROTEIN	Background: Only about 50% of patients chronically infected with HCV genotype 1 (HCV-1) respond to treatment with pegylated interferon-alfa and ribavirin (dual therapy), and protease inhibitors have to be administered together with these drugs increasing costs and side-effects. We aimed to develop a predictive model of treatment response based on a combination of baseline clinical and viral parameters. Methodology: Seventy-four patients chronically infected with HCV-1b and treated with dual therapy were studied (53 retrospectively -training group-, and 21 prospectively -validation group-). Host and viral-related factors (viral load, and genetic variability in the E1-E2, core and Interferon Sensitivity Determining Region) were assessed. Multivariate discriminant analysis and decision tree analysis were used to develop predictive models on the training group, which were then validated in the validation group. Principal Findings: A multivariate discriminant predictive model was generated including the following variables in decreasing order of significance: the number of viral variants in the E1-E2 region, an amino acid substitution pattern in the viral core region, the IL28B polymorphism, serum GGT and ALT levels, and viral load. Using this model treatment outcome was accurately predicted in the training group (AUROC = 0.9444; 96.3% specificity, 94.7% PPV, 75% sensitivity, 81% NPV), and the accuracy remained high in the validation group (AUROC = 0.8148, 88.9% specificity, 90.0% PPV, 75.0% sensitivity, 72.7% NPV). A second model was obtained by a decision tree analysis and showed a similarly high accuracy in the training group but a worse reproducibility in the validation group (AUROC = 0.9072 vs. 0.7361, respectively). Conclusions and Significance: The baseline predictive models obtained including both host and viral variables had a high positive predictive value in our population of Spanish HCV-1b treatment naive patients. Accurately identifying those patients that would respond to the dual therapy could help reducing implementation costs and additional side effects of new treatment regimens.	[Saludes, Veronica; Bascunana, Elisabet; Jordana-Lluch, Elena; Casanovas, Sonia; Ausina, Vicente; Martro, Elisa] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Microbiol Serv, Fundacio Inst Invest Ciencies Salut German Trias, Badalona, Spain; [Saludes, Veronica; Martro, Elisa] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Ardevol, Merce] Hosp Badalona Germans Trias & Pujol, Hosp Pharm, Badalona, Spain; [Soler, Esther; Planas, Ramon] Hosp Badalona Germans Trias & Pujol, Liver Unit, Badalona, Spain; [Soler, Esther; Planas, Ramon] CIBER Enfermedades Hepat & Digestivas CIBEREHD, Barcelona, Spain; [Ausina, Vicente] CIBER Enfermedades Resp CIBERES, Bunyola, Spain	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Martro, E (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Microbiol Serv, Fundacio Inst Invest Ciencies Salut German Trias, Badalona, Spain.	emartro.igtp.germanstrias@gencat.cat	JORDANA LLUCH, ELENA/L-2976-2015; Martró, Elisa/K-9688-2015; Saludes, Veronica/L-2059-2015	JORDANA LLUCH, ELENA/0000-0002-1115-2048; Martró, Elisa/0000-0002-2867-6649; Saludes, Veronica/0000-0003-2139-3360; AUSINA, VICENTE/0000-0002-1798-9869	"Instituto de Salud Carlos III - Fondo de Investigaciones Sanitarias" (ISCIII-FIS) [PI05/1131, CP09/00044]; Contratos Postdoctorales de Perfeccionamiento [CD05/00258]; "Miguel Servet" from "Ministerio de Economia y Competitividad", within the "Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I)"; Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya i del Fons Social Europeu	"Instituto de Salud Carlos III - Fondo de Investigaciones Sanitarias" (ISCIII-FIS)(Instituto de Salud Carlos III); Contratos Postdoctorales de Perfeccionamiento; "Miguel Servet" from "Ministerio de Economia y Competitividad", within the "Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I)"; Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya i del Fons Social Europeu	This study was funded by "Instituto de Salud Carlos III - Fondo de Investigaciones Sanitarias" (ISCIII-FIS) projects PI05/1131 (EM, RP, VA) and CP09/00044 (EM, RP, VA, VS), grants CD05/00258 ("Contratos Postdoctorales de Perfeccionamiento") and "Miguel Servet" from "Ministerio de Economia y Competitividad", within the "Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I)" (EM); and with the support from "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya i del Fons Social Europeu" (VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Akuta N, 2012, INTERVIROLOGY, V55, P231, DOI 10.1159/000328327; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; Alestig E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-124; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Berg T, 2003, HEPATOLOGY, V37, P600, DOI 10.1053/jhep.2003.50106; Blindenbacher A, 2003, GASTROENTEROLOGY, V124, P1465, DOI 10.1016/S0016-5085(03)00290-7; Bruguera M, 2012, GASTROENT HEPAT-BARC, V35, P667, DOI 10.1016/j.gastrohep.2012.03.005; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Cuevas JM, 2008, J VIRAL HEPATITIS, V15, P578, DOI 10.1111/j.1365-2893.2008.00991.x; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; de Lucas S, 2005, J INFECT DIS, V191, P93, DOI 10.1086/426509; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Everhart JE, 2013, HEPATOLOGY, V57, P1725, DOI 10.1002/hep.26203; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Farci P, 2011, SEMIN LIVER DIS, V31, P356, DOI 10.1055/s-0031-1297925; Fattovich G, 2011, ALIMENT PHARM THER, V33, P1162, DOI 10.1111/j.1365-2036.2011.04635.x; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Ferenci P, 2005, J HEPATOL, V43, P425, DOI 10.1016/j.jhep.2005.04.009; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Funaoka Y, 2011, J VIROL, V85, P5986, DOI 10.1128/JVI.02583-10; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hashimoto Y, 2011, J MED VIROL, V83, P981, DOI 10.1002/jmv.22028; Innes HA, 2012, EUR J GASTROEN HEPAT, V24, P646, DOI 10.1097/MEG.0b013e32835201a4; Jacobson IM, 2012, J VIRAL HEPATITIS, V19, P1, DOI 10.1111/j.1365-2893.2012.01590.x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jimenez-Hernandez N, 2007, J GEN VIROL, V88, P123, DOI 10.1099/vir.0.82277-0; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Kurosaki M, 2011, J MED VIROL, V83, P445, DOI 10.1002/jmv.22005; Kurosaki M, 2011, J HEPATOL, V54, P439, DOI 10.1016/j.jhep.2010.07.037; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martinez-Bauer E, 2006, HEPATOLOGY, V43, P72, DOI 10.1002/hep.21002; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; MCLACHAN GJ, 1992, DISCRIMINANT ANAL ST; Miki D, 2012, J VIRAL HEPATITIS, V19, pE126, DOI 10.1111/j.1365-2893.2011.01516.x; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Vidal-Castineira JR, 2012, J HEPATOL, V56, P1230, DOI 10.1016/j.jhep.2012.01.011; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Montoro VS, 2011, ENFERM INFEC MICR CL, V29, P51, DOI 10.1016/S0213-005X(11)70044-1; Saludes V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014132; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Soriano V, 2012, J ANTIMICROB CHEMOTH, V67, P523, DOI 10.1093/jac/dkr506; Staden R, 2000, Methods Mol Biol, V132, P115; Su XW, 2008, J HEPATOL, V49, P184, DOI 10.1016/j.jhep.2008.04.011; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tai AW, 2009, J HEPATOL, V50, P412, DOI 10.1016/j.jhep.2008.11.010; Takayama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027223; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Torres-Puente M, 2008, J VIRAL HEPATITIS, V15, P188, DOI 10.1111/j.1365-2893.2007.00929.x; Tsubota A, 2012, LIVER INT, V32, P826, DOI 10.1111/j.1478-3231.2011.02727.x; Tsukada H, 2009, GASTROENTEROLOGY, V136, P1796, DOI 10.1053/j.gastro.2009.01.061; Umemura T, 2011, ANTIVIR THER, V16, P1073, DOI 10.3851/IMP1869; Weich V, 2011, J GASTROENTEROL, V46, P1427, DOI 10.1007/s00535-011-0458-y; Witten IH, 2011, MOR KAUF D, P1; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; Yeh BI, 2002, J MED VIROL, V66, P481, DOI 10.1002/jmv.2169	63	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72600	10.1371/journal.pone.0072600	http://dx.doi.org/10.1371/journal.pone.0072600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015264	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800068
J	Bertram, SM; Harrison, SJ; Thomson, IR; Fitzsimmons, LP				Bertram, Susan M.; Harrison, Sarah J.; Thomson, Ian R.; Fitzsimmons, Lauren P.			Adaptive Plasticity in Wild Field Cricket's Acoustic Signaling	PLOS ONE			English	Article							CALLING-SONG RECOGNITION; PHENOTYPIC PLASTICITY; GRYLLUS-BIMACULATUS; SEXUAL SELECTION; FEMALE CHOICE; SOUND PRODUCTION; BODY-SIZE; SEARCHING BEHAVIOR; SPECIES ORTHOPTERA; AUDITORY-BEHAVIOR	Phenotypic plasticity can be adaptive when phenotypes are closely matched to changes in the environment. In crickets, rhythmic fluctuations in the biotic and abiotic environment regularly result in diel rhythms in density of sexually active individuals. Given that density strongly influences the intensity of sexual selection, we asked whether crickets exhibit plasticity in signaling behavior that aligns with these rhythmic fluctuations in the socio-sexual environment. We quantified the acoustic mate signaling behavior of wild-caught males of two cricket species, Gryllus veletis and G. pennsylvanicus. Crickets exhibited phenotypically plastic mate signaling behavior, with most males signaling more often and more attractively during the times of day when mating activity is highest in the wild. Most male G. pennsylvanicus chirped more often and louder, with shorter interpulse durations, pulse periods, chirp durations, and interchirp durations, and at slightly higher carrier frequencies during the time of the day that mating activity is highest in the wild. Similarly, most male G. veletis chirped more often, with more pulses per chirp, longer interpulse durations, pulse periods, and chirp durations, shorter interchirp durations, and at lower carrier frequencies during the time of peak mating activity in the wild. Among-male variation in signaling plasticity was high, with some males signaling in an apparently maladaptive manner. Body size explained some of the among-male variation in G. pennsylvanicus plasticity but not G. veletis plasticity. Overall, our findings suggest that crickets exhibit phenotypically plastic mate attraction signals that closely match the fluctuating socio-sexual context they experience.	[Bertram, Susan M.; Harrison, Sarah J.; Thomson, Ian R.; Fitzsimmons, Lauren P.] Carleton Univ Ottawa, Dept Biol, Toronto, ON, Canada		Bertram, SM (corresponding author), Carleton Univ Ottawa, Dept Biol, Toronto, ON, Canada.	Sue.Bertram@carleton.ca	Fitzsimmons, Lauren P/H-5530-2012	Munshi-South, Jason/0000-0002-8067-4341	Natural Science and Engineering Research Council of Canada (NSERC); Ontario Graduate Scholarship (OGS); NSERC; Philanthropic Education Organization (PEO); Canadian Foundation for Innovation (CFI); Ontario Research Fund (ORF); Carleton University (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM099055] Funding Source: NIH RePORTER	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Philanthropic Education Organization (PEO); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); Carleton University (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by a Natural Science and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship to LPF, an Ontario Graduate Scholarship (OGS) to SJF, an NSERC Undergraduate Research Scholarships to IRT and SJH, and a Philanthropic Education Organization (PEO) Scholar Award to LPF. SMB received funding support from an NSERC Discovery Grant, the Canadian Foundation for Innovation (CFI), the Ontario Research Fund (ORF), and Carleton University (NSERC: http://www.nserc-crsng.gc.ca/, OGS: https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/TCONT003465.html, PEO: http://www.peointernational.org/, CFI: http://www.innovation.ca/, ORF: http://www.mri.gov.on.ca/english/programs/ResearchFund.asp, Carleton: http://www.carleton.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; BAILEY WJ, 1993, J EXP BIOL, V178, P21; Benjamini Y, 2001, ANN STAT, V29, P1165; Berrigan D., 2004, PHENOTYPIC PLASTICIT, P82; Bertram SM, 2004, ETHOLOGY, V110, P963, DOI 10.1111/j.1439-0310.2004.01031.x; Bertram SM, 2013, PEERJ IN PRESS  0529; Bertram SM, 2012, ECOL EVOL, V2, P181, DOI 10.1002/ece3.76; BIGELOW R. S., 1960, CANADIAN JOUR ZOOL, V38, P509, DOI 10.1139/z60-055; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Buzatto BA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-118; CADE WH, 1992, ANIM BEHAV, V43, P49, DOI 10.1016/S0003-3472(05)80070-3; Crnokrak P, 1995, ANIM BEHAV, V50, P1475, DOI 10.1016/0003-3472(95)80004-2; Davidson AJ, 2003, CURR OPIN NEUROBIOL, V13, P765, DOI 10.1016/j.conb.2003.10.011; del Castillo RC, 2005, GENET MOL BIOL, V28, P843, DOI 10.1590/S1415-47572005000500030; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Doherty J, 1983, VERH DTSCH ZOOL GES, V188, P188; DOHERTY JA, 1985, J COMP PHYSIOL A, V156, P787, DOI 10.1007/BF00610831; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Fitzsimmons LP, 2011, BEHAVIOUR, V148, P1045, DOI 10.1163/000579511X588812; FRENCH BW, 1987, BEHAV ECOL SOCIOBIOL, V21, P157, DOI 10.1007/BF00303205; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Garland T, 2006, J EXP BIOL, V209, P2344, DOI 10.1242/jeb.02244; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Ghalambor Cameron K., 2010, P90; GOULD SJ, 1975, CONTRIB PRIMATOL, V5, P244; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Gray DA, 1999, J INSECT BEHAV, V12, P691, DOI 10.1023/A:1020983821436; Gray DA, 2001, ANIM BEHAV, V62, P871, DOI 10.1006/anbe.2001.1825; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hack MA, 1998, J INSECT BEHAV, V11, P853, DOI 10.1023/A:1020864111073; HEDRICK AV, 1986, BEHAV ECOL SOCIOBIOL, V19, P73, DOI 10.1007/BF00303845; Hedwig B, 2004, NATURE, V430, P781, DOI 10.1038/nature02787; Helm B, 2006, ANIM BEHAV, V72, P245, DOI 10.1016/j.anbehav.2005.12.007; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hoback WW, 1997, PHYSIOL ENTOMOL, V22, P286, DOI 10.1111/j.1365-3032.1997.tb01170.x; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jacot A, 2008, P ROY SOC B-BIOL SCI, V275, P579, DOI 10.1098/rspb.2007.1500; Jeffery J, 2005, J EXP ZOOL PART A, V303A, P377, DOI 10.1002/jez.a.176; Judge KA, 2008, EVOLUTION, V62, P868, DOI 10.1111/j.1558-5646.2008.00318.x; Judge KA, 2011, ANIM BEHAV, V81, P185, DOI 10.1016/j.anbehav.2010.09.032; Judge KA, 2010, CAN J ZOOL, V88, P219, DOI 10.1139/Z09-139; Kasumovic MM, 2011, Q REV BIOL, V86, P181, DOI 10.1086/661119; KAVANAGH MW, 1987, J EXP BIOL, V130, P107; Kelly SA, 2012, COMPR PHYSIOL, V2, P1417, DOI 10.1002/cphy.c110008; Kokko H, 2001, ECOL LETT, V4, P159, DOI 10.1046/j.1461-0248.2001.00212.x; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Komers PE, 1997, CAN J ZOOL, V75, P161, DOI 10.1139/z97-023; Kotiaho JS, 1999, OIKOS, V87, P399, DOI 10.2307/3546755; LEVINS RICHARD, 1968; Lyons C, 2006, ANIM BEHAV, V72, P673, DOI 10.1016/j.anbehav.2005.12.006; Martin SD, 2000, CAN J ZOOL, V78, P706, DOI 10.1139/cjz-78-5-706; Millar NP, 2006, OIKOS, V113, P1; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; MOUSSEAU TA, 1989, EVOLUTION, V43, P1483, DOI 10.1111/j.1558-5646.1989.tb02598.x; NUR N, 1984, J THEOR BIOL, V110, P275, DOI 10.1016/S0022-5193(84)80059-4; PFAU HK, 1994, J EXP BIOL, V195, P147; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Popov A, 1977, J COMP PHYSIOL A, V126, P111; POPOV A V, 1974, Journal of Evolutionary Biochemistry and Physiology, V10, P61; Prestwich KN, 2007, PHYSIOL BIOCHEM ZOOL, V80, P157, DOI 10.1086/509238; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; Prestwich KN, 2005, J EXP BIOL, V208, P1495, DOI 10.1242/jeb.01550; PRESTWICH KN, 1981, J COMP PHYSIOL, V143, P199; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P95, DOI 10.1016/S0169-5347(00)02063-2; Rebar D, 2011, BEHAV ECOL, V22, P303, DOI 10.1093/beheco/arq195; Roth T, 2009, P ROY SOC B-BIOL SCI, V276, P2045, DOI 10.1098/rspb.2008.1726; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Scheuber H, 2003, P ROY SOC B-BIOL SCI, V270, P1779, DOI 10.1098/rspb.2003.2449; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Simmons LW, 1996, P ROY SOC B-BIOL SCI, V263, P1305, DOI 10.1098/rspb.1996.0191; SIMMONS LW, 1988, ANIM BEHAV, V36, P380, DOI 10.1016/S0003-3472(88)80009-5; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P313, DOI 10.1007/BF00299969; Snell-Rood EC, 2012, INTEGR COMP BIOL, V52, P31, DOI 10.1093/icb/ics067; Stout J, 2010, PHYSIOL ENTOMOL, V35, P99, DOI 10.1111/j.1365-3032.2009.00713.x; THORSON J, 1982, J COMP PHYSIOL, V146, P361, DOI 10.1007/BF00612706; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; VANTIENDEREN PH, 1991, EVOLUTION, V45, P1317, DOI [10.1111/j.1558-5646.1991.tb02638.x, 10.2307/2409882]; Wagner WE, 1996, BEHAV ECOL, V7, P279, DOI 10.1093/beheco/7.3.279; WAGNER WE, 1995, ANIM BEHAV, V49, P1269, DOI 10.1006/anbe.1995.0159; WALKER THOMAS J., 1962, ANN ENTOMOL SOC AMER, V55, P303; WALKER THOMAS J., 1957, ANN ENT SOC AMER, V50, P626; WALKER TJ, 1975, J COMP PHYSIOL, V101, P57, DOI 10.1007/BF00660119; WALKER TJ, 1962, EVOLUTION, V16, P407, DOI 10.2307/2406176; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Whattam EM, 2011, ANIM BEHAV, V81, P135, DOI 10.1016/j.anbehav.2010.09.024; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	97	70	69	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69247	10.1371/journal.pone.0069247	http://dx.doi.org/10.1371/journal.pone.0069247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935965	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000094
J	Li, YC; Li, CI; Lin, WY; Liu, CS; Hsu, HS; Lee, CC; Chen, FN; Li, TC; Lin, CC				Li, Yi-Chun; Li, Chia-Ing; Lin, Wen-Yuan; Liu, Chiu-Shong; Hsu, Hua-Shui; Lee, Cheng-Chun; Chen, Fei-Na; Li, Tsai-Chung; Lin, Cheng-Chieh			Percentage of Body Fat Assessment Using Bioelectrical Impedance Analysis and Dual-Energy X-ray Absorptiometry in a Weight Loss Program for Obese or Overweight Chinese Adults	PLOS ONE			English	Article							QUANTITATIVE ULTRASOUND; CARDIOVASCULAR-DISEASE; ADIPONECTIN; WOMEN; ADOLESCENTS; PREVALENCE; CHILDREN; GROWTH; CANCER; DEXA	The current study aimed to compare the estimates of body fat percentage (%BF) by performing bioelectrical impedance analysis (BIA) and dual energy X-ray absorptiometry (DXA) in a sample of obese or overweight Chinese adults who participated in a weight-loss randomized control trial stratified by gender to determine whether or not BIA is a valid measurement tool. Among 189 adults [73 males, 116 females; age = 41 to 74 years; mean body mass index (BMI) = 27.3 kg/m(2)], assessments of %BF at the baseline and six months from the baseline were conducted by performing BIA and DXA. Bland-Altman analyses and multiple regression analyses were used to assess the relationships between %BFBIA and %BFDXA. Compared with DXA, BIA underestimated %BF [in males: 4.6, -2.4 to 11.7 (mean biases, 95% limit of agreement) at the baseline, 1.4, -7.4 to 10.2 at the endpoint, and 3.2, -4.8 to 11.3 in changes; in females: 5.1, -2.4 to 12.7; 2.2, -6.1 to 10.4; and 3.0, -4.8 to 10.7, respectively]. For males and females, %BFDXA proved to be a significant predictor of the difference between DXA and BIA at the baseline, the endpoint, and in changes when BMI and age were considered (in males: p<0.01 and R-2 = 23.1%, 24.1%, 20.7%, respectively; for females: p<0.001 and R-2 = 40.4%, 48.8%, 25.4%, respectively). The current study suggests that BIA provides a relatively accurate prediction of %BF in individuals with normal weight, overweight, or obesity after the end of weight-loss program, but less accurate prediction of %BF in obese individuals at baseline or weight change during the weight-loss intervention program.	[Li, Yi-Chun; Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Li, Chia-Ing; Lin, Wen-Yuan; Liu, Chiu-Shong; Lee, Cheng-Chun; Chen, Fei-Na; Lin, Cheng-Chieh] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Wen-Yuan; Liu, Chiu-Shong; Hsu, Hua-Shui; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Lee, Cheng-Chun] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Hlth Sci, Inst Hlth Care Adm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Chen, FN (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.	feina@mail.cmu.edu.tw; tcli@mail.cmu.edu.tw; cclin@mail.cmuh.org.tw	Li, Tsai-Chung/P-2052-2015; Lin, Cheng-Chieh/P-2564-2015; qin, yuanyuan/G-4351-2010	Li, Tsai-Chung/0000-0002-3346-7462; Lin, Cheng-Chieh/0000-0002-9625-6216; qin, yuanyuan/0000-0002-0673-3200	National Science Council of Taiwan [NSC93-2314-B-039-025, NSC94-2314-B-039-024, NSC96-2628-B-039-011-MY3]; Department of Health, Executive Yuan, Taiwan [DOH97-TD-F-113-96002]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH102-TD-B-111-004]; National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan; Taiwan Department of Health Clinical Trial and Research Center for Excellence; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (NSC93-2314-B-039-025 & NSC94-2314-B-039-024 & NSC96-2628-B-039-011-MY3), the Department of Health, Executive Yuan, Taiwan (DOH97-TD-F-113-96002), the Taiwan Department of Health Clinical Trial and Research Center for Excellence (DOH102-TD-B-111-004), the National Science Council of Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7), and the Department of Health, Executive Yuan, Taiwan (http://www.doh.gov.tw/EN2006/index_EN.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Aslam M, 2009, OBES RES CLIN PRACT, V3, P209, DOI 10.1016/j.orcp.2009.03.005; Bosy-Westphal A, 2008, OBESITY FACTS, V1, P319, DOI 10.1159/000176061; Carroll KK, 1998, LIPIDS, V33, P1055, DOI 10.1007/s11745-998-0305-8; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Consultation W, 2000, WHO TECH REP SER, V894, p[i, 1]; Crepaldi G, 2006, DIABETES VOICE, V51, P8; De Schepper J, 2012, J CYST FIBROS, V11, P119, DOI 10.1016/j.jcf.2011.10.004; Dee A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-343; Department of Health Executive Yuan R.O.C., 2002, DEF OB INT PRINC COM; DEURENBERG P, 1991, INT J OBESITY, V15, P17; Ellis KJ, 1998, J BONE MINER RES, V13, P1613, DOI 10.1359/jbmr.1998.13.10.1613; Erceg DN, 2010, NUTR RES, V30, P297, DOI 10.1016/j.nutres.2010.04.009; Evans EM, 2010, EUR J CLIN NUTR, V64, P218, DOI 10.1038/ejcn.2009.128; Festen DAM, 2007, J CLIN ENDOCR METAB, V92, P1549, DOI 10.1210/jc.2006-2241; Frisard MI, 2005, OBES RES, V13, P845, DOI 10.1038/oby.2005.97; Gomez-Ambrosi J, 2011, OBESITY, V19, P1439, DOI 10.1038/oby.2011.36; Houtkooper L. B., 1996, AM J CLIN NUTR S, V64, p436S; Kannel William B., 1996, American Journal of Clinical Nutrition, V63, p419S, DOI 10.1093/ajcn/87.6.1602; Kim HJ, 2005, AM J CHINESE MED, V33, P851, DOI 10.1142/S0192415X05003454; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Lazzer S, 2003, BRIT J NUTR, V90, P987, DOI 10.1079/BJN2003983; Liu CR, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-70; Lloret Linares C, 2011, OBES SURG, V21, P1; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Neovius M, 2006, OBESITY, V14, P1731, DOI 10.1038/oby.2006.199; Newton RL, 2005, INT J OBESITY, V29, P594, DOI 10.1038/sj.ijo.0802968; Newton RL, 2006, OBESITY, V14, P415, DOI 10.1038/oby.2006.55; Roubenoff Ronenn, 1996, American Journal of Clinical Nutrition, V64, p459S, DOI 10.1093/ajcn/64.3.459S; Sato Susumu, 2007, Journal of Physiological Anthropology, V26, P533, DOI 10.2114/jpa2.26.533; Seidell JC, 1996, ARCH INTERN MED, V156, P958, DOI 10.1001/archinte.156.9.958; Shafer KJ, 2009, NUTRITION, V25, P25, DOI 10.1016/j.nut.2008.07.004; Shea JL, 2012, NUTR METAB CARDIOVAS, V22, P741, DOI 10.1016/j.numecd.2010.11.009; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Taylor R., 1990, J DIAGNOSTIC MED SON, V1, P35; Verdich C, 2011, DIABETES METAB, V37, P222, DOI 10.1016/j.diabet.2010.10.007; Xu B, 2009, SPIE, V7443; Yamashita K, 2012, CIRC J, V76, P2435, DOI 10.1253/circj.CJ-12-0337; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	41	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e58272	10.1371/journal.pone.0058272	http://dx.doi.org/10.1371/journal.pone.0058272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	24019905	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900003
J	Torres, I; Hernandez, O; Tamayo, D; Munoz, JF; Leitao, NP; Garcia, AM; Restrepo, A; Puccia, R; McEwen, JG				Torres, Isaura; Hernandez, Orville; Tamayo, Diana; Munoz, Jose F.; Leitao, Natanael P., Jr.; Garcia, Ana M.; Restrepo, Angela; Puccia, Rosana; McEwen, Juan G.			Inhibition of PbGP43 Expression May Suggest that gp43 is a Virulence Factor in Paracoccidioides brasiliensis	PLOS ONE			English	Article							MAJOR DIAGNOSTIC ANTIGEN; 43 KDA GLYCOPROTEIN; 43-KILODALTON GLYCOPROTEIN; EXOCELLULAR COMPONENTS; PROTEOLYTIC ACTIVITY; YEAST PHASE; GENE; PROTEINS; IDENTIFICATION; CHEMOTHERAPY	Glycoprotein gp43 is an immunodominant diagnostic antigen for paracoccidioidomycosis caused by Paracoccidioides brasiliensis. It is abundantly secreted in isolates such as Pb339. It is structurally related to beta-1,3-exoglucanases, however inactive. Its function in fungal biology is unknown, but it elicits humoral, innate and protective cellular immune responses; it binds to extracellular matrix-associated proteins. In this study we applied an antisense RNA (aRNA) technology and Agrobacterium tumefaciens-mediated transformation to generate mitotically stable PbGP43 mutants (PbGP43 aRNA) derived from wild type Pb339 to study its role in P. brasiliensis biology and during infection. Control PbEV was transformed with empty vector. Growth curve, cell vitality and morphology of PbGP43 aRNA mutants were indistinguishable from those of controls. PbGP43 expression was reduced 80-85% in mutants 1 and 2, as determined by real time PCR, correlating with a massive decrease in gp43 expression. This was shown by immunoblotting of culture supernatants revealed with anti-gp43 mouse monoclonal and rabbit polyclonal antibodies, and also by affinity-ligand assays of extracellular molecules with laminin and fibronectin. In vitro, there was significantly increased TNF-alpha production and reduced yeast recovery when PbGP43 aRNA1 was exposed to IFN-gamma-stimulated macrophages, suggesting reduced binding/uptake and/or increased killing. In vivo, fungal burden in lungs of BALB/c mice infected with silenced mutant was negligible and associated with decreased lung I Lambda-10 and IL-6. Therefore, our results correlated low gp43 expression with lower pathogenicity in mice, but that will be definitely proven when PbGP43 knockouts become available. This is the first study of gp43 using genetically modified P. brasiliensis.	[Torres, Isaura; Hernandez, Orville; Tamayo, Diana; Munoz, Jose F.] CIB, Unidad Biol Celular & Mol, Medellin, Colombia; [Torres, Isaura; McEwen, Juan G.] Univ Antioquia, Fac Med, Medellin, Colombia; [Torres, Isaura; Tamayo, Diana; Munoz, Jose F.] Univ Antioquia, Inst Biol, Medellin, Colombia; [Hernandez, Orville] Inst Univ Colegio Mayor Antioquia, Fac Ciencias Salud, Medellin, Colombia; [Leitao, Natanael P., Jr.; Puccia, Rosana] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidad de Antioquia; Universidad de Antioquia; Institucion Universitaria Colegio Mayor de Antioquia; Universidade Federal de Sao Paulo (UNIFESP)	Torres, I (corresponding author), CIB, Unidad Biol Celular & Mol, Medellin, Colombia.	isaurap10@gmail.com	Puccia, Rosana/D-7303-2012; McEwen, Juan/AAG-6621-2021; Ciudad, Carlos/D-7917-2014; Noe, Veronica/K-3615-2014	Puccia, Rosana/0000-0002-3332-0487; Ciudad, Carlos/0000-0002-7855-392X; hernandez, jose luis/0000-0002-9172-6004; Munoz, Jose/0000-0003-4987-7957; Garcia Cepero, Ana Maria/0000-0001-9189-764X; Tamayo, Diana/0000-0002-2826-8573; McEwen, Juan Guillermo/0000-0001-8594-9087; Noe, Veronica/0000-0001-7937-8038; Torres, Isaura/0000-0002-4022-8072; Mitjans, Francesc/0000-0001-8331-9954; Messeguer, Ramon/0000-0003-1913-7624	Colciencias project [221340820447]; Corporacion para Investigaciones Biologicas; Universidad de Antioquia Estrategia de Sostenibilidad; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Colciencias project(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Corporacion para Investigaciones Biologicas; Universidad de Antioquia Estrategia de Sostenibilidad; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided by Colciencias project No 221340820447, Corporacion para Investigaciones Biologicas and the Universidad de Antioquia Estrategia de Sostenibilidad 2010-2011. This work was also financed by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AJ, 2007, FUNGAL GENET BIOL, V44, P1387, DOI 10.1016/j.fgb.2007.04.004; Almeida AJ, 2009, FUNGAL GENET BIOL, V46, P919, DOI 10.1016/j.fgb.2009.08.004; Almeida IC, 1996, GLYCOBIOLOGY, V6, P507, DOI 10.1093/glycob/6.5.507; Almeida SR, 1998, MED MYCOL, V36, P405, DOI 10.1080/02681219880000641; BAVA AJ, 1991, MICROBIOL IMMUNOL, V35, P167, DOI 10.1111/j.1348-0421.1991.tb01545.x; BEIJERSBERGEN A, 1992, SCIENCE, V256, P1324, DOI 10.1126/science.256.5061.1324; Blotta MHSL, 1999, AM J TROP MED HYG, V61, P390, DOI 10.4269/ajtmh.1999.61.390; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Buissa-Filho R, 2008, INFECT IMMUN, V76, P3321, DOI 10.1128/IAI.00349-08; Camargo ZP, 2003, MED MYCOL, V41, P539, DOI 10.1080/13693780310001615358; CAMARGO ZP, 1991, J MED VET MYCOL, V29, P31; CAMPOS MCRM, 1995, J MED VET MYCOL, V33, P223; CARMONA AK, 1995, BIOCHEM J, V309, P209, DOI 10.1042/bj3090209; Carvalho KC, 2005, MICROBES INFECT, V7, P55, DOI 10.1016/j.micinf.2004.09.008; Cisalpino PS, 1996, J BIOL CHEM, V271, P4553, DOI 10.1074/jbc.271.8.4553; de Camargo Z P, 2000, Rev Iberoam Micol, V17, P41; DECAMARGO ZP, 1988, J CLIN MICROBIOL, V26, P2147, DOI 10.1128/JCM.26.10.2147-2151.1988; Donofrio FC, 2009, J MED MICROBIOL, V58, P706, DOI 10.1099/jmm.0.003830-0; Fernandes VC, 2012, MYCOPATHOLOGIA, V174, P93, DOI 10.1007/s11046-012-9530-2; Fernandes VC, 2011, MICROBES INFECT, V13, P1062, DOI 10.1016/j.micinf.2011.06.004; Ferreira KS, 2003, SCAND J IMMUNOL, V58, P290, DOI 10.1046/j.1365-3083.2003.01291.x; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Hanna SA, 2000, MICROBES INFECT, V2, P877, DOI 10.1016/S1286-4579(00)00390-7; Hernandez O, 2010, INFECT IMMUN, V78, P5280, DOI 10.1128/IAI.00692-10; Kara B. V., 1987, Proceedings, European Brewery Convention, P409; Konno AYC, 2009, MICROBES INFECT, V11, P92, DOI 10.1016/j.micinf.2008.10.011; Konno FTC, 2012, MICROBES INFECT, V14, P517, DOI 10.1016/j.micinf.2011.12.012; KURITA N, 1993, J MED VET MYCOL, V31, P201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magalhaes A, 2012, CLIN VACCINE IMMUNOL, V19, P23, DOI 10.1128/CVI.05414-11; Marques AF, 2008, MICROBES INFECT, V10, P1251, DOI 10.1016/j.micinf.2008.07.027; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; MENDESGIANNINI MJS, 1990, REV INST MED TROP SP, V32, P384, DOI 10.1590/S0036-46651990000500014; Morais FV, 2000, J CLIN MICROBIOL, V38, P3960, DOI 10.1128/JCM.38.11.3960-3966.2000; Pinto AR, 2000, VACCINE, V18, P3050, DOI 10.1016/S0264-410X(00)00074-8; PUCCIA R, 1986, INFECT IMMUN, V53, P199, DOI 10.1128/IAI.53.1.199-206.1986; PUCCIA R, 1991, J MED VET MYCOL, V29, P57; Puccia R, 1998, MED MYCOL, V36, P345, DOI 10.1080/02681219880000541; PUCCIA R, 1991, ARCH BIOCHEM BIOPHYS, V289, P298, DOI 10.1016/0003-9861(91)90475-X; Puccia R, 2008, MYCOPATHOLOGIA, V165, P275, DOI 10.1007/s11046-007-9055-2; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rappleye CA, 2006, ANNU REV MICROBIOL, V60, P281, DOI 10.1146/annurev.micro.59.030804.121055; Reis BS, 2008, VACCINE, V26, P5461, DOI 10.1016/j.vaccine.2008.07.097; Rittner GMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001519; Rocha AA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-277; Rocha AA, 2009, FUNGAL GENET BIOL, V46, P85, DOI 10.1016/j.fgb.2008.10.009; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; SINGERVERMES LM, 1992, J MED VET MYCOL, V30, P261; Mendes-Giannini MJS, 2006, MICROBES INFECT, V8, P1550, DOI 10.1016/j.micinf.2006.01.012; Straus AH, 1996, J MED VET MYCOL, V34, P181; Taborda CP, 1998, INFECT IMMUN, V66, P786, DOI 10.1128/IAI.66.2.786-793.1998; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Travassos Luiz R., 2007, P241, DOI 10.1007/978-1-4020-6397-8_11; VICENTINI AP, 1994, INFECT IMMUN, V62, P1465, DOI 10.1128/IAI.62.4.1465-1469.1994	56	85	85	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68434	10.1371/journal.pone.0068434	http://dx.doi.org/10.1371/journal.pone.0068434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874627	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800032
J	Anglesio, MS; Wiegand, KC; Melnyk, N; Chow, C; Salamanca, C; Prentice, LM; Senz, J; Yang, WN; Spillman, MA; Cochrane, DR; Shumansky, K; Shah, SP; Kalloger, SE; Huntsman, DG				Anglesio, Michael S.; Wiegand, Kimberly C.; Melnyk, Nataliya; Chow, Christine; Salamanca, Clara; Prentice, Leah M.; Senz, Janine; Yang, Winnie; Spillman, Monique A.; Cochrane, Dawn R.; Shumansky, Karey; Shah, Sohrab P.; Kalloger, Steve E.; Huntsman, David G.			Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research	PLOS ONE			English	Article							GRADE SEROUS CARCINOMA; MISMATCH REPAIR PROTEINS; CLEAR-CELL; MICROSATELLITE INSTABILITY; TUMOR TYPE; ENDOMETRIOSIS; EXPRESSION; MUTATIONS; AMPLIFICATION; PATHOGENESIS	Background: Ovarian carcinomas consist of at least five distinct diseases: high-grade serous, low-grade serous, clear cell, endometrioid, and mucinous. Biomarker and molecular characterization may represent a more biologically relevant basis for grouping and treating this family of tumors, rather than site of origin. Molecular characteristics have become the new standard for clinical pathology, however development of tailored type-specific therapies is hampered by a failure of basic research to recognize that model systems used to study these diseases must also be stratified. Unrelated model systems do offer value for study of biochemical processes but specific cellular context needs to be applied to assess relevant therapeutic strategies. Methods: We have focused on the identification of clear cell carcinoma cell line models. A panel of 32 "ovarian cancer'' cell lines has been classified into histotypes using a combination of mutation profiles, IHC mutation-surrogates, and a validated immunohistochemical model. All cell lines were identity verified using STR analysis. Results: Many described ovarian clear cell lines have characteristic mutations (including ARID1A and PIK3CA) and an overall molecular/immuno-profile typical of primary tumors. Mutations in TP53 were present in the majority of high-grade serous cell lines. Advanced genomic analysis of bona-fide clear cell carcinoma cell lines also support copy number changes in typical biomarkers such at MET and HNF1B and a lack of any recurrent expressed re-arrangements. Conclusions: As with primary ovarian tumors, mutation status of cancer genes like ARID1A and TP53 and a general immuno-profile serve well for establishing histotype of ovarian cancer cell We describe specific biomarkers and molecular features to re-classify generic "ovarian carcinoma'' cell lines into type specific categories. Our data supports the use of prototype clear cell lines, such as TOV21G and JHOC-5, and questions the use of SKOV3 and A2780 as models of high-grade serous carcinoma.	[Anglesio, Michael S.; Wiegand, Kimberly C.; Melnyk, Nataliya; Salamanca, Clara; Senz, Janine; Shah, Sohrab P.; Kalloger, Steve E.; Huntsman, David G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Chow, Christine; Huntsman, David G.] Univ British Columbia, Genet Pathol Evaluat Ctr, Vancouver, BC V5Z 1M9, Canada; [Chow, Christine; Huntsman, David G.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Prentice, Leah M.; Yang, Winnie; Cochrane, Dawn R.; Huntsman, David G.] BC Canc Agcy, CTAG, Vancouver, BC, Canada; [Spillman, Monique A.] Univ Colorado, Dept Obstet & Gynecol, Aurora, CO USA; [Shumansky, Karey; Shah, Sohrab P.] BC Canc Agcy, Dept Mol Oncol, Canc Res Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of Colorado System; University of Colorado Anschutz Medical Campus; British Columbia Cancer Agency	Huntsman, DG (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	dhuntsma@bccancer.bc.ca	Huntsman, David/ABE-6082-2020	Anglesio, Michael/0000-0003-1639-5003	BC Cancer Foundation; The VGH Hospital Foundation; Canadian Institutes for Health Research (CIHR) [FRN: 111627]; UBC Hospital Foundation	BC Cancer Foundation; The VGH Hospital Foundation; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); UBC Hospital Foundation	Support for this project was provided to the Ovarian Cancer Research Team of BC (OVCARE; http://www.ovcare.ca) through the BC Cancer Foundation, The VGH and UBC Hospitals Foundation and the Canadian Institutes for Health Research (CIHR) Emerging Team Grant: Personalized siRNA-Based Nanomedicines (FRN: 111627). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Altman AD, 2013, MOD PATHOL; Anglesio MS, 2008, MOL CANCER RES, V6, P1678, DOI 10.1158/1541-7786.MCR-08-0193; Anglesio MS, 2013, J PATHOL, V229, P111, DOI 10.1002/path.4088; Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berns EMJJ, 2012, CANCER RES, V72, P2701, DOI 10.1158/0008-5472.CAN-11-3911; Cai KQ, 2004, HUM PATHOL, V35, P552, DOI 10.1016/j.humpath.2003.12.009; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Campbell IG, 2001, HUM REPROD UPDATE, V7, P15, DOI 10.1093/humupd/7.1.15; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Carlson JW, 2010, INT J GYNECOL PATHOL, V29, P310, DOI 10.1097/PGP.0b013e3181c713a8; CRAMER SF, 1987, ARCH PATHOL LAB MED, V111, P819; Crum CP, 2007, CLIN MED RES, V5, P35, DOI 10.3121/cmr.2007.702; Crum CP, 2009, MOL ONCOL, V3, P165, DOI 10.1016/j.molonc.2009.01.004; Danjoh I, 2013, CYTOGENET GENOME RES, V139, P88, DOI 10.1159/000343757; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Domanska K, 2007, INT J GYNECOL CANCER, V17, P789, DOI 10.1111/j.1525-1438.2007.00875.x; Duska LR, 2010, GYNECOL ONCOL, V116, P374, DOI 10.1016/j.ygyno.2009.10.069; Farley JH, 2012, AACR ANN M 2012 CHIC; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gershenson DM, 2012, CLIN OBSTET GYNECOL, V55, P65, DOI 10.1097/GRF.0b013e318248045b; Gilks CB, 2008, HUM PATHOL, V39, P1239, DOI 10.1016/j.humpath.2008.01.003; HERNANDEZ E, 1984, GYNECOL ONCOL, V17, P117, DOI 10.1016/0090-8258(84)90065-9; Hess V, 2004, J CLIN ONCOL, V22, P1040, DOI 10.1200/JCO.2004.08.078; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Hunter SM, 2011, CLIN CANCER RES, V17, P7273, DOI 10.1158/1078-0432.CCR-11-2080; Jensen KC, 2008, AM J SURG PATHOL, V32, P1029, DOI 10.1097/PAS.0b013e31816380c4; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kalloger SE, 2011, MODERN PATHOL, V24, P512, DOI 10.1038/modpathol.2010.215; Kobel M, 2011, INT J GYNECOL PATHOL, V30, P366, DOI 10.1097/PGP.0b013e31820d20ba; Kobel M, 2010, J PATHOL, V222, P191, DOI 10.1002/path.2744; Kobel M, 2010, AM J SURG PATHOL, V34, P984, DOI 10.1097/PAS.0b013e3181e1a3bb; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kobel M, 2010, GYNECOL ONCOL, V116, P50, DOI 10.1016/j.ygyno.2009.09.029; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kobel M, 2009, AM J SURG PATHOL, V33, P14, DOI 10.1097/PAS.0b013e3181788546; Kommoss S, 2013, HISTOPATHOLOGY; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Kuo KT, 2010, CLIN CANCER RES, V16, P1997, DOI 10.1158/1078-0432.CCR-09-2105; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; LAGRENADE A, 1988, HUM PATHOL, V19, P1080, DOI 10.1016/S0046-8177(88)80090-X; Laury AR, 2011, AM J SURG PATHOL, V35, P1759, DOI 10.1097/PAS.0b013e318233b0f7; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Liu JS, 2004, MODERN PATHOL, V17, P75, DOI 10.1038/modpathol.3800017; Lu FI, 2012, INT J GYNECOL PATHOL, V31, P524, DOI 10.1097/PGP.0b013e31824fe2aa; Mackay HJ, 2010, INT J GYNECOL CANCER, V20, P945, DOI 10.1111/IGC.0b013e3181dd0110; Madore J, 2010, J PATHOL, V220, P392, DOI 10.1002/path.2659; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; McAlpine JN, 2012, MODERN PATHOL, V25, P740, DOI 10.1038/modpathol.2011.211; McAlpine JN, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-433; McBride DJ, 2012, J PATHOL; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; McConechy MK, 2012, J PATHOL, V228, P20, DOI 10.1002/path.4056; McGuire V, 2002, GYNECOL ONCOL, V84, P399, DOI 10.1006/gyno.2001.6536; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Prowse AH, 2006, INT J CANCER, V119, P556, DOI 10.1002/ijc.21845; Quirk JT, 2005, GYNECOL ONCOL, V97, P519, DOI 10.1016/j.ygyno.2005.02.007; Rahman MT, 2012, CANCER-AM CANCER SOC, V118, P2846, DOI 10.1002/cncr.26598; Razzouk K, 2007, GYNECOL OBSTET INVES, V63, P140, DOI 10.1159/000096437; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; SAKAMOTO A, 1994, GYNECOL ONCOL, V54, P54, DOI 10.1006/gyno.1994.1165; Schiavone MB, 2011, AM J OBSTET GYNECOL, V205; Schmeler KM, 2008, GYNECOL ONCOL, V108, P510, DOI 10.1016/j.ygyno.2007.11.013; Seidman JD, 2008, ARCH PATHOL LAB MED, V132, P1753, DOI 10.1043/1543-2165-132.11.1753; Shaw PA, 2002, INT J GYNECOL PATHOL, V21, P407, DOI 10.1097/00004347-200210000-00011; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Soslow RA, 2008, INT J GYNECOL PATHOL, V27, P161, DOI 10.1097/PGP.0b013e31815ea812; Spowart JE, 2012, J PATHOL; Storey DJ, 2008, CANCER-AM CANCER SOC, V112, P2211, DOI 10.1002/cncr.23438; Swenerton KD, 2011, ANN ONCOL, V22, P341, DOI 10.1093/annonc/mdq383; Tan DSP, 2011, CLIN CANCER RES, V17, P1521, DOI 10.1158/1078-0432.CCR-10-1688; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Taverna P, 2000, CANCER CHEMOTH PHARM, V46, P507, DOI 10.1007/s002800000186; Thomas EJ, 2000, GYNECOL OBSTET INVES, V50, P44, DOI 10.1159/000052878; Thomas EJ, 2000, GYNECOL OBSTET INVES, V50, P2, DOI 10.1159/000052872; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Warnick CT, 2001, J BIOL CHEM, V276, P27363, DOI 10.1074/jbc.M103088200; Wei JJ, 2011, INT J GYNECOL PATHOL, V30, P553, DOI 10.1097/PGP.0b013e31821f4b85; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yamamoto S, 2012, MODERN PATHOL, V25, P122, DOI 10.1038/modpathol.2011.143; Yamamoto S, 2011, MODERN PATHOL, V24, P1146, DOI 10.1038/modpathol.2011.70; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8	92	179	182	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e72162	10.1371/journal.pone.0072162	http://dx.doi.org/10.1371/journal.pone.0072162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023729	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600013
J	Kato, T; Thompson, JR; Park, EY				Kato, Tatsuya; Thompson, James R.; Park, Enoch Y.			Construction of New Ligation-Independent Cloning Vectors for the Expression and Purification of Recombinant Proteins in Silkworms Using BmNPV Bacmid System	PLOS ONE			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; TRIGLYCERIDE TRANSFER PROTEIN; MICROSOMAL TRIGLYCERIDE; ESCHERICHIA-COLI; DISULFIDE-ISOMERASE; MEMBRANE-PROTEINS; COEXPRESSION; COMPLEX; SCALE; SET	A ligation independent cloning (LIC) system has been developed to facilitate the rapid and high-efficiency cloning of genes in a Bombyx mori expression system. This system was confirmed by the expression of human microsomal triglyceride transfer protein (hMTP) fused with EGFP in silkworm larvae and pupae. Moreover, hMTP and human protein disulfide isomerase (hPDI) genes were inserted into two LIC vectors harboring gcLINK sequences and were combined by using the LIC through gcLINK sequences. The constructed vector was incorporated into the Bombyx mori nucleopolyhedrovirus (BmNPV) bacmid, and injected into silkworm larvae. The expressed hMTP-hPDI complex was purified from the fat bodies of silkworm larvae. This LIC vector system was applied to express the E1, E2, and E3 subunits of human alpha-ketoglutarate dehydrogenase (KGDH) in silkworm larvae. The expressed proteins were purified easily from fat bodies using three different affinity chromatography steps. The LIC vectors constructed as described in this report allow for the rapid expression and purification of recombinant proteins or their complexes by using the BmNPV bacmid system.	[Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Biotechnol Lab,Suruga Ku, Shizuoka 4228529, Japan; [Thompson, James R.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Park, Enoch Y.] Shizuoka Univ, Grad Sch Sci & Technol, Lab Biotechnol Integrated Biosci Sect, Suruga Ku, Shizuoka, Japan; [Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Suruga Ku, Shizuoka, Japan	Shizuoka University; Mayo Clinic; Shizuoka University; Shizuoka University	Park, EY (corresponding author), Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Biotechnol Lab,Suruga Ku, Shizuoka 4228529, Japan.	acypark@ipc.shizuoka.ac.jp	Park, Enoch/AAU-2614-2020; Kato, Tatsuya/E-3095-2010	Kato, Tatsuya/0000-0001-7990-2557; Park, Enoch Y./0000-0002-7840-1424	Japan Society for the Promotion of Science (JSPS), Japan; Promotion of Nanobio-technology Research to support aging and welfare society from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion of Nanobio-technology Research to support aging and welfare society from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported partly by Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Japan Society for the Promotion of Science (JSPS), Japan, and funded partly by Promotion of Nanobio-technology Research to support aging and welfare society from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2004, MOL CELL PROTEOMICS, V3, P934, DOI 10.1074/mcp.T400008-MCP200; Alzari PM, 2006, ACTA CRYSTALLOGR D, V62, P1103, DOI 10.1107/S0907444906029775; Aoki T, 1996, FEBS LETT, V384, P193, DOI 10.1016/0014-5793(96)00289-X; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1114, DOI 10.1107/S0907444906029805; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bardoczy V, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-32; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; Chanda PK, 2006, PROTEIN EXPRES PURIF, V47, P217, DOI 10.1016/j.pep.2005.10.019; Du DN, 2009, MOL BIOTECHNOL, V43, P154, DOI 10.1007/s12033-009-9183-7; HAUN RS, 1992, GENE, V112, P37, DOI 10.1016/0378-1119(92)90300-E; Hsu TA, 1997, BIOTECHNOL PROGR, V13, P96, DOI 10.1021/bp960088d; Huo J, 2010, PROTEIN EXPRES PURIF, V72, P95, DOI 10.1016/j.pep.2010.01.014; Lamberg A, 1996, BIOCHEM J, V315, P533, DOI 10.1042/bj3150533; Lee J, 2009, PROTEIN EXPRES PURIF, V63, P58, DOI 10.1016/j.pep.2008.09.005; Li M, 2009, J MOL BIOL, V385, P820, DOI 10.1016/j.jmb.2008.11.021; McLain AL, 2011, FREE RADICAL RES, V45, P29, DOI 10.3109/10715762.2010.534163; Motohashi T, 2005, BIOCHEM BIOPH RES CO, V326, P564, DOI 10.1016/j.bbrc.2004.11.060; Qin HJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-51; Ritchie PJ, 1999, BIOCHEM J, V338, P305, DOI 10.1042/0264-6021:3380305; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Shi QL, 2011, J BIOL CHEM, V286, P17640, DOI 10.1074/jbc.M110.203018; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WETTERAU JR, 1985, CHEM PHYS LIPIDS, V38, P205, DOI 10.1016/0009-3084(85)90068-4; Zhou YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022224	26	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e64007	10.1371/journal.pone.0064007	http://dx.doi.org/10.1371/journal.pone.0064007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675518	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400059
J	Wang, YL; Wang, YJ; Luan, JB; Yan, GH; Liu, SS; Wang, XW				Wang, Yong-Liang; Wang, Yu-Jun; Luan, Jun-Bo; Yan, Gen-Hong; Liu, Shu-Sheng; Wang, Xiao-Wei			Analysis of the Transcriptional Differences between Indigenous and Invasive Whiteflies Reveals Possible Mechanisms of Whitefly Invasion	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; SUPEROXIDE-DISMUTASE GENE; INSECTICIDE RESISTANCE; ALEYRODIDAE BIOTYPES; B-BIOTYPE; EXPRESSION; DIVERGENCE; ADAPTATION; GENNADIUS; CATALASE	Background: The whitefly Bemisa tabaci is a species complex of more than 31 cryptic species which include some of the most destructive invasive pests of crops worldwide. Among them, Middle East-Asia Minor 1 (MEAM1) and Mediterranean have invaded many countries and displaced the native whitefly species. The successful invasion of the two species is largely due to their wide range of host plants, high resistance to insecticides and remarkable tolerance to environmental stresses. However, the molecular differences between invasive and indigenous whiteflies remain largely unknown. Methodology/Principal Findings: Here the global transcriptional difference between the two invasive whitefly species (MEAM1, MED) and one indigenous whitefly species (Asia II 3) were analyzed using the Illumina sequencing. Our analysis indicated that 2,422 genes between MEAM1 and MED; 3,073 genes between MEAM1 and Asia II 3; and 3,644 genes between MED and Asia II 3 were differentially expressed. Gene Ontology enrichment analysis revealed that the differently expressed genes between the invasive and indigenous whiteflies were significantly enriched in the term of 'oxidoreductase activity'. Pathway enrichment analysis showed that carbohydrate, amino acid and glycerolipid metabolisms were more active in MEAM1 and MED than in Asia II 3, which may contribute to their differences in biological characteristics. Our analysis also illustrated that the majority of genes involved in 'drug metabolic pathway' were expressed at a higher level in MEAM1 and MED than in Asia II 3. Taken together, these results revealed that the genes related to basic metabolism and detoxification were expressed at an elevated level in the invasive whiteflies, which might be responsible for their higher resistance to insecticides and environmental stresses. Conclusions/Significance: The extensive comparison of MEAM1, MED and Asia II 3 gene expression may serve as an invaluable resource for revealing the molecular mechanisms underlying their biological differences and the whitefly invasion.	[Wang, Yong-Liang; Wang, Yu-Jun; Luan, Jun-Bo; Yan, Gen-Hong; Liu, Shu-Sheng; Wang, Xiao-Wei] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University	Liu, SS (corresponding author), Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China.	shshliu@zju.edu.cn; xwwang@zju.edu.cn	Chen, kewei/P-6304-2015	Chen, kewei/0000-0001-8497-3069	National Natural Science Foundation of China [31272104, 31171848]; National Basic Research Program of China [2009CB119203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	Financial support for this study was provided by the National Natural Science Foundation of China (Project 31272104, 31171848) and the National Basic Research Program of China (Project 2009CB119203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2011, ARCH INSECT BIOCHEM, V78, P104, DOI 10.1002/arch.20444; Alemandri V, 2012, J ECON ENTOMOL, V105, P48, DOI 10.1603/EC11161; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barro P, 2007, AUST J ENTOMOL, V36, P149; BEENAKKE.AM, 1969, J INSECT PHYSIOL, V15, P353, DOI 10.1016/0022-1910(69)90281-9; BOLTER CJ, 1990, PESTIC BIOCHEM PHYS, V36, P52, DOI 10.1016/0048-3575(90)90020-3; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Byrne FJ, 2003, PEST MANAG SCI, V59, P347, DOI 10.1002/ps.649; Carabali A, 2005, CROP PROT, V24, P643, DOI 10.1016/j.cropro.2004.11.008; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Crowder DW, 2011, BASIC APPL ECOL, V12, P685, DOI 10.1016/j.baae.2011.09.007; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Crowder DW, 2010, ANIM BEHAV, V79, P579, DOI 10.1016/j.anbehav.2009.11.025; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; FELTON GW, 1991, J CHEM ECOL, V17, P1715, DOI 10.1007/BF00993724; Fernandez E, 2009, PEST MANAG SCI, V65, P885, DOI 10.1002/ps.1769; Gao XL, 2013, INT J MOL SCI, V14, P871, DOI 10.3390/ijms14010871; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Horowitz AR, 2003, PHYTOPARASITICA, V31, P94, DOI 10.1007/BF02979772; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; LARDY HA, 1969, ANNU REV BIOCHEM, V38, P991, DOI 10.1146/annurev.bi.38.070169.005015; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li JM, 2011, ARCH INSECT BIOCHEM, V77, P118, DOI 10.1002/arch.20428; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Marchioro CA, 2012, AGR FOREST ENTOMOL, V14, P29, DOI 10.1111/j.1461-9563.2011.00548.x; McKenzie CL, 2009, J ECON ENTOMOL, V102, P670, DOI 10.1603/029.102.0227; McKenzie CL, 2012, J ECON ENTOMOL, V105, P753, DOI 10.1603/EC11337; Naranjo Steven E., 2010, P185; Neves CA, 2000, DIS AQUAT ORGAN, V39, P155, DOI 10.3354/dao039155; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Parker JD, 2004, INSECT MOL BIOL, V13, P587, DOI 10.1111/j.0962-1075.2004.00515.x; Parrella G, 2012, J PEST SCI, V85, P227, DOI 10.1007/s10340-012-0417-2; Pavey SA, 2010, ANN NY ACAD SCI, V1206, P110, DOI 10.1111/j.1749-6632.2010.05765.x; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Qiu Bao-Li, 2003, Acta Entomologica Sinica, V46, P605; Rao Q, 2011, B ENTOMOL RES, V101, P81, DOI 10.1017/S0007485310000428; Rao Q, 2012, J INTEGR AGR, V11, P321, DOI 10.1016/S2095-3119(12)60016-1; Shin S, 2012, J EXP BOT, V63, P4731, DOI 10.1093/jxb/ers141; Sun DB, 2013, B ENTOMOL RES, V103, P344, DOI 10.1017/S0007485312000788; Sun W, 2012, INSECT BIOCHEM MOLEC, V42, P935, DOI 10.1016/j.ibmb.2012.09.006; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Wan FH, 2008, J INSECT SCI, V8, P49; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wu XX, 2003, PROG NAT SCI-MATER, V13, P276, DOI 10.1360/03jz9049; Yoo HY, 1999, MOL GEN GENET, V262, P310, DOI 10.1007/s004380051088; Yoshinaga N, 2010, J CHEM ECOL, V36, P319, DOI 10.1007/s10886-010-9764-8; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x; Zang LianSheng, 2005, Biodiversity Science, V13, P181, DOI 10.1360/biodiv.040202	72	13	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62176	10.1371/journal.pone.0062176	http://dx.doi.org/10.1371/journal.pone.0062176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	24015315	gold, Green Submitted, Green Published			2022-12-27	WOS:000319055600017
J	Harris, SE; Munshi-South, J; Obergfell, C; O'Neill, R				Harris, Stephen E.; Munshi-South, Jason; Obergfell, Craig; O'Neill, Rachel			Signatures of Rapid Evolution in Urban and Rural Transcriptomes of White-Footed Mice (Peromyscus leucopus) in the New York Metropolitan Area	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; GENOME-WIDE SCANS; NEXT-GENERATION; POPULATION GENOMICS; POSITIVE SELECTION; AIR-POLLUTION; GENETIC DIFFERENTIATION; PARUS-MAJOR; SEQUENCE; URBANIZATION	Urbanization is a major cause of ecological degradation around the world, and human settlement in large cities is accelerating. New York City (NYC) is one of the oldest and most urbanized cities in North America, but still maintains 20% vegetation cover and substantial populations of some native wildlife. The white-footed mouse, Peromyscus leucopus, is a common resident of NYC's forest fragments and an emerging model system for examining the evolutionary consequences of urbanization. In this study, we developed transcriptomic resources for urban P. leucopus to examine evolutionary changes in protein-coding regions for an exemplar "urban adapter." We used Roche 454 GS FLX+ high throughput sequencing to derive transcriptomes from multiple tissues from individuals across both urban and rural populations. From these data, we identified 31,015 SNPs and several candidate genes potentially experiencing positive selection in urban populations of P. leucopus. These candidate genes are involved in xenobiotic metabolism, innate immune response, demethylation activity, and other important biological phenomena in novel urban environments. This study is one of the first to report candidate genes exhibiting signatures of directional selection in divergent urban ecosystems.	[Harris, Stephen E.] CUNY, Grad Ctr, Program Ecol Evolutionary Biol & Behav, New York, NY USA; [Munshi-South, Jason] Fordham Univ, Louis Calder Ctr, Armonk, NY USA; [Obergfell, Craig; O'Neill, Rachel] Univ Connecticut, Storrs, CT USA	City University of New York (CUNY) System; Fordham University; University of Connecticut	Munshi-South, J (corresponding author), Fordham Univ, Louis Calder Ctr, Armonk, NY USA.	jason@NYCevolution.org	Fitzsimmons, Lauren P/H-5530-2012	Munshi-South, Jason/0000-0002-8067-4341	National Science Foundation [DEB 0817259]; National Institute of General Medical Sciences/National Institutes of Health [1R15GM099055-01A1]; National Science Foundation Graduate Research Fellowship; Center for Applied Genetics and Technology at UCONN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM099055] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Center for Applied Genetics and Technology at UCONN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the National Science Foundation (DEB 0817259) and National Institute of General Medical Sciences/National Institutes of Health (1R15GM099055-01A1) to JMS, and a National Science Foundation Graduate Research Fellowship to SEH. The Center for Applied Genetics and Technology at UCONN provided funding for RO and CO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2012, HUM GENET, V131, P1541, DOI 10.1007/s00439-012-1213-z; Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299; Babik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-390; Baldo L, 2011, GENOME BIOL EVOL, V3, P443, DOI 10.1093/gbe/evr047; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barko VA, 2003, SOUTHEAST NAT, V2, P369, DOI 10.1656/1528-7092(2003)002[0369:UHADOW]2.0.CO;2; Becker J, 2011, J BIOTECHNOL, V156, P227, DOI 10.1016/j.jbiotec.2011.09.014; Bjorklund M, 2010, BIOL J LINN SOC, V99, P9, DOI 10.1111/j.1095-8312.2009.01335.x; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; BLANKENBERG D, 2010, CURRENT PROTOC MOL B, V89, P42727; Boitard S, 2012, MOL BIOL EVOL, V29, P2177, DOI 10.1093/molbev/mss090; Bonin A, 2008, MOL ECOL, V17, P3583, DOI 10.1111/j.1365-294X.2008.03854.x; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brady SP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00235; BUNTGE A, 2010, RACING SIGNATURES PO; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; CHAPPLE R, 2012, DEV LIVER TRANSCRIPT; Cheptou PO, 2008, P NATL ACAD SCI USA, V105, P3796, DOI 10.1073/pnas.0708446105; Chrast R, 2000, GENOME RES, V10, P2006, DOI 10.1101/gr.10.12.2006; CHRISTODOULOU DC, 2011, CURR PROTOC MOL BIOL, V4, P1, DOI DOI 10.1002/0471142727.MB0412S94.C0NSTRUCTI0N; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; de Carvalho JF, 2013, HEREDITY, V110, P181, DOI 10.1038/hdy.2012.76; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; Degner JF, 2007, CONSERV GENET, V8, P1441, DOI 10.1007/s10592-007-9295-1; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ekblom Robert, 2012, Comparative and Functional Genomics, P281693, DOI 10.1155/2012/281693; EKERNAS LS, 2007, T LINNAEAN SOC NEW Y, V10, P239; Ellegren H, 2008, MOL ECOL, V17, P1629, DOI 10.1111/j.1365-294X.2008.03699.x; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Francis RA, 2012, APPL GEOGR, V32, P514, DOI 10.1016/j.apgeog.2011.06.013; Fu CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-208; Glenn JLW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-300; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gompert Z, 2011, GENETICS, V187, P903, DOI 10.1534/genetics.110.124693; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hoffman JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023283; Hohenlohe PA, 2010, INT J PLANT SCI, V171, P1059, DOI 10.1086/656306; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; Janssens TKS, 2009, INSECT SCI, V16, P3, DOI 10.1111/j.1744-7917.2009.00249.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; LANKAU R, 2010, ANNU REV ECOL EVOL S, V42, P335, DOI DOI 10.1146/ANNUREV-EC0LSYS-102710-145100; Lankau RA, 2011, EVOL APPL, V4, P338, DOI 10.1111/j.1752-4571.2010.00173.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnen CR, 2009, COLD SH Q B, V74, P155, DOI 10.1101/sqb.2009.74.045; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; MacManes MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045524; Malik A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021227; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058020; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; METZGAR LH, 1971, AM MIDL NAT, V86, P434, DOI 10.2307/2423635; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mlynarski EE, 2010, MAMM GENOME, V21, P77, DOI 10.1007/s00335-009-9242-1; Montoya-Burgos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024800; Mueller JC, 2013, MOL ECOL, V22, P3629, DOI 10.1111/mec.12288; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Munshi-South J, 2012, MOL ECOL, V21, P1360, DOI 10.1111/j.1365-294X.2012.05476.x; Munshi-South J, 2010, MOL ECOL, V19, P4242, DOI 10.1111/j.1365-294X.2010.04816.x; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Nupp TE, 1996, CAN J ZOOL, V74, P467, DOI 10.1139/z96-054; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; ONEILL R, 1998, SEQUENCING GENOME PE, P14; Ozer F, 2011, MOL ECOL, V20, P3525, DOI 10.1111/j.1365-294X.2011.05165.x; Peluc SI, 2008, BEHAV ECOL, V19, P830, DOI 10.1093/beheco/arn033; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Pontius J., 2003, NCBI HDB, P1; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Puth LM, 2009, DIVERS DISTRIB, V15, P12, DOI 10.1111/j.1472-4642.2008.00499.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramsdell CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-65; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Rice AM, 2011, ECOL LETT, V14, P9, DOI 10.1111/j.1461-0248.2010.01546.x; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Santure AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-283; Shaw TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048472; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sloan DB, 2012, MOL ECOL RESOUR, V12, P333, DOI 10.1111/j.1755-0998.2011.03079.x; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Somers CM, 2009, HUM GENET, V125, P119, DOI 10.1007/s00439-008-0613-6; Somers CM, 2002, P NATL ACAD SCI USA, V99, P15904, DOI 10.1073/pnas.252499499; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Storz JF, 2007, J MAMMAL, V88, P1, DOI 10.1644/06-MAMM-S-232R1.1; Su T, 2004, TOXICOL APPL PHARM, V199, P285, DOI 10.1016/j.taap.2003.11.029; Sun J, 2012, MOL ECOL RESOUR, V12, P1133, DOI 10.1111/1755-0998.12014; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Turner LM, 2008, GENETICS, V179, P2075, DOI 10.1534/genetics.107.085902; Ungerer MC, 2008, HEREDITY, V100, P178, DOI 10.1038/sj.hdy.6800992; Ungvari Z, 2008, AGE, V30, P121, DOI 10.1007/s11357-008-9059-y; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vessey SH, 2007, INTEGR ZOOL, V2, P123, DOI 10.1111/j.1749-4877.2007.00053.x; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wandeler P, 2003, MOL ECOL, V12, P647, DOI 10.1046/j.1365-294X.2003.01768.x; Wang GM, 2009, POPUL ECOL, V51, P133, DOI 10.1007/s10144-008-0094-4; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; White JG, 2005, LANDSCAPE URBAN PLAN, V71, P123, DOI 10.1016/j.landurbplan.2004.02.006; Whitehead A, 2010, MOL ECOL, V19, P5186, DOI 10.1111/j.1365-294X.2010.04829.x; Wirgin I, 2011, SCIENCE, V331, P1322, DOI 10.1126/science.1197296; World Bank, 2015, LEVERAGING URBANIZAT; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yang DS, 2009, MOL ECOL, V18, P5115, DOI 10.1111/j.1365-294X.2009.04399.x; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105; Zhai WW, 2012, MOL BIOL EVOL, V29, P2889, DOI 10.1093/molbev/mss104; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	134	70	69	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e74938	10.1371/journal.pone.0074938	http://dx.doi.org/10.1371/journal.pone.0074938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	23935965	Green Published, gold			2022-12-27	WOS:000323733800116
J	Hill, DK; Orton, MR; Mariotti, E; Boult, JKR; Panek, R; Jafar, M; Parkes, HG; Jamin, Y; Miniotis, MF; Al-Saffar, NMS; Beloueche-Babari, M; Robinson, SP; Leach, MO; Chung, YL; Eykyn, TR				Hill, Deborah K.; Orton, Matthew R.; Mariotti, Erika; Boult, Jessica K. R.; Panek, Rafal; Jafar, Maysam; Parkes, Harold G.; Jamin, Yann; Miniotis, Maria Falck; Al-Saffar, Nada M. S.; Beloueche-Babari, Mounia; Robinson, Simon P.; Leach, Martin O.; Chung, Yuen-Li; Eykyn, Thomas R.			Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized C-13 Magnetic Resonance Spectroscopy Data	PLOS ONE			English	Article							TO-NOISE RATIO; ANTICANCER AGENTS; BRAIN-TUMORS; CANCER; PYRUVATE; LACTATE; NMR; METABOLISM; EXCHANGE; INHIBITION	Real-time detection of the rates of metabolic flux, or exchange rates of endogenous enzymatic reactions, is now feasible in biological systems using Dynamic Nuclear Polarization Magnetic Resonance. Derivation of reaction rate kinetics from this technique typically requires multi-compartmental modeling of dynamic data, and results are therefore model-dependent and prone to misinterpretation. We present a model-free formulism based on the ratio of total areas under the curve (AUC) of the injected and product metabolite, for example pyruvate and lactate. A theoretical framework to support this novel analysis approach is described, and demonstrates that the AUC ratio is proportional to the forward rate constant k. We show that the model-free approach strongly correlates with k for whole cell in vitro experiments across a range of cancer cell lines, and detects response in cells treated with the pan-class I PI3K inhibitor GDC-0941 with comparable or greater sensitivity. The same result is seen in vivo with tumor xenograft-bearing mice, in control tumors and following drug treatment with dichloroacetate. An important finding is that the area under the curve is independent of both the input function and of any other metabolic pathways arising from the injected metabolite. This model-free approach provides a robust and clinically relevant alternative to kinetic model-based rate measurements in the clinical translation of hyperpolarized C-13 metabolic imaging in humans, where measurement of the input function can be problematic.	[Hill, Deborah K.; Orton, Matthew R.; Boult, Jessica K. R.; Panek, Rafal; Jafar, Maysam; Parkes, Harold G.; Jamin, Yann; Miniotis, Maria Falck; Al-Saffar, Nada M. S.; Beloueche-Babari, Mounia; Robinson, Simon P.; Leach, Martin O.; Chung, Yuen-Li; Eykyn, Thomas R.] Inst Canc Res, CR UK, Canc Imaging Ctr, Div Radiotherapy & Imaging, Sutton, Surrey, England; [Hill, Deborah K.; Orton, Matthew R.; Boult, Jessica K. R.; Panek, Rafal; Jafar, Maysam; Parkes, Harold G.; Jamin, Yann; Miniotis, Maria Falck; Al-Saffar, Nada M. S.; Beloueche-Babari, Mounia; Robinson, Simon P.; Leach, Martin O.; Chung, Yuen-Li; Eykyn, Thomas R.] Inst Canc Res, EPSRC, Canc Imaging Ctr, Div Radiotherapy & Imaging, Sutton, Surrey, England; [Hill, Deborah K.; Orton, Matthew R.; Boult, Jessica K. R.; Panek, Rafal; Jafar, Maysam; Parkes, Harold G.; Jamin, Yann; Miniotis, Maria Falck; Al-Saffar, Nada M. S.; Beloueche-Babari, Mounia; Robinson, Simon P.; Leach, Martin O.; Chung, Yuen-Li; Eykyn, Thomas R.] Royal Marsden NHS Trust, Sutton, Surrey, England; [Mariotti, Erika; Eykyn, Thomas R.] St Thomas Hosp, Div Imaging Sci & Biomed Engn, Kings Coll London, London, England	University of London; Institute of Cancer Research - UK; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Leach, MO (corresponding author), Inst Canc Res, CR UK, Canc Imaging Ctr, Div Radiotherapy & Imaging, Sutton, Surrey, England.	martin.leach@icr.ac.uk; thomas.eykyn@icr.ac.uk	leach, martin o/C-2248-2008; Chung, Yuen-Li/K-2269-2019; Eykyn, Thomas/J-3284-2016; Parkes, Harold G/I-7412-2012	leach, martin o/0000-0002-0756-5368; Chung, Yuen-Li/0000-0003-0807-1658; Eykyn, Thomas/0000-0003-1768-3808; Robinson, Simon/0000-0003-4101-7274; Li Wai Suen, Connie/0000-0003-0529-0804; Hill, Danika/0000-0001-6284-7061; Panek, Rafal/0000-0002-9432-6698; Hill, Deborah/0000-0002-6441-5489; Chiu, Yu Ho Chris/0000-0002-5380-1114; Parkes, Harold/0000-0003-4981-864X; Jamin, yann/0000-0003-0350-3757; Eriksson, Emily/0000-0002-7851-973X	Cancer Research UK [C1060/A6916]; EPSRC Cancer Imaging Centre; NHS; Marie Curie Action: Early Stage Training [MEST-CT-2005 020718]; EPSRC platform [EP/H046526/1]; MRC; Department of Health (England) [C1060/A10334]; Cancer Research UK [16464] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H046526/1] Funding Source: researchfish; Medical Research Council [G0701533] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10162] Funding Source: researchfish; EPSRC [EP/H046526/1] Funding Source: UKRI; MRC [G0701533] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NHS; Marie Curie Action: Early Stage Training; EPSRC platform(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by the Cancer Research UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) (refs C1060/A10334). The authors acknowledge NHS Funding to the NIHR Biomedical Research Centre. MFM and MBB acknowledge funding from Cancer Research UK (grant C1060/A6916), Marie Curie Action: Early Stage Training (grant MEST-CT-2005 020718), and EPSRC platform (grant EP/H046526/1). MOL is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Beloueche-Babari M, 2011, CELL CYCLE, V10, P2883, DOI 10.4161/cc.10.17.17192; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Coen M, 2008, CHEM RES TOXICOL, V21, P9, DOI 10.1021/tx700335d; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; HaasKogan DA, 1996, INT J RADIAT ONCOL, V36, P95, DOI 10.1016/S0360-3016(96)00244-1; Harris T, 2009, P NATL ACAD SCI USA, V106, P18131, DOI 10.1073/pnas.0909049106; Harrison C, 2012, NMR BIOMED, V25, P1286, DOI 10.1002/nbm.2801; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Kazan SM, 2012, MAGN RESON MED; Keshari KR, 2013, CANCER RES, V73, P529, DOI 10.1158/0008-5472.CAN-12-3461; Keshari KR, 2010, MAGN RESON MED, V63, P322, DOI 10.1002/mrm.22225; Kettunen MI, 2012, MAGN RESON MED; Koelsch BL, 2013, ANALYST, V138, P1011, DOI 10.1039/c2an36715g; Larson PEZ, 2012, J MAGN RESON, V225, P71, DOI 10.1016/j.jmr.2012.09.014; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Menichetti L, 2012, CONTRAST MEDIA MOL I, V7, P85, DOI 10.1002/cmmi.480; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Park JM, 2012, MAGN RESON MED, V68, P1886, DOI 10.1002/mrm.24181; Peet AC, 2012, NAT REV CLIN ONCOL, V9, P700, DOI 10.1038/nrclinonc.2012.187; Santarelli MF, 2012, NMR BIOMED, V25, P925, DOI 10.1002/nbm.1813; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; von Morze C, 2011, J MAGN RESON IMAGING, V33, P692, DOI 10.1002/jmri.22484; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zierhut ML, 2010, J MAGN RESON, V202, P85, DOI 10.1016/j.jmr.2009.10.003	31	133	133	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e71996	10.1371/journal.pone.0071996	http://dx.doi.org/10.1371/journal.pone.0071996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023724	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600010
J	McGarry, LJ; Krishnarajah, G; Hill, G; Skornicki, M; Pruttivarasin, N; Masseria, C; Arondekar, B; Pelton, SI; Weinstein, MC				McGarry, Lisa J.; Krishnarajah, Girishanthy; Hill, Gregory; Skornicki, Michelle; Pruttivarasin, Narin; Masseria, Cristina; Arondekar, Bhakti; Pelton, Stephen I.; Weinstein, Milton C.			Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; VACCINE; POPULATION; AGE; US	Objectives: Health benefits and costs of combined reduced-antigen-content tetanus, diphtheria, and pertussis (Tdap) immunization among adults >= 65 years have not been evaluated. In February 2012, the Advisory Committee on Immunization Practices (ACIP) recommended expanding Tdap vaccination (one single dose) to include adults >= 65 years not previously vaccinated with Tdap. Our study estimated the health and economic outcomes of one-time replacement of the decennial tetanus and diphtheria (Td) booster with Tdap in the 10% of individuals aged 65 years assumed eligible each year compared with a baseline scenario of continued Td vaccination. Methods: We constructed a model evaluating the cost-effectiveness of vaccinating a cohort of adults aged 65 with Tdap, by calculating pertussis cases averted due to direct vaccine effects only. Results are presented from societal and payer perspectives for a range of pertussis incidences (25-200 cases per 100,000), due to the uncertainty in estimating true annual incidence. Cases averted were accrued throughout the patient's lifetime, and a probability tree used to estimate the clinical outcomes and costs (US$ 2010) for each case. Quality-adjusted life-years (QALYs) lost to acute disease were calculated by multiplying cases of mild/moderate/severe pertussis by the associated health-state disutility; QALY losses due to death and long-term sequelae were also considered. Incremental costs and QALYs were summed over the cohort to derive incremental cost-effectiveness ratios. Scenario analyses evaluated the effect of alternative plausible parameter estimates on results. Results: At incidence levels of 25, 100, 200 cases/100,000, vaccinating adults aged 65 years costs an additional $336,000, $63,000 and $17,000/QALY gained, respectively. Vaccination has a cost-effectiveness ratio less than $50,000/QALY if pertussis incidence is >116 cases/100,000 from societal and payer perspectives. Results were robust to scenario analyses. Conclusions: Tdap immunization of adults aged 65 years according to current ACIP recommendations is a cost-effective health-care intervention at plausible incidence assumptions.	[McGarry, Lisa J.; Hill, Gregory; Skornicki, Michelle; Pruttivarasin, Narin; Weinstein, Milton C.] OptumInsight, Cambridge, MA USA; [Krishnarajah, Girishanthy; Masseria, Cristina; Arondekar, Bhakti] GlaxoSmithKline, Philadelphia, PA USA; [Pelton, Stephen I.] Boston Univ, Boston, MA 02215 USA; [Weinstein, Milton C.] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA	Optum; GlaxoSmithKline; Boston University; Harvard University; Harvard T.H. Chan School of Public Health	McGarry, LJ (corresponding author), OptumInsight, Cambridge, MA USA.	lisa.mcgarry@ariad.com	Williams, Mathew/G-6140-2016	Williams, Mathew/0000-0001-6117-5208; Mitchard, Edward/0000-0002-5690-4055; Pelton, Stephen/0000-0003-4862-5344; Ryan, Casey/0000-0002-1802-0128	GSK	GSK(GlaxoSmithKline)	Funding for this research was provided by GSK. GSK employees listed as coauthors may have participated in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu B, 2004, HEALTH SERV RES, V39, P627, DOI 10.1111/j.1475-6773.2004.00248.x; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Bureau of Labor Statistics, 2011, CONS PRIC IND; California Department of Public Health, 2011, PERT REP FIG 5 PERT; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Centers for Disease Control and Prevention, 2012, ADV COMM IMM PRACT S; Centers for Disease Control and Prevention, 2011, PERT SUMM VACC REC; Centers for Disease Control and Prevention, 2011, SURV REP TRENDS; Centers for Disease Control and Prevention, 2010, VACC PRIC LIST; Centers for Disease Control and Prevention, 2012, ACIP PROV TDAP REC; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P13; Cortese MM, 2007, AM J PREV MED, V32, P177, DOI 10.1016/j.amepre.2006.10.015; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; de Vries R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013392; Gold MR, 1996, COST EFFECTIVENESS H; Grenfell B, 2011, P NATL ACAD SCI USA, V108, P7279, DOI 10.1073/pnas.1103408108; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989; McDowell Margaret A, 2009, Vital Health Stat 11, P1; Meltzer D, 1997, J HEALTH ECON, V16, P33, DOI 10.1016/S0167-6296(96)00507-3; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; O'Brien JA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-57; PDR Network LLC, 2010, RED BOOK PHARM FUND; Pellissier JM, 2007, VACCINE, V25, P8326, DOI 10.1016/j.vaccine.2007.09.066; Schmitt HJ, 1996, JAMA-J AM MED ASSOC, V275, P37, DOI 10.1001/jama.275.1.37; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; U.S. Bureau of Labor Statistics, 2011, CONS EXP SURV 2010 A; U. S. Bureau of the Census, 2009, AM COMM SURV; US Bureau of Labor Statistics, 2011, CURR POP SURV 2010; US Bureau of Labor Statistics, 2011, EMPL HOURS EARN CURR; Washington State Department of Health, 2012, WEEKL PERT PERT UPD; Wells CD, 2004, DIGEST DIS SCI, V49, P453, DOI 10.1023/B:DDAS.0000020502.46886.c1	35	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e67260	10.1371/journal.pone.0067260	http://dx.doi.org/10.1371/journal.pone.0067260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24069275	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200001
J	Li, X; Xu, F; Xie, L; Ji, YJ; Cheng, K; Zhou, QM; Wang, T; Shively, C; Wu, QY; Gong, W; Fang, L; Zhan, QL; Melgiri, ND; Xie, P				Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Shively, Carol; Wu, Qingyuan; Gong, Wei; Fang, Liang; Zhan, Qunlin; Melgiri, N. D.; Xie, Peng			Depression-Like Behavioral Phenotypes by Social and Social Plus Visual Isolation in the Adult Female Macaca fascicularis	PLOS ONE			English	Article							ANIMAL-MODELS; BODY-IMAGE; MACAQUES; THERMOREGULATION; ACTIVATION; ATTACHMENT; DISORDER; BRAIN; US	Major depressive disorder (MDD) is a debilitating psychiatric mood disorder that affects millions of individuals globally. Our understanding of the biological basis of MDD is poor, and current treatments are ineffective in a significant proportion of cases. This current situation may relate to the dominant rodent animal models of depression, which possess translational limitations due to limited homologies with humans. Therefore, a more homologous primate model of depression is needed to advance investigation into the pathophysiological mechanisms underlying depression and to conduct pre-clinical therapeutic trials. Here, we report two convenient methods - social isolation and social plus visual isolation - which can be applied to construct a non-human primate model of depression in the adult female cynomolgus monkey (Macaca fascicularis). Both social and social plus visual isolation were shown to be effective in inducing depression-like behavior by significantly reducing socially dominant aggressive conflict behavior, communicative behavior, sexual behavior, and parental behavior. The addition of visual isolation produced more profound behavioral changes than social isolation alone by further reducing parental behavior and sexual behavior. Thus, the degree of behavioral pathology may be manipulated by the degree of isolation. These methods can be applied to construct a non-human primate model of depression in order to assess physiological, behavioral, and social phenomena in a controlled laboratory setting.	[Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Melgiri, N. D.; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Melgiri, N. D.; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Zhan, Qunlin] Fifth Peoples Hosp, Dept Neurol, Chongqing, Peoples R China; [Shively, Carol] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA	Chongqing Medical University; Chongqing Medical University; Wake Forest University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Cheng, Ke/HCH-8846-2022; Shively, Carol/L-2921-2019	Wong, Frank Y./0000-0001-5835-9938	National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]; Chongqing Postdoctoral Science Foundation [XM20120010]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Postdoctoral Science Foundation	This work was supported by the National Basic Research Program of China (973 Program) (Grant NO. 2009CB918300), the National Natural Science Foundation of China (Grant NO. 31271189), the Chongqing Postdoctoral Science Foundation (Grant No. XM20120010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifulco A, 2004, BRIT J PSYCHIAT, V184, pS31, DOI 10.1192/bjp.184.46.s31; BROTHERS L, 1990, MOTIV EMOTION, V14, P81, DOI 10.1007/BF00991637; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Canales JZ, 2010, REV BRAS PSIQUIATR, V32, P375, DOI 10.1590/S1516-44462010000400010; CLARKE AS, 1988, INT J PRIMATOL, V9, P347, DOI 10.1007/BF02737382; Clarke AS, 2005, AM J PRIMATOL, V14, P37; Ehlers CL, 1989, ANIMAL MODELS DEPRES; Ellgring H, 1989, NONVERBAL COMMUNICAT, P168; Fava M, 1997, J NERV MENT DIS, V185, P140, DOI 10.1097/00005053-199703000-00002; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Gelenberg AJ, 2010, J CLIN PSYCHIAT, V71, P6; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; GOTTMAN JM, 1977, CHILD DEV, V48, P513, DOI 10.1111/j.1467-8624.1977.tb01191.x; Grippo AJ, 2007, PSYCHOSOM MED, V69, P149, DOI 10.1097/PSY.0b013e31802f054b; Hanya G, 2007, AM J PRIMATOL, V69, P802, DOI 10.1002/ajp.20397; HARLOW HF, 1974, BEHAV BIOL, V12, P273, DOI 10.1016/S0091-6773(74)91475-8; Hayward BA, 2007, INT J MENT HEALTH NU, V16, P15, DOI 10.1111/j.1447-0349.2006.00439.x; Helms CM, 2012, PSYCHOPHARMACOLOGY, V224, P133, DOI 10.1007/s00213-012-2707-z; Kennedy SH, 2009, J CLIN PSYCHOPHARM, V29, P157, DOI 10.1097/JCP.0b013e31819c76e9; Kim JW, 1996, BIOL PSYCHIAT, V40, P918, DOI 10.1016/0006-3223(95)00546-3; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Maestripieri D, 1997, EVOL COMMUN, V1, P193, DOI [10.1075/eoc.1.2.03mae, DOI 10.1075/E0C.1.2.03MAE]; Maestripieri D., 2005, GESTURE, V5, P57, DOI [DOI 10.1075/GEST.5.1.06MAE, 10.1075/gest.5.1.06mae]; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; Malkesman O, 2006, BEHAV BRAIN RES, V175, P408, DOI 10.1016/j.bbr.2006.09.017; Masayuki Nakamichi FC, 1990, PRIMATES, V31, P213; MAXIM PE, 1972, BRAIN RES, V42, P243, DOI 10.1016/0006-8993(72)90529-X; Michopoulos V, 2012, PSYCHONEUROENDOCRINO, V37, P1071, DOI 10.1016/j.psyneuen.2011.12.004; Nakamichi M, 2003, INT J PRIMATOL, V24, P607, DOI 10.1023/A:1023744515134; Noldus LPJJ, 2000, BEHAV RES METH INS C, V32, P197, DOI 10.3758/BF03200802; NOLES SW, 1985, J CONSULT CLIN PSYCH, V53, P88, DOI 10.1037/0022-006X.53.1.88; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; Rahaman H., 1968, Primates, V9, P259, DOI 10.1007/BF01730973; Reding K, 2012, HORM BEHAV, V62, P612, DOI 10.1016/j.yhbeh.2012.09.010; RUBIN KH, 1989, J PERS, V57, P237, DOI 10.1111/j.1467-6494.1989.tb00482.x; Rubin KH, 1998, SOCIAL NONSOCIAL PLA; Scaccianoce S, 2006, BEHAV BRAIN RES, V168, P323, DOI 10.1016/j.bbr.2005.04.024; SCHINO G, 1990, PHYSIOL BEHAV, V47, P1125, DOI 10.1016/0031-9384(90)90362-8; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Smolmsky AN, 2009, MOOD ANXIETY RELATED; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SWARTZ KB, 1982, J HUM EVOL, V11, P237, DOI 10.1016/S0047-2484(82)80039-0; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318; Tse WS, 2002, PSYCHOPHARMACOLOGY, V161, P324, DOI 10.1007/s00213-002-1049-7; Vollmayr B, 2007, EUR ARCH PSY CLIN N, V257, P300, DOI 10.1007/s00406-007-0734-2; Watson SL, 1998, ATHEROSCLEROSIS, V137, P259, DOI 10.1016/S0021-9150(97)00277-3; Willard SL, 2012, AM J PRIMATOL, V74, P528, DOI 10.1002/ajp.21013; Xu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037486	50	43	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73293	10.1371/journal.pone.0073293	http://dx.doi.org/10.1371/journal.pone.0073293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24086565	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600094
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400065
